PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hinkley, T; Martins, J; Chappey, C; Haddad, M; Stawiski, E; Whitcomb, JM; Petropoulos, CJ; Bonhoeffer, S				Hinkley, Trevor; Martins, Joao; Chappey, Colombe; Haddad, Mojgan; Stawiski, Eric; Whitcomb, Jeannette M.; Petropoulos, Christos J.; Bonhoeffer, Sebastian			A systems analysis of mutational effects in HIV-1 protease and reverse transcriptase	NATURE GENETICS			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DRUG-RESISTANCE; FITNESS; EPISTASIS; EVOLUTION; INHIBITORS; LANDSCAPE	The development of a quantitative understanding of viral evolution and the fitness landscape in HIV-1 drug resistance is a formidable challenge given the large number of available drugs and drug resistance mutations. We analyzed a dataset measuring the in vitro fitness of 70,081 virus samples isolated from HIV-1 subtype B infected individuals undergoing routine drug resistance testing. We assayed virus samples for in vitro replicative capacity in the absence of drugs as well as in the presence of 15 individual drugs. We employed a generalized kernel ridge regression to estimate main fitness effects and epistatic interactions of 1,859 single amino acid variants found within the HIV-1 protease and reverse transcriptase sequences. Models including epistatic interactions predict an average of 54.8% of the variance in replicative capacity across the 16 different environments and substantially outperform models based on main fitness effects only. We find that the fitness landscape of HIV-1 protease and reverse transcriptase is characterized by strong epistasis.	[Hinkley, Trevor; Martins, Joao; Bonhoeffer, Sebastian] ETH, Inst Integrat Biol, Zurich, Switzerland; [Chappey, Colombe; Haddad, Mojgan; Stawiski, Eric; Whitcomb, Jeannette M.; Petropoulos, Christos J.] Monogram Biosci, San Francisco, CA USA	Swiss Federal Institutes of Technology Domain; ETH Zurich	Bonhoeffer, S (corresponding author), ETH, Inst Integrat Biol, Zurich, Switzerland.	cpetropoulos@monogrambio.com; sebastian.bonhoeffer@env.ethz.ch	Bonhoeffer, Sebastian/A-2735-2008; Martins, Joao/P-4795-2019	Bonhoeffer, Sebastian/0000-0001-8052-3925; Martins, Joao/0000-0001-7961-4280	Swiss National Science Foundation [NF 3100A0-116408]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	T.H., J.M. and S.B. thank the Swiss National Science Foundation (NF 3100A0-116408) for financial support. We thank R. Regos, R. Kouyos, J. Engelstadter, S. Alizon and T. Gernhard-Stadler for valuable comments and critical reading of the manuscript.	Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Candes E, 2007, ANN STAT, V35, P2313, DOI 10.1214/009053606000001523; Chen LM, 2004, J VIROL, V78, P3722, DOI 10.1128/JVI.78.7.3722-3732.2004; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Croteau G, 1997, J VIROL, V71, P1089, DOI 10.1128/JVI.71.2.1089-1096.1997; De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010; de Visser JAGM, 2007, NAT REV GENET, V8, P139, DOI 10.1038/nrg1985; Dykes C, 2007, CLIN MICROBIOL REV, V20, P550, DOI 10.1128/CMR.00017-07; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Harrigan PR, 2002, ANTIMICROB AGENTS CH, V46, P909, DOI 10.1128/AAC.46.3.909-912.2002; Hornak V, 2006, P NATL ACAD SCI USA, V103, P915, DOI 10.1073/pnas.0508452103; Jasnos L, 2007, NAT GENET, V39, P550, DOI 10.1038/ng1986; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Kouyos RD, 2007, TRENDS ECOL EVOL, V22, P308, DOI 10.1016/j.tree.2007.02.014; Mammano F, 2000, J VIROL, V74, P8524, DOI 10.1128/JVI.74.18.8524-8531.2000; Martinez-Picado J, 1999, J VIROL, V73, P3744, DOI 10.1128/JVI.73.5.3744-3752.1999; Martins JZR, 2010, EPIDEMICS-NETH, V2, P85, DOI 10.1016/j.epidem.2010.03.003; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Petropoulos CJ, 2000, ANTIMICROB AGENTS CH, V44, P920, DOI 10.1128/AAC.44.4.920-928.2000; PETROPOULOS CJ, 2011, NATURE, DOI DOI 10.1038/NPRE.2011.5668.1>; Provine, 1971, ORIGINS THEORETICAL; Rhee SY, 2006, P NATL ACAD SCI USA, V103, P17355, DOI 10.1073/pnas.0607274103; Rhee SY, 2004, ANTIMICROB AGENTS CH, V48, P3122, DOI 10.1128/AAC.48.8.3122-3126.2004; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Shafer RW, 2008, AIDS REV, V10, P67; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Wolf J.B., 2000, EPISTASIS EVOLUTIONA; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133	32	132	134	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2011	43	5					487	+		10.1038/ng.795	http://dx.doi.org/10.1038/ng.795			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	755XF	21441930				2022-12-25	WOS:000289972600022
J	Daughdrill, GW				Daughdrill, Gary W.			PROTEIN DYNAMICS Bridging the gap	NATURE CHEMICAL BIOLOGY			English	News Item							INHIBITOR		[Daughdrill, Gary W.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Daughdrill, Gary W.] Univ S Florida, Ctr Drug Discovery & Innovat, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Daughdrill, GW (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	gdaughdrill@usf.edu						Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eliezer D, 2009, CURR OPIN STRUC BIOL, V19, P23, DOI 10.1016/j.sbi.2008.12.004; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; TOMPA P, 2010, STRUCTURE FUNCTION I, V331; Wang YF, 2011, NAT CHEM BIOL, V7, P214, DOI 10.1038/NCHEMBIO.536; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; [No title captured], DOI DOI 10.1002/9783527619498.CH41	10	0	0	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					193	194		10.1038/nchembio.544	http://dx.doi.org/10.1038/nchembio.544			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21423160				2022-12-25	WOS:000288545000002
J	Nielsen, J				Nielsen, Jens			BIOFUELS Chimeric synthetic pathways	NATURE CHEMICAL BIOLOGY			English	News Item							SACCHAROMYCES-CEREVISIAE; BUTANOL		Chalmers, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden	Chalmers University of Technology	Nielsen, J (corresponding author), Chalmers, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.	nielsenj@chalmers.se	Nielsen, Jens/Q-1347-2017	Nielsen, Jens/0000-0002-9955-6003				Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Bond-Watts BB, 2011, NAT CHEM BIOL, V7, P222, DOI 10.1038/NCHEMBIO.537; Inui M, 2008, APPL MICROBIOL BIOT, V77, P1305, DOI 10.1007/s00253-007-1257-5; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Nielsen DR, 2009, METAB ENG, V11, P262, DOI 10.1016/j.ymben.2009.05.003; Nielsen J, 2001, APPL MICROBIOL BIOT, V55, P263, DOI 10.1007/s002530000511; Nissen TL, 2000, METAB ENG, V2, P69, DOI 10.1006/mben.1999.0140; Shen CR, 2008, METAB ENG, V10, P312, DOI 10.1016/j.ymben.2008.08.001; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; Vemuri GN, 2007, P NATL ACAD SCI USA, V104, P2402, DOI 10.1073/pnas.0607469104	10	8	8	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					195	196		10.1038/nchembio.548	http://dx.doi.org/10.1038/nchembio.548			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21423162				2022-12-25	WOS:000288545000004
J	Adrianto, I; Wen, F; Templeton, A; Wiley, G; King, JB; Lessard, CJ; Bates, JS; Hu, YQ; Kelly, JA; Kaufman, KM; Guthridge, JM; Alarcon-Riquelme, ME; Anaya, JM; Bae, SC; Bang, SY; Boackle, SA; Brown, EE; Petri, MA; Gallant, C; Ramsey-Goldman, R; Reveille, JD; Vila, LM; Criswell, LA; Edberg, JC; Freedman, BI; Gregersen, PK; Gilkeson, GS; Jacob, CO; James, JA; Kamen, DL; Kimberly, RP; Martin, J; Merrill, JT; Niewold, TB; Park, SY; Pons-Estel, BA; Scofield, RH; Stevens, AM; Tsao, BP; Vyse, TJ; Langefeld, CD; Harley, JB; Moser, KL; Webb, CF; Humphrey, MB; Montgomery, CG; Gaffney, PM				Adrianto, Indra; Wen, Feng; Templeton, Amanda; Wiley, Graham; King, Jarrod B.; Lessard, Christopher J.; Bates, Jared S.; Hu, Yanqing; Kelly, Jennifer A.; Kaufman, Kenneth M.; Guthridge, Joel M.; Alarcon-Riquelme, Marta E.; Anaya, Juan-Manuel; Bae, Sang-Cheol; Bang, So-Young; Boackle, Susan A.; Brown, Elizabeth E.; Petri, Michelle A.; Gallant, Caroline; Ramsey-Goldman, Rosalind; Reveille, John D.; Vila, Luis M.; Criswell, Lindsey A.; Edberg, Jeffrey C.; Freedman, Barry I.; Gregersen, Peter K.; Gilkeson, Gary S.; Jacob, Chaim O.; James, Judith A.; Kamen, Diane L.; Kimberly, Robert P.; Martin, Javier; Merrill, Joan T.; Niewold, Timothy B.; Park, So-Yeon; Pons-Estel, Bernardo A.; Scofield, R. Hal; Stevens, Anne M.; Tsao, Betty P.; Vyse, Timothy J.; Langefeld, Carl D.; Harley, John B.; Moser, Kathy L.; Webb, Carol F.; Humphrey, Mary Beth; Montgomery, Courtney Gray; Gaffney, Patrick M.		BIOLUPUS Network; GENLES Network	Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; AFRICAN-AMERICANS; RHEUMATOID-ARTHRITIS; ENZYME A20; ADMIXTURE; HAPLOTYPE; RISK; 6Q23; MAP; POLYMORPHISMS	Systemic lupus erythematosus (SLE, MIM152700) is an autoimmune disease characterized by self-reactive antibodies resulting in systemic inflammation and organ failure. TNFAIP3, encoding the ubiquitin-modifying enzyme A20, is an established susceptibility locus for SLE. By fine mapping and genomic re-sequencing in ethnically diverse populations, we fully characterized the TNFAIP3 risk haplotype and identified a TT>A polymorphic dinucleotide (deletion T followed by a T to A transversion) associated with SLE in subjects of European (P = 1.58 x 10(-8), odds ratio = 1.70) and Korean (P = 8.33 x 10(-10), odds ratio = 2.54) ancestry. This variant, located in a region of high conservation and regulatory potential, bound a nuclear protein complex composed of NF-kappa B subunits with reduced avidity. Further, compared with the non-risk haplotype, the haplotype carrying this variant resulted in reduced TNFAIP3 mRNA and A20 protein expression. These results establish this TT>A variant as the most likely functional polymorphism responsible for the association between TNFAIP3 and SLE.	[Adrianto, Indra; Wen, Feng; Wiley, Graham; Lessard, Christopher J.; Bates, Jared S.; Kelly, Jennifer A.; Kaufman, Kenneth M.; Guthridge, Joel M.; Alarcon-Riquelme, Marta E.; James, Judith A.; Scofield, R. Hal; Moser, Kathy L.; Montgomery, Courtney Gray; Gaffney, Patrick M.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, Oklahoma City, OK 73104 USA; [Templeton, Amanda; King, Jarrod B.; Lessard, Christopher J.; Hu, Yanqing; Kaufman, Kenneth M.; James, Judith A.; Scofield, R. Hal; Moser, Kathy L.; Humphrey, Mary Beth] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Oklahoma City, OK 73190 USA; [Kaufman, Kenneth M.; Harley, John B.] US Dept Vet Affairs Med Ctr, Oklahoma City, OK USA; [Alarcon-Riquelme, Marta E.] Ctr Genom & Oncol Res GENyO, Granada, Spain; [Anaya, Juan-Manuel] Univ Rosario, Ctr Autoimmune Dis Res CREA, Bogota, Colombia; [Bae, Sang-Cheol; Bang, So-Young; Park, So-Yeon] Hanyang Univ Hosp Rheumat Dis, Dept Rheumatol, Seoul, South Korea; [Boackle, Susan A.] Univ Colorado Denver, Div Rheumatol, Aurora, CO USA; [Brown, Elizabeth E.] Univ Alabama, Dept Epidemiol, Birmingham, AL USA; [Petri, Michelle A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Gallant, Caroline] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden; [Ramsey-Goldman, Rosalind] Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA; [Reveille, John D.] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA; [Vila, Luis M.] Univ Puerto Rico, Dept Med, Div Rheumatol, San Juan, PR 00936 USA; [Criswell, Lindsey A.] Univ Calif San Francisco, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; [Edberg, Jeffrey C.; Kimberly, Robert P.] Univ Alabama, Dept Med, Birmingham, AL 35294 USA; [Freedman, Barry I.] Wake Forest Univ Hlth Sci, Dept Internal Med, Winston Salem, NC USA; [Gregersen, Peter K.] N Shore Long Isl Jewish LIJ Hlth Syst, Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, Manhasset, NY USA; [Gilkeson, Gary S.; Kamen, Diane L.] Univ S Carolina, Div Rheumatol, Charleston, SC USA; [Jacob, Chaim O.] Univ So Calif, Dept Med, Los Angeles, CA USA; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Merrill, Joan T.] Oklahoma Med Res Fdn, Clin Pharmacol Res Program, Oklahoma City, OK 73104 USA; [Niewold, Timothy B.] Univ Chicago, Rheumatol Sect, Chicago, IL 60637 USA; [Niewold, Timothy B.] Univ Chicago, Gwen Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA; [Pons-Estel, Bernardo A.] Sanat Parque, Rosario, Santa Fe, Argentina; [Stevens, Anne M.] Univ Washington, Dept Pediat, Div Rheumatol, Seattle, WA 98195 USA; [Stevens, Anne M.] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA USA; [Tsao, Betty P.] Univ Calif Los Angeles, Dept Med, Div Rheumatol, Los Angeles, CA 90024 USA; [Vyse, Timothy J.] Kings Coll London, Div Genet & Mol Med, London WC2R 2LS, England; [Vyse, Timothy J.] Kings Coll London, Div Immunol Infect & Inflammatory Dis, London WC2R 2LS, England; [Langefeld, Carl D.] Wake Forest Univ Hlth Sci, Dept Biostat Sci, Winston Salem, NC USA; [Harley, John B.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Webb, Carol F.] Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Universidad del Rosario; Hanyang University; Hanyang University Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Alabama System; University of Alabama Birmingham; Johns Hopkins University; Uppsala University; Northwestern University; Feinberg School of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; Wake Forest University; Wake Forest University School of Medicine; Northwell Health; University of South Carolina; University of Southern California; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Oklahoma Medical Research Foundation; University of Chicago; University of Chicago; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of California System; University of California Los Angeles; University of London; King's College London; University of London; King's College London; Wake Forest University; Wake Forest University School of Medicine; Cincinnati Children's Hospital Medical Center; Oklahoma Medical Research Foundation	Gaffney, PM (corresponding author), Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	gaffneyp@omrf.org	Adrianto, Indra/D-4214-2013; Bae, Sang-Cheol/P-2051-2015; Scofield, Robert Hal/AEJ-8314-2022; Martin, Javier/B-8141-2008; Martín, María/HDL-9512-2022; Anaya, Juan-Manuel/J-1960-2016; Alarcón-Riquelme, Marta E./ABF-8163-2020; Merrill, Joan/HDL-9141-2022; Martín, Javier/AAV-5209-2021; Niewold, Timothy/D-2669-2018	Adrianto, Indra/0000-0002-9973-3057; Martin, Javier/0000-0002-2202-0622; Anaya, Juan-Manuel/0000-0002-6444-1249; Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Bae, Sang-Cheol/0000-0003-4658-1093; Kelly, Jennifer/0000-0002-3203-2467; Tsao, Betty/0000-0001-7938-5975; Niewold, Timothy/0000-0003-3532-6660; Guthridge, Joel/0000-0002-9308-237X; Lessard, Christopher J./0000-0003-2440-3843; Kimberly, Robert/0000-0002-5330-3086; Templeton, Amanda/0000-0001-9373-3921; Universidad del Rosario, Biblioteca/0000-0003-3491-9392; Gaffney, Patrick/0000-0002-1580-869X; Pons-Estel, Bernardo/0000-0003-2518-0266; Montgomery, Courtney/0000-0002-9606-3772	US National Institutes of Health [R01 AI063274, R01 AR056360, R01 AR043274, N01 AR62277, R37 24717, R01 AR042460, P01 AI083194, P20 RR020143, R01 DE018209, P01 AR49084, R01 AR33062, P30 AR055385, K08 AI083790, LRP AI071651, UL1 RR024999, R01CA141700]; Ministry for Health and Welfare, Republic of Korea [A010252, A080588]; US Department of Veterans Affairs; Swedish Research Council for Medicine; Gustaf Vth-80th Jubilee Fund; Swedish Association Against Rheumatism, Instituto de Salud Carlos III, Oklahoma Center for Advancement of Science and Technology (OCAST) [HR09-106]; European Science Foundation; Oklahoma Medical Research Foundation (OMRF); Lupus Research Institute; Alliance for Lupus Research; Arthritis National Research Foundation; Arthritis Foundation; Lupus Foundation of Minnesota; Wellcome Trust; Arthritis Research UK; Kirkland Scholar Award; Wake Forest University Health Sciences Center for Public Health Genomics of EMSA; The US National Institutes of Health [RC1 AR058621, R01AR051545-01A2, ULI RR025014-02, P30 AR053483, N01 AI50026, P20 RR015577, R21 AI070304, R01 AI070983, R01 AR43814, P60 AR053308, M01 RR-00079, R01 AR043727, UL1 RR025005]; NATIONAL CANCER INSTITUTE [R01CA141700] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000154] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079, UL1RR025005, UL1RR024999, P20RR020143, P20RR015577, UL1RR025014, P30RR031152, UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083194, R01AI070983, N01AI050026, R37AI024717, K08AI083790, R21AI070304, K24AI078004, R01AI063274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR033062, P01AR049084, P60AR053308, R01AR042460, R01AR043727, R01AR056360, R01AR043274, P30AR048311, R01AR043814, P30AR053483, R01AR051545, RC1AR058621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103510] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry for Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); US Department of Veterans Affairs(US Department of Veterans Affairs); Swedish Research Council for Medicine; Gustaf Vth-80th Jubilee Fund; Swedish Association Against Rheumatism, Instituto de Salud Carlos III, Oklahoma Center for Advancement of Science and Technology (OCAST)(Instituto de Salud Carlos III); European Science Foundation(European Science Foundation (ESF)European Commission); Oklahoma Medical Research Foundation (OMRF); Lupus Research Institute; Alliance for Lupus Research; Arthritis National Research Foundation(National Research Foundation of Korea); Arthritis Foundation; Lupus Foundation of Minnesota; Wellcome Trust(Wellcome Trust); Arthritis Research UK(Versus Arthritis); Kirkland Scholar Award; Wake Forest University Health Sciences Center for Public Health Genomics of EMSA; The US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. C. Comeau, M. C. Marion, P. S. Ramos, A. Williams, J. Zigler, A. Adler, S. Frank, S. Glenn and M. L. Zhu for their assistance in genotyping, quality control analyses and clinical data management; R. Lu and N. Dominguez for their assistance with EMSA; J. D. Capra for his critical reading of the manuscript; and the staff of the Lupus Family Registry and Repository (LFRR) for collecting and maintaining SLE samples. Support for this work was obtained from the US National Institutes of Health grants R01 AI063274 and R01 AR056360 (P. M. G.); R01 AR043274 (K. L. M.); N01 AR62277, R37 24717, R01 AR042460, P01 AI083194, P20 RR020143, R01 DE018209 (J. B. H.); P01 AR49084 (R. P. K. and E. E. B); R01 AR33062 (R. P. K.); P30 AR055385 (E. E. B); K08 AI083790, LRP AI071651, UL1 RR024999 (T. B. N.); R01CA141700, RC1 AR058621 (M.E.A.-R.); R01AR051545-01A2, ULI RR025014-02 (A. M. S.); P30 AR053483, N01 AI50026 (J. A. J. and J. M. G.); P20 RR015577 (J. A. J.); R21 AI070304, R01 AI070983 (S. A. B.); R01 AR43814 (B. P. T.); P60 AR053308, M01 RR-00079 (L. A. C.); R01 AR043727, UL1 RR025005 (M. A. P.). A portion of this study was supported by a grant of the Korea Healthcare Technology Research and Development Project, Ministry for Health and Welfare, Republic of Korea (A010252, A080588; S.-C. B.). Additional support was granted from the Alliance for Lupus Research (K. L. M.); Merit Award from the US Department of Veterans Affairs (J. B. H. and G. S. G.); the Swedish Research Council for Medicine, Gustaf Vth-80th Jubilee Fund and Swedish Association Against Rheumatism, Instituto de Salud Carlos III, Oklahoma Center for Advancement of Science and Technology (OCAST) HR09-106 (M.E.A.-R.); the European Science Foundation funds the BIOLUPUS network (M.E.A.-R. coordinator); the Barrett Scholarship Fund Oklahoma Medical Research Foundation (OMRF) (C. J. L.); Lupus Research Institute (T. B. N.); The Alliance for Lupus Research (T. B. N., L. A. C. and C.O.J.); the Arthritis National Research Foundation Eng Tan Scholar Award (T. B. N.); Arthritis Foundation (P. M. G. and A. M. S.); the Lupus Foundation of Minnesota (P. M. G. and K. L. M.); the Wellcome Trust (T. J. V.); Arthritis Research UK (T. J. V.); Kirkland Scholar Award (L. A. C.); and Wake Forest University Health Sciences Center for Public Health Genomics of EMSA bands were performed using a Bio-Rad Universal Hood II Gel Docking Station and Quantity One analysis software. The density value of each band was recorded and normalized to the background for each blot. Statistical analyses were performed using a paired t-test and Prism 5.0 software.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bates JS, 2009, GENES IMMUN, V10, P470, DOI 10.1038/gene.2009.31; Bertoni B, 2003, HUM BIOL, V75, P1, DOI 10.1353/hub.2003.0016; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Dieude P, 2010, ANN RHEUM DIS, V69, P1958, DOI 10.1136/ard.2009.127928; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Halder I, 2008, HUM MUTAT, V29, P648, DOI 10.1002/humu.20695; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jaattela M, 1996, J IMMUNOL, V156, P1166; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lodolce JP, 2010, J IMMUNOL, V184, P7001, DOI 10.4049/jimmunol.1000324; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257	34	205	210	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2011	43	3					253	U102		10.1038/ng.766	http://dx.doi.org/10.1038/ng.766			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726BR	21336280	Green Accepted			2022-12-25	WOS:000287693800017
J	Handsaker, RE; Korn, JM; Nemesh, J; McCarroll, SA				Handsaker, Robert E.; Korn, Joshua M.; Nemesh, James; McCarroll, Steven A.			Discovery and genotyping of genome structural polymorphism by sequencing on a population scale	NATURE GENETICS			English	Article							COPY-NUMBER; IMPUTATION; VARIANTS; MAP; SNPS	Accurate and complete analysis of genome variation in large populations will be required to understand the role of genome variation in complex disease. We present an analytical framework for characterizing genome deletion polymorphism in populations using sequence data that are distributed across hundreds or thousands of genomes. Our approach uses population-level concepts to reinterpret the technical features of sequence data that often reflect structural variation. In the 1000 Genomes Project pilot, this approach identified deletion polymorphism across 168 genomes (sequenced at 4x average coverage) with sensitivity and specificity unmatched by other algorithms. We also describe a way to determine the allelic state or genotype of each deletion polymorphism in each genome; the 1000 Genomes Project used this approach to type 13,826 deletion polymorphisms (48-995,664 bp) at high accuracy in populations. These methods offer a way to relate genome structural polymorphism to complex disease in populations.	[Handsaker, Robert E.; Korn, Joshua M.; Nemesh, James; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Handsaker, Robert E.; Korn, Joshua M.; Nemesh, James; McCarroll, Steven A.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [McCarroll, Steven A.] Stanley Ctr Psychiat Dis Res, Cambridge, MA USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	McCarroll, SA (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	mccarroll@genetics.med.harvard.edu	Handsaker, Bob/AAX-9095-2021	Handsaker, Bob/0000-0002-3128-3547; McCarroll, Steven/0000-0002-6954-8184	National Human Genome Research Institute [U01HG005208-01S1]; Department of Genetics at Harvard Medical School; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005208] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Department of Genetics at Harvard Medical School; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors wish to thank the 1000 Genomes Structural Variation Analysis Group for helpful conversations throughout this work and for collaborative work to evaluate the sensitivity and specificity of structural variation discovery algorithms. We would particularly like to acknowledge K. Chen for creation of a high-quality breakpoint library for the 1000 Genomes Project, on which Genome STRiP's genotyping algorithm drew, and R. Mills for managing the 1000 Genomes Project deletion discovery sets and validation data. We also thank C. Stewart, K. Walter, M. Hurles and N. Patterson for helpful conversations during the course of this work; D. Altshuler, M. DePristo and M. Daly for helpful comments on the manuscript and figures; and the anonymous reviewers of this manuscript, whose feedback improved it. This work was supported by the National Human Genome Research Institute (U01HG005208-01S1) and by startup funds from the Department of Genetics at Harvard Medical School.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Coin LJM, 2010, NAT METHODS, V7, P541, DOI [10.1038/NMETH.1466, 10.1038/nmeth.1466]; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Korbel JO, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r23; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; MILLS RE, 2011, NATURE          0203, DOI DOI 10.1038/NATURE09708; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109	26	226	234	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2011	43	3					269	U126		10.1038/ng.768	http://dx.doi.org/10.1038/ng.768			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726BR	21317889	Green Accepted, Green Submitted			2022-12-25	WOS:000287693800020
J	Liu, F; Wu, S; Ren, H; Gu, J				Liu, Feng; Wu, Su; Ren, Hongwei; Gu, Jun			Klotho suppresses RIG-I-mediated senescence-associated inflammation	NATURE CELL BIOLOGY			English	Article							INDUCIBLE GENE-I; TRANSCRIPTS ENCODING MEMBRANE; OXIDATIVE STRESS; ADAPTER PROTEIN; MOUSE; INVOLVEMENT; IDENTIFICATION; EXPRESSION; RECEPTOR; CULTURE	It is well known that aged or senescent cells develop a complex senescence-associated secretory phenotype (SASP), which is observed both in culture and in vivo. However, the mechanisms underlying the induction of the SASP are largely unknown. We demonstrate that retinoic-acid-inducible gene-I (RIG-I) is induced through the ataxia telangiectasia mutated-interferon regulatory factor 1 (ATM-IRF1) axis in senescent cells and that RIG-I signalling mediates the expression of two important mediators of inflammation, interleukin-6 (IL-6) and IL-8. Klotho has been associated with ageing. We show here that the intracellular, but not the secreted, form of klotho interacts with RIG-I and that this interaction inhibits RIG-I-induced expression of IL-6 and IL-8 both in vitro and in vivo. Our study uncovers a mechanism in which klotho functions as an anti-ageing factor through the suppression of RIG-I-mediated inflammation.	[Liu, Feng; Wu, Su; Ren, Hongwei; Gu, Jun] Peking Univ, LSC, Natl Key Lab Prot Engn & Plant Gene Engn, Beijing 100871, Peoples R China	Peking University	Gu, J (corresponding author), Peking Univ, Coll Life Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China.	gj@pku.edu.cn		Wu, Su/0000-0003-4963-0524	National Basic Research Program, China [2010CB911801, 2011CB503904]	National Basic Research Program, China(National Basic Research Program of China)	We thank H. Shu, C. R. Abraham, M. Kuro-o, R. T. Moon and Y. Yang for plasmids, H. Deng and Y. Gao for irradiation, J. Luo and T. Tong for cell lines, Z. J. Chen and M. Kuro-o for knockout mice, M. Kuro-o for comments and J. L. Teeing for revising this paper. This work was supported by grants (2010CB911801 and 2011CB503904) from the National Basic Research Program, China.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Ikushima M, 2006, BIOCHEM BIOPH RES CO, V339, P827, DOI 10.1016/j.bbrc.2005.11.094; Imaizumi T, 2008, CLIN EXP IMMUNOL, V153, P240, DOI 10.1111/j.1365-2249.2008.03685.x; Imaizumi T, 2010, LUPUS, V19, P830, DOI 10.1177/0961203309360540; Imaizumi T, 2009, IMMUNOL LETT, V122, P89, DOI 10.1016/j.imlet.2008.12.005; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawaguchi S, 2009, IMMUNOL LETT, V123, P9, DOI 10.1016/j.imlet.2009.01.008; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kubota K, 2006, ORAL MICROBIOL IMMUN, V21, P399, DOI 10.1111/j.1399-302X.2006.00326.x; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Maekawa Y, 2009, ENDOCRINE, V35, P341, DOI 10.1007/s12020-009-9181-3; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mitobe M, 2005, NEPHRON EXP NEPHROL, V101, pE67, DOI 10.1159/000086500; Nagai R, 2000, CELL MOL LIFE SCI, V57, P738, DOI 10.1007/s000180050038; Nagai T, 2002, FASEB J, V16, P50, DOI 10.1096/fj.02-0448fje; Pamment J, 2002, ONCOGENE, V21, P7776, DOI 10.1038/sj.onc.1205981; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Saito Y, 1998, BIOCHEM BIOPH RES CO, V248, P324, DOI 10.1006/bbrc.1998.8943; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Shiraki-Iida T, 1998, FEBS LETT, V424, P6, DOI 10.1016/S0014-5793(98)00127-6; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wang J, 2008, J IMMUNOL, V180, P8011, DOI 10.4049/jimmunol.180.12.8011; Wei WY, 2001, MOL CELL BIOL, V21, P6748, DOI 10.1128/MCB.21.20.6748-6757.2001; Xiao NM, 2004, CHINESE MED J-PEKING, V117, P742; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Xu LJ, 2009, P NATL ACAD SCI USA, V106, P1530, DOI 10.1073/pnas.0811029106; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	43	169	185	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2011	13	3					254	U396		10.1038/ncb2167	http://dx.doi.org/10.1038/ncb2167			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	728BB	21336305				2022-12-25	WOS:000287847600013
J	Rolland, M; Tovanabutra, S; deCamp, AC; Frahm, N; Gilbert, PB; Sanders-Buell, E; Heath, L; Magaret, CA; Bose, M; Bradfield, A; O'Sullivan, A; Crossler, J; Jones, T; Nau, M; Wong, K; Zhao, H; Raugi, DN; Sorensen, S; Stoddard, JN; Maust, BS; Deng, WJ; Hural, J; Dubey, S; Michael, NL; Shiver, J; Corey, L; Li, FS; Self, SG; Kim, J; Buchbinder, S; Casimiro, DR; Robertson, MN; Duerr, A; McElrath, MJ; McCutchan, FE; Mullins, JI				Rolland, Morgane; Tovanabutra, Sodsai; deCamp, Allan C.; Frahm, Nicole; Gilbert, Peter B.; Sanders-Buell, Eric; Heath, Laura; Magaret, Craig A.; Bose, Meera; Bradfield, Andrea; O'Sullivan, Annemarie; Crossler, Jacqueline; Jones, Teresa; Nau, Marty; Wong, Kim; Zhao, Hong; Raugi, Dana N.; Sorensen, Stephanie; Stoddard, Julia N.; Maust, Brandon S.; Deng, Wenjie; Hural, John; Dubey, Sheri; Michael, Nelson L.; Shiver, John; Corey, Lawrence; Li, Fusheng; Self, Steve G.; Kim, Jerome; Buchbinder, Susan; Casimiro, Danilo R.; Robertson, Michael N.; Duerr, Ann; McElrath, M. Juliana; McCutchan, Francine E.; Mullins, James I.			Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial	NATURE MEDICINE			English	Article							T-LYMPHOCYTE RESPONSE; CELL RESPONSES; ESCAPE; PREDICTION; IMMUNITY; BINDING; GAG	We analyzed HIV-1 genome sequences from 68 newly infected volunteers in the STEP HIV-1 vaccine trial. To determine whether the vaccine exerted selective T cell pressure on breakthrough viruses, we identified potential T cell epitopes in the founder sequences and compared them to epitopes in the vaccine. We found greater distances to the vaccine sequence for sequences from vaccine recipients than from placebo recipients. The most significant signature site distinguishing vaccine from placebo recipients was Gag amino acid 84, a site encompassed by several epitopes contained in the vaccine and restricted by human leukocyte antigen (HLA) alleles common in the study cohort. Moreover, the extended divergence was confined to the vaccine components of the virus (HIV-1 Gag, Pol and Nef) and not found in other HIV-1 proteins. These results represent what is to our knowledge the first evidence of selective pressure from vaccine-induced T cell responses on HIV-1 infection in humans.	[Rolland, Morgane; Heath, Laura; Wong, Kim; Zhao, Hong; Raugi, Dana N.; Sorensen, Stephanie; Stoddard, Julia N.; Maust, Brandon S.; Deng, Wenjie; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Tovanabutra, Sodsai; Sanders-Buell, Eric; Bose, Meera; Bradfield, Andrea; O'Sullivan, Annemarie; Crossler, Jacqueline; Jones, Teresa; Nau, Marty; Michael, Nelson L.; Kim, Jerome; McCutchan, Francine E.] US Mil HIV Res Program, Rockville, MD USA; [deCamp, Allan C.; Frahm, Nicole; Gilbert, Peter B.; Magaret, Craig A.; Hural, John; Corey, Lawrence; Li, Fusheng; Self, Steve G.; Duerr, Ann; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98104 USA; [Dubey, Sheri; Shiver, John; Casimiro, Danilo R.; Robertson, Michael N.] Merck Res Labs, West Point, PA USA; [Buchbinder, Susan] San Francisco Dept Hlth, San Francisco, CA USA	University of Washington; University of Washington Seattle; Walter Reed Army Institute of Research (WRAIR); Fred Hutchinson Cancer Center; Merck & Company	Mullins, JI (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	jmullins@uw.edu	Corey, Lawrence/AAE-1796-2020	Corey, Lawrence/0000-0002-2179-2436	US Public Health Service grant [AI41505]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068618, U01AI068618, R37AI054165, P30AI027757] Funding Source: NIH RePORTER	US Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the study participants for their time and dedication; the HIV Vaccine Trials Network Laboratory Program, the Statistical Center for HIV/AIDS Research & Prevention and Core staff who contributed to the study implementation and analysis; the Merck functional teams: the Clinical Research Specialist Organization, Worldwide Clinical Data Management Operation, Clinical Research Operations, J.T. Herbeck and B.B. Larsen for comments on the manuscript, and the Clinical Assay and Sample Receiving Operations. This work was supported by US Public Health Service grant AI41505.	Betts MR, 2005, P NATL ACAD SCI USA, V102, P4512, DOI 10.1073/pnas.0408773102; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; Gilbert PB, 2008, BIOMETRICS, V64, P198, DOI 10.1111/j.1541-0420.2007.00845.x; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Heckerman D, 2007, J COMPUT BIOL, V14, P736, DOI 10.1089/cmb.2007.R013; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; KORBER BTM, 2006, HIV MOL IMMUNOLOGY; Lafuente EM, 2009, CURR PHARM DESIGN, V15, P3209, DOI 10.2174/138161209789105162; LEITNER T, 2006, HIV SEQUENCE COMPEND, P648; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Nickle DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000503; Reece JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012774; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; TARONE RE, 1990, BIOMETRICS, V46, P515, DOI 10.2307/2531456; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005	19	172	174	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2011	17	3					366	U168		10.1038/nm.2316	http://dx.doi.org/10.1038/nm.2316			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21358627	Green Accepted			2022-12-25	WOS:000288070000048
J	Zhou, YJ; Lee, J; Reno, CM; Sun, C; Park, SW; Chung, J; Lee, J; Fisher, SJ; White, MF; Biddinger, SB; Ozcan, U				Zhou, Yingjiang; Lee, Justin; Reno, Candace M.; Sun, Cheng; Park, Sang Won; Chung, Jason; Lee, Jaemin; Fisher, Simon J.; White, Morris F.; Biddinger, Sudha B.; Ozcan, Umut			Regulation of glucose homeostasis through a XBP-1-FoxO1 interaction	NATURE MEDICINE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR FOXO1; INSULIN-RESISTANCE; ER STRESS; TRANSMEMBRANE PROTEIN; MESSENGER-RNA; MICE LACKING; OBESITY; XBP-1; PHOSPHORYLATION	To date, the only known role of the spliced form of X-box-binding protein-1 (XBP-1s) in metabolic processes has been its ability to act as a transcription factor that regulates the expression of genes that increase the endoplasmic reticulum (ER) folding capacity, thereby improving insulin sensitivity. Here we show that XBP-1s interacts with the Forkhead box O1 (FoxO1) transcription factor and directs it toward proteasome-mediated degradation. Given this new insight, we tested modest hepatic overexpression of XBP-1s in vivo in mouse models of insulin deficiency or insulin resistance and found it improved serum glucose concentrations, even without improving insulin signaling or ER folding capacity. The notion that XBP-1s can act independently of its role in the ER stress response is further supported by our finding that in the severely insulin resistant ob/ob mouse strain a DNA-binding-defective mutant of XBP-1s, which does not have the ability to increase ER folding capacity, is still capable of reducing serum glucose concentrations and increasing glucose tolerance. Our results thus provide the first evidence to our knowledge that XBP-1s, through its interaction with FoxO1, can bypass hepatic insulin resistance independent of its effects on ER folding capacity, suggesting a new therapeutic approach for the treatment of type 2 diabetes.	[Zhou, Yingjiang; Lee, Justin; Sun, Cheng; Park, Sang Won; Chung, Jason; Lee, Jaemin; White, Morris F.; Biddinger, Sudha B.; Ozcan, Umut] Harvard Univ, Sch Med, Div Endocrinol, Childrens Hosp Boston, Boston, MA 02115 USA; [Reno, Candace M.; Fisher, Simon J.] Washington Univ, Div Endocrinol Metab & Lipid Res, St Louis, MO USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Washington University (WUSTL)	Ozcan, U (corresponding author), Harvard Univ, Sch Med, Div Endocrinol, Childrens Hosp Boston, Boston, MA 02115 USA.	umut.ozcan@childrens.harvard.edu	Lee, Jaemin/AAP-4875-2021	Lee, Jaemin/0000-0002-0224-7141	Children's Hospital Boston [R01DK081009]; US National Institutes of Health; Timothy Murphy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081009] Funding Source: NIH RePORTER	Children's Hospital Boston; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Timothy Murphy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Ozcan laboratory for their help during the execution of the experiments. We thank L. Glimcher (Harvard School of Public Health) for providing us with the Xbp1<SUP>flox/flox</SUP> mouse strain. We are grateful to D. Accili (Columbia University) for providing us with various FoxO1 adenoviruses and to R. Kahn (Joslin Diabetes Center) for his permission to use LIRKO mice in our studies. We thank J. Majzoub (Harvard Medical School) for providing us with the mammalian two-hybrid system and R. King (Harvard Medical School) for providing us with a ubiquitin-expressing plasmid. We thank M. Birnbaum (University of Pennsylvania) for providing us with Akt1/2 double-knockout cells. This study was supported by junior faculty start-up funds provided to U.O. by Children's Hospital Boston, an RO1 grant (R01DK081009) provided to U.O. by the US National Institutes of Health, and the Timothy Murphy funds provided to the Division of Endocrinology, Children's Hospital Boston.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; de Luca C, 2006, NAT MED, V12, P41, DOI 10.1038/nm0106-41; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; FAN W, 2010, EMBO J; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Henis-Korenblit S, 2010, P NATL ACAD SCI USA, V107, P9730, DOI 10.1073/pnas.1002575107; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; James PT, 2004, EUR J CARDIOV PREV R, V11, P3, DOI 10.1097/01.hjr.0000114707.27531.48; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kitamura Y, 2004, REV ENDOCR METAB DIS, V5, P143, DOI 10.1023/B:REMD.0000021436.91347.93; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Matsumoto M, 2006, NAT MED, V12, P33, DOI 10.1038/nm0106-33; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; MORI K, 1993, CELL, V74, P743; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozawa K, 2005, DIABETES, V54, P657, DOI 10.2337/diabetes.54.3.657; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	46	205	224	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2011	17	3					356	U161		10.1038/nm.2293	http://dx.doi.org/10.1038/nm.2293			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21317886	Green Accepted			2022-12-25	WOS:000288070000047
J	Hoffstrom, BG; Kaplan, A; Letso, R; Schmid, RS; Turmel, GJ; Lo, DC; Stockwell, BR				Hoffstrom, Benjamin G.; Kaplan, Anna; Letso, Reka; Schmid, Ralf S.; Turmel, Gregory J.; Lo, Donald C.; Stockwell, Brent R.			Inhibitors of protein disulfide isomerase suppress apoptosis induced by misfolded proteins	NATURE CHEMICAL BIOLOGY			English	Article							OUTER-MEMBRANE PERMEABILIZATION; AMYOTROPHIC-LATERAL-SCLEROSIS; HUNTINGTONS-DISEASE; MUTANT HUNTINGTIN; MOUSE MODEL; CYTOCHROME-C; TERMINAL ALKYNES; TRANSGENIC MICE; BCL-2 FAMILY; CELL-DEATH	A hallmark of many neurodegenerative diseases is accumulation of misfolded proteins within neurons, leading to cellular dysfunction and cell death. Although several mechanisms have been proposed to link protein misfolding to cellular toxicity, the connection remains enigmatic. Here, we report a cell death pathway involving protein disulfide isomerase (PDI), a protein chaperone that catalyzes isomerization, reduction and oxidation of disulfides. Through a small molecule screening approach, we discovered five structurally distinct compounds that prevent apoptosis induced by mutant huntingtin protein. Using modified Huisgen cycloaddition chemistry, we then identified PDI as the molecular target of these small molecules. Expression of polyglutamine-expanded huntingtin exon 1 in PC12 cells caused PDI to accumulate at mitochondrial-associated ER membranes and trigger apoptotic cell death via mitochondrial outer-membrane permeabilization. Inhibiting PDI in rat brain cells suppressed the toxicity of mutant huntingtin exon 1 and Ab peptides processed from the amyloid precursor protein. This pro-apoptotic function of PDI represents a new mechanism linking protein misfolding and apoptotic cell death.	[Hoffstrom, Benjamin G.; Kaplan, Anna; Letso, Reka; Stockwell, Brent R.] Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10032 USA; [Schmid, Ralf S.; Turmel, Gregory J.; Lo, Donald C.] Duke Univ, Med Ctr, Ctr Drug Discovery, Durham, NC USA; [Schmid, Ralf S.; Turmel, Gregory J.; Lo, Donald C.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Stockwell, Brent R.] Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University; Howard Hughes Medical Institute; Duke University; Duke University; Columbia University	Hoffstrom, BG (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10032 USA.	bstockwell@columbia.edu	Schmid, Ralf/AAN-1011-2021; Stockwell, Brent R/AAE-7200-2019	Schmid, Ralf/0000-0002-1721-5775; Stockwell, Brent R/0000-0002-3532-3868	US National Institutes of Health [NIGMS 1RO1GM085081, NINDS R21NS048181]; Hereditary Disease Foundation; High Q Foundation; CHDI Foundation; Arnold and Mabel Beckman Foundation; Training Program in Molecular Biophysics [T32GM008281]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008281, R01GM085081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS048181] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hereditary Disease Foundation; High Q Foundation; CHDI Foundation; Arnold and Mabel Beckman Foundation; Training Program in Molecular Biophysics; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Schweitzer (University of California-Los Angeles) for the transfected PC12 cell lines; C. Ross (Johns Hopkins University) for HTT DNAs upon which the constructs used here were based; I. Smukste for assistance with organic synthesis; A. Bauer for compound library assembly library; D. Dunn for additional brain-slice experiments; C. Thompson (University of Pennsylvania) for the Bax/Bak double-knockout MEF cells; L. Moore (Gage laboratory, Salk Institute) for tebufenozide; A. Speers, J. Alexander and B. Cravatt for reagents and advice on the cycloaddition reactions; E. Miller, E. Signer, A. Tobin, N. Wexler, C. Johnson, R. Pacifici and M. Finn for useful discussions; and E. Miller and S. Hoffschmidt for editorial comments on the manuscript. This research was supported by grants from the US National Institutes of Health (NIGMS 1RO1GM085081 to B.R.S. and NINDS R21NS048181 to D.C.L.), the Hereditary Disease Foundation (D.C.L., B.R.S.), the High Q Foundation (B.R.S.), CHDI Foundation (D.C.L., B.R.S.), the Arnold and Mabel Beckman Foundation (B.R.S.), the Training Program in Molecular Biophysics (T32GM008281 to A.K.) and a Burroughs Wellcome Fund Career Award at the Scientific Interface (B.R.S.). B.G.H. was supported in part by a postdoctoral fellowship from the High Q Foundation. B.R.S. is an Early Career Scientist of the Howard Hughes Medical Institute.	Aiken CT, 2004, NEUROBIOL DIS, V16, P546, DOI 10.1016/j.nbd.2004.04.001; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Bailey CDC, 2006, NEUROBIOL AGING, V27, P871, DOI 10.1016/j.neurobiolaging.2005.04.001; Braithwaite SP, 2010, NEUROBIOL DIS, V39, P311, DOI 10.1016/j.nbd.2010.04.015; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Ciammola A, 2006, CELL DEATH DIFFER, V13, P2068, DOI 10.1038/sj.cdd.4401967; Conn KJ, 2004, BRAIN RES, V1022, P164, DOI 10.1016/j.brainres.2004.07.026; Dedeoglu A, 2002, J NEUROSCI, V22, P8942; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Friedlander RM, 1997, NATURE, V388, P31, DOI 10.1038/40299; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gregersen N, 2006, J INHERIT METAB DIS, V29, P456, DOI 10.1007/s10545-006-0301-4; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Hickey MA, 2003, PROG NEURO-PSYCHOPH, V27, P255, DOI 10.1016/S0278-5846(03)00021-6; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; HUISGEN R, 1984, 1 3 DIPOLAR CYCLOADD, P1; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Khoshnan A, 2004, J NEUROSCI, V24, P7999, DOI 10.1523/JNEUROSCI.2675-04.2004; Kiechle T, 2002, NEUROMOL MED, V1, P183; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Nie C, 2008, J BIOL CHEM, V283, P15359, DOI 10.1074/jbc.M800847200; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510; Rigobello MP, 2001, BIOCHEM J, V356, P567, DOI 10.1042/0264-6021:3560567; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Southwell AL, 2008, J NEUROSCI, V28, P9013, DOI 10.1523/JNEUROSCI.2747-08.2008; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; THOMAS LB, 1995, EXP NEUROL, V133, P265, DOI 10.1006/exnr.1995.1029; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Tremblay ME, 2006, NEUROBIOL AGING, V27, P862, DOI 10.1016/j.neurobiolaging.2005.04.004; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Van Raamsdonk JM, 2005, J NEUROCHEM, V95, P210, DOI 10.1111/j.1471-4159.2005.03357.x; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Varma H, 2007, P NATL ACAD SCI USA, V104, P14525, DOI 10.1073/pnas.0704482104; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Yoo BC, 2002, NEUROSCI LETT, V334, P196, DOI 10.1016/S0304-3940(02)01071-6; Yu ZX, 2003, J NEUROSCI, V23, P2193; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	50	220	231	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					900	906		10.1038/NCHEMBIO.467	http://dx.doi.org/10.1038/NCHEMBIO.467			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079601	Green Accepted			2022-12-25	WOS:000284214700019
J	Tabashnik, BE; Sisterson, MS; Ellsworth, PC; Dennehy, TJ; Antilla, L; Liesner, L; Whitlow, M; Staten, RT; Fabrick, JA; Unnithan, GC; Yelich, AJ; Ellers-Kirk, C; Harpold, VS; Li, XC; Carriere, Y				Tabashnik, Bruce E.; Sisterson, Mark S.; Ellsworth, Peter C.; Dennehy, Timothy J.; Antilla, Larry; Liesner, Leighton; Whitlow, Mike; Staten, Robert T.; Fabrick, Jeffrey A.; Unnithan, Gopalan C.; Yelich, Alex J.; Ellers-Kirk, Christa; Harpold, Virginia S.; Li, Xianchun; Carriere, Yves			Suppressing resistance to Bt cotton with sterile insect releases	NATURE BIOTECHNOLOGY			English	Article							PINK-BOLLWORM LEPIDOPTERA; BACILLUS-THURINGIENSIS; TRANSGENIC COTTON; FITNESS COSTS; CROPS; POPULATIONS; GENETICS; ALLELES; TOXIN	Genetically engineered crops that produce insecticidal toxins from Bacillus thuringiensis (Bt) are grown widely for pest control(1). However, insect adaptation can reduce the toxins' efficacy(2-5). The predominant strategy for delaying pest resistance to Bt crops requires refuges of non-Bt host plants to provide susceptible insects to mate with resistant insects(2-7). Variable farmer compliance is one of the limitations of this approach. Here we report the benefits of an alternative strategy where sterile insects are released to mate with resistant insects and refuges are scarce or absent. Computer simulations show that this approach works in principle against pests with recessive or dominant inheritance of resistance. During a large-scale, four-year field deployment of this strategy in Arizona, resistance of pink bollworm (Pectinophora gossypiella) to Bt cotton did not increase. A multitactic eradication program that included the release of sterile moths reduced pink bollworm abundance by >99%, while eliminating insecticide sprays against this key invasive pest.	[Tabashnik, Bruce E.; Dennehy, Timothy J.; Unnithan, Gopalan C.; Yelich, Alex J.; Ellers-Kirk, Christa; Harpold, Virginia S.; Li, Xianchun; Carriere, Yves] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Sisterson, Mark S.] USDA ARS, San Joaquin Valley Agr Sci Ctr, Parlier, CA USA; [Ellsworth, Peter C.] Univ Arizona, Dept Entomol, Maricopa Agr Ctr, Maricopa, AZ USA; [Dennehy, Timothy J.] Monsanto Co, St Louis, MO USA; [Antilla, Larry; Liesner, Leighton; Whitlow, Mike] Arizona Cotton Res & Protect Council, Phoenix, AZ USA; [Fabrick, Jeffrey A.] USDA ARS, US Arid Land Res Ctr, Maricopa, AZ USA	University of Arizona; United States Department of Agriculture (USDA); University of Arizona; Monsanto; United States Department of Agriculture (USDA)	Tabashnik, BE (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	brucet@cals.arizona.edu	Ellsworth, Peter C./I-2524-2019	Ellsworth, Peter C./0000-0002-2485-0830; Fabrick, Jeffrey/0000-0002-3893-9545	USDA-National Institute of Food and Agriculture; ACRPC; Arizona Cotton Growers Association; Cotton Foundation; Cotton Inc.; National Cotton Council; Western IPM Center; Arizona Pest Management Center; Monsanto and Dow AgroSciences	USDA-National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); ACRPC; Arizona Cotton Growers Association; Cotton Foundation; Cotton Inc.; National Cotton Council; Western IPM Center; Arizona Pest Management Center; Monsanto and Dow AgroSciences	We thank N. Alphey, D. Crowder, F. Gould, W. Hutchison, S. Naranjo, G. Rosenthal, R.L. Smith and K.M. Wu for their thoughtful comments and assistance; and E. Miller, D. Parker, M. Krueger, N. Manhardt and Arizona Cotton Research and Protection Council (ACRPC) staff members for their contributions to the eradication program. This work was supported by funding from the USDA-National Institute of Food and Agriculture program, ACRPC, Arizona Cotton Growers Association, Cotton Foundation, Cotton Inc., National Cotton Council, Western IPM Center, Arizona Pest Management Center, and Monsanto and Dow AgroSciences.	ADAMCZYK JJ, 2006, J COTTON SCI, V10, P155; Alphey N, 2009, J ECON ENTOMOL, V102, P717, DOI 10.1603/029.102.0233; [Anonymous], 2008, JMP 8 0; Antilla L., 2008, BELTWIDE COTTON C, P1162; Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Carriere Y, 2005, PEST MANAG SCI, V61, P327, DOI 10.1002/ps.1039; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Carriere Y, 2006, J ECON ENTOMOL, V99, P1925, DOI 10.1603/0022-0493-99.6.1925; DENNEHY TJ, 2007, P151 USDA U AR COOP; Ellsworth P.C., 2010, COTTON INSECT LOSSES; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Gould F, 2004, ANNU REV ENTOMOL, V49, P193, DOI 10.1146/annurev.ento.49.061802.123344; GRAHAM HM, 1971, J ECON ENTOMOL, V64, P376, DOI 10.1093/jee/64.2.376; Grefenstette B., 2009, PINK BOLLWORM ERADIC; Henneberry T. J., 1998, Integrated Pest Management Reviews, V3, P31, DOI 10.1023/A:1009673622862; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Krafsur ES, 1998, J AGR ENTOMOL, V15, P303; Kruger M, 2009, CROP PROT, V28, P684, DOI 10.1016/j.cropro.2009.04.001; Liu YB, 2001, J ECON ENTOMOL, V94, P1237, DOI 10.1603/0022-0493-94.5.1237; Liu YB, 1999, NATURE, V400, P519, DOI 10.1038/22919; Micinski S, 2008, SOUTHWEST ENTOMOL, V33, P139, DOI 10.3958/0147-1724-33.2.139; Morin S, 2004, INSECT BIOCHEM MOLEC, V34, P1225, DOI 10.1016/j.ibmb.2004.08.003; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; NARANJO SE, 2010, SW ENTOMOL, V35, P439; Naranjo SE, 2009, PEST MANAG SCI, V65, P1267, DOI 10.1002/ps.1861; SIMS MA, 2001, P 2001 BELTW COTT C, V2, P1175; Sisterson MS, 2004, J ECON ENTOMOL, V97, P1413, DOI 10.1603/0022-0493-97.4.1413; Sokal Robert R., 1969, BIOMETRY; Stone GD, 2004, HUM ORGAN, V63, P127, DOI 10.17730/humo.63.2.jgvu7rlfafk9jwf9; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Storer Nicholas P., 2008, V5, P273, DOI 10.1007/978-1-4020-8373-0_10; Tabashnik BE, 2000, P NATL ACAD SCI USA, V97, P12980, DOI 10.1073/pnas.97.24.12980; Tabashnik BE, 2005, J ECON ENTOMOL, V98, P635, DOI 10.1603/0022-0493-98.3.635; Tabashnik BE, 1999, J ECON ENTOMOL, V92, P772, DOI 10.1093/jee/92.4.772; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2006, J ECON ENTOMOL, V99, P1525, DOI 10.1603/0022-0493-99.5.1525; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tabashnik BE, 2009, P NATL ACAD SCI USA, V106, P11889, DOI 10.1073/pnas.0901351106; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; *US EPA, SCI ADV PAN OCT 24 2; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; 2009, PINK BOLLWORM ERADIC	44	159	166	1	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2010	28	12					1304	U119		10.1038/nbt.1704	http://dx.doi.org/10.1038/nbt.1704			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	691NP	21057498				2022-12-25	WOS:000285088400026
J	Virdee, S; Ye, Y; Nguyen, DP; Komander, D; Chin, JW				Virdee, Satpal; Ye, Yu; Nguyen, Duy P.; Komander, David; Chin, Jason W.			Engineered diubiquitin synthesis reveals Lys29-isopeptide specificity of an OTU deubiquitinase	NATURE CHEMICAL BIOLOGY			English	Article							UBIQUITIN CHAINS; POLYUBIQUITIN CHAINS; PROTEIN UBIQUITINATION; PEPTIDE UBIQUITYLATION; POLYPEPTIDE-SYNTHESIS; TRANSFER-RNA; BINDING; PYRROLYSINE; ENZYME; THIOESTER	Ubiquitination is a reversible post-translational modification that regulates a myriad of eukaryotic functions. Our ability to study the effects of ubiquitination is often limited by the inaccessibility of homogeneously ubiquitinated proteins. In particular, elucidating the roles of the so-called 'atypical' ubiquitin chains (chains other than Lys48- or Lys63-linked ubiquitin), which account for a large fraction of ubiquitin polymers, is challenging because the enzymes for their biosynthesis are unknown. Here we combine genetic code expansion, intein chemistry and chemoselective ligations to synthesize 'atypical' ubiquitin chains. We solve the crystal structure of Lys6-linked diubiquitin, which is distinct from that of structurally characterized ubiquitin chains, providing a molecular basis for the different biological functions this linkage may regulate. Moreover, we profile a panel containing 10% of the known human deubiquitinases on Lys6- and Lys29-linked ubiquitin and discover that TRABID cleaves the Lys29 linkage 40-fold more efficiently than the Lys63 linkage.	[Virdee, Satpal; Ye, Yu; Nguyen, Duy P.; Komander, David; Chin, Jason W.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Virdee, S (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	dk@mrc-lmb.cam.ac.uk; chin@mrc-lmb.cam.ac.uk	Ye, Yu/D-5727-2019; Ye, Yu/ABE-7107-2021	Ye, Yu/0000-0003-0441-6399; Ye, Yu/0000-0003-0441-6399; Virdee, Satpal/0000-0002-7052-9802	Medical Research Council, United Kingdom; MRC [MC_U105181009, MC_UP_A024_1008, MC_U105192732] Funding Source: UKRI; Medical Research Council [MC_U105192732, MC_U105181009, MC_UP_A024_1008] Funding Source: researchfish	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank K. D. Wilkinson (Emory University), B. Kessler (Oxford University), S. Urbe, M. Clague (Liverpool University) and P. Cohen (MRC Protein Phosphorylation Unit, Dundee) for constructs, S. Peak-Chew, F. Begum and E. Stephens for MS/MS and members of the Laboratory of Molecular Biology for reagents. We thank L. James (Laboratory of Molecular Biology) for suggestions on kinetic analysis. This work was supported by the Medical Research Council, United Kingdom.	Aimoto S, 1999, BIOPOLYMERS, V51, P247, DOI 10.1002/(SICI)1097-0282(1999)51:4<247::AID-BIP2>3.3.CO;2-N; Ambrogelly A, 2007, P NATL ACAD SCI USA, V104, P3141, DOI 10.1073/pnas.0611634104; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Chatterjee C, 2007, ANGEW CHEM INT EDIT, V46, P2814, DOI 10.1002/anie.200605155; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; COOK WJ, 1992, J BIOL CHEM, V267, P16467; Cooper EM, 2010, J BIOL CHEM, V285, P10344, DOI 10.1074/jbc.M109.059667; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Fushman D, 2010, J MOL BIOL, V395, P803, DOI 10.1016/j.jmb.2009.10.039; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HODGINS RRW, 1992, J BIOL CHEM, V267, P8807; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kawakami T, 2001, J PEPT SCI, V7, P474, DOI 10.1002/psc.341; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Kumar KSA, 2009, ANGEW CHEM INT EDIT, V48, P8090, DOI 10.1002/anie.200902936; Li X, 2009, ANGEW CHEM INT EDIT, V48, P9184, DOI 10.1002/anie.200904472; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nishikawa H, 2009, CANCER RES, V69, P111, DOI 10.1158/0008-5472.CAN-08-3355; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Polycarpo CR, 2006, FEBS LETT, V580, P6695, DOI 10.1016/j.febslet.2006.11.028; Popp MW, 2009, J BIOL CHEM, V284, P3593, DOI 10.1074/jbc.M807172200; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; TAM JP, 1986, J AM CHEM SOC, V108, P5242, DOI 10.1021/ja00277a031; Tan ZP, 2009, J AM CHEM SOC, V131, P5424, DOI 10.1021/ja808704m; Tran H, 2008, GENE DEV, V22, P528, DOI 10.1101/gad.463208; Wang HP, 2008, P NATL ACAD SCI USA, V105, P20197, DOI 10.1073/pnas.0810461105; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang RL, 2009, J AM CHEM SOC, V131, P13592, DOI 10.1021/ja905491p	43	230	242	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2010	6	10					750	757		10.1038/NCHEMBIO.426	http://dx.doi.org/10.1038/NCHEMBIO.426			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	651YM	20802491				2022-12-25	WOS:000281964100012
J	Davila, S; Wright, VJ; Khor, CC; Sim, KS; Binder, A; Breunis, WB; Inwald, D; Nadel, S; Betts, H; Carrol, ED; de Groot, R; Hermans, PWM; Hazelzet, J; Emonts, M; Lim, CC; Kuijpers, TW; Martinon-Torres, F; Salas, A; Zenz, W; Levin, M; Hibberd, ML				Davila, Sonia; Wright, Victoria J.; Khor, Chiea Chuen; Sim, Kar Seng; Binder, Alexander; Breunis, Willemijn B.; Inwald, David; Nadel, Simon; Betts, Helen; Carrol, Enitan D.; de Groot, Ronald; Hermans, Peter W. M.; Hazelzet, Jan; Emonts, Marieke; Lim, Chui Chin; Kuijpers, Taco W.; Martinon-Torres, Federico; Salas, Antonio; Zenz, Werner; Levin, Michael; Hibberd, Martin L.		Int Meningococcal Genetics Consort	Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease	NATURE GENETICS			English	Article							4G/5G PROMOTER POLYMORPHISM; COMPLEMENT FACTOR-H; PLASMINOGEN-ACTIVATOR-INHIBITOR-1 GENE; HAPLOTYPE; CHILDREN; RISK	Meningococcal disease is an infection caused by Neisseria meningitidis. Genetic factors contribute to host susceptibility and progression to disease, but the genes responsible for disease development are largely unknown(1-3). We report here a genome-wide association study for host susceptibility to meningococcal disease using 475 individuals with meningococcal disease (cases) and 4,703 population controls from the UK. We performed, in Western European and South European cohorts (consisting of 968 cases and 1,376 controls), two replication studies for the most significant SNPs. A cluster of complement factor SNPs replicated independently in both cohorts, including SNPs within complement factor H (CFH) (rs1065489 (p.936D<E), P = 2.2 x 10(-11)) and in CFH-related protein 3 (CFHR3)(rs426736, P = 4.6 x 10(-13)). N. meningitidis is known to evade complement-mediated killing by the binding of host CFH to the meningococcal factor H-binding protein (fHbp)(4). Our study suggests that host genetic variation in these regulators of complement activation plays a role in determining the occurrence of invasive disease versus asymptomatic colonization by this pathogen.	[Davila, Sonia; Khor, Chiea Chuen; Sim, Kar Seng; Lim, Chui Chin; Hibberd, Martin L.] Genome Inst Singapore, Singapore, Singapore; [Wright, Victoria J.; Inwald, David; Nadel, Simon; Betts, Helen; Levin, Michael] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Infect Dis, London, England; [Binder, Alexander; Zenz, Werner] Med Univ Graz, Dept Gen Pediat, Graz, Austria; [Breunis, Willemijn B.; Kuijpers, Taco W.] Emma Childrens Hosp Acad Med Ctr, Div Pediat Hematol Immunol & Infect Dis, Amsterdam, Netherlands; [Carrol, Enitan D.] Univ Liverpool, Inst Child Hlth, Alder Hey Childrens Natl Hlth Serv Fdn Trust, Liverpool L69 3BX, Merseyside, England; [de Groot, Ronald; Hermans, Peter W. M.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, NL-6525 ED Nijmegen, Netherlands; [Hazelzet, Jan; Emonts, Marieke] Sophia Childrens Univ Hosp, Univ Med Ctr, Erasmus Med Ctr, Dept Pediat, Rotterdam, Netherlands; [Emonts, Marieke] Univ Med Ctr, Erasmus Med Ctr, Dept Immunol, Rotterdam, Netherlands; [Martinon-Torres, Federico] Hosp Clin Univ Santiago, Dept Pediat, Pediat Emergency & Crit Care Div, Santiago De Compostela, Spain; [Martinon-Torres, Federico] Inst Invest Sanitaria Santiago, Grp Gallego Genet Vacunas & Invest Pediat, Galicia, Spain; [Salas, Antonio] Univ Santiago de Compostela, Unidade Xenet, Dept Anat Patol & Ciencias Forenses, Fac Med, Santiago De Compostela, Spain; [Salas, Antonio] Univ Santiago de Compostela, Inst Med Legal, Fac Med, Santiago De Compostela, Galicia, Spain	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Imperial College London; Medical University of Graz; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Alder Hey Children's NHS Foundation Trust; University of Liverpool; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Davila, S (corresponding author), Genome Inst Singapore, Singapore, Singapore.	sonia@gis.a-star.edu.sg; m.levin@imperial.ac.uk; hibberdml@gis.a-star.edu.sg	Hermans, Peter W.M./H-8042-2014; Hazelzet, Jan A/L-2888-2015; Zenz, Werner/AAZ-3375-2021; Hibberd, Martin L/D-5050-2009; Hermans, Peter P.W.M./F-4655-2010; Salas, Antonio/U-2029-2019; Salas, Antonio/E-3977-2012; de Groot, R./H-8039-2014; Martinon-Torres, Federico/E-4982-2016	Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X; Martinon-Torres, Federico/0000-0002-9023-581X; Inwald, David/0000-0001-9518-7821; Zenz, Werner/0000-0002-6218-3143; Wright, Victoria/0000-0001-7826-1516; Khor, Chiea Chuen/0000-0002-1128-4729; Hazelzet, Jan/0000-0002-9414-5539; Levin, Michael/0000-0003-2767-6919; , International Journal of Business and Applied Social Science/0000-0001-7850-0193; Sim, Kar Seng/0000-0002-3822-7759; Emonts, Marieke/0000-0002-2822-3527; Carrol, Enitan/0000-0001-8357-7726; Hibberd, Martin/0000-0001-8587-1849	Wellcome Trust (UK) [085475]; Agency for Science and Technology and Research of Singapore (A*STAR) (Singapore); Meningitis Research Foundation (UK); European Society for Pediatric Infectious Diseases; Oesterreichische Nationalbank (Austria) [8842, 10112, 12710]; Department for Science and Research of the Styrian federal government (Austria) [A3-16.K-8/2008-11, A3-16.K-8/2006-9]; 'In Vita', Graz (Austria); Xunta de Galicia [PGIDIT06PXIB208079PR, 2008/037]; Fundacion de Investigacion Medica Mutua Madrilena [2008/CL444]; Ministerio de Ciencia e Innovacion [SAF2008-02971]; Conselleria de Sanidade (Xunta de Galicia) [RHI07/2]; Instituto Carlos III (Intensificacion de la actividad investigadora); Convenio de colaboracion de investigacion (Wyeth Espana-Fundacion); Fondo de Investigacion Sanitaria (FIS) [PI070069]; Fondos FEDER; Erasmus MC Revolving Fund Foundation (The Netherlands) [RF 2001/24]	Wellcome Trust (UK)(Wellcome Trust); Agency for Science and Technology and Research of Singapore (A*STAR) (Singapore)(Agency for Science Technology & Research (A*STAR)); Meningitis Research Foundation (UK)(Meningitis Research Foundation (MRF)); European Society for Pediatric Infectious Diseases; Oesterreichische Nationalbank (Austria); Department for Science and Research of the Styrian federal government (Austria); 'In Vita', Graz (Austria); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fundacion de Investigacion Medica Mutua Madrilena; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Conselleria de Sanidade (Xunta de Galicia)(Xunta de Galicia); Instituto Carlos III (Intensificacion de la actividad investigadora)(Instituto de Salud Carlos III); Convenio de colaboracion de investigacion (Wyeth Espana-Fundacion); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Fondos FEDER(European Commission); Erasmus MC Revolving Fund Foundation (The Netherlands)(Netherlands Government)	We thank C. H. Wong, D. Tan, J.W. Tay, W.Y. Meah, S. Rajaram and C. B. Ang (Genome Institute of Singapore) for technical and logistical assistance. We also would like to thank all the children and parents who participated in this study. This study makes use of data generated by the Wellcome Trust Case-Control Consortium 2. A full list of the investigators who contributed to the generation of the data is available from the WTCCC website (see URLs). Funding for the project was provided by the Wellcome Trust under award 085475 (UK). The present work has been supported in part by funding from the Agency for Science and Technology and Research of Singapore (A*STAR) (Singapore). The UK meningococcal disease cohort was established with grant support from the Meningitis Research Foundation (UK). The coordination of the European cohorts was supported by a grant from the European Society for Pediatric Infectious Diseases. The Western Europe study was supported by grants no 8842, 10112 and 12710 of the Oesterreichische Nationalbank (Austria), grants A3-16.K-8/2008-11 and A3-16.K-8/2006-9 of the Department for Science and Research of the Styrian federal government (Austria) and the nonprofit association 'In Vita', Graz (Austria). The ESIGEM research group activities were supported by grants from Xunta de Galicia (PGIDIT06PXIB208079PR and Grupos Emerxentes: 2008/037), Fundacion de Investigacion Medica Mutua Madrilena (2008/CL444) and Ministerio de Ciencia e Innovacion (SAF2008-02971) given to A. S.; Conselleria de Sanidade (Xunta de Galicia, RHI07/2-intensificacion actividad investigadora), Instituto Carlos III (Intensificacion de la actividad investigadora), Convenio de colaboracion de investigacion (Wyeth Espana-Fundacion IDICHUS 2007-2010), Fondo de Investigacion Sanitaria (FIS; PI070069) del plan nacional de I+D+I and 'fondos FEDER' given to F.M.-T.M.E. was financially supported by the Erasmus MC Revolving Fund Foundation (RF 2001/24) (The Netherlands).	Abarrategui-Garrido C, 2009, BLOOD, V114, P4261, DOI 10.1182/blood-2009-05-223834; Binder A, 2007, HUM GENET, V122, P183, DOI 10.1007/s00439-007-0392-5; Brouwer MC, 2009, LANCET INFECT DIS, V9, P31, DOI 10.1016/S1473-3099(08)70261-5; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Emonts M, 2003, LANCET INFECT DIS, V3, P565, DOI 10.1016/S1473-3099(03)00740-0; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Geishofer G, 2005, EUR J PEDIATR, V164, P486, DOI 10.1007/s00431-005-1673-4; Haralambous E, 2003, CRIT CARE MED, V31, P2788, DOI 10.1097/01.CCM.0000100122.57249.5D; Haralambous E, 2003, EPIDEMIOL INFECT, V130, P413, DOI 10.1017/S0950268803008513; Haralambous E, 2006, SCAND J INFECT DIS, V38, P764, DOI 10.1080/00365540600643203; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Hazelzet JA, 2005, PEDIATR CRIT CARE ME, V6, P50; Hermans PWM, 1999, LANCET, V354, P556, DOI 10.1016/S0140-6736(99)02220-5; Hibberd ML, 1999, LANCET, V353, P1049, DOI 10.1016/S0140-6736(98)08350-0; Hollox EJ, 2008, GENOME RES, V18, P1686, DOI 10.1101/gr.080945.108; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Male DA, 2000, MOL IMMUNOL, V37, P41, DOI 10.1016/S0161-5890(00)00024-9; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mathew S, 2006, PEDIATR INFECT DIS J, V25, P255, DOI 10.1097/01.inf.0000209215.65445.04; Nadel S, 1996, J INFECT DIS, V174, P878, DOI 10.1093/infdis/174.4.878; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Salas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008347; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; Wright V, 2009, VACCINE, V27, pB90, DOI 10.1016/j.vaccine.2009.05.002; Zipfel PF, 2007, PLOS GENET, V3, P387, DOI 10.1371/journal.pgen.0030041	30	205	215	0	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					772	U63		10.1038/ng.640	http://dx.doi.org/10.1038/ng.640			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20694013				2022-12-25	WOS:000281388400013
J	Barb, AW; Prestegard, JH				Barb, Adam W.; Prestegard, James H.			NMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic	NATURE CHEMICAL BIOLOGY			English	Article							MAGNETIC-RESONANCE RELAXATION; MODEL-FREE APPROACH; FC-GAMMA RECEPTOR; ANTIINFLAMMATORY ACTIVITY; RHEUMATOID-ARTHRITIS; CRYSTAL-STRUCTURE; GLYCOSYLATION; OLIGOSACCHARIDE; SPECTROSCOPY; COMPLEX	The N-glycan at Asn297 of the immunoglobulin G Fc fragment modulates cellular responses of the adaptive immune system. However, the underlying mechanism remains undefined, as existing structural data suggest the glycan does not directly engage cell surface receptors. Here we characterize the dynamics of the glycan termini using solution NMR spectroscopy. Contrary to previous conclusions based on X-ray crystallography and limited NMR data, our spin relaxation studies indicate that the termini of both glycan branches are highly dynamic and experience considerable motion in addition to tumbling of the Fc molecule. Relaxation dispersion and temperature-dependent chemical shift perturbations demonstrate exchange of the alpha 1-6Man-linked branch between a protein-bound and a previously unobserved unbound state, suggesting the glycan samples conformational states that can be accessed by glycan-modifying enzymes and possibly glycan recognition domains. These findings suggest a role for Fc-glycan dynamics in Fc-receptor interactions and enzymatic glycan remodeling.	[Barb, Adam W.; Prestegard, James H.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Barb, AW (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	jpresteg@ccrc.uga.edu		Barb, Adam/0000-0003-3290-8649	US National Institutes of Health [R01GM033225, P41RR005351]; Kirschstein National Research Service [F32AR058084]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR058084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, R01GM033225] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Yang and M. Bar-Peled for the galactokinase, Y. Liu for discussions of dynamics and pulse sequences and E. Brady for preparing the UDP-<SUP>13</SUP>C-galactose, all of the University of Georgia. This research was funded by grants from the US National Institutes of Health (R01GM033225 and P41RR005351). A. W. B. was supported by a Kirschstein National Research Service Award fellowship (F32AR058084).	Alavi A, 2008, RHEUMATOLOGY, V47, P760, DOI 10.1093/rheumatology/ken081; Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Barb AW, 2010, METHOD ENZYMOL, V478, P365, DOI 10.1016/S0076-6879(10)78018-6; Barb AW, 2009, BIOCHEMISTRY-US, V48, P9705, DOI 10.1021/bi901430h; BOCK K, 1984, ADV CARBOHYD CHEM BI, V42, P193, DOI 10.1016/S0065-2318(08)60125-0; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Goronzy JJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2758; Hansen DF, 2008, J AM CHEM SOC, V130, P2667, DOI 10.1021/ja078337p; HIROTSU K, 1974, B CHEM SOC JPN, V47, P1872, DOI 10.1246/bcsj.47.1872; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Kaneko Y, 2006, J EXP MED, V203, P789, DOI 10.1084/jem.20051900; Kobata A, 2008, BBA-GEN SUBJECTS, V1780, P472, DOI 10.1016/j.bbagen.2007.06.012; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lund J, 1996, J IMMUNOL, V157, P4963; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; Mimura Y, 2001, J BIOL CHEM, V276, P45539, DOI 10.1074/jbc.M107478200; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Raju TS, 2001, BIOCHEMISTRY-US, V40, P8868, DOI 10.1021/bi010475i; Roitt I., 2001, IMMUNOLOGY, V6th; Scallon BJ, 2007, MOL IMMUNOL, V44, P1524, DOI 10.1016/j.molimm.2006.09.005; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; VLIEGENTHART JFG, 1983, ADV CARBOHYD CHEM BI, V41, P209, DOI 10.1016/S0065-2318(08)60059-1; Voynov V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008425; WIERUSZESKI JM, 1989, GLYCOCONJUGATE J, V6, P183, DOI 10.1007/BF01050647; Wormald MR, 1997, BIOCHEMISTRY-US, V36, P1370, DOI 10.1021/bi9621472; Yamaguchi Y, 2006, BBA-GEN SUBJECTS, V1760, P693, DOI 10.1016/j.bbagen.2005.10.002; Yamaguchi Y, 1998, J BIOMOL NMR, V12, P385, DOI 10.1023/A:1008392229694	38	133	144	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2011	7	3					147	153		10.1038/NCHEMBIO.511	http://dx.doi.org/10.1038/NCHEMBIO.511			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	720UH	21258329	Green Accepted			2022-12-25	WOS:000287307600007
J	Zhang, Q; Li, YX; Chen, DD; Yu, Y; Duan, LA; Shen, B; Liu, W				Zhang, Qi; Li, Yuxue; Chen, Dandan; Yu, Yi; Duan, Lian; Shen, Ben; Liu, Wen			Radical-mediated enzymatic carbon chain fragmentation-recombination	NATURE CHEMICAL BIOLOGY			English	Article							PEPTIDE ANTIBIOTIC NOSIHEPTIDE; STREPTOMYCES-ACTUOSUS; SAM SUPERFAMILY; POSTTRANSLATIONAL MODIFICATIONS; THIOPEPTIDE ANTIBIOTICS; ESCHERICHIA-COLI; GLUTAMATE MUTASE; BIOSYNTHESIS; THIOSTREPTON; IDENTIFICATION	The radical S-adenosylmethionine (S-AdoMet) superfamily contains thousands of proteins that catalyze highly diverse conversions, most of which are poorly understood, owing to a lack of information regarding chemical products and radical-dependent transformations. We here report that NosL, involved in forming the indole side ring of the thiopeptide nosiheptide (NOS), is a radical S-AdoMet 3-methyl-2-indolic acid (MIA) synthase. NosL catalyzed an unprecedented carbon chain reconstitution of L-tryptophan to give MIA, showing removal of the C alpha-N unit and shift of the carboxylate to the indole ring. Dissection of the enzymatic process upon the identification of products and a putative glycyl intermediate uncovered a radical-mediated, unusual fragmentation-recombination reaction. This finding unveiled a key step in radical S-AdoMet enzyme-catalyzed structural rearrangements during complex biotransformations. Additionally, NosL tolerated fluorinated L-tryptophan as the substrate, allowing for production of a regiospecifically halogenated thiopeptide that has not been found among the more than 80 members of the naturally occurring thiopeptide family.	[Zhang, Qi; Chen, Dandan; Yu, Yi; Duan, Lian; Liu, Wen] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Li, Yuxue] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Organometall Chem, Shanghai 200032, Peoples R China; [Shen, Ben] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53706 USA	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; University of Wisconsin System; University of Wisconsin Madison	Zhang, Q (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 345 Lingling Lu, Shanghai 200032, Peoples R China.	wliu@mail.sioc.ac.cn	Chen, Dan/GRY-2691-2022	Chen, Dan/0000-0002-1570-9034; Duan, Lian/0000-0002-8266-717X	US National Institutes of Health [CA094426]; Chinese National Natural Science Foundation [20832009, 30525001, 90713012, 20921091]; Chinese Ministry of Science and Technology [2009ZX09501-008]; Chinese National Basic Research Program ("973 program)" [2010CB833200]; Chinese Academy of Sciences [KJCX2-YW-H08, KSCX2-YW-G-06]; Science and Technology Commission of Shanghai Municipality of China [09QH1402700]; NATIONAL CANCER INSTITUTE [R01CA094426] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese National Basic Research Program ("973 program)"(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality of China(Science & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank H. G. Floss (University of Washington) for providing S. actuosus ATCC25421 and for his pioneering work on NOS biosynthesis and Y. Zhang and W. Tong, (High Magnetic Field Laboratory, Chinese Academy of Sciences) for assistance with EPR analysis. This work was supported in part by grants from US National Institutes of Health (CA094426 to B. S.), Chinese National Natural Science Foundation (20832009, 30525001, 90713012 and 20921091), Chinese Ministry of Science and Technology (2009ZX09501-008), Chinese National Basic Research Program ("973 program," 2010CB833200), Chinese Academy of Sciences (KJCX2-YW-H08 and KSCX2-YW-G-06) and Science and Technology Commission of Shanghai Municipality (09QH1402700) of China (all to W.L).	Acker MG, 2009, J AM CHEM SOC, V131, P17563, DOI 10.1021/ja908777t; Arndt HD, 2009, ANGEW CHEM INT EDIT, V48, P6770, DOI 10.1002/anie.200901808; Bagley MC, 2005, CHEM REV, V105, P685, DOI 10.1021/cr0300441; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Bonifacic M, 1998, J AM CHEM SOC, V120, P9930, DOI 10.1021/ja9815428; Bowers AA, 2010, J AM CHEM SOC, V132, P7519, DOI 10.1021/ja102339q; Brown LCW, 2009, P NATL ACAD SCI USA, V106, P2549, DOI [10.1073/pnas.0900008105, 10.1073/pnas.0900008106]; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Chih HW, 2000, J AM CHEM SOC, V122, P10732, DOI 10.1021/ja002488+; Chih HW, 1999, BIOCHEMISTRY-US, V38, P13684, DOI 10.1021/bi991064t; Ding Y, 2010, MOL BIOSYST, V6, P1180, DOI 10.1039/c005121g; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; HOUCK DR, 1988, J AM CHEM SOC, V110, P5800, DOI 10.1021/ja00225a035; Kelly WL, 2009, J AM CHEM SOC, V131, P4327, DOI 10.1021/ja807890a; Kriek M, 2007, ANGEW CHEM INT EDIT, V46, P9223, DOI 10.1002/anie.200702554; Kriek M, 2007, J BIOL CHEM, V282, P17413, DOI 10.1074/jbc.M700782200; Li CX, 2010, NAT PROD REP, V27, P153, DOI 10.1039/b922434c; Liao RJ, 2009, CHEM BIOL, V16, P141, DOI 10.1016/j.chembiol.2009.01.007; Marsh ENG, 2010, CHEMBIOCHEM, V11, P604, DOI 10.1002/cbic.200900777; MOCEK U, 1993, J AM CHEM SOC, V115, P7992, DOI 10.1021/ja00071a009; MOCEK U, 1993, J AM CHEM SOC, V115, P7557, DOI 10.1021/ja00070a001; Morris RP, 2009, J AM CHEM SOC, V131, P5946, DOI 10.1021/ja900488a; Nicolaou KC, 2009, ANGEW CHEM INT EDIT, V48, P660, DOI 10.1002/anie.200801695; Nicolet Y, 2004, NUCLEIC ACIDS RES, V32, P4015, DOI 10.1093/nar/gkh728; Priestley ND, 1996, BIOORGAN MED CHEM, V4, P1135, DOI 10.1016/0968-0896(96)00126-5; SMITH TM, 1993, J CHEM SOC CHEM COMM, P1612, DOI 10.1039/c39930001612; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Wang J, 2010, APPL ENVIRON MICROB, V76, P2335, DOI 10.1128/AEM.01790-09; Wang SC, 2007, TRENDS BIOCHEM SCI, V32, P101, DOI 10.1016/j.tibs.2007.01.002; Yu Y, 2009, ACS CHEM BIOL, V4, P855, DOI 10.1021/cb900133x	31	108	114	3	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2011	7	3					154	160		10.1038/NCHEMBIO.512	http://dx.doi.org/10.1038/NCHEMBIO.512			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	720UH	21240261	Green Accepted			2022-12-25	WOS:000287307600008
J	Lausch, E; Janecke, A; Bros, M; Trojandt, S; Alanay, Y; De Laet, C; Hubner, CA; Meinecke, P; Nishimura, G; Matsuo, M; Hirano, Y; Tenoutasse, S; Kiss, A; Rosa, RFM; Unger, SL; Renella, R; Bonafe, L; Spranger, J; Unger, S; Zabel, B; Superti-Furga, A				Lausch, Ekkehart; Janecke, Andreas; Bros, Matthias; Trojandt, Stefanie; Alanay, Yasemin; De Laet, Corinne; Huebner, Christian A.; Meinecke, Peter; Nishimura, Gen; Matsuo, Mari; Hirano, Yoshiko; Tenoutasse, Sylvie; Kiss, Andrea; Machado Rosa, Rafael Fabiano; Unger, Sharon L.; Renella, Raffaele; Bonafe, Luisa; Spranger, Juergen; Unger, Sheila; Zabel, Bernhard; Superti-Furga, Andrea			Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity	NATURE GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DENDRITIC CELLS; MULTIPLE-SCLEROSIS; T-CELLS; OSTEOPONTIN EXPRESSION; STAPHYLOCOCCUS-AUREUS; ACP 5; SPONDYLOENCHONDRODYSPLASIA; SURVIVAL; DISEASE	Vertebral and metaphyseal dysplasia, spasticity with cerebral calcifications, and strong predisposition to autoimmune diseases are the hallmarks of the genetic disorder spondyloenchondrodysplasia. We mapped a locus in five consanguineous families to chromosome 19p13 and identified mutations in ACP5, which encodes tartrate-resistant phosphatase (TRAP), in 14 affected individuals and showed that these mutations abolish enzyme function in the serum and cells of affected individuals. Phosphorylated osteopontin, a protein involved in bone reabsorption and in immune regulation, accumulates in serum, urine and cells cultured from TRAP-deficient individuals. Case-derived dendritic cells exhibit an altered cytokine profile and are more potent than matched control cells in stimulating allogeneic T cell proliferation in mixed lymphocyte reactions. These findings shed new light on the role of osteopontin and its regulation by TRAP in the pathogenesis of common autoimmune disorders.	[Lausch, Ekkehart; Spranger, Juergen; Unger, Sheila; Zabel, Bernhard; Superti-Furga, Andrea] Univ Freiburg, Freiburg Univ Hosp, Ctr Pediat & Adolescent Med, Freiburg, Germany; [Janecke, Andreas] Innsbruck Med Univ, Dept Pediat 2, Innsbruck, Austria; [Janecke, Andreas] Innsbruck Med Univ, Div Human Genet, Innsbruck, Austria; [Bros, Matthias; Trojandt, Stefanie] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Dermatol, Mainz, Germany; [Alanay, Yasemin] Hacettepe Univ, Fac Med, Dept Pediat, Pediat Genet Unit, TR-06100 Ankara, Turkey; [De Laet, Corinne; Tenoutasse, Sylvie] Queen Fabiola Childrens Univ Hosp, Nutr & Metab Unit, Brussels, Belgium; [Huebner, Christian A.] Univ Jena, Univ Hosp Jena, Inst Human Genet, Jena, Germany; [Meinecke, Peter] Childrens Hosp Altona, Clin Genet Unit, Hamburg, Germany; [Nishimura, Gen] Tokyo Metropolitan Childrens Med Ctr, Dept Pediat Imaging, Tokyo, Japan; [Matsuo, Mari; Hirano, Yoshiko] Tokyo Womens Med Univ, Dept Pediat, Tokyo, Japan; [Kiss, Andrea; Machado Rosa, Rafael Fabiano] Univ Fed Ciencias Saude Porto Alegre, Div Clin Genet, Porto Alegre, RS, Brazil; [Kiss, Andrea; Machado Rosa, Rafael Fabiano] Univ Fed Ciencias Saude Porto Alegre, Grad Program Pathol, Porto Alegre, RS, Brazil; [Unger, Sharon L.] Univ Toronto, Mt Sinai Hosp, Div Neonatol, Toronto, ON M5G 1X5, Canada; [Renella, Raffaele] Childrens Hosp, Dept Pediat Hematol Oncol, Boston, MA 02115 USA; [Renella, Raffaele] Dana Farber Canc Inst, Boston, MA 02115 USA; [Renella, Raffaele; Bonafe, Luisa; Superti-Furga, Andrea] CHU Vaudois, Dept Pediat, CH-1011 Lausanne, Switzerland; [Unger, Sheila] CHU Vaudois, Dept Med Genet, CH-1011 Lausanne, Switzerland	University of Freiburg; Medical University of Innsbruck; Medical University of Innsbruck; Johannes Gutenberg University of Mainz; Hacettepe University; Friedrich Schiller University of Jena; University of Hamburg; University Medical Center Hamburg-Eppendorf; Tokyo Metropolitan Children's Medical Center; Tokyo Women's Medical University; Universidade Federal de Ciencias da Saude de Porto Alegre; Universidade Federal de Ciencias da Saude de Porto Alegre; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Superti-Furga, A (corresponding author), Univ Freiburg, Freiburg Univ Hosp, Ctr Pediat & Adolescent Med, Freiburg, Germany.	asuperti@unil.ch	Renella, Raffaele/AAO-1729-2020; superti-furga, andrea/E-9162-2015; Rosa, Rafael FM/C-6912-2017; Janecke, Andreas/AAA-5227-2019; Alanay, Yasemin/A-1516-2016; unger, sheila/E-9177-2015; Hübner, Christian/A-2950-2017	superti-furga, andrea/0000-0002-3543-7531; Alanay, Yasemin/0000-0003-0683-9731; Hübner, Christian/0000-0002-1030-4943; Unger, Sheila/0000-0002-9539-8941; Unger, Sharon/0000-0001-8091-5742; Janecke, Andreas/0000-0001-7155-0315; Renella, Raffaele/0000-0002-5041-2308	Deutsche Forschungsgemeinschaft [La 1381/1-3]; German Bundesministerium fur Bildung und Forschung; Leenaards Foundation (Lausanne, Switzerland)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Leenaards Foundation (Lausanne, Switzerland)	We thank our cases and their families for participation in this study. We are also grateful to T. Velten and to the Lausch/Zabel lab for excellent technical assistance and to M. Osawa and H. Katumori, Tokyo, for clinical information. S. Ehl and his group at the Centre for Chronic Immunodeficiency in Freiburg were most helpful in discussing immunological aspects and experimental strategies. This work was made possible by continuous grant support from the Deutsche Forschungsgemeinschaft to E. L. and B.Z. (La 1381/1-3). B.Z. is also supported by the German Bundesministerium fur Bildung und Forschung (SKELNET project), and A.S.-F. is supported by the Leenaards Foundation (Lausanne, Switzerland). The paper is dedicated to Celine and Sinai.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Andersson G, 2003, J BONE MINER RES, V18, P1912, DOI 10.1359/jbmr.2003.18.10.1912; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bune AJ, 2001, IMMUNOLOGY, V102, P103, DOI 10.1046/j.1365-2567.2001.01145.x; Burdo TH, 2007, J LEUKOCYTE BIOL, V81, P1504, DOI 10.1189/jlb.1106711; Cantor H, 2009, NAT REV IMMUNOL, V9, P137, DOI 10.1038/nri2460; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; D'Alfonso S, 2005, ARTHRITIS RHEUM, V52, P539, DOI 10.1002/art.20808; EKRYLANDER B, 1994, J BIOL CHEM, V269, P14853; Esfandiari E, 2006, J BONE MINER RES, V21, P1367, DOI 10.1359/JBMR.060611; FRYDMAN M, 1990, AM J MED GENET, V36, P279, DOI 10.1002/ajmg.1320360306; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Halleen JM, 2000, J BONE MINER RES, V15, P1337, DOI 10.1359/jbmr.2000.15.7.1337; Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667; Hayman AR, 2001, J HISTOCHEM CYTOCHEM, V49, P675, DOI 10.1177/002215540104900601; Hayman AR, 1996, DEVELOPMENT, V122, P3151; HAYMAN AR, 1989, BIOCHEM J, V261, P601, DOI 10.1042/bj2610601; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; Iizuka J, 1998, LAB INVEST, V78, P1523; Janckila AJ, 2009, CALCIFIED TISSUE INT, V85, P465, DOI 10.1007/s00223-009-9309-8; Kaija H, 2002, BIOCHEM BIOPH RES CO, V292, P128, DOI 10.1006/bbrc.2002.6615; Kawamura K, 2005, CLIN DIAGN LAB IMMUN, V12, P206, DOI 10.1128/CDLI.12.1.206-212.2005; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Lausch E, 2009, AM J HUM GENET, V85, P168, DOI 10.1016/j.ajhg.2009.06.014; MENGER H, 1989, J MED GENET, V26, P93, DOI 10.1136/jmg.26.2.93; Murugaiyan G, 2008, J IMMUNOL, V181, P7480, DOI 10.4049/jimmunol.181.11.7480; Nakanishi M, 1998, CLIN CHEM, V44, P221; Oddie GW, 2000, BONE, V27, P575, DOI 10.1016/S8756-3282(00)00368-9; Raisanen SR, 2005, BIOCHEM BIOPH RES CO, V331, P120, DOI 10.1016/j.bbrc.2005.03.133; Raisanen SR, 2001, BIOCHEM BIOPH RES CO, V288, P142, DOI 10.1006/bbrc.2001.5715; Renella R, 2006, AM J MED GENET A, V140A, P541, DOI 10.1002/ajmg.a.31081; Renkl AC, 2005, BLOOD, V106, P946, DOI 10.1182/blood-2004-08-3228; Rosenthal AK, 2007, MATRIX BIOL, V26, P96, DOI 10.1016/j.matbio.2006.10.004; SCHARER K, 1958, Helv Paediatr Acta, V13, P40; SCHORR S, 1976, RADIOLOGY, V118, P133, DOI 10.1148/118.1.133; SENGER DR, 1994, MOL BIOL CELL, V5, P565, DOI 10.1091/mbc.5.5.565; Shinohara ML, 2008, IMMUNITY, V29, P68, DOI 10.1016/j.immuni.2008.05.008; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Steinman L, 2009, NAT REV IMMUNOL, V9, P440, DOI 10.1038/nri2548; Strater N, 2005, J MOL BIOL, V351, P233, DOI 10.1016/j.jmb.2005.04.014; Stromnes IM, 2007, NAT IMMUNOL, V8, P19, DOI 10.1038/ni0107-19; Sun PL, 2008, P NATL ACAD SCI USA, V105, P16590, DOI 10.1073/pnas.0807472105; Suter A, 2001, DEVELOPMENT, V128, P4899; Vogt MHJ, 2003, ANN NEUROL, V53, P819, DOI 10.1002/ana.10606; WALKER BS, 1954, AM J CLIN PATHOL, V24, P807; Weber GF, 2002, J LEUKOCYTE BIOL, V72, P752; Wong CK, 2005, RHEUMATOLOGY, V44, P602, DOI 10.1093/rheumatology/keh558; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328	50	115	123	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2011	43	2					132	U79		10.1038/ng.749	http://dx.doi.org/10.1038/ng.749			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	711XD	21217752				2022-12-25	WOS:000286623800011
J	Zhang, F; Cong, L; Lodato, S; Kosuri, S; Church, GM; Arlotta, P				Zhang, Feng; Cong, Le; Lodato, Simona; Kosuri, Sriram; Church, George M.; Arlotta, Paola			Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription	NATURE BIOTECHNOLOGY			English	Article							III EFFECTORS; HOMING ENDONUCLEASE; DNA RECOGNITION; PROTEINS; GENOME; GENE; LIBRARIES; PROMOTER; BINDING; AVRBS3	The ability to direct functional proteins to specific DNA sequences is a long-sought goal in the study and engineering of biological processes. Transcription activator-like effectors (TALEs) from Xanthomonas sp. are site-specific DNA-binding proteins that can be readily designed to target new sequences. Because TALEs contain a large number of repeat domains, it can be difficult to synthesize new variants. Here we describe a method that overcomes this problem. We leverage codon degeneracy and type IIs restriction enzymes to generate orthogonal ligation linkers between individual repeat monomers, thus allowing full-length, customized, repeat domains to be constructed by hierarchical ligation. We synthesized 17 TALEs that are customized to recognize specific DNA-binding sites, and demonstrate that they can specifically modulate transcription of endogenous genes (SOX2 and KLF4) in human cells.	[Zhang, Feng; Cong, Le; Kosuri, Sriram; Church, George M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Zhang, Feng; Cong, Le; Kosuri, Sriram; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Cong, Le] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA USA; [Zhang, Feng; Lodato, Simona; Arlotta, Paola] Harvard Univ, Sch Med, Dept Stem Cell & Regenerat Biol, Boston, MA USA; [Lodato, Simona; Arlotta, Paola] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA USA; [Lodato, Simona; Arlotta, Paola] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurosurg, Boston, MA USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Zhang, F (corresponding author), MIT & Harvard, Broad Inst, Cambridge, MA USA.	zhang_f@mit.edu; paola_arlotta@hms.harvard.edu	Macrae, Rhiannon/AAX-1536-2020; Lodato, Simona/A-3525-2017; Cong, Le/M-9981-2013	Lodato, Simona/0000-0001-6498-2590; Cong, Le/0000-0003-4725-8714; Kosuri, Sriram/0000-0002-4661-0600; church, george/0000-0001-6232-9969	Harvard Society of Fellows; National Human Genome Research Institute Center for Excellence in Genomics Science [P50 HG003170]; Department of Energy Genomes to Life [DE-FG02-02ER63445]; Defense Advanced Research Projects Agency [W911NF-08-1-0254]; Wyss Institute for Biologically Inspired Engineering; National Institutes of Health [R01 NS073124-01]; European School of Molecular Medicine; Church and Arlotta laboratories; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062849, R01NS073124] Funding Source: NIH RePORTER	Harvard Society of Fellows; National Human Genome Research Institute Center for Excellence in Genomics Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Department of Energy Genomes to Life; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Wyss Institute for Biologically Inspired Engineering; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European School of Molecular Medicine; Church and Arlotta laboratories; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Harvard Society of Fellows (F.Z.), National Human Genome Research Institute Center for Excellence in Genomics Science (P50 HG003170, G.M.C.), Department of Energy Genomes to Life (DE-FG02-02ER63445, G.M.C.), Defense Advanced Research Projects Agency (W911NF-08-1-0254, G.M.C.), the Wyss Institute for Biologically Inspired Engineering (G.M.C.) and National Institutes of Health Transformative R01 (R01 NS073124-01, F.Z. and P.A.). S.L. was partially supported by a predoctoral fellowship from the European School of Molecular Medicine (S.E.M.M.). We thank the entire Church and Arlotta laboratories for discussion and support.	Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Blancafort P, 2003, NAT BIOTECHNOL, V21, P269, DOI 10.1038/nbt794; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Gonzalez B, 2010, NAT PROTOC, V5, P791, DOI 10.1038/nprot.2010.34; Gordley RM, 2009, P NATL ACAD SCI USA, V106, P5053, DOI 10.1073/pnas.0812502106; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kay S, 2009, PLANT J, V59, P859, DOI 10.1111/j.1365-313X.2009.03922.x; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Maeder ML, 2009, NAT PROTOC, V4, P1471, DOI 10.1038/nprot.2009.98; Meister GE, 2010, NUCLEIC ACIDS RES, V38, P1749, DOI 10.1093/nar/gkp1126; MILLER JC, 2010, NAT BIOTECHNOL, DOI DOI 10.1038/NBT.1755; Morbitzer R, 2010, P NATL ACAD SCI USA, V107, P21617, DOI 10.1073/pnas.1013133107; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Romer P, 2009, PLANT PHYSIOL, V150, P1697, DOI 10.1104/pp.109.139931; Rosen LE, 2006, NUCLEIC ACIDS RES, V34, P4791, DOI 10.1093/nar/gkl645; Scholze H, 2010, VIRULENCE, V1, P428, DOI 10.4161/viru.1.5.12863; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	28	563	864	4	153	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2011	29	2					149	U90		10.1038/nbt.1775	http://dx.doi.org/10.1038/nbt.1775			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	717DJ	21248753	Green Submitted, Green Accepted			2022-12-25	WOS:000287023000022
J	Merveille, AC; Davis, EE; Becker-Heck, A; Legendre, M; Amirav, I; Bataille, G; Belmont, J; Beydon, N; Billen, F; Clement, A; Clercx, C; Coste, A; Crosbie, R; de Blic, J; Deleuze, S; Duquesnoy, P; Escalier, D; Escudier, E; Fliegauf, M; Horvath, J; Hill, K; Jorissen, M; Just, J; Kispert, A; Lathrop, M; Loges, NT; Marthin, JK; Momozawa, Y; Montantin, G; Nielsen, KG; Olbrich, H; Papon, JF; Rayet, I; Roger, G; Schmidts, M; Tenreiro, H; Towbin, JA; Zelenika, D; Zentgraf, H; Georges, M; Lequarre, AS; Katsanis, N; Omran, H; Amselem, S				Merveille, Anne-Christine; Davis, Erica E.; Becker-Heck, Anita; Legendre, Marie; Amirav, Israel; Bataille, Geraldine; Belmont, John; Beydon, Nicole; Billen, Frederic; Clement, Annick; Clercx, Cecile; Coste, Andre; Crosbie, Rachelle; de Blic, Jacques; Deleuze, Stephane; Duquesnoy, Philippe; Escalier, Denise; Escudier, Estelle; Fliegauf, Manfred; Horvath, Judith; Hill, Kent; Jorissen, Mark; Just, Jocelyne; Kispert, Andreas; Lathrop, Mark; Loges, Niki Tomas; Marthin, June K.; Momozawa, Yukihide; Montantin, Guy; Nielsen, Kim G.; Olbrich, Heike; Papon, Jean-Francois; Rayet, Isabelle; Roger, Gilles; Schmidts, Miriam; Tenreiro, Henrique; Towbin, Jeffrey A.; Zelenika, Diana; Zentgraf, Hanswalter; Georges, Michel; Lequarre, Anne-Sophie; Katsanis, Nicholas; Omran, Heymut; Amselem, Serge			CCDC39 is required for assembly of inner dynein arms and the dynein regulatory complex and for normal ciliary motility in humans and dogs	NATURE GENETICS			English	Article							CHLAMYDOMONAS; DYSKINESIA; MUTATIONS; FLAGELLA; DNAH5; DEFECTS; HOMOLOG; MOUSE; HEART	Primary ciliary dyskinesia (PCD) is an inherited disorder characterized by recurrent infections of the upper and lower respiratory tract, reduced fertility in males and situs inversus in about 50% of affected individuals (Kartagener syndrome). It is caused by motility defects in the respiratory cilia that are responsible for airway clearance, the flagella that propel sperm cells and the nodal monocilia that determine left-right asymmetry(1). Recessive mutations that cause PCD have been identified in genes encoding components of the outer dynein arms, radial spokes and cytoplasmic pre-assembly factors of axonemal dyneins, but these mutations account for only about 50% of cases of PCD. We exploited the unique properties of dog populations to positionally clone a new PCD gene, CCDC39. We found that loss-of-function mutations in the human ortholog underlie a substantial fraction of PCD cases with axonemal disorganization and abnormal ciliary beating. Functional analyses indicated that CCDC39 localizes to ciliary axonemes and is essential for assembly of inner dynein arms and the dynein regulatory complex.	[Merveille, Anne-Christine; Bataille, Geraldine; Momozawa, Yukihide; Georges, Michel; Lequarre, Anne-Sophie] Grp Interdisciplinaire Genom Appliquee Rech GIGA, Unit Anim Genom, Liege, Belgium; [Merveille, Anne-Christine; Bataille, Geraldine; Momozawa, Yukihide; Georges, Michel; Lequarre, Anne-Sophie] Univ Liege B34, Fac Vet Med, Liege, Belgium; [Davis, Erica E.; Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Becker-Heck, Anita; Fliegauf, Manfred; Horvath, Judith; Loges, Niki Tomas; Olbrich, Heike; Schmidts, Miriam; Omran, Heymut] Univ Hosp Freiburg, Dept Pediat & Adolescent Med, Freiburg, Germany; [Becker-Heck, Anita] Univ Freiburg, Fac Biol, Freiburg, Germany; [Becker-Heck, Anita; Loges, Niki Tomas; Omran, Heymut] Univ Childrens Hosp Munster, Dept Gen Pediat, Munster, Germany; [Legendre, Marie; Duquesnoy, Philippe; Escalier, Denise; Escudier, Estelle; Montantin, Guy; Olbrich, Heike; Papon, Jean-Francois; Tenreiro, Henrique; Amselem, Serge] Univ Paris 06, INSERM, U933, Paris, France; [Legendre, Marie; Duquesnoy, Philippe; Escalier, Denise; Escudier, Estelle; Montantin, Guy; Olbrich, Heike; Papon, Jean-Francois; Tenreiro, Henrique; Amselem, Serge] Hop Armand Trousseau, AP HP, Paris, France; [Amirav, Israel] Ziv Med Ctr, Dept Pediat, Safed, Israel; [Amirav, Israel] Technion Israel Inst Technol, Rapaport Fac Med, Haifa, Israel; [Belmont, John; Towbin, Jeffrey A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Beydon, Nicole] Hop Armand Trousseau, AP HP, Serv Explorat Fonct Resp, Paris, France; [Billen, Frederic; Clercx, Cecile; Deleuze, Stephane] Univ Liege, Fac Vet Med, Dept Clin Sci, B-4000 Liege, Belgium; [Clement, Annick] Hop Armand Trousseau, AP HP, Unite Pneumol Pediat, Ctr Reference Malad Resp Rares, Paris, France; [Coste, Andre; Papon, Jean-Francois] Hop Intercommunal Creteil, AP HP, Creteil, France; [Coste, Andre; Papon, Jean-Francois] Grp Hosp Henri Mondor Albert Chenevier, Serv ORL & Chirurg Cervicofaciale, Creteil, France; [Crosbie, Rachelle; Hill, Kent] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [de Blic, Jacques] Grp Hosp Necker Enfants Malades, AP HP, Serv Pneumol & Allergol Pediat, Paris, France; [Jorissen, Mark] Univ Hosp Leuven, Dept Otorhinolaryngol Head & Neck Surg, Louvain, Belgium; [Just, Jocelyne] Hop Armand Trousseau, AP HP, Ctr Invest Asthme & Allergies, Paris, France; [Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, D-30623 Hannover, Germany; [Lathrop, Mark; Zelenika, Diana] Ctr Natl Genotypage, Evry, France; [Marthin, June K.; Rayet, Isabelle] Ctr Hosp Univ St Etienne, Hop Nord, Serv Reanimat Pediat, St Etienne, France; [Nielsen, Kim G.] Rigshosp, Copenhagen Univ Hosp, Danish Primary Ciliary Dyskinesia Ctr, Pediat Pulm Serv, DK-2100 Copenhagen, Denmark; [Roger, Gilles] Hop Armand Trousseau, AP HP, Serv ORL & Chirurg Cervicofaciale Pediat, Paris, France; [Zentgraf, Hanswalter] German Canc Res Ctr, Dept Tumor Virol, D-6900 Heidelberg, Germany	University of Liege; Duke University; University of Freiburg; University of Freiburg; University of Munster; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Ziv Medical Center; Technion Israel Institute of Technology; Baylor College of Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Liege; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; University of California System; University of California Los Angeles; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; KU Leuven; University Hospital Leuven; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Hannover Medical School; CEA; UDICE-French Research Universities; Universite Paris Saclay; CHU de St Etienne; Rigshospitalet; University of Copenhagen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; German Cancer Research Center (DKFZ)	Georges, M (corresponding author), Grp Interdisciplinaire Genom Appliquee Rech GIGA, Unit Anim Genom, Liege, Belgium.	michel.georges@ulg.ac.be	Legendre, Marie/AAD-7018-2021; Schmidts, Miriam/A-3777-2012; Nielsen, KG/AAE-6575-2020; Momozawa, Yukihide/N-6453-2015; Belmont, John W/AAI-2494-2019; Belmont, John/AAH-6084-2021; Amirav, Israel/I-9286-2019; Katsanis, Nicholas/E-1837-2012; Towbin, Jeffrey A./J-5595-2019	Legendre, Marie/0000-0003-2178-0846; Schmidts, Miriam/0000-0002-1714-6749; Nielsen, KG/0000-0001-5906-9449; Belmont, John W/0000-0001-7409-3578; Amirav, Israel/0000-0002-6917-5285; Towbin, Jeffrey A./0000-0002-6585-714X; Georges, Michel/0000-0003-4124-2375; Katsanis, Nicholas/0000-0002-2480-0171; Lequarre, Anne Sophie/0000-0002-2187-4482; Merveille, Anne-Christine/0000-0003-3864-6336; Papon, Jean Francois/0000-0002-2323-9239; Omran, Heymut/0000-0003-0282-6765; COSTE, Andre/0000-0002-8386-3455; Davis, Erica/0000-0002-2412-8397	European Union (LUPA IP); Police Scientifique Federale de Belgique (GENFUNC PAI); Legs Poix from the Chancellerie des Universites; Assistance Publique-Hopitaux de Paris [PHRC AOM06053, P060245]; Agence Nationale pour la Recherche [ANR-05-MRAR-022-01]; US National Institutes of Health [HD04260, DK072301, DK075972, DK079541]; "Deutsche Forschungsgemeinschaft" DFG [Om 6/4, GRK1104, SFB592]; European Community; Japanese Society for the Promotion of Science (JSPS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072301, F32DK079541, R01DK075972] Funding Source: NIH RePORTER	European Union (LUPA IP)(European Commission); Police Scientifique Federale de Belgique (GENFUNC PAI); Legs Poix from the Chancellerie des Universites; Assistance Publique-Hopitaux de Paris; Agence Nationale pour la Recherche(French National Research Agency (ANR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "Deutsche Forschungsgemeinschaft" DFG(German Research Foundation (DFG)); European Community(European Commission); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the European Union (LUPA IP) and from the Police Scientifique Federale de Belgique (GENFUNC PAI) (to M.G.), from the Legs Poix from the Chancellerie des Universites, the Assistance Publique-Hopitaux de Paris (PHRC AOM06053, P060245) and the Agence Nationale pour la Recherche (ANR-05-MRAR-022-01) (to S.A.), the US National Institutes of Health (HD04260, DK072301 and DK075972 (to N.K.) and DK079541 (to E.E.D.)) and by grants from the "Deutsche Forschungsgemeinschaft" DFG Om 6/4, GRK1104, SFB592, and the European Community (EU-CILIA; SYS-CILIA) (to H.O.). A.C.M. is a fellow from the FRIA. N.K. is the Jean and George W. Brumley Professor. Y.M. benefits from a postdoctoral fellowship to study abroad from the Japanese Society for the Promotion of Science (JSPS). We thank the Bobtail breeders for assistance; patients and their family members whose cooperation made this study possible; all referring physicians; the German patient support group "Kartagener Syndrom und Primaere Ciliaere Dyskinesie e.V."; K. Nakamura and the GIGA-R genomics platform for their contribution to sequencing; E. Ostrander for samples from healthy Old English Sheepdogs; the Unite de Recherche Clinique (URC) Est (AP-HP, Hopital Saint-Antoine, Paris, France) for support; and A. Heer, C. Reinhard, C. Kopp, K. Sutter, M. Petry, C. Tessmer, A.-M. Vojtek and S. Franz for technical assistance.	Baker K, 2008, P NATL ACAD SCI USA, V105, P13924, DOI 10.1073/pnas.0802159105; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Cavrenne R, 2008, VET REC, V163, P54, DOI 10.1136/vr.163.2.54; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Colantonio JR, 2009, NATURE, V457, P205, DOI 10.1038/nature07520; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Ge B, 2005, GENOME RES, V15, P1584, DOI 10.1101/gr.4023805; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; Hill KL, 2000, J BIOL CHEM, V275, P39369, DOI 10.1074/jbc.M006907200; HUANG B, 1982, CELL, V28, P115, DOI 10.1016/0092-8674(82)90381-6; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Olbrich H, 2006, PEDIATR RES, V59, P418, DOI 10.1203/01.pdr.0000200809.21364.e2; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Papon JF, 2010, EUR RESPIR J, V35, P1057, DOI 10.1183/09031936.00046209; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Piperno G, 1996, J CELL BIOL, V133, P371, DOI 10.1083/jcb.133.2.371; PIPERNO G, 1994, J CELL BIOL, V125, P1109, DOI 10.1083/jcb.125.5.1109; PIPERNO G, 1992, J CELL BIOL, V118, P1455, DOI 10.1083/jcb.118.6.1455; Ralston KS, 2006, EUKARYOT CELL, V5, P696, DOI 10.1128/EC.5.4.696-711.2006; RANDOLPH JF, 1984, J SMALL ANIM PRACT, V25, P679, DOI 10.1111/j.1748-5827.1984.tb03381.x; Rupp G, 2003, J CELL BIOL, V162, P47, DOI 10.1083/jcb.200303019; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301	29	226	245	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2011	43	1					72	U98		10.1038/ng.726	http://dx.doi.org/10.1038/ng.726			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	699SQ	21131972	Green Accepted			2022-12-25	WOS:000285683500019
J	Astin, JW; Batson, J; Kadir, S; Charlet, J; Persad, RA; Gillatt, D; Oxley, JD; Nobes, CD				Astin, Jonathan W.; Batson, Jennifer; Kadir, Shereen; Charlet, Jessica; Persad, Raj A.; Gillatt, David; Oxley, Jon D.; Nobes, Catherine D.			Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells	NATURE CELL BIOLOGY			English	Article							MICROARRAY ANALYSIS; TYROSINE KINASE; TUMOR-CELLS; MIGRATION; MOTILITY; EXPRESSION; INDUCTION; CARCINOMA; ROLES; PROLIFERATION	Metastatic cancer cells typically fail to halt migration on contact with non-cancer cells. This invasiveness is in contrast to normal mesenchymal cells that retract on contact with another cell. Why cancer cells are defective in contact inhibition of locomotion is not understood. Here, we analyse the dynamics of prostate cancer cell lines co-cultured with fibroblasts, and demonstrate that a combinatorial code of Eph receptor activation dictates whether cell migration will be contact inhibited. The unimpeded migration of metastatic PC-3 cells towards fibroblasts is dependent on activation of EphB3 and EphB4 by ephrin-B2, which we show activates Cdc42 and cell migration. Knockdown of EphB3 and EphB4 restores contact inhibition of locomotion to PC-3 cells. Conversely, homotypic collisions between two cancer cells results in contact inhibition of locomotion, mediated by EphA-Rho-Rho kinase (ROCK) signalling. Thus, the migration of cancer cells can switch from restrained to invasive, depending on the Eph-receptor profile of the cancer cell and the reciprocal ephrin ligands expressed by neighbouring cells.	[Astin, Jonathan W.; Batson, Jennifer; Kadir, Shereen; Charlet, Jessica; Nobes, Catherine D.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England; [Nobes, Catherine D.] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Persad, Raj A.; Gillatt, David] Southmead Hosp, Bristol Urol Inst, Bristol BS10 5NB, Avon, England; [Oxley, Jon D.] Southmead Hosp, Dept Cellular Pathol, Bristol BS10 5NB, Avon, England	University of Bristol; University of Bristol; Southmead Hospital; Southmead Hospital	Nobes, CD (corresponding author), Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England.	Catherine.Nobes@bristol.ac.uk		Kadir, Shereen/0000-0002-3960-988X; Astin, Jonathan/0000-0002-3554-0133	Wellcome Trust; MRC; Cancer Research UK	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	We thank H. Ross for technical assistance and I. Hers for advice on immunoprecipitations, M. Brown for BMECs, A. Ziemiecki and A. -C. Andres for anti-EphB4, D. Wilkinson for anti-EphA4 and E. Pasquale for anti-EphB3. We thank P. Martin, N. Perkins and C. Paraskeva for critically reading the manuscript. We are grateful to J. Dovovan and NCRI/MRC ProMPT collaborative for facilitating clinical aspects of the work. This study has been approved by the Southmead Research Ethics Committee and was funded by a Wellcome Trust PhD studentship to J.B., an MRC studentship to S.K. and a Cancer Research UK project grant to C.D.N.	ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; ABERCROMBIE M, 1970, IN VITRO CELL DEV B, V6, P128; ABERCROMBIE M, 1978, MED BIOL, V56, P299; Bochenek ML, 2010, J CELL SCI, V123, P1235, DOI 10.1242/jcs.061903; BOSTWICK DG, 1995, PATHOL RES PRACT, V191, P850, DOI 10.1016/S0344-0338(11)80967-2; Bracke ME, 1997, EUR J CELL BIOL, V74, P342; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Chaib H, 2001, NEOPLASIA, V3, P43, DOI 10.1038/sj.neo.7900126; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048; Hooper S, 2006, METHOD ENZYMOL, V406, P625, DOI 10.1016/S0076-6879(06)06049-6; Huang XD, 2008, J CELL BIOL, V183, P711, DOI 10.1083/jcb.200801192; Huttenlocher A, 1998, J CELL BIOL, V141, P515, DOI 10.1083/jcb.141.2.515; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; KAIGHN ME, 1979, INVEST UROL, V17, P16; KOZLOWSKI JM, 1984, CANCER RES, V44, P3522; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Kumar SR, 2009, CANCER RES, V69, P3736, DOI 10.1158/0008-5472.CAN-08-3232; Lee YC, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-119; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Matsuoka H, 2005, J BIOL CHEM, V280, P29355, DOI 10.1074/jbc.M500010200; Merlos-Suarez A, 2008, CURR OPIN CELL BIOL, V20, P194, DOI 10.1016/j.ceb.2008.01.011; Mickey D D, 1980, Prog Clin Biol Res, V37, P67; Munarini N, 2002, J CELL SCI, V115, P25; Nakayama M, 2008, DEV CELL, V14, P205, DOI 10.1016/j.devcel.2007.11.021; Noren NK, 2007, CANCER RES, V67, P3994, DOI 10.1158/0008-5472.CAN-07-0525; Noren NK, 2004, CELL SIGNAL, V16, P655, DOI 10.1016/j.cellsig.2003.10.006; PADDOCK SW, 1986, J CELL SCI, V81, P163; Parri M, 2007, J BIOL CHEM, V282, P19619, DOI 10.1074/jbc.M701319200; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Stephenson S A, 2001, BMC Mol Biol, V2, P15, DOI 10.1186/1471-2199-2-15; Stramer B, 2010, J CELL BIOL, V189, P681, DOI 10.1083/jcb.200912134; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; VESELY P, 1973, INT J CANCER, V11, P64, DOI 10.1002/ijc.2910110108; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Xia GB, 2005, CANCER RES, V65, P4623, DOI 10.1158/0008-5472.CAN-04-2667; Zhu A, 2008, CANCER RES, V68, P1267, DOI 10.1158/0008-5472.CAN-07-2304	46	172	173	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2010	12	12					1194	U175		10.1038/ncb2122	http://dx.doi.org/10.1038/ncb2122			33	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	688DY	21076414				2022-12-25	WOS:000284831200011
J	Hwang, CS; Shemorry, A; Auerbach, D; Varshavsky, A				Hwang, Cheol-Sang; Shemorry, Anna; Auerbach, Daniel; Varshavsky, Alexander			The N-end rule pathway is mediated by a complex of the RING-type Ubr1 and HECT-type Ufd4 ubiquitin ligases	NATURE CELL BIOLOGY			English	Article							PROTEIN-QUALITY CONTROL; SACCHAROMYCES-CEREVISIAE; PROTEASOMAL DEGRADATION; MULTIUBIQUITIN CHAIN; PROTEOLYTIC PATHWAY; CYTOSOLIC PROTEINS; STRUCTURAL BASIS; SPLIT-UBIQUITIN; 26S PROTEASOME; IN-VIVO	Substrates of the N-end rule pathway are recognized by the Ubr1 E3 ubiquitin ligase through their destabilizing amino-terminal residues. Our previous work showed that the Ubr1 E3 and the Ufd4 E3 together target an internal degradation signal (degron) of the Mgt1 DNA repair protein. Ufd4 is an E3 enzyme of the ubiquitin-fusion degradation (UFD) pathway that recognizes an N-terminal ubiquitin moiety. Here we show that the RING-type Ubr1 E3 and the HECT-type Ufd4 E3 interact, both physically and functionally. Although Ubr1 can recognize and polyubiquitylate an N-end rule substrate in the absence of Ufd4, the Ubr1-Ufd4 complex is more processive in that it produces a longer substrate-linked polyubiquitin chain. Conversely, Ubr1 can function as a polyubiquitylation-enhancing component of the Ubr1-Ufd4 complex in its targeting of UFD substrates. We also found that Ubr1 can recognize the N-terminal ubiquitin moiety. These and related advances unify two proteolytic systems that have been studied separately for two decades.	[Hwang, Cheol-Sang; Shemorry, Anna; Varshavsky, Alexander] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Auerbach, Daniel] Dualsyst Biotech AG, CH-8952 Schlieren, Switzerland	California Institute of Technology	Varshavsky, A (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	avarsh@caltech.edu	Hwang, Cheol-Sang/Q-7391-2019	Hwang, Cheol-Sang/0000-0002-0105-5957	National Institutes of Health [GM031530, DK039520, GM085371]; March of Dimes Foundation; Caltech City of Hope Biomedical Initiative; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039520, R56DK039520, R37DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530, R01GM085371] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); Caltech City of Hope Biomedical Initiative; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Jentsch and A. Toh-e for strains and plasmids; the present and former members of the Varshavsky laboratory, particularly J. Sheng and K. Piatkov, for gifts of plasmids and strains; and O. Batygin for technical assistance. This work was supported by National Institutes of Health grants GM031530, DK039520 and GM085371 (A.V.), and also by grants from the March of Dimes Foundation and the Caltech City of Hope Biomedical Initiative (A.V.).	Ausubel F.M., 2006, CURRENT PROTOCOLS MO; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Brower CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007757; Cai HJ, 2006, GENETICS, V172, P1459, DOI 10.1534/genetics.105.053041; CAPRIO MA, 2010, BIOCHEM J, V429, P63; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen C, 2008, ONCOGENE, V27, P6845, DOI 10.1038/onc.2008.288; Choi WS, 2010, NAT STRUCT MOL BIOL, V17, P1175, DOI 10.1038/nsmb.1907; Courbard JR, 2002, J BIOL CHEM, V277, P45267, DOI 10.1074/jbc.M206460200; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Graciet E, 2010, TRENDS PLANT SCI, V15, P447, DOI 10.1016/j.tplants.2010.04.011; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hoppe T, 2005, TRENDS BIOCHEM SCI, V30, P183, DOI 10.1016/j.tibs.2005.02.004; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Hwang CS, 2009, P NATL ACAD SCI USA, V106, P2142, DOI 10.1073/pnas.0812316106; Hwang CS, 2008, P NATL ACAD SCI USA, V105, P19188, DOI 10.1073/pnas.0808891105; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Ju DH, 2007, FEBS LETT, V581, P265, DOI 10.1016/j.febslet.2006.12.024; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Kee Y, 2007, BIOCHEM BIOPH RES CO, V354, P329, DOI 10.1016/j.bbrc.2007.01.025; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kurosaka S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000878; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Liu C, 2010, J BIOL CHEM, V285, P10265, DOI 10.1074/jbc.M110.110551; Liu F, 2010, TRENDS BIOCHEM SCI, V35, P352, DOI 10.1016/j.tibs.2010.01.002; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Magnifico A, 2003, J BIOL CHEM, V278, P43169, DOI 10.1074/jbc.M308009200; Matta-Camacho E, 2010, NAT STRUCT MOL BIOL, V17, P1182, DOI 10.1038/nsmb.1894; Mockli N, 2007, BIOTECHNIQUES, V42, P725, DOI 10.2144/000112455; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Nillegoda NB, 2010, MOL BIOL CELL, V21, P2102, DOI 10.1091/mbc.E10-02-0098; Park Y, 2009, J BIOL CHEM, V284, P1540, DOI 10.1074/jbc.M807554200; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Roman-Hernandez G, 2009, P NATL ACAD SCI USA, V106, P8888, DOI 10.1073/pnas.0903614106; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Schmidt R, 2009, MOL MICROBIOL, V72, P506, DOI 10.1111/j.1365-2958.2009.06666.x; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Sriram SM, 2010, NAT STRUCT MOL BIOL, V17, P1164, DOI 10.1038/nsmb1010-1164; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Tasaki T, 2009, J BIOL CHEM, V284, P1884, DOI 10.1074/jbc.M803641200; Tu D, 2007, P NATL ACAD SCI USA, V104, P15599, DOI 10.1073/pnas.0701369104; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2004, CURR BIOL, V14, pR181, DOI 10.1016/j.cub.2004.02.014; Varshavsky A, 2008, J BIOL CHEM, V283, P34469, DOI 10.1074/jbc.X800009200; Wang HQ, 2009, MOL CELL, V34, P686, DOI 10.1016/j.molcel.2009.04.032; Xia ZX, 2008, J BIOL CHEM, V283, P28958, DOI 10.1074/jbc.M803980200; Xia ZX, 2008, J BIOL CHEM, V283, P24011, DOI 10.1074/jbc.M802583200; Xie YM, 2000, P NATL ACAD SCI USA, V97, P2497, DOI 10.1073/pnas.060025497; Xie YM, 2002, NAT CELL BIOL, V4, P1003, DOI 10.1038/ncb889; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Zaaroor-Regev D, 2010, P NATL ACAD SCI USA, V107, P6788, DOI 10.1073/pnas.1003108107	70	99	100	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2010	12	12					1177	U120		10.1038/ncb2121	http://dx.doi.org/10.1038/ncb2121			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	688DY	21076411	Green Accepted			2022-12-25	WOS:000284831200009
J	Murrough, JW; Charney, DS				Murrough, James W.; Charney, Dennis S.			Lifting the mood with ketamine	NATURE MEDICINE			English	Editorial Material							D-ASPARTATE ANTAGONIST; ANTIDEPRESSANT; DEPRESSION; RECEPTORS		[Murrough, James W.] Mt Sinai Sch Med, Mood & Anxiety Disorders Program, New York, NY USA; [Charney, Dennis S.] Mt Sinai Sch Med, Off Dean, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Murrough, JW (corresponding author), Mt Sinai Sch Med, Mood & Anxiety Disorders Program, New York, NY USA.	james.murrough@mssm.edu	Murrough, James/J-7129-2013	Murrough, James/0000-0001-6286-1242				Aan het Rot M, 2010, BIOL PSYCHIAT, V67, P139, DOI DOI 10.1016/J.BIOPSYCH.2009.08.038; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Mathew SJ, 2010, INT J NEUROPSYCHOPH, V13, P71, DOI 10.1017/S1461145709000169; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; Perry EB, 2007, PSYCHOPHARMACOLOGY, V192, P253, DOI 10.1007/s00213-007-0706-2; Preskorn SH, 2008, J CLIN PSYCHOPHARM, V28, P631, DOI 10.1097/JCP.0b013e31818a6cea; Price RB, 2009, BIOL PSYCHIAT, V66, P522, DOI 10.1016/j.biopsych.2009.04.029; Skolnick P, 1996, PHARMACOPSYCHIATRY, V29, P23, DOI 10.1055/s-2007-979537; TRULLAS R, 1990, EUR J PHARMACOL, V185, P1, DOI 10.1016/0014-2999(90)90204-J; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	12	22	26	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2010	16	12					1384	1385		10.1038/nm1210-1384	http://dx.doi.org/10.1038/nm1210-1384			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21135850				2022-12-25	WOS:000285048900029
J	Heid, IM; Jackson, AU; Randall, JC; Winkler, TW; Qi, L; Steinthorsdottir, V; Thorleifsson, G; Zillikens, MC; Speliotes, EK; Magi, R; Workalemahu, T; White, CC; Bouatia-Naji, N; Harris, TB; Berndt, SI; Ingelsson, E; Willer, CJ; Weedon, MN; Luan, JA; Vedantam, S; Esko, T; Kilpelainen, TO; Kutalik, Z; Li, SX; Monda, KL; Dixon, AL; Holmes, CC; Kaplan, LM; Liang, LM; Min, JL; Moffatt, MF; Molony, C; Nicholson, G; Schadt, EE; Zondervan, KT; Feitosa, MF; Ferreira, T; Allen, HL; Weyant, RJ; Wheeler, E; Wood, AR; Estrada, K; Goddard, ME; Lettre, G; Mangino, M; Nyholt, DR; Purcell, S; Smith, AV; Visscher, PM; Yang, JA; McCarroll, SA; Nemesh, J; Voight, BF; Absher, D; Amin, N; Aspelund, T; Coin, L; Glazer, NL; Hayward, C; Heard-Costa, NL; Hottenga, JJ; Johansson, A; Johnson, T; Kaakinen, M; Kapur, K; Ketkar, S; Knowles, JW; Kraft, P; Kraja, AT; Lamina, C; Leitzmann, MF; McKnight, B; Morris, AP; Ong, KK; Perry, JRB; Peters, MJ; Polasek, O; Prokopenko, I; Rayner, NW; Ripatti, S; Rivadeneira, F; Robertson, NR; Sanna, S; Sovio, U; Surakka, I; Teumer, A; van Wingerden, S; Vitart, V; Zhao, JH; Cavalcanti-Proenca, C; Chines, PS; Fisher, E; Kulzer, JR; Lecoeur, C; Narisu, N; Sandholt, C; Scott, LJ; Silander, K; Stark, K; Tammesoo, ML; Teslovich, TM; Timpson, NJ; Watanabe, RM; Welch, R; Chasman, DI; Cooper, MN; Jansson, JO; Kettunen, J; Lawrence, RW; Pellikka, N; Perola, M; Vandenput, L; Alavere, H; Almgren, P; Atwood, LD; Bennett, AJ; Biffar, R; Bonnycastle, LL; Bornstein, SR; Buchanan, TA; Campbell, H; Day, INM; Dei, M; Dorr, M; Elliott, P; Erdos, MR; Eriksson, JG; Freimer, NB; Fu, M; Gaget, S; Geus, EJC; Gjesing, AP; Grallert, H; Grassler, J; Groves, CJ; Guiducci, C; Hartikainen, AL; Hassanali, N; Havulinna, AS; Herzig, KH; Hicks, AA; Hui, JN; Igl, W; Jousilahti, P; Jula, A; Kajantie, E; Kinnunen, L; Kolcic, I; Koskinen, S; Kovacs, P; Kroemer, HK; Krzelj, V; Kuusisto, J; Kvaloy, K; Laitinen, J; Lantieri, O; Lathrop, GM; Lokki, ML; Luben, RN; Ludwig, B; McArdle, WL; McCarthy, A; Morken, MA; Nelis, M; Neville, MJ; Pare, G; Parker, AN; Peden, JF; Pichler, I; Pietilainen, KH; Platou, CGP; Pouta, A; Ridderstrale, M; Samani, NJ; Saramies, J; Sinisalo, J; Smit, JH; Strawbridge, RJ; Stringham, HM; Swift, AJ; Teder-Laving, M; Thomson, B; Usala, G; van Meurs, JBJ; van Ommen, GJ; Vatin, V; Volpato, CB; Wallaschofski, H; Walters, GB; Widen, E; Wild, SH; Willemsen, G; Witte, DR; Zgaga, L; Zitting, P; Beilby, JP; James, AL; Kahonen, M; Lehtimaki, T; Nieminen, MS; Ohlsson, C; Palmer, LJ; Raitakari, O; Ridker, PM; Stumvoll, M; Tonjes, A; Viikari, J; Balkau, B; Ben-Shlomo, Y; Bergman, RN; Boeing, H; Smith, GD; Ebrahim, S; Froguel, P; Hansen, T; Hengstenberg, C; Hveem, K; Isomaa, B; Jorgensen, T; Karpe, F; Khaw, KT; Laakso, M; Lawlor, DA; Marre, M; Meitinger, T; Metspalu, A; Midthjell, K; Pedersen, O; Salomaa, V; Schwarz, PEH; Tuomi, T; Tuomilehto, J; Valle, TT; Wareham, NJ; Arnold, AM; Beckmann, JS; Bergmann, S; Boerwinkle, E; Boomsma, DI; Caulfield, MJ; Collins, FS; Eiriksdottir, G; Gudnason, V; Gyllensten, U; Hamsten, A; Hattersley, AT; Hofman, A; Hu, FB; Illig, T; Iribarren, C; Jarvelin, MR; Kao, WHL; Kaprio, J; Launer, LJ; Munroe, PB; Oostra, B; Penninx, BW; Pramstaller, PP; Psaty, BM; Quertermous, T; Rissanen, A; Rudan, I; Shuldiner, AR; Soranzo, N; Spector, TD; Syvanen, AC; Uda, M; Uitterlinden, A; Volzke, H; Vollenweider, P; Wilson, JF; Witteman, JC; Wright, AF; Abecasis, GR; Boehnke, M; Borecki, IB; Deloukas, P; Frayling, TM; Groop, LC; Haritunians, T; Hunter, DJ; Kaplan, RC; North, KE; O'Connell, JR; Peltonen, L; Schlessinger, D; Strachan, DP; Hirschhorn, JN; Assimes, TL; Wichmann, HE; Thorsteinsdottir, U; van Duijn, CM; Stefansson, K; Cupples, LA; Loos, RJF; Barroso, I; McCarthy, MI; Fox, CS; Mohlke, KL; Lindgren, CM				Heid, Iris M.; Jackson, Anne U.; Randall, Joshua C.; Winkler, Thomas W.; Qi, Lu; Steinthorsdottir, Valgerdur; Thorleifsson, Gudmar; Zillikens, M. Carola; Speliotes, Elizabeth K.; Maegi, Reedik; Workalemahu, Tsegaselassie; White, Charles C.; Bouatia-Naji, Nabila; Harris, Tamara B.; Berndt, Sonja I.; Ingelsson, Erik; Willer, Cristen J.; Weedon, Michael N.; Luan, Jianan; Vedantam, Sailaja; Esko, Tonu; Kilpelaeinen, Tuomas O.; Kutalik, Zoltan; Li, Shengxu; Monda, Keri L.; Dixon, Anna L.; Holmes, Christopher C.; Kaplan, Lee M.; Liang, Liming; Min, Josine L.; Moffatt, Miriam F.; Molony, Cliona; Nicholson, George; Schadt, Eric E.; Zondervan, Krina T.; Feitosa, Mary F.; Ferreira, Teresa; Allen, Hana Lango; Weyant, Robert J.; Wheeler, Eleanor; Wood, Andrew R.; Estrada, Karol; Goddard, Michael E.; Lettre, Guillaume; Mangino, Massimo; Nyholt, Dale R.; Purcell, Shaun; Smith, Albert Vernon; Visscher, Peter M.; Yang, Jian; McCarroll, Steven A.; Nemesh, James; Voight, Benjamin F.; Absher, Devin; Amin, Najaf; Aspelund, Thor; Coin, Lachlan; Glazer, Nicole L.; Hayward, Caroline; Heard-Costa, Nancy L.; Hottenga, Jouke-Jan; Johansson, Asa; Johnson, Toby; Kaakinen, Marika; Kapur, Karen; Ketkar, Shamika; Knowles, Joshua W.; Kraft, Peter; Kraja, Aldi T.; Lamina, Claudia; Leitzmann, Michael F.; McKnight, Barbara; Morris, Andrew P.; Ong, Ken K.; Perry, John R. B.; Peters, Marjolein J.; Polasek, Ozren; Prokopenko, Inga; Rayner, Nigel W.; Ripatti, Samuli; Rivadeneira, Fernando; Robertson, Neil R.; Sanna, Serena; Sovio, Ulla; Surakka, Ida; Teumer, Alexander; van Wingerden, Sophie; Vitart, Veronique; Zhao, Jing Hua; Cavalcanti-Proenca, Christine; Chines, Peter S.; Fisher, Eva; Kulzer, Jennifer R.; Lecoeur, Cecile; Narisu, Narisu; Sandholt, Camilla; Scott, Laura J.; Silander, Kaisa; Stark, Klaus; Tammesoo, Mari-Liis; Teslovich, Tanya M.; Timpson, Nicholas John; Watanabe, Richard M.; Welch, Ryan; Chasman, Daniel I.; Cooper, Matthew N.; Jansson, John-Olov; Kettunen, Johannes; Lawrence, Robert W.; Pellikka, Niina; Perola, Markus; Vandenput, Liesbeth; Alavere, Helene; Almgren, Peter; Atwood, Larry D.; Bennett, Amanda J.; Biffar, Reiner; Bonnycastle, Lori L.; Bornstein, Stefan R.; Buchanan, Thomas A.; Campbell, Harry; Day, Ian N. M.; Dei, Mariano; Doerr, Marcus; Elliott, Paul; Erdos, Michael R.; Eriksson, Johan G.; Freimer, Nelson B.; Fu, Mao; Gaget, Stefan; Geus, Eco J. C.; Gjesing, Anette P.; Grallert, Harald; Graessler, Juergen; Groves, Christopher J.; Guiducci, Candace; Hartikainen, Anna-Liisa; Hassanali, Neelam; Havulinna, Aki S.; Herzig, Karl-Heinz; Hicks, Andrew A.; Hui, Jennie; Igl, Wilmar; Jousilahti, Pekka; Jula, Antti; Kajantie, Eero; Kinnunen, Leena; Kolcic, Ivana; Koskinen, Seppo; Kovacs, Peter; Kroemer, Heyo K.; Krzelj, Vjekoslav; Kuusisto, Johanna; Kvaloy, Kirsti; Laitinen, Jaana; Lantieri, Olivier; Lathrop, G. Mark; Lokki, Marja-Liisa; Luben, Robert N.; Ludwig, Barbara; McArdle, Wendy L.; McCarthy, Anne; Morken, Mario A.; Nelis, Mari; Neville, Matt J.; Pare, Guillaume; Parker, Alex N.; Peden, John F.; Pichler, Irene; Pietilainen, Kirsi H.; Platou, Carl G. P.; Pouta, Anneli; Ridderstrale, Martin; Samani, Nilesh J.; Saramies, Jouko; Sinisalo, Juha; Smit, Jan H.; Strawbridge, Rona J.; Stringham, Heather M.; Swift, Amy J.; Teder-Laving, Maris; Thomson, Brian; Usala, Gianluca; van Meurs, Joyce B. J.; van Ommen, Gert-Jan; Vatin, Vincent; Volpato, Claudia B.; Wallaschofski, Henri; Walters, G. Bragi; Widen, Elisabeth; Wild, Sarah H.; Willemsen, Gonneke; Witte, Daniel R.; Zgaga, Lina; Zitting, Paavo; Beilby, John P.; James, Alan L.; Kahonen, Mika; Lehtimaki, Terho; Nieminen, Markku S.; Ohlsson, Claes; Palmer, Lyle J.; Raitakari, Olli; Ridker, Paul M.; Stumvoll, Michael; Toenjes, Anke; Viikari, Jorma; Balkau, Beverley; Ben-Shlomo, Yoav; Bergman, Richard N.; Boeing, Heiner; Smith, George Davey; Ebrahim, Shah; Froguel, Philippe; Hansen, Torben; Hengstenberg, Christian; Hveem, Kristian; Isomaa, Bo; Jorgensen, Torben; Karpe, Fredrik; Khaw, Kay-Tee; Laakso, Markku; Lawlor, Debbie A.; Marre, Michel; Meitinger, Thomas; Metspalu, Andres; Midthjell, Kristian; Pedersen, Oluf; Salomaa, Veikko; Schwarz, Peter E. H.; Tuomi, Tiinamaija; Tuomilehto, Jaakko; Valle, Timo T.; Wareham, Nicholas J.; Arnold, Alice M.; Beckmann, Jacques S.; Bergmann, Sven; Boerwinkle, Eric; Boomsma, Dorret I.; Caulfield, Mark J.; Collins, Francis S.; Eiriksdottir, Gudny; Gudnason, Vilmundur; Gyllensten, Ulf; Hamsten, Anders; Hattersley, Andrew T.; Hofman, Albert; Hu, Frank B.; Illig, Thomas; Iribarren, Carlos; Jarvelin, Marjo-Riitta; Kao, W. H. Linda; Kaprio, Jaakko; Launer, Lenore J.; Munroe, Patricia B.; Oostra, Ben; Penninx, Brenda W.; Pramstaller, Peter P.; Psaty, Bruce M.; Quertermous, Thomas; Rissanen, Aila; Rudan, Igor; Shuldiner, Alan R.; Soranzo, Nicole; Spector, Timothy D.; Syvanen, Ann-Christine; Uda, Manuela; Uitterlinden, Andre; Voelzke, Henry; Vollenweider, Peter; Wilson, James F.; Witteman, Jacqueline C.; Wright, Alan F.; Abecasis, Goncalo R.; Boehnke, Michael; Borecki, Ingrid B.; Deloukas, Panos; Frayling, Timothy M.; Groop, Leif C.; Haritunians, Talin; Hunter, David J.; Kaplan, Robert C.; North, Kari E.; O'Connell, Jeffrey R.; Peltonen, Leena; Schlessinger, David; Strachan, David P.; Hirschhorn, Joel N.; Assimes, Themistocles L.; Wichmann, H-Erich; Thorsteinsdottir, Unnur; van Duijn, Cornelia M.; Stefansson, Kari; Cupples, L. Adrienne; Loos, Ruth J. F.; Barroso, Ines; McCarthy, Mark I.; Fox, Caroline S.; Mohlke, Karen L.; Lindgren, Cecilia M.		MAGIC	Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; BODY-FAT; GLUCOSE-HOMEOSTASIS; ABDOMINAL ADIPOSITY; SUSCEPTIBILITY LOCI; INSULIN-RESISTANCE; COMMON VARIANTS; RISK; OBESITY	Waist-hip ratio (WHR) is a measure of body fat distribution and a predictor of metabolic consequences independent of overall adiposity. WHR is heritable, but few genetic variants influencing this trait have been identified. We conducted a meta-analysis of 32 genome-wide association studies for WHR adjusted for body mass index (comprising up to 77,167 participants), following up 16 loci in an additional 29 studies (comprising up to 113,636 subjects). We identified 13 new loci in or near RSPO3, VEGFA, TBX15-WARS2, NFE2L3, GRB14, DNM3-PIGC, ITPR2-SSPN, LY86, HOXC13, ADAMTS9, ZNRF3-KREMEN1, NISCH-STAB1 and CPEB4 (P = 1.9 x 10(-9) to P = 1.8 x 10(-40)) and the known signal at LYPLAL1. Seven of these loci exhibited marked sexual dimorphism, all with a stronger effect on WHR in women than men (P for sex difference = 1.9 x 10(-3) to P = 1.2 x 10(-13)). These findings provide evidence for multiple loci that modulate body fat distribution independent of overall adiposity and reveal strong gene-by-sex interactions.	[Randall, Joshua C.; Maegi, Reedik; Ferreira, Teresa; Morris, Andrew P.; Prokopenko, Inga; Rayner, Nigel W.; Robertson, Neil R.; Peden, John F.; McCarthy, Mark I.; Lindgren, Cecilia M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Heid, Iris M.; Winkler, Thomas W.; Leitzmann, Michael F.] Regensburg Univ Med Ctr, Dept Epidemiol & Prevent Med, Regensburg, Germany; [Heid, Iris M.; Lamina, Claudia; Grallert, Harald; Illig, Thomas; Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Jackson, Anne U.; Willer, Cristen J.; Weyant, Robert J.; Scott, Laura J.; Teslovich, Tanya M.; Welch, Ryan; Stringham, Heather M.; Abecasis, Goncalo R.; Boehnke, Michael] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Qi, Lu; Workalemahu, Tsegaselassie; Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Qi, Lu; Kaplan, Lee M.; Chasman, Daniel I.; Ridker, Paul M.; Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Med, Boston, MA USA; [Qi, Lu; Hu, Frank B.; Hunter, David J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Steinthorsdottir, Valgerdur; Thorleifsson, Gudmar; Walters, G. Bragi; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Zillikens, M. Carola; Estrada, Karol; Peters, Marjolein J.; Rivadeneira, Fernando; van Meurs, Joyce B. J.; Uitterlinden, Andre] Erasmus Med Ctr MC, Dept Internal Med, Rotterdam, Netherlands; [Zillikens, M. Carola; Estrada, Karol; Peters, Marjolein J.; Rivadeneira, Fernando; van Meurs, Joyce B. J.; Hofman, Albert; Uitterlinden, Andre; Witteman, Jacqueline C.; van Duijn, Cornelia M.] NGI, NCHA, Rotterdam, Netherlands; [Speliotes, Elizabeth K.; Vedantam, Sailaja; Guiducci, Candace; Thomson, Brian; Hirschhorn, Joel N.] Broad Inst, Metab Initiat, Cambridge, MA USA; [Speliotes, Elizabeth K.; Vedantam, Sailaja; Guiducci, Candace; Thomson, Brian; Hirschhorn, Joel N.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Speliotes, Elizabeth K.; Kaplan, Lee M.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [White, Charles C.; Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Bouatia-Naji, Nabila; Cavalcanti-Proenca, Christine; Lecoeur, Cecile; Gaget, Stefan; Vatin, Vincent; Froguel, Philippe] Inst Pasteur, IBL, UMR8199, CNRS, F-59019 Lille, France; [Bouatia-Naji, Nabila; Cavalcanti-Proenca, Christine; Lecoeur, Cecile; Gaget, Stefan; Vatin, Vincent; Froguel, Philippe] Univ Lille Nord France, Lille, France; [Harris, Tamara B.; Launer, Lenore J.] NIA, Lab Epidemiol, NIH, Bethesda, MD 20892 USA; [Berndt, Sonja I.] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Ingelsson, Erik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Weedon, Michael N.; Allen, Hana Lango; Wood, Andrew R.; Perry, John R. B.; Hattersley, Andrew T.; Frayling, Timothy M.] Univ Exeter, Peninsula Coll Med & Dent, Exeter, Devon, England; [Luan, Jianan; Kilpelaeinen, Tuomas O.; Li, Shengxu; Ong, Ken K.; Zhao, Jing Hua; Wareham, Nicholas J.; Loos, Ruth J. F.] Addenbrookes Hosp, Inst Metab Sci, MRC, Epidemiol Unit, Cambridge, England; [Vedantam, Sailaja; Hirschhorn, Joel N.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Vedantam, Sailaja; Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Vedantam, Sailaja; Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Esko, Tonu; Tammesoo, Mari-Liis; Alavere, Helene; Nelis, Mari; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Esko, Tonu; Nelis, Mari; Teder-Laving, Maris; Metspalu, Andres] Estonian Bioctr, Tartu, Estonia; [Esko, Tonu; Nelis, Mari; Teder-Laving, Maris; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Kutalik, Zoltan; Johnson, Toby; Kapur, Karen; Beckmann, Jacques S.; Bergmann, Sven] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Kutalik, Zoltan; Johnson, Toby; Kapur, Karen; Bergmann, Sven] Swiss Inst Bioinformat, Lausanne, Switzerland; [Monda, Keri L.; North, Kari E.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Dixon, Anna L.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Holmes, Christopher C.] MRC Harwell, Oxford, England; [Holmes, Christopher C.; Nicholson, George] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Kaplan, Lee M.] Massachusetts Gen Hosp, Weight Ctr, Boston, MA 02114 USA; [Liang, Liming; Kraft, Peter; Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Liang, Liming; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Min, Josine L.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Moffatt, Miriam F.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Molony, Cliona] Merck & Co Inc, Merck Res Labs, Boston, MA USA; [Schadt, Eric E.] Pacific Biosci, Menlo Pk, CA USA; [Schadt, Eric E.] Sage Bionetworks, Seattle, WA USA; [Zondervan, Krina T.] Wellcome Trust Ctr Human Genet, Genet & Genom Epidemiol Unit, Oxford, England; [Feitosa, Mary F.; Ketkar, Shamika; Kraja, Aldi T.; Borecki, Ingrid B.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Wheeler, Eleanor; Soranzo, Nicole; Deloukas, Panos; Peltonen, Leena; Barroso, Ines] Wellcome Trust Sanger Inst, Cambridge, England; [Estrada, Karol; Amin, Najaf; Rivadeneira, Fernando; van Wingerden, Sophie; van Meurs, Joyce B. J.; Hofman, Albert; Uitterlinden, Andre; Witteman, Jacqueline C.; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Goddard, Michael E.] Univ Melbourne, Parkville, Vic 3052, Australia; [Goddard, Michael E.] Dept Primary Ind, Melbourne, Vic, Australia; [Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Lettre, Guillaume] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Mangino, Massimo; Soranzo, Nicole; Spector, Timothy D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Nyholt, Dale R.] Queensland Inst Med Res, Neurogenet Lab, Brisbane, Qld 4006, Australia; [Purcell, Shaun; McCarroll, Steven A.; Voight, Benjamin F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Purcell, Shaun; McCarroll, Steven A.; Nemesh, James; Voight, Benjamin F.; Peltonen, Leena] MIT, Cambridge, MA 02139 USA; [Purcell, Shaun] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Smith, Albert Vernon; Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert Vernon; Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Visscher, Peter M.; Yang, Jian] Queensland Inst Med Res, Queensland Stat Genet Lab, Brisbane, Qld 4006, Australia; [McCarroll, Steven A.; Nemesh, James; Voight, Benjamin F.] Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA USA; [McCarroll, Steven A.; Voight, Benjamin F.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Absher, Devin] Hudson Alpha Inst Biotechnol, Huntsville, AL USA; [Coin, Lachlan; Sovio, Ulla; Elliott, Paul; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Fac Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Glazer, Nicole L.] Univ Washington, Dept Med, Seattle, WA USA; [Glazer, Nicole L.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Hayward, Caroline; Vitart, Veronique; Wright, Alan F.] Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Heard-Costa, Nancy L.; Atwood, Larry D.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Hottenga, Jouke-Jan; Geus, Eco J. C.; Willemsen, Gonneke; Boomsma, Dorret I.] Univ Amsterdam, Vrije Univ, Dept Biol Psychol, Amsterdam, Netherlands; [Johansson, Asa; Igl, Wilmar; Gyllensten, Ulf] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden; [Johansson, Asa] Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Canc Res & Mol Med, Trondheim, Norway; [Johnson, Toby] Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Johnson, Toby; Caulfield, Mark J.; Munroe, Patricia B.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, Barts & London Genome Ctr, London, England; [Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Kaakinen, Marika; Herzig, Karl-Heinz; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Knowles, Joshua W.; Quertermous, Thomas; Assimes, Themistocles L.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Lamina, Claudia] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, Innsbruck, Austria; [McKnight, Barbara; Arnold, Alice M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Polasek, Ozren; Kolcic, Ivana; Zgaga, Lina] Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Zagreb 41001, Croatia; [Polasek, Ozren] Gen Info Ltd, Zagreb, Croatia; [Prokopenko, Inga; Rayner, Nigel W.; Robertson, Neil R.; Bennett, Amanda J.; Groves, Christopher J.; Hassanali, Neelam; Neville, Matt J.; Karpe, Fredrik; McCarthy, Mark I.; Lindgren, Cecilia M.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Ripatti, Samuli; Surakka, Ida; Silander, Kaisa; Kettunen, Johannes; Pellikka, Niina; Perola, Markus; Widen, Elisabeth; Kaprio, Jaakko; Peltonen, Leena] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Ripatti, Samuli; Surakka, Ida; Silander, Kaisa; Kettunen, Johannes; Pellikka, Niina; Perola, Markus] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Unit Publ Hlth Genom, Helsinki, Finland; [Sanna, Serena; Dei, Mariano; Usala, Gianluca; Uda, Manuela] Ist Neurogenet & Neurofarmacol CNR, Cagliari, Italy; [Teumer, Alexander] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Chines, Peter S.; Narisu, Narisu; Bonnycastle, Lori L.; Erdos, Michael R.; Morken, Mario A.; Swift, Amy J.; Collins, Francis S.] NHGRI, NIH, Bethesda, MD 20892 USA; [Fisher, Eva; Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Kulzer, Jennifer R.; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Sandholt, Camilla; Gjesing, Anette P.; Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Stark, Klaus] Univ Regensburg, Med Ctr, Clin & Policlin Internal Med 2, Regensburg, Germany; [Timpson, Nicholas John; Day, Ian N. M.; Smith, George Davey; Lawlor, Debbie A.] MRC Ctr Causal Anal Translat Epidemiol, Dept Social Med, Bristol, Avon, England; [Watanabe, Richard M.; Buchanan, Thomas A.; Bergman, Richard N.] Univ So Calif, Keck Sch Med, Dept Phys & Biophys, Los Angeles, CA 90033 USA; [Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Chasman, Daniel I.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Cooper, Matthew N.; Lawrence, Robert W.; Hui, Jennie; Palmer, Lyle J.] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Crawley, WA, Australia; [Jansson, John-Olov] Univ Gothenburg, Inst Neurosci & Physiol, Dept Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Vandenput, Liesbeth; Ohlsson, Claes] Univ Gothenburg, Inst Med, Dept Internal Med, Sahlgrenska Acad, Gothenburg, Sweden; [Almgren, Peter; Groop, Leif C.] Lund Univ, Ctr Diabet, Dept Clin Sci, Malmo, Sweden; [Biffar, Reiner] Zentrum Zahn Mund & Kieferheilkunde, Greifswald, Germany; [Bornstein, Stefan R.; Graessler, Juergen; Ludwig, Barbara] Univ Dresden, Dept Med 3, Dresden, Germany; [Buchanan, Thomas A.] Univ So Calif, Keck Sch Med, Div Endocrinol, Los Angeles, CA 90033 USA; [Campbell, Harry; Wild, Sarah H.; Rudan, Igor; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Doerr, Marcus] Ernst Moritz Arndt Univ Greifswald, Dept Internal Med B, Greifswald, Germany; [Elliott, Paul] Ctr Environm & Hlth, MRC Hlth Protect Agcy HPA, London, England; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.; Kajantie, Eero; Peltonen, Leena] Natl Inst Hlth & Welf, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.; Isomaa, Bo; Tuomi, Tiinamaija] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland; [Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [Fu, Mao; Shuldiner, Alan R.; O'Connell, Jeffrey R.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Hartikainen, Anna-Liisa; Pouta, Anneli] Univ Oulu, Dept Clin Sci Obstet & Gynecol, Oulu, Finland; [Havulinna, Aki S.; Jousilahti, Pekka; Koskinen, Seppo; Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Chron Dis Epidemiol & Prevent Unit, Helsinki, Finland; [Herzig, Karl-Heinz] Univ Oulu, Dept Physiol, Inst Biomed, Oulu, Finland; [Herzig, Karl-Heinz] Kuopio Univ Hosp, Dept Psychiat, SF-70210 Kuopio, Finland; [Hicks, Andrew A.; Pichler, Irene; Volpato, Claudia B.; Pramstaller, Peter P.] European Acad Bozen Bolzano EURAC, Inst Med Genet, Bolzano, Italy; [Hui, Jennie; Beilby, John P.] QEII Med Ctr, Dept Mol Genet, PathW Lab Western Australia, Nedlands, WA, Australia; [Hicks, Andrew A.; Pichler, Irene; Volpato, Claudia B.; Pramstaller, Peter P.] Univ Lubeck, Affiliated Inst, Lubeck, Germany; [Hui, Jennie; Beilby, John P.; James, Alan L.; Palmer, Lyle J.] Sir Charles Gairdner Hosp, Busselton Populat Med Res Fdn Inc, Nedlands, WA, Australia; [Jula, Antti] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Populat Studies Unit, Turku, Finland; [Kajantie, Eero] Univ Helsinki, Cent Hosp, Hosp Children & Adolescents, Helsinki, Finland; [Kinnunen, Leena; Tuomilehto, Jaakko; Valle, Timo T.] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res, Leipzig, Germany; [Kroemer, Heyo K.] Ernst Moritz Arndt Univ Greifswald, Inst Pharmakol, Greifswald, Germany; [Krzelj, Vjekoslav; Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia; [Kuusisto, Johanna; Laakso, Markku] Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland; [Kvaloy, Kirsti; Platou, Carl G. P.; Hveem, Kristian; Midthjell, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Nord Trondelag Hlth Study HUNT Res Ctr, Levanger, Norway; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Oulu, Finland; [Lantieri, Olivier] Inst Interreg Sante IRSA, La Riche, France; [Lathrop, G. Mark] Ctr Natl Genotypage, Paris, France; [Lokki, Marja-Liisa] Univ Helsinki, Haartman Inst, Transplantat Lab, Helsinki, Finland; [Luben, Robert N.; Khaw, Kay-Tee] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [McArdle, Wendy L.] Univ Bristol, Dept Social Med, Avon Longitudinal Study Parents & Children ALSPAC, Bristol, Avon, England; [McCarthy, Anne] Res Board, Div Hlth, Dublin, Ireland; [Pare, Guillaume] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Parker, Alex N.] Amgen Inc, Cambridge, MA USA; [Peden, John F.] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England; [Pietilainen, Kirsi H.; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Finnish Twin Cohort Study, Helsinki, Finland; [Pietilainen, Kirsi H.; Rissanen, Aila] Univ Helsinki, Cent Hosp, Dept Psychiat, Obes Res Unit, Helsinki, Finland; [Platou, Carl G. P.] Levanger Hosp, Nord Trondelag Hlth Trust, Dept Med, Levanger, Norway; [Ridderstrale, Martin] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Samani, Nilesh J.] Glenfield Hosp, Biomed Res Unit Cardiovasc Dis, Leicester Natl Inst Hlth Res NIHR, Leicester, Leics, England; [Saramies, Jouko] S Karelia Cent Hosp, Lappeenranta, Finland; [Sinisalo, Juha; Nieminen, Markku S.] Univ Helsinki, Cent Hosp, Cardiovasc Lab, Div Cardiol, Helsinki, Finland; [Smit, Jan H.; Penninx, Brenda W.] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Inst Extramuraal Geneeskundig Onderzoek EMGO Inst, Amsterdam, Netherlands; [Strawbridge, Rona J.; Hamsten, Anders] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden; [van Ommen, Gert-Jan] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [van Ommen, Gert-Jan] Leiden Univ, Med Ctr, Ctr Med Syst Biol, Leiden, Netherlands; [Wallaschofski, Henri] Ernst Moritz Arndt Univ Greifswald, Inst Klin Chem & Lab Med, Greifswald, Germany; [Witte, Daniel R.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Zitting, Paavo] Lapland Cent Hosp, Dept Physiatr, Rovaniemi, Finland; [Beilby, John P.] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [James, Alan L.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Kahonen, Mika; Lehtimaki, Terho] Tampere Univ Hosp, Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, FIN-33101 Tampere, Finland; [Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol, FIN-20520 Turku, Finland; [Stumvoll, Michael; Toenjes, Anke] Univ Leipzig, Dept Med, Leipzig, Germany; [Stumvoll, Michael] Univ Leipzig, Leipziger Interdisziplinarer Forschungskomplex Mo, Leipzig, Germany; [Toenjes, Anke] Univ Leipzig, Coordinat Ctr Clin Trials, Leipzig, Germany; [Viikari, Jorma] Univ Turku, Dept Med, Turku, Finland; [Balkau, Beverley] INSERM Ctr Rech Epidemiol & Sante Populat CESP, F-01018 Villejuif, France; [Balkau, Beverley] Univ Paris Sud 11, Unit Mixte Rech Sante UMRS 1018, Villejuif, France; [Ben-Shlomo, Yoav] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Ebrahim, Shah] London Sch Hyg & Trop Med, London WC1, England; [Ebrahim, Shah] S Asia Network Chron Dis, New Delhi, India; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark; [Hengstenberg, Christian] Univ Regensburg, Klin & Poliklin Innere Med 2, Regensburg, Germany; [Hengstenberg, Christian] Univ Regensburg, Med Ctr, Innere Med 2, Regensburg, Germany; [Isomaa, Bo] Dept Social Serv & Hlth Care, Pietarsaari, Finland; [Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Karpe, Fredrik; McCarthy, Mark I.] Churchill Hosp, NIHR Oxford Biomed Res Ctr, Oxford OX3 7LJ, England; [Marre, Michel] Bichat Claude Bernard Univ Hosp, AP HP, Dept Endocrinol Diabetol & Nutr, Paris, France; [Marre, Michel] Univ Henri Poincar Nancy 1, Cardiovasc Genet Res Unit, Nancy, France; [Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-8000 Munich, Germany; [Meitinger, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Pedersen, Oluf] Univ Copenhagen, Inst Biomed Sci, Copenhagen, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Schwarz, Peter E. H.] Univ Dresden, Dept Med Prevent & Care Diabet 3, Dresden, Germany; [Tuomi, Tiinamaija] Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland; [Tuomi, Tiinamaija] Univ Helsinki, Res Program Mol Med, Helsinki, Finland; [Tuomilehto, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Tuomilehto, Jaakko] S Ostrobothnia Cent Hosp, Seinajoki, Finland; [Arnold, Alice M.] Collaborat Hlth Studies Coordinating Ctr, Seattle, WA USA; [Beckmann, Jacques S.] Univ Lausanne Hosp, CHUV, Serv Med Genet, Lausanne, Switzerland; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Inst Mol Med, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Iribarren, Carlos] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Iribarren, Carlos] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Kao, W. H. Linda] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol & Med, Baltimore, MD USA; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Dept Mental Hlth, Helsinki, Finland; [Kaprio, Jaakko] Unit Child & Adolescent Mental Hlth, Substance Abuse Serv, Helsinki, Finland; [Oostra, Ben] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Penninx, Brenda W.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Penninx, Brenda W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Pramstaller, Peter P.] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth, Grp Hlth Res Inst, Seattle, WA USA; [Shuldiner, Alan R.] Baltimore Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD USA; [Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Voelzke, Henry] Inst Community Med, Greifswald, Germany; [Vollenweider, Peter] Univ Lausanne Hosp, CHUV, Dept Internal Med, Lausanne, Switzerland; [Borecki, Ingrid B.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Haritunians, Talin] Cedars Sinai Med Ctr, Med Genet Inst, Los Angeles, CA 90048 USA; [Kaplan, Robert C.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [North, Kari E.] Univ N Carolina, Sch Publ Hlth, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Peltonen, Leena] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA; [Strachan, David P.] Univ London, Div Community Hlth Sci, London, England; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Barroso, Ines] Univ Cambridge, Metab Res Labs, Inst Metab Sci, Addenbrookes Hosp, Cambridge, England; [Fox, Caroline S.] NHLBI, Div Intramural Res, Framingham Heart Study, Framingham, MA USA	University of Oxford; Wellcome Centre for Human Genetics; University of Regensburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Michigan System; University of Michigan; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Erasmus University Rotterdam; Erasmus MC; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Boston University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Karolinska Institutet; University of Exeter; University of Plymouth; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Tartu; Estonian Biocentre; University of Tartu; University of Lausanne; Swiss Institute of Bioinformatics; University of North Carolina; University of North Carolina Chapel Hill; University of Bath; University of Oxford; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Imperial College London; Merck & Company; University of Oxford; Wellcome Centre for Human Genetics; Washington University (WUSTL); Wellcome Trust Sanger Institute; Erasmus University Rotterdam; Erasmus MC; University of Melbourne; Universite de Montreal; Universite de Montreal; University of London; King's College London; QIMR Berghofer Medical Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Icelandic Heart Association; University of Iceland; QIMR Berghofer Medical Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Imperial College London; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Edinburgh; Boston University; University of Amsterdam; Vrije Universiteit Amsterdam; Uppsala University; Norwegian University of Science & Technology (NTNU); University of London; Queen Mary University London; University of London; Queen Mary University London; University of Oulu; University of Oulu; Stanford University; Medical University of Innsbruck; University of Washington; University of Washington Seattle; University of Zagreb; University of Oxford; University of Helsinki; Finland National Institute for Health & Welfare; Ernst Moritz Arndt Universitat Greifswald; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of North Carolina; University of North Carolina Chapel Hill; Novo Nordisk; Hagedorn Research Institute; University of Regensburg; University of Bristol; University of Southern California; University of Southern California; Harvard University; Brigham & Women's Hospital; University of Western Australia; University of Gothenburg; University of Gothenburg; Lund University; Technische Universitat Dresden; University of Southern California; University of Edinburgh; Ernst Moritz Arndt Universitat Greifswald; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Vaasa Central Hospital; University of California System; University of California Los Angeles; University System of Maryland; University of Maryland Baltimore; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; Kuopio University Hospital; University of Eastern Finland; European Academy of Bozen-Bolzano; University of Western Australia; University of Lubeck; University of Western Australia; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; Leipzig University; Ernst Moritz Arndt Universitat Greifswald; University of Split; University of Eastern Finland; Norwegian University of Science & Technology (NTNU); Finnish Institute of Occupational Health; CEA; University of Helsinki; University of Cambridge; University of Bristol; McMaster University; Amgen; University of Oxford; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Lund University; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Helsinki; Helsinki University Central Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Karolinska Institutet; Karolinska University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Ernst Moritz Arndt Universitat Greifswald; Steno Diabetes Center; University of Western Australia; University of Western Australia; Tampere University; Tampere University; Tampere University Hospital; Tampere University; University of Turku; University of Turku; Leipzig University; Leipzig University; Leipzig University; University of Turku; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Bristol; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of Southern Denmark; University of Regensburg; University of Regensburg; University of Copenhagen; University of Copenhagen; University of Oxford; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lorraine; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Copenhagen; Aarhus University; Technische Universitat Dresden; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Kaiser Permanente; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Finland National Institute for Health & Welfare; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Krankenhaus Bozen; University of Lubeck; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; Uppsala University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Washington University (WUSTL); Cedars Sinai Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of Helsinki; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; Harvard University; Harvard Medical School; University of Munich; University of Munich; University of Iceland; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lindgren, CM (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	iris.heid@klinik.uni-regensburg.de; mark.mccarthy@drl.ox.ac.uk; foxca@nhlbi.nih.gov; mohlke@med.unc.edu; celi@well.ox.ac.uk	Abecasis, Goncalo R/B-7840-2010; Dörr, Marcus/F-1919-2010; Pedersen, Oluf/AAG-8015-2020; Berndt, Sonja I/J-8423-2016; Pramstaller, Peter P/C-2357-2008; Johansson, Åsa/G-5270-2011; Attrill, Lauren/V-1688-2018; Campbell, Harry/E-2959-2010; Vandenput, Liesbeth/AAP-3655-2020; Wood, Andrew R/AAB-3807-2019; sanna, serena/H-3009-2019; Johansson, Åsa/AAG-6799-2021; Havulinna, Aki/AAM-4769-2021; Coin, Lachlan JM/A-9001-2014; Assimes, Themistocles Leonard/D-9696-2015; Pare, Guillaume/T-9631-2018; Prokopenko, Inga/H-3241-2014; Hui, Jennie/A-9543-2013; Kilpeläinen, Tuomas/F-8569-2012; Luben, Robert N/H-5519-2015; Loos, Ruth J F/Q-2862-2016; Sovio, Ulla/H-8532-2019; Zondervan, Krina T/M-1143-2013; Strawbridge, Rona/H-5422-2012; Prokopenko, Inga/AAU-9895-2020; Rudan, Igor/I-1467-2012; Cooper, Matthew N/J-4420-2014; Grallert, Harald/B-3424-2013; Hicks, Andrew Anthony/E-9518-2017; Meitinger, Thomas/O-1318-2015; Ridderstråle, Martin/F-7678-2012; FROGUEL, Philippe/O-6799-2017; Raitakari, Olli/AAQ-7389-2021; Dei, Mariano/AAY-3870-2020; Jørgensen, Torben/Z-1335-2018; Bouatia-Naji, Nabila/AGF-1400-2022; Hveem, Kristian/AFV-4683-2022; Kaplan, Robert/A-2526-2011; Kinnunen, Leena/B-7059-2012; Krzelj, Vjekoslav/D-6491-2017; Lamina, Claudia/F-7608-2010; Hengstenberg, Christian/U-5485-2019; Penninx, Brenda WJH/S-7627-2017; Palmer, Lyle John/K-3196-2014; Stark, Klaus/D-3813-2009; Narisu, Narisu/T-6908-2019; Hayward, Caroline/M-8818-2016; Vandenput, Liesbeth/AAI-4100-2021; Ben-Shlomo, Yoav/ABD-2004-2021; Stark, Klaus/L-7367-2013; Boomsma, Dorret I/AAX-4470-2020; Ripatti, Samuli/H-9446-2014; Wilson, James F/A-5704-2009; Feitosa, Mary F/K-8044-2012; Kolcic, Ivana/E-2713-2017; Polasek, Ozren/B-6002-2011; Colaus, PsyColaus/K-6607-2013; Coin, Lachlan/O-4976-2019; Nyholt, Dale Robert/J-3174-2017; Gudnason, Vilmundur/K-6885-2015; Kutalik, Zoltan/HHZ-5697-2022; BOUATIA-NAJI, NABILA/D-5863-2013; Allen, Hana Lango/G-9026-2012; Witte, Daniel/AAF-9535-2019; Walters, G. Bragi/L-4215-2013; Ohlsson, Claes/AGP-3544-2022; Mägi, Reedik/AAJ-9679-2021; Beckmann, Jacques S/A-9772-2008; Voight, Benjamin/F-1775-2011; Stefansson, Kari/AAE-7187-2019; Gjesing, Anette/ACC-7521-2022; Aspelund, Thor/K-7022-2019; Zgaga, Lina/Q-9415-2018; Palmer, Lyle John/N-1948-2019; Loos, Ruth/GON-5877-2022; Gudnason, Vilmundur/AAE-7126-2019; Smith, Albert Vernon/K-5150-2015; Kaprio, Jaakko/A-1820-2008; Rivadeneira, Fernando/O-5385-2015; de Geus, Eco J.C./M-9318-2015; Pedersen, Oluf/Z-1731-2019; Deloukas, Panos/B-2922-2013; Uda, Manuela/AAC-2645-2019; Davey Smith, George/A-7407-2013; Timpson, Nicholas John/O-7548-2015; Stumvoll, Michael/ABE-1121-2021; Khaw, Kay-Tee/AAZ-3209-2021; Mangino, Massimo/F-5134-2011; Aspelund, Thor/F-4826-2011; Amin, Najaf N/D-1859-2012; Li, Shengxu/D-8915-2012; Aspelund, Thor/C-5983-2008; Witte, Daniel R/C-1722-2008; Teumer, Alexander/S-7438-2019; Wichmann, Heinz Erich/AAA-5695-2022; Spector, Tim D/F-6533-2012; Yang, Jian/A-5852-2010; Visscher, Peter/ABB-6151-2020; Lehtimäki, Terho/AAD-1094-2022; Nelis, Mari/ABG-7775-2020	Dörr, Marcus/0000-0001-7471-475X; Johansson, Åsa/0000-0002-2915-4498; Campbell, Harry/0000-0002-6169-6262; Vandenput, Liesbeth/0000-0002-1712-6131; Wood, Andrew R/0000-0003-1726-948X; sanna, serena/0000-0002-3768-1749; Johansson, Åsa/0000-0002-2915-4498; Coin, Lachlan JM/0000-0002-4300-455X; Assimes, Themistocles Leonard/0000-0003-2349-0009; Pare, Guillaume/0000-0002-6795-4760; Prokopenko, Inga/0000-0003-1624-7457; Hui, Jennie/0000-0002-1653-2496; Kilpeläinen, Tuomas/0000-0002-8349-3028; Luben, Robert N/0000-0002-5088-6343; Loos, Ruth J F/0000-0002-8532-5087; Sovio, Ulla/0000-0002-0799-1105; Zondervan, Krina T/0000-0002-0275-9905; Strawbridge, Rona/0000-0001-8506-3585; Rudan, Igor/0000-0001-6993-6884; Cooper, Matthew N/0000-0003-1139-3682; Hicks, Andrew Anthony/0000-0001-6320-0411; FROGUEL, Philippe/0000-0003-2972-0784; Bouatia-Naji, Nabila/0000-0001-5424-2134; Kinnunen, Leena/0000-0001-8739-4812; Lamina, Claudia/0000-0002-5398-5806; Penninx, Brenda WJH/0000-0001-7779-9672; Palmer, Lyle John/0000-0002-1628-3055; Stark, Klaus/0000-0002-7832-1942; Hayward, Caroline/0000-0002-9405-9550; Vandenput, Liesbeth/0000-0002-1712-6131; Ben-Shlomo, Yoav/0000-0001-6648-3007; Stark, Klaus/0000-0002-7832-1942; Ripatti, Samuli/0000-0002-0504-1202; Wilson, James F/0000-0001-5751-9178; Feitosa, Mary F/0000-0002-0933-2410; Kolcic, Ivana/0000-0001-7918-6052; Polasek, Ozren/0000-0002-5765-1862; Coin, Lachlan/0000-0002-4300-455X; Nyholt, Dale Robert/0000-0001-7159-3040; Gudnason, Vilmundur/0000-0001-5696-0084; Kutalik, Zoltan/0000-0001-8285-7523; Allen, Hana Lango/0000-0002-7803-8688; Witte, Daniel/0000-0002-0769-2922; Walters, G. Bragi/0000-0002-5415-6487; Ohlsson, Claes/0000-0002-9633-2805; Beckmann, Jacques S/0000-0002-9741-1900; Gjesing, Anette/0000-0003-4580-1576; Aspelund, Thor/0000-0002-7998-5433; Zgaga, Lina/0000-0003-4089-9703; Palmer, Lyle John/0000-0002-1628-3055; Gudnason, Vilmundur/0000-0001-5696-0084; Smith, Albert Vernon/0000-0003-1942-5845; Kaprio, Jaakko/0000-0002-3716-2455; Rivadeneira, Fernando/0000-0001-9435-9441; de Geus, Eco J.C./0000-0001-6022-2666; Pedersen, Oluf/0000-0002-3321-3972; Deloukas, Panos/0000-0001-9251-070X; Uda, Manuela/0000-0002-4890-6456; Davey Smith, George/0000-0002-1407-8314; Timpson, Nicholas John/0000-0002-7141-9189; Stumvoll, Michael/0000-0001-6225-8240; Mangino, Massimo/0000-0002-2167-7470; Aspelund, Thor/0000-0002-7998-5433; Witte, Daniel R/0000-0002-0769-2922; Teumer, Alexander/0000-0002-8309-094X; Yang, Jian/0000-0003-2001-2474; Visscher, Peter/0000-0002-2143-8760; Lehtimäki, Terho/0000-0002-2555-4427; Nelis, Mari/0000-0001-9748-1020; Graessler, Juergen/0000-0003-3619-8517; Amin, Najaf/0000-0002-8944-1771; Schwarz, Peter/0000-0002-0483-8594; Meitinger, Thomas/0000-0002-8838-8403; Surakka, Ida/0000-0002-6669-5541; Van Duijn, Cornelia/0000-0002-2374-9204; Esko, Tonu/0000-0003-1982-6569; Caulfield, Mark/0000-0001-9295-3594; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Kaakinen, Marika/0000-0002-9228-0462; Weedon, Michael/0000-0002-6174-6135; Pichler, Irene/0000-0001-8251-0757; Bergmann, Sven/0000-0002-6785-9034; Pramstaller, Peter P/0000-0002-9831-8302; Goddard, Michael/0000-0001-9917-7946; Lindgren, Cecilia/0000-0002-4903-9374; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Willemsen, Gonneke/0000-0003-3755-0236; Heard-Costa, Nancy/0000-0001-9730-0306; Peters, Marjolein/0000-0003-3167-9063; Tuomi, Tiinamaija/0000-0002-8306-6202; Shuldiner, Alan/0000-0001-9921-4305; Glazer, Nicole/0000-0002-6397-609X; Karpe, Fredrik/0000-0002-2751-1770; Randall, Joshua/0000-0003-1540-203X; Workalemahu, Tsegaselassie/0000-0003-4571-9740; Soranzo, Nicole/0000-0003-1095-3852; Johnson, Toby/0000-0002-5998-3270; Sinisalo, Juha/0000-0002-0169-5137; Elliott, Paul/0000-0002-7511-5684; Magi, Reedik/0000-0002-2964-6011; Ballantyne, Christie/0000-0002-6432-1730; Hansen, Torben/0000-0001-8748-3831; Dei, Mariano/0000-0002-7404-508X; Krzelj, Vjekoslav/0000-0001-6086-4669; bennett, amanda/0000-0003-2140-8710; Kovacs, Peter/0000-0002-0290-5423; Nicholson, George/0000-0001-9588-6075; Cupples, L. Adrienne/0000-0003-0273-7965; Marre, Michel/0000-0002-3071-1837; Munroe, Patricia/0000-0002-4176-2947; Lawlor, Debbie A/0000-0002-6793-2262; Jorgensen, Torben/0000-0001-9453-2830; Beilby, John/0000-0002-4915-2254; Abecasis, Goncalo/0000-0003-1509-1825; Quertermous, Thomas/0000-0002-7645-9067; Voight, Benjamin/0000-0002-6205-9994; Weyant, Robert/0000-0002-5252-9120; Venkatasubramanian, Siddharth/0000-0002-5860-0768; van Meurs, Joyce/0000-0001-6245-2123; Bergman, Richard/0000-0003-1539-4471; Wheeler, Eleanor/0000-0002-8616-6444; Eriksson, Johan/0000-0002-2516-2060; Pietilainen, Kirsi/0000-0002-8522-1288; Barroso, Ines/0000-0001-5800-4520; Willer, Cristen/0000-0001-5645-4966; Hattersley, Andrew/0000-0001-5620-473X; Kahonen, Mika/0000-0002-4510-7341	Academy of Finland [104781, 120315, 129269, 117797, 121584, 126925, 129418, 129568, 77299, 124243, 129680, 129494, 10404, 213506, 114382, 126775, 127437, 129255, 129306, 130326, 209072, 210595, 213225, 216374]; ADA [N02-HL-6-4278]; ALF/LUA Gothenburg; Althingi (the Icelandic Parliament); Amgen; Augustinus Foundation; Becket Foundation; Biocentrum Helsinki; Biomedicum Helsinki Foundation; Boston Obesity Nutrition Research Center [DK46200]; British Diabetes Association [1192]; British Diabetic Association Research; British Heart Foundation [97020, PG/02/128]; Busselton Population Medical Research Foundation; Cambridge NIHR Comprehensive Biomedical Research Centre; CamStrad; Chief Scientist Office of the Scottish Government; Contrat Plan Etat Region de France; Danish Centre for Health Technology Assessment; Danish Diabetes Association; Danish Ministry of Internal Affairs and Health; Danish Heart Foundation; Danish Pharmaceutical Association; Danish Research Council; DIAB Core (German Network of Diabetes); Diabetes UK; Donald W. Reynolds Foundation; Dresden University of Technology; Med Drive; EMGO+ institute; Emil and Vera Cornell Foundation; Erasmus Medical Center and Erasmus University, Rotterdam, The Netherlands; Estonian Government [SF0180142s08]; European Commission [2004310, 212111, 205419, 245536, DG XII, HEALTH-F4-2007-201413, FP7/2007-2013, QLG1-CT-2000-01643, QLG2-CT-2002-01254, LSHG-CT-2006-018947, LSHG-CT-2006-01947, LSHG-CT-2004-512066, LSHM-CT-2007-037273, EU/WLRT-2001-01254, LSHG-CT-2004-518153, SOC 95201408 05F02]; Federal Ministry of Education and Research, Germany [01ZZ9603, 01ZZ0103, 01ZZ0403, 03ZIK012, 01 EA 9401]; Federal State of Mecklenburg-West Pomerania; Finnish Diabetes Research Foundation; Finnish Diabetes Research Society; Finnish Foundation for Pediatric Research; Finnish Foundation of Cardiovascular Research; Finnish Medical Society; Finska Lakaresallskapet; Finnish Ministry of Education; Folkhalsan Research Foundation; Fond Europeen pour le Developpement Regional; Fondation LeDucq; Foundation for Life and Health in Finland; GEN-AU 'GOLD' from Austria; German Bundesministerium fuer Forschung und Technology [01 AK 803 A-H, 01 IG 07015 G]; German National Genome Research Net NGFN2 and NGFNplus [01GS0823, FKZ 01GS0823]; German Research Council [KFO-152]; GlaxoSmithKline; Goteborg Medical Society; Gyllenberg Foundation; Health Care Center in Vasa; Healthway, Western Australia; Helmholtz Center Munich; Helsinki University Central Hospital; Hjartavernd (the Icelandic Heart Association); Ib Henriksen Foundation; IZKF [B27]; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Juvenile Diabetes Research Foundation International (JDRF); Karolinska Institute and the Stockholm County Council [560183]; Knut and Alice Wallenberg Foundation; Lundbeck Foundation Centre of Applied Medical Genomics; Knut Krohn, Microarray Core Facility of the Interdisciplinary Centre for Clinical Research (IZKF), University of Leipzig, Germany; MC Health; Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania, Germany; South Tyrol Ministry of Health; Ministry of Science, Education and Sport of the Republic of Croatia [216-1080315-0302]; Medical Research Council UK [G0000649, G0601261, G9521010D, G0000934, G0500539, G0600331]; Montreal Heart Institute Foundation; MRC Centre for Obesity-Related Metabolic Disease; Municipal Health Care Center and Hospital in Jakobstad; Municipality of Rotterdam; Narpes Health Care Foundation; National Health and Medical Research Council of Australia and the Great Wine Estates Auctions; Netherlands Centre for Medical Systems Biology [SPI 56-464-1419]; Netherlands Ministry for Health; Welfare and Sports; Netherlands Ministry of Education, Culture and Science; Netherlands Genomics Initiative; Netherlands Consortium [050-060-810]; Netherlands Organisation of Scientific Research Netherlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) Investments [175.010.2005.011, 911-03-012, 904-61-090, 904-61-193, 480-04-004, 400-05-717]; National Institute on Aging; US National Institutes of Health [CA047988, CA65725, CA87969, CA49449, CA67262, CA50385, DK075787, DK062370, DK58845, DK072193, K23-DK080145, K99HL094535, N01-HC85079, N01-HC85086, N01-HG-65403, N01-AG-12100, N01-HC-25195, N01-HC35129, N01-HC15103, N01-HC55222, N01-HC75150, N01-HC45133, N01-HC55015, N01-HC55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, N01-AG-1-2109, HL71981, HG005581, HG002651, HL084729, HL043851, HHSN268200625226C, MH084698, P30-DK072488, R01 HL087652, R01-HL087641, R01-HL59367, R01-HL086694, R01-HL087647, R01-HL087679, R01-HL087700, R01-AG031890, R01-HL088119, R01-DK068336, R01-DK075681, R01-DK-073490, R01-DK075787, R01-MH63706, U01-HL72515, U01-GM074518, U01-HL084756, U01-HG004399, UO1-CA098233, UL1-RR025005, U01-HG004402, U01-DK062418, U01 HL080295, T32-HG00040, 263-MA-410953, 1RL1-MH083268-01, 1Z01-HG000024]; National Institute for Health Research (NIHR); Neuroscience Campus Amsterdam; Novo Nordisk Foundation; Novo Nordisk Inc.; Ollqvist Foundation; Paavo Nurmi Foundation; Paivikki and Sakari Sohlberg Foundation; Pew Scholarship for the Biomedical Sciences; Perklen Foundation; Petrus and Augusta Hedlunds Foundation; Research Institute for Diseases in the Elderly [014-93-015]; Sahlgrenska Center for Cardiovascular and Metabolic Research (CMR) [A305:188]; Siemens Healthcare, Erlangen, Germany; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Social Insurance Institution of Finland; Social Ministry of the Federal State of Mecklenburg-West Pomerania, Germany; South Tyrolean Sparkasse Foundation; State of Bavaria, Germany; Support for Science Funding programme; Swedish Cultural Foundation in Finland; Swedish Foundation for Strategic Research (SSF); Swedish Medical Research Council [8691, K2007-66X-20270-01-3, K2010-54X-09894-19-3]; Swedish Society of Medicine; Swiss National Science Foundation [33CSCO-122661]; Royal Society; Royal Swedish Academy of Science; Torsten and Ragnar Soderberg's Foundation; Turku University Hospitals; UK Department of Health Policy Research Programme; University and Research of the Autonomous Province of Bolzano; University Hospital Medical; University Hospital Oulu, Biocenter, University of Oulu, Finland [75617]; Vastra Gotaland Foundation; Wellcome Trust [077016/Z/05/Z, 068545/Z/02, 072960, 076113, 083270, 085301, 079557, 081682, 075491, 076113/B/04/Z, 091746/Z/10/Z, 079895, WT086596/Z/08/Z]; Western Australian Genetic Epidemiology Resource; Western Australian DNA Bank (both National Health and Medical Research Council of Australia Enabling Facilities); Yrjo Jahnsson Foundation; AstraZeneca AB; Lundberg Foundation; Swedish Heart-Lung Foundation; Research Foundation of Copenhagen County; Health care center in Nerpes; Health care center in Korsholm; MRC [G0801056, MC_U127561128, G0500115, MC_qA137934, G0600705, G0000934, MC_U106188470, G0600331, MC_UP_A390_1107, G0601261, MC_U106179472, G0501184] Funding Source: UKRI; Medical Research Council [MC_qA137934, MC_U106179472, G0500115, G0401527, G0000934, G0801056B, MC_U106188470, MC_U127561128, G0501184, G0600331, MC_UP_A390_1107, G0600705, G0601261, G0801056] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085083, N01HC085079, N01HC055020, N01HC055022, N01HC085084, N01HC075150, N01HC085085, N01HC055016, N01HC055222, N01HC085081, N01HC085086, N01HC025195, N01HC015103, N01HC035129, N01HC045133, N01HC085080, N01HC055015, N01HC055019, N01HC055018, N01HC055021, N01HC085082] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA049449, U01CA098233, U01CA067262, R01CA050385, R01CA065725, R01CA049449, R01CA067262, R01CA047988, P01CA087969] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117078, U01HL072515, U01HL080295, R01HL087641, R01HL043851, R01HL071981, R01HL087700, R01HL087652, R01HL088119, R42HL055018, R01HL086694, ZIAHL006094, R41HL055018, K99HL094535, R01HL059367, U01HL084729, R41HL055019, U01HL084756, U01HL054527, R01HL087679, R01HL087647] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005581, N01HG065403, ZIAHG000024, R01HG002651, T32HG000040, Z01HG000024, U01HG004399, U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075787, K23DK080145, U01DK062418, R56DK062370, P30DK046200, R01DK075681, U01DK062370, R01DK058845, R01DK072193, R01DK073490, R01DK056690, R01DK062370, R01DK068336, R01DK089256, P30DK072488, F32DK079466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063706, R01MH084698, RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000675, N01AG012100, R01AG031890] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); ADA(American Diabetes Association); ALF/LUA Gothenburg; Althingi (the Icelandic Parliament); Amgen(Amgen); Augustinus Foundation; Becket Foundation; Biocentrum Helsinki; Biomedicum Helsinki Foundation; Boston Obesity Nutrition Research Center; British Diabetes Association(Diabetes UK); British Diabetic Association Research; British Heart Foundation(British Heart Foundation); Busselton Population Medical Research Foundation; Cambridge NIHR Comprehensive Biomedical Research Centre; CamStrad; Chief Scientist Office of the Scottish Government; Contrat Plan Etat Region de France; Danish Centre for Health Technology Assessment; Danish Diabetes Association; Danish Ministry of Internal Affairs and Health; Danish Heart Foundation; Danish Pharmaceutical Association; Danish Research Council(Det Frie Forskningsrad (DFF)); DIAB Core (German Network of Diabetes); Diabetes UK(Diabetes UK); Donald W. Reynolds Foundation; Dresden University of Technology; Med Drive; EMGO+ institute; Emil and Vera Cornell Foundation; Erasmus Medical Center and Erasmus University, Rotterdam, The Netherlands(Netherlands Government); Estonian Government; European Commission(European CommissionEuropean Commission Joint Research Centre); Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Federal State of Mecklenburg-West Pomerania; Finnish Diabetes Research Foundation; Finnish Diabetes Research Society; Finnish Foundation for Pediatric Research; Finnish Foundation of Cardiovascular Research; Finnish Medical Society; Finska Lakaresallskapet; Finnish Ministry of Education; Folkhalsan Research Foundation; Fond Europeen pour le Developpement Regional; Fondation LeDucq(Leducq Foundation); Foundation for Life and Health in Finland; GEN-AU 'GOLD' from Austria; German Bundesministerium fuer Forschung und Technology; German National Genome Research Net NGFN2 and NGFNplus; German Research Council(German Research Foundation (DFG)); GlaxoSmithKline(GlaxoSmithKline); Goteborg Medical Society; Gyllenberg Foundation; Health Care Center in Vasa; Healthway, Western Australia; Helmholtz Center Munich(Helmholtz Association); Helsinki University Central Hospital; Hjartavernd (the Icelandic Heart Association); Ib Henriksen Foundation; IZKF; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); Karolinska Institute and the Stockholm County Council(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Lundbeck Foundation Centre of Applied Medical Genomics; Knut Krohn, Microarray Core Facility of the Interdisciplinary Centre for Clinical Research (IZKF), University of Leipzig, Germany; MC Health; Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania, Germany; South Tyrol Ministry of Health; Ministry of Science, Education and Sport of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Montreal Heart Institute Foundation; MRC Centre for Obesity-Related Metabolic Disease(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Municipal Health Care Center and Hospital in Jakobstad; Municipality of Rotterdam; Narpes Health Care Foundation; National Health and Medical Research Council of Australia and the Great Wine Estates Auctions(National Health and Medical Research Council (NHMRC) of Australia); Netherlands Centre for Medical Systems Biology; Netherlands Ministry for Health; Welfare and Sports; Netherlands Ministry of Education, Culture and Science; Netherlands Genomics Initiative; Netherlands Consortium; Netherlands Organisation of Scientific Research Netherlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) Investments(Netherlands Organization for Scientific Research (NWO)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Neuroscience Campus Amsterdam; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Inc.(Novo Nordisk); Ollqvist Foundation; Paavo Nurmi Foundation; Paivikki and Sakari Sohlberg Foundation; Pew Scholarship for the Biomedical Sciences; Perklen Foundation; Petrus and Augusta Hedlunds Foundation; Research Institute for Diseases in the Elderly; Sahlgrenska Center for Cardiovascular and Metabolic Research (CMR); Siemens Healthcare, Erlangen, Germany(Siemens AG); Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Social Insurance Institution of Finland; Social Ministry of the Federal State of Mecklenburg-West Pomerania, Germany; South Tyrolean Sparkasse Foundation; State of Bavaria, Germany; Support for Science Funding programme; Swedish Cultural Foundation in Finland; Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Society of Medicine; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Royal Society(Royal Society of London); Royal Swedish Academy of Science; Torsten and Ragnar Soderberg's Foundation; Turku University Hospitals; UK Department of Health Policy Research Programme; University and Research of the Autonomous Province of Bolzano; University Hospital Medical; University Hospital Oulu, Biocenter, University of Oulu, Finland; Vastra Gotaland Foundation; Wellcome Trust(Wellcome Trust); Western Australian Genetic Epidemiology Resource; Western Australian DNA Bank (both National Health and Medical Research Council of Australia Enabling Facilities); Yrjo Jahnsson Foundation; AstraZeneca AB(AstraZeneca); Lundberg Foundation(European Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Research Foundation of Copenhagen County; Health care center in Nerpes; Health care center in Korsholm; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for this study was provided by the Academy of Finland (grants 104781, 120315, 129269, 117797, 121584, 126925, 129418, 129568, 77299, 124243, 213506, 129680, 129494, 10404, 213506, 129680, 114382, 126775, 127437, 129255, 129306, 130326, 209072, 210595, 213225 and 216374); an ADA Mentor-Based Postdoctoral Fellowship grant; Affymetrix, Inc., for genotyping services (N02-HL-6-4278); ALF/LUA Gothenburg; Althingi (the Icelandic Parliament); Amgen; AstraZeneca AB; Augustinus Foundation; Becket Foundation; Biocentrum Helsinki; Biomedicum Helsinki Foundation; Boston Obesity Nutrition Research Center (DK46200); British Diabetes Association (1192); British Diabetic Association Research; British Heart Foundation (97020, PG/02/128); Busselton Population Medical Research Foundation; Cambridge NIHR Comprehensive Biomedical Research Centre; CamStrad; Chief Scientist Office of the Scottish Government; Contrat Plan Etat Region de France; Danish Centre for Health Technology Assessment; Danish Diabetes Association; Danish Ministry of Internal Affairs and Health; Danish Heart Foundation; Danish Pharmaceutical Association; Danish Research Council; DIAB Core (German Network of Diabetes); Diabetes UK; Donald W.; Reynolds Foundation; Dresden University of Technology Funding Grant, Med Drive; EMGO+ institute; Emil and Vera Cornell Foundation; Erasmus Medical Center and Erasmus University, Rotterdam, The Netherlands; Estonian Government SF0180142s08; European Commission (2004310, 212111, 205419, 245536, DG XII, HEALTH-F4-2007-201413, FP7/2007-2013, QLG1-CT-2000-01643, QLG2-CT-2002-01254, LSHG-CT-2006-018947, LSHG-CT-2006-01947, LSHG-CT-2004-512066, LSHM-CT-2007-037273, EU/WLRT-2001-01254, LSHG-CT-2004-518153, SOC 95201408 05F02, Marie Curie Intra-European Fellowship); Federal Ministry of Education and Research, Germany (01ZZ9603, 01ZZ0103, 01ZZ0403, 03ZIK012, 01 EA 9401); Federal State of Mecklenburg-West Pomerania; Finnish Diabetes Research Foundation; Finnish Diabetes Research Society; Finnish Foundation for Pediatric Research; Finnish Foundation of Cardiovascular Research; Finnish Medical Society; Finska Lakaresallskapet; Finnish Ministry of Education; Folkhalsan Research Foundation; Fond Europeen pour le Developpement Regional; Fondation LeDucq; Foundation for Life and Health in Finland; GEN-AU 'GOLD' from Austria; German Bundesministerium fuer Forschung und Technology (# 01 AK 803 A-H, # 01 IG 07015 G); German National Genome Research Net NGFN2 and NGFNplus (01GS0823, FKZ 01GS0823); German Research Council (KFO-152); GlaxoSmithKline; Goteborg Medical Society; Gyllenberg Foundation; Health Care Centers in Vasa, Narpes and Korsholm; Healthway, Western Australia; Helmholtz Center Munich; Helsinki University Central Hospital; Hjartavernd ( the Icelandic Heart Association); Ib Henriksen Foundation; IZKF (B27); Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Juvenile Diabetes Research Foundation International (JDRF); Karolinska Institute and the Stockholm County Council (560183); Knut and Alice Wallenberg Foundation; Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care; Knut Krohn, Microarray Core Facility of the Interdisciplinary Centre for Clinical Research (IZKF), University of Leipzig, Germany; Lundberg Foundation; MC Health; Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania, Germany; South Tyrol Ministry of Health; Ministry of Science, Education and Sport of the Republic of Croatia (216-1080315-0302); Medical Research Council UK (G0000649, G0601261, 9521010D, G0000934, G0500539, G0600331, PrevMetSyn); Montreal Heart Institute Foundation; MRC Centre for Obesity-Related Metabolic Disease; Municipal Health Care Center and Hospital in Jakobstad; Municipality of Rotterdam; Narpes Health Care Foundation; National Health and Medical Research Council of Australia and the Great Wine Estates Auctions; Netherlands Centre for Medical Systems Biology (SPI 56-464-1419); Netherlands Ministry for Health, Welfare and Sports; Netherlands Ministry of Education, Culture and Science; Netherlands Genomics Initiative; Netherlands Consortium for Healthy Aging (050-060-810); Netherlands Organisation of Scientific Research Netherlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) Investments (175.010.2005.; 011, 911-03-012, 904-61-090, 904-61-193, 480-04-004, 400-05-717); National Institute on Aging Intramural Research Program; US National Institutes of Health (CA047988, CA65725, CA87969, CA49449, CA67262, CA50385, DK075787, DK062370, DK58845, DK072193, K23-DK080145, K99HL094535, N01-HC85079 through N01-HC85086, N01-HG-65403, N01-AG-12100, N01-HC-25195, N01-HC35129, N01-HC15103, N01-HC55222, N01-HC75150, N01-HC45133, N01-HC55015, N01-HC55016, N01-HC-55018, N01-HC-5019, N01-HC-55020, N01-HC-55021, N01-HC-55022, N01-AG-1-2109, HL71981, HG005581, HG002651, HL084729, HL043851, HHSN268200625226C, K23-DK080145, MH084698, P30-DK072488, R01-DK075787, R01 HL087652, R01-HL087641, R01-HL59367, R01-HL086694, R01-HL087647, R01-HL087679, R01-HL087700, R01-AG031890, R01-HL088119, R01-DK068336, R01-DK075681, R01-DK-073490, R01-DK075787, R01-MH63706, U01-HL72515, U01-GM074518, U01-HL084756, U01-HG004399, UO1-CA098233, UL1-RR025005, UL1-RR025005, U01-HG004402, U01-DK062418, U01 HL080295, T32-HG00040, 263-MA-410953, 1RL1-MH083268-01, intramural project 1Z01-HG000024); National Institute for Health Research (NIHR); Neuroscience Campus Amsterdam; Novo Nordisk Foundation; Novo Nordisk Inc., Research Foundation of Copenhagen County; Ollqvist Foundation; Paavo Nurmi Foundation; Paivikki and Sakari Sohlberg Foundation; Pew Scholarship for the Biomedical Sciences; Perklen Foundation; Petrus and Augusta Hedlunds Foundation; Research Institute for Diseases in the Elderly (014-93-015, RIDE, RIDE2); Sahlgrenska Center for Cardiovascular and Metabolic Research (CMR, A305:188); Siemens Healthcare, Erlangen, Germany; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Social Insurance Institution of Finland; Social Ministry of the Federal State of Mecklenburg-West Pomerania, Germany; South Tyrolean Sparkasse Foundation; State of Bavaria, Germany; Support for Science Funding programme; Swedish Cultural Foundation in Finland; Swedish Foundation for Strategic Research (SSF); Swedish Heart-Lung Foundation; Swedish Medical Research Council (8691, K2007-66X-20270-01-3, K2010-54X-09894-19-3); Swedish Society of Medicine; Swiss National Science Foundation (33CSCO-122661); the Royal Society; the Royal Swedish Academy of Science; Torsten and Ragnar Soderberg's Foundation; Turku University Hospitals; UK Department of Health Policy Research Programme; University and Research of the Autonomous Province of Bolzano; University Hospital Medical funds to Tampere; University Hospital Oulu, Biocenter, University of Oulu, Finland (75617); Vastra Gotaland Foundation; Wellcome Trust (077016/Z/05/Z, 068545/Z/02, 072960, 076113, 083270, 085301, 079557, 081682, 075491, 076113/B/04/Z, 091746/Z/10/Z, 079895, WT086596/Z/08/Z, WT Research Career Development Fellowship; WT Career Development Award); Western Australian Genetic Epidemiology Resource and the Western Australian DNA Bank (both National Health and Medical Research Council of Australia Enabling Facilities); Yrjo Jahnsson Foundation.	Agarwal AK, 2006, ANNU REV GENOM HUM G, V7, P175, DOI 10.1146/annurev.genom.7.080505.115715; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Boesgaard TW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007236; Candille SI, 2004, PLOS BIOL, V2, P30, DOI 10.1371/journal.pbio.0020003; Canoy D, 2008, CURR OPIN CARDIOL, V23, P591, DOI 10.1097/HCO.0b013e328313133a; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooney GJ, 2004, EMBO J, V23, P582, DOI 10.1038/sj.emboj.7600082; Cox D.R., 1979, THEORETICAL STAT; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; de la Torre NG, 2008, J CLIN ENDOCR METAB, V93, P4276, DOI 10.1210/jc.2007-1370; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; Lanctot C, 2007, EXP CELL RES, V313, P1449, DOI 10.1016/j.yexcr.2007.01.027; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mills GW, 2004, DIABETOLOGIA, V47, P732, DOI 10.1007/s00125-004-1338-2; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Pennacchio LA, 2007, GENOME RES, V17, P201, DOI 10.1101/gr.5972507; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Ridker PM, 2009, CIRC-CARDIOVASC GENE, V2, P26, DOI 10.1161/CIRCGENETICS.108.817304; Rose KM, 1998, OBES RES, V6, P383, DOI 10.1002/j.1550-8528.1998.tb00369.x; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Scherzer R, 2008, AM J CLIN NUTR, V87, P1809, DOI 10.1093/ajcn/87.6.1809; SELBY JV, 1990, INT J OBESITY, V14, P593; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Shifman S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040028; Silha JV, 2005, INT J OBESITY, V29, P1308, DOI 10.1038/sj.ijo.0802987; Snijder MB, 2003, AM J CLIN NUTR, V77, P1192, DOI 10.1093/ajcn/77.5.1192; Snijder MB, 2004, DIABETES CARE, V27, P372, DOI 10.2337/diacare.27.2.372; Souren NY, 2007, DIABETOLOGIA, V50, P2107, DOI 10.1007/s00125-007-0784-z; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stouffer S.A., 1949, ADJUSTMENT ARMY LIFE; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Vega GL, 2006, J CLIN ENDOCR METAB, V91, P4459, DOI 10.1210/jc.2006-0814; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zillikens MC, 2008, DIABETOLOGIA, V51, P2233, DOI 10.1007/s00125-008-1163-0	61	663	680	2	137	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					949	U160		10.1038/ng.685	http://dx.doi.org/10.1038/ng.685			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20935629	Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000283540500011
J	Popov, N; Schulein, C; Jaenicke, LA; Eilers, M				Popov, Nikita; Schuelein, Christina; Jaenicke, Laura A.; Eilers, Martin			Ubiquitylation of the amino terminus of Myc by SCF beta-TrCP antagonizes SCFFbw7-mediated turnover	NATURE CELL BIOLOGY			English	Article							KAPPA-B-ALPHA; C-MYC; DNA-REPLICATION; LIGASE COMPLEX; DEPENDENT DEGRADATION; UBIQUITIN CHAINS; CELL-CYCLE; PROTEIN; PROTEOLYSIS; DESTRUCTION	The SCFFbw7 ubiquitin ligase mediates growth-factor-regulated turnover of the Myc oncoprotein. Here we show that SCF beta-TrCP binds to Myc by means of a characteristic phosphodegron and ubiquitylates Myc; this results in enhanced Myc stability. SCFFbw7 and SCF beta-TrCP can exert these differential effects through polyubiquitylation of the amino terminus of Myc. Whereas SCFFbw7 with the Cdc34 ubiquitin-conjugating enzyme specifically requires lysine 48 (K48) of ubiquitin, SCF beta-TrCP uses the UbcH5 ubiquitin-conjugating enzyme to form heterotypic polyubiquitin chains on Myc. Ubiquitylation of Myc by SCF beta-TrCP is required for Myc-dependent acceleration of cell cycle progression after release from an arrest in S phase. Therefore, alternative ubiquitylation events at the N terminus can lead to the ubiquitylation-dependent stabilization of Myc.	[Popov, Nikita; Schuelein, Christina; Jaenicke, Laura A.; Eilers, Martin] Univ Wurzburg, Bioctr, Theodor Boveri Inst, D-97074 Wurzburg, Germany	University of Wurzburg	Eilers, M (corresponding author), Univ Wurzburg, Bioctr, Theodor Boveri Inst, D-97074 Wurzburg, Germany.	martin.eilers@biozentrum.uni-wuerzburg.de		Eilers, Martin/0000-0002-0376-6533	Deutsche Forschungsgemeinschaft; Wilhelm Sander Stiftung fur Krebsforschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm Sander Stiftung fur Krebsforschung	We thank Markus Welcker and Bruce Clurman for expression vectors encoding Fbw7 and beta-TrCP2; Victoria Cowling for IMECs; and Axel Behrens for anti-Fbw7 antibody. This study was supported by grants from the Deutsche Forschungsgemeinschaft through the Transregio 17 ('Ras-dependent pathways in human tumours') project and the Wilhelm Sander Stiftung fur Krebsforschung.	Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; BHATIA K, 1993, NAT GENET, V5, P56, DOI 10.1038/ng0993-56; Blanco-Bose WE, 2008, HEPATOLOGY, V48, P1302, DOI 10.1002/hep.22475; Brzovic PS, 2006, CELL CYCLE, V5, P2867, DOI 10.4161/cc.5.24.3592; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Chakraborty AA, 2009, EXP CELL RES, V315, P1772, DOI 10.1016/j.yexcr.2009.01.011; Choi SH, 2010, GENE DEV, V24, P1236, DOI 10.1101/gad.1920310; DiRenzo J, 2002, CANCER RES, V62, P89; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fong A, 2002, J BIOL CHEM, V277, P22111, DOI 10.1074/jbc.C200151200; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gonen H, 1999, J BIOL CHEM, V274, P14823, DOI 10.1074/jbc.274.21.14823; HANN SR, 1985, NATURE, V314, P366, DOI 10.1038/314366a0; Hattori K, 1999, J BIOL CHEM, V274, P29641, DOI 10.1074/jbc.274.42.29641; Herold S, 2008, EMBO J, V27, P2851, DOI 10.1038/emboj.2008.200; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Koch HB, 2007, CELL CYCLE, V6, P205, DOI 10.4161/cc.6.2.3742; Kuras L, 2002, MOL CELL, V10, P69, DOI 10.1016/S1097-2765(02)00561-0; Levens DL, 2003, GENE DEV, V17, P1071, DOI 10.1101/gad.1095203; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Robinson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005951; Schorl C, 2003, MOL BIOL CELL, V14, P823, DOI 10.1091/mbc.E02-10-0649; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Trenz K, 2008, EMBO J, V27, P876, DOI 10.1038/emboj.2008.29; Verma R, 1997, MOL BIOL CELL, V8, P1427, DOI 10.1091/mbc.8.8.1427; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; ZAAROORREGEV D, 2010, P NATL ACAD SCI US; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009	48	111	114	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					973	981		10.1038/ncb2104	http://dx.doi.org/10.1038/ncb2104			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20852628				2022-12-25	WOS:000282363500012
J	Chan, AP; Crabtree, J; Zhao, Q; Lorenzi, H; Orvis, J; Puiu, D; Melake-Berhan, A; Jones, KM; Redman, J; Chen, G; Cahoon, EB; Gedil, M; Stanke, M; Haas, BJ; Wortman, JR; Fraser-Liggett, CM; Ravel, J; Rabinowicz, PD				Chan, Agnes P.; Crabtree, Jonathan; Zhao, Qi; Lorenzi, Hernan; Orvis, Joshua; Puiu, Daniela; Melake-Berhan, Admasu; Jones, Kristine M.; Redman, Julia; Chen, Grace; Cahoon, Edgar B.; Gedil, Melaku; Stanke, Mario; Haas, Brian J.; Wortman, Jennifer R.; Fraser-Liggett, Claire M.; Ravel, Jacques; Rabinowicz, Pablo D.			Draft genome sequence of the oilseed species Ricinus communis	NATURE BIOTECHNOLOGY			English	Article							DIACYLGLYCEROL ACYLTRANSFERASE; ARABIDOPSIS-THALIANA; FATTY-ACIDS; CASTOR-OIL; TRANSGENIC ARABIDOPSIS; GENE; PLANTS; ANNOTATION; CLONING; ENZYME	Castor bean (Ricinus communis) is an oilseed crop that belongs to the spurge (Euphorbiaceae) family, which comprises similar to 6,300 species that include cassava (Manihot esculenta), rubber tree (Hevea brasiliensis) and physic nut (Jatropha curcas). It is primarily of economic interest as a source of castor oil, used for the production of high-quality lubricants because of its high proportion of the unusual fatty acid ricinoleic acid. However, castor bean genomics is also relevant to biosecurity as the seeds contain high levels of ricin, a highly toxic, ribosome-inactivating protein. Here we report the draft genome sequence of castor bean (4.6-fold coverage), the first for a member of the Euphorbiaceae. Whereas most of the key genes involved in oil synthesis and turnover are single copy, the number of members of the ricin gene family is larger than previously thought. Comparative genomics analysis suggests the presence of an ancient hexaploidization event that is conserved across the dicotyledonous lineage.	[Chan, Agnes P.; Zhao, Qi; Lorenzi, Hernan; Melake-Berhan, Admasu; Rabinowicz, Pablo D.] JCVI, Rockville, MD USA; [Crabtree, Jonathan; Orvis, Joshua; Jones, Kristine M.; Redman, Julia; Wortman, Jennifer R.; Fraser-Liggett, Claire M.; Ravel, Jacques; Rabinowicz, Pablo D.] Univ Maryland, Sch Med, IGS, Baltimore, MD 21201 USA; [Puiu, Daniela] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Chen, Grace] USDA ARS, Western Reg Res Ctr Crop Improvement & Utilizat, Albany, CA USA; [Cahoon, Edgar B.] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE USA; [Cahoon, Edgar B.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Gedil, Melaku] Int Inst Trop Agr, Ibadan, Nigeria; [Stanke, Mario] Univ Gottingen, Abt Bioinformat, Inst Mikrobiol & Genet, Gottingen, Germany; [Haas, Brian J.] Massachusetts Inst Technol & Harvard, Broad Inst, Cambridge, MA USA; [Rabinowicz, Pablo D.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	J. Craig Venter Institute; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; CGIAR; International Institute of Tropical Agriculture (IITA); University of Gottingen; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University System of Maryland; University of Maryland Baltimore	Rabinowicz, PD (corresponding author), JCVI, Rockville, MD USA.	prabinowicz@som.umaryland.edu	Ravel, Jacques/D-2530-2009; Stanke, Mario/P-7876-2019; Gedil, Melaku/H-9445-2019	Stanke, Mario/0000-0001-8696-0384; Gedil, Melaku/0000-0002-6258-6014; Ravel, Jacques/0000-0002-0851-2233; Fraser, Claire/0000-0003-1462-2428; Lorenzi, Hernan/0000-0003-0910-7894; Wortman, Jennifer/0000-0002-8713-1227; Chan, Agnes/0000-0003-2373-9580	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services [N01-AI-30071]; Federal Bureau of Investigation [J-FBI-04-186]; National Science Foundation [DBI 0701919]	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Federal Bureau of Investigation; National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services, under NIAID Contract N01-AI-30071 (R. communis subproject) awarded to C.M.F.-L., J.R., J.R.W. and P.D.R.; Federal Bureau of Investigation grant J-FBI-04-186 to C.M.F.-L., J.R. and P.D.R.; and National Science Foundation grant DBI 0701919 to E.B.C. We thank the Joint Technology Center at J. Craig Venter Institute for carrying out all sequencing work, and K. Wurdack for his assistance with phylogenetics.	Allan G, 2008, GENET RESOUR CROP EV, V55, P365, DOI 10.1007/s10722-007-9244-3; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; BIRREN B, 1997, GENOME ANAL LAB MANU, V1; BRIGHAM RD, 1970, CROP SCI, V10, P457; Broun P, 1997, PLANT PHYSIOL, V113, P933, DOI 10.1104/pp.113.3.933; Burgal J, 2008, PLANT BIOTECHNOL J, V6, P819, DOI 10.1111/j.1467-7652.2008.00361.x; Cahoon EB, 2007, CURR OPIN PLANT BIOL, V10, P236, DOI 10.1016/j.pbi.2007.04.005; Cahoon EB, 2006, PHYTOCHEMISTRY, V67, P1166, DOI 10.1016/j.phytochem.2006.04.013; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Childs KL, 2007, NUCLEIC ACIDS RES, V35, pD846, DOI 10.1093/nar/gkl785; Claudel-Renard C, 2003, NUCLEIC ACIDS RES, V31, P6633, DOI 10.1093/nar/gkg847; Crabtree Jonathan, 2007, V408, P93, DOI 10.1007/978-1-59745-547-3_6; Da Silva ND, 2006, APPL BIOCHEM BIOTECH, V130, P405, DOI 10.1385/ABAB:130:1:405; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Fidias Panos, 2002, Clin Lung Cancer, V3, P219, DOI 10.3816/CLC.2002.n.006; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Foster JT, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-13; FRISTENSKY B, 1988, PLANT MOL BIOL, V11, P713, DOI 10.1007/BF00017470; Goodrum JW, 2005, BIORESOURCE TECHNOL, V96, P851, DOI 10.1016/j.biortech.2004.07.006; Haas BJ, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-7; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; HALLING KC, 1985, NUCLEIC ACIDS RES, V13, P8019, DOI 10.1093/nar/13.22.8019; He SM, 2008, NUCLEIC ACIDS RES, V36, pD170, DOI 10.1093/nar/gkm1011; He XH, 2004, LIPIDS, V39, P311, DOI 10.1007/s11745-004-1234-2; Hillocks RJ, 2003, INT J PEST MANAGE, V49, P225, DOI 10.1080/0967087031000101061; Huang XQ, 1997, GENOMICS, V46, P37, DOI 10.1006/geno.1997.4984; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [DOI 10.1111/J.1469-8137.1912.TB05611.X, 10.1111/j.1469-8137.1912.tb05611.x]; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; KNIGHT B, 1979, BRIT MED J, V1, P350; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kroon JTM, 2006, PHYTOCHEMISTRY, V67, P2541, DOI 10.1016/j.phytochem.2006.09.020; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Leshin J, 2010, TOXICON, V55, P658, DOI 10.1016/j.toxicon.2009.09.002; Li RZ, 2010, PLANT BIOTECHNOL J, V8, P184, DOI 10.1111/j.1467-7652.2009.00476.x; Lord J M, 1991, Semin Cell Biol, V2, P15; LORD JM, 1994, FASEB J, V8, P201, DOI 10.1096/fasebj.8.2.8119491; LORD JM, 1985, EUR J BIOCHEM, V146, P403, DOI 10.1111/j.1432-1033.1985.tb08666.x; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu CF, 2006, PLANT J, V45, P847, DOI 10.1111/j.1365-313X.2005.02636.x; Lu CF, 2009, P NATL ACAD SCI USA, V106, P18837, DOI 10.1073/pnas.0908848106; Macbeth MR, 1999, J MOL BIOL, V285, P567, DOI 10.1006/jmbi.1998.2337; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; McKeon TA, 2000, BIOCHEM SOC T, V28, P972, DOI 10.1042/BST0280972; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Musshoff F, 2009, DRUG TEST ANAL, V1, P184, DOI 10.1002/dta.27; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Rabinowicz PD, 1999, NAT GENET, V23, P305, DOI 10.1038/15479; RAMOS LCD, 1984, J AM OIL CHEM SOC, V61, P1841, DOI 10.1007/BF02540812; ROBERTS LM, 1985, J BIOL CHEM, V260, P5682; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sambrook J, 2001, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCARPA A, 1982, J ETHNOPHARMACOL, V5, P117, DOI 10.1016/0378-8741(82)90038-1; Schnell R, 2002, CLIN CANCER RES, V8, P1779; Smith MA, 2003, PLANTA, V217, P507, DOI 10.1007/s00425-003-1015-6; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Thelen JJ, 2002, METAB ENG, V4, P12, DOI 10.1006/mben.2001.0204; Thomaeus S, 2001, PLANT SCI, V161, P997, DOI 10.1016/S0168-9452(01)00500-3; TREGEAR JW, 1992, PLANT MOL BIOL, V18, P515, DOI 10.1007/BF00040667; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; UMANAH EE, 1973, J AM SOC HORTIC SCI, V98, P272; van Ooijen G, 2007, ANNU REV PHYTOPATHOL, V45, P43, DOI 10.1146/annurev.phyto.45.062806.094430; VANDELOO FJ, 1995, P NATL ACAD SCI USA, V92, P6743, DOI 10.1073/pnas.92.15.6743; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Wortman JR, 2003, PLANT PHYSIOL, V132, P461, DOI 10.1104/pp.103.022251	75	345	450	2	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2010	28	9					951	U3		10.1038/nbt.1674	http://dx.doi.org/10.1038/nbt.1674			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	648UF	20729833	Green Accepted, hybrid			2022-12-25	WOS:000281719100021
J	Anand, S; Majeti, BK; Acevedo, LM; Murphy, EA; Mukthavaram, R; Scheppke, L; Huang, M; Shields, DJ; Lindquist, JN; Lapinski, PE; King, PD; Weis, SM; Cheresh, DA				Anand, Sudarshan; Majeti, Bharat K.; Acevedo, Lisette M.; Murphy, Eric A.; Mukthavaram, Rajesh; Scheppke, Lea; Huang, Miller; Shields, David J.; Lindquist, Jeffrey N.; Lapinski, Philip E.; King, Philip D.; Weis, Sara M.; Cheresh, David A.			MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis	NATURE MEDICINE			English	Article							ARTERIOVENOUS-MALFORMATIONS; VASCULAR INTEGRITY; BINDING PROTEIN; RASA1 MUTATIONS; MICE; CAPILLARY; TISSUES; KINASE; METASTASIS; PHENOTYPE	Although it is well established that tumors initiate an angiogenic switch, the molecular basis of this process remains incompletely understood. Here we show that the miRNA miR-132 acts as an angiogenic switch by targeting p120RasGAP in the endothelium and thereby inducing neovascularization. We identified miR-132 as a highly upregulated miRNA in a human embryonic stem cell model of vasculogenesis and found that miR-132 was highly expressed in the endothelium of human tumors and hemangiomas but was undetectable in normal endothelium. Ectopic expression of miR-132 in endothelial cells in vitro increased their proliferation and tube-forming capacity, whereas intraocular injection of an antagomir targeting miR-132, anti-miR-132, reduced postnatal retinal vascular development in mice. Among the top-ranking predicted targets of miR-132 was p120RasGAP, which we found to be expressed in normal but not tumor endothelium. Endothelial expression of miR-132 suppressed p120RasGAP expression and increased Ras activity, whereas a miRNA-resistant version of p120RasGAP reversed the vascular response induced by miR-132. Notably, administration of anti-miR-132 inhibited angiogenesis in wild-type mice but not in mice with an inducible deletion of Rasa1 (encoding p120RasGAP). Finally, vessel-targeted nanoparticle delivery(1) of anti-miR-132 restored p120RasGAP expression in the tumor endothelium, suppressed angiogenesis and decreased tumor burden in an orthotopic xenograft mouse model of human breast carcinoma. We conclude that miR-132 acts as an angiogenic switch by suppressing endothelial p120RasGAP expression, leading to Ras activation and the induction of neovascularization, whereas the application of anti-miR-132 inhibits neovascularization by maintaining vessels in the resting state.	[Anand, Sudarshan; Majeti, Bharat K.; Acevedo, Lisette M.; Murphy, Eric A.; Mukthavaram, Rajesh; Scheppke, Lea; Huang, Miller; Shields, David J.; Lindquist, Jeffrey N.; Weis, Sara M.; Cheresh, David A.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Anand, Sudarshan; Majeti, Bharat K.; Acevedo, Lisette M.; Murphy, Eric A.; Mukthavaram, Rajesh; Scheppke, Lea; Huang, Miller; Shields, David J.; Lindquist, Jeffrey N.; Weis, Sara M.; Cheresh, David A.] Univ Calif San Diego, Moores UCSD Canc Ctr, San Diego, CA 92103 USA; [Lapinski, Philip E.; King, Philip D.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Michigan System; University of Michigan	Cheresh, DA (corresponding author), Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA.	dcheresh@ucsd.edu	King, Phil/C-7104-2013; ANAND, SUDARSHAN/I-5316-2019	ANAND, SUDARSHAN/0000-0002-4969-6884; Huang, Miller/0000-0002-3371-0100	US National Institutes of Health [HL078912, CA104898, CA050286, HL096498]; American Heart Association [09POST2040038]; NATIONAL CANCER INSTITUTE [R37CA050286, P01CA104898, R01CA050286] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096498, R01HL078912] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank L. Barnes, E. Goka, B. Walsh and D. Wu for technical support. We thank S. Weng and J. Desgrosellier for discussions. We thank E. Brown (University of Pennsylvania) for the Ert2-ubiquitin-Cre mice. We thank R. Kerbel (University of Toronto) for the fast-growing variant of MDA-MB-231 breast carcinoma cells. We thank S. Kajiji (Scripps Research Institute) for FG human pancreatic adenocarcinoma cells. This work was supported by US National Institutes of Health grants HL078912, CA104898 and CA050286 to D.A.C. and HL096498 to P.D.K.S.A. is supported in part by an American Heart Association postdoctoral fellowship 09POST2040038.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Boon LM, 2005, CURR OPIN GENET DEV, V15, P265, DOI 10.1016/j.gde.2005.03.004; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793; Eng KT, 2006, CLIN INTERV AGING, V1, P451, DOI 10.2147/ciia.2006.1.4.451; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Fish JE, 2009, SCI SIGNAL, V1, DOI 10.1126/scisignal.252pe1; Folkman J, 1992, Semin Cancer Biol, V3, P65; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; HENKEMEYER M, 1995, NATURE, V377, P695, DOI 10.1038/377695a0; Hershkovitz D, 2008, BRIT J DERMATOL, V158, P1035, DOI 10.1111/j.1365-2133.2008.08493.x; HOBSON B, 1984, BRIT J CANCER, V49, P405, DOI 10.1038/bjc.1984.66; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; HOSHINO M, 1988, MOL CELL BIOL, V8, P4169, DOI 10.1128/MCB.8.10.4169; Kelly MA, 2009, ARTERIOSCL THROM VAS, V29, P718, DOI 10.1161/ATVBAHA.109.184200; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Komada M, 2005, J BIOCHEM, V137, P1, DOI 10.1093/jb/mvi001; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kulkarni SV, 2000, J CELL BIOL, V149, P457, DOI 10.1083/jcb.149.2.457; Lapinski PE, 2007, GENESIS, V45, P762, DOI 10.1002/dvg.20354; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LINDQUIST JN, 2010, CURR PROTOC STEM CEL, V12; Mayo LD, 2001, J BIOL CHEM, V276, P25184, DOI 10.1074/jbc.M102932200; MCCORMICK F, 1989, CELL, V56, P5, DOI 10.1016/0092-8674(89)90976-8; Meadows KN, 2004, ONCOGENE, V23, P192, DOI 10.1038/sj.onc.1206921; Munoz R, 2006, CANCER RES, V66, P3386, DOI 10.1158/0008-5472.CAN-05-4411; Murphy EA, 2008, P NATL ACAD SCI USA, V105, P9343, DOI 10.1073/pnas.0803728105; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005	40	406	434	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2010	16	8					909	U109		10.1038/nm.2186	http://dx.doi.org/10.1038/nm.2186			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20676106	Green Accepted			2022-12-25	WOS:000280649200031
J	Fujiu, K; Nakayama, Y; Iida, H; Sokabe, M; Yoshimura, K				Fujiu, Kenta; Nakayama, Yoshitaka; Iida, Hidetoshi; Sokabe, Masahiro; Yoshimura, Kenjiro			Mechanoreception in motile flagella of Chlamydomonas	NATURE CELL BIOLOGY			English	Article							REINHARDTII; TRANSPORT; CHANNELS; PROTEINS; ELEGANS	Ciliates and flagellates temporarily swim backwards on collision by generating a mechanoreceptor potential. Although this potential has been shown to be associated with cilia in Paramecium, the molecular entity of the mechanoreceptor has remained unknown. Here we show that Chlamydomonas cells express TRP11, a member of the TRP (transient receptor potential) subfamily V, in the proximal region of the flagella, and that suppression of TRP11 expression results in loss of the avoiding reaction. The results indicate that Chlamydomonas flagella exhibit mechanosensitivity, despite constant motility, by localizing the mechanoreceptor in the proximal region, where active bending is restricted.	[Fujiu, Kenta; Sokabe, Masahiro; Yoshimura, Kenjiro] Japan Sci & Technol Agcy, ICORP SORST Cell Mechanosensing Project, Nagoya, Aichi 4668550, Japan; [Nakayama, Yoshitaka; Yoshimura, Kenjiro] Univ Tsukuba, Div Struct Biosci, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Nakayama, Yoshitaka; Iida, Hidetoshi] Tokyo Gakugei Univ, Dept Biol, Tokyo 1848501, Japan; [Sokabe, Masahiro] Nagoya Univ Grad Sch Med, Dept Physiol, Nagoya, Aichi 4668550, Japan	Japan Science & Technology Agency (JST); University of Tsukuba; Tokyo Gakugei University; Nagoya University	Yoshimura, K (corresponding author), Japan Sci & Technol Agcy, ICORP SORST Cell Mechanosensing Project, Nagoya, Aichi 4668550, Japan.	kenjiro@mbb.nifty.ne.jp	Iida, Hidetoshi/AAO-5506-2020; Nakayama, Yoshitaka/AAT-9699-2020; Sokabe, Masahiro/I-1565-2012; Nakayama, Yoshitaka/J-4973-2014	Nakayama, Yoshitaka/0000-0001-6797-5556; Nakayama, Yoshitaka/0000-0001-6797-5556	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology, Japan [10J02008, 21026009, 21370017, 21247021, 16GS0308, 16370034]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Japan Science and Technology Agency and Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan under grant numbers 10J02008 (to Y.N.), 21026009, 21370017 (to HI.), 21247021, 16GS0308 (to M.S.) and 16370034 (to K.Y.).	Colbert HA, 1997, J NEUROSCI, V17, P8259; Damann N, 2008, CURR BIOL, V18, pR880, DOI 10.1016/j.cub.2008.07.063; Fujiu K, 2009, CURR BIOL, V19, P133, DOI 10.1016/j.cub.2008.11.068; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; HUANG B, 1977, J CELL BIOL, V72, P67, DOI 10.1083/jcb.72.1.67; Huang K, 2007, J CELL BIOL, V179, P501, DOI 10.1083/jcb.200704069; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Kottgen M, 2007, BBA-MOL BASIS DIS, V1772, P836, DOI 10.1016/j.bbadis.2007.01.003; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Minke B, 2006, CELL CALCIUM, V40, P261, DOI 10.1016/j.ceca.2006.05.002; NAITOH Y, 1969, SCIENCE, V164, P963, DOI 10.1126/science.164.3882.963; OGURA A, 1976, NATURE, V264, P171; Qin HM, 2005, CURR BIOL, V15, P1695, DOI 10.1016/j.cub.2005.08.047; REMILLARD SP, 1982, J CELL BIOL, V93, P615, DOI 10.1083/jcb.93.3.615; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; WITMAN GB, 1978, J CELL BIOL, V76, P729, DOI 10.1083/jcb.76.3.729; Yagi T, 2009, J CELL SCI, V122, P1306, DOI 10.1242/jcs.045096; Yoshimura K, 1996, J EXP BIOL, V199, P295	20	64	65	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY 11	2011	13	5					630	U304		10.1038/ncb2214	http://dx.doi.org/10.1038/ncb2214			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	758FY	21478860				2022-12-25	WOS:000290148700023
J	Cha, PC; Takahashi, A; Hosono, N; Low, SK; Kamatani, N; Kubo, M; Nakamura, Y				Cha, Pei-Chieng; Takahashi, Atsushi; Hosono, Naoya; Low, Siew-Kee; Kamatani, Naoyuki; Kubo, Michiaki; Nakamura, Yusuke			A genome-wide association study identifies three loci associated with susceptibility to uterine fibroids	NATURE GENETICS			English	Article							EXTRACELLULAR-MATRIX; EXPRESSION; PATHOGENESIS; LEIOMYOMAS; NUCLEOTIDE; ETIOLOGY	Uterine fibroids are a common benign tumor of the female genital tract. We conducted a genome-wide association study in which 457,044 SNPs were analyzed in 1,607 individuals with clinically diagnosed uterine fibroids and 1,428 female controls. SNPs showing suggestive associations (P < 5 x 10(-5)) were further genotyped in 3,466 additional cases and 3,245 female controls. Three loci on chromosomes 10q24.33, 22q13.1 and 11p15.5 revealed genome-wide significant associations with uterine fibroids. The SNPs showing the most significant association in a combination analysis at each of these loci were rs7913069 (P = 8.65 x 10(-14), odds ratio (OR) = 1.47), rs12484776 (P = 2.79 x 10(-12), OR = 1.23) and rs2280543 (P = 3.82 x 10(-12), OR = 1.39), respectively. Subsequent fine mapping of these regions will be necessary to pinpoint the causal variants. Our findings should shed light on the pathogenesis of uterine fibroids.	[Cha, Pei-Chieng; Low, Siew-Kee; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Lab Mol Med, Ctr Human Genome, Tokyo, Japan; [Takahashi, Atsushi; Kubo, Michiaki] RIKEN Ctr Genom Med, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Hosono, Naoya; Kubo, Michiaki] RIKEN Ctr Genom Med, Lab Genotyping Dev, Yokohama, Kanagawa, Japan	University of Tokyo; RIKEN; RIKEN	Nakamura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Lab Mol Med, Ctr Human Genome, Tokyo, Japan.	yusuke@ims.u-tokyo.ac.jp	Kubo, Michiaki/N-7947-2015	Low, Siew-Kee/0000-0003-2386-0698	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We extend our heartfelt gratitude to all subjects who kindly participated in the current study. We also thank the BioBank Japan for providing DNA samples and clinical information. Finally, we acknowledge members of the Laboratory for Genotyping Development, Center for Genomic Medicine, RIKEN, for their excellent technical assistance. This work was supported by Leading Project for Personalized Medicine in the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Bonatz G, 1998, AM J OBSTET GYNECOL, V179, P591, DOI 10.1016/S0002-9378(98)70050-X; BUTTRAM VC, 1981, FERTIL STERIL, V36, P433; de Carvalho CE, 2002, BIOL REPROD, V66, P785, DOI 10.1095/biolreprod66.3.785; El-Gharib MN, 2010, J OBSTET GYNAECOL RE, V36, P101, DOI 10.1111/j.1447-0756.2009.01099.x; Flake GP, 2003, ENVIRON HEALTH PERSP, V111, P1037, DOI 10.1289/ehp.5787; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Luo X, 2008, SEMIN REPROD MED, V26, P500, DOI 10.1055/s-0028-1096130; Malik M, 2010, SEMIN REPROD MED, V28, P168, DOI 10.1055/s-0030-1251475; Marsh EE, 2008, FERTIL STERIL, V89, P1771, DOI 10.1016/j.fertnstert.2007.05.074; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Parazzini F, 1996, EPIDEMIOLOGY, V7, P440, DOI 10.1097/00001648-199607000-00018; Sozen I, 2002, FERTIL STERIL, V78, P1, DOI 10.1016/S0015-0282(02)03154-0; Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Storbeck CJ, 2004, MUSCLE NERVE, V29, P553, DOI 10.1002/mus.20000; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Thomas CJ, 2008, J BIOL CHEM, V283, P23150, DOI 10.1074/jbc.M802422200; TRELOAR SA, 1992, AM J OBSTET GYNECOL, V167, P82, DOI 10.1016/S0002-9378(11)91632-9; VIKHLYAEVA EM, 1995, INT J GYNECOL OBSTET, V51, P127, DOI 10.1016/0020-7292(95)02533-I; Wagner S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001868; Xu Y, 2002, MOL BIOL CELL, V13, P3493, DOI 10.1091/mbc.E02-01-0004	24	85	87	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2011	43	5					447	+		10.1038/ng.805	http://dx.doi.org/10.1038/ng.805			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	755XF	21460842				2022-12-25	WOS:000289972600014
J	Khosla, S				Khosla, Sundeep			A shift in calcium	NATURE MEDICINE			English	Editorial Material							VASCULAR CALCIFICATION; OSTEOPOROSIS; ASSOCIATION; DISEASE; CELLS; BONE		Mayo Clin, Coll Med, Endocrine Res Unit, Rochester, MN 55905 USA	Mayo Clinic	Khosla, S (corresponding author), Mayo Clin, Coll Med, Endocrine Res Unit, Rochester, MN 55905 USA.	khosla.sundeep@mayo.edu	Khosla, Sundeep/AAE-6170-2020	Khosla, Sundeep/0000-0002-2936-4372				Al-Aly Z, 2007, ARTERIOSCL THROM VAS, V27, P2589, DOI 10.1161/ATVBAHA.107.153668; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Gossl M, 2008, J AM COLL CARDIOL, V52, P1314, DOI 10.1016/j.jacc.2008.07.019; Hyder JA, 2009, AM J EPIDEMIOL, V169, P186, DOI 10.1093/aje/kwn303; Iribarren C, 2000, JAMA-J AM MED ASSOC, V283, P2810, DOI 10.1001/jama.283.21.2810; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Khosla S, 2007, NEW ENGL J MED, V356, P2293, DOI 10.1056/NEJMcp070341; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Modder UI, 2011, OSTEOIMMUNOLOGY: INTERACTIONS OF THE IMMUNE AND SKELETAL SYSTEMS, P269, DOI 10.1016/B978-0-12-375670-1.10009-3; Osako MK, 2010, CIRC RES, V107, P466, DOI 10.1161/CIRCRESAHA.110.216846; Sage AP, 2010, NAT REV CARDIOL, V7, P528, DOI 10.1038/nrcardio.2010.115; Tanko LB, 2005, J BONE MINER RES, V20, P1912, DOI 10.1359/JBMR.050711	12	26	31	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2011	17	4					430	431		10.1038/nm0411-430	http://dx.doi.org/10.1038/nm0411-430			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21475237				2022-12-25	WOS:000289245100031
J	Quarles, LD				Quarles, L. Darryl			'Dem bones' are made for more than walking	NATURE MEDICINE			English	Editorial Material							CHRONIC KIDNEY-DISEASE; VITAMIN-D; FGF23 LEVELS; FIBROBLAST-GROWTH-FACTOR-23; EXPRESSION; RATS; PTH		Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Quarles, LD (corresponding author), Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA.	dquarles@uthsc.edu		Quarles, L. Darryl/0000-0002-5082-7896	NIAMS NIH HHS [R01 AR045955] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045955] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hasegawa H, 2010, KIDNEY INT, V78, P975, DOI 10.1038/ki.2010.313; Katsnelson A, 2010, NATURE, V466, P914, DOI 10.1038/466914a; Komaba H, 2010, KIDNEY INT, V77, P292, DOI 10.1038/ki.2009.466; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; Riminucci M, 2003, J CLIN INVEST, V112, P683, DOI 10.1172/JC120031899; Saji F, 2010, AM J PHYSIOL-RENAL, V299, pF1212, DOI 10.1152/ajprenal.00169.2010; Samadfam R, 2009, ENDOCRINOLOGY, V150, P4835, DOI 10.1210/en.2009-0472; Sato T, 2004, AM J KIDNEY DIS, V44, P481, DOI 10.1053/j.ajkd.2004.05.026; Tsuji K, 2010, J BONE MINER RES, V25, P1711, DOI 10.1002/jbmr.65; Weber TJ, 2003, J BONE MINER RES, V18, P1227, DOI 10.1359/jbmr.2003.18.7.1227; Wetmore JB, 2010, CLIN J AM SOC NEPHRO, V5, P110, DOI 10.2215/CJN.03630509	16	28	29	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2011	17	4					428	430		10.1038/nm0411-428	http://dx.doi.org/10.1038/nm0411-428			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21475236	Green Accepted			2022-12-25	WOS:000289245100030
J	Bradbury, ARM; Sidhu, S; Dubel, S; McCafferty, J				Bradbury, Andrew R. M.; Sidhu, Sachdev; Duebel, Stefan; McCafferty, John			Beyond natural antibodies: the power of in vitro display technologies	NATURE BIOTECHNOLOGY			English	Article							SINGLE-CHAIN ANTIBODIES; HIGH-THROUGHPUT GENERATION; HUMAN MONOCLONAL-ANTIBODY; PHAGE-DISPLAY; RECOMBINANT ANTIBODIES; SYNTHETIC ANTIBODIES; THERAPEUTIC ANTIBODIES; BOTULINUM NEUROTOXIN; MOLECULAR EVOLUTION; CRYSTAL-STRUCTURE	In vitro display technologies, best exemplified by phage and yeast display, were first described for the selection of antibodies some 20 years ago. Since then, many antibodies have been selected and improved upon using these methods. Although it is not widely recognized, many of the antibodies derived using in vitro display methods have properties that would be extremely difficult, if not impossible, to obtain by immunizing animals. The first antibodies derived using in vitro display methods are now in the clinic, with many more waiting in the wings. Unlike immunization, in vitro display permits the use of defined selection conditions and provides immediate availability of the sequence encoding the antibody. The amenability of in vitro display to high-throughput applications broadens the prospects for their wider use in basic and applied research.	[Bradbury, Andrew R. M.] Los Alamos Natl Lab, Los Alamos, NM USA; [Sidhu, Sachdev] Univ Toronto, Toronto, ON, Canada; [Duebel, Stefan] Tech Univ Carolo Wilhelmina Braunschweig, Braunschweig, Germany; [McCafferty, John] Univ Cambridge, Cambridge, England	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Toronto; Braunschweig University of Technology; University of Cambridge	Bradbury, ARM (corresponding author), Los Alamos Natl Lab, Los Alamos, NM USA.	amb@lanl.gov		Bradbury, Andrew/0000-0002-5567-8172; Dubel, Stefan/0000-0001-8811-7390	US National Institutes of Health [P50GM085273, R01-HG004852-01A1]; US Department of Energy; US Department of Defense, Defense Threat Reduction Agency; EU; Wellcome Trust; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085273] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy(United States Department of Energy (DOE)); US Department of Defense, Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); EU(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.R.M.B. is grateful to the US National Institutes of Health (P50GM085273 and R01-HG004852-01A1), US Department of Energy (GTL program) and the US Department of Defense, Defense Threat Reduction Agency for funding. S. D. gratefully acknowledges funding by the EU 7<SUP>th</SUP> framework programme (Projects: Affinomics and AffinityProteome). J.M. is pleased to acknowledge funding by the Wellcome Trust.	Amstutz P, 2005, J BIOL CHEM, V280, P24715, DOI 10.1074/jbc.M501746200; Atwell JL, 1999, PROTEIN ENG, V12, P597, DOI 10.1093/protein/12.7.597; Ayriss J, 2007, J PROTEOME RES, V6, P1072, DOI 10.1021/pr0604108; Baker KP, 2003, ARTHRITIS RHEUM-US, V48, P3253, DOI 10.1002/art.11299; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Beck A, 2008, CURR PHARM BIOTECHNO, V9, P482, DOI 10.2174/138920108786786411; BEERLI RR, 1994, J BIOL CHEM, V269, P23931; Bikker FJ, 2007, CHEM BIOL DRUG DES, V69, P314, DOI 10.1111/j.1747-0285.2007.00504.x; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Binz HK, 2005, CURR OPIN BIOTECH, V16, P459, DOI 10.1016/j.copbio.2005.06.005; BIOCCA S, 1994, BIO-TECHNOL, V12, P396, DOI 10.1038/nbt0494-396; BIOCCA S, 1995, TRENDS CELL BIOL, V5, P248, DOI 10.1016/S0962-8924(00)89019-4; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Bradbury ARM, 2004, J IMMUNOL METHODS, V290, P29, DOI 10.1016/j.jim.2004.04.007; BREITLING F, 1991, GENE, V104, P147, DOI 10.1016/0378-1119(91)90244-6; Cabezas S, 2009, ARCH VIROL, V154, P1035, DOI 10.1007/s00705-009-0401-1; Casey JL, 2000, PROTEIN ENG, V13, P445, DOI 10.1093/protein/13.6.445; Chames P, 1998, J IMMUNOL, V161, P5421; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Cirino NM, 1999, INFECT IMMUN, V67, P2957, DOI 10.1128/IAI.67.6.2957-2963.1999; Cloutier SM, 2000, MOL IMMUNOL, V37, P1067, DOI 10.1016/S0161-5890(01)00023-2; Cohen CJ, 2003, J MOL RECOGNIT, V16, P324, DOI 10.1002/jmr.640; Dadaglio G, 1997, IMMUNITY, V6, P727, DOI 10.1016/S1074-7613(00)80448-3; Dalum I, 1999, NAT BIOTECHNOL, V17, P666, DOI 10.1038/10878; Deckert PM, 2009, CURR DRUG TARGETS, V10, P158, DOI 10.2174/138945009787354502; deKruif J, 1996, J BIOL CHEM, V271, P7630, DOI 10.1074/jbc.271.13.7630; der Maur AA, 2001, FEBS LETT, V508, P407, DOI 10.1016/S0014-5793(01)03101-5; Desiderio A, 2001, J MOL BIOL, V310, P603, DOI 10.1006/jmbi.2001.4756; Dobson CL, 2009, MABS-AUSTIN, V1, P552, DOI 10.4161/mabs.1.6.10057; Dorsam H, 1997, FEBS LETT, V414, P7, DOI 10.1016/S0014-5793(97)00966-6; DUBEL S, 1995, J IMMUNOL METHODS, V178, P201, DOI 10.1016/0022-1759(94)00257-W; Dubel S, 2010, TRENDS BIOTECHNOL, V28, P333, DOI 10.1016/j.tibtech.2010.05.001; Edwards BM, 2003, J MOL BIOL, V334, P103, DOI 10.1016/j.jmb.2003.09.054; Eisenhardt SU, 2007, NAT PROTOC, V2, P3063, DOI 10.1038/nprot.2007.455; Ellmark P, 2008, AIDS RES HUM RETROV, V24, P367, DOI 10.1089/aid.2007.0215; Engberg J, 1999, IMMUNOTECHNOLOGY, V4, P273; EXLEY D, 1971, STEROIDS, V18, P605, DOI 10.1016/0039-128X(71)90073-0; Fagete S, 2009, MABS-AUSTIN, V1, P288, DOI 10.4161/mabs.1.3.8527; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Foote J, 2000, P NATL ACAD SCI USA, V97, P10679, DOI 10.1073/pnas.97.20.10679; Fuchs H, 2009, CURR DRUG TARGETS, V10, P89, DOI 10.2174/138945009787354557; Gao JJ, 2009, P NATL ACAD SCI USA, V106, P3071, DOI 10.1073/pnas.0812952106; Garcia-Rodriguez C, 2011, PROTEIN ENG DES SEL, V24, P321, DOI 10.1093/protein/gzq111; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; GAWLITTA W, 1981, EUR J CELL BIOL, V26, P83; Griep RA, 1999, PROTEIN EXPRES PURIF, V16, P63, DOI 10.1006/prep.1999.1041; Grimsey NL, 2008, J NEUROSCI METH, V171, P78, DOI 10.1016/j.jneumeth.2008.02.014; Grunewald J, 2009, P NATL ACAD SCI USA, V106, P4337, DOI 10.1073/pnas.0900507106; Hallborn J, 2002, BIOTECHNIQUES, P30; Hamilton SR, 2007, CURR OPIN BIOTECH, V18, P387, DOI 10.1016/j.copbio.2007.09.001; Hanes J, 2000, NAT BIOTECHNOL, V18, P1287, DOI 10.1038/82407; HANING R, 1972, STEROIDS, V20, P73, DOI 10.1016/0039-128X(72)90119-5; Hayhurst A, 2003, J IMMUNOL METHODS, V276, P185, DOI 10.1016/S0022-1759(03)00100-5; Heitner T, 2001, J IMMUNOL METHODS, V248, P17, DOI 10.1016/S0022-1759(00)00340-9; Hemminki A, 1998, IMMUNOTECHNOLOGY, V4, P59, DOI 10.1016/S1380-2933(98)00002-5; Hoffhines AJ, 2006, J BIOL CHEM, V281, P37877, DOI 10.1074/jbc.M609398200; Hu SZ, 1996, CANCER RES, V56, P3055; Hudson PJ, 1999, J IMMUNOL METHODS, V231, P177, DOI 10.1016/S0022-1759(99)00157-X; Huie MA, 2001, P NATL ACAD SCI USA, V98, P2682, DOI 10.1073/pnas.051631798; HUSE WD, 1989, SCIENCE, V246, P1275, DOI 10.1126/science.2531466; Hust M, 2011, J BIOTECHNOL, V152, P159, DOI 10.1016/j.jbiotec.2010.09.945; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; JESPERS LS, 1994, BIO-TECHNOL, V12, P899, DOI 10.1038/nbt0994-899; Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966; Jositsch G, 2009, N-S ARCH PHARMACOL, V379, P389, DOI 10.1007/s00210-008-0365-9; Kalb SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012237; Kehoe JW, 2006, MOL CELL PROTEOMICS, V5, P2350, DOI 10.1074/mcp.M600314-MCP200; Kirsch MI, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-66; Kohl A, 2005, STRUCTURE, V13, P1131, DOI 10.1016/j.str.2005.04.020; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Kontermann RE, 2004, METHODS, V34, P163, DOI 10.1016/j.ymeth.2004.04.002; Kreitman RJ, 2000, J CLIN ONCOL, V18, P1622, DOI 10.1200/JCO.2000.18.8.1622; Krogsgaard M, 2000, J EXP MED, V191, P1395, DOI 10.1084/jem.191.8.1395; LARRICK JW, 1989, BIOCHEM BIOPH RES CO, V160, P1250, DOI 10.1016/S0006-291X(89)80138-X; Lassen KS, 2008, ELECTROPHORESIS, V29, P2557, DOI 10.1002/elps.200700908; Le Gall F, 1999, FEBS LETT, V453, P164, DOI 10.1016/S0014-5793(99)00713-9; Lee CV, 2006, BLOOD, V108, P3103, DOI 10.1182/blood-2006-03-011031; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Li K, 2008, J BIOL CHEM, V283, P8046, DOI 10.1074/jbc.M800170200; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Lim APC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-130; Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336; Liu B, 2007, J MOL MED, V85, P1113, DOI 10.1007/s00109-007-0208-z; Lloyd C, 2009, PROTEIN ENG DES SEL, V22, P159, DOI 10.1093/protein/gzn058; Lou JL, 2001, J IMMUNOL METHODS, V253, P233, DOI 10.1016/S0022-1759(01)00385-4; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; Mabry R, 2005, INFECT IMMUN, V73, P8362, DOI 10.1128/IAI.73.12.8362-8368.2005; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Marks JD, 2004, MOVEMENT DISORD, V19, pS101, DOI 10.1002/mds.20023; Martens T, 2006, CLIN CANCER RES, V12, P6144, DOI 10.1158/1078-0432.CCR-05-1418; Maur AAD, 2002, J BIOL CHEM, V277, P45075, DOI 10.1074/jbc.M205264200; Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Meissner F, 2002, VIROLOGY, V300, P236, DOI 10.1006/viro.2002.1533; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Mersmann M, 2010, NEW BIOTECHNOL, V27, P118, DOI 10.1016/j.nbt.2009.10.007; Moghaddam A, 2003, J IMMUNOL METHODS, V280, P139, DOI 10.1016/S0022-1759(03)00109-1; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Muller D, 2010, BIODRUGS, V24, P89, DOI 10.2165/11530960-000000000-00000; Mutuberria R, 2004, J IMMUNOL METHODS, V287, P31, DOI 10.1016/j.jim.2004.01.011; Nielsen UB, 2002, BBA-MOL CELL RES, V1591, P109, DOI 10.1016/S0167-4889(02)00256-2; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Okada J, 2010, VIROLOGY, V397, P322, DOI 10.1016/j.virol.2009.11.025; ORLANDI R, 1989, P NATL ACAD SCI USA, V86, P3833, DOI 10.1073/pnas.86.10.3833; Osbourn J, 2005, METHODS, V36, P61, DOI 10.1016/j.ymeth.2005.01.006; Paganetti P, 2005, J CELL BIOL, V168, P863, DOI 10.1083/jcb.200410047; Park JW, 2001, J CONTROL RELEASE, V74, P95, DOI 10.1016/S0168-3659(01)00315-7; Parsons HL, 1996, PROTEIN ENG, V9, P1043, DOI 10.1093/protein/9.11.1043; Paschke M, 2006, APPL MICROBIOL BIOT, V70, P2, DOI 10.1007/s00253-005-0270-9; Pei XY, 1997, P NATL ACAD SCI USA, V94, P9637, DOI 10.1073/pnas.94.18.9637; Peipp M, 2008, CURR OPIN IMMUNOL, V20, P436, DOI 10.1016/j.coi.2008.05.012; PERISIC O, 1994, STRUCTURE, V2, P1217, DOI 10.1016/S0969-2126(94)00123-5; Pershad K, 2010, PROTEIN ENG DES SEL, V23, P279, DOI 10.1093/protein/gzq003; Persic L, 1997, GENE, V187, P9, DOI 10.1016/S0378-1119(96)00628-2; Philibert P, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-81; Pini A, 1998, J BIOL CHEM, V273, P21769, DOI 10.1074/jbc.273.34.21769; Pope A, 1996, IMMUNOTECHNOLOGY, V2, P209, DOI 10.1016/S1380-2933(96)00051-6; Poul MA, 2000, J MOL BIOL, V301, P1149, DOI 10.1006/jmbi.2000.4026; Pozner-Moulis S, 2007, LAB INVEST, V87, P251, DOI 10.1038/labinvest.3700515; Presta LG, 2008, CURR OPIN IMMUNOL, V20, P460, DOI 10.1016/j.coi.2008.06.012; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; RICHARDSON JH, 1995, P NATL ACAD SCI USA, V92, P3137, DOI 10.1073/pnas.92.8.3137; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; RIGBY PWJ, 1976, J BACTERIOL, V125, P728, DOI 10.1128/JB.125.2.728-738.1976; Rizk SS, 2009, P NATL ACAD SCI USA, V106, P11011, DOI 10.1073/pnas.0904907106; Roth A, 2007, MOL CANCER THER, V6, P2737, DOI 10.1158/1535-7163.MCT-07-0140; Rothlisberger D, 2004, FEBS LETT, V564, P340, DOI 10.1016/S0014-5793(04)00359-X; Runnels HA, 2010, ADV THER, V27, P458, DOI 10.1007/s12325-010-0026-5; SAKO D, 1995, CELL, V83, P323, DOI 10.1016/0092-8674(95)90173-6; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; SASTRY L, 1989, P NATL ACAD SCI USA, V86, P5728, DOI 10.1073/pnas.86.15.5728; Saviranta P, 1998, PROTEIN ENG, V11, P143, DOI 10.1093/protein/11.2.143; Schier R, 1996, J MOL BIOL, V263, P551, DOI 10.1006/jmbi.1996.0598; Schliemann C, 2007, BBA-REV CANCER, V1776, P175, DOI 10.1016/j.bbcan.2007.08.002; Schliemann C, 2010, RECENT RESULTS CANC, V180, P201, DOI 10.1007/978-3-540-78281-0_12; Schofield DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r254; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; SMITH TW, 1975, BIOCHEMISTRY-US, V14, P1496, DOI 10.1021/bi00678a023; SPICER SS, 1994, J HISTOCHEM CYTOCHEM, V42, P213, DOI 10.1177/42.2.7507139; Steiniger SCJ, 2007, MOL IMMUNOL, V44, P2749, DOI 10.1016/j.molimm.2006.11.011; Storz U, 2010, ANTIBODY ENGINEERING, VOL 2, SECOND EDITION, P517, DOI 10.1007/978-3-642-01147-4_39; Strebe N, 2009, J IMMUNOL METHODS, V341, P30, DOI 10.1016/j.jim.2008.10.012; Stryhn A, 1996, P NATL ACAD SCI USA, V93, P10338, DOI 10.1073/pnas.93.19.10338; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; Szent-Gyorgyi C, 2008, NAT BIOTECHNOL, V26, P235, DOI 10.1038/nbt1368; Tanaka T, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng023; TATEISHI K, 1980, J STEROID BIOCHEM, V13, P951; Thie H, 2009, NEW BIOTECHNOL, V26, P314, DOI 10.1016/j.nbt.2009.07.005; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Turunen L, 2009, J BIOMOL SCREEN, V14, P282, DOI 10.1177/1087057108330113; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; Velappan N, 2007, J IMMUNOL METHODS, V321, P60, DOI 10.1016/j.jim.2007.01.011; Villa A, 2008, INT J CANCER, V122, P2405, DOI 10.1002/ijc.23408; Visintin M, 1999, P NATL ACAD SCI USA, V96, P11723, DOI 10.1073/pnas.96.21.11723; VOLK WA, 1984, INFECT IMMUN, V45, P604, DOI 10.1128/IAI.45.3.604-609.1984; Watanabe H, 2008, J BIOL CHEM, V283, P36031, DOI 10.1074/jbc.M805547200; Wild MA, 2003, NAT BIOTECHNOL, V21, P1305, DOI 10.1038/nbt891; WRIGHT K, 1973, STEROIDS, V27, P755; Wu HR, 1998, P NATL ACAD SCI USA, V95, P6037, DOI 10.1073/pnas.95.11.6037; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Xiang Jim, 1999, Human Antibodies, V9, P23; Xie MH, 1997, NAT BIOTECHNOL, V15, P768, DOI 10.1038/nbt0897-768; YANG WP, 1995, J MOL BIOL, V254, P392, DOI 10.1006/jmbi.1995.0626; Ye JD, 2008, P NATL ACAD SCI USA, V105, P82, DOI 10.1073/pnas.0709082105; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003; Zhou B, 2002, P NATL ACAD SCI USA, V99, P5241, DOI 10.1073/pnas.082121599; Zhou Y, 2010, J MOL BIOL, V404, P88, DOI 10.1016/j.jmb.2010.09.006; Zou NX, 2007, EXP BIOL MED, V232, P550	179	381	414	5	215	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2011	29	3					245	254		10.1038/nbt.1791	http://dx.doi.org/10.1038/nbt.1791			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	732RL	21390033	Green Accepted			2022-12-25	WOS:000288206700020
J	Gloster, TM; Zandberg, WF; Heinonen, JE; Shen, DL; Deng, LH; Vocadlo, DJ				Gloster, Tracey M.; Zandberg, Wesley F.; Heinonen, Julia E.; Shen, David L.; Deng, Lehua; Vocadlo, David J.			Hijacking a biosynthetic pathway yields a glycosyltransferase inhibitor within cells	NATURE CHEMICAL BIOLOGY			English	Article							O-GLCNAC TRANSFERASE; BETA-N-ACETYLGLUCOSAMINE; NUCLEOCYTOPLASMIC PROTEINS; GLYCOSYLATION; MECHANISM; ACID; PHOSPHORYLATION; GLCNACYLATION; CATALYSIS; CLONING	Glycosyltransferases are ubiquitous enzymes that catalyze the assembly of glycoconjugates throughout all kingdoms of nature. A long-standing problem is the rational design of probes that can be used to manipulate glycosyltransferase activity in cells and tissues. Here we describe the rational design and synthesis of a nucleotide sugar analog that inhibits, with high potency both in vitro and in cells, the human glycosyltransferase responsible for the reversible post-translational modification of nucleocytoplasmic proteins with O-linked N-acetylglucosamine residues (O-GlcNAc). We show that the enzymes of the hexosamine biosynthetic pathway can transform, both in vitro and in cells, a synthetic carbohydrate precursor into the nucleotide sugar analog. Treatment of cells with the precursor lowers O-GlcNAc in a targeted manner with a single-digit micromolar EC(50). This approach to inhibition of glycosyltransferases should be applicable to other members of this superfamily of enzymes and enable their manipulation in a biological setting.	[Gloster, Tracey M.; Zandberg, Wesley F.; Heinonen, Julia E.; Deng, Lehua; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Shen, David L.; Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Gloster, TM (corresponding author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.	dvocadlo@sfu.ca	Vocadlo, David J/E-5508-2014; Zandberg, Wesley/AAX-5568-2021	Vocadlo, David J/0000-0001-6897-5558; 	Natural Sciences and Engineering Research Council of Canada; Simon Fraser University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Simon Fraser University	The plasmid encoding GNK was a gift from M. Berger (Charite Universitatsmedizin Berlin) and S. Hinderlich (University of Applied Sciences, Berlin), and the plasmid encoding AGX1 was a gift from V. Piller (Centre de Recherche Scientifique, UPR 4301). Polyclonal antibody to OGA was a gift from G. Hart (John Hopkins University). EMEG32 cells were a gift from T. Mak (University of Toronto). We thank G. Davies (University of York) for the E. coli expression construct of BtGH84. T. M. G. is a Sir Henry Wellcome postdoctoral fellow and a Michael Smith for Health Research (MSFHR) trainee award holder. D.J.V. is a scholar of MSFHR and holds a Canada Research Chair in Chemical Glycobiology. We thank the Natural Sciences and Engineering Research Council of Canada and Simon Fraser University for funding support.	Agard NJ, 2009, ACCOUNTS CHEM RES, V42, P788, DOI 10.1021/ar800267j; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Bourgeaux V, 2005, BIOORG MED CHEM LETT, V15, P5459, DOI 10.1016/j.bmcl.2005.08.088; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; CSUK R, 1986, J CHEM SOC CHEM COMM, P343, DOI 10.1039/c39860000343; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Granovsky M, 2000, NAT MED, V6, P306; Greig IR, 2009, J AM CHEM SOC, V131, P13415, DOI 10.1021/ja904506u; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hinderlich S, 2000, EUR J BIOCHEM, V267, P3301, DOI 10.1046/j.1432-1327.2000.01360.x; Jones MB, 2004, BIOTECHNOL BIOENG, V85, P394, DOI 10.1002/bit.10901; Keppler OT, 2001, GLYCOBIOLOGY, V11, p11R, DOI 10.1093/glycob/11.2.11R; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LAMBERT JB, 1981, J ORG CHEM, V46, P3193, DOI 10.1021/jo00329a009; Lee KY, 2002, J BIOL CHEM, V277, P49341, DOI 10.1074/jbc.M209618200; LENZEN S, 1988, DIABETOLOGIA, V31, P337, DOI 10.1007/BF02341500; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1391, DOI 10.1152/ajpheart.00285.2007; Lowe JB, 2003, CURR OPIN CELL BIOL, V15, P531, DOI 10.1016/j.ceb.2003.08.002; LUBAS WA, 1995, BIOCHEMISTRY-US, V34, P1686, DOI 10.1021/bi00005a025; LYONS SD, 1990, J BIOL CHEM, V265, P11377; Macauley MS, 2005, J AM CHEM SOC, V127, P17202, DOI 10.1021/ja0567687; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Mio T, 2000, BBA-GENE STRUCT EXPR, V1492, P369, DOI 10.1016/S0167-4781(00)00120-2; Ngoh GA, 2008, J MOL CELL CARDIOL, V45, P313, DOI 10.1016/j.yjmcc.2008.04.009; Ngoh GA, 2009, AM J PHYSIOL-HEART C, V297, pH1711, DOI 10.1152/ajpheart.00553.2009; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Offen W, 2006, EMBO J, V25, P1396, DOI 10.1038/sj.emboj.7600970; Pesnot T, 2010, NAT CHEM BIOL, V6, P321, DOI 10.1038/nchembio.343; PLATT FM, 1994, J BIOL CHEM, V269, P8362; RALTON JE, 1993, J BIOL CHEM, V268, P24183; Roquemore EP, 1996, BIOCHEMISTRY-US, V35, P3578, DOI 10.1021/bi951918j; SARKAR AK, 1995, P NATL ACAD SCI USA, V92, P3323, DOI 10.1073/pnas.92.8.3323; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; SCHNEIDER EG, 1978, J BIOL CHEM, V253, P2348; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; TANAHASHI E, 1983, CARBOHYD RES, V117, P304, DOI 10.1016/0008-6215(83)88098-7; Tsuruta O, 2003, J ORG CHEM, V68, P6400, DOI 10.1021/jo0300035; Tsuruta O, 1997, BIOORG MED CHEM LETT, V7, P2523, DOI 10.1016/S0960-894X(97)10009-9; Varki A., 2009, ESSENTIALS GLYCOBIOL; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yuasa H, 2009, CURR TOP MED CHEM, V9, P76, DOI 10.2174/156802609787354270; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zhao GH, 2010, NAT PROTOC, V5, P636, DOI 10.1038/nprot.2010.3	50	217	221	1	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2011	7	3					174	181		10.1038/NCHEMBIO.520	http://dx.doi.org/10.1038/NCHEMBIO.520			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	720UH	21258330	Green Accepted			2022-12-25	WOS:000287307600011
J	Landes, CF; Rambhadran, A; Taylor, JN; Salatan, F; Jayaraman, V				Landes, Christy F.; Rambhadran, Anu; Taylor, J. Nick; Salatan, Ferandre; Jayaraman, Vasanthi			Structural landscape of isolated agonist-binding domains from single AMPA receptors	NATURE CHEMICAL BIOLOGY			English	Article							MOLECULE FLUORESCENCE SPECTROSCOPY; ENZYME CONFORMATIONAL DYNAMICS; MONTE-CARLO SIMULATIONS; GLUTAMATE-RECEPTOR; FRET TRAJECTORIES; CLEFT CLOSURE; PROTEIN; MECHANISM; CHANNEL; CORE	AMPA receptors mediate fast excitatory neurotransmission by converting chemical signals into electrical signals, and thus it is important to understand the relationship between their chemical biology and their function. We used single-molecule fluorescence resonance energy transfer to examine the conformations explored by the agonist-binding domain of the AMPA receptor for wild-type and T686S mutant proteins. Each form of the agonist binding domain showed a dynamic, multistate sequential equilibrium, which could be identified only using wavelet shrinkage, a signal processing technique that removes experimental shot noise. These results illustrate that the extent of activation depends not on a rigid closed cleft but instead on the probability that a given subunit will occupy a closed-cleft conformation, which in turn is determined not only by the lowest energy state but also by the range of states that the protein explores.	[Landes, Christy F.; Taylor, J. Nick; Salatan, Ferandre] Rice Univ, Dept Chem, Houston, TX 77251 USA; [Rambhadran, Anu; Jayaraman, Vasanthi] Univ Texas Hlth Sci Ctr, Ctr Membrane Biol, Dept Biochem & Mol Biol, Grad Sch Biomed Sci, Houston, TX USA	Rice University; University of Texas System; University of Texas Health Science Center Houston	Landes, CF (corresponding author), Rice Univ, Dept Chem, Houston, TX 77251 USA.	cflandes@rice.edu; vasanthi.jayaraman@uth.tmc.edu	Landes, Christy/I-5501-2014		American Chemical Society; US National Institutes of Health [R01GM073102]; American Heart Association [0855081F]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073102] Funding Source: NIH RePORTER	American Chemical Society(American Chemical Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	C.F.L. thanks the Norman Hackerman Welch Young Investigator Program at Rice University. We acknowledge the Donors of the American Chemical Society Petroleum Research Fund for partial support of this research (to C. F. L.). This work was supported by US National Institutes of Health Grant R01GM073102 (to V.J.) and American Heart Association Grant 0855081F (V.J.). We also thank H. Yang and R. Goldsmith for suggestions.	Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Ahmed AH, 2007, J BIOL CHEM, V282, P12773, DOI 10.1074/jbc.M610077200; Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Benitez JJ, 2008, J AM CHEM SOC, V130, P2446, DOI 10.1021/ja7107867; Birdsey-Benson A, 2010, J NEUROSCI, V30, P1463, DOI 10.1523/JNEUROSCI.4558-09.2010; Cheng Q, 2005, NAT CHEM BIOL, V1, P329, DOI 10.1038/nchembio738; Chung HS, 2010, BIOPHYS J, V98, P696, DOI 10.1016/j.bpj.2009.12.4322; Cordes T, 2009, J AM CHEM SOC, V131, P5018, DOI 10.1021/ja809117z; Cosa G, 2004, BIOPHYS J, V87, P2759, DOI 10.1529/biophysj.104.043083; Darugar Q, 2008, J VIROL, V82, P12164, DOI 10.1128/JVI.01158-08; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fenwick MK, 2010, J BIOL CHEM, V285, P12334, DOI 10.1074/jbc.M109.086371; FICHTHORN KA, 1991, J CHEM PHYS, V95, P1090, DOI 10.1063/1.461138; Fleming JJ, 2010, NAT CHEM BIOL, V6, P89, DOI [10.1038/nchembio.298, 10.1038/NCHEMBIO.298]; Flynn EM, 2010, J AM CHEM SOC, V132, P4772, DOI 10.1021/ja909968n; Gouaux E, 2004, J PHYSIOL-LONDON, V554, P249, DOI 10.1113/jphysiol.2003.054320; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; Hanson JA, 2007, P NATL ACAD SCI USA, V104, P18055, DOI 10.1073/pnas.0708600104; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Landes CF, 2007, J AM CHEM SOC, V129, P10181, DOI 10.1021/ja071491r; Lau AY, 2007, STRUCTURE, V15, P1203, DOI 10.1016/j.str.2007.07.015; Li CB, 2008, P NATL ACAD SCI USA, V105, P536, DOI 10.1073/pnas.0707378105; Li CB, 2009, J PHYS CHEM B, V113, P14732, DOI 10.1021/jp9059483; Madden DR, 2005, J BIOL CHEM, V280, P23637, DOI 10.1074/jbc.M414523200; Makarov DE, 2002, J CHEM PHYS, V116, P5205, DOI 10.1063/1.1450123; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; Mamonova T, 2008, BIOCHEMISTRY-US, V47, P11077, DOI 10.1021/bi801367d; McFeeters RL, 2002, BIOCHEMISTRY-US, V41, P10472, DOI 10.1021/bi026010p; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; METIU H, 1992, SCIENCE, V255, P1088, DOI 10.1126/science.255.5048.1088; NAKANISHI S, 1994, ANNU REV BIOPH BIOM, V23, P319, DOI 10.1146/annurev.bb.23.060194.001535; Ramanoudjame G, 2006, P NATL ACAD SCI USA, V103, P10473, DOI 10.1073/pnas.0603225103; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Robert A, 2005, J NEUROSCI, V25, P3752, DOI 10.1523/JNEUROSCI.0188-05.2005; Robert A, 2003, J NEUROSCI, V23, P847; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Talaga DS, 2007, CURR OPIN COLLOID IN, V12, P285, DOI 10.1016/j.cocis.2007.08.014; Taylor JN, 2008, BIOCHEM BIOPH RES CO, V373, P213, DOI 10.1016/j.bbrc.2008.05.191; Taylor JN, 2011, J PHYS CHEM B, V115, P1105, DOI 10.1021/jp1050707; Taylor JN, 2010, BIOPHYS J, V98, P164, DOI 10.1016/j.bpj.2009.09.047; VOTER AF, 1986, PHYS REV B, V34, P6819, DOI 10.1103/PhysRevB.34.6819; Zeng YN, 2007, P NATL ACAD SCI USA, V104, P12651, DOI 10.1073/pnas.0700350104; Zhang W, 2008, J NEUROSCI, V28, P932, DOI 10.1523/JNEUROSCI.3309-07.2008	48	75	75	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2011	7	3					168	173		10.1038/NCHEMBIO.523	http://dx.doi.org/10.1038/NCHEMBIO.523			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	720UH	21297640	Green Accepted			2022-12-25	WOS:000287307600010
J	Nowak, M; Machate, A; Yu, SR; Gupta, M; Brand, M				Nowak, Matthias; Machate, Anja; Yu, Shuizi Rachel; Gupta, Mansi; Brand, Michael			Interpretation of the FGF8 morphogen gradient is regulated by endocytic trafficking	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR RECEPTORS; POSITIONAL INFORMATION; LIGASE ACTIVITY; C-CBL; MAINTENANCE; INDUCTION; MECHANISM; EGF; DIFFERENTIATION; UBIQUITINATION	Forty years ago, it was proposed that during embryonic development and organogenesis, morphogen gradients provide positional in formation to the individual cells within a tissue leading to specific fate decisions(1,2). Recently, much insight has been gained in to how such morphogen gradients are formed and maintained; however, which cellular mechanisms govern their interpretation within target tissues remains debated(3). Here we used in vivo fluorescence correlation spectroscopy and automated image analysis to assess the role of endocytic sorting dynamics on fibroblast growth factor 8 (Fgf8) morphogen gradient interpretation. By interfering with the function of the ubiquitin ligase Cbl, we found an expanded range of Fgf target gene expression and a delay of Fgf8 lysosomal transport. However,the extracellular Fgf8 morphogen gradient remained unchanged, indicating that the observed signalling changes are due to altered gradient interpretation. We propose that regulation of morphogen signalling activity through endocytic sorting allows fast feedback-induced changes in gradient interpretation during the establishment of complex patterns.	[Nowak, Matthias; Machate, Anja; Yu, Shuizi Rachel; Gupta, Mansi; Brand, Michael] TUD, Ctr Biotechnol, D-01307 Dresden, Germany; [Nowak, Matthias; Machate, Anja; Yu, Shuizi Rachel; Gupta, Mansi; Brand, Michael] TUD, Ctr Regenerat Therapies, D-01307 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Brand, M (corresponding author), TUD, Ctr Biotechnol, Tatzberg 47-49, D-01307 Dresden, Germany.	michael.brand@biotec.tu-dresden.de	Brand, Michael/A-5509-2010	Brand, Michael/0000-0001-5711-6512	HFSP network [050503-50]; EU [050503-52]	HFSP network; EU(European Commission)	We thank members of the Brand and M. Zerial laboratories for stimulating discussions; C. Boekel, C. P. Heisenberg and M. McShane for critical comments on the manuscript; M. Fischer and K. Sipple for fish care; and P. Schwille and the Biotec/CRTD imaging facility for technical advice. This work was supported by an HFSP network grant (050503-50) and by the EU Endotrack grant (050503-52) to M.B.	AMAYA E, 1993, DEVELOPMENT, V118, P477; Bao J, 2003, P NATL ACAD SCI USA, V100, P2438, DOI 10.1073/pnas.0437945100; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Haugsten EM, 2008, MOL BIOL CELL, V19, P3390, DOI 10.1091/mbc.E07-12-1219; Haugsten EM, 2005, J CELL SCI, V118, P3869, DOI 10.1242/jcs.02509; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Jaeger J, 2008, DEVELOPMENT, V135, P3175, DOI 10.1242/dev.018697; JULLIEN J, 2005, GENES DEV; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; Leger S, 2002, MECH DEVELOP, V119, P91, DOI 10.1016/S0925-4773(02)00343-X; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; MACARTHUR CA, 1995, DEVELOPMENT, V121, P3603; Nahmad M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000202; Nau MM, 2003, GENE, V308, P103, DOI 10.1016/S0378-1119(03)00471-2; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Piddini E, 2009, CELL, V136, P296, DOI 10.1016/j.cell.2008.11.036; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; Reifers F, 1998, DEVELOPMENT, V125, P2381; Reifers F, 2000, DEVELOPMENT, V127, P225; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rohner N, 2009, CURR BIOL, V19, P1642, DOI 10.1016/j.cub.2009.07.065; Ryan PE, 2006, TRENDS BIOCHEM SCI, V31, P79, DOI 10.1016/j.tibs.2005.12.004; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Scholpp S, 2004, CURR BIOL, V14, P1834, DOI 10.1016/j.cub.2004.09.084; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	33	46	46	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2011	13	2					153	U104		10.1038/ncb2155	http://dx.doi.org/10.1038/ncb2155			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714JM	21258372				2022-12-25	WOS:000286805900009
J	Clement, LC; Avila-Casado, C; Mace, C; Soria, E; Bakker, WW; Kersten, S; Chugh, SS				Clement, Lionel C.; Avila-Casado, Carmen; Mace, Camille; Soria, Elizabeth; Bakker, Winston W.; Kersten, Sander; Chugh, Sumant S.			Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome	NATURE MEDICINE			English	Article							GENE-EXPRESSION; OLIGOMERIZATION	The main manifestations of nephrotic syndrome include proteinuria, hypoalbuminemia, edema, hyperlipidemia and lipiduria. Common causes of nephrotic syndrome are diabetic nephropathy, minimal change disease (MCD), focal and segmental glomerulosclerosis (FSGS) and membranous nephropathy. Among the primary glomerular diseases, MCD is usually sensitive to glucocorticoid treatment, whereas the other diseases show variable responses(1). Despite the identification of key structural proteins in the glomerular capillary loop which may contribute to defects in ultrafiltration, many of the disease mechanisms of nephrotic syndrome remain unresolved. In this study, we show that the glomerular expression of angiopoietin-like-4 (Angptl4), a secreted glycoprotein, is glucocorticoid sensitive and is highly upregulated in the serum and in podocytes in experimental models of MCD and in the human disease. Podocyte-specific transgenic overexpression of Angptl4 (NPHS2-Angptl4) in rats induced nephrotic-range, and selective, proteinuria (over 500-fold increase in albuminuria), loss of glomerular basement membrane (GBM) charge and foot process effacement, whereas transgenic expression specifically in the adipose tissue (aP2-Angptl4) resulted in increased circulating Angptl4, but no proteinuria. Angptl4-/-mice that were injected with lipopolysaccharide (LPS) or nephritogenic antisera developed markedly less proteinuria than did control mice. Angptl4 secreted from podocytes in some forms of nephrotic syndrome lacks normal sialylation. When we fed the sialic acid precursor N-acetyl-D-mannosamine (ManNAc) to NPHS2-Angptl4 transgenic rats it increased the sialylation of Angptl4 and decreased albuminuria by more than 40%. These results suggest that podocyte-secreted Angptl4 has a key role in nephrotic syndrome.	[Clement, Lionel C.; Mace, Camille; Chugh, Sumant S.] Univ Alabama Birmingham, Glomerular Dis Therapeut Lab, Birmingham, AL 35294 USA; [Clement, Lionel C.; Mace, Camille; Chugh, Sumant S.] Univ Alabama Birmingham, Nephrol Res & Training Ctr, Birmingham, AL USA; [Avila-Casado, Carmen; Soria, Elizabeth] Inst Nacl Cardiol, Dept Pathol, Mexico City, DF, Mexico; [Bakker, Winston W.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 AV Groningen, Netherlands; [Kersten, Sander] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Institute of Cardiology - Mexico; University of Groningen; Wageningen University & Research	Chugh, SS (corresponding author), Univ Alabama Birmingham, Glomerular Dis Therapeut Lab, Birmingham, AL 35294 USA.	chugh@uab.edu	Kersten, Sander/A-1116-2011	Kersten, Sander/0000-0003-4488-7734; SORIA-CASTRO, ELIZABETH/0000-0001-8050-1961	US National Institutes of Health [R56DK077073, R01DK077073]; Norman S. Coplon Satellite Research Grant; CONACYT [111]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077073, R56DK077073] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norman S. Coplon Satellite Research Grant; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank B. Spiegelman (Dana-Farber Cancer Institute) for the mouse aP2 promoter construct; L. Holzman (University of Michigan) for the human NPHS2 promoter construct; P. Mundel (University of Miami) for mouse GECs; T. van Kuppevelt (Radboud University Nijmegen Medical Center) for the heparan sulfate proteoglycan-specific antibody p1113; D. Salant (Boston University) for gamma 2-NTS; and A. Koster (Eli Lilly) for Angptl4<SUP>-/-</SUP> mice. We also thank G. Bai for the generation of probe for in situ hybridization; S. Shastry for some ELISA assays for rat and mouse albumin; S. Rahmanuddin for selected immunogold studies and polyethyleneimine studies; F. Mattijssen for mouse LPS study; J. Novak for advice on choice of lectins; and Y.S. Kanwar and M. Venkatachalam for useful discussions on heparan sulfate proteoglycans. Supported by the US National Institutes of Health (R56DK077073, R01DK077073 to S.S.C.), Norman S. Coplon Satellite Research Grant to S.S.C. and CONACYT 111 grant to C.A.-C. We thank the University of Alabama at Birmingham-University of California-San Diego George O'Brien Center Core C for measuring mouse urine creatinine by mass spectrometry. The use of sialic acid precursors, including ManNAc, to treat proteinuria and nephrotic syndrome is covered by US Provisional Application 61/351,865 filed by S.S.C.	Avila-Casado MD, 2004, KIDNEY INT, V66, P133, DOI 10.1111/j.1523-1755.2004.00715.x; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Chugh S, 2001, KIDNEY INT, V59, P601, DOI 10.1046/j.1523-1755.2001.059002601.x; Clement LC, 2007, KIDNEY INT, V72, P337, DOI 10.1038/sj.ki.5002302; Davis B, 2007, J AM SOC NEPHROL, V18, P2320, DOI 10.1681/ASN.2006101093; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; GRAVES RA, 1992, J CELL BIOCHEM, V49, P219, DOI 10.1002/jcb.240490303; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kim I, 2000, BIOCHEM J, V346, P603, DOI 10.1042/0264-6021:3460603; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Liu G, 2006, J BIOL CHEM, V281, P39681, DOI 10.1074/jbc.M606664200; Malicdan MCV, 2009, NAT MED, V15, P690, DOI 10.1038/nm.1956; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Nachman PH., 2008, BRENNER RECTORS KIDN, V8th, P987; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200	23	214	235	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					117	U294		10.1038/nm.2261	http://dx.doi.org/10.1038/nm.2261			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21151138	Green Accepted			2022-12-25	WOS:000285994000044
J	Jones, P				Jones, Peter			Out of Africa and into epigenetics: discovering reprogramming drugs	NATURE CELL BIOLOGY			English	Editorial Material									USC Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA	University of Southern California	Jones, P (corresponding author), USC Norris Comprehens Canc Ctr, 1441 Eastlake Ave, Los Angeles, CA 90033 USA.	pjones@med.usc.edu							0	7	7	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2011	13	1					2	2		10.1038/ncb0111-2	http://dx.doi.org/10.1038/ncb0111-2			1	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697GV	21173799				2022-12-25	WOS:000285502200002
J	Sarkar, P; Saleh, T; Tzeng, SR; Birge, RB; Kalodimos, CG				Sarkar, Paramita; Saleh, Tamjeed; Tzeng, Shiou-Ru; Birge, Raymond B.; Kalodimos, Charalampos G.			Structural basis for regulation of the Crk signaling protein by a proline switch	NATURE CHEMICAL BIOLOGY			English	Article							CIS-TRANS ISOMERIZATION; TERMINAL SH3 DOMAIN; C-ABL KINASE; TYROSINE KINASE; MOLECULAR TIMER; PROLYL ISOMERIZATION; CYCLOPHILIN-A; ADAPTER; NMR; COMPLEX	Proline switches, controlled by cis-trans isomerization, have emerged as a particularly effective regulatory mechanism in a wide range of biological processes. Here we report the structures of both the cis and trans conformers of a proline switch in the Crk signaling protein. Proline isomerization toggles Crk between two conformations: an autoinhibitory conformation, stabilized by the intramolecular association of two tandem SH3 domains in the cis form, and an uninhibited, activated conformation promoted by the trans form. In addition to acting as a structural switch, the heterogeneous proline recruits cyclophilin A, which accelerates the interconversion rate between the isomers, thereby regulating the kinetics of Crk activation. The data provide atomic insight into the mechanisms that underpin the functionality of this binary switch and elucidate its remarkable efficiency. The results also reveal new SH3 binding surfaces, highlighting the binding versatility and expanding the noncanonical ligand repertoire of this important signaling domain.	[Sarkar, Paramita; Saleh, Tamjeed; Tzeng, Shiou-Ru; Kalodimos, Charalampos G.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Birge, Raymond B.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [Kalodimos, Charalampos G.] Rutgers State Univ, BioMaPS Inst Quantitat Biol, Piscataway, NJ USA; [Kalodimos, Charalampos G.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Kalodimos, CG (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.	babis@rutgers.edu	Sarkar, Paramita/G-7663-2012; Kalodimos, Charalampos/Q-9846-2018; Saleh, Tamjeed/M-8698-2016	Kalodimos, Charalampos/0000-0001-6354-2796; TZENG, SHIOU-RU/0000-0002-7180-0190; Saleh, Tamjeed/0000-0002-7539-7300	US National Institutes of Health [GM80308]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080308] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health (GM80308 to C.G.K.).	Akakura S, 2005, J CELL PHYSIOL, V204, P344, DOI 10.1002/jcp.20288; Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; Bax A, 2005, CURR OPIN STRUC BIOL, V15, P563, DOI 10.1016/j.sbi.2005.08.006; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Calabrese MF, 2008, NAT STRUCT MOL BIOL, V15, P965, DOI 10.1038/nsmb.1483; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Donaldson LW, 2002, P NATL ACAD SCI USA, V99, P14053, DOI 10.1073/pnas.212518799; Eckert B, 2005, NAT STRUCT MOL BIOL, V12, P619, DOI 10.1038/nsmb946; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Isakov N, 2008, TRENDS IMMUNOL, V29, P388, DOI 10.1016/j.it.2008.04.006; KizakaKondoh S, 1996, P NATL ACAD SCI USA, V93, P12177, DOI 10.1073/pnas.93.22.12177; KNUDSEN BS, 1995, EMBO J, V14, P2191, DOI 10.1002/j.1460-2075.1995.tb07213.x; Kobashigawa Y, 2007, NAT STRUCT MOL BIOL, V14, P503, DOI 10.1038/nsmb1241; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Linghu H, 2006, ONCOGENE, V25, P3547, DOI 10.1038/sj.onc.1209398; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Mallis RJ, 2002, NAT STRUCT BIOL, V9, P900, DOI 10.1038/nsb864; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; Miller CT, 2003, ONCOGENE, V22, P7950, DOI 10.1038/sj.onc.1206529; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Muralidharan V, 2006, BIOCHEMISTRY-US, V45, P8874, DOI 10.1021/bi060590z; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Nicholson LK, 2007, MOL CELL, V25, P483, DOI 10.1016/j.molcel.2007.02.005; Nishihara H, 2002, CANCER LETT, V180, P55, DOI 10.1016/S0304-3835(01)00763-7; OGAWA S, 1994, ONCOGENE, V9, P1669; OuYang B, 2008, STRUCTURE, V16, P916, DOI 10.1016/j.str.2008.03.011; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Reichman C, 2005, ONCOGENE, V24, P8187, DOI 10.1038/sj.onc.1208988; REN RB, 1994, GENE DEV, V8, P783, DOI 10.1101/gad.8.7.783; ROSEN MK, 1995, NATURE, V374, P477, DOI 10.1038/374477a0; Sarkar P, 2007, MOL CELL, V25, P413, DOI 10.1016/j.molcel.2007.01.004; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Severin A, 2009, J MOL BIOL, V387, P726, DOI 10.1016/j.jmb.2009.02.012; Shishido T, 2001, GENES CELLS, V6, P431, DOI 10.1046/j.1365-2443.2001.00431.x; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Vaynberg J, 2005, MOL CELL, V17, P513, DOI 10.1016/j.molcel.2004.12.031; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Wang ZX, 2010, CELL, V141, P1183, DOI 10.1016/j.cell.2010.05.016; WU XD, 1995, STRUCTURE, V3, P215, DOI 10.1016/S0969-2126(01)00151-4; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zvara A, 2001, ONCOGENE, V20, P951, DOI 10.1038/sj.onc.1204173	50	62	64	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2011	7	1					51	57		10.1038/NCHEMBIO.494	http://dx.doi.org/10.1038/NCHEMBIO.494			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	695PA	21131971	Green Accepted			2022-12-25	WOS:000285383400012
J	Kohli, RM				Kohli, Rahul M.			The chemistry of a dynamic genome	NATURE CHEMICAL BIOLOGY			English	Article							SOMATIC HYPERMUTATION; DNA DEMETHYLATION; AID; CONVERSION	In the postsequencing era, chemical biology is uniquely situated to investigate genomic DNA alterations arising through epigenetic modifications, genetic rearrangements or active mutation. These transformations significantly expand nature's diversity and may profoundly alter our view of DNA's coding potential.	[Kohli, Rahul M.] Univ Penn, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA; [Kohli, Rahul M.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Kohli, RM (corresponding author), Univ Penn, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA.	rkohli@upenn.edu		Kohli, Rahul/0000-0002-7689-5678				Barry D, 2009, NATURE, V459, P172, DOI 10.1038/459172a; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Borst P, 2008, ANNU REV MICROBIOL, V62, P235, DOI 10.1146/annurev.micro.62.081307.162750; Cahoon LA, 2009, SCIENCE, V325, P764, DOI 10.1126/science.1175653; Chelico L, 2009, J BIOL CHEM, V284, P27761, DOI 10.1074/jbc.R109.052449; Fugmann SD, 2010, SEMIN IMMUNOL, V22, P10, DOI 10.1016/j.smim.2009.11.004; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Maul RW, 2010, ADV IMMUNOL, V105, P159, DOI 10.1016/S0065-2776(10)05006-6; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nathans R, 2008, NAT BIOTECHNOL, V26, P1187, DOI 10.1038/nbt.1496; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Patel M, 2010, CRIT REV BIOCHEM MOL, V45, P171, DOI 10.3109/10409238.2010.480968; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Quintas-Cardama A, 2010, NAT REV CLIN ONCOL, V7, P433, DOI 10.1038/nrclinonc.2010.87; Smith PA, 2007, NAT CHEM BIOL, V3, P549, DOI 10.1038/nchembio.2007.27; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	20	3	3	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					866	868		10.1038/nchembio.471	http://dx.doi.org/10.1038/nchembio.471			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079591				2022-12-25	WOS:000284214700007
J	Lewis, NE; Schramm, G; Bordbar, A; Schellenberger, J; Andersen, MP; Cheng, JK; Patel, N; Yee, A; Lewis, RA; Eils, R; Konig, R; Palsson, BO				Lewis, Nathan E.; Schramm, Gunnar; Bordbar, Aarash; Schellenberger, Jan; Andersen, Michael P.; Cheng, Jeffrey K.; Patel, Nilam; Yee, Alex; Lewis, Randall A.; Eils, Roland; Koenig, Rainer; Palsson, Bernhard O.			Large-scale in silico modeling of metabolic interactions between cell types in the human brain	NATURE BIOTECHNOLOGY			English	Article							ALPHA-KETOGLUTARATE DEHYDROGENASE; CEREBRAL BLOOD-FLOW; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; KETONE-BODIES; FLUX ANALYSIS; AMINO-ACIDS; RAT-BRAIN; GLUCOSE; RECONSTRUCTION	Metabolic interactions between multiple cell types are difficult to model using existing approaches. Here we present a workflow that integrates gene expression data, proteomics data and literature-based manual curation to model human metabolism within and between different types of cells. Transport reactions are used to account for the transfer of metabolites between models of different cell types via the interstitial fluid. We apply the method to create models of brain energy metabolism that recapitulate metabolic interactions between astrocytes and various neuron types relevant to Alzheimer's disease. Analysis of the models identifies genes and pathways that may explain observed experimental phenomena, including the differential effects of the disease on cell types and regions of the brain. Constraint-based modeling can thus contribute to the study and analysis of multicellular metabolic processes in the human tissue microenvironment and provide detailed mechanistic insight into high-throughput data analysis.	[Lewis, Nathan E.; Bordbar, Aarash; Andersen, Michael P.; Cheng, Jeffrey K.; Patel, Nilam; Yee, Alex; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Schramm, Gunnar; Eils, Roland; Koenig, Rainer] Univ Heidelberg, Inst Pharm & Mol Biotechnol & Bioquant, Dept Bioinformat & Funct Genom, Heidelberg, Germany; [Schellenberger, Jan] Univ Calif San Diego, Bioinformat Program, La Jolla, CA 92093 USA; [Lewis, Randall A.] MIT, Dept Econ, Cambridge, MA 02139 USA; [Schramm, Gunnar; Eils, Roland; Koenig, Rainer] German Canc Res Ctr, Dept Theoret Bioinformat, Heidelberg, Germany	University of California System; University of California San Diego; Ruprecht Karls University Heidelberg; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); Helmholtz Association; German Cancer Research Center (DKFZ)	Palsson, BO (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	palsson@ucsd.edu	/AAG-5264-2021; Lewis, Nathan/ABE-7290-2020; Eils, Roland/B-6121-2009	/0000-0001-6460-6771; Lewis, Nathan/0000-0001-7700-3654; Eils, Roland/0000-0002-0034-4036; Palsson, Bernhard/0000-0003-2357-6785	Fulbright fellowship; National Science Foundation [DGE-0504645]; US National Institutes of Health [2R01GM068837_05A1, RO1 GM071808]; Helmholtz Alliance on Systems Biology; BMBF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068837, R01GM071808] Funding Source: NIH RePORTER	Fulbright fellowship; National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmholtz Alliance on Systems Biology; BMBF(Federal Ministry of Education & Research (BMBF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank G. Gibson at Cornell University, I. Thiele at the University of Iceland and M. Abrams, M. Mo and C. Barrett at UCSD for suggestions pertaining to this work. This work was funded in part by a Fulbright fellowship, a National Science Foundation IGERT Plant Systems Biology training grant (no. DGE-0504645), US National Institutes of Health grants 2R01GM068837_05A1 and RO1 GM071808 and the Helmholtz Alliance on Systems Biology and the BMBF by the NGFN+ neuroblastoma project ENGINE.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Benjamini Y, 2001, ANN STAT, V29, P1165; Bordbar A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.68; Breitling R, 2008, NAT REV MICROBIOL, V6, P156, DOI 10.1038/nrmicro1797; Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474; Cakir T, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-48; Casley CS, 2002, J NEUROCHEM, V80, P91, DOI 10.1046/j.0022-3042.2001.00681.x; Chang RL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000938; Chatziioannou A, 2003, METAB ENG, V5, P201, DOI 10.1016/S1096-7176(03)00029-6; COOPER JR, 1994, J NEUROCHEM, V63, P395; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Fujii Yasuyuki, 2004, Tanpakushitsu Kakusan Koso, V49, P1937; Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104; Gibson GE, 1998, ANN NEUROL, V44, P676, DOI 10.1002/ana.410440414; GIBSON GE, 1975, BIOCHEM J, V148, P17, DOI 10.1042/bj1480017; Ginsberg Stephen D, 2006, NeuroRx, V3, P302, DOI 10.1016/j.nurx.2006.05.007; Gorman AM, 2000, DEV NEUROSCI-BASEL, V22, P348, DOI 10.1159/000017460; Hassel B, 1998, J NEUROCHEM, V71, P1511; Hoshi M, 1996, P NATL ACAD SCI USA, V93, P2719, DOI 10.1073/pnas.93.7.2719; Ibanez V, 1998, NEUROLOGY, V50, P1585, DOI 10.1212/WNL.50.6.1585; Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56; KARCZMAR AG, 2006, EXPLORING VERTEBRATE, P686; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Lai MK, 2007, NEUROBIOLOGY ALZHEIM, P245; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Lewis NE, 2009, ENCY COMPLEXITY SYST, P5535; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; LYINGTUNELL U, 1981, ACTA NEUROL SCAND, V63, P337; LYINGTUNELL U, 1980, ACTA NEUROL SCAND, V62, P265; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Occhipinti R, 2007, ANN BIOMED ENG, V35, P886, DOI 10.1007/s10439-007-9270-5; Olave I, 2002, GENE DEV, V16, P2509, DOI 10.1101/gad.992102; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Palsson B, 2010, NAT CHEM BIOL, V6, P787, DOI 10.1038/nchembio.462; Palsson BO, 2006, SYSTEMS BIOL PROPERT, P322; Ponten F, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.93; Ragozzino ME, 1998, J NEUROSCI, V18, P1595; Reidegeld KA, 2006, PROTEOMICS, V6, P4997, DOI 10.1002/pmic.200600305; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Santos SS, 2006, J NEUROSCI RES, V83, P450, DOI 10.1002/jnr.20749; Schramm G, 2010, BIOINFORMATICS, V26, P1225, DOI 10.1093/bioinformatics/btq113; Schryer DW, 2009, INT J MOL SCI, V10, P1697, DOI 10.3390/ijms10041697; Serres S, 2008, J CEREBR BLOOD F MET, V28, P712, DOI 10.1038/sj.jcbfm.9600568; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Thompson MD, 1998, NEUROPSYCHOL REV, V8, P11, DOI 10.1023/A:1025627106073; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Watson GS, 2004, EUR J PHARMACOL, V490, P97, DOI 10.1016/j.ejphar.2004.02.048	53	182	185	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2010	28	12					1279	U91		10.1038/nbt.1711	http://dx.doi.org/10.1038/nbt.1711			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	691NP	21102456	Green Accepted			2022-12-25	WOS:000285088400021
J	Pogoryelov, D; Krah, A; Langer, JD; Yildiz, O; Faraldo-Gomez, JD; Meier, T				Pogoryelov, Denys; Krah, Alexander; Langer, Julian D.; Yildiz, Oezkan; Faraldo-Gomez, Jose D.; Meier, Thomas			Microscopic rotary mechanism of ion translocation in the F-0 complex of ATP synthases	NATURE CHEMICAL BIOLOGY			English	Article							MEMBRANE-PROTEIN DYNAMICS; SUBUNIT-C; PROPIONIGENIUM-MODESTUM; ILYOBACTER-TARTARICUS; PROTON TRANSLOCATION; BINDING-SITE; NA+-ATPASE; ROTOR RING; DICYCLOHEXYLCARBODIIMIDE; ENVIRONMENT	The microscopic mechanism of coupled c-ring rotation and ion translocation in F1F0-ATP synthases is unknown. Here we present conclusive evidence supporting the notion that the ability of c-rings to rotate within the F-0 complex derives from the interplay between the ion-binding sites and their nonhomogenous microenvironment. This evidence rests on three atomic structures of the c(15) rotor from crystals grown at low pH, soaked at high pH and, after N,N'-dicyclohexylcarbodiimide (DCCD) modification, resolved at 1.8, 3.0 and 2.2 angstrom, respectively. Alongside a quantitative DCCD-labeling assay and free-energy molecular dynamics calculations, these data demonstrate how the thermodynamic stability of the so-called proton-locked state is maximized by the lipid membrane. By contrast, a hydrophilic environment at the a-subunit-c-ring interface appears to unlock the binding-site conformation and promotes proton exchange with the surrounding solution. Rotation thus occurs as c-subunits stochastically alternate between these environments, directionally biased by the electrochemical transmembrane gradient.	[Pogoryelov, Denys; Yildiz, Oezkan; Meier, Thomas] Max Planck Inst Biophys, Dept Biol Struct, Frankfurt, Germany; [Krah, Alexander; Faraldo-Gomez, Jose D.] Max Planck Inst Biophys, Theoret Mol Biophys Grp, D-6000 Frankfurt, Germany; [Langer, Julian D.] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-6000 Frankfurt, Germany; [Faraldo-Gomez, Jose D.; Meier, Thomas] Cluster Excellence Macromol Complexes, Frankfurt, Germany	Max Planck Society; Max Planck Society; Max Planck Society	Pogoryelov, D (corresponding author), Max Planck Inst Biophys, Dept Biol Struct, Frankfurt, Germany.	jose.faraldo@biophys.mpg.de; thomas.meier@biophys.mpg.de	Meier, Thomas/AAV-6912-2021; Faraldo-Gomez, Jose/H-7127-2016; Yildiz, Ozkan/P-9207-2016	Meier, Thomas/0000-0003-3364-3320; Krah, Alexander/0000-0001-8871-5550; Yildiz, Ozkan/0000-0003-3659-2805; Langer, Julian David/0000-0002-5190-577X	DFG [EXC 115]; DFG Collaborative Research Center [(S.F.B.) 807]; European Science Foundation	DFG(German Research Foundation (DFG)); DFG Collaborative Research Center(German Research Foundation (DFG)); European Science Foundation(European Science Foundation (ESF)European Commission)	The authors thank the staff of the Swiss Light Source (PXII) and the European Synchrotron Radiation Facility (ID23-1 and ID23-2) for their assistance at the beamlines. We also thank R.H. Fillingame (University of Wisconsin) for providing unpublished data and discussions on water accessibility of the a-c interface, K.M. Pos for helpful discussions on DCCD labeling and H. Michel for his comments on this work. T.M., O.Y. and D.P. wish to express their gratitude to W. Kuhlbrandt for his exceptional scientific support. This work was funded in part by the Cluster of Excellence "Macromolecular Complexes" (DFG Project EXC 115) (to J.D.F.-G. and T.M.), the DFG Collaborative Research Center (S.F.B.) 807 (to T.M.) and a EUROCORES project (EuroSYNBIO) of the European Science Foundation (to T.M). Experimental and computational resources were provided in part by the EU ESFRI INSTRUCT program, the BMBF Membrane Protein Core Center and the Julich Supercomputing Centre.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Aksimentiev A, 2004, BIOPHYS J, V86, p245A; AssadiPorter FM, 1995, BIOCHEMISTRY-US, V34, P16186, DOI 10.1021/bi00049a034; Bond PJ, 2006, P NATL ACAD SCI USA, V103, P9518, DOI 10.1073/pnas.0600398103; Bond PJ, 2003, J MOL BIOL, V329, P1035, DOI 10.1016/S0022-2836(03)00408-X; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Dimroth P, 1997, BBA-BIOENERGETICS, V1318, P11, DOI 10.1016/S0005-2728(96)00127-2; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; KLUGE C, 1993, BIOCHEMISTRY-US, V32, P10378, DOI 10.1021/bi00090a013; KLUGE C, 1993, J BIOL CHEM, V268, P14557; Krah A, 2010, BBA-BIOENERGETICS, V1797, P763, DOI 10.1016/j.bbabio.2010.04.014; Krah A, 2010, J MOL BIOL, V395, P20, DOI 10.1016/j.jmb.2009.10.059; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Lau WCY, 2010, P NATL ACAD SCI USA, V107, P1367, DOI 10.1073/pnas.0911085107; LIGHTOWLERS RN, 1987, BIOCHIM BIOPHYS ACTA, V894, P399, DOI 10.1016/0005-2728(87)90118-6; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2003, J MOL BIOL, V325, P389, DOI 10.1016/S0022-2836(02)01204-4; Meier T, 2001, FEBS LETT, V505, P353, DOI 10.1016/S0014-5793(01)02837-X; Meier T, 2009, J MOL BIOL, V391, P498, DOI 10.1016/j.jmb.2009.05.082; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Mitome N, 2010, BIOCHEM J, V430, P171, DOI 10.1042/BJ20100621; Moore KJ, 2008, J BIOL CHEM, V283, P13044, DOI 10.1074/jbc.M800900200; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Nakanishi-Matsui M, 2006, J BIOL CHEM, V281, P4126, DOI 10.1074/jbc.M510090200; Neale EJ, 2007, J BIOL CHEM, V282, P37597, DOI 10.1074/jbc.M706437200; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Pogoryelov D, 2003, J BIOENERG BIOMEMBR, V35, P427, DOI 10.1023/A:1027339814544; Pogoryelov D, 2008, FEBS J, V275, P4850, DOI 10.1111/j.1742-4658.2008.06623.x; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; SEBALD W, 1980, P NATL ACAD SCI-BIOL, V77, P785, DOI 10.1073/pnas.77.2.785; SITKOFF D, 1994, BIOPHYS CHEM, V51, P397, DOI 10.1016/0301-4622(94)00062-X; SITKOFF D, 1994, BIOPHYS CHEM, V51, P404; Steed PR, 2009, J BIOL CHEM, V284, P23243, DOI 10.1074/jbc.M109.002501; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Valiyaveetil F, 2002, BBA-BIOENERGETICS, V1553, P296, DOI 10.1016/S0005-2728(01)00251-1; Viard M, 2001, BIOPHYS J, V80, P347, DOI 10.1016/S0006-3495(01)76019-5; VIK SB, 1994, J BIOL CHEM, V269, P30364; von Ballmoos C, 2007, BIOCHEMISTRY-US, V46, P11800, DOI 10.1021/bi701083v; Vorburger T, 2008, FEBS J, V275, P2137, DOI 10.1111/j.1742-4658.2008.06368.x; Wiedenmann A, 2009, MOL MICROBIOL, V72, P479, DOI 10.1111/j.1365-2958.2009.06658.x	51	111	113	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					891	899		10.1038/NCHEMBIO.457	http://dx.doi.org/10.1038/NCHEMBIO.457			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	20972431				2022-12-25	WOS:000284214700018
J	Wilhelm, K; Ganesan, J; Muller, T; Durr, C; Grimm, M; Beilhack, A; Krempl, CD; Sorichter, S; Gerlach, UV; Juttner, E; Zerweck, A; Gartner, F; Pellegatti, P; Di Virgilio, F; Ferrari, D; Kambham, N; Fisch, P; Finke, J; Idzko, M; Zeiser, R				Wilhelm, Konrad; Ganesan, Jayanthi; Mueller, Tobias; Duerr, Christoph; Grimm, Melanie; Beilhack, Andreas; Krempl, Christine D.; Sorichter, Stephan; Gerlach, Ulrike V.; Juettner, Eva; Zerweck, Alf; Gaertner, Frank; Pellegatti, Patrizia; Di Virgilio, Francesco; Ferrari, Davide; Kambham, Neeraja; Fisch, Paul; Finke, Juergen; Idzko, Marco; Zeiser, Robert			Graft-versus-host disease is enhanced by extracellular ATP activating P2X(7)R	NATURE MEDICINE			English	Article							REGULATORY T-CELLS; NICOTINAMIDE ADENINE-DINUCLEOTIDE; BONE-MARROW-TRANSPLANTATION; RAPAMYCIN INHIBITION; MAMMALIAN TARGET; HIGH-SENSITIVITY; DENDRITIC CELLS; RECEPTOR; RESPONSES; GAMMA	Danger signals released upon cell damage can cause excessive immune-mediated tissue destruction such as that found in acute graft-versus-host disease (GVHD), allograft rejection and systemic inflammatory response syndrome. Given that ATP is found in small concentrations in the extracellular space under physiological conditions(1), and its receptor P2X(7)R is expressed on several immune cell types, ATP could function as a danger signal when released from dying cells. We observed increased ATP concentrations in the peritoneal fluid after total body irradiation, and during the development of GVHD in mice and in humans. Stimulation of antigen-presenting cells (APCs) with ATP led to increased expression of CD80 and CD86 in vitro and in vivo and actuated a cascade of proinflammatory events, including signal transducer and activator of transcription-1 (STAT1) phosphorylation, interferon-gamma (IFN-gamma) production and donor T cell expansion, whereas regulatory T cell numbers were reduced. P2X(7)R expression increased when GVHD evolved, rendering APCs more responsive to the detrimental effects of ATP, thereby providing positive feedback signals. ATP neutralization, early P2X(7)R blockade or genetic deficiency of P2X(7)R during GVHD development improved survival without immune paralysis. These data have major implications for transplantation medicine, as pharmacological interference with danger signals that act via P2X(7)R could lead to the development of tolerance without the need for intensive immunosuppression.	[Wilhelm, Konrad; Ganesan, Jayanthi; Duerr, Christoph; Zerweck, Alf; Gaertner, Frank; Finke, Juergen; Zeiser, Robert] Univ Freiburg, Med Ctr, Dept Hematol & Oncol, D-7800 Freiburg, Germany; [Ganesan, Jayanthi; Mueller, Tobias; Grimm, Melanie; Sorichter, Stephan; Idzko, Marco] Univ Freiburg, Med Ctr, Dept Pneumol, D-7800 Freiburg, Germany; [Ganesan, Jayanthi; Duerr, Christoph] Univ Freiburg, Dept Biol, D-7800 Freiburg, Germany; [Beilhack, Andreas] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany; [Beilhack, Andreas] Univ Hosp Wurzburg, Interdisciplinary Ctr Clin Res, Wurzburg, Germany; [Krempl, Christine D.] Univ Wurzburg, Inst Virol & Immunbiol, D-8700 Wurzburg, Germany; [Gerlach, Ulrike V.; Juettner, Eva; Fisch, Paul] Univ Freiburg, Med Ctr, Dept Pathol, D-7800 Freiburg, Germany; [Pellegatti, Patrizia; Di Virgilio, Francesco; Ferrari, Davide] Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, Interdisciplinary Ctr Study Inflammat, I-44100 Ferrara, Italy; [Kambham, Neeraja] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	University of Freiburg; University of Freiburg; University of Freiburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Freiburg; University of Ferrara; Stanford University	Zeiser, R (corresponding author), Univ Freiburg, Med Ctr, Dept Hematol & Oncol, D-7800 Freiburg, Germany.	marco.idzko@uniklinik-freiburg.de; robert.zeiser@uniklinik-freiburg.de	Di Virgilio, Francesco/J-3754-2018; Ferrari, Davide/F-5644-2015; Müller, Tobias/ABH-7263-2020; Pellegatti, Patrizia/A-1891-2011; DI VIRGILIO, Francesco/O-4634-2019; Krempl, Christine D/O-2081-2015	Di Virgilio, Francesco/0000-0003-3566-1362; Ferrari, Davide/0000-0002-5727-9204; Müller, Tobias/0000-0002-9801-3496; DI VIRGILIO, Francesco/0000-0003-3566-1362; Zeiser, Robert/0000-0001-6565-3393; Kambham, Neeraja/0000-0003-1136-3686; Anand, Jayanthi/0000-0002-8883-7299	Forschungskommission der Universitat Freiburg (FoKo) [ZEI616/08]; Wilhelm Sander Stiftung [2008.046.1]; Deutsche Forschungsgemeinschaft [ID 7/4-1, ZE 872/1-1]	Forschungskommission der Universitat Freiburg (FoKo); Wilhelm Sander Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We are grateful to S. Kruger, C. Faller, C. Kiesel, C. A. Bauerlein, M. Ritz and V. Schmidt. This study was supported by the Forschungskommission der Universitat Freiburg (FoKo ZEI616/08 to R.Z.), the Wilhelm Sander Stiftung (2008.046.1 to R.Z., M. I. and J.F.) and the Deutsche Forschungsgemeinschaft (ID 7/4-1 to M. I. and ZE 872/1-1 to R.Z.).	Anderson BE, 2008, BLOOD, V111, P5242, DOI 10.1182/blood-2007-09-107953; Aswad F, 2005, J IMMUNOL, V175, P3075, DOI 10.4049/jimmunol.175.5.3075; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Chen LF, 2006, CRIT REV IMMUNOL, V26, P499, DOI 10.1615/CritRevImmunol.v26.i6.30; Di Virgilio Francesco, 2005, Purinergic Signal, V1, P205, DOI 10.1007/s11302-005-6312-z; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Granstein RD, 2005, J IMMUNOL, V174, P7725, DOI 10.4049/jimmunol.174.12.7725; Hauri-Hohl MM, 2007, BLOOD, V109, P4080, DOI 10.1182/blood-2006-07-034157; Heiss K, 2008, J IMMUNOL, V181, P3861, DOI 10.4049/jimmunol.181.6.3861; Hill GR, 2000, BLOOD, V95, P2754, DOI 10.1182/blood.V95.9.2754.009k25_2754_2759; Hill GR, 1999, J CLIN INVEST, V104, P459, DOI 10.1172/JCI6896; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kaplan DH, 2004, J IMMUNOL, V173, P5467, DOI 10.4049/jimmunol.173.9.5467; Kawamura H, 2005, J IMMUNOL, V174, P1971, DOI 10.4049/jimmunol.174.4.1971; Krempl CD, 2007, J VIROL, V81, P9490, DOI 10.1128/JVI.00364-07; Lee KH, 2007, HAEMATOL-HEMATOL J, V92, P651, DOI 10.3324/haematol.10810; Metaxas Y, 2005, LEUKEMIA, V19, P1287, DOI 10.1038/sj.leu.2403789; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Rao V, 2008, SCAND J IMMUNOL, V68, P645, DOI 10.1111/j.1365-3083.2008.02179.x; Reichardt W, 2008, J IMMUNOL, V181, P4770, DOI 10.4049/jimmunol.181.7.4770; Sadzak I, 2008, P NATL ACAD SCI USA, V105, P8944, DOI 10.1073/pnas.0801794105; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Vogtenhuber C, 2010, BLOOD, V116, P466, DOI 10.1182/blood-2009-11-252825; Wang H, 2009, BLOOD, V113, P3612, DOI 10.1182/blood-2008-07-168419; Zeiser R, 2007, BLOOD, V110, P4588, DOI 10.1182/blood-2007-08-106005; Zeiser R, 2008, BLOOD, V111, P453, DOI 10.1182/blood-2007-06-094482; Zeiser R, 2007, BIOL BLOOD MARROW TR, V13, P1427, DOI 10.1016/j.bbmt.2007.08.041; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	30	308	317	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2010	16	12					1434	U117		10.1038/nm.2242	http://dx.doi.org/10.1038/nm.2242			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21102458				2022-12-25	WOS:000285048900038
J	Hohne, M; Schatzle, S; Jochens, H; Robins, K; Bornscheuer, UT				Hoehne, Matthias; Schaetzle, Sebastian; Jochens, Helge; Robins, Karen; Bornscheuer, Uwe T.			Rational assignment of key motifs for function guides in silico enzyme identification	NATURE CHEMICAL BIOLOGY			English	Article							AMINO-ACID AMINOTRANSFERASE; ASYMMETRIC-SYNTHESIS; DIRECTED EVOLUTION; INVERTING ENANTIOSELECTIVITY; SUBSTRATE RECOGNITION; CRYSTAL-STRUCTURES; CHIRAL AMINES; BIOCATALYSIS; TRANSAMINASE; BIOTRANSFORMATIONS	Biocatalysis has emerged as a powerful alternative to traditional chemistry, especially for asymmetric synthesis. One key requirement during process development is the discovery of a biocatalyst with an appropriate enantiopreference and enantioselectivity, which can be achieved, for instance, by protein engineering or screening of metagenome libraries. We have developed an in silico strategy for a sequence-based prediction of substrate specificity and enantiopreference. First, we used rational protein design to predict key amino acid substitutions that indicate the desired activity. Then, we searched protein databases for proteins already carrying these mutations instead of constructing the corresponding mutants in the laboratory. This methodology exploits the fact that naturally evolved proteins have undergone selection over millions of years, which has resulted in highly optimized catalysts. Using this in silico approach, we have discovered 17 (R)-selective amine transaminases, which catalyzed the synthesis of several (R)-amines with excellent optical purity up to >99% enantiomeric excess.	[Hoehne, Matthias; Schaetzle, Sebastian; Jochens, Helge; Bornscheuer, Uwe T.] Ernst Moritz Arndt Univ Greifswald, Inst Biochem, Dept Biotechnol & Enzyme Catalysis, Greifswald, Germany; [Robins, Karen] Lonza AG, Valais Works, Visp, Switzerland	Ernst Moritz Arndt Universitat Greifswald; Lonza Group	Hohne, M (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Biochem, Dept Biotechnol & Enzyme Catalysis, Greifswald, Germany.	uwe.bornscheuer@uni-greifswald.de	Höhne, Matthias/E-7129-2013; Höhne, Matthias/O-4044-2019; Bornscheuer, Uwe T/C-4612-2012	Höhne, Matthias/0000-0002-2542-725X; Höhne, Matthias/0000-0002-2542-725X; Bornscheuer, Uwe T/0000-0003-0685-2696				Bartsch S, 2008, ANGEW CHEM INT EDIT, V47, P1508, DOI 10.1002/anie.200704606; Bommarius AS, 2004, BIOCATALYSIS FUNDAME; Bornscheuer UT, 2006, HYDROLASES IN ORGANIC SYNTHESIS: REGIO- AND STEREOSELECTIVE BIOTRANSFORMATIONS, 2ND EDITION, P1; Breuer M, 2004, ANGEW CHEM INT EDIT, V43, P788, DOI 10.1002/anie.200300599; BUCHHOLZ K, 2005, BIOCATALYSIS ENZYME; CAHN RS, 1966, ANGEW CHEM INT EDIT, V5, P385, DOI 10.1002/anie.196603851; Cheon YH, 2002, BIOCHEMISTRY-US, V41, P9410, DOI 10.1021/bi0201567; Faber K., 2018, BIOTRANSFORMATIONS O; Fox RJ, 2007, NAT BIOTECHNOL, V25, P338, DOI 10.1038/nbt1286; Goto M, 2003, BIOCHEMISTRY-US, V42, P3725, DOI 10.1021/bi026722f; Griengl H, 2000, TRENDS BIOTECHNOL, V18, P252, DOI 10.1016/S0167-7799(00)01452-9; Groger H, 2006, ANGEW CHEM INT EDIT, V45, P5677, DOI 10.1002/anie.200503394; Grunwald P., 2009, BIOCATALYSIS BIOCH F; Hanson RL, 2008, ADV SYNTH CATAL, V350, P1367, DOI 10.1002/adsc.200800084; Hohn M, 2009, CHEMCATCHEM, V1, P42, DOI 10.1002/cctc.200900110; Hohne M, 2008, CHEMBIOCHEM, V9, P363, DOI 10.1002/cbic.200700601; Hou C.T., 2005, HDB IND BIOCATALYSIS; Ivancic M, 2007, J BIOTECHNOL, V129, P109, DOI 10.1016/j.jbiotec.2006.10.007; Iwasaki A, 2003, BIOTECHNOL LETT, V25, P1843, DOI 10.1023/A:1026229610628; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; Kazlauskas RJ, 2009, NAT CHEM BIOL, V5, P526, DOI 10.1038/nchembio0809-526; Koga Y, 2003, J MOL BIOL, V331, P585, DOI 10.1016/S0022-2836(03)00782-4; Koszelewski D, 2008, ADV SYNTH CATAL, V350, P2761, DOI 10.1002/adsc.200800496; Liese A., 2006, IND BIOTRANSFORMATIO; LUTZ S, 2009, PROTEIN ENG HDB; Magnusson AO, 2005, ANGEW CHEM INT EDIT, V44, P4582, DOI 10.1002/anie.200500971; Matcham GW, 1996, CHIM OGGI, V14, P20; May O, 2000, NAT BIOTECHNOL, V18, P317, DOI 10.1038/73773; MEHTA PK, 1993, EUR J BIOCHEM, V214, P549, DOI 10.1111/j.1432-1033.1993.tb17953.x; Mizuguchi H, 2001, BIOCHEMISTRY-US, V40, P353, DOI 10.1021/bi001403e; Mugford PF, 2008, ANGEW CHEM INT EDIT, V47, P8782, DOI 10.1002/anie.200705159; Okamoto A, 1998, J MOL BIOL, V280, P443, DOI 10.1006/jmbi.1998.1869; Patel RN., 2006, BIOCATALYSIS PHARM B; Percudani R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-273; Pollard DJ, 2007, TRENDS BIOTECHNOL, V25, P66, DOI 10.1016/j.tibtech.2006.12.005; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P7745, DOI 10.1002/anie.200602795; Savile CK, 2010, SCIENCE, V329, P305, DOI 10.1126/science.1188934; Schatzle S, 2010, ANAL CHEM, V82, P2082, DOI 10.1021/ac9028483; Schatzle S, 2009, ANAL CHEM, V81, P8244, DOI 10.1021/ac901640q; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Schoemaker HE, 2003, SCIENCE, V299, P1694, DOI 10.1126/science.1079237; Shin JS, 2003, APPL MICROBIOL BIOT, V61, P463, DOI 10.1007/s00253-003-1250-6; Straathof AJJ, 2002, CURR OPIN BIOTECH, V13, P548, DOI 10.1016/S0958-1669(02)00360-9; SUGIO S, 1995, BIOCHEMISTRY-US, V34, P9661, DOI 10.1021/bi00030a002; Tao J., 2009, BIOCATALYSIS PHARM I; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Williams GJ, 2006, J AM CHEM SOC, V128, P16238, DOI 10.1021/ja065233q; Wolf Y, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-19; Zha DX, 2001, CHEM COMMUN, P2664, DOI 10.1039/b109913m	49	270	280	13	178	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2010	6	11					807	813		10.1038/NCHEMBIO.447	http://dx.doi.org/10.1038/NCHEMBIO.447			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	667MP	20871599				2022-12-25	WOS:000283197800009
J	Oldershaw, RA; Baxter, MA; Lowe, ET; Bates, N; Grady, LM; Soncin, F; Brison, DR; Hardingham, TE; Kimber, SJ				Oldershaw, Rachel A.; Baxter, Melissa A.; Lowe, Emma T.; Bates, Nicola; Grady, Lisa M.; Soncin, Francesca; Brison, Daniel R.; Hardingham, Timothy E.; Kimber, Susan J.			Directed differentiation of human embryonic stem cells toward chondrocytes	NATURE BIOTECHNOLOGY			English	Article							CHONDROGENIC DIFFERENTIATION; DEFINITIVE ENDODERM; IN-VITRO; MESSENGER-RNA; STROMAL CELLS; MESODERM; EXPRESSION; INDUCTION; SOX9; SPECIFICATION	We report a chemically defined, efficient, scalable and reproducible protocol for differentiation of human embryonic stem cells (hESCs) toward chondrocytes. HESCs are directed through intermediate developmental stages using substrates of known matrix proteins and chemically defined media supplemented with exogenous growth factors. Gene expression analysis suggests that the hESCs progress through primitive streak or mesendoderm to mesoderm, before differentiating into a chondrocytic culture comprising cell aggregates. At this final stage, 74% (HUES1 cells) and up to 95-97% (HUES7 and HUES8 cells) express the chondrogenic transcription factor SOX9. The cell aggregates also express cell surface CD44 and aggrecan and deposit a sulfated glycosaminoglycan and cartilage-specific collagen II matrix, but show very low or no expression of genes and proteins associated with nontarget cell types. Our protocol should facilitate studies of chondrocyte differentiation and of cell replacement therapies for cartilage repair.	[Oldershaw, Rachel A.; Baxter, Melissa A.; Lowe, Emma T.; Bates, Nicola; Grady, Lisa M.; Brison, Daniel R.; Hardingham, Timothy E.; Kimber, Susan J.] Univ Manchester, N W Embryon Stem Cell Ctr, Fac Life Sci, Core Technol Facil, Manchester, Lancs, England; [Lowe, Emma T.; Hardingham, Timothy E.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester, Lancs, England; [Soncin, Francesca] Univ Manchester, Fac Med & Human Sci, Core Technol Facil, Manchester, Lancs, England; [Brison, Daniel R.] Cent Manchester Univ Hosp NHS Fdn Trust, Dept Reprod Med, St Marys Hosp Women & Children, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester	Kimber, SJ (corresponding author), Univ Manchester, N W Embryon Stem Cell Ctr, Fac Life Sci, Core Technol Facil, Manchester, Lancs, England.	sue.kimber@manchester.ac.uk	Soncin, Francesca/AAB-6143-2021	Hardingham, Timothy/0000-0001-8271-6763; Kimber, Susan/0000-0002-0568-6342; Bates, Nicola/0000-0001-5875-548X	North West Regional Development Agency; UK Medical Research Council; UK National Institute for Health Research Biomedical Research; Medical Research Council [G0300484, G0700092, G0801057, G0300248] Funding Source: researchfish; MRC [G0801057, G0300248, G0300484, G0700092] Funding Source: UKRI	North West Regional Development Agency; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute for Health Research Biomedical Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the North West Regional Development Agency; North West Embryonic Stem Cell Centre is also supported by the UK Medical Research Council and the UK National Institute for Health Research Biomedical Research Funding Scheme. We thank N. Hanley (University of Manchester) for the gift of human fetal cDNA.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Baxter MA, 2009, STEM CELL RES, V3, P28, DOI 10.1016/j.scr.2009.03.002; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Bigdeli N, 2009, STEM CELLS, V27, P1812, DOI 10.1002/stem.114; Boyd NL, 2009, TISSUE ENG PT A, V15, P1897, DOI 10.1089/ten.tea.2008.0351; Coipeau P, 2009, CYTOTHERAPY, V11, P584, DOI 10.1080/14653240903079385; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; De Sousa PA, 2009, STEM CELL RES, V2, P188, DOI 10.1016/j.scr.2009.01.002; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Era T, 2008, STEM CELLS, V26, P401, DOI 10.1634/stemcells.2006-0809; Faloon P, 2000, DEVELOPMENT, V127, P1931; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; GROVER J, 1995, BIOCHEM J, V309, P963, DOI 10.1042/bj3090963; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; HARDINGHAM TE, 2004, OXFORD TXB RHEUMATOL, P325; Hardingham TE, 2006, J ANAT, V209, P469, DOI 10.1111/j.1469-7580.2006.00630.x; Hatakeyama Y, 2004, J CELL BIOCHEM, V91, P1204, DOI 10.1002/jcb.20019; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Hoben GM, 2009, STEM CELLS DEV, V18, P283, DOI 10.1089/scd.2008.0024; Izumi N, 2007, STEM CELLS, V25, P1664, DOI 10.1634/stemcells.2006-0681; Izzi L, 2007, EMBO J, V26, P3132, DOI 10.1038/sj.emboj.7601753; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; KISPERT A, 1994, GENE DEV, V8, P2137, DOI 10.1101/gad.8.18.2137; Koay EJ, 2007, STEM CELLS, V25, P2183, DOI 10.1634/stemcells.2007-0105; Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lee EJ, 2010, TISSUE ENG PT A, V16, P705, DOI 10.1089/ten.tea.2008.0596; Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lian QZ, 2007, STEM CELLS, V25, P425, DOI 10.1634/stemcells.2006-0420; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Murphy JM, 2002, ARTHRITIS RHEUM-US, V46, P704, DOI 10.1002/art.10118; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nakagawa T, 2009, ARTHRITIS RHEUM-US, V60, P3686, DOI 10.1002/art.27229; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Oldershaw RA, 2008, STEM CELLS, V26, P666, DOI 10.1634/stemcells.2007-0806; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pacifici Maurizio, 2005, Birth Defects Research, V75, P237, DOI 10.1002/bdrc.20050; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; Sachlos E, 2008, BIOMATERIALS, V29, P4471, DOI 10.1016/j.biomaterials.2008.08.012; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Sui YP, 2003, DIFFERENTIATION, V71, P578, DOI 10.1111/j.1432-0436.2003.07109001.x; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takenaga M, 2007, J CELL SCI, V120, P2078, DOI 10.1242/jcs.004127; Tew SR, 2006, J BIOL CHEM, V281, P39471, DOI 10.1074/jbc.M604322200; Vats A, 2006, TISSUE ENG, V12, P1687, DOI 10.1089/ten.2006.12.1687; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Winslow BB, 2007, DEV DYNAM, V236, P2371, DOI 10.1002/dvdy.21254; Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365; Yang Z, 2009, STEM CELLS DEV, V18, P929, DOI 10.1089/scd.2008.0219; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120; zur Nieden NI, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-1	58	194	206	0	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2010	28	11					1221	U80		10.1038/nbt.1683	http://dx.doi.org/10.1038/nbt.1683			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	676PI	20967028				2022-12-25	WOS:000283924100021
J	Rothman, N; Garcia-Closas, M; Chatterjee, N; Malats, N; Wu, XF; Figueroa, JD; Real, FX; Van den Berg, D; Matullo, G; Baris, D; Thun, M; Kiemeney, LA; Vineis, P; De Vivo, I; Albanes, D; Purdue, MP; Rafnar, T; Hildebrandt, MAT; Kiltie, AE; Cussenot, O; Golka, K; Kumar, R; Taylor, JA; Mayordomo, JI; Jacobs, KB; Kogevinas, M; Hutchinson, A; Wang, ZW; Fu, YP; Prokunina-Olsson, L; Burdett, L; Yeager, M; Wheeler, W; Tardon, A; Serra, C; Carrato, A; Garcia-Closas, R; Lloreta, J; Johnson, A; Schwenn, M; Karagas, MR; Schned, A; Andriole, G; Grubb, R; Black, A; Jacobs, EJ; Diver, WR; Gapstur, SM; Weinstein, SJ; Virtamo, J; Cortessis, VK; Gago-Dominguez, M; Pike, MC; Stern, MC; Yuan, JM; Hunter, DJ; McGrath, M; Dinney, CP; Czerniak, B; Chen, M; Yang, HS; Vermeulen, SH; Aben, KK; Witjes, JA; Makkinje, RR; Sulem, P; Besenbacher, S; Stefansson, K; Riboli, E; Brennan, P; Panico, S; Navarro, C; Allen, NE; Bueno-De-Mesquita, HB; Trichopoulos, D; Caporaso, N; Landi, MT; Canzian, F; Ljungberg, B; Tjonneland, A; Clavel-Chapelon, F; Bishop, DT; Teo, MTW; Knowles, MA; Guarrera, S; Polidoro, S; Ricceri, F; Sacerdote, C; Allione, A; Cancel-Tassin, G; Selinski, S; Hengstler, JG; Dietrich, H; Fletcher, T; Rudnai, P; Gurzau, E; Koppova, K; Bolick, SCE; Godfrey, A; Xu, ZL; Sanz-Velez, JI; Garcia-Prats, MD; Sanchez, M; Valdivia, G; Porru, S; Benhamou, S; Hoover, RN; Fraumeni, JF; Silverman, DT; Chanock, SJ				Rothman, Nathaniel; Garcia-Closas, Montserrat; Chatterjee, Nilanjan; Malats, Nuria; Wu, Xifeng; Figueroa, Jonine D.; Real, Francisco X.; Van den Berg, David; Matullo, Giuseppe; Baris, Dalsu; Thun, Michael; Kiemeney, Lambertus A.; Vineis, Paolo; De Vivo, Immaculata; Albanes, Demetrius; Purdue, Mark P.; Rafnar, Thorunn; Hildebrandt, Michelle A. T.; Kiltie, Anne E.; Cussenot, Olivier; Golka, Klaus; Kumar, Rajiv; Taylor, Jack A.; Mayordomo, Jose I.; Jacobs, Kevin B.; Kogevinas, Manolis; Hutchinson, Amy; Wang, Zhaoming; Fu, Yi-Ping; Prokunina-Olsson, Ludmila; Burdett, Laurie; Yeager, Meredith; Wheeler, William; Tardon, Adonina; Serra, Consol; Carrato, Alfredo; Garcia-Closas, Reina; Lloreta, Josep; Johnson, Alison; Schwenn, Molly; Karagas, Margaret R.; Schned, Alan; Andriole, Gerald, Jr.; Grubb, Robert, III; Black, Amanda; Jacobs, Eric J.; Diver, W. Ryan; Gapstur, Susan M.; Weinstein, Stephanie J.; Virtamo, Jarmo; Cortessis, Victoria K.; Gago-Dominguez, Manuela; Pike, Malcolm C.; Stern, Mariana C.; Yuan, Jian-Min; Hunter, David J.; McGrath, Monica; Dinney, Colin P.; Czerniak, Bogdan; Chen, Meng; Yang, Hushan; Vermeulen, Sita H.; Aben, Katja K.; Witjes, J. Alfred; Makkinje, Remco R.; Sulem, Patrick; Besenbacher, Soren; Stefansson, Kari; Riboli, Elio; Brennan, Paul; Panico, Salvatore; Navarro, Carmen; Allen, Naomi E.; Bueno-de-Mesquita, H. Bas; Trichopoulos, Dimitrios; Caporaso, Neil; Landi, Maria Teresa; Canzian, Federico; Ljungberg, Borje; Tjonneland, Anne; Clavel-Chapelon, Francoise; Bishop, David T.; Teo, Mark T. W.; Knowles, Margaret A.; Guarrera, Simonetta; Polidoro, Silvia; Ricceri, Fulvio; Sacerdote, Carlotta; Allione, Alessandra; Cancel-Tassin, Geraldine; Selinski, Silvia; Hengstler, Jan G.; Dietrich, Holger; Fletcher, Tony; Rudnai, Peter; Gurzau, Eugen; Koppova, Kvetoslava; Bolick, Sophia C. E.; Godfrey, Ashley; Xu, Zongli; Sanz-Velez, Jose I.; Garcia-Prats, Maria D.; Sanchez, Manuel; Valdivia, Gabriel; Porru, Stefano; Benhamou, Simone; Hoover, Robert N.; Fraumeni, Joseph F., Jr.; Silverman, Debra T.; Chanock, Stephen J.			A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci	NATURE GENETICS			English	Article							CONFERS SUSCEPTIBILITY; UDP-GLUCURONOSYLTRANSFERASES; TELOMERASE MUTATIONS; SEQUENCE VARIANT; COMMON VARIANTS; DOWN-REGULATION; RISK; GENE; STRATIFICATION; POLYMORPHISMS	We conducted a multi-stage, genome-wide association study of bladder cancer with a primary scan of 591,637 SNPs in 3,532 affected individuals (cases) and 5,120 controls of European descent from five studies followed by a replication strategy, which included 8,382 cases and 48,275 controls from 16 studies. In a combined analysis, we identified three new regions associated with bladder cancer on chromosomes 22q13.1, 19q12 and 2q37.1: rs1014971, (P = 8 x 10(-12)) maps to a non-genic region of chromosome 22q13.1, rs8102137 (P = 2 x 10(-11)) on 19q12 maps to CCNE1 and rs11892031 (P = 1 x 10(-7)) maps to the UGT1A cluster on 2q37.1. We confirmed four previously identified genome-wide associations on chromosomes 3q28, 4p16.3, 8q24.21 and 8q24.3, validated previous candidate associations for the GSTM1 deletion (P = 4 x 10(-11)) and a tag SNP for NAT2 acetylation status (P = 4 x 10(-11)), and found interactions with smoking in both regions. Our findings on common variants associated with bladder cancer risk should provide new insights into the mechanisms of carcinogenesis.	[Rothman, Nathaniel; Garcia-Closas, Montserrat; Chatterjee, Nilanjan; Figueroa, Jonine D.; Baris, Dalsu; Albanes, Demetrius; Purdue, Mark P.; Fu, Yi-Ping; Prokunina-Olsson, Ludmila; Black, Amanda; Weinstein, Stephanie J.; Caporaso, Neil; Landi, Maria Teresa; Hoover, Robert N.; Fraumeni, Joseph F., Jr.; Silverman, Debra T.; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Malats, Nuria; Real, Francisco X.] Spanish Natl Canc Res Ctr, Madrid, Spain; [Wu, Xifeng; Hildebrandt, Michelle A. T.; Chen, Meng; Yang, Hushan] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Real, Francisco X.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Van den Berg, David; Cortessis, Victoria K.; Gago-Dominguez, Manuela; Pike, Malcolm C.; Stern, Mariana C.] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA; [Matullo, Giuseppe] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Matullo, Giuseppe; Vineis, Paolo; Guarrera, Simonetta; Polidoro, Silvia; Ricceri, Fulvio; Sacerdote, Carlotta; Allione, Alessandra] Human Genet Fdn HuGeF, Turin, Italy; [Thun, Michael; Jacobs, Eric J.; Diver, W. Ryan; Gapstur, Susan M.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Kiemeney, Lambertus A.; Vermeulen, Sita H.; Aben, Katja K.] Radboud Univ Nijmegen Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Comprehens Canc Ctr E, Nijmegen, Netherlands; [Kiemeney, Lambertus A.; Witjes, J. Alfred] Radboud Univ Nijmegen Med Ctr, Dept Urol, Nijmegen, Netherlands; [Vineis, Paolo; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, London, England; [De Vivo, Immaculata] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Rafnar, Thorunn; Sulem, Patrick; Besenbacher, Soren; Stefansson, Kari] DeCODE Genet, Reykjavik, Iceland; [Kiltie, Anne E.] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford, England; [Cussenot, Olivier] Tenon Hosp, AP HP, Dept Urol, Paris, France; [Cussenot, Olivier; Cancel-Tassin, Geraldine] Ctr Rech Pathol Prostat, Paris, France; [Golka, Klaus; Selinski, Silvia; Hengstler, Jan G.] Leibniz Res Ctr Working Environm & Human Factor, Dortmund, Germany; [Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany; [Taylor, Jack A.; Bolick, Sophia C. E.; Godfrey, Ashley; Xu, Zongli] Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA; [Mayordomo, Jose I.; Sanchez, Manuel; Valdivia, Gabriel] Univ Zaragoza, Zaragoza, Spain; [Jacobs, Kevin B.; Hutchinson, Amy; Wang, Zhaoming; Burdett, Laurie; Yeager, Meredith] SAIC Frederick Inc, Natl Canc Inst Frederick, Core Genotype Facil, Frederick, MD USA; [Kogevinas, Manolis] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Kogevinas, Manolis] Municipal Inst Med Res, Barcelona, Spain; [Kogevinas, Manolis; Tardon, Adonina; Navarro, Carmen] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Kogevinas, Manolis] Natl Sch Publ Hlth, Athens, Greece; [Wheeler, William] Informat Management Serv Inc, Rockville, MD USA; [Tardon, Adonina] Univ Oviedo, Inst Univ Oncol, Oviedo, Spain; [Carrato, Alfredo] Ramon & Cajal Univ Hosp, Madrid, Spain; [Garcia-Closas, Reina] Hosp Univ Canarias, Unidad Invest, San Cristobal la Laguna, Spain; [Lloreta, Josep] Univ Pompeu Fabra, Hosp Mar Inst Municipal Invest Med IMIM, Barcelona, Spain; [Johnson, Alison] Vermont Canc Registry, Burlington, VT USA; [Schwenn, Molly] Maine Canc Registry, Augusta, ME USA; [Karagas, Margaret R.; Schned, Alan] Dartmouth Med Sch, Hanover, NH USA; [Andriole, Gerald, Jr.; Grubb, Robert, III] Washington Univ, Sch Med, Dept Urol, St Louis, MO USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Helsinki, Finland; [Pike, Malcolm C.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Yuan, Jian-Min] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN USA; [Hunter, David J.; McGrath, Monica] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Dinney, Colin P.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Czerniak, Bogdan] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Vermeulen, Sita H.; Makkinje, Remco R.] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Brennan, Paul] Int Agcy Res Canc, Lyon, France; [Panico, Salvatore] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Navarro, Carmen] Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain; [Allen, Naomi E.] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford, England; [Bueno-de-Mesquita, H. Bas] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Trichopoulos, Dimitrios] Acad Athens, Bur Epidemiol Res, Athens, Greece; [Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [Ljungberg, Borje] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Tjonneland, Anne] Inst Canc Epidemiol, Danish Canc Soc, Copenhagen, Denmark; [Clavel-Chapelon, Francoise] Paris S Univ, Inst Gustave Roussy, Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Bishop, David T.; Teo, Mark T. W.; Knowles, Margaret A.] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Sacerdote, Carlotta] Univ Turin, Canc Epidemiol Unit, Turin, Italy; [Dietrich, Holger] Paul Gerhardt Fdn, Dept Urol, Wittenberg, Germany; [Fletcher, Tony] Inst Hyg & Trop Med, London, England; [Rudnai, Peter] Natl Inst Environm Hlth, Budapest, Hungary; [Gurzau, Eugen] Univ Babes Bolyai, Ctr Environm Hlth, R-3400 Cluj Napoca, Romania; [Koppova, Kvetoslava] State Hlth Inst, Banska Bystrica, Slovakia; [Sanz-Velez, Jose I.; Garcia-Prats, Maria D.] San Jorge Univ Hosp, Huesca, Spain; [Porru, Stefano] Univ Brescia, Sect Occupat Med & Ind Hyg, Dept Expt & Appl Med, Brescia, Italy; [Benhamou, Simone] CEPH, Fdn Jean Dausset, U946, INSERM, Paris, France; [Benhamou, Simone] Inst Gustave Roussy, UMR8200, CNRS, Villejuif, France	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centro Nacional de Investigaciones Oncologicas (CNIO); University of Texas System; UTMD Anderson Cancer Center; Pompeu Fabra University; University of Southern California; University of Turin; American Cancer Society; Radboud University Nijmegen; Radboud University Nijmegen; Imperial College London; Harvard University; Brigham & Women's Hospital; University of Oxford; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Helmholtz Association; German Cancer Research Center (DKFZ); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Zaragoza; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; National & Kapodistrian University of Athens; Information Management Services, Inc.; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Hospital Universitario Ramon y Cajal; Universidad de la Laguna; Pompeu Fabra University; Dartmouth College; Washington University (WUSTL); Finland National Institute for Health & Welfare; Memorial Sloan Kettering Cancer Center; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Radboud University Nijmegen; University of Iceland; World Health Organization; International Agency for Research on Cancer (IARC); University of Naples Federico II; Murcia Regional Health Council; University of Oxford; Netherlands National Institute for Public Health & the Environment; Academy of Athens; Helmholtz Association; German Cancer Research Center (DKFZ); Umea University; Danish Cancer Society; UNICANCER; Gustave Roussy; Saint James's University Hospital; University of Leeds; University of Turin; University of London; London School of Hygiene & Tropical Medicine; Babes Bolyai University from Cluj; Hospital Universidad San Jorge; University of Brescia; Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Gustave Roussy	Garcia-Closas, M (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	montse.garciaclosas@icr.ac.uk	Prokunina-Olsson, Ludmila/A-8240-2019; Albanes, Demetrius/B-9749-2015; Figueroa, Jonine/GWD-1322-2022; Yeager, Meredith/AAA-5322-2020; Guarrera, Simonetta/AAB-8482-2022; Purdue, Mark P/C-9228-2016; taylor, jack a/C-7154-2019; Arribas, Francisco X Real/H-5275-2015; Serra, C/E-6879-2014; Wang, Zhaoming/R-5527-2018; Benhamou, Simone/K-6554-2015; Diver, Ryan/AAG-3469-2019; Figueroa, Jonine/AFK-2752-2022; Van Den Berg, David J/G-8598-2017; Polidoro, Silvia/GYJ-3517-2022; Panico, Salvatore/K-6506-2016; Gago-Dominguez, Manuela/AAP-6611-2021; Vermeulen, Sita H./L-4716-2015; Clavel-Chapelon, Francoise/G-6733-2014; TARDON, ADONINA/B-6563-2014; Figueroa, Jonine/AAG-1065-2022; Kiemeney, Lambertus A./D-3357-2009; Stefansson, Kari/AAE-7187-2019; Mayordomo, Jose/K-3453-2013; Prokunina-Olsson, Ludmila/V-7960-2019; Benhamou, Simone/ABD-2590-2020; Malats, Nuria/H-7041-2015; Aben, Katja KH/G-9686-2016; Makkinje, Remco/Q-2406-2015; Weinstein, Stephanie J/P-1627-2017; Ricceri, Fulvio/I-9910-2018; Kumar, Rajiv/H-6431-2019; Garcia-Closas, Montserrat/F-3871-2015; Lloreta-Trull, Josep/GRR-9682-2022; Lloreta-Trull, Josep/AAZ-1229-2020; Canzian, Federico/I-2804-2014; Witjes, Fred/N-9665-2013; Matullo, Giuseppe/K-6383-2016; Garcia-Closas, Montserrat/AAZ-6930-2021; Lloreta, J/I-2112-2014; Hengstler, Jan G./O-1415-2013; Kogevinas, Manolis/C-3918-2017; Fletcher, Tony/D-2394-2011	Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Figueroa, Jonine/0000-0002-5100-623X; Purdue, Mark P/0000-0003-1177-3108; taylor, jack a/0000-0001-5303-6398; Arribas, Francisco X Real/0000-0001-9501-498X; Serra, C/0000-0001-8337-8356; Wang, Zhaoming/0000-0001-7556-3869; Diver, Ryan/0000-0002-5418-9000; Figueroa, Jonine/0000-0002-5100-623X; Van Den Berg, David J/0000-0002-5404-5218; Panico, Salvatore/0000-0002-5498-8312; Vermeulen, Sita H./0000-0003-4913-8601; TARDON, ADONINA/0000-0001-5150-1209; Figueroa, Jonine/0000-0002-5100-623X; Kiemeney, Lambertus A./0000-0002-2368-1326; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Malats, Nuria/0000-0003-2538-3784; Aben, Katja KH/0000-0002-0214-2147; Weinstein, Stephanie J/0000-0002-3834-1535; Ricceri, Fulvio/0000-0001-8749-9737; Kumar, Rajiv/0000-0002-6093-0395; Garcia-Closas, Montserrat/0000-0003-1033-2650; Matullo, Giuseppe/0000-0003-0674-7757; Garcia-Closas, Montserrat/0000-0003-1033-2650; Lloreta, J/0000-0003-1644-9470; Kogevinas, Manolis/0000-0002-9605-0461; Gago, Manuela/0000-0001-6713-4351; cussenot, olivier/0000-0002-9912-0533; BENHAMOU, Simone/0000-0001-5853-8047; Ljungberg, Borje/0000-0002-4121-3753; CARRATO, ALFREDO/0000-0001-7749-8140; Allione, Alessandra/0000-0001-9599-309X; Yuan, Jian-Min/0000-0002-4620-3108; Riboli, Elio/0000-0001-6795-6080; Tjonneland, Anne/0000-0003-4385-2097; Cancel-Tassin, Geraldine/0000-0002-9583-6382; Kiltie, Anne/0000-0001-7208-2912; xu, zongli/0000-0002-9034-8902; Hengstler, Jan/0000-0002-1427-5246; Gurzau, Eugen/0000-0002-8688-6118; Dinney, Colin/0000-0002-8969-711X; Fletcher, Tony/0000-0003-3385-200X; Polidoro, Silvia/0000-0003-2968-0575; Sacerdote, Carlotta/0000-0002-8008-5096; Knowles, Margaret/0000-0002-9363-8657; Jacobs, Kevin/0000-0002-4657-6473; Canzian, Federico/0000-0002-4261-4583; Bishop, Tim/0000-0002-8752-8785; Besenbacher, Soren/0000-0003-1455-1738; Navarro, Carmen/0000-0001-8896-7483; Cortessis, Victoria/0000-0002-2339-1089	National Cancer Institute, US National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIACP010201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049033] Funding Source: NIH RePORTER; Cancer Research UK [10589, 12933] Funding Source: researchfish; Medical Research Council [G0801056B] Funding Source: researchfish; National Institute for Health Research [ACF-2006-02-005] Funding Source: researchfish	National Cancer Institute, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This project has been funded in part with federal funds from the National Cancer Institute, US National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government.	Aben KKH, 2006, EUR J CANCER, V42, P1428, DOI 10.1016/j.ejca.2005.07.039; Ando Y, 2000, CANCER RES, V60, P6921; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; BELL DA, 1993, J NATL CANCER I, V85, P1159, DOI 10.1093/jnci/85.14.1159; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Calado RT, 2008, BLOOD, V111, P4446, DOI 10.1182/blood-2007-08-019729; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Fearnhead P, 2004, GENETICS, V167, P2067, DOI 10.1534/genetics.103.021584; Fearnhead P, 2006, BIOINFORMATICS, V22, P3061, DOI 10.1093/bioinformatics/btl540; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Garcia-Closas M, 2005, LANCET, V366, P649, DOI 10.1016/S0140-6736(05)67137-1; Garcia-Closas M, 2011, PHARMACOGENET GENOM, V21, P231, DOI 10.1097/FPC.0b013e32833e1b54; Giuliani L, 2001, INT J CANCER, V91, P141, DOI 10.1002/1097-0215(20010101)91:1<141::AID-IJC1005>3.0.CO;2-H; Hein DW, 2006, ONCOGENE, V25, P1649, DOI 10.1038/sj.onc.1209374; Iida K, 2010, J BIOCHEM, V147, P353, DOI 10.1093/jb/mvp169; KANTOR AF, 1985, INT J CANCER, V35, P703, DOI 10.1002/ijc.2910350602; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Kiemeney LA, 2010, NAT GENET, V42, P415, DOI 10.1038/ng.558; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; LOWER GM, 1979, ENVIRON HEALTH PERSP, V29, P71, DOI 10.2307/3429048; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Murta-Nascimento C, 2007, CANCER EPIDEM BIOMAR, V16, P1595, DOI 10.1158/1055-9965.EPI-06-0743; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Richter J, 2000, AM J PATHOL, V157, P787, DOI 10.1016/S0002-9440(10)64592-0; Rothwell A, 2007, PERS REV, V36, P23, DOI 10.1108/00483480710716704; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Silverman DT, 2006, CANC EPIDEMIOLOGY PR, V3, P1101; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Strassburg CP, 2008, ARCH TOXICOL, V82, P415, DOI 10.1007/s00204-008-0314-x; Strassburg CP, 1998, MOL PHARMACOL, V54, P647; Strassburg CP, 1997, CANCER RES, V57, P2979; Sun L, 2002, HUM HERED, V54, P99, DOI 10.1159/000067666; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	52	333	342	1	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					978	U98		10.1038/ng.687	http://dx.doi.org/10.1038/ng.687			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20972438	Green Accepted			2022-12-25	WOS:000283540500015
J	Kedde, M; van Kouwenhove, M; Zwart, W; Vrielink, JAFO; Elkon, R; Agami, R				Kedde, Martijn; van Kouwenhove, Marieke; Zwart, Wilbert; Vrielink, Joachim A. F. Oude; Elkon, Ran; Agami, Reuven			A Pumilio-induced RNA structure switch in p27-3 ' UTR controls miR-221 and miR-222 accessibility	NATURE CELL BIOLOGY			English	Article							MESSENGER-RNA; TUMOR-SUPPRESSOR; STRESS GRANULES; LET-7 MICRORNA; P27(KIP1); REVEALS; CANCER; PROLIFERATION; GENE	Key regulators of 3' untranslated regions (3' UTRs) are microRNAs and RNA-binding proteins (RBPs)(1,2). The p27 tumour suppressor is highly expressed in quiescent cells, and its downregulation is required for cell cycle entry after growth factor stimulation(3,4). Intriguingly, p27 accumulates in quiescent cells despite high levels of its inhibitors miR-221 and miR-222 (refs 5, 6). Here we show that miR-221 and miR-222 are underactive towards p27-3' UTR in quiescent cells, as a result of target site hindrance. Pumilio-1 (PUM1) is a ubiquitously expressed RBP that was shown to interact with p27-3' UTR(7,8). In response to growth factor stimulation, PUM1 is upregulated and phosphorylated for optimal induction of its RNA-binding activity towards the p27-3' UTR. PUM1 binding induces a local change in RNA structure that favours association with miR-221 and miR-222, efficient suppression of p27 expression, and rapid entry to the cell cycle. We have therefore uncovered a novel RBP-induced structural switch modulating microRNA-mediated gene expression regulation.	[Kedde, Martijn; van Kouwenhove, Marieke; Vrielink, Joachim A. F. Oude; Elkon, Ran; Agami, Reuven] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [Zwart, Wilbert] Netherlands Canc Inst, Div Cell Biol 2, NL-1066 CX Amsterdam, Netherlands; [Agami, Reuven] Ctr Biomed Genet UMCU, NL-3584 CG Utrecht, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Agami, R (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.agami@nki.nl	agami, reuven/GOG-8289-2022; Kedde, Martijn/F-9716-2016	Agami, Reuven/0000-0002-2848-2473; Zwart, Wilbert/0000-0002-9823-7289	EURYI (European research young investigator award); ERC (European Research Council); Dutch cancer foundation; Horizon-NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek); EMBO	EURYI (European research young investigator award)(European Science Foundation (ESF)); ERC (European Research Council)(European Research Council (ERC)); Dutch cancer foundation(KWF Kankerbestrijding); Horizon-NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek)(Netherlands Organization for Scientific Research (NWO)); EMBO(European Molecular Biology Organization (EMBO))	We thank all members of the Agami laboratory for technical help and discussions. We also thank Andre Gerber for constructs, Kees Jalink for advice on fluorescence lifetime imaging microscopy measurements, and R.B. Israel for assistance with statistical analysis. This work was supported by the EURYI (European research young investigator award), ERC (European Research Council), KWF (koningin wilhelmina fonds; Dutch cancer foundation) and Horizon-NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek; R.A.) and an EMBO long-term fellowship (R.E.).	Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Duursma A, 2005, MOL CELL BIOL, V25, P6937, DOI 10.1128/MCB.25.16.6937-6947.2005; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Kedde M, 2008, CELL CYCLE, V7, P899, DOI 10.4161/cc.7.7.5644; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Lotterman CD, 2008, CELL CYCLE, V7, P2493, DOI 10.4161/cc.7.16.6452; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Morris AR, 2008, MOL CELL BIOL, V28, P4093, DOI 10.1128/MCB.00155-08; Nolde MJ, 2007, DEV BIOL, V305, P551, DOI 10.1016/j.ydbio.2007.02.040; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Voorhoeve PM, 2007, BBA-REV CANCER, V1775, P274, DOI 10.1016/j.bbcan.2006.11.003; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037	25	296	313	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					1014	1020		10.1038/ncb2105	http://dx.doi.org/10.1038/ncb2105			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20818387				2022-12-25	WOS:000282363500017
J	McElhinny, SAN; Kumar, D; Clark, AB; Watt, DL; Watts, BE; Lundstrom, EB; Johansson, E; Chabes, A; Kunkel, TA				McElhinny, Stephanie A. Nick; Kumar, Dinesh; Clark, Alan B.; Watt, Danielle L.; Watts, Brian E.; Lundstrom, Else-Britt; Johansson, Erik; Chabes, Andrei; Kunkel, Thomas A.			Genome instability due to ribonucleotide incorporation into DNA	NATURE CHEMICAL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; POLYMERASE-EPSILON; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; REPLICATION FORK; YEAST; PURIFICATION; MUTATIONS; RESIDUE; SUGAR	Maintaining the chemical identity of DNA depends on ribonucleotide exclusion by DNA polymerases. However, ribonucleotide exclusion during DNA synthesis in vitro is imperfect. To determine whether ribonucleotides are incorporated during DNA replication in vivo, we substituted leucine or glycine for an active-site methionine in yeast DNA polymerase epsilon ( Pol epsilon). Ribonucleotide incorporation in vitro was three-fold lower for M644L and 11-fold higher for M644G Pol epsilon compared to wildtype Pol epsilon. This hierarchy was recapitulated in vivo in yeast strains lacking RNase H2. Moreover, the pol2-M644G rnh201 Delta strain progressed more slowly through S phase, had elevated dNTP pools and generated 2-5-base-pair deletions in repetitive sequences at a high rate and in a gene orientation-dependent manner. The data indicate that ribonucleotides are incorporated during replication in vivo, that they are removed by RNase H2-dependent repair and that defective repair results in replicative stress and genome instability via DNA strand misalignment.	[McElhinny, Stephanie A. Nick; Clark, Alan B.; Watt, Danielle L.; Watts, Brian E.; Kunkel, Thomas A.] NIEHS, Mol Genet Lab, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [McElhinny, Stephanie A. Nick; Clark, Alan B.; Watt, Danielle L.; Watts, Brian E.; Kunkel, Thomas A.] NIEHS, Struct Biol Lab, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Kumar, Dinesh; Lundstrom, Else-Britt; Johansson, Erik; Chabes, Andrei] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Chabes, Andrei] Umea Univ, Lab Mol Infect Med Sweden, Umea, Sweden	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Umea University; Umea University	McElhinny, SAN (corresponding author), NIEHS, Mol Genet Lab, NIH, Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA.	kunkel@niehs.nih.gov	Kunkel, Thomas A./D-5088-2019; Kalra, D/H-6661-2019	Kunkel, Thomas A./0000-0002-9900-1788; Kalra, D/0000-0001-5254-4067; Watts, Brian/0000-0003-1731-2441; Chabes, Andrei/0000-0003-1708-8259; Johansson, Erik/0000-0002-8526-6224	Division of Intramural Research of the US National Institutes of Health, National Institute of Environmental Health Sciences; Swedish Foundation for Strategic Research; Swedish Research Council; Swedish Cancer Society; Umea University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065070, Z01ES065070] Funding Source: NIH RePORTER	Division of Intramural Research of the US National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Umea University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank K. Bebenek and J. Williams for thoughtful comments on the manuscript and the National Institute of Environmental Health Sciences Molecular Genetics Core for technical support in DNA sequence analysis of ura3 mutants. This work was supported in part by Project Z01 ES065070 (to T. A. K.) from the Division of Intramural Research of the US National Institutes of Health, National Institute of Environmental Health Sciences, in part by the Swedish Foundation for Strategic Research, the Swedish Research Council and the Swedish Cancer Society (to A. C.) and in part by the Swedish Research Council, the Swedish Cancer Society, Smartafonden and the fund for Basic Science-oriented Biotechnology, Medical Faculty of Umea University (to E. J.).	Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; BEBENEK K, 1990, P NATL ACAD SCI USA, V87, P4946, DOI 10.1073/pnas.87.13.4946; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; CAI H, 1995, J BIOL CHEM, V270, P15327, DOI 10.1074/jbc.270.25.15327; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Chen JJZ, 2000, NUCLEIC ACIDS RES, V28, P3649, DOI 10.1093/nar/28.18.3649; Chilkova O, 2003, J BIOL CHEM, V278, P14082, DOI 10.1074/jbc.M211818200; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; DeLucia AM, 2003, NUCLEIC ACIDS RES, V31, P4129, DOI 10.1093/nar/gkg417; EDER PS, 1993, BIOCHIMIE, V75, P123, DOI 10.1016/0300-9084(93)90033-O; EDER PS, 1991, J BIOL CHEM, V266, P6472; Frank P, 1999, FEBS LETT, V450, P251, DOI 10.1016/S0014-5793(99)00512-8; Gardner AF, 1999, NUCLEIC ACIDS RES, V27, P2545, DOI 10.1093/nar/27.12.2545; HAMATAKE RK, 1990, J BIOL CHEM, V265, P4072; Jeong HS, 2004, NUCLEIC ACIDS RES, V32, P407, DOI 10.1093/nar/gkh209; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; Kirchner JM, 2000, GENETICS, V155, P1623; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Kornberg A., 1992, DNA REPLICATION; KUNKEL TA, 1989, MOL CELL BIOL, V9, P4447, DOI 10.1128/MCB.9.10.4447; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Pavlov YI, 2001, GENETICS, V159, P47; Pavlov YI, 2002, P NATL ACAD SCI USA, V99, P9954, DOI 10.1073/pnas.152126799; Pursell ZF, 2007, NUCLEIC ACIDS RES, V35, P3076, DOI 10.1093/nar/gkm132; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361, DOI 10.1128/mcb.19.12.8361; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Sabouri N, 2008, NUCLEIC ACIDS RES, V36, P5660, DOI 10.1093/nar/gkn555; SAMBROOK J, 1989, MOL CLONING LAB J; Shcherbakova PV, 1999, MOL CELL BIOL, V19, P3177; Shinkai A, 2001, J BIOL CHEM, V276, P18836, DOI 10.1074/jbc.M011472200; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171	37	283	286	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2010	6	10					774	781		10.1038/NCHEMBIO.424	http://dx.doi.org/10.1038/NCHEMBIO.424			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	651YM	20729855	Green Accepted			2022-12-25	WOS:000281964100015
J	Ferreira, RC; Pan-Hammarstrom, Q; Graham, RR; Gateva, V; Fontan, G; Lee, AT; Ortmann, W; Urcelay, E; Fernandez-Arquero, M; Nunez, C; Jorgensen, G; Ludviksson, BR; Koskinen, S; Haimila, K; Clark, HF; Klareskog, L; Gregersen, PK; Behrens, TW; Hammarstrom, L				Ferreira, Ricardo C.; Pan-Hammarstrom, Qiang; Graham, Robert R.; Gateva, Vesela; Fontan, Gumersindo; Lee, Annette T.; Ortmann, Ward; Urcelay, Elena; Fernandez-Arquero, Miguel; Nunez, Concepcion; Jorgensen, Gudmundur; Ludviksson, Bjorn R.; Koskinen, Sinikka; Haimila, Katri; Clark, Hilary F.; Klareskog, Lars; Gregersen, Peter K.; Behrens, Timothy W.; Hammarstrom, Lennart			Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIABLE IMMUNODEFICIENCY; ANTI-IGA; RIG-I; LINKAGE; AUTOANTIBODIES; RESPONSES; PATTERN; GENE; MDA5	To understand the genetic predisposition to selective immunoglobulin A deficiency (IgAD), we performed a genome-wide association study in 430 affected individuals (cases) from Sweden and Iceland and 1,090 ethnically matched controls, and we performed replication studies in two independent European cohorts. In addition to the known association of HLA with IgAD, we identified association with a nonsynonymous variant in IFIH1 (rs1990760G>A, P = 7.3 x 10(-10)) which was previously associated with type 1 diabetes and systemic lupus erythematosus. Variants in CLEC16A, another known autoimmunity locus, showed suggestive evidence for association (rs6498142C>G, P = 1.8 x 10(-7)), and 29 additional loci were identified with P < 5 x 10(-5). A survey in IgAD of 118 validated non-HLA autoimmunity loci indicated a significant enrichment for association with autoimmunity loci as compared to non-autoimmunity loci (P = 9.0 x 10(-4)) or random SNPs across the genome (P < 0.0001). These findings support the hypothesis that autoimmune mechanisms may contribute to the pathogenesis of IgAD.	[Ferreira, Ricardo C.; Graham, Robert R.; Gateva, Vesela; Ortmann, Ward; Clark, Hilary F.; Behrens, Timothy W.] Genentech Inc, San Francisco, CA 94080 USA; [Pan-Hammarstrom, Qiang; Hammarstrom, Lennart] Karolinska Inst, Div Clin Immunol, Dept Lab Med, Stockholm, Sweden; [Pan-Hammarstrom, Qiang; Hammarstrom, Lennart] Karolinska Univ Hosp, Stockholm, Sweden; [Fontan, Gumersindo] Hosp Univ La Paz, Dept Immunol, Madrid, Spain; [Lee, Annette T.; Gregersen, Peter K.] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Urcelay, Elena; Fernandez-Arquero, Miguel; Nunez, Concepcion] Hosp Clin San Carlos, Dept Clin Immunol, Madrid, Spain; [Jorgensen, Gudmundur; Ludviksson, Bjorn R.] Univ Iceland, Landspitali Univ Hosp, Reykjavik, Iceland; [Jorgensen, Gudmundur; Ludviksson, Bjorn R.] Univ Iceland, Dept Med, Reykjavik, Iceland; [Koskinen, Sinikka; Haimila, Katri] Finnish Red Cross Blood Serv, Clin Lab, Helsinki, Finland; [Klareskog, Lars] Karolinska Univ Solna, Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden	Roche Holding; Genentech; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Hospital Universitario La Paz; Northwell Health; Hospital Clinico San Carlos; Landspitali National University Hospital; University of Iceland; University of Iceland; Karolinska Institutet	Behrens, TW (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	behrens.tim@gene.com; lennart.hammarstrom@ki.se	hammarstrom, qiang pan/ABA-4589-2021; Lúðvíksson, Björn Rúnar/AFQ-7993-2022	Klareskog, Lars/0000-0001-9601-6186; Haimila, Katri/0000-0001-8904-666X; pan-hammarstrom, qiang/0000-0003-1990-8804; Ludviksson, Bjorn/0000-0002-6445-148X; Urcelay, Elena/0000-0001-8470-8396; Ferreira, Ricardo C./0000-0001-5733-3285	US National Institutes of Health [U19 AI067152, AR043274, R01NS057756, U24 NS051869]; Swedish Research Council; European Research Council [242551-ImmunoSwitch]; EURO-PADnet [201549]; Genentech, Inc.; Stockholm County Council; Karolinska Institutet; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/16281/2004]; Nordic Center of Excellence in Disease Genetics; Yale Center for Human Genetics and Genomics; Yale Program on Neurogenetics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057756, U24NS051869] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); EURO-PADnet; Genentech, Inc.(Roche HoldingGenentech); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Nordic Center of Excellence in Disease Genetics; Yale Center for Human Genetics and Genomics; Yale Program on Neurogenetics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the individuals with IgAD and their physicians for their contributions to this work. These studies were supported by the US National Institutes of Health (U19 AI067152 and AR043274), the Swedish Research Council, the European Research Council (242551-ImmunoSwitch) and EURO-PADnet grant 201549. Genentech, Inc. provided partial funding for the GWAS studies. Financial support was also provided through the regional agreement on medical training and clinical research the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet between the Stockholm county council and the Karolinska Institute. R. C. F. was supported by a fellowship from the Fundacao para a Ciencia e Tecnologia, Portugal (SFRH/BD/16281/2004). The population allele and genotype frequencies were obtained from a data source funded by the Nordic Center of Excellence in Disease Genetics based on regional samples from Finland and Sweden. The Helsinki 4 study was supported by the Yale Center for Human Genetics and Genomics and the Yale Program on Neurogenetics and US National Institutes of Health grants R01NS057756 and U24 NS051869.	BARKA N, 1995, CLIN DIAGN LAB IMMUN, V2, P469, DOI 10.1128/CDLI.2.4.469-472.1995; Booth DR, 2009, GENES IMMUN, V10, P11, DOI 10.1038/gene.2008.83; Burrows PD, 1997, ADV IMMUNOL, V65, P245, DOI 10.1016/S0065-2776(08)60744-0; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Conley ME, 1999, CLIN IMMUNOL, V93, P190, DOI 10.1006/clim.1999.4799; Cunningham-Rundles C, 2001, J CLIN IMMUNOL, V21, P303, DOI 10.1023/A:1012241117984; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; GOSHEN E, 1989, J AUTOIMMUN, V2, P51, DOI 10.1016/0896-8411(89)90107-8; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hammarstrom L, 2000, CLIN EXP IMMUNOL, V120, P225, DOI 10.1046/j.1365-2249.2000.01131.x; HAMMARSTROM L, 1983, SCAND J IMMUNOL, V18, P509, DOI 10.1111/j.1365-3083.1983.tb00885.x; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Notarangelo LD, 2009, J ALLERGY CLIN IMMUN, V124, P1161, DOI 10.1016/j.jaci.2009.10.013; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Salmela E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003519; Shigemoto T, 2009, J BIOL CHEM, V284, P13348, DOI 10.1074/jbc.M809449200; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; VORECHOVSKY I, 1995, CLIN IMMUNOL IMMUNOP, V77, P185, DOI 10.1006/clin.1995.1142; Vorechovsky I, 1999, AM J HUM GENET, V64, P1096, DOI 10.1086/302326	26	106	112	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					777	U69		10.1038/ng.644	http://dx.doi.org/10.1038/ng.644			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20694011				2022-12-25	WOS:000281388400014
J	Lingwood, D; Binnington, B; Rog, T; Vattulainen, I; Grzybek, M; Coskun, U; Lingwood, CA; Simons, K				Lingwood, Daniel; Binnington, Beth; Rog, Tomasz; Vattulainen, Ilpo; Grzybek, Michal; Coskun, Unal; Lingwood, Clifford A.; Simons, Kai			Cholesterol modulates glycolipid conformation and receptor activity	NATURE CHEMICAL BIOLOGY			English	Article							ZONA-PELLUCIDA BINDING; SPERM; MEMBRANES; CAPACITATION; MURINE; GLYCOSPHINGOLIPIDS; SPERMATOZOA; EFFLUX	We document a new dimension of surface recognition in which communication is controlled through the collective behavior of lipids. Membrane cholesterol induces a tilt in glycolipid receptor headgroup, resulting in loss of access for ligand binding. This property appears to organize erythrocyte blood group presentation and glycolipid receptor function during the activation of sperm fertility, suggesting that lipid 'allostery' is a means to regulate membrane recognition processes.	[Lingwood, Daniel; Grzybek, Michal; Coskun, Unal; Simons, Kai] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Binnington, Beth; Lingwood, Clifford A.] Hosp Sick Children, Res Inst, Div Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Rog, Tomasz; Vattulainen, Ilpo] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland; [Vattulainen, Ilpo] Aalto Univ, Sch Sci & Technol, Dept Appl Phys, Espoo, Finland; [Vattulainen, Ilpo] Univ So Denmark, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark; [Lingwood, Clifford A.] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada; [Lingwood, Clifford A.] Univ Toronto, Dept Biochem, Toronto, ON, Canada	Max Planck Society; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Tampere University; Aalto University; University of Southern Denmark; University of Toronto; University of Toronto	Simons, K (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	simons@mpi-cbg.de	Coskun, Ünal/F-4683-2011; Rog, Tomasz/ABE-3044-2020; Vattulainen, Ilpo T/G-4224-2014; Grzybek, Michal/D-3802-2017	Coskun, Ünal/0000-0003-4375-3144; Rog, Tomasz/0000-0001-6765-7013; Grzybek, Michal/0000-0003-2083-0506; Simons, Kai/0000-0002-9231-9996	MPI-CBG; EU [LSHB-CT2007-037740]; DFG [SI459/2-1, TRR83 TP02]; BMBF [03FO1212]; ESF [SI459/3-1]; Canadian Institutes of Health Research [MT 13747]	MPI-CBG; EU(European Commission); DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); ESF(European Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank I. Nuesslein, M. Gerl, I. Levental, H. Kaiser (Max Planck Institute for Molecular Cell Biology and Genetics), K. Holig (Technische Univesitat), P. Paroutis, M. Woodside (Hospital for Sick Children), U. Devi, W. Jones and M. Swann (Farfield Sensors) for their assistance in this project. This work was supported by a MPI-CBG stipend (D. L.) and funding to K. S. (EU FP6 Lipid PRISM Grant LSHB-CT2007-037740, DFG Schwerpunktprogramm 1175 Grant SI459/2-1, DFG Transregio 83 Grant: TRR83 TP02, BMBF ForMaT Grant: 03FO1212, ESF "LIPIDPROD" Grant: SI459/3-1); I. V. (Academy of Finland); and funding to C. A. L. (Canadian Institutes of Health Research Grant MT 13747, Ontario HIV Treatment Network and Canfar support).	Bedford JM, 2008, INT J DEV BIOL, V52, P415, DOI 10.1387/ijdb.072551jb; BITZAN M, 1994, INFECT IMMUN, V62, P3337, DOI 10.1128/IAI.62.8.3337-3347.1994; Cross NL, 1998, BIOL REPROD, V59, P7, DOI 10.1095/biolreprod59.1.7; Evans SV, 1999, J MOL RECOGNIT, V12, P155, DOI 10.1002/(SICI)1099-1352(199905/06)12:3<155::AID-JMR456>3.0.CO;2-S; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Huflejt ME, 2009, MOL IMMUNOL, V46, P3037, DOI 10.1016/j.molimm.2009.06.010; Jones R, 2010, DEV BIOL, V339, P398, DOI 10.1016/j.ydbio.2009.12.044; Kawano N, 2008, BIOL REPROD, V79, P1153, DOI 10.1095/biolreprod.108.069054; Khan F, 2009, KIDNEY INT, V75, P1209, DOI 10.1038/ki.2009.7; Lingwood CA, 1996, GLYCOCONJUGATE J, V13, P495, DOI 10.1007/BF00731435; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Mahfoud R, 2010, J BIOL CHEM, V285, P36049, DOI 10.1074/jbc.M110.110189; Merritt EA, 1997, PROTEIN SCI, V6, P1516, DOI 10.1002/pro.5560060716; Selvaraj V, 2006, J CELL PHYSIOL, V206, P636, DOI 10.1002/jcp.20504; Selvaraj V, 2007, J ANDROL, V28, P588, DOI 10.2164/jandrol.106.002279; Shi JJ, 2007, J AM CHEM SOC, V129, P5954, DOI 10.1021/ja069375w; Strott CA, 2003, J LIPID RES, V44, P1268, DOI 10.1194/jlr.R300005-JLR200; Visconti PE, 1999, J BIOL CHEM, V274, P3235, DOI 10.1074/jbc.274.5.3235; Weerachatyanukul W, 2001, MOL REPROD DEV, V60, P569, DOI 10.1002/mrd.1122; White D, 2000, BIOL REPROD, V63, P147, DOI 10.1095/biolreprod63.1.147; Yahi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009079	22	158	167	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2011	7	5					260	262		10.1038/nchembio.551	http://dx.doi.org/10.1038/nchembio.551			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751KZ	21460830				2022-12-25	WOS:000289617800008
J	Xiong, W; Cheng, KJ; Cui, TX; Godlewski, G; Rice, KC; Xu, Y; Zhang, L				Xiong, Wei; Cheng, KeJun; Cui, Tanxing; Godlewski, Grzegorz; Rice, Kenner C.; Xu, Yan; Zhang, Li			Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia	NATURE CHEMICAL BIOLOGY			English	Article							MODULATION; PAIN; SUBUNIT; DYNAMICS; MODEL; MICE; INHIBITION; ALPHA-1; TARGET; 2ND	Cannabinoids enhance the function of glycine receptors (GlyRs). However, little is known about the mechanisms and behavioral implication of cannabinoid-GlyR interaction. Using mutagenesis and NMR analysis, we have identified a serine at 296 in the GlyR protein critical for the potentiation of I-Gly by Delta(9)-tetrahydrocannabinol (THC), a major psychoactive component of marijuana. The polarity of the amino acid residue at 296 and the hydroxyl groups of THC are critical for THC potentiation. Removal of the hydroxyl groups of THC results in a compound that does not affect I-Gly when applied alone but selectively antagonizes cannabinoid-induced potentiating effect on I-Gly and analgesic effect in a tail-flick test in mice. The cannabinoid-induced analgesia is absent in mice lacking alpha 3GlyRs but not in those lacking CB1 and CB2 receptors. These findings reveal a new mechanism underlying cannabinoid potentiation of GlyRs, which could contribute to some of the cannabis-induced analgesic and therapeutic effects.	[Xiong, Wei; Zhang, Li] US Natl Inst Alcohol Abuse & Alcoholism, Lab Integrat Neurosci, US Natl Inst Hlth, Bethesda, MD USA; [Cheng, KeJun; Rice, Kenner C.] US Natl Inst Drug Abuse, Chem Biol Res Branch, US Natl Inst Hlth, Bethesda, MD USA; [Cui, Tanxing; Xu, Yan] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Cui, Tanxing; Xu, Yan] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Cui, Tanxing; Xu, Yan] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15261 USA; [Godlewski, Grzegorz] US Natl Inst Alcohol Abuse & Alcoholism, Lab Physiol Studies, US Natl Inst Hlth, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Zhang, L (corresponding author), US Natl Inst Alcohol Abuse & Alcoholism, Lab Integrat Neurosci, US Natl Inst Hlth, Bethesda, MD USA.	lzhang@mail.nih.gov	Zhang, Li/W-2104-2019; Xiong, Wei/G-9027-2018; Xiong, Wei/F-8251-2011	Xu, Yan/0000-0003-2773-8024	US National Institute on Alcohol Abuse and Alcoholism; US National Institute of General Medical Sciences of the US National Institutes of Health [R37GM049202]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000529] Funding Source: NIH RePORTER	US National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); US National Institute of General Medical Sciences of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank C. L. Cepko for providing alpha 2<SUP>-/-</SUP> Glra mice. We especially thank D. M. Lovinger for critical comments on the manuscript. This work was supported by funds from the intramural program of the US National Institute on Alcohol Abuse and Alcoholism. We acknowledge the grant support (R37GM049202 to Y.X.) from the US National Institute of General Medical Sciences of the US National Institutes of Health.	Ahrens J, 2009, PHARMACOLOGY, V83, P217, DOI 10.1159/000201556; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Canlas CG, 2008, J PHYS CHEM B, V112, P14312, DOI 10.1021/jp805952w; Compton DR, 1996, J PHARMACOL EXP THER, V277, P586; Delaney AJ, 2010, NEUROSCI LETT, V469, P237, DOI 10.1016/j.neulet.2009.12.003; Demir R, 2009, PHARMACOLOGY, V83, P270, DOI 10.1159/000209291; Findlay GS, 2003, J NEUROSCI, V23, P8051; Griffon N, 1999, EMBO J, V18, P4711, DOI 10.1093/emboj/18.17.4711; GROSSMAN ML, 1982, J COMP NEUROL, V206, P9, DOI 10.1002/cne.902060103; Harris RA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.128re7; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Hejazi N, 2006, MOL PHARMACOL, V69, P991, DOI 10.1124/mol.105.019174; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hu XQ, 2003, J BIOL CHEM, V278, P46583, DOI 10.1074/jbc.M308974200; Huestis MA, 2007, CHEM BIODIVERS, V4, P1770, DOI 10.1002/cbdv.200790152; Izzo AA, 2009, TRENDS PHARMACOL SCI, V30, P515, DOI 10.1016/j.tips.2009.07.006; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kimura T, 2009, BIOPHYS J, V96, P4916, DOI 10.1016/j.bpj.2009.03.033; Klein TW, 2007, ADV EXP MED BIOL, V601, P395; Laube B, 2002, TRENDS PHARMACOL SCI, V23, P519, DOI 10.1016/S0165-6147(02)02138-7; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Lobo IA, 2005, INT REV NEUROBIOL, V65, P53, DOI 10.1016/S0074-7742(04)65003-3; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Ma DJ, 2005, BIOCHEMISTRY-US, V44, P8790, DOI 10.1021/bi050256n; Marris E, 2009, NATURE, V458, P394, DOI 10.1038/458394a; Oz M, 2006, PHARMACOL THERAPEUT, V111, P114, DOI 10.1016/j.pharmthera.2005.09.009; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pernia-Andrade AJ, 2009, SCIENCE, V325, P760, DOI 10.1126/science.1171870; SHIANG R, 1995, ANN NEUROL, V38, P85, DOI 10.1002/ana.410380115; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; SMITH PB, 1992, BRAIN RES, V578, P8, DOI 10.1016/0006-8993(92)90222-U; Spivak CE, 2007, MOL PHARMACOL, V72, P1024, DOI 10.1124/mol.107.036939; Tang P, 2002, BIOPHYS J, V83, P252, DOI 10.1016/S0006-3495(02)75166-7; Varvel SA, 2005, J PHARMACOL EXP THER, V314, P329, DOI 10.1124/jpet.104.080739; Welch SP, 1998, J PHARMACOL EXP THER, V286, P1301; Xiong W, 2008, MOL PHARMACOL, V73, P314, DOI 10.1124/mol.107.039149; Yang Z, 2008, BIOCHEM PHARMACOL, V76, P1014, DOI 10.1016/j.bcp.2008.07.037; Young-Pearse TL, 2006, MOL CELL BIOL, V26, P5728, DOI 10.1128/MCB.00237-06; Zeilhofer HU, 2007, BIOCHEM PHARMACOL, V73, P165, DOI 10.1016/j.bcp.2006.07.037; Zeilhofer HU, 2005, CELL MOL LIFE SCI, V62, P2027, DOI 10.1007/s00018-005-5107-2; Zhang GH, 2010, EUR J NEUROSCI, V31, P225, DOI 10.1111/j.1460-9568.2009.07075.x; Zhang L, 2009, VITAM HORM, V81, P315, DOI 10.1016/S0083-6729(09)81012-1; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	44	102	105	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2011	7	5					296	303		10.1038/nchembio.552	http://dx.doi.org/10.1038/nchembio.552			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751KZ	21460829	Green Accepted			2022-12-25	WOS:000289617800013
J	Zhang, M; Zheng, XL; Song, SQ; Zeng, QW; Hou, L; Li, DM; Zhao, J; Wei, Y; Li, XB; Luo, M; Xiao, YH; Luo, XY; Zhang, JF; Xiang, CB; Pei, Y				Zhang, Mi; Zheng, Xuelian; Song, Shuiqing; Zeng, Qiwei; Hou, Lei; Li, Demou; Zhao, Juan; Wei, Yuan; Li, Xianbi; Luo, Ming; Xiao, Yuehua; Luo, Xiaoying; Zhang, Jinfa; Xiang, Chengbin; Pei, Yan			Spatiotemporal manipulation of auxin biosynthesis in cotton ovule epidermal cells enhances fiber yield and quality	NATURE BIOTECHNOLOGY			English	Article							MADS BOX GENES; INDOLEACETIC-ACID; EXPRESSION; INITIATION; CLONING; GROWTH	The capacity of conventional breeding to simultaneously improve the yield and quality of cotton fiber is limited(1). The accumulation of the plant hormone indole-3-acetic acid (IAA) in cotton fiber initials prompted us to investigate the effects of genetically engineering increased IAA levels in the ovule epidermis. Targeted expression of the IAA biosynthetic gene iaaM, driven by the promoter of the petunia MADS box gene Floral Binding protein 7 (FBP7)(2), increased IAA levels in the epidermis of cotton ovules at the fiber initiation stage. This substantially increased the number of lint fibers, an effect that was confirmed in a 4-year field trial. The lint percentage of the transgenic cotton, an important component of fiber yield, was consistently higher in our transgenic plants than in nontransgenic controls, resulting in a > 15% increase in lint yield. Fiber fineness was also notably improved.	[Zhang, Mi; Zheng, Xuelian; Song, Shuiqing; Zeng, Qiwei; Hou, Lei; Li, Demou; Zhao, Juan; Wei, Yuan; Li, Xianbi; Luo, Ming; Xiao, Yuehua; Luo, Xiaoying; Pei, Yan] Southwest Univ, Key Lab Biotechnol & Crop Qual Improvement, Minist Agr, Biotechnol Res Ctr, Chongqing, Peoples R China; [Zhang, Jinfa] New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA; [Xiang, Chengbin] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China	Ministry of Agriculture & Rural Affairs; Southwest University - China; New Mexico State University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Pei, Y (corresponding author), Southwest Univ, Key Lab Biotechnol & Crop Qual Improvement, Minist Agr, Biotechnol Res Ctr, Chongqing, Peoples R China.	peiyan3@swu.edu.cn		Zhang, Mi/0000-0001-8180-2029				Barg R, 2005, PLANTA, V221, P197, DOI 10.1007/s00425-004-1433-0; Basra AS, 1999, COTTON FIBERS: DEVELOPMENTAL BIOLOGY, QUALITY IMPROVEMENT, AND TEXTILE PROCESSING, P47; BEASLEY CA, 1973, SCIENCE, V179, P1003, DOI 10.1126/science.179.4077.1003; BEASLEY CA, 1974, AM J BOT, V61, P188, DOI 10.2307/2441189; BENEDICT CR, 1999, COTTON, P270; Chen JG, 1997, J PLANT GROWTH REGUL, V16, P181, DOI 10.1007/PL00006994; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Colombo L, 1997, PLANT CELL, V9, P703, DOI 10.1105/tpc.9.5.703; Debeaujon I, 2003, PLANT CELL, V15, P2514, DOI 10.1105/tpc.014043; Gialvalis S., 2001, Journal of Cotton Science, V5, P252; GLASS NL, 1986, J BACTERIOL, V166, P598, DOI 10.1128/jb.166.2.598-603.1986; Gordon S, 2007, WOODHEAD TEXT SER, P68, DOI 10.1533/9781845692483.1.68; Gou JQ, 2010, PLANT CELL, V22, P623, DOI 10.1105/tpc.109.073239; GUINN G, 1988, PLANT PHYSIOL, V87, P629, DOI 10.1104/pp.87.3.629; Hou L, 2008, CHINESE SCI BULL, V53, P2639, DOI 10.1007/s11434-008-0290-9; Hou ZX, 2005, PLANTA, V222, P678, DOI 10.1007/s00425-005-0014-1; Ji SJ, 2003, NUCLEIC ACIDS RES, V31, P2534, DOI 10.1093/nar/gkg358; JOHN ME, 1992, P NATL ACAD SCI USA, V89, P5769, DOI 10.1073/pnas.89.13.5769; John ME, 1999, COTTON FIBERS: DEVELOPMENTAL BIOLOGY, QUALITY IMPROVEMENT, AND TEXTILE PROCESSING, P271; Li Y, 2004, GENETICALLY MODIFIED, P101; Luo M, 2007, PLANT J, V51, P419, DOI 10.1111/j.1365-313X.2007.03144.x; MARRISON JL, 1994, PLANT J, V6, P605, DOI 10.1046/j.1365-313X.1994.6040605.x; Meredith W.R., 1984, COTTON, P131; Meredith W. R. Jr., 2000, Better Crops with Plant Food, V84, P6; MORGAN DG, 1964, NATURE, V201, P476, DOI 10.1038/201476a0; Phillips AL, 2004, PLANT HORMONES: BIOSYNTHESIS, SIGNAL TRANSDUCTION, ACTION, P582; Ryser U, 1999, COTTON FIBERS: DEVELOPMENTAL BIOLOGY, QUALITY IMPROVEMENT, AND TEXTILE PROCESSING, P1; SAVIDGE B, 1995, PLANT CELL, V7, P721, DOI 10.1105/tpc.7.6.721; Seagull R. W., 2004, Journal of Cotton Science, V8, P105; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; STEWART JM, 1975, AM J BOT, V62, P723, DOI 10.2307/2442061; Sun Y, 2005, PLANT CELL PHYSIOL, V46, P1384, DOI 10.1093/pcp/pci150; Tu LL, 2007, PLANT CELL REP, V26, P1309, DOI 10.1007/s00299-007-0337-4; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wilkins TA, 2000, CRIT REV PLANT SCI, V19, P511, DOI 10.1016/S0735-2689(01)80007-1; Zhang JF, 2005, CROP SCI, V45, P2363, DOI 10.2135/cropsci2005.0140	37	185	216	3	109	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2011	29	5					453	+		10.1038/nbt.1843	http://dx.doi.org/10.1038/nbt.1843			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	760CX	21478877				2022-12-25	WOS:000290301700027
J	Bond-Watts, BB; Bellerose, RJ; Chang, MCY				Bond-Watts, Brooks B.; Bellerose, Robert J.; Chang, Michelle C. Y.			Enzyme mechanism as a kinetic control element for designing synthetic biofuel pathways	NATURE CHEMICAL BIOLOGY			English	Article							CLOSTRIDIUM-ACETOBUTYLICUM ATCC-824; ALCALIGENES-EUTROPHUS H16; FATTY-ACID BIOSYNTHESIS; ESCHERICHIA-COLI; BUTANOL PRODUCTION; TRANS-2-ENOYL-COA REDUCTASE; MICROBIAL-PRODUCTION; ACETONE FORMATION; EXPRESSION; BACTERIA	Living systems have evolved remarkable molecular functions that can be redesigned for in vivo chemical synthesis as we gain a deeper understanding of the underlying biochemical principles for de novo construction of synthetic pathways. We have focused on developing pathways for next-generation biofuels as they require carbon to be channeled to product at quantitative yields. However, these fatty acid-inspired pathways must manage the highly reversible nature of the enzyme components. For targets in the biodiesel range, the equilibrium can be driven to completion by physical sequestration of an insoluble product, which is a mechanism unavailable to soluble gasoline-sized products. In this work, we report the construction of a chimeric pathway assembled from three different organisms for the high-level production of n-butanol (4,650 +/- 720 mg l(-1)) that uses an enzymatic chemical reaction mechanism in place of a physical step as a kinetic control element to achieve high yields from glucose (28%).	[Bond-Watts, Brooks B.; Bellerose, Robert J.; Chang, Michelle C. Y.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bond-Watts, Brooks B.; Bellerose, Robert J.; Chang, Michelle C. Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Chang, Michelle C. Y.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bond-Watts, BB (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	mcchang@berkeley.edu			Aldo DeBenedictis Fund; University of California, Berkeley; Camille and Henry Dreyfus Foundation; Arnold and Mabel Beckman Foundation; Dow Sustainable Products and Solutions Program	Aldo DeBenedictis Fund; University of California, Berkeley(University of California System); Camille and Henry Dreyfus Foundation; Arnold and Mabel Beckman Foundation; Dow Sustainable Products and Solutions Program	We thank K. Hirano for her work on the ter gene assembly during her rotation. B.B.B.-W. would like to thank the Aldo DeBenedictis Fund for a predoctoral fellowship, and R.J.B. would like to acknowledge the University of California, Berkeley, Summer Undergraduate Research Fellowship program. This work was funded by generous support from University of California, Berkeley, the Camille and Henry Dreyfus Foundation, the Arnold and Mabel Beckman Foundation and the Dow Sustainable Products and Solutions Program.	AGIUS L, 1996, CHANNELING INTERMEDI; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; Atsumi S, 2008, CURR OPIN BIOTECH, V19, P414, DOI 10.1016/j.copbio.2008.08.008; Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Biebl H, 1999, APPL MICROBIOL BIOT, V52, P289, DOI 10.1007/s002530051523; Boynton ZL, 1996, J BACTERIOL, V178, P3015, DOI 10.1128/jb.178.11.3015-3024.1996; BRAGG JR, 1994, NATURE, V368, P413, DOI 10.1038/368413a0; Draths KM, 1999, J AM CHEM SOC, V121, P1603, DOI 10.1021/ja9830243; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Duerre Peter, 2007, Biotechnology Journal, V2, P1525, DOI 10.1002/biot.200700168; Erb TJ, 2009, P NATL ACAD SCI USA, V106, P8871, DOI 10.1073/pnas.0903939106; Fischer CR, 2008, METAB ENG, V10, P295, DOI 10.1016/j.ymben.2008.06.009; Fontaine L, 2002, J BACTERIOL, V184, P821, DOI 10.1128/JB.184.3.821-830.2002; Fukui T, 1998, J BACTERIOL, V180, P667, DOI 10.1128/JB.180.3.667-673.1998; Hoffmeister M, 2005, J BIOL CHEM, V280, P4329, DOI 10.1074/jbc.M411010200; HOPWOOD DA, 1990, ANNU REV GENET, V24, P37, DOI 10.1146/annurev.ge.24.120190.000345; Inui M, 2008, APPL MICROBIOL BIOT, V77, P1305, DOI 10.1007/s00253-007-1257-5; Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; Leaf TA, 1998, BIOTECHNOL BIOENG, V57, P557, DOI 10.1002/(SICI)1097-0290(19980305)57:5<557::AID-BIT8>3.0.CO;2-F; Lee SY, 2008, BIOTECHNOL BIOENG, V101, P209, DOI 10.1002/bit.22003; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; LYNEN F, 1953, BIOCHIM BIOPHYS ACTA, V12, P299, DOI 10.1016/0006-3002(53)90149-8; Nair RV, 1999, J BACTERIOL, V181, P319, DOI 10.1128/JB.181.1.319-330.1999; Nielsen DR, 2009, METAB ENG, V11, P262, DOI 10.1016/j.ymben.2009.05.003; Papoutsakis ET, 2008, CURR OPIN BIOTECH, V19, P420, DOI 10.1016/j.copbio.2008.08.003; PEOPLES OP, 1989, J BIOL CHEM, V264, P15298; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Roca C, 2003, APPL ENVIRON MICROB, V69, P4732, DOI 10.1128/AEM.69.8.4732-4736.2003; Rohlin L, 2001, CURR OPIN MICROBIOL, V4, P330, DOI 10.1016/S1369-5274(00)00213-7; Sanchez AM, 2006, BIOTECHNOL PROGR, V22, P420, DOI 10.1021/bp050375u; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Scotcher MC, 2005, APPL ENVIRON MICROB, V71, P1987, DOI 10.1128/AEM.71.4.1987-1995.2005; SLATER SC, 1988, J BACTERIOL, V170, P4431, DOI 10.1128/jb.170.10.4431-4436.1988; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; STEPHANOPOULOS G, 1993, TRENDS BIOTECHNOL, V11, P392, DOI 10.1016/0167-7799(93)90099-U; Tucci S, 2007, FEBS LETT, V581, P1561, DOI 10.1016/j.febslet.2007.03.013; Tummala SB, 2003, J BACTERIOL, V185, P1923, DOI 10.1128/JB.185.6.1923-1934.2003; WAKIL SJ, 1954, J BIOL CHEM, V207, P631; WAKIL SJ, 1956, BIOCHIM BIOPHYS ACTA, V19, P497, DOI 10.1016/0006-3002(56)90473-5; WALLACE KK, 1995, EUR J BIOCHEM, V233, P954, DOI 10.1111/j.1432-1033.1995.954_3.x; WATERSON RM, 1972, J BIOL CHEM, V247, P5266; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wu WJ, 2000, J AM CHEM SOC, V122, P3987, DOI 10.1021/ja992286h; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Zaslavskaia LA, 2001, SCIENCE, V292, P2073, DOI 10.1126/science.160015; [No title captured]	50	267	303	1	146	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					222	227		10.1038/NCHEMBIO.537	http://dx.doi.org/10.1038/NCHEMBIO.537			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21358636				2022-12-25	WOS:000288545000010
J	Korolchuk, VI; Saiki, S; Lichtenberg, M; Siddiqi, FH; Roberts, EA; Imarisio, S; Jahreiss, L; Sarkar, S; Futter, M; Menzies, FM; O'Kane, CJ; Deretic, V; Rubinsztein, DC				Korolchuk, Viktor I.; Saiki, Shinji; Lichtenberg, Maike; Siddiqi, Farah H.; Roberts, Esteban A.; Imarisio, Sara; Jahreiss, Luca; Sarkar, Sovan; Futter, Marie; Menzies, Fiona M.; O'Kane, Cahir J.; Deretic, Vojo; Rubinsztein, David C.			Lysosomal positioning coordinates cellular nutrient responses	NATURE CELL BIOLOGY			English	Article							AGGREGATE-PRONE PROTEINS; DROSOPHILA-MELANOGASTER; HUNTINGTONS-DISEASE; NONNEURONAL CELLS; GENE-PRODUCTS; RAG GTPASES; AUTOPHAGY; MTOR; RAPAMYCIN; PATHWAY	mTOR (mammalian target of rapamycin) signalling and macroautophagy (henceforth autophagy) regulate numerous pathological and physiological processes, including cellular responses to altered nutrient levels. However, the mechanisms regulating mTOR and autophagy remain incompletely understood. Lysosomes are dynamic intracellular organelles(1,2) intimately involved both in the activation of mTOR complex 1 (mTORC1) signalling and in degrading autophagic substrates(3-8). Here we report that lysosomal positioning coordinates anabolic and catabolic responses with changes in nutrient availability by orchestrating early plasma-membrane signalling events, mTORC1 signalling and autophagy. Activation of mTORC1 by nutrients correlates with its presence on peripheral lysosomes that are physically close to the upstream signalling modules, whereas starvation causes perinuclear clustering of lysosomes, driven by changes in intracellular pH. Lysosomal positioning regulates mTORC1 signalling, which in turn influences autophagosome formation. Lysosome positioning also influences autophagosome-lysosome fusion rates, and thus controls autophagic flux by acting at both the initiation and termination stages of the process. Our findings provide a physiological role for the dynamic state of lysosomal positioning in cells as a coordinator of mTORC1 signalling with autophagic flux.	[Korolchuk, Viktor I.; Saiki, Shinji; Lichtenberg, Maike; Siddiqi, Farah H.; Imarisio, Sara; Jahreiss, Luca; Sarkar, Sovan; Futter, Marie; Menzies, Fiona M.; Rubinsztein, David C.] Cambridge Inst Med Genet, Dept Med Genet, Cambridge CB2 0XY, England; [Roberts, Esteban A.; Deretic, Vojo] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Imarisio, Sara; O'Kane, Cahir J.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Deretic, Vojo] Univ New Mexico, Sch Med, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA	University of Cambridge; University of New Mexico; University of Cambridge; University of New Mexico	Rubinsztein, DC (corresponding author), Cambridge Inst Med Genet, Dept Med Genet, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	dcr1000@cam.ac.uk	Saiki, Shinji/ABC-8214-2021; O'Kane, Cahir/Q-6681-2019; Sarkar, Sovan/F-8486-2017; Rubinsztein, David C/C-3472-2011; O'Kane, Cahir J/C-4413-2011	Saiki, Shinji/0000-0002-9732-8488; O'Kane, Cahir/0000-0002-3488-2078; Sarkar, Sovan/0000-0002-9456-4362; Deretic, Vojo/0000-0002-3624-5208; Korolchuk, Viktor/0000-0002-4071-592X	Eli Lilly Japan; British Council Japan Association; MRC; Heiser Foundation; NIH [AI069345, AI045148, AI042999]; Wellcome Trust; EU; Medical Research Council [G0600194] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045148, R01AI042999, R01AI069345] Funding Source: NIH RePORTER; MRC [G0600194] Funding Source: UKRI	Eli Lilly Japan(Eli Lilly); British Council Japan Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Heiser Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); EU(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Munro (Medical Research Council, Laboratory of Molecular Biology, Cambridge; ARL8 constructs and antibody), T. Katada (University of Tokyo; anti-ARL8 antibody), W. G. Kaelin (Harvard Medical School; KIF1B beta), N. Hirokawa (University of Tokyo; KIF2), D. M. Sabatini (Massachusetts Institute of Technology; mTOR, raptor, rictor), T. Yoshimori (Osaka University; eGFP-LC3, mRFP-GFP-LC3), N. Mizushima (Tokyo Medical and Dental University; Atg5-deficient and wild-type Atg5 mouse embryonic fibroblast cell lines), W. J. Strittmatter (Duke University; Q81-eGFP), J. P. Luzio (University of Cambridge; lgp120-eGFP), A. Tolkovsky (University of Cambridge; GFP-LC3 cells), R. Tsien (University of California at San Diego; mCherry), T. Kouno (Toyama Medical and Pharmaceutical University; hLC3B) and K-L. Guan (University of California at San Diego; Rheb); B. Ravikumar, S. Luo and B. Underwood (University of Cambridge) for suggestions, M. Gratian and M. Bowen (University of Cambridge) for microscopy assistance, and the Bloomington Drosophila Stock Center. We are grateful for financial support from a Hughes Hall Research Fellowship (V.I.K. and S. Sarkar), a 2005 Pergolide Fellowship from Eli Lilly Japan (S. Saiki), the British Council Japan Association (S. Saiki), MRC studentships (M.L. and L.J.), a Daphne Jackson Trust Fellowship funded by the MRC (F.H.S.), a Heiser Foundation Postdoctoral Fellowship in Tuberculosis and Leprosy Research (E.A.R.), NIH grant AI069345, and in part NIH grants AI045148 and AI042999 (V.D.), a Wellcome Trust Senior Fellowship in Clinical Science (D.C.R.), an MRC programme grant (D.C.R., C.J.O'K.) and an EU Framework VI (EUROSCA) grant (D.C.R.).	Bagshaw RD, 2006, BIOCHEM BIOPH RES CO, V344, P1186, DOI 10.1016/j.bbrc.2006.03.221; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HEUSER J, 1989, J CELL BIOL, V108, P855, DOI 10.1083/jcb.108.3.855; Hofmann I, 2006, J CELL SCI, V119, P1494, DOI 10.1242/jcs.02958; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Jiang H, 2008, ONCOGENE, V27, P5729, DOI 10.1038/onc.2008.180; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Matsushita M, 2004, TRAFFIC, V5, P140, DOI 10.1111/j.1600-0854.2003.00165.x; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Narain Y, 1999, J MED GENET, V36, P739, DOI 10.1136/jmg.36.10.739; NODA Y, 1995, J CELL BIOL, V129, P157, DOI 10.1083/jcb.129.1.157; Okai T, 2004, J CELL SCI, V117, P4705, DOI 10.1242/jcs.01347; Ong V, 2008, J PHARMACOL EXP THER, V324, P434, DOI 10.1124/jpet.107.128926; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ravikumar B, 2009, J CELL SCI, V122, P1707, DOI 10.1242/jcs.031773; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; SANCAK Y, CELL, V141, P290; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Santama N, 1998, EMBO J, V17, P5855, DOI 10.1093/emboj/17.20.5855; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Sarkar S, 2009, AUTOPHAGY, V5, P307, DOI 10.4161/auto.5.3.7664; Schlisio S, 2008, GENE DEV, V22, P884, DOI 10.1101/gad.1648608; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Soulard A, 2007, CELL, V129, P434, DOI 10.1016/j.cell.2007.04.010; Tafani M, 2002, J BIOL CHEM, V277, P49569, DOI 10.1074/jbc.M208915200; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P8923, DOI 10.1073/pnas.0903621106	44	547	557	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2011	13	4					453	U242		10.1038/ncb2204	http://dx.doi.org/10.1038/ncb2204			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	744CK	21394080	Green Accepted			2022-12-25	WOS:000289070900017
J	Lemieux, GA; Liu, J; Mayer, N; Bainton, RJ; Ashrafi, K; Werb, Z				Lemieux, George A.; Liu, Jason; Mayer, Nasima; Bainton, Roland J.; Ashrafi, Kaveh; Werb, Zena			A whole-organism screen identifies new regulators of fat storage	NATURE CHEMICAL BIOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; C-ELEGANS; LIFE-SPAN; CHEMICAL GENETICS; RECEPTOR NHR-49; FOOD RESPONSE; OBESITY; GENES; MODEL	The regulation of energy homeostasis integrates diverse biological processes ranging from behavior to metabolism and is linked fundamentally to numerous disease states. To identify new molecules that can bypass homeostatic compensatory mechanisms of energy balance in intact animals, we screened for small-molecule modulators of Caenorhabditis elegans fat content. We report on several molecules that modulate fat storage without obvious deleterious effects on feeding, growth and reproduction. A subset of these compounds also altered fat storage in mammalian and insect cell culture. We found that one of the newly identified compounds exerts its effects in C. elegans through a pathway that requires previously undescribed functions of an AMP-activated kinase catalytic subunit and a transcription factor previously unassociated with fat regulation. Thus, our strategy identifies small molecules that are effective within the context of intact animals and reveals relationships between new pathways that operate across phyla to influence energy homeostasis.	[Lemieux, George A.; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Liu, Jason; Ashrafi, Kaveh] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Mayer, Nasima; Bainton, Roland J.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lemieux, GA (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	kaveh.ashrafi@ucsf.edu; zena.werb@ucsf.edu			US National Cancer Institute; US National Institute of Environmental Health Sciences [ES012801, ES019458, CA056721]; US National Institute of Diabetes and Digestive and Kidney Diseases [DK070149]; US National Institute of General Medicine [GM081863]; Byers; NATIONAL CANCER INSTITUTE [R01CA056721, R01CA057621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES012801, U01ES019458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081863] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US National Institute of General Medicine; Byers; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to D. Lum for his help and advice with the initial C. elegans experiments. We are thankful to B. Mullaney and K. Cunningham for helpful discussions and comments on the manuscript. We thank K. Thorn and the Nikon Imaging Center for use of the Nikon 6D automated epifluorescence microscope and help with imaging as well as the Small Molecule Discovery Center at the University of California, San Francisco, for providing the small-molecule library. This work was supported by grants from the US National Cancer Institute and US National Institute of Environmental Health Sciences (ES012801, ES019458 and CA056721) to Z.W., the US National Institute of Diabetes and Digestive and Kidney Diseases (DK070149) to K. A., the US National Institute of General Medicine (GM081863) to R.J.B. and a Byers Award to K. A. and R.J.B.	Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; DAVIES SP, 1990, EUR J BIOCHEM, V187, P183, DOI 10.1111/j.1432-1033.1990.tb15293.x; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Goldstone AP, 2008, FRONT HORM RES, V36, P37, DOI 10.1159/000115336; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jones AK, 2005, NAT REV DRUG DISCOV, V4, P321, DOI 10.1038/nrd1692; Jones KS, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-23; Jones KT, 2009, DIS MODEL MECH, V2, P224, DOI 10.1242/dmm.001933; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Knight ZA, 2007, CELL, V128, P425, DOI 10.1016/j.cell.2007.01.021; Kodiha M, 2007, AM J PHYSIOL-CELL PH, V293, pC1427, DOI 10.1152/ajpcell.00176.2007; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; MacRae CA, 2003, CHEM BIOL, V10, P901, DOI 10.1016/j.chembiol.2003.10.003; McKay RM, 2003, DEV CELL, V4, P131, DOI 10.1016/S1534-5807(02)00411-2; Morck C, 2009, P NATL ACAD SCI USA, V106, P18285, DOI 10.1073/pnas.0907117106; Moy TI, 2009, ACS CHEM BIOL, V4, P527, DOI 10.1021/cb900084v; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; Schafer WR, 1996, GENETICS, V143, P1219; Shiri-Sverdlov R, 2006, DIABETES, V55, P385, DOI 10.2337/diabetes.55.02.06.db05-0997; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Suo S, 2009, EMBO J, V28, P2437, DOI 10.1038/emboj.2009.194; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Wang XD, 2006, DEV BIOL, V289, P456, DOI 10.1016/j.ydbio.2005.10.029; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Watts JL, 2000, BIOCHEM BIOPH RES CO, V272, P263, DOI 10.1006/bbrc.2000.2772; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; Wheeler GN, 2009, DEV DYNAM, V238, P1287, DOI 10.1002/dvdy.21967; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	50	53	56	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					206	213		10.1038/NCHEMBIO.534	http://dx.doi.org/10.1038/NCHEMBIO.534			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21390037	Green Accepted, Green Submitted			2022-12-25	WOS:000288545000008
J	Li, ZJ; Vizeacoumar, FJ; Bahr, S; Li, JJ; Warringer, J; Vizeacoumar, FS; Min, RQ; VanderSluis, B; Bellay, J; DeVit, M; Fleming, JA; Stephens, A; Haase, J; Lin, ZY; Baryshnikova, A; Lu, H; Yan, Z; Jin, K; Barker, S; Datti, A; Giaever, G; Nislow, C; Bulawa, C; Myers, CL; Costanzo, M; Gingras, AC; Zhang, ZL; Blomberg, A; Bloom, K; Andrews, B; Boone, C				Li, Zhijian; Vizeacoumar, Franco J.; Bahr, Sondra; Li, Jingjing; Warringer, Jonas; Vizeacoumar, Frederick S.; Min, Renqiang; VanderSluis, Benjamin; Bellay, Jeremy; DeVit, Michael; Fleming, James A.; Stephens, Andrew; Haase, Julian; Lin, Zhen-Yuan; Baryshnikova, Anastasia; Lu, Hong; Yan, Zhun; Jin, Ke; Barker, Sarah; Datti, Alessandro; Giaever, Guri; Nislow, Corey; Bulawa, Chris; Myers, Chad L.; Costanzo, Michael; Gingras, Anne-Claude; Zhang, Zhaolei; Blomberg, Anders; Bloom, Kerry; Andrews, Brenda; Boone, Charles			Systematic exploration of essential yeast gene function with temperature-sensitive mutants	NATURE BIOTECHNOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; CHROMOSOME CONDENSATION; BUDDING YEAST; SCHIZOSACCHAROMYCES-POMBE; SPINDLE CHECKPOINT; SQUALENE SYNTHASE; DELETION MUTANTS; PROTEIN-KINASE; ANAPHASE	Conditional temperature-sensitive (ts) mutations are valuable reagents for studying essential genes in the yeast Saccharomyces cerevisiae. We constructed 787 ts strains, covering 497 (similar to 45%) of the 1,101 essential yeast genes, with similar to 30% of the genes represented by multiple alleles. All of the alleles are integrated into their native genomic locus in the S288C common reference strain and are linked to a kanMX selectable marker, allowing further genetic manipulation by synthetic genetic array (SGA)-based, high-throughput methods. We show two such manipulations: barcoding of 440 strains, which enables chemical-genetic suppression analysis, and the construction of arrays of strains carrying different fluorescent markers of subcellular structure, which enables quantitative analysis of phenotypes using high-content screening. Quantitative analysis of a GFP-tubulin marker identified roles for cohesin and condensin genes in spindle disassembly. This mutant collection should facilitate a wide range of systematic studies aimed at understanding the functions of essential genes.	[Andrews, Brenda] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada; [Li, Zhijian; Vizeacoumar, Franco J.; Bahr, Sondra; Li, Jingjing; Min, Renqiang; Lin, Zhen-Yuan; Baryshnikova, Anastasia; Lu, Hong; Yan, Zhun; Jin, Ke; Barker, Sarah; Giaever, Guri; Nislow, Corey; Costanzo, Michael; Gingras, Anne-Claude; Zhang, Zhaolei; Andrews, Brenda; Boone, Charles] Univ Toronto, Dept Mol Genet, Donnelly Ctr, Toronto, ON, Canada; [Warringer, Jonas; Blomberg, Anders] Univ Gothenburg, Dept Cell & Mol Biol, Gothenburg, Sweden; [Vizeacoumar, Frederick S.; Datti, Alessandro] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [VanderSluis, Benjamin; Bellay, Jeremy; Myers, Chad L.] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA; [DeVit, Michael; Fleming, James A.; Bulawa, Chris] FoldRx Pharmaceut Inc, Cambridge, MA USA; [Stephens, Andrew; Haase, Julian; Bloom, Kerry] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Datti, Alessandro] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy	University of Toronto; University of Toronto; University of Gothenburg; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; University of Perugia	Andrews, B (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada.	brenda.andrews@utoronto.ca; charlie.boone@utoronto.ca	Vizeacoumar, Franco/GLS-7161-2022; Gingras, Anne-Claude/ABA-8341-2020; Giaever, Guri/D-3930-2009; Warringer, Jonas/B-8520-2013; Li, Jingjing/B-5136-2016; Zhang, Zhaolei/G-2369-2017; Bloom, Kerry/AAE-5336-2019; Gingras, Anne-Claude/E-9982-2010; Datti, Alessandro/ABA-1108-2021	Gingras, Anne-Claude/0000-0002-6090-4437; Warringer, Jonas/0000-0001-6144-2740; Li, Jingjing/0000-0001-6025-9522; Bloom, Kerry/0000-0002-3457-004X; Gingras, Anne-Claude/0000-0002-6090-4437; Datti, Alessandro/0000-0001-6824-7382; Nislow, Corey/0000-0002-4016-8874; Blomberg, Anders/0000-0002-1260-3920; Vizeacoumar, Frederick/0000-0002-4676-2911; Baryshnikova, Anastasia/0000-0002-0123-2052; Stephens, Andrew/0000-0001-5474-7845	Best Foundation; Genome Canada through the Ontario Genomics Institute [2004-OGI-3-01]; Canadian Institutes of Health Research [MOP-97939]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032238, R01GM032238] Funding Source: NIH RePORTER	Best Foundation; Genome Canada through the Ontario Genomics Institute(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Boone, Andrews and Bloom laboratory for their input and discussions. We thank S. Biggins (Fred Hutchinson Cancer Research Center) for her insights on cohesin and condensin components. We thank M. Zackrisson (University of Gothenburg) for statistical support. The Sli15-6A-GFP construct was a gift from E. Schiebel (University of Heidelberg) and the Mad1-NLS construct was a gift from R. Wozniak (University of Alberta). We also thank Jennifer Reginold for manual inspection of HCS images. F.J.V. was supported by a postdoctoral fellowship from the Best Foundation. B. A. and C. B. were supported by Genome Canada through the Ontario Genomics Institute as per research agreement 2004-OGI-3-01 and the Canadian Institutes of Health Research (MOP-97939).	AMBERG DC, 1995, NAT STRUCT BIOL, V2, P28, DOI 10.1038/nsb0195-28; Bachellier-Bassi S, 2008, J STRUCT BIOL, V162, P248, DOI 10.1016/j.jsb.2008.01.002; Baryshnikova A, 2010, METHOD ENZYMOL, V470, P145, DOI 10.1016/S0076-6879(10)70007-0; BAXTER A, 1992, J BIOL CHEM, V267, P11705; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; BERGSTROM JD, 1993, P NATL ACAD SCI USA, V90, P80, DOI 10.1073/pnas.90.1.80; Brachmann CB, 1998, YEAST, V14, P115; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Buvelot S, 2003, J CELL BIOL, V160, P329, DOI 10.1083/jcb.200209018; Charlton-Menys V, 2008, EXP PHYSIOL, V93, P27, DOI 10.1113/expphysiol.2007.035147; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Costanzo M, 2009, METHODS MOL BIOL, V548, P37, DOI 10.1007/978-1-59745-540-4_3; Dimster-Denk D, 1999, J LIPID RES, V40, P850; Dreze M, 2009, NAT METHODS, V6, P843, DOI [10.1038/NMETH.1394, 10.1038/nmeth.1394]; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; Fridman V, 2009, EMBO REP, V10, P387, DOI 10.1038/embor.2009.7; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534; Holland J.H., 1992, ADAPTATION NATURAL A; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Hughes Timothy R, 2002, Funct Integr Genomics, V2, P199, DOI 10.1007/s10142-002-0059-1; Jones GM, 2008, NAT METHODS, V5, P239, DOI 10.1038/NMETH.1181; Kanemaki M, 2003, NATURE, V423, P720, DOI 10.1038/nature01692; Khmelinskii A, 2007, J CELL BIOL, V177, P981, DOI 10.1083/jcb.200702145; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kuranda K, 2010, FEMS YEAST RES, V10, P14, DOI 10.1111/j.1567-1364.2009.00560.x; Lavoie BD, 2004, GENE DEV, V18, P76, DOI 10.1101/gad.1150404; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; Mirchenko L, 2010, CURR BIOL, V20, P1396, DOI 10.1016/j.cub.2010.06.023; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; MOIR D, 1982, GENETICS, V100, P547; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Ruchaud S, 2007, CELL, V131, P230, DOI 10.1016/j.cell.2007.10.002; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Smith AM, 2009, GENOME RES, V19, P1836, DOI 10.1101/gr.093955.109; Song JL, 2003, MED MYCOL, V41, P417, DOI 10.1080/1369378031000137233; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Stern BM, 2001, CURR BIOL, V11, P1462, DOI 10.1016/S0960-9822(01)00451-1; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Vizeacoumar FJ, 2010, J CELL BIOL, V188, P69, DOI 10.1083/jcb.200909013; Vizeacoumar FJ, 2009, FEBS LETT, V583, P1656, DOI 10.1016/j.febslet.2009.03.068; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; Warringer Jonas, 2008, BMC Chemical Biology, V8, P3, DOI 10.1186/1472-6769-8-3; Yan Z, 2008, NAT METHODS, V5, P719, DOI 10.1038/nmeth.1231; Yeh E, 2008, CURR BIOL, V18, P81, DOI 10.1016/j.cub.2007.12.019; Zeng XM, 1999, J CELL BIOL, V146, P415, DOI 10.1083/jcb.146.2.415	58	256	257	2	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2011	29	4					361	U105		10.1038/nbt.1832	http://dx.doi.org/10.1038/nbt.1832			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	746XY	21441928	Green Accepted, Green Published			2022-12-25	WOS:000289284900023
J	Muramatsu, R; Kubo, T; Mori, M; Nakamura, Y; Fujita, Y; Akutsu, T; Okuno, T; Taniguchi, J; Kumanogoh, A; Yoshida, M; Mochizuki, H; Kuwabara, S; Yamashita, T				Muramatsu, Rieko; Kubo, Takekazu; Mori, Masahiro; Nakamura, Yuka; Fujita, Yuki; Akutsu, Tsugio; Okuno, Tatsusada; Taniguchi, Junko; Kumanogoh, Atsushi; Yoshida, Mari; Mochizuki, Hideki; Kuwabara, Satoshi; Yamashita, Toshihide			RGMa modulates T cell responses and is involved in autoimmune encephalomyelitis	NATURE MEDICINE			English	Article							MULTIPLE-SCLEROSIS; GUIDANCE MOLECULE; RAP1; ACTIVATION; DISABILITY; PATHOLOGY; ADHESION; DISTINCT; INJURY; SYSTEM	In multiple sclerosis, activated CD4(+) T cells initiate an immune response in the brain and spinal cord, resulting in demyelination, degeneration and progressive paralysis. Repulsive guidance molecule-a (RGMa) is an axon guidance molecule that has a role in the visual system and in neural tube closure. Our study shows that RGMa is expressed in bone marrow-derived dendritic cells (BMDCs) and that CD4(+) T cells express neogenin, a receptor for RGMa. Binding of RGMa to CD4(+) T cells led to activation of the small GTPase Rap1 and increased adhesion of T cells to intracellular adhesion molecule-1 (ICAM-1). Neutralizing antibodies to RGMa attenuated clinical symptoms of mouse myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) and reduced invasion of inflammatory cells into the CNS. Silencing of RGMa in MOG-pulsed BMDCs reduced their capacity to induce EAE following adoptive transfer to naive C57BL/6 mice. CD4(+) T cells isolated from mice treated with an RGMa-specific antibody showed diminished proliferative responses and reduced interferon-gamma (IFN-gamma), interleukin-2 (IL-2), IL-4 and IL-17 secretion. Incubation of PBMCs from patients with multiple sclerosis with an RGMa-specific antibody reduced proliferative responses and pro-inflammatory cytokine expression. These results demonstrate that an RGMa-specific antibody suppresses T cell responses, and suggest that RGMa could be a promising molecular target for the treatment of multiple sclerosis.	[Muramatsu, Rieko; Nakamura, Yuka; Fujita, Yuki; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Osaka, Japan; [Muramatsu, Rieko; Nakamura, Yuka; Fujita, Yuki; Mochizuki, Hideki; Yamashita, Toshihide] Japan Sci & Technol Agcy, Tokyo, Japan; [Kubo, Takekazu; Yamashita, Toshihide] Chiba Univ, Grad Sch Med, Dept Neurobiol, Chiba, Japan; [Mori, Masahiro; Taniguchi, Junko; Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan; [Akutsu, Tsugio; Mochizuki, Hideki] Kitasato Univ, Sch Med, Dept Neurol, Kanagawa, Japan; [Okuno, Tatsusada; Kumanogoh, Atsushi] Osaka Univ, Microbial Dis Res Inst, Dept Immunopathol, Osaka, Japan; [Yoshida, Mari] Aichi Med Univ, Inst Med Sci Aging, Aichi, Japan	Osaka University; Japan Science & Technology Agency (JST); Chiba University; Chiba University; Kitasato University; Osaka University; Aichi Medical University	Yamashita, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Osaka, Japan.	yamashita@molneu.med.osaka-u.ac.jp	Muramatsu, Rieko/F-4109-2014	Muramatsu, Rieko/0000-0001-5342-7823; Kuwabara, Satoshi/0000-0002-4716-8578; Yamashita, Toshihide/0000-0003-4559-7018	Japan Society for the Promotion of Sciences [19679007]; Ministry of Health, Labour and Welfare	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Young Scientists (S) from the Japan Society for the Promotion of Sciences (19679007) to T. Y., and a Grant-in-Aid from Ministry of Health, Labour and Welfare to T. Y. We thank H. Hayakawa and members of the Yamashita laboratory for fruitful discussion and help.	Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Karnezis T, 2004, NAT NEUROSCI, V7, P736, DOI 10.1038/nn1261; Katagiri K, 2002, MOL CELL BIOL, V22, P1001, DOI 10.1128/MCB.22.4.1001-1015.2002; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; MCRAE BL, 1995, J EXP MED, V182, P75, DOI 10.1084/jem.182.1.75; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Nohra R, 2010, GENES IMMUN, V11, P279, DOI 10.1038/gene.2009.111; Onuki I, 2001, MICROSC RES TECHNIQ, V52, P731; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Serafini B, 2006, J NEUROPATH EXP NEUR, V65, P124, DOI 10.1097/01.jnen.0000199572.96472.1c; Smith A, 2007, IMMUNOL REV, V218, P135, DOI 10.1111/j.1600-065X.2007.00537.x; STAHL B, 1990, NEURON, V5, P735, DOI 10.1016/0896-6273(90)90227-7; Suga K, 2001, FEBS LETT, V489, P249, DOI 10.1016/S0014-5793(00)02222-5; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; Trapp BD, 1999, NEUROSCIENTIST, V5, P48, DOI 10.1177/107385849900500107; Yamashita T, 2007, CURR OPIN NEUROBIOL, V17, P29, DOI 10.1016/j.conb.2006.12.001	19	85	92	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2011	17	4					488	U129		10.1038/nm.2321	http://dx.doi.org/10.1038/nm.2321			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21423182				2022-12-25	WOS:000289245100040
J	Weber, K; Thomaschewski, M; Warlich, M; Volz, T; Cornils, K; Niebuhr, B; Tager, M; Lutgehetmann, M; Pollok, JM; Stocking, C; Dandri, M; Benten, D; Fehse, B				Weber, Kristoffer; Thomaschewski, Michael; Warlich, Michael; Volz, Tassilo; Cornils, Kerstin; Niebuhr, Birte; Taeger, Maike; Luetgehetmann, Marc; Pollok, Joerg-Matthias; Stocking, Carol; Dandri, Maura; Benten, Daniel; Fehse, Boris			RGB marking facilitates multicolor clonal cell tracking	NATURE MEDICINE			English	Article							HEMATOPOIETIC STEM-CELLS; ONTOLOGY LEGO VECTORS; HEPATITIS-B-VIRUS; FLUORESCENT PROTEINS; IN-VIVO; RETROVIRAL VECTORS; LENTIVIRAL VECTOR; TUMOR CLONALITY; SITE ANALYSIS; GENE-THERAPY	We simultaneously transduced cells with three lentiviral gene ontology (LeGO) vectors encoding red, green or blue fluorescent proteins. Individual cells were thereby marked by different combinations of inserted vectors, resulting in the generation of numerous mixed colors, a principle we named red-green-blue (RGB) marking. We show that lentiviral vector-mediated RGB marking remained stable after cell division, thus facilitating the analysis of clonal cell fates in vitro and in vivo. Particularly, we provide evidence that RGB marking allows assessment of clonality after regeneration of injured livers by transplanted primary hepatocytes. We also used RGB vectors to mark hematopoietic stem/progenitor cells that generated colored spleen colonies. Finally, based on limiting-dilution and serial transplantation assays with tumor cells, we found that clonal tumor cells retained their specific color-code over extensive periods of time. We conclude that RGB marking represents a useful tool for cell clonality studies in tissue regeneration and pathology.	[Weber, Kristoffer; Thomaschewski, Michael; Warlich, Michael; Cornils, Kerstin; Fehse, Boris] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Clin Stem Cell Transplantat, Res Dept Cell & Gene Therapy, Hamburg, Germany; [Niebuhr, Birte; Taeger, Maike; Stocking, Carol] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Pollok, Joerg-Matthias] Univ Med Ctr Hamburg Eppendorf, Dept Hepatobiliary & Transplant Surg, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf	Fehse, B (corresponding author), Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Clin Stem Cell Transplantat, Res Dept Cell & Gene Therapy, Hamburg, Germany.	fehse@uke.de	Fehse, Boris/A-8721-2012; Riecken, Kristoffer/AAD-2371-2020; Volz, Tassilo/U-1942-2019; Dandri, Maura/ABG-4773-2021	Fehse, Boris/0000-0001-9780-7211; Riecken, Kristoffer/0000-0001-9050-6766; Dandri, Maura/0000-0002-0073-6689; Warlich, Michael/0000-0001-8915-4134; Volz, Tassilo/0000-0003-3120-8958	Deutsche Forschungsgemeinschaft [SFB841, FE568/11-1]; integrated graduate school "Inflammation and Regeneration" of the University Medical Center Hamburg-Eppendorf	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); integrated graduate school "Inflammation and Regeneration" of the University Medical Center Hamburg-Eppendorf	We wish to thank to V. Matzat and U. Bergholz for expert technical assistance, R. Reusch for excellent mouse care and J. Petersen for continuous support with the uPA model and critical reading of the manuscript. Confocal imaging was performed with the kind help from O. Bruns in collaboration with the Nikon Application Center Northern Germany (Nikon). We are indebted to many colleagues for their kind support with various cells and constructs: H. Wege (University Medical Center Hamburg-Eppendorf) for FH-hTERT, D. Hosch (University Marburg) for BON cells, W. Beyer (Heinrich-Pette-Institute) for vesicular stomatitis virus G protein cDNA R. Y. Tsien (Howard Hughes Medical Institute) for mCherry cDNA, A. Miyawaki (RIKEN) and T. Schroeder (Institute for Stem Cell Research) for Venus cDNA and D. W. Piston (Vanderbilt-Ingram Cancer Center) for Cerulean cDNA. This work was supported by the Deutsche Forschungsgemeinschaft (SFB841 to B. F., D. B. and M. D. and FE568/11-1 to B. F.). M. Thomaschewski was supported by the integrated graduate school "Inflammation and Regeneration" of the University Medical Center Hamburg-Eppendorf.	Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Appelt JU, 2009, GENE THER, V16, P885, DOI 10.1038/gt.2009.37; Benten D, 2005, HEPATOLOGY, V42, P140, DOI 10.1002/hep.20746; Beyer WR, 2002, J VIROL, V76, P1488, DOI 10.1128/JVI.76.3.1488-1495.2002; Cornils K, 2009, MOL THER, V17, P131, DOI 10.1038/mt.2008.238; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dandri M, 2001, HEPATOLOGY, V33, P981, DOI 10.1053/jhep.2001.23314; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Fehse B, 2004, GENE THER, V11, P879, DOI 10.1038/sj.gt.3302270; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Hock H, 2010, J EXP MED, V207, P1127, DOI 10.1084/jem.20100950; Kim YJ, 2009, BLOOD, V113, P5434, DOI 10.1182/blood-2008-10-185199; Kustikova Olga S., 2009, V506, P373, DOI 10.1007/978-1-59745-409-4_25; Kustikova Olga S., 2008, V430, P255, DOI 10.1007/978-1-59745-182-6_18; Kustikova OS, 2003, BLOOD, V102, P3934, DOI 10.1182/blood-2003-05-1424; Leedham SJ, 2008, J PATHOL, V215, P351, DOI 10.1002/path.2379; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lutgehetmann M, 2010, HEPATOLOGY, V52, P16, DOI 10.1002/hep.23611; Metcalf D, 2008, P NATL ACAD SCI USA, V105, P18501, DOI 10.1073/pnas.0810072105; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Novelli M, 2003, P NATL ACAD SCI USA, V100, P3311, DOI 10.1073/pnas.0437825100; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rozen S, 2000, Methods Mol Biol, V132, P365; Schuler A, 2008, BLOOD, V111, P4532, DOI 10.1182/blood-2007-10-116343; Schwieger M, 2009, BLOOD, V114, P2476, DOI 10.1182/blood-2008-05-158196; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; TOWNSEND CM, 1993, ACTA ONCOL, V32, P125, DOI 10.3109/02841869309083900; Tysnes BB, 2010, NEOPLASIA, V12, P506, DOI 10.1593/neo.10290; Vafaizadeh V, 2010, STEM CELLS, V28, P928, DOI 10.1002/stem.407; Weber K, 2010, GENE THER, V17, P511, DOI 10.1038/gt.2009.149; WEBER K, 2009, CELL THER TRANSPLANT, V1; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Wege H, 2003, GASTROENTEROLOGY, V124, P432, DOI 10.1053/gast.2003.50064; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927	40	105	105	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2011	17	4					504	U147		10.1038/nm.2338	http://dx.doi.org/10.1038/nm.2338			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21441917				2022-12-25	WOS:000289245100043
J	Di Micco, R; Sulli, G; Dobreva, M; Liontos, M; Botrugno, OA; Gargiulo, G; dal Zuffo, R; Matti, V; d'Ario, G; Montani, E; Mercurio, C; Hahn, WC; Gorgoulis, V; Minucci, S; di Fagagna, FD				Di Micco, Raffaella; Sulli, Gabriele; Dobreva, Miryana; Liontos, Michalis; Botrugno, Oronza A.; Gargiulo, Gaetano; dal Zuffo, Roberto; Matti, Valentina; d'Ario, Giovanni; Montani, Erica; Mercurio, Ciro; Hahn, William C.; Gorgoulis, Vassilis; Minucci, Saverio; di Fagagna, Fabrizio d'Adda			Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; CELLULAR SENESCENCE; HISTONE METHYLTRANSFERASE; CHROMATIN-STRUCTURE; CELLS; ARREST; CHECKPOINT; INHIBITOR; REPAIR; ATM	Two major mechanisms have been causally implicated in the establishment of cellular senescence: the activation of the DNA damage response (DDR) pathway and the formation of senescence-associated heterochromatic foci (SAHF). Here we show that in human fibroblasts resistant to premature p16(INK4a) induction, SAHF are preferentially formed following oncogene activation but are not detected during replicative cellular senescence or on exposure to a variety of senescence-inducing stimuli. Oncogene-induced SAHF formation depends on DNA replication and ATR (ataxia telangiectasia and Rad3-related). Inactivation of ATM (ataxia telangiectasia mutated) or p53 allows the proliferation of oncogene-expressing cells that retain increased heterochromatin induction. In human cancers, levels of heterochromatin markers are higher than in normal tissues, and are independent of the proliferative index or stage of the tumours. Pharmacological and genetic perturbation of heterochromatin in oncogene-expressing cells increase DDR signalling and lead to apoptosis. In vivo, a histone deacetylase inhibitor (HDACi) causes heterochromatin relaxation, increased DDR, apoptosis and tumour regression. These results indicate that heterochromatin induced by oncogenic stress restrains DDR and suggest that the use of chromatin-modifying drugs in cancer therapies may benefit from the study of chromatin and DDR status of tumours.	[Di Micco, Raffaella; Sulli, Gabriele; Dobreva, Miryana; Matti, Valentina; d'Ario, Giovanni; di Fagagna, Fabrizio d'Adda] IFOM Fdn, FIRC Inst Mol Oncol Fdn, Milan, Italy; [Liontos, Michalis; Gorgoulis, Vassilis] Univ Athens, Sch Med, Dept Histol & Embryol, Mol Carcinogenesis Grp, GR-11527 Athens, Greece; [Botrugno, Oronza A.; Gargiulo, Gaetano; Minucci, Saverio] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [dal Zuffo, Roberto; Mercurio, Ciro] DAC Genextra Grp, Milan, Italy; [Montani, Erica] Consortium Genom Technol, Milan, Italy; [Hahn, William C.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Hahn, William C.] Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; Athens Medical School; National & Kapodistrian University of Athens; IRCCS European Institute of Oncology (IEO); Harvard University; Dana-Farber Cancer Institute; University of Milan	di Fagagna, FD (corresponding author), IFOM Fdn, FIRC Inst Mol Oncol Fdn, Milan, Italy.	fabrizio.dadda@ifom-ieo-campus.it	d'Adda di Fagagna, Fabrizio/AAC-4683-2022; Di MICCO, RAFFAELLA/ABH-7906-2020; Botrugno, Oronza Antonietta/P-2065-2017; qiao, zhixin/I-3408-2012; Liontos, Michalis/ABA-7587-2020; Gorgoulis, Vassilis/AAD-3630-2019; Liontos, Michalis/AAF-1965-2019; Minucci, Saverio/J-9669-2012	d'Adda di Fagagna, Fabrizio/0000-0002-9603-5966; Botrugno, Oronza Antonietta/0000-0002-2568-9815; Gorgoulis, Vassilis/0000-0001-9001-4112; Liontos, Michalis/0000-0001-7192-4575; Di Micco, Raffaella/0000-0002-0639-8238; DADDADIFAGAGNA, FABRIZIO/0000-0002-1976-3185; Mercurio, Ciro/0000-0001-6240-4607	European Commission; U.S. NIH/NIA [ROI AG023145]; European Community [202230]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; Fondazione Telethon Funding Source: Custom; NATIONAL INSTITUTE ON AGING [R01AG023145] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); U.S. NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); European Community(European Commission); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Telethon(Fondazione Telethon); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Fumagalli for providing fibroblasts undergoing senescence following telomere shortening and for editing the manuscript; A. Oldani and D. Parazzoli from IFOM Imaging Unit for help with imaging; qRT-PCR and Cell Biology Units for support; S. Vultaggio for help with tumour xenograft generation and M. Romanenghi for technical assistance with ChIP. We thank O. Fernandez-Capetillo for pLKO.1 shATR; G. Smith for KU55933 (KuDOS Pharmaceuticals Ltd.). G. Manfioletti for sharing HMGA antibodies; P.P. Di Fiore for support; U. Herbig, B. Amati and M. Foiani for critical reading of the manuscript and all F.d'A.d.F. lab members for discussion and feedback throughout this work. M.L. and V.G. are funded by the European Commission (FP7-GENICA project). W.C.H. is supported in part by an U.S. NIH/NIA grant (ROI AG023145). The S.M. laboratory is supported in part by the European Union (Epitron). The F.d'A.d.F laboratory is supported by AIRC (Associazione Italiana per la Ricerca sul Cancro), the European Community's 7th Framework Programme (FP7/2007-2013) under grant agreement number 202230 (Genomic instability and genomic alterations in pre-cancerous lesions and/or cancer; GENINCA), HFSP (Human Frontier Science Program), AICR (Association for International Cancer Research), EMBO Young Investigator Program and Telethon.	Adams PD, 2007, AGING CELL, V6, P425, DOI 10.1111/j.1474-9726.2007.00313.x; Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Altucci L, 2009, EUR J CANCER, V45, P1137, DOI 10.1016/j.ejca.2009.03.001; Auth T, 2006, EXP CELL RES, V312, P3349, DOI 10.1016/j.yexcr.2006.07.014; Ayoub N, 2009, CELL CYCLE, V8, P2945; Bandyopadhyay D, 2007, AGING CELL, V6, P577, DOI 10.1111/j.1474-9726.2007.00308.x; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; De Koning L, 2009, EMBO MOL MED, V1, P178, DOI 10.1002/emmm.200900022; Denchi EL, 2005, MOL CELL BIOL, V25, P2660, DOI 10.1128/MCB.25.7.2660-2672.2005; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Di Micco R, 2007, TRENDS CELL BIOL, V17, P529, DOI 10.1016/j.tcb.2007.07.012; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Fanti L, 1998, MOL CELL, V2, P527, DOI 10.1016/S1097-2765(00)80152-5; Funayama R, 2007, CHROMOSOMA, V116, P431, DOI 10.1007/s00412-007-0115-7; Gargiulo G, 2009, DEV CELL, V16, P466, DOI 10.1016/j.devcel.2009.02.002; George P, 2005, BLOOD, V105, P1768, DOI 10.1182/blood-2004-09-3413; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2010, DNA REPAIR, V9, P1273, DOI 10.1016/j.dnarep.2010.09.013; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hemann MT, 2007, GENE DEV, V21, P1, DOI 10.1101/gad.1514207; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Humbert N, 2009, CANCER RES, V69, P4101, DOI 10.1158/0008-5472.CAN-08-2864; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Kang MY, 2007, INT J CANCER, V121, P2192, DOI 10.1002/ijc.22953; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kim IA, 2010, J RADIAT RES, V51, P257, DOI 10.1269/jrr.09115; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kim JA, 2009, P NATL ACAD SCI USA, V106, P1151, DOI 10.1073/pnas.0812578106; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Liontos M, 2007, CANCER RES, V67, P10899, DOI 10.1158/0008-5472.CAN-07-2837; Liontos M, 2009, AM J PATHOL, V175, P376, DOI 10.2353/ajpath.2009.081160; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ronzoni S, 2005, CYTOM PART A, V66A, P52, DOI 10.1002/cyto.a.20151; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Schmitt CA, 2003, NAT REV CANCER, V3, P286, DOI 10.1038/nrc1044; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shimada K, 2008, CURR BIOL, V18, P566, DOI 10.1016/j.cub.2008.03.049; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; Ye XF, 2007, MOL CELL BIOL, V27, P2452, DOI 10.1128/MCB.01592-06; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	64	229	231	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2011	13	3					292	U244		10.1038/ncb2170	http://dx.doi.org/10.1038/ncb2170			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	728BB	21336312	Green Accepted			2022-12-25	WOS:000287847600017
J	Bhang, HEC; Gabrielson, KL; Laterra, J; Fisher, PB; Pomper, MG				Bhang, Hyo-eun C.; Gabrielson, Kathleen L.; Laterra, John; Fisher, Paul B.; Pomper, Martin G.			Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression	NATURE MEDICINE			English	Article							2-STEP TRANSCRIPTIONAL AMPLIFICATION; LYMPH-NODE METASTASIS; TK GENE; PHASE-I; THERAPY; DNA; ADENOVIRUS; DELIVERY; BIODISTRIBUTION; INTEGRATION	Molecular-genetic imaging is advancing from a valuable preclinical tool to a guide for patient management. The strategy involves pairing an imaging reporter gene with a complementary imaging agent in a system that can be used to measure gene expression or protein interaction or track gene-tagged cells in vivo. Tissue-specific promoters can be used to delineate gene expression in certain tissues, particularly when coupled with an appropriate amplification mechanism. Here we show that the progression elevated gene-3 (PEG-3) promoter, derived from a rodent gene mediating tumor progression and metastatic phenotypes, can be used to drive imaging reporters selectively to enable detection of micrometastatic disease in mouse models of human melanoma and breast cancer using bioluminescence and radionuclide-based molecular imaging techniques. Because of its strong promoter activity, tumor specificity and capacity for clinical translation, PEG-3 promoter-driven gene expression may represent a practical, new system for facilitating cancer imaging and therapy.	[Bhang, Hyo-eun C.; Pomper, Martin G.] Johns Hopkins Med Inst, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Gabrielson, Kathleen L.] Johns Hopkins Med Inst, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Laterra, John] Johns Hopkins Med Inst, Dept Neurol, Baltimore, MD 21205 USA; [Laterra, John] Kennedy Krieger Inst, Baltimore, MD USA; [Fisher, Paul B.] Virginia Commonwealth Univ, Massey Canc Ctr, Inst Mol Med, Dept Human & Mol Genet,Sch Med, Richmond, VA USA; [Pomper, Martin G.] Johns Hopkins Med Inst, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Kennedy Krieger Institute; Virginia Commonwealth University; Johns Hopkins University; Johns Hopkins Medicine	Pomper, MG (corresponding author), Johns Hopkins Med Inst, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	mpomper@jhmi.edu			US National Institutes of Health [U24 CA92871, P01 CA104177]; Society of Nuclear Medicine; Korea Science and Engineering Foundation; US National Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA127641, P01CA104177, U24CA092871, R01CA097318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH093195] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society of Nuclear Medicine; Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); US National Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We appreciate the technical support provided by S. Dhara, S. Nimmagadda, M. Goggins and M. Griffith. We are grateful to J. Fox and G. Green for providing [<SUP>125</SUP>I]FIAU and assisting in the SPECT-CT and PET-CT imaging studies. We also thank C. Endres, B. Tsui, J. Yu and J. Fox for help with SPECT and PET data processing. The MDA-MB-231 cell line and pCMV-Tri construct were generous gifts from Z. Bhujwalla (Johns Hopkins University) and S. Gambhir (Stanford University), respectively. Funding was provided by US National Institutes of Health grant U24 CA92871 (to M.G.P.), by the Predoctoral Molecular Imaging Scholar Program from the Society of Nuclear Medicine and the Korea Science and Engineering Foundation Fellowship Program (to H.C.B.) and by the US National Institutes of Health grant P01 CA104177 and the US National Foundation for Cancer Research (to P.B.F.). P.B.F. holds the Thelma Newmeyer Corman Chair in Cancer Research at the Virginia Commonwealth University Massey Cancer Center.	Blasberg RG, 2003, J CLIN INVEST, V111, P1620, DOI 10.1172/JCI200318855; Bonnet ME, 2008, PHARM RES-DORDR, V25, P2972, DOI 10.1007/s11095-008-9693-1; Burton JB, 2008, NAT MED, V14, P882, DOI 10.1038/nm.1727; Coelho-Castelo A A M, 2006, Genet Vaccines Ther, V4, P1, DOI 10.1186/1479-0556-4-1; Dwyer RM, 2005, CLIN CANCER RES, V11, P1483, DOI 10.1158/1078-0432.CCR-04-1636; Evans Kevin D, 2007, Radiol Technol, V78, P361; Freytag SO, 2007, MOL THER, V15, P1016, DOI 10.1038/mt.sj.6300120; Huyn ST, 2009, CLIN CANCER RES, V15, P3126, DOI 10.1158/1078-0432.CCR-08-2666; Immonen A, 2004, MOL THER, V10, P967, DOI 10.1016/j.ymthe.2004.08.002; Iyer M, 2001, P NATL ACAD SCI USA, V98, P14595, DOI 10.1073/pnas.251551098; Iyer M, 2004, MOL THER, V10, P545, DOI 10.1016/j.ymthe.2004.06.118; Jacobs A, 2001, LANCET, V358, P727, DOI 10.1016/S0140-6736(01)05904-9; Kang KK, 2003, INTERVIROLOGY, V46, P270, DOI 10.1159/000073206; Kishimoto H, 2006, NAT MED, V12, P1213, DOI 10.1038/nm1404; Klatzmann D, 1998, HUM GENE THER, V9, P2595, DOI 10.1089/hum.1998.9.17-2595; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Manam S, 2000, INTERVIROLOGY, V43, P273, DOI 10.1159/000053994; Padmanabhan P, 2006, J NUCL MED, V47, P270; Peng KW, 2001, GENE THER, V8, P1456, DOI 10.1038/sj.gt.3301552; Qiao J, 2002, GENE THER, V9, P168, DOI 10.1038/sj.gt.3301618; Ramirez K, 2008, HUM GENE THER, V19, P522, DOI 10.1089/hum.2007.172; Ray S, 2008, MOL THER, V16, P1848, DOI 10.1038/mt.2008.180; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Sarkar D, 2008, CANCER GENE THER, V15, P293, DOI 10.1038/cgt.2008.14; Sarkar D, 2005, P NATL ACAD SCI USA, V102, P14034, DOI 10.1073/pnas.0506837102; Sarkar D, 2005, CANCER RES, V65, P9056, DOI 10.1158/0008-5472.CAN-05-1261; Sarkar D, 2007, CANCER RES, V67, P5434, DOI 10.1158/0008-5472.CAN-07-0195; Shreve PD, 1999, RADIOGRAPHICS, V19, P61, DOI 10.1148/radiographics.19.1.g99ja0761; Su ZZ, 1997, P NATL ACAD SCI USA, V94, P9125, DOI 10.1073/pnas.94.17.9125; Su ZZ, 2000, ONCOGENE, V19, P3411, DOI 10.1038/sj.onc.1203666; Su ZZ, 2005, ONCOGENE, V24, P2247, DOI 10.1038/sj.onc.1208420; Su ZZ, 2005, P NATL ACAD SCI USA, V102, P1059, DOI 10.1073/pnas.0409141102; Trask TW, 2000, MOL THER, V1, P195, DOI 10.1006/mthe.2000.0030; Tsuruta Y, 2008, CLIN CANCER RES, V14, P3582, DOI 10.1158/1078-0432.CCR-07-5053; Uhrbom L, 2004, NAT MED, V10, P1257, DOI 10.1038/nm1120; Wood M, 1999, CANCER GENE THER, V6, P367, DOI 10.1038/sj.cgt.7700090; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278; Zhang YM, 2007, CANCER RES, V67, P9389, DOI 10.1158/0008-5472.CAN-07-0944	38	71	80	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					123	U302		10.1038/nm.2269	http://dx.doi.org/10.1038/nm.2269			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21151140	Green Accepted			2022-12-25	WOS:000285994000045
J	Hagel, M; Niu, DQ; St Martin, T; Sheets, MP; Qiao, LX; Bernard, H; Karp, RM; Zhu, ZD; Labenski, MT; Chaturvedi, P; Nacht, M; Westlin, WF; Petter, RC; Singh, J				Hagel, Margit; Niu, Deqiang; St Martin, Thia; Sheets, Michael P.; Qiao, Lixin; Bernard, Hugues; Karp, Russell M.; Zhu, Zhendong; Labenski, Matthew T.; Chaturvedi, Prasoon; Nacht, Mariana; Westlin, William F.; Petter, Russell C.; Singh, Juswinder			Selective irreversible inhibition of a protease by targeting a noncatalytic cysteine	NATURE CHEMICAL BIOLOGY			English	Article							HEPATITIS-C VIRUS; PRECLINICAL PROFILE; SERINE-PROTEASE; DISCOVERY; NS3; INFECTION; COVALENT; POTENT; DRUGS; VX-950	Designing selective inhibitors of proteases has proven problematic, in part because pharmacophores that confer potency exploit the conserved catalytic apparatus. We developed a fundamentally different approach by designing irreversible inhibitors that target noncatalytic cysteines that are structurally unique to a target in a protein family. We have successfully applied this approach to the important therapeutic target HCV protease, which has broad implications for the design of other selective protease inhibitors.	[Hagel, Margit; Niu, Deqiang; St Martin, Thia; Sheets, Michael P.; Qiao, Lixin; Karp, Russell M.; Zhu, Zhendong; Labenski, Matthew T.; Chaturvedi, Prasoon; Nacht, Mariana; Westlin, William F.; Petter, Russell C.; Singh, Juswinder] Avila Therapeut Inc, Waltham, MA USA; [Bernard, Hugues] Millenium Takeda Oncol Co, Cambridge, MA USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Takeda Oncology	Singh, J (corresponding author), Avila Therapeut Inc, Waltham, MA USA.	jsingh@avilatx.com						Bartenschlager R, 2007, VIRUS RES, V127, P127, DOI 10.1016/j.virusres.2007.07.003; CAMPBELL JA, 2003, Patent No. 2003053349; HAGEL M, 2009, REV ANTIVIRAL THERAP, V5, P15; Kou YH, 2007, J VIROL, V81, P7999, DOI 10.1128/JVI.00348-07; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Lin C., 2006, Infectious Disorders - Drug Targets, V6, P3, DOI 10.2174/187152606776056706; Lin TI, 2009, ANTIMICROB AGENTS CH, V53, P1377, DOI 10.1128/AAC.01058-08; LING C, 2006, HEPATITIS C VIRUSES, P163; Liverton NJ, 2010, ANTIMICROB AGENTS CH, V54, P305, DOI 10.1128/AAC.00677-09; McCauley JA, 2010, J MED CHEM, V53, P2443, DOI 10.1021/jm9015526; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Njoroge FG, 2008, ACCOUNTS CHEM RES, V41, P50, DOI 10.1021/ar700109k; Perni RB, 2006, ANTIMICROB AGENTS CH, V50, P899, DOI 10.1128/AAC.50.3.899-909.2006; Potashman MH, 2009, J MED CHEM, V52, P1231, DOI 10.1021/jm8008597; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Robertson JG, 2005, BIOCHEMISTRY-US, V44, P5561, DOI 10.1021/bi050247e; Seiwert SD, 2008, ANTIMICROB AGENTS CH, V52, P4432, DOI 10.1128/AAC.00699-08; Singh J, 2010, CURR OPIN CHEM BIOL, V14, P475, DOI 10.1016/j.cbpa.2010.06.168; Smith AJT, 2009, J MED CHEM, V52, P225, DOI 10.1021/jm800498e; Stauber RE, 2008, DRUGS, V68, P1347, DOI 10.2165/00003495-200868100-00002; Thompson AJV, 2009, J VIRAL HEPATITIS, V16, P377, DOI 10.1111/j.1365-2893.2009.01124.x; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Venkatraman S, 2006, J MED CHEM, V49, P6074, DOI 10.1021/jm060325b	23	75	75	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2011	7	1					22	24		10.1038/NCHEMBIO.492	http://dx.doi.org/10.1038/NCHEMBIO.492			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	695PA	21113170				2022-12-25	WOS:000285383400008
J	Mao, YTS; Sunwoo, H; Zhang, B; Spector, DL				Mao, Yuntao S.; Sunwoo, Hongjae; Zhang, Bin; Spector, David L.			Direct visualization of the co-transcriptional assembly of a nuclear body by noncoding RNAs	NATURE CELL BIOLOGY			English	Article							LIVING CELLS; GENE-EXPRESSION; DYNAMICS; PARASPECKLES; ORGANIZATION; RETENTION; LOCALIZATION; HETERODIMER; ORGANELLES	The cell nucleus is a highly compartmentalized organelle harbouring a variety of dynamic membraneless nuclear bodies(1-4). How these subnuclear domains are established and maintained is not well understood(5-8). Here, we investigate the molecular mechanism of how one nuclear body, the paraspeckle, is assembled and organized. Paraspeckles are discrete ribonucleoprotein bodies found in mammalian cells and implicated in nuclear retention of hyperedited mRNAs(9-11). We developed a live-cell imaging system that allows for the inducible transcription of Men epsilon/beta (also known as Neat1; ref. 12) noncoding RNAs (ncRNAs) and the direct visualization of the recruitment of paraspeckle proteins. Using this system, we demonstrate that Men epsilon/beta ncRNAs are essential to initiate the de novo assembly of paraspeckles. These newly formed structures effectively harbour nuclear-retained mRNAs confirming that they are bona fide functional paraspeckles. By three independent approaches, we show that it is the act of Men epsilon/beta transcription, but not ncRNAs alone, that regulates paraspeckle maintenance. Finally, fluorescence recovery after photobleaching (FRAP) analyses supported a critical structural role for Men epsilon/beta ncRNAs in paraspeckle organization. This study establishes a model in which Men epsilon/beta ncRNAs serve as a platform to recruit proteins to assemble paraspeckles.	[Mao, Yuntao S.; Sunwoo, Hongjae; Zhang, Bin; Spector, David L.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Spector, DL (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	spector@cshl.edu	Mao, Yuntao/E-9168-2012		National Cancer Center; Department of Defense; NIH [NIGMS 42694, 5PO1CA013106-38]; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042694] Funding Source: NIH RePORTER	National Cancer Center; Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Caceres, G. G. Carmichael, L.-L. Chen, Y. Kurihara, and A. I. Lamond for reagents, S. Hearn and Z. Lazar for assistance in microscopy, C. Berasain, M. Bodnar, M. Eckersley-Maslin, M. Huebner, I. R. Kumaran, J. Li, E. Reis, J. E. Wilusz, and R. Zhao of the Spector laboratory for discussions and comments. Y.S.M. is supported by a National Cancer Center Postdoctoral Fellowship. B.Z. is supported by a Department of Defense Prostate Cancer Research Program Postdoctoral Fellowship. This work was supported by grants to D.L.S. from NIH (NIGMS 42694 and 5PO1CA013106-38).	Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; Cardinale S, 2007, MOL BIOL CELL, V18, P1282, DOI 10.1091/mbc.E06-09-0846; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Dousset T, 2000, MOL BIOL CELL, V11, P2705, DOI 10.1091/mbc.11.8.2705; Fox AH, 2005, MOL BIOL CELL, V16, P5304, DOI 10.1091/mbc.E05-06-0587; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Kaiser TE, 2008, SCIENCE, V322, P1713, DOI 10.1126/science.1165216; Kumaran RI, 2008, CELL, V132, P929, DOI 10.1016/j.cell.2008.03.004; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Matera AG, 2009, DEV CELL, V17, P639, DOI 10.1016/j.devcel.2009.10.017; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Sasaki YTF, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-227; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; ZHANG WW, 1993, BIOCHEM J, V290, P267, DOI 10.1042/bj2900267; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4; Zhao R, 2009, CURR OPIN GENET DEV, V19, P172, DOI 10.1016/j.gde.2009.02.007	29	326	337	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2011	13	1					95	U227		10.1038/ncb2140	http://dx.doi.org/10.1038/ncb2140			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697GV	21170033	Green Accepted			2022-12-25	WOS:000285502200016
J	Mack, GS				Mack, George S.			To selectivity and beyond	NATURE BIOTECHNOLOGY			English	Article							METHYLATION; CANCER											Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Jones JR, 2008, AM J MED GENET A, V146A, P2213, DOI 10.1002/ajmg.a.32396; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075	8	54	57	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2010	28	12					1259	1266		10.1038/nbt.1724	http://dx.doi.org/10.1038/nbt.1724			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	691NP	21139608				2022-12-25	WOS:000285088400016
J	Singh, SB; Ornatowski, W; Vergne, I; Naylor, J; Delgado, M; Roberts, E; Ponpuak, M; Master, S; Pilli, M; White, E; Komatsu, M; Deretic, V				Singh, Sudha B.; Ornatowski, Wojciech; Vergne, Isabelle; Naylor, John; Delgado, Monica; Roberts, Esteban; Ponpuak, Marisa; Master, Sharon; Pilli, Manohar; White, Eileen; Komatsu, Masaaki; Deretic, Vojo			Human IRGM regulates autophagy and cell-autonomous immunity functions through mitochondria	NATURE CELL BIOLOGY			English	Article							GENOME-WIDE ASSOCIATION; DYNAMIN-LIKE PROTEIN-1; 3,000 SHARED CONTROLS; MYCOBACTERIUM-TUBERCULOSIS; CYTOCHROME-C; PHAGOLYSOSOME BIOGENESIS; PEROXISOMAL FISSION; MAMMALIAN-CELLS; APOPTOTIC CELLS; DENDRITIC CELLS	IRGM, a human immunity-related GTPase, confers autophagic defence against intracellular pathogens by an unknown mechanism. Here, we report an unexpected mode of IRGM action. IRGM demonstrated differential affinity for the mitochondrial lipid cardiolipin, translocated to mitochondria, affected mitochondrial fission and induced autophagy. Mitochondrial fission was necessary for autophagic control of intracellular mycobacteria by IRGM. IRGM influenced mitochondrial membrane polarization and cell death. Overexpression of IRGMd, but not IRGMb splice isoforms, caused mitochondrial depolarization and autophagy-independent, but Bax/Bak-dependent, cell death. By acting on mitochondria, IRGM confers autophagic protection or cell death, explaining IRGM action both in defence against tuberculosis and in the damaging inflammation caused by Crohn's disease.	[Singh, Sudha B.; Ornatowski, Wojciech; Vergne, Isabelle; Naylor, John; Delgado, Monica; Roberts, Esteban; Ponpuak, Marisa; Master, Sharon; Pilli, Manohar; Deretic, Vojo] Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Ponpuak, Marisa] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok 10400, Thailand; [White, Eileen] Rutgers State Univ, Canc Inst New Jersey, Dept Mol Biol & Biochem, CABM, Piscataway, NJ 08854 USA; [Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138421, Japan; [Komatsu, Masaaki] Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan	University of New Mexico; University of New Mexico's Health Sciences Center; Mahidol University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Tokyo Metropolitan Institute of Medical Science; Juntendo University	Deretic, V (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, 915 Camino Salud NE, Albuquerque, NM 87131 USA.	vderetic@salud.unm.edu	Pilli, Manohar/G-6568-2015; Komatsu, Masaaki/B-8321-2011; White, Eileen/ABD-6745-2021	Pilli, Manohar/0000-0002-3084-8788; Komatsu, Masaaki/0000-0001-7672-7722; White, Eileen/0000-0003-2961-3065; Deretic, Vojo/0000-0002-3624-5208; Ponpuak, Marisa/0000-0002-2889-1314	NIH [AI069345, RC1AI086845, AI42999]; Crohn's & Colitis Foundation of America; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI086845, R01AI045148, R01AI042999, R01AI069345] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's & Colitis Foundation of America; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI069345, RC1AI086845 and AI42999, a grant from Crohn's & Colitis Foundation of America and a grant from the Bill and Melinda Gates Foundation.	Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Arnoult D, 2005, CURR BIOL, V15, P2112, DOI 10.1016/j.cub.2005.10.041; Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Bekpen C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000403; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Blanchet FP, 2010, IMMUNITY, V32, P654, DOI 10.1016/j.immuni.2010.04.011; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chua J, 2004, J BIOL CHEM, V279, P36982, DOI 10.1074/jbc.M405082200; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Delgado M, 2009, IMMUNOL REV, V227, P189, DOI 10.1111/j.1600-065X.2008.00725.x; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107; Feng CG, 2008, NAT IMMUNOL, V9, P1279, DOI 10.1038/ni.1653; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gerlich D, 2003, NAT CELL BIOL, pS14, DOI 10.1038/ncb1033; Gerlich D, 2001, NAT CELL BIOL, V3, P852, DOI 10.1038/ncb0901-852; Gomes LC, 2008, BBA-BIOENERGETICS, V1777, P860, DOI 10.1016/j.bbabio.2008.05.442; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Haines TH, 2009, BBA-BIOMEMBRANES, V1788, P1997, DOI 10.1016/j.bbamem.2009.09.008; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Howard J, 2008, IMMUNOBIOLOGY, V213, P367, DOI 10.1016/j.imbio.2007.11.005; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Kaiser F, 2004, J CELL SCI, V117, P1747, DOI 10.1242/jcs.01039; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Koch A, 2004, J CELL SCI, V117, P3995, DOI 10.1242/jcs.01268; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Kyei GB, 2006, EMBO J, V25, P5250, DOI 10.1038/sj.emboj.7601407; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee YL, 2004, EPIDEMIOLOGY, V15, pS138, DOI 10.1097/00001648-200407000-00358; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Manders EMM, 1999, J CELL BIOL, V144, P813, DOI 10.1083/jcb.144.5.813; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Miller BC, 2008, AUTOPHAGY, V4, P309, DOI 10.4161/auto.5474; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Muenz C, 2009, ANNU REV IMMUNOL, V27, P423, DOI 10.1146/annurev.immunol.021908.132537; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Oberst A, 2008, CELL DEATH DIFFER, V15, P1139, DOI 10.1038/cdd.2008.65; Orrenius S, 2005, NAT CHEM BIOL, V1, P188, DOI 10.1038/nchembio0905-188; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Platani M, 2002, NAT CELL BIOL, V4, P502, DOI 10.1038/ncb809; Ponpuak M, 2009, METHOD ENZYMOL, V452, P345, DOI 10.1016/S0076-6879(08)03621-5; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Roberts EA, 2006, J CELL BIOL, V174, P923, DOI 10.1083/jcb.200603026; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Tasdemir Ezgi, 2008, V445, P29, DOI 10.1007/978-1-59745-157-4_3; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Tiwari S, 2009, NAT IMMUNOL, V10, P907, DOI 10.1038/ni.1759; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003	80	178	185	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2010	12	12					1154	U83		10.1038/ncb2119	http://dx.doi.org/10.1038/ncb2119			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	688DY	21102437	Green Accepted			2022-12-25	WOS:000284831200007
J	Grumati, P; Coletto, L; Sabatelli, P; Cescon, M; Angelin, A; Bertaggia, E; Blaauw, B; Urciuolo, A; Tiepolo, T; Merlini, L; Maraldi, NM; Bernardi, P; Sandri, M; Bonaldo, P				Grumati, Paolo; Coletto, Luisa; Sabatelli, Patrizia; Cescon, Matilde; Angelin, Alessia; Bertaggia, Enrico; Blaauw, Bert; Urciuolo, Anna; Tiepolo, Tania; Merlini, Luciano; Maraldi, Nadir M.; Bernardi, Paolo; Sandri, Marco; Bonaldo, Paolo			Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration	NATURE MEDICINE			English	Article							MITOCHONDRIAL DYSFUNCTION; MUSCLE APOPTOSIS; DISEASE; PATHOGENESIS; DEGRADATION; PREVENTS; MYOPATHY; CELLS; MICE	Autophagy is crucial in the turnover of cell components, and clearance of damaged organelles by the autophagic-lysosomal pathway is essential for tissue homeostasis. Defects of this degradative system have a role in various diseases, but little is known about autophagy in muscular dystrophies. We have previously found that muscular dystrophies linked to collagen VI deficiency show dysfunctional mitochondria and spontaneous apoptosis, leading to myofiber degeneration. Here we demonstrate that this persistence of abnormal organelles and apoptosis are caused by defective autophagy. Skeletal muscles of collagen VI-knockout (Col6a1(-/-)) mice had impaired autophagic flux, which matched the lower induction of beclin-1 and BCL-2/adenovirus E1B-interacting protein-3 (Bnip3) and the lack of autophagosomes after starvation. Forced activation of autophagy by genetic, dietary and pharmacological approaches restored myofiber survival and ameliorated the dystrophic phenotype of Col6a1(-/-) mice. Furthermore, muscle biopsies from subjects with Bethlem myopathy or Ullrich congenital muscular dystrophy had reduced protein amounts of beclin-1 and Bnip3. These findings indicate that defective activation of the autophagic machinery is pathogenic in some congenital muscular dystrophies.	[Grumati, Paolo; Cescon, Matilde; Urciuolo, Anna; Tiepolo, Tania; Bonaldo, Paolo] Univ Padua, Dept Histol Microbiol & Med Biotechnol, Padua, Italy; [Coletto, Luisa; Bertaggia, Enrico; Sandri, Marco] Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy; [Sabatelli, Patrizia; Maraldi, Nadir M.] CNR, Inst Med Genet, Bologna, Italy; [Angelin, Alessia; Bernardi, Paolo; Sandri, Marco] Univ Padua, Dept Biomed Sci, Padua, Italy; [Blaauw, Bert] Univ Padua, Dept Human Anat & Physiol, Padua, Italy; [Merlini, Luciano] Univ Ferrara, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy; [Maraldi, Nadir M.] Univ Bologna, Dept Anat Sci, Bologna, Italy	University of Padua; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua; University of Ferrara; University of Bologna	Bonaldo, P (corresponding author), Univ Padua, Dept Histol Microbiol & Med Biotechnol, Padua, Italy.	marco.sandri@unipd.it; bonaldo@bio.unipd.it	Bernardi, Paolo/C-3656-2008; Cescon, Matilde/Y-3116-2019; Sabatelli, Patrizia/C-7479-2019; blaauw, bert/A-7614-2014; Merlini, Luciano/N-6478-2019; Grumati, Paolo/AAA-5787-2019	Bernardi, Paolo/0000-0001-9187-3736; Cescon, Matilde/0000-0001-7138-1857; Sabatelli, Patrizia/0000-0003-2345-5094; blaauw, bert/0000-0002-3893-1463; Merlini, Luciano/0000-0002-1108-1198; Grumati, Paolo/0000-0002-9942-9389; BLAAUW, BERT/0000-0002-4167-5106; Bonaldo, Paolo/0000-0002-9571-8140; Urciuolo, Anna/0000-0001-7571-9747	Telethon Foundation [GGP08107, TCP04009]; Italian Ministry of University and Research, Association Francaise contre les Myopathies; EU	Telethon Foundation(Fondazione Telethon); Italian Ministry of University and Research, Association Francaise contre les Myopathies; EU(European Commission)	We thank N. Bergamin for her involvement in the initial study, P. Braghetta for help with mouse manipulations, E. Rizzo and S. Castagnaro for histology, S. Cogliati for assistance with mitochondria isolation and F. Gualandi for muscle biopsies. We are grateful to N. Heintz (Rockefeller University) for supplying the beclin-1-EGFP expression construct and E. Kominami (Juntendo University School of Medicine) for the YFP-LC3 construct. This work was supported by the Telethon Foundation (GGP08107 and TCP04009), the Italian Ministry of University and Research, Association Francaise contre les Myopathies and the EU (BIO-NMD and MYOAGE).	Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blaauw B, 2008, HUM MOL GENET, V17, P3686, DOI 10.1093/hmg/ddn264; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; DEGRASSI A, 1994, AIDS RES HUM RETROV, V10, P675, DOI 10.1089/aid.1994.10.675; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Malicdan MC, 2008, NEUROMUSCULAR DISORD, V18, P521, DOI 10.1016/j.nmd.2008.04.010; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Menazza S, 2010, HUM MOL GENET, V19, P4207, DOI 10.1093/hmg/ddq339; Merlini L, 2008, P NATL ACAD SCI USA, V105, P5225, DOI 10.1073/pnas.0800962105; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Pallet N, 2008, AUTOPHAGY, V4, P783, DOI 10.4161/auto.6477; Palma E, 2009, HUM MOL GENET, V18, P2024, DOI 10.1093/hmg/ddp126; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pepe G, 2002, NEUROMUSCULAR DISORD, V12, P720; Ramachandran N, 2009, CELL, V137, P235, DOI 10.1016/j.cell.2009.01.054; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; SCHMALBRUCH H, 1980, J NEUROPATH EXP NEUR, V39, P65, DOI 10.1097/00005072-198001000-00006; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sugawara T, 2009, AMINO ACIDS, V37, P609, DOI 10.1007/s00726-008-0180-0; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Yoo YM, 2010, J PINEAL RES, V48, P204, DOI 10.1111/j.1600-079X.2010.00744.x; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	43	380	394	3	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1313	U169		10.1038/nm.2247	http://dx.doi.org/10.1038/nm.2247			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21037586	Green Published			2022-12-25	WOS:000283860100044
J	Huffmeier, U; Uebe, S; Ekici, AB; Bowes, J; Giardina, E; Korendowych, E; Juneblad, K; Apel, M; McManus, R; Ho, P; Bruce, IN; Ryan, AW; Behrens, F; Lascorz, J; Bohm, B; Traupe, H; Lohmann, J; Gieger, C; Wichmann, HE; Herold, C; Steffens, M; Klareskog, L; Wienker, TF; FitzGerald, O; Alenius, GM; McHugh, NJ; Novelli, G; Burkhardt, H; Barton, A; Reis, A				Hueffmeier, Ulrike; Uebe, Steffen; Ekici, Arif B.; Bowes, John; Giardina, Emiliano; Korendowych, Eleanor; Juneblad, Kristina; Apel, Maria; McManus, Ross; Ho, Pauline; Bruce, Ian N.; Ryan, Anthony W.; Behrens, Frank; Lascorz, Jesus; Boehm, Beate; Traupe, Heiko; Lohmann, Joerg; Gieger, Christian; Wichmann, Heinz-Erich; Herold, Christine; Steffens, Michael; Klareskog, Lars; Wienker, Thomas F.; FitzGerald, Oliver; Alenius, Gerd-Marie; McHugh, Neil J.; Novelli, Giuseppe; Burkhardt, Harald; Barton, Anne; Reis, Andre			Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis	NATURE GENETICS			English	Article							GENES; IL23R; IL12B; ACT1	Psoriatic arthritis (PsA) is an inflammatory joint disease that is distinct from other chronic arthritides and which is frequently accompanied by psoriasis vulgaris (PsV) and seronegativity for rheumatoid factor. We conducted a genome-wide association study in 609 German individuals with PsA (cases) and 990 controls with replication in 6 European cohorts including a total of 5,488 individuals. We replicated PsA associations at HLA-C and IL12B and identified a new association at TRAF3IP2 (rs13190932, P = 8.56 x 10(-17)). TRAF3IP2 was also associated with PsV in a German cohort including 2,040 individuals (rs13190932, P = 1.95 x 10(-3)). Sequencing of the exons of TRAF3IP2 identified a coding variant (p.Asp10Asn, rs33980500) as the most significantly associated SNP (P = 1.13 x 10(-20), odds ratio = 1.95). Functional assays showed reduced binding of this TRAF3IP2 variant to TRAF6, suggesting altered modulation of immunoregulatory signals through altered TRAF interactions as a new and shared pathway for PsA and PsV.	[Hueffmeier, Ulrike; Uebe, Steffen; Ekici, Arif B.; Lascorz, Jesus; Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany; [Bowes, John; Ho, Pauline; Bruce, Ian N.; Barton, Anne] Univ Manchester, Arthritis Res UK Epidemiol Unit, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Giardina, Emiliano; Novelli, Giuseppe] Univ Roma Tor Vergata, Dept Biopathol, Ctr Excellence Genom Risk Assessment Multifactori, Sch Med, Rome, Italy; [Giardina, Emiliano; Novelli, Giuseppe] Fdn PTV Policlin Tor Vergata, Rome, Italy; [Korendowych, Eleanor; McHugh, Neil J.] Royal Natl Hosp Rheumat Dis, Bath BA1 1RL, Avon, England; [Juneblad, Kristina; Alenius, Gerd-Marie] Univ Hosp, Dept Publ Hlth & Clin Med, Umea, Sweden; [McManus, Ross; Ryan, Anthony W.] Trinity Coll Dublin, Inst Mol Med, Dept Clin Med, Dublin, Ireland; [Behrens, Frank; Boehm, Beate; Burkhardt, Harald] Goethe Univ Frankfurt, Div Rheumatol, Dept Internal Med 2, Frankfurt, Germany; [Traupe, Heiko] Univ Munster, Dept Dermatol, D-4400 Munster, Germany; [Lohmann, Joerg] Psoriasis Rehabil Hosp, Bad Bentheim, Germany; [Gieger, Christian; Wichmann, Heinz-Erich] Helmholtz Ctr Munich, Inst Epidemiol, Munich, Germany; [Wichmann, Heinz-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Epidemiol, Munich, Germany; [Wichmann, Heinz-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Herold, Christine; Steffens, Michael; Wienker, Thomas F.] Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-5300 Bonn, Germany; [Klareskog, Lars] Karolinska Inst, Stockholm, Sweden; [FitzGerald, Oliver] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [FitzGerald, Oliver] Univ Coll Dublin, Sch Med & Med Sci, St Vincents Univ Hosp, Dept Rheumatol, Dublin 2, Ireland; [McHugh, Neil J.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England	University of Erlangen Nuremberg; University of Manchester; University of Rome Tor Vergata; Royal National Hospital for Rheumatic Diseases (RNHRD); Umea University; Trinity College Dublin; Goethe University Frankfurt; University of Munster; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Bonn; Karolinska Institutet; University College Dublin; University College Dublin; Saint Vincent's University Hospital; University of Bath	Reis, A (corresponding author), Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany.	andre.reis@uk-erlangen.de	Wichmann, Heinz Erich/AAA-5695-2022; Giardina, Emiliano/J-1965-2012; Novelli, Giuseppe/GQB-3329-2022; McManus, Ross/AAE-9236-2020; Huffmeier, Ulrike/D-2806-2013; Barton, Anne/N-2053-2014; Ekici, Arif B/C-3971-2013; Behrens, Frank/AAI-8910-2021; Bowes, John/B-3472-2015; Novelli, Giuseppe/A-5195-2013; Ryan, Anthony W/A-1336-2010; Reis, André/D-2309-2009; Novelli, Giuseppe/T-8822-2019	Novelli, Giuseppe/0000-0002-7781-602X; Huffmeier, Ulrike/0000-0001-6448-4671; Barton, Anne/0000-0003-3316-2527; Ekici, Arif B/0000-0001-6099-7066; Behrens, Frank/0000-0001-8750-7186; Bowes, John/0000-0003-4659-031X; Novelli, Giuseppe/0000-0002-7781-602X; Reis, André/0000-0002-6301-6363; Ryan, Anthony/0000-0001-5005-3344; Gieger, Christian/0000-0001-6986-9554; Steffens, Michael/0000-0002-6445-8593; FitzGerald, Oliver/0000-0002-6607-6070; Klareskog, Lars/0000-0001-9601-6186; Bruce, Ian/0000-0003-3047-500X; giardina, emiliano/0000-0002-2741-5009; McManus, Ross/0000-0002-0529-9617	Interdisciplinary Centre for Clinical Research of the University of Erlangen-Nuremberg [IZKF B32/A8]; Helmholtz Center Munich; German Federal Ministry of Education and Research (BMBF); German National Genome Research Network [NGFN-2, NGFNPlus: 01GS0823]; Munich Center of Health Sciences (MC Health); National Institute for Health Research; Manchester Biomedical Research Centre; Science Foundation Ireland; Arthritis Research; Wyeth Pharma GmbH, Germany; ADIPSO (Association for the Defense of Psoriasis Patients); Wellcome Trust [076113]	Interdisciplinary Centre for Clinical Research of the University of Erlangen-Nuremberg; Helmholtz Center Munich(Helmholtz Association); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network; Munich Center of Health Sciences (MC Health); National Institute for Health Research(National Institute for Health Research (NIHR)); Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Arthritis Research(Versus Arthritis); Wyeth Pharma GmbH, Germany; ADIPSO (Association for the Defense of Psoriasis Patients); Wellcome Trust(Wellcome TrustEuropean Commission)	We are grateful to all subjects and control probands for participation in this study. We thank P. Rothe, M. Kirsch, P. Badorf, P. Gilbert and K. Krause for excellent technical assistance. We thank D. Fried for helping with the cloning of constructs. The work was supported in part by a grant from the Interdisciplinary Centre for Clinical Research (IZKF B32/A8) of the University of Erlangen-Nuremberg and a grant from the ELAN fund (Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung) of the University of Erlangen-Nuremberg. The KORA (Cooperative Health Research in the Region of Augsburg) research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFN-2 and NGFNPlus: 01GS0823). Our research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. We acknowledge the National Institute for Health Research, Manchester Biomedical Research Centre and Science Foundation Ireland for support. A. B., I.N. B. and J.B. are funded by Arthritis Research. H. B. and F. B. were supported by a research grant of Wyeth Pharma GmbH, Germany (Forschungsforderungspreis Rheumatologie 2008). E.G. and G.N. are funded by the ADIPSO (Association for the Defense of Psoriasis Patients).; The Irish control DNA was provided by the Irish Blood Transfusion Service and Trinity College Dublin population DNA Biobank. This study makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of the investigators who contributed to the generation of the data is available from http://www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under award 076113. U.H., E.G., E.K., M.A., P.H., I.N.B., F.B., O.F., G.-M.A., N.J.M., G.N., H.B., A.B. and A.R. are members of the Psoriatic Arthritis Genetics in Europe (PAGE) Consortium.	Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; ELDER JT, 1994, ARCH DERMATOL, V130, P216, DOI 10.1001/archderm.130.2.216; Feng BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000606; Filer C, 2008, ARTHRITIS RHEUM-US, V58, P3705, DOI 10.1002/art.24128; Ho PYPC, 2008, ANN RHEUM DIS, V67, P677, DOI 10.1136/ard.2007.071399; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Huffmeier U, 2009, J MED GENET, V46, P736, DOI 10.1136/jmg.2008.065029; Huffmeier U, 2010, ANN RHEUM DIS, V69, P876, DOI 10.1136/ard.2009.108951; Huffmeier U, 2009, J INVEST DERMATOL, V129, P355, DOI 10.1038/jid.2008.233; Hunter CA, 2007, NAT IMMUNOL, V8, P232, DOI 10.1038/ni0307-232; Ibrahim G, 2009, ARTHRIT CARE RES, V61, P1373, DOI 10.1002/art.24608; Kanamori M, 2002, FEBS LETT, V532, P241, DOI 10.1016/S0014-5793(02)03688-8; Karason A, 2009, RHEUMATOLOGY, V48, P1424, DOI 10.1093/rheumatology/kep243; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Uebe S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-472	29	275	290	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					996	U118		10.1038/ng.688	http://dx.doi.org/10.1038/ng.688			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20953186	Green Accepted			2022-12-25	WOS:000283540500018
J	Mionnet, C; Buatois, V; Kanda, A; Milcent, V; Fleury, S; Lair, D; Langelot, M; Lacoeuille, Y; Hessel, E; Coffman, R; Magnan, A; Dombrowicz, D; Glaichenhaus, N; Julia, V				Mionnet, Cyrille; Buatois, Vanessa; Kanda, Akira; Milcent, Valerie; Fleury, Sebastien; Lair, David; Langelot, Marie; Lacoeuille, Yannick; Hessel, Edith; Coffman, Robert; Magnan, Antoine; Dombrowicz, David; Glaichenhaus, Nicolas; Julia, Valerie			CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung	NATURE MEDICINE			English	Article							FRACTALKINE-RECEPTOR CX(3)CR1; INTERFERON-GAMMA; CHEMOKINE; EXPRESSION; ACTIVATION; ASTHMA; RECRUITMENT; INTERLEUKIN-4; EOSINOPHILS; INVOLVEMENT	Allergic asthma is a T helper type 2 (T(H)2)-dominated disease of the lung. In people with asthma, a fraction of CD4(+) T cells express the CX3CL1 receptor, CX3CR1, and CX3CL1 expression is increased in airway smooth muscle, lung endothelium and epithelium upon allergen challenge. Here we found that untreated CX3CR1-deficient mice or wild-type (WT) mice treated with CX3CR1-blocking reagents show reduced lung disease upon allergen sensitization and challenge. Transfer of WT CD4+ T cells into CX3CR1-deficient mice restored the cardinal features of asthma, and CX3CR1-blocking reagents prevented airway inflammation in CX3CR1-deficient recipients injected with WT T(H)2 cells. We found that CX3CR1 signaling promoted T(H)2 survival in the inflamed lungs, and injection of B cell leukemia/lymphoma-2 protein (BCl-2)-transduced CX3CR1-deficient T(H)2 cells into CX3CR1-deficient mice restored asthma. CX3CR1-induced survival was also observed for T(H)1 cells upon airway inflammation but not under homeostatic conditions or upon peripheral inflammation. Therefore, CX3CR1 and CX3CL1 may represent attractive therapeutic targets in asthma.	[Mionnet, Cyrille; Buatois, Vanessa; Milcent, Valerie; Glaichenhaus, Nicolas; Julia, Valerie] Univ Nice Sophia Antipolis, U924, Valbonne, France; [Mionnet, Cyrille; Buatois, Vanessa; Kanda, Akira; Milcent, Valerie; Fleury, Sebastien; Lair, David; Langelot, Marie; Lacoeuille, Yannick; Magnan, Antoine; Dombrowicz, David; Glaichenhaus, Nicolas; Julia, Valerie] Inst Natl Sante & Rech Med, Paris, France; [Kanda, Akira; Fleury, Sebastien; Dombrowicz, David] Univ Lille 2, U1011, Lille, France; [Kanda, Akira; Fleury, Sebastien; Dombrowicz, David] Inst Pasteur, F-59019 Lille, France; [Lair, David; Langelot, Marie; Lacoeuille, Yannick; Magnan, Antoine] Univ Nantes, Inst Thorax, UMR915, Nantes, France; [Hessel, Edith; Coffman, Robert] Dynavax Technol, Berkeley, CA USA	UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Nantes Universite; CHU de Nantes	Julia, V (corresponding author), Univ Nice Sophia Antipolis, U924, Valbonne, France.	vjulia@unice.fr	MAGNAN, ANTOINE/GVT-4308-2022; mionnet, cyrille/P-9168-2016; Magnan, Antoine/D-4100-2015; Hessel, Edith M/AAB-6002-2021; Dombrowicz, David/F-7044-2013	mionnet, cyrille/0000-0001-8431-3837; Hessel, Edith M/0000-0002-2339-4482; Dombrowicz, David/0000-0002-0485-8923; Fleury, Sebastien/0000-0002-0679-3086	Fondation pour la Recherche Medical; Agence Nationale de la Recherche; French Society of Allergology; French Pneumologie Society; Genavie foundation; Pays de la Loire and Provence Alpes Cote d'Azur regional councils	Fondation pour la Recherche Medical(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); French Society of Allergology; French Pneumologie Society; Genavie foundation; Pays de la Loire and Provence Alpes Cote d'Azur regional councils	We thank N. Guy, V. Thieffin and A. Barbot for animal care, J. Cazareth and F. Larbret for cell sorting and S. Kirschnek (Institute for Medical Microbiology, Immunology and Hygiene, Technical University Munich) for providing the MIG-mBcl-2 and MIGR1 vectors. IFN-gamma-specific antibody R4-6A2 and IL-4 specific antibody 11B11 were kind gifts from DNAX Research Institute. Cx3cr1<SUP>GFP/GFP</SUP> mice were a gift from S. Jung (Weizmann Institute of Science, Immunology Department). This research was supported by the Fondation pour la Recherche Medical, the Agence Nationale de la Recherche, the French Society of Allergology, the French Pneumologie Society, the Genavie foundation and the Pays de la Loire and Provence Alpes Cote d'Azur regional councils.	Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Benamar K, 2008, EUR J PHARMACOL, V592, P93, DOI 10.1016/j.ejphar.2008.07.009; Boniface S, 2003, CLIN EXP ALLERGY, V33, P1238, DOI 10.1046/j.1365-2222.2003.01762.x; Chen SZ, 2002, J NEUROIMMUNOL, V133, P46, DOI 10.1016/S0165-5728(02)00354-5; Chensue SW, 2001, J EXP MED, V193, P573, DOI 10.1084/jem.193.5.573; Cho SH, 2005, AM J RESP CRIT CARE, V171, P224, DOI 10.1164/rccm.200310-1416OC; Chung CD, 2003, J IMMUNOL, V170, P581, DOI 10.4049/jimmunol.170.1.581; Chvatchko Y, 2000, J EXP MED, V191, P1755, DOI 10.1084/jem.191.10.1755; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; Conroy DM, 2003, J LEUKOCYTE BIOL, V74, P558, DOI 10.1189/jlb.0103030; Depner M, 2007, INT ARCH ALLERGY IMM, V144, P91, DOI 10.1159/000102620; Echigo T, 2004, J ALLERGY CLIN IMMUN, V113, P940, DOI 10.1016/S0091-6749(04)01061-9; El Biaze M, 2003, ALLERGY, V58, P844, DOI 10.1034/j.1398-9995.2003.00282.x; El-Shazly A, 2006, J IMMUNOL, V176, P1860, DOI 10.4049/jimmunol.176.3.1860; Foussat A, 2000, EUR J IMMUNOL, V30, P87, DOI 10.1002/1521-4141(200001)30:1<87::AID-IMMU87>3.3.CO;2-Z; Fraticelli P, 2001, J CLIN INVEST, V107, P1173, DOI 10.1172/JCI11517; Garin A, 2002, BIOCHEM J, V368, P753, DOI 10.1042/BJ20020951; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gonzalo JA, 2000, J IMMUNOL, V165, P499, DOI 10.4049/jimmunol.165.1.499; Goya I, 2003, J IMMUNOL, V170, P2138, DOI 10.4049/jimmunol.170.4.2138; Hamelmann E, 2008, CLIN EXP ALLERGY, V38, P233, DOI 10.1111/j.1365-2222.2007.02901.x; Hippe A, 2010, RECENT RESULTS CANC, V180, P35, DOI 10.1007/978-3-540-78281-0_4; Honda K, 2004, J ALLERGY CLIN IMMUN, V113, P882, DOI 10.1016/j.jaci.2004.02.036; Humbles AA, 2002, P NATL ACAD SCI USA, V99, P1479, DOI 10.1073/pnas.261462598; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Inoue A, 2005, ARTHRITIS RHEUM-US, V52, P1522, DOI 10.1002/art.21007; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kawasaki S, 2001, J IMMUNOL, V166, P2055, DOI 10.4049/jimmunol.166.3.2055; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Linge HM, 2008, ANTIMICROB AGENTS CH, V52, P2599, DOI 10.1128/AAC.00028-08; Linge HM, 2008, J INTERF CYTOK RES, V28, P190, DOI 10.1089/jir.2007.0100; Liu XD, 2007, AM J RESP CELL MOL, V37, P121, DOI 10.1165/rcmb.2005-0253OC; Lopez Vina A, 2006, ARCH BRONCONEUMOL, V42, P20; Lukacs NW, 2002, AM J PATHOL, V160, P1353, DOI 10.1016/S0002-9440(10)62562-X; Mamessier E, 2008, ALLERGY, V63, P1202, DOI 10.1111/j.1398-9995.2008.01687.x; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Mikhak Z, 2009, J ALLERGY CLIN IMMUN, V123, P67, DOI 10.1016/j.jaci.2008.09.049; Miller Richard J, 2009, Handb Exp Pharmacol, P417, DOI 10.1007/978-3-540-79090-7_12; Milligan ED, 2008, J NEUROIMMUNOL, V198, P113, DOI 10.1016/j.jneuroim.2008.04.011; MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103; Muehlhoefer A, 2000, J IMMUNOL, V164, P3368, DOI 10.4049/jimmunol.164.6.3368; Nanki T, 2004, J IMMUNOL, V173, P7010, DOI 10.4049/jimmunol.173.11.7010; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Nishimura M, 2002, J IMMUNOL, V168, P6173, DOI 10.4049/jimmunol.168.12.6173; O'Byrne PM, 2007, AM J RESP CRIT CARE, V176, P1059, DOI 10.1164/rccm.200708-1264ED; Papadopoulos EJ, 1999, EUR J IMMUNOL, V29, P2551, DOI 10.1002/(SICI)1521-4141(199908)29:08<2551::AID-IMMU2551>3.0.CO;2-T; Ramos MV, 2010, IMMUNOLOGY, V129, P600, DOI 10.1111/j.1365-2567.2009.03181.x; Rimaniol AC, 2003, J ALLERGY CLIN IMMUN, V112, P1139, DOI 10.1016/j.jaci.2003.09.041; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Suzuki F, 2005, J IMMUNOL, V175, P6987, DOI 10.4049/jimmunol.175.10.6987; Tremblay K, 2006, GENES IMMUN, V7, P632, DOI 10.1038/sj.gene.6364340; Verhasselt V, 2008, NAT MED, V14, P170, DOI 10.1038/nm1718; Wang Q, 2001, J IMMUNOL, V167, P4311, DOI 10.4049/jimmunol.167.8.4311; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Yajima N, 2005, ARTHRITIS RHEUM-US, V52, P1670, DOI 10.1002/art.21042; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024	59	89	92	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1305	U160		10.1038/nm.2253	http://dx.doi.org/10.1038/nm.2253			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21037587				2022-12-25	WOS:000283860100043
J	Tiklova, K; Senti, KA; Wang, SQ; Graslund, A; Samakovlis, C				Tiklova, Katarina; Senti, Kirsten-Andre; Wang, Shenqiu; Graslund, Astrid; Samakovlis, Christos			Epithelial septate junction assembly relies on melanotransferrin iron binding and endocytosis in Drosophila	NATURE CELL BIOLOGY			English	Article								Iron is an essential element in many biological processes. In vertebrates, serum transferrin is the major supplier of iron to tissues, but the function of additional transferrin-like proteins remains poorly understood. Melanotransferrin (MTf) is a phylogenetically conserved, iron-binding epithelial protein. Elevated MTf levels have been implicated in melanoma pathogenesis. Here, we present a functional analysis of MTf in Drosophila melanogaster. Similarly to its human homologue, Drosophila MTf is a lipid-modified, iron-binding protein attached to epithelial cell membranes, and is a component of the septate junctions that form the paracellular permeability barrier in epithelial tissues. We demonstrate that septate junction assembly during epithelial maturation relies on endocytosis and apicolateral recycling of iron-bound MTf. Mouse MTf complements the defects of Drosophila MTf mutants. Drosophila provides the first genetic model for the functional dissection of MTf in epithelial junction assembly and morphogenesis.	[Tiklova, Katarina; Senti, Kirsten-Andre; Wang, Shenqiu; Samakovlis, Christos] Stockholm Univ, Dept Dev Biol, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Graslund, Astrid] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University	Samakovlis, C (corresponding author), Stockholm Univ, Dept Dev Biol, Wenner Gren Inst, S-10691 Stockholm, Sweden.	christos@devbio.su.se	Senti, Kirsten-Andre/AAB-3036-2020	Senti, Kirsten-Andre/0000-0002-7208-7593	EMBO; G. Gustafsson Foundation; Vetenskapsradet; Cancerfonden	EMBO(European Molecular Biology Organization (EMBO)); G. Gustafsson Foundation; Vetenskapsradet(Swedish Research Council); Cancerfonden(Swedish Cancer Society)	We are indebted to S. Baumgartner, M. Gonzalez-Gaitan, R. Fehon, G. Beitel, M. Bhat, F. Missirlis, H. Bellen, M. Hortsch, D. Ready, V. Auld, the Bloomington Drosophila Stock Center, the Drosophila Genomics Resource Center (DGRC; Indiana), and the Developmental Studies Hybridoma Bank (DSHB; Iowa) for Drosophila strains, clones and antibodies. We thank M. Sahlin for initial help with iron detection, T. Astlind for the EPR measurements and M. Bjork and I. Granell for expert technical assistance. We are grateful to members of the Samakovlis lab for suggestions. K.S. was supported by an EMBO postdoctoral fellowship. The work was supported by grants from the G. Gustafsson Foundation, Vetenskapsradet and Cancerfonden to C.S.	ALEMANY R, 1993, J CELL SCI, V104, P1155; BAUMGARTNER S, 1996, CELL, V1059, P87; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Laprise P, 2010, CURR BIOL, V20, P55, DOI 10.1016/j.cub.2009.11.017; Laval M, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-38; Rahmanto YS, 2009, BBA-MOL CELL RES, V1793, P1210, DOI 10.1016/j.bbamcr.2009.02.003; SURYO R, 2007, ONCOGENE, V26, P6113; TOMANCAK P, 2002, GENOME BIOL, V14, P88	8	61	62	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2010	12	11					1071	U57		10.1038/ncb2111	http://dx.doi.org/10.1038/ncb2111			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	674CO	20935638				2022-12-25	WOS:000283711500010
J	Guo, ZG; Zheng, L; Xu, H; Dai, HF; Zhou, MA; Pascua, MR; Chen, QM; Shen, BH				Guo, Zhigang; Zheng, Li; Xu, Hong; Dai, Huifang; Zhou, Mian; Pascua, Mary Rose; Chen, Qin M.; Shen, Binghui			Methylation of FEN1 suppresses nearby phosphorylation and facilitates PCNA binding	NATURE CHEMICAL BIOLOGY			English	Article							BASE-EXCISION-REPAIR; CELL NUCLEAR ANTIGEN; PROTEIN ARGININE METHYLATION; FLAP ENDONUCLEASE-1 ACTIVITY; DNA-POLYMERASE-BETA; REPLICATION FORK; BREAST-CANCER; LIGASE I; DAMAGE; PRMT1	Flap endonuclease 1 (FEN1), a structure-specific endo- and exonuclease, has multiple functions that determine essential biological processes, such as cell proliferation and cell death. As such, the enzyme must be precisely regulated to execute each of its functions with the right timing and in a specific subcellular location. Here we report that FEN1 is methylated at arginine residues, primarily at Arg192. The methylation suppresses FEN1 phosphorylation at Ser187. The methylated form, but not the phosphorylated form, of FEN1 strongly interacts with proliferating cell nuclear antigen (PCNA), ensuring the 'on' and 'off' timing of its reaction. Mutations of FEN1 disrupting arginine methylation and PCNA interaction result in unscheduled phosphorylation and a failure to localize to DNA replication or repair foci. This consequently leads to a defect in Okazaki fragment maturation, a delay in cell cycle progression, impairment of DNA repair and a high frequency of genome-wide mutations.	[Guo, Zhigang; Zheng, Li; Xu, Hong; Dai, Huifang; Zhou, Mian; Pascua, Mary Rose; Shen, Binghui] City Hope Natl Med Ctr, Dept Canc Biol, Duarte, CA 91010 USA; [Guo, Zhigang; Zheng, Li; Xu, Hong; Dai, Huifang; Zhou, Mian; Pascua, Mary Rose; Shen, Binghui] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Chen, Qin M.] Univ Arizona, Dept Pharmacol, Tucson, AZ USA	City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of Arizona	Guo, ZG (corresponding author), City Hope Natl Med Ctr, Dept Canc Biol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	bshen@coh.org		Shen, Binghui/0000-0002-4408-407X	US National Institutes of Health [RO1 CA073764, R01CA085344]; NATIONAL CANCER INSTITUTE [R01CA085344, R01CA073764] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Tsaprailis in the Proteomics Core facility of University of Arizona for technical assistance in determining the methylation sites on FEN1. We thank S. R. da Costa for editorial assistance. This work was supported by US National Institutes of Health grants RO1 CA073764 and R01CA085344 to B. S.	Adams MM, 2005, CELL CYCLE, V4, P1854, DOI 10.4161/cc.4.12.2282; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Boisvert FM, 2005, GENE DEV, V19, P671, DOI 10.1101/gad.1279805; Boisvert FM, 2005, CELL CYCLE, V4, P1834, DOI 10.4161/cc.4.12.2250; Boisvert FM, 2005, CELL CYCLE, V4, P981, DOI 10.4161/cc.4.7.1830; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chen DH, 2004, J BIOCHEM, V136, P371, DOI 10.1093/jb/mvh131; Chen JJ, 1996, P NATL ACAD SCI USA, V93, P11597, DOI 10.1073/pnas.93.21.11597; Cheung N, 2007, NAT CELL BIOL, V9, P1208, DOI 10.1038/ncb1642; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Dery U, 2008, MOL CELL BIOL, V28, P3058, DOI 10.1128/MCB.02025-07; El-Andaloussi N, 2006, MOL CELL, V22, P51, DOI 10.1016/j.molcel.2006.02.013; El-Andaloussi N, 2007, FASEB J, V21, P26, DOI 10.1096/fj.06-6194com; Frietze S, 2008, CANCER RES, V68, P301, DOI 10.1158/0008-5472.CAN-07-1983; Guo ZG, 2008, MOL CELL BIOL, V28, P4310, DOI 10.1128/MCB.00200-08; Guo ZG, 2008, J MOL BIOL, V377, P679, DOI 10.1016/j.jmb.2007.10.074; Hasan S, 2001, MOL CELL, V7, P1221, DOI 10.1016/S1097-2765(01)00272-6; Henneke G, 2003, ONCOGENE, V22, P4301, DOI 10.1038/sj.onc.1206606; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kalifa L, 2009, DNA REPAIR, V8, P1242, DOI 10.1016/j.dnarep.2009.07.008; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Levin DS, 2000, CURR BIOL, V10, P919, DOI 10.1016/S0960-9822(00)00619-9; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; LIU Q, 1995, MOL CELL BIOL, V15, P2800; Lu RQ, 2000, P NATL ACAD SCI USA, V97, P3993, DOI 10.1073/pnas.97.8.3993; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; Mitra AK, 2008, ONCOL RES, V17, P127, DOI 10.3727/096504008785055567; Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320; Qian Y, 1998, MUTAT RES-GEN TOX EN, V418, P61, DOI 10.1016/S1383-5718(98)00108-9; Qiu JZ, 2001, J BIOL CHEM, V276, P4901, DOI 10.1074/jbc.M007825200; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; Shibata Y, 2002, J BIOL CHEM, V277, P746, DOI 10.1074/jbc.M109461200; Soza S, 2009, MOL CELL BIOL, V29, P2032, DOI 10.1128/MCB.01730-08; Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tom S, 2000, J BIOL CHEM, V275, P10498, DOI 10.1074/jbc.275.14.10498; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Weber S, 2009, CELL CYCLE, V8, P1464; Weber S, 2009, GENE DEV, V23, P118, DOI 10.1101/gad.489409; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024; Zheng L, 2007, MOL CELL BIOL, V27, P3176, DOI 10.1128/MCB.01652-06	50	90	94	15	137	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2010	6	10					766	773		10.1038/NCHEMBIO.422	http://dx.doi.org/10.1038/NCHEMBIO.422			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	651YM	20729856	Green Accepted			2022-12-25	WOS:000281964100014
J	Lafreniere, RG; Cader, MZ; Poulin, JF; Andres-Enguix, I; Simoneau, M; Gupta, N; Boisvert, K; Lafreniere, F; McLaughlan, S; Dube, MP; Marcinkiewicz, MM; Ramagopalan, S; Ansorge, O; Brais, B; Sequeiros, J; Pereira-Monteiro, JM; Griffiths, LR; Tucker, SJ; Ebers, G; Rouleau, GA				Lafreniere, Ronald G.; Cader, M. Zameel; Poulin, Jean-Francois; Andres-Enguix, Isabelle; Simoneau, Maryse; Gupta, Namrata; Boisvert, Karine; Lafreniere, Francois; McLaughlan, Shannon; Dube, Marie-Pierre; Marcinkiewicz, Martin M.; Ramagopalan, Sreeram; Ansorge, Olaf; Brais, Bernard; Sequeiros, Jorge; Pereira-Monteiro, Jose Maria; Griffiths, Lyn R.; Tucker, Stephen J.; Ebers, George; Rouleau, Guy A.			A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura	NATURE MEDICINE			English	Article							DOMAIN K+ CHANNEL; SPREADING DEPRESSION; HEMIPLEGIC MIGRAINE; ACTIVATION; CALCINEURIN; CURRENTS; LONG	Migraine with aura is a common, debilitating, recurrent headache disorder associated with transient and reversible focal neurological symptoms(1). A role has been suggested for the two-pore domain (K2P) potassium channel, TWIK-related spinal cord potassium channel (TRESK, encoded by KCNK18), in pain pathways and general anaesthesia(2). We therefore examined whether TRESK is involved in migraine by screening the KCNK18 gene in subjects diagnosed with migraine. Here we report a frameshift mutation, F139WfsX24, which segregates perfectly with typical migraine with aura in a large pedigree. We also identified prominent TRESK expression in migraine-salient areas such as the trigeminal ganglion. Functional characterization of this mutation demonstrates that it causes a complete loss of TRESK function and that the mutant subunit suppresses wild-type channel function through a dominant-negative effect, thus explaining the dominant penetrance of this allele. These results therefore support a role for TRESK in the pathogenesis of typical migraine with aura and further support the role of this channel as a potential therapeutic target.	[Lafreniere, Ronald G.; Brais, Bernard; Rouleau, Guy A.] Univ Montreal, Res Ctr, Ctr Excellence Neur, Ctr Hosp Univ Montreal,Notre Dame Hosp, Montreal, PQ H3C 3J7, Canada; [Lafreniere, Ronald G.; Brais, Bernard; Rouleau, Guy A.] Univ Montreal, Res Ctr, Dept Med, Ctr Hosp Univ Montreal,Notre Dame Hosp, Montreal, PQ H3C 3J7, Canada; [Lafreniere, Ronald G.; Poulin, Jean-Francois; Simoneau, Maryse; Gupta, Namrata; Boisvert, Karine; Lafreniere, Francois; McLaughlan, Shannon; Rouleau, Guy A.] Emerillon Therapeut, Montreal, PQ, Canada; [Cader, M. Zameel] Univ Oxford, Med Res Council Funct Genom Unit, Dept Physiol Anat & Genet, Oxford, England; [Cader, M. Zameel] John Radcliffe Hosp, Dept Clin Neurol, Oxford OX3 9DU, England; [Andres-Enguix, Isabelle] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Dube, Marie-Pierre] Univ Montreal, Montreal Heart Inst, Fac Med, Montreal, PQ H3C 3J7, Canada; [Marcinkiewicz, Martin M.] Cytochem, Montreal, PQ, Canada; [Ramagopalan, Sreeram; Ebers, George] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Ansorge, Olaf] Univ Oxford, Dept Neuropathol, Oxford, England; [Sequeiros, Jorge] Univ Porto, Inst Mol & Cell Biol, UnlGENe, P-4100 Oporto, Portugal; [Pereira-Monteiro, Jose Maria] Hosp Santo Antonio, Oporto, Portugal; [Griffiths, Lyn R.] Griffith Univ, Griffith Hlth Inst, Gen Res Ctr, Gold Coast, Qld, Australia	Universite de Montreal; Universite de Montreal; University of Oxford; University of Oxford; University of Oxford; Universite de Montreal; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Universidade do Porto; Griffith University; Menzies Health Institute Queensland	Rouleau, GA (corresponding author), Univ Montreal, Res Ctr, Ctr Excellence Neur, Ctr Hosp Univ Montreal,Notre Dame Hosp, Montreal, PQ H3C 3J7, Canada.	zameel.cader@dpag.ox.ac.uk; guy.rouleau@umontreal.ca	Tucker, Stephen J./ABE-7468-2020; Pereira-Monteiro, José/K-6036-2013; Tucker, Stephen J./ABE-6741-2020; Dubé, Marie-Pierre/B-9364-2008; Brais, Bernard/Y-3910-2019	Tucker, Stephen J./0000-0001-8996-2000; Tucker, Stephen J./0000-0001-8996-2000; Dubé, Marie-Pierre/0000-0001-8442-4393; Ebers, George/0000-0003-4771-4177; Pereira-Monteiro, Jose/0000-0001-8846-0754; Griffiths, Lyn/0000-0002-6774-5475; Sequeiros, Jorge/0000-0002-9846-1037; Cader, Zameel/0000-0002-6952-406X	Genome Canada; Genome Quebec; Emerillon Therapeutics; Wellcome Trust; Pfizer; Medical Research Council (UK); Natural Sciences and Engineering Research Council of Canada; Medical Research Council [G0601887] Funding Source: researchfish; MRC [G0601887] Funding Source: UKRI	Genome Canada(Genome Canada); Genome Quebec; Emerillon Therapeutics; Wellcome Trust(Wellcome TrustEuropean Commission); Pfizer(Pfizer); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the subjects and their families for participating in the study and M. K. Charles, M. Albanese, M. Imbeau, A. Anton, S. Meilleur and F. Fernandez for technical assistance. Funding was kindly provided by Genome Canada, Genome Quebec, Emerillon Therapeutics, the Wellcome Trust and Pfizer. M.Z.C. was supported by the Medical Research Council (UK). J.-F.P. was supported by an industrial postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Barel O, 2008, AM J HUM GENET, V83, P193, DOI 10.1016/j.ajhg.2008.07.010; Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Cader ZM, 2003, HUM MOL GENET, V12, P2511, DOI 10.1093/hmg/ddg252; Colson NJ, 2005, NEUROGENETICS, V6, P17, DOI 10.1007/s10048-004-0205-0; Czirjak B, 2004, J BIOL CHEM, V279, P18550, DOI 10.1074/jbc.M312229200; Czirjak G, 2006, J BIOL CHEM, V281, P14677, DOI 10.1074/jbc.M602495200; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; de Vries B, 2009, HUM GENET, V126, P115, DOI 10.1007/s00439-009-0684-z; Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4; Dobler T, 2007, J PHYSIOL-LONDON, V585, P867, DOI 10.1113/jphysiol.2007.145649; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Ferrari Uta, 2005, Headache, V45, P211, DOI 10.1111/j.1526-4610.2005.05046.x; Huang Dong-Yue, 2008, Neurosci Bull, V24, P166, DOI 10.1007/s12264-008-0225-0; Iadecola C, 2002, NAT MED, V8, P110, DOI 10.1038/nm0202-110; Lemos C, 2009, HEADACHE, V49, P404, DOI 10.1111/j.1526-4610.2008.01177.x; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Liu CH, 2004, ANESTH ANALG, V99, P1715, DOI 10.1213/01.ANE.0000136849.07384.44; London B, 1998, P NATL ACAD SCI USA, V95, P2926, DOI 10.1073/pnas.95.6.2926; Mathie A, 2007, J PHYSIOL-LONDON, V578, P377, DOI 10.1113/jphysiol.2006.121582; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Piper RD, 1996, CEPHALALGIA, V16, P87, DOI 10.1046/j.1468-2982.1996.1602087.x; Ramagopalan SV, 2007, J NEUROL, V254, P1629, DOI 10.1007/s00415-007-0641-5; Sano Y, 2003, J BIOL CHEM, V278, P27406, DOI 10.1074/jbc.M206810200; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Smith HS, 2009, PAIN PHYSICIAN, V12, pE309; Wuttke TV, 2007, NEUROLOGY, V69, P2045, DOI 10.1212/01.wnl.0000275523.95103.36; Yoo S, 2009, NEUROSCI LETT, V465, P79, DOI 10.1016/j.neulet.2009.08.062; Zerr P, 1998, J NEUROSCI, V18, P2842; Zhang XC, 2010, J NEUROSCI, V30, P8807, DOI 10.1523/JNEUROSCI.0511-10.2010	30	231	243	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2010	16	10					1157	U1501		10.1038/nm.2216	http://dx.doi.org/10.1038/nm.2216			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20871611				2022-12-25	WOS:000282644800048
J	Roukens, MG; Alloul-Ramdhani, M; Baan, B; Kobayashi, K; Peterson-Maduro, J; van Dam, H; Schulte-Merker, S; Baker, DA				Roukens, M. Guy; Alloul-Ramdhani, Mariam; Baan, Bart; Kobayashi, Kazuki; Peterson-Maduro, Josi; van Dam, Hans; Schulte-Merker, Stefan; Baker, David A.			Control of endothelial sprouting by a Tel-CtBP complex	NATURE CELL BIOLOGY			English	Article							INHIBITS TUMOR-GROWTH; EMBRYONIC LETHALITY; NOTCH; VEGF; DLL4; MORPHOGENESIS; MODULATION; ARTERIAL; LACKING; KINASE	We show that the transcriptional repressor Tel plays an evolutionarily conserved role in angiogenesis: it is indispensable for the sprouting of human endothelial cells and for normal development of the Danio rerio blood circulatory system. Tel orchestrates endothelial sprouting by binding to the generic co-repressor, CtBP. The Tel-CtBP complex temporally restricts a VEGF (vascular endothelial growth factor)-mediated pulse of dll4 expression and thereby directly links VEGF receptor intracellular signalling and intercellular Notch-Dll4 signalling. It further controls branching by regulating expression of other factors that constrain angiogenesis such as sprouty family members and ve-cadherin. Thus, the Tel-CtBP complex conditions endothelial cells for angiogenesis by controlling the balance between stimulatory and antagonistic sprouting cues. Tel control of branching seems to be a refinement of invertebrate tracheae morphogenesis that requires Yan, the invertebrate orthologue of Tel. This work highlights Tel and its associated networks as potential targets for the development of therapeutic strategies to inhibit pathological angiogenesis.	[Roukens, M. Guy; Alloul-Ramdhani, Mariam; Baker, David A.] LUMC, Sect Growth Control & Transcript, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; [Baan, Bart; Kobayashi, Kazuki; van Dam, Hans] LUMC, Sect Signal Transduct, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; [Peterson-Maduro, Josi; Schulte-Merker, Stefan] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Peterson-Maduro, Josi; Schulte-Merker, Stefan] Univ Med Ctr, NL-3584 CT Utrecht, Netherlands; [Peterson-Maduro, Josi; Schulte-Merker, Stefan] Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Baker, DA (corresponding author), LUMC, Sect Growth Control & Transcript, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands.	d.baker@lumc.nl		van Dam, Hans/0000-0002-8307-4325; Roukens, Guy/0000-0002-4270-8678				Bahary N, 2007, BLOOD, V110, P3627, DOI 10.1182/blood-2006-04-016378; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gerhardt H., 2008, ORGANOGENESIS, V4, P241, DOI [DOI 10.4161/0RG.4.4.7414, DOI 10.4161/org.4.4.7414]; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Hogan BM, 2009, DEVELOPMENT, V136, P4001, DOI 10.1242/dev.039990; Ikeya T, 1999, DEVELOPMENT, V126, P4455; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Krebs LT, 2000, GENE DEV, V14, P1343; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Lopez R, 1999, J BIOL CHEM, V274, P30132, DOI 10.1074/jbc.274.42.30132; Nakatsu MN, 2008, METHOD ENZYMOL, V443, P65, DOI 10.1016/S0076-6879(08)02004-1; Nardini M, 2003, EMBO J, V22, P3122, DOI 10.1093/emboj/cdg283; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Roukens MG, 2008, MOL CELL BIOL, V28, P4394, DOI 10.1128/MCB.01914-07; Roukens MG, 2008, MOL CELL BIOL, V28, P2342, DOI 10.1128/MCB.01159-07; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Ruhrberg C, 2003, BIOESSAYS, V25, P1052, DOI 10.1002/bies.10351; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Siekmann AF, 2008, BIOESSAYS, V30, P303, DOI 10.1002/bies.20736; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Turner J, 2001, BIOESSAYS, V23, P683, DOI 10.1002/bies.1097; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Wang LC, 1997, EMBO J, V16, P4374, DOI 10.1093/emboj/16.14.4374; Zhang QH, 2002, SCIENCE, V295, P1895; Zhao LJ, 2006, J BIOL CHEM, V281, P4183, DOI 10.1074/jbc.M509051200	48	37	37	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					933	942		10.1038/ncb2096	http://dx.doi.org/10.1038/ncb2096			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20835243				2022-12-25	WOS:000282363500008
J	Van Dyke, T				Van Dyke, Terry			Approximating a human cancer	NATURE MEDICINE			English	Editorial Material							PANCREATIC-CANCER; CHEMOTHERAPY		[Van Dyke, Terry] NCI, Mouse Canc Genet Program, Frederick, MD 21701 USA; [Van Dyke, Terry] NCI, Ctr Adv Preclin Res, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Van Dyke, T (corresponding author), NCI, Mouse Canc Genet Program, Frederick, MD 21701 USA.	vandyket@mail.nih.gov			Intramural NIH HHS [Z99 CA999999] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZICBC011137, ZIABC011240] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Rekhert JM, 2008, DRUG DISCOV TODAY, V13, P30, DOI 10.1016/j.drudis.2007.09.003; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; Xiong HQ, 2006, DRUGS, V66, P1059, DOI 10.2165/00003495-200666080-00003; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	8	13	13	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2010	16	9					976	977		10.1038/nm0910-976	http://dx.doi.org/10.1038/nm0910-976			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20823881	Green Accepted			2022-12-25	WOS:000281622900024
J	Feinstein, TN; Wehbi, VL; Ardura, JA; Wheeler, DS; Ferrandon, S; Gardella, TJ; Vilardaga, JP				Feinstein, Timothy N.; Wehbi, Vanessa L.; Ardura, Juan A.; Wheeler, David S.; Ferrandon, Sebastien; Gardella, Thomas J.; Vilardaga, Jean-Pierre			Retromer terminates the generation of cAMP by internalized PTH receptors	NATURE CHEMICAL BIOLOGY			English	Article							PARATHYROID-HORMONE RECEPTOR; PROTEIN-COUPLED-RECEPTOR; BONE-MINERAL DENSITY; BETA-ARRESTIN; KINASE-C; BETA-2-ADRENERGIC RECEPTOR; MAMMALIAN RETROMER; DESENSITIZATION; ACTIVATION; IDENTIFICATION	The generation of cAMP by G protein-coupled receptors (GPCRs) and its termination are currently thought to occur exclusively at the plasma membrane of cells. Under existing models of receptor regulation, this signal is primarily restricted by desensitization of the receptors through their binding to beta-arrestins. However, this paradigm is not consistent with recent observations that the parathyroid hormone receptor type 1 (PTHR) continues to stimulate cAMP production even after receptor internalization, as beta-arrestins are known to rapidly bind and internalize activated PTHR. Here we show that binding to beta-arrestin1 prolongs rather than terminates the generation of cAMP by PTHR, and that cAMP generation correlates with the persistence of arrestin-receptor complexes on endosomes. PTHR signaling is instead turned off by the retromer complex, which regulates the movement of internalized receptor from endosomes to the Golgi apparatus. Thus, binding by the retromer complex regulates the sustained generation of cAMP triggered by an internalized GPCR.	[Feinstein, Timothy N.; Wehbi, Vanessa L.; Ardura, Juan A.; Wheeler, David S.; Vilardaga, Jean-Pierre] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15260 USA; [Ferrandon, Sebastien; Gardella, Thomas J.; Vilardaga, Jean-Pierre] Massachusetts Gen Hosp, Dept Med, Endocrine Unit, Boston, MA 02114 USA; [Ferrandon, Sebastien; Gardella, Thomas J.; Vilardaga, Jean-Pierre] Harvard Univ, Sch Med, Boston, MA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Vilardaga, JP (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15260 USA.	jpv@pitt.edu	Feinstein, Timothy/G-3110-2011; Ardura, Juan/L-8139-2014; Ardura, Juan Antonio/F-3378-2017	Ardura, Juan/0000-0002-8881-4775; Ardura, Juan Antonio/0000-0002-2827-3364; Feinstein, Timothy/0000-0002-9801-9708; Vilardaga, Jean-Pierre/0000-0002-1217-1435	US National Institutes of Health [R01DK087688]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087688] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the US National Institutes of Health award R01DK087688 (to J.-P.V.). We thank J. Bonifacino for plasmids encoding retromer subunits Vps26 and Vps29<SUP>YFP</SUP> and L. Traub for plasmids encoding beta-arrestin1<SUP>tom</SUP> and beta-arrestin1[I386A, V387A]<SUP>tom</SUP>.	Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Aubry L, 2009, CURR GENOMICS, V10, P133, DOI 10.2174/138920209787847014; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Burtey A, 2007, TRAFFIC, V8, P914, DOI 10.1111/j.1600-0854.2007.00578.x; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Castro M, 2002, ENDOCRINOLOGY, V143, P3854, DOI 10.1210/en.2002-220232; Chauvin S, 2002, MOL ENDOCRINOL, V16, P2720, DOI 10.1210/me.2002-0049; Collins BM, 2008, TRAFFIC, V9, P1811, DOI 10.1111/j.1600-0854.2008.00777.x; Collins BM, 2008, TRAFFIC, V9, P366, DOI 10.1111/j.1600-0854.2007.00688.x; Eaton S, 2008, DEV CELL, V14, P4, DOI 10.1016/j.devcel.2007.12.014; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Ferrari SL, 1999, J BIOL CHEM, V274, P29968, DOI 10.1074/jbc.274.42.29968; Finkelstein JS, 1999, J CLIN ENDOCR METAB, V84, P1214, DOI 10.1210/jc.84.4.1214; Gaidarov I, 1999, EMBO J, V18, P871, DOI 10.1093/emboj/18.4.871; Garrido JL, 2009, MOL ENDOCRINOL, V23, P2048, DOI 10.1210/me.2008-0436; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Hoffmann R, 1999, EMBO J, V18, P893, DOI 10.1093/emboj/18.4.893; Horwitz MJ, 2003, J CLIN ENDOCR METAB, V88, P1603, DOI 10.1210/jc.2002-020773; Johnston CA, 2008, STRUCTURE, V16, P1086, DOI 10.1016/j.str.2008.04.010; Keyel PA, 2008, MOL BIOL CELL, V19, P5309, DOI 10.1091/mbc.E08-07-0712; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; Lerner JM, 2004, CYTOM PART A, V62A, P8, DOI 10.1002/cyto.a.20087; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Mahon MJ, 2006, MOL ENDOCRINOL, V20, P136, DOI 10.1210/me.2005-0169; Malecz N, 1998, MOL ENDOCRINOL, V12, P1846, DOI 10.1210/me.12.12.1846; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Nikolaev VO, 2006, J BIOL CHEM, V281, P24506, DOI 10.1074/jbc.M603266200; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Nothwehr SF, 1999, MOL BIOL CELL, V10, P875, DOI 10.1091/mbc.10.4.875; Okazaki M, 2008, P NATL ACAD SCI USA, V105, P16525, DOI 10.1073/pnas.0808750105; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; PIPPIG S, 1993, J BIOL CHEM, V268, P3201; PITCHER J, 1992, BIOCHEMISTRY-US, V31, P3193, DOI 10.1021/bi00127a021; Popoff V, 2007, J CELL SCI, V120, P2022, DOI 10.1242/jcs.003020; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Robben JH, 2009, P NATL ACAD SCI USA, V106, P12195, DOI 10.1073/pnas.0900130106; Rosenblatt M, 2009, NAT CHEM BIOL, V5, P707, DOI 10.1038/nchembio.225; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Verges M, 2004, NAT CELL BIOL, V6, P763, DOI 10.1038/ncb1153; Vilardaga JP, 2002, J BIOL CHEM, V277, P8121, DOI 10.1074/jbc.M110433200; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Yang M, 2009, BIOCHEM J, V417, P287, DOI 10.1042/BJ20081561; Zucker RM, 2005, MICROSC RES TECHNIQ, V68, P307, DOI 10.1002/jemt.20249	49	155	157	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2011	7	5					278	284		10.1038/nchembio.545	http://dx.doi.org/10.1038/nchembio.545			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751KZ	21445058	Green Accepted			2022-12-25	WOS:000289617800011
J	Mylne, JS; Colgrave, ML; Daly, NL; Chanson, AH; Elliott, AG; McCallum, EJ; Jones, A; Craik, DJ				Mylne, Joshua S.; Colgrave, Michelle L.; Daly, Norelle L.; Chanson, Aurelie H.; Elliott, Alysha G.; McCallum, Emily J.; Jones, Alun; Craik, David J.			Albumins and their processing machinery are hijacked for cyclic peptides in sunflower	NATURE CHEMICAL BIOLOGY			English	Article							SEED STORAGE PROTEINS; TRYPSIN-INHIBITOR; ARABIDOPSIS-THALIANA; PROTEASE INHIBITORS; SERINE-PROTEASE; ENZYME; POTENT; ENDOPEPTIDASE; BIOSYNTHESIS; PROPEPTIDES	The cyclic peptide sunflower trypsin inhibitor 1 (SFTI-1) blocks trypsin and is a promising drug lead and protein engineering scaffold. We show that SFTI-1 and the newfound SFT-L1 are buried within PawS1 and PawS2, precursors for seed storage protein albumins. Proalbumins are matured by asparaginyl endopeptidase, which we show is required to liberate both ends of SFTI-1 as well as to mature PawS1 albumin. Thus, these peptides emerge from within an albumin precursor by the action of albumin's own processing enzyme.	[Mylne, Joshua S.; Daly, Norelle L.; Chanson, Aurelie H.; Elliott, Alysha G.; McCallum, Emily J.; Jones, Alun; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Colgrave, Michelle L.] Commonwealth Sci & Ind Res Org Livestock Ind, Brisbane, Qld, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Mylne, JS (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	j.mylne@imb.uq.edu.au; d.craik@imb.uq.edu.au	Elliott, Alysha/K-2733-2015; Mylne, Joshua S/A-5581-2009; Colgrave, Michelle/A-5710-2012; Daly, Norelle L/D-4302-2013; Mylne, Josh/GMX-4544-2022; Craik, David/B-1695-2010	Elliott, Alysha/0000-0002-2983-0484; Mylne, Joshua S/0000-0003-4957-6388; Colgrave, Michelle/0000-0001-8463-805X; Daly, Norelle L/0000-0002-4697-6602; Mylne, Josh/0000-0003-4957-6388; Craik, David/0000-0003-0007-6796; Benfield, Aurelie/0000-0002-3068-906X; McCallum, Emily/0000-0001-8783-4873	United States Department of Agriculture Initiative for Future Agriculture and Food Systems; National Science Foundation	United States Department of Agriculture Initiative for Future Agriculture and Food Systems(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF))	The authors thank staff at the Arizona Genomics Institute (University of Arizona) for providing Helianthus cDNA clones, the Compositae Genome Project website (http://cgpdb.ucdavis.edu/) that was supported by the United States Department of Agriculture Initiative for Future Agriculture and Food Systems program and National Science Foundation Plant Genome Program for EST data, S. Dillon (Australian Plant Genetic Resource Information Service) for Helianthus seeds, I. Hara-Nishimura (University of Kyoto) for aep null seeds, A. Argyros for technical assistance, H. Schirra (University of Queensland) for providing the structural image used in Supplementary Figure 1 as well as R. Jung, M. Anderson, D. Ortiz-Barrientos and S. Balasubramanian for comments. D.J.C. is a National Health and Medical Research Council Professorial Fellow. J.S.M. is an Australian Research Council Queen Elizabeth II Fellow (DP0879133) and The John S. Mattick Fellow. N.L.D. is a Queensland Smart State Fellow.	Autelitano DJ, 2006, DRUG DISCOV TODAY, V11, P306, DOI 10.1016/j.drudis.2006.02.003; Daly NL, 2006, J BIOL CHEM, V281, P23668, DOI 10.1074/jbc.M601426200; DHONDT K, 1993, J BIOL CHEM, V268, P20884; Gillon AD, 2008, PLANT J, V53, P505, DOI 10.1111/j.1365-313X.2007.03357.x; Gruis DF, 2004, PLANT CELL, V16, P270, DOI 10.1105/tpc.016378; HARAHISHIMURA I, 1993, PLANT J, V4, P793, DOI 10.1046/j.1365-313X.1993.04050793.x; Hartl M, 2010, PLANT CELL, V22, P4158, DOI 10.1105/tpc.109.073395; Hiraiwa N, 1999, FEBS LETT, V447, P213, DOI 10.1016/S0014-5793(99)00286-0; Hiraiwa N, 1997, EUR J BIOCHEM, V246, P133, DOI 10.1111/j.1432-1033.1997.00133.x; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Korsinczky MLJ, 2001, J MOL BIOL, V311, P579, DOI 10.1006/jmbi.2001.4887; Kuroyanagi M, 2005, J BIOL CHEM, V280, P32914, DOI 10.1074/jbc.M504476200; Long YQ, 2001, BIOORG MED CHEM LETT, V11, P2515, DOI 10.1016/S0960-894X(01)00493-0; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; Mulvenna JP, 2005, J BIOL CHEM, V280, P32245, DOI 10.1074/jbc.M506060200; Otegui MS, 2006, PLANT CELL, V18, P2567, DOI 10.1105/tpc.106.040931; PANERO J, 2007, FLOWERING PLANTS EUD, V8, P635; Robinson JA, 2008, ACCOUNTS CHEM RES, V41, P1278, DOI 10.1021/ar700259k; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; Shewry PR, 1999, SEED PROTEINS, P883; Shimada T, 2003, J BIOL CHEM, V278, P32292, DOI 10.1074/jbc.M305740200; Swedberg JE, 2009, CHEM BIOL, V16, P633, DOI 10.1016/j.chembiol.2009.05.008	22	114	119	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2011	7	5					257	259		10.1038/nchembio.542	http://dx.doi.org/10.1038/nchembio.542			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751KZ	21423169				2022-12-25	WOS:000289617800007
J	Xu, J; Reumers, J; Couceiro, JR; De Smet, F; Gallardo, R; Rudyak, S; Cornelis, A; Rozenski, J; Zwolinska, A; Marine, JC; Lambrechts, D; Suh, YA; Rousseau, F; Schymkowitz, J				Xu, Jie; Reumers, Joke; Couceiro, Jose R.; De Smet, Frederik; Gallardo, Rodrigo; Rudyak, Stanislav; Cornelis, Ann; Rozenski, Jef; Zwolinska, Aleksandra; Marine, Jean-Christophe; Lambrechts, Diether; Suh, Young-Ah; Rousseau, Frederic; Schymkowitz, Joost			Gain of function of mutant p53 by coaggregation with multiple tumor suppressors	NATURE CHEMICAL BIOLOGY			English	Article							DNA-BINDING; WILD-TYPE; PROGNOSTIC-SIGNIFICANCE; ACTIVATING MUTATIONS; PROTEIN AGGREGATION; LI-FRAUMENI; CANCER; P73; P63; TRANSFORMATION	Many p53 missense mutations possess dominant-negative activity and oncogenic gain of function. We report that for structurally destabilized p53 mutants, these effects result from mutant-induced coaggregation of wild-type p53 and its paralogs p63 and p73, thereby also inducing a heat-shock response. Aggregation of mutant p53 resulted from self-assembly of a conserved aggregation-nucleating sequence within the hydrophobic core of the DNA-binding domain, which becomes exposed after mutation. Suppressing the aggregation propensity of this sequence by mutagenesis abrogated gain of function and restored activity of wild-type p53 and its paralogs. In the p53 germline mutation database, tumors carrying aggregation-prone p53 mutations have a significantly lower frequency of wild-type allele loss as compared to tumors harboring nonaggregating mutations, suggesting a difference in clonal selection of aggregating mutants. Overall, our study reveals a novel disease mechanism for mutant p53 gain of function and suggests that, at least in some respects, cancer could be considered an aggregation-associated disease.	[Xu, Jie; Reumers, Joke; Couceiro, Jose R.; De Smet, Frederik; Gallardo, Rodrigo; Rudyak, Stanislav; Rousseau, Frederic; Schymkowitz, Joost] Vrije Univ Brussel, Flanders Inst Biotechnol, SWITCH Lab, Brussels, Belgium; [Cornelis, Ann] Reg Ziekenhuis Heilig Hart, Dept Pathol, Tienen, Belgium; [Rozenski, Jef] Katholieke Univ Leuven, Rega Inst Med Res, Med Chem Lab, B-3000 Louvain, Belgium; [Zwolinska, Aleksandra; Marine, Jean-Christophe] Katholieke Univ Leuven, Flanders Inst Biotechnol, Dept Mol & Dev Genet, Lab Mol Canc Biol, Louvain, Belgium; [Lambrechts, Diether] Katholieke Univ Leuven, Flanders Inst Biotechnol, Vesalius Res Ctr, Louvain, Belgium; [Suh, Young-Ah] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Texas System; UTMD Anderson Cancer Center	Rousseau, F (corresponding author), Katholieke Univ Leuven, Dept Mol Cell Biol, Flanders Inst Biotechnol, SWITCH Lab, Louvain, Belgium.	frederic.rousseau@med.kuleuven.be; joost.schymkowitz@med.kuleuven.be	Xu, Jie/K-3712-2019; Marine, Jean-Christophe/K-3292-2016; Rudyak, Stanislav/U-1781-2017; Rousseau, Frederic/J-9044-2016; Bustelo, Xose R./A-9526-2010; Rodríguez Couceiro, Jose/F-1497-2016; Marine, Jean Christophe/J-2237-2015; Schymkowitz, Joost/AAV-3680-2021; De Smet, Frederik/Q-7808-2016; Lambrechts, Diether/AAJ-3167-2020; Verdrengh, Evelien/H-4571-2012; Schymkowitz, Joost/K-7764-2016	Xu, Jie/0000-0001-9163-3898; Marine, Jean-Christophe/0000-0003-2433-9837; Rousseau, Frederic/0000-0002-9189-7399; Bustelo, Xose R./0000-0001-9398-6072; Rodríguez Couceiro, Jose/0000-0002-5742-1071; De Smet, Frederik/0000-0002-6669-3335; Lambrechts, Diether/0000-0002-3429-302X; Schymkowitz, Joost/0000-0003-2020-0168; Rozenski, Jef/0000-0001-9624-5536; Reumers, Joke/0000-0001-5434-6515; Gallardo, Rodrigo/0000-0003-1584-3564	Research Foundation Flanders; Agency for Innovation by Science and Technology Flanders; Linking Sino-European Universities through Mobility and National Natural Science Foundation of China [81000861]; Research Council Katholieke Universiteit Leuven, Center of Excellence [KUL PFV/10/016 SymBioSys]; Stichting Tegen Kanker	Research Foundation Flanders(FWO); Agency for Innovation by Science and Technology Flanders; Linking Sino-European Universities through Mobility and National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Council Katholieke Universiteit Leuven, Center of Excellence; Stichting Tegen Kanker	The VIB Switch Laboratory was supported by the Research Foundation Flanders and the Agency for Innovation by Science and Technology Flanders. J.X. and A.Z. were supported by Linking Sino-European Universities through Mobility and National Natural Science Foundation of China (81000861) and the Research Foundation Flanders, respectively. D. L. was supported by the Research Council Katholieke Universiteit Leuven, Center of Excellence (KUL PFV/10/016 SymBioSys) and the Stichting Tegen Kanker. We thank G. Peuteman, D. Smeets and T. Van Brussel for technical assistance. We thank G. Lozano for access to tumor tissues from transgenic mice and G. Melino for plasmids.	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Bensaad K, 2003, J BIOL CHEM, V278, P10546, DOI 10.1074/jbc.M208233200; Boominathan L, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-27; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Cam H, 2006, CANCER CELL, V10, P281, DOI 10.1016/j.ccr.2006.08.024; Chan WM, 2004, MOL CELL BIOL, V24, P3536, DOI 10.1128/MCB.24.8.3536-3551.2004; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Davison TS, 1999, J BIOL CHEM, V274, P18709, DOI 10.1074/jbc.274.26.18709; Davison TS, 1998, ONCOGENE, V17, P651, DOI 10.1038/sj.onc.1202062; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; FRIEDMAN PN, 1993, P NATL ACAD SCI USA, V90, P3319, DOI 10.1073/pnas.90.8.3319; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Hishiya A, 2008, ONCOGENE, V27, P6489, DOI 10.1038/onc.2008.314; Huo Q, 2010, COLLOID SURFACE B, V78, P259, DOI 10.1016/j.colsurfb.2010.03.012; Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Joerger AC, 2009, P NATL ACAD SCI USA, V106, P17705, DOI 10.1073/pnas.0905867106; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kruse JP, 2009, J BIOL CHEM, V284, P3250, DOI 10.1074/jbc.M805658200; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Leong CO, 2007, J CLIN INVEST, V117, P1370, DOI 10.1172/JCI30866; Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311; Liang SH, 1999, J BIOL CHEM, V274, P32699, DOI 10.1074/jbc.274.46.32699; Maslon MM, 2010, TRENDS CELL BIOL, V20, P542, DOI 10.1016/j.tcb.2010.06.005; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Okorokov AL, 2009, CURR OPIN STRUC BIOL, V19, P197, DOI 10.1016/j.sbi.2009.02.003; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Ostermeyer AG, 1996, P NATL ACAD SCI USA, V93, P15190, DOI 10.1073/pnas.93.26.15190; Powell B, 2000, CLIN CANCER RES, V6, P443; Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798; ROTTER V, 1983, P NATL ACAD SCI-BIOL, V80, P2613, DOI 10.1073/pnas.80.9.2613; Samowitz WS, 2002, INT J CANCER, V99, P597, DOI 10.1002/ijc.10405; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sedlacek Z, 1998, NUCLEIC ACIDS RES, V26, P214, DOI 10.1093/nar/26.1.214; Strano S, 2000, J BIOL CHEM, V275, P29503, DOI 10.1074/jbc.M003360200; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716	48	358	373	2	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2011	7	5					285	295		10.1038/nchembio.546	http://dx.doi.org/10.1038/nchembio.546			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751KZ	21445056				2022-12-25	WOS:000289617800012
J	Simpson, MA; Irving, MD; Asilmaz, E; Gray, MJ; Dafou, D; Elmslie, FV; Mansour, S; Holder, SE; Brain, CE; Burton, BK; Kim, KH; Pauli, RM; Aftimos, S; Stewart, H; Kim, CA; Holder-Espinasse, M; Robertson, SP; Drake, WM; Trembath, RC				Simpson, Michael A.; Irving, Melita D.; Asilmaz, Esra; Gray, Mary J.; Dafou, Dimitra; Elmslie, Frances V.; Mansour, Sahar; Holder, Sue E.; Brain, Caroline E.; Burton, Barbara K.; Kim, Katherine H.; Pauli, Richard M.; Aftimos, Salim; Stewart, Helen; Kim, Chong Ae; Holder-Espinasse, Muriel; Robertson, Stephen P.; Drake, William M.; Trembath, Richard C.			Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss	NATURE GENETICS			English	Article								We used an exome-sequencing strategy and identified an allelic series of NOTCH2 mutations in Hajdu-Cheney syndrome, an autosomal dominant multisystem disorder characterized by severe and progressive bone loss. The Hajdu-Cheney syndrome mutations are predicted to lead to the premature truncation of NOTCH2 with either disruption or loss of the C-terminal proline-glutamate-serine-threonine-rich proteolytic recognition sequence, the absence of which has previously been shown to increase Notch signaling.	[Simpson, Michael A.; Irving, Melita D.; Asilmaz, Esra; Dafou, Dimitra; Trembath, Richard C.] Kings Coll London, Div Genet & Mol Med, Sch Med, Guys Hosp, London WC2R 2LS, England; [Irving, Melita D.] Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, Guys Hosp, London, England; [Gray, Mary J.; Robertson, Stephen P.] Dunedin Sch Med, Dept Paediat, Dunedin, New Zealand; [Elmslie, Frances V.; Mansour, Sahar] Univ London, S W Thames Reg Genet Serv, London, England; [Holder, Sue E.] N W London Hosp NHS Trust, N W Thames Reg Genet Serv, Harrow, Middx, England; [Brain, Caroline E.] Great Ormond St Hosp Sick Children, Dept Paediat Endocrinol, London WC1N 3JH, England; [Burton, Barbara K.; Kim, Katherine H.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Childrens Mem Hosp, Chicago, IL 60611 USA; [Burton, Barbara K.; Kim, Katherine H.] Northwestern Univ, Div Genet, Feinberg Sch Med, Childrens Mem Hosp, Chicago, IL 60611 USA; [Pauli, Richard M.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA; [Aftimos, Salim] No Reg Genet Serv, Auckland, New Zealand; [Stewart, Helen] Churchill Hosp, Dept Clin Genet, Oxford OX3 7LJ, England; [Kim, Chong Ae] Univ Sao Paulo FMUSP, Fac Medicinda, Genet Unit, Inst Crianca,Hosp Clin, Sao Paulo, Brazil; [Holder-Espinasse, Muriel] Hop Jeanne Flandre, Serv Genet Clin, Lille, France; [Drake, William M.] St Bartholomews Hosp, Dept Endocrinol, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of Otago; University of London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; University of Wisconsin System; University of Wisconsin Madison; University of Oxford; Universidade de Sao Paulo; Universite de Lille - ISITE; CHU Lille; University of London; Queen Mary University London	Trembath, RC (corresponding author), Kings Coll London, Div Genet & Mol Med, Sch Med, Guys Hosp, London WC2R 2LS, England.	richard.trembath@kcl.ac.uk	Gray, Mary/J-9669-2014; Simpson, Michael/F-4737-2011; Dafou, Dimitra/N-6094-2015	Gray, Mary/0000-0003-1610-0674; Simpson, Michael/0000-0002-8539-8753; Dafou, Dimitra/0000-0003-4170-0612; Kim, Chong/0000-0002-1754-1300; Trembath, Richard/0000-0003-0550-3400; Robertson, Stephen/0000-0002-5181-7809	British Heart Foundation (BHF); Cure Kids New Zealand; UK Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; British Heart Foundation [RG/08/006/25302] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10379] Funding Source: researchfish	British Heart Foundation (BHF)(British Heart Foundation); Cure Kids New Zealand; UK Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors thank the families for participating in this study. This work was supported by grants from the British Heart Foundation (BHF) to R.C.T. and from Cure Kids New Zealand to S.P.R. and M.J.G. The authors also acknowledge support from the UK Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St. Thomas' National Health Service (NHS) Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. Grateful acknowledgment is also made to I. Marik, Chief of the Centre for Patients with Locomotor Defects, Prague, Czech Republic for assistance in recruitment to this study.	Albano LMJ, 2007, CLIN DYSMORPHOL, V16, P27, DOI 10.1097/01.mcd.0000228418.74413.52; Brennan AM, 2001, AM J MED GENET, V100, P292, DOI 10.1002/1096-8628(20010515)100:4<292::AID-AJMG1308>3.0.CO;2-4; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Hamada Y, 1999, DEVELOPMENT, V126, P3415; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kung AWC, 2010, AM J HUM GENET, V86, P229, DOI 10.1016/j.ajhg.2009.12.014; Lee SY, 2009, CANCER SCI, V100, P920, DOI 10.1111/j.1349-7006.2009.01130.x; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Morrissette JJD, 2001, HUM MOL GENET, V10, P405, DOI 10.1093/hmg/10.4.405; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Ostergaard P, 2011, J MED GENET, V48, P251, DOI 10.1136/jmg.2010.085563; Ralston SH, 2010, ENDOCR REV, V31, P629, DOI 10.1210/er.2009-0044; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09	15	210	222	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2011	43	4					303	305		10.1038/ng.779	http://dx.doi.org/10.1038/ng.779			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	741YL	21378985				2022-12-25	WOS:000288903700007
J	Doyon, JB; Zeitler, B; Cheng, J; Cheng, AT; Cherone, JM; Santiago, Y; Lee, AH; Vo, TD; Doyon, Y; Miller, JC; Paschon, DE; Zhang, L; Rebar, EJ; Gregory, PD; Urnov, FD; Drubin, DG				Doyon, Jeffrey B.; Zeitler, Bryan; Cheng, Jackie; Cheng, Aaron T.; Cherone, Jennifer M.; Santiago, Yolanda; Lee, Andrew H.; Vo, Thuy D.; Doyon, Yannick; Miller, Jeffrey C.; Paschon, David E.; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.; Drubin, David G.			Rapid and efficient clathrin-mediated endocytosis revealed in genome-edited mammalian cells	NATURE CELL BIOLOGY			English	Article							ZINC; GENE; PROTEASOME; PROTEINS; COMPLEX; CFTR	Clathrin-mediated endocytosis (CME) is the best-studied pathway by which cells selectively internalize molecules from the plasma membrane and surrounding environment. Previous live-cell imaging studies using ectopically overexpressed fluorescent fusions of endocytic proteins indicated that mammalian CME is a highly dynamic but inefficient and heterogeneous process. In contrast, studies of endocytosis in budding yeast using fluorescent protein fusions expressed at physiological levels from native genomic loci have revealed a process that is very regular and efficient. To analyse endocytic dynamics in mammalian cells in which endogenous protein stoichiometry is preserved, we targeted zinc finger nucleases (ZFNs) to the clathrin light chain A and dynamin-2 genomic loci and generated cell lines expressing fluorescent protein fusions from each locus. The genome-edited cells exhibited enhanced endocytic function, dynamics and efficiency when compared with previously studied cells, indicating that CME is highly sensitive to the levels of its protein components. Our study establishes that ZFN-mediated genome editing is a robust tool for expressing protein fusions at endogenous levels to faithfully report subcellular localization and dynamics.	[Doyon, Jeffrey B.; Cheng, Jackie; Cheng, Aaron T.; Drubin, David G.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Zeitler, Bryan; Cherone, Jennifer M.; Santiago, Yolanda; Lee, Andrew H.; Vo, Thuy D.; Doyon, Yannick; Miller, Jeffrey C.; Paschon, David E.; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.] Sangamo BioSci Inc, Richmond, CA 94804 USA	University of California System; University of California Berkeley; Sangamo Therapeutics, Inc.	Drubin, DG (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	drubin@berkeley.edu	Cheng, Jackie/GRS-6421-2022	Gregory, Philip/0000-0001-9249-2468; Doyon, Yannick/0000-0002-3889-9563	Jane Coffin Childs Memorial Fund; Croucher Foundation; NIH [R01 GM65462]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065462] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund; Croucher Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Nolla and A. Valeros for their cell-sorting expertise, A. Fischer and M. Yasukawa for help with cell culture, the Biological Imaging Facility for use of the Imaris software, the Sangamo Production group for technical assistance and members of the Drubin/Barnes lab for critical reading of this manuscript. We also thank T. Kirchhausen, L. Greene, and R. Tsien for providing the BSC-1 GFP-CLTA cell line, human CLTA plasmid, and TagRFP-T plasmid, respectively. J.B.D. and J.C. were supported by postdoctoral fellowships from the Jane Coffin Childs Memorial Fund and The Croucher Foundation, respectively. This work was supported by NIH grant R01 GM65462 to D.G.D.	Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Isalan M, 2001, NAT BIOTECHNOL, V19, P656, DOI 10.1038/90264; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kirchhausen T, 2009, TRENDS CELL BIOL, V19, P596, DOI 10.1016/j.tcb.2009.09.002; Knoops L, 2008, ONCOGENE, V27, P1511, DOI 10.1038/sj.onc.1210800; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Le Clainche C, 2007, EMBO J, V26, P1199, DOI 10.1038/sj.emboj.7601576; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Luo T, 2001, MOL REPROD DEV, V60, P331, DOI 10.1002/mrd.1095; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Mettlen M, 2010, J CELL BIOL, V188, P919, DOI 10.1083/jcb.200908078; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Mettlen M, 2009, MOL BIOL CELL, V20, P3251, DOI 10.1091/mbc.E09-03-0256; Miyama K, 1999, DEV BIOL, V208, P123, DOI 10.1006/dbio.1998.9197; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Rappoport JZ, 2006, AM J PHYSIOL-CELL PH, V291, pC1072, DOI 10.1152/ajpcell.00160.2006; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wu XF, 2001, J CELL BIOL, V155, P291, DOI 10.1083/jcb.200104085; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	37	175	178	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2011	13	3					331	U327		10.1038/ncb2175	http://dx.doi.org/10.1038/ncb2175			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	728BB	21297641	Green Accepted			2022-12-25	WOS:000287847600022
J	Efe, JA; Hilcove, S; Kim, J; Zhou, H; Ouyang, K; Wang, G; Chen, J; Ding, S				Efe, Jem A.; Hilcove, Simon; Kim, Janghwan; Zhou, Hongyan; Ouyang, Kunfu; Wang, Gang; Chen, Ju; Ding, Sheng			Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy	NATURE CELL BIOLOGY			English	Article							PLURIPOTENT STEM-CELLS; CARDIOVASCULAR DIFFERENTIATION; PROGENITOR CELLS; GENERATION; PROTEINS; EXPRESSION; RENEWAL; PATHWAY; HEART; MYC	Here we show that conventional reprogramming towards pluripotency through overexpression of Oct4, Sox2, Klf4 and c-Myc can be shortcut and directed towards cardiogenesis in a fast and efficient manner. With as little as 4 days of transgenic expression of these factors, mouse embryonic fibroblasts (MEFs) can be directly reprogrammed to spontaneously contracting patches of differentiated cardiomyocytes over a period of 11-12 days. Several lines of evidence suggest that a pluripotent intermediate is not involved. Our method represents a unique strategy that allows a transient, plastic developmental state established early in reprogramming to effectively function as a cellular transdifferentiation platform, the use of which could extend beyond cardiogenesis. Our study has potentially wide-ranging implications for induced pluripotent stem cell (iPSC)-factor-based reprogramming and broadens the existing paradigm.	[Efe, Jem A.; Hilcove, Simon; Kim, Janghwan; Zhou, Hongyan; Ding, Sheng] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Ouyang, Kunfu; Wang, Gang; Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Scripps Research Institute; University of California System; University of California San Diego	Ding, S (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	sding@scripps.edu	zhou, hongyan/B-3689-2011; ouyang, kunfu/B-3073-2011; Chen, Ju/E-5579-2011; Kim, Janghwan/B-4522-2009	zhou, hongyan/0000-0001-5919-7715; ouyang, kunfu/0000-0003-0292-375X; 	NICHD; NHLBI; NIMH/NIH; California Institute for Regenerative Medicine; Prostate Cancer Foundation; Fate Therapeutics; Esther B. O'Keeffe Foundation; Scripps Research Institute	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Prostate Cancer Foundation; Fate Therapeutics; Esther B. O'Keeffe Foundation; Scripps Research Institute	We thank C. Desponts, X. Yuan, S. Zhu, R. Ambasudhan, R. Abujarour and W. Li for discussions, technical assistance, and critical reading of the manuscript. We also thank H. Scholer for providing TTFs, and D. Watry for assistance with FACS analyses. S.D. is supported by funding from NICHD, NHLBI and NIMH/NIH, California Institute for Regenerative Medicine, Prostate Cancer Foundation, Fate Therapeutics, Esther B. O'Keeffe Foundation and the Scripps Research Institute. J.A.E. is a Lowe Family Foundation fellow.	Anjos-Afonso F, 2007, BLOOD, V109, P1298, DOI 10.1182/blood-2006-06-030551; Artyomov MN, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000785; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cai CL, 2005, DEVELOPMENT, V132, P2475, DOI 10.1242/dev.01832; Christen B, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-5; Cohen ED, 2008, DEVELOPMENT, V135, P789, DOI 10.1242/dev.016865; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Klaus A, 2009, PEDIATR CARDIOL, V30, P609, DOI 10.1007/s00246-008-9352-7; Koso H, 2006, DEV BIOL, V292, P265, DOI 10.1016/j.ydbio.2005.09.051; Kuzmenkin A, 2009, FASEB J, V23, P4168, DOI 10.1096/fj.08-128546; Markoulaki S, 2009, NAT BIOTECHNOL, V27, P169, DOI 10.1038/nbt.1520; Martin-Puig S, 2008, CELL STEM CELL, V2, P320, DOI 10.1016/j.stem.2008.03.010; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okada M, 2010, BBA-GEN SUBJECTS, V1800, P956, DOI 10.1016/j.bbagen.2010.04.004; Ouyang K, 2005, J BIOL CHEM, V280, P15898, DOI 10.1074/jbc.C500026200; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Schenke-Layland K, 2008, STEM CELLS, V26, P1537, DOI 10.1634/stemcells.2008-0033; Shah AP, 2010, CARDIOVASC RES, V87, P683, DOI 10.1093/cvr/cvq111; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Snyder A, 2004, J CELL BIOCHEM, V93, P224, DOI 10.1002/jcb.20191; Snyder M, 2010, J BIOL CHEM, V285, P23639, DOI 10.1074/jbc.M110.101063; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Stieber J, 2003, P NATL ACAD SCI USA, V100, P15235, DOI 10.1073/pnas.2434235100; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	36	471	522	1	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2011	13	3					215	U61		10.1038/ncb2164	http://dx.doi.org/10.1038/ncb2164			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	728BB	21278734				2022-12-25	WOS:000287847600009
J	Green, MD; Chen, A; Nostro, MC; d'Souza, SL; Schaniel, C; Lemischka, IR; Gouon-Evans, V; Keller, G; Snoeck, HW				Green, Michael D.; Chen, Antonia; Nostro, Maria-Cristina; d'Souza, Sunita L.; Schaniel, Christoph; Lemischka, Ihor R.; Gouon-Evans, Valerie; Keller, Gordon; Snoeck, Hans-Willem			Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							DIFFERENTIATION; SPECIFICATION; EXPRESSION; INDUCTION; ES	Directed differentiation of human embryonic stem (hES) cells and human induced pluripotent stem (hiPS) cells captures in vivo developmental pathways for specifying lineages in vitro, thus avoiding perturbation of the genome with exogenous genetic material. Thus far, derivation of endodermal lineages has focused predominantly on hepatocytes, pancreatic endocrine cells and intestinal cells(1-5). The ability to differentiate pluripotent cells into anterior foregut endoderm (AFE) derivatives would expand their utility for cell therapy and basic research to tissues important for immune function, such as the thymus; for metabolism, such as thyroid and parathyroid; and for respiratory function, such as trachea and lung. We find that dual inhibition of transforming growth factor (TGF)-beta and bone morphogenic protein (BMP) signaling after specification of definitive endoderm from pluripotent cells results in a highly enriched AFE population that is competent to be patterned along dorsoventral and anteroposterior axes. These findings provide an approach for the generation of AFE derivatives.	[Green, Michael D.; Chen, Antonia; d'Souza, Sunita L.; Schaniel, Christoph; Lemischka, Ihor R.; Gouon-Evans, Valerie; Snoeck, Hans-Willem] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY USA; [Green, Michael D.; Chen, Antonia; d'Souza, Sunita L.; Schaniel, Christoph; Lemischka, Ihor R.; Gouon-Evans, Valerie; Snoeck, Hans-Willem] Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY USA; [Nostro, Maria-Cristina; Keller, Gordon] Ontario Canc Inst, Div Stem Cell & Dev Biol, Toronto, ON M4X 1K9, Canada; [Nostro, Maria-Cristina; Keller, Gordon] Ontario Canc Inst, McEwen Ctr Regenerat Med, Toronto, ON M4X 1K9, Canada	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Snoeck, HW (corresponding author), Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY USA.	hans.snoeck@mssm.edu	Schaniel, Chrisoph/C-9655-2012; Chen, Antonia/K-5284-2019; Schaniel, Christoph/P-3836-2019	Schaniel, Christoph/0000-0002-1343-4858; Green, Michael/0000-0003-4951-7118; Nostro, Maria Cristina/0000-0003-1166-8252; Keller, Gordon/0000-0001-9309-9297; Gouon-Evans, Valerie/0000-0001-5424-6573	NYSTEM [NO8G-422]; NATIONAL INSTITUTE ON AGING [R01AG016327] Funding Source: NIH RePORTER	NYSTEM; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NYSTEM grant NO8G-422 to H.-W.S.	Bachiller D, 2003, DEVELOPMENT, V130, P3567, DOI 10.1242/dev.00581; Bingham EL, 2009, STEM CELLS DEV, V18, P1071, DOI 10.1089/scd.2008.0337; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen F, 2010, J CLIN INVEST, V120, P2040, DOI 10.1172/JCI40253; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Graham A, 2008, J EXP ZOOL PART B, V310B, P336, DOI 10.1002/jez.b.21182; Hidaka K, 2010, STEM CELLS DEV, V19, P1735, DOI 10.1089/scd.2009.0466; Jenq RR, 2010, NAT REV CANCER, V10, P213, DOI 10.1038/nrc2804; Lai LJ, 2009, STEM CELLS, V27, P3012, DOI 10.1002/stem.238; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308; Lin RY, 2003, ENDOCRINOLOGY, V144, P2644, DOI 10.1210/en.2002-0122; Moore-Scott BA, 2005, DEV BIOL, V278, P323, DOI 10.1016/j.ydbio.2004.10.027; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Sherwood RI, 2009, DEV DYNAM, V238, P29, DOI 10.1002/dvdy.21810; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Tanaka M, 2001, MOL CELL BIOL, V21, P4391, DOI 10.1128/MCB.21.13.4391-4398.2001; Vitelli F, 2002, DEVELOPMENT, V129, P4605; Wallin J, 1996, DEVELOPMENT, V122, P23; Wang D, 2007, P NATL ACAD SCI USA, V104, P4449, DOI 10.1073/pnas.0700052104; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	31	238	261	2	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2011	29	3					267	U153		10.1038/nbt.1788	http://dx.doi.org/10.1038/nbt.1788			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	732RL	21358635	Green Accepted			2022-12-25	WOS:000288206700022
J	Plachta, N; Bollenbach, T; Pease, S; Fraser, SE; Pantazis, P				Plachta, Nicolas; Bollenbach, Tobias; Pease, Shirley; Fraser, Scott E.; Pantazis, Periklis			Oct4 kinetics predict cell lineage patterning in the early mammalian embryo	NATURE CELL BIOLOGY			English	Article							MOUSE 8-CELL BLASTOMERES; NEURAL STEM-CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; POU-DOMAIN; DYNAMICS; IDENTIFICATION; PLURIPOTENCY; BLASTOCYST; SOX2	Transcription factors are central to sustaining pluripotency, yet little is known about transcription factor dynamics in defining pluripotency in the early mammalian embryo. Here, we establish a fluorescence decay after photoactivation (FDAP) assay to quantitatively study the kinetic behaviour of Oct4, a key transcription factor controlling pre-implantation development in the mouse embryo. FDAP measurements reveal that each cell in a developing embryo shows one of two distinct Oct4 kinetics, before there are any morphologically distinguishable differences or outward signs of lineage patterning. The differences revealed by FDAP are due to differences in the accessibility of Oct4 to its DNA binding sites in the nucleus. Lineage tracing of the cells in the two distinct sub-populations demonstrates that the Oct4 kinetics predict lineages of the early embryo. Cells with slower Oct4 kinetics are more likely to give rise to the pluripotent cell lineage that contributes to the inner cell mass. Those with faster Oct4 kinetics contribute mostly to the extra-embryonic lineage. Our findings identify Oct4 kinetics, rather than differences in total transcription factor expression levels, as a predictive measure of developmental cell lineage patterning in the early mouse embryo.	[Plachta, Nicolas; Pease, Shirley; Fraser, Scott E.; Pantazis, Periklis] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Bollenbach, Tobias] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	California Institute of Technology; Harvard University; Harvard Medical School	Pantazis, P (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	pantazis@caltech.edu	Pantazis, Periklis/AAR-1795-2021; Bollenbach, Tobias/AAK-3206-2020; Fraser, Scott/Y-3406-2019	Bollenbach, Tobias/0000-0003-4398-476X; Fraser, Scott/0000-0002-5377-0223; Pantazis, Periklis (Laki)/0000-0002-8367-9332	California Institute for Regenerative Medicine (CIRM); European Molecular Biology Organization (EMBO); Swiss National Science Foundation (SNF); Alexander von Humboldt foundation; German Science Foundation (DFG); NHGRI Center of Excellence in Genomic Science [P50HG004071]; Beckman Institute and Biological Imaging Center at the California Institute of Technology; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004071] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Alexander von Humboldt foundation(Alexander von Humboldt Foundation); German Science Foundation (DFG)(German Research Foundation (DFG)); NHGRI Center of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Beckman Institute and Biological Imaging Center at the California Institute of Technology; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We especially thank Juan Silva and John Earle for excellent technical support with mouse embryo work. We also thank H. Scholer, J. Lippincott-Schwartz, G. Patterson and Li-Jin Chew for constructs. N.P. is supported by California Institute for Regenerative Medicine (CIRM), European Molecular Biology Organization (EMBO) and Swiss National Science Foundation (SNF), fellowships. T. B. was supported by the Alexander von Humboldt foundation. P. P. is supported by the German Science Foundation (DFG). This work was supported by the Beckman Institute and Biological Imaging Center at the California Institute of Technology and by the NHGRI Center of Excellence in Genomic Science grant P50HG004071.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Boer B, 2007, NUCLEIC ACIDS RES, V35, P1773, DOI 10.1093/nar/gkm059; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Dudu V, 2006, CURR BIOL, V16, P625, DOI 10.1016/j.cub.2006.02.061; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; JOHNSON MH, 1981, J CELL BIOL, V91, P303, DOI 10.1083/jcb.91.1.303; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Morris SA, 2010, P NATL ACAD SCI USA, V107, P6364, DOI 10.1073/pnas.0915063107; Motosugi N, 2005, GENE DEV, V19, P1081, DOI 10.1101/gad.1304805; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nowling TK, 2000, J BIOL CHEM, V275, P3810, DOI 10.1074/jbc.275.6.3810; Pan GJ, 2004, J BIOL CHEM, V279, P37013, DOI 10.1074/jbc.M405117200; Pantazis P, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2770478; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Remenyi A, 2004, NAT STRUCT MOL BIOL, V11, P812, DOI 10.1038/nsmb820; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Sohn J, 2006, J NEUROSCI, V26, P9722, DOI 10.1523/JNEUROSCI.1716-06.2006; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; WOLFFE AP, 1995, CURR BIOL, V5, P452, DOI 10.1016/S0960-9822(95)00088-1; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564; Zernicka-Goetz MZ, 2005, NAT REV MOL CELL BIO, V6, P919, DOI 10.1038/nrm1782; ZIOMEK CA, 1980, CELL, V21, P935, DOI 10.1016/0092-8674(80)90457-2	43	164	171	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2011	13	2					117	U24		10.1038/ncb2154	http://dx.doi.org/10.1038/ncb2154			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714JM	21258368				2022-12-25	WOS:000286805900004
J	Bouman, HJ; Schomig, E; van Werkum, JW; Velder, J; Hackeng, CM; Hirschhauser, C; Waldmann, C; Schmalz, HG; ten Berg, JM; Taubert, D				Bouman, Heleen J.; Schoemig, Edgar; van Werkum, Jochem W.; Velder, Janna; Hackeng, Christian M.; Hirschhaeuser, Christoph; Waldmann, Christopher; Schmalz, Hans-Guenther; ten Berg, Jurrien M.; Taubert, Dirk			Paraoxonase-1 is a major determinant of clopidogrel efficacy	NATURE MEDICINE			English	Article							CARDIOVASCULAR RISK; GENE POLYMORPHISMS; ACTIVE METABOLITE; RESPONSIVENESS; METAANALYSIS; ASSOCIATION; VARIABILITY; CYP2C19; DISEASE; EVENTS	Clinical efficacy of the antiplatelet drug clopidogrel is hampered by its variable biotransformation into the active metabolite1,2. The variability in the clinical response to clopidogrel treatment has been attributed to genetic factors, but the specific genes and mechanisms underlying clopidogrel bioactivation remain unclear. Using in vitro metabolomic profiling techniques, we identified paraoxonase-1 (PON1) as the crucial enzyme for clopidogrel bioactivation, with its common Q192R polymorphism determining the rate of active metabolite formation. We tested the clinical relevance of the PON1 Q192R genotype in a population of individuals with coronary artery disease who underwent stent implantation and received clopidogrel therapy. PON1 QQ192 homozygous individuals showed a considerably higher risk than RR192 homozygous individuals of stent thrombosis, lower PON1 plasma activity, lower plasma concentrations of active metabolite and lower platelet inhibition. Thus, we identified PON1 as a key factor for the bioactivation and clinical activity of clopidogrel. These findings have therapeutic implications and may be exploited to prospectively assess the clinical efficacy of clopidogrel.	[Schoemig, Edgar; Taubert, Dirk] Univ Hosp Cologne, Dept Pharmacol, Cologne, Germany; [Bouman, Heleen J.; van Werkum, Jochem W.; Hackeng, Christian M.; ten Berg, Jurrien M.] St Antonius Hosp, Dept Cardiol, Nieuwegein, Netherlands; [Bouman, Heleen J.; van Werkum, Jochem W.; ten Berg, Jurrien M.] St Antonius Hosp, St Antonius Ctr Platelet Funct Res, Nieuwegein, Netherlands; [Bouman, Heleen J.] Univ Maastricht, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands; [Velder, Janna; Hirschhaeuser, Christoph; Schmalz, Hans-Guenther] Univ Cologne, Dept Chem, Cologne, Germany; [Hackeng, Christian M.] St Antonius Hosp, Dept Clin Chem, Nieuwegein, Netherlands; [Waldmann, Christopher] Univ Munster, Klin & Poliklin Nukl Med, Munster, Germany	University of Cologne; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; Maastricht University; University of Cologne; St. Antonius Hospital Utrecht; University of Munster	Taubert, D (corresponding author), Univ Hosp Cologne, Dept Pharmacol, Cologne, Germany.	dirk.taubert@medizin.uni-koeln.de	Schmalz, Hans-Guenther/S-4940-2016; Waldmann, Christoph/F-3386-2017; Hirschhäuser, Christoph/AHB-8450-2022	Schmalz, Hans-Guenther/0000-0003-0489-1827; Waldmann, Christoph/0000-0003-3388-7579; Hirschhäuser, Christoph/0000-0002-9409-1550				ADKINS S, 1993, AM J HUM GENET, V52, P598; Angiolillo DJ, 2006, ARTERIOSCL THROM VAS, V26, P1895, DOI 10.1161/01.ATV.0000223867.25324.1a; Angiolillo DJ, 2010, REV ESP CARDIOL, V63, P60, DOI 10.1016/S0300-8932(10)70010-5; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Bertrand-Thiebault C, 2008, ANN HUM GENET, V72, P178, DOI 10.1111/j.1469-1809.2007.00417.x; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335; Bouman HJ, 2010, J THROMB HAEMOST, V8, P482, DOI 10.1111/j.1538-7836.2009.03733.x; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Clarke TA, 2003, DRUG METAB DISPOS, V31, P53, DOI 10.1124/dmd.31.1.53; Correia M. A., 2005, CYTOCHROME P450 STRU, P253; Dansette PM, 2009, CHEM RES TOXICOL, V22, P369, DOI 10.1021/tx8004828; Gurbel PA, 2007, J AM COLL CARDIOL, V50, P1822, DOI 10.1016/j.jacc.2007.07.051; Gurbel PA, 2009, EXPERT OPIN DRUG MET, V5, P989, DOI 10.1517/17425250903107772; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Holmes DR, 2010, CIRCULATION, V122, P537, DOI 10.1161/CIR.0b013e3181ee08ed; Hulot JS, 2010, J AM COLL CARDIOL, V56, P134, DOI 10.1016/j.jacc.2009.12.071; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Kosaka T, 2005, CLIN CHIM ACTA, V359, P156, DOI 10.1016/j.cccn.2005.03.046; Pereillo JM, 2002, DRUG METAB DISPOS, V30, P1288, DOI 10.1124/dmd.30.11.1288; Perla-Kajan J, 2010, FASEB J, V24, P931, DOI 10.1096/fj.09-144410; PRENTICE RL, 1986, BIOMETRICS, V42, P301, DOI 10.2307/2531051; Rainwater DL, 2009, HEREDITY, V102, P147, DOI 10.1038/hdy.2008.110; Serebruany VL, 2005, J AM COLL CARDIOL, V45, P246, DOI 10.1016/j.jacc.2004.09.067; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Sofi F, 2010, THROMB HAEMOSTASIS, V103, P841, DOI 10.1160/TH09-06-0418; Suh JW, 2006, CAN MED ASSOC J, V174, P1715, DOI 10.1503/cmaj.060664; Taubert D, 2004, THROMB HAEMOSTASIS, V92, P311, DOI 10.1160/TH04-02-0105; Wheeler JG, 2004, LANCET, V363, P689, DOI 10.1016/S0140-6736(04)15642-0; Yusuf S, 2001, NEW ENGL J MED, V345, P494	33	380	420	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					110	U287		10.1038/nm.2281	http://dx.doi.org/10.1038/nm.2281			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21170047				2022-12-25	WOS:000285994000043
J	Di Paolo, JA; Huang, T; Balazs, M; Barbosa, J; Barck, KH; Bravo, BJ; Carano, RAD; Darrow, J; Davies, DR; DeForge, LE; Diehl, L; Ferrando, R; Gallion, SL; Giannetti, AM; Gribling, P; Hurez, V; Hymowitz, SG; Jones, R; Kropf, JE; Lee, WP; Maciejewski, PM; Mitchell, SA; Rong, H; Staker, BL; Whitney, JA; Yeh, S; Young, WB; Yu, C; Zhang, JA; Reif, K; Currie, KS				Di Paolo, Julie A.; Huang, Tao; Balazs, Mercedesz; Barbosa, James; Barck, Kai H.; Bravo, Brandon J.; Carano, Richard A. D.; Darrow, James; Davies, Douglas R.; DeForge, Laura E.; Diehl, Lauri; Ferrando, Ronald; Gallion, Steven L.; Giannetti, Anthony M.; Gribling, Peter; Hurez, Vincent; Hymowitz, Sarah G.; Jones, Randall; Kropf, Jeffrey E.; Lee, Wyne P.; Maciejewski, Patricia M.; Mitchell, Scott A.; Rong, Hong; Staker, Bart L.; Whitney, J. Andrew; Yeh, Sherry; Young, Wendy B.; Yu, Christine; Zhang, Juan; Reif, Karin; Currie, Kevin S.			Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis	NATURE CHEMICAL BIOLOGY			English	Article							BRUTONS TYROSINE KINASE; COLLAGEN-INDUCED ARTHRITIS; FC-GAMMA RECEPTORS; RHEUMATOID-ARTHRITIS; II COLLAGEN; CITRULLINATED PROTEINS; ACTIVATION; PHOSPHORYLATION; MACROPHAGES; INDUCTION	Bruton's tyrosine kinase (Btk) is a therapeutic target for rheumatoid arthritis, but the cellular and molecular mechanisms by which Btk mediates inflammation are poorly understood. Here we describe the discovery of CGI1746, a small-molecule Btk inhibitor chemotype with a new binding mode that stabilizes an inactive nonphosphorylated enzyme conformation. CGI1746 has exquisite selectivity for Btk and inhibits both auto- and transphosphorylation steps necessary for enzyme activation. Using CGI1746, we demonstrate that Btk regulates inflammatory arthritis by two distinct mechanisms. CGI1746 blocks B cell receptor-dependent B cell proliferation and in prophylactic regimens reduces autoantibody levels in collagen-induced arthritis. In macrophages, Btk inhibition abolishes Fc gamma RIII-induced TNF alpha, IL-1 beta and IL-6 production. Accordingly, in myeloid- and Fc gamma R-dependent autoantibody-induced arthritis, CGI1746 decreases cytokine levels within joints and ameliorates disease. These results provide new understanding of the function of Btk in both B cell-or myeloid cell-driven disease processes and provide a compelling rationale for targeting Btk in rheumatoid arthritis.	[Huang, Tao; Balazs, Mercedesz; Gribling, Peter; Hurez, Vincent; Lee, Wyne P.; Zhang, Juan; Reif, Karin] Genentech Inc, Dept Immunobiol, San Francisco, CA 94080 USA; [Di Paolo, Julie A.; Jones, Randall; Maciejewski, Patricia M.; Rong, Hong; Whitney, J. Andrew] CGI Pharmaceut, Dept Discovery Biol, Branford, CT USA; [Barck, Kai H.; Carano, Richard A. D.] Genentech Inc, Dept Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA; [Bravo, Brandon J.; Giannetti, Anthony M.] Genentech Inc, Dept Biochem Pharmacol, San Francisco, CA 94080 USA; [Darrow, James; Kropf, Jeffrey E.; Mitchell, Scott A.; Currie, Kevin S.] CGI Pharmaceut, Dept Med Chem, Branford, CT USA; [Davies, Douglas R.; Staker, Bart L.] Emerald BioStruct, Bainbridge Isl, WA USA; [DeForge, Laura E.; Yeh, Sherry] Genentech Inc, Dept Assay & Automat Technol, San Francisco, CA 94080 USA; [Barbosa, James; Diehl, Lauri; Ferrando, Ronald] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Gallion, Steven L.] Computat Chem CGI Pharmaceut, Branford, CT USA; [Hymowitz, Sarah G.; Yu, Christine] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Young, Wendy B.] Genentech Inc, Dept Med Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Reif, K (corresponding author), Genentech Inc, Dept Immunobiol, San Francisco, CA 94080 USA.	kreif@gene.com; kevin.currie@gilead.com	Jones, Jeffrey A/E-9827-2013; Hurez, Vincent/AAF-6765-2019; Zhang, Juan/GRX-2638-2022; Reif, Karin/AAD-4692-2020	Reif, Karin/0000-0001-5490-8389; Staker, Bart/0000-0001-9570-5086; Hurez, Vincent/0000-0003-0271-4157				Andren M, 2006, SCAND J IMMUNOL, V63, P282, DOI 10.1111/j.1365-3083.2006.01743.x; Boross P, 2006, SPRINGER SEMIN IMMUN, V28, P339, DOI 10.1007/s00281-006-0049-9; Bouaziz JD, 2007, P NATL ACAD SCI USA, V104, P20878, DOI 10.1073/pnas.0709205105; BRITTELLI DR, 2006, Patent No. 2006099075; Brunner C, 2005, HISTOL HISTOPATHOL, V20, P945, DOI 10.14670/HH-20.945; Clavel C, 2008, ARTHRITIS RHEUM-US, V58, P678, DOI 10.1002/art.23284; Cook AD, 1996, ARTHRITIS RHEUM, V39, P1720, DOI 10.1002/art.1780391015; CURRIE KS, 2008, Patent No. 7393848; Fleischmann RM, 2005, J RHEUMATOL, V32, P29; Goldstein MD, 1996, MOL IMMUNOL, V33, P541, DOI 10.1016/0161-5890(96)00005-3; Hamilton JA, 2009, ARTHRITIS RHEUM-US, V60, P1210, DOI 10.1002/art.24505; Horwood NJ, 2006, J IMMUNOL, V176, P3635, DOI 10.4049/jimmunol.176.6.3635; Humphries LA, 2004, J BIOL CHEM, V279, P37651, DOI 10.1074/jbc.M311985200; JANSSON L, 1993, CLIN EXP IMMUNOL, V94, P459, DOI 10.1111/j.1365-2249.1993.tb08218.x; Jongstra-Bilen J, 2008, J IMMUNOL, V181, P288, DOI 10.4049/jimmunol.181.1.288; Kagari T, 2003, J IMMUNOL, V170, P4318, DOI 10.4049/jimmunol.170.8.4318; Kagari T, 2002, J IMMUNOL, V169, P1459, DOI 10.4049/jimmunol.169.3.1459; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Katschke KJ, 2007, J EXP MED, V204, P1319, DOI 10.1084/jem.20070432; Khan WN, 2001, IMMUNOL RES, V23, P147, DOI 10.1385/IR:23:2-3:147; Kim YJ, 2004, MOL CELL BIOL, V24, P9986, DOI 10.1128/MCB.24.22.9986-9999.2004; Knight ZA, 2007, CELL, V128, P425, DOI 10.1016/j.cell.2007.01.021; KNOERZER DB, 1995, J CLIN INVEST, V96, P987, DOI 10.1172/JCI118146; Lee SH, 2008, J BIOL CHEM, V283, P11526, DOI 10.1074/jbc.M708935200; Lin L, 2009, BIOCHEMISTRY-US, V48, P2021, DOI 10.1021/bi8019756; Lindvall JM, 2005, IMMUNOL REV, V203, P200, DOI 10.1111/j.0105-2896.2005.00225.x; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Mangla A, 2004, BLOOD, V104, P1191, DOI 10.1182/blood-2004-01-0207; Marcotte DJ, 2010, PROTEIN SCI, V19, P429, DOI 10.1002/pro.321; Marshall AJ, 2000, IMMUNOL REV, V176, P30; Monach PA, 2004, ADV IMMUNOL, V82, P217, DOI 10.1016/S0065-2776(04)82005-4; Mullazehi M, 2006, ARTHRITIS RHEUM-US, V54, P1759, DOI 10.1002/art.21892; Nell VPK, 2005, ANN RHEUM DIS, V64, P1731, DOI 10.1136/ard.2005.035691; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Palmer CD, 2008, BLOOD, V111, P1781, DOI 10.1182/blood-2007-07-102343; Pan ZY, 2008, DRUG NEWS PERSPECT, V21, P357, DOI 10.1358/dnp.2008.21.7.1255308; Panayi GS, 2005, J RHEUMATOL, V32, P19; Satterthwaite AB, 2000, IMMUNOL REV, V175, P120, DOI 10.1034/j.1600-065X.2000.017504.x; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schmidt U, 2004, INT ARCH ALLERGY IMM, V134, P65, DOI 10.1159/000078339; Sharma S, 2009, J IMMUNOL, V182, P329, DOI 10.4049/jimmunol.182.1.329; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Solomon S, 2005, EUR J IMMUNOL, V35, P3064, DOI 10.1002/eji.200526167; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Thabet MM, 2009, ANN RHEUM DIS, V68, P1775, DOI 10.1136/ard.2008.099309; TSUKADA S, 1994, CURR OPIN IMMUNOL, V6, P623, DOI 10.1016/0952-7915(94)90151-1; Vincent C, 2005, AUTOIMMUNITY, V38, P17, DOI 10.1080/08916930400022582; Watanabe D, 2001, J BIOL CHEM, V276, P38595, DOI 10.1074/jbc.M103675200; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yanaba K, 2008, IMMUNOL REV, V223, P284, DOI 10.1111/j.1600-065X.2008.00646.x; Yanaba K, 2007, J IMMUNOL, V179, P1369, DOI 10.4049/jimmunol.179.2.1369	51	258	284	2	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2011	7	1					41	50		10.1038/NCHEMBIO.481	http://dx.doi.org/10.1038/NCHEMBIO.481			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	695PA	21113169	Bronze			2022-12-25	WOS:000285383400011
J	Good, MF; Engwerda, C				Good, Michael F.; Engwerda, Christian			Arming T cells to halt malaria	NATURE MEDICINE			English	Editorial Material							PLASMODIUM-YOELII; MEDIATED-IMMUNITY; PROTECTION; SPOROZOITES; ANTIBODIES; INFECTION; MICE		[Good, Michael F.] Griffith Univ, Gold Coast, Qld, Australia; [Engwerda, Christian] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	Griffith University; QIMR Berghofer Medical Research Institute	Good, MF (corresponding author), Griffith Univ, Gold Coast, Qld, Australia.	Michael.Good@griffith.edu.au; Christian.Engwerda@qimr.edu.au	Engwerda, Christian/I-3072-2015	Engwerda, Christian/0000-0003-2813-4804				BRAKE DA, 1988, J IMMUNOL, V140, P1989; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Elliott SR, 2005, INFECT IMMUN, V73, P2478, DOI 10.1128/IAI.73.4.2478-2485.2005; Good MF, 2005, ANNU REV IMMUNOL, V23, P69, DOI 10.1146/annurev.immunol.23.021704.115638; Imai T, 2010, EUR J IMMUNOL, V40, P1053, DOI 10.1002/eji.200939525; JAYAWARDENA AN, 1982, J IMMUNOL, V129, P377; MOGIL RJ, 1987, J IMMUNOL, V138, P1933; Pinzon-Charry A, 2010, J CLIN INVEST, V120, P2967, DOI 10.1172/JCI39222; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; van der Heyde HC, 2006, INFECT IMMUN, V74, P2717, DOI 10.1128/IAI.74.5.2717-2725.2006; VINETZ JM, 1990, J IMMUNOL, V144, P1069; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573	14	20	20	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					49	51		10.1038/nm0111-49	http://dx.doi.org/10.1038/nm0111-49			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21217684	Bronze			2022-12-25	WOS:000285994000035
J	Kalay, E; Yigit, G; Aslan, Y; Brown, KE; Pohl, E; Bicknell, LS; Kayserili, H; Li, Y; Tuysuz, B; Nurnberg, G; Kiess, W; Koegl, M; Baessmann, I; Buruk, K; Toraman, B; Kayipmaz, S; Kul, S; Ikbal, M; Turner, DJ; Taylor, MS; Aerts, J; Scott, C; Milstein, K; Dollfus, H; Wieczorek, D; Brunner, HG; Hurles, M; Jackson, AP; Rauch, A; Nurnberg, P; Karaguzel, A; Wollnik, B				Kalay, Ersan; Yigit, Goekhan; Aslan, Yakup; Brown, Karen E.; Pohl, Esther; Bicknell, Louise S.; Kayserili, Hulya; Li, Yun; Tuysuz, Beyhan; Nuernberg, Gudrun; Kiess, Wieland; Koegl, Manfred; Baessmann, Ingelore; Buruk, Kurtulus; Toraman, Bayram; Kayipmaz, Saadettin; Kul, Sibel; Ikbal, Mevlit; Turner, Daniel J.; Taylor, Martin S.; Aerts, Jan; Scott, Carol; Milstein, Karen; Dollfus, Helene; Wieczorek, Dagmar; Brunner, Han G.; Hurles, Matthew; Jackson, Andrew P.; Rauch, Anita; Nuernberg, Peter; Karaguzel, Ahmet; Wollnik, Bernd			CEP152 is a genome maintenance protein disrupted in Seckel syndrome	NATURE GENETICS			English	Article							DNA-DAMAGE; ATR; PERICENTRIN; MUTATIONS; CENTROSOME	Functional impairment of DNA damage response pathways leads to increased genomic instability. Here we describe the centrosomal protein CEP152 as a new regulator of genomic integrity and cellular response to DNA damage. Using homozygosity mapping and exome sequencing, we identified CEP152 mutations in Seckel syndrome and showed that impaired CEP152 function leads to accumulation of genomic defects resulting from replicative stress through enhanced activation of ATM signaling and increased H2AX phosphorylation.	[Kalay, Ersan; Yigit, Goekhan; Pohl, Esther; Li, Yun; Wollnik, Bernd] Univ Cologne, Inst Human Genet, Cologne, Germany; [Kalay, Ersan; Karaguzel, Ahmet] Karadeniz Tech Univ, Fac Med, Dept Med Biol, Trabzon, Turkey; [Kalay, Ersan; Yigit, Goekhan; Pohl, Esther; Li, Yun; Nuernberg, Gudrun; Baessmann, Ingelore; Nuernberg, Peter; Wollnik, Bernd] Univ Cologne, CMMC, Cologne, Germany; [Yigit, Goekhan; Nuernberg, Gudrun; Nuernberg, Peter; Wollnik, Bernd] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Aslan, Yakup] Karadeniz Tech Univ, Fac Med, Dept Pediat, Trabzon, Turkey; [Brown, Karen E.] Hammersmith Hosp, Imperial Coll Sch Med, MRC, Chromosome Biol Grp,Clin Sci Ctr, London, England; [Bicknell, Louise S.; Taylor, Martin S.; Jackson, Andrew P.] Western Gen Hosp, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Kayserili, Hulya] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, Istanbul, Turkey; [Tuysuz, Beyhan] Istanbul Univ, Cerrahpasa Med Fac, Dept Pediat Genet, Istanbul, Turkey; [Nuernberg, Gudrun; Baessmann, Ingelore; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Kiess, Wieland] Univ Leipzig, Hosp Children & Adolescents, Dept Women & Child Hlth, Leipzig, Germany; [Koegl, Manfred] German Canc Res Ctr, Preclin Target Dev Facil, D-6900 Heidelberg, Germany; [Koegl, Manfred] German Canc Res Ctr, Genom & Prote Core Facil, D-6900 Heidelberg, Germany; [Buruk, Kurtulus] Karadeniz Tech Univ, Fac Med, Dept Clin Microbiol, Trabzon, Turkey; [Kayipmaz, Saadettin] Karadeniz Tech Univ, Fac Dent, Dept Oral Diag & Radiol, Trabzon, Turkey; [Kul, Sibel] Karadeniz Tech Univ, Fac Med, Dept Radiol, Trabzon, Turkey; [Ikbal, Mevlit] Karadeniz Tech Univ, Fac Med, Dept Med Genet, Trabzon, Turkey; [Turner, Daniel J.; Aerts, Jan; Scott, Carol; Hurles, Matthew] Wellcome Trust Sanger Inst, Cambridge, England; [Milstein, Karen] Natl Hlth Lab Serv, Div Human Genet, Johannesburg, South Africa; [Milstein, Karen] Univ Witwatersrand, Johannesburg, South Africa; [Dollfus, Helene] Hop Univ Strasbourg, Serv Genet Med, Ctr Reference Affect Rares Genet Ophtalmol, Strasbourg, France; [Wieczorek, Dagmar] Univ Klinikum Essen, Inst Humangenet, Essen, Germany; [Brunner, Han G.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Rauch, Anita] Univ Zurich, Inst Med Genet, Zurich, Switzerland	University of Cologne; Karadeniz Technical University; University of Cologne; University of Cologne; Karadeniz Technical University; Imperial College London; University of Edinburgh; Istanbul University; Istanbul University; Istanbul University - Cerrahpasa; University of Cologne; Leipzig University; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Karadeniz Technical University; Karadeniz Technical University; Karadeniz Technical University; Karadeniz Technical University; Wellcome Trust Sanger Institute; National Health Laboratory Service; University of Witwatersrand; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Duisburg Essen; Radboud University Nijmegen; University of Zurich	Wollnik, B (corresponding author), Univ Cologne, Inst Human Genet, Cologne, Germany.	ersankalay@hotmail.com; bwollnik@uni-koeln.de	Wollnik, Bernd/GRY-6062-2022; Kalay, Ersan/AAL-2906-2021; Toraman, Bayram/AAU-2772-2020; Rauch, Anita/C-5568-2014; Kul, Sibel/AAA-4293-2021; Kayserili, Hülya/AAA-5593-2021; Wieczorek, Dagmar/AAU-6008-2021; Taylor, Martin S/C-3825-2009; Bicknell, Louise/AAL-8003-2020; Tüysüz, Beyhan/AAN-4858-2020; ikbal, mevlit/D-5880-2015; Jackson, Andrew P/D-3442-2009; TORAMAN, Bayram/A-6798-2018; Kul, Sibel/AAL-9071-2021; Brunner, Han/C-9928-2013; ASLAN, YAKUP/AAL-6790-2021; KAYIPMAZ, Saadettin/AAT-8487-2020; Aerts, Jan/AAQ-6949-2020	Wollnik, Bernd/0000-0003-2589-0364; Kalay, Ersan/0000-0002-1467-2268; Rauch, Anita/0000-0003-2930-3163; Kayserili, Hülya/0000-0003-0376-499X; Wieczorek, Dagmar/0000-0003-2812-6492; Taylor, Martin S/0000-0001-7656-330X; Jackson, Andrew P/0000-0002-8739-2646; TORAMAN, Bayram/0000-0003-4500-5668; Kul, Sibel/0000-0002-0174-2634; Aerts, Jan/0000-0002-6416-2717; Tuysuz, Beyhan/0000-0002-9620-5021; Dollfus, Helene/0000-0002-2249-895X	German Federal Ministry of Education and Research (BMBF) [01GM0880, 01GM0801]; Karadeniz Technical University [2008.114.001.02, 2008.114.001.12]; Medical Research Council; Lister Institute; Wellcome Trust [077014/Z/05/Z]; Medical Research Council [MC_U127597124, MC_U120081295, MC_U127580972] Funding Source: researchfish; MRC [MC_U127580972, MC_U127597124, MC_U120081295] Funding Source: UKRI	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Karadeniz Technical University(Karadeniz Technical University); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lister Institute; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all family members who participated in this study, E. Milz, A. Alver and A. Coffey for excellent technical assistance, F. Kokocinski and A. Palotie for experimental design, and C. Kubisch, B. Wirth and K. Boss for critical reading the manuscript. The CINP antibody was a kind gift from D. Cortez (Nashville, Tennessee, USA). This work was supported by the German Federal Ministry of Education and Research (BMBF) by grant numbers 01GM0880 (SKELNET) and 01GM0801 (E-RARE network CRANIRARE) to B.W., the Karadeniz Technical University Research Fund by grant numbers 2008.114.001.02 and 2008.114.001.12 to E.K., the Medical Research Council and Lister Institute to A.P.J. and by the Wellcome Trust, grant 077014/Z/05/Z.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003; Liu QH, 2000, GENE DEV, V14, P1448; Lovejoy CA, 2009, P NATL ACAD SCI USA, V106, P19304, DOI 10.1073/pnas.0909345106; MAJEWSKI F, 1982, AM J MED GENET, V12, P7, DOI 10.1002/ajmg.1320120103; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174	15	163	167	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2011	43	1					23	26		10.1038/ng.725	http://dx.doi.org/10.1038/ng.725			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	699SQ	21131973	Green Accepted			2022-12-25	WOS:000285683500010
J	Painter, JN; Anderson, CA; Nyholt, DR; Macgregor, S; Lin, JH; Lee, SH; Lambert, A; Zhao, ZZ; Roseman, F; Guo, Q; Gordon, SD; Wallace, L; Henders, AK; Visscher, PM; Kraft, P; Martin, NG; Morris, AP; Treloar, SA; Kennedy, SH; Missmer, SA; Montgomery, GW; Zondervan, KT				Painter, Jodie N.; Anderson, Carl A.; Nyholt, Dale R.; Macgregor, Stuart; Lin, Jianghai; Lee, Sang Hong; Lambert, Ann; Zhao, Zhen Z.; Roseman, Fenella; Guo, Qun; Gordon, Scott D.; Wallace, Leanne; Henders, Anjali K.; Visscher, Peter M.; Kraft, Peter; Martin, Nicholas G.; Morris, Andrew P.; Treloar, Susan A.; Kennedy, Stephen H.; Missmer, Stacey A.; Montgomery, Grant W.; Zondervan, Krina T.			Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis	NATURE GENETICS			English	Article							LINKAGE; RISK; GENE; WOMEN; HERITABILITY; EXPRESSION; FAMILIES; DESIGN; SIZE	Endometriosis is a common gynecological disease associated with pelvic pain and subfertility. We conducted a genome-wide association study (GWAS) in 3,194 individuals with surgically confirmed endometriosis (cases) and 7,060 controls from Australia and the UK. Polygenic predictive modeling showed significantly increased genetic loading among 1,364 cases with moderate to severe endometriosis. The strongest association signal was on 7p15.2 (rs12700667) for 'all' endometriosis (P = 2.6 x 10(-7), odds ratio (OR) = 1.22, 95% CI 1.13-1.32) and for moderate to severe disease (P = 1.5 x 10(-9), OR = 1.38, 95% CI 1.24-1.53). We replicated rs12700667 in an independent cohort from the United States of 2,392 self-reported, surgically confirmed endometriosis cases and 2,271 controls (P = 1.2 x 10(-3), OR = 1.17, 95% CI 1.06-1.28), resulting in a genome-wide significant P value of 1.4 x 10(-9) (OR = 1.20, 95% CI 1.13-1.27) for 'all' endometriosis in our combined datasets of 5,586 cases and 9,331 controls. rs12700667 is located in an intergenic region upstream of the plausible candidate genes NFE2L3 and HOXA10.	[Anderson, Carl A.; Morris, Andrew P.; Zondervan, Krina T.] Univ Oxford, Wellcome Trust Ctr Human Genet, Genet & Genom Epidemiol Unit, Oxford, England; [Nyholt, Dale R.] Queensland Inst Med Res, Neurogenet Lab, Herston, Qld 4006, Australia; [Anderson, Carl A.] Wellcome Trust Sanger Inst, Hinxton, England; [Lin, Jianghai; Lambert, Ann; Roseman, Fenella; Kennedy, Stephen H.; Zondervan, Krina T.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England; [Guo, Qun; Missmer, Stacey A.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Guo, Qun; Missmer, Stacey A.] Harvard Univ, Sch Med, Boston, MA USA; [Gordon, Scott D.; Martin, Nicholas G.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Kraft, Peter; Missmer, Stacey A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Treloar, Susan A.] Univ Queensland, Mayne Med Sch, Ctr Mil & Vet Hlth, Brisbane, Qld 4072, Australia; Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA	University of Oxford; Wellcome Centre for Human Genetics; QIMR Berghofer Medical Research Institute; Wellcome Trust Sanger Institute; University of Oxford; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; QIMR Berghofer Medical Research Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Queensland; Harvard University; Brigham & Women's Hospital	Zondervan, KT (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Genet & Genom Epidemiol Unit, Oxford, England.	jodie.painter@qimr.edu.au; krina.zondervan@well.ox.ac.uk	Montgomery, Grant W/B-7148-2008; Macgregor, Stuart/C-6442-2009; Painter, Jodie N/AAC-6332-2019; Visscher, Peter/ABB-6151-2020; Martin, Nicholas/R-9235-2019; Zondervan, Krina T/M-1143-2013; Anderson, Carl A/B-8327-2013; Lee, Sang Hong/A-2569-2011; Nyholt, Dale Robert/J-3174-2017; Henders, Anjali/E-3126-2017; WALLACE, Leanne/V-2097-2018	Montgomery, Grant W/0000-0002-4140-8139; Macgregor, Stuart/0000-0001-6731-8142; Painter, Jodie N/0000-0002-4992-2458; Visscher, Peter/0000-0002-2143-8760; Martin, Nicholas/0000-0003-4069-8020; Zondervan, Krina T/0000-0002-0275-9905; Anderson, Carl A/0000-0003-1719-7009; Lee, Sang Hong/0000-0001-9701-2718; Nyholt, Dale Robert/0000-0001-7159-3040; Henders, Anjali/0000-0003-3672-1451; WALLACE, Leanne/0000-0003-4310-7572; Gordon, Scott/0000-0001-7623-328X	Endometriosis Associations; National Health and Medical Research Council (NHMRC) of Australia [241944, 339462, 389927, 389875, 389891, 389892, 389938, 443036, 442915, 442981, 496610, 496739, 552485, 552498]; Cooperative Research Centre for Discovery of Genes for Common Human Diseases (CRC); Cerylid Biosciences (Melbourne); NHMRC [339462, 442915, 613674, 496674, 613705, 339446, 619667]; ARC [FT0991022]; Wellcome Trust [WT084766/Z/08/Z, 076113, 085475, WT91745/Z/10/Z, WT085235/Z/08/Z]; Department of Health NIHR Biomedical Research Centres; National Institutes of Health (NIH) of the United States [P01 CA087969, R01 CA049449, UO1 CA098233, P01 DK070756, R01 CA050385, R01 CA067262, R01 HD052473, R01 HD057210]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057210] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052473] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA098233, P01CA087969, R01CA050385, R01CA049449, R01CA067262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK070756] Funding Source: NIH RePORTER	Endometriosis Associations; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cooperative Research Centre for Discovery of Genes for Common Human Diseases (CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Cerylid Biosciences (Melbourne); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health NIHR Biomedical Research Centres(National Institute for Health Research (NIHR)); National Institutes of Health (NIH) of the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge with appreciation all the women who participated in the QIMR, OXEGENE and NHS studies. We thank Endometriosis Associations for supporting the study recruitment. We also thank the many hospital directors and staff, gynecologists, general practitioners and pathology services in Australia, the UK and the United States who provided assistance with confirmation of diagnoses. We thank S. Nicolaides and the Queensland Medical Laboratory for pro bono collection and delivery of blood samples and other pathology services for assistance with blood collection.; The QIMR Study was supported by grants from the National Health and Medical Research Council (NHMRC) of Australia (241944, 339462, 389927, 389875, 389891, 389892, 389938, 443036, 442915, 442981, 496610, 496739, 552485 and 552498), the Cooperative Research Centre for Discovery of Genes for Common Human Diseases (CRC), Cerylid Biosciences (Melbourne) and donations from N. Hawkins and S. Hawkins. D.R.N. was supported by the NHMRC Fellowship (339462 and 613674) and the ARC Future Fellowship (FT0991022) schemes. S.M. was supported by NHMRC Career Development Awards (496674, 613705). P.M.V. (442915) and G.W.M. (339446, 619667) were supported by the NHMRC Fellowships Scheme. We thank B. Haddon, D. Smyth, H. Beeby, O. Zheng, B. Chapman and S. Medland for project and database management, sample processing, genotyping and imputation. We thank Brisbane gynecologist D.T. O'Connor for his important role in initiating the early stages of the project and for confirmation of diagnosis and staging of disease from clinical records of many cases, including 251 in these analyses. We are grateful to the many research assistants and interviewers for assistance with the studies contributing to the QIMR collection.; The work presented here was supported by a grant from the Wellcome Trust (WT084766/Z/08/Z) and makes use of WTCCC2 control data generated by the Wellcome Trust Case-Control Consortium. A full list of the investigators who contributed to the generation of these data is available from http://www.wtccc.org.uk. Funding for the WTCCC project was provided by the Wellcome Trust under awards 076113 and 085475. Imputation analyses were conducted using computational resources at the Oxford Supercomputing Centre (OSC). C.A.A. was funded by the Wellcome Trust (WT91745/Z/10/Z). A.P.M. was supported by a Wellcome Trust Senior Research Fellowship. S.H.K. is supported by the Oxford Partnership Comprehensive Biomedical Research Centre with funding from the Department of Health NIHR Biomedical Research Centres funding scheme. K.T.Z. is supported by a Wellcome Trust Research Career Development Fellowship (WT085235/Z/08/Z). We thank L. Cotton, L. Pope, G. Chalk and G. Farmer (University of Oxford). We also thank P. Koninckx (Leuven, Belgium), M. Sillem (Heidelberg, Germany), C. O'Herlihy and M. Wingfield (Dublin, Ireland), M. Moen (Trondheim, Norway), L. Adamyan (Moscow, Russia), E. McVeigh (Oxford, UK), C. Sutton (Guildford, UK), D. Adamson (Palo Alto, California, USA) and R. Batt (Buffalo, New York, USA) for providing diagnostic confirmation.; The Nurses' Health Studies I and II were supported by grants from the National Institutes of Health (NIH) of the United States, NHS1 cohort (primary investigator: S. Hankinson)-P01 CA087969, NHS1 blood cohort (primary investigator, S. Hankinson)-R01 CA049449, NHS1 Breast Cancer GWAS (primary investigator, D. Hunter)-UO1 CA098233, NHS1/NHS2 Kidney Stones GWAS (primary investigator, G. Curhan)-P01 DK070756, NHS2 cohort (primary investigator, W. Willett)-R01 CA050385, NHS2 blood cohort (primary investigator, S. Hankinson)-R01 CA067262, NHS2 endometriosis (primary investigator, S. Missmer)-R01 HD052473 and R01 HD057210. We thank L. Marshall, D. Hunter and R. Barbieri for their contributions to the endometriosis case validation study and B. Egan and L. Ward for surgical records procurement.	[Anonymous], 1985, Fertil Steril, V43, P351; Boyer A, 2010, FASEB J, V24, P3010, DOI 10.1096/fj.09-145789; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Curhan GC, 2008, KIDNEY INT, V73, P489, DOI 10.1038/sj.ki.5002708; Ferreira MAR, 2010, AM J HUM GENET, V86, P88, DOI 10.1016/j.ajhg.2009.12.008; Gilmour A., 2006, ASREML USER GUIDE RE; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Hadfield RM, 1997, FERTIL STERIL, V68, P941, DOI 10.1016/S0015-0282(97)00359-2; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jones GL, 2002, AM J OBSTET GYNECOL, V187, P501, DOI 10.1067/mob.2002.124940; Kennedy S, 1998, J REPROD MED, V43, P263; Kjerulff KH, 1996, AM J PUBLIC HEALTH, V86, P195, DOI 10.2105/AJPH.86.2.195; KONINCKX PR, 1994, ANN NY ACAD SCI, V734, P333, DOI 10.1111/j.1749-6632.1994.tb21763.x; Kraft P, 2008, EPIDEMIOLOGY, V19, P649, DOI 10.1097/EDE.0b013e318181b865; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; McGregor B, 1999, GENET EPIDEMIOL, V16, P40, DOI 10.1002/(SICI)1098-2272(1999)16:1<40::AID-GEPI4>3.3.CO;2-T; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Missmer SA, 2004, AM J EPIDEMIOL, V160, P784, DOI 10.1093/aje/kwh275; Montgomery GW, 2008, HUM REPROD UPDATE, V14, P447, DOI 10.1093/humupd/dmn016; Naillat F, 2010, HUM MOL GENET, V19, P1539, DOI 10.1093/hmg/ddq027; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Oliehoek PA, 2006, GENETICS, V173, P483, DOI 10.1534/genetics.105.049940; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Simoens S, 2007, HUM REPROD UPDATE, V13, P395, DOI 10.1093/humupd/dmm010; Simpson JL, 2002, ANN NY ACAD SCI, V955, P239, DOI 10.1111/j.1749-6632.2002.tb02785.x; Stefanson H, 2002, HUM REPROD, V17, P555, DOI 10.1093/humrep/17.3.555; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Taylor HS, 1999, HUM REPROD, V14, P1328, DOI 10.1093/humrep/14.5.1328; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Treloar S, 2002, FERTIL STERIL, V78, P679, DOI 10.1016/S0015-0282(02)03341-1; Treloar SA, 1999, FERTIL STERIL, V71, P701, DOI 10.1016/S0015-0282(98)00540-8; Treloar SA, 2005, AM J HUM GENET, V77, P365, DOI 10.1086/432960; Uno S, 2010, NAT GENET, V42, P707, DOI 10.1038/ng.612; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Vitonis AF, 2010, HUM REPROD, V25, P1325, DOI 10.1093/humrep/deq039; Wu Y, 2005, AM J OBSTET GYNECOL, V193, P371, DOI 10.1016/j.ajog.2005.01.034; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhao ZZ, 2008, HUM REPROD, V23, P1661, DOI 10.1093/humrep/den035; Zhao ZZ, 2007, HUM REPROD, V22, P2389, DOI 10.1093/humrep/dem182; Zhu G, 1999, AM J HUM GENET, V65, P483, DOI 10.1086/302494; Zondervan KT, 2001, CURR OPIN OBSTET GYN, V13, P309, DOI 10.1097/00001703-200106000-00011; Zondervan KT, 2004, HUM REPROD, V19, P448, DOI 10.1093/humrep/deh052; Zondervan KT, 2002, HUM REPROD, V17, P1415, DOI 10.1093/humrep/17.6.1415	47	214	226	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2011	43	1					51	U69		10.1038/ng.731	http://dx.doi.org/10.1038/ng.731			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	699SQ	21151130	Green Submitted, Green Accepted			2022-12-25	WOS:000285683500015
J	Medici, D; Shore, EM; Lounev, VY; Kaplan, FS; Kalluri, R; Olsen, BR				Medici, Damian; Shore, Eileen M.; Lounev, Vitali Y.; Kaplan, Frederick S.; Kalluri, Raghu; Olsen, Bjorn R.			Conversion of vascular endothelial cells into multipotent stem-like cells	NATURE MEDICINE			English	Article							TO-MESENCHYMAL TRANSITION; FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; GROWTH-FACTOR-BETA; ATRIOVENTRICULAR CUSHION TRANSFORMATION; CARDIAC FIBROSIS; PROGENITOR CELLS; EMBRYONIC HEART; BMP RECEPTOR; SKELETOGENESIS; MOUSE	Mesenchymal stem cells can give rise to several cell types, but varying results depending on isolation methods and tissue source have led to controversies about their usefulness in clinical medicine. Here we show that vascular endothelial cells can transform into multipotent stem-like cells by an activin-like kinase-2 (ALK2) receptor-dependent mechanism. In lesions from individuals with fibrodysplasia ossificans progressiva (FOP), a disease in which heterotopic ossification occurs as a result of activating ALK2 mutations, or from transgenic mice expressing constitutively active ALK2, chondrocytes and osteoblasts expressed endothelial markers. Lineage tracing of heterotopic ossification in mice using a Tie2-Cre construct also suggested an endothelial origin of these cell types. Expression of constitutively active ALK2 in endothelial cells caused endothelial-to-mesenchymal transition and acquisition of a stem cell-like phenotype. Similar results were obtained by treatment of untransfected endothelial cells with the ligands transforming growth factor-beta 2 (TGF-beta 2) or bone morphogenetic protein-4 (BMP4) in an ALK2-dependent manner. These stem-like cells could be triggered to differentiate into osteoblasts, chondrocytes or adipocytes. We suggest that conversion of endothelial cells to stem-like cells may provide a new approach to tissue engineering. (C) 2010 Nature America, Inc. All rights reserved.	[Medici, Damian; Kalluri, Raghu] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Matrix Biol, Sch Med,Dept Med, Boston, MA 02215 USA; [Shore, Eileen M.; Lounev, Vitali Y.; Kaplan, Frederick S.] Univ Penn, Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; [Shore, Eileen M.; Lounev, Vitali Y.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Shore, Eileen M.; Lounev, Vitali Y.; Kaplan, Frederick S.] Univ Penn, Sch Med, Ctr Res Fibrodysplasia Ossificans Progressiva & R, Philadelphia, PA 19104 USA; [Kaplan, Frederick S.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Kalluri, Raghu] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02215 USA; [Kalluri, Raghu] Harvard Mit Div Hlth Sci & Technol, Boston, MA USA; [Olsen, Bjorn R.] Harvard Univ, Sch Dent, Dept Dev Biol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Harvard University; Harvard Medical School; Harvard University; Harvard University	Medici, D (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Div Matrix Biol, Sch Med,Dept Med, Boston, MA 02215 USA.	dmedici@bidmc.harvard.edu; bjorn_olsen@hms.harvard.edu	Kalluri, Raghu/E-2677-2015	Kalluri, Raghu/0000-0002-2190-547X	US National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR048564] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank M. Xu for technical assistance, J. Bischoff (Children's Hospital Boston) for providing primary cultures of human endothelial cells, A. Maidment for X-rays and Y. Mishina (University of Michigan) for providing caALK2-transgenic mice. We also thank E. Hay (Harvard Medical School) for human corneal fibroblasts. This work was supported by grants from the US National Institutes of Health to B.R.O., R. K., F. S. K. and E. M. S. and to the University of Pennsylvania Vector Core. Additional support was from the International Fibrodysplasia Ossificans Progressiva Association, the Ian Cali and the Weldon Family Endowments, the Penn Center for Musculoskeletal Disorders, the Isaac and Rose Nassau Professorship of Orthopaedic Molecular Medicine and the Rita Allen Foundation.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Arciniegas E, 2007, AM J PHYSIOL-LUNG C, V293, pL1, DOI 10.1152/ajplung.00378.2006; Azhar M, 2009, DEV DYNAM, V238, P431, DOI 10.1002/dvdy.21854; Boye E, 2001, J CLIN INVEST, V107, P745, DOI 10.1172/JCI11432; Boyer AS, 1999, DEV BIOL, V208, P530, DOI 10.1006/dbio.1999.9211; Camenisch TD, 2002, DEV BIOL, V248, P170, DOI 10.1006/dbio.2002.0731; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Dai J, 2007, J DENT RES, V86, P937, DOI 10.1177/154405910708601006; Fukuda T, 2006, GENESIS, V44, P159, DOI 10.1002/dvg.20201; Goumans MJ, 2008, TRENDS CARDIOVAS MED, V18, P293, DOI 10.1016/j.tcm.2009.01.001; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; ILIZAROV GA, 1988, B HOSP JOINT DIS ORT, V48, P1; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaplan FS, 2008, J BONE MINER METAB, V26, P521, DOI 10.1007/s00774-008-0879-8; Kaplan FS, 2007, J BONE JOINT SURG AM, V89A, P347, DOI 10.2106/JBJS.F.00472; Karhausen J, 2005, CELL CYCLE, V4, P256; Kizu A, 2009, AM J PATHOL, V175, P1371, DOI 10.2353/ajpath.2009.090698; Lai YT, 2000, DEV BIOL, V222, P1, DOI 10.1006/dbio.2000.9698; Lee JG, 2006, EXP EYE RES, V83, P1309, DOI 10.1016/j.exer.2006.04.007; Lewinson D, 2001, HISTOCHEM CELL BIOL, V116, P381, DOI 10.1007/s004180100331; Li JH, 2009, AM J PATHOL, V175, P1380, DOI 10.2353/ajpath.2009.090096; Lounev VY, 2009, J BONE JOINT SURG AM, V91A, P652, DOI 10.2106/JBJS.H.01177; Mercado-Pimentel ME, 2007, CELLS TISSUES ORGANS, V185, P146, DOI 10.1159/000101315; Mironov V., 1995, ANN BIOMED ENG, V23; Okagawa H, 2007, DEV BIOL, V306, P179, DOI 10.1016/j.ydbio.2007.03.015; Paruchuri S, 2006, CIRC RES, V99, P861, DOI 10.1161/01.RES.0000245188.41002.2c; Potenta S, 2008, BRIT J CANCER, V99, P1375, DOI 10.1038/sj.bjc.6604662; Shore EM, 2008, BONE, V43, P427, DOI 10.1016/j.bone.2008.05.013; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wang JK, 2005, DEV BIOL, V286, P299, DOI 10.1016/j.ydbio.2005.07.035; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513	38	538	563	0	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2010	16	12					1400	U80		10.1038/nm.2252	http://dx.doi.org/10.1038/nm.2252			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21102460	Green Accepted			2022-12-25	WOS:000285048900033
J	Ori-McKenney, KM; Xu, J; Gross, SP; Vallee, RB				Ori-McKenney, Kassandra M.; Xu, Jing; Gross, Steven P.; Vallee, Richard B.			A cytoplasmic dynein tail mutation impairs motor processivity	NATURE CELL BIOLOGY			English	Article							RETROGRADE TRANSPORT; G59S MUTATION; IN-VITRO; DYNACTIN; KINESIN; SUBUNIT; MAP-1C; FORCE; MICE; COORDINATION	Mutations in the tail of the cytoplasmic dynein molecule have been reported to cause neurodegenerative disease in mice. The mutant mouse strain Legs at odd angles (Loa) has impaired retrograde axonal transport, but the molecular deficiencies in the mutant dynein molecule, and how they contribute to neurodegeneration, are unknown. To address these questions, we purified dynein from wild-type mice and the Legs at odd angles mutant mice. Using biochemical, single-molecule, and live-cell-imaging techniques, we find a marked inhibition of motor run-length in vitro and in vivo, and significantly altered motor domain coordination in the dynein from mutant mice. These results suggest a potential role for the dynein tail in motor function, and provide direct evidence for a link between single-motor processivity and disease.	[Ori-McKenney, Kassandra M.; Vallee, Richard B.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Ori-McKenney, Kassandra M.; Vallee, Richard B.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Xu, Jing; Gross, Steven P.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	Columbia University; Columbia University; University of California System; University of California Irvine	Vallee, RB (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA.	sgross@uci.edu; rv2025@columbia.edu			NIH [GM47434, RO1GM070676, GM008798-09]; AHA [825278F]; Columbia University Motor Neuron Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047434, T32GM008798, R37GM047434, R01GM070676] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Columbia University Motor Neuron Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. McKenney for help with the quantum dot assays and useful discussion, and M. Vershinnin for developing the tracking program. This work was supported by NIH grants GM47434 (to R.B.V.), RO1GM070676 (to S.P.G.) and GM008798-09 (to K.M.O.M.), AHA grant 825278F (to J.X.), and the Columbia University Motor Neuron Center.	Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; Carter BC, 2005, PHYS BIOL, V2, P60, DOI 10.1088/1478-3967/2/1/008; Carter BC, 2008, BIOPHYS J, V94, P306, DOI 10.1529/biophysj.107.110601; Chen XJ, 2007, J NEUROSCI, V27, P14515, DOI 10.1523/JNEUROSCI.4338-07.2007; Chevalier-Larsen ES, 2008, HUM MOL GENET, V17, P1946, DOI 10.1093/hmg/ddn092; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; GILBERT GA, 1956, NATURE, V177, P853, DOI 10.1038/177853a0; Grabham PW, 2007, J NEUROSCI, V27, P5823, DOI 10.1523/JNEUROSCI.1135-07.2007; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Ilieva HS, 2008, P NATL ACAD SCI USA, V105, P12599, DOI 10.1073/pnas.0805422105; Kalafut B, 2008, COMPUT PHYS COMMUN, V179, P716, DOI 10.1016/j.cpc.2008.06.008; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kieran D, 2005, J CELL BIOL, V169, P561, DOI 10.1083/jcb.200501085; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; King SJ, 2002, PROTEIN SCI, V11, P1239, DOI 10.1110/ps.2520102; Lai C, 2007, J NEUROSCI, V27, P13982, DOI 10.1523/JNEUROSCI.4226-07.2007; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; MIKAMI A, 1993, NEURON, V10, P787, DOI 10.1016/0896-6273(93)90195-W; Myers KR, 2007, J NEUROSCI RES, V85, P2640, DOI 10.1002/jnr.21213; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; Perlson E, 2009, J NEUROSCI, V29, P9903, DOI 10.1523/JNEUROSCI.0813-09.2009; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Shima T, 2006, J STRUCT BIOL, V156, P182, DOI 10.1016/j.jsb.2006.03.014; SHPETNER HS, 1988, J CELL BIOL, V107, P1001, DOI 10.1083/jcb.107.3.1001; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Sweeney HL, 2007, EMBO J, V26, P2682, DOI 10.1038/sj.emboj.7601720; Vershinin M, 2008, TRAFFIC, V9, P882, DOI 10.1111/j.1600-0854.2008.00741.x; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Wang ZH, 1995, BIOPHYS J, V69, P2011, DOI 10.1016/S0006-3495(95)80071-8; Zhang QG, 2009, TRAFFIC, V10, P1337, DOI 10.1111/j.1600-0854.2009.00945.x	38	122	123	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2010	12	12					1228	U256		10.1038/ncb2127	http://dx.doi.org/10.1038/ncb2127			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	688DY	21102439	Green Accepted			2022-12-25	WOS:000284831200015
J	Sharma, SK; De Los Rios, P; Christen, P; Lustig, A; Goloubinoff, P				Sharma, Sandeep K.; De Los Rios, Paolo; Christen, Philipp; Lustig, Ariel; Goloubinoff, Pierre			The kinetic parameters and energy cost of the Hsp70 chaperone as a polypeptide unfoldase	NATURE CHEMICAL BIOLOGY			English	Article							HEAT-SHOCK PROTEINS; DNAK CHAPERONE; ESCHERICHIA-COLI; MOLECULAR CHAPERONES; SUBSTRATE-SPECIFICITY; MANGANESE IONS; GRPE; MECHANISM; SYSTEM; ATP	Hsp70-Hsp40-NEF and possibly Hsp100 are the only known molecular chaperones that can use the energy of ATP to convert stably pre-aggregated polypeptides into natively refolded proteins. However, the kinetic parameters and ATP costs have remained elusive because refolding reactions have only been successful with a molar excess of chaperones over their polypeptide substrates. Here we describe a stable, misfolded luciferase species that can be efficiently renatured by substoichiometric amounts of bacterial Hsp70-Hsp40-NEF. The reactivation rates increased with substrate concentration and followed saturation kinetics, thus allowing the determination of apparent V(max)' and K(m)' values for a chaperone-mediated renaturation reaction for the first time. Under the in vitro conditions used, one Hsp70 molecule consumed five ATPs to effectively unfold a single misfolded protein into an intermediate that, upon chaperone dissociation, spontaneously refolded to the native state, a process with an ATP cost a thousand times lower than expected for protein degradation and resynthesis.	[Sharma, Sandeep K.; Goloubinoff, Pierre] Univ Lausanne, Dept Biol Mol Vegetale, Lausanne, Switzerland; [De Los Rios, Paolo] Ecole Polytech Fed Lausanne, Sch Basic Sci, Lab Biophys Stat, Lausanne, Switzerland; [Christen, Philipp] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland; [Lustig, Ariel] Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Zurich; University of Basel	Sharma, SK (corresponding author), Univ Lausanne, Dept Biol Mol Vegetale, Lausanne, Switzerland.	pierre.goloubinoff@unil.ch	De Los Rios, Paolo/B-2456-2010; Sharma, Sandeep K./F-7420-2010; Sharma, Sandeep K./ABH-2409-2021	De Los Rios, Paolo/0000-0002-5394-5062; Sharma, Sandeep K./0000-0002-0039-7883; Sharma, Sandeep K./0000-0002-0039-7883; Goloubinoff, Pierre/0000-0002-4802-0807	Swiss National Science Foundation [3100A0-109290]; Faculty of Biology and Medicine, University of Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Faculty of Biology and Medicine, University of Lausanne	We thank A. S. Spirin (Institute of Protein Research, Russian Academy of Sciences) for the luciferase plasmid, H. J. SchOnfeld (F. Hoffmann-La Roche) for DnaK, DnaJ and GrpE, A. Azem (Tel Aviv University) for discussions and AUC analyses, M. Muriset and R. U. H. Mattoo for discussions and technical assistance, G. Lorimer and J. Buchner for suggesting, respectively, the experiments in Figures 5b and 2b, and A. Finka and S. Priya for discussions and manuscript correction. This research was financed by grant 3100A0-109290 from the Swiss National Science Foundation and in part by the Zwahlen Grant from the Faculty of Biology and Medicine, University of Lausanne.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Azem A, 1995, P NATL ACAD SCI USA, V92, P12021, DOI 10.1073/pnas.92.26.12021; Barouch W, 1997, BIOCHEMISTRY-US, V36, P4303, DOI 10.1021/bi962727z; Ben-Zvi A, 2004, J BIOL CHEM, V279, P37298, DOI 10.1074/jbc.M405627200; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bischofberger P, 2003, J BIOL CHEM, V278, P19044, DOI 10.1074/jbc.M300922200; Brehmer D, 2004, J BIOL CHEM, V279, P27957, DOI 10.1074/jbc.M403558200; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; Diamant S, 1998, BIOCHEMISTRY-US, V37, P9688, DOI 10.1021/bi980338u; DIAMANT S, 1995, J BIOL CHEM, V270, P28387; DIAMANT S, 1995, BIOCHEMISTRY-US, V34, P273, DOI 10.1021/bi00001a033; Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Feifel B, 1996, EUR J BIOCHEM, V237, P318, DOI 10.1111/j.1432-1033.1996.0318n.x; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; FISHBEIN WN, 1979, PROTEINS LOW TEMPERA, V180, P55; GAMER J, 1992, CELL, V69, P833, DOI 10.1016/0092-8674(92)90294-M; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Goloubinoff P, 2007, TRENDS BIOCHEM SCI, V32, P372, DOI 10.1016/j.tibs.2007.06.008; Han WJ, 2003, J BIOL CHEM, V278, P19038, DOI 10.1074/jbc.M300756200; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HELLEBUST H, 1990, J BACTERIOL, V172, P5030, DOI 10.1128/jb.172.9.5030-5034.1990; Hinault MP, 2006, J MOL NEUROSCI, V30, P249, DOI 10.1385/JMN:30:3:249; Hu B, 2006, BIOPHYS J, V91, P496, DOI 10.1529/biophysj.106.083394; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Mally A, 2001, NAT STRUCT BIOL, V8, P254, DOI 10.1038/85002; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Popp S, 2005, J MOL BIOL, V347, P1039, DOI 10.1016/j.jmb.2005.02.026; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; SCHONFELD HJ, 1995, J BIOL CHEM, V270, P2183, DOI 10.1074/jbc.270.5.2183; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Sharma SK, 2009, CURR PROTEIN PEPT SC, V10, P432, DOI 10.2174/138920309789351930; SKOWYRA D, 1990, CELL, V62, P939, DOI 10.1016/0092-8674(90)90268-J; Svetlov MS, 2007, MOL BIOL+, V41, P86, DOI 10.1134/S0026893307010128; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0	48	156	160	2	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					914	920		10.1038/NCHEMBIO.455	http://dx.doi.org/10.1038/NCHEMBIO.455			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	20953191				2022-12-25	WOS:000284214700021
J	Su, T; Bryant, DM; Luton, F; Verges, M; Ulrich, SM; Hansen, KC; Datta, A; Eastburn, DJ; Burlingame, AL; Shokat, KM; Mostov, KE				Su, Tao; Bryant, David M.; Luton, Frederic; Verges, Marcel; Ulrich, Scott M.; Hansen, Kirk C.; Datta, Anirban; Eastburn, Dennis J.; Burlingame, Alma L.; Shokat, Kevan M.; Mostov, Keith E.			A kinase cascade leading to Rab11-FIP5 controls transcytosis of the polymeric immunoglobulin receptor	NATURE CELL BIOLOGY			English	Article							GROWTH-FACTOR RECEPTOR; UNNATURAL NUCLEOTIDE SPECIFICITY; POLARIZED EPITHELIAL-CELLS; PROTEIN-TYROSINE KINASE; CANINE KIDNEY-CELLS; PHOSPHOINOSITIDE 3-KINASE; MEMBRANE TRAFFICKING; RECYCLING ENDOSOMES; SIGNAL-TRANSDUCTION; PHOSPHOLIPASE-C	Polymeric immunoglobulin A (plgA) transcytosis, mediated by the polymeric immunoglobulin receptor (plgR), is a central component of mucosal immunity and a model for regulation of polarized epithelial membrane traffic. Binding of plgA to plgR stimulates transcytosis in a process requiring Yes, a Src family tyrosine kinase (SFK). We show that Yes directly phosphorylates EGF receptor (EGFR) on liver endosomes. Injection of plgA into rats induced EGFR phosphorylation. Similarly, in MDCK cells, plgA treatment significantly increased phosphorylation of EGFR on various sites, subsequently activating extracellular signal-regulated protein kinase (ERK). Furthermore, we find that the Rab11 effector Rab11-FIP5 is a substrate of ERK. Knocking down Yes or Rab11-FIP5, or inhibition of the Yes-EGFR-ERK cascade, decreased plgA-plgR transcytosis. Finally, we demonstrate that Rab11-FIP5 phosphorylation by ERK controls Rab11a endosome distribution and plgA-plgR transcytosis. Our results reveal a novel Yes-EGFR-ERK-FIP5 signalling network for regulation of plgA-plgR transcytosis.	[Su, Tao; Bryant, David M.; Luton, Frederic; Verges, Marcel; Datta, Anirban; Eastburn, Dennis J.; Mostov, Keith E.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Luton, Frederic] Univ Nice, CNRS, Inst Pharmacol Mol & Cellulaire, UMR6097, F-06560 Sophia Antipolis, France; [Verges, Marcel] Univ Girona, IdIBGi, Cardiovasc Genet Ctr, Girona 17003, Spain; [Ulrich, Scott M.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Ulrich, Scott M.] Ithaca Coll, Dept Chem, Ithaca, NY 14850 USA; [Hansen, Kirk C.; Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Hansen, Kirk C.] Univ Colorado, Hlth Sci Ctr, Aurora, CO 80045 USA	University of California System; University of California San Francisco; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Anschutz Medical Campus	Mostov, KE (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA.	keith.mostov@ucsf.edu	Bryant, David/AAH-5620-2019; Su, Tao/T-4411-2019; Verges, Marcel/L-5784-2014; Luton, Frederic/N-7673-2017	Bryant, David/0000-0003-2721-5012; Su, Tao/0000-0002-9148-6127; Verges, Marcel/0000-0002-2606-223X; mostov, keith/0000-0002-8123-6247	NIDDK UCSF Liver Center at UCSF [NIH P30 DK026743]; Susan G Komen Foundation; DOD; NIH [NCRR 01614, R01EB001987, R01AI25144, R01DK083330, R01DK074398]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074398, R01DK083330, P30DK026743] Funding Source: NIH RePORTER	NIDDK UCSF Liver Center at UCSF; Susan G Komen Foundation(Susan G. Komen Breast Cancer Foundation); DOD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Mostov lab members and M. von Zastrow for valuable input and critical reading of the manuscript. We thank K. Young and T. Evans for technical assistance. We acknowledge J. Brugge, J. Goldenring, J. Gordon, M. McCaffrey, J. Peppard, M. Sudol, D. C. James, Q. Fan and J. -P. Vaerman for reagents. This work was supported by NIDDK UCSF Liver Center Pilot Project to the Molecular Structure Core of the Liver Center at UCSF (NIH P30 DK026743; awarded to TS), a Susan G Komen Foundation Fellowship (to D.M.B.), a DOD Lung Cancer Concept Award (to A.D.), NIH NCRR 01614 (to ALB), NIH R01EB001987 (to K.M.S.), and R01AI25144, R01DK083330 and R01DK074398 (to K.E.M.).	APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; BELCHER JD, 1987, P NATL ACAD SCI USA, V84, P6785, DOI 10.1073/pnas.84.19.6785; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bishop AC, 1999, J AM CHEM SOC, V121, P627, DOI 10.1021/ja983267v; BOMSEL M, 1992, MOL BIOL CELL, V3, P1317, DOI 10.1091/mbc.3.12.1317; CARDONE MH, 1994, J CELL BIOL, V124, P717, DOI 10.1083/jcb.124.5.717; Cardone MH, 1996, J CELL BIOL, V133, P997, DOI 10.1083/jcb.133.5.997; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; FRANCO M, 1995, J BIOL CHEM, V270, P1337, DOI 10.1074/jbc.270.3.1337; Giffroy D, 1998, INT IMMUNOL, V10, P347, DOI 10.1093/intimm/10.3.347; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; HANSEN SH, 1995, J BIOL CHEM, V270, P28425; Haugh Jason M, 2002, Mol Interv, V2, P292, DOI 10.1124/mi.2.5.292; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; KAETZEL CM, 2005, IMMUNOGLOBULIN TRANS, P211; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Lamm ME, 1998, AM J PHYSIOL-GASTR L, V274, pG614, DOI 10.1152/ajpgi.1998.274.4.G607; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Lecuit T, 2003, NAT CELL BIOL, V5, P103, DOI 10.1038/ncb0203-103; Li BX, 2007, J CELL BIOL, V177, P659, DOI 10.1083/jcb.200610157; Lindsay AJ, 2004, J CELL SCI, V117, P4365, DOI 10.1242/jcs.01280; Liu Y, 1998, CHEM BIOL, V5, P91, DOI 10.1016/S1074-5521(98)90143-0; Luton F, 1999, MOL CELL, V4, P627, DOI 10.1016/S1097-2765(00)80213-0; Luton F, 1998, MOL BIOL CELL, V9, P1787, DOI 10.1091/mbc.9.7.1787; Luton F, 2009, TRAFFIC, V10, P1128, DOI 10.1111/j.1600-0854.2009.00941.x; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; MOSTOV KE, 1986, CELL, V47, P359, DOI 10.1016/0092-8674(86)90592-1; MULLOCK BM, 1980, FEBS LETT, V113, P201, DOI 10.1016/0014-5793(80)80591-6; O'Brien LE, 2004, DEV CELL, V7, P21, DOI 10.1016/j.devcel.2004.06.001; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Polson AG, 2001, J VIROL, V75, P3175, DOI 10.1128/JVI.75.7.3175-3184.2001; Prekeris R, 2000, MOL CELL, V6, P1437, DOI 10.1016/S1097-2765(00)00140-4; Robertson SE, 2006, MOL BIOL CELL, V17, P645, DOI 10.1091/mbc.E05-07-0662; Rojas R, 2002, NAT REV MOL CELL BIO, V3, P944, DOI 10.1038/nrm972; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; SONG WX, 1994, P NATL ACAD SCI USA, V91, P163, DOI 10.1073/pnas.91.1.163; SONG WX, 1994, J BIOL CHEM, V269, P29474; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Strugnell RA, 2010, NAT REV MICROBIOL, V8, P656, DOI 10.1038/nrmicro2384; Sun GQ, 1997, ARCH BIOCHEM BIOPHYS, V345, P135, DOI 10.1006/abbi.1997.0236; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Ulrich SM, 2003, BIOCHEMISTRY-US, V42, P7915, DOI 10.1021/bi030042a; van IJzendoorn SCD, 2002, DEV CELL, V2, P219, DOI 10.1016/S1534-5807(02)00115-6; VEGA QC, 1992, MOL CELL BIOL, V12, P128, DOI 10.1128/MCB.12.1.128; Verges M, 2004, NAT CELL BIOL, V6, P763, DOI 10.1038/ncb1153; Verges M, 1999, P NATL ACAD SCI USA, V96, P10146, DOI 10.1073/pnas.96.18.10146; Verges M, 2007, EXP CELL RES, V313, P707, DOI 10.1016/j.yexcr.2006.11.010; Wang XY, 2000, J BIOL CHEM, V275, P29138, DOI 10.1074/jbc.M004410200; Weisz OA, 2009, J CELL SCI, V122, P4253, DOI 10.1242/jcs.032615; Witucki LA, 2002, CHEM BIOL, V9, P25, DOI 10.1016/S1074-5521(02)00091-1; Wu SL, 2006, MOL CELL PROTEOMICS, V5, P1610, DOI 10.1074/mcp.M600105-MCP200; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	63	62	63	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	DEC	2010	12	12					1143	U60		10.1038/ncb2118	http://dx.doi.org/10.1038/ncb2118			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	688DY	21037565	Green Accepted			2022-12-25	WOS:000284831200006
J	Ucar, A; Vafaizadeh, V; Jarry, H; Fiedler, J; Klemmt, PAB; Thum, T; Groner, B; Chowdhury, K				Ucar, Ahmet; Vafaizadeh, Vida; Jarry, Hubertus; Fiedler, Jan; Klemmt, Petra A. B.; Thum, Thomas; Groner, Bernd; Chowdhury, Kamal			miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development	NATURE GENETICS			English	Article							TGF-BETA; BRANCHING MORPHOGENESIS; IN-VIVO; MICRORNA; GROWTH; EXPRESSION; RECEPTOR; CELLS; AMPHIREGULIN; MAINTENANCE	MicroRNAs are small noncoding RNAs that carry out post-transcriptional regulation of the expression of their target genes. However, their roles in mammalian organogenesis are only beginning to be understood. Here we show that the microRNA-212/132 family ( which comprises miR-212 and miR-132) is indispensable during the development of the mammary glands in mice, particulary for the regulation of the outgrowth of the epithelial ducts. Mammary transplantation experiments revealed that the function of the miR-212/132 family is required in the stroma but not in the epithelia. Both miR-212 and miR-132 are expressed exclusively in mammary stroma and directly target the matrix metalloproteinase MMP-9. In glands that lack miR-212 and miR-132, MMP-9 expression increases and accumulates around the ducts. This may interfere with collagen deposition and lead to hyperactivation of the tumor growth factor-beta signaling pathway, thereby impairing ductal outgrowth. Our results identify the miR-212/132 family as one of the main regulators of the epithelial-stromal interactions that are required for proper pubertal development of the mammary gland.	[Ucar, Ahmet; Chowdhury, Kamal] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany; [Vafaizadeh, Vida; Klemmt, Petra A. B.; Groner, Bernd] Inst Biomed Res, Frankfurt, Germany; [Jarry, Hubertus] Univ Gottingen, Dept Endocrinol, Gottingen, Germany; [Fiedler, Jan] Hannover Med Sch, Inst Mol & Translat Therapeut Strategies, Hannover, Germany	Max Planck Society; University of Gottingen; Hannover Medical School	Chowdhury, K (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany.	kchowdh@gwdg.de	Ucar, Ahmet/E-8981-2012	Thum, Thomas/0000-0003-4360-1511; Ucar, Ahmet/0000-0002-6551-3486; Vafaizadeh, Vida/0000-0002-0875-6246	Max Planck Society; Deutsche Forschungsgemeinschaft (DFG) [GR 536/9-2, GR 536/11-1, TH 903/7-2]	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank S. Geisendorf for technical assistance, S. Hille for DNA sequencing, S. Mahsur and U. Franke for technical help in generation of knockout mouse line, A. Kurth, A. Driehorst, K. Kiel and U. Teichman for animal care work, M. Smalley for discussion about mammary epithelial transplantation method, N. Ba Tiep for technical help with collecting blood samples, A. Yalcin for creative contribution to the initial phase of the work, and P. Gruss and G. Eichele for encouragement and support. Funded by the Max Planck Society. Additional funding was provided by the Deutsche Forschungsgemeinschaft (DFG, GR 536/9-2 and GR 536/11-1 to B.G. and TH 903/7-2 to T.T.).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Chou YT, 2006, ONCOGENE, V25, P5547, DOI 10.1038/sj.onc.1209552; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Daniel CW, 1996, J MAMMARY GLAND BIOL, V1, P331, DOI 10.1007/BF02017389; Fiedler SD, 2008, BIOL REPROD, V79, P1030, DOI 10.1095/biolreprod.108.069690; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Howlin J, 2006, ONCOGENE, V25, P1532, DOI 10.1038/sj.onc.1209183; Howlin J, 2006, J MAMMARY GLAND BIOL, V11, P283, DOI 10.1007/s10911-006-9024-2; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Kawashima H, 2010, NEUROSCIENCE, V165, P1301, DOI 10.1016/j.neuroscience.2009.11.057; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Konrad L, 2009, REGUL PEPTIDES, V155, P28, DOI 10.1016/j.regpep.2009.04.012; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Mailleux AA, 2008, CELL CYCLE, V7, P57, DOI 10.4161/cc.7.1.5150; Neville MC, 1998, J MAMMARY GLAND BIOL, V3, P109, DOI 10.1023/A:1018786604818; Okamoto T, 2009, BIOCHEM BIOPH RES CO, V383, P475, DOI 10.1016/j.bbrc.2009.04.038; Parmar H, 2004, ENDOCR-RELAT CANCER, V11, P437, DOI 10.1677/erc.1.00659; Parsa S, 2008, DEV BIOL, V317, P121, DOI 10.1016/j.ydbio.2008.02.014; Rasmussen S. B., 2000, METHODS MAMMARY GLAN, P75; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; ROBINSON SD, 1991, DEVELOPMENT, V113, P867; Sangai T, 2006, BIOCHEM BIOPH RES CO, V346, P1173, DOI 10.1016/j.bbrc.2006.06.025; Seomun Y, 2008, J CELL BIOCHEM, V104, P934, DOI 10.1002/jcb.21675; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Shioda T, 1998, P NATL ACAD SCI USA, V95, P9785, DOI 10.1073/pnas.95.17.9785; Silberstein GB, 2001, MICROSC RES TECHNIQ, V52, P155, DOI 10.1002/1097-0029(20010115)52:2<155::AID-JEMT1001>3.0.CO;2-P; SILBERSTEIN GB, 1990, J CELL BIOL, V110, P2209, DOI 10.1083/jcb.110.6.2209; Sinpitaksakul SN, 2008, BIOCHEM BIOPH RES CO, V371, P713, DOI 10.1016/j.bbrc.2008.04.128; Smibert P, 2008, CELL CYCLE, V7, P2500, DOI 10.4161/cc.7.16.6454; Tanaka T, 2009, DIFFERENTIATION, V77, P181, DOI 10.1016/j.diff.2008.10.001; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wiesen JF, 1999, DEVELOPMENT, V126, P335; Wilson TJ, 2009, MOL CANCER RES, V7, P1224, DOI 10.1158/1541-7786.MCR-09-0028; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090; Young LJT, 2000, METHODS MAMMARY GLAN, P67; Yu Q, 2000, GENE DEV, V14, P163; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	48	129	137	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2010	42	12					1101	U100		10.1038/ng.709	http://dx.doi.org/10.1038/ng.709			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684UZ	21057503	Green Published			2022-12-25	WOS:000284578800013
J	Gold, MS; Gebhart, GF				Gold, Michael S.; Gebhart, Gerald F.			Nociceptor sensitization in pain pathogenesis	NATURE MEDICINE			English	Review							PERIPHERAL-NERVE INJURY; IRRITABLE-BOWEL-SYNDROME; DORSAL-ROOT-GANGLIA; SENSORY NEURONS; K+ CHANNELS; 1D RECEPTORS; RAT; TRPA1; ACTIVATION; COLD	The incidence of chronic pain is estimated to be 20-25% worldwide. Few patients with chronic pain obtain complete relief from the drugs that are currently available, and more than half report inadequate relief. Underlying the challenge of developing better drugs to manage chronic pain is incomplete understanding of the heterogeneity of mechanisms that contribute to the transition from acute tissue insult to chronic pain and to pain conditions for which the underlying pathology is not apparent. An intact central nervous system (CNS) is required for the conscious perception of pain, and changes in the CNS are clearly evident in chronic pain states. However, the blockage of nociceptive input into the CNS can effectively relieve or markedly attenuate discomfort and pain, revealing the importance of ongoing peripheral input to the maintenance of chronic pain. Accordingly, we focus here on nociceptors: their excitability, their heterogeneity and their role in initiating and maintaining pain.	[Gold, Michael S.; Gebhart, Gerald F.] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Ctr Pain Res, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gebhart, GF (corresponding author), Univ Pittsburgh, Sch Med, Dept Anesthesiol, Ctr Pain Res, Pittsburgh, PA 15261 USA.	gebhartgf@upmc.edu		Gold, Michael/0000-0002-2083-6206	National Institutes of Health [NS019912, NS035790, DE018252, NS063010]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035790, R01NS019912, R01NS063010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are supported by National Institutes of Health awards NS019912 (G.F.G.), NS035790 (G.F.G.), DE018252 (M.S.G.) and NS063010 (M.S.G.).	Abbadie C, 2009, BRAIN RES REV, V60, P125, DOI 10.1016/j.brainresrev.2008.12.002; Alessandri-Haber N, 2009, J NEUROSCI, V29, P6217, DOI 10.1523/JNEUROSCI.0893-09.2009; Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; Alves DP, 2004, EUR J PHARMACOL, V489, P59, DOI 10.1016/j.ejphar.2004.02.022; Amir R, 2006, J PAIN, V7, pS1, DOI 10.1016/j.jpain.2006.01.444; Backonja MM, 2004, J PAIN, V5, P491, DOI 10.1016/j.jpain.2004.09.001; Baumann TK, 2004, EUR J NEUROSCI, V19, P1343, DOI 10.1111/j.1460-9568.2004.03097.x; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; BESSOU P, 1969, J NEUROPHYSIOL, V32, P1025, DOI 10.1152/jn.1969.32.6.1025; Bharucha AE, 2010, NEUROGASTROENT MOTIL, V22, P227, DOI 10.1111/j.1365-2982.2009.01465.x; Birder LA, 1999, J PHYSIOL-LONDON, V515, P533, DOI 10.1111/j.1469-7793.1999.533ac.x; Braz JM, 2005, NEURON, V47, P787, DOI 10.1016/j.neuron.2005.08.015; Brierley SM, 2009, GASTROENTEROLOGY, V137, P2084, DOI 10.1053/j.gastro.2009.07.048; Burnstock G, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-69; Burnstock G, 2009, CURR PHARM DESIGN, V15, P1717, DOI 10.2174/138161209788186335; Camilleri M, 2009, ALIMENT PHARM THER, V31, P35, DOI 10.1111/j.1365-2036.2009.04153.x; Carlton SM, 1999, BRAIN RES, V820, P63, DOI 10.1016/S0006-8993(98)01328-6; Carlton SM, 2007, J COMP NEUROL, V501, P780, DOI 10.1002/cne.21285; Cummins TR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0001.1999; DAO TTT, 1995, PAIN, V62, P241, DOI 10.1016/0304-3959(95)00025-N; DELCAMINO D, 2001, J NEUROSCI IN PRESS; Dubreuil AS, 2004, J NEUROSCI, V24, P8480, DOI 10.1523/JNEUROSCI.1598-04.2004; Edvinsson L, 2010, NEUROTHERAPEUTICS, V7, P164, DOI 10.1016/j.nurt.2010.02.004; Elitt CM, 2006, J NEUROSCI, V26, P8578, DOI 10.1523/JNEUROSCI.2185-06.2006; Fehrenbacher JC, 2009, BRAIN RES REV, V60, P114, DOI 10.1016/j.brainresrev.2008.12.019; GEBHART GF, 2008, SENSES COMPREHENSIVE, P543; GOLD MS, 2008, SENSES COMPREHENSIVE, V5, P43; GRACELY RH, 1992, PAIN, V51, P175, DOI 10.1016/0304-3959(92)90259-E; Guler AD, 2002, J NEUROSCI, V22, P6408; Harriott AM, 2008, CEPHALALGIA, V28, P933, DOI 10.1111/j.1468-2982.2008.01635.x; Harriott AM, 2009, CURR PAIN HEADACHE R, V13, P197, DOI 10.1007/s11916-009-0034-9; Hefti FF, 2006, TRENDS PHARMACOL SCI, V27, P85, DOI 10.1016/j.tips.2005.12.001; Hokfelt T, 1997, PROG PAIN RES MANAG, V9, P115; Honore P, 2005, J PHARMACOL EXP THER, V314, P410, DOI 10.1124/jpet.105.083915; HOWE JF, 1977, PAIN, V3, P25, DOI 10.1016/0304-3959(77)90033-1; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Janig W, 2009, EXP BRAIN RES, V196, P101, DOI 10.1007/s00221-008-1673-5; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; KIRCHHOFF C, 1992, J NEUROPHYSIOL, V67, P125, DOI 10.1152/jn.1992.67.1.125; Kohno T, 2005, PAIN, V117, P77, DOI 10.1016/j.pain.2005.05.035; Koltzenburg M., 2005, NEUROBIOLOGY PAIN, P1; Kremeyer B, 2010, NEURON, V66, P671, DOI 10.1016/j.neuron.2010.04.030; Kruger L, 1988, Prog Brain Res, V74, P253; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; Lewis T, 1936, CLIN SCI, V2, P373; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; LYNN B, 1982, BRAIN RES, V238, P29, DOI 10.1016/0006-8993(82)90768-5; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Maingret F, 1999, J BIOL CHEM, V274, P1381, DOI 10.1074/jbc.274.3.1381; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; MCLACHLAN EM, 1993, NATURE, V363, P543, DOI 10.1038/363543a0; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; MEYER RA, 1991, BRAIN RES, V561, P252, DOI 10.1016/0006-8993(91)91601-V; Michaelis M, 1999, NEUROSCIENCE, V94, P7, DOI 10.1016/S0306-4522(99)00325-5; Mousa SA, 2003, ADV EXP MED BIOL, V521, P77; Murdaca G, 2009, INT J IMMUNOPATH PH, V22, P557, DOI 10.1177/039463200902200301; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Page AJ, 2005, GUT, V54, P1408, DOI 10.1136/gut.2005.071084; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Patel L, 2003, EXPERT OPIN PHARMACO, V4, P2279; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Potrebic S, 2003, J NEUROSCI, V23, P10988; Price DD, 2006, J PAIN, V7, P529, DOI 10.1016/j.jpain.2005.12.011; Price DD, 2009, NEUROIMAGE, V47, P995, DOI 10.1016/j.neuroimage.2009.04.028; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Price TJ, 2009, BRAIN RES REV, V60, P149, DOI 10.1016/j.brainresrev.2008.12.015; Rau KK, 2005, J NEUROPHYSIOL, V93, P1358, DOI 10.1152/jn.00591.2004; Reimann F, 2010, P NATL ACAD SCI USA, V107, P5148, DOI 10.1073/pnas.0913181107; Ren K, 2010, NAT MED, V16, P1267, DOI 10.1038/nm.2234; Richardson JD, 2002, J PHARMACOL EXP THER, V302, P839, DOI 10.1124/jpet.102.032797; Riera CE, 2007, AM J PHYSIOL-REG I, V293, pR626, DOI 10.1152/ajpregu.00286.2007; RITTER AM, 1992, J NEUROPHYSIOL, V68, P2033, DOI 10.1152/jn.1992.68.6.2033; Robinson DR, 2008, MOL INTERV, V8, P242, DOI 10.1124/mi.8.5.9; Rukwied R, 2010, PAIN, V148, P407, DOI 10.1016/j.pain.2009.11.022; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Russell FA, 2010, J NEUROPHYSIOL, V103, P155, DOI 10.1152/jn.00486.2009; Schaible HG, 2010, ANN NY ACAD SCI, V1193, P60, DOI 10.1111/j.1749-6632.2009.05301.x; SCHAIBLE HG, 1983, J NEUROPHYSIOL, V49, P1118, DOI 10.1152/jn.1983.49.5.1118; Schaible HG, 2002, ANN NY ACAD SCI, V966, P343, DOI 10.1111/j.1749-6632.2002.tb04234.x; SENGUPTA JN, 1995, PROG PAIN RES MANAG, V5, P75; SHAKHANBEH J, 1993, BRAIN RES, V607, P314, DOI 10.1016/0006-8993(93)91522-T; Shinoda M, 2009, GASTROENTEROLOGY, V137, P2096, DOI 10.1053/j.gastro.2009.06.048; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Staud R, 2009, PAIN, V145, P96, DOI 10.1016/j.pain.2009.05.020; Steranka L R, 1988, Adv Exp Med Biol, V236, P111; Tfelt-Hansen P, 2000, DRUGS, V60, P1259, DOI 10.2165/00003495-200060060-00003; Tsunozaki M, 2009, CURR OPIN NEUROBIOL, V19, P362, DOI 10.1016/j.conb.2009.07.008; Tsuzuki K, 2001, PAIN, V91, P351, DOI 10.1016/S0304-3959(00)00456-5; Vaughn AH, 2010, J NEUROSCI, V30, P7878, DOI 10.1523/JNEUROSCI.6053-09.2010; Verne GN, 2003, PAIN, V105, P223, DOI 10.1016/S0304-3959(03)00210-0; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Walder RY, 2010, J PAIN, V11, P210, DOI 10.1016/j.jpain.2009.07.004; Waxman SG, 2007, NAT NEUROSCI, V10, P405, DOI 10.1038/nn1857; Willis WD, 1999, EXP BRAIN RES, V124, P395, DOI 10.1007/s002210050637; Woodbury CJ, 2004, J NEUROSCI, V24, P6410, DOI 10.1523/JNEUROSCI.1421-04.2004; Zhao J, 2010, J NEUROSCI, V30, P10860, DOI 10.1523/JNEUROSCI.1980-10.2010; Zimmermann K, 2007, NATURE, V447, P855, DOI 10.1038/nature05880	101	471	485	2	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1248	1257		10.1038/nm.2235	http://dx.doi.org/10.1038/nm.2235			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	20948530	Green Accepted			2022-12-25	WOS:000283860100036
J	Lee, EK; Jin, YW; Park, JH; Yoo, YM; Hong, SM; Amir, R; Yan, ZJ; Kwon, E; Elfick, A; Tomlinson, S; Halbritter, F; Waibel, T; Yun, BW; Loake, GJ				Lee, Eun-Kyong; Jin, Young-Woo; Park, Joong Hyun; Yoo, Young Mi; Hong, Sun Mi; Amir, Rabia; Yan, Zejun; Kwon, Eunjung; Elfick, Alistair; Tomlinson, Simon; Halbritter, Florian; Waibel, Thomas; Yun, Byung-Wook; Loake, Gary J.			Cultured cambial meristematic cells as a source of plant natural products	NATURE BIOTECHNOLOGY			English	Article							SUSPENSION-CULTURES; TAXUS-CUSPIDATA; EXPRESSION ANALYSIS; TAXOL; ARABIDOPSIS; DIFFERENTIATION; ROOT; BIOCONDUCTOR; PACLITAXEL; CHINENSIS	A plethora of important, chemically diverse natural products are derived from plants(1). In principle, plant cell culture offers an attractive option for producing many of these compounds(2,3). However, it is often not commercially viable because of difficulties associated with culturing dedifferentiated plant cells (DDCs) on an industrial scale(3). To bypass the dedifferentiation step, we isolated and cultured innately undifferentiated cambial meristematic cells (CMCs). Using a combination of deep sequencing technologies, we identified marker genes and transcriptional programs consistent with a stem cell identity. This notion was further supported by the morphology of CMCs, their hypersensitivity to gamma-irradiation and radiomimetic drugs and their ability to differentiate at high frequency. Suspension culture of CMCs derived from Taxus cuspidata, the source of the key anticancer drug, paclitaxel (Taxol)(2,3), circumvented obstacles routinely associated with the commercial growth of DDCs. These cells may provide a cost-effective and environmentally friendly platform for sustainable production of a variety of important plant natural products.	[Amir, Rabia; Yan, Zejun; Kwon, Eunjung; Waibel, Thomas; Yun, Byung-Wook; Loake, Gary J.] Univ Edinburgh, Inst Mol Plant Sci, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Lee, Eun-Kyong; Jin, Young-Woo; Park, Joong Hyun; Yoo, Young Mi; Hong, Sun Mi] Unhwa Corp, Jeonju, South Korea; [Kwon, Eunjung; Elfick, Alistair] Univ Edinburgh, Sch Engn, Edinburgh, Midlothian, Scotland; [Tomlinson, Simon; Halbritter, Florian] Univ Edinburgh, Inst Stem Cell Res, Sch Biol Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Loake, GJ (corresponding author), Univ Edinburgh, Inst Mol Plant Sci, Sch Biol Sci, Kings Bldg, Edinburgh, Midlothian, Scotland.	gloake@ed.ac.uk	Halbritter, Florian/K-1746-2013; GenePool, The/D-8812-2012; Halbritter, Florian/AAI-1000-2019	Halbritter, Florian/0000-0003-2452-4784; Halbritter, Florian/0000-0003-2452-4784; Loake, Gary/0000-0002-7989-9180; ELFICK, ALISTAIR/0000-0002-4429-6232	BBSRC; Korea Institute for Advancement of Technology (KIAT) [10030175]; Ministry of Knowledge Economy (MKE), Republic of Korea; HEC Pakistan; Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/F018746/1] Funding Source: researchfish; Medical Research Council [G0700711B, G0900740] Funding Source: researchfish; BBSRC [BB/F018746/1] Funding Source: UKRI; MRC [G0900740] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Korea Institute for Advancement of Technology (KIAT); Ministry of Knowledge Economy (MKE), Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); HEC Pakistan(Higher Education Commission of Pakistan); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	T.W. was awarded a BBSRC CASE PhD studentship. This project was funded in part by a grant from the Korea Institute for Advancement of Technology (KIAT) (R & D project number: 10030175), the Ministry of Knowledge Economy (MKE), Republic of Korea to E.-K.L., J.H.P., S. M. H. and G.J.L. R. A. was supported by a scholarship from HEC Pakistan. E. K. was supported by a studentship from the Engineering and Physical Sciences Research Council. We acknowledge the expert technical assistance of A. Montazam and D. Cleven for Roche 454 sequencing and M. Thomson for Illumina Solexa sequencing. Further, S. Bridgett and U. Trivedi provided invaluable input for bioinformatic analysis of the deep sequencing data. All sequencing was undertaken at the GenePool facility, University of Edinburgh.	Baebler S, 2005, IN VITRO CELL DEV-PL, V41, P338, DOI 10.1079/IVP2005642; Bai J, 2004, J NAT PROD, V67, P58, DOI 10.1021/np0301083; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Croteau Rodney, 2006, Phytochemistry Reviews, V5, P75, DOI 10.1007/s11101-005-3748-2; Dan M, 2008, PHYTOCHEMISTRY, V69, P2237, DOI 10.1016/j.phytochem.2008.04.015; Fisher K, 2007, CURR BIOL, V17, P1061, DOI 10.1016/j.cub.2007.05.049; Frankenstein Claus, 2005, Dendrochronologia, V23, P57, DOI 10.1016/j.dendro.2005.07.007; Fulcher N, 2009, P NATL ACAD SCI USA, V106, P20984, DOI 10.1073/pnas.0909218106; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grafi G, 2007, DEV BIOL, V306, P838, DOI 10.1016/j.ydbio.2007.03.023; Ito Y, 2006, SCIENCE, V313, P842, DOI 10.1126/science.1128436; Joshi JB, 1996, CHEM ENG J BIOCH ENG, V62, P121, DOI 10.1016/0923-0467(95)03062-X; Kataoka T, 2004, PLANT CELL, V16, P2693, DOI 10.1105/tpc.104.023960; Kutchan T, 2005, CURR OPIN PLANT BIOL, V8, P227, DOI 10.1016/j.pbi.2005.03.016; Laux T, 2003, CELL, V113, P281, DOI 10.1016/S0092-8674(03)00312-X; Lee Y, 2008, PLANT PHYSIOL, V147, P1886, DOI 10.1104/pp.108.121590; Leung K.W., 2010, CHINESE MED, V5, P20; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mirjalili N, 1996, BIOTECHNOL PROGR, V12, P110, DOI 10.1021/bp9500831; Moore R., 1995, BOTANY; Nieminen K, 2008, P NATL ACAD SCI USA, V105, P20032, DOI 10.1073/pnas.0805617106; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Reynolds L. B., 1998, Journal of Herbs, Spices & Medicinal Plants, V6, P63, DOI 10.1300/J044v06n02_08; Roberts SC, 2007, NAT CHEM BIOL, V3, P387, DOI 10.1038/nchembio.2007.8; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schmid R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-180; Schmidt BM, 2007, NAT CHEM BIOL, V3, P360, DOI 10.1038/nchembio0707-360; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; STROBEL GA, 1993, PLANT SCI, V92, P1, DOI 10.1016/0168-9452(93)90060-D; Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; Thorpe TA, 2007, MOL BIOTECHNOL, V37, P169, DOI 10.1007/s12033-007-0031-3; Turner S, 2007, ANNU REV PLANT BIOL, V58, P407, DOI 10.1146/annurev.arplant.57.032905.105236; Wang CG, 2001, BIOTECHNOL PROGR, V17, P89, DOI 10.1021/bp0001359; Wu ZL, 2000, BIOCHEM ENG J, V5, P137, DOI 10.1016/S1369-703X(00)00052-8; Yang SJ, 1999, J CHIN CHEM SOC-TAIP, V46, P811, DOI 10.1002/jccs.199900109; Ye ZH, 2002, ANNU REV PLANT BIOL, V53, P183, DOI 10.1146/annurev.arplant.53.100301.135245; Yukimune Y, 1996, NAT BIOTECHNOL, V14, P1129, DOI 10.1038/nbt0996-1129; Zang X, 2001, BIOTECHNOL LETT, V23, P1047, DOI 10.1023/A:1010589304749; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	44	109	129	9	129	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2010	28	11					1213	U111		10.1038/nbt.1693	http://dx.doi.org/10.1038/nbt.1693			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	676PI	20972422				2022-12-25	WOS:000283924100025
J	MacDonald, TT				MacDonald, Thomas T.			Inside the microbial and immune labyrinth: Totally gutted	NATURE MEDICINE			English	Editorial Material							SEVERE CROHNS-DISEASE; ANTIINTERFERON-GAMMA ANTIBODY; MONOCLONAL-ANTIBODY; RANDOMIZED-TRIAL; DOUBLE-BLIND; MODERATE; FONTOLIZUMAB; INFLAMMATION; SAFETY	In Crohn's disease, immune damage to the gut wall is both induced and modified by the gut microflora, challenging researchers to solve the maze of interactions exploitable for therapeutic benefit. Whether these microbial 'guests' are worsening or helping in this scenario is still open to debate. In 'Bench to Bedside', Warren Strober highlights mice studies showing that certain microbes in the gut have a protective role promoting a shift towards an increased regulatory response that protects from recurrence of the disease. In 'Bedside to Bench', Thomas MacDonald examines how human studies using strategies to block soluble proinflammatory cytokines-despite solid supporting data from animal models-have shown disappointing results compared with therapies that neutralize soluble cytokines but also deplete proinflammatory cells, calling into question whether targeting a single soluble cytokine will ever be useful to treat people with Crohn's disease.	Barts & London Queen Marys Sch Med & Dent, Blizard Inst Cell & Mol Sci, Ctr Immunol & Infect Dis, London, England	University of London; Queen Mary University London	MacDonald, TT (corresponding author), Barts & London Queen Marys Sch Med & Dent, Blizard Inst Cell & Mol Sci, Ctr Immunol & Infect Dis, London, England.	t.t.macdonald@qmul.ac.uk						Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Hommes DW, 2006, GUT, V55, P1131, DOI 10.1136/gut.2005.079392; Ito H, 2004, GASTROENTEROLOGY, V126, P989, DOI 10.1053/j.gastro.2004.01.012; MacDonald T. T., 2010, INFLAMM BOWEL DIS, P82; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Nesbitt A, 2007, INFLAMM BOWEL DIS, V13, P1323, DOI 10.1002/ibd.20225; Reinisch W, 2006, GUT, V55, P1138, DOI 10.1136/gut.2005.079434; Reinisch W, 2010, INFLAMM BOWEL DIS, V16, P233, DOI 10.1002/ibd.21038; Rovedatti L, 2009, GUT, V58, P1629, DOI 10.1136/gut.2009.182170; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014	12	18	18	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2010	16	11					1194	1195		10.1038/nm1110-1194	http://dx.doi.org/10.1038/nm1110-1194			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21052069				2022-12-25	WOS:000283860100022
J	Morgan, G; Haile, LA				Morgan, Gareth; Haile, Lisa A.			A shadow falls over gene patents in the United States and Europe	NATURE BIOTECHNOLOGY			English	Editorial Material								Will a pair of court decisions that restrict the protection offered to DNA-based claims reduce financial incentives and thus chill investment?	[Morgan, Gareth; Haile, Lisa A.] DLA Piper LLP, London, England		Morgan, G (corresponding author), DLA Piper LLP, London, England.	gareth.morgan@dlapiper.com; lisa.haile@dlapiper.com						[Anonymous], 1998, OJ L, VL213, P13; BARRY GF, 1991, Patent No. 0546090; Cohen S, 2008, NAT BIOTECHNOL, V26, P289, DOI 10.1038/nbt0308-289; Morgan G, 2010, NATURE, V465, P1005, DOI 10.1038/4651005b; 2010, NATURE, V465, P267	5	2	2	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2010	28	11					1172	1174		10.1038/nbt1110-1172	http://dx.doi.org/10.1038/nbt1110-1172			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	676PI	21057483				2022-12-25	WOS:000283924100015
J	Nicholas, AK; Khurshid, M; Desir, J; Carvalho, OP; Cox, JJ; Thornton, G; Kausar, R; Ansar, M; Ahmad, W; Verloes, A; Passemard, S; Misson, JP; Lindsay, S; Gergely, F; Dobyns, WB; Roberts, E; Abramowicz, M; Woods, CG				Nicholas, Adeline K.; Khurshid, Maryam; Desir, Julie; Carvalho, Ofelia P.; Cox, James J.; Thornton, Gemma; Kausar, Rizwana; Ansar, Muhammad; Ahmad, Wasim; Verloes, Alain; Passemard, Sandrine; Misson, Jean-Paul; Lindsay, Susan; Gergely, Fanni; Dobyns, William B.; Roberts, Emma; Abramowicz, Marc; Woods, C. Geoffrey			WDR62 is associated with the spindle pole and is mutated in human microcephaly	NATURE GENETICS			English	Article							CEREBRAL-CORTEX; NEURAL STEM; MUTATIONS; DIVISIONS; CDK5RAP2; REVEALS; PROTEIN; LOCUS; ASPM	Autosomal recessive primary microcephaly (MCPH) is a disorder of neurodevelopment resulting in a small brain(1,2). We identified WDR62 as the second most common cause of MCPH after finding homozygous missense and frame-shifting mutations in seven MCPH families. In human cell lines, we found that WDR62 is a spindle pole protein, as are ASPM and STIL, the MCPH7 and MCHP7 proteins3(-5). Mutant WDR62 proteins failed to localize to the mitotic spindle pole. In human and mouse embryonic brain, we found that WDR62 expression was restricted to neural precursors undergoing mitosis. These data lend support to the hypothesis that the exquisite control of the cleavage furrow orientation in mammalian neural precursor cell mitosis, controlled in great part by the centrosomes and spindle poles, is critical both in causing MCPH when perturbed and, when modulated, generating the evolutionarily enlarged human brain(6-9).	[Desir, Julie; Abramowicz, Marc] Univ Libre Bruxelles IRIBHM, ULB, Dept Med Genet, Hop Erasme, Brussels, Belgium; [Desir, Julie; Abramowicz, Marc] Univ Libre Bruxelles IRIBHM, ULB, Inst Rech Interdisciplinaire Biol Humaine & Mol, Brussels, Belgium; [Nicholas, Adeline K.; Khurshid, Maryam; Carvalho, Ofelia P.; Cox, James J.; Thornton, Gemma; Woods, C. Geoffrey] Univ Cambridge, Dept Med Genet, Cambridge Inst Med Res, Cambridge, England; [Kausar, Rizwana; Ansar, Muhammad; Ahmad, Wasim] Quaid I Azam Univ, Dept Biochem, Fac Biol Sci, Islamabad, Pakistan; [Verloes, Alain; Passemard, Sandrine] Robert Debre Univ Hosp, Dept Genet, Paris, France; [Passemard, Sandrine] Robert Debre Univ Hosp, AP HP, Dept Child Neurol, Paris, France; [Misson, Jean-Paul] La Citadelle Univ Hosp, Dept Pediat, Liege, Belgium; [Misson, Jean-Paul] Univ Liege, Sch Med, Liege, Belgium; [Lindsay, Susan] Newcastle Univ, Inst Human Genet, Int Ctr Life, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Gergely, Fanni] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge, England; [Dobyns, William B.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Roberts, Emma] St James Univ Hosp, Leeds Inst Mol Med, Microcephaly & Neurogenesis Res Grp, Leeds LS9 7TF, W Yorkshire, England	Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Cambridge; Quaid I Azam University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; University of Liege; Newcastle University - UK; Cancer Research UK; CRUK Cambridge Institute; University of Chicago; Saint James's University Hospital; University of Leeds	Abramowicz, M (corresponding author), Univ Libre Bruxelles IRIBHM, ULB, Dept Med Genet, Hop Erasme, Brussels, Belgium.	marcabra@ulb.ac.be; cw347@cam.ac.uk	/AAK-8500-2021; Ansar, Muhammad/H-5967-2011; Cox, James/R-1910-2016; Ansar, Muhammad/F-4808-2015; Dobyns, William Brian/ABC-6525-2021; Carvalho, Ofelia/L-2780-2014; Abramowicz, Marc/AAX-6419-2020; Ahmad, Wasim/E-9713-2015; Ahmad, Wasim/GSD-8904-2022; Dobyns, William/AAI-2768-2020; Lindsay, Susan/B-3828-2013; VERLOES, Alain/E-7287-2014	Ansar, Muhammad/0000-0001-5891-7063; Carvalho, Ofelia/0000-0002-7450-9980; Dobyns, William/0000-0002-7681-2844; Lindsay, Susan/0000-0003-2980-4582; VERLOES, Alain/0000-0003-4819-0264; Nicholas, Adeline/0000-0002-7124-629X; Abramowicz, Marc/0000-0003-0623-8768; Gergely, Fanni/0000-0002-2441-8095	Wellcome Trust; Medical Research Council; Action Research; Higher Education Commission of Pakistan; Belgian Kids' Fund; Fonds Erasme; Belgian Fonds de la Recherche Scientifique Medicale (FRSM); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058721, P01NS039404] Funding Source: NIH RePORTER; Medical Research Council [G9900837, G0700089] Funding Source: researchfish; MRC [G9900837, G0700089] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Action Research; Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Belgian Kids' Fund; Fonds Erasme; Belgian Fonds de la Recherche Scientifique Medicale (FRSM)(Fonds de la Recherche Scientifique - FNRS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank the research families for their participation in this project and the Wellcome Trust, Medical Research Council, Action Research and the Higher Education Commission of Pakistan for funding (to A.K.N., M. K., O.P.C., J.J.C., G. T. and E. R.). J.D. was supported by the Belgian Kids' Fund. M.A. was supported by grants from the Fonds Erasme and the Belgian Fonds de la Recherche Scientifique Medicale (FRSM). We thank S. Strollo for expert technical assistance. We thank the Medical Research Council (MRC)-Wellcome Trust Human Developmental Biology Resource (HDBR), Newcastle for providing the human tissue for the expression studies.	Attardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002388; Avides MD, 2001, NAT CELL BIOL, V3, P421, DOI 10.1038/35070110; Barr AR, 2010, J CELL BIOL, V189, P23, DOI 10.1083/jcb.200912163; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; BILGUVAR K, 2010, NATURE          0822, DOI DOI 10.1038/NATURE09327; Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Caspi M, 2003, J BIOL CHEM, V278, P38740, DOI 10.1074/jbc.M301147200; Field M, 2007, AM J HUM GENET, V81, P367, DOI 10.1086/520677; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; GARDETTE R, 1982, J HIRNFORSCH, V23, P415; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Malik R, 2009, J PROTEOME RES, V8, P4553, DOI 10.1021/pr9003773; Mardis ER, 2009, GENOME MED, V1, DOI 10.1186/gm40; Marthiens V, 2009, EMBO REP, V10, P515, DOI 10.1038/embor.2009.36; Mochida GH, 2004, ARCH NEUROL-CHICAGO, V61, P637, DOI 10.1001/archneur.61.5.637; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; O'Rahilly R, 2010, CELLS TISSUES ORGANS, V192, P73, DOI 10.1159/000289817; PASSEMARD S, 2009, GENEREVIEWS; Pfaff KL, 2007, MOL CELL BIOL, V27, P5887, DOI 10.1128/MCB.00175-07; Roberts E, 1999, EUR J HUM GENET, V7, P815, DOI 10.1038/sj.ejhg.5200385; Roberts E, 2002, J MED GENET, V39, P718, DOI 10.1136/jmg.39.10.718; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Uylings HBM, 2000, EUR J MORPHOL, V38, P309, DOI 10.1076/0924-3860(200012)38:5;1-H;FT309; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930	32	217	225	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					1010	U138		10.1038/ng.682	http://dx.doi.org/10.1038/ng.682			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20890279	Green Accepted			2022-12-25	WOS:000283540500021
J	Ren, K; Dubner, R				Ren, Ke; Dubner, Ronald			Interactions between the immune and nervous systems in pain	NATURE MEDICINE			English	Review							DORSAL-ROOT GANGLIA; SATELLITE GLIAL-CELLS; PROINFLAMMATORY CYTOKINE EXPRESSION; MONOCYTE CHEMOATTRACTANT PROTEIN-1; PERIPHERAL TISSUE INFLAMMATION; MICROGLIAL CATHEPSIN-S; SPINAL-CORD; NEUROPATHIC PAIN; SCIATIC-NERVE; MECHANICAL ALLODYNIA	Immune cells and glia interact with neurons to alter pain sensitivity and to mediate the transition from acute to chronic pain. In response to injury, resident immune cells are activated and blood-borne immune cells are recruited to the site of injury. Immune cells not only contribute to immune protection but also initiate the sensitization of peripheral nociceptors. Through the synthesis and release of inflammatory mediators and interactions with neurotransmitters and their receptors, the immune cells, glia and neurons form an integrated network that coordinates immune responses and modulates the excitability of pain pathways. The immune system also reduces sensitization by producing immune-derived analgesic and anti-inflammatory or proresolution agents. A greater understanding of the role of the immune system in pain processing and modulation reveals potential targets for analgesic drug development and new therapeutic opportunities for managing chronic pain.	[Ren, Ke] Univ Maryland, Sch Dent, Dept Neural & Pain Sci, Baltimore, MD 21201 USA; Univ Maryland, Program Neurosci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Ren, K (corresponding author), Univ Maryland, Sch Dent, Dept Neural & Pain Sci, Baltimore, MD 21201 USA.	kren@umaryland.edu			US National Institutes of Health [R01-DE11964, R01-NS060735, R01-NS059028]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059028, R01NS060735] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors' work is supported by US National Institutes of Health grants R01-DE11964, R01-NS060735 and R01-NS059028.	Barbara G, 2007, GASTROENTEROLOGY, V132, P26, DOI 10.1053/j.gastro.2006.11.039; Barclay J, 2007, PAIN, V130, P225, DOI 10.1016/j.pain.2006.11.017; BRENNAN PC, 1994, J MANIP PHYSIOL THER, V17, P219; Bruck W, 1996, J NEUROSCI RES, V46, P477; Cailhier JFO, 2006, AM J RESP CRIT CARE, V173, P540, DOI 10.1164/rccm.200504-538OC; Calvo M, 2010, J NEUROSCI, V30, P5437, DOI 10.1523/JNEUROSCI.5169-09.2010; Cao L, 2008, EUR J IMMUNOL, V38, P448, DOI 10.1002/eji.200737485; Capuano A, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-43; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Chacur M, 2009, EUR J PAIN, V13, P915, DOI 10.1016/j.ejpain.2008.11.008; Chen Y, 2008, P NATL ACAD SCI USA, V105, P16773, DOI 10.1073/pnas.0801793105; Chen Y, 2009, EXP NEUROL, V220, P383, DOI 10.1016/j.expneurol.2009.09.030; Chiang CY, 2007, J NEUROSCI, V27, P9068, DOI 10.1523/JNEUROSCI.2260-07.2007; Choi JI, 2010, PAIN, V149, P243, DOI 10.1016/j.pain.2010.02.008; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Clark AK, 2007, EUR J PAIN, V11, P223, DOI 10.1016/j.ejpain.2006.02.003; Clark AK, 2006, J NEUROCHEM, V99, P868, DOI 10.1111/j.1471-4159.2006.04126.x; Clark AK, 2010, J NEUROSCI, V30, P573, DOI 10.1523/JNEUROSCI.3295-09.2010; Clark AK, 2009, J NEUROSCI, V29, P6945, DOI 10.1523/JNEUROSCI.0828-09.2009; Clark JD, 2006, ANESTHESIOLOGY, V104, P1274, DOI 10.1097/00000542-200606000-00024; Constantinescu CS, 2001, CYTOKINE, V13, P244, DOI 10.1006/cyto.2000.0818; Costigan M, 2009, J NEUROSCI, V29, P14415, DOI 10.1523/JNEUROSCI.4569-09.2009; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Cui JG, 2000, PAIN, V88, P239, DOI 10.1016/S0304-3959(00)00331-6; DeLeo JA, 2004, NEUROSCIENTIST, V10, P40, DOI 10.1177/1073858403259950; Deruddre S, 2010, BRAIN BEHAV IMMUN, V24, P652, DOI 10.1016/j.bbi.2010.01.013; Diatchenko L, 2006, PAIN, V125, P216, DOI 10.1016/j.pain.2006.05.024; Dominguez E, 2010, J NEUROSCI, V30, P5754, DOI 10.1523/JNEUROSCI.5007-09.2010; Dublin P, 2007, BRAIN BEHAV IMMUN, V21, P592, DOI 10.1016/j.bbi.2006.11.011; Durham PL., 2010, OPEN PAIN J, V3, P3, DOI 10.2174/1876386301003010003; Eijkelkamp N, 2010, J NEUROSCI, V30, P2138, DOI 10.1523/JNEUROSCI.5752-09.2010; Feng QX, 2010, NEUROSCIENCE, V167, P501, DOI 10.1016/j.neuroscience.2010.02.005; Folgueras AR, 2009, P NATL ACAD SCI USA, V106, P16451, DOI 10.1073/pnas.0908507106; Fu ES, 2010, PAIN, V148, P509, DOI 10.1016/j.pain.2010.01.001; Fu KY, 2000, NEUROSCIENCE, V101, P1127, DOI 10.1016/S0306-4522(00)00376-6; Gao YJ, 2010, PAIN, V148, P309, DOI 10.1016/j.pain.2009.11.017; Gardner J, 2006, J NEUROSCI RES, V83, P1281, DOI 10.1002/jnr.20823; GARRISON CJ, 1994, EXP NEUROL, V129, P237, DOI 10.1006/exnr.1994.1165; GILMANSACHS A, 1989, HEADACHE, V29, P290, DOI 10.1111/j.1526-4610.1989.hed2905290.x; Gomez-Nicola D, 2008, J NEUROCHEM, V107, P1741, DOI 10.1111/j.1471-4159.2008.05746.x; Griffin RS, 2007, J NEUROSCI, V27, P8699, DOI 10.1523/JNEUROSCI.2018-07.2007; Guerrero ATG, 2008, J LEUKOCYTE BIOL, V83, P122, DOI 10.1189/jlb.0207123; Guo LH, 2007, CELL MOL LIFE SCI, V64, P1128, DOI 10.1007/s00018-007-6494-3; Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Hathway GJ, 2009, PAIN, V144, P110, DOI 10.1016/j.pain.2009.03.022; Hemley SJ, 2009, J NEUROSURG-SPINE, V11, P696, DOI 10.3171/2009.6.SPINE08564; Honore P, 2000, NEUROSCIENCE, V98, P585, DOI 10.1016/S0306-4522(00)00110-X; Hu P, 2002, NEUROSCIENCE, V112, P23, DOI 10.1016/S0306-4522(02)00065-9; Hu P, 2007, BRAIN BEHAV IMMUN, V21, P599, DOI 10.1016/j.bbi.2006.10.013; Hua S, 2010, TRENDS PHARMACOL SCI, V31, P427, DOI 10.1016/j.tips.2010.05.008; Hua XY, 2005, EUR J NEUROSCI, V22, P2431, DOI 10.1111/j.1460-9568.2005.04451.x; Hutchinson MR, 2009, BRAIN BEHAV IMMUN, V23, P240, DOI 10.1016/j.bbi.2008.09.012; Ikeda H, 2007, EUR J NEUROSCI, V25, P1297, DOI 10.1111/j.1460-9568.2007.05386.x; Jang JH, 2010, PAIN, V148, P343, DOI 10.1016/j.pain.2009.11.021; Jessop DS, 2010, ANN NY ACAD SCI, V1193, P117, DOI 10.1111/j.1749-6632.2009.05294.x; Johnston IN, 2004, J NEUROSCI, V24, P7353, DOI 10.1523/JNEUROSCI.1850-04.2004; Jung H, 2008, J NEUROCHEM, V104, P254, DOI 10.1111/j.1471-4159.2007.04969.x; Kaufmann A, 2005, J BIOL CHEM, V280, P32459, DOI 10.1074/jbc.M505301200; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Khodorova A, 2003, NAT MED, V9, P1055, DOI 10.1038/nm885; Kiguchi N, 2010, PAIN, V149, P305, DOI 10.1016/j.pain.2010.02.025; Kramer HH, 2009, NEUROBIOL DIS, V35, P177, DOI 10.1016/j.nbd.2008.11.002; Lalo U, 2006, J NEUROSCI, V26, P2673, DOI 10.1523/JNEUROSCI.4689-05.2006; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Ledda M, 2009, NEUROSCIENCE, V164, P1538, DOI 10.1016/j.neuroscience.2009.09.038; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; Levin ME, 2008, PAIN, V137, P182, DOI 10.1016/j.pain.2007.11.005; LEVINE JD, 1985, J NEUROSCI, V5, P3025; Levy D, 2007, PAIN, V130, P166, DOI 10.1016/j.pain.2007.03.012; LEWIN GR, 1994, EUR J NEUROSCI, V6, P1903, DOI 10.1111/j.1460-9568.1994.tb00581.x; Li M, 2007, EUR J NEUROSCI, V26, P3486, DOI 10.1111/j.1460-9568.2007.05971.x; Listing J, 2005, ARTHRITIS RHEUM-US, V52, P3403, DOI 10.1002/art.21386; Liu T, 2000, PAIN, V86, P25, DOI 10.1016/S0304-3959(99)00306-1; Lu PM, 2009, LIFE SCI, V85, P450, DOI 10.1016/j.lfs.2009.07.009; MELLER ST, 1994, NEUROPHARMACOLOGY, V33, P1471, DOI 10.1016/0028-3908(94)90051-5; Miller Richard J, 2009, Handb Exp Pharmacol, P417, DOI 10.1007/978-3-540-79090-7_12; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Mitchell K, 2009, NEUROSCIENCE, V158, P885, DOI 10.1016/j.neuroscience.2008.10.047; Mitchell K, 2008, PAIN, V134, P216, DOI 10.1016/j.pain.2007.10.024; Miyoshi K, 2008, J NEUROSCI, V28, P12775, DOI 10.1523/JNEUROSCI.3512-08.2008; Moalem G, 2004, NEUROSCIENCE, V129, P767, DOI 10.1016/j.neuroscience.2004.08.035; Molander C, 1997, BRAIN RES, V747, P122, DOI 10.1016/S0006-8993(96)01230-9; Nie H, 2009, J NEUROPHYSIOL, V101, P2041, DOI 10.1152/jn.91138.2008; Oka Y, 2007, NEUROSCIENCE, V145, P530, DOI 10.1016/j.neuroscience.2006.10.055; Okada-Ogawa A, 2009, J NEUROSCI, V29, P11161, DOI 10.1523/JNEUROSCI.3365-09.2009; Orhan CE, 2010, NEUROSCI LETT, V481, P17, DOI 10.1016/j.neulet.2010.06.039; Ottosson A, 1997, CEPHALALGIA, V17, P166, DOI 10.1046/j.1468-2982.1997.1703166.x; PERRETTI M, 1993, IMMUNOLOGY, V80, P73; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Raghavendra V, 2004, EUR J NEUROSCI, V20, P467, DOI 10.1111/j.1460-9568.2004.03514.x; Ren K, 2008, CURR OPIN ANESTHESIO, V21, P570, DOI 10.1097/ACO.0b013e32830edbdf; Ren K, 2010, JPN DENT SCI REV, V46, P86, DOI 10.1016/j.jdsr.2009.10.005; Riazi K, 2008, P NATL ACAD SCI USA, V105, P17151, DOI 10.1073/pnas.0806682105; Rittner HL, 2008, BRIT J ANAESTH, V101, P40, DOI 10.1093/bja/aen078; Roberts J, 2009, EUR J NEUROSCI, V30, P229, DOI 10.1111/j.1460-9568.2009.06813.x; Romero-Sandoval A, 2008, BRAIN RES, V1219, P116, DOI 10.1016/j.brainres.2008.05.004; Romero-Sandoval EA, 2008, CURR OPIN INVEST DR, V9, P726; Rudick CN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002096; Rutkowski MD, 2000, PHYSIOL BEHAV, V71, P225, DOI 10.1016/S0031-9384(00)00333-4; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; SCHOBITZ B, 1993, EUR J NEUROSCI, V5, P1426, DOI 10.1111/j.1460-9568.1993.tb00210.x; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shan S, 2007, PAIN, V129, P64, DOI 10.1016/j.pain.2006.09.035; Shubayev VI, 2006, MOL CELL NEUROSCI, V31, P407, DOI 10.1016/j.mcn.2005.10.011; Shubayev VI, 2000, BRAIN RES, V855, P83, DOI 10.1016/S0006-8993(99)02321-5; Soderquist RG, 2010, PHARM RES-DORDR, V27, P841, DOI 10.1007/s11095-010-0077-y; Sorkin LS, 1997, NEUROSCIENCE, V81, P255, DOI 10.1016/S0306-4522(97)00147-4; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Sun JH, 2006, J NEUROPHYSIOL, V96, P2189, DOI 10.1152/jn.00222.2006; Sung BK, 2003, J NEUROSCI, V23, P2899; Suzuki A, 2004, BIOL PHARM BULL, V27, P1891, DOI 10.1248/bpb.27.1891; Svensson CI, 2007, J EXP MED, V204, P245, DOI 10.1084/jem.20061826; Sweitzer SM, 1999, BRAIN RES, V829, P209, DOI 10.1016/S0006-8993(99)01326-8; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang X, 2010, NEUROSCIENCE, V166, P397, DOI 10.1016/j.neuroscience.2010.01.005; Tchivileva IE, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-13; Terkeltaub R, 2009, ANN RHEUM DIS, V68, P1613, DOI 10.1136/ard.2009.108936; Thacker MA, 2007, ANESTH ANALG, V105, P838, DOI 10.1213/01.ane.0000275190.42912.37; Thalakoti S, 2007, HEADACHE, V47, P1008, DOI 10.1111/j.1526-4610.2007.00854.x; Ting E, 2008, BRIT J PHARMACOL, V153, P1043, DOI 10.1038/sj.bjp.0707640; Torres R, 2009, ANN RHEUM DIS, V68, P1602, DOI 10.1136/ard.2009.109355; Trang T, 2009, J NEUROSCI, V29, P3518, DOI 10.1523/JNEUROSCI.5714-08.2009; Twining CM, 2005, J PAIN, V6, P174, DOI 10.1016/j.jpain.2004.11.011; Uceyler N, 2007, BRAIN BEHAV IMMUN, V21, P553, DOI 10.1016/j.bbi.2006.10.003; Vallieres L, 1997, J NEUROCHEM, V69, P1668, DOI 10.1046/j.1471-4159.1997.69041668.x; Verge GM, 2004, EUR J NEUROSCI, V20, P1150, DOI 10.1111/j.1460-9568.2004.03593.x; Vergunst CE, 2007, RHEUMATOLOGY, V46, P1773, DOI 10.1093/rheumatology/kem222; Verri WA, 2006, P NATL ACAD SCI USA, V103, P9721, DOI 10.1073/pnas.0603286103; Vit JP, 2008, J NEUROSCI, V28, P4161, DOI 10.1523/JNEUROSCI.5053-07.2008; Wang W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006973; Watkins LR, 2005, J INTERN MED, V257, P139, DOI 10.1111/j.1365-2796.2004.01443.x; Wei F, 2008, J NEUROSCI, V28, P10482, DOI 10.1523/JNEUROSCI.3593-08.2008; Wen YR, 2007, ANESTHESIOLOGY, V107, P312, DOI 10.1097/01.anes.0000270759.11086.e7; Weyerbacher Amanda R, 2010, Pain, V148, P237, DOI 10.1016/j.pain.2009.11.003; Willemen HLDM, 2010, PAIN, V150, P550, DOI 10.1016/j.pain.2010.06.015; Willis CL, 2008, CURR PHARM DESIGN, V14, P1625, DOI 10.2174/138161208784705414; Xie W, 2009, NEUROSCIENCE, V160, P847, DOI 10.1016/j.neuroscience.2009.03.016; Xu M, 2007, J NEUROSCI, V27, P2570, DOI 10.1523/JNEUROSCI.3728-06.2007; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Zhang J, 2003, EUR J NEUROSCI, V17, P2750, DOI 10.1046/j.1460-9568.2003.02704.x; Zhang J, 2007, J NEUROSCI, V27, P12396, DOI 10.1523/JNEUROSCI.3016-07.2007; Zhang RX, 2005, PAIN, V118, P125, DOI 10.1016/j.pain.2005.08.001; Zhao P, 2007, J NEUROSCI, V27, P8893, DOI 10.1523/JNEUROSCI.2209-07.2007; Zhuang ZY, 2007, BRAIN BEHAV IMMUN, V21, P642, DOI 10.1016/j.bbi.2006.11.003; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024	148	542	569	2	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1267	1276		10.1038/nm.2234	http://dx.doi.org/10.1038/nm.2234			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	20948535	Green Accepted			2022-12-25	WOS:000283860100038
J	Strober, W				Strober, Warren			Gut microbes: friends or fiends?	NATURE MEDICINE			English	Editorial Material							INFLAMMATORY BOWEL DISEASES; IMMUNE-SYSTEM; T-CELLS; MICROFLORA		US Natl Inst Allergy & Infect Dis, Mucosal Immun Sect, Host Def Lab, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Strober, W (corresponding author), US Natl Inst Allergy & Infect Dis, Mucosal Immun Sect, Host Def Lab, Bethesda, MD USA.	wstrober@niaid.nih.gov			Intramural NIH HHS [Z01 AI000354-25] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000432, ZIAAI000354] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Avci FY, 2010, ANNU REV IMMUNOL, V28, P107, DOI 10.1146/annurev-immunol-030409-101159; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; de Chambrun GP, 2008, CURR OPIN GASTROEN, V24, P440, DOI 10.1097/MOG.0b013e3283023be5; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Strober W, 2009, IMMUNITY, V31, P377, DOI 10.1016/j.immuni.2009.09.001; Takaishi H, 2008, INT J MED MICROBIOL, V298, P463, DOI 10.1016/j.ijmm.2007.07.016; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725	14	17	19	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2010	16	11					1195	1197		10.1038/nm1110-1195	http://dx.doi.org/10.1038/nm1110-1195			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21052070	Green Accepted			2022-12-25	WOS:000283860100023
J	Tracey, I				Tracey, Irene			Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans	NATURE MEDICINE			English	Review							CHOLECYSTOKININ ANTAGONIST PROGLUMIDE; OPIOID RECEPTOR AVAILABILITY; MEDIAL PREFRONTAL CORTEX; BOWEL-SYNDROME PATIENTS; NEUROPATHIC PAIN; BRAIN ACTIVITY; CENTRAL SENSITIZATION; ANALGESIC RESPONSE; EMOTION REGULATION; NEURAL MECHANISMS	The perception of pain is subject to powerful influences. Understanding how these are mediated at a neuroanatomical and neurobiological level provides us with valuable information that has a direct impact on our ability to harness positive and minimize negative effects therapeutically, as well as optimize clinical trial designs when developing new analgesics. This is particularly relevant for placebo and nocebo effects. New research findings have directly contributed to an increased understanding of how placebo and nocebo effects are produced and what biological and psychological factors influence variances in the magnitude of the effect. The findings have relevance for chronic pain states and other disorders, where abnormal functioning of crucial brain regions might affect analgesic outcome even in the normal therapeutic setting.	[Tracey, Irene] Univ Oxford, Nuffield Dept Anaesthet, Oxford, England; [Tracey, Irene] Univ Oxford, Oxford Ctr Funct Magnet Resonance Imaging Brain, Dept Clin Neurol, Oxford, England	University of Oxford; University of Oxford	Tracey, I (corresponding author), Univ Oxford, Nuffield Dept Anaesthet, Oxford, England.	irene@fmrib.ox.ac.uk		Tracey, Irene/0000-0003-4134-6115	Medical Research Council [G0700399] Funding Source: Medline; MRC [G0700399] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ADER R, 1995, LANCET, V345, P99, DOI 10.1016/S0140-6736(95)90066-7; Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Apkarian AV, 2001, NEUROSCI LETT, V311, P193, DOI 10.1016/S0304-3940(01)02122-X; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; BEECHER HK, 1955, JAMA-J AM MED ASSOC, V159, P1602, DOI 10.1001/jama.1955.02960340022006; Benedetti F, 2006, PAIN, V121, P133, DOI 10.1016/j.pain.2005.12.016; Benedetti F, 2003, J NEUROSCI, V23, P4315; Benedetti F, 1997, PROG NEUROBIOL, V52, P109, DOI 10.1016/S0301-0082(97)00006-3; Benedetti F, 1997, PAIN, V71, P135, DOI 10.1016/S0304-3959(97)03346-0; Benedetti F, 1999, J NEUROSCI, V19, P3639; Benedetti F, 1996, PAIN, V64, P535, DOI 10.1016/0304-3959(95)00179-4; BENEDETTI F, 1995, LANCET, V346, P1231, DOI 10.1016/S0140-6736(95)92938-X; Benedetti F, 2006, J NEUROSCI, V26, P12014, DOI 10.1523/JNEUROSCI.2947-06.2006; Benedetti F, 2008, ANNU REV PHARMACOL, V48, P33, DOI 10.1146/annurev.pharmtox.48.113006.094711; Bingel U, 2006, PAIN, V120, P8, DOI 10.1016/j.pain.2005.08.027; Borsook D, 2010, NEUROSCIENTIST, V16, P171, DOI 10.1177/1073858409349902; Colloca L, 2008, EUR J APPL PHYSIOL, V102, P371, DOI 10.1007/s00421-007-0593-6; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Eippert F, 2009, SCIENCE, V326, P404, DOI 10.1126/science.1180142; Eippert F, 2009, NEURON, V63, P533, DOI 10.1016/j.neuron.2009.07.014; Fairhurst M, 2007, PAIN, V128, P101, DOI 10.1016/j.pain.2006.09.001; Fields H.L., 2005, TXB PAIN, P125; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Gebhart GF, 2004, NEUROSCI BIOBEHAV R, V27, P729, DOI 10.1016/j.neubiorev.2003.11.008; Geers AL, 2005, J PSYCHOSOM RES, V58, P121, DOI 10.1016/j.jpsychores.2004.08.011; GELFAND DM, 1965, PSYCHOL REP, V17, P555, DOI 10.2466/pr0.1965.17.2.555; Goebel MU, 2002, FASEB J, V16, P1869, DOI 10.1096/fj.02-0389com; GRACELY RH, 1983, NATURE, V306, P264, DOI 10.1038/306264a0; Gundel H, 2008, PAIN, V137, P413, DOI 10.1016/j.pain.2007.10.003; Gwilym SE, 2009, ARTHRIT RHEUM-ARTHR, V61, P1226, DOI 10.1002/art.24837; Harris RE, 2007, J NEUROSCI, V27, P10000, DOI 10.1523/JNEUROSCI.2849-07.2007; Haygarth John, 1801, IMAGINATION CAUSE CU; Jones AKP, 2004, EUR J PAIN, V8, P479, DOI 10.1016/j.ejpain.2003.11.017; Kalisch R, 2005, J COGNITIVE NEUROSCI, V17, P874, DOI 10.1162/0898929054021184; Kalisch R, 2006, J COGNITIVE NEUROSCI, V18, P1266, DOI 10.1162/jocn.2006.18.8.1266; Kalivas PW, 1999, ANN NY ACAD SCI, V877, P64, DOI 10.1111/j.1749-6632.1999.tb09261.x; Kaptchuk TJ, 2009, CULT MED PSYCHIAT, V33, P382, DOI 10.1007/s11013-009-9141-7; Keltner JR, 2006, J NEUROSCI, V26, P4437, DOI 10.1523/JNEUROSCI.4463-05.2006; Kong J, 2006, J NEUROSCI, V26, P381, DOI 10.1523/JNEUROSCI.3556-05.2006; Kong J, 2008, J NEUROSCI, V28, P13354, DOI 10.1523/JNEUROSCI.2944-08.2008; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; Lee MC, 2008, J NEUROSCI, V28, P11642, DOI 10.1523/JNEUROSCI.2638-08.2008; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; LEVINE JD, 1984, NATURE, V312, P755, DOI 10.1038/312755a0; LEVINE JD, 1978, LANCET, V2, P654, DOI 10.1016/S0140-6736(78)92762-9; Lieberman MD, 2004, NEUROIMAGE, V22, P447, DOI 10.1016/j.neuroimage.2004.01.037; LIPMAN JJ, 1990, PSYCHOPHARMACOLOGY, V102, P112, DOI 10.1007/BF02245754; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Lorenz R, 2005, BRAIN BEHAV IMMUN, V19, P283, DOI 10.1016/j.bbi.2005.03.010; Maarrawi J, 2007, PAIN, V127, P183, DOI 10.1016/j.pain.2006.10.013; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; Mayberg HS, 2002, AM J PSYCHIAT, V159, P728, DOI 10.1176/appi.ajp.159.5.728; Metz AE, 2009, P NATL ACAD SCI USA, V106, P2423, DOI 10.1073/pnas.0809897106; Miller FG, 2008, J ROY SOC MED, V101, P222, DOI 10.1258/jrsm.2008.070466; Montgomery GH, 1997, PAIN, V72, P107, DOI 10.1016/S0304-3959(97)00016-X; Morton DL, 2009, PAIN, V146, P194, DOI 10.1016/j.pain.2009.07.026; Ochsner KN, 2008, SOC COGN AFFECT NEUR, V3, P144, DOI 10.1093/scan/nsn006; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Pacheco-Lopez G, 2006, BRAIN BEHAV IMMUN, V20, P430, DOI 10.1016/j.bbi.2006.05.003; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Petrovic P, 2005, NEURON, V46, P957, DOI 10.1016/j.neuron.2005.05.023; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Ploghaus A, 2001, J NEUROSCI, V21, P9896, DOI 10.1523/JNEUROSCI.21-24-09896.2001; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Pollo A, 2009, PROG BRAIN RES, V175, P283, DOI 10.1016/S0079-6123(09)17520-9; Porreca F, 2002, TRENDS NEUROSCI, V25, P319, DOI 10.1016/S0166-2236(02)02157-4; Price DD, 1999, PAIN, V83, P147, DOI 10.1016/S0304-3959(99)00081-0; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Price DD, 2007, PAIN, V127, P63, DOI 10.1016/j.pain.2006.08.001; Quirk GJ, 2006, BIOL PSYCHIAT, V60, P337, DOI 10.1016/j.biopsych.2006.03.010; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Schweinhardt P, 2009, J NEUROSCI, V29, P4882, DOI 10.1523/JNEUROSCI.5634-08.2009; Scott DJ, 2008, ARCH GEN PSYCHIAT, V65, P220, DOI 10.1001/archgenpsychiatry.2007.34; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Seifert F, 2009, J NEUROSCI, V29, P6167, DOI 10.1523/JNEUROSCI.4654-08.2009; Seminowicz DA, 2009, NEUROIMAGE, V47, P1007, DOI 10.1016/j.neuroimage.2009.05.068; Suzuki R, 2004, TRENDS PHARMACOL SCI, V25, P613, DOI 10.1016/j.tips.2004.10.002; Tracey I, 2002, J NEUROSCI, V22, P2748, DOI 10.1523/JNEUROSCI.22-07-02748.2002; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Tracey I, 2009, J PAIN, V10, P1113, DOI 10.1016/j.jpain.2009.09.001; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; Vase L, 2003, PAIN, V105, P17, DOI 10.1016/S0304-3959(03)00073-3; Volkow ND, 2006, NEUROIMAGE, V32, P1782, DOI 10.1016/j.neuroimage.2006.04.192; VOUDOURIS NJ, 1990, PAIN, V43, P121, DOI 10.1016/0304-3959(90)90057-K; Waber RL, 2008, JAMA-J AM MED ASSOC, V299, P1016, DOI 10.1001/jama.299.9.1016; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2006, BRAIN BEHAV IMMUN, V20, P219, DOI 10.1016/j.bbi.2006.01.007; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wager TD, 2007, P NATL ACAD SCI USA, V104, P11056, DOI 10.1073/pnas.0702413104; Wasan AD, 2006, PAIN MED, V7, P217, DOI 10.1111/j.1526-4637.2006.00154.x; Wiech K, 2008, TRENDS COGN SCI, V12, P306, DOI 10.1016/j.tics.2008.05.005; Wiech K, 2006, J NEUROSCI, V26, P11501, DOI 10.1523/JNEUROSCI.2568-06.2006; Wiech K, 2009, NEUROIMAGE, V47, P987, DOI 10.1016/j.neuroimage.2009.05.059; Wood PB, 2007, EUR J NEUROSCI, V25, P3576, DOI 10.1111/j.1460-9568.2007.05623.x; Wood PB, 2007, J PAIN, V8, P51, DOI 10.1016/j.jpain.2006.05.014; Zubieta JK, 2006, BRAIN BEHAV IMMUN, V20, P15, DOI 10.1016/j.bbi.2005.08.006; Zubieta JK, 2005, J NEUROSCI, V25, P7754, DOI 10.1523/JNEUROSCI.0439-05.2005	102	329	336	1	133	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1277	1283		10.1038/nm.2229	http://dx.doi.org/10.1038/nm.2229			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	20948533				2022-12-25	WOS:000283860100039
J	Holst, J; Watson, S; Lord, MS; Eamegdool, SS; Bax, DV; Nivison-Smith, LB; Kondyurin, A; Ma, LA; Oberhauser, AF; Weiss, AS; Rasko, JEJ				Holst, Jeff; Watson, Sarah; Lord, Megan S.; Eamegdool, Steven S.; Bax, Daniel V.; Nivison-Smith, Lisa B.; Kondyurin, Alexey; Ma, Liang; Oberhauser, Andres F.; Weiss, Anthony S.; Rasko, John E. J.			Substrate elasticity provides mechanical signals for the expansion of hemopoietic stem and progenitor cells	NATURE BIOTECHNOLOGY			English	Article							RECEPTOR RETROGENIC MICE; HUMAN TROPOELASTIN; AORTIC ENDOTHELIUM; ESCHERICHIA-COLI; PROTEIN; FORCES; MECHANOTRANSDUCTION; EXPRESSION; REVEALS; NICHES	Surprisingly little is known about the effects of the physical microenvironment on hemopoietic stem and progenitor cells. To explore the physical effects of matrix elasticity on well-characterized primitive hemopoietic cells, we made use of a uniquely elastic biomaterial, tropoelastin. Culturing mouse or human hemopoietic cells on a tropoelastin substrate led to a two- to threefold expansion of undifferentiated cells, including progenitors and mouse stem cells. Treatment with cytokines in the presence of tropoelastin had an additive effect on this expansion. These biological effects required substrate elasticity, as neither truncated nor cross-linked tropoelastin reproduced the phenomenon, and inhibition of mechanotransduction abrogated the effects. Our data suggest that substrate elasticity and tensegrity are important mechanisms influencing hemopoietic stem and progenitor cell subsets and could be exploited to facilitate cell culture.	[Holst, Jeff; Watson, Sarah; Rasko, John E. J.] Centenary Inst, Gene & Stem Cell Therapy Program, Camperdown, NSW, Australia; [Holst, Jeff; Rasko, John E. J.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Lord, Megan S.] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia; [Eamegdool, Steven S.; Bax, Daniel V.; Nivison-Smith, Lisa B.; Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Kondyurin, Alexey] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Ma, Liang; Oberhauser, Andres F.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX USA; [Rasko, John E. J.] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia	University of Sydney; Centenary Institute; University of Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney; University of Texas System; University of Texas Medical Branch Galveston; University of Sydney	Rasko, JEJ (corresponding author), Centenary Inst, Gene & Stem Cell Therapy Program, Camperdown, NSW, Australia.	j.rasko@centenary.org.au	Watson, Sarah/HGB-2661-2022; Nivison-Smith, Lisa/H-3297-2019; Rasko, John EJ/F-5754-2013; Kondyurin, Alexey/B-9580-2011; Weiss, Anthony S/F-8103-2010; Holst, Jeff/H-7634-2012; Lord, Megan/D-4673-2013; Weiss, Anthony S/GYV-0157-2022	Kondyurin, Alexey/0000-0002-8837-9734; Weiss, Anthony S/0000-0002-8106-4836; Holst, Jeff/0000-0002-0377-9318; Lord, Megan/0000-0002-0506-9811; rasko, John/0000-0003-2975-807X; Nivison-Smith, Lisa/0000-0001-6677-1949	Cancer Institute of New South Wales; US National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073394] Funding Source: NIH RePORTER	Cancer Institute of New South Wales; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Vignali for scientific discussion. J.H. received grant support from the Cancer Institute of New South Wales, A. S. W. from the Australian Research Council and National Health and Medical Research Council, A.F.O. received support from the US National Institutes of Health and J.E.J.R. from the National Health and Medical Research Council and the Cell and Gene Trust, Cure The Future.	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Ainsworth C, 2008, NATURE, V456, P696, DOI 10.1038/456696a; Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; CARTER WG, 1988, J BIOL CHEM, V263, P4193; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Clark K, 2007, TRENDS CELL BIOL, V17, P178, DOI 10.1016/j.tcb.2007.02.002; Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Even-Ram S, 2006, CELL, V126, P645, DOI 10.1016/j.cell.2006.08.008; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Gan BK, 2007, LANGMUIR, V23, P2741, DOI 10.1021/la062722v; GHAFFARI S, 1995, BLOOD, V86, P2976; Greene DN, 2008, BIOPHYS J, V95, P1360, DOI 10.1529/biophysj.108.130237; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Holst J, 2008, NAT IMMUNOL, V9, P658, DOI 10.1038/ni.1611; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057; Lord MS, 2006, BIOMATERIALS, V27, P4529, DOI 10.1016/j.biomaterials.2006.04.006; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M; Mecham R.P., 1991, CELL BIOL EXTRACELLU, V2nd, P79; MECHAM RP, 1989, BIOCHEMISTRY-US, V28, P3716, DOI 10.1021/bi00435a014; Miller E, 2006, BIOPHYS J, V91, P3848, DOI 10.1529/biophysj.106.088989; Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055; Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]; Ostuni A, 2002, INT J BIOCHEM CELL B, V34, P130, DOI 10.1016/S1357-2725(01)00115-7; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Puttini S, 2009, MOL THER, V17, P19, DOI 10.1038/mt.2008.239; Rodgers UR, 2005, PATHOL BIOL, V53, P390, DOI 10.1016/j.patbio.2004.12.022; Rodgers UR, 2004, BIOCHIMIE, V86, P173, DOI 10.1016/j.biochi.2004.03.002; Sauvageau G, 2004, ONCOGENE, V23, P7223, DOI 10.1038/sj.onc.1207942; Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776; Spofford CM, 2003, J BIOMECH, V36, P645, DOI 10.1016/S0021-9290(02)00442-6; Spofford CM, 2001, AM J PHYSIOL-HEART C, V280, pH1354, DOI 10.1152/ajpheart.2001.280.3.H1354; Toonkool P, 2001, J BIOL CHEM, V276, P44575, DOI 10.1074/jbc.M107920200; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719; Wu WJ, 1999, EUR J BIOCHEM, V266, P308, DOI 10.1046/j.1432-1327.1999.00891.x; Yin YB, 2009, BIOMATERIALS, V30, P1675, DOI 10.1016/j.biomaterials.2008.11.009; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	54	209	210	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2010	28	10					1123	U168		10.1038/nbt.1687	http://dx.doi.org/10.1038/nbt.1687			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	663GF	20890282				2022-12-25	WOS:000282870500035
J	Fordyce, PM; Gerber, D; Tran, D; Zheng, JS; Li, H; DeRisi, JL; Quake, SR				Fordyce, Polly M.; Gerber, Doron; Tran, Danh; Zheng, Jiashun; Li, Hao; DeRisi, Joseph L.; Quake, Stephen R.			De novo identification and biophysical characterization of transcription-factor binding sites with microfluidic affinity analysis	NATURE BIOTECHNOLOGY			English	Article							PROTEIN-DNA INTERACTIONS; MOTIF DISCOVERY; GENOME; SPECIFICITY; EXPRESSION; SEQUENCE; PROMOTERS; REGIONS; SYSTEM; TOOLS	Gene expression is regulated in part by protein transcription factors that bind target regulatory DNA sequences. Predicting DNA binding sites and affinities from transcription factor sequence or structure is difficult; therefore, experimental data are required to link transcription factors to target sequences. We present a microfluidics-based approach for de novo discovery and quantitative biophysical characterization of DNA target sequences. We validated our technique by measuring sequence preferences for 28 Saccharomyces cerevisiae transcription factors with a variety of DNA-binding domains, including several that have proven difficult to study by other techniques. For each transcription factor, we measured relative binding affinities to oligonucleotides covering all possible 8-bp DNA sequences to create a comprehensive map of sequence preferences; for four transcription factors, we also determined absolute affinities. We expect that these data and future use of this technique will provide information essential for understanding transcription factor specificity, improving identification of regulatory sites and reconstructing regulatory interactions.	[Fordyce, Polly M.; DeRisi, Joseph L.; Quake, Stephen R.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Fordyce, Polly M.; Zheng, Jiashun; Li, Hao; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Gerber, Doron] Bar Ilan Univ, Dept Life Sci, Ramat Gan, Israel; [Tran, Danh; Quake, Stephen R.] Stanford Univ, Dept Bioengn, Palo Alto, CA 94304 USA; [Tran, Danh; Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Palo Alto, CA 94304 USA; [Li, Hao] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Bar Ilan University; Stanford University; Stanford University; Peking University	Quake, SR (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.	joe@derisilab.ucsf.edu; quake@stanford.edu	Fordyce, Polly/AAY-6365-2020; Zheng, Jiashun/A-3098-2012	Fordyce, Polly/0000-0002-9505-0638; 	Howard Hughes Medical Institute/Helen Hay Whitney Foundation; Howard Hughes Medical Institute	Howard Hughes Medical Institute/Helen Hay Whitney Foundation(Howard Hughes Medical Institute); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	P.M.F. was supported by a Howard Hughes Medical Institute/Helen Hay Whitney Foundation Postdoctoral Fellowship. J.L.D., S.R.Q. and this work were supported by the Howard Hughes Medical Institute. We thank A. Potanina for assistance with fabrication of microfluidic devices, O. Homann for implementation of PSAM functionality with MochiView and D. Breslow, F. Caro, S. Churchman, M. Dimon, T. Kiers, A. Kistler, C. Nelson, K. Sorber, E. Yeh and I. Zuleta for careful reading of the manuscript.	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Bonham AJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp424; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; JOST JP, 1991, NUCLEIC ACIDS RES, V19, P2788, DOI 10.1093/nar/19.10.2788; Kim HD, 2008, NAT STRUCT MOL BIOL, V15, P1192, DOI 10.1038/nsmb.1500; Liu YY, 2004, NUCLEIC ACIDS RES, V32, pW204, DOI 10.1093/nar/gkh461; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Meng XD, 2005, NAT BIOTECHNOL, V23, P988, DOI 10.1038/nbt1120; Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857; Pavesi G, 2006, NUCLEIC ACIDS RES, V34, pW566, DOI 10.1093/nar/gkl285; Ralston A., 1982, MATH MAG, V55, P131, DOI [DOI 10.2307/2690079, 10.2307/2690079]; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; VOGEL K, 1989, MOL CELL BIOL, V9, P2050, DOI 10.1128/MCB.9.5.2050; Wieland G, 2001, NUCLEIC ACIDS RES, V29, P1054, DOI 10.1093/nar/29.5.1054; Wu RZ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-399; Yuh CH, 2001, DEVELOPMENT, V128, P617; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	30	133	134	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2010	28	9					970	976		10.1038/nbt.1675	http://dx.doi.org/10.1038/nbt.1675			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	648UF	20802496	Green Accepted, Green Submitted			2022-12-25	WOS:000281719100024
J	Schmitz, MHA; Held, M; Janssens, V; Hutchins, JRA; Hudecz, O; Ivanova, E; Goris, J; Trinkle-Mulcahy, L; Lamond, AI; Poser, I; Hyman, AA; Mechtler, K; Peters, JM; Gerlich, DW				Schmitz, Michael H. A.; Held, Michael; Janssens, Veerle; Hutchins, James R. A.; Hudecz, Otto; Ivanova, Elitsa; Goris, Jozef; Trinkle-Mulcahy, Laura; Lamond, Angus I.; Poser, Ina; Hyman, Anthony A.; Mechtler, Karl; Peters, Jan-Michael; Gerlich, Daniel W.			Live-cell imaging RNAi screen identifies PP2A-B55 alpha and importin-beta 1 as key mitotic exit regulators in human cells	NATURE CELL BIOLOGY			English	Article							XENOPUS EGG EXTRACTS; CHROMOSOME SEGREGATION; PROTEIN PHOSPHATASE-2A; VERTEBRATE CELLS; LIVING CELLS; MITOSIS; DROSOPHILA; SUBUNIT; DEPHOSPHORYLATION; CALCINEURIN	When vertebrate cells exit mitosis various cellular structures are re-organized to build functional interphase cells(1). This depends on Cdk1 (cyclin dependent kinase 1) inactivation and subsequent dephosphorylation of its substrates(2-4). Members of the protein phosphatase 1 and 2A (PP1 and PP2A) families can dephosphorylate Cdk1 substrates in biochemical extracts during mitotic exit(5,6), but how this relates to postmitotic reassembly of interphase structures in intact cells is not known. Here, we use a live-cell imaging assay and RNAi knockdown to screen a genome-wide library of protein phosphatases for mitotic exit functions in human cells. We identify a trimeric PP2A-B55 alpha complex as a key factor in mitotic spindle breakdown and postmitotic reassembly of the nuclear envelope, Golgi apparatus and decondensed chromatin. Using a chemically induced mitotic exit assay, we find that PP2A-B55 alpha functions downstream of Cdk1 inactivation. PP2A-B55 alpha isolated from mitotic cells had reduced phosphatase activity towards the Cdk1 substrate, histone H1, and was hyper-phosphorylated on all subunits. Mitotic PP2A complexes co-purified with the nuclear transport factor importin-beta 1, and RNAi depletion of importin-beta 1 delayed mitotic exit synergistically with PP2A-B55 alpha. This demonstrates that PP2A-B55 alpha and importin-beta 1 cooperate in the regulation of postmitotic assembly mechanisms in human cells.	[Schmitz, Michael H. A.; Held, Michael; Gerlich, Daniel W.] Swiss Fed Inst Technol Zurich ETHZ, Inst Biochem, CH-8093 Zurich, Switzerland; [Schmitz, Michael H. A.; Held, Michael; Gerlich, Daniel W.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Janssens, Veerle; Ivanova, Elitsa; Goris, Jozef] Katholieke Univ Leuven, Gasthuisberg O&N1, Lab Prot Phosphorylat & Prote, Dept Mol Cell Biol,Fac Med, B-3000 Louvain, Belgium; [Hutchins, James R. A.; Mechtler, Karl; Peters, Jan-Michael] Inst Mol Pathol, A-1030 Vienna, Austria; [Hudecz, Otto; Mechtler, Karl] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Trinkle-Mulcahy, Laura] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Trinkle-Mulcahy, Laura] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; [Lamond, Angus I.] Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland; [Poser, Ina; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Marine Biological Laboratory - Woods Hole; KU Leuven; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Ottawa; University of Ottawa; University of Dundee; Max Planck Society	Gerlich, DW (corresponding author), Univ Zurich, Div Psychiat Res, August Forel Str 1, CH-8008 Zurich, Switzerland.	daniel.gerlich@bc.biol.ethz.ch	Gerlich, Daniel Wolfram W/A-6991-2016; Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011; Mechtler, Karl/AAF-2717-2019; Trinkle-Mulcahy, Laura/E-2197-2013; Janssens, Veerle/I-7059-2016	Gerlich, Daniel Wolfram W/0000-0003-1637-3365; Hyman, Anthony A/0000-0003-3664-154X; Mechtler, Karl/0000-0002-3392-9946; Janssens, Veerle/0000-0002-6772-8448	Swiss National Science Foundation (SNF) [3100A0-114120, PDFMP3_124904]; European Science Foundation; Evelyn and Melvin Spiegel Fund; Roche; Molecular Life Sciences Ph.D. programme Zurich; 'Geconcerteerde OnderzoeksActies' of the Flemish government; 'Interuniversitary Attraction Poles' of the Belgian Science Policy [P6/28]; 'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen'; Max Planck Society; MitoCheck (EU); BMBF (Bundesministerium fur Bildung and Forschung); DiGtoP [01GS0859]; Boehringer Ingelheim; Austrian Federal Ministry of Science and Research (Austrian Proteomics Platform III); European Commission; Austrian Science Foundation (FWF); Medical Research Council [G0801738, G0301131] Funding Source: researchfish; MRC [G0801738, G0301131] Funding Source: UKRI	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); European Science Foundation(European Science Foundation (ESF)European Commission); Evelyn and Melvin Spiegel Fund; Roche(Roche Holding); Molecular Life Sciences Ph.D. programme Zurich; 'Geconcerteerde OnderzoeksActies' of the Flemish government; 'Interuniversitary Attraction Poles' of the Belgian Science Policy; 'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen'(FWO); Max Planck Society(Max Planck SocietyFoundation CELLEX); MitoCheck (EU)(European Commission); BMBF (Bundesministerium fur Bildung and Forschung)(Federal Ministry of Education & Research (BMBF)); DiGtoP; Boehringer Ingelheim(Boehringer Ingelheim); Austrian Federal Ministry of Science and Research (Austrian Proteomics Platform III); European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank F. Uhlmann and B. Novak for critical comments on the manuscript. We thank S. Maar, the ETHZ Light Microscopy Centre (LMC), the ETHZ RNAi Screening Centre (RISC), M. Augsburg (The Max Planck Institute of Molecular Cell Biology and Genetics; MPI-CBG), M. Leuschner (MPI-CBG) and A. Ssykor (MPI-CBG) for technical assistance. We thank U. Kutay (ETHZ) for anti-importin-beta 1 and anti-nucleolin antibodies,). Rohrer (University of Zurich) for providing GalT-eGFP plasmid, J. Ellenberg (EMBL, Heidelberg) for IBB-eGFP plasmid, M.C. Cardoso (Technical University, Darmstadt) for eGFP-PCNA plasmid and Sanofi Aventis and the National Cancer Institute for providing flavopiridol. This work was supported by Swiss National Science Foundation (SNF) research grant 3100A0-114120, SNF ProDoc grant PDFMP3_124904, a European Young Investigator (EURYI) award of the European Science Foundation to D.W.G., a MBL Summer Research Fellowship by the Evelyn and Melvin Spiegel Fund to D.W.G., a Roche Ph.D. fellowship to M.H.A.S. and a Mueller fellowship of the Molecular Life Sciences Ph.D. programme Zurich to M.H. M.H. and M.H.A.S. are fellows of the Zurich Ph.D. programme in Molecular Life Sciences. V.J. and J.G. were supported by grants of the 'Geconcerteerde OnderzoeksActies' of the Flemish government, the 'Interuniversitary Attraction Poles of the Belgian Science Policy P6/28 and the 'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen' A.I.L. is a Wellcome Trust Principal Research Fellow. A.A.H. acknowledges funding by the Max Planck Society, MitoCheck (the EU-FP6 integrated project), and a BMBF (Bundesministerium fur Bildung and Forschung) grant, DiGtoP (01GS0859). Work in the groups of K.M. and J.M.P. was supported by MitoCheck (the EU-FP6 integrated project), Boehringer Ingelheim, the GEN-AU programme of the Austrian Federal Ministry of Science and Research (Austrian Proteomics Platform III), MeioSys within the Seventh Framework Programme of the European Commission and by Chromosome Dynamics, which is funded by the Austrian Science Foundation (FWF).	AXTON JM, 1990, CELL, V63, P33, DOI 10.1016/0092-8674(90)90286-N; Berdougo E, 2008, CELL CYCLE, V7, P1184, DOI 10.4161/cc.7.9.5792; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; DOONAN JH, 1989, CELL, V57, P987, DOI 10.1016/0092-8674(89)90337-1; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Gruneberg U, 2002, J CELL BIOL, V158, P901, DOI 10.1083/jcb.200202054; GUO H, 1993, P NATL ACAD SCI USA, V90, P2500, DOI 10.1073/pnas.90.6.2500; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Held M, 2010, NAT METHODS, V7, P747, DOI 10.1038/nmeth.1486; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; LEE TH, 1994, MOL BIOL CELL, V5, P323, DOI 10.1091/mbc.5.3.323; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Longin S, 2007, J BIOL CHEM, V282, P26971, DOI 10.1074/jbc.M704059200; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; MAYERJAEKEL RE, 1994, J CELL SCI, V107, P2609; MAYERJAEKEL RE, 1993, CELL, V72, P621, DOI 10.1016/0092-8674(93)90080-A; Mocciaro A, 2010, J CELL BIOL, V189, P631, DOI 10.1083/jcb.200910057; Mochida S, 2007, NATURE, V449, P336, DOI 10.1038/nature06121; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nishiyama T, 2007, NATURE, V449, P341, DOI 10.1038/nature06136; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Queralt E, 2008, CURR OPIN CELL BIOL, V20, P661, DOI 10.1016/j.ceb.2008.09.003; Schaub BE, 2006, MOL BIOL CELL, V17, P5153, DOI 10.1091/mbc.E06-08-0665; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Skoufias DA, 2007, J CELL BIOL, V179, P671, DOI 10.1083/jcb.200704117; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Trinkle-Mulcahy L, 2006, CURR OPIN CELL BIOL, V18, P623, DOI 10.1016/j.ceb.2006.09.001; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006	34	250	252	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					886	893		10.1038/ncb2092	http://dx.doi.org/10.1038/ncb2092			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20711181	Green Submitted, Green Accepted			2022-12-25	WOS:000281561900012
J	Schreiber, SL; Shamji, AF; Clemons, PA; Hon, C; Koehler, AN; Munoz, B; Palmer, M; Stern, AM; Wagner, BK; Powers, S; Lowe, SW; Guo, XC; Krasnitz, A; Sawey, ET; Sordella, R; Stein, L; Trotman, LC; Califano, A; Dalla-Favera, R; Ferrando, A; Iavarone, A; Pasqualucci, L; Silva, J; Stockwell, BR; Hahn, WC; Chin, L; DePinho, RA; Boehm, JS; Gopal, S; Huang, A; Root, DE; Weir, BA; Gerhard, DS; Zenklusen, JC; Roth, MG; White, MA; Minna, JD; MacMillan, JB; Posner, BA				Schreiber, Stuart L.; Shamji, Alykhan F.; Clemons, Paul A.; Hon, Cindy; Koehler, Angela N.; Munoz, Benito; Palmer, Michelle; Stern, Andrew M.; Wagner, Bridget K.; Powers, Scott; Lowe, Scott W.; Guo, Xuecui; Krasnitz, Alex; Sawey, Eric T.; Sordella, Raffaella; Stein, Lincoln; Trotman, Lloyd C.; Califano, Andrea; Dalla-Favera, Riccardo; Ferrando, Adolfo; Iavarone, Antonio; Pasqualucci, Laura; Silva, Jose; Stockwell, Brent R.; Hahn, William C.; Chin, Lynda; DePinho, Ronald A.; Boehm, Jesse S.; Gopal, Shuba; Huang, Alan; Root, David E.; Weir, Barbara A.; Gerhard, Daniela S.; Zenklusen, Jean Claude; Roth, Michael G.; White, Michael A.; Minna, John D.; MacMillan, John B.; Posner, Bruce A.		Canc Target Discovery Dev Network	Towards patient-based cancer therapeutics	NATURE BIOTECHNOLOGY			English	Article							ONCOGENE ADDICTION; LIVER-CANCER; CELL-LINES; STEM-CELLS; IDENTIFICATION; GENOTYPE; THERAPY; MODELS; TUMORS		[Schreiber, Stuart L.; Shamji, Alykhan F.; Clemons, Paul A.; Hon, Cindy; Koehler, Angela N.; Munoz, Benito; Palmer, Michelle; Stern, Andrew M.; Wagner, Bridget K.; Canc Target Discovery Dev Network] Harvard & MIT, Broad Inst, Cambridge, MA USA; [Powers, Scott; Lowe, Scott W.; Guo, Xuecui; Krasnitz, Alex; Sawey, Eric T.; Sordella, Raffaella; Stein, Lincoln; Trotman, Lloyd C.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Califano, Andrea; Dalla-Favera, Riccardo; Ferrando, Adolfo; Iavarone, Antonio; Pasqualucci, Laura; Silva, Jose; Stockwell, Brent R.] Columbia Univ, New York, NY USA; [Hahn, William C.; Chin, Lynda; DePinho, Ronald A.; Boehm, Jesse S.; Gopal, Shuba; Huang, Alan; Root, David E.; Weir, Barbara A.] Dana Farber Canc Inst, Cambridge, MA USA; [Gerhard, Daniela S.; Zenklusen, Jean Claude] US Natl Canc Inst, Bethesda, MD USA; [Roth, Michael G.; White, Michael A.; Minna, John D.; MacMillan, John B.; Posner, Bruce A.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cold Spring Harbor Laboratory; Columbia University; Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; University of Texas Southwestern Medical Center Dallas	Schreiber, SL (corresponding author), Harvard & MIT, Broad Inst, Cambridge, MA USA.	stuart_schreiber@harvard.edu	Stockwell, Brent R/AAE-7200-2019	Stockwell, Brent R/0000-0002-3532-3868; DePinho, Ronald/0000-0002-5625-577X; Stern, Andrew/0000-0002-8437-2957; Sawey, Eric/0000-0003-4045-4499; Califano, Andrea/0000-0003-4742-3679; Boehm, Jesse/0000-0002-6795-6336; MacMillan, John/0000-0003-1430-1077; Powers, Scott/0000-0003-2769-1932; Roth, Michael/0000-0002-9056-332X; Iavarone, Antonio/0000-0002-0683-4634	NCI NIH HHS [RC2 CA148225, R01 CA071443-14, R01 CA071443-15, R01 CA071443, R01 CA071443-16, R01 CA137050, RC2 CA148399-01, RC2 CA148399] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA071443, RC2CA148225, R01CA137050, RC2CA148399] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aggarwal S, 2010, NAT REV DRUG DISCOV, V9, P427, DOI 10.1038/nrd3186; Bach PB, 2009, NEW ENGL J MED, V360, P626, DOI 10.1056/NEJMhpr0807774; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Deininger MWN, 1997, BLOOD, V90, P3691, DOI 10.1182/blood.V90.9.3691; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Thompson CB, 2009, CELL, V138, P1051, DOI 10.1016/j.cell.2009.09.002; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; van Staveren WCG, 2009, BBA-REV CANCER, V1795, P92, DOI 10.1016/j.bbcan.2008.12.004; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zuber J, 2009, GENE DEV, V23, P877, DOI 10.1101/gad.1771409	22	52	53	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2010	28	9					904	906		10.1038/nbt0910-904	http://dx.doi.org/10.1038/nbt0910-904			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	648UF	20829823	Green Accepted			2022-12-25	WOS:000281719100011
J	Goris, T; Wait, AF; Saggu, M; Fritsch, J; Heidary, N; Stein, M; Zebger, I; Lendzian, F; Armstrong, FA; Friedrich, B; Lenz, O				Goris, Tobias; Wait, Annemarie F.; Saggu, Miguel; Fritsch, Johannes; Heidary, Nina; Stein, Matthias; Zebger, Ingo; Lendzian, Friedhelm; Armstrong, Fraser A.; Friedrich, Baerbel; Lenz, Oliver			A unique iron-sulfur cluster is crucial for oxygen tolerance of a [NiFe]-hydrogenase	NATURE CHEMICAL BIOLOGY			English	Article							MEMBRANE-BOUND HYDROGENASE; RALSTONIA-EUTROPHA H16; ALCALIGENES-EUTROPHUS; NIFE HYDROGENASE; O-2; ACTIVATION; OXIDATION; SUBUNIT; PROTEIN; H-2	Hydrogenases are essential for H-2 cycling in microbial metabolism and serve as valuable blueprints for H-2-based biotechnological applications. However, most hydrogenases are extremely oxygen sensitive and prone to inactivation by even traces of O-2. The O-2-tolerant membrane-bound [NiFe]-hydrogenase of Ralstonia eutropha H16 is one of the few examples that can perform H-2 uptake in the presence of ambient O-2. Here we show that O-2 tolerance is crucially related to a modification of the internal electron-transfer chain. The iron-sulfur cluster proximal to the active site is surrounded by six instead of four conserved coordinating cysteines. Removal of the two additional cysteines alters the electronic structure of the proximal iron-sulfur cluster and renders the catalytic activity sensitive to O-2 as shown by physiological, biochemical, spectroscopic and electrochemical studies. The data indicate that the mechanism of O-2 tolerance relies on the reductive removal of oxygenic species guided by the unique architecture of the electron relay rather than a restricted access of O-2 to the active site.	[Goris, Tobias; Fritsch, Johannes; Friedrich, Baerbel; Lenz, Oliver] Humboldt Univ, Inst Biol Mikrobiol, Berlin, Germany; [Wait, Annemarie F.; Armstrong, Fraser A.] Univ Oxford, Dept Chem, Inorgan Chem Lab, Oxford, England; [Saggu, Miguel; Heidary, Nina; Zebger, Ingo; Lendzian, Friedhelm] Tech Univ Berlin, Inst Chem, Berlin, Germany; [Stein, Matthias] Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany	Humboldt University of Berlin; University of Oxford; Technical University of Berlin; Max Planck Society	Lenz, O (corresponding author), Humboldt Univ, Inst Biol Mikrobiol, Berlin, Germany.	oliver.lenz@cms.hu-berlin.de	Goris, Tobias/I-9370-2019; Lenz, Oliver/C-1582-2019; Stein, Matthias/A-2865-2011; Saggu, Miguel/B-1224-2009; Lenz, Oliver/N-5130-2019	Goris, Tobias/0000-0002-9977-5994; Lenz, Oliver/0000-0003-4550-5128; Stein, Matthias/0000-0001-7793-0052; Lenz, Oliver/0000-0003-4550-5128	German Federal ministry of Education and Research; Deutsche Forschungsgemeinschaft; European Union; Klaus Tschira Foundation; Max Planck Society for the Advancement of Science; Engineering and Physical Sciences Research Council UK; Biotechnology and Biological Sciences Research Council UK; Biotechnology and Biological Sciences Research Council [BB/H003878/1] Funding Source: researchfish; BBSRC [BB/H003878/1] Funding Source: UKRI	German Federal ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); Klaus Tschira Foundation; Max Planck Society for the Advancement of Science(Max Planck SocietyEuropean Commission); Engineering and Physical Sciences Research Council UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors wish to thank J. Priebe for obtaining preliminary EPR results, J. Hamann and A. Strack for excellent technical assistance and P. Hildebrandt and R. Bittl for generous support. This work was supported by the German Federal ministry of Education and Research (T. G.; BMBF project "H2 Design Cells"), the Deutsche Forschungsgemeinschaft (M. Saggu, N.H., I.Z., B. F., O.L.; Cluster of Excellence "UniCat"), the FP7 of the European Union (J. F.; energy network project SOLAR-H2), the Klaus Tschira Foundation and the Max Planck Society for the Advancement of Science (M. Stein), and the Engineering and Physical Sciences Research Council UK (A. F. W., F. A. A; Grant Supergen 5) and the Biotechnology and Biological Sciences Research Council UK (A. F. W., F. A. A; Grant BB/H003878/1).	Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; BARD AJ, 2001, ELECTROCHEMICAL METH, pCH6; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bernhard M, 1997, EUR J BIOCHEM, V248, P179, DOI 10.1111/j.1432-1033.1997.00179.x; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Buhrke T, 2005, J BIOL CHEM, V280, P23791, DOI 10.1074/jbc.M503260200; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; CAMMACK R, 1982, ELECTRON TRANSPORT O, P411; Chartron J, 2006, J MOL BIOL, V364, P152, DOI 10.1016/j.jmb.2006.08.080; Cracknell JA, 2008, J AM CHEM SOC, V130, P424, DOI 10.1021/ja078299+; Cracknell JA, 2009, P NATL ACAD SCI USA, V106, P20681, DOI 10.1073/pnas.0905959106; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; Esswein AJ, 2007, CHEM REV, V107, P4022, DOI 10.1021/cr050193e; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Fontecilla-Camps JC, 2009, NATURE, V460, P814, DOI 10.1038/nature08299; Gabdoulline RR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-373; Goldet G, 2008, J AM CHEM SOC, V130, P11106, DOI 10.1021/ja8027668; Hamann N, 2007, BIOCHEMISTRY-US, V46, P12875, DOI 10.1021/bi700679u; Happe RP, 1997, NATURE, V385, P126, DOI 10.1038/385126a0; HEERING HA, 1995, BIOCHEMISTRY-US, V34, P14675, DOI 10.1021/bi00045a008; HEERING HA, 1995, EUR J BIOCHEM, V232, P811, DOI 10.1111/j.1432-1033.1995.811zz.x; KNUTTEL K, 1994, B POL ACAD SCI-CHEM, V42, P495; Krassen H, 2009, ACS NANO, V3, P4055, DOI 10.1021/nn900748j; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamle SE, 2004, J AM CHEM SOC, V126, P14899, DOI 10.1021/ja047939v; Lenz O, 2010, CHEMPHYSCHEM, V11, P1107, DOI 10.1002/cphc.200901002; Leroux F, 2008, P NATL ACAD SCI USA, V105, P11188, DOI 10.1073/pnas.0803689105; Liebgott PP, 2010, NAT CHEM BIOL, V6, P63, DOI [10.1038/NCHEMBIO.276, 10.1038/nchembio.276]; Lubitz W, 2007, CHEM REV, V107, P4331, DOI 10.1021/cr050186q; Lubner CE, 2010, BIOCHEMISTRY-US, V49, P404, DOI 10.1021/bi901704v; Ludwig M, 2009, J BIOL CHEM, V284, P2159, DOI 10.1074/jbc.M808488200; Ludwig M, 2009, J BIOL CHEM, V284, P465, DOI 10.1074/jbc.M803676200; Lukey MJ, 2010, J BIOL CHEM, V285, P3928, DOI 10.1074/jbc.M109.067751; Ogata H, 2009, DALTON T, P7577, DOI 10.1039/b903840j; Pandelia ME, 2010, J AM CHEM SOC, V132, P6991, DOI 10.1021/ja910838d; Saggu M, 2010, PHYS CHEM CHEM PHYS, V12, P2139, DOI 10.1039/b922236g; Saggu M, 2009, J BIOL CHEM, V284, P16264, DOI 10.1074/jbc.M805690200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; SCHINK B, 1979, BIOCHIM BIOPHYS ACTA, V567, P315, DOI 10.1016/0005-2744(79)90117-7; SCHNEIDER K, 1983, BIOCHIM BIOPHYS ACTA, V748, P353, DOI 10.1016/0167-4838(83)90179-6; Schubert T, 2007, MOL MICROBIOL, V66, P453, DOI 10.1111/j.1365-2958.2007.05933.x; SCHWARTZ E, 2006, PROKARYOTES, V3, P496; Tran PD, 2010, ENERG ENVIRON SCI, V3, P727, DOI 10.1039/b926749b; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vincent KA, 2005, J AM CHEM SOC, V127, P18179, DOI 10.1021/ja055160v; Vincent KA, 2005, P NATL ACAD SCI USA, V102, P16951, DOI 10.1073/pnas.0504499102; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Volbeda A, 2002, INT J HYDROGEN ENERG, V27, P1449, DOI 10.1016/S0360-3199(02)00072-1; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0	50	189	188	3	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2011	7	5					310	U87		10.1038/nchembio.555	http://dx.doi.org/10.1038/nchembio.555			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751KZ	21390036				2022-12-25	WOS:000289617800015
J	Huo, YX; Cho, KM; Rivera, JGL; Monte, E; Shen, CR; Yan, YJ; Liao, JC				Huo, Yi-Xin; Cho, Kwang Myung; Rivera, Jimmy G. Lafontaine; Monte, Emma; Shen, Claire R.; Yan, Yajun; Liao, James C.			Conversion of proteins into biofuels by engineering nitrogen flux	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; MICROBIAL-PRODUCTION; AUTOINDUCER AI-2; METABOLISM; ALCOHOLS; GROWTH; FUELS	Biofuels are currently produced from carbohydrates and lipids in feedstock. Proteins, in contrast, have not been used to synthesize fuels because of the difficulties of deaminating protein hydrolysates. Here we apply metabolic engineering to generate Escherichia coli that can deaminate protein hydrolysates, enabling the cells to convert proteins to C4 and C5 alcohols at 56% of the theoretical yield. We accomplish this by introducing three exogenous transamination and deamination cycles, which provide an irreversible metabolic force that drives deamination reactions to completion. We show that Saccharomyces cerevisiae, E. coli, Bacillus subtilis and microalgae can be used as protein sources, producing up to 4,035 mg/l of alcohols from biomass containing similar to 22 g/l of amino acids. These results show the feasibility of using proteins for biorefineries, for which high-protein microalgae could be used as a feedstock with a possibility of maximizing algal growth(1) and total CO2 fixation.	[Huo, Yi-Xin; Cho, Kwang Myung; Rivera, Jimmy G. Lafontaine; Monte, Emma; Shen, Claire R.; Yan, Yajun; Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Cho, Kwang Myung; Liao, James C.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Liao, JC (corresponding author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA.	liaoj@seas.ucla.edu	Rivera, Jimmy G Lafontaine/E-5652-2015	Rivera, Jimmy G Lafontaine/0000-0002-3858-0835; Liao, James/0000-0002-4580-7276; huo, yixin/0000-0003-4644-999X	UCLA-Department of Energy Institute for Genomics and Proteomics	UCLA-Department of Energy Institute for Genomics and Proteomics	This work was partially supported by UCLA-Department of Energy Institute for Genomics and Proteomics.	[Anonymous], 1998, [No title captured]; Atkinson MR, 2002, J BACTERIOL, V184, P5358, DOI 10.1128/JB.184.19.5358-5363.2002; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586; Atsumi S, 2010, APPL MICROBIOL BIOT, V85, P651, DOI 10.1007/s00253-009-2085-6; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; *BD BIOSC, 2006, BD BIONUTR TECHN MAN; Becker EW, 2007, BIOTECHNOL ADV, V25, P207, DOI 10.1016/j.biotechadv.2006.11.002; Biebl H, 1999, APPL MICROBIOL BIOT, V52, P289, DOI 10.1007/s002530051523; Cann AF, 2010, APPL MICROBIOL BIOT, V85, P893, DOI 10.1007/s00253-009-2262-7; Connor MR, 2010, APPL MICROBIOL BIOT, V86, P1155, DOI 10.1007/s00253-009-2401-1; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; DeLisa MP, 2001, J BACTERIOL, V183, P2918, DOI 10.1128/JB.183.9.2918-2928.2001; Erisman JW, 2008, NAT GEOSCI, V1, P636, DOI 10.1038/ngeo325; Hazelwood LA, 2008, APPL ENVIRON MICROB, V74, P2259, DOI 10.1128/AEM.02625-07; INGRAM LO, 1987, APPL ENVIRON MICROB, V53, P2420, DOI 10.1128/AEM.53.10.2420-2425.1987; Melillo JM, 2009, SCIENCE, V326, P1397, DOI 10.1126/science.1180251; Miller SA, 2010, ENVIRON SCI TECHNOL, V44, P3932, DOI 10.1021/es902405a; Neidhardt F.C., 1996, ESCHERICHIA COLI SAL, V2nd; OHSHIMA T, 1994, EUR J BIOCHEM, V222, P305, DOI 10.1111/j.1432-1033.1994.tb18869.x; PRUSS BM, 1994, J BACTERIOL, V176, P2143; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; Smith KM, 2010, APPL MICROBIOL BIOT, V87, P1045, DOI 10.1007/s00253-010-2522-6; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Wan MY, 2009, APPL BIOCHEM BIOTECH, V159, P394, DOI 10.1007/s12010-008-8497-4; Wang L, 2005, J BACTERIOL, V187, P2066, DOI 10.1128/JB.187.6.2066-2076.2005; Werpy T., 2004, TOP VALUE ADDED CHEM, VI; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; Xavier KB, 2005, J BACTERIOL, V187, P238, DOI 10.1128/JB.187.1.238-248.2005; Zhang KC, 2008, P NATL ACAD SCI USA, V105, P20653, DOI 10.1073/pnas.0807157106	30	208	220	7	142	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2011	29	4					346	U160		10.1038/nbt.1789	http://dx.doi.org/10.1038/nbt.1789			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	746XY	21378968				2022-12-25	WOS:000289284900020
J	Huang, Z; Wu, QL; Guryanova, OA; Cheng, L; Shou, WN; Rich, JN; Bao, SD				Huang, Zhi; Wu, Qiulian; Guryanova, Olga A.; Cheng, Lin; Shou, Weinian; Rich, Jeremy N.; Bao, Shideng			Deubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells	NATURE CELL BIOLOGY			English	Article							RESTRICTIVE SILENCER FACTOR; TARGET GENES; REST/NRSF; REPRESSOR; PROTEIN; DIFFERENTIATION; TRANSCRIPTION; PLURIPOTENCY; EXPRESSION; NRSF/REST	The repressor element 1-silencing transcription factor (REST) functions as a master regulator to maintain neural stem/progenitor cells (NPCs). REST under goes proteasomal degradation through beta-TrCP-mediated ubiquitylation during neuronal differentiation. However, reciprocal mechanisms that stabilize REST in NPCs are undefined. Here we show that the deubiquitylase HAUSP counterbalances REST ubiquitylation and prevents NPC differentiation. HAUSP expression declines concordantly with REST on neuronal differentiation and reciprocally with beta-TrCP levels. HAUSP knock down in NPCs decreases REST and induces differentiation In contrast, HAUSP overexpression upregulates REST by overriding beta-TrCP-mediated ubiquitylation. A consensus site (310-PYSS-313) in human REST is required for HAUSP-mediated REST deubiquitylation. Furthermore, REST overexpression in NPCs rescues the differentiation phenotype induced by HAUSP knock down. These data demonstrate that HAUSP stabilizes REST through deubiquitylation and antagonizes beta-TrCP in regulating REST at the post-translational level. Thus, HAUSP-mediated deubiquitylation represents a critical regulatory mechanism involved in the maintenance of NPCs.	[Huang, Zhi; Wu, Qiulian; Guryanova, Olga A.; Cheng, Lin; Rich, Jeremy N.; Bao, Shideng] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA; [Cheng, Lin] Shanghai Jiao Tong Univ, Peoples Hosp 1, Ctr Expt Res, Shanghai 200080, Peoples R China; [Shou, Weinian] Indiana Univ, Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res,Riley Heart Res Ctr, Indianapolis, IN 46202 USA	Cleveland Clinic Foundation; Shanghai Jiao Tong University; Indiana University System; Indiana University-Purdue University Indianapolis	Bao, SD (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, 9500 Euclid Ave,NE30, Cleveland, OH 44195 USA.	baos@ccf.org	Rich, Jeremy/AAM-1445-2021	Guryanova, Olga/0000-0002-6514-8466	Cleveland Clinic Foundation; NIH [NS070315]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081092, P01HL085098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070315] Funding Source: NIH RePORTER	Cleveland Clinic Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members in the J.N.R. lab for helpful discussions and suggestions. We are also grateful to the Flow Cytometry Core, Imaging Core and Central Cell Services at Cleveland Clinic Lerner Research Institute for their help and services. This work was supported by a research fund from Cleveland Clinic Foundation and a NIH grant (NS070315) to S.B.	Abrajano JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007665; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Boutell C, 2005, J VIROL, V79, P12342, DOI 10.1128/JVI.79.19.12342-12354.2005; Buckley NJ, 2009, NATURE, V457, pE5, DOI 10.1038/nature07784; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Fuller GN, 2005, MOL CANCER THER, V4, P343; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Holowaty MN, 2003, J BIOL CHEM, V278, P29987, DOI 10.1074/jbc.M303977200; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Jorgensen HF, 2009, DEVELOPMENT, V136, P715, DOI 10.1242/dev.028548; Lawinger P, 2000, NAT MED, V6, P826, DOI 10.1038/77565; Lepagnol-Bestel AM, 2009, HUM MOL GENET, V18, P1405, DOI 10.1093/hmg/ddp047; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Su XH, 2006, MOL CELL BIOL, V26, P1666, DOI 10.1128/MCB.26.5.1666-1678.2006; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Yamada Y, 2010, CELL STEM CELL, V6, P10, DOI 10.1016/j.stem.2009.12.003; Zhang P, 2008, CURR BIOL, V18, P1489, DOI 10.1016/j.cub.2008.08.048; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	34	118	122	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2011	13	2					142	U91		10.1038/ncb2153	http://dx.doi.org/10.1038/ncb2153			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714JM	21258371	Green Accepted			2022-12-25	WOS:000286805900008
J	Momozawa, Y; Mni, M; Nakamura, K; Coppieters, W; Almer, S; Amininejad, L; Cleynen, I; Colombel, JF; de Rijk, P; Dewit, O; Finkel, Y; Gassull, MA; Goossens, D; Laukens, D; Lemann, M; Libioulle, C; O'Morain, C; Reenaers, C; Rutgeerts, P; Tysk, C; Zelenika, D; Lathrop, M; Del-Favero, J; Hugot, JP; de Vos, M; Franchimont, D; Vermeire, S; Louis, E; Georges, M				Momozawa, Yukihide; Mni, Myriam; Nakamura, Kayo; Coppieters, Wouter; Almer, Sven; Amininejad, Leila; Cleynen, Isabelle; Colombel, Jean-Frederic; de Rijk, Peter; Dewit, Olivier; Finkel, Yigael; Gassull, Miquel A.; Goossens, Dirk; Laukens, Debby; Lemann, Marc; Libioulle, Cecile; O'Morain, Colm; Reenaers, Catherine; Rutgeerts, Paul; Tysk, Curt; Zelenika, Diana; Lathrop, Mark; Del-Favero, Jurgen; Hugot, Jean-Pierre; de Vos, Martine; Franchimont, Denis; Vermeire, Severine; Louis, Edouard; Georges, Michel			Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RARE VARIANTS; COMPLEX DISEASES; CROHNS-DISEASE; SUSCEPTIBILITY; GENES; HERITABILITY; CONTRIBUTE; COMMON; SNPS	Genome-wide association studies (GWAS) have identified dozens of risk loci for many complex disorders, including Crohn's disease(1,2). However, common disease-associated SNPs explain at most similar to 20% of the genetic variance for Crohn's disease. Several factors may account for this unexplained heritability(3-5), including rare risk variants not adequately tagged thus far in GWAS(6-8). That rare susceptibility variants indeed contribute to variation in multifactorial phenotypes has been demonstrated for colorectal cancer(9), plasma high-density lipoprotein cholesterol levels(10), blood pressure(11), type 1 diabetes(12), hypertriglyceridemia(13) and, in the case of Crohn's disease, for NOD2 (refs. 14,15). Here we describe the use of high-throughput resequencing of DNA pools to search for rare coding variants influencing susceptibility to Crohn's disease in 63 GWAS-identified positional candidate genes. We identify low frequency coding variants conferring protection against inflammatory bowel disease in IL23R, but we conclude that rare coding variants in positional candidates do not make a large contribution to inherited predisposition to Crohn's disease.	[Momozawa, Yukihide; Mni, Myriam; Nakamura, Kayo; Coppieters, Wouter; Libioulle, Cecile; Georges, Michel] Grp Interdisciplinaire Genoprote Appliquee GIGA R, Unit Anim Genom, Liege, Belgium; [Momozawa, Yukihide; Mni, Myriam; Nakamura, Kayo; Coppieters, Wouter; Libioulle, Cecile; Georges, Michel] Univ Liege B34, Fac Vet Med, Liege, Belgium; [Almer, Sven] Linkopings Univ, Inst Mol & Klin Med IMK, Div Gastroenterol & Hepatol, Linkoping, Sweden; [Amininejad, Leila; Franchimont, Denis] Univ Libre Brussels, Erasme Hosp, Dept Gastroenterol, Brussels, Belgium; [Cleynen, Isabelle; Rutgeerts, Paul; Vermeire, Severine] Catholic Univ Louvain, Dept Pathophysiol, Gastroenterol Sect, B-3000 Louvain, Belgium; [Colombel, Jean-Frederic] Hop Calmette, Registre MICI Nord Quest France EPIMAD, Lille, France; [de Rijk, Peter; Goossens, Dirk; Del-Favero, Jurgen] Univ Antwerp VIB, Dept Mol Genet, B-2610 Antwerp, Belgium; [Dewit, Olivier] Catholic Univ Louvain, Clin Univ St Luc, Dept Gastroenterol, B-1200 Brussels, Belgium; [Finkel, Yigael] Karolinska Childrens Hosp, Dept Gastroenterol, Stockholm, Sweden; [Gassull, Miquel A.] Hosp Badalona Germans Trias & Pujol, Dept Gastroenterol, Badalona, Spain; [Laukens, Debby; de Vos, Martine] Univ Ghent, Univ Hosp, Dept Gastroenterol, B-9000 Ghent, Belgium; [Lemann, Marc] Univ Paris 07, Hop St Louis, AP HP, Dept Gastroenterol, Paris, France; [O'Morain, Colm] Adelaide & Meath Hosp, Dublin, Ireland; [Reenaers, Catherine; Louis, Edouard] GIGA R, Unit Hepatogastroenterol, Liege, Belgium; [Reenaers, Catherine; Louis, Edouard] Univ Liege B34, Fac Med, Liege, Belgium; [Tysk, Curt] Orebro Med Ctr Hosp, Dept Gastroenterol, S-70185 Orebro, Sweden; [Zelenika, Diana; Lathrop, Mark] Ctr Natl Genotypage, Evry, France; [Hugot, Jean-Pierre] Hop Robert Debre, INSERM, U843, F-75019 Paris, France	University of Liege; Linkoping University; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Catholique Louvain; Universite de Lille - ISITE; CHU Lille; Flanders Institute for Biotechnology (VIB); University of Antwerp; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Karolinska Institutet; Karolinska University Hospital; Hospital Germans Trias i Pujol; Ghent University; Ghent University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Trinity College Dublin; University of Liege; CEA; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Georges, M (corresponding author), Grp Interdisciplinaire Genoprote Appliquee GIGA R, Unit Anim Genom, Liege, Belgium.	michel.georges@ulg.ac.be	Hugot, Jean-Pierre/F-6594-2012; De Rijk, Peter/GXH-9837-2022; Coppieters, Wouter/AAF-5030-2021; Momozawa, Yukihide/N-6453-2015	De Rijk, Peter/0000-0001-8558-9288; Coppieters, Wouter/0000-0001-8109-7825; Goossens, Dirk/0000-0002-2080-7464; Almer, Sven/0000-0001-9334-1821; Laukens, Debby/0000-0002-1984-5850; Vermeire, Severine/0000-0001-9942-3019; Georges, Michel/0000-0003-4124-2375; Del Favero, jurgen/0000-0002-7427-7489; Hugot, Jean-Pierre/0000-0002-8446-6056	Walloon Region; Politique Scientifique Federale (IAP GENFUNC); Fonds National de la Recherche Scientifique (FNRS); Communaute Francaise de Belgique (ARC BIOMOD); University of Liege	Walloon Region; Politique Scientifique Federale (IAP GENFUNC); Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Communaute Francaise de Belgique (ARC BIOMOD); University of Liege(University of Liege)	This work was funded by the Walloon Region (IPSEQ, Crohn & CIBLES projects), by the Politique Scientifique Federale (IAP GENFUNC), by the Fonds National de la Recherche Scientifique (FNRS) and by the Communaute Francaise de Belgique (ARC BIOMOD). E.L. is a senior research associate from the FNRS. K.N. benefitted from a post-doctoral fellowship from the University of Liege. We are grateful to A. Kvasz, F. Farnir and D. Baurain for their help with bioinformatic analyses. We thank the personnel of the Flanders Institute for Biotechnology (VIB) Genetic Service Facility (http://www.vibgeneticservicefacility.be) and the GIGA-R genotranscriptomic platform for their contribution to sequencing. We are grateful to N. Wray and P. Visscher for fruitful discussions.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fearnhead NS, 2004, P NATL ACAD SCI USA, V101, P15992, DOI 10.1073/pnas.0407187101; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kruglyak L, 2008, NAT REV GENET, V9, P314, DOI 10.1038/nrg2316; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rozen S, 2000, Methods Mol Biol, V132, P365; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	23	149	150	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2011	43	1					43	U58		10.1038/ng.733	http://dx.doi.org/10.1038/ng.733			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	699SQ	21151126	Green Published, Green Submitted			2022-12-25	WOS:000285683500013
J	Nilsson, EC; Storm, RJ; Bauer, J; Johansson, SMC; Lookene, A; Angstrom, J; Hedenstrom, M; Eriksson, TL; Frangsmyr, L; Rinaldi, S; Willison, HJ; Domellof, FP; Stehle, T; Arnberg, N				Nilsson, Emma C.; Storm, Rickard J.; Bauer, Johannes; Johansson, Susanne M. C.; Lookene, Aivar; Angstrom, Jonas; Hedenstrom, Mattias; Eriksson, Therese L.; Frangsmyr, Lars; Rinaldi, Simon; Willison, Hugh J.; Domellof, Fatima Pedrosa; Stehle, Thilo; Arnberg, Niklas			The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis	NATURE MEDICINE			English	Article							USES SIALIC-ACID; STRUCTURAL-ANALYSIS; BINDING; TYPE-37; TROPISM; VIRUS; SITE	Adenovirus type 37 (Ad37) is a leading cause of epidemic keratoconjunctivitis (EKC)(1,2), a severe and highly contagious ocular disease. Whereas most other adenoviruses infect cells by engaging CD46 or the coxsackie and adenovirus receptor (CAR), Ad37 binds previously unknown sialic acid-containing cell surface molecules(3,4). By glycan array screening, we show here that the receptor-recognizing knob domain of the Ad37 fiber protein specifically binds a branched hexasaccharide that is present in the GD1a ganglioside and that features two terminal sialic acids. Soluble GD1a glycan and GD1a-binding antibodies efficiently prevented Ad37 virions from binding and infecting corneal cells. Unexpectedly, the receptor is constituted by one or more glycoproteins containing the GD1a glycan motif rather than the ganglioside itself, as shown by binding, infection and flow cytometry experiments. Molecular modeling, nuclear magnetic resonance and X-ray crystallography reveal that the two terminal sialic acids dock into two of three previously established sialic acid-binding sites in the trimeric Ad37 knob. Surface plasmon resonance analysis shows that the knob-GD1a glycan interaction has high affinity. Our findings therefore form a basis for the design and development of sialic acid-containing antiviral drugs for topical treatment of EKC.	[Nilsson, Emma C.; Storm, Rickard J.; Johansson, Susanne M. C.; Eriksson, Therese L.; Frangsmyr, Lars; Arnberg, Niklas] Umea Univ, Div Virol, Dept Clin Microbiol, Umea, Sweden; [Bauer, Johannes; Stehle, Thilo] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Lookene, Aivar] Tallinn Univ Technol, Dept Chem, Tallinn, Estonia; [Angstrom, Jonas] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden; [Hedenstrom, Mattias] Umea Univ, Dept Chem, Umea, Sweden; [Rinaldi, Simon; Willison, Hugh J.] Univ Glasgow, Glasgow Biomed Res Ctr, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Domellof, Fatima Pedrosa] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [Arnberg, Niklas] Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden; [Domellof, Fatima Pedrosa] Umea Univ, Dept Clin Sci, Umea, Sweden	Umea University; Eberhard Karls University of Tubingen; Tallinn University of Technology; University of Gothenburg; Umea University; University of Glasgow; Umea University; Vanderbilt University; Umea University; Umea University	Arnberg, N (corresponding author), Umea Univ, Div Virol, Dept Clin Microbiol, Umea, Sweden.	niklas.arnberg@climi.umu.se	willison, hugh/HCI-7819-2022; Nilsson, Emma/HGB-0605-2022; Arnberg, Niklas/G-2663-2012; Arnberg, Niklas/K-5878-2019	Arnberg, Niklas/0000-0002-7069-6678; Rinaldi, Simon/0000-0003-2039-3457; Nilsson, Emma/0000-0001-8123-3292	National Institute of General Medical Sciences [GM62116]; Swedish Research Council [2007-3402, 2009-3859, 11612]; Swedish Foundation for Strategic Research [F06-0011]; Swedish Society of Medicine [97031]; Estonian Science Foundation [8300]; Collaborative Research Center [SFB-685]; University of Tubingen; Wellcome Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Society of Medicine; Estonian Science Foundation; Collaborative Research Center; University of Tubingen; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We highly appreciate the support from F. Lindh and S. Spjut regarding the purification of GD1a glycan; F. Lindh (Isosep) provided GD1a gangliosides. We also thank A. Carlsson (Medigelium) for providing GD1a-containing liposomes; D. Guilligay (EMBL) for providing the Ad37 knob gene cloned into pPROEX Htb plasmid (Life Technologies)<SUP>16</SUP>; R.L. Schnaar (The Johns Hopkins University School of Medicine) for providing P4 compounds; and K. Lindman, M. Hagg and F. Jamshidi for technical support. HCE cells were provided by K. Araki-Sasaki (Kinki Central Hospital). GM3 and GD2 glycans were provided by the Consortium for Functional Glycomics. We also highly appreciate the resources provided by the Consortium for Functional Glycomics (funded by National Institute of General Medical Sciences grant no. GM62116) Core D and H, as well as related technical support from O. Blixt and N. Reza. We are grateful to the Berlin Electron Storage Ring Society for Synchrotron Radiation (BESSY) for beamtime and beamline support. This project was supported by the Swedish Research Council (grants no. 2007-3402 (N.A.); 2009-3859 (N.A.) and 11612 (J.A. via M.E. Breimer)), the Swedish Foundation for Strategic Research (grant no. F06-0011 to N.A.), the Swedish Society of Medicine (grant no. 97031 to N.A.), the Estonian Science Foundation (grant 8300 to A.L.), the Collaborative Research Center SFB-685 (T.S.), a student fellowship from the University of Tubingen (J.B.) and The Wellcome Trust (S.R. and H.J.W.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Arnberg N, 1997, VIROLOGY, V227, P239, DOI 10.1006/viro.1996.8269; Arnberg N, 2000, J VIROL, V74, P7691, DOI 10.1128/JVI.74.16.7691-7693.2000; Arnberg N, 2000, J VIROL, V74, P42, DOI 10.1128/JVI.74.1.42-48.2000; Arnberg N, 2002, VIROLOGY, V302, P33, DOI 10.1006/viro.2002.1503; Arnberg N, 2002, J VIROL, V76, P8834, DOI 10.1128/JVI.76.17.8834-8841.2002; Arnberg N, 2009, REV MED VIROL, V19, P165, DOI 10.1002/rmv.612; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bewley MC, 1999, SCIENCE, V286, P1579, DOI 10.1126/science.286.5444.1579; Boffey J, 2005, J NEUROIMMUNOL, V165, P92, DOI 10.1016/j.jneuroim.2005.04.011; Burmeister WP, 2004, J VIROL, V78, P7727, DOI 10.1128/JVI.78.14.7727-7736.2004; Cashman SM, 2004, VIROLOGY, V324, P129, DOI 10.1016/j.virol.2004.04.001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FORD E, 1987, EPIDEMIOL REV, V9, P244, DOI 10.1093/oxfordjournals.epirev.a036304; Gordon Y., 1996, OCULAR INFECT IMMUNI, P877; Johansson SMC, 2007, ANTIVIR RES, V73, P92, DOI 10.1016/j.antiviral.2006.08.004; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Kinchington PR, 2005, J ANTIMICROB CHEMOTH, V55, P424, DOI 10.1093/jac/dki057; Kirby I, 2000, J VIROL, V74, P2804, DOI 10.1128/JVI.74.6.2804-2813.2000; Lecollinet S, 2006, J VIROL, V80, P2747, DOI 10.1128/JVI.80.6.2747-2759.2006; Lenaerts L, 2008, REV MED VIROL, V18, P357, DOI 10.1002/rmv.589; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Persson BD, 2007, NAT STRUCT MOL BIOL, V14, P164, DOI 10.1038/nsmb1190; Rinaldi S, 2009, GLYCOBIOLOGY, V19, P789, DOI 10.1093/glycob/cwp049; SAUTER NK, 1989, BIOCHEMISTRY-US, V28, P8388, DOI 10.1021/bi00447a018; Thirion C, 2006, HUM GENE THER, V17, P193, DOI 10.1089/hum.2006.17.193; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Wold W.S.M., 2007, FIELDS VIROLOGY, V7th, P2395; Wu E, 2004, J VIROL, V78, P3897, DOI 10.1128/JVI.78.8.3897-3905.2004	34	148	153	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					105	U279		10.1038/nm.2267	http://dx.doi.org/10.1038/nm.2267			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21151139				2022-12-25	WOS:000285994000042
J	Ye, JQ; Chen, SB; Maniatis, T				Ye, Junqiang; Chen, Shuibing; Maniatis, Tom			Cardiac glycosides are potent inhibitors of interferon-beta gene expression	NATURE CHEMICAL BIOLOGY			English	Article							DOUBLE-STRANDED-RNA; RIG-I; KAPPA-B; ANTIVIRAL RESPONSES; BINDING SITE; INNATE; ADAPTER; DOMAIN; ACTIVATION; INDUCTION	Here we report that bufalin and other cardiac glycoside inhibitors of the sodium-potassium ATPase (sodium pump) potently inhibit the induction of the interferon-beta (IFN beta) gene by virus, double-stranded RNA or double-stranded DNA. Cardiac glycosides increase the intracellular sodium concentration, which appears to inhibit the ATPase activity of the RNA sensor RIG-I, an essential and early component in the IFN beta activation pathway. This, in turn, prevents the activation of the critical transcription factors IRF3 and NF kappa B. Bufalin inhibition can be overcome by expressing a drug-resistant variant of the sodium pump and knocking down the pump by short hairpin RNA inhibits IFN beta expression. Thus, bufalin acts exclusively through the sodium pump. We also show that bufalin inhibits tumor necrosis factor (TNF) signaling, at least in part by interfering with the nuclear translocation of NF kappa B. These findings suggest that bufalin could be used to treat inflammatory and autoimmune diseases in which IFN or TNF are hyperactivated.	[Ye, Junqiang; Maniatis, Tom] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; [Chen, Shuibing] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Maniatis, T (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10027 USA.	tm2472@mail.cumc.columbia.edu		Ye, Junqiang/0000-0002-4529-0713	US National Institutes of Health [5R01AI020642-26]; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020642] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by US National Institutes of Health grant 5R01AI020642-26 (to T. M.). S. C. is supported by the postdoctoral fellowship from Juvenile Diabetes Research Foundation. We thank X. Sun (Brandeis University) for help with the microarray analysis. We also thank S.-L. Ng for critical reading of this manuscript and S. Schalm for helpful discussions.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Ford E, 2010, BBA-GENE REGUL MECH, V1799, P328, DOI 10.1016/j.bbagrm.2010.01.010; Fujita T, 2009, IMMUNITY, V31, P4, DOI 10.1016/j.immuni.2009.06.014; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2010, J VIROL, V84, P3220, DOI 10.1128/JVI.02241-09; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; GARVIN JL, 1985, J MEMBRANE BIOL, V87, P45, DOI 10.1007/BF01870698; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Hall JC, 2010, NAT REV RHEUMATOL, V6, P40, DOI 10.1038/nrrheum.2009.237; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; IZQUIERDO I, 1990, TRENDS PHARMACOL SCI, V11, P309, DOI 10.1016/0165-6147(90)90229-2; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; LANGER GA, 1977, ANNU REV MED, V28, P13, DOI 10.1146/annurev.me.28.020177.000305; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Meng ZQ, 2009, CANCER-AM CANCER SOC, V115, P5309, DOI 10.1002/cncr.24602; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; OHTSUBO M, 1990, BIOCHIM BIOPHYS ACTA, V1021, P157, DOI 10.1016/0005-2736(90)90028-M; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Ronnblom L, 2010, NAT REV RHEUMATOL, V6, P339, DOI 10.1038/nrrheum.2010.64; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Simpson CD, 2009, CANCER RES, V69, P2739, DOI 10.1158/0008-5472.CAN-08-2530; Sun LJ, 2010, CELL, V140, P436, DOI 10.1016/j.cell.2010.01.041; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; TRUBE G, 1986, PFLUG ARCH EUR J PHY, V407, P493, DOI 10.1007/BF00657506; WHITTEMORE LA, 1990, MOL CELL BIOL, V10, P1329, DOI 10.1128/MCB.10.4.1329; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; Yang QF, 2005, P NATL ACAD SCI USA, V102, P9631, DOI 10.1073/pnas.0504097102; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	48	40	44	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2011	7	1					25	33		10.1038/NCHEMBIO.476	http://dx.doi.org/10.1038/NCHEMBIO.476			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	695PA	21076398	Green Accepted			2022-12-25	WOS:000285383400009
J	Choi, HS; Ashitate, Y; Lee, JH; Kim, SH; Matsui, A; Insin, N; Bawendi, MG; Semmler-Behnke, M; Frangioni, JV; Tsuda, A				Choi, Hak Soo; Ashitate, Yoshitomo; Lee, Jeong Heon; Kim, Soon Hee; Matsui, Aya; Insin, Numpon; Bawendi, Moungi G.; Semmler-Behnke, Manuela; Frangioni, John V.; Tsuda, Akira			Rapid translocation of nanoparticles from the lung airspaces to the body	NATURE BIOTECHNOLOGY			English	Article							INSOLUBLE IRIDIUM PARTICLES; QUANTUM DOTS; ULTRAFINE PARTICLES; CLEARANCE; BIODISTRIBUTION; MACROPHAGES; ORGANS	Nano-size particles show promise for pulmonary drug delivery, yet their behavior after deposition in the lung remains poorly understood. In this study, a series of near-infrared (NIR) fluorescent nanoparticles were systematically varied in chemical composition, shape, size and surface charge, and their biodistribution and elimination were quantified in rat models after lung instillation. We demonstrate that nanoparticles with hydrodynamic diameter (HD) less than approximate to 34 nm and a noncationic surface charge translocate rapidly from the lung to mediastinal lymph nodes. Nanoparticles of HD <6 nm can traffic rapidly from the lungs to lymph nodes and the bloodstream, and then be subsequently cleared by the kidneys. We discuss the importance of these findings for drug delivery, air pollution and carcinogenesis.	[Choi, Hak Soo; Ashitate, Yoshitomo; Lee, Jeong Heon; Kim, Soon Hee; Matsui, Aya; Frangioni, John V.] Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA; [Insin, Numpon; Bawendi, Moungi G.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Semmler-Behnke, Manuela] German Res Ctr Environm Hlth, Helmholtz Ctr Munchen, Inst Lung Biol & Dis, Neuherberg, Germany; [Frangioni, John V.] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA; [Tsuda, Akira] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Massachusetts Institute of Technology (MIT); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health	Frangioni, JV (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA.	jfrangio@bidmc.harvard.edu; atsuda@hsph.harvard.edu	Choi, Hak Soo/C-9954-2011; Kim, Soon Hee/GXF-6736-2022		NIH [HL054885, HL070542, HL074022, R01-CA-115296]; NATIONAL CANCER INSTITUTE [R01CA115296] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054885, R01HL070542, R01HL074022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Oketokoun and S. Gioux for help with developing the FLARE imaging system and E.P. Lunsford of the Longwood Small Animal Imaging Facility for assistance with SPECT/CT imaging. The Biophysical Instrumentation Facility for the Study of Complex Macromolecular Systems (National Science Foundation-0070319 and US National Institutes of Health (NIH) GM68762) is gratefully acknowledged. We thank W. Liu and B.I. Ipe for providing quantum dots, L. Moffitt for editing, and L. Keys and E. Trabucchi for administrative support. This work was supported in part by NIH grant HL054885 (A.T.), HL070542 (A.T.), HL074022 (A.T.) and R01-CA-115296 (J.V.F.).	Brown DM, 2001, TOXICOL APPL PHARM, V175, P191, DOI 10.1006/taap.2001.9240; Burns AA, 2009, NANO LETT, V9, P442, DOI 10.1021/nl803405h; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Choi HS, 2010, MOL IMAGING, V9, P291, DOI 10.2310/7290.2010.00031; Choi HS, 2010, NAT NANOTECHNOL, V5, P42, DOI [10.1038/NNANO.2009.314, 10.1038/nnano.2009.314]; Choi HS, 2009, NANO LETT, V9, P2354, DOI 10.1021/nl900872r; Courrier HM, 2002, CRIT REV THER DRUG, V19, P425, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i45.40; Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Geiser M, 2008, AM J RESP CELL MOL, V38, P371, DOI 10.1165/rcmb.2007-0138OC; Gioux S, 2009, MOL IMAGING, V8, P156, DOI 10.2310/7290.2009.00009; HARMSEN AG, 1985, SCIENCE, V230, P1277, DOI 10.1126/science.4071052; Insin N, 2008, ACS NANO, V2, P197, DOI 10.1021/nn700344x; Janib S. M., 2010, ADV DRUG DELIV REV, V3, P1; Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920; Kreyling WG, 2002, J TOXICOL ENV HEAL A, V65, P1513, DOI 10.1080/00984100290071649; Liu WH, 2007, J AM CHEM SOC, V129, P14530, DOI 10.1021/ja073790m; Mills NL, 2009, NAT CLIN PRACT CARD, V6, P36, DOI 10.1038/ncpcardio1399; Moller W, 2008, AM J RESP CRIT CARE, V177, P426, DOI 10.1164/rccm.200602-301OC; Nemmar A, 2002, AM J RESP CRIT CARE, V166, P998, DOI 10.1164/rccm.200110-026OC; Oberdorster G, 2001, INT ARCH OCC ENV HEA, V74, P1; Semmler M, 2004, INHAL TOXICOL, V16, P453, DOI 10.1080/08958370490439650; Semmler-Behnke M, 2008, SMALL, V4, P2108, DOI 10.1002/smll.200800922; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; Tsuda A, 2002, P NATL ACAD SCI USA, V99, P10173, DOI 10.1073/pnas.102318299; Wichmann H E, 2000, Res Rep Health Eff Inst, P5; WICHMANN HE, 2000, RES REP HLTH EFF I, P87; Zhang LW, 2009, TOXICOL SCI, V110, P138, DOI 10.1093/toxsci/kfp087; Zrazhevskiy P., 2010, CHEM SOC REV, V3, P1	29	440	449	7	180	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2010	28	12					1300	U113		10.1038/nbt.1696	http://dx.doi.org/10.1038/nbt.1696			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	691NP	21057497	Green Submitted, Green Accepted			2022-12-25	WOS:000285088400025
J	[Anonymous]				[Anonymous]			Microglial pilgrimage to the brain	NATURE MEDICINE			English	Editorial Material							CELLS; DERIVE; MICE											Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Lebson L, 2010, J NEUROSCI, V30, P9651, DOI 10.1523/JNEUROSCI.0329-10.2010; Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615	7	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1380	1380		10.1038/nm1210-1380	http://dx.doi.org/10.1038/nm1210-1380			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21135848				2022-12-25	WOS:000285048900024
J	Boehlke, C; Kotsis, F; Patel, V; Braeg, S; Voelker, H; Bredt, S; Beyer, T; Janusch, H; Hamann, C; Godel, M; Muller, K; Herbst, M; Hornung, M; Doerken, M; Kottgen, M; Nitschke, R; Igarashi, P; Walz, G; Kuehn, EW				Boehlke, Christopher; Kotsis, Fruzsina; Patel, Vishal; Braeg, Simone; Voelker, Henriette; Bredt, Saskia; Beyer, Theresa; Janusch, Heike; Hamann, Christoph; Goedel, Markus; Mueller, Klaus; Herbst, Martin; Hornung, Miriam; Doerken, Mara; Koettgen, Michael; Nitschke, Roland; Igarashi, Peter; Walz, Gerd; Kuehn, E. Wolfgang			Primary cilia regulate mTORC1 activity and cell size through Lkb1	NATURE CELL BIOLOGY			English	Article							POLYCYSTIC KIDNEY-DISEASE; CYST FORMATION; MECHANISMS; POLARITY; COMPLEX; GROWTH; PHOSPHORYLATION; TARGET; RAPTOR; GENE	The mTOR pathway is the central regulator of cell size(1). External signals from growth factors and nutrients converge on the mTORC1 multi-protein complex to modulate downstream targets, but how the different inputs are integrated and translated into specific cellular responses is incompletely understood(2-4). Deregulation of the mTOR pathway occurs in polycystic kidney disease (PKD)(5-7), where cilia (filiform sensory organelles) fail to sense urine flow because of inherited mutations in ciliary proteins(8). We therefore investigated if cilia have a role in mTOR regulation. Here, we show that ablation of cilia in transgenic mice results in enlarged cells when compared with control animals. In vitro analysis demonstrated that bending of the cilia by flow is required for mTOR downregulation and cell-size control. Surprisingly, regulation of cell size by cilia is independent of flow-induced calcium transients, or Akt. However, the tumour-suppressor protein Lkb1 localises in the cilium, and flow results in increased AMPK phosphorylation at the basal body. Conversely, knockdown of Lkb1 prevents normal cell-size regulation under flow conditions. Our results demonstrate that the cilium regulates mTOR signalling and cell size, and identify the cilium-basal body compartment as a spatially restricted activation site for Lkb1 signalling.	[Boehlke, Christopher; Kotsis, Fruzsina; Braeg, Simone; Voelker, Henriette; Bredt, Saskia; Beyer, Theresa; Janusch, Heike; Hamann, Christoph; Goedel, Markus; Mueller, Klaus; Herbst, Martin; Hornung, Miriam; Doerken, Mara; Koettgen, Michael; Walz, Gerd; Kuehn, E. Wolfgang] Univ Freiburg, Renal Unit, Dept Med, Univ Med Ctr, D-79106 Freiburg, Germany; [Patel, Vishal; Igarashi, Peter] Univ Texas Dallas, SW Med Ctr, Div Nephrol, Dallas, TX 75390 USA; [Nitschke, Roland] Univ Freiburg, Life Imaging Ctr, Ctr Biol Syst Anal, D-79104 Freiburg, Germany; [Nitschke, Roland] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79108 Freiburg, Germany	University of Freiburg; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Freiburg; University of Freiburg	Kuehn, EW (corresponding author), Univ Freiburg, Renal Unit, Dept Med, Univ Med Ctr, Hugstetter Str 55, D-79106 Freiburg, Germany.	wolfgang.kuehn@uniklinik-freiburg.de	Patel, Vishal/GMW-7076-2022; Nitschke, Roland/F-9525-2010; Boehlke, Christopher/AAZ-6627-2021	Patel, Vishal/0000-0003-2875-4659; Nitschke, Roland/0000-0002-9397-8475; Boehlke, Christopher/0000-0002-6985-0201; Kottgen, Michael/0000-0003-2406-5039; Igarashi, Peter/0000-0001-8698-1185	DFG [KFO 201, WA597, SFB 592, SFB 592 Z2]; Excellence Initiative of the German Federal and State Governments [EXC 294]; NIH [P30DK79328, R01DK67565, T32DK07257]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067565, T32DK007257, P30DK079328] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants DFG KFO 201 (to E.W.K.), WA597 and SFB 592 (to G.W.), SFB 592 Z2 and by the Excellence Initiative of the German Federal and State Governments (EXC 294 to R.N.), and NIH grants P30DK79328, R01DK67565 and T32DK07257 (to P.I.). We thank B. Yoder for anti-sera, R. Lamb, H. Clevers, Y. Mimori-Kiyosue, M. Sebbagh and A. Miyawaki for constructs, S. Arnold, M. Simons, D. Bennet and M. Bloech for critical appraisal of the manuscript and S. Lienkamp, F. Grahammer and members of the Walz lab for helpful discussions.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Distefano G, 2009, MOL CELL BIOL, V29, P2359, DOI 10.1128/MCB.01259-08; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; GRANTHAM JJ, 1987, KIDNEY INT, V31, P1145, DOI 10.1038/ki.1987.121; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Kotsis F, 2008, PFLUG ARCH EUR J PHY, V456, P1025, DOI 10.1007/s00424-008-0475-8; Kotsis F, 2007, PFLUG ARCH EUR J PHY, V453, P819, DOI 10.1007/s00424-006-0168-0; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Liu W, 2003, AM J PHYSIOL-RENAL, V285, pF998, DOI 10.1152/ajprenal.00067.2003; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maekawa F, 2000, ENDOCRINOLOGY, V141, P375, DOI 10.1210/en.141.1.375; Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Rekas A, 2002, J BIOL CHEM, V277, P50573, DOI 10.1074/jbc.M209524200; Sebbagh M, 2009, CURR BIOL, V19, P37, DOI 10.1016/j.cub.2008.11.033; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; VAN L, 2006, J BIOL CHEM */* RHEB, V281, P19793; Wahl PR, 2006, NEPHROL DIAL TRANSPL, V21, P598, DOI 10.1093/ndt/gfi181; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie ZL, 2009, MOL CELL BIOL, V29, P3582, DOI 10.1128/MCB.01417-08; Zhang QH, 2005, LAB INVEST, V85, P45, DOI 10.1038/labinvest.3700207	44	248	255	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2010	12	11					1115	U126		10.1038/ncb2117	http://dx.doi.org/10.1038/ncb2117			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	674CO	20972424	Green Accepted			2022-12-25	WOS:000283711500016
J	Igawa, T; Ishii, S; Tachibana, T; Maeda, A; Higuchi, Y; Shimaoka, S; Moriyama, C; Watanabe, T; Takubo, R; Doi, Y; Wakabayashi, T; Hayasaka, A; Kadono, S; Miyazaki, T; Haraya, K; Sekimori, Y; Kojima, T; Nabuchi, Y; Aso, Y; Kawabe, Y; Hattori, K				Igawa, Tomoyuki; Ishii, Shinya; Tachibana, Tatsuhiko; Maeda, Atsuhiko; Higuchi, Yoshinobu; Shimaoka, Shin; Moriyama, Chifumi; Watanabe, Tomoyuki; Takubo, Ryoko; Doi, Yoshiaki; Wakabayashi, Tetsuya; Hayasaka, Akira; Kadono, Shoujiro; Miyazaki, Takuya; Haraya, Kenta; Sekimori, Yasuo; Kojima, Tetsuo; Nabuchi, Yoshiaki; Aso, Yoshinori; Kawabe, Yoshiki; Hattori, Kunihiro			Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization	NATURE BIOTECHNOLOGY			English	Article							NEONATAL FC-RECEPTOR; THERAPEUTIC MONOCLONAL-ANTIBODIES; INTERLEUKIN-6 RECEPTOR; RHEUMATOID-ARTHRITIS; HALF-LIFE; TOCILIZUMAB; PHARMACOKINETICS; INFLAMMATION; MECHANISMS; CYTOKINES	For many antibodies, each antigen-binding site binds to only one antigen molecule during the antibody's lifetime in plasma. To increase the number of cycles of antigen binding and lysosomal degradation, we engineered tocilizumab (Actemra)(1), an antibody against the IL-6 receptor (IL-6R), to rapidly dissociate from IL-6R within the acidic environment of the endosome (pH 6.0) while maintaining its binding affinity to IL-6R in plasma (pH 7.4). Studies using normal mice and mice expressing human IL-6R(2) suggested that this pH-dependent IL-6R dissociation within the acidic environment of the endosome resulted in lysosomal degradation of the previously bound IL-6R while releasing the free antibody back to the plasma to bind another IL-6R molecule. In cynomolgus monkeys, an antibody with pH-dependent antigen binding, but not an affinity-matured variant, significantly improved the pharmacokinetics and duration of C-reactive protein inhibition. Engineering pH dependency into the interactions of therapeutic antibodies with their targets may enable them to be delivered less frequently or at lower doses.	[Igawa, Tomoyuki; Ishii, Shinya; Tachibana, Tatsuhiko; Maeda, Atsuhiko; Higuchi, Yoshinobu; Shimaoka, Shin; Moriyama, Chifumi; Watanabe, Tomoyuki; Takubo, Ryoko; Doi, Yoshiaki; Wakabayashi, Tetsuya; Hayasaka, Akira; Kadono, Shoujiro; Miyazaki, Takuya; Haraya, Kenta; Sekimori, Yasuo; Kojima, Tetsuo; Nabuchi, Yoshiaki; Aso, Yoshinori; Kawabe, Yoshiki; Hattori, Kunihiro] Chugai Pharmaceut Co Ltd, Fuji Gotemba Res Labs, Shizuoka, Japan	Chugai Pharmaceutical Co., Ltd.; Roche Holding	Igawa, T (corresponding author), Chugai Pharmaceut Co Ltd, Fuji Gotemba Res Labs, Shizuoka, Japan.	igawatmy@chugai-pharm.co.jp	HARAYA, KENTA/AAW-4267-2020	HARAYA, KENTA/0000-0002-9142-5607; Kawabe, Yoshiki/0000-0002-6465-7146; Tachibana, Tatsuhiko/0000-0001-8339-3986				Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Bostrom Jenny, 2009, V525, P353, DOI 10.1007/978-1-59745-554-1_19; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Deng R, 2010, DRUG METAB DISPOS, V38, P600, DOI 10.1124/dmd.109.031310; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Genovese MC, 2008, ARTHRITIS RHEUM-US, V58, P2968, DOI 10.1002/art.23940; GERHARTZ C, 1994, EUR J BIOCHEM, V223, P265, DOI 10.1111/j.1432-1033.1994.tb18991.x; HIROTA H, 1995, P NATL ACAD SCI USA, V92, P4862, DOI 10.1073/pnas.92.11.4862; Kelley SK, 2006, BRIT J PHARMACOL, V148, P1116, DOI 10.1038/sj.bjp.0706828; Maeda K, 2002, J CONTROL RELEASE, V82, P71, DOI 10.1016/S0168-3659(02)00126-8; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mihara M, 2004, J RHEUMATOL, V31, P1132; Mircic M, 2009, DRUG TODAY, V45, P189, DOI 10.1358/dot.2009.45.3.1343794; Ng CM, 2006, PHARM RES-DORDR, V23, P95, DOI 10.1007/s11095-005-8814-3; Ohsugi Y, 2008, EXPERT OPIN BIOL TH, V8, P669, DOI 10.1517/14712598.8.5.669 ; Okazaki M, 2002, IMMUNOL LETT, V84, P231, DOI 10.1016/S0165-2478(02)00202-X; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Sarkar CA, 2002, NAT BIOTECHNOL, V20, P908, DOI 10.1038/nbt725; SATO K, 1993, CANCER RES, V53, P851; Shinkura H, 1998, ANTICANCER RES, V18, P1217; Tabrizi MA, 2006, DRUG DISCOV TODAY, V11, P81, DOI 10.1016/S1359-6446(05)03638-X; Tabrizi M, 2010, AAPS J, V12, P33, DOI 10.1208/s12248-009-9157-5; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; YASUKAWA K, 1990, J BIOCHEM-TOKYO, V108, P673, DOI 10.1093/oxfordjournals.jbchem.a123261; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601	27	220	304	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2010	28	11					1203	U96		10.1038/nbt.1691	http://dx.doi.org/10.1038/nbt.1691			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	676PI	20953198				2022-12-25	WOS:000283924100023
J	Chuikov, S; Levi, BP; Smith, ML; Morrison, SJ				Chuikov, Sergei; Levi, Boaz P.; Smith, Michael L.; Morrison, Sean J.			Prdm16 promotes stem cell maintenance in multiple tissues, partly by regulating oxidative stress	NATURE CELL BIOLOGY			English	Article							HEMATOPOIETIC STEM; PROGENITOR CELLS; SELF-RENEWAL; MICE; HOMEOSTASIS; PATHWAYS; FAMILY; GENES; FOXOS; LGR5	To better understand the mechanisms that regulate stem cell identity and function, we sought to identify genes that are preferentially expressed by stem cells and critical for their function in multiple tissues. Prdm16 is a transcription factor that regulates leukaemogenesis(1), palatogenesis(2) and brown-fat development(3-5), but which was not known to be required for stem cell function. We demonstrate that Prdm16 is preferentially expressed by stem cells throughout the nervous and haematopoietic systems and is required for their maintenance. In the haematopoietic and nervous systems, Prdm16 deficiency led to changes in the levels of reactive oxygen species (ROS), depletion of stem cells, increased cell death and altered cell-cycle distribution. In neural stem/progenitor cells, Prdm16 binds to the Hgf promoter, and Hgf expression declined in the absence of Prdm16. Addition of recombinant HGF to Prdm16-deficient neural stem cells in cell culture reduced the depletion of these cells and partially rescued the increase in ROS levels. Administration of the anti-oxidant, N-acetyl-cysteine, to Prdm16-deficient mice partially rescued defects in neural stem/progenitor cell function and neural development. Prdm16 therefore promotes stem cell maintenance in multiple tissues, partly by modulating oxidative stress.	[Chuikov, Sergei; Levi, Boaz P.; Smith, Michael L.; Morrison, Sean J.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Chuikov, Sergei; Levi, Boaz P.; Smith, Michael L.; Morrison, Sean J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Chuikov, Sergei; Levi, Boaz P.; Smith, Michael L.; Morrison, Sean J.] Univ Michigan, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329	Howard Hughes Medical Institute; National Institutes of Neurological Disease and Stroke [NS40750]; Leukemia and Lymphoma Society; American Heart Association [0725726Z]; Irvington Institute-Cancer Research Institute; UM-Comprehensive Cancer, NIH [CA46592]; Rheumatic Core Disease Center [P30 AR48310]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040750] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Neurological Disease and Stroke; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Heart Association(American Heart Association); Irvington Institute-Cancer Research Institute; UM-Comprehensive Cancer, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rheumatic Core Disease Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Howard Hughes Medical Institute and by the National Institutes of Neurological Disease and Stroke (NS40750). S. C. was supported by a career development award from the Leukemia and Lymphoma Society. B.P.L. was supported by an American Heart Association Postdoctoral Fellowship (0725726Z) and an Irvington Institute-Cancer Research Institute/Edmond J. Safra Memorial Fellowship. Flow-cytometry work was partially supported by the UM-Comprehensive Cancer, NIH CA46592. We thank M. White and D. Adams for flow-cytometry assistance, G. Wendt for technical assistance, and E. Smith (Hybridoma Core Facility) for antibody production, partially supported through the Rheumatic Core Disease Center (P30 AR48310).	Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Deneault E, 2009, CELL, V137, P369, DOI 10.1016/j.cell.2009.03.026; Du Y, 2005, BLOOD, V106, P3932, DOI 10.1182/blood-2005-03-1113; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kiel MJ, 2008, BLOOD, V111, P4413, DOI 10.1182/blood-2007-12-129601; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Morishita K, 2007, INT J HEMATOL, V85, P279, DOI 10.1532/IJH97.06174; Murholm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008458; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Ozaki M, 2003, CELL DEATH DIFFER, V10, P508, DOI 10.1038/sj.cdd.4401172; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Ren T, 2007, J NEUROSCI, V27, P10345, DOI 10.1523/JNEUROSCI.2787-07.2007; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; West AK, 2008, NEUROTOXICOLOGY, V29, P489, DOI 10.1016/j.neuro.2007.12.006; Yoon YS, 2005, ONCOGENE, V24, P1895, DOI 10.1038/sj.onc.1208262	29	148	151	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					999	1006		10.1038/ncb2101	http://dx.doi.org/10.1038/ncb2101			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20835244	Green Accepted			2022-12-25	WOS:000282363500015
J	van Steensel, B; Dekker, J				van Steensel, Bas; Dekker, Job			Genomics tools for unraveling chromosome architecture	NATURE BIOTECHNOLOGY			English	Review							NUCLEAR LAMINA INTERACTIONS; BETA-GLOBIN LOCUS; CHROMATIN INTERACTIONS; CONFORMATION CAPTURE; GENE-EXPRESSION; DNA INTERACTIONS; PORE COMPLEXES; X-INACTIVATION; ORGANIZATION; TRANSCRIPTION	The spatial organization of chromosomes inside the cell nucleus is still poorly understood. This organization is guided by intra- and interchromosomal contacts and by interactions of specific chromosomal loci with relatively fixed nuclear 'landmarks' such as the nuclear envelope and the nucleolus. Researchers have begun to use new molecular genome-wide mapping techniques to uncover both types of molecular interactions, providing insights into the fundamental principles of interphase chromosome folding.	[van Steensel, Bas] Netherlands Canc Inst, Div Gene Regulat, Amsterdam, Netherlands; [Dekker, Job] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Dept Biochem & Mol Pharmacol, Worcester, MA USA	Netherlands Cancer Institute; University of Massachusetts System; University of Massachusetts Worcester	van Steensel, B (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Amsterdam, Netherlands.	b.v.steensel@nki.nl; job.dekker@umassmed.edu			Netherlands Genomics Initiative; Netherlands Organization for Scientific Research-Earth and Life Sciences (NWO-ALW); US National Institutes of Health [HG003143]; W. M. Keck Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	Netherlands Genomics Initiative; Netherlands Organization for Scientific Research-Earth and Life Sciences (NWO-ALW)(Netherlands Organization for Scientific Research (NWO)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank members of the van Steensel and Dekker labs and M. Walhout for suggestions. This work was supported by the Netherlands Genomics Initiative and an Netherlands Organization for Scientific Research-Earth and Life Sciences (NWO-ALW) VICI grant to B. v. S., a grant from the US National Institutes of Health (HG003143) and a W. M. Keck Foundation Distinguished Young Scholar Award to J.D.	Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Brown CR, 2008, GENE DEV, V22, P627, DOI 10.1101/gad.1632708; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chuang CH, 2007, SEMIN CELL DEV BIOL, V18, P698, DOI 10.1016/j.semcdb.2007.08.012; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2008, J BIOL CHEM, V283, P34532, DOI 10.1074/jbc.M806479200; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Fedorova E, 2009, CURR OPIN GENET DEV, V19, P166, DOI 10.1016/j.gde.2009.02.003; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; FRANKE WW, 1974, INT REV CYTOL, P71; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Greil F, 2006, METHOD ENZYMOL, V410, P342, DOI 10.1016/S0076-6879(06)10016-6; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Harewood L, 2010, GENOME RES, V20, P554, DOI 10.1101/gr.103622.109; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Hetzer MW, 2009, DEV CELL, V17, P606, DOI 10.1016/j.devcel.2009.10.007; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; Miele A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000478; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Nemeth A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000889; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Pombo A, 2007, CURR OPIN GENET DEV, V17, P451, DOI 10.1016/j.gde.2007.08.008; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Rodley CDM, 2009, FUNGAL GENET BIOL, V46, P879, DOI 10.1016/j.fgb.2009.07.006; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Sandhu KS, 2009, GENE DEV, V23, P2598, DOI 10.1101/gad.552109; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; Shopland LS, 2006, J CELL BIOL, V174, P27, DOI 10.1083/jcb.200603083; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Simonis M, 2009, NAT METHODS, V6, P837, DOI [10.1038/NMETH.1391, 10.1038/nmeth.1391]; Soutoglou E, 2007, CURR OPIN GENET DEV, V17, P435, DOI 10.1016/j.gde.2007.08.004; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; STAHL A, 1976, HUM GENET, V35, P27, DOI 10.1007/BF00295616; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Taddei A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000612; Taimen P, 2009, P NATL ACAD SCI USA, V106, P20788, DOI 10.1073/pnas.0911895106; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Tiwari VK, 2008, GENOME RES, V18, P1171, DOI 10.1101/gr.073452.107; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vaquerizas JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000846; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5; Yokochi T, 2009, P NATL ACAD SCI USA, V106, P19363, DOI 10.1073/pnas.0906142106; Zhao R, 2009, CURR OPIN GENET DEV, V19, P172, DOI 10.1016/j.gde.2009.02.007; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	79	157	165	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2010	28	10					1089	1095		10.1038/nbt.1680	http://dx.doi.org/10.1038/nbt.1680			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	663GF	20944601	Green Accepted			2022-12-25	WOS:000282870500031
J	Kraft, C; Peter, M; Hofmann, K				Kraft, Claudine; Peter, Matthias; Hofmann, Kay			Selective autophagy: ubiquitin-mediated recognition and beyond	NATURE CELL BIOLOGY			English	Article							PROTEIN AGGREGATION; SACCHAROMYCES-CEREVISIAE; TARGETING PATHWAY; DEGRADATION; PARKIN; P62/SQSTM1; RECEPTOR; P62; CYTOPLASM; HDAC6	Eukaryotic cells use autophagy and the ubiquitin-proteasome system as their major protein degradation pathways. Whereas the ubiquitin-proteasome system is involved in the rapid degradation of proteins, autophagy pathways can selectively remove protein aggregates and damaged or excess organelles. Proteasome-mediated degradation requires previous ubiquitylation of the cargo, which is then recognized by ubiquitin receptors directing it to 26S proteasomes. Although autophagy has long been viewed as a random cytoplasmic degradation system, the involvement of ubiquitin as a specificity factor for selective autophagy is rapidly emerging. Recent evidence also suggests active crosstalk between proteasome-mediated degradation and selective autophagy. Here, we discuss the molecular mechanisms that link autophagy and the proteasome system, as well as the emerging roles of ubiquitin and ubiquitin-binding proteins in selective autophagy. On the basis of the evolutionary history of autophagic ubiquitin receptors, we propose a common origin for metazoan ubiquitin-dependent autophagy and the cytoplasm-to-vacuole targeting pathway of yeast.	[Kraft, Claudine; Peter, Matthias] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Hofmann, Kay] Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Miltenyi Biotec	Kraft, C (corresponding author), ETH, Inst Biochem, Schafmattstr 18, CH-8093 Zurich, Switzerland.	matthias.peter@bc.biol.ethz.ch; kay.hofmann@miltenyibiotec.de	Hofmann, Kay/D-6714-2011	Hofmann, Kay/0000-0002-2289-9083; Peter, Matthias/0000-0002-2160-6824	Swiss National Science Foundation (SNF); SystemsX.ch; Eidgenossische Technische Hochschule Zurich; Deutsche Forschungsgemeinschaft [SPP1365]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); SystemsX.ch; Eidgenossische Technische Hochschule Zurich(ETH Zurich); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Reinhard Dechant and Jason Mercer for critical reading of the manuscript. C.K. is supported by a Marie-Heim Vogtlin fellowship from the Swiss National Science Foundation (SNF). M.P. is a member of the Competence Center for Systems Physiology and Metabolic Diseases (SPMD), and supported by grants from the SNF, SystemsX.ch and the Eidgenossische Technische Hochschule Zurich. K.H. is supported by the Deutsche Forschungsgemeinschaft priority programme SPP1365.	Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; Hattori N, 2004, LANCET, V364, P722, DOI 10.1016/S0140-6736(04)16901-8; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kraft C, 2009, BBA-MOL CELL RES, V1793, P1404, DOI 10.1016/j.bbamcr.2009.02.006; Moore DJ, 2006, BIOCHEM SOC T, V34, P749, DOI 10.1042/BST0340749; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nazarko TY, 2009, MOL BIOL CELL, V20, P3828, DOI 10.1091/mbc.E09-03-0221; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pohl C, 2009, NAT CELL BIOL, V11, P65, DOI 10.1038/ncb1813; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Simonsen A, 2004, J CELL SCI, V117, P4239, DOI 10.1242/jcs.01287; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	45	479	491	5	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					836	841		10.1038/ncb0910-836	http://dx.doi.org/10.1038/ncb0910-836			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20811356				2022-12-25	WOS:000281561900005
J	Zhang, Y; Liu, SM; Mickanin, C; Feng, Y; Charlat, O; Michaud, GA; Schirle, M; Shi, XY; Hild, M; Bauer, A; Myer, VE; Finan, PM; Porter, JA; Huang, SMA; Cong, F				Zhang, Yue; Liu, Shanming; Mickanin, Craig; Feng, Yan; Charlat, Olga; Michaud, Gregory A.; Schirle, Markus; Shi, Xiaoying; Hild, Marc; Bauer, Andreas; Myer, Vic E.; Finan, Peter M.; Porter, Jeffery A.; Huang, Shih-Min A.; Cong, Feng			RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling	NATURE CELL BIOLOGY			English	Article							BREAST-CANCER; BETA-CATENIN; TANKYRASE; COMPLEX; UBIQUITINATION; PATHWAY; ACTIVATION; EXPRESSION; MEMBRANE; PROTEINS	The Wnt/beta-catenin signalling pathway plays essential roles in embryonic development and adult tissue homeostasis, and deregulation of this pathway has been linked to cancer. Axin is a concentration-limiting component of the beta-catenin destruction complex, and its stability is regulated by tankyrase. However, the molecular mechanism by which tankyrase-dependent poly(ADP-ribosyl)ation (PARsylation) is coupled to ubiquitylation and degradation of axin remains undefined. Here, we identify RNF146, a RING-domain E3 ubiquitin ligase, as a positive regulator of Wnt signalling. RNF146 promotes Wnt signalling by mediating tankyrase-dependent degradation of axin. Mechanistically, RNF146 directly interacts with poly(ADP-ribose) through its WWE domain, and promotes degradation of PARsylated proteins. Using proteomics approaches, we have identified BLZF1 and CASC3 as further substrates targeted by tankyrase and RNF146 for degradation. Thus, identification of RNF146 as a PARsylation-directed E3 ligase establishes a molecular paradigm that links tankyrase-dependent PARsylation to ubiquitylation. RNF146-dependent protein degradation may emerge as a major mechanism by which tankyrase exerts its function.	[Zhang, Yue; Liu, Shanming; Mickanin, Craig; Feng, Yan; Charlat, Olga; Michaud, Gregory A.; Schirle, Markus; Shi, Xiaoying; Hild, Marc; Bauer, Andreas; Myer, Vic E.; Finan, Peter M.; Porter, Jeffery A.; Huang, Shih-Min A.; Cong, Feng] Novartis Inst Biomed Res, Cambridge, MA 02139 USA	Novartis	Cong, F (corresponding author), Novartis Inst Biomed Res, Cambridge, MA 02139 USA.	feng.cong@novartis.com	高, 雨莉/HGU-8187-2022					Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P273, DOI 10.1016/S0968-0004(01)01787-X; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Gagne JP, 2006, CURR OPIN CELL BIOL, V18, P145, DOI 10.1016/j.ceb.2006.02.013; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Hsiao SJ, 2008, BIOCHIMIE, V90, P83, DOI 10.1016/j.biochi.2007.07.012; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Mohinta S, 2007, FRONT BIOSCI-LANDMRK, V12, P4020, DOI 10.2741/2368; NUSSE R, 1984, NATURE, V307, P131, DOI 10.1038/307131a0; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Sbodio JI, 2002, J BIOL CHEM, V277, P31887, DOI 10.1074/jbc.M203916200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Scovassi AI, 2007, RIV BIOL-BIOL FORUM, V100, P351; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Yeh TYJ, 2006, BIOCHEM J, V399, P415, DOI 10.1042/BJ20060713; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890	30	276	293	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY 11	2011	13	5					623	U292		10.1038/ncb2222	http://dx.doi.org/10.1038/ncb2222			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	758FY	21478859				2022-12-25	WOS:000290148700022
J	Backus, KM; Boshoff, HL; Barry, CS; Boutureira, O; Patel, MK; D'Hooge, F; Lee, SS; Via, LE; Tahlan, K; Barry, CE; Davis, BG				Backus, Keriann M.; Boshoff, Helena L.; Barry, Conor S.; Boutureira, Omar; Patel, Mitul K.; D'Hooge, Francois; Lee, Seung Seo; Via, Laura E.; Tahlan, Kapil; Barry, Clifton E., III; Davis, Benjamin G.			Uptake of unnatural trehalose analogs as a reporter for Mycobacterium tuberculosis	NATURE CHEMICAL BIOLOGY			English	Article							CORD FACTOR; ANTIGEN 85C; BIOSYNTHESIS; GLYCOSYLATION; TRAFFICKING; BIOGENESIS; INHIBITORS; MECHANISM; DELIVERY; BACILLI	The detection of tuberculosis currently relies upon insensitive and unspecific techniques; newer diagnostics would ideally co-opt specific bacterial processes to provide real-time readouts. The trehalose mycolyltransesterase enzymes (antigens 85A, 85B and 85C (Ag85A, Ag85B, Ag85C)) serve as essential mediators of cell envelope function and biogenesis in Mycobacterium tuberculosis. Through the construction of a systematically varied sugar library, we show here that Ag85 enzymes have exceptionally broad substrate specificity. This allowed exogenously added synthetic probes to be specifically incorporated into M. tuberculosis growing in vitro and within macrophages. Even bulky substituents, such as a fluorescein-containing trehalose probe (FITC-trehalose), were incorporated by growing bacilli, thereby producing fluorescent bacteria; microscopy revealed selective labeling of poles and membrane. Addition of FITC-trehalose to M. tuberculosis-infected macrophages allowed selective, sensitive detection of M. tuberculosis within infected mammalian macrophages. These studies suggest that analogs of trehalose may prove useful as probes of function and for other imaging modalities.	[Backus, Keriann M.; Barry, Conor S.; Boutureira, Omar; Patel, Mitul K.; D'Hooge, Francois; Lee, Seung Seo; Davis, Benjamin G.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford, England; [Backus, Keriann M.; Boshoff, Helena L.; Via, Laura E.; Tahlan, Kapil; Barry, Clifton E., III] US Natl Inst Allergy & Infect Dis, TB Res Sect, Lab Clin Infect Dis, Bethesda, MD USA	University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Backus, KM (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Oxford, England.	cbarry@niaid.nih.gov; ben.davis@chem.ox.ac.uk	Lee, Seung S/K-8669-2018; Barry, Clifton E/ABE-7992-2020; Davis, Benjamin G/C-5281-2011; D'Hooge, François/C-3571-2009; Boutureira, Omar/I-9045-2014; Via, Laura/AAD-3917-2021; Barry, III, Clifton/H-3839-2012	Lee, Seung S/0000-0002-8598-3303; Barry, Clifton E/0000-0002-2927-270X; Davis, Benjamin G/0000-0002-5056-407X; D'Hooge, François/0000-0003-2531-085X; Boutureira, Omar/0000-0002-0768-8309; Via, Laura/0000-0001-6074-9521; Barry, III, Clifton/0000-0002-2927-270X	Colorado State "Tuberculosis Vaccine Testing and Research Materials"; US National Institutes of Health; US National Institute of Allergy and Infectious Disease; Rhodes Trust; Marie Curie Intra European Fellowship; Engineering and Physical Sciences Research Council; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000783, ZIAAI000734] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [EGA17763, BB/E004350/1, BB/C510824/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/E000614/1, EP/D023335/1, EP/I500200/1, EP/G026688/1, GR/T26542/01, EP/D023343/1] Funding Source: researchfish; BBSRC [BB/E004350/1] Funding Source: UKRI; EPSRC [EP/E000614/1, EP/G026688/1, EP/I500200/1] Funding Source: UKRI	Colorado State "Tuberculosis Vaccine Testing and Research Materials"; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Rhodes Trust; Marie Curie Intra European Fellowship(European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank T. Claridge, B. Odell and T. Jackson for assistance with NMR spectra and C. Sparrow, J. McCullagh and R. Procter for their assistance with mass spectrometry. O. Schwartz, L. Koo, M. Gastinger, S. Becker and J. Kabat provided tremendous assistance on all imaging of M. tuberculosis. We thank the Colorado State "Tuberculosis Vaccine Testing and Research Materials" Contract (Colorado State University, Fort Collins) and G. J. Davies (University of York) for providing Ag85 and OtsA plasmids, respectively. We thank A. Sher (US National Institute of Allergy and Infectious Disease, US National Institutes of Health) for M. bovis BCG expressing DSRed1 and T. Oh (Yonsei University) for H37Rv carrying the mCherry-PMV261 plasmid. This study was supported (in part) by the Intramural Research Program of the US National Institutes of Health, the US National Institute of Allergy and Infectious Disease (C. E. B.), the Rhodes Trust (K. M. B.), a Marie Curie Intra European Fellowship (O. B.), the Engineering and Physical Sciences Research Council (Platform Grant to B. G. D.) and the Bill and Melinda Gates Foundation through the Tuberculosis Drug Accelerator Program (C. E. B., B. G. D.).	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Anderson DH, 2001, J MOL BIOL, V307, P671, DOI 10.1006/jmbi.2001.4461; Barry CE, 1996, TRENDS MICROBIOL, V4, P275, DOI 10.1016/0966-842X(96)10031-7; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Daffe M., 1999, Tubercle and Lung Disease, V79, P153, DOI 10.1054/tuld.1998.0200; Demchenko AV, 2003, CURR ORG CHEM, V7, P35, DOI 10.2174/1385272033373175; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; FUKUI Y, 1965, BIKEN J, V8, P189; GIAEVER HM, 1988, J BACTERIOL, V170, P2841, DOI 10.1128/jb.170.6.2841-2849.1988; GlatmanFreedman A, 1996, J CLIN MICROBIOL, V34, P2795, DOI 10.1128/JCM.34.11.2795-2802.1996; Gobec S, 2007, EUR J MED CHEM, V42, P54, DOI 10.1016/j.ejmech.2006.08.007; HADFIELD AF, 1979, CARBOHYD RES, V72, P93, DOI 10.1016/S0008-6215(00)83926-9; Hatzios SK, 2009, J BIOL CHEM, V284, P12745, DOI 10.1074/jbc.M809088200; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Hui Y, 2002, ORG LETT, V4, P2245, DOI 10.1021/ol026095m; Indrigo J, 2003, MICROBIOL-SGM, V149, P2049, DOI 10.1099/mic.0.26226-0; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; Kalscheuer R, 2010, P NATL ACAD SCI USA, V107, P21761, DOI 10.1073/pnas.1014642108; KILBURN JO, 1982, BIOCHEM BIOPH RES CO, V108, P132, DOI 10.1016/0006-291X(82)91841-1; Kyei GB, 2006, EMBO J, V25, P5250, DOI 10.1038/sj.emboj.7601407; Li XL, 2001, TETRAHEDRON, V57, P4297, DOI 10.1016/S0040-4020(01)00321-0; Matsunaga I, 2008, J BIOL CHEM, V283, P28835, DOI 10.1074/jbc.M805776200; Murphy HN, 2005, J BIOL CHEM, V280, P14524, DOI 10.1074/jbc.M414232200; Namme R, 2007, EUR J ORG CHEM, V2007, P3758, DOI 10.1002/ejoc.200700145; Pratt MR, 2003, ORG LETT, V5, P3185, DOI 10.1021/ol034836t; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Puech V, 2000, MOL MICROBIOL, V35, P1026, DOI 10.1046/j.1365-2958.2000.01738.x; Rodriguez MA, 2007, J ORG CHEM, V72, P8998, DOI 10.1021/jo701738m; Ronning DR, 2004, J BIOL CHEM, V279, P36771, DOI 10.1074/jbc.M400811200; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Schorey JS, 1997, SCIENCE, V277, P1091, DOI 10.1126/science.277.5329.1091; Slayden RA, 2000, MICROBES INFECT, V2, P659, DOI 10.1016/S1286-4579(00)00359-2; SLURGILLKOSZYCK.S, 1994, SCIENCE, V263, P678; SPARGO BJ, 1991, P NATL ACAD SCI USA, V88, P737, DOI 10.1073/pnas.88.3.737; Thanky NR, 2007, TUBERCULOSIS, V87, P231, DOI 10.1016/j.tube.2006.10.004; Titgemeyer F, 2007, J BACTERIOL, V189, P5903, DOI 10.1128/JB.00257-07; Tufariello JM, 2003, LANCET INFECT DIS, V3, P578, DOI 10.1016/S1473-3099(03)00741-2; Ullrich HJ, 1999, EUR J CELL BIOL, V78, P739, DOI 10.1016/S0171-9335(99)80042-9; Weingart CL, 1999, INFECT IMMUN, V67, P4264, DOI 10.1128/IAI.67.8.4264-4267.1999; *WHO, 2008, GLOB TUB CONTR REP 2; Woodruff PJ, 2004, J BIOL CHEM, V279, P28835, DOI 10.1074/jbc.M313103200; Yamagami H, 2001, INFECT IMMUN, V69, P810, DOI 10.1128/IAI.69.2.810-815.2001; Yang M, 2005, J AM CHEM SOC, V127, P9336, DOI 10.1021/ja051482n; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614	47	153	160	6	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					228	235		10.1038/NCHEMBIO.539	http://dx.doi.org/10.1038/NCHEMBIO.539			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21378984	Green Accepted			2022-12-25	WOS:000288545000011
J	Collisson, EA; Sadanandam, A; Olson, P; Gibb, WJ; Truitt, M; Gu, SD; Cooc, J; Weinkle, J; Kim, GE; Jakkula, L; Feiler, HS; Ko, AH; Olshen, AB; Danenberg, KL; Tempero, MA; Spellman, PT; Hanahan, D; Gray, JW				Collisson, Eric A.; Sadanandam, Anguraj; Olson, Peter; Gibb, William J.; Truitt, Morgan; Gu, Shenda; Cooc, Janine; Weinkle, Jennifer; Kim, Grace E.; Jakkula, Lakshmi; Feiler, Heidi S.; Ko, Andrew H.; Olshen, Adam B.; Danenberg, Kathleen L.; Tempero, Margaret A.; Spellman, Paul T.; Hanahan, Douglas; Gray, Joe W.			Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy	NATURE MEDICINE			English	Article							GENE-EXPRESSION; BREAST-CANCER; LUNG-CANCER; K-RAS; IDENTIFICATION; CHEMOTHERAPY; DIFFERENTIATION; MICROARRAYS; SENSITIVITY; MUTATIONS	Pancreatic ductal adenocarcinoma (PDA) is a lethal disease. Overall survival is typically 6 months from diagnosis(1). Numerous phase 3 trials of agents effective in other malignancies have failed to benefit unselected PDA populations, although patients do occasionally respond. Studies in other solid tumors have shown that heterogeneity in response is determined, in part, by molecular differences between tumors. Furthermore, treatment outcomes are improved by targeting drugs to tumor subtypes in which they are selectively effective, with breast(2) and lung(3) cancers providing recent examples. Identification of PDA molecular subtypes has been frustrated by a paucity of tumor specimens available for study. We have overcome this problem by combined analysis of transcriptional profiles of primary PDA samples from several studies, along with human and mouse PDA cell lines. We define three PDA subtypes: classical, quasimesenchymal and exocrine-like, and we present evidence for clinical outcome and therapeutic response differences between them. We further define gene signatures for these subtypes that may have utility in stratifying patients for treatment and present preclinical model systems that may be used to identify new subtype specific therapies.	[Collisson, Eric A.; Sadanandam, Anguraj; Gibb, William J.; Gu, Shenda; Weinkle, Jennifer; Jakkula, Lakshmi; Feiler, Heidi S.; Spellman, Paul T.; Gray, Joe W.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Collisson, Eric A.; Ko, Andrew H.; Tempero, Margaret A.] Univ Calif San Francisco, Div Hematol & Oncol, San Francisco, CA 94143 USA; [Sadanandam, Anguraj; Hanahan, Douglas] Swiss Fed Inst Technol, Swiss Inst Expt Canc Res, CH-1015 Lausanne, Switzerland; [Olson, Peter; Truitt, Morgan; Hanahan, Douglas] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Olson, Peter; Truitt, Morgan; Hanahan, Douglas] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Cooc, Janine; Danenberg, Kathleen L.] Response Genet, Los Angeles, CA USA; [Kim, Grace E.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA; [Olshen, Adam B.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Olshen, Adam B.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Gray, Joe W.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Oregon Health & Science University	Gray, JW (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.	grayjo@ohsu.edu	Gray, Joe/AAX-9549-2020	Sadanandam, Anguraj/0000-0001-8485-5150; Gu, Shenda/0000-0003-2271-0524; Kim, Grace/0000-0003-4603-9448	American Society of Clinical Oncology; US National Cancer Institute (NCI) [K08 CA137153]; US Department of Defense [BC087768]; NCI [PO1 CA 117969, P50 CA 58207, P50 CA 83639, U54 CA 112970]; American Cancer Society; Office of Science, Office of Biological & Environmental Research, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P50CA058207, P50CA083639, P01CA117969, K08CA137153, U54CA112970] Funding Source: NIH RePORTER	American Society of Clinical Oncology; US National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Defense(United States Department of Defense); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Office of Science, Office of Biological & Environmental Research, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to M. Lenburg and the Gray, Hanahan and Speed labs for discussion. We thank L. Chin (Dana-Farber Cancer Institute) for 3.27, TU8988S, TU8988T, Tu8902, DanG and HupT3, S. Batra (University of Nebraska Medical Center) for Suit2, M. McMahon (UCSF) for HPAC, Capan2, HPAF II, 6.03, CFPac1, MPanc96, 2.13, Panc1, MiaPaca2, 10.05 and Colo357, and A. Singh (Massachusetts General Hospital) for Sw1990. B. Stockwell (New York University) kindly provided pLKOshKRAS 5. R. Adam (Children's Hospital Boston) kindly provided pLKOshGATA6 5. E. A. C. was supported by a Young Investigator Award from the American Society of Clinical Oncology and US National Cancer Institute (NCI) K08 CA137153. A. S. was supported by a US Department of Defense Postdoctoral Fellowship (BC087768). The research in the laboratory of D. H. was supported by an NCI Program Project Grant PO1 CA 117969; D. H. is an American Cancer Society Research Professor. This work was supported by the Director, Office of Science, Office of Biological & Environmental Research, of the United States Department of Energy under contract no. DE-AC02-05CH11231, and by NCI grants P50 CA 58207, P50 CA 83639 and U54 CA 112970 to J. W. G.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Balagurunathan Y, 2008, MOL CANCER THER, V7, P3071, DOI 10.1158/1535-7163.MCT-08-0402; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; Biankin AV, 2009, GASTROENTEROLOGY, V137, P558, DOI 10.1053/j.gastro.2009.04.009; Blackford A, 2009, CLIN CANCER RES, V15, P4674, DOI 10.1158/1078-0432.CCR-09-0227; Brennan MF, 2004, ANN SURG, V240, P293, DOI 10.1097/01.sla.0000133125.85489.07; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Collisson EA, 2003, CANCER RES, V63, P5669; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; Decker K, 2006, DEV BIOL, V298, P415, DOI 10.1016/j.ydbio.2006.06.046; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Fu BJ, 2008, CANCER BIOL THER, V7, P1593, DOI 10.4161/cbt.7.10.6565; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grutzmann R, 2004, NEOPLASIA, V6, P611, DOI 10.1593/neo.04295; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Kanematsu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1093, DOI 10.1152/ajpcell.00225.2007; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; KUEHN H, 2008, CURR PROTOC BIOINFOR, V22; Kwei KA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000081; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Mehra R, 2005, CANCER RES, V65, P11259, DOI 10.1158/0008-5472.CAN-05-2495; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Raut Chandrajit P, 2004, Surg Oncol Clin N Am, V13, P639, DOI 10.1016/j.soc.2004.06.007; SADANANDAM A, 2011, NATURE PROTOCOLS, DOI DOI 10.1038/PROTEX.2011.231; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492	36	997	1030	1	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2011	17	4					500	U140		10.1038/nm.2344	http://dx.doi.org/10.1038/nm.2344			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21460848	Green Accepted, Green Submitted			2022-12-25	WOS:000289245100042
J	Hsiao, YY; Yang, CC; Lin, CL; Lin, JLJ; Duh, Y; Yuan, HS				Hsiao, Yu-Yuan; Yang, Che-Chuan; Lin, Chia Liang; Lin, Jason L. J.; Duh, Yulander; Yuan, Hanna S.			Structural basis for RNA trimming by RNase T in stable RNA 3 '-end maturation	NATURE CHEMICAL BIOLOGY			English	Article							CRYSTAL-STRUCTURE; RIBOSOMAL-RNA; EXONUCLEASE TREX1; PROCESSING ENZYME; DNASE ACTIVITY; EXORIBONUCLEASE; MECHANISM; END; IDENTIFICATION; SPECIFICITY	RNA maturation relies on various exonucleases to remove nucleotides successively from the 5' or 3' end of nucleic acids. However, little is known regarding the molecular basis for substrate and cleavage preference of exonucleases. Our biochemical and structural analyses on RNase T-DNA complexes show that the RNase T dimer has an ideal architecture for binding a duplex with a short 3' overhang to produce a digestion product of a duplex with a 2-nucleotide (nt) or 1-nt 3' overhang, depending on the composition of the last base pair in the duplex. A 'C-filter' in RNase T screens out the nucleic acids with 3'-terminal cytosines for hydrolysis by inducing a disruptive conformational change at the active site. Our results reveal the general principles and the working mechanism for the final trimming step made by RNase T in the maturation of stable RNA and pave the way for the understanding of other DEDD family exonucleases.	[Hsiao, Yu-Yuan; Lin, Chia Liang] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Hsiao, Yu-Yuan; Yang, Che-Chuan; Lin, Chia Liang; Lin, Jason L. J.; Duh, Yulander; Yuan, Hanna S.] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Yang, Che-Chuan; Yuan, Hanna S.] Natl Taiwan Univ, Grad Inst Biochem & Mol Biol, Taipei 10764, Taiwan	National Tsing Hua University; Academia Sinica - Taiwan; National Taiwan University	Hsiao, YY (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.	hanna@sinica.edu.tw	Hsiao, Yu-Yuan/AAA-7408-2022; Yuan, Hanna S./AAA-4005-2021	Yuan, Hanna S./0000-0001-9671-6967; Hsiao, Yu-Yuan/0000-0002-9648-5879; Lin, Chia-Liang/0000-0002-7158-6091	Academia Sinica; National Science Council, Taiwan; National Science Council of Taiwan; National Research Program for Genomic Medicine	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan)	This work was supported by research grants from Academia Sinica and the National Science Council, Taiwan. Portions of this research were carried out at the National Synchrotron Radiation Research Center (BL-13B1 and BL-13C1), a national user facility supported by the National Science Council of Taiwan. The Synchrotron Radiation Protein Crystallography Facility is supported by the National Research Program for Genomic Medicine. We thank S. Lin-Chao (Academia Sinica) for providing the E. coli knockout strains used in this study.	Allas U, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-8; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Chin KH, 2006, PROTEINS, V65, P1036, DOI 10.1002/prot.21148; CORMACK RS, 1992, J MOL BIOL, V228, P1078, DOI 10.1016/0022-2836(92)90316-C; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; DEUTSCHER MP, 1984, P NATL ACAD SCI-BIOL, V81, P4290, DOI 10.1073/pnas.81.14.4290; Dupasquier M, 2008, J MOL BIOL, V379, P579, DOI 10.1016/j.jmb.2008.04.005; EHRETSMANN CP, 1992, GENE DEV, V6, P149, DOI 10.1101/gad.6.1.149; Ellis JJ, 2007, PROTEINS, V66, P903, DOI 10.1002/prot.21211; GUERRIERTAKADA C, 1984, SCIENCE, V223, P285, DOI 10.1126/science.6199841; GUERRIERTAKADA C, 1986, CELL, V45, P177, DOI 10.1016/0092-8674(86)90381-8; Hamdan S, 2002, STRUCTURE, V10, P535, DOI 10.1016/S0969-2126(02)00738-4; Hartmann RK, 2009, PROG MOL BIOL TRANSL, V85, P319, DOI 10.1016/S0079-6603(08)00808-8; Hsiao YY, 2009, MOL CELL BIOL, V29, P448, DOI 10.1128/MCB.01006-08; Jones S, 2001, NUCLEIC ACIDS RES, V29, P943, DOI 10.1093/nar/29.4.943; Kavanagh D, 2008, CELL CYCLE, V7, P1718, DOI 10.4161/cc.7.12.6162; KELLY KO, 1992, J BACTERIOL, V174, P6682, DOI 10.1128/JB.174.20.6682-6684.1992; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; LI ZW, 1995, P NATL ACAD SCI USA, V92, P6883, DOI 10.1073/pnas.92.15.6883; Li ZW, 1999, RNA, V5, P139, DOI 10.1017/S1355838299981669; Li ZW, 1998, P NATL ACAD SCI USA, V95, P2856, DOI 10.1073/pnas.95.6.2856; Li ZW, 2002, RNA, V8, P97, DOI 10.1017/S1355838202014929; LI ZW, 1994, J BIOL CHEM, V269, P6064; Li ZW, 1996, CELL, V86, P503, DOI 10.1016/S0092-8674(00)80123-3; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; MISRA TK, 1979, J BIOL CHEM, V254, P1154; PADMANABHA KP, 1991, J BACTERIOL, V173, P1376, DOI 10.1128/jb.173.4.1376-1381.1991; Perry JJP, 2006, NAT STRUCT MOL BIOL, V13, P414, DOI 10.1038/nsmb1088; RIGGS AD, 1968, J MOL BIOL, V34, P365, DOI 10.1016/0022-2836(68)90261-1; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Viswanathan M, 1998, J BIOL CHEM, V273, P35126, DOI 10.1074/jbc.273.52.35126; Viswanathan M, 1999, GENETICS, V151, P929; Wu MS, 2005, EMBO J, V24, P4082, DOI 10.1038/sj.emboj.7600869; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Zuo YH, 1999, NUCLEIC ACIDS RES, V27, P4077, DOI 10.1093/nar/27.20.4077; Zuo YH, 2005, STRUCTURE, V13, P973, DOI 10.1016/j.str.2005.04.015; Zuo YH, 2002, J BIOL CHEM, V277, P50160, DOI 10.1074/jbc.M207707200; Zuo YH, 2002, J BIOL CHEM, V277, P50155, DOI 10.1074/jbc.M207706200; Zuo YH, 2002, J BIOL CHEM, V277, P29654, DOI 10.1074/jbc.M204252200; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017; Zuo YH, 2007, STRUCTURE, V15, P417, DOI 10.1016/j.str.2007.02.004	46	32	33	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					236	243		10.1038/NCHEMBIO.524	http://dx.doi.org/10.1038/NCHEMBIO.524			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21317904				2022-12-25	WOS:000288545000012
J	Kubota, Y; O'Grady, P; Saito, H; Takekawa, M				Kubota, Yuji; O'Grady, Pauline; Saito, Haruo; Takekawa, Mutsuhiro			Oncogenic Ras abrogates MEK SUMOylation that suppresses the ERK pathway and cell transformation	NATURE CELL BIOLOGY			English	Article							CONSERVED DOCKING SITE; MAP KINASE KINASE; PROTEIN; SUMO; ACTIVATION; NUCLEAR; UBIQUITIN; RECEPTOR; CASCADE; BINDING	The ERK (extracellular signal-regulated kinase) MAPK (mitogen-activated protein kinase) cascade (Raf-MEK-ERK) mediates mitogenic signalling, and is frequently hyperactivated by Ras oncogenes in human cancer. The entire range of activities of multifunctional Ras in carcinogenesis remains elusive. Here we report that the ERK pathway is downregulated by MEK (MAPK-ERK kinase) SUMOylation, which is inhibited by oncogenic Ras. MEK SUMOylation blocked ERK activation by disrupting the specific docking interaction between MEK and ERK. Expression of un-SUMOylatable MEK enhanced ERK activation, cell differentiation, proliferation and malignant transformation by oncogenic ErbB2 or Raf, but not by active Ras. Interestingly, MEK SUMOylation was abrogated in cancer cells harbouring Ras mutations. Oncogenic Ras inhibits MEK SUMOylation by impairing the function of the MEKK1 MAPKKK as a SUMO-E3 ligase specific for MEK. Furthermore, forced enhancement of MEK SUMOylation suppressed Ras-induced cell transformation. Thus, oncogenic Ras efficiently activates the ERK pathway both by activating Raf and by inhibiting MEK SUMOylation, thereby inducing carcinogenesis.	[Kubota, Yuji; O'Grady, Pauline; Saito, Haruo; Takekawa, Mutsuhiro] Univ Tokyo, Inst Med Sci, Dept Mol Cell Signaling, Minato Ku, Tokyo 1088639, Japan; [Kubota, Yuji; Saito, Haruo; Takekawa, Mutsuhiro] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Kubota, Yuji; Takekawa, Mutsuhiro] Nagoya Univ, Environm Med Res Inst, Dept Cell Signaling & Mol Med, Chikusa Ku, Nagoya, Aichi 4648601, Japan	University of Tokyo; University of Tokyo; Nagoya University	Saito, H (corresponding author), Univ Tokyo, Inst Med Sci, Dept Mol Cell Signaling, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	h-saito@ims.u-tokyo.ac.jp; takekawa@riem.nagoya-u.ac.jp	Saito, Haruo/AAF-6113-2019	Saito, Haruo/0000-0001-7891-1689; Kubota, Yuji/0000-0002-8744-7176; Takekawa, Mutsuhiro/0000-0002-8027-3847	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Takeda Science Foundation; Naito foundation; DAIKO foundation; MEXT, Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito foundation(Naito Memorial Foundation); DAIKO foundation(Daiko Foundation); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas and other grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (M.T. and H.S.), by the Takeda Science Foundation, the Naito foundation and the DAIKO foundation (M.T.) and by the Global CUE Program from MEXT, Japan. We thank J. Charron (Universite Laval, Quebec) for the MEK1<SUP>-/-</SUP> MEFs, T. Kitamura (University of Tokyo) for Plat-E cells and H. Saitoh (Kumamoto University), T. Yamamoto (University of Tokyo), T. Kataoka (Kobe University) and S. Iwata (University of Tokyo) for plasmids.	AKIYAMA T, 1991, MOL CELL BIOL, V11, P833, DOI 10.1128/MCB.11.2.833; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Bardwell AJ, 2009, J BIOL CHEM, V284, P13165, DOI 10.1074/jbc.M900080200; Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Calvo F, 2010, BIOESSAYS, V32, P412, DOI 10.1002/bies.200900155; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Cuevas BD, 2006, ONCOGENE, V25, P4998, DOI 10.1038/sj.onc.1209507; Dadke S, 2007, NAT CELL BIOL, V9, P80, DOI 10.1038/ncb1522; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Dhanasekaran DN, 2007, ONCOGENE, V26, P3097, DOI 10.1038/sj.onc.1210395; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Enslen H, 2001, BIOL CELL, V93, P5, DOI 10.1016/S0248-4900(01)01156-X; Galperin E, 2008, TRAFFIC, V9, P1776, DOI 10.1111/j.1600-0854.2008.00788.x; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson GL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-222; Kamitani T, 1997, J BIOL CHEM, V272, P14001, DOI 10.1074/jbc.272.22.14001; Kang JS, 2008, NAT CELL BIOL, V10, P654, DOI 10.1038/ncb1728; Karandikar M, 2000, J BIOL CHEM, V275, P40120, DOI 10.1074/jbc.M005926200; Kim JH, 2006, NAT CELL BIOL, V8, P631, DOI 10.1038/ncb1415; Kranenburg O, 1999, J BIOL CHEM, V274, P35301, DOI 10.1074/jbc.274.50.35301; Lerner EC, 1997, ONCOGENE, V15, P1283, DOI 10.1038/sj.onc.1201296; Li TW, 2004, P NATL ACAD SCI USA, V101, P8551, DOI 10.1073/pnas.0402889101; Liang XQ, 2002, J BIOL CHEM, V277, P33032, DOI 10.1074/jbc.M204607200; LIU YC, 1994, J NEUROSCI, V14, P5807; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mody A, 2009, NAT CELL BIOL, V11, P484, DOI 10.1038/ncb1856; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; RUSSELL M, 1995, J BIOL CHEM, V270, P11757, DOI 10.1074/jbc.270.20.11757; Saltzman A, 1998, FEBS LETT, V425, P431, DOI 10.1016/S0014-5793(98)00287-7; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Sobko A, 2002, DEV CELL, V2, P745, DOI 10.1016/S1534-5807(02)00186-7; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Takekawa M, 2005, MOL CELL, V18, P295, DOI 10.1016/j.molcel.2005.04.001; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Terai K, 2005, EMBO REP, V6, P251, DOI 10.1038/sj.embor.7400349; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Witowsky JA, 2003, J BIOL CHEM, V278, P1403, DOI 10.1074/jbc.C200616200; Wohlschlegel JA, 2006, J PROTEOME RES, V5, P761, DOI 10.1021/pr050451o; Xu BE, 2001, J BIOL CHEM, V276, P26509, DOI 10.1074/jbc.M102769200; Xu J, 2006, J BIOL CHEM, V281, P982, DOI 10.1074/jbc.M505484200; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; Yao Z, 2009, BIOFACTORS, V35, P407, DOI 10.1002/biof.52; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6	65	48	49	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2011	13	3					282	U477		10.1038/ncb2169	http://dx.doi.org/10.1038/ncb2169			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	728BB	21336309				2022-12-25	WOS:000287847600016
J	Miller, JC; Tan, SY; Qiao, GJ; Barlow, KA; Wang, JB; Xia, DF; Meng, XD; Paschon, DE; Leung, E; Hinkley, SJ; Dulay, GP; Hua, KL; Ankoudinova, I; Cost, GJ; Urnov, FD; Zhang, HS; Holmes, MC; Zhang, L; Gregory, PD; Rebar, EJ				Miller, Jeffrey C.; Tan, Siyuan; Qiao, Guijuan; Barlow, Kyle A.; Wang, Jianbin; Xia, Danny F.; Meng, Xiangdong; Paschon, David E.; Leung, Elo; Hinkley, Sarah J.; Dulay, Gladys P.; Hua, Kevin L.; Ankoudinova, Irina; Cost, Gregory J.; Urnov, Fyodor D.; Zhang, H. Steve; Holmes, Michael C.; Zhang, Lei; Gregory, Philip D.; Rebar, Edward J.			A TALE nuclease architecture for efficient genome editing	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER NUCLEASES; DOUBLE-STRAND BREAKS; III EFFECTORS; DNA RECOGNITION; TARGETED MUTAGENESIS; GENE MODIFICATION; HUMAN-CELLS; PROTEIN; PLANT; RESISTANCE	Nucleases that cleave unique genomic sequences in living cells can be used for targeted gene editing and mutagenesis. Here we develop a strategy for generating such reagents based on transcription activator-like effector (TALE) proteins from Xanthomonas. We identify TALE truncation variants that efficiently cleave DNA when linked to the catalytic domain of FokI and use these nucleases to generate discrete edits or small deletions within endogenous human NTF3 and CCR5 genes at efficiencies of up to 25%. We further show that designed TALEs can regulate endogenous mammalian genes. These studies demonstrate the effective application of designed TALE transcription factors and nucleases for the targeted regulation and modification of endogenous genes.	[Miller, Jeffrey C.; Tan, Siyuan; Qiao, Guijuan; Barlow, Kyle A.; Wang, Jianbin; Xia, Danny F.; Meng, Xiangdong; Paschon, David E.; Leung, Elo; Hinkley, Sarah J.; Dulay, Gladys P.; Hua, Kevin L.; Ankoudinova, Irina; Cost, Gregory J.; Urnov, Fyodor D.; Zhang, H. Steve; Holmes, Michael C.; Zhang, Lei; Gregory, Philip D.; Rebar, Edward J.] Sangamo BioSci Inc, Richmond, CA USA	Sangamo Therapeutics, Inc.	Rebar, EJ (corresponding author), Sangamo BioSci Inc, Richmond, CA USA.	erebar@sangamo.com		Hua, Kevin/0000-0003-2186-6674; Cost, Gregory/0000-0002-8509-4653; Gregory, Philip/0000-0001-9249-2468				Benabdallah BF, 2010, CYTOTHERAPY, V12, P394, DOI 10.3109/14653240903583803; Bibikova M, 2002, GENETICS, V161, P1169; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Camenisch TD, 2008, MINI-REV MED CHEM, V8, P669, DOI 10.2174/138955708784567458; Carroll D, 2008, GENE THER, V15, P1463, DOI 10.1038/gt.2008.145; Cathomen T, 2008, MOL THER, V16, P1200, DOI 10.1038/mt.2008.114; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Davis D, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-42; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Galetto R, 2009, EXPERT OPIN BIOL TH, V9, P1289, DOI 10.1517/14712590903213669; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Jeggo PA, 1998, ADV GENET, V38, P185, DOI 10.1016/S0065-2660(08)60144-3; Kay S, 2009, CURR OPIN MICROBIOL, V12, P37, DOI 10.1016/j.mib.2008.12.006; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kay S, 2009, PLANT J, V59, P859, DOI 10.1111/j.1365-313X.2009.03922.x; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Liu PQ, 2005, J BIOMOL SCREEN, V10, P304, DOI 10.1177/1087057104272663; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; MORBITZER R, 2010, P NATL ACAD SCI US; Morton J, 2006, P NATL ACAD SCI USA, V103, P16370, DOI 10.1073/pnas.0605633103; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Ochiai H, 2010, GENES CELLS, V15, P875, DOI 10.1111/j.1365-2443.2010.01425.x; Orlando SJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq512; Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Reik A, 2007, BIOTECHNOL BIOENG, V97, P1180, DOI 10.1002/bit.21304; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Szurek B, 2002, MOL MICROBIOL, V46, P13, DOI 10.1046/j.1365-2958.2002.03139.x; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P759, DOI 10.1016/j.ibmb.2010.07.012; Tan SY, 2003, P NATL ACAD SCI USA, V100, P11997, DOI 10.1073/pnas.2035056100; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Whitlock PR, 2004, MOL THER, V9, P67, DOI 10.1016/j.ymthe.2003.09.014; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	52	1431	1825	18	399	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2011	29	2					143	U149		10.1038/nbt.1755	http://dx.doi.org/10.1038/nbt.1755			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	717DJ	21179091				2022-12-25	WOS:000287023000021
J	Shulaev, V; Sargent, DJ; Crowhurst, RN; Mockler, TC; Folkerts, O; Delcher, AL; Jaiswal, P; Mockaitis, K; Liston, A; Mane, SP; Burns, P; Davis, TM; Slovin, JP; Bassil, N; Hellens, RP; Evans, C; Harkins, T; Kodira, C; Desany, B; Crasta, OR; Jensen, RV; Allan, AC; Michael, TP; Setubal, JC; Celton, JM; Rees, DJG; Williams, KP; Holt, SH; Rojas, JJR; Chatterjee, M; Liu, B; Silva, H; Meisel, L; Adato, A; Filichkin, SA; Troggio, M; Viola, R; Ashman, TL; Wang, H; Dharmawardhana, P; Elser, J; Raja, R; Priest, HD; Bryant, DW; Fox, SE; Givan, SA; Wilhelm, LJ; Naithani, S; Christoffels, A; Salama, DY; Carter, J; Girona, EL; Zdepski, A; Wang, WQ; Kerstetter, RA; Schwab, W; Korban, SS; Davik, J; Monfort, A; Denoyes-Rothan, B; Arus, P; Mittler, R; Flinn, B; Aharoni, A; Bennetzen, JL; Salzberg, SL; Dickerman, AW; Velasco, R; Borodovsky, M; Veilleux, RE; Folta, KM				Shulaev, Vladimir; Sargent, Daniel J.; Crowhurst, Ross N.; Mockler, Todd C.; Folkerts, Otto; Delcher, Arthur L.; Jaiswal, Pankaj; Mockaitis, Keithanne; Liston, Aaron; Mane, Shrinivasrao P.; Burns, Paul; Davis, Thomas M.; Slovin, Janet P.; Bassil, Nahla; Hellens, Roger P.; Evans, Clive; Harkins, Tim; Kodira, Chinnappa; Desany, Brian; Crasta, Oswald R.; Jensen, Roderick V.; Allan, Andrew C.; Michael, Todd P.; Setubal, Joao Carlos; Celton, Jean-Marc; Rees, D. Jasper G.; Williams, Kelly P.; Holt, Sarah H.; Rojas, Juan Jairo Ruiz; Chatterjee, Mithu; Liu, Bo; Silva, Herman; Meisel, Lee; Adato, Avital; Filichkin, Sergei A.; Troggio, Michela; Viola, Roberto; Ashman, Tia-Lynn; Wang, Hao; Dharmawardhana, Palitha; Elser, Justin; Raja, Rajani; Priest, Henry D.; Bryant, Douglas W., Jr.; Fox, Samuel E.; Givan, Scott A.; Wilhelm, Larry J.; Naithani, Sushma; Christoffels, Alan; Salama, David Y.; Carter, Jade; Girona, Elena Lopez; Zdepski, Anna; Wang, Wenqin; Kerstetter, Randall A.; Schwab, Wilfried; Korban, Schuyler S.; Davik, Jahn; Monfort, Amparo; Denoyes-Rothan, Beatrice; Arus, Pere; Mittler, Ron; Flinn, Barry; Aharoni, Asaph; Bennetzen, Jeffrey L.; Salzberg, Steven L.; Dickerman, Allan W.; Velasco, Riccardo; Borodovsky, Mark; Veilleux, Richard E.; Folta, Kevin M.			The genome of woodland strawberry (Fragaria vesca)	NATURE GENETICS			English	Article							PHYLOGENETIC TREE SELECTION; DIPLOID STRAWBERRY; GENE-EXPRESSION; SEQUENCE; ALIGNMENT; PROTEINS; ROSACEAE; PLANTS; IDENTIFICATION; TRANSFORMATION	The woodland strawberry, Fragaria vesca (2n = 2x = 14), is a versatile experimental plant system. This diminutive herbaceous perennial has a small genome (240 Mb), is amenable to genetic transformation and shares substantial sequence identity with the cultivated strawberry (Fragaria x ananassa) and other economically important rosaceous plants. Here we report the draft F. vesca genome, which was sequenced to x39 coverage using second-generation technology, assembled de novo and then anchored to the genetic linkage map into seven pseudochromosomes. This diploid strawberry sequence lacks the large genome duplications seen in other rosids. Gene prediction modeling identified 34,809 genes, with most being supported by transcriptome mapping. Genes critical to valuable horticultural traits including flavor, nutritional value and flowering time were identified. Macrosyntenic relationships between Fragaria and Prunus predict a hypothetical ancestral Rosaceae genome that had nine chromosomes. New phylogenetic analysis of 154 protein-coding genes suggests that assignment of Populus to Malvidae, rather than Fabidae, is warranted.	[Chatterjee, Mithu; Salama, David Y.; Folta, Kevin M.] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA; [Shulaev, Vladimir; Mittler, Ron] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Crowhurst, Ross N.; Hellens, Roger P.; Allan, Andrew C.] New Zealand Inst Plant & Food Res Ltd Plant & Foo, Mt Albert Res Ctr, Auckland, New Zealand; [Mockler, Todd C.; Jaiswal, Pankaj; Liston, Aaron; Filichkin, Sergei A.; Dharmawardhana, Palitha; Elser, Justin; Raja, Rajani; Priest, Henry D.; Bryant, Douglas W., Jr.; Fox, Samuel E.; Givan, Scott A.; Wilhelm, Larry J.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Mockler, Todd C.; Filichkin, Sergei A.; Priest, Henry D.; Bryant, Douglas W., Jr.; Fox, Samuel E.; Givan, Scott A.; Wilhelm, Larry J.] Oregon State Univ, CGRB, Corvallis, OR 97331 USA; [Folkerts, Otto; Crasta, Oswald R.] Chromatin Inc, Champaign, IL USA; [Delcher, Arthur L.; Salzberg, Steven L.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Mockaitis, Keithanne; Carter, Jade] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN USA; [Mane, Shrinivasrao P.; Evans, Clive; Setubal, Joao Carlos; Williams, Kelly P.; Dickerman, Allan W.] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Burns, Paul; Borodovsky, Mark] Joint Georgia Tech & Emory Wallace H Coulter Dept, Atlanta, GA USA; [Davis, Thomas M.; Liu, Bo] Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA; [Slovin, Janet P.] ARS, USDA, Henry Wallace Beltsville Agr Res Ctr, Beltsville, MD USA; [Bassil, Nahla] ARS, USDA, Corvallis, OR USA; [Harkins, Tim; Kodira, Chinnappa; Desany, Brian] Roche Appl Sci, Roche Diagnost, Indianapolis, IN USA; [Jensen, Roderick V.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Allan, Andrew C.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Michael, Todd P.; Zdepski, Anna; Wang, Wenqin; Kerstetter, Randall A.] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08855 USA; [Setubal, Joao Carlos] Virginia Tech, Dept Comp Sci, Blacksburg, VA USA; [Celton, Jean-Marc; Rees, D. Jasper G.] Univ Western Cape, Dept Biotechnol, ZA-7535 Bellville, South Africa; [Holt, Sarah H.; Rojas, Juan Jairo Ruiz; Veilleux, Richard E.] Virginia Polytech Inst & State Univ, Dept Hort, Blacksburg, VA 24061 USA; [Holt, Sarah H.; Flinn, Barry] Inst Adv Learning & Res, Inst Sustainable & Renewable Resources, Danville, PA USA; [Chatterjee, Mithu; Folta, Kevin M.] Univ Florida, Grad Program Plant Mol & Cellular Biol, Gainesville, FL USA; [Silva, Herman] Univ Chile, Fac Agron, Santiago, Chile; [Meisel, Lee; Aharoni, Asaph] Univ Andres Bello, Fac Ciencias Biol, Ctr Biotecnol Vegetal, Santiago, Chile; [Adato, Avital] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Troggio, Michela; Viola, Roberto; Velasco, Riccardo] Fdn Edmund Mach, Res & Innovat Ctr, IASMA, San Michele All Adige, Trento, Italy; [Ashman, Tia-Lynn] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Wang, Hao; Bennetzen, Jeffrey L.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Naithani, Sushma] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA; [Christoffels, Alan] Univ Western Cape, S African Natl Bioinformat Inst, ZA-7535 Bellville, South Africa; [Schwab, Wilfried] Tech Univ Munich, D-8000 Munich, Germany; [Korban, Schuyler S.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Davik, Jahn] Norwegian Inst Agr & Environm Res, Kvithamar, Stjordal, Norway; [Monfort, Amparo; Arus, Pere] IRTA, Barcelona, Spain; [Monfort, Amparo; Arus, Pere] Ctr Recerca Agrigenom CSIC IRTA UAB, Barcelona, Spain; [Denoyes-Rothan, Beatrice] INRA, UREF, Villenave Dornon, France; [Borodovsky, Mark] Georgia Tech, Sch Computat Sci & Engn, Atlanta, GA USA	State University System of Florida; University of Florida; University of North Texas System; University of North Texas Denton; New Zealand Institute for Plant & Food Research Ltd; Oregon State University; Oregon State University; University System of Maryland; University of Maryland College Park; Indiana University System; Indiana University Bloomington; Virginia Polytechnic Institute & State University; University System Of New Hampshire; University of New Hampshire; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Roche Holding; Virginia Polytechnic Institute & State University; University of Auckland; Rutgers State University New Brunswick; Virginia Polytechnic Institute & State University; University of the Western Cape; Virginia Polytechnic Institute & State University; State University System of Florida; University of Florida; Universidad de Chile; Universidad Andres Bello; Weizmann Institute of Science; Fondazione Edmund Mach; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Georgia; University of Georgia; Oregon State University; South African National Biodiversity Institute; University of the Western Cape; Technical University of Munich; University of Illinois System; University of Illinois Urbana-Champaign; Bioforsk; IRTA; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; INRAE; University System of Georgia; Georgia Institute of Technology	Folta, KM (corresponding author), Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA.	kfolta@ufl.edu	Silva, Herman P/C-7252-2012; Allan, Andrew C/L-3253-2016; Jaiswal, Pankaj/R-4214-2019; Naithani, Sushma/AAU-1450-2021; Salzberg, Steven/Q-6514-2019; Sargent, Daniel James/A-2933-2014; Viola, Roberto/D-2277-2010; Crowhurst, Ross N/N-8892-2017; Flinn, Barry/AAE-6341-2020; Arús, Pere/F-6443-2015; Mockler, Todd C/L-2609-2013; Monfort, Amparo/K-1356-2015; Velasco, Riccardo/G-8710-2011; Setubal, Joao Carlos/C-7305-2012; Mittler, Ron/ABE-6496-2020; Rees, Jasper/D-9672-2011; Meisel, Lee Ann/J-6755-2012; Lopez-Girona, Elena/V-2790-2019; Meisel, Lee/C-3864-2008; López-Girona, Elena/Q-4822-2016; Wang, Wenqin/AAR-2970-2021; Rees, David Jasper Gilbert/AAZ-8073-2020; aharoni, asaph/W-6670-2019; Salzberg, Steven L/F-6162-2011; Jaiswal, Pankaj/H-7599-2016; Christoffels, Alan/C-3269-2014; Viola, Roberto/F-3657-2014; Wang, Hao/C-7651-2009	Silva, Herman P/0000-0003-1007-7442; Allan, Andrew C/0000-0003-1944-7067; Jaiswal, Pankaj/0000-0002-1005-8383; Naithani, Sushma/0000-0001-7819-4552; Salzberg, Steven/0000-0002-8859-7432; Sargent, Daniel James/0000-0002-6686-7147; Crowhurst, Ross N/0000-0003-0608-2134; Flinn, Barry/0000-0002-3843-3990; Arús, Pere/0000-0003-0939-8038; Mockler, Todd C/0000-0002-0462-5775; Monfort, Amparo/0000-0001-7106-7745; Setubal, Joao Carlos/0000-0001-9174-2816; Rees, Jasper/0000-0003-3321-1325; Meisel, Lee Ann/0000-0002-4806-6864; Lopez-Girona, Elena/0000-0003-0376-6135; López-Girona, Elena/0000-0003-0376-6135; Wang, Wenqin/0000-0001-6427-6338; Rees, David Jasper Gilbert/0000-0003-3321-1325; Salzberg, Steven L/0000-0002-8859-7432; Jaiswal, Pankaj/0000-0002-1005-8383; Christoffels, Alan/0000-0002-0420-2916; Mane, Shrinivasrao/0000-0003-4123-624X; Carter, Jade/0000-0003-2792-1662; Viola, Roberto/0000-0002-8202-8503; Givan, Scott/0000-0002-0630-8589; Hellens, Roger/0000-0003-2094-0887; Velasco, Riccardo/0000-0002-8760-5031; Slovin, Janet/0000-0001-6609-7034; Michael, Todd/0000-0001-6272-2875; Wang, Hao/0000-0002-9634-8778; Celton, Jean-Marc/0000-0002-1452-4812; Denoyes, Beatrice/0000-0002-0369-9609	Roche; Virginia Bioinformatics Institute; University of Florida Institute of Food and Agricultural Sciences (IFAS) Dean for Research; University of Florida Strawberry Breeding Program; Province of Trento, Italy; Driscoll's Strawberry Associates; United States Department of Agriculture/Cooperative State Research, Education and Extension Service (USDA/CSREES) [VA-135816]; Rutgers Busch Biomedical Funding; East Malling Trust (EMT); Biotechnology and Biological Sciences Research Council (BBSRC); Oregon State Agricultural Research Foundation [ARF4435]; Oregon State Computational and Genome Biology Initiative; Oregon State University; Center for Genomics and Bioinformatics; METACyt Initiative of Indiana University; US National Institutes of Health [HG00783]; USDA-CSREES National Research Initiative (NRI) [2008-35300-04411]; New Hampshire Agricultural Experiment Station Project [NH00535]; USDA/ARS CRIS [1275-21000-180-01R]; Division Of Integrative Organismal Systems [0822201] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000783, R01HG006677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083873] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	Roche(Roche Holding); Virginia Bioinformatics Institute; University of Florida Institute of Food and Agricultural Sciences (IFAS) Dean for Research(University of Florida); University of Florida Strawberry Breeding Program; Province of Trento, Italy(Autonomous Province of Trento); Driscoll's Strawberry Associates; United States Department of Agriculture/Cooperative State Research, Education and Extension Service (USDA/CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Rutgers Busch Biomedical Funding; East Malling Trust (EMT); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Oregon State Agricultural Research Foundation; Oregon State Computational and Genome Biology Initiative; Oregon State University; Center for Genomics and Bioinformatics; METACyt Initiative of Indiana University; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA-CSREES National Research Initiative (NRI)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); New Hampshire Agricultural Experiment Station Project; USDA/ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by Roche and 454 Sequencing; the Virginia Bioinformatics Institute; the University of Florida Institute of Food and Agricultural Sciences (IFAS) Dean for Research; the University of Florida Strawberry Breeding Program; The Province of Trento, Italy (to R. V.); Driscoll's Strawberry Associates; United States Department of Agriculture/Cooperative State Research, Education and Extension Service (USDA/CSREES) Hatch Project VA-135816 (to B. F.); Rutgers Busch Biomedical Funding (to T. P. M.); East Malling Trust (EMT) and Biotechnology and Biological Sciences Research Council (BBSRC) (to D.J.S. and E. L. G.); the Oregon State Agricultural Research Foundation #ARF4435 (to T. C. M.); the Oregon State Computational and Genome Biology Initiative (to T. C. M.); Oregon State University start-up fund (to P.J.); the Center for Genomics and Bioinformatics, supported in part by the METACyt Initiative of Indiana University (to K. M.); US National Institutes of Health (grant HG00783; to M. B.); USDA-CSREES National Research Initiative (NRI) Plant Genome Grant 2008-35300-04411 and New Hampshire Agricultural Experiment Station Project NH00535 (to T. M. D.); and USDA/ARS CRIS #1275-21000-180-01R (to J.P.S.).	Aharoni A, 2002, J EXP BOT, V53, P2073, DOI 10.1093/jxb/erf026; Alsheikh MK, 2002, PLANT CELL REP, V20, P1173, DOI 10.1007/s00299-002-0453-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; Bryant DW, 2010, BIOINFORMATICS, V26, P1500, DOI 10.1093/bioinformatics/btq206; Cabrera A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-562; Choisne N, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-20; Daniell H, 2008, THEOR APPL GENET, V116, P723, DOI 10.1007/s00122-007-0706-y; Darrow GM, 1966, STRAWBERRY HIST BREE; Davis TM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-81; Davis TM, 1997, J HERED, V88, P215, DOI 10.1093/oxfordjournals.jhered.a023091; Dempsey DA, 1998, TRENDS MICROBIOL, V6, P54, DOI 10.1016/S0966-842X(97)01186-4; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Endress PK, 2006, PLANT SYST EVOL, V260, P223, DOI 10.1007/s00606-006-0444-7; Folta KM, 2010, PLANT GENOME-US, V3, P90, DOI 10.3835/plantgenome2010.02.0003; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Klessig DF, 2000, P NATL ACAD SCI USA, V97, P8849, DOI 10.1073/pnas.97.16.8849; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lim KY, 2004, ACTA HORTIC, P103, DOI 10.17660/ActaHortic.2004.649.18; Liu B, 2006, INT J PLANT SCI, V167, P367, DOI 10.1086/499317; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Oosumi T, 2006, PLANTA, V223, P1219, DOI 10.1007/s00425-005-0170-3; Oosumi T, 2010, PHYSIOL PLANTARUM, V140, P1, DOI 10.1111/j.1399-3054.2010.01378.x; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pontaroli AC, 2009, PLANT GENOME-US, V2, P93, DOI 10.3835/plantgenome2008.09.0007; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; QUI YL, 2010, J SYST EVOL, V48, P391; Renoult JP, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-248; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ruiz-Rojas JJ, 2010, THEOR APPL GENET, V121, P449, DOI 10.1007/s00122-010-1322-9; Sargent DJ, 2008, GENOME, V51, P120, DOI [10.1139/G07-107, 10.1139/g07-107]; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Shulaev V, 2008, PLANT PHYSIOL, V147, P985, DOI 10.1104/pp.107.115618; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tian YY, 2007, NUCLEIC ACIDS RES, V35, pD328, DOI 10.1093/nar/gkl905; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wachter A, 2007, PLANT CELL, V19, P3437, DOI 10.1105/tpc.107.053645; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Wei YL, 2007, MOL BIOL REP, V34, P105, DOI 10.1007/s11033-006-9024-8; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Wurdack KJ, 2009, AM J BOT, V96, P1551, DOI 10.3732/ajb.0800207; Yoshida K, 2008, PLANT CELL PHYSIOL, V49, P157, DOI 10.1093/pcp/pcn009; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu XY, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-217; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	61	843	900	6	263	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2011	43	2					109	116		10.1038/ng.740	http://dx.doi.org/10.1038/ng.740			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	711XD	21186353	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000286623800007
J	Wang, HJ; Li, ZY; Liu, Y; Persson, J; Beyer, I; Moller, T; Koyuncu, D; Drescher, MR; Strauss, R; Zhang, XB; Wahl, JK; Urban, N; Drescher, C; Hemminki, A; Fender, P; Lieber, A				Wang, Hongjie; Li, Zong-Yi; Liu, Ying; Persson, Jonas; Beyer, Ines; Moeller, Thomas; Koyuncu, Dilara; Drescher, Max R.; Strauss, Robert; Zhang, Xiao-Bing; Wahl, James K., III; Urban, Nicole; Drescher, Charles; Hemminki, Akseli; Fender, Pascal; Lieber, Andre			Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14	NATURE MEDICINE			English	Article							CELLULAR ATTACHMENT RECEPTORS; GENE-TRANSFER; FIBER KNOB; DESMOSOMAL CADHERINS; B ADENOVIRUSES; BINDING-SITES; CELLS; CD46; CANCER; EXPRESSION	We have identified desmoglein-2 (DSG-2) as the primary high-affinity receptor used by adenoviruses Ad3, Ad7, Ad11 and Ad14. These serotypes represent key human pathogens causing respiratory and urinary tract infections. In epithelial cells, adenovirus binding of DSG-2 triggers events reminiscent of epithelial-to-mesenchymal transition, leading to transient opening of intercellular junctions. This opening improves access to receptors, for example, CD46 and Her2/neu, that are trapped in intercellular junctions. In addition to complete virions, dodecahedral particles (PtDds), formed by excess amounts of viral capsid proteins, penton base and fiber during viral replication, can trigger DSG-2-mediated opening of intercellular junctions as shown by studies with recombinant Ad3 PtDds. Our findings shed light on adenovirus biology and pathogenesis and may have implications for cancer therapy.	[Wang, Hongjie; Li, Zong-Yi; Liu, Ying; Persson, Jonas; Beyer, Ines; Drescher, Max R.; Strauss, Robert; Lieber, Andre] Univ Washington, Div Med Genet, Seattle, WA 98195 USA; [Wang, Hongjie; Hemminki, Akseli] Univ Helsinki, Canc Gene Therapy Grp, Helsinki, Finland; [Wang, Hongjie; Hemminki, Akseli] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Moeller, Thomas] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Koyuncu, Dilara] Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey; [Zhang, Xiao-Bing] Loma Linda Univ, Dept Med, Div Regenerat Med, Loma Linda, CA 92350 USA; [Wahl, James K., III] Univ Nebraska Med Ctr, Omaha, NE USA; [Urban, Nicole; Drescher, Charles] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Fender, Pascal] Unit Virus Host Cell Interact, Grenoble, France	University of Washington; University of Washington Seattle; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Washington; University of Washington Seattle; Bogazici University; Loma Linda University; University of Nebraska System; University of Nebraska Medical Center; Fred Hutchinson Cancer Center; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Lieber, A (corresponding author), Univ Washington, Div Med Genet, Seattle, WA 98195 USA.	lieber00@u.washington.edu	Beyer, Ines/Q-3236-2017	Beyer, Ines/0000-0001-7468-4466; Zhang, Xiao-Bing/0000-0003-4319-6181; Lieber, Andre/0000-0001-6742-6266; Fender, Pascal/0000-0002-6698-3367	US National Institutes of Health [R01 CA080192, R01 HLA078836]; Pacific Ovarian Cancer Research Consortium/Specialized Program of Research Excellence in Ovarian Cancer [P50 CA83636]; NATIONAL CANCER INSTITUTE [R01CA144057, R01CA136487, R01CA080192, P50CA083636] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI072774] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pacific Ovarian Cancer Research Consortium/Specialized Program of Research Excellence in Ovarian Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US National Institutes of Health grants R01 CA080192 and R01 HLA078836 and Pacific Ovarian Cancer Research Consortium/Specialized Program of Research Excellence in Ovarian Cancer Grant P50 CA83636. We thank R. van Rensburg for critical comments and the Functional Genomics Core at the Center for Ecogenetics and Environmental Health, School of Public Health University of Washington for array analysis.	Abbod MF, 2009, EXPERT REV ANTICANC, V9, P867, DOI [10.1586/era.09.47, 10.1586/ERA.09.47]; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Biedermann K, 2005, J PATHOL, V207, P199, DOI 10.1002/path.1821; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Chitaev NA, 1997, J CELL BIOL, V138, P193, DOI 10.1083/jcb.138.1.193; COWIN P, 1994, P NATL ACAD SCI USA, V91, P10759, DOI 10.1073/pnas.91.23.10759; Coyne CB, 2007, CELL HOST MICROBE, V2, P181, DOI 10.1016/j.chom.2007.07.003; Coyne CB, 2005, ADV DRUG DELIVER REV, V57, P869, DOI 10.1016/j.addr.2005.01.007; DIGUILMI AM, 1995, VIRUS RES, V38, P71, DOI 10.1016/0168-1702(95)00043-P; Fender P, 1997, NAT BIOTECHNOL, V15, P52, DOI 10.1038/nbt0197-52; Fender P, 2005, VIROLOGY, V340, P167, DOI 10.1016/j.virol.2005.06.030; Fleischli C, 2007, J GEN VIROL, V88, P2925, DOI 10.1099/vir.0.83142-0; Fuschiotti P, 2006, J MOL BIOL, V356, P510, DOI 10.1016/j.jmb.2005.11.048; Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952; Gaggar Anuj, 2007, Methods Mol Med, V131, P141; Gao WT, 2003, CANCER GENE THER, V10, pS21; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; Green SK, 2002, CANCER RES, V62, P6891; Gustafsson DJ, 2006, J VIROL, V80, P1897, DOI 10.1128/JVI.80.4.1897-1905.2006; Harada H, 1996, ACTA DERM-VENEREOL, V76, P417; Keim SA, 2008, HYBRIDOMA, V27, P249, DOI 10.1089/hyb.2008.0020; Khatri P, 2006, NUCLEIC ACIDS RES, V34, pW626, DOI 10.1093/nar/gkl213; KOWALCZYK AP, 1994, BIOPHYS CHEM, V50, P97, DOI 10.1016/0301-4622(94)85023-2; Leopold PL, 2007, ADV DRUG DELIVER REV, V59, P810, DOI 10.1016/j.addr.2007.06.007; Li Z, 2009, BLOOD, V113, P5423, DOI 10.1182/blood-2008-10-187237; Louie JK, 2008, CLIN INFECT DIS, V46, P421, DOI 10.1086/525261; Mahoney MG, 2002, EXP DERMATOL, V11, P115, DOI 10.1034/j.1600-0625.2002.110203.x; Marttila M, 2005, J VIROL, V79, P14429, DOI 10.1128/JVI.79.22.14429-14436.2005; Nava P, 2007, MOL BIOL CELL, V18, P4565, DOI 10.1091/mbc.E07-05-0426; NORRBY E., 1967, J VIROL, V1, P1101; Persson BD, 2009, J VIROL, V83, P673, DOI 10.1128/JVI.01967-08; SCHAFER S, 1994, EXP CELL RES, V211, P391, DOI 10.1006/excr.1994.1103; Schlegel N, 2010, AM J PHYSIOL-GASTR L, V298, pG774, DOI 10.1152/ajpgi.00239.2009; Schmitt CJ, 2007, J INVEST DERMATOL, V127, P2191, DOI 10.1038/sj.jid.5700849; Segerman A, 2003, J VIROL, V77, P1157, DOI 10.1128/JVI.77.2.1157-1162.2003; Seppen J, 2001, BLOOD, V98, P594, DOI 10.1182/blood.V98.3.594; Shayakhmetov DM, 2000, J VIROL, V74, P2567, DOI 10.1128/JVI.74.6.2567-2583.2000; Short JJ, 2004, VIROLOGY, V322, P349, DOI 10.1016/j.virol.2004.02.016; Short JJ, 2006, VIRUS RES, V122, P144, DOI 10.1016/j.virusres.2006.07.009; Sirena D, 2004, J VIROL, V78, P4454, DOI 10.1128/JVI.78.9.4454-4462.2004; Strauss R, 2009, CANCER RES, V69, P5115, DOI 10.1158/0008-5472.CAN-09-0645; Tate JE, 2009, J INFECT DIS, V199, P1419, DOI 10.1086/598520; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Trojan L, 2005, ANTICANCER RES, V25, P183; Turley EA, 2008, NAT CLIN PRACT ONCOL, V5, P280, DOI 10.1038/ncponc1089; Tuve S, 2007, CANCER RES, V67, P5929, DOI 10.1158/0008-5472.CAN-06-4296; Tuve S, 2006, J VIROL, V80, P12109, DOI 10.1128/JVI.01370-06; Tuve S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000189; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang HJ, 2008, J VIROL, V82, P10567, DOI 10.1128/JVI.01308-08; Wang HJ, 2007, J VIROL, V81, P12785, DOI 10.1128/JVI.01732-07; Wang HJ, 2010, BLOOD, V115, P592, DOI 10.1182/blood-2009-05-222463; Wang HJ, 2009, VIROLOGY, V387, P436, DOI 10.1016/j.virol.2009.02.034; Yamamoto M, 2010, MOL THER, V18, P243, DOI 10.1038/mt.2009.266	54	274	288	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					96	U273		10.1038/nm.2270	http://dx.doi.org/10.1038/nm.2270			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21151137	Green Accepted			2022-12-25	WOS:000285994000041
J	Fujita, K; Horikawa, I; Mondal, AM; Jenkins, LMM; Appella, E; Vojtesek, B; Bourdon, JC; Lane, DP; Harris, CC				Fujita, Kaori; Horikawa, Izumi; Mondal, Abdul M.; Jenkins, Lisa M. Miller; Appella, Ettore; Vojtesek, Borivoj; Bourdon, Jean-Christophe; Lane, David P.; Harris, Curtis C.			Positive feedback between p53 and TRF2 during telomere-damage signalling and cellular senescence	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; BETA-CATENIN; STEM-CELLS; IN-VIVO; TUMOR SUPPRESSION; PROTEIN; UBIQUITIN; CANCER; DYSFUNCTION; SIAH-1	The telomere-capping complex shelterin protects functional telomeres and prevents the initiation of unwanted DNA-damage-response pathways. At the end of cellular replicative lifespan, uncapped telomeres lose this protective mechanism and DNA-damage signalling pathways are triggered that activate p53 and thereby induce replicative senescence. Here, we identify a signalling pathway involving p53, Siah1 (a p53-inducible E3 ubiquitin ligase) and TRF2 (telomere repeat binding factor 2; a component of the shelterin complex). Endogenous Siah1 and TRF2 were upregulated and downregulated, respectively, during replicative senescence with activated p53. Experimental manipulation of p53 expression demonstrated that p53 induces Siah1 and represses TRF2 protein levels. The p53-dependent ubiquitylation and proteasomal degradation of TRF2 are attributed to the E3 ligase activity of Siah1. Knockdown of Siah1 stabilized TRF2 and delayed the onset of cellular replicative senescence, suggesting a role for Siah1 and TRF2 in p53-regulated senescence. This study reveals that p53, a downstream effector of telomere-initiated damage signalling, also functions upstream of the shelterin complex.	[Fujita, Kaori; Horikawa, Izumi; Mondal, Abdul M.; Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Jenkins, Lisa M. Miller; Appella, Ettore] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Vojtesek, Borivoj] Masaryk Mem Canc Inst, Brno 65653, Czech Republic; [Bourdon, Jean-Christophe; Lane, David P.] Univ Dundee, Ninewells Hosp, Dept Surg & Mol Oncol, Inserm European Associated Lab, Dundee DD1 9SY, Scotland; [Lane, David P.] Inst Mol & Cell Biol, Singapore 138673, Singapore	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Masaryk Memorial Cancer Institute; University of Dundee; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Harris, CC (corresponding author), NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, 37 Convent Dr, Bethesda, MD 20892 USA.	curtis_harris@nih.gov	JC, Bourdon/A-4439-2008; Jenkins, Lisa/AAI-2490-2021	JC, Bourdon/0000-0003-4623-9386; Lane, David/0000-0003-0551-3545	NIH, NCI; Grant Agency of the Czech Republic [301/08/1468]; Internal Grant Agency of Health of Czech Republic [NS/9812-4]; Breast Cancer Campaign; Cancer-Research UK; Institut National de la Sante et de la Recherche Medicale; NATIONAL CANCER INSTITUTE [ZIABC005795, ZIABC005599] Funding Source: NIH RePORTER	NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Internal Grant Agency of Health of Czech Republic; Breast Cancer Campaign; Cancer-Research UK(Cancer Research UK); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Tainsky, B. Vogelstein and T. de Lange for cells and reagents. We also thank K. Kumamoto for carrying out Nutlin-3a treatment, A. Robles for carrying out doxorubicin treatment of lymphoblast cells, M. Yoneda for technical assistance and E. Spillare for continuous support. This research was supported in part by the Intramural Research Program of the NIH, NCI. B.V. was supported by the grants from the Grant Agency of the Czech Republic (number 301/08/1468) and the Internal Grant Agency of Health of Czech Republic (number NS/9812-4). J.C.B. was supported by Breast Cancer Campaign, Cancer-Research UK and the Institut National de la Sante et de la Recherche Medicale. D.L. is a Gibb fellow of Cancer-Research UK.	Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; Begus-Nahrmann Y, 2009, NAT GENET, V41, P1138, DOI 10.1038/ng.426; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; BISCHOFF FZ, 1990, CANCER RES, V50, P7979; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Buolamwini JK, 2005, CURR CANCER DRUG TAR, V5, P57, DOI 10.2174/1568009053332672; Buscemi G, 2009, CURR BIOL, V19, P874, DOI 10.1016/j.cub.2009.03.064; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Cosme-Blanco W, 2007, EMBO REP, V8, P497, DOI 10.1038/sj.embor.7400937; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; D'Alcontres MS, 2007, J CELL BIOL, V179, P855, DOI 10.1083/jcb.200703020; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; Dimitrova YN, 2010, J BIOL CHEM, V285, P13507, DOI 10.1074/jbc.M109.049411; Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026; Frew IJ, 2002, MOL CELL BIOL, V22, P8155, DOI 10.1128/MCB.22.23.8155-8164.2002; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hu G, 1999, MOL CELL BIOL, V19, P724; Jacobs JJL, 2004, CURR BIOL, V14, P2302, DOI 10.1016/j.cub.2004.12.025; Jeram SM, 2009, PROTEOMICS, V9, P922, DOI 10.1002/pmic.200800666; Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Katoh S, 2003, J BIOL CHEM, V278, P15341, DOI 10.1074/jbc.M210531200; Lechel A, 2005, EMBO REP, V6, P275, DOI 10.1038/sj.embor.7400352; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Munoz P, 2006, CELL CYCLE, V5, P718, DOI 10.4161/cc.5.7.2636; Nalapareddy K, 2008, EXP GERONTOL, V43, P998, DOI 10.1016/j.exger.2008.09.002; Robles AI, 2006, CLIN CANCER RES, V12, P6547, DOI 10.1158/1078-0432.CCR-06-1178; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Roperch JP, 1999, P NATL ACAD SCI USA, V96, P8070, DOI 10.1073/pnas.96.14.8070; Sengupta S, 2003, EMBO J, V22, P1210, DOI 10.1093/emboj/cdg114; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433; Stansel RM, 2001, EMBO J, V20, P5532; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Tanikawa J, 2000, J BIOL CHEM, V275, P15578, DOI 10.1074/jbc.M000372200; Telerman A, 2009, NAT REV CANCER, V9, P206, DOI 10.1038/nrc2589; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592; Yang Q, 2005, MOL CELL BIOL, V25, P1070, DOI 10.1128/MCB.25.3.1070-1080.2005; Yang Q, 2007, CANCER RES, V67, P11677, DOI 10.1158/0008-5472.CAN-07-1390; Zhang TL, 2007, CELL CYCLE, V6, P85, DOI 10.4161/cc.6.1.3705; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	59	72	74	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2010	12	12					1205	U196		10.1038/ncb2123	http://dx.doi.org/10.1038/ncb2123			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	688DY	21057505	Green Accepted			2022-12-25	WOS:000284831200012
J	He, L; Wang, XB; Tang, HL; Montell, DJ				He, Li; Wang, Xiaobo; Tang, Ho Lam; Montell, Denise J.			Tissue elongation requires oscillating contractions of a basal actomyosin network	NATURE CELL BIOLOGY			English	Article							CELL-SHAPE; APICAL CONSTRICTION; FOLLICLE CELLS; DROSOPHILA; MORPHOGENESIS; POLARITY; CYTOSKELETON; MECHANISM; MIGRATION; DYNAMICS	Understanding how molecular dynamics leads to cellular behaviours that ultimately sculpt organs and tissues is a major challenge not only in basic developmental biology but also in tissue engineering and regenerative medicine. Here we use live imaging to show that the basal surfaces of Drosophila follicle cells undergo a series of directional, oscillating contractions driven by periodic myosin accumulation on a polarized actin network. Inhibition of the actomyosin contractions or their coupling to extracellular matrix (ECM) blocked elongation of the whole tissue, whereas enhancement of the contractions exaggerated it. Myosin accumulated in a periodic manner before each contraction and was regulated by the small GTPase Rho, its downstream kinase, ROCK, and cytosolic calcium. Disrupting the link between the actin cytoskeleton and the ECM decreased the amplitude and period of the contractions, whereas enhancing cell-ECM adhesion increased them. In contrast, disrupting cell-cell adhesions resulted in loss of the actin network. Our findings reveal a mechanism controlling organ shape and an experimental model for the study of the effects of oscillatory actomyosin activity within a coherent cell sheet.	[He, Li; Wang, Xiaobo; Tang, Ho Lam; Montell, Denise J.] Johns Hopkins Sch Med, Dept Biol Chem, Ctr Cell Dynam, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Montell, DJ (corresponding author), Johns Hopkins Sch Med, Dept Biol Chem, Ctr Cell Dynam, 855 N Wolfe St, Baltimore, MD 21205 USA.	dmontell@jhmi.edu	Wang, Xiaobo/A-8604-2011	Wang, Xiaobo/0000-0002-3311-1378; HE, LI/0000-0003-2155-606X	National Institute of General Medical Sciences [R01 GM46425, GM73164]; Cell Migration Consortium; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073164, R01GM046425] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cell Migration Consortium; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Doug Robinson for invaluable discussions, critical reading of the manuscript and help with writing the discussion of the myosin oscillation mechanism. Nick Brown and Eric Wieschaus generously donated reagents. This work was supported by grants to D.J.M. from the National Institute of General Medical Sciences including R01 GM46425, GM73164 and the Cell Migration Consortium. Bloomington Drosophila Stock Center and Vienna Drosophila RNAi Center resources contributed to this work. FlyBase provided important information used in this work. Clones provided by the Berkeley Drosophila Genome Project and distributed by Drosophila Genetic Resource Center were used.	Bateman J, 2001, CURR BIOL, V11, P1317, DOI 10.1016/S0960-9822(01)00420-1; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blanchard GB, 2010, DEVELOPMENT, V137, P2743, DOI 10.1242/dev.045872; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Conder R, 2007, DEV BIOL, V305, P470, DOI 10.1016/j.ydbio.2007.02.034; Conway WC, 2006, J CELL BIOCHEM, V98, P1507, DOI 10.1002/jcb.20819; David DJV, 2010, DEVELOPMENT, V137, P1645, DOI 10.1242/dev.044107; Delon I, 2009, J CELL SCI, V122, P4363, DOI 10.1242/jcs.055996; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Frydman HM, 2001, DEVELOPMENT, V128, P3209; Gutzeit H O, 1991, Acta Histochem Suppl, V41, P201; GUTZEIT HO, 1990, EUR J CELL BIOL, V53, P349; GUTZEIT HO, 1991, J CELL SCI, V100, P781; Hilgers RHP, 2005, EXP BIOL MED, V230, P829, DOI 10.1177/153537020523001107; Horne-Badovinac S, 2005, DEV DYNAM, V232, P559, DOI 10.1002/dvdy.20286; Kee YS, 2008, CURR BIOL, V18, pR860, DOI 10.1016/j.cub.2008.07.071; Kolahi KS, 2009, DEV BIOL, V331, P129, DOI 10.1016/j.ydbio.2009.04.028; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166; Martin AC, 2010, DEV BIOL, V341, P114, DOI 10.1016/j.ydbio.2009.10.031; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; McDonald Jocelyn A., 2004, V294, P175; Millan J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-11; Mirouse V, 2009, DEV CELL, V16, P83, DOI 10.1016/j.devcel.2008.11.006; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Oda H, 2001, J CELL SCI, V114, P493; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Prasad M, 2007, NAT PROTOC, V2, P2467, DOI 10.1038/nprot.2007.363; Prasad M, 2007, DEV CELL, V12, P997, DOI 10.1016/j.devcel.2007.03.021; Ren YX, 2009, CURR BIOL, V19, P1421, DOI 10.1016/j.cub.2009.07.018; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Viktorinova I, 2009, DEVELOPMENT, V136, P4123, DOI 10.1242/dev.039099; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Wang Y, 2007, CURR BIOL, V17, P1349, DOI 10.1016/j.cub.2007.06.067; Wu XD, 2008, SEMIN CELL DEV BIOL, V19, P271, DOI 10.1016/j.semcdb.2008.01.004	42	178	179	3	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2010	12	12					1133	U40		10.1038/ncb2124	http://dx.doi.org/10.1038/ncb2124			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	688DY	21102441	Green Accepted			2022-12-25	WOS:000284831200005
J	O'Rourke, SM; Christensen, SN; Bowerman, B				O'Rourke, Sean M.; Christensen, Sara N.; Bowerman, Bruce			Caenorhabditis elegans EFA-6 limits microtubule growth at the cell cortex	NATURE CELL BIOLOGY			English	Article							FUNCTIONAL-ANALYSIS; DYNAMIC INSTABILITY; EARLY EMBRYOGENESIS; CYTOPLASMIC DYNEIN; DEPENDENT FORCES; EXCHANGE FACTOR; SPINDLE; PROTEIN; KINETOCHORE; MEMBRANE	Microtubules are polymers of tubulin heterodimers that exhibit dynamic instability: periods of growth followed by periods of shrinkage(1). However, the molecular regulation of dynamic instability remains elusive. Here, we show that EFA-6, a cortically-localized protein(2), limits the growth of microtubules near the cell cortex of early embryonic cells from Caenorhabidits elegans, possibly by inducing microtubule catastrophes. Compared with wild type, embryos lacking EFA-6 had abnormally long and dense microtubules at the cell cortex, and growing microtubule plus ends resided at the cortex for up to five-fold longer. Loss of EFA-6 also caused excess centrosome separation and displacement towards the cell cortex early in mitosis, and subsequently a loss of anaphase spindle-pole oscillations and increased rates of spindle elongation. The centrosome separation phenotype was dependent on the motor protein dynein, suggesting a possible link between the modulation of microtubule dynamics at the cortex and dynein-dependent force production. EFA-6 orthologues activate ARF6-type GTPases to regulate vesicle trafficking(3). However, we show that only the C. elegans EFA-6 amino-terminus is both necessary and sufficient to limit microtubule growth along the cortex, and that this function is independent of ARF-6.	[O'Rourke, Sean M.; Christensen, Sara N.; Bowerman, Bruce] 1229 Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon	O'Rourke, SM (corresponding author), 1229 Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	seanor@molbio.uoregon.edu; bbowerman@molbio.uoregon.edu			Leukemia and Lymphoma Society of America; NIH [R01GM058017, R01GMO49869]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049869, R01GM058017] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Price, G. von Dassow, L Pelletier, and C. Doe for insightful discussions; M. Goulding and E. Munro for technical advice; S. Schneider for advice on taxonomical and sequence alignments; S. Mitani for isolating and providing efa-6(tm3124); V. Davis Haug for the mC-TBA-1 strain; and C. Doe and C. Cabernard for comments on the manuscript. S.M.O was supported by the Leukemia and Lymphoma Society of America, S.M.O. and B.B. are supported by NIH R01GM058017 and R01GMO49869.	BRENNER S, 1974, GENETICS, V77, P71; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Diogon M, 2007, DEVELOPMENT, V134, P2469, DOI 10.1242/dev.005074; Dorfman M, 2009, GENETICS, V182, P1035, DOI 10.1534/genetics.109.104885; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gassmann R, 2008, GENE DEV, V22, P2385, DOI 10.1101/gad.1687508; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Labbe JC, 2006, GENETICS, V174, P285, DOI 10.1534/genetics.106.060517; Macia E, 2008, J BIOL CHEM, V283, P19836, DOI 10.1074/jbc.M800781200; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; O'Rourke SM, 2007, PLOS GENET, V3, P1339, DOI 10.1371/journal.pgen.0030128; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Oegema Karen, 2006, WormBook, P1, DOI 10.1895/wormbook.1.72.1; Park D, 2008, GENOMICS, V92, P414, DOI 10.1016/j.ygeno.2008.08.001; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Phillips JB, 2004, CELL MOTIL CYTOSKEL, V58, P112, DOI 10.1002/cm.20003; Portereiko MF, 2001, DEV BIOL, V233, P482, DOI 10.1006/dbio.2001.0235; Praitis V, 2001, GENETICS, V157, P1217; SAMMAK PJ, 1988, NATURE, V332, P724, DOI 10.1038/332724a0; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; Schmidt DJ, 2005, MOL BIOL CELL, V16, P1200, DOI 10.1091/mbc.E04-06-0523; SCHULZE E, 1988, NATURE, V334, P356, DOI 10.1038/334356a0; Severson AF, 2003, J CELL BIOL, V161, P21, DOI 10.1083/jcb.200210171; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Skop AR, 1998, CURR BIOL, V8, P1110, DOI 10.1016/S0960-9822(98)70465-8; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035	40	44	49	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2010	12	12					1235	U271		10.1038/ncb2128	http://dx.doi.org/10.1038/ncb2128			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	688DY	21076413	Green Accepted			2022-12-25	WOS:000284831200016
J	Sun, LD; Cheng, H; Wang, ZX; Zhang, AP; Wang, PG; Xu, JH; Zhu, QX; Zhou, HS; Ellinghaus, E; Zhang, FR; Pu, XM; Yang, XQ; Zhang, JZ; Xu, AE; Wu, RN; Xu, LM; Peng, L; Helms, CA; Ren, YQ; Zhang, C; Zhang, SM; Nair, RP; Wang, HY; Lin, GS; Stuart, PE; Fan, X; Chen, G; Tejasvi, T; Li, P; Zhu, J; Li, ZM; Ge, HM; Weichenthal, M; Ye, WZ; Zhang, C; Shen, SK; Yang, BQ; Sun, YY; Li, SS; Lin, Y; Jiang, JH; Li, CT; Chen, RX; Cheng, JA; Jiang, X; Zhang, P; Song, WM; Tang, J; Zhang, HQ; Sun, L; Cui, J; Zhang, LJ; Tang, BA; Huang, F; Qin, QA; Pei, XP; Zhou, AM; Shao, LM; Liu, JL; Zhang, FY; Du, WD; Franke, A; Bowcock, AM; Elder, JT; Liu, JJ; Yang, S; Zhang, XJ				Sun, Liang-Dan; Cheng, Hui; Wang, Zai-Xing; Zhang, An-Ping; Wang, Pei-Guang; Xu, Jin-Hua; Zhu, Qi-Xing; Zhou, Hai-Sheng; Ellinghaus, Eva; Zhang, Fu-Ren; Pu, Xiong-Ming; Yang, Xue-Qin; Zhang, Jian-Zhong; Xu, Ai-E; Wu, Ri-Na; Xu, Li-Min; Peng, Lin; Helms, Cynthia A.; Ren, Yun-Qing; Zhang, Chi; Zhang, Shu-Mei; Nair, Rajan P.; Wang, Hong-Yan; Lin, Guo-Shu; Stuart, Philip E.; Fan, Xing; Chen, Gang; Tejasvi, Trilokraj; Li, Pan; Zhu, Jun; Li, Zhi-Ming; Ge, Hong-Mei; Weichenthal, Michael; Ye, Wen-Zheng; Zhang, Cheng; Shen, Song-Ke; Yang, Bao-Qi; Sun, Yuan-Yuan; Li, Shan-Shan; Lin, Yan; Jiang, Jian-Hua; Li, Cun-Tao; Chen, Ri-Xin; Cheng, Juan; Jiang, Xin; Zhang, Peng; Song, Wei-Min; Tang, Jin; Zhang, Hao-Qin; Sun, Li; Cui, Jing; Zhang, Li-Jun; Tang, Biao; Huang, Fei; Qin, Qian; Pei, Xiao-Ping; Zhou, Ai-Min; Shao, Li-Mei; Liu, Jian-Lan; Zhang, Feng-Yu; Du, Wei-Dong; Franke, Andre; Bowcock, Anne M.; Elder, James T.; Liu, Jian-Jun; Yang, Sen; Zhang, Xue-Jun			Association analyses identify six new psoriasis susceptibility loci in the Chinese population	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ENDOTHELIAL GROWTH-FACTOR; GENE-CLUSTER; IDENTIFICATION; EXPRESSION; VARIANTS; SYSTEM; ERAP1	We extended our previous genome-wide association study for psoriasis with a multistage replication study including 8,312 individuals with psoriasis (cases) and 12,919 controls from China as well as 3,293 cases and 4,188 controls from Germany and the United States and 254 nuclear families from the United States. We identified six new susceptibility loci associated with psoriasis in the Chinese study containing the candidate genes ERAP1, PTTG1, CSMD1, GJB2, SERPINB8 and ZNF816A (combined P < 5 x 10(-8)) and replicated one locus, 5q33.1 (TNIP1-ANXA6), previously reported (combined P = 3.8 x 10(-21)) in the European studies. Two of these loci showed evidence for association in the German study at ZNF816A and GJB2 with P = 3.6 x 10(-3) and P = 7.9 x 10(-3), respectively. ERAP1 and ZNF816A were associated with type 1 (early onset) psoriasis in the Chinese Han population (test for heterogeneity P = 6.5 x 10(-3) and P = 1.5 x 10(-3), respectively). Comparisons with the results of previous GWAS of psoriasis highlight the heterogeneity of disease susceptibility between the Chinese and European populations. Our study identifies new genetic susceptibility factors and suggests new biological pathways in psoriasis.	[Sun, Liang-Dan; Cheng, Hui; Wang, Zai-Xing; Zhang, An-Ping; Wang, Pei-Guang; Zhu, Qi-Xing; Ren, Yun-Qing; Zhang, Chi; Zhang, Shu-Mei; Wang, Hong-Yan; Lin, Guo-Shu; Fan, Xing; Li, Pan; Zhu, Jun; Li, Zhi-Ming; Ge, Hong-Mei; Ye, Wen-Zheng; Zhang, Cheng; Shen, Song-Ke; Sun, Yuan-Yuan; Li, Shan-Shan; Lin, Yan; Li, Cun-Tao; Chen, Ri-Xin; Jiang, Xin; Zhang, Peng; Tang, Jin; Zhang, Hao-Qin; Cui, Jing; Zhang, Li-Jun; Tang, Biao; Huang, Fei; Qin, Qian; Pei, Xiao-Ping; Shao, Li-Mei; Liu, Jian-Lan; Zhang, Feng-Yu; Du, Wei-Dong; Liu, Jian-Jun; Yang, Sen; Zhang, Xue-Jun] Anhui Med Univ, Inst Dermatol, Hosp 1, Hefei, Anhui, Peoples R China; [Sun, Liang-Dan; Cheng, Hui; Wang, Zai-Xing; Zhang, An-Ping; Wang, Pei-Guang; Zhu, Qi-Xing; Ren, Yun-Qing; Zhang, Chi; Zhang, Shu-Mei; Wang, Hong-Yan; Lin, Guo-Shu; Fan, Xing; Li, Pan; Zhu, Jun; Li, Zhi-Ming; Ge, Hong-Mei; Ye, Wen-Zheng; Zhang, Cheng; Shen, Song-Ke; Sun, Yuan-Yuan; Li, Shan-Shan; Lin, Yan; Li, Cun-Tao; Chen, Ri-Xin; Jiang, Xin; Zhang, Peng; Tang, Jin; Zhang, Hao-Qin; Cui, Jing; Zhang, Li-Jun; Tang, Biao; Huang, Fei; Qin, Qian; Pei, Xiao-Ping; Shao, Li-Mei; Liu, Jian-Lan; Zhang, Feng-Yu; Du, Wei-Dong; Liu, Jian-Jun; Yang, Sen; Zhang, Xue-Jun] Anhui Med Univ, Dept Dermatol, Hosp 1, Hefei, Anhui, Peoples R China; [Sun, Liang-Dan; Cheng, Hui; Wang, Zai-Xing; Zhang, An-Ping; Wang, Pei-Guang; Zhu, Qi-Xing; Zhang, Fu-Ren; Pu, Xiong-Ming; Yang, Xue-Qin; Xu, Ai-E; Ren, Yun-Qing; Zhang, Chi; Wang, Hong-Yan; Lin, Guo-Shu; Fan, Xing; Chen, Gang; Li, Pan; Zhu, Jun; Li, Zhi-Ming; Ge, Hong-Mei; Ye, Wen-Zheng; Zhang, Cheng; Shen, Song-Ke; Sun, Yuan-Yuan; Li, Shan-Shan; Lin, Yan; Li, Cun-Tao; Chen, Ri-Xin; Jiang, Xin; Zhang, Peng; Tang, Jin; Zhang, Hao-Qin; Cui, Jing; Zhang, Li-Jun; Tang, Biao; Huang, Fei; Qin, Qian; Pei, Xiao-Ping; Shao, Li-Mei; Liu, Jian-Lan; Yang, Sen; Zhang, Xue-Jun] Anhui Med Univ, Dept Dermatol & Venereol, Hefei, Anhui, Peoples R China; [Sun, Liang-Dan; Cheng, Hui; Wang, Zai-Xing; Zhang, An-Ping; Wang, Pei-Guang; Zhu, Qi-Xing; Zhou, Hai-Sheng; Ren, Yun-Qing; Zhang, Chi; Zhang, Shu-Mei; Wang, Hong-Yan; Lin, Guo-Shu; Fan, Xing; Chen, Gang; Li, Pan; Zhu, Jun; Li, Zhi-Ming; Ge, Hong-Mei; Ye, Wen-Zheng; Zhang, Cheng; Shen, Song-Ke; Sun, Yuan-Yuan; Li, Shan-Shan; Lin, Yan; Li, Cun-Tao; Chen, Ri-Xin; Jiang, Xin; Zhang, Peng; Tang, Jin; Zhang, Hao-Qin; Cui, Jing; Zhang, Li-Jun; Tang, Biao; Huang, Fei; Qin, Qian; Pei, Xiao-Ping; Shao, Li-Mei; Liu, Jian-Lan; Zhang, Feng-Yu; Du, Wei-Dong; Liu, Jian-Jun; Yang, Sen; Zhang, Xue-Jun] Minist Natl Sci & Technol, State Key Lab Incubat Base Dermatol, Hefei, Anhui, Peoples R China; [Xu, Jin-Hua; Zhang, Xue-Jun] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China; [Zhou, Hai-Sheng] Anhui Med Univ, Dept Biochem & Mol Biol, Hefei, Anhui, Peoples R China; [Ellinghaus, Eva; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Zhang, Fu-Ren; Yang, Bao-Qi] Shandong Prov Inst Dermatol & Venereol, Jinan, Shandong, Peoples R China; [Pu, Xiong-Ming; Jiang, Jian-Hua] Peoples Hosp Xinjiang Uygur Autonomous Reg, Dept Dermatol, Urumqi, Xinjiang, Peoples R China; [Yang, Xue-Qin; Cheng, Juan] Gen Hosp Air Force, Dept Dermatol, Beijing, Peoples R China; [Zhang, Jian-Zhong] Peking Univ, Peoples Hosp, Dept Dermatol, Beijing 100871, Peoples R China; [Xu, Ai-E; Song, Wei-Min] Third Peoples Hosp Hangzhou, Hangzhou, Zhejiang, Peoples R China; [Wu, Ri-Na] Affiliated Hosp, Inner Mongolia Med Coll, Dept Dermatol, Hohhot, Inner Mongolia, Peoples R China; [Xu, Li-Min; Zhou, Ai-Min] Changzheng Hosp, Dept Dermatol, Tianjin, Peoples R China; [Peng, Lin; Helms, Cynthia A.; Bowcock, Anne M.] Washington Univ, Sch Med, Div Human Genet, St Louis, MO USA; [Nair, Rajan P.; Stuart, Philip E.; Tejasvi, Trilokraj; Elder, James T.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Weichenthal, Michael] Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany; [Liu, Jian-Jun] Genome Inst Singapore, Singapore, Singapore	Anhui Medical University; Anhui Medical University; Anhui Medical University; Fudan University; Anhui Medical University; University of Kiel; Shandong First Medical University & Shandong Academy of Medical Sciences; Peking University; Inner Mongolia Medical University; Naval Medical University; Washington University (WUSTL); University of Michigan System; University of Michigan; University of Kiel; Schleswig Holstein University Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Zhang, XJ (corresponding author), Anhui Med Univ, Inst Dermatol, Hosp 1, Hefei, Anhui, Peoples R China.	ayzxj@vip.sina.com	Weichenthal, Michael/A-5692-2009; Ellinghaus, Eva/E-6490-2012; Chen, Gang/G-2722-2010; Zhang, Fengyu/M-1396-2019; Franke, Andre/B-2151-2010; Liu, Jianjun/AAK-4989-2020; Pillay, Nischalan/F-9536-2012; Zhu, Qixing/AAM-4214-2020; Lin, P/G-7702-2014	Ellinghaus, Eva/0000-0003-2914-3382; Zhang, Fengyu/0000-0001-8504-0770; Franke, Andre/0000-0003-1530-5811; Liu, Jianjun/0000-0002-3255-3019; Bowcock, Anne/0000-0001-8691-9090	High-Tech Research and Development Program of China [2007AA02Z161]; Natural Science Foundation of China [30530670, 30771196, 30771942, 30800990, 81072461, 81071285, 30972727, 30800610, 81000691]; US National Institutes of Health (NIH) [R01AR050266, R01AR42742, R01AR054966, R01AR050511]; German Ministry of Education; National Genome Research Network [BMFT 01GS 0171, BMBF NUW-S23T10]; National Psoriasis Foundation of the US; Agency for Science, Technology and Research of Singapore; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050266, R01AR050511, R01AR042742, R01AR054966] Funding Source: NIH RePORTER	High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Ministry of Education; National Genome Research Network; National Psoriasis Foundation of the US; Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the individuals and their families who participated in this project; the study staff; S.-H. Duan for her contribution to the genotyping; and X.-B. Zuo for his help in creating the GWAS database, the data processing and the statistical analysis. This study was funded by the High-Tech Research and Development Program of China (863 Plan) (2007AA02Z161), the Key Project of Natural Science Foundation of China (30530670), Anhui Provincial Special Scientific Program (2007-7), the National Basic Research Program of China (973 Plan) (2007B516801), the General Program of National Natural Science Foundation of China (30771196, 30771942, 30800990, 81072461, 81071285, 30972727, 30800610 and 81000691), US National Institutes of Health (NIH) grant R01AR050266 (to A. M. B.), NIH grants R01AR42742, R01AR050511 and R01AR054966 (to J.T.E.), the German Ministry of Education and Research through the National Genome Research Network (BMFT 01GS 0171/BMBF NUW-S23T10), the National Psoriasis Foundation of the US and the Agency for Science, Technology and Research of Singapore.	Bourgain C, 2003, AM J HUM GENET, V73, P612, DOI 10.1086/378208; Bowcock AM, 2001, HUM MOL GENET, V10, P1793, DOI 10.1093/hmg/10.17.1793; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Davidson SI, 2009, ARTHRITIS RHEUM-US, V60, P3263, DOI 10.1002/art.24933; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Djalilian AR, 2006, J CLIN INVEST, V116, P1243, DOI 10.1172/JCI27186; Enerback C, 1997, J INVEST DERMATOL, V109, P695, DOI 10.1111/1523-1747.ep12338329; Espina AG, 2009, MOL BIOL CELL, V20, P3353, DOI 10.1091/mbc.E08-09-0965; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Graham RR, 2009, J INTERN MED, V265, P680, DOI 10.1111/j.1365-2796.2009.02096.x; Grewal T, 2009, CELL SIGNAL, V21, P847, DOI 10.1016/j.cellsig.2009.01.031; Haider AS, 2008, J IMMUNOL, V180, P1913, DOI 10.4049/jimmunol.180.3.1913; Hamid T, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-3; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Harvey D, 2009, HUM MOL GENET, V18, P4204, DOI 10.1093/hmg/ddp371; Helms C, 2005, HUM GENET, V118, P466, DOI 10.1007/s00439-005-0048-2; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huffmeier U, 2009, J MED GENET, V46, P736, DOI 10.1136/jmg.2008.065029; Hunter JAC, 2003, EUR J ENDOCRINOL, V148, P203, DOI 10.1530/eje.0.1480203; Kamal M, 2010, BREAST CANCER RES TR, V121, P555, DOI 10.1007/s10549-009-0500-4; Kraus DM, 2006, J IMMUNOL, V176, P4419, DOI 10.4049/jimmunol.176.7.4419; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; MANTEL N, 1959, J NATL CANCER I, V22, P719; Meyer-Hoffert U, 2004, J INVEST DERMATOL, V123, P338, DOI 10.1111/j.0022-202X.2004.23202.x; Meyer-Hoffert U, 2009, ARCH IMMUNOL THER EX, V57, P345, DOI 10.1007/s00005-009-0045-6; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Serwold T, 2001, NAT IMMUNOL, V2, P644, DOI 10.1038/89800; Smith RLL, 2009, GENOME MED, V1, DOI 10.1186/gm72; Speckman RA, 2003, HUM GENET, V112, P34, DOI 10.1007/s00439-002-0851-y; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Thornton T, 2007, AM J HUM GENET, V81, P321, DOI 10.1086/519497; Young HS, 2004, J INVEST DERMATOL, V122, P209, DOI 10.1046/j.0022-202X.2003.22107.x; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang MT, 2009, J INFRARED MILLIM W, V28, P173, DOI 10.3724/SP.J.1010.2009.00173; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310	41	240	262	2	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					1005	U132		10.1038/ng.690	http://dx.doi.org/10.1038/ng.690			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20953187	Green Accepted			2022-12-25	WOS:000283540500020
J	Mazumdar, J; O'Brien, WT; Johnson, RS; LaManna, JC; Chavez, JC; Klein, PS; Simon, MC				Mazumdar, Jolly; O'Brien, W. Timothy; Johnson, Randall S.; LaManna, Joseph C.; Chavez, Juan C.; Klein, Peter S.; Simon, M. Celeste			O-2 regulates stem cells through Wnt/beta-catenin signalling	NATURE CELL BIOLOGY			English	Article							BETA-CATENIN; HEMATOPOIETIC STEM; VASCULAR NICHE; HYPOXIA; TRANSCRIPTION; HIF-2-ALPHA; HIF-1-ALPHA; DIFFERENTIATION; PROLIFERATION; ANGIOGENESIS	Stem cells reside in specialized microenvironments or 'niches' that regulate their function. In vitro studies using hypoxic culture conditions (< 5% O-2) have revealed strong regulatory links between O-2 availability and functions of stem and precursor cells(1-6). Although some stem cells are perivascular, others may occupy hypoxic niches and be regulated by O-2 gradients. However, the underlying mechanisms remain unclear. Here, we show that hypoxia inducible factor-1 alpha (HIF-1 alpha), a principal mediator of hypoxic adaptations, modulates Wnt/beta-catenin signalling in hypoxic embryonic stem (ES) cells by enhancing beta-catenin activation and expression of the downstream effectors LEF-1 and TCF-1. This regulation extends to primary cells, including isolated neural stem cells (NSCs), and is not observed in differentiated cells. In vivo, Wnt/beta-catenin activity is closely associated with low O-2 regions in the subgranular zone of the hippocampus, a key NSC niche(7). Hif-1 alpha deletion impairs hippocampal Wnt-dependent processes, including NSC proliferation, differentiation and neuronal maturation. This decline correlates with reduced Wnt/beta-catenin signalling in the subgranular zone. O-2 availability, therefore, may have a direct role in stem cell regulation through HIF-1 alpha modulation of Wnt/beta-catenin signalling.	[Mazumdar, Jolly; Simon, M. Celeste] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [O'Brien, W. Timothy; Klein, Peter S.] Univ Penn, Sch Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Johnson, Randall S.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [LaManna, Joseph C.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Chavez, Juan C.] Wyeth Res, Translat Med, Collegeville, PA 19426 USA; [Mazumdar, Jolly; Simon, M. Celeste] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of California System; University of California San Diego; Case Western Reserve University; Pfizer; Howard Hughes Medical Institute; University of Pennsylvania	Simon, MC (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	celeste2@mail.med.upenn.edu	LaManna, Joseph C/C-3347-2012; Johnson, Randall/AAM-1189-2021; LaManna, Joseph/D-3860-2013; Simon, Celeste/AAG-3941-2021	LaManna, Joseph C/0000-0002-0159-4512; Johnson, Randall/0000-0002-4084-6639; LaManna, Joseph/0000-0002-0159-4512; 	Howard Hughes Medical Institute (HHMI); Abramson Family Cancer Research Institute; National Institutes of Health [MH58324]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038632] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Abramson Family Cancer Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Kinzler and B. Vogelstein for the Wnt (TOP/FOP) reporter constructs; P. Carmeliet for Hif-1 alpha<SUP>-/-</SUP>ES cells; and E. Brown for Ubc-Cre-ER<SUP>T2</SUP> mice. We thank X. Sun, Case Western Reserve University, and H. Yu, University of Pennsylvania for technical assistance with tissue harvesting and sectioning. We thank B. Keith and the Simon lab for discussion and critical review of the manuscript. This work was supported by funds from the Howard Hughes Medical Institute (HHMI), the Abramson Family Cancer Research Institute, and the National Institutes of Health (Grant No. MH58324 to P.S.K). M.C.S. is an investigator of the HHMI.	Adelman DM, 2000, GENE DEV, V14, P3191, DOI 10.1101/gad.853700; Adelman DM, 1999, GENE DEV, V13, P2478, DOI 10.1101/gad.13.19.2478; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Barth AIM, 1999, P NATL ACAD SCI USA, V96, P4947, DOI 10.1073/pnas.96.9.4947; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Dragatsis I, 2000, GENESIS, V26, P133, DOI 10.1002/(SICI)1526-968X(200002)26:2<133::AID-GENE10>3.0.CO;2-V; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Maltepe E, 2000, BIOCHEM BIOPH RES CO, V273, P231, DOI 10.1006/bbrc.2000.2928; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Naito AT, 2005, CIRC RES, V97, P144, DOI 10.1161/01.RES.0000175241.92285.f8; Raleigh JA, 1998, CANCER RES, V58, P3765; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Studer L, 2000, J NEUROSCI, V20, P7377; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885	34	352	370	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					1007	1013		10.1038/ncb2102	http://dx.doi.org/10.1038/ncb2102			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20852629	Green Accepted			2022-12-25	WOS:000282363500016
J	Berkley, S; Bertram, K; Delfraissy, JF; Draghia-Akli, R; Fauci, A; Hallenbeck, C; Kagame, MJ; Kim, P; Mafubelu, D; Makgoba, MW; Piot, P; Walport, M; Warren, M; Yamada, T; Esparza, J; Hankins, C; Johnston, MI; Levy, Y; Romaris, M; Ahmed, R; Bernstein, A				Berkley, Seth; Bertram, Kenneth; Delfraissy, Jean-Francois; Draghia-Akli, Ruxandra; Fauci, Anthony; Hallenbeck, Cynthia; Kagame, Madame Jeannette; Kim, Peter; Mafubelu, Daisy; Makgoba, Malegapuru W.; Piot, Peter; Walport, Mark; Warren, Mitchell; Yamada, Tadataka; Esparza, Jose; Hankins, Catherine; Johnston, Margaret I.; Levy, Yves; Romaris, Manuel; Ahmed, Rafi; Bernstein, Alan		Council Global HIV Vaccine Enterpr	The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise	NATURE MEDICINE			English	Article							YELLOW-FEVER VACCINE; MONOCLONAL-ANTIBODIES; CELL RESPONSES; IMMUNOLOGY; CHALLENGES; PROTECTION; INFECTION; EFFICACY		[Berkley, Seth] IAVI, New York, NY USA; [Bertram, Kenneth] MHRP, Rockville, MD USA; [Delfraissy, Jean-Francois; Levy, Yves] ANRS, Paris, France; [Draghia-Akli, Ruxandra; Romaris, Manuel] European Commiss, Brussels, Belgium; [Fauci, Anthony; Johnston, Margaret I.] NIAID, NIH, Bethesda, MD 20892 USA; [Hallenbeck, Cynthia] Enterprise Secretary Treasurer, New York, NY USA; [Kagame, Madame Jeannette] First Lady Rwanda, Kigali, Rwanda; [Kim, Peter] Merck Res Labs, Rahway, NJ USA; [Mafubelu, Daisy; Hankins, Catherine] WHO UNAIDS, Geneva, Switzerland; [Makgoba, Malegapuru W.] Univ KwaZulu Natal, Durban, South Africa; [Piot, Peter] London Sch Hyg & Trop Med, London WC1, England; [Walport, Mark] Wellcome Trust Res Labs, London, England; [Warren, Mitchell] AVAC Global Advocacy HIV Prevent, New York, NY USA; [Yamada, Tadataka; Esparza, Jose] Bill & Melinda Gates Fdn, Seattle, WA USA; [Bernstein, Alan] Global HIV Vaccine Enterprise, New York, NY USA; [Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA	International AIDS Vaccine Initiative; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Merck & Company; UNAIDS; World Health Organization; University of Kwazulu Natal; University of London; London School of Hygiene & Tropical Medicine; Bill & Melinda Gates Foundation; Emory University; Emory University	Berkley, S (corresponding author), IAVI, New York, NY USA.	abernstein@vaccineenterprise.org		Walport, Mark/0000-0001-7220-5273; Draghia-Akli, Ruxandra/0000-0001-6372-4039; Hankins, Catherine/0000-0002-1642-8592				BAROUCH DH, 2010, PREPRINT; Bhan MK, 2005, PLOS MED, V2, P111, DOI 10.1371/journal.pmed.0020025; Bongaarts J, 2010, SCIENCE, V328, P1359, DOI 10.1126/science.1191804; CENTRES R, 2007, LANCET, V370, P1665; [Committee on Science Engineering and Public Policy (US) Committee on Ensuring the Utility and Integrity of Research Data in a Digital Age], 2009, ENS INT ACC STEW RES; COREY L, 2010, PREPRINT; Corey L, 2009, AIDS, V23, P3, DOI 10.1097/QAD.0b013e32830e6d6d; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Geschwind DH, 2009, NATURE, V461, P908, DOI 10.1038/nature08537; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; *HIV VACC MICR RES, 2010, ADV SCI TIM FISC CON; Johnston MI, 2008, NEW ENGL J MED, V359, P888, DOI 10.1056/NEJMp0806162; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2009, CURR OPIN HIV AIDS, V4, P352, DOI 10.1097/COH.0b013e32832d9fef; Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Lambotte O, 2009, AIDS, V23, P897, DOI 10.1097/QAD.0b013e328329f97d; Le Clerc S, 2009, J INFECT DIS, V200, P1194, DOI 10.1086/605892; MASCOLA J, 2010, PREPRINT; McDermott AB, 2004, J VIROL, V78, P3140, DOI 10.1128/JVI.78.6.3140-3144.2004; MCMICHAEL A, 2010, PREPRINT; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Montefiori D, 2007, PLOS MED, V4, P1867, DOI 10.1371/journal.pmed.0040348; Noorani S, 2007, GOOD PART PRACT GUID; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; PULENDRAN B, 2010, PREPRINT; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; ROBINSON ET, 2010, COMMUNICATIONS HDB C; Schief WR, 2009, CURR OPIN HIV AIDS, V4, P431, DOI 10.1097/COH.0b013e32832e6184; Shattock RJ, 2008, PLOS MED, V5, P537, DOI 10.1371/journal.pmed.0050081; UNAIDS, 2009, AIDS EP UPD NOV 2009; UNAIDS WHO, 2007, ETH CONS BIOM HIV PR; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; Woodman Z, 2009, CURR OPIN HIV AIDS, V4, P247, DOI 10.1097/COH.0b013e32832c0672; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao P, 2010, J VIROL, V84, P7161, DOI 10.1128/JVI.00410-10	46	31	33	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2010	16	9					981	989		10.1038/nm0910-981	http://dx.doi.org/10.1038/nm0910-981			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20823883	Bronze			2022-12-25	WOS:000281622900025
J	Ku, NO; Toivola, DM; Strnad, P; Omary, MB				Ku, Nam-On; Toivola, Diana M.; Strnad, Pavel; Omary, M. Bishr			Cytoskeletal keratin glycosylation protects epithelial tissue from injury	NATURE CELL BIOLOGY			English	Article							LINKED N-ACETYLGLUCOSAMINE; O-GLCNAC MODIFICATION; INTERMEDIATE-FILAMENTS; TRANSGENIC MICE; SIGNALING PATHWAYS; LIVER-DISEASE; NUCLEOCYTOPLASMIC PROTEINS; MITOTIC ARREST; KINASE-B; CELLS	Keratins 8 and 18 (K8 and K18) are heteropolymeric intermediate filament phosphoglycoproteins of simple-type epithelia. Mutations in K8 and K18 predispose the affected individual to liver disease as they protect hepatocytes from apoptosis. K18 undergoes dynamic O-linked N-acetylglucosamine glycosylation at Ser 30, 31 and 49. We investigated the function of K18 glycosylation by generating mice that overexpress human K18 S30/31/49A substitution mutants that cannot be glycosylated (K18-Gly(-)), and compared the susceptibility of these mice to injury with wild-type and other keratin-mutant mice. K18-Gly(-) mice are more susceptible to liver and pancreatic injury and apoptosis induced by streptozotocin or to liver injury by combined N-acetyl-D-glucosaminidase inhibition and Fas administration. The enhanced apoptosis in the livers of mice that express K18-Gly(-) involves the inactivation of Akt1 and protein kinase C theta as a result of their site-specific hypophosphorylation. Akt1 binds to K8, which probably contributes to the reciprocal hyperglycosylation and hypophosphorylation of Akt1 that occurs on K18 hypoglycosylation, and leads to decreased Akt1 kinase activity. Therefore, K18 glycosylation provides a unique protective role in epithelial injury by promoting the phosphorylation and activation of cell-survival kinases.	[Ku, Nam-On; Omary, M. Bishr] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Ku, Nam-On] Yonsei Univ, Dept Biomed Sci, Grad Sch, Seoul 120749, South Korea; [Ku, Nam-On; Toivola, Diana M.] Abo Akad Univ, Dept Biosci, FI-20521 Turku, Finland; [Strnad, Pavel] Univ Med Ctr Ulm, Dept Internal Med 1, D-89081 Ulm, Germany	University of Michigan System; University of Michigan; Yonsei University; Abo Akademi University; Ulm University	Ku, NO (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, 7744 Med Sci 2,1301 E Catherine St, Ann Arbor, MI 48109 USA.	namonku@yonsei.ac.kr; mbishr@umich.edu		Omary, Bishr/0000-0002-8624-2347; Toivola, Diana M./0000-0001-7165-9839	NIH [DK47918]; Department of Veterans Affairs; NIH Digestive Disease Center [DK56339]; NIH Michigan Gastrointestinal Peptide Research Center [DK34933]; Korean Ministry of Education, Science and Technology [R31-2008-000-10086-0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047918, P30DK056339, P30DK034933] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NIH Digestive Disease Center; NIH Michigan Gastrointestinal Peptide Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to R. shim (The Sanford-Burnham Medical Research Institute) and T. Magin (University of Leipzig) for making the mice that express wild-type K18 and the K18-null available to us, Y. Chen-Tsai and the Stanford University Transgenic Facility for helping generate the transgenic mice, E. Resurreccion for assistance with immune staining and P. Chu for assistance with hematoxylin and eosin staining. This work was supported by NIH grant DK47918 and the Department of Veterans Affairs (M.B.O.), NIH Digestive Disease Center grant DK56339 to Stanford University, NIH Michigan Gastrointestinal Peptide Research Center grant DK34933 and WCU project (R31-2008-000-10086-0) from the Korean Ministry of Education, Science and Technology to N.-O.K.	ABE M, 1990, J CELL BIOL, V111, P1197, DOI 10.1083/jcb.111.3.1197; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; CHOU CF, 1992, J BIOL CHEM, V267, P3901; CHOU CF, 1994, J CELL SCI, V107, P1833; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Dong DLY, 1996, J BIOL CHEM, V271, P20845, DOI 10.1074/jbc.271.34.20845; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Gao Y, 2000, ARCH BIOCHEM BIOPHYS, V383, P296, DOI 10.1006/abbi.2000.2094; Gukovskaya AS, 2002, J BIOL CHEM, V277, P22595, DOI 10.1074/jbc.M202929200; Haltiwanger RS, 1997, J BIOL CHEM, V272, P8752, DOI 10.1074/jbc.272.13.8752; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hayashi K, 2007, PHARMACOL RES, V55, P537, DOI 10.1016/j.phrs.2007.04.009; Kim S, 2010, NAT REV MOL CELL BIO, V11, P75, DOI 10.1038/nrm2818; Ku NO, 2007, HEPATOLOGY, V46, P1639, DOI 10.1002/hep.21976; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 2005, GASTROENTEROLOGY, V129, P885, DOI 10.1053/j.gastro.2005.06.065; Ku NO, 1999, AM J PHYSIOL-GASTR L, V277, pG1108, DOI 10.1152/ajpgi.1999.277.6.G1108; KU NO, 1995, J CELL BIOL, V131, P1303, DOI 10.1083/jcb.131.5.1303; Ku NO, 2003, HEPATOLOGY, V37, P1006, DOI 10.1053/jhep.2003.50181; Ku NO, 1998, J CELL BIOL, V143, P2023, DOI 10.1083/jcb.143.7.2023; Ku NO, 2001, NEW ENGL J MED, V344, P1580, DOI 10.1056/NEJM200105243442103; KU NO, 1995, J BIOL CHEM, V270, P11820, DOI 10.1074/jbc.270.20.11820; Kudlow JE, 2006, J CELL BIOCHEM, V98, P1062, DOI 10.1002/jcb.20926; Liu Y, 2002, BIOCHEM J, V361, P255, DOI 10.1042/bj3610255; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Magin TM, 1998, J CELL BIOL, V140, P1441, DOI 10.1083/jcb.140.6.1441; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Nadeau SI, 2007, ADV EXP MED BIOL, V594, P100; Ngoh GA, 2009, CIRC RES, V104, P41, DOI 10.1161/CIRCRESAHA.108.189431; Omary M B, 1998, Subcell Biochem, V31, P105; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Oriolo AS, 2007, EXP CELL RES, V313, P2255, DOI 10.1016/j.yexcr.2007.02.030; Paramio JM, 2001, MOL CELL BIOL, V21, P7449, DOI 10.1128/MCB.21.21.7449-7459.2001; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Soesanto YA, 2008, AM J PHYSIOL-ENDOC M, V295, pE974, DOI 10.1152/ajpendo.90366.2008; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Strnad P, 2010, GASTROENTEROLOGY, V139, P828, DOI 10.1053/j.gastro.2010.06.007; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678	50	90	92	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					876	885		10.1038/ncb2091	http://dx.doi.org/10.1038/ncb2091			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20729838	Green Accepted			2022-12-25	WOS:000281561900011
J	Madeo, F; Tavernarakis, N; Kroemer, G				Madeo, Frank; Tavernarakis, Nektarios; Kroemer, Guido			Can autophagy promote longevity?	NATURE CELL BIOLOGY			English	Article							LIFE-SPAN EXTENSION; CELL-SURVIVAL; CALORIC RESTRICTION; RESVERATROL; APOPTOSIS; GENES; SIRT1; YEAST; ACTIVATORS; DROSOPHILA	Organismal lifespan can be extended by genetic manipulation of cellular processes such as histone acetylation, the insulin/IGF-1 (insulin-like growth factor 1) pathway or the p53 system. Longevity-promoting regimens, including caloric restriction and inhibition of TOR with rapamycin, resveratrol or the natural polyamine spermidine, have been associated with autophagy (a cytoprotective self-digestive process) and in some cases were reported to require autophagy for their effects. We summarize recent developments that outline these links and hypothesize that clearing cellular damage by autophagy is a common denominator of many lifespan-extending manipulations.	[Madeo, Frank] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Tavernarakis, Nektarios] Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece; [Kroemer, Guido] INSERM, U848, F-94805 Villejuif, France; [Kroemer, Guido] Inst Gustave Roussy, Villejuif, France; [Kroemer, Guido] Ctr Rech Cordeliers, Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Paris, France; [Kroemer, Guido] Univ Paris 05, Paris, France	University of Graz; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Madeo, F (corresponding author), Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria.	kroemer@orange.fr	Kroemer, Guido/AAY-9859-2020; Tavernarakis, Nektarios/B-9684-2013; KROEMER, Guido/B-4263-2013	Tavernarakis, Nektarios/0000-0002-5253-1466; KROEMER, Guido/0000-0002-9334-4405; Madeo, Frank/0000-0002-5070-1329	Ligue Nationale contre le Cancer (equipe labellisee); Fondation pour la Recherche Medicate; European Union; Canceropole Ile-de-France; Institut National du Cancer; Agence Nationale pour la Recherche; Austrian Science Fund [S-9304-B05]; European Commission (APOSYS); European Research Council (ERC); European Commission; European Molecular Biology Organization (EMBO)	Ligue Nationale contre le Cancer (equipe labellisee)(Ligue nationale contre le cancer); Fondation pour la Recherche Medicate(Fondation pour la Recherche Medicale); European Union(European Commission); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Austrian Science Fund(Austrian Science Fund (FWF)); European Commission (APOSYS)(European CommissionEuropean Commission Joint Research Centre); European Research Council (ERC)(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	G.K. is supported by grants from the Ligue Nationale contre le Cancer (equipe labellisee), Fondation pour la Recherche Medicate, the European Union, Canceropole Ile-de-France, Institut National du Cancer and Agence Nationale pour la Recherche. F.M. is supported by grants from the Austrian Science Fund (S-9304-B05, LIPOTOX) and European Commission (APOSYS). N.T. is supported by grants from the European Research Council (ERC), the European Commission 6<SUP>th</SUP> and 7<SUP>th</SUP> Framework programs and the European Molecular Biology Organization (EMBO).	Alvers AL, 2009, AUTOPHAGY, V5, P847, DOI 10.4161/auto.8824; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Demidenko ZN, 2009, CELL CYCLE, V8, P1888, DOI 10.4161/cc.8.12.8606; DORMAN JB, 1995, GENETICS, V141, P1399; Edinger AL, 2003, CANCER CELL, V4, P422, DOI 10.1016/S1535-6108(03)00306-4; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Hamann A, 2007, MOL MICROBIOL, V65, P948, DOI 10.1111/j.1365-2958.2007.05839.x; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hars ES, 2007, AUTOPHAGY, V3, P93, DOI 10.4161/auto.3636; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Kaeberlein M, 2008, CELL METAB, V8, P4, DOI 10.1016/j.cmet.2008.06.004; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kwak HB, 2006, FASEB J, V20, P791, DOI 10.1096/fj.05-5116fje; Lee CH, 2010, CANCER RES, V70, P1564, DOI 10.1158/0008-5472.CAN-09-3228; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; LI Y, 1989, CANCER RES, V68, P6889; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Longo VD, 1999, NEUROBIOL AGING, V20, P479, DOI 10.1016/S0197-4580(99)00089-5; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 2009, GENE DEV, V23, P2253, DOI 10.1101/gad.1858009; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morselli E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.8; Morselli E, 2010, AUTOPHAGY, V6, P186, DOI 10.4161/auto.6.1.10817; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pistilli EE, 2006, J GERONTOL A-BIOL, V61, P245, DOI 10.1093/gerona/61.3.245; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Rockenfeller P, 2010, BBA-MOL CELL RES, V1803, P499, DOI 10.1016/j.bbamcr.2010.01.001; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Soda K, 2009, EXP GERONTOL, V44, P727, DOI 10.1016/j.exger.2009.08.013; SUN JY, 1994, J BIOL CHEM, V269, P18638; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tavernarakis N, 2008, AUTOPHAGY, V4, P870, DOI 10.4161/auto.6730; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Toth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618; Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8; Vigne P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005422; White E, 2009, GENE DEV, V23, P784, DOI 10.1101/gad.1795309; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yang ZF, 2007, AUTOPHAGY, V3, P149, DOI 10.4161/auto.3631; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851; Zheng SQ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000838; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	72	335	347	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					842	846		10.1038/ncb0910-842	http://dx.doi.org/10.1038/ncb0910-842			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20811357				2022-12-25	WOS:000281561900006
J	Warren, TK; Warfield, KL; Wells, J; Swenson, DL; Donner, KS; Van Tongeren, SA; Garza, NL; Dong, LA; Mourich, DV; Crumley, S; Nichols, DK; Iversen, PL; Bavari, S				Warren, Travis K.; Warfield, Kelly L.; Wells, Jay; Swenson, Dana L.; Donner, Kelly S.; Van Tongeren, Sean A.; Garza, Nicole L.; Dong, Lian; Mourich, Dan V.; Crumley, Stacy; Nichols, Donald K.; Iversen, Patrick L.; Bavari, Sina			Advanced antisense therapies for postexposure protection against lethal filovirus infections	NATURE MEDICINE			English	Article							EBOLA HEMORRHAGIC-FEVER; NONHUMAN-PRIMATES; VIRUS INFECTION; MARBURG VIRUSES; MOUSE MODEL; GUINEA-PIGS; PATHOGENESIS; EFFICACY; MONKEYS	Currently, no vaccines or therapeutics are licensed to counter Ebola or Marburg viruses, highly pathogenic filoviruses that are causative agents of viral hemorrhagic fever. Here we show that administration of positively charged phosphorodiamidate morpholino oligomers (PMOplus), delivered by various dosing strategies initiated 30-60 min after infection, protects >60% of rhesus monkeys against lethal Zaire Ebola virus (ZEBOV) and 100% of cynomolgus monkeys against Lake Victoria Marburg virus (MARV) infection. PMOplus may be useful for treating these and other highly pathogenic viruses in humans.	[Warren, Travis K.; Warfield, Kelly L.; Wells, Jay; Swenson, Dana L.; Donner, Kelly S.; Van Tongeren, Sean A.; Garza, Nicole L.; Dong, Lian; Nichols, Donald K.; Bavari, Sina] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Mourich, Dan V.; Crumley, Stacy; Iversen, Patrick L.] AVI Biopharma, Corvallis, OR USA		Bavari, S (corresponding author), USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA.	piversen@avibio.com; sina.bavari@amedd.army.mil	Iversen, Patrick L./L-5454-2019; Bavari, Sina/L-3642-2019; Iversen, Patrick L/D-8854-2019	Iversen, Patrick L./0000-0003-0106-9790; Bavari, Sina/0000-0001-8424-5635; Iversen, Patrick L/0000-0003-0106-9790	US Defense Threat Reduction Agency [HDTRA1-07-C-010, 4.10022-08-RD-B, TMTI0048-09-RD-T]	US Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	We thank C. Rice, D. Reed, N. Posten and J. Stockman for technical assistance and M. Ait Ichou and J. Hardick for their help in the initial viral quantification studies. S. Norris and D. Fisher provided statistical assistance and conducted animal randomization procedures. L. Welch, S. Bradfute, R. Panchal and J. Kuhn provided support and discussions and critically reviewed the manuscript. These studies were supported by the US Defense Threat Reduction Agency awarded to AVI BioPharma (HDTRA1-07-C-010) and S. B. (4.10022-08-RD-B and TMTI0048-09-RD-T).	Bente D, 2009, DIS MODEL MECH, V2, P12, DOI 10.1242/dmm.000471; BOWEN ETW, 1978, T ROY SOC TROP MED H, V72, P188, DOI 10.1016/0035-9203(78)90058-5; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Connolly BM, 1999, J INFECT DIS, V179, pS203, DOI 10.1086/514305; Daddario-DiCaprio KM, 2006, LANCET, V367, P1399, DOI 10.1016/S0140-6736(06)68546-2; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; FISHERHOCH SP, 1985, J INFECT DIS, V152, P887, DOI 10.1093/infdis/152.5.887; FISHERHOCH SP, 1983, LANCET, V2, P1055; Geisbert TW, 2008, J VIROL, V82, P5664, DOI 10.1128/JVI.00456-08; Geisbert TW, 2007, J INFECT DIS, V196, pS372, DOI 10.1086/520608; Geisbert TW, 2010, EMERG INFECT DIS, V16, P1119, DOI 10.3201/eid1607.100159; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Hensley LE, 2007, J INFECT DIS, V196, pS390, DOI 10.1086/520598; Hevey M, 1998, VIROLOGY, V251, P28, DOI 10.1006/viro.1998.9367; Iversen P, 2001, ANTISENSE DRUG TECHNOLOGY: PRINCIPLES, STRATEGIES, AND APPLICATIONS, P375; Mohamadzadeh M, 2007, NAT REV IMMUNOL, V7, P556, DOI 10.1038/nri2098; Swenson DL, 2009, ANTIMICROB AGENTS CH, V53, P2089, DOI 10.1128/AAC.00936-08; Warfield K.L., 2006, BIODEFENSE RES METHO, P227; Warfield Kelly L., 2006, PLoS Pathogens, V2, P5; Warfield KL, 2009, J VIROL, V83, P6404, DOI 10.1128/JVI.00126-09	20	149	167	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2010	16	9					991	994		10.1038/nm.2202	http://dx.doi.org/10.1038/nm.2202			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20729866				2022-12-25	WOS:000281622900026
J	Vassiliou, GS; Cooper, JL; Rad, R; Li, J; Rice, S; Uren, A; Rad, L; Ellis, P; Andrews, R; Banerjee, R; Grove, C; Wang, W; Liu, PT; Wright, P; Arends, M; Bradley, A				Vassiliou, George S.; Cooper, Jonathan L.; Rad, Roland; Li, Juan; Rice, Stephen; Uren, Anthony; Rad, Lena; Ellis, Peter; Andrews, Rob; Banerjee, Ruby; Grove, Carolyn; Wang, Wei; Liu, Pentao; Wright, Penny; Arends, Mark; Bradley, Allan			Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; CANCER GENE DISCOVERY; CYTOPLASMIC NUCLEOPHOSMIN; MUTAGENESIS; NPM1; MUTATIONS; TRANSFORMATION; ABNORMALITIES; BEARING; GROWTH	Acute myeloid leukemia (AML) is a molecularly diverse malignancy with a poor prognosis whose largest subgroup is characterized by somatic mutations in NPM1, which encodes nucleophosmin(1). These mutations, termed NPM1c, result in cytoplasmic dislocation of nucleophosmin1 and are associated with distinctive transcriptional signatures(2), yet their role in leukemogenesis remains obscure. Here we report that activation of a humanized Npm1c knock-in allele in mouse hemopoietic stem cells causes Hox gene overexpression, enhanced self renewal and expanded myelopoiesis. One third of mice developed delayed-onset AML, suggesting a requirement for cooperating mutations. We identified such mutations using a Sleeping Beauty(3,4) transposon, which caused rapid-onset AML in 80% of mice with Npm1c, associated with mutually exclusive integrations in Csf2, Flt3 or Rasgrp1 in 55 of 70 leukemias. We also identified recurrent integrations in known and newly discovered leukemia genes including Nf1, Bach2, Dleu2 and Nup98. Our results provide new pathogenetic insights and identify possible therapeutic targets in NPM1c+AML.	[Vassiliou, George S.; Cooper, Jonathan L.; Rad, Roland; Rice, Stephen; Rad, Lena; Ellis, Peter; Andrews, Rob; Banerjee, Ruby; Grove, Carolyn; Wang, Wei; Liu, Pentao; Bradley, Allan] Wellcome Trust Sanger Inst, Mouse Genom Team, Cambridge, England; [Li, Juan] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge, England; [Uren, Anthony] Netherlands Canc Inst, Amsterdam, Netherlands; [Wright, Penny; Arends, Mark] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England	Wellcome Trust Sanger Institute; University of Cambridge; Netherlands Cancer Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Vassiliou, GS (corresponding author), Wellcome Trust Sanger Inst, Mouse Genom Team, Wellcome Trust Genome Campus, Cambridge, England.	gsv20@sanger.ac.uk; abradley@sanger.ac.uk	Uren, Anthony G/A-5784-2009	Uren, Anthony G/0000-0002-6019-7111; Vassiliou, George/0000-0003-4337-8022; Bradley, Allan/0000-0002-2349-8839	Cancer Research UK; MRC [MC_UP_A652_1001] Funding Source: UKRI; Medical Research Council [MC_UP_A652_1001, 1116184] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We acknowledge the use of the Research Support Facility at the Wellcome Trust Sanger Institute, the Department of Pathology Tissue Bank and the Cambridge National Institute of Health Research (NIHR) Biomedical Research Centre, University of Cambridge. We thank F. Law and J. Gadiot for assistance in generating the Npm1<SUP>flox-CA</SUP> and Rosa<SUP>flox-SB</SUP> mice; F. Foyer and B. Graham for help with fluorescent microscopy; B. Ling, W. Cheng, R. Macintyre and P. Chan for help with flow cytometry; R. Bautista for help with gene expression images; C. Hale and A. Nyzhnyk for help with ELISAs; B. Huntly, D. Adams, J. Cadinanos, H. Prosser, N. Conte, K. Yusa and Q. Liang for helpful discussions during the project; and P. Campbell and A. Green for critical reading of the manuscript. This work was supported by a Clinician Scientist Fellowship from Cancer Research UK (G.S.V.).	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Alcalay M, 2005, BLOOD, V106, P899, DOI 10.1182/blood-2005-02-0560; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen YT, 2000, GENESIS, V28, P31, DOI 10.1002/1526-968X(200009)28:1<31::AID-GENE40>3.0.CO;2-K; Cheng K, 2010, BLOOD, V115, P3341, DOI 10.1182/blood-2009-03-208587; Collier LS, 2009, CANCER RES, V69, P8429, DOI 10.1158/0008-5472.CAN-09-1760; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; de Ridder J, 2006, PLOS COMPUT BIOL, V2, P1530, DOI 10.1371/journal.pcbi.0020166; DUHRSEN U, 1990, EMBO J, V9, P1087, DOI 10.1002/j.1460-2075.1990.tb08214.x; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2009, LEUKEMIA, V23, P1731, DOI 10.1038/leu.2009.124; Falini B, 2008, HAEMATOLOGICA, V93, P439, DOI 10.3324/haematol.12153; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Kim R, 2003, J VIROL, V77, P2056, DOI 10.1128/JVI.77.3.2056-2062.2003; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lauchle JO, 2009, NATURE, V461, P411, DOI 10.1038/nature08279; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li JA, 2010, BLOOD, V116, P1528, DOI 10.1182/blood-2009-12-259747; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Nakamura T, 1996, NAT GENET, V12, P149, DOI 10.1038/ng0296-149; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Rocquain J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-401; ROGERS SY, 1994, EXP HEMATOL, V22, P593; SMITH GS, 1973, J NATL CANCER I, V50, P1195, DOI 10.1093/jnci/50.5.1195; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sportoletti P, 2008, BLOOD, V111, P3859, DOI 10.1182/blood-2007-06-098251; Takeda A, 2010, J BIOL CHEM, V285, P16248, DOI 10.1074/jbc.M109.048785; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; Verhaak RGW, 2005, BLOOD, V106, P3747, DOI 10.1182/blood-2005-05-2168; Voisin W, 2006, J VIROL, V80, P4026, DOI 10.1128/JVI.80.8.4026-4037.2006; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; YOUNG DC, 1986, BLOOD, V68, P1178	40	148	156	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2011	43	5					470	+		10.1038/ng.796	http://dx.doi.org/10.1038/ng.796			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	755XF	21441929	Green Accepted, Green Submitted			2022-12-25	WOS:000289972600019
J	Peng, W				Peng, Wayne			GM crop cultivation surges, but novel traits languish	NATURE BIOTECHNOLOGY			English	News Item																			0	7	7	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2011	29	4					302	302		10.1038/nbt.1842	http://dx.doi.org/10.1038/nbt.1842			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	746XY	21478839	Bronze			2022-12-25	WOS:000289284900007
J	Iacovino, M; Chong, D; Szatmari, I; Hartweck, L; Rux, D; Caprioli, A; Cleaver, O; Kyba, M				Iacovino, Michelina; Chong, Diana; Szatmari, Istvan; Hartweck, Lynn; Rux, Danielle; Caprioli, Arianna; Cleaver, Ondine; Kyba, Michael			HoxA3 is an apical regulator of haemogenic endothelium	NATURE CELL BIOLOGY			English	Article							HEMATOPOIETIC STEM-CELLS; MOUSE EMBRYO; YOLK-SAC; AORTIC ENDOTHELIUM; DEFINITIVE HEMATOPOIESIS; HOMEOBOX GENES; IN-VITRO; PROGENITORS; EXPRESSION; SPECIFICATION	During development, haemogenesis occurs invariably at sites of vasculogenesis. Between embryonic day (E) 9.5 and E10.5 in mice, endothelial cells in the caudal part of the dorsal aorta generate haematopoietic stem cells(1,2) and are referred to as haemogenic endothelium(3-8). The mechanisms by which haematopoiesis is restricted to this domain, and how the morphological transformation from endothelial to haematopoietic is controlled are unknown. We show here that HoxA3, a gene uniquely expressed in the embryonic but not yolk sac vasculature, restrains haematopoietic differentiation of the earliest endothelial progenitors, and induces reversion of the earliest haematopoietic progenitors into CD41-negative endothelial cells. This reversible modulation of endothelial-haematopoietic state is accomplished by targeting key haematopoietic transcription factors for downregulation, including Runx1, Gata1, Gfi1B, Ikaros, and PU. 1. Through loss-of-function, and gain-of-function epistasis experiments, and the identification of antipodally regulated targets, we show that among these factors, Runx1 is uniquely able to erase the endothelial program set up by HoxA3. These results suggest both why a frank endothelium does not precede haematopoiesis in the yolk sac, and why haematopoietic stem cell generation requires Runx1 expression only in endothelial cells.	[Iacovino, Michelina; Szatmari, Istvan; Hartweck, Lynn; Rux, Danielle; Kyba, Michael] Univ Minnesota, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Iacovino, Michelina; Szatmari, Istvan; Hartweck, Lynn; Rux, Danielle; Kyba, Michael] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Chong, Diana; Caprioli, Arianna; Cleaver, Ondine] UT SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kyba, M (corresponding author), Univ Minnesota, Lillehei Heart Inst, 312 Church St SE, Minneapolis, MN 55455 USA.	kyba@umn.edu	Szatmari, Istvan/B-3152-2010	Szatmari, Istvan/0000-0001-5260-1498; Hartweck, Lynn/0000-0002-7926-3342; Cleaver, Ondine/0000-0003-2454-6641; Kyba, Michael/0000-0002-5579-7534; Rux, Danielle/0000-0002-9952-4474; iacovino, michelina/0000-0002-1076-3146	NIH [1R01HL081186-01]; March of Dimes [5-FY2006-272]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081186, U01HL100407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007057] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank the Bob and Jean Smith Foundation for their generous support. This work was supported by the NIH grant 1R01HL081186-01 and the March of Dimes grant 5-FY2006-272. We thank Nardina Nash for genotyping and animal husbandry.	Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Boudreau N, 1997, J CELL BIOL, V139, P257, DOI 10.1083/jcb.139.1.257; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Cellot S, 2007, EXP HEMATOL, V35, P802, DOI 10.1016/j.exphem.2007.02.013; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; Choi K, 1998, DEVELOPMENT, V125, P725; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; Guidato S, 2003, DEVELOPMENT, V130, P2981, DOI 10.1242/dev.00496; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Iacovino M, 2009, STEM CELLS DEV, V18, P783, DOI 10.1089/scd.2008.0227; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Li WM, 2005, STEM CELLS DEV, V14, P44, DOI 10.1089/scd.2005.14.44; Mace KA, 2005, J CELL SCI, V118, P2567, DOI 10.1242/jcs.02399; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mitjavila-Garcia MT, 2002, DEVELOPMENT, V129, P2003; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Myers C, 2000, J CELL BIOL, V148, P343, DOI 10.1083/jcb.148.2.343; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Sabin F, 1920, CONTRIB EMBRYOL, V9, P213; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Taghon T, 2003, LEUKEMIA, V17, P1157, DOI 10.1038/sj.leu.2402947; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; XU K, 2009, DEV BIOL; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568	40	64	66	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2011	13	1					72	U165		10.1038/ncb2137	http://dx.doi.org/10.1038/ncb2137			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697GV	21170035	Green Accepted, Green Submitted			2022-12-25	WOS:000285502200013
J	Yang, XD; Ai, W; Asfaha, S; Bhagat, G; Friedman, RA; Jin, GC; Park, H; Shykind, B; Diacovo, TG; Falus, A; Wang, TC				Yang, Xiang Dong; Ai, Walden; Asfaha, Samuel; Bhagat, Govind; Friedman, Richard A.; Jin, Guangchun; Park, Heuijoon; Shykind, Benjamin; Diacovo, Thomas G.; Falus, Andras; Wang, Timothy C.			Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b(+)Ly6G(+) immature myeloid cells	NATURE MEDICINE			English	Article							L-HISTIDINE DECARBOXYLASE; TUMOR-ASSOCIATED MACROPHAGES; SUPPRESSOR-CELLS; T-CELL; TRANSCRIPTIONAL REGULATION; COLORECTAL-CANCER; CPG METHYLATION; RISK; POLARIZATION; EXPRESSION	Histidine decarboxylase (HDC), the unique enzyme responsible for histamine generation, is highly expressed in myeloid cells, but its function in these cells is poorly understood. Here we show that Hdc-knockout mice show a high rate of colon and skin carcinogenesis. Using Hdc-EGFP bacterial artificial chromosome (BAC) transgenic mice in which EGFP expression is controlled by the Hdc promoter, we show that Hdc is expressed primarily in CD11b(+)Ly6G(+) immature myeloid cells (IMCs) that are recruited early on in chemical carcinogenesis. Transplant of Hdc-deficient bone marrow to wild-type recipients results in increased CD11b(+)Ly6G(+) cell mobilization and reproduces the cancer susceptibility phenotype of Hdc-knockout mice. In addition, Hdc-deficient IMCs promote the growth of tumor allografts, whereas mouse CT26 colon cancer cells downregulate Hdc expression through promoter hypermethylation and inhibit myeloid cell maturation. Exogenous histamine induces the differentiation of IMCs and suppresses their ability to support the growth of tumor allografts. These data indicate key roles for Hdc and histamine in myeloid cell differentiation and CD11b(+)Ly6G(+) IMCs in early cancer development.	[Yang, Xiang Dong; Ai, Walden; Asfaha, Samuel; Jin, Guangchun; Park, Heuijoon; Wang, Timothy C.] Columbia Univ, Dept Med, Div Digest & Liver Dis, New York, NY 10027 USA; [Yang, Xiang Dong; Ai, Walden; Asfaha, Samuel; Jin, Guangchun; Park, Heuijoon; Wang, Timothy C.] Columbia Univ, Irving Canc Ctr, New York, NY USA; [Ai, Walden] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC USA; [Bhagat, Govind] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Friedman, Richard A.] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Shykind, Benjamin] Columbia Univ, Dept Neurosci, New York, NY USA; [Diacovo, Thomas G.] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Falus, Andras] Semmelweis Univ, Dept Genet Cell & Immunobiol, H-1085 Budapest, Hungary	Columbia University; Columbia University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Columbia University; Columbia University; Columbia University; Columbia University; Semmelweis University	Wang, TC (corresponding author), Columbia Univ, Dept Med, Div Digest & Liver Dis, New York, NY 10027 USA.	tcw21@columbia.edu	Bhagat, Govind/AAE-9493-2021; Asfaha, Samuel/I-8245-2015	Bhagat, Govind/0000-0001-6250-048X; Asfaha, Samuel/0000-0001-6972-0338; Falus, Andras/0000-0002-6843-6789; Wang, Timothy/0000-0001-5730-3019	US National Institutes of Health [RO1 DK048077, RO1 DK52778, U54 CA126513]; Canadian Institutes for Health Research; Alberta Heritage Foundation; NATIONAL CANCER INSTITUTE [U54CA126513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048077, R01DK052778] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation(Alberta Heritage Foundation for Medical Research); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank S.P. Tu, S.W. Wang, S. Takaishi and H. Tomita for their helpful contributions. We thank K.S. Betz for her help with animal procedures. We are grateful to A. Leiter (University of Massachusetts) for the PKD4-NICD-EGFP plasmid. RAGE-knockout mice were kindly provided by A.M. Schmidt (Columbia University). This work was funded by the US National Institutes of Health grants RO1 DK048077, RO1 DK52778 and U54 CA126513. S.A. was supported by a Canadian Institutes for Health Research Clinician Scientist Award and Alberta Heritage Foundation for Medical Research Clinical Fellowship.	Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bolton E, 2000, SEMIN CANCER BIOL, V10, P3, DOI 10.1006/scbi.2000.0301; Elenkov IJ, 1998, J IMMUNOL, V161, P2586; Ercan-Sencicek AG, 2010, NEW ENGL J MED, V362, P1901, DOI 10.1056/NEJMoa0907006; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gandini S, 2005, CANCER EPIDEM BIOMAR, V14, P1908, DOI 10.1158/1055-9965.EPI-05-0119; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Haile LA, 2008, GASTROENTEROLOGY, V135, P871, DOI 10.1053/j.gastro.2008.06.032; Haile LA, 2010, J IMMUNOL, V185, P203, DOI 10.4049/jimmunol.0903573; Higuchi S, 2001, FEBS LETT, V505, P217, DOI 10.1016/S0014-5793(01)02823-X; Hirasawa N, 1997, IMMUNOPHARMACOLOGY, V36, P87, DOI 10.1016/S0162-3109(96)00164-6; Ikuta S, 2008, CANCER RES, V68, P64, DOI 10.1158/0008-5472.CAN-07-3245; Jutel M, 2001, NATURE, V413, P420, DOI 10.1038/35096564; Karlstedt K, 2001, DEV DYNAM, V221, P81, DOI 10.1002/dvdy.1127; Kitamura Y, 1983, Princess Takamatsu Symp, V14, P327; Kuramasu A, 1998, J BIOL CHEM, V273, P31607, DOI 10.1074/jbc.273.47.31607; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; NISSINEN MJ, 1995, J HISTOCHEM CYTOCHEM, V43, P1241, DOI 10.1177/43.12.8537641; NISSINEN MJ, 1995, J HISTOCHEM CYTOCHEM, V43, P211, DOI 10.1177/43.2.7822777; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Ohtsu H, 2003, BIOCHEM BIOPH RES CO, V305, P443, DOI 10.1016/S0006-291X(03)00696-X; PEKAREK LA, 1995, J EXP MED, V181, P435, DOI 10.1084/jem.181.1.435; Prizment AE, 2007, CANCER EPIDEM BIOMAR, V16, P2357, DOI 10.1158/1055-9965.EPI-07-0468; Rad FH, 2007, P NATL ACAD SCI USA, V104, P2837, DOI 10.1073/pnas.0611022104; Radeke HH, 2005, EXP DERMATOL, V14, P641, DOI 10.1111/j.0906-6705.2005.00350.x; Reynolds JL, 1997, EUR J SURG ONCOL, V23, P224, DOI 10.1016/S0748-7983(97)92388-X; Robertson DJ, 2005, ALIMENT PHARM THER, V22, P123, DOI 10.1111/j.1365-2036.2005.02529.x; Sasaguri Y, 2005, CIRC RES, V96, P974, DOI 10.1161/01.RES.0000166325.00383.ed; Schmielau J, 2001, CANCER RES, V61, P4756; Shen L, 2007, CLIN EXP IMMUNOL, V149, P155, DOI 10.1111/j.1365-2249.2007.03376.x; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Suzuki-Ishigaki S, 2000, NUCLEIC ACIDS RES, V28, P2627, DOI 10.1093/nar/28.14.2627; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Tazawa H, 2003, AM J PATHOL, V163, P2221, DOI 10.1016/S0002-9440(10)63580-8; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Vajdic CM, 2009, CANCER RES, V69, P6482, DOI 10.1158/0008-5472.CAN-08-4372; van der Pouw Kraan TCTM, 1998, J CLIN INVEST, V102, P1866, DOI 10.1172/JCI3692; Velicer CM, 2006, ANN EPIDEMIOL, V16, P895, DOI 10.1016/j.annepidem.2006.03.003; Wang H, 2005, ALLERGY, V60, P1098, DOI 10.1111/j.1398-9995.2005.00813.x; Watanabe S, 2008, J IMMUNOL, V181, P3291, DOI 10.4049/jimmunol.181.5.3291; Wiener Z, 2002, INT IMMUNOL, V14, P381, DOI 10.1093/intimm/14.4.381; Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zwadlo-Klarwasser G, 1998, INFLAMM RES, V47, P434, DOI 10.1007/s000110050357	49	157	163	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					87	U263		10.1038/nm.2278	http://dx.doi.org/10.1038/nm.2278			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21170045	Green Submitted, Green Accepted			2022-12-25	WOS:000285994000040
J	Chahine, KG				Chahine, Kenneth G.			Anchoring gene patent eligibility to its constitutional mooring	NATURE BIOTECHNOLOGY			English	Article									Univ Utah, SJ Quinney Coll Law, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Chahine, KG (corresponding author), Univ Utah, SJ Quinney Coll Law, Salt Lake City, UT 84112 USA.	chahinek@law.utah.edu						Carbone J, 2010, NAT BIOTECHNOL, V28, P784, DOI 10.1038/nbt0810-784; Cook-Deegan R, 2010, GENET MED, V12, pS1, DOI 10.1097/GIM.0b013e3181d694b0; Fore Joe Jr, 2006, J Biomed Discov Collab, V1, P7, DOI 10.1186/1747-5333-1-7	3	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2010	28	12					1251	1255		10.1038/nbt.1728	http://dx.doi.org/10.1038/nbt.1728			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	691NP	21139606				2022-12-25	WOS:000285088400014
J	Haack, TB; Danhauser, K; Haberberger, B; Hoser, J; Strecker, V; Boehm, D; Uziel, G; Lamantea, E; Invernizzi, F; Poulton, J; Rolinski, B; Iuso, A; Biskup, S; Schmidt, T; Mewes, HW; Wittig, I; Meitinger, T; Zeviani, M; Prokisch, H				Haack, Tobias B.; Danhauser, Katharina; Haberberger, Birgit; Hoser, Jonathan; Strecker, Valentina; Boehm, Detlef; Uziel, Graziella; Lamantea, Eleonora; Invernizzi, Federica; Poulton, Joanna; Rolinski, Boris; Iuso, Arcangela; Biskup, Saskia; Schmidt, Thorsten; Mewes, Hans-Werner; Wittig, Ilka; Meitinger, Thomas; Zeviani, Massimo; Prokisch, Holger			Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency	NATURE GENETICS			English	Article							BETA-OXIDATION; MITOCHONDRIAL; DIAGNOSIS; DATABASE; CAPTURE; CELLS; PAGE	An isolated defect of respiratory chain complex I activity is a frequent biochemical abnormality in mitochondrial disorders. Despite intensive investigation in recent years, in most instances, the molecular basis underpinning complex I defects remains unknown. We report whole-exome sequencing of a single individual with severe, isolated complex I deficiency. This analysis, followed by filtering with a prioritization of mitochondrial proteins, led us to identify compound heterozygous mutations in ACAD9, which encodes a poorly understood member of the mitochondrial acyl-CoA dehydrogenase protein family. We demonstrated the pathogenic role of the ACAD9 variants by the correction of the complex I defect on expression of the wildtype ACAD9 protein in fibroblasts derived from affected individuals. ACAD9 screening of 120 additional complex I-defective index cases led us to identify two additional unrelated cases and a total of five pathogenic ACAD9 alleles.	[Lamantea, Eleonora; Invernizzi, Federica; Zeviani, Massimo] IRCCS Fdn, Neurol Inst Carlo Besta, Unit Mol Neurogenet, Milan, Italy; [Haack, Tobias B.; Danhauser, Katharina; Haberberger, Birgit; Iuso, Arcangela; Meitinger, Thomas; Prokisch, Holger] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Haack, Tobias B.; Danhauser, Katharina; Haberberger, Birgit; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Hoser, Jonathan; Schmidt, Thorsten; Mewes, Hans-Werner] Germany Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Strecker, Valentina; Wittig, Ilka] Goethe Univ Frankfurt, Sch Med, Frankfurt, Germany; [Boehm, Detlef; Biskup, Saskia] CeGaT GmbH, Tubingen, Germany; [Uziel, Graziella] IRCCS Fdn, Neurol Inst Carlo Besta, Unit Child Neurol, Milan, Italy; [Poulton, Joanna] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Womens Ctr, Oxford OX3 9DU, England; [Rolinski, Boris] Stadt Klinikum Munchen GmbH, Dept Klin Chem, Munich, Germany; [Mewes, Hans-Werner] Tech Univ Munich, Freising Weihenstephan, Ctr Life & Food Sci, Chair Genome Oriented Bioinformat, Munich, Germany	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Goethe University Frankfurt; CeGaT; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; University of Oxford; Munchen Klinik; Technical University of Munich	Zeviani, M (corresponding author), IRCCS Fdn, Neurol Inst Carlo Besta, Unit Mol Neurogenet, Milan, Italy.	zeviani@istituto-besta.it; prokisch@helmholtz-muenchen.de	Zeviani, Massimo/AAU-2632-2021; Zeviani, Massimo/K-2891-2014; Poulton, Joanna/AAB-4828-2021; Invernizzi, Federica/J-9849-2016; Lamantea, Eleonora/J-8339-2016; Meitinger, Thomas/O-1318-2015; Prokisch, Holger/N-8964-2013; Mewes, Hans-Werner/A-8204-2019	Zeviani, Massimo/0000-0002-9067-5508; Invernizzi, Federica/0000-0001-8072-0152; Lamantea, Eleonora/0000-0001-5090-6028; Mewes, Hans-Werner/0000-0002-9713-6398; Schmidt, Thorsten/0000-0002-6719-0633; Meitinger, Thomas/0000-0002-8838-8403; Prokisch, Holger/0000-0003-2379-6286; Poulton, Joanna/0000-0002-2460-5587	MRC [G0500695] Funding Source: UKRI; Medical Research Council [G0500695] Funding Source: Medline; Telethon [GGP07019] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Telethon(Fondazione Telethon)		Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Elstner M, 2009, METHOD ENZYMOL, V457, P3, DOI 10.1016/S0076-6879(09)05001-0; Ensenauer R, 2005, J BIOL CHEM, V280, P32309, DOI 10.1074/jbc.M504460200; Feng DJ, 2009, J BIOL CHEM, V284, P11436, DOI 10.1074/jbc.M806991200; Gempel K, 2007, BRAIN, V130, P2037, DOI 10.1093/brain/awm054; Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gobin-Limballe S, 2007, AM J HUM GENET, V81, P1133, DOI 10.1086/522375; He M, 2007, AM J HUM GENET, V81, P87, DOI 10.1086/519219; Hedges D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008232; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Meisinger C, 2009, AM J HUM GENET, V84, P66, DOI 10.1016/j.ajhg.2008.11.015; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002; OHTSUKA T, 1993, J BIOL CHEM, V268, P22914; SAIJO T, 1995, J BIOL CHEM, V270, P1899, DOI 10.1074/jbc.270.4.1899; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sgobbo P, 2007, BBA-BIOENERGETICS, V1767, P222, DOI 10.1016/j.bbabio.2007.01.023; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006; Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zhang J, 2002, BIOCHEM BIOPH RES CO, V297, P1033, DOI 10.1016/S0006-291X(02)02336-7	28	182	195	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2010	42	12					1131	+		10.1038/ng.706	http://dx.doi.org/10.1038/ng.706			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684UZ	21057504				2022-12-25	WOS:000284578800018
J	Lagana, A; Dorn, JF; De Rop, V; Ladouceur, AM; Maddox, AS; Maddox, PS				Lagana, Anaick; Dorn, Jonas F.; De Rop, Valerie; Ladouceur, Anne-Marie; Maddox, Amy S.; Maddox, Paul S.			A small GTPase molecular switch regulates epigenetic centromere maintenance by stabilizing newly incorporated CENP-A	NATURE CELL BIOLOGY			English	Article							HISTONE H3; ACTIVATING PROTEIN; NUCLEAR ACTIN; CYTOKINESIS; MGCRACGAP; CHROMATIN; COMPLEX; KINETOCHORE; NUCLEOSOMES; DOMAIN	Epigenetic mechanisms regulate genome activation in diverse events, including normal development and cancerous transformation. Centromeres are epigenetically designated chromosomal regions that maintain genomic stability by directing chromosome segregation during cell division. The histone H3 variant CENP-A resides specifically at centromeres, is fundamental to centromere function and is thought to act as the epigenetic mark defining centromere loci. Mechanisms directing assembly of CENP-A nucleosomes have recently emerged, but how CENP-A is maintained after assembly is unknown. Here, we show that a small GTPase switch functions to maintain newly assembled CENP-A nucleosomes. Using functional proteomics, we found that MgcRacGAP (a Rho family GTPase activating protein) interacts with the CENP-A licensing factor HsKNL2. High-resolution live-cell imaging assays, designed in this study, demonstrated that MgcRacGAP, the Rho family guanine nucleotide exchange factor (GEF) Ect2, and the small GTPases Cdc42 and Rac, are required for stability of newly incorporated CENP-A at centromeres. Thus, a small GTPase switch ensures epigenetic centromere maintenance after loading of new CENP-A.	[Lagana, Anaick; Dorn, Jonas F.; De Rop, Valerie; Ladouceur, Anne-Marie; Maddox, Amy S.; Maddox, Paul S.] Univ Montreal, IRIC, Montreal, PQ H3C 3J7, Canada; [Maddox, Amy S.; Maddox, Paul S.] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Maddox, PS (corresponding author), Univ Montreal, IRIC, POB 6128,Stn Ctr Ville, Montreal, PQ H3C 3J7, Canada.	paul.maddox@umontreal.ca		Dorn, Jonas/0000-0001-6696-0117	Swiss National Science Foundation; CIHR; FRSQ; Terry Fox Foundation [018450, 019162]; CCSRI	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CIHR(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec); Terry Fox Foundation; CCSRI	The authors would like to thank J.-C. Labbe, A. Desai, K. Bloom and S. Meloche for helpful comments and discussions, the IRIC proteomics facility (specifically E. Bonneil and P. Thibault) for LC-MS/MS analysis, the IRIC genomics facility for sequencing and qPCR analyses, and A. Straight and B. Moree for the generous gift of the CENP-A SNAP-tag cell line. LED. was supported by a postdoctoral fellowship from the Swiss National Science Foundation; V.D.R. was supported by a student fellowship from the CIHR. A.S.M. receives salary support from the FRSQ. P.S.M. holds the Canada Research Chair in Chromosome Organization and Mitotic Mechanisms. This work was funded by grants #018450 awarded to P.S.M. and #019162 awarded to A.S.M. from the Terry Fox Foundation and the CCSRI. V.D.R., A.S.M. and P.S.M. participate in the Systems biology option in the graduate program in Molecular Biology, Universite de Montreal.	Bernad R, 2009, EXP CELL RES, V315, P3233, DOI 10.1016/j.yexcr.2009.07.023; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Canman JC, 2008, SCIENCE, V322, P1543, DOI 10.1126/science.1163086; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; CHEESEMAN IM, 2005, SCI STKE, pPL1, DOI DOI 10.1126/STKE.2662005PL1; Chen MM, 2007, CURR OPIN CELL BIOL, V19, P326, DOI 10.1016/j.ceb.2007.04.009; Choo KHA, 2000, TRENDS CELL BIOL, V10, P182, DOI 10.1016/S0962-8924(00)01739-6; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Collins KA, 2004, CURR BIOL, V14, P1968, DOI 10.1016/j.cub.2004.10.024; Dorn JF, 2005, BIOPHYS J, V89, P2835, DOI 10.1529/biophysj.104.058461; Dorn JF, 2008, METHOD CELL BIOL, V85, P497, DOI 10.1016/S0091-679X(08)85022-4; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Field C, 1999, CURR OPIN CELL BIOL, V11, P68, DOI 10.1016/S0955-0674(99)80009-X; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hirose K, 2001, J BIOL CHEM, V276, P5821, DOI 10.1074/jbc.M007252200; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Jaqaman K, 2010, J CELL BIOL, V188, P665, DOI 10.1083/jcb.200909005; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Kawashima T, 2000, BLOOD, V96, P2116; Lindeberg T., 1990, Proceedings. Third International Conference on Computer Vision (Cat. No.90CH2934-8), P416, DOI 10.1109/ICCV.1990.139563; Maddox AS, 2003, NAT CELL BIOL, V5, P773, DOI 10.1038/ncb0903-773b; Maddox AS, 2003, MOL CELL, V11, P846, DOI 10.1016/S1097-2765(03)00151-5; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; Miller AL, 2009, NAT CELL BIOL, V11, P71, DOI 10.1038/ncb1814; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; Oceguera-Yanez F, 2005, J CELL BIOL, V168, P221, DOI 10.1083/jcb.200408085; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PALMER DK, 1991, P NATL ACAD SCI USA, V88, P3734, DOI 10.1073/pnas.88.9.3734; Pavicic-Kaltenbrunner V, 2007, MOL BIOL CELL, V18, P4992, DOI 10.1091/mbc.E07-05-0468; Perpelescu M, 2009, J CELL BIOL, V185, P397, DOI 10.1083/jcb.200903088; Rando OJ, 2000, TRENDS CELL BIOL, V10, P92, DOI 10.1016/S0962-8924(99)01713-4; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Silva MCC, 2009, CHROMOSOMA, V118, P567, DOI 10.1007/s00412-009-0227-3; Stelzer E H, 1991, Semin Cell Biol, V2, P145; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; Tomonaga T, 2003, CANCER RES, V63, P3511; Toure A, 1998, J BIOL CHEM, V273, P6019, DOI 10.1074/jbc.273.11.6019; von Dassow G, 2009, J CELL BIOL, V187, P831, DOI 10.1083/jcb.200907090; Yasuda S, 2004, NATURE, V428, P767, DOI 10.1038/nature02452; Ye J, 2008, GENE DEV, V22, P322, DOI 10.1101/gad.455908; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097	52	90	90	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2010	12	12					1186	U142		10.1038/ncb2129	http://dx.doi.org/10.1038/ncb2129			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	688DY	21102442				2022-12-25	WOS:000284831200010
J	Pei, L; Li, SP; Wang, M; Diwan, M; Anisman, H; Fletcher, PJ; Nobrega, JN; Liu, F				Pei, Lin; Li, Shupeng; Wang, Min; Diwan, Mustansir; Anisman, Hymie; Fletcher, Paul J.; Nobrega, Jose N.; Liu, Fang			Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects	NATURE MEDICINE			English	Article							REUPTAKE INHIBITORS; SWIMMING TEST; DEPRESSION; SCHIZOPHRENIA; IMMOBILITY; ACTIVATION; PROTEIN; SYSTEM; DRUGS	We report that coupling between dopamine D1 and D2 receptors was markedly increased in postmortem brain of subjects suffering from major depression. Biochemical analyses revealed that D1 and D2 receptors form heterodimers via a direct protein-protein interaction. Administration of an interfering peptide that disrupts the D1-D2 receptor complex substantially reduced immobility in the forced swim test (FST) without affecting locomotor activity, and decreased escape failures in learned helplessness tests in rats. (C) 2010 Nature America, Inc. All rights reserved.	[Pei, Lin; Li, Shupeng; Wang, Min; Diwan, Mustansir; Fletcher, Paul J.; Nobrega, Jose N.; Liu, Fang] Ctr Addict & Mental Hlth, Dept Neurosci, Toronto, ON, Canada; [Anisman, Hymie] Carleton Univ, Inst Neurosci, Ottawa, ON K1S 5B6, Canada; [Fletcher, Paul J.; Nobrega, Jose N.; Liu, Fang] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Fletcher, Paul J.; Nobrega, Jose N.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Carleton University; University of Toronto; University of Toronto	Liu, F (corresponding author), Ctr Addict & Mental Hlth, Dept Neurosci, Toronto, ON, Canada.	f.liu.a@utoronto.ca	soler, martha maricel m gomez/L-6025-2014; Yan, Shuo/B-8381-2009	soler, martha maricel m gomez/0000-0002-4412-8108; Fletcher, Paul/0000-0001-8906-2280	Centre for Addictions and Mental Health; Ontario Mental Health Foundation; Heart and Stroke Foundation of Canada	Centre for Addictions and Mental Health; Ontario Mental Health Foundation; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	We thank the Stanley Foundation Neuropathology Consortium for the brain samples. This work was supported by the Centre for Addictions and Mental Health (F. L.) and the Ontario Mental Health Foundation (J.N.N.). S. L. is a recipient of postdoctoral fellowship from the Heart and Stroke Foundation of Canada.	Agid O, 2008, EXPERT OPIN EMERG DR, V13, P479, DOI [10.1517/14728214.13.3.479, 10.1517/14728214.13.3.479 ]; Basso AM, 2005, NEUROPSYCHOPHARMACOL, V30, P1257, DOI 10.1038/sj.npp.1300677; CERVO L, 1988, J PHARM PHARMACOL, V40, P155, DOI 10.1111/j.2042-7158.1988.tb05208.x; D'Aquila PS, 2000, EUR J PHARMACOL, V405, P365, DOI 10.1016/S0014-2999(00)00566-5; Free RB, 2007, J BIOL CHEM, V282, P21285, DOI 10.1074/jbc.M701555200; Fuxe K, 2008, BRAIN RES REV, V58, P415, DOI 10.1016/j.brainresrev.2007.11.007; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; KAPUR S, 1992, BIOL PSYCHIAT, V32, P1, DOI 10.1016/0006-3223(92)90137-O; Lee FJS, 2009, SYNAPSE, V63, P710, DOI 10.1002/syn.20648; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MUSCAT R, 1992, BIOL PSYCHIAT, V31, P937, DOI 10.1016/0006-3223(92)90119-K; Nutt DJ, 2006, J CLIN PSYCHIAT, V67, P3; Pigott HE, 2010, PSYCHOTHER PSYCHOSOM, V79, P267, DOI 10.1159/000318293; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Yadid G, 2008, PROG BRAIN RES, V172, P265, DOI 10.1016/S0079-6123(08)00913-8; Yamada J, 2004, EUR J PHARMACOL, V504, P207, DOI 10.1016/j.ejphar.2004.09.057; Zisook S, 2006, BIOL PSYCHIAT, V59, P203, DOI 10.1016/j.biopsych.2005.06.027	20	129	130	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1393	1395		10.1038/nm.2263	http://dx.doi.org/10.1038/nm.2263			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21113156				2022-12-25	WOS:000285048900031
J	Jakobsson, L; Franco, CA; Bentley, K; Collins, RT; Ponsioen, B; Aspalter, IM; Rosewell, I; Busse, M; Thurston, G; Medvinsky, A; Schulte-Merker, S; Gerhardt, H				Jakobsson, Lars; Franco, Claudio A.; Bentley, Katie; Collins, Russell T.; Ponsioen, Bas; Aspalter, Irene M.; Rosewell, Ian; Busse, Marta; Thurston, Gavin; Medvinsky, Alexander; Schulte-Merker, Stefan; Gerhardt, Holger			Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting	NATURE CELL BIOLOGY			English	Article						m	TYROSINE KINASE; GROWTH-FACTOR; IN-VIVO; NOTCH; VEGF; FLT-1; EMBRYOS; BINDING; DLL4; VASCULOGENESIS	Sprouting angiogenesis requires the coordinated behaviour of endothelial cells, regulated by Notch and vascular endothelial growth factor receptor (VEGFR) signalling. Here, we use computational modelling and genetic mosaic sprouting assays in vitro and in vivo to investigate the regulation and dynamics of endothelial cells during tip cell selection. We find that endothelial cells compete for the tip cell position through relative levels of Vegfr1 and Vegfr2, demonstrating a biological role for differential Vegfr regulation in individual endothelial cells. Differential Vegfr levels affect tip selection only in the presence of a functional Notch system by modulating the expression of the ligand Dll4. Time-lapse microscopy imaging of mosaic sprouts identifies dynamic position shuffling of tip and stalk cells in vitro and in vivo, indicating that the VEGFR-Dll4-Notch signalling circuit is constantly re-evaluated as cells meet new neighbours. The regular exchange of the leading tip cell raises novel implications for the concept of guided angiogenic sprouting.	[Jakobsson, Lars; Franco, Claudio A.; Bentley, Katie; Collins, Russell T.; Aspalter, Irene M.; Busse, Marta; Gerhardt, Holger] Canc Res UK, London Res Inst, Vasc Biol Lab, London WC2A 3PX, England; [Ponsioen, Bas; Schulte-Merker, Stefan] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Rosewell, Ian] Canc Res UK, Clare Hall Labs, London Res Inst, Transgen Serv, Potters Bar EN6 3LD, Herts, England; [Thurston, Gavin] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Medvinsky, Alexander] MRC, Ctr Regenerat Med, Edinburgh EH16 4SB, Midlothian, Scotland; [Gerhardt, Holger] Vesalius Res Ctr, Vasc Patterning Lab, O&N1, B-3000 Louvain, Belgium	Cancer Research UK; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Cancer Research UK; Regeneron	Gerhardt, H (corresponding author), Canc Res UK, London Res Inst, Vasc Biol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	holger.gerhardt@cancer.org.uk	Franco, Claudio A/D-8117-2015; Gerhardt, Holger/G-4610-2011; Franco, Claudio A/B-1060-2013; Jakobsson, Lars/B-4200-2011; Gerhardt, Holger/G-4610-2011	Franco, Claudio A/0000-0002-2861-3883; Gerhardt, Holger/0000-0002-3030-0384; Franco, Claudio A/0000-0002-2861-3883; Jakobsson, Lars/0000-0001-7956-587X; Bentley, Katie/0000-0002-9391-659X; Thurston, Gavin/0000-0002-4105-5919; Gerhardt, Holger/0000-0001-9228-7472; Aspalter, Irene Maria/0000-0002-6155-9006; Collins, Russell T/0000-0002-1847-4517	CRUK; Lister Institute of Preventive Medicine; European Molecular Biology Organization (EMBO); Fondation Leducq Transatlantic Network of Excellence ARTEMIS; Leukaemia Research Fund; Dutch Organization of Scientific Research [175.010.2007.007]; Nederlandse Akademie van Wetenschappen (KNAW); Medical Research Council [G0700711B] Funding Source: researchfish	CRUK(Cancer Research UK); Lister Institute of Preventive Medicine; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Fondation Leducq Transatlantic Network of Excellence ARTEMIS; Leukaemia Research Fund; Dutch Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Nederlandse Akademie van Wetenschappen (KNAW); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank the Cancer Research UK (CRUK) Light Microscopy facility, P. Jordan, the Protein Purification lab, S. Kjaer, J. Yang and J. Ure. We thank D. Barr and I. Moal for simulation and analysis work performed in the Biomolecular Modelling Laboratory CRUK, D. Sauvaget and J. Babbage for technical assistance and B. Thompson for comments on the manuscript. The authors are supported by CRUK, the Lister Institute of Preventive Medicine, the European Molecular Biology Organization (EMBO) Young Investigator Programme, the Fondation Leducq Transatlantic Network of Excellence ARTEMIS (H.G.), the Leukaemia Research Fund (to A.M.) and an EMBO long-term post-doctoral fellowship (to L.J.). We thank J. van Rheenen for discussions and assistance on the SP5 microscope (Leica Microsystems; equipment grant from the Dutch Organization of Scientific Research; NOW, 175.010.2007.007). We also thank A. de Graaff (M.Sc.) and the Hubrecht Imaging Centre (HIC) for imaging support. B.P. and S.S.-M. were supported by the Nederlandse Akademie van Wetenschappen (KNAW).	Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bentley K, 2008, J THEOR BIOL, V250, P25, DOI 10.1016/j.jtbi.2007.09.015; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chappell JC, 2009, DEV CELL, V17, P377, DOI 10.1016/j.devcel.2009.07.011; Chi X, 2009, DEV CELL, V17, P199, DOI 10.1016/j.devcel.2009.07.013; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829; Harrington LS, 2008, MICROVASC RES, V75, P144, DOI 10.1016/j.mvr.2007.06.006; Hayashi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002401; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Holderfield MT, 2006, BIOCHEM BIOPH RES CO, V346, P637, DOI 10.1016/j.bbrc.2006.05.177; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Jakobsson L, 2008, FASEB J, V22, P1530, DOI 10.1096/fj.07-9617com; Jakobsson L, 2007, J CELL BIOL, V177, P751, DOI 10.1083/jcb.200701146; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Kappas NC, 2008, J CELL BIOL, V181, P847, DOI 10.1083/jcb.200709114; Lamar E, 2001, GENE DEV, V15, P1885, DOI 10.1101/gad.908101; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; PARK JE, 1994, J BIOL CHEM, V269, P25646; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Suchting S, 2007, NOVART FDN SYMP, V283, P238; SUCHTING S, 2007, NOVART FDN SYMP, V80, P77; SUCHTING S, 2007, NOVART FDN SYMP, V283, P238; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000	49	629	641	3	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					943	953		10.1038/ncb2103	http://dx.doi.org/10.1038/ncb2103			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20871601				2022-12-25	WOS:000282363500009
J	Khodjakov, A; Pines, J				Khodjakov, Alexey; Pines, Jonathon			Centromere tension: a divisive issue	NATURE CELL BIOLOGY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; AURORA B KINASE; CHROMOSOMAL INSTABILITY; MICROTUBULE ATTACHMENT; ANAPHASE ONSET; BUDDING YEAST; KINETOCHORE; CELLS; SEGREGATION; ORIENTATION	It has been proposed that the spindle assembly checkpoint detects both unattached kinetochores and lack of tension between sister kinetochores when sister chromatids are not attached to opposite spindle poles. However, here we argue that there is only one signal - whether kinetochores are attached to microtubules or not - and this has implications for our understanding of both chromosome segregation and the control of genomic stability.	[Khodjakov, Alexey] Wadsworth Ctr, Albany, NY 12201 USA; [Khodjakov, Alexey] Rensselaer Polytech Inst, Troy, NY 12180 USA; [Pines, Jonathon] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Pines, Jonathon] Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England	Wadsworth Center; Rensselaer Polytechnic Institute; University of Cambridge; University of Cambridge	Khodjakov, A (corresponding author), Wadsworth Ctr, Albany, NY 12201 USA.	khodj@wadsworth.org; jp103@cam.ac.uk	Holt, Janet E/B-2415-2013	Pines, Jonathon/0000-0002-5227-6004	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059363] Funding Source: NIH RePORTER; Cancer Research UK Funding Source: Medline; NIGMS NIH HHS [R01 GM059363-12, R01 GM059363] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Research UK(Cancer Research UK); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; BAKHOUM SF, 2009, CURR BIOL, V19, pR1032; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Dong YM, 2007, NAT CELL BIOL, V9, P516, DOI 10.1038/ncb1576; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Khodjakov Alexey, 2009, Journal of Biology (London), V8, P1, DOI 10.1186/jbiol195; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Liu D, 2009, BIOCHEM SOC T, V37, P976, DOI 10.1042/BST0370976; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Maresca TJ, 2010, J CELL SCI, V123, P825, DOI 10.1242/jcs.064790; Maresca TJ, 2009, J CELL BIOL, V184, P373, DOI 10.1083/jcb.200808130; McEwen BF, 1997, J CELL BIOL, V137, P1567, DOI 10.1083/jcb.137.7.1567; Nezi LG, 2009, CURR OPIN CELL BIOL, V21, P785, DOI 10.1016/j.ceb.2009.09.007; NICKLAS RB, 1994, J CELL BIOL, V126, P1241, DOI 10.1083/jcb.126.5.1241; Nicklas RB, 2001, J CELL SCI, V114, P4173; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; O'Connell CB, 2008, J CELL BIOL, V183, P29, DOI 10.1083/jcb.200801038; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Skoufias DA, 2001, P NATL ACAD SCI USA, V98, P4492, DOI 10.1073/pnas.081076898; Stern BM, 2001, CURR BIOL, V11, P1462, DOI 10.1016/S0960-9822(01)00451-1; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Uchida KSK, 2009, J CELL BIOL, V184, P383, DOI 10.1083/jcb.200811028; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Yang ZY, 2009, J CELL BIOL, V186, P675, DOI 10.1083/jcb.200906150; ZIRKLE RE, 1970, RADIAT RES, V41, P516, DOI 10.2307/3572841	32	69	69	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					919	923		10.1038/ncb1010-919	http://dx.doi.org/10.1038/ncb1010-919			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20885417	Green Accepted			2022-12-25	WOS:000282363500003
J	Demir, E; Cary, MP; Paley, S; Fukuda, K; Lemer, C; Vastrik, I; Wu, GN; D'Eustachio, P; Schaefer, C; Luciano, J; Schacherer, F; Martinez-Flores, I; Hu, ZJ; Jimenez-Jacinto, V; Joshi-Tope, G; Kandasamy, K; Lopez-Fuentes, AC; Mi, HY; Pichler, E; Rodchenkov, I; Splendiani, A; Tkachev, S; Zucker, J; Gopinath, G; Rajasimha, H; Ramakrishnan, R; Shah, I; Syed, M; Anwar, N; Babur, O; Blinov, M; Brauner, E; Corwin, D; Donaldson, S; Gibbons, F; Goldberg, R; Hornbeck, P; Luna, A; Murray-Rust, P; Neumann, E; Reubenacker, O; Samwald, M; van Iersel, M; Wimalaratne, S; Allen, K; Braun, B; Whirl-Carrillo, M; Cheung, KH; Dahlquist, K; Finney, A; Gillespie, M; Glass, E; Gong, L; Haw, R; Honig, M; Hubaut, O; Kane, D; Krupa, S; Kutmon, M; Leonard, J; Marks, D; Merberg, D; Petri, V; Pico, A; Ravenscroft, D; Ren, LY; Shah, N; Sunshine, M; Tang, R; Whaley, R; Letovksy, S; Buetow, KH; Rzhetsky, A; Schachter, V; Sobral, BS; Dogrusoz, U; McWeeney, S; Aladjem, M; Birney, E; Collado-Vides, J; Goto, S; Hucka, M; Le Novere, N; Maltsev, N; Pandey, A; Thomas, P; Wingender, E; Karp, PD; Sander, C; Bader, GD				Demir, Emek; Cary, Michael P.; Paley, Suzanne; Fukuda, Ken; Lemer, Christian; Vastrik, Imre; Wu, Guanming; D'Eustachio, Peter; Schaefer, Carl; Luciano, Joanne; Schacherer, Frank; Martinez-Flores, Irma; Hu, Zhenjun; Jimenez-Jacinto, Veronica; Joshi-Tope, Geeta; Kandasamy, Kumaran; Lopez-Fuentes, Alejandra C.; Mi, Huaiyu; Pichler, Elgar; Rodchenkov, Igor; Splendiani, Andrea; Tkachev, Sasha; Zucker, Jeremy; Gopinath, Gopal; Rajasimha, Harsha; Ramakrishnan, Ranjani; Shah, Imran; Syed, Mustafa; Anwar, Nadia; Babur, Oezguen; Blinov, Michael; Brauner, Erik; Corwin, Dan; Donaldson, Sylva; Gibbons, Frank; Goldberg, Robert; Hornbeck, Peter; Luna, Augustin; Murray-Rust, Peter; Neumann, Eric; Reubenacker, Oliver; Samwald, Matthias; van Iersel, Martijn; Wimalaratne, Sarala; Allen, Keith; Braun, Burk; Whirl-Carrillo, Michelle; Cheung, Kei-Hoi; Dahlquist, Kam; Finney, Andrew; Gillespie, Marc; Glass, Elizabeth; Gong, Li; Haw, Robin; Honig, Michael; Hubaut, Olivier; Kane, David; Krupa, Shiva; Kutmon, Martina; Leonard, Julie; Marks, Debbie; Merberg, David; Petri, Victoria; Pico, Alex; Ravenscroft, Dean; Ren, Liya; Shah, Nigam; Sunshine, Margot; Tang, Rebecca; Whaley, Ryan; Letovksy, Stan; Buetow, Kenneth H.; Rzhetsky, Andrey; Schachter, Vincent; Sobral, Bruno S.; Dogrusoz, Ugur; McWeeney, Shannon; Aladjem, Mirit; Birney, Ewan; Collado-Vides, Julio; Goto, Susumu; Hucka, Michael; Le Novere, Nicolas; Maltsev, Natalia; Pandey, Akhilesh; Thomas, Paul; Wingender, Edgar; Karp, Peter D.; Sander, Chris; Bader, Gary D.			The BioPAX community standard for pathway data sharing	NATURE BIOTECHNOLOGY			English	Article							COLLABORATIVE CONSTRUCTION; INTERACTION NETWORK; REPRESENTATION; ONTOLOGY; SOFTWARE; KNOWLEDGEBASE; INFORMATION; UNIFICATION; ENVIRONMENT; EVOLUTION	Biological Pathway Exchange (BioPAX) is a standard language to represent biological pathways at the molecular and cellular level and to facilitate the exchange of pathway data. The rapid growth of the volume of pathway data has spurred the development of databases and computational tools to aid interpretation; however, use of these data is hampered by the current fragmentation of pathway information across many databases with incompatible formats. BioPAX, which was created through a community process, solves this problem by making pathway data substantially easier to collect, index, interpret and share. BioPAX can represent metabolic and signaling pathways, molecular and genetic interactions and gene regulation networks. Using BioPAX, millions of interactions, organized into thousands of pathways, from many organisms are available from a growing number of databases. This large amount of pathway data in a computable form will support visualization, analysis and biological discovery. (C) 2010 Nature America, Inc. All rights reserved.	[Rodchenkov, Igor; Donaldson, Sylva; Bader, Gary D.] Univ Toronto, Banting & Best Dept Med Res, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Demir, Emek; Cary, Michael P.; Anwar, Nadia; Babur, Oezguen; Sander, Chris] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Demir, Emek; Babur, Oezguen; Dogrusoz, Ugur] Bilkent Univ, Ctr Bioinformat, Ankara, Turkey; [Demir, Emek; Babur, Oezguen; Dogrusoz, Ugur] Bilkent Univ, Dept Comp Engn, Ankara, Turkey; [Mi, Huaiyu; Thomas, Paul] SRI Int, Ctr Artificial Intelligence, Menlo Pk, CA 94025 USA; Japan Sci & Technol Agcy, Inst Bioinformat Res & Dev, Tokyo, Japan; [Lemer, Christian; Hubaut, Olivier] Univ Libre Bruxelles, Brussels, Belgium; [Vastrik, Imre; Birney, Ewan; Le Novere, Nicolas] European Bioinformat Inst, Cambridge, England; [Wu, Guanming; Haw, Robin] Ontario Inst Canc Res, Toronto, ON, Canada; [D'Eustachio, Peter] NYU, Sch Med, New York, NY USA; [Schaefer, Carl] NCI, Ctr Biomed Informat & Informat Technol, Rockville, MD USA; [Luciano, Joanne] Predict Med, Belmont, MA USA; [Schacherer, Frank; Braun, Burk] BIOBASE Corp, Beverly, MA USA; [Martinez-Flores, Irma; Jimenez-Jacinto, Veronica; Collado-Vides, Julio] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca 62191, Morelos, Mexico; [Hu, Zhenjun] Boston Univ, Biomol Syst Lab, Boston, MA 02215 USA; [Joshi-Tope, Geeta; Ren, Liya] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Kandasamy, Kumaran; Pandey, Akhilesh] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Kandasamy, Kumaran; Pandey, Akhilesh] Johns Hopkins Univ, Dept Biol Chem, Baltimore, MD USA; [Kandasamy, Kumaran; Pandey, Akhilesh] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Kandasamy, Kumaran; Pandey, Akhilesh] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Splendiani, Andrea] Univ Rennes 1, Fac Med, Rennes, France; [Splendiani, Andrea] Rothamsted Res, Harpenden, Herts, England; [Tkachev, Sasha; Hornbeck, Peter] Cell Signaling Technol Inc, Danvers, MA USA; [Zucker, Jeremy] Broad Inst, Cambridge, MA USA; [Gopinath, Gopal] US FDA, Ctr Food Safety & Appl Nutr, Laurel, MD USA; [Rajasimha, Harsha; Sobral, Bruno S.] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Rajasimha, Harsha] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA; [Ramakrishnan, Ranjani; McWeeney, Shannon] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Shah, Imran] US Environm Protect Agcy Durham, Durham, NC USA; [Syed, Mustafa; Glass, Elizabeth; Maltsev, Natalia] Argonne Natl Lab, Math & Comp Sci Div, Argonne, IL 60439 USA; [Blinov, Michael] Univ Connecticut, Ctr Hlth, Farmington, CT USA; [Brauner, Erik; Gibbons, Frank] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Corwin, Dan] Lexikos Corp, Boston, MA USA; [Goldberg, Robert] Natl Inst Stand & Technol, Div Biotechnol, Gaithersburg, MD 20899 USA; [Luna, Augustin; Sunshine, Margot; Aladjem, Mirit] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Murray-Rust, Peter] Univ Cambridge, Dept Chem, Unilever Ctr Mol Sci Informat, Cambridge CB2 1EW, England; [Neumann, Eric] Clin Semant Grp, Lexington, MA USA; [Reubenacker, Oliver] Univ Connecticut, Ctr Hlth, Ctr Cell Anal & Modeling, Storrs, CT USA; [Samwald, Matthias] Natl Univ Ireland, Digital Enterprise Res Inst, Galway, Ireland; [Samwald, Matthias] Konrad Lorenz Inst Evolut & Cognit Res, Altenberg, Austria; [van Iersel, Martijn] Maastricht Univ, Dept Bioinformat, Maastricht, Netherlands; [Wimalaratne, Sarala] Univ Auckland, Auckland 1, New Zealand; [Allen, Keith; Leonard, Julie] Syngenta Biotech Inc, Res Triangle Pk, NC USA; [Whirl-Carrillo, Michelle; Gong, Li; Tang, Rebecca; Whaley, Ryan] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Cheung, Kei-Hoi] Yale Univ, Yale Ctr Med Informat, New Haven, CT USA; [Dahlquist, Kam] Loyola Marymount Univ, Los Angeles, CA 90045 USA; [Finney, Andrew] Physiomics PLC, Magdalen Ctr, Oxford, England; [Gillespie, Marc] St Johns Univ, Jamaica, NY 11439 USA; [Honig, Michael] Columbia Univ, New York, NY USA; [Kane, David] SRA Int, Fairfax, VA USA; [Krupa, Shiva] Novartis Knowledge Ctr, Cambridge, MA USA; [Kutmon, Martina] Univ Ottawa, Ottawa, ON, Canada; [Marks, Debbie] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Merberg, David] Vertex Pharmaceut, Cambridge, MA USA; [Petri, Victoria] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; [Pico, Alex] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Ravenscroft, Dean] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY USA; [Shah, Nigam] Stanford Univ, Sch Med, Ctr Biomed Informat, Stanford, CA 94305 USA; [Letovksy, Stan] Millennium Pharmaceut Inc, Computat Sci Informat, Cambridge, MA USA; [Buetow, Kenneth H.] NCI, Ctr Biomed Informat & Informat Technol, Bethesda, MD 20892 USA; [Rzhetsky, Andrey] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Rzhetsky, Andrey] Argonne Natl Lab, Chicago, IL USA; [Schachter, Vincent] Total Gas & Power, Paris, France; [Goto, Susumu] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Kyoto 606, Japan; [Hucka, Michael] CALTECH, Biol Network Modeling Ctr, Pasadena, CA 91125 USA; [Wingender, Edgar] Dept Bioinformat, Gottingen, Germany; [Fukuda, Ken] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Tokyo, Japan	University of Toronto; Memorial Sloan Kettering Cancer Center; Ihsan Dogramaci Bilkent University; Ihsan Dogramaci Bilkent University; SRI International; Japan Science & Technology Agency (JST); Universite Libre de Bruxelles; European Molecular Biology Laboratory (EMBL); Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; New York University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universidad Nacional Autonoma de Mexico; Boston University; Cold Spring Harbor Laboratory; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Universite de Rennes; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; US Food & Drug Administration (FDA); Virginia Polytechnic Institute & State University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Oregon Health & Science University; United States Environmental Protection Agency; United States Department of Energy (DOE); Argonne National Laboratory; University of Connecticut; Harvard University; Harvard Medical School; National Institute of Standards & Technology (NIST) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Cambridge; University of Connecticut; Ollscoil na Gaillimhe-University of Galway; Maastricht University; University of Auckland; Syngenta; Stanford University; Yale University; Loyola Marymount University; Saint John's University; Columbia University; SRA International; Novartis; University of Ottawa; Harvard University; Harvard Medical School; Vertex Pharmaceuticals; Medical College of Wisconsin; University of California System; University of California San Francisco; The J David Gladstone Institutes; Cornell University; Stanford University; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; Total SA; Kyoto University; California Institute of Technology; National Institute of Advanced Industrial Science & Technology (AIST)	Bader, GD (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada.	biopax-paper@biopax.org	Hornbeck, Peter V/K-2226-2017; Dogrusoz, Ugur/ABI-7050-2020; Vastrik, Imre/C-2690-2009; Kandasamy, Richard Kumaran/C-8981-2009; Shah, Syed I/B-8275-2011; rzhetsky, andrey/B-6118-2012; Syed, Mustafa/A-5252-2011; Zucker, Jeremy/M-3643-2016; van Iersel, Martijn P/E-9105-2010; Sander, Chris/H-1452-2011; Fukuda, Ken/A-9870-2017; Hucka, Michael/B-1896-2012; Kutmon, Martina/AAT-2718-2021; Bader, Gary/C-1176-2009; Paley, Suzanne Mercer/HII-3163-2022; Sobral, Bruno/GVU-7637-2022; Pico, Alexander/HCH-4305-2022; Dogrusoz, Ugur/HGC-3914-2022; Pandey, Akhilesh/B-4127-2009; Le Novère, Nicolas/F-9973-2010; Haw, Robin/D-1393-2009; Karp, Peter/C-3514-2012	Hornbeck, Peter V/0000-0002-1126-5149; Dogrusoz, Ugur/0000-0002-7153-0784; Kandasamy, Richard Kumaran/0000-0002-0894-1222; rzhetsky, andrey/0000-0001-6959-7405; Zucker, Jeremy/0000-0002-7276-9009; van Iersel, Martijn P/0000-0002-5877-4338; Sander, Chris/0000-0001-6059-6270; Fukuda, Ken/0000-0001-7366-1094; Hucka, Michael/0000-0001-9105-5960; Kutmon, Martina/0000-0002-7699-8191; Bader, Gary/0000-0003-0185-8861; Paley, Suzanne Mercer/0000-0001-5763-8935; Sobral, Bruno/0000-0003-3908-577X; Pandey, Akhilesh/0000-0001-9943-6127; Le Novère, Nicolas/0000-0002-6309-7327; Gillespie, Marc/0000-0002-5766-1702; Shah, Imran/0000-0003-0808-0140; McWeeney, Shannon/0000-0001-8333-6607; Murray-Rust, Peter/0000-0003-3386-3972; Blinov, Michael/0000-0002-9363-9705; Birney, Ewan/0000-0001-8314-8497; Wingender, Edgar/0000-0002-7729-8453; Pico, Alexander/0000-0001-5706-2163; Thomas, Paul/0000-0002-9074-3507; Collado-Vides, Julio/0000-0001-8780-7664; Whirl-Carrillo, Michelle/0000-0003-2414-9312; Haw, Robin/0000-0002-2013-7835; Karp, Peter/0000-0002-5876-6418; Jimenez-Jacinto, Veronica/0000-0001-6742-1537; Whaley, Ryan/0000-0002-8810-3893; D'Eustachio, Peter/0000-0002-5494-626X; Samwald, Matthias/0000-0002-4855-2571; Wimalaratne, Sarala/0000-0002-5355-2576; Demir, Emek/0000-0002-3663-7113; Vastrik, Imre/0000-0001-6658-9311; BABUR, OZGUN/0000-0002-0239-5259; Splendiani, Andrea/0000-0002-3201-9617	US Department of Energy [DE-FG02-04ER63931]; caBIG program; US National Institute of General Medical Sciences workshop [1R13GM076939, P41HG004118]; US National Human Genome Research Institute and Genome Canada through the Ontario Genomics Institute [2007-OGI-TD-05]; US National Institutes of Health [R01GM071962-07]; NATIONAL CANCER INSTITUTE [P30CA069533] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR022971] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004028, P41HG004118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI081680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R13GM076939, R01GM071962, U24GM077678, R01GM070923] Funding Source: NIH RePORTER; BBSRC [BB/F010516/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F010516/1] Funding Source: researchfish	US Department of Energy(United States Department of Energy (DOE)); caBIG program; US National Institute of General Medical Sciences workshop(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Human Genome Research Institute and Genome Canada through the Ontario Genomics Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funded by the US Department of Energy workshop grant DE-FG02-04ER63931, the caBIG program, the US National Institute of General Medical Sciences workshop grant 1R13GM076939, grant P41HG004118 from the US National Human Genome Research Institute and Genome Canada through the Ontario Genomics Institute (2007-OGI-TD-05) and US National Institutes of Health grant R01GM071962-07. Thanks to many people who contributed to discussions on BioPAX mailing lists, at conferences and at BioPAX workshops, especially A. Ruttenberg and J. Rees.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2006, NUCLEIC ACIDS RES, V34, pD504, DOI 10.1093/nar/gkj126; Bader GD, 2000, BIOINFORMATICS, V16, P465, DOI 10.1093/bioinformatics/16.5.465; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Berners-Lee T, 2001, NATURE, V410, P1023, DOI 10.1038/35074206; Cary MP, 2005, FEBS LETT, V579, P1815, DOI 10.1016/j.febslet.2005.02.005; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Cerami EG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-497; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Demir E, 2004, BIOINFORMATICS, V20, P349, DOI 10.1093/bioinformatics/btg416; Demir E, 2002, BIOINFORMATICS, V18, P996, DOI 10.1093/bioinformatics/18.7.996; Efroni S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002901; Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44; Fukuda K, 2001, BIOINFORMATICS, V17, P829, DOI 10.1093/bioinformatics/17.9.829; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Hermjakob H, 2004, NAT BIOTECHNOL, V22, P177, DOI 10.1038/nbt926; Hlavacek William S, 2006, Sci STKE, V2006, pre6, DOI 10.1126/stke.3442006re6; Hoffmann R, 2005, SCI STKE, V2005, P21; Hu ZJ, 2007, NUCLEIC ACIDS RES, V35, pW625, DOI 10.1093/nar/gkm295; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Isserlin R, 2010, PROTEOMICS, V10, P1316, DOI 10.1002/pmic.200900412; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Karp PD, 2000, BIOINFORMATICS, V16, P269, DOI 10.1093/bioinformatics/16.3.269; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kerrien S, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-44; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Kitano Hiroaki, 2003, Biosilico, V1, P169, DOI 10.1016/S1478-5382(03)02380-1; Knublauch H, 2004, LECT NOTES COMPUT SC, V3298, P229; Koh G, 2006, BIOINFORMATICS, V22, pE271, DOI 10.1093/bioinformatics/btl264; Kohn KW, 1999, MOL BIOL CELL, V10, P2703, DOI 10.1091/mbc.10.8.2703; Krull M, 2006, NUCLEIC ACIDS RES, V34, pD546, DOI 10.1093/nar/gkj107; Laibe C, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-58; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Lloyd CM, 2004, PROG BIOPHYS MOL BIO, V85, P433, DOI 10.1016/j.pbiomolbio.2004.01.004; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Moraru II, 2008, IET SYST BIOL, V2, P352, DOI 10.1049/iet-syb:20080102; Nicholson DE, 2000, IUBMB LIFE, V50, P341, DOI 10.1080/713803744; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Racunas SA, 2004, BIOINFORMATICS, V20, P257, DOI 10.1093/bioinformatics/bth905; Racunas SA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-196; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sauro Herbert M., 2003, OMICS A Journal of Integrative Biology, V7, P355, DOI 10.1089/153623103322637670; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sowa J. F., 2000, KNOWLEDGE REPRESENTA; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Yamamoto S, 2004, COMP FUNCT GENOM, V5, P528, DOI 10.1002/cfg.432	65	423	426	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2010	28	9					935	942		10.1038/nbt.1666	http://dx.doi.org/10.1038/nbt.1666			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	648UF	20829833	Green Published, Green Accepted			2022-12-25	WOS:000281719100019
J	Kim, AM; Vogt, S; O'Halloran, TV; Woodruff, TK				Kim, Alison M.; Vogt, Stefan; O'Halloran, Thomas V.; Woodruff, Teresa K.			Zinc availability regulates exit from meiosis in maturing mammalian oocytes	NATURE CHEMICAL BIOLOGY			English	Article							XENOPUS-LAEVIS OOCYTES; MOUSE OOCYTES; CYTOPLASMIC MATURATION; MEIOTIC MATURATION; GENE-EXPRESSION; EGG ACTIVATION; CELL; TRANSITION; EMBRYOS; HOMEOSTASIS	Cellular metal ion fluxes are known in alkali and alkaline earth metals but are not well documented in transition metals. Here we describe major changes in the zinc physiology of the mammalian oocyte as it matures and initiates embryonic development. Single-cell elemental analysis of mouse oocytes by synchrotron-based X-ray fluorescence microscopy (XFM) revealed a 50% increase in total zinc content within the 12-14-h period of meiotic maturation. Perturbation of zinc homeostasis with a cell-permeable small-molecule chelator blocked meiotic progression past telophase I. Zinc supplementation rescued this phenotype when administered before this meiotic block. However, after telophase arrest, zinc triggered parthenogenesis, suggesting that exit from this meiotic step is tightly regulated by the availability of a zinc-dependent signal. These results implicate the zinc bolus acquired during meiotic maturation as an important part of the maternal legacy to the embryo.	[Kim, Alison M.; Woodruff, Teresa K.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Kim, Alison M.; O'Halloran, Thomas V.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL USA; [Vogt, Stefan] Argonne Natl Lab, Xray Sci Div, Argonne, IL 60439 USA; [O'Halloran, Thomas V.; Woodruff, Teresa K.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL USA; [O'Halloran, Thomas V.] Northwestern Univ, Dept Chem, Evanston, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory; Northwestern University; Northwestern University	Kim, AM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA.	t-ohalloran@northwestern.edu; tkw@northwestern.edu	Vogt, Stefan/J-7937-2013; O'Halloran, Thomas/ABE-6125-2021; Kim, Alison/D-6969-2014; Vogt, Stefan/B-9547-2009	Vogt, Stefan/0000-0002-8034-5513; O'Halloran, Thomas/0000-0001-8732-5059; Kim, Alison/0000-0001-5845-1865; Vogt, Stefan/0000-0002-8034-5513; Woodruff, Teresa/0000-0002-1197-3399	US National Institutes of Health [P01 HD021921, GM38784]; W.M. Keck Foundation; Chicago Biomedical Consortium Spark Award; Office of Basic Energy Sciences in the Office of Science of the US Department of Energy [DE-AC02-06CH11357];  [HD007068]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD021921] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038784, R29GM038784, R37GM038784] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck Foundation(W.M. Keck Foundation); Chicago Biomedical Consortium Spark Award; Office of Basic Energy Sciences in the Office of Science of the US Department of Energy; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge J. Jozefik, S. Kiesewetter and D. Mackovic for animal care and concerns. We would also like to thank the P01 Histology Core (T. Wellington, director), the Analytical Services Laboratory and the Quantitative Bioelement Imaging Center in the Chemistry of Life Processes Institute at Northwestern University for reagents and discussions regarding sample processing. This work is supported by US National Institutes of Health grants P01 HD021921 and GM38784, the W.M. Keck Foundation Medical Research Award and the Chicago Biomedical Consortium Spark Award. A.M.K. was a fellow of the Reproductive Biology Training Grant HD007068. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the Office of Basic Energy Sciences in the Office of Science of the US Department of Energy, under contract no. DE-AC02-06CH11357.	Ajduk A, 2008, REPROD BIOLOGY, V8, P3, DOI 10.1016/S1642-431X(12)60001-1; Araki K, 1996, BIOL REPROD, V55, P1315, DOI 10.1095/biolreprod55.6.1315; ARSLAN P, 1985, J BIOL CHEM, V260, P2719; Barrett SL, 2007, BIOL REPROD, V76, P949, DOI 10.1095/biolreprod.106.057141; Beyersmann D, 2001, BIOMETALS, V14, P331, DOI 10.1023/A:1012905406548; Bruinsma JJ, 2002, DEV CELL, V2, P567, DOI 10.1016/S1534-5807(02)00151-X; Brunet S, 2005, REPRODUCTION, V130, P801, DOI 10.1530/rep.1.00364; COOLEY L, 1995, DEV GENET, V16, P1, DOI 10.1002/dvg.1020160103; Ducibella T, 2002, DEV BIOL, V250, P280, DOI 10.1006/dbio.2002.0788; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; EPPIG JJ, 1994, DEV BIOL, V164, P1, DOI 10.1006/dbio.1994.1175; ERICKSON GF, 1974, J EXP ZOOL, V190, P123, DOI 10.1002/jez.1401900112; Falchuk KH, 1995, BIOCHEMISTRY-US, V34, P16524, DOI 10.1021/bi00050a037; Falchuk KH, 2001, BIOMETALS, V14, P385, DOI 10.1023/A:1012994427351; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Galaris D, 2008, CANCER LETT, V266, P21, DOI 10.1016/j.canlet.2008.02.038; Gandolfi TALB, 2001, THERIOGENOLOGY, V55, P1255, DOI 10.1016/S0093-691X(01)00481-2; Gosden RG, 2002, MOL CELL ENDOCRINOL, V186, P149, DOI 10.1016/S0303-7207(01)00683-9; Ibanez E, 2005, REPRODUCTION, V130, P845, DOI 10.1530/rep.1.00558; Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Martell A.E., 1998, NIST STANDARD REFERE, V46; Nagy A., 2003, MANIPULATING MOUSE E; NOMIZU T, 1993, MOL REPROD DEV, V36, P419, DOI 10.1002/mrd.1080360403; OHALLORAN TV, 1993, SCIENCE, V261, P715, DOI 10.1126/science.8342038; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Ozil JP, 2006, DEV BIOL, V300, P534, DOI 10.1016/j.ydbio.2006.08.041; PERREAULT SD, 1988, DEV BIOL, V125, P181, DOI 10.1016/0012-1606(88)90070-X; Picton H, 1998, MOL CELL ENDOCRINOL, V145, P27, DOI 10.1016/S0303-7207(98)00166-X; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Santos F, 2006, METH MOL B, V325, P129; SORENSEN RA, 1976, DEV BIOL, V50, P531, DOI 10.1016/0012-1606(76)90172-X; Stitzel ML, 2007, SCIENCE, V316, P407, DOI 10.1126/science.1138236; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Suhy DA, 1999, J BIOL CHEM, V274, P9183, DOI 10.1074/jbc.274.14.9183; Sun L, 2007, J CELL PHYSIOL, V213, P98, DOI 10.1002/jcp.21090; Taki M, 2004, J AM CHEM SOC, V126, P712, DOI 10.1021/ja039073j; Toth S, 2006, REPRODUCTION, V131, P27, DOI 10.1530/rep.1.00764; Turski ML, 2009, J BIOL CHEM, V284, P717, DOI 10.1074/jbc.R800055200; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Vogt S, 2003, J PHYS IV, V104, P635, DOI 10.1051/jp4:20030160; WICKRAMASINGHE D, 1991, DEV BIOL, V143, P162, DOI 10.1016/0012-1606(91)90063-9; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Zhang AS, 2009, J BIOL CHEM, V284, P711, DOI 10.1074/jbc.R800017200	44	168	174	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2010	6	9					674	681		10.1038/NCHEMBIO.419	http://dx.doi.org/10.1038/NCHEMBIO.419			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	640WO	20693991	Green Accepted, Green Published			2022-12-25	WOS:000281084900011
J	Yao, LN; Fan, PD; Arolfo, M; Jiang, Z; Olive, MF; Zablocki, J; Sun, HL; Chu, N; Lee, J; Kim, HY; Leung, K; Shryock, J; Blackburn, B; Diamond, I				Yao, Lina; Fan, Peidong; Arolfo, Maria; Jiang, Zhang; Olive, M. Foster; Zablocki, Jeff; Sun, Hai-Ling; Chu, Nancy; Lee, Jeongrim; Kim, Hee-Yong; Leung, Kwan; Shryock, John; Blackburn, Brent; Diamond, Ivan			Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesis	NATURE MEDICINE			English	Article							VENTRAL TEGMENTAL AREA; PROTEIN-KINASE-A; NUCLEUS-ACCUMBENS; TYROSINE-HYDROXYLASE; DRUG-ADDICTION; NEUROBIOLOGY; BRAIN; METABOLISM; CIRCUITRY; ASSAY	There is no effective treatment for cocaine addiction despite extensive knowledge of the neurobiology of drug addiction(1-4). Here we show that a selective aldehyde dehydrogenase-2 (ALDH-2) inhibitor, ALDH2i, suppresses cocaine self-administration in rats and prevents cocaine-or cue-induced reinstatement in a rat model of cocaine relapse-like behavior. We also identify a molecular mechanism by which ALDH-2 inhibition reduces cocaine-seeking behavior: increases in tetrahydropapaveroline (THP) formation due to inhibition of ALDH-2 decrease cocaine-stimulated dopamine production and release in vitro and in vivo. Cocaine increases extracellular dopamine concentration, which activates dopamine D2 autoreceptors to stimulate cAMP-dependent protein kinase A (PKA) and protein kinase C (PKC) in primary ventral tegmental area (VTA) neurons. PKA and PKC phosphorylate and activate tyrosine hydroxylase, further increasing dopamine synthesis in a positive-feedback loop. Monoamine oxidase converts dopamine to 3,4-dihydroxyphenylacetaldehyde (DOPAL), a substrate for ALDH-2. Inhibition of ALDH-2 enables DOPAL to condense with dopamine to form THP in VTA neurons. THP selectively inhibits phosphorylated (activated) tyrosine hydroxylase to reduce dopamine production via negative-feedback signaling. Reducing cocaine-and craving-associated increases in dopamine release seems to account for the effectiveness of ALDH2i in suppressing cocaine-seeking behavior. Selective inhibition of ALDH-2 may have therapeutic potential for treating human cocaine addiction and preventing relapse.	[Yao, Lina; Fan, Peidong; Arolfo, Maria; Jiang, Zhang; Zablocki, Jeff; Sun, Hai-Ling; Chu, Nancy; Leung, Kwan; Shryock, John; Blackburn, Brent; Diamond, Ivan] Gilead Sci Inc, Palo Alto, CA USA; [Olive, M. Foster] Med Univ S Carolina, Dept Psychiat, Ctr Drug & Alcohol Programs, Charleston, SC 29425 USA; [Olive, M. Foster] Med Univ S Carolina, Dept Neurosci, Ctr Drug & Alcohol Programs, Charleston, SC 29425 USA; [Lee, Jeongrim; Kim, Hee-Yong] NIAAA, Lab Mol Signaling, NIH, Bethesda, MD USA	Gilead Sciences; Medical University of South Carolina; Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Yao, LN (corresponding author), Gilead Sci Inc, Palo Alto, CA USA.	lina.yao@gilead.com	Jiang, Zhang/Q-3827-2019	Jiang, Zhang/0000-0003-3503-8909; Olive, Foster/0000-0002-2517-0351	Intramural NIH HHS [Z01 AA000500-05] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000500] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Arolfo MP, 2009, ALCOHOL CLIN EXP RES, V33, P1935, DOI 10.1111/j.1530-0277.2009.01031.x; Balter M, 1996, SCIENCE, V271, P909, DOI 10.1126/science.271.5251.909; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bossert JM, 2005, EUR J PHARMACOL, V526, P36, DOI 10.1016/j.ejphar.2005.09.030; BRODIE MS, 1990, N-S ARCH PHARMACOL, V342, P660, DOI 10.1007/BF00175709; Chen SY, 1996, BRAIN RES, V729, P294, DOI 10.1016/0006-8993(96)00671-3; Dickinson SD, 1999, J NEUROCHEM, V72, P148, DOI 10.1046/j.1471-4159.1999.0720148.x; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; Gaval-Cruz M, 2009, MOL INTERV, V9, P175, DOI 10.1124/mi.9.4.6; Hahn J, 2006, J NEUROSCI, V26, P5240, DOI 10.1523/JNEUROSCI.4976-05.2006; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Inoue Y, 2007, J PHARMACOL EXP THER, V322, P23, DOI 10.1124/jpet.107.120675; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; KEUNG WM, 1995, P NATL ACAD SCI USA, V92, P8990, DOI 10.1073/pnas.92.19.8990; Kim YM, 2005, NEUROSCI LETT, V386, P1, DOI 10.1016/j.neulet.2005.04.105; Koob GF, 2009, NAT REV DRUG DISCOV, V8, P500, DOI 10.1038/nrd2828; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; LACEY MG, 1990, BRIT J PHARMACOL, V99, P731, DOI 10.1111/j.1476-5381.1990.tb12998.x; Lamensdorf I, 2000, BRAIN RES, V868, P191, DOI 10.1016/S0006-8993(00)02309-X; Marchitti SA, 2007, PHARMACOL REV, V59, P125, DOI 10.1124/pr.59.2.1; MCCAFFERY P, 1994, P NATL ACAD SCI USA, V91, P7772, DOI 10.1073/pnas.91.16.7772; McFarland K, 2004, J NEUROSCI, V24, P1551, DOI 10.1523/JNEUROSCI.4177-03.2004; MYERS RD, 1990, ALCOHOL, V7, P449, DOI 10.1016/0741-8329(90)90031-7; NAGATSU T, 1972, CLIN CHEM, V18, P980; Negus SS, 1996, J PHARMACOL EXP THER, V278, P879; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Nestler Eric J, 2005, Sci Pract Perspect, V3, P4; RASSNICK S, 1992, PSYCHOPHARMACOLOGY, V109, P92, DOI 10.1007/BF02245485; ROBERTS DCS, 1982, PHARMACOL BIOCHEM BE, V17, P901, DOI 10.1016/0091-3057(82)90469-5; Saeedi H, 2006, SCHIZOPHR RES, V85, P222, DOI 10.1016/j.schres.2006.03.033; SHERALD AF, 1973, ANAL BIOCHEM, V56, P300, DOI 10.1016/0003-2697(73)90194-2; Sofuoglu Mehmet, 2006, Expert Opin Emerg Drugs, V11, P91, DOI 10.1517/14728214.11.1.91; Sombers LA, 2009, J NEUROSCI, V29, P1735, DOI 10.1523/JNEUROSCI.5562-08.2009; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Suh JJ, 2006, J CLIN PSYCHOPHARM, V26, P290, DOI 10.1097/01.jcp.0000222512.25649.08; Tinsley RB, 2009, ANN NEUROL, V66, P472, DOI 10.1002/ana.21716; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; YAMAUCHI T, 1978, ANAL BIOCHEM, V89, P143, DOI 10.1016/0003-2697(78)90735-2; Yao L, 2008, MOL PHARMACOL, V73, P1105, DOI 10.1124/mol.107.042580	41	76	79	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2010	16	9					1024	U120		10.1038/nm.2200	http://dx.doi.org/10.1038/nm.2200			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20729865	Green Accepted			2022-12-25	WOS:000281622900032
J	Carbone, J; Gold, ER; Sampat, B; Chandrasekharan, S; Knowles, L; Angrist, M; Cook-Deegan, R				Carbone, Julia; Gold, E. Richard; Sampat, Bhaven; Chandrasekharan, Subhashini; Knowles, Lori; Angrist, Misha; Cook-Deegan, Robert			DNA patents and diagnostics: not a pretty picture	NATURE BIOTECHNOLOGY			English	Article							GENE PATENTS; LICENSING PRACTICES; INTELLECTUAL PROPERTY; ACCESS; IMPACT; POLICY		[Carbone, Julia] Duke Univ, Sch Law, Durham, NC 27706 USA; [Gold, E. Richard] McGill Univ, Fac Law, Montreal, PQ, Canada; [Gold, E. Richard] Fac Med, Montreal, PQ, Canada; [Sampat, Bhaven] Columbia Univ, Dept Hlth Policy & Management, New York, NY USA; [Chandrasekharan, Subhashini; Cook-Deegan, Robert] Duke Univ, Ctr Genome Eth Law & Policy, Inst Genome Sci & Policy, Durham, NC USA; [Knowles, Lori] Univ Alberta, Hlth Law Inst, Edmonton, AB, Canada; [Angrist, Misha] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA	Duke University; McGill University; Columbia University; Duke University; University of Alberta; Duke University	Carbone, J (corresponding author), Duke Univ, Sch Law, Durham, NC 27706 USA.	bob.cd@duke.edu		Gold, E. Richard/0000-0002-3789-9238; Cook-Deegan, Robert/0000-0002-8251-4237	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003391] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG003391-050001, P50 HG003391] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		*AM MED ASS, 2000, REP 9 COUNC SCI AFF; Andrews LB, 2002, NAT REV GENET, V3, P803, DOI 10.1038/nrg909; Angrist M, 2010, GENET MED, V12, pS111, DOI 10.1097/GIM.0b013e3181d68293; Australian Law Reform Commission, 2003, ESS YOURS PROT HUM G; AUTM, 2007, PUBL INT 9 POINTS CO; *AUTM, 2009, U PRINC GLOB ACC MED; Caulfield T, 2006, NAT BIOTECHNOL, V24, P1091, DOI 10.1038/nbt0906-1091; Chandrasekharan S, 2009, GENOME MED, V1, DOI 10.1186/gm92; Chandrasekharan S, 2010, GENET MED, V12, pS155, DOI 10.1097/GIM.0b013e3181d7acb0; Chandrasekharan S, 2010, GENET MED, V12, pS194, DOI 10.1097/GIM.0b013e3181d7cf7d; Chandrasekharan S, 2010, GENET MED, V12, pS171, DOI 10.1097/GIM.0b013e3181d7b053; Cho MK, 2003, J MOL DIAGN, V5, P3, DOI 10.1016/S1525-1578(10)60444-8; Colaianni A, 2010, GENET MED, V12, pS5, DOI 10.1097/GIM.0b013e3181d5a669; Cook-Deegan R, 2010, GENET MED, V12, pS15, DOI 10.1097/GIM.0b013e3181d5a67b; Cook-Deegan R, 2009, NATURE, V458, P405, DOI 10.1038/458405a; Gold ER, 2007, NAT BIOTECHNOL, V25, P388, DOI 10.1038/nbt0407-388; Gold ER, 2010, GENET MED, V12, pS39, DOI 10.1097/GIM.0b013e3181d72661; Gold ER, 2000, NAT BIOTECHNOL, V18, P1319, DOI 10.1038/82460; GOLD ER, 2005, RES EXPT USE EXCEPTI; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Henry MR, 2002, SCIENCE, V297, P1279, DOI 10.1126/science.1070899; Holman CM, 2008, SCIENCE, V322, P198, DOI 10.1126/science.1160687; Huys I, 2009, NAT BIOTECHNOL, V27, P903, DOI 10.1038/nbt1009-903; Merrill Stephen A., 2006, REAP BEN GEN PROT RE; Merz JF, 2002, NATURE, V415, P577, DOI 10.1038/415577a; Merz JF, 1998, CAMB Q HEALTHC ETHIC, V7, P425, DOI 10.1017/S0963180198004149; Merz JF, 1999, CLIN CHEM, V45, P324; Merz JF, 1997, MOL DIAGN, V2, P299, DOI 10.1016/S1084-8592(97)80041-0; MERZ JF, 2009, PENN CTR GUIDE BIOET, P383; Mowery DC, 2001, RES POLICY, V30, P99, DOI 10.1016/S0048-7333(99)00100-6; National Institute of Health, 2005, FED REGISTER, V70, P18413; Nelson R. R, 2001, J TECHNOLOGY TRANSFE, V26, P13, DOI DOI 10.1023/A:1007875910066; NICOL D, 2003, 6 CTR LAW GEN; *NUFF COUNC BIOETH, 2002, ETH PAT DNA; *ONT REP PROV TERR, 2002, GEN TEST GEN PAT CHA; Organisation for Economic Cooperation and Development, 2006, GUID LIC GEN INV; OVERWALLE GV, 2006, INT REV INTELLECT PR, V889, P908; Powell A, 2010, GENET MED, V12, pS83, DOI 10.1097/GIM.0b013e3181d67e44; Pressman L, 2006, NAT BIOTECHNOL, V24, P31, DOI 10.1038/nbt0106-31; Rai AK, 1999, NORTHWEST U LAW REV, V94, P77; Rimmer M., 2003, EUR INTELLECT PROP R, V25, P20; Schissel A, 1999, NATURE, V402, P118, DOI 10.1038/45907; Secretary's Advisory Committee on Genetics Health and Society, 2010, REP GEN PAT LIC PRAC; Siegel DS, 2007, OXFORD REV ECON POL, V23, P529, DOI 10.1093/oxrep/grm033; Skeehan K, 2010, GENET MED, V12, pS71, DOI 10.1097/GIM.0b013e3181d5a68e; US Patent and Trademark Office, 2001, FED REGISTER, V66, P1092; Van Overwalle G, 2006, NAT REV GENET, V7, P143, DOI 10.1038/nrg1765; WALSH JP, 2003, EFFECTS RES TOOL PAT, P285	48	22	23	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2010	28	8					784	791		10.1038/nbt0810-784	http://dx.doi.org/10.1038/nbt0810-784			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	636RM	20697400	Green Accepted			2022-12-25	WOS:000280757500015
J	Daniel, K; Lange, J; Hached, K; Fu, J; Anastassiadis, K; Roig, I; Cooke, HJ; Stewart, AF; Wassmann, K; Jasin, M; Keeney, S; Toth, A				Daniel, Katrin; Lange, Julian; Hached, Khaled; Fu, Jun; Anastassiadis, Konstantinos; Roig, Ignasi; Cooke, Howard J.; Stewart, A. Francis; Wassmann, Katja; Jasin, Maria; Keeney, Scott; Toth, Attila			Meiotic homologue alignment and its quality surveillance are controlled by mouse HORMAD1	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; SEX-CHROMOSOME INACTIVATION; SISTER CHROMATIDS; CHIASMA FORMATION; PROPHASE ARREST; NON-CROSSOVER; C. ELEGANS; SYNAPSIS; MEIOSIS; RECOMBINATION	Meiotic crossover formation between homologous chromosomes (homologues) entails DNA double-strand break (DSB) formation, homology search using DSB ends, and synaptonemal-complex formation coupled with DSB repair. Meiotic progression must be prevented until DSB repair and homologue alignment are completed, to avoid the formation of aneuploid gametes. Here we show that mouse HORMAD1 ensures that sufficient numbers of processed DSBs are available for successful homology search. HORMAD1 is needed for normal synaptonemal-complex formation and for the efficient recruitment of AIR checkpoint kinase activity to unsynapsed chromatin. The latter phenomenon was proposed to be important in meiotic prophase checkpoints in both sexes. Consistent with this hypothesis, HORMAD1 is essential for the elimination of synaptonemal-complex-defective oocytes. Synaptonemal-complex formation results in HORMAD1 depletion from chromosome axes. Thus, we propose that the synaptonemal complex and HORMAD1 are key components of a negative feedback loop that coordinates meiotic progression with homologue alignment: HORMAD1 promotes homologue alignment and synaptonemal-complex formation, and synaptonemal complexes downregulate HORMAD1 function, thereby permitting progression past meiotic prophase checkpoints.	[Daniel, Katrin; Toth, Attila] Tech Univ Dresden, Inst Physiol Chem, D-01307 Dresden, Germany; [Lange, Julian; Roig, Ignasi; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Hached, Khaled; Wassmann, Katja] CNRS UMR7622 Biol Dev, F-75005 Paris, France; [Hached, Khaled; Wassmann, Katja] Univ Paris 06, F-75005 Paris, France; [Anastassiadis, Konstantinos] Tech Univ Dresden, BioInnovat Zentrum, Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany; [Cooke, Howard J.] Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Keeney, Scott] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA	Technische Universitat Dresden; Memorial Sloan Kettering Cancer Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Technische Universitat Dresden; University of Edinburgh; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Toth, A (corresponding author), Tech Univ Dresden, Inst Physiol Chem, Fiedlerstr 42, D-01307 Dresden, Germany.	attila.Toth@mailbox.tu-dresden.de	Roig, Ignasi/A-9697-2012; Toth, Attila/C-9624-2013; Keeney, Scott/GVR-8515-2022; Stewart, A. Francis/E-7789-2010; Anastassiadis, Konstantinos/A-8944-2010; Fu, Jun/C-9133-2011	Roig, Ignasi/0000-0003-0313-3581; Toth, Attila/0000-0001-5744-3847; Anastassiadis, Konstantinos/0000-0002-9814-0559; Keeney, Scott/0000-0002-1283-6417; Hached, Khaled/0000-0003-1143-6929; Wassmann, Katja/0000-0001-5442-5192	Deutsche Forschungsgemeinschaft (DFG) [TO421/4-1 SPP1384, TO421/3-1]; Sachsisches Staatsministerium fur Wissenschaft und Kunst; US National Institutes of Health [HD53855, HD40916]; ARC [1143]; La Ligue Regionale [RS09/75-39]; Medical Research Council UK; DFG research centre and cluster of excellence; CRTD; EFRE (Europaischer Fonds fur Regionale Entwicklung); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053855] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040916] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Sachsisches Staatsministerium fur Wissenschaft und Kunst; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARC(Australian Research Council); La Ligue Regionale; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DFG research centre and cluster of excellence(German Research Foundation (DFG)); CRTD; EFRE (Europaischer Fonds fur Regionale Entwicklung); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank A. Hientzsch and K. Duerschke for general laboratory support and technical assistance; R. Jessberger for sharing ideas, antibodies (anti-SYCP3, anti-STAG3 and anti-SMC3) and support; F. Baudat and B. De Massy for providing us with Spo11<SUP>+/-</SUP> mice; J. Chen for the anti-TOPBP1 antibody; E. Marcon for the anti RPA antibody; C. Hoog for anti-SYCE1 and anti SYCE2 antibodies; G.C. Enders for the anti-GCNA antibody; and M.P. Thelen for the anti-SPO11 antibody. We are grateful to M. Siomos and D. Knapp for discussion, revising and proofreading the manuscript. The Deutsche Forschungsgemeinschaft (DFG; grants: TO421/4-1 SPP1384 and TO421/3-1) and the Sachsisches Staatsministerium fur Wissenschaft und Kunst supported K.D. and A.T.; Grants HD53855 and HD40916 from the US National Institutes of Health supported J.L., I.R., M.J. and S.K.; ARC (Subvention fixe 1143) and La Ligue Regionale (RS09/75-39) supported K.H. and K.W.; the Medical Research Council UK supported H.J.C.; the DFG research centre and cluster of excellence to the Center for Regenerative Therapies Dresden (CRTD) supported the work of K.A.; a CRTD seed grant supported K.A. and A.T.; and an EFRE grant (Europaischer Fonds fur Regionale Entwicklung) supported K.A., J.F. and A.F.S.	Ahmed EA, 2009, METHODS MOL BIOL, V558, P263, DOI 10.1007/978-1-60761-103-5_16; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P284, DOI 10.1016/S0968-0004(98)01257-2; Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Bailis JM, 2000, MOL CELL BIOL, V20, P4838, DOI 10.1128/MCB.20.13.4838-4848.2000; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barchi M, 2005, MOL CELL BIOL, V25, P7203, DOI 10.1128/MCB.25.16.7203-7215.2005; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; Bellani MA, 2005, J CELL SCI, V118, P3233, DOI 10.1242/jcs.02466; Bolcun-Filas E, 2007, J CELL BIOL, V176, P741, DOI 10.1083/jcb.200610027; Bolcun-Filas E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000393; Burgoyne PS, 2007, BIOESSAYS, V29, P974, DOI 10.1002/bies.20639; Burgoyne PS, 2009, NAT REV GENET, V10, P207, DOI 10.1038/nrg2505; Carballo JA, 2008, CELL, V132, P758, DOI 10.1016/j.cell.2008.01.035; Couteau F, 2005, GENE DEV, V19, P2744, DOI 10.1101/gad.1348205; Couteau F, 2004, CURR BIOL, V14, P585, DOI 10.1016/j.cub.2004.03.033; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; ENDERS GC, 1994, DEV BIOL, V163, P331, DOI 10.1006/dbio.1994.1152; Fernandez-Capetillo O, 2003, J CELL BIOL, V163, P15, DOI 10.1083/jcb.200305124; Fukuda T, 2010, EXP CELL RES, V316, P158, DOI 10.1016/j.yexcr.2009.08.007; Goodyer W, 2008, DEV CELL, V14, P263, DOI 10.1016/j.devcel.2007.11.016; Hamer G, 2008, THERIOGENOLOGY, V69, P333, DOI 10.1016/j.theriogenology.2007.09.029; Hamer G, 2008, J CELL SCI, V121, P2445, DOI 10.1242/jcs.033233; Hayashi M, 2007, PLOS GENET, V3, P2068, DOI 10.1371/journal.pgen.0030191; Hodges CA, 2002, CHROMOSOMA, V111, P165, DOI 10.1007/s00412-002-0195-3; HOLLINGSWORTH NM, 1989, GENETICS, V121, P445; Hollingsworth NM, 1997, GENETICS, V147, P33; HUNTER N, 2007, MEIOTIC RECOMBINATIO; Joshi N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000557; Keegan KS, 1996, GENE DEV, V10, P2423, DOI 10.1101/gad.10.19.2423; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; LOIDL J, 1994, J CELL BIOL, V125, P1191, DOI 10.1083/jcb.125.6.1191; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; Mahadevaiah SK, 2008, J CELL BIOL, V182, P263, DOI 10.1083/jcb.200710195; Marcon E, 2003, GENETICS, V165, P2283; Martinez-Perez E, 2005, GENE DEV, V19, P2727, DOI 10.1101/gad.1338505; Martinez-Perez E, 2008, GENE DEV, V22, P2886, DOI 10.1101/gad.1694108; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Moens PB, 1999, CHROMOSOMA, V108, P95, DOI 10.1007/s004120050356; Moens PB, 2007, J CELL SCI, V120, P1017, DOI 10.1242/jcs.03394; Nabeshima K, 2004, GENETICS, V168, P1275, DOI 10.1534/genetics.104.030700; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Niault T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001165; Niu H, 2007, MOL CELL BIOL, V27, P5456, DOI 10.1128/MCB.00416-07; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; Nonomura KI, 2006, J CELL SCI, V119, P217, DOI 10.1242/jcs.02736; Perera D, 2004, MOL BIOL CELL, V15, P1568, DOI 10.1091/mbc.E03-06-0444; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Plug AW, 1998, J CELL SCI, V111, P413; Plug AW, 1997, NAT GENET, V17, P457, DOI 10.1038/ng1297-457; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Royo H, 2010, CURR BIOL, V20, P2117, DOI 10.1016/j.cub.2010.11.010; Sanchez-Moran E, 2007, GENE DEV, V21, P2220, DOI 10.1101/gad.439007; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Severson AF, 2009, GENE DEV, V23, P1763, DOI 10.1101/gad.1808809; Shin YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001190; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; Suzumori N, 2002, MECH DEVELOP, V111, P137, DOI 10.1016/S0925-4773(01)00620-7; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; Turner JMA, 2004, CURR BIOL, V14, P2135, DOI 10.1016/j.cub.2004.11.032; Wojtasz L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000702; Woltering D, 2000, MOL CELL BIOL, V20, P6646, DOI 10.1128/MCB.20.18.6646-6658.2000; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Zetka M., 2009, V5, P43, DOI 10.1159/000166618; Zetka MC, 1999, GENE DEV, V13, P2258, DOI 10.1101/gad.13.17.2258; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	70	149	151	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY 11	2011	13	5					599	U232		10.1038/ncb2213	http://dx.doi.org/10.1038/ncb2213			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	758FY	21478856	Green Accepted			2022-12-25	WOS:000290148700019
J	Okamoto, K; Tokunaga, K; Doi, K; Fujita, T; Suzuki, H; Katoh, T; Watanabe, T; Nishida, N; Mabuchi, A; Takahashi, A; Kubo, M; Maeda, S; Nakamura, Y; Noiri, E				Okamoto, Koji; Tokunaga, Katsushi; Doi, Kent; Fujita, Toshiro; Suzuki, Hodaka; Katoh, Tetsuo; Watanabe, Tsuyoshi; Nishida, Nao; Mabuchi, Akihiko; Takahashi, Atsushi; Kubo, Michiaki; Maeda, Shiro; Nakamura, Yusuke; Noiri, Eisei			Common variation in GPC5 is associated with acquired nephrotic syndrome	NATURE GENETICS			English	Article							FIBROBLAST-GROWTH-FACTOR; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; PODOCYTE INJURY; AFRICAN-AMERICANS; KIDNEY-DISEASE; EXPRESSION; GENE; NEPHROPATHY; GENOME; SUSCEPTIBILITY	Severe proteinuria is a defining factor of nephrotic syndrome irrespective of the etiology. Investigation of congenital nephrotic syndrome has shown that dysfunction of glomerular epithelial cells (podocytes) plays a crucial role in this disease(1). Acquired nephrotic syndrome is also assumed to be associated with podocyte injury. Here we identify an association between variants in GPC5, encoding glypican-5, and acquired nephrotic syndrome through a genome-wide association study and replication analysis (P value under a recessive model (P-rec) = 6.0 x 10(-11), odds ratio = 2.54). We show that GPC5 is expressed in podocytes and that the risk genotype is associated with higher expression. We further show that podocyte-specific knockdown and systemic short interfering RNA injection confers resistance to podocyte injury in mouse models of nephrosis. This study identifies GPC5 as a new susceptibility gene for nephrotic syndrome and implicates GPC5 as a promising therapeutic target for reducing podocyte vulnerability in glomerular disease.	[Okamoto, Koji; Doi, Kent; Fujita, Toshiro; Noiri, Eisei] Univ Tokyo, Dept Nephrol & Endocrinol, Dept Hemodialysis & Apheresis, Univ Hosp, Tokyo, Japan; [Okamoto, Koji; Tokunaga, Katsushi; Nishida, Nao; Mabuchi, Akihiko] Univ Tokyo, Dept Human Genet, Grad Sch Med, Tokyo, Japan; [Suzuki, Hodaka; Katoh, Tetsuo; Watanabe, Tsuyoshi] Fukushima Med Univ, Sch Med, Dept Nephrol Hypertens Diabetol Endocrinol & Meta, Fukushima, Japan; [Takahashi, Atsushi] RIKEN, Lab Stat Anal, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Kubo, Michiaki] RIKEN, Lab Genotyping Dev, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Maeda, Shiro] RIKEN, Lab Endocrinol & Metab, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Lab Mol Med, Ctr Human Genome, Tokyo, Japan; [Noiri, Eisei] Japan Sci Technol, Sci & Technol Res Partnership Sustainable Dev SAT, Tokyo, Japan	University of Tokyo; University of Tokyo; Fukushima Medical University; RIKEN; RIKEN; RIKEN; University of Tokyo; Japan Science & Technology Agency (JST)	Noiri, E (corresponding author), Univ Tokyo, Dept Nephrol & Endocrinol, Dept Hemodialysis & Apheresis, Univ Hosp, Tokyo, Japan.	noiri-tky@umin.ac.jp	Kubo, Michiaki/N-7947-2015	Fujita, Toshiro/0000-0001-9141-7060; NOIRI, Eisei/0000-0002-9515-7582	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [3023168]; MEXT, Japan [17020003]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank all participating doctors and staff from collaborating institutes for providing DNA samples. We also thank the technical staff of the Laboratory for Endocrinology and Metabolism at the RIKEN Center for Genomic Medicine for providing technical assistance. This study was partially supported by the BioBank Japan Project on the Implementation of Personalized Medicine, Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, to E.N. (#3023168). This study was also supported by a Grant-in-Aid for Scientific research on Priority Area 'Comprehensive Genomics' from MEXT, Japan to K.T. (#17020003).	Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bradley SP, 2005, PANCREAS, V31, P373, DOI 10.1097/01.mpa.0000179730.69081.64; Chen J, 2002, AM J PHYSIOL-CELL PH, V282, pC1053, DOI 10.1152/ajpcell.00292.2001; De Cat B, 2001, SEMIN CELL DEV BIOL, V12, P117, DOI 10.1006/scdb.2000.0240; Doi Kent, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P173, DOI 10.2174/187153008785700136; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Floege J, 1995, J CLIN INVEST, V96, P2809, DOI 10.1172/JCI118351; Freedman BI, 2010, J AM SOC NEPHROL, V21, P1422, DOI 10.1681/ASN.2010070730; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Hara M, 1998, PEDIATR NEPHROL, V12, P43, DOI 10.1007/s004670050401; Hara M, 2005, J AM SOC NEPHROL, V16, P408, DOI 10.1681/ASN.2004070564; Johnstone DB, 2006, NAT CLIN PRACT NEPHR, V2, P271, DOI 10.1038/ncpneph0180; Kawachi H, 2003, J AM SOC NEPHROL, V14, P46, DOI 10.1097/01.ASN.0000037401.02391.76; Kawachi H, 2009, CLIN EXP NEPHROL, V13, P275, DOI 10.1007/s10157-009-0162-x; Kim BS, 2002, J AM SOC NEPHROL, V13, P2027, DOI 10.1097/01.ASN.0000024436.00520.D8; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; KRIZ W, 1995, KIDNEY INT, V48, P1435, DOI 10.1038/ki.1995.433; Lai JP, 2008, HEPATOLOGY, V47, P1211, DOI 10.1002/hep.22202; Larson SD, 2007, SURGERY, V142, P262, DOI 10.1016/j.surg.2007.03.011; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Mathieson PW, 2009, CURR OPIN NEPHROL HY, V18, P206, DOI 10.1097/MNH.0b013e328326f3ca; Nakamura T, 2000, NEPHROL DIAL TRANSPL, V15, P1379, DOI 10.1093/ndt/15.9.1379; Nishida N, 2007, ANAL BIOCHEM, V364, P78, DOI 10.1016/j.ab.2007.02.005; NOSAKA K, 1993, KIDNEY INT, V43, P470, DOI 10.1038/ki.1993.69; Ogata S, 2001, J AM SOC NEPHROL, V12, P2787, DOI 10.1681/ASN.V12122787; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Okamoto K, 2010, AM J HUM GENET, V86, P54, DOI 10.1016/j.ajhg.2009.12.009; Ray PE, 1999, PEDIATR NEPHROL, V13, P586, DOI 10.1007/s004670050749; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Rico M, 2005, AM J PHYSIOL-RENAL, V289, pF431, DOI 10.1152/ajprenal.00389.2004; SAITO T, 1987, KIDNEY INT, V32, P691, DOI 10.1038/ki.1987.262; SCHLESSINGER J, 1995, CELL, V83, P357, DOI 10.1016/0092-8674(95)90112-4; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; Somlo S, 2000, NAT GENET, V24, P333, DOI 10.1038/74139; Song HH, 1997, J BIOL CHEM, V272, P7574, DOI 10.1074/jbc.272.12.7574; Steinfeld R, 1996, J CELL BIOL, V133, P405, DOI 10.1083/jcb.133.2.405; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Veugelers M, 1997, GENOMICS, V40, P24, DOI 10.1006/geno.1996.4518; Williamson D, 2007, CANCER RES, V67, P57, DOI 10.1158/0008-5472.CAN-06-1650; Wong W, 2010, AM J TRANSPLANT, V10, P2463, DOI 10.1111/j.1600-6143.2010.03290.x	40	66	69	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2011	43	5					459	+		10.1038/ng.792	http://dx.doi.org/10.1038/ng.792			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	755XF	21441931				2022-12-25	WOS:000289972600017
J	Kim, S; Zaghloul, NA; Bubenshchikova, E; Oh, EC; Rankin, S; Katsanis, N; Obara, T; Tsiokas, L				Kim, Sehyun; Zaghloul, Norann A.; Bubenshchikova, Ekaterina; Oh, Edwin C.; Rankin, Susannah; Katsanis, Nicholas; Obara, Tomoko; Tsiokas, Leonidas			Nde1-mediated inhibition of ciliogenesis affects cell cycle re-entry	NATURE CELL BIOLOGY			English	Article							DYNEIN LIGHT-CHAIN; INTRAFLAGELLAR TRANSPORT; PRIMARY CILIUM; CYTOPLASMIC DYNEIN; PROTEIN; COMPLEX; MOTOR; LIS1; LOCALIZATION; CILIOPATHIES	The primary cilium is an antenna-like organelle that is dynamically regulated during the cell cycle. Ciliogenesis is initiated as cells enter quiescence, whereas resorption of the cilium precedes mitosis. The mechanisms coordinating ciliogenesis with the cell cycle are unknown. Here we identify the centrosomal protein Nde1 (nuclear distribution gene E homologue 1) as a negative regulator of ciliary length. Nde1 is expressed at high levels in mitosis, low levels in quiescence and localizes at the mother centriole, which nucleates the primary cilium. Cells depleted of Nde1 have longer cilia and a delay in cell cycle re-entry that correlates with ciliary length. Knockdown of Nde1 in zebrafish embryos results in increased ciliary length, suppression of cell division, reduction of the number of cells forming the Kupffer's vesicle and left-right patterning defects. These data suggest that Nde1 is an integral component of a network coordinating ciliary length with cell cycle progression and have implications for understanding the transition from a quiescent to a proliferative state.	[Kim, Sehyun; Bubenshchikova, Ekaterina; Rankin, Susannah; Obara, Tomoko; Tsiokas, Leonidas] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Zaghloul, Norann A.; Oh, Edwin C.; Katsanis, Nicholas] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Zaghloul, Norann A.; Oh, Edwin C.; Katsanis, Nicholas] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Rankin, Susannah] Oklahoma Med Res Fdn, Dept Cell Cycle & Canc Biol, Oklahoma City, OK 73114 USA; [Oh, Edwin C.; Katsanis, Nicholas] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Oh, Edwin C.; Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Johns Hopkins University; Johns Hopkins University; Oklahoma Medical Research Foundation; Duke University; Duke University	Tsiokas, L (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 975 NE 10th St, Oklahoma City, OK 73104 USA.	leonidas-tsiokas@ouhsc.edu	Katsanis, Nicholas/E-1837-2012	Katsanis, Nicholas/0000-0002-2480-0171; Rankin, Susannah/0000-0002-4056-6610; Tsiokas, Leonidas/0000-0002-3659-1813	National Institute of Child Health and Development [R01HD04260]; National Institute of Diabetes, Digestive and Kidney disorders [R01DK072301, R01DK075972, R01DK078209, R01DK59599]; National Center for Research Resources [P20RR017703]; National Eye Institute; Oklahoma Center for the Advancement of Science and Technology [HR06-175, HR07-097]; John S. Gammill Endowed Chair; Pew Charitable Trusts; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078209, R56DK059599, R01DK072301, R01DK075972, R01DK059599] Funding Source: NIH RePORTER	National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Diabetes, Digestive and Kidney disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Oklahoma Center for the Advancement of Science and Technology; John S. Gammill Endowed Chair; Pew Charitable Trusts; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Rosenbaum, S. Doxsey, C. Wood, N. Wilson, D. Dawson, S. Plafker and R. Janknecht for comments on the manuscript, S. Munro, B. Yoder, J. Peranen, J. Salisbury, A. S. McCallion and G. Pazour for reagents, and the Yost, Sive, Amack and Zon labs for zebrafish immunostaining protocols. This work was supported by grants R01HD04260 from the National Institute of Child Health and Development (to N.K.), grants R01DK072301, R01DK075972 (to N.K.), R01DK078209 (to T.O.) and R01DK59599 (to L.T.) from the National Institute of Diabetes, Digestive and Kidney disorders, grant P20RR017703 from the National Center for Research Resources (to L.T.), a Visual Neuroscience Training Program grant from the National Eye Institute (to N.A.Z.), grants HR06-175 (to S.R.) and HR07-097 (to L.T.) from the Oklahoma Center for the Advancement of Science and Technology, and the John S. Gammill Endowed Chair for PKD (to L.T.). S.R. is a Pew Scholar in the Biomedical Sciences, supported by The Pew Charitable Trusts.	Baker SA, 2003, J BIOL CHEM, V278, P34211, DOI 10.1074/jbc.M300156200; Bershteyn M, 2010, DEV CELL, V19, P270, DOI 10.1016/j.devcel.2010.07.009; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Efimov VP, 2000, J CELL BIOL, V150, P681, DOI 10.1083/jcb.150.3.681; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; GILLINGHAM AK, 2010, NATURE, V464, P1048; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Lam C, 2010, J CELL SCI, V123, P202, DOI 10.1242/jcs.059337; Martinez-Moreno M, 2003, FEBS LETT, V544, P262, DOI 10.1016/S0014-5793(03)00516-7; Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pan JM, 2007, CELL, V129, P1255, DOI 10.1016/j.cell.2007.06.018; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; Quarmby LM, 2005, J CELL BIOL, V169, P707, DOI 10.1083/jcb.200503053; RASH JE, 1969, J ULTRA MOL STRUCT R, V29, P470, DOI 10.1016/S0022-5320(69)90067-7; RIEDER CL, 1979, J ULTRA MOL STRUCT R, V68, P173, DOI 10.1016/S0022-5320(79)90152-7; Robert A, 2007, J CELL SCI, V120, P628, DOI 10.1242/jcs.03366; Rompolas P, 2007, J CELL SCI, V120, P3653, DOI 10.1242/jcs.012773; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Rubtsova SN, 1998, FEBS LETT, V430, P353, DOI 10.1016/S0014-5793(98)00692-9; Shmueli A, 2010, EMBO J, V29, P107, DOI 10.1038/emboj.2009.325; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Stehman SA, 2007, J CELL BIOL, V178, P583, DOI 10.1083/jcb.200610112; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; TSANG WY, 2009, CURR BIOL, V19, P1005; TUCKER RW, 1979, CELL, V18, P1065, DOI 10.1016/0092-8674(79)90219-8; TUCKER RW, 1979, CELL, V17, P527, DOI 10.1016/0092-8674(79)90261-7; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077	42	164	170	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2011	13	4					351	U50		10.1038/ncb2183	http://dx.doi.org/10.1038/ncb2183			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	744CK	21394081	Green Accepted			2022-12-25	WOS:000289070900007
J	Lignitto, L; Carlucci, A; Sepe, M; Stefan, E; Cuomo, O; Nistico, R; Scorziello, A; Savoia, C; Garbi, C; Annunziato, L; Feliciello, A				Lignitto, Luca; Carlucci, Annalisa; Sepe, Maria; Stefan, Eduard; Cuomo, Ornella; Nistico, Robert; Scorziello, Antonella; Savoia, Claudia; Garbi, Corrado; Annunziato, Lucio; Feliciello, Antonio			Control of PKA stability and signalling by the RING ligase praja2	NATURE CELL BIOLOGY			English	Article							DEPENDENT PROTEIN-KINASE; TERM SYNAPTIC PLASTICITY; RII-BETA-SUBUNIT; REGULATORY SUBUNIT; CYCLIC-AMP; ANCHORING PROTEINS; II-BETA; CAMP; UBIQUITIN; LOCALIZATION	Activation of G-protein-coupled receptors (GPCRs) mobilizes compartmentalized pulses of cyclic AMP. The main cellular effector of cAMP is protein kinase A (PKA), which is assembled as an inactive holoenzyme consisting of two regulatory (R) and two catalytic (PKAc) subunits. cAMP binding to R subunits dissociates the holoenzyme and releases the catalytic moiety, which phosphorylates a wide array of cellular proteins. Reassociation of PKAc and R components terminates the signal. Here we report that the RING ligase praja2 controls the stability of mammalian R subunits. Praja2 forms a stable complex with, and is phosphorylated by, PKA. Rising cAMP levels promote praja2-mediated ubiquitylation and subsequent proteolysis of compartmentalized R subunits, leading to sustained substrate phosphorylation by the activated kinase. Praja2 is required for efficient nuclear cAMP signalling and for PKA-mediated long-term memory. Thus, praja2 regulates the total concentration of R subunits, tuning the strength and duration of PKA signal output in response to cAMP.	[Lignitto, Luca; Carlucci, Annalisa; Sepe, Maria; Garbi, Corrado; Feliciello, Antonio] Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol L Calif, I-80131 Naples, Italy; [Stefan, Eduard] Univ Innsbruck, Ctr Mol Biosci, A-6020 Innsbruck, Austria; [Stefan, Eduard] Univ Innsbruck, Inst Biochem, A-6020 Innsbruck, Austria; [Cuomo, Ornella; Scorziello, Antonella; Savoia, Claudia; Annunziato, Lucio] Univ Naples Federico 2, Div Farmacol, Dipartimento Neurosci, I-80131 Naples, Italy; [Nistico, Robert] Univ Calabria, Dipartimento Farmacobiol, I-87036 Cosenza, Italy; [Nistico, Robert] IRCCS Fdn Santa Lucia, Lab Neurol Sperimentale, I-00143 Rome, Italy	University of Naples Federico II; University of Innsbruck; University of Innsbruck; University of Naples Federico II; University of Calabria; IRCCS Santa Lucia	Feliciello, A (corresponding author), Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol L Calif, I-80131 Naples, Italy.	feliciel@unina.it	Lignitto, Luca/AHB-6287-2022; Scorziello, Antonella/K-6131-2018	Feliciello, Antonio/0000-0002-7932-2170; Stefan, Eduard/0000-0003-3650-4713; ANNUNZIATO, LUCIO/0000-0002-8534-8270; Nistico, Robert/0000-0003-3433-9232; CUOMO, ORNELLA/0000-0002-6459-2530	Associazione Italiana per la Ricerca sul Cancro (AIRC); Italian Ministry of University and Research (MIUR) [2007KS47FW_002]; Austrian Science Fund (FWF) [P22608]; University of Innsbruck; Austrian Science Fund (FWF) [P 22608] Funding Source: researchfish	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); University of Innsbruck; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Grants from Associazione Italiana per la Ricerca sul Cancro (AIRC) and the Italian Ministry of University and Research (MIUR) 2008-2009 (2007KS47FW_002). E.S. was supported from Austrian Science Fund (FWF) Grant P22608 and Junior Researcher Support 2009 (University of Innsbruck). Special thanks to M. Gottesman, E. Avvedimento and K. Bister for discussion and critical reading of the manuscript, D. Viaggiano for help in immunohistochemistry and confocal microscopy analysis, R.D. Donne for help in carrying out experiments and S. McKnight and M. Ginsberg for providing the vectors for epitope-tagged R subunits. This manuscript is dedicated to the memory of M. Graziano.	Amieux PS, 2002, ANN NY ACAD SCI, V968, P75, DOI 10.1111/j.1749-6632.2002.tb04328.x; Amieux PS, 2002, J BIOL CHEM, V277, P27294, DOI 10.1074/jbc.M200302200; ARMSTRONG R, 1995, MOL CELL BIOL, V15, P1826; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; BREGMAN DB, 1991, J BIOL CHEM, V266, P7207; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Carlucci A, 2008, EMBO J, V27, P1073, DOI 10.1038/emboj.2008.33; Carlucci A, 2008, TRENDS CELL BIOL, V18, P604, DOI 10.1016/j.tcb.2008.09.006; CHAIN DG, 1995, J NEUROSCI, V15, P7592; Chain DG, 1999, NEURON, V22, P147, DOI 10.1016/S0896-6273(00)80686-8; Chain DG, 1999, MOL NEUROBIOL, V20, P125, DOI 10.1007/BF02742438; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Feliciello A, 2005, CELL SIGNAL, V17, P279, DOI 10.1016/j.cellsig.2004.09.009; Feliciello A, 1997, CURR BIOL, V7, P1011, DOI 10.1016/S0960-9822(06)00424-6; Feliciello A, 2000, J BIOL CHEM, V275, P303, DOI 10.1074/jbc.275.1.303; Feliciello A, 2001, J MOL BIOL, V308, P99, DOI 10.1006/jmbi.2001.4585; GLANTZ SB, 1992, MOL BIOL CELL, V3, P1215, DOI 10.1091/mbc.3.11.1215; Gomez LL, 2002, J NEUROSCI, V22, P7027; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; HEGDE AN, 1993, P NATL ACAD SCI USA, V90, P7436, DOI 10.1073/pnas.90.16.7436; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Huang Y Y, 1994, Learn Mem, V1, P74; Jurado S, 2010, NAT NEUROSCI, V13, P1053, DOI 10.1038/nn.2613; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Malleret G, 2010, J NEUROSCI, V30, P3813, DOI 10.1523/JNEUROSCI.1330-09.2010; Mauban JRH, 2009, PHYSIOLOGY, V24, P78, DOI 10.1152/physiol.00041.2008; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; NAKAYAMA M, 1995, J NEUROSCI, V15, P5238; Newhall KJ, 2005, MOL ENDOCRINOL, V19, P982, DOI 10.1210/me.2004-0343; RUBINO HM, 1989, NEURON, V3, P631, DOI 10.1016/0896-6273(89)90273-0; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Stefan E, 2007, P NATL ACAD SCI USA, V104, P16916, DOI 10.1073/pnas.0704257104; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; Yu P, 2002, GENOMICS, V79, P869, DOI 10.1006/geno.2002.6770; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013; Zhou Y, 2007, J NEUROSCI, V27, P13843, DOI 10.1523/JNEUROSCI.4486-07.2007	48	55	63	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2011	13	4					412	U163		10.1038/ncb2209	http://dx.doi.org/10.1038/ncb2209			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	744CK	21423175				2022-12-25	WOS:000289070900013
J	Zhang, SY; Huang, WC; Li, P; Guo, H; Poh, SB; Brady, SW; Xiong, Y; Tseng, LM; Li, SH; Ding, ZX; Sahin, AA; Esteva, FJ; Hortobagyi, GN; Yu, DH				Zhang, Siyuan; Huang, Wen-Chien; Li, Ping; Guo, Hua; Poh, Say-Bee; Brady, Samuel W.; Xiong, Yan; Tseng, Ling-Ming; Li, Shau-Hsuan; Ding, Zhaoxi; Sahin, Aysegul A.; Esteva, Francisco J.; Hortobagyi, Gabriel N.; Yu, Dihua			Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways	NATURE MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; FACTOR-I RECEPTOR; METASTATIC BREAST-CANCER; C-SRC; TYROSINE KINASES; FAMILY KINASES; CELLS; CONTRIBUTES; APOPTOSIS; ERBB2	Trastuzumab is a successful rationally designed ERBB2-targeted therapy. However, about half of individuals with ERBB2-overexpressing breast cancer do not respond to trastuzumab-based therapies, owing to various resistance mechanisms. Clinically applicable regimens for overcoming trastuzumab resistance of different mechanisms are not yet available. We show that the nonreceptor tyrosine kinase c-SRC (SRC) is a key modulator of trastuzumab response and a common node downstream of multiple trastuzumab resistance pathways. We find that SRC is activated in both acquired and de novo trastuzumab-resistant cells and uncover a novel mechanism of SRC regulation involving dephosphorylation by PTEN. Increased SRC activation conferred considerable trastuzumab resistance in breast cancer cells and correlated with trastuzumab resistance in patients. Targeting SRC in combination with trastuzumab sensitized multiple lines of trastuzumab-resistant cells to trastuzumab and eliminated trastuzumab-resistant tumors in vivo, suggesting the potential clinical application of this strategy to overcome trastuzumab resistance.	[Zhang, Siyuan; Huang, Wen-Chien; Li, Ping; Guo, Hua; Poh, Say-Bee; Brady, Samuel W.; Xiong, Yan; Tseng, Ling-Ming; Li, Shau-Hsuan; Ding, Zhaoxi; Esteva, Francisco J.; Yu, Dihua] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Brady, Samuel W.; Esteva, Francisco J.; Yu, Dihua] Univ Texas Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX USA; [Sahin, Aysegul A.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Esteva, Francisco J.; Hortobagyi, Gabriel N.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Yu, DH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	dyu@mdanderson.org	Zhang, Siyuan/A-1276-2014; Zhang, Siyuan/AAH-1157-2021	Zhang, Siyuan/0000-0003-0910-3666; Zhang, Siyuan/0000-0003-0910-3666; Esteva, Francisco J./0000-0003-2437-3920; Yu, Dihua/0000-0001-6231-9381	US National Institutes of Health [P30-CA 16672, RO1-CA112567, PO1-CA099031]; MD Anderson Cancer Center Breast SPORE [P50 CA116199]; US Department of Defense Center of Excellence [W81XWH-06-2-0033]; Susan G. Komen Breast Cancer Foundation [KG091020]; Cancer Prevention Research Institute of Texas [RP100726]; MD Anderson Cancer Center Breast SPORE; Susan G. Komen Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA112567, P50CA116199, P01CA099031, P30CA016672] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Cancer Center Breast SPORE; US Department of Defense Center of Excellence(United States Department of Defense); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Cancer Prevention Research Institute of Texas; MD Anderson Cancer Center Breast SPORE; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank AstraZeneca for providing us with saracatinib and W. Zhang in the Department of Pathology, MD Anderson Cancer Center for providing us with the IGF-1R expression vector. We also thank C. Neal, J. Lu, S. Rehman and F. J. Lowery for insightful comments on this manuscript. This work was supported by US National Institutes of Health grants P30-CA 16672 (MD Anderson Cancer Center), RO1-CA112567 (D. Y.), PO1-CA099031 project 4 (D. Y.), MD Anderson Cancer Center Breast SPORE P50 CA116199 (G. N. H.) project 4 (D. Y.), US Department of Defense Center of Excellence subproject W81XWH-06-2-0033 (D. Y.), Susan G. Komen Breast Cancer Foundation promise grant KG091020 (D. Y.), Cancer Prevention Research Institute of Texas grant RP100726 (D. Y.), the MD Anderson Cancer Center Breast SPORE Career Development Award (S.Z.) and the Susan G. Komen Breast Cancer Foundation postdoctoral fellowship (S.Z.). D. Y. is the Hubert L. and Olive Stringer Distinguished Chair in Basic Science at MD Anderson Cancer Center.	Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Belsches-Jablonski AP, 2001, ONCOGENE, V20, P1465, DOI 10.1038/sj.onc.1204205; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Boyer B, 2002, ONCOGENE, V21, P2347, DOI 10.1038/sj.onc.1205298; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Chang FM, 2003, INT J ONCOL, V22, P469; Dua R, 2010, BREAST CANCER RES TR, V122, P685, DOI 10.1007/s10549-009-0592-x; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Huang XP, 2010, CANCER RES, V70, P1204, DOI 10.1158/0008-5472.CAN-09-3321; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Ishizawar RC, 2007, ONCOGENE, V26, P3503, DOI 10.1038/sj.onc.1210138; Johnson D, 2000, CELL DEATH DIFFER, V7, P685, DOI 10.1038/sj.cdd.4400700; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Karni R, 1999, ONCOGENE, V18, P4654, DOI 10.1038/sj.onc.1202835; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; Lan KH, 2005, ANN NY ACAD SCI, V1059, P70, DOI 10.1196/annals.1339.026; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Lu CH, 2007, CLIN CANCER RES, V13, P5883, DOI 10.1158/1078-0432.CCR-06-2837; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Moulder SL, 2001, CANCER RES, V61, P8887; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nahta R, 2004, CANCER RES, V64, P3981, DOI 10.1158/0008-5472.CAN-03-3900; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Narayan M, 2009, CANCER RES, V69, P2191, DOI 10.1158/0008-5472.CAN-08-1056; Nautiyal J, 2010, MOL CANCER THER, V9, P1503, DOI 10.1158/1535-7163.MCT-10-0019; Olayioye MA, 2001, EXP CELL RES, V267, P81, DOI 10.1006/excr.2001.5242; Parsons JT, 1997, CURR OPIN CELL BIOL, V9, P187, DOI 10.1016/S0955-0674(97)80062-2; Piccart M, 2008, CLIN BREAST CANCER, V8, pS100, DOI 10.3816/CBC.2008.s.006; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Ren ZY, 2002, J BIOL CHEM, V277, P38486, DOI 10.1074/jbc.M112438200; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Seidman AD, 2008, J CLIN ONCOL, V26, P1642, DOI 10.1200/JCO.2007.11.6699; Seoane S, 2010, JNCI-J NATL CANCER I, V102, P1432, DOI 10.1093/jnci/djq315; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; TABERNERO J, 2007, ASCO ANN M P 1, V25, P3520; Tan M, 2006, ONCOGENE, V25, P3286, DOI 10.1038/sj.onc.1209361; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Wang SE, 2009, CANCER RES, V69, P475, DOI 10.1158/0008-5472.CAN-08-2649; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	53	384	398	3	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2011	17	4					461	U101		10.1038/nm.2309	http://dx.doi.org/10.1038/nm.2309			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21399647	Green Accepted			2022-12-25	WOS:000289245100037
J	Callendret, B; Walker, C				Callendret, Benoit; Walker, Christopher			A siege of hepatitis Immune boost for viral hepatitis	NATURE MEDICINE			English	Editorial Material							T-CELLS; C VIRUS; INFECTION; BLOCKADE; LIVER	Finding mechanisms of viral resistance and new ways to tackle chronic hepatitis will help find a cure for this disease. In 'Bench to Bedside', Christopher Walker and Benoit Callendret highlight studies showing that overcoming immune exhaustion during chronic infection by blocking several inhibitory pathways of T cells may restore an adequate immune response. In 'Bedside to Bench', Lawrence Corey, Joshua Schiffer and John Scott discuss recent advances in antiviral therapy with protease inhibitors and the findings of a mathematical model that predicts possible single and double mutations prior to antiviral therapy.	[Callendret, Benoit; Walker, Christopher] Ohio State Univ, Ctr Vaccines & Immun, Nationwide Childrens Hosp, Columbus, OH 43210 USA; Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Callendret, B (corresponding author), Ohio State Univ, Ctr Vaccines & Immun, Nationwide Childrens Hosp, Columbus, OH 43210 USA.	christopher.walker@nationwidechildrens.org	callendret, benoit/U-4193-2019		NIAID NIH HHS [R37 AI047367] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047367] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Brillanti S, 2011, DIGEST LIVER DIS, V43, P425, DOI 10.1016/j.dld.2010.10.007; Di Giacomo AM, 2010, SEMIN ONCOL, V37, P499, DOI 10.1053/j.seminoncol.2010.09.007; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Ha SJ, 2008, J EXP MED, V205, P543, DOI 10.1084/jem.20071949; Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001; Maier H, 2007, J IMMUNOL, V178, P2714, DOI 10.4049/jimmunol.178.5.2714; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Raziorrouh B, 2010, HEPATOLOGY, V52, P1934, DOI 10.1002/hep.23936; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Thompson AJV, 2009, J VIRAL HEPATITIS, V16, P377, DOI 10.1111/j.1365-2893.2009.01124.x; Walker CM, 2010, ADV VIRUS RES, V78, P43, DOI 10.1016/S0065-3527(10)78002-7	15	19	19	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2011	17	3					252	253		10.1038/nm0311-252	http://dx.doi.org/10.1038/nm0311-252			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21383718	Green Accepted			2022-12-25	WOS:000288070000018
J	Pardoll, D				Pardoll, Drew			Timeline: a decade of advances in immunotherapy	NATURE MEDICINE			English	Editorial Material									Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Baltimore, MD 21218 USA	Johns Hopkins University	Pardoll, D (corresponding author), Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Baltimore, MD 21218 USA.	dpardol1@jhmi.edu			NATIONAL CANCER INSTITUTE [P30CA006973, P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA006973, P30 CA021765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))			0	3	3	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2011	17	3					296	296		10.1038/nm0311-296	http://dx.doi.org/10.1038/nm0311-296			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21383743	Bronze, Green Accepted			2022-12-25	WOS:000288070000039
J	Briggs, TA; Rice, GI; Daly, S; Urquhart, J; Gornall, H; Bader-Meunier, B; Baskar, K; Baskar, S; Baudouin, V; Beresford, MW; Black, GCM; Dearman, RJ; de Zegher, F; Foster, ES; Frances, C; Hayman, AR; Hilton, E; Job-Deslandre, C; Kulkarni, ML; Le Merrer, M; Linglart, A; Lovell, SC; Maurer, K; Musset, L; Navarro, V; Picard, C; Puel, A; Rieux-Laucat, F; Roifman, CM; Scholl-Burgi, S; Smith, N; Szynkiewicz, M; Wiedeman, A; Wouters, C; Zeef, LAH; Casanova, JL; Elkon, KB; Janckila, A; Lebon, P; Crow, YJ				Briggs, Tracy A.; Rice, Gillian I.; Daly, Sarah; Urquhart, Jill; Gornall, Hannah; Bader-Meunier, Brigitte; Baskar, Kannan; Baskar, Shankar; Baudouin, Veronique; Beresford, Michael W.; Black, Graeme C. M.; Dearman, Rebecca J.; de Zegher, Francis; Foster, Emily S.; Frances, Camille; Hayman, Alison R.; Hilton, Emma; Job-Deslandre, Chantal; Kulkarni, Muralidhar L.; Le Merrer, Martine; Linglart, Agnes; Lovell, Simon C.; Maurer, Kathrin; Musset, Lucile; Navarro, Vincent; Picard, Capucine; Puel, Anne; Rieux-Laucat, Frederic; Roifman, Chaim M.; Scholl-Buergi, Sabine; Smith, Nigel; Szynkiewicz, Marcin; Wiedeman, Alice; Wouters, Carine; Zeef, Leo A. H.; Casanova, Jean-Laurent; Elkon, Keith B.; Janckila, Anthony; Lebon, Pierre; Crow, Yanick J.			Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature	NATURE GENETICS			English	Article							ALPHA PRODUCTION; ACP 5; SERUM; SPONDYLOENCHONDRODYSPLASIA; OSTEOPONTIN; CELLS; TRACP; TREX1; DNA	We studied ten individuals from eight families showing features consistent with the immuno-osseous dysplasia spondyloenchondrodysplasia. Of particular note was the diverse spectrum of autoimmune phenotypes observed in these individuals (cases), including systemic lupus erythematosus, Sjogren's syndrome, hemolytic anemia, thrombocytopenia, hypothyroidism, inflammatory myositis, Raynaud's disease and vitiligo. Haplotype data indicated the disease gene to be on chromosome 19p13, and linkage analysis yielded a combined multipoint log(10) odds (LOD) score of 3.6. Sequencing of ACP5, encoding tartrate-resistant acid phosphatase, identified biallelic mutations in each of the cases studied, and in vivo testing confirmed a loss of expressed protein. All eight cases assayed showed elevated serum interferon alpha activity, and gene expression profiling in whole blood defined a type I interferon signature. Our findings reveal a previously unrecognized link between tartrate-resistant acid phosphatase activity and interferon metabolism and highlight the importance of type I interferon in the genesis of autoimmunity.	[Briggs, Tracy A.; Rice, Gillian I.; Daly, Sarah; Urquhart, Jill; Gornall, Hannah; Black, Graeme C. M.; Hilton, Emma; Szynkiewicz, Marcin; Crow, Yanick J.] Univ Manchester, Manchester Acad Heath Sci Ctr, Manchester, Lancs, England; [Bader-Meunier, Brigitte] Hop Necker Enfants Malad, AP HP, Dept Pediat Immunol Hematol & Rheumatol, Paris, France; [Baskar, Kannan; Baskar, Shankar; Kulkarni, Muralidhar L.] JJM Med Coll, Dept Pediat, Davangere, India; [Baudouin, Veronique] Robert Debre Hosp, AP HP, Pediat Nephrol Dept, Paris, France; [Beresford, Michael W.] Univ Liverpool, Inst Child Hlth, Liverpool L69 3BX, Merseyside, England; [Dearman, Rebecca J.; Foster, Emily S.; Lovell, Simon C.; Zeef, Leo A. H.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [de Zegher, Francis; Wouters, Carine] Katholieke Univ Leuven, Dept Paediat, Louvain, Belgium; [Frances, Camille] Hop Tenon, Dept Dermatol & Allergy, F-75970 Paris, France; [Hayman, Alison R.] Univ Bristol, Dept Vet Clin Sci, Bristol, Avon, England; [Job-Deslandre, Chantal] AP HP Cochin, Serv Rheumatol A, Paris, France; [Le Merrer, Martine] Hop Necker Enfants Malad, INSERM, U781, Paris, France; [Linglart, Agnes] INSERM, U986, Paris, France; [Maurer, Kathrin] Innsbruck Med Univ, Dept Radiol, Innsbruck, Austria; [Musset, Lucile] AP HP, Dept Immunochem, Paris, France; [Navarro, Vincent] AP HP, Epilepsy Unit, Paris, France; [Picard, Capucine; Puel, Anne; Casanova, Jean-Laurent] INSERM, Necker Fac, U980, Lab Human Genet Infect Dis, Paris, France; [Picard, Capucine; Puel, Anne; Rieux-Laucat, Frederic; Casanova, Jean-Laurent] Paris Descartes Univ, Necker Fac, Paris, France; [Picard, Capucine] Hop Necker Enfants Malad, AP HP, Study Ctr Primary Immunodeficiencies, Paris, France; [Rieux-Laucat, Frederic] Hop Necker Enfants Malad, INSERM, U768, Paris, France; [Roifman, Chaim M.] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Scholl-Buergi, Sabine] Innsbruck Med Univ, Dept Pediat Neonatol Neuropediat & Inherited Meta, Innsbruck, Austria; [Smith, Nigel] Univ Manchester, Paterson Inst Canc Res, Clin & Expt Pharmacol Grp, Manchester, Lancs, England; [Wiedeman, Alice; Elkon, Keith B.] Univ Washington, Dept Med, Seattle, WA USA; [Wiedeman, Alice; Elkon, Keith B.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Casanova, Jean-Laurent] Rockefeller Univ, Lab Human Genet Infect Dis, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10021 USA; [Janckila, Anthony] Vet Affairs Med Ctr, Special Hematol Lab, Robley Rex Dept, Louisville, KY USA; [Lebon, Pierre] Univ Paris 05, Serv Virol, Paris, France	University of Manchester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; University of Liverpool; University of Manchester; KU Leuven; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Bristol; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Medical University of Innsbruck; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Medical University of Innsbruck; Paterson Institute for Cancer Research; University of Manchester; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Rockefeller University; US Department of Veterans Affairs; Veterans Health Administration (VHA); UDICE-French Research Universities; Universite Paris Cite	Crow, YJ (corresponding author), Univ Manchester, Manchester Acad Heath Sci Ctr, Manchester, Lancs, England.	yanickcrow@mac.com	Urquhart, Jill/G-2282-2015; Rieux-Laucat, Frédéric/A-7916-2017; Linglart, Agnès/A-8047-2016; Beresford, Michael William/AAB-5261-2021; Rice, Gillian I/G-3128-2015; wei, wei/HHR-8613-2022; Casanova, Jean-Laurent/I-3418-2017; Zeef, Leo/D-6922-2011; Wiedeman, Alice/GWC-2566-2022; Picard, Capucine/H-3914-2017; Puel, Anne/H-7305-2017; Crow, Yanick J/N-6120-2014; Black, Graeme/K-7374-2015	Urquhart, Jill/0000-0002-5788-5511; Rieux-Laucat, Frédéric/0000-0001-7858-7866; Linglart, Agnès/0000-0003-3455-002X; Beresford, Michael William/0000-0002-5400-9911; Rice, Gillian I/0000-0002-4223-0571; Picard, Capucine/0000-0001-8788-5056; Puel, Anne/0000-0003-2603-0323; Crow, Yanick J/0000-0001-7211-7564; Hilton, Emma/0000-0002-3750-577X; Wouters, Carine/0000-0002-6426-8845; Scholl-Burgi, Sabine/0000-0002-2529-4231; Black, Graeme/0000-0001-8727-6592; Casanova, Jean-Laurent/0000-0002-7782-4169; Lovell, Simon/0000-0002-4092-8458; Wiedeman, Alice/0000-0001-7329-7288; Navarro, Vincent/0000-0003-0077-8114; bader-meunier, brigitte/0000-0001-8476-8196; Briggs, Tracy/0000-0001-5208-2691	European Union [241779]; Biotechnology and Biological Sciences Research Council [BB/H006818/1] Funding Source: researchfish; BBSRC [BB/H006818/1] Funding Source: UKRI	European Union(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We would like to thank the families for their cooperation in the research presented here; B. Eguia, AP-HP, Department of Dermatology and Allergy, Hopital Tenon, Paris, France for providing medical images; B. Smith for technical support; and D. Bonthron for insightful comments on the manuscript. We wish to acknowledge L. Wardleworth and A. Hayes from the Microarray Facility, Faculty of Life Sciences, University of Manchester, Manchester, UK. T.A.B. is supported as a Wellcome Trust Clinical Fellow. Y.J.C., J.U. and S.D. acknowledge the Manchester National Institute for Health Research Biomedical Research Centre. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 241779.	Ankel H, 1998, VIROLOGY, V251, P317, DOI 10.1006/viro.1998.9432; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Botto M, 2009, MOL IMMUNOL, V46, P2774, DOI 10.1016/j.molimm.2009.04.029; Bune AJ, 2001, IMMUNOLOGY, V102, P103, DOI 10.1046/j.1365-2567.2001.01145.x; Campos-Xavier AB, 2009, AM J HUM GENET, V84, P760, DOI 10.1016/j.ajhg.2009.05.002; Chao TY, 2005, CLIN CHIM ACTA, V359, P132, DOI 10.1016/j.cccn.2005.03.039; Chen VB, 2009, PROTEIN SCI, V18, P2403, DOI 10.1002/pro.250; Crow MK, 2007, CURR TOP MICROBIOL, V316, P359; Crow YJ, 2008, DEV MED CHILD NEUROL, V50, P410, DOI 10.1111/j.1469-8749.2008.02062.x; Dubos F, 2004, MED MALADIES INFECT, V34, P561, DOI 10.1016/j.medmal.2004.09.004; Hayman AR, 2001, J HISTOCHEM CYTOCHEM, V49, P675, DOI 10.1177/002215540104900601; Hayman AR, 1996, DEVELOPMENT, V122, P3151; Jabs WJ, 1999, J INTERF CYTOK RES, V19, P463; Janckila AJ, 2008, J BONE MINER RES, V23, P1287, DOI 10.1359/JBMR.080329; Kariuki SN, 2009, GENES IMMUN, V10, P487, DOI 10.1038/gene.2009.15; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lood C, 2009, ARTHRITIS RHEUM-US, V60, P3081, DOI 10.1002/art.24852; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Muhonen P, 2007, BIOCHEM BIOPH RES CO, V359, P889, DOI 10.1016/j.bbrc.2007.05.205; Navarro V, 2008, AM J MED GENET A, V146A, P2810, DOI 10.1002/ajmg.a.32518; Raymond AA, 1996, LUPUS, V5, P123, DOI 10.1177/096120339600500207; Renella R, 2006, AM J MED GENET A, V140A, P541, DOI 10.1002/ajmg.a.31081; Santer DM, 2010, J IMMUNOL, V185, P4738, DOI 10.4049/jimmunol.1001731; SCHORR S, 1976, RADIOLOGY, V118, P133, DOI 10.1148/118.1.133; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Strater N, 2005, J MOL BIOL, V351, P233, DOI 10.1016/j.jmb.2005.04.014; Suter A, 2001, DEVELOPMENT, V128, P4899; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Weber GF, 2002, J LEUKOCYTE BIOL, V72, P752; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400	33	163	174	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2011	43	2					127	U71		10.1038/ng.748	http://dx.doi.org/10.1038/ng.748			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	711XD	21217755	Green Accepted			2022-12-25	WOS:000286623800010
J	Wang, JX; Jiao, JQ; Li, QA; Long, B; Wang, K; Liu, JP; Li, YR; Li, PF				Wang, Jian-Xun; Jiao, Jian-Qin; Li, Qian; Long, Bo; Wang, Kun; Liu, Jin-Ping; Li, Yan-Rui; Li, Pei-Feng			miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1	NATURE MEDICINE			English	Article							ISCHEMIA-REPERFUSION INJURY; CASPASE RECRUITMENT DOMAIN; MUSCLE-SPECIFIC MICRORNA; MYOCARDIAL-INFARCTION; APOPTOSIS REPRESSOR; HUMAN HEART; FISSION; GENES; DEPHOSPHORYLATION; PATHWAY	Myocardial infarction is a leading cause of mortality worldwide. Here we report that modulation of microRNA-499 (miR-499) levels affects apoptosis and the severity of myocardial infarction and cardiac dysfunction induced by ischemia-reperfusion. We found that both the alpha-and beta-isoforms of the calcineurin catalytic subunit are direct targets of miR-499 and that miR-499 inhibits cardiomyocyte apoptosis through its suppression of calcineurin-mediated dephosphorylation of dynamin-related protein-1 (Drp1), thereby decreasing Drp1 accumulation in mitochondria and Drp1-mediated activation of the mitochondrial fission program. We also found that p53 transcriptionally downregulates miR-499 expression. Our data reveal a role for miR-499 in regulating the mitochondrial fission machinery and we suggest that modulation of miR-499 levels may provide a therapeutic approach for treating myocardial infarction.	[Wang, Jian-Xun; Jiao, Jian-Qin; Li, Qian; Long, Bo; Wang, Kun; Liu, Jin-Ping; Li, Yan-Rui; Li, Pei-Feng] Chinese Acad Sci, Inst Zool, Div Cardiovasc Res, Natl Key Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Li, PF (corresponding author), Chinese Acad Sci, Inst Zool, Div Cardiovasc Res, Natl Key Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China.	peifli@ioz.ac.cn	Long, Bo/AGX-8013-2022; Long, Bo/GQH-5131-2022; Li, Peifeng/AHE-6906-2022; Li, Peifeng/ABD-5663-2021	Li, Peifeng/0000-0002-0969-9407; LI, YANRUI/0000-0002-0930-0590; Wang, Jianxun/0000-0002-3731-6514	National Natural Science Foundation of China [30730045, 31010103911]; National Basic Research Program of China (973 Program) [2007CB512000, 2011CB965300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (30730045, 31010103911) and the National Basic Research Program of China (973 Program, 2007CB512000, 2011CB965300). p alpha MHC-clone26 was kindly provided by Z. Yang (Nanjing University). CnA alpha and CnA beta cDNAs were kindly provided by T. Kuno (Kobe University). The antibody to phospho-Drp1 (Ser656) was kindly provided by S. Strack (University of Iowa).	Basson M, 2007, NAT MED, V13, P541, DOI 10.1038/nm0507-541; Cai Q, 1998, CARDIOVASC DRUG THER, V12, P499, DOI 10.1023/A:1007745814463; Callis TE, 2008, TRENDS MOL MED, V14, P254, DOI 10.1016/j.molmed.2008.03.006; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chao W, 2002, J BIOL CHEM, V277, P31639, DOI 10.1074/jbc.M204104200; CHENG W, 1995, J CLIN INVEST, V96, P2247, DOI 10.1172/JCI118280; Chien KR, 2007, NATURE, V447, P389, DOI 10.1038/447389a; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; de Frutos S, 2007, J BIOL CHEM, V282, P15081, DOI 10.1074/jbc.M702679200; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Fan GC, 2004, CIRC RES, V94, P1474, DOI 10.1161/01.RES.0000129179.66631.00; Fisher PW, 2005, CIRCULATION, V111, P1601, DOI 10.1161/01.CIR.0000160359.49478.C2; Foo RSY, 2005, J CLIN INVEST, V115, P565, DOI 10.1172/JCI200524569; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Harada M, 2005, NAT MED, V11, P305, DOI 10.1038/nm1199; Kajstura J, 1997, J MOL CELL CARDIOL, V29, P859, DOI 10.1006/jmcc.1996.0333; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Kim HJ, 2006, GENOME, V49, P1283, DOI 10.1139/G06-120; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Lee P, 2003, AM J PHYSIOL-HEART C, V284, pH456, DOI 10.1152/ajpheart.00777.2002; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li YZ, 2008, MOL CELL BIOL, V28, P564, DOI 10.1128/MCB.00738-07; Lim HW, 1999, NAT MED, V5, P246, DOI 10.1038/6430; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Mann DL, 2007, NEW ENGL J MED, V356, P2644, DOI 10.1056/NEJMcibr072068; Molkentin JD, 2000, CIRC RES, V87, P731, DOI 10.1161/01.RES.87.9.731; Nakamura T, 2000, CIRCULATION, V102, P572; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shizukuda Y, 1998, AM J PHYSIOL-HEART C, V275, pH961, DOI 10.1152/ajpheart.1998.275.3.H961; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Tan WQ, 2008, CIRCULATION, V118, P2268, DOI 10.1161/CIRCULATIONAHA.107.750869; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Tang XQ, 2007, RNA, V13, P1803, DOI 10.1261/rna.498607; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Toth A, 2006, AM J PHYSIOL-HEART C, V291, pH52, DOI 10.1152/ajpheart.01046.2005; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang JX, 2009, CANCER RES, V69, P492, DOI 10.1158/0008-5472.CAN-08-2962; Wang L, 1998, CIRC RES, V83, P516, DOI 10.1161/01.RES.83.5.516; Weinbrenner C, 1998, CARDIOVASC RES, V38, P676, DOI 10.1016/S0008-6363(98)00064-9; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	59	454	502	5	186	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					71	U243		10.1038/nm.2282	http://dx.doi.org/10.1038/nm.2282			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21186368				2022-12-25	WOS:000285994000038
J	Zink, CF; Weinberger, DR				Zink, Caroline F.; Weinberger, Daniel R.			Cracking the moody brain The rewards of self starvation	NATURE MEDICINE			English	Editorial Material							ANOREXIA-NERVOSA; DOPAMINE		[Zink, Caroline F.; Weinberger, Daniel R.] NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Zink, CF (corresponding author), NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, US Natl Inst Hlth, Bethesda, MD 20892 USA.	weinberd@mail.nih.gov						American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Attia E, 2010, ANNU REV MED, V61, P425, DOI 10.1146/annurev.med.050208.200745; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Carvelli L, 2002, J NEUROCHEM, V81, P859, DOI 10.1046/j.1471-4159.2002.00892.x; Fladung AK, 2010, AM J PSYCHIAT, V167, P206, DOI 10.1176/appi.ajp.2009.09010071; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hoek HW, 2006, CURR OPIN PSYCHIATR, V19, P389, DOI 10.1097/01.yco.0000228759.95237.78; Kaye WH, 2009, NAT REV NEUROSCI, V10, P573, DOI 10.1038/nrn2682; Kaye WH, 2005, INT J EAT DISORDER, V37, pS15, DOI 10.1002/eat.20109; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507; Zink CF, 2006, NEUROIMAGE, V29, P977, DOI 10.1016/j.neuroimage.2005.08.006	12	44	44	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1382	1383		10.1038/nm1210-1382	http://dx.doi.org/10.1038/nm1210-1382			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21135849				2022-12-25	WOS:000285048900028
J	Castillo-Lluva, S; Tatham, MH; Jones, RC; Jaffray, EG; Edmondson, RD; Hay, RT; Malliri, A				Castillo-Lluva, Sonia; Tatham, Michael H.; Jones, Richard C.; Jaffray, Ellis G.; Edmondson, Ricky D.; Hay, Ronald T.; Malliri, Angeliki			SUMOylation of the GTPase Rac1 is required for optimal cell migration	NATURE CELL BIOLOGY			English	Article							RHO-FAMILY GTPASES; GROWTH-FACTOR; IN-VIVO; NUCLEAR-LOCALIZATION; POLYBASIC REGION; PIAS PROTEINS; KINASE; SUMO; UBIQUITIN; IDENTIFICATION	The Rho-like GTPase, Rac1, induces cytoskeletal rearrangements required for cell migration. Rac activation is regulated through a number of mechanisms, including control of nucleotide exchange and hydrolysis, regulation of subcellular localization or modulation of protein-expression levels(1-3). Here, we demonstrate that (the small ubiquitin-like modifier) SUMO E3-ligase, PIAS3, interacts with Rac1 and is required for increased Rac activation and optimal cell migration in response to hepatocyte growth factor (HGF) signalling. Rac1 can be conjugated to SUMO-1 in response to hepatocyte growth factor treatment and SUMOylation is enhanced by PIAS3. Furthermore, we identify non-consensus sites within the polybasic region of Rac1 as the main location for SUMO conjugation. PIAS3-mediated SUMOylation of Rac1 controls the levels of Rac1-GTP and the ability of Rac1 to stimulate lamellipodia, cell migration and invasion. The finding that a Ras superfamily member can be SUMOylated provides insights into the regulation of these critical mediators of cell behaviour. Our data reveal a role for SUMO in the regulation of cell migration and invasion.	[Castillo-Lluva, Sonia; Malliri, Angeliki] Univ Manchester, Cell Signalling Grp, Canc Res UK Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England; [Tatham, Michael H.; Jaffray, Ellis G.; Hay, Ronald T.] Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Sir James Black Ctr Coll Life Sci, Dundee DD1 5EH, Scotland; [Jones, Richard C.; Edmondson, Ricky D.] US FDA, NCTR, Jefferson, AR 72079 USA	Cancer Research UK; University of Manchester; University of Dundee; US Food & Drug Administration (FDA)	Malliri, A (corresponding author), Univ Manchester, Cell Signalling Grp, Canc Res UK Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England.	amalliri@picr.man.ac.uk	Hay, Ronald/S-3233-2019; CASTILLO-LLUVA, SONIA/AAA-1776-2020; Hay, Ronald T/F-9338-2011; Tatham, Michael H/E-9622-2010	Hay, Ronald/0000-0001-7113-9024; Hay, Ronald T/0000-0001-7113-9024; Tatham, Michael H/0000-0001-6986-1691; Castillo-LLuva, Sonia/0000-0001-5357-7178; Malliri, Angeliki/0000-0001-6848-090X	CRUK [C147/A6058]; EMBO; Cancer Research UK [12937] Funding Source: researchfish	CRUK(Cancer Research UK); EMBO(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK)	This study was supported by CRUK grant C147/A6058 and an EMBO Long-Term fellowship to S.C.L. M.H.T. and E.G.J. were supported by CRUK. We thank N. Maurice (Glasgow, UK) for mass spectrometry analysis, I. Matic (Dundee, UK) for help with SUMO-Rac1 branched-peptide data interpretation, H. Yokosawa, L. Trusolino and L. Vidali for reagents, N. Mack for help with the calcium-switch experiments, I. Arozarena and C. Wellbrock for help with invasion assays, and members of the Cell Signalling Group, A. Hurlstone, N. Divecha, J. Perez-Martin and C. Wilkinson, for critical reading of the manuscript and helpful discussions.	Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Gentile A, 2008, CANCER METAST REV, V27, P85, DOI 10.1007/s10555-007-9107-6; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hays JL, 2003, J BIOL CHEM, V278, P27456, DOI 10.1074/jbc.M210648200; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Maiolica A, 2007, MOL CELL PROTEOMICS, V6, P2200, DOI 10.1074/mcp.M700274-MCP200; Martin SF, 2007, ANAL BIOCHEM, V363, P83, DOI 10.1016/j.ab.2006.12.018; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; Rooney C, 2010, EMBO REP, V11, P292, DOI 10.1038/embor.2010.10; Royal I, 2000, MOL BIOL CELL, V11, P1709, DOI 10.1091/mbc.11.5.1709; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Suzuki T, 1999, J BIOL CHEM, V274, P31131, DOI 10.1074/jbc.274.44.31131; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Tolias KF, 2000, CURR BIOL, V10, P153, DOI 10.1016/S0960-9822(00)00315-8; Tolias KF, 1998, MOL CELL BIOL, V18, P762, DOI 10.1128/MCB.18.2.762; van Hennik PB, 2003, J BIOL CHEM, V278, P39166, DOI 10.1074/jbc.M307001200; Vidali L, 2006, MOL BIOL CELL, V17, P2377, DOI 10.1091/mbc.e05-10-0955; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Woodcock SA, 2009, J PROTEOME RES, V8, P5629, DOI 10.1021/pr900716e; Woodcock SA, 2009, MOL CELL, V33, P639, DOI 10.1016/j.molcel.2009.02.012; Yamashina K, 2006, J BIOCHEM, V139, P305, DOI 10.1093/jb/mvj033; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934	38	111	116	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2010	12	11					1078	U70		10.1038/ncb2112	http://dx.doi.org/10.1038/ncb2112			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	674CO	20935639	Green Accepted			2022-12-25	WOS:000283711500011
J	De Keersmaecker, K; Real, PJ; Della Gatta, G; Palomero, T; Sulis, ML; Tosello, V; Van Vlierberghe, P; Barnes, K; Castillo, M; Sole, X; Hadler, M; Lenz, J; Aplan, PD; Kelliher, M; Kee, BL; Pandolfi, PP; Kappes, D; Gounari, F; Petrie, H; Van der Meulen, J; Speleman, F; Paietta, E; Racevskis, J; Wiernik, PH; Rowe, JM; Soulier, J; Avran, D; Cave, H; Dastugue, N; Raimondi, S; Meijerink, JPP; Cordon-Cardo, C; Califano, A; Ferrando, AA				De Keersmaecker, Kim; Real, Pedro J.; Della Gatta, Giusy; Palomero, Teresa; Luisa Sulis, Maria; Tosello, Valeria; Van Vlierberghe, Pieter; Barnes, Kelly; Castillo, Mireia; Sole, Xavier; Hadler, Michael; Lenz, Jack; Aplan, Peter D.; Kelliher, Michelle; Kee, Barbara L.; Pandolfi, Pier Paolo; Kappes, Dietmar; Gounari, Fotini; Petrie, Howard; Van der Meulen, Joni; Speleman, Frank; Paietta, Elisabeth; Racevskis, Janis; Wiernik, Peter H.; Rowe, Jacob M.; Soulier, Jean; Avran, David; Cave, Helene; Dastugue, Nicole; Raimondi, Susana; Meijerink, Jules P. P.; Cordon-Cardo, Carlos; Califano, Andrea; Ferrando, Adolfo A.			The TLX1 oncogene drives aneuploidy in T cell transformation	NATURE MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GENE-EXPRESSION; MUTATIONS; HOX11; BCL11B; NOTCH1; LYMPHOMAGENESIS; SELECTION; RECURRENT; PATHWAYS	The TLX1 oncogene (encoding the transcription factor T cell leukemia homeobox protein-1) has a major role in the pathogenesis of T cell acute lymphoblastic leukemia (T-ALL). However, the specific mechanisms of T cell transformation downstream of TLX1 remain to be elucidated. Here we show that transgenic expression of human TLX1 in mice induces T-ALL with frequent deletions and mutations in Bcl11b (encoding B cell leukemia/lymphoma-11B) and identify the presence of recurrent mutations and deletions in BCL11B in 16% of human T-ALLs. Most notably, mouse TLX1 tumors were typically aneuploid and showed a marked defect in the activation of the mitotic checkpoint. Mechanistically, TLX1 directly downregulates the expression of CHEK1 (encoding CHK1 checkpoint homolog) and additional mitotic control genes and induces loss of the mitotic checkpoint in nontransformed preleukemic thymocytes. These results identify a previously unrecognized mechanism contributing to chromosomal missegregation and aneuploidy active at the earliest stages of tumor development in the pathogenesis of cancer.	[De Keersmaecker, Kim; Real, Pedro J.; Della Gatta, Giusy; Palomero, Teresa; Luisa Sulis, Maria; Tosello, Valeria; Van Vlierberghe, Pieter; Barnes, Kelly; Hadler, Michael; Califano, Andrea; Ferrando, Adolfo A.] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [De Keersmaecker, Kim] VIB, Dept Mol & Dev Genet, Louvain, Belgium; [De Keersmaecker, Kim] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Palomero, Teresa; Castillo, Mireia; Cordon-Cardo, Carlos; Ferrando, Adolfo A.] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Luisa Sulis, Maria; Ferrando, Adolfo A.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA; [Sole, Xavier] Inst Invest Biomed Bellvitge, Biomarkers & Susceptibil Unit, Catalan Inst Oncol, Barcelona, Spain; [Sole, Xavier] IDIBELL, Biomed Res Ctr Network Epidemiol & Publ Hlth, Catalan Inst Oncol, Barcelona, Spain; [Lenz, Jack] Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10467 USA; [Aplan, Peter D.] NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Kelliher, Michelle] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA; [Kee, Barbara L.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Canc Ctr, Boston, MA USA; [Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Canc Ctr, Boston, MA 02115 USA; [Kappes, Dietmar] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Gounari, Fotini] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Petrie, Howard] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Van der Meulen, Joni; Speleman, Frank] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Paietta, Elisabeth; Racevskis, Janis; Wiernik, Peter H.] Montefiore Med Ctr, North Div, New York, NY USA; [Paietta, Elisabeth; Racevskis, Janis; Wiernik, Peter H.] New York Med Coll, New York, NY USA; [Rowe, Jacob M.] Technion Israel Inst Technol, Haifa, Israel; [Soulier, Jean; Avran, David] Hop St Louis, AP HP, Hematol Lab, Paris, France; [Soulier, Jean; Avran, David] Hop St Louis, INSERM, U944, Paris, France; [Soulier, Jean; Avran, David] Univ Paris 07, Hop St Louis, Inst Univ Hematol, Paris, France; [Cave, Helene] Univ Paris 07, Hop Robert Debre, AP HP, Dept Genet, Paris, France; [Dastugue, Nicole] Hop Purpan, Hematol Lab, Toulouse, France; [Raimondi, Susana] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Meijerink, Jules P. P.] Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; [Califano, Andrea] Columbia Univ, Joint Ctr Syst Biol, New York, NY USA; [Rowe, Jacob M.] Rambam Med Ctr, Haifa, Israel	Columbia University; Flanders Institute for Biotechnology (VIB); KU Leuven; Columbia University; Columbia University; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Massachusetts System; University of Massachusetts Worcester; University of Chicago; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Fox Chase Cancer Center; University of Chicago; Scripps Research Institute; Ghent University; Ghent University Hospital; Montefiore Medical Center; New York Medical College; Technion Israel Institute of Technology; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; St Jude Children's Research Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Columbia University; Rambam Health Care Campus; Technion Israel Institute of Technology	Ferrando, AA (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.	af2196@columbia.edu	De Keersmaecker, Kim/W-9702-2018; Solé, Xavier/AAF-3015-2019; Raimondi, Susana C/N-8166-2018; Real, Pedro J./K-2994-2014; Aplan, Peter D/K-9064-2016; Van Vlierberghe, Pieter/G-8894-2013; speleman, frank/AAR-5184-2020; Real, Pedro J./ABH-3493-2021; Meijerink, Jules P/D-4393-2017; Ferrando, Adolfo A/Q-7026-2016; Castillo-Martin, Mireia/H-6152-2013; Van der Meulen, Joni/AFS-1616-2022; Tosello, Valeria/N-1010-2016	De Keersmaecker, Kim/0000-0002-7420-9531; Solé, Xavier/0000-0002-2197-3325; Real, Pedro J./0000-0001-7968-5353; Van Vlierberghe, Pieter/0000-0001-9063-7205; speleman, frank/0000-0002-6628-8559; Meijerink, Jules P/0000-0002-6860-798X; Van der Meulen, Joni/0000-0002-1916-2769; Cave, Helene/0000-0003-2840-1511; Pandolfi, Pier Paolo/0000-0002-5352-5295; van der Meulen, Jan/0000-0002-9451-2335; Califano, Andrea/0000-0003-4742-3679; Tosello, Valeria/0000-0001-9560-340X	New York Community Trust; US National Institutes of Health [R01CA120196, R01CA129382, CA21765, U24 CA114737]; Eastern Cooperative Oncology Group tumor bank; European Organization for Research and Treatment of Cancer Children Leukemia Group; Leukemia AMP; Lymphoma Society Scholar Award; US National Institutes of Health; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen; Belgian American Educational Foundation; France National Cancer Institute; NATIONAL CANCER INSTITUTE [U24CA114737, R01CA120196, ZIASC010378, R01CA129382, P30CA021765] Funding Source: NIH RePORTER	New York Community Trust; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eastern Cooperative Oncology Group tumor bank; European Organization for Research and Treatment of Cancer Children Leukemia Group; Leukemia AMP; Lymphoma Society Scholar Award; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); Belgian American Educational Foundation; France National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Blood Disease Research Project research grant from The New York Community Trust (A.A.F.); the US National Institutes of Health (grants R01CA120196 and R01CA129382 to A.A.F.; CA21765 to S.R. and U24 CA114737 to E.P.), the Spanish Ministry of Science and Innovation (fellowship EX-2006-0739 to P.J.R.), a Canceropole Ile-de-France Research research grant (J.S.), the Eastern Cooperative Oncology Group tumor bank and the European Organization for Research and Treatment of Cancer Children Leukemia Group, the Leukemia & Lymphoma Society Scholar Award (A.A.F.) and the Intramural Program of the US National Institutes of Health (P.D.A.). K.D.K. is a postdoctoral researcher funded by the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen and a recipient of a Belgian American Educational Foundation fellowship. D.A. is recipient of a predoctoral fellowship from the France National Cancer Institute. We are also grateful to T. Ludwig for helpful discussions, to J.C. Zuniga-Pflucker (University of Toronto) for the OP9-DL1 cells, to F. Gounari (University of Chicago) for the pUC1017 vector and S. Cory (Walter and Eliza Hall Institute of Medical Research) and H.G. Wendel (Memorial Sloan Kettering Cancer Center) for the Vav-Bcl2 mouse line.	Albu DI, 2007, J EXP MED, V204, P3003, DOI 10.1084/jem.20070863; Berger R, 2003, LEUKEMIA, V17, P1851, DOI 10.1038/sj.leu.2403061; Bergeron J, 2007, BLOOD, V110, P2324, DOI 10.1182/blood-2007-04-079988; Bernard OA, 2001, LEUKEMIA, V15, P1495, DOI 10.1038/sj.leu.2402249; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; Chandhok NS, 2009, CURR OPIN GENET DEV, V19, P74, DOI 10.1016/j.gde.2008.12.004; Chen E, 2006, ONCOGENE, V25, P2575, DOI 10.1038/sj.onc.1209285; Egle A, 2004, BLOOD, V103, P2276, DOI 10.1182/blood-2003-07-2469; Ferrando AA, 2004, LANCET, V363, P535, DOI 10.1016/S0140-6736(04)15542-6; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Gould J, 2006, BIOINFORMATICS, V22, P1924, DOI 10.1093/bioinformatics/btl196; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; HATANO M, 1991, SCIENCE, V253, P79, DOI 10.1126/science.1676542; HEBERT J, 1994, BLOOD, V84, P4038, DOI 10.1182/blood.V84.12.4038.bloodjournal84124038; Hough MR, 1998, P NATL ACAD SCI USA, V95, P13853, DOI 10.1073/pnas.95.23.13853; Kamimura K, 2007, BIOCHEM BIOPH RES CO, V355, P538, DOI 10.1016/j.bbrc.2007.02.003; Kawabe T, 1997, NATURE, V385, P454, DOI 10.1038/385454a0; Kawamura M, 1999, LEUKEMIA RES, V23, P115, DOI 10.1016/S0145-2126(98)00146-5; Kees UR, 2003, LEUKEMIA, V17, P887, DOI 10.1038/sj.leu.2402892; Kohn EA, 2003, CANCER RES, V63, P31; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Margolin AA, 2009, P NATL ACAD SCI USA, V106, P244, DOI 10.1073/pnas.0806445106; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sulis ML, 2008, BLOOD, V112, P733, DOI 10.1182/blood-2007-12-130096; Tosello V, 2009, BLOOD, V114, P1038, DOI 10.1182/blood-2008-12-192039; Van Vlierberghe P, 2008, BLOOD, V111, P4668, DOI 10.1182/blood-2007-09-111872; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Vilimas T, 2007, NAT MED, V13, P70, DOI 10.1038/nm1524; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; WILDIN RS, 1991, J EXP MED, V173, P383, DOI 10.1084/jem.173.2.383	35	104	107	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1321	+		10.1038/nm.2246	http://dx.doi.org/10.1038/nm.2246			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	20972433	Green Accepted			2022-12-25	WOS:000283860100045
J	Vetting, MW; Hegde, SS; Blanchard, JS				Vetting, Matthew W.; Hegde, Subray S.; Blanchard, John S.			The structure and mechanism of the Mycobacterium tuberculosis cyclodityrosine synthetase	NATURE CHEMICAL BIOLOGY			English	Article							BIOSYNTHETIC GENE-CLUSTER; ASPERGILLUS-FUMIGATUS; IN-VITRO; PEPTIDE; CYTOCHROME-P450; GLIOTOXIN; CYP121; VIVO	The Mycobacterium tuberculosis enzyme Rv2275 catalyzes the formation of cyclo(L-Tyr-L-Tyr) using two molecules of Tyr-tRNA(Tyr) as substrates. The three-dimensional (3D) structure of Rv2275 was determined to 2.0-angstrom resolution, revealing that Rv2275 is structurally related to the class Ic aminoacyl-tRNA synthetase family of enzymes. Mutagenesis and radioactive labeling suggests a covalent intermediate in which L-tyrosine is transferred from Tyr-tRNA(Tyr) to an active site serine (Ser88) by transesterification with Glu233 serving as a critical base, catalyzing dipeptide bond formation.	[Vetting, Matthew W.; Hegde, Subray S.; Blanchard, John S.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Vetting, MW (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA.	blanchar@aecom.yu.edu			US National Institutes of Health [A133696]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033696] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Del Amo and M. Callaway (Albert Einstein College of Medicine) for their help in cYY synthesis and ESI mass spectrometry, respectively. This work was supported by US National Institutes of Health Grant A133696.	Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15029, DOI 10.1021/bi061845b; Belin P, 2009, P NATL ACAD SCI USA, V106, P7426, DOI 10.1073/pnas.0812191106; FUKUSHIMA K, 1973, J ANTIBIOT, V26, P175, DOI 10.7164/antibiotics.26.175; Gardiner DM, 2005, FEMS MICROBIOL LETT, V248, P241, DOI 10.1016/j.femsle.2005.05.046; Gardiner DM, 2004, MOL MICROBIOL, V53, P1307, DOI 10.1111/j.1365-2958.2004.04215.x; Gondry M, 2009, NAT CHEM BIOL, V5, P414, DOI 10.1038/nchembio.175; Hegde SS, 2003, J BIOL CHEM, V278, P22861, DOI 10.1074/jbc.M301565200; Kanoh K, 1999, BIOSCI BIOTECH BIOCH, V63, P1130, DOI 10.1271/bbb.63.1130; Kobayashi T, 2003, NAT STRUCT BIOL, V10, P425, DOI 10.1038/nsb934; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; NISHIDA M, 1972, J ANTIBIOT, V25, P582, DOI 10.7164/antibiotics.25.582; PURDIE JE, 1973, J CHEM SOC P2, V2, P1845; Schwarzer D, 2001, CHEM BIOL, V8, P997, DOI 10.1016/S1074-5521(01)00068-0; STEINBERG SM, 1983, J ORG CHEM, V48, P2295, DOI 10.1021/jo00161a036; Strom K, 2002, APPL ENVIRON MICROB, V68, P4322, DOI 10.1128/AEM.68.9.4322-4327.2002	16	55	58	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2010	6	11					797	799		10.1038/NCHEMBIO.440	http://dx.doi.org/10.1038/NCHEMBIO.440			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	667MP	20852636	Green Accepted			2022-12-25	WOS:000283197800007
J	Berg, IL; Neumann, R; Lam, KWG; Sarbajna, S; Odenthal-Hesse, L; May, CA; Jeffreys, AJ				Berg, Ingrid L.; Neumann, Rita; Lam, Kwan-Wood G.; Sarbajna, Shriparna; Odenthal-Hesse, Linda; May, Celia A.; Jeffreys, Alec J.			PRDM9 variation strongly influences recombination hot-spot activity and meiotic instability in humans	NATURE GENETICS			English	Article							CONSTITUTIONAL T(11/22); MINISATELLITE MUTATION; GERMLINE MUTATION; GENETIC-VARIATION; HUMAN GENOME; HOTSPOT; CROSSOVER; SPERM; POLYMORPHISM; FREQUENCY	PRDM9 has recently been identified as a likely trans regulator of meiotic recombination hot spots in humans and mice(1-3). PRDM9 contains a zinc finger array that, in humans, can recognize a short sequence motif associated with hot spots(4), with binding to this motif possibly triggering hot-spot activity via chromatin remodeling(5). We now report that human genetic variation at the PRDM9 locus has a strong effect on sperm hot-spot activity, even at hot spots lacking the sequence motif. Subtle changes within the zinc finger array can create hot-spot nonactivating or enhancing variants and can even trigger the appearance of a new hot spot, suggesting that PRDM9 is a major global regulator of hot spots in humans. Variation at the PRDM9 locus also influences aspects of genome instability-specifically, a megabase-scale rearrangement underlying two genomic disorders(6) as well as minisatellite instability(7)-implicating PRDM9 as a risk factor for some pathological genome rearrangements.	[Berg, Ingrid L.; Neumann, Rita; Lam, Kwan-Wood G.; Sarbajna, Shriparna; Odenthal-Hesse, Linda; May, Celia A.; Jeffreys, Alec J.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Leicester	Jeffreys, AJ (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	ajj@le.ac.uk	Odenthal-Hesse, Linda/HCI-6463-2022	May, Celia/0000-0001-8541-2458; Odenthal-Hesse, Linda/0000-0002-5519-2375; Lam, Kwan Wood Gabriel/0000-0003-2527-9186	Medical Research Council; Wellcome Trust [081227/Z/06/Z]; Boehringer Ingelheim Fonds; Royal Society; Louis-Jeantet Foundation; MRC [G0601068] Funding Source: UKRI; Medical Research Council [G0601068] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Royal Society(Royal Society of London); Louis-Jeantet Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Blower and volunteers for providing semen samples, colleagues for helpful discussions and the Medical Research Council, the Wellcome Trust (ref. 081227/Z/06/Z), the Boehringer Ingelheim Fonds, the Royal Society and the Louis-Jeantet Foundation for funding support.	Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg I, 2003, AM J HUM GENET, V72, P1436, DOI 10.1086/375629; Buard J, 1998, EMBO J, V17, P3495, DOI 10.1093/emboj/17.12.3495; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; Jeffreys AJ, 2005, HUM MOL GENET, V14, P2277, DOI 10.1093/hmg/ddi232; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; Jeffreys AJ, 2009, NAT GENET, V41, P625, DOI 10.1038/ng.346; Kato T, 2006, SCIENCE, V311, P971, DOI 10.1126/science.1121452; Kong A, 2008, SCIENCE, V319, P1398, DOI 10.1126/science.1152422; Kurahashi H, 2000, AM J HUM GENET, V67, P763, DOI 10.1086/303054; Kurahashi H, 2001, NAT GENET, V29, P139, DOI 10.1038/ng1001-139; Lindsay SJ, 2006, AM J HUM GENET, V79, P890, DOI 10.1086/508709; MONCKTON DG, 1994, NAT GENET, V8, P162, DOI 10.1038/ng1094-162; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Neumann R, 2006, HUM MOL GENET, V15, P1401, DOI 10.1093/hmg/ddl063; Paigen K, 2010, NAT REV GENET, V11, P221, DOI 10.1038/nrg2712; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Tamaki K, 1999, HUM MOL GENET, V8, P879, DOI 10.1093/hmg/8.5.879; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Webb AJ, 2008, P NATL ACAD SCI USA, V105, P10471, DOI 10.1073/pnas.0804933105; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183	30	231	232	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2010	42	10					859	+		10.1038/ng.658	http://dx.doi.org/10.1038/ng.658			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	655UO	20818382	Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000282276600015
J	Llewellyn, ME; Thompson, KR; Deisseroth, K; Delp, SL				Llewellyn, Michael E.; Thompson, Kimberly R.; Deisseroth, Karl; Delp, Scott L.			Orderly recruitment of motor units under optical control in vivo	NATURE MEDICINE			English	Article							LEBERS CONGENITAL AMAUROSIS; ELECTRICAL-STIMULATION; SKELETAL-MUSCLE; MEDIAL GASTROCNEMIUS; CAT GASTROCNEMIUS; SIZE PRINCIPLE; GENE-THERAPY; MOUSE; MOTONEURONS; FORCE	A drawback of electrical stimulation for muscle control is that large, fatigable motor units are preferentially recruited before smaller motor units by the lowest-intensity electrical cuff stimulation. This phenomenon limits therapeutic applications because it is precisely the opposite of the normal physiological (orderly) recruitment pattern; therefore, a mechanism to achieve orderly recruitment has been a long-sought goal in physiology, medicine and engineering. Here we demonstrate a technology for reliable orderly recruitment in vivo. We find that under optical control with microbial opsins, recruitment of motor units proceeds in the physiological recruitment sequence, as indicated by multiple independent measures of motor unit recruitment including conduction latency, contraction and relaxation times, stimulation threshold and fatigue. As a result, we observed enhanced performance and reduced fatigue in vivo. These findings point to an unanticipated new modality of neural control with broad implications for nervous system and neuromuscular physiology, disease research and therapeutic innovation.	[Llewellyn, Michael E.; Thompson, Kimberly R.; Deisseroth, Karl; Delp, Scott L.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Delp, Scott L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Delp, SL (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu; delp@stanford.edu		Delp, Scott/0000-0002-9643-7551	Stanford Bio-X Interdisciplinary Initiatives; National Alliance for Research on Schizophrenia and Depression; Stanford-US National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD065690] Funding Source: NIH RePORTER	Stanford Bio-X Interdisciplinary Initiatives; National Alliance for Research on Schizophrenia and Depression(NARSAD); Stanford-US National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank R. Barretto and D. Wetmore for technical assistance and K. McGill, Z. Lateva, R. Lieber, D. Lin and F. Zajac for fruitful discussions. This work was supported by a Stanford Bio-X Interdisciplinary Initiatives award (S. L. D. and K. D.), the National Alliance for Research on Schizophrenia and Depression (K. R. T.), and the Stanford-US National Institutes of Health Medical Scientist Training Program (M. E. L.).	ALAMOOD WS, 1991, J PHYSIOL-LONDON, V441, P243, DOI 10.1113/jphysiol.1991.sp018749; ALLEN DG, 1995, J PHYSIOL-LONDON, V487, P331, DOI 10.1113/jphysiol.1995.sp020883; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; BAKELS R, 1993, J PHYSIOL-LONDON, V463, P307, DOI 10.1113/jphysiol.1993.sp019596; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BURKE RE, 1971, SCIENCE, V174, P709, DOI 10.1126/science.174.4010.709; BURKE RE, 1973, J PHYSIOL-LONDON, V234, P723, DOI 10.1113/jphysiol.1973.sp010369; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; COPE TC, 1991, J NEUROPHYSIOL, V66, P1127, DOI 10.1152/jn.1991.66.4.1127; FANG ZP, 1991, IEEE T BIO-MED ENG, V38, P175, DOI 10.1109/10.76384; FANG ZP, 1991, IEEE T BIO-MED ENG, V38, P168, DOI 10.1109/10.76383; FUGLEVAND AJ, 1993, J NEUROPHYSIOL, V70, P2470, DOI 10.1152/jn.1993.70.6.2470; Gordon T, 2004, CAN J PHYSIOL PHARM, V82, P645, DOI 10.1139/Y04-081; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Hamada T, 2004, J ELECTROMYOGR KINES, V14, P531, DOI 10.1016/j.jelekin.2004.03.008; Hayashi A, 2007, J RECONSTR MICROSURG, V23, P381, DOI 10.1055/s-2007-992344; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; IRINTCHEV A, 1990, NEUROSCIENCE, V39, P231, DOI 10.1016/0306-4522(90)90236-W; Kan HE, 2005, AM J PHYSIOL-CELL PH, V289, pC113, DOI 10.1152/ajpcell.00040.2005; Lertmanorat Z, 2004, J NEURAL ENG, V1, P202, DOI 10.1088/1741-2560/1/4/003; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; McClelland S, 2007, AM J PHYS MED REHAB, V86, P412, DOI 10.1097/PHM.0b013e31804a83cf; MCHANWELL S, 1981, PROC R SOC SER B-BIO, V213, P201, DOI 10.1098/rspb.1981.0062; Mendell LM, 2005, J NEUROPHYSIOL, V93, P3024, DOI 10.1152/classicessays.00025.2005; MILNERBR.HS, 1973, J PHYSIOL-LONDON, V230, P359, DOI 10.1113/jphysiol.1973.sp010192; Rasband MN, 2001, DEV BIOL, V236, P5, DOI 10.1006/dbio.2001.0326; Singh K, 2000, IEEE T REHABIL ENG, V8, P276; Sokoloff AJ, 1999, J NEUROPHYSIOL, V81, P2485, DOI 10.1152/jn.1999.81.5.2485; Thrasher A, 2005, ARTIF ORGANS, V29, P453, DOI 10.1111/j.1525-1594.2005.29076.x; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; WUERKER RB, 1965, J NEUROPHYSIOL, V28, P85, DOI 10.1152/jn.1965.28.1.85; ZAJAC FE, 1985, J NEUROPHYSIOL, V53, P1303, DOI 10.1152/jn.1985.53.5.1303; Zhan WZ, 1999, J APPL PHYSIOL, V87, P2326, DOI 10.1152/jappl.1999.87.6.2326; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; ZHOU BH, 1987, IEEE T BIO-MED ENG, V34, P128, DOI 10.1109/TBME.1987.326037	38	137	185	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2010	16	10					1161	U144		10.1038/nm.2228	http://dx.doi.org/10.1038/nm.2228			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20871612	Green Accepted			2022-12-25	WOS:000282644800049
J	Swarbrick, A; Woods, SL; Shaw, A; Balakrishnan, A; Phua, Y; Nguyen, A; Chanthery, Y; Lim, L; Ashton, LJ; Judson, RL; Huskey, N; Blelloch, R; Haber, M; Norris, MD; Lengyel, P; Hackett, CS; Preiss, T; Chetcuti, A; Sullivan, CS; Marcusson, EG; Weiss, W; L'Etoile, N; Goga, A				Swarbrick, Alexander; Woods, Susan L.; Shaw, Alexander; Balakrishnan, Asha; Phua, Yuwei; Nguyen, Akira; Chanthery, Yvan; Lim, Lionel; Ashton, Lesley J.; Judson, Robert L.; Huskey, Noelle; Blelloch, Robert; Haber, Michelle; Norris, Murray D.; Lengyel, Peter; Hackett, Christopher S.; Preiss, Thomas; Chetcuti, Albert; Sullivan, Christopher S.; Marcusson, Eric G.; Weiss, William; L'Etoile, Noelle; Goga, Andrei			miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma	NATURE MEDICINE			English	Article							INDUCED APOPTOSIS; IN-VIVO; MICRORNA; EXPRESSION; PATHWAY; RESTORATION; INHIBITION; SENESCENCE; PROTEIN; TARGET	Inactivation of the p53 tumor suppressor pathway allows cell survival in times of stress and occurs in many human cancers; however, normal embryonic stem cells and some cancers such as neuroblastoma maintain wild-type human TP53 and mouse Trp53 (referred to collectively as p53 herein). Here we describe a miRNA, miR-380-5p, that represses p53 expression via a conserved sequence in the p53 3' untranslated region (UTR). miR-380-5p is highly expressed in mouse embryonic stem cells and neuroblastomas, and high expression correlates with poor outcome in neuroblastomas with neuroblastoma derived v-myc myelocytomatosis viral-related oncogene (MYCN) amplification. miR-380 overexpression cooperates with activated HRAS oncoprotein to transform primary cells, block oncogene-induced senescence and form tumors in mice. Conversely, inhibition of endogenous miR-380-5p in embryonic stem or neuroblastoma cells results in induction of p53, and extensive apoptotic cell death. In vivo delivery of a miR-380-5p antagonist decreases tumor size in an orthotopic mouse model of neuroblastoma. We demonstrate a new mechanism of p53 regulation in cancer and stem cells and uncover a potential therapeutic target for neuroblastoma.	[Balakrishnan, Asha; Lengyel, Peter; Goga, Andrei] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Swarbrick, Alexander; Shaw, Alexander; Phua, Yuwei; Nguyen, Akira] Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia; [Swarbrick, Alexander; Phua, Yuwei; Preiss, Thomas] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Woods, Susan L.] Univ Calif San Francisco, GW Hooper Res Fdn, San Francisco, CA 94143 USA; [Woods, Susan L.] Queensland Inst Med Res, Div Genet & Populat Hlth, Brisbane, Qld, Australia; [Shaw, Alexander; Preiss, Thomas] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; [Shaw, Alexander; Preiss, Thomas] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Balakrishnan, Asha; Lengyel, Peter; Goga, Andrei] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Chanthery, Yvan; Lim, Lionel; Judson, Robert L.; Huskey, Noelle; Hackett, Christopher S.] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA; [Ashton, Lesley J.; Haber, Michelle; Norris, Murray D.] Childrens Canc Inst Australia Med Res, Sydney, NSW, Australia; [Judson, Robert L.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Blelloch, Robert] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Blelloch, Robert] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Chetcuti, Albert] Childrens Hosp, Childrens Canc Res Inst, Westmead, NSW, Australia; [Hackett, Christopher S.] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Marcusson, Eric G.] Regulus Therapeut, San Diego, CA USA; [Weiss, William] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Weiss, William] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [L'Etoile, Noelle] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Goga, Andrei] Univ Calif San Francisco, Helen Diller Canc Ctr, San Francisco, CA USA; [Goga, Andrei] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Garvan Institute of Medical Research; University of New South Wales Sydney; University of California System; University of California San Francisco; QIMR Berghofer Medical Research Institute; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Children's Cancer Institute; Children's Medical Research Institute - Australia; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Children's Cancer Institute; University of Sydney; University of Texas System; University of Texas Austin; Isis Pharmaceuticals Inc; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Goga, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	a.swarbrick@garvan.org.au; andrei.goga@ucsf.edu	Swarbrick, Alexander/E-6107-2010; Xie, Huangming/B-2260-2012; Shaw, Alex/C-9826-2011; Preiss, Thomas/F-7355-2010	Swarbrick, Alexander/0000-0002-3051-5676; Preiss, Thomas/0000-0001-6273-784X; Weiss, William/0000-0003-2230-9132; Norris, Murray/0000-0002-0632-4589; Haber, Michelle/0000-0003-2036-8817; Woods, Susan/0000-0002-8955-2017; Marcusson, Eric/0000-0002-0504-8674	US National Institutes of Health [P50-CA58207, K08-CA104032, 1R01CA136717, 5R01DC005991, R01CA102321, R01NS055750, P01CA081403]; NATIONAL CANCER INSTITUTE [R01CA136717, K08CA104032, P50CA058207, P01CA081403, R01CA102321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048118, R01NS055750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005991] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We gratefully thank J.M. Bishop, N.K. Hayward and R. L. Sutherland for their support of this project, the Children's Oncology Group and M. Grimmer (University of California-San Francisco) for providing tumor samples, D. Lynch and J. Brugge (Harvard Medical School) for MCF10A cells expressing the ecotropic receptor, R. Jaenisch (Whitehead Institute) for Trp53<SUP>-/-</SUP> ES cells and S. Lowe (Cold Spring Harbor) for the p53 shRNA retrovirus. TH-MYCN transgenic mice were from W. Weiss (University of California-San Francisco). This work was supported by grants from the US National Institutes of Health: P50-CA58207, K08-CA104032 and 1R01CA136717 (to A. G.), 5R01DC005991 (to N.L.), R01CA102321, R01NS055750 and P01CA081403 (to W. W.) and K08NS48118 (to R. B.); the Susan G. Komen Foundation; the University of California-San Francisco Program for Breakthrough Biomedical Research (to A. G.); the G. W. Hooper Foundation; the Australian National Health and Medical Research Council (to T. P., M. H., M.D.N. and A. Swarbrick) and the Cancer Institute New South Wales (M. H. and M.D.N.). A. Swarbrick is a recipient of a Cancer Institute New South Wales early career development fellowship, and R. L. J. received a US National Science Foundation fellowship. A. G. is a V-Foundation Scholar, A. Shaw is a Cancer Institute New South Wales Research Scholar and Y.P. is supported by an Australian Postgraduate Award from the Australian National Health and Medical Research Council.	Chesler L, 2008, NEOPLASIA, V10, P1268, DOI 10.1593/neo.08778; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; CLARKE AR, 1994, ONCOGENE, V9, P1767; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Davis S, 2009, NUCLEIC ACIDS RES, V37, P70, DOI 10.1093/nar/gkn904; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Fu LN, 1999, ONCOGENE, V18, P6419, DOI 10.1038/sj.onc.1203064; Gottlieb E, 1997, EMBO J, V16, P1381, DOI 10.1093/emboj/16.6.1381; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Haber M, 2006, J CLIN ONCOL, V24, P1546, DOI 10.1200/JCO.2005.01.6196; Halaby MJ, 2007, GENE, V395, P1, DOI 10.1016/j.gene.2007.01.029; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hogarty MD, 2008, CANCER RES, V68, P9735, DOI 10.1158/0008-5472.CAN-07-6866; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kuhn DE, 2008, METHODS, V44, P47, DOI 10.1016/j.ymeth.2007.09.005; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Liu T, 2007, P NATL ACAD SCI USA, V104, P18682, DOI 10.1073/pnas.0705524104; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; MEDINA PP, 2010, NATURE          0808, DOI DOI 10.1038/NATURE09284; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Rounbehler RJ, 2009, CANCER RES, V69, P547, DOI 10.1158/0008-5472.CAN-08-2968; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; Tedeschi A, 2009, EMBO REP, V10, P576, DOI 10.1038/embor.2009.89; Tweddle DA, 2003, CANCER LETT, V197, P93, DOI 10.1016/S0304-3835(03)00088-0; Tweddle DA, 2001, CANCER RES, V61, P8; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Welm AL, 2005, P NATL ACAD SCI USA, V102, P4324, DOI 10.1073/pnas.0500470102; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yoon H, 2002, P NATL ACAD SCI USA, V99, P15632, DOI 10.1073/pnas.242597299; Zhao RB, 2000, GENE DEV, V14, P981; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	148	155	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2010	16	10					1134	U113		10.1038/nm.2227	http://dx.doi.org/10.1038/nm.2227			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20871609	Green Accepted			2022-12-25	WOS:000282644800044
J	Abnet, CC; Freedman, ND; Hu, N; Wang, ZM; Yu, K; Shu, XO; Yuan, JM; Zheng, W; Dawsey, SM; Dong, LM; Lee, MP; Ding, T; Qiao, YL; Gao, YT; Koh, WP; Xiang, YB; Tang, ZZ; Fan, JH; Wang, CY; Wheeler, W; Gail, MH; Yeager, M; Yuenger, J; Hutchinson, A; Jacobs, KB; Giffen, CA; Burdett, L; Fraumeni, JF; Tucker, MA; Chow, WH; Goldstein, AM; Chanock, SJ; Taylor, PR				Abnet, Christian C.; Freedman, Neal D.; Hu, Nan; Wang, Zhaoming; Yu, Kai; Shu, Xiao-Ou; Yuan, Jian-Min; Zheng, Wei; Dawsey, Sanford M.; Dong, Linda M.; Lee, Maxwell P.; Ding, Ti; Qiao, You-Lin; Gao, Yu-Tang; Koh, Woon-Puay; Xiang, Yong-Bing; Tang, Ze-Zhong; Fan, Jin-Hu; Wang, Chaoyu; Wheeler, William; Gail, Mitchell H.; Yeager, Meredith; Yuenger, Jeff; Hutchinson, Amy; Jacobs, Kevin B.; Giffen, Carol A.; Burdett, Laurie; Fraumeni, Joseph F., Jr.; Tucker, Margaret A.; Chow, Wong-Ho; Goldstein, Alisa M.; Chanock, Stephen J.; Taylor, Philip R.			A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CANCER; CHINA; RISK; MUTATIONS; VARIANT; TRACT; CHEK2	We conducted a genome-wide association study of gastric cancer and esophageal squamous cell carcinoma (ESCC) in ethnic Chinese subjects in which we genotyped 551,152 SNPs. We report a combined analysis of 2,240 gastric cancer cases, 2,115 ESCC cases and 3,302 controls drawn from five studies. In logistic regression models adjusted for age, sex and study, multiple variants at 10q23 had genome-wide significance for gastric cancer and ESCC independently. A notable signal was rs2274223, a nonsynonymous SNP located in PLCE1, for gastric cancer (P = 8.40 x 10(-9); per-allele odds ratio (OR) = 1.31) and ESCC (P = 3.85 x 10(-9); OR = 1.34). The association with gastric cancer differed by anatomic subsite. For tumors in the cardia the association was stronger (P = 4.19 x 10(-15); OR = 1.57), and for those in the noncardia stomach it was absent (P = 0.44; OR = 1.05). Our findings at 10q23 could provide insight into the high incidence of both cancers in China.	[Abnet, Christian C.; Freedman, Neal D.; Hu, Nan; Wang, Zhaoming; Yu, Kai; Dawsey, Sanford M.; Dong, Linda M.; Wang, Chaoyu; Gail, Mitchell H.; Yeager, Meredith; Yuenger, Jeff; Hutchinson, Amy; Jacobs, Kevin B.; Burdett, Laurie; Fraumeni, Joseph F., Jr.; Tucker, Margaret A.; Chow, Wong-Ho; Goldstein, Alisa M.; Chanock, Stephen J.; Taylor, Philip R.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Wang, Zhaoming; Yeager, Meredith; Yuenger, Jeff; Hutchinson, Amy; Jacobs, Kevin B.; Burdett, Laurie] SAIC Frederick Inc, NCI Frederick, Core Genotyping Facil, Frederick, MD USA; [Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Shu, Xiao-Ou; Zheng, Wei] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Yuan, Jian-Min] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Lee, Maxwell P.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Ding, Ti; Tang, Ze-Zhong] Shanxi Canc Hosp, Taiyuan, Shanxi, Peoples R China; [Qiao, You-Lin; Fan, Jin-Hu] Chinese Acad Med Sci, Dept Epidemiol, Canc Inst Hosp, Beijing 100037, Peoples R China; [Gao, Yu-Tang; Xiang, Yong-Bing] Shanghai Canc Inst, Shanghai, Peoples R China; [Koh, Woon-Puay] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore; [Wheeler, William; Giffen, Carol A.] Informat Management Serv Inc, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Vanderbilt University; Vanderbilt University; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Shanghai Jiao Tong University; National University of Singapore; Information Management Services, Inc.	Abnet, CC (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	abnetc@mail.nih.gov	Gao, Y./GWZ-3665-2022; Zheng, Wei/O-3351-2013; Yeager, Meredith/AAA-5322-2020; Abnet, Christian C/C-4111-2015; Freedman, Neal David/B-9741-2015; Wang, Zhaoming/R-5527-2018; zhang, weihua/GXV-1334-2022; Qiao, You-Lin/B-4139-2012; Tucker, Margaret A/B-4297-2015; Gao, Yu/HGE-1937-2022; Liao, Linda M/B-3960-2011; gao, yi/HCI-8298-2022	Zheng, Wei/0000-0003-1226-070X; Abnet, Christian C/0000-0002-3008-7843; Freedman, Neal David/0000-0003-0074-1098; Wang, Zhaoming/0000-0001-7556-3869; Qiao, You-Lin/0000-0001-6380-0871; Liao, Linda M/0000-0002-1923-5294; Yuan, Jian-Min/0000-0002-4620-3108; Jacobs, Kevin/0000-0002-4657-6473; fan, jinhu/0000-0003-3159-7893	National Cancer Institute [SMHS: R01 CA82729, SWHS: R37 CA70837, NO2-CP-11010, SCHS: R01 CA55069, R35 CA53890, R01 CA80205, R01 CA144034, NO2-SC-66211, NO1-SC-91030, HHSN261200477001C]; Shanxi Cancer Hospital and Institute; Cancer Institute of the Chinese Academy of Medical Sciences; NIH, National Cancer Institute; Division of Cancer Epidemiology and Genetics; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011253] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Shanxi Cancer Hospital and Institute; Cancer Institute of the Chinese Academy of Medical Sciences; NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the study participants and staff of the Shanghai Men's Health Study (SMHS), Shanghai Women's Health Study (SWHS) and Singapore Chinese Health Study (SCHS). Supported by the National Cancer Institute (SMHS: R01 CA82729; SWHS: R37 CA70837 and contract NO2-CP-11010 with Vanderbilt University; SCHS: R01 CA55069, R35 CA53890, R01 CA80205 and R01 CA144034). We thank M. C. Yu and H.-P. Lee for establishing this cohort. Cancer cases were identified through database linkage by the Ministry of Health in Singapore. The Shanxi Upper Gastrointestinal Cancer Genetics Project was supported by the National Cancer Institute contract NO2-SC-66211 with the Shanxi Cancer Hospital and Institute. The Nutrition Intervention Trials (NIT) were supported by National Cancer Institute contracts NO1-SC-91030 and HHSN261200477001C with the Cancer Institute of the Chinese Academy of Medical Sciences. The current analysis was supported by the Intramural Research Program of the NIH, National Cancer Institute, the Division of Cancer Epidemiology and Genetics, and the Center for Cancer Research.	Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; Brennan P, 2007, HUM MOL GENET, V16, P1794, DOI 10.1093/hmg/ddm127; Bunney TD, 2009, ADV ENZYME REGUL, V49, P54, DOI 10.1016/j.advenzreg.2009.01.004; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; Cybulski C, 2004, AM J HUM GENET, V75, P1131, DOI 10.1086/426403; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Engel LS, 2003, J NATL CANCER I, V95, P1404, DOI 10.1093/jnci/djg047; Falush D, 2003, GENETICS, V164, P1567; Gao Y, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-269; Hall J, 2007, CARCINOGENESIS, V28, P665, DOI 10.1093/carcin/bgl160; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Islami F, 2004, BRIT J CANCER, V90, P1402, DOI 10.1038/sj.bjc.6601737; Johmura Y, 2008, BIOL PHARM BULL, V31, P1092, DOI 10.1248/bpb.31.1092; Kamangar F, 2009, GASTROENTEROL CLIN N, V38, P27, DOI 10.1016/j.gtc.2009.01.004; Li J Y, 1982, Natl Cancer Inst Monogr, V62, P113; Li K, 2002, INT J CANCER, V102, P271, DOI [10.1002/ijc.10706, 10.1002/jhc.10706]; Li MZ, 2009, CARCINOGENESIS, V30, P1424, DOI 10.1093/carcin/bgp125; Lu Y, 2010, INT J CANCER, V127, P2183, DOI 10.1002/ijc.25228; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Tran G.D., 2004, INT J CANCER, V113, P176; YANG CS, 1980, CANCER RES, V40, P2633; Yokoyama A, 2003, JPN J CLIN ONCOL, V33, P111, DOI 10.1093/jjco/hyg026; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551; ZHENG W, 1993, BRIT J CANCER, V68, P978, DOI 10.1038/bjc.1993.465	28	395	424	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					764	U51		10.1038/ng.649	http://dx.doi.org/10.1038/ng.649			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20729852	Green Accepted			2022-12-25	WOS:000281388400011
J	Miyazaki, I; Simizu, S; Okumura, H; Takagi, S; Osada, H				Miyazaki, Isao; Simizu, Siro; Okumura, Hideo; Takagi, Satoshi; Osada, Hiroyuki			A small-molecule inhibitor shows that pirin regulates migration of melanoma cells	NATURE CHEMICAL BIOLOGY			English	Article							NUCLEAR-PROTEIN; GENE-EXPRESSION; E-CADHERIN; DISCOVERY; SNAIL; SLUG; MICROARRAYS; IDENTIFICATION; DIVERSITY; CANCER	The discovery of small molecules that bind to a specific target and disrupt the function of proteins is an important step in chemical biology, especially for poorly characterized proteins. Human pirin is a nuclear protein of unknown function that is widely expressed in punctate subnuclear structures in human tissues. Here, we report the discovery of a small molecule that binds to pirin. We determined how the small molecule bound to pirin by solving the cocrystal structure. Either knockdown of pirin or treatment with the small molecule inhibited melanoma cell migration. Thus, inhibition of pirin by the small molecule has led to a greater understanding of the function of pirin and represents a new method of studying pirin-mediated signaling pathways.	[Miyazaki, Isao; Simizu, Siro; Okumura, Hideo; Takagi, Satoshi; Osada, Hiroyuki] RIKEN Adv Sci Inst, Dept Biol Chem, Chem Biol Core Facil, Chem Lib Validat Team, Wako, Saitama, Japan	RIKEN	Miyazaki, I (corresponding author), RIKEN Adv Sci Inst, Dept Biol Chem, Chem Biol Core Facil, Chem Lib Validat Team, Wako, Saitama, Japan.	hisyo@riken.jp	Osada, Hiroyuki/N-4305-2014; Osada, Hiroyuki/AAY-6254-2020	Simizu, Siro/0000-0003-2949-2427	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank N. Kanoh, H. Aono, T. Yoshimura, Y. Fukushima, H. Miyatake and Y. Kondoh for suggestions; M. Muroi and H. Kondo for technical assistance with the LC-MS/MS analysis; T. Nakamura and Y. Hongo for mass spectrometry (RIKEN); R. Nakazawa for DNA sequencing (RIKEN); and the Support Unit for Bio-material Analysis, RIKEN BSI Research Resources Center, and K. Fukumoto for DNA microarray analysis. The synchrotron radiation experiments were performed at BL26B2 in SPring-8 with the Mail-in data collection system with the approval of RIKEN (Proposal No. 20090085). This study was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT).	Adams M, 2005, J BIOL CHEM, V280, P28675, DOI 10.1074/jbc.M501034200; Ahmed SU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007305; Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barnes-Seeman D, 2003, ANGEW CHEM INT EDIT, V42, P2376, DOI 10.1002/anie.200351043; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bergman AC, 1999, CELL MOL LIFE SCI, V55, P467, DOI 10.1007/s000180050303; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clemons PA, 2001, CHEM BIOL, V8, P1183, DOI 10.1016/S1074-5521(01)00086-2; Cobaleda C, 2007, ANNU REV GENET, V41, P41, DOI 10.1146/annurev.genet.41.110306.130146; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; De la Houssaye G, 2008, MOL VIS, V14, P1912; Dechend R, 1999, ONCOGENE, V18, P3316, DOI 10.1038/sj.onc.1202717; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Elloul S, 2005, CANCER-AM CANCER SOC, V103, P1631, DOI 10.1002/cncr.20946; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Kanoh N, 2003, ANGEW CHEM INT EDIT, V42, P5584, DOI 10.1002/anie.200352164; Kawatani M, 2008, P NATL ACAD SCI USA, V105, P11691, DOI 10.1073/pnas.0712239105; Koehler AN, 2003, J AM CHEM SOC, V125, P8420, DOI 10.1021/ja0352698; Kuruvilla FG, 2002, NATURE, V416, P653, DOI 10.1038/416653a; Lapik YR, 2003, PLANT CELL, V15, P1578, DOI 10.1105/tpc.011890; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; McKeithan TW, 1997, GENE CHROMOSOME CANC, V20, P64, DOI 10.1002/(SICI)1098-2264(199709)20:1<64::AID-GCC10>3.0.CO;2-F; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miyazaki I, 2008, BIOSCI BIOTECH BIOCH, V72, P2739, DOI 10.1271/bbb.80383; Miyazaki I, 2009, CHEMBIOCHEM, V10, P845, DOI 10.1002/cbic.200800728; Miyazaki I, 2009, CHEMBIOCHEM, V10, P838, DOI 10.1002/cbic.200800704; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; Orzaez D, 2001, PLANT MOL BIOL, V46, P459, DOI 10.1023/A:1010618515051; Osada H, 2010, BIOSCI BIOTECH BIOCH, V74, P1135, DOI 10.1271/bbb.100061; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pang H, 2004, J BIOL CHEM, V279, P1491, DOI 10.1074/jbc.M310022200; Park SH, 2008, MOL ENDOCRINOL, V22, P2085, DOI 10.1210/me.2007-0512; Park SG, 2006, J BIOL CHEM, V281, P31770, DOI 10.1074/jbc.M603194200; Rothhammer T, 2005, CANCER RES, V65, P448; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Stanton BZ, 2009, NAT CHEM BIOL, V5, P154, DOI 10.1038/nchembio.142; Steiner RA, 2002, BIOCHEMISTRY-US, V41, P7955, DOI 10.1021/bi0159736; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Uttamchandani M, 2004, J COMB CHEM, V6, P862, DOI 10.1021/cc049900s; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vegas AJ, 2007, ANGEW CHEM INT EDIT, V46, P7960, DOI 10.1002/anie.200703198; Voz ML, 2004, ONCOGENE, V23, P179, DOI 10.1038/sj.onc.1207013; Wendler WMF, 1997, J BIOL CHEM, V272, P8482, DOI 10.1074/jbc.272.13.8482; Zhu G, 2003, ONCOGENE, V22, P3742, DOI 10.1038/sj.onc.1206428	50	68	74	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2010	6	9					667	673		10.1038/NCHEMBIO.423	http://dx.doi.org/10.1038/NCHEMBIO.423			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	640WO	20711196				2022-12-25	WOS:000281084900010
J	Stephan, MT; Moon, JJ; Um, SH; Bershteyn, A; Irvine, DJ				Stephan, Matthias T.; Moon, James J.; Um, Soong Ho; Bershteyn, Anna; Irvine, Darrell J.			Therapeutic cell engineering with surface-conjugated synthetic nanoparticles	NATURE MEDICINE			English	Article							T-LYMPHOCYTES; STEM-CELLS; TRANSPLANTATION; ANTIGEN; IMPACT; CANCER; EXPANSION; TARGET; IL-15; TRIAL	A major limitation of cell therapies is the rapid decline in viability and function of the transplanted cells. Here we describe a strategy to enhance cell therapy via the conjugation of adjuvant drug-loaded nanoparticles to the surfaces of therapeutic cells. With this method of providing sustained pseudoautocrine stimulation to donor cells, we elicited marked enhancements in tumor elimination in a model of adoptive T cell therapy for cancer. We also increased the in vivo repopulation rate of hematopoietic stem cell grafts with very low doses of adjuvant drugs that were ineffective when given systemically. This approach is a simple and generalizable strategy to augment cytoreagents while minimizing the systemic side effects of adjuvant drugs. In addition, these results suggest therapeutic cells are promising vectors for actively targeted drug delivery.	[Stephan, Matthias T.; Moon, James J.; Um, Soong Ho; Bershteyn, Anna; Irvine, Darrell J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Stephan, Matthias T.; Moon, James J.; Um, Soong Ho; Bershteyn, Anna; Irvine, Darrell J.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Um, Soong Ho; Irvine, Darrell J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Irvine, Darrell J.] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA; [Irvine, Darrell J.] Harvard Univ, Boston, MA 02115 USA; [Irvine, Darrell J.] Howard Hughes Med Inst, Chevy Chase, MD USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Howard Hughes Medical Institute	Irvine, DJ (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	djirvine@mit.edu	Moon, James J/ABE-4429-2021	Moon, James J/0000-0003-2238-2372; Stephan, Matthias/0000-0001-8310-0100	US National Institutes of Health [CA140476]; US National Science Foundation [DMR-02-13282]; US National Cancer Institute [P30-CA14051]; NATIONAL CANCER INSTITUTE [R01CA140476, P30CA014051] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the US National Institutes of Health (CA140476), the US National Science Foundation (Materials Research Science and Engineering Center award DMR-02-13282), Cancer Center Support (core) grant P30-CA14051 from the US National Cancer Institute and a gift to the Koch Institute by Curtis and Cathy Marble. D.J.I. is an investigator of the Howard Hughes Medical Institute. We thank M. Sadelain (Memorial Sloan-Kettering Cancer Center) for extG-luc and M. van den Brink (Memorial Sloan-Kettering Cancer Center) for F-luc-transgenic mice.	Alison MR, 2009, CURR OPIN MOL THER, V11, P364; Alper J, 2009, NAT BIOTECHNOL, V27, P213, DOI 10.1038/nbt0309-213a; Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104; Berger C, 2009, BLOOD, V114, P2417, DOI 10.1182/blood-2008-12-189266; BERNSTEIN I, 2008, BIOL BLOOD MARROW TR, V14, P94; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Dhar S, 2008, P NATL ACAD SCI USA, V105, P17356, DOI 10.1073/pnas.0809154105; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Dinauer N, 2005, BIOMATERIALS, V26, P5898, DOI 10.1016/j.biomaterials.2005.02.038; Fiorina P, 2008, AM J TRANSPLANT, V8, P1990, DOI 10.1111/j.1600-6143.2008.02353.x; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Jain RK, 2009, NEW ENGL J MED, V360, P2669, DOI 10.1056/NEJMcibr0902054; Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199; Lu J, 2002, CLIN CANCER RES, V8, P3877; Mackinnon S, 2008, BLOOD CELL MOL DIS, V40, P63, DOI 10.1016/j.bcmd.2007.07.003; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Na HB, 2009, ADV MATER, V21, P2133, DOI 10.1002/adma.200802366; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Prescher JA, 2004, NATURE, V430, P873, DOI 10.1038/nature02791; Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332; Reichardt W, 2008, J IMMUNOL, V181, P4770, DOI 10.4049/jimmunol.181.7.4770; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Sahaf B, 2003, P NATL ACAD SCI USA, V100, P4001, DOI 10.1073/pnas.2628032100; THOMPSON JA, 1987, CANCER RES, V47, P4202; Tong R, 2009, MRS BULL, V34, P422, DOI 10.1557/mrs2009.118; TREISMAN J, 1995, BLOOD, V85, P139, DOI 10.1182/blood.V85.1.139.bloodjournal851139; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Wallace A, 2008, CLIN CANCER RES, V14, P3966, DOI 10.1158/1078-0432.CCR-08-0356; Weissleder R, 2005, NAT BIOTECHNOL, V23, P1418, DOI 10.1038/nbt1159; Woodrow KA, 2009, NAT MATER, V8, P526, DOI [10.1038/NMAT2444, 10.1038/nmat2444]; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057	32	491	508	14	322	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2010	16	9					1035	U135		10.1038/nm.2198	http://dx.doi.org/10.1038/nm.2198			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20711198	Green Accepted			2022-12-25	WOS:000281622900034
J	Bertschinger, J				Bertschinger, Julian			At ground level	NATURE BIOTECHNOLOGY			English	Editorial Material									Covagen, Zurich, Switzerland		Bertschinger, J (corresponding author), Covagen, Zurich, Switzerland.	julian.bertschinger@covagen.com							0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2010	28	8					775	777		10.1038/bioe.2010.6	http://dx.doi.org/10.1038/bioe.2010.6			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	636RM	20722095	Bronze			2022-12-25	WOS:000280757500009
J	Qualls, JE; Murray, PJ				Qualls, Joseph E.; Murray, Peter J.			A double agent in cancer: Stopping macrophages wounds tumors	NATURE MEDICINE			English	Editorial Material							PROGRESSION; METASTASIS		[Qualls, Joseph E.; Murray, Peter J.] St Jude Childrens Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Qualls, Joseph E.; Murray, Peter J.] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Qualls, JE (corresponding author), St Jude Childrens Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	peter.murray@stjude.org	Murray, Peter J/K-4725-2018	Murray, Peter J/0000-0001-6329-9802				Ahn GO, 2010, P NATL ACAD SCI USA, V107, P8363, DOI 10.1073/pnas.0911378107; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; FANTIN A, 2010, BLOOD           0419, DOI DOI 10.1182/BLOOD-2009-12-257832; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Meng YR, 2010, CANCER RES, V70, P1534, DOI 10.1158/0008-5472.CAN-09-2995; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445	9	10	10	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2010	16	8					863	864		10.1038/nm0810-863	http://dx.doi.org/10.1038/nm0810-863			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20689551				2022-12-25	WOS:000280649200024
J	Ding, ZJ; Galvan-Ampudia, CS; Demarsy, E; Langowski, L; Kleine-Vehn, J; Fan, YW; Morita, MT; Tasaka, M; Fankhauser, C; Offringa, R; Friml, J				Ding, Zhaojun; Galvan-Ampudia, Carlos S.; Demarsy, Emilie; Langowski, Lukasz; Kleine-Vehn, Juergen; Fan, Yuanwei; Morita, Miyo T.; Tasaka, Masao; Fankhauser, Christian; Offringa, Remko; Friml, Jiri			Light-mediated polarization of the PIN3 auxin transporter for the phototropic response in Arabidopsis	NATURE CELL BIOLOGY			English	Article							LATERAL TRANSPORT; EFFLUX; PROTEIN; GRADIENTS; CARRIERS; GROWTH; GNOM; PHOSPHORYLATION; TRANSCYTOSIS; COLEOPTILES	Phototropism is an adaptation response, through which plants grow towards the light(1). It involves light perception and asymmetric distribution of the plant hormone auxin(2-12). Here we identify a crucial part of the mechanism for phototropism, revealing how light perception initiates auxin redistribution that leads to directional growth. We show that light polarizes the cellular localization of the auxin efflux carrier PIN3 in hypocotyl endodermis cells, resulting in changes in auxin distribution and differential growth. In the dark, high expression and activity of the PINOID (PID) kinase correlates with a polar targeting of PIN3 to all cell sides. Following illumination, light represses PINOID transcription and PIN3 ispolarized specifically to the inner cell sides by GNOM ARF GTPase GEF (guanine nucleotide exchange factor)-dependent trafficking. Thus, differential trafficking at the shaded and illuminated hypocotyl side aligns PIN3 polarity with the light direction, and presumably redirects auxin flow towards the shaded side, where auxin promotes growth, causing hypocotyls to bend towards the light. Our results imply that PID phosphorylation-dependent recruitment of PIN proteins into distinct trafficking pathways is a mechanism to polarize auxin fluxes in response to different environmental and endogenous cues	[Ding, Zhaojun; Langowski, Lukasz; Kleine-Vehn, Juergen; Friml, Jiri] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Ding, Zhaojun; Demarsy, Emilie; Langowski, Lukasz; Friml, Jiri] Univ Ghent, Dept Plant Biotechnol & Genet, B-9052 Ghent, Belgium; [Galvan-Ampudia, Carlos S.; Fan, Yuanwei; Offringa, Remko] Leiden Univ, Inst Biol Leiden, NL-2333 BE Leiden, Netherlands; [Demarsy, Emilie; Fankhauser, Christian] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Morita, Miyo T.; Tasaka, Masao] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300101, Japan	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Leiden University; Leiden University - Excl LUMC; University of Lausanne; Nara Institute of Science & Technology	Friml, J (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, Technol Pk 927, B-9052 Ghent, Belgium.	jiri.friml@psb.vib-ugent.be	Kleine-Vehn, Jürgen/C-8984-2014; Fan, Yuanwei/AAD-2376-2021; Fankhauser, Christian/ABE-8757-2021; Friml, Jiri/D-9511-2012; Fankhauser, Christian/C-4291-2018	Kleine-Vehn, Jürgen/0000-0002-4354-3756; Fankhauser, Christian/0000-0003-4719-5901; Friml, Jiri/0000-0002-8302-7596; Fankhauser, Christian/0000-0003-4719-5901; Morita, Miyo/0000-0002-6176-5758	Research Foundation-Flanders (Odysseus); Research Council for Earth and Life Sciences [ALW 813.06.004]; Dutch Organization of Scientific Research (NWO); Chinese Science Council; Swiss National Science Foundation [31003A_124747/1]	Research Foundation-Flanders (Odysseus)(FWO); Research Council for Earth and Life Sciences(Netherlands Organization for Scientific Research (NWO)); Dutch Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Chinese Science Council; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank W. Briggs, G. Jurgens and I. Moore for sharing published materials; the Nottingham Arabidopsis Stock Centre (NASC) for seed stocks; D. Van Der Straeten, F. Vandenbussche and Q. Zhu for help with the blue-light treatment; W. Briggs, J. Christie and A. Murphy for helpful discussions; and M. De Cock for help in preparing the manuscript. This work was supported by grants from the Research Foundation-Flanders (Odysseus), from the Research Council for Earth and Life Sciences (C.S.G-A., ALW 813.06.004) with financial aid from the Dutch Organization of Scientific Research (NWO) to R.O., and from the Chinese Science Council (Y.F.). Work in the Fankhauser laboratory is supported by the Swiss National Science Foundation (grant no. 31003A_124747/1).	Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Benjamins R, 2001, DEVELOPMENT, V128, P4057; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blakeslee JJ, 2004, PLANT PHYSIOL, V134, P28, DOI 10.1104/pp.103.031690; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Briggs WR, 2001, PLANT CELL, V13, P993, DOI 10.1105/tpc.13.5.993; BRIGGS WR, 1963, PLANT PHYSIOL, V38, P237, DOI 10.1104/pp.38.3.237; Christensen SK, 2000, CELL, V100, P469, DOI 10.1016/S0092-8674(00)80682-0; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Dhonukshe P, 2010, DEVELOPMENT, V137, P3245, DOI 10.1242/dev.052456; EPEL BL, 1992, J PLANT PHYSIOL, V140, P310, DOI 10.1016/S0176-1617(11)81084-9; Esmon CA, 2006, P NATL ACAD SCI USA, V103, P236, DOI 10.1073/pnas.0507127103; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Fuchs I, 2003, P NATL ACAD SCI USA, V100, P11795, DOI 10.1073/pnas.2032704100; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2004, DEVELOPMENT, V131, P389, DOI 10.1242/dev.00926; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; Gray WM, 1998, P NATL ACAD SCI USA, V95, P7197, DOI 10.1073/pnas.95.12.7197; Haga K, 2005, PLANT CELL, V17, P103, DOI 10.1105/tpc.104.028357; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Huang F, 2010, PLANT CELL, V22, P1129, DOI 10.1105/tpc.109.072678; Inada S, 2004, PLANT CELL, V16, P887, DOI 10.1105/tpc.019901; Inoue S, 2008, P NATL ACAD SCI USA, V105, P5626, DOI 10.1073/pnas.0709189105; Kaiserli E, 2009, PLANT CELL, V21, P3226, DOI 10.1105/tpc.109.067876; Kleine-Vehn J, 2008, CURR BIOL, V18, P526, DOI 10.1016/j.cub.2008.03.021; Kleine-Vehn J, 2009, PLANT CELL, V21, P3839, DOI 10.1105/tpc.109.071639; Kleine-Vehn J, 2010, P NATL ACAD SCI USA, V107, P22344, DOI 10.1073/pnas.1013145107; Lariguet P, 2006, P NATL ACAD SCI USA, V103, P10134, DOI 10.1073/pnas.0603799103; LI Y, 1991, PLANT CELL, V3, P1167, DOI 10.1105/tpc.3.11.1167; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Motchoulski A, 1999, SCIENCE, V286, P961, DOI 10.1126/science.286.5441.961; Mravec J, 2008, DEVELOPMENT, V135, P3345, DOI 10.1242/dev.021071; Nagashima A, 2008, PLANT J, V53, P516, DOI 10.1111/j.1365-313X.2007.03358.x; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; SHEVELL DE, 1994, CELL, V77, P1051, DOI 10.1016/0092-8674(94)90444-8; Sorefan K, 2009, NATURE, V459, P583, DOI 10.1038/nature07875; Stone BB, 2008, MOL PLANT, V1, P129, DOI 10.1093/mp/ssm013; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Wan YL, 2008, MOL PLANT, V1, P103, DOI 10.1093/mp/ssm011; WENT FW, 1974, ANNU REV PLANT PHYS, V25, P1, DOI 10.1146/annurev.pp.25.060174.000245; Whippo CW, 2006, PLANT CELL, V18, P1110, DOI 10.1105/tpc.105.039669; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Zadnikova P, 2010, DEVELOPMENT, V137, P607, DOI 10.1242/dev.041277	49	225	245	7	126	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2011	13	4					447	U222		10.1038/ncb2208	http://dx.doi.org/10.1038/ncb2208			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	744CK	21394084				2022-12-25	WOS:000289070900016
J	Veeravalli, K; Boyd, D; Iverson, BL; Beckwith, J; Georgiou, G				Veeravalli, Karthik; Boyd, Dana; Iverson, Brent L.; Beckwith, Jon; Georgiou, George			Laboratory evolution of glutathione biosynthesis reveals natural compensatory pathways	NATURE CHEMICAL BIOLOGY			English	Article							GLUTAMYL-TRANSFERASE KINASE; ESCHERICHIA-COLI; GAMMA-GLUTAMYL; PROLINE BIOSYNTHESIS; CRYSTAL-STRUCTURE; ACID KINASE; IDENTIFICATION; PEROXIDASE; BACTERIA; THIOL	The first and highly conserved step in glutathione (GSH) biosynthesis is formation of gamma-glutamyl cysteine by the enzyme glutamate-cysteine ligase (GshA). However, bioinformatic analysis revealed that many prokaryotic species that encode GSH-dependent proteins lack the gene for this enzyme. To understand how bacteria cope without gshA, we isolated Escherichia coli Delta gshA multigenic suppressors that accumulated physiological levels of GSH. Mutations in both proB and proA, the first two genes in L-proline biosynthesis, provided a new pathway for gamma-glutamyl cysteine formation via the selective interception of ProB-bound gamma-glutamyl phosphate by amino acid thiols, likely through an S-to-N acyl shift mechanism. Bioinformatic analysis suggested that the L-proline biosynthetic pathway may have a second role in gamma-glutamyl cysteine formation in prokaryotes. Also, we showed that this mechanism could be exploited to generate cytoplasmic redox buffers bioorthogonal to GSH.	[Veeravalli, Karthik; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Boyd, Dana; Beckwith, Jon] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Iverson, Brent L.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Iverson, Brent L.; Georgiou, George] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Harvard University; Harvard Medical School; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Veeravalli, K (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.	gg@che.utexas.edu			US National Institutes of Health [GMO41883, GM55090]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041883, R01GM055090] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Stone and M. Faulkner for discussions. This work was supported by US National Institutes of Health grant GMO41883 to J.B. and US National Institutes of Health grant GM55090 to G.G.	BAICH A, 1969, BIOCHIM BIOPHYS ACTA, V192, P462, DOI 10.1016/0304-4165(69)90395-X; Brenot A, 2004, INFECT IMMUN, V72, P408, DOI 10.1128/IAI.72.1.408-413.2004; FAHEY RC, 1978, J BACTERIOL, V133, P1126, DOI 10.1128/JB.133.3.1126-1129.1978; Faulkner MJ, 2008, P NATL ACAD SCI USA, V105, P6735, DOI 10.1073/pnas.0801986105; Fujita T, 2003, J BIOL CHEM, V278, P14203, DOI 10.1074/jbc.M212177200; HAYZER DJ, 1980, J GEN MICROBIOL, V118, P287; Lehmann C, 2004, PROTEINS, V56, P376, DOI 10.1002/prot.20103; Marco-Marin C, 2007, J MOL BIOL, V367, P1431, DOI 10.1016/j.jmb.2007.01.073; Masip L, 2006, ANTIOXID REDOX SIGN, V8, P753, DOI 10.1089/ars.2006.8.753; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; ODEN KL, 1994, MOL MICROBIOL, V12, P301, DOI 10.1111/j.1365-2958.1994.tb01018.x; OMORI K, 1992, J GEN MICROBIOL, V138, P693, DOI 10.1099/00221287-138-4-693; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; Perez-Arellano I, 2006, FEBS LETT, V580, P6247, DOI 10.1016/j.febslet.2006.10.031; RUSHLOW KE, 1985, GENE, V39, P109, DOI 10.1016/0378-1119(85)90115-5; SCHNOLZER M, 1992, SCIENCE, V256, P221, DOI 10.1126/science.1566069; SMITH CJ, 1984, J BACTERIOL, V157, P545, DOI 10.1128/JB.157.2.545-551.1984; Spector D, 2001, J BIOL CHEM, V276, P7011, DOI 10.1074/jbc.M009814200; Zhan XM, 2004, J BACTERIOL, V186, P654, DOI 10.1128/JB.186.3.654-660.2004	20	33	34	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2011	7	2					101	105		10.1038/NCHEMBIO.499	http://dx.doi.org/10.1038/NCHEMBIO.499			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	707XM	21186348	Green Accepted			2022-12-25	WOS:000286324600010
J	Engel, DR; Koscielny, A; Wehner, S; Maurer, J; Schiwon, M; Franken, L; Schumak, B; Limmer, A; Sparwasser, T; Hirner, A; Knolle, PA; Kalff, JC; Kurts, C				Engel, Daniel R.; Koscielny, Arne; Wehner, Sven; Maurer, Juliane; Schiwon, Marzena; Franken, Lars; Schumak, Beatrix; Limmer, Andreas; Sparwasser, Tim; Hirner, Andreas; Knolle, Percy A.; Kalff, Joerg C.; Kurts, Christian			T helper type 1 memory cells disseminate postoperative ileus over the entire intestinal tract	NATURE MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SMOOTH-MUSCLE DYSFUNCTION; NITRIC-OXIDE SYNTHASE; DENDRITIC CELLS; LAMINA-PROPRIA; RETINOIC-ACID; AUTOIMMUNE INFLAMMATION; RESIDENT MACROPHAGES; ABDOMINAL-SURGERY; ECONOMIC BURDEN	Localized abdominal surgery can lead to disruption of motility in the entire gastrointestinal tract (postoperative ileus). Intestinal macrophages produce mediators that paralyze myocytes, but it is unclear how the macrophages are activated, especially those in unmanipulated intestinal areas. Here we show that intestinal surgery activates intestinal CD103(+) CD11b(+) dendritic cells (DCs) to produce interleukin-12 (IL-12). This promotes interferon-gamma(IFN-gamma) secretion by CCR9(+) memory T helper type 1 (T(H)1) cells which activates the macrophages. IL-12 also caused some T(H)1 cells to migrate from surgically manipulated sites through the bloodstream to unmanipulated intestinal areas where they induced ileus. Preventing T cell migration with the drug FTY720 or inhibition of IL-12, T-bet (T(H)1-specific T box transcription factor) or IFN-gamma prevented postoperative ileus. CCR9(+) T(H)1 memory cells were detected in the venous blood of subjects 1 h after abdominal surgery. These findings indicate that postoperative ileus is a T(H)1 immune-mediated disease and identify potential targets for disease monitoring and therapy. (C) 2010 Nature America, Inc. All rights reserved.	[Koscielny, Arne; Wehner, Sven; Hirner, Andreas; Kalff, Joerg C.] Univ Bonn, Sch Med, Dept Surg, D-5300 Bonn, Germany; [Engel, Daniel R.; Maurer, Juliane; Schiwon, Marzena; Franken, Lars; Schumak, Beatrix; Limmer, Andreas; Knolle, Percy A.; Kurts, Christian] Univ Clin Bonn, Inst Mol Med, Bonn, Germany; [Engel, Daniel R.; Maurer, Juliane; Schiwon, Marzena; Franken, Lars; Schumak, Beatrix; Limmer, Andreas; Knolle, Percy A.; Kurts, Christian] Univ Clin Bonn, Inst Expt Immunol, Bonn, Germany; [Sparwasser, Tim] Twincore Res Ctr, Inst Infect Immunol, Hannover, Germany	University of Bonn; University of Bonn; University of Bonn; Helmholtz Association; Helmholtz-Center for Infection Research	Kalff, JC (corresponding author), Univ Bonn, Sch Med, Dept Surg, D-5300 Bonn, Germany.	kalff@uni-bonn.de; ckurts@web.de	Engel, Daniel Robert/C-5945-2013; Wehner, Sven/X-6326-2019; Sparwasser, Tim/AAF-7085-2019; Kalff, Joerg C/U-8580-2017; Sparwasser, Tim D/AAA-4306-2022; Koscielny, Arne/M-6185-2016	Engel, Daniel Robert/0000-0001-7301-353X; Sparwasser, Tim/0000-0001-5645-902X; Wehner, Sven/0000-0002-8632-7631; Knolle, Percy A./0000-0003-2983-0414	Institutes for Molecular Medicine and Experimental Immunology; Cooperative Clinical Research Center of Deutsche Forschungsgemeinschaft [Ka1270/9-1/2, Ku1063/4-1, KFO115]	Institutes for Molecular Medicine and Experimental Immunology; Cooperative Clinical Research Center of Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank M. Lysson for technical assistance, S. Hegenbarth for producing monoclonal antibodies and M. Forst for animal maintenance, and we acknowledge the support of the Central Animal Facilities and the Flow Cytometry Core Facility at the Institutes for Molecular Medicine and Experimental Immunology. D. R. E., S. W., J.C.K., A. K. and C. K. were supported by the Cooperative Clinical Research Center KFO115 of the Deutsche Forschungsgemeinschaft (Grants Ka1270/9-1/2 and Ku1063/4-1).	Ahern PP, 2008, IMMUNOL REV, V226, P147, DOI 10.1111/j.1600-065X.2008.00705.x; Barada KA, 2006, LIFE SCI, V79, P2032, DOI 10.1016/j.lfs.2006.06.047; Barquist E, 1996, AM J PHYSIOL-REG I, V270, pR888, DOI 10.1152/ajpregu.1996.270.4.R888; Bauer AJ, 2008, NEUROGASTROENT MOTIL, V20, P81, DOI 10.1111/j.1365-2982.2008.01105.x; Bauer Anthony J, 2002, Curr Opin Crit Care, V8, P152, DOI 10.1097/00075198-200204000-00011; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Boeckxstaens GE, 2009, GUT, V58, P1300, DOI 10.1136/gut.2008.169250; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Chirdo FG, 2005, EUR J IMMUNOL, V35, P1831, DOI 10.1002/eji.200425882; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Dardalhon V, 2008, J AUTOIMMUN, V31, P252, DOI 10.1016/j.jaut.2008.04.017; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; De Jonge WJ, 2003, GASTROENTEROLOGY, V125, P1137, DOI 10.1016/S0016-5085(03)01197-1; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Goldstein JL, 2007, P & T, V32, P82; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Heymann F, 2009, J CLIN INVEST, V119, P1286, DOI 10.1172/JCI38399; Hu JF, 2008, J IMMUNOL, V180, P6544, DOI 10.4049/jimmunol.180.10.6544; Iyer S, 2009, J MANAGE CARE PHARM, V15, P485, DOI 10.18553/jmcp.2009.15.6.485; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kalff JC, 1998, ANN SURG, V228, P652, DOI 10.1097/00000658-199811000-00004; Kalff JC, 1998, J LEUKOCYTE BIOL, V63, P683, DOI 10.1002/jlb.63.6.683; Kalff JC, 2000, GASTROENTEROLOGY, V118, P316, DOI 10.1016/S0016-5085(00)70214-9; Kunisawa J, 2007, J EXP MED, V204, P2335, DOI 10.1084/jem.20062446; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Ludwig-Portugall I, 2008, J IMMUNOL, V181, P4447, DOI 10.4049/jimmunol.181.7.4447; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Neurath MF, 2002, NAT MED, V8, P567, DOI 10.1038/nm0602-567; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Paust HJ, 2009, J AM SOC NEPHROL, V20, P969, DOI 10.1681/ASN.2008050556; Rescigno M, 2009, J CLIN INVEST, V119, P2441, DOI 10.1172/JCI39134; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schaefer N, 2007, AM J TRANSPLANT, V7, P1062, DOI 10.1111/j.1600-6143.2007.01747.x; Schafer N, 2008, TRANSPL INT, V21, P778, DOI 10.1111/j.1432-2277.2008.00676.x; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Schwarz NT, 2004, GASTROENTEROLOGY, V126, P159, DOI 10.1053/j.gastro.2003.10.060; Semmling V, 2010, NAT IMMUNOL, V11, P313, DOI 10.1038/ni.1848; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Tomita T, 2008, INFLAMM BOWEL DIS, V14, P1630, DOI 10.1002/ibd.20636; Turler A, 2006, ANN SURG, V244, P220, DOI 10.1097/01.sla.0000229963.37544.59; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Varol C, 2010, NAT REV IMMUNOL, V10, P415, DOI 10.1038/nri2778; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; WEHNER S, 2010, NAT PROTOC      1128, DOI DOI 10.1038/PROTEX.2010.1158; Wehner S, 2007, GUT, V56, P176, DOI 10.1136/gut.2005.089615; Wehner S, 2009, GASTROENTEROLOGY, V136, P619, DOI 10.1053/j.gastro.2008.10.017; Weigmann B, 2008, J EXP MED, V205, P2099, DOI 10.1084/jem.20072484; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404	60	78	85	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1407	U88		10.1038/nm.2255	http://dx.doi.org/10.1038/nm.2255			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21113155				2022-12-25	WOS:000285048900034
J	Palczewska, G; Maeda, T; Imanishi, Y; Sun, WY; Chen, Y; Williams, DR; Piston, DW; Maeda, A; Palczewski, K				Palczewska, Grazyna; Maeda, Tadao; Imanishi, Yoshikazu; Sun, Wenyu; Chen, Yu; Williams, David R.; Piston, David W.; Maeda, Akiko; Palczewski, Krzysztof			Noninvasive multiphoton fluorescence microscopy resolves retinol and retinal condensation products in mouse eyes	NATURE MEDICINE			English	Article							COMPLEMENT ACTIVATION; VISUAL FUNCTIONS; 2-PHOTON; EXCITATION; PIGMENT; CELLS; LIGHT; MODEL; FLUOROPHORES; ACCUMULATION	Multiphoton excitation fluorescence microscopy (MPM) can image certain molecular processes in vivo. In the eye, fluorescent retinyl esters in subcellular structures called retinosomes mediate regeneration of the visual chromophore, 11-cis-retinal, by the visual cycle. But harmful fluorescent condensation products of retinoids also occur in the retina. We report that in wild-type mice, excitation with a wavelength of similar to 730 nm identified retinosomes in the retinal pigment epithelium, and excitation with a wavelength of similar to 910 nm revealed at least one additional retinal fluorophore. The latter fluorescence was absent in eyes of genetically modified mice lacking a functional visual cycle, but accentuated in eyes of older wild-type mice and mice with defective clearance of all-trans-retinal, an intermediate in the visual cycle. MPM, a noninvasive imaging modality that facilitates concurrent monitoring of retinosomes along with potentially harmful products in aging eyes, has the potential to detect early molecular changes due to age-related macular degeneration and other defects in retinoid metabolism.	[Palczewska, Grazyna; Sun, Wenyu; Palczewski, Krzysztof] Polgenix, Cleveland, OH USA; [Maeda, Tadao; Maeda, Akiko] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Maeda, Tadao; Imanishi, Yoshikazu; Chen, Yu; Maeda, Akiko; Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Williams, David R.] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA; [Williams, David R.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Case Western Reserve University; Case Western Reserve University; University of Rochester; Vanderbilt University	Palczewski, K (corresponding author), Polgenix, Cleveland, OH USA.	gpalczewska@polgenixinc.com; kxp65@case.edu	Imanishi, Yoshikazu/E-8178-2010	Imanishi, Yoshikazu/0000-0003-4696-4836	US National Institutes of Health [EY008061, EY009339, EY019880, EY019031, EY020715, P30 EY11373]; State of Ohio Department of Development and Third Frontier Commission [TECH 09-004]; European Life Scientist Organization; Klaus Tschira Foundation; NATIONAL EYE INSTITUTE [R01EY008061, K08EY019031, P30EY011373, K08EY019880, R29EY008061, R01EY009339, R43EY020715] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Ohio Department of Development and Third Frontier Commission; European Life Scientist Organization; Klaus Tschira Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank M. Golczak for help during the course of this study and Z. Dong for expert handling of mice. We also thank L. T. Webster and members of Palczewski laboratory for critical comments on the manuscript. Rpe65<SUP>-/-</SUP> mice were a kind gift from M. Redmond ( US National Eye Institute). This research was supported in part by grants EY008061, EY009339, EY019880, EY019031, EY020715 and P30 EY11373 from the US National Institutes of Health, TECH 09-004 from the State of Ohio Department of Development and Third Frontier Commission, the European Life Scientist Organization and the Klaus Tschira Foundation.	Batten ML, 2005, PLOS MED, V2, P1177, DOI 10.1371/journal.pmed.0020333; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; DaCosta RS, 2005, CURR OPIN GASTROEN, V21, P70; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DRABENT R, 1997, J FLUORESC, V7, P347, DOI DOI 10.1023/A:1022594329601; Evgenov NV, 2006, NAT MED, V12, P144, DOI 10.1038/nm1316; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; Imanishi Y, 2004, J CELL BIOL, V166, P447, DOI 10.1083/jcb.200405110; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Imanishi Y, 2008, J BIOL CHEM, V283, P25091, DOI 10.1074/jbc.M802981200; Imanishi Y, 2007, BIOCHEMISTRY-US, V46, P9674, DOI 10.1021/bi701055g; Imanishi Y, 2010, METHODS MOL BIOL, V652, P247, DOI 10.1007/978-1-60327-325-1_14; Katz ML, 2001, INVEST OPHTH VIS SCI, V42, P3023; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kim JS, 2008, SCIENCE, V321, P1472, DOI 10.1126/science.1161517; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2009, INVEST OPHTH VIS SCI, V50, P5435, DOI 10.1167/iovs.09-3944; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Maeda T, 2009, INVEST OPHTH VIS SCI, V50, P322, DOI 10.1167/iovs.08-2301; Maiti S, 1997, SCIENCE, V275, P530, DOI 10.1126/science.275.5299.530; Piston DW, 1999, TRENDS CELL BIOL, V9, P66, DOI 10.1016/S0962-8924(98)01432-9; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Schenke-Layland K, 2006, ADV DRUG DELIVER REV, V58, P878, DOI 10.1016/j.addr.2006.07.004; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; So PTC, 2000, ANNU REV BIOMED ENG, V2, P399, DOI 10.1146/annurev.bioeng.2.1.399; Sparrow JR, 2010, J LIPID RES, V51, P247, DOI 10.1194/jlr.R000687; Sparrow JM, 1999, INVEST OPHTH VIS SCI, V40, pS195; Sparrow JR, 2002, INVEST OPHTH VIS SCI, V43, P1222; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Van Hooser JP, 2002, J BIOL CHEM, V277, P19173, DOI 10.1074/jbc.M112384200; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Wielgus AR, 2010, PHOTOCHEM PHOTOBIOL, V86, P781, DOI 10.1111/j.1751-1097.2010.00750.x; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; Xu C, 1996, J OPT SOC AM B, V13, P481, DOI 10.1364/JOSAB.13.000481; Zhang EZ, 2009, PHYS MED BIOL, V54, P1035, DOI 10.1088/0031-9155/54/4/014; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103; Zhou J, 2009, INVEST OPHTH VIS SCI, V50, P1392, DOI 10.1167/iovs.08-2868; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	40	59	60	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1444	U130		10.1038/nm.2260	http://dx.doi.org/10.1038/nm.2260			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21076393	Green Accepted			2022-12-25	WOS:000285048900040
J	Chen, SA; Bohrer, LR; Rai, AN; Pan, YQ; Gan, L; Zhou, XZ; Bagchi, A; Simon, JA; Huang, HJ				Chen, Shuai; Bohrer, Laura R.; Rai, Aswathy N.; Pan, Yunqian; Gan, Lu; Zhou, Xianzheng; Bagchi, Anindya; Simon, Jeffrey A.; Huang, Haojie			Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2	NATURE CELL BIOLOGY			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; H3 LYSINE-27 METHYLATION; DEVELOPMENTAL REGULATORS; POLYCOMB; EXPRESSION; CANCER; COMPLEXES; DIFFERENTIATION; PROLIFERATION; MECHANISMS	The Polycomb group (PcG) protein, enhancer of zeste homologue 2 (EZH2), has an essential role in promoting histone H3 lysine 27 trimethylation (H3K27me3) and epigenetic gene silencing(1-4). This function of EZH2 is important for cell proliferation and inhibition of cell differentiation, and is implicated in cancer progression(5-10). Here, we demonstrate that under physiological conditions, cyclin-dependent kinase 1 (CDK1) and cyclin-dependent kinase 2 (CDK2) phosphorylate EZH2 at Thr 350 in an evolutionarily conserved motif. Phosphorylation of Thr 350 is important for recruitment of EZH2 and maintenance of H3K27me3 levels at EZH2-target loci. Blockage of Thr 350 phosphorylation not only diminishes the global effect of EZH2 on gene silencing, it also mitigates EZH2-mediated cell proliferation and migration. These results demonstrate that CDK-mediated phosphorylation is a key mechanism governing EZH2 function and that there is a link between the cell-cycle machinery and epigenetic gene silencing.	[Chen, Shuai; Bohrer, Laura R.; Rai, Aswathy N.; Pan, Yunqian; Gan, Lu; Zhou, Xianzheng; Bagchi, Anindya; Simon, Jeffrey A.; Huang, Haojie] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Chen, Shuai; Bohrer, Laura R.; Pan, Yunqian; Gan, Lu; Huang, Haojie] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Rai, Aswathy N.; Simon, Jeffrey A.] Univ Minnesota, Biochem Mol Biol & Biophys Grad Program, Minneapolis, MN 55455 USA; [Zhou, Xianzheng] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Bagchi, Anindya; Simon, Jeffrey A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Huang, HJ (corresponding author), Univ Minnesota, Masonic Canc Ctr, 420 Delaware St SE, Minneapolis, MN 55455 USA.	haojie.huang@stonybrook.edu		Chen, Shuai/0000-0003-1280-018X	National Institutes of Health [CA134514, CA130908, GM49850]; Department of Defense [W81XWH-07-1-0137, W81XWH-09-1-622, W81XWH-07-1-0373]; University of Minnesota Masonic Cancer Center; NATIONAL CANCER INSTITUTE [R01CA134514, R01CA130908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); University of Minnesota Masonic Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank M. -C. Hung, Y. Zhang, H. Piwnica-Worms and L. Naldini for plasmids, R. A. Weinberg for BJ cells, K. Zhang for helping in the analysis of mass spectrometry data, and Z. Zhang for critical comments and suggestions. This work was supported in part by grants from the National Institutes of Health (CA134514 and CA130908 to H.H. and GM49850 to J.S.), the Department of Defense (W81XWH-07-1-0137 and W81XWH-09-1-622 to H.H. and W81XWH-07-1-0373 to J.S.), and a Brainstorm Award from University of Minnesota Masonic Cancer Center (to H.H.).	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Huang HJ, 2004, ONCOGENE, V23, P2161, DOI 10.1038/sj.onc.1207326; Huang X, 2008, MOL THER, V16, P580, DOI 10.1038/sj.mt.6300404; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu P, 2008, ONCOGENE, V27, P4733, DOI 10.1038/onc.2008.104; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; PETER M, 1990, CELL, V60, P791, DOI 10.1016/0092-8674(90)90093-T; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Yu J, 2007, CANCER CELL, V12, P419, DOI 10.1016/j.ccr.2007.10.016	38	188	199	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2010	12	11					1108	U118		10.1038/ncb2116	http://dx.doi.org/10.1038/ncb2116			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	674CO	20935635	Green Accepted			2022-12-25	WOS:000283711500015
J	Lo, EH				Lo, Eng H.			Degeneration and repair in central nervous system disease	NATURE MEDICINE			English	Article							CEREBRAL ENDOTHELIAL-CELLS; AMYLOID-BETA PEPTIDES; ALZHEIMERS-DISEASE; DOPAMINERGIC-NEURONS; NEUROVASCULAR NICHE; PHYSIOLOGICAL ROLES; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; MUTANT HUNTINGTIN; BLOOD-VESSELS	Divergent disease triggers in neurodegeneration may induce convergent endogenous pathways in neuronal, glial and vascular elements as the central nervous system (CNS) attempts to compensate, remodel and recover. Dissecting these multicellular mechanisms and the integrative responses in cerebral blood flow and metabolism may allow us to understand the balance between injury and repair, validate new targets and define therapeutic time windows for neurodegeneration.	[Lo, Eng H.] Massachusetts Gen Hosp, Dept Neurol, Neuroprotect Res Lab, Boston, MA 02114 USA; [Lo, Eng H.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Lo, Eng H.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lo, EH (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Neuroprotect Res Lab, Boston, MA 02114 USA.	lo@helix.mgh.harvard.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055104] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS055104] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Agosta F, 2010, HUM BRAIN MAPP, V31, P515, DOI 10.1002/hbm.20883; Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x; Arai K, 2009, J NEUROSCI, V29, P4351, DOI 10.1523/JNEUROSCI.0035-09.2009; Barcia C, 2004, FRONT BIOSCI-LANDMRK, V9, P277, DOI 10.2741/1145; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Betarbet R, 1997, J NEUROSCI, V17, P6761; BLANCHARD V, 1995, J NEUROCHEM, V64, P1669; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bradford J, 2010, J BIOL CHEM, V285, P10653, DOI 10.1074/jbc.M109.083287; Cantara S, 2004, FASEB J, V18, P1943, DOI 10.1096/fj.04-2114fje; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Desai BS, 2009, J NEURAL TRANSM, V116, P587, DOI 10.1007/s00702-009-0226-9; Dugas JC, 2008, J NEUROSCI, V28, P8294, DOI 10.1523/JNEUROSCI.2010-08.2008; Fisher M, 2009, STROKE, V40, pE288, DOI 10.1161/STROKEAHA.109.551820; Fotuhi M, 2009, NAT REV NEUROL, V5, P649, DOI 10.1038/nrneurol.2009.175; Garbuzova-Davis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001205; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gu XF, 2005, NEURON, V46, P433, DOI 10.1016/j.neuron.2005.03.025; Guo SZ, 2008, P NATL ACAD SCI USA, V105, P7582, DOI 10.1073/pnas.0801105105; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Holley JE, 2010, NEUROSCI LETT, V470, P65, DOI 10.1016/j.neulet.2009.12.059; Huot P, 2007, BRAIN, V130, P222, DOI 10.1093/brain/awl332; HYMAN BT, 1987, ANN NEUROL, V21, P259, DOI 10.1002/ana.410210307; Iacono D, 2009, NEUROLOGY, V73, P665, DOI 10.1212/WNL.0b013e3181b01077; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Iadecola C, 2003, CELL MOL NEUROBIOL, V23, P681, DOI 10.1023/A:1025092617651; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Jin HK, 2009, CELL PROLIFERAT, V42, P571, DOI 10.1111/j.1365-2184.2009.00625.x; Koch P, 2009, LANCET NEUROL, V8, P819, DOI 10.1016/S1474-4422(09)70202-9; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Lazarov O, 2010, EXP NEUROL, V223, P267, DOI 10.1016/j.expneurol.2009.08.009; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; Leuba G, 2008, NEUROBIOL DIS, V30, P408, DOI 10.1016/j.nbd.2008.02.012; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Madri JA, 2009, J PHYSIOL PHARMACOL, V60, P95; Marlatt MW, 2010, CURR ALZHEIMER RES, V7, P113, DOI 10.2174/156720510790691362; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pearson HA, 2006, J PHYSIOL-LONDON, V575, P5, DOI 10.1113/jphysiol.2006.111203; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Porritt MJ, 2000, LANCET, V356, P44, DOI 10.1016/S0140-6736(00)02437-5; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Tande D, 2006, BRAIN, V129, P1194, DOI 10.1093/brain/awl041; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; Vagnucci AH, 2003, LANCET, V361, P605, DOI 10.1016/S0140-6736(03)12521-4; Varga AW, 2009, J NEUROL SCI, V282, P28, DOI 10.1016/j.jns.2008.12.036; Waetzig V, 2006, PROG NEUROBIOL, V80, P84, DOI 10.1016/j.pneurobio.2006.08.002; Wang Y, 2010, NEURODEGENER DIS, V7, P103, DOI 10.1159/000285516; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Zacchigna S, 2008, NAT REV NEUROSCI, V9, P169, DOI 10.1038/nrn2336; Zahs KR, 2010, TRENDS NEUROSCI, V33, P381, DOI 10.1016/j.tins.2010.05.004; Zhang M, 2008, J NEUROSCI RES, V86, P2848, DOI 10.1002/jnr.21730; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	65	86	92	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2010	16	11					1205	1209		10.1038/nm.2226	http://dx.doi.org/10.1038/nm.2226			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21052074	Green Accepted			2022-12-25	WOS:000283860100026
J	Ramachandran, R; Fausett, BV; Goldman, D				Ramachandran, Rajesh; Fausett, Blake V.; Goldman, Daniel			Ascl1a regulates Muller glia dedifferentiation and retinal regeneration through a Lin-28-dependent, let-7 microRNA signalling pathway	NATURE CELL BIOLOGY			English	Article							NEURONAL PROGENITORS; NEURAL REGENERATION; PHOTORECEPTOR; EXPRESSION; IDENTIFICATION; PROLIFERATION; INHIBITION	Unlike mammals, teleost fish mount a robust regenerative response to retinal injury that culminates in restoration of visual function(1,2). This regenerative response relies on dedifferentiation of Muller glia into a cycling population of progenitor cells. However, the mechanism underlying this dedifferentiation is unknown. Here, we report that genes encoding pluripotency factors are induced following retinal injury. Interestingly, the proneural transcription factor, Ascl1a, and the pluripotency factor, Lin-28, are induced in Muller glia within 6 h following retinal injury and are necessary for Muller glia dedifferentiation. We demonstrate that Ascl1a is necessary for lin-28 expression and that Lin-28 suppresses let-7 microRNA (miRNA) expression. Furthermore, we demonstrate that let-7 represses expression of regeneration-associated genes such as, ascl1a, hspd1, lin-28, oct4, pax6b and c-myc. hspd1, oct4 and c-myc(a) exhibit basal expression in the uninjured retina and let-7 may inhibit this expression to prevent premature Muller glia dedifferentiation. The opposing actions of Lin-28 and let-7 miRNAs on Muller glia differentiation and dedifferentiation are similar to that of embryonic stem cells(3) and suggest novel targets for stimulating Muller glia dedifferentiation and retinal regeneration in mammals.	[Ramachandran, Rajesh; Fausett, Blake V.; Goldman, Daniel] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Ramachandran, Rajesh; Fausett, Blake V.; Goldman, Daniel] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Goldman, D (corresponding author), Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.	neuroman@umich.edu		Ramachandran, Rajesh/0000-0002-9888-4750	NIH NEI [RO1 EY018132]; NIH NICHD [T32HD007507]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007507] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018132] Funding Source: NIH RePORTER	NIH NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Hyde for sharing gfap:gfp transgenic fish, R. Thompson, D. Turner and M. Uhler for sharing expression vectors and reagents, J. Beals for help with confocal microscopy, the UM Flow Cytometry Core for help purifying GFP-labelled Muller glia, V. Kapuria for help with western blots; B. R. Wilfred and D. Turner for advice on miRNAs, P. Macpherson for help with statistics, T. Melendez for expert care of fish and D. Turner, J. Parent and members of the Goldman lab for their support and comments on this work. This work was supported by funds from the NIH NEI RO1 EY018132 (to DG.) and NIH NICHD T32HD007507 (to R.R.).	Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Fausett BV, 2008, J NEUROSCI, V28, P1109, DOI 10.1523/JNEUROSCI.4853-07.2008; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Jadhav AP, 2009, PROG RETIN EYE RES, V28, P249, DOI 10.1016/j.preteyeres.2009.05.002; Jowett T, 2001, METHODS, V23, P345, DOI 10.1006/meth.2000.1147; Karl MO, 2008, P NATL ACAD SCI USA, V105, P19508, DOI 10.1073/pnas.0807453105; Kassen SC, 2007, DEV NEUROBIOL, V67, P1009, DOI 10.1002/dneu.20362; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Li J, 2006, BIOCHEM BIOPH RES CO, V350, P648, DOI 10.1016/j.bbrc.2006.09.114; Lindeman LC, 2009, METHODS MOL BIOL, V567, P75, DOI 10.1007/978-1-60327-414-2_5; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mensinger AF, 1999, VISUAL NEUROSCI, V16, P241, DOI 10.1017/S0952523899162059; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nimmo RA, 2009, CHROMOSOMA, V118, P405, DOI 10.1007/s00412-009-0210-z; Ooto Sotaro, 2006, Nippon Ganka Gakkai Zasshi, V110, P864; Qin Z, 2009, P NATL ACAD SCI USA, V106, P9310, DOI 10.1073/pnas.0811186106; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Senut MC, 2004, J NEUROSCI, V24, P7663, DOI 10.1523/JNEUROSCI.2281-04.2004; Sherpa T, 2008, DEV NEUROBIOL, V68, P166, DOI 10.1002/dneu.20568; Takeda M, 2008, INVEST OPHTH VIS SCI, V49, P1142, DOI 10.1167/iovs.07-0434; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; Thummel R, 2008, EXP EYE RES, V87, P433, DOI 10.1016/j.exer.2008.07.009; Thummel R, 2008, DEV NEUROBIOL, V68, P392, DOI 10.1002/dneu.20596; Thummel R, 2010, EXP EYE RES, V90, P572, DOI 10.1016/j.exer.2010.02.001; Trimarchi JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001588; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wan J, 2008, VISION RES, V48, P223, DOI 10.1016/j.visres.2007.11.002; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; ZUPANC GKH, 1995, J COMP NEUROL, V353, P213, DOI 10.1002/cne.903530205	40	245	257	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2010	12	11					1101	U106		10.1038/ncb2115	http://dx.doi.org/10.1038/ncb2115			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	674CO	20935637	Green Accepted			2022-12-25	WOS:000283711500014
J	[Anonymous]				[Anonymous]			The persistence of memory	NATURE MEDICINE			English	Editorial Material							PLURIPOTENT STEM-CELLS											Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Loh KM, 2010, CELL STEM CELL, V7, P137, DOI 10.1016/j.stem.2010.07.005; McLean CA, 2010, ANIM REPROD SCI, V118, P388, DOI 10.1016/j.anireprosci.2009.06.017; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017	6	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2010	16	10					1082	1083		10.1038/nm1010-1082	http://dx.doi.org/10.1038/nm1010-1082			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20930747				2022-12-25	WOS:000282644800032
J	Lee, BD; Shin, JH; VanKampen, J; Petrucelli, L; West, AB; Ko, HS; Lee, YI; Maguire-Zeiss, KA; Bowers, WJ; Federoff, HJ; Dawson, VL; Dawson, TM				Lee, Byoung Dae; Shin, Joo-Ho; VanKampen, Jackalina; Petrucelli, Leonard; West, Andrew B.; Ko, Han Seok; Lee, Yun-Il; Maguire-Zeiss, Kathleen A.; Bowers, William J.; Federoff, Howard J.; Dawson, Valina L.; Dawson, Ted M.			Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease	NATURE MEDICINE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; NEURONAL TOXICITY; LRRK2; PHOSPHORYLATION	Leucine-rich repeat kinase-2 (LRRK2) mutations are a common cause of Parkinson's disease. Here we identify inhibitors of LRRK2 kinase that are protective in in vitro and in vivo models of LRRK2-induced neurodegeneration. These results establish that LRRK2-induced degeneration of neurons in vivo is kinase dependent and that LRRK2 kinase inhibition provides a potential new neuroprotective paradigm for the treatment of Parkinson's disease.	[Lee, Byoung Dae; Shin, Joo-Ho; West, Andrew B.; Ko, Han Seok; Lee, Yun-Il; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat Program, Baltimore, MD 21218 USA; [Lee, Byoung Dae; Shin, Joo-Ho; West, Andrew B.; Ko, Han Seok; Lee, Yun-Il; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD USA; [Lee, Byoung Dae; Shin, Joo-Ho; West, Andrew B.; Ko, Han Seok; Lee, Yun-Il; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [VanKampen, Jackalina; Petrucelli, Leonard] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; [Maguire-Zeiss, Kathleen A.] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Bowers, William J.] Univ Rochester, Med Ctr, Dept Neurol, Ctr Neural Dev & Dis, Rochester, NY 14642 USA; [Federoff, Howard J.] Georgetown Univ, Med Ctr, Off Execut Vice President & Execut Dean, Washington, DC 20007 USA; [Federoff, Howard J.] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA; [Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Mayo Clinic; Georgetown University; University of Rochester; Georgetown University; Georgetown University; Johns Hopkins University; Johns Hopkins University	Dawson, TM (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat Program, Baltimore, MD 21218 USA.	vdawson@jhmi.edu; tdawson@jhmi.edu	Dawson, Valina/Y-9757-2019; Shin, Joo-Ho/P-1417-2018	West, Andrew/0000-0002-3034-4061; Dawson, Valina/0000-0002-2915-3970	US National Institutes of Health [P50NS38377, R01ES014470, R01-AG023593, R00-NS058111, NS36420]; Army Medical Research and Materiel Command [DAMD17-02-1-0695]; Mayo Foundation; Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038377, R00NS058111, R01NS036420, R01NS064934, RC2NS069450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023593] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Mayo Foundation; Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Burris and L. Lotta for packaging helper virus-free amplicons. C. Cook, K. Kehoe, J. Dunmore and C. Eckman provided technical support for some of the in vivo HSV studies. We also thank G. and K. Caldwell and S. Hamamichi for helpful discussions. This work was supported by grants from the US National Institutes of Health, P50NS38377, R01ES014470 (K.A.M.-Z.), R01-AG023593 (W. J. B.), R00-NS058111 (A. B. W.), NS36420 (H. J. F.) and Army Medical Research and Materiel Command, DAMD17-02-1-0695 (H. J. F.), the Mayo Foundation and the Michael J. Fox Foundation.	Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; Chin PC, 2004, J NEUROCHEM, V90, P595, DOI 10.1111/j.1471-4159.2004.02530.x; Covy JP, 2009, BIOCHEM BIOPH RES CO, V378, P473, DOI 10.1016/j.bbrc.2008.11.048; GASSER T, 2009, MOL MED, V11, pE22; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Leclerc S, 2001, J BIOL CHEM, V276, P251, DOI 10.1074/jbc.M002466200; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Reichling LJ, 2009, BIOCHEM BIOPH RES CO, V384, P255, DOI 10.1016/j.bbrc.2009.04.098; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Wang WY, 2007, NEUROPHARMACOLOGY, V52, P1678, DOI 10.1016/j.neuropharm.2007.03.017; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Whaley NR, 2006, J NEURAL TRANSM-SUPP, P221	15	285	297	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2010	16	9					998	1000		10.1038/nm.2199	http://dx.doi.org/10.1038/nm.2199			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20729864	Green Accepted, Green Submitted			2022-12-25	WOS:000281622900028
J	Gomes, LC; Di Benedetto, G; Scorrano, L				Gomes, Ligia C.; Di Benedetto, Giulietta; Scorrano, Luca			During autophagy mitochondria elongate, are spared from degradation and sustain cell viability	NATURE CELL BIOLOGY			English	Article							DEPENDENT PROTEIN-KINASE; ENDOPLASMIC-RETICULUM; ATP SYNTHESIS; CYTOCHROME-C; FISSION; DRP1; FUSION; REQUIRES; DYNAMICS; PATHWAY	A plethora of cellular processes, including apoptosis, depend on regulated changes in mitochondrial shape and ultrastructure. The role of mitochondria and of their morphology during autophagy, a bulk degradation and recycling process of eukaryotic cells' constituents, is not well understood. Here we show that mitochondrial morphology determines the cellular response to macroautophagy. When autophagy is triggered, mitochondria elongate in vitro and in vivo. During starvation, cellular cyclic AMP levels increase and protein kinase A (PKA) is activated. PKA in turn phosphorylates the pro-fission dynamin-related protein 1 (DRP1), which is therefore retained in the cytoplasm, leading to unopposed mitochondria! fusion. Elongated mitochondria are spared from autophagic degradation, possess more cristae, increased levels of dimerization and activity of ATP synthase, and maintain ATP production. Conversely, when elongation is genetically or pharmacologically blocked, mitochondria consume ATP, precipitating starvation-induced death. Thus, regulated changes in mitochondrial morphology determine the fate of the cell during autophagy.	[Gomes, Ligia C.; Scorrano, Luca] Dulbecco Telethon Inst, I-35129 Padua, Italy; [Gomes, Ligia C.; Di Benedetto, Giulietta; Scorrano, Luca] Venetian Inst Mol Med, I-35129 Padua, Italy; [Gomes, Ligia C.] Univ Coimbra, PhD Programme Expt Biol & Biomed, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; [Di Benedetto, Giulietta] CNR Inst Neurosci, Sect Padova, I-35129 Padua, Italy; [Scorrano, Luca] Univ Geneva, Dept Cell Physiol & Med, CH-1211 Geneva, Switzerland	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; Universidade de Coimbra; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Geneva	Scorrano, L (corresponding author), Dulbecco Telethon Inst, Via Orus 2, I-35129 Padua, Italy.	luca.scorrano@unige.ch	Di Benedetto, Giulietta/L-9842-2019; Scorrano, Luca/A-6652-2008; Scorrano, Luca/K-3967-2019	Di Benedetto, Giulietta/0000-0002-1489-3896; Scorrano, Luca/0000-0002-8515-8928; Scorrano, Luca/0000-0002-8515-8928	'Bolsa de Doutoramento' of the 'Fundacao para a Ciencia e Tecnologia', Portugal; Telethon Italy [S02016]; AIRC Italy; Swiss National Foundation SNF [31-118171]	'Bolsa de Doutoramento' of the 'Fundacao para a Ciencia e Tecnologia', Portugal; Telethon Italy(Fondazione Telethon); AIRC Italy(Fondazione AIRC per la ricerca sul cancro); Swiss National Foundation SNF(Swiss National Science Foundation (SNSF))	L.C.G. is the recipient of a 'Bolsa de Doutoramento' of the 'Fundacao para a Ciencia e Tecnologia', Portugal. L.S. is a Senior Telethon Scientist of the Dulbecco-Telethon Institute. This research was supported by Telethon Italy S02016, AIRC Italy, Swiss National Foundation SNF 31-118171. We thank D. Chan, K. Mihara, C. Blackstone and N. Mizushima for reagents and T. Pozzan for helpful discussions on mitochondrially targeted luciferase calibration.	Alirol E, 2006, MOL BIOL CELL, V17, P4593, DOI 10.1091/mbc.E06-05-0377; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86; BROWN GC, 1992, BIOCHEM J, V284, P1; Budovskaya YV, 2004, J BIOL CHEM, V279, P20663, DOI 10.1074/jbc.M400272200; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Cereghetti GM, 2010, CELL DEATH DIFFER, V17, P1785, DOI 10.1038/cdd.2010.61; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Costa V, 2010, EMBO MOL MED, V2, P490, DOI 10.1002/emmm.201000102; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Giraud MF, 2002, BBA-BIOENERGETICS, V1555, P174, DOI 10.1016/S0005-2728(02)00274-8; Gomes LC, 2008, BBA-BIOENERGETICS, V1777, P860, DOI 10.1016/j.bbabio.2008.05.442; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; Mavrakis M, 2006, HUM MOL GENET, V15, P2962, DOI 10.1093/hmg/ddl239; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Mopert K, 2009, EXP CELL RES, V315, P2165, DOI 10.1016/j.yexcr.2009.04.016; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Pan XW, 1999, MOL CELL BIOL, V19, P4874; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rich P, 2003, NATURE, V421, P583, DOI 10.1038/421583a; Santel A, 2001, J CELL SCI, V114, P867; Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Slattery MG, 2008, EUKARYOT CELL, V7, P358, DOI 10.1128/EC.00334-07; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; TUTTLE DL, 1993, EUR J CELL BIOL, V60, P283; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; UNGER RH, 1985, DIABETOLOGIA, V28, P574, DOI 10.1007/BF00281991; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	64	1148	1162	3	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY 11	2011	13	5					589	U207		10.1038/ncb2220	http://dx.doi.org/10.1038/ncb2220			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	758FY	21478857	Green Accepted			2022-12-25	WOS:000290148700018
J	Giardine, B; Borg, J; Higgs, DR; Peterson, KR; Philipsen, S; Maglott, D; Singleton, BK; Anstee, DJ; Basak, AN; Clark, B; Costa, FC; Faustino, P; Fedosyuk, H; Felice, AE; Francina, A; Galanello, R; Gallivan, MVE; Georgitsi, M; Gibbons, RJ; Giordano, PC; Harteveld, CL; Hoyer, JD; Jarvis, M; Joly, P; Kanavakis, E; Kollia, P; Menzel, S; Miller, W; Moradkhani, K; Old, J; Papachatzopoulou, A; Papadakis, MN; Papadopoulos, P; Pavlovic, S; Perseu, L; Radmilovic, M; Riemer, C; Satta, S; Schrijver, I; Stojiljkovic, M; Thein, SL; Traeger-Synodinos, J; Tully, R; Wada, T; Waye, JS; Wiemann, C; Zukic, B; Chui, DHK; Wajcman, H; Hardison, RC; Patrinos, GP				Giardine, Belinda; Borg, Joseph; Higgs, Douglas R.; Peterson, Kenneth R.; Philipsen, Sjaak; Maglott, Donna; Singleton, Belinda K.; Anstee, David J.; Basak, A. Nazli; Clark, Barnaby; Costa, Flavia C.; Faustino, Paula; Fedosyuk, Halyna; Felice, Alex E.; Francina, Alain; Galanello, Renzo; Gallivan, Monica V. E.; Georgitsi, Marianthi; Gibbons, Richard J.; Giordano, Piero C.; Harteveld, Cornelis L.; Hoyer, James D.; Jarvis, Martin; Joly, Philippe; Kanavakis, Emmanuel; Kollia, Panagoula; Menzel, Stephan; Miller, Webb; Moradkhani, Kamran; Old, John; Papachatzopoulou, Adamantia; Papadakis, Manoussos N.; Papadopoulos, Petros; Pavlovic, Sonja; Perseu, Lucia; Radmilovic, Milena; Riemer, Cathy; Satta, Stefania; Schrijver, Iris; Stojiljkovic, Maja; Thein, Swee Lay; Traeger-Synodinos, Jan; Tully, Ray; Wada, Takahito; Waye, John S.; Wiemann, Claudia; Zukic, Branka; Chui, David H. K.; Wajcman, Henri; Hardison, Ross C.; Patrinos, George P.			Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the microattribution approach	NATURE GENETICS			English	Article							SICKLE-CELL-ANEMIA; FACTOR KLF1 CAUSES; FETAL-HEMOGLOBIN; ALPHA-THALASSEMIA; MUTATIONS; GLOBIN; VARIANTS; DATABASE; ERYTHROPOIESIS; DETERMINANTS	We developed a series of interrelated locus-specific databases to store all published and unpublished genetic variation related to hemoglobinopathies and thalassemia and implemented microattribution to encourage submission of unpublished observations of genetic variation to these public repositories. A total of 1,941 unique genetic variants in 37 genes, encoding globins and other erythroid proteins, are currently documented in these databases, with reciprocal attribution of microcitations to data contributors. Our project provides the first example of implementing microattribution to incentivise submission of all known genetic variation in a defined system. It has demonstrably increased the reporting of human variants, leading to a comprehensive online resource for systematically describing human genetic variation in the globin genes and other genes contributing to hemoglobinopathies and thalassemias. The principles established here will serve as a model for other systems and for the analysis of other common and/or complex human genetic diseases.	[Georgitsi, Marianthi; Patrinos, George P.] Univ Patras, Dept Pharm, Sch Hlth Sci, Patras, Greece; [Giardine, Belinda; Miller, Webb; Riemer, Cathy; Hardison, Ross C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, Philadelphia, PA USA; [Borg, Joseph] Univ Malta, Dept Appl Biomed Sci, Msida, Malta; [Borg, Joseph; Felice, Alex E.] Univ Malta, Dept Physiol & Biochem, Lab Mol Genet, Msida, Malta; [Borg, Joseph; Felice, Alex E.] Mater Dei Hosp, Sect Pathol, Thalassemia Clin, Msida, Malta; [Higgs, Douglas R.; Gibbons, Richard J.] Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford, England; [Peterson, Kenneth R.; Costa, Flavia C.; Fedosyuk, Halyna] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA; [Philipsen, Sjaak; Papadopoulos, Petros] Erasmus Univ, Fac Med & Hlth Sci, Med Ctr, Dept Cell Biol, NL-3000 DR Rotterdam, Netherlands; [Maglott, Donna; Tully, Ray] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Singleton, Belinda K.; Anstee, David J.] Bristol Inst Transfus Sci BITS, Natl Hlth Serv NHS Blood & Transplant, Bristol, Avon, England; [Basak, A. Nazli] Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey; [Clark, Barnaby; Menzel, Stephan; Thein, Swee Lay] Kings Coll London, London WC2R 2LS, England; [Faustino, Paula] Inst Nacl Saude Dr Ricardo Jorge, Unidade Invest & Desenvolvimento, Dept Genet, Lisbon, Portugal; [Francina, Alain; Joly, Philippe] Edouard Herriot Univ Hosp, Dept Biochem, Lyon, France; [Galanello, Renzo; Satta, Stefania] Univ Cagliari, Dipartimento Sci Biomed & Biotecnol, Cagliari, Sardinia, Italy; [Gallivan, Monica V. E.] Quest Diagnost Nichols Inst, Chantilly, VA USA; [Giordano, Piero C.; Harteveld, Cornelis L.] Leiden Univ, Hemoglobinopathies Lab, Human & Clin Genet Dept, Med Ctr, Leiden, Netherlands; [Hoyer, James D.] Mayo Clin, Div Hematopathol, Rochester, MN USA; [Jarvis, Martin] N Middlesex Univ Hosp, London, England; [Kanavakis, Emmanuel; Traeger-Synodinos, Jan] Univ Athens, Sch Med, St Sophias Childrens Hosp, Athens 11528, Greece; [Kollia, Panagoula] Univ Athens, Dept Biol, Sch Phys Sci, Athens 11528, Greece; [Moradkhani, Kamran; Wajcman, Henri] Hosp Henri Mondor, Creteil, France; [Moradkhani, Kamran; Wajcman, Henri] Albert Chenevier Grp, Dept Biochem & Genet, Cretile, France; [Old, John] Churchill Hosp, Natl Haemoglobinopathy Reference Lab, Oxford Haemophilia Ctr, Oxford OX3 7LJ, England; [Papachatzopoulou, Adamantia] Univ Patras, Fac Med, Lab Gen Biol, Patras, Greece; [Papadakis, Manoussos N.] Laikon Gen Hosp, Unit Prenatal Diag, Ctr Thalassemia, Athens, Greece; [Pavlovic, Sonja; Radmilovic, Milena; Stojiljkovic, Maja; Zukic, Branka] Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia; [Perseu, Lucia] Ist Neurogenet & Neurofarmacol, Natl Res Council, Cagliari, Sardinia, Italy; [Schrijver, Iris] Stanford Univ, Sch Med, Dept Pathol & Pediat, Stanford, CA 94305 USA; [Wada, Takahito] Kanagawa Childrens Med Ctr, Div Neurol, Kanagawa, Japan; [Waye, John S.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Waye, John S.] Hamilton Reg Lab Program, Hamilton, ON, Canada; [Wiemann, Claudia] Med Versorgungszentrum MVZ, Lab Prof Seelig, Karlsruhe, Germany; [Chui, David H. K.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Chui, David H. K.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [Wajcman, Henri] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Hardison, Ross C.] Penn State Univ, Dept Biochem & Mol Biol, Philadelphia, PA USA	University of Patras; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Malta; University of Malta; University of Oxford; University of Kansas; University of Kansas Medical Center; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Bogazici University; University of London; King's College London; Instituto Nacional de Saude Dr. Ricardo Jorge; CHU Lyon; University of Cagliari; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Mayo Clinic; Athens Medical School; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; University of Oxford; University of Patras; Laiko General Hospital; University of Belgrade; Stanford University; McMaster University; Boston University; Boston University; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Patrinos, GP (corresponding author), Univ Patras, Dept Pharm, Sch Hlth Sci, Patras, Greece.	gpatrinos@upatras.gr	Faustino, Paula/E-4546-2010; Traeger-Synodinos, J/E-4283-2010; Papadopoulos, Petros/B-1913-2015; Anstee, David/AAE-9231-2020; Hardison, Ross C/G-1142-2010; Stojiljkovic, Maja M/A-4888-2013; WADA, Takahito/GYR-3028-2022; Menzel, Stephan/U-6906-2019; Wiemann, Claudia/B-1746-2010	Faustino, Paula/0000-0002-6269-4867; Traeger-Synodinos, J/0000-0002-1860-5628; Papadopoulos, Petros/0000-0002-8342-329X; Hardison, Ross C/0000-0003-4084-7516; Higgs, Douglas/0000-0003-3579-8705; Felice, Alex/0000-0003-0015-3923; Ugrin, Milena/0000-0002-7464-9406; Chui, David/0000-0002-1475-7309; Borg, Joseph/0000-0002-2220-5651; Menzel, Stephan/0000-0002-1590-9108; Georgitsi, Marianthi/0000-0002-0354-0913	Netherlands Genomics Initiative (NGI), Erasmus MC (MRace) [296088]; Landsteiner Foundation for Blood Transfusion Research (LSBR) [1040]; US National Institutes of Health (NIH) [R01-HL073455]; Netherlands Scientific Organization [NWO DN 82-301, 912-07-019]; NIH [R01 DK065806, RC HG005573, U01 HG004695]; National Institutes for Health Research Biomedical Research Centre (Oxford); European Commission [FP6-026539, FP7-200754]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073455] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004695, RC2HG005573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065806] Funding Source: NIH RePORTER; Medical Research Council [G1000801j, G0000111, G1000801b, MC_U137961147] Funding Source: researchfish; MRC [MC_U137961147, G0000111] Funding Source: UKRI	Netherlands Genomics Initiative (NGI), Erasmus MC (MRace); Landsteiner Foundation for Blood Transfusion Research (LSBR); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Scientific Organization; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes for Health Research Biomedical Research Centre (Oxford); European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Netherlands Genomics Initiative (NGI), Erasmus MC (MRace; 296088), the Landsteiner Foundation for Blood Transfusion Research (LSBR; 1040), US National Institutes of Health (NIH) (R01-HL073455) and the Netherlands Scientific Organization (NWO DN 82-301 and 912-07-019) to S.P., the NIH grants R01 DK065806, RC HG005573 and U01 HG004695 to R.C.H., the National Institutes for Health Research Biomedical Research Centre (Oxford) to D.R.H. and European Commission grants (FP6-026539 (ITHANET), FP7-200754 (GEN2PHEN)) to G.P.P.	Amoyal I, 2004, CLIN LAB HAEMATOL, V26, P187, DOI 10.1111/j.1365-2257.2004.00606.x; [Anonymous], 2008, NAT GENET, V40, P1, DOI 10.1038/ng0108-1; Arnaud L, 2010, AM J HUM GENET, V87, P721, DOI 10.1016/j.ajhg.2010.10.010; Bohmer RM, 2001, METHOD CELL BIOL, V64, P139; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; Borg J, 2009, CLIN BIOCHEM, V42, P1839, DOI 10.1016/j.clinbiochem.2009.07.014; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; Fokkema IFAC, 2005, HUM MUTAT, V26, P63, DOI 10.1002/humu.20201; Gibbons RJ, 2003, NAT GENET, V34, P446, DOI 10.1038/ng1213; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Hardison RC, 2002, HUM MUTAT, V19, P225, DOI 10.1002/humu.10044; Harju S, 2005, MOL CELL BIOL, V25, P8765, DOI 10.1128/MCB.25.20.8765-8778.2005; Harju-Baker S, 2008, MOL CELL BIOL, V28, P3101, DOI 10.1128/MCB.01858-07; Heruth DP, 2010, GENOMICS, V96, P303, DOI 10.1016/j.ygeno.2010.07.009; Ma Q, 2007, PHARMACOGENOMICS J, V7, P386, DOI 10.1038/sj.tpj.6500433; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Moradkhani K, 2009, ANN HEMATOL, V88, P535, DOI 10.1007/s00277-008-0624-3; Papadakis MN, 1996, HUM GENET, V97, P260, DOI 10.1007/BF02265278; Patrinos GP, 2008, HEMOGLOBIN, V32, P229, DOI 10.1080/03630260701680367; Patrinos GP, 2004, HEMOGLOBIN, V28, pV, DOI 10.1081/HEM-120034249; Patrinos GP, 2004, NUCLEIC ACIDS RES, V32, pD537, DOI 10.1093/nar/gkh006; PATRINOS GP, 2010, HUMAN GENETICS PROBL, P366; PETERSON KR, 1995, P NATL ACAD SCI USA, V92, P5655, DOI 10.1073/pnas.92.12.5655; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Siatecka M, 2010, P NATL ACAD SCI USA, V107, P15151, DOI 10.1073/pnas.1004996107; Singleton BK, 2008, BLOOD, V112, P2081, DOI 10.1182/blood-2008-03-145672; Singleton BK, 2009, BLOOD, V114, P72; Steensma DP, 2005, BLOOD, V105, P443, DOI 10.1182/blood-2004-07-2792; Steinberg MH, 1997, BLOOD, V89, P1078, DOI 10.1182/blood.V89.3.1078; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; Viprakasit V, 2001, HUM MOL GENET, V10, P2797, DOI 10.1093/hmg/10.24.2797; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Yu CN, 2002, BLOOD, V100, P2040, DOI 10.1182/blood-2002-02-0387	33	112	114	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2011	43	4					295	302		10.1038/ng.785	http://dx.doi.org/10.1038/ng.785			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	741YL	21423179	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000288903700006
J	Harari, A; Rozot, V; Enders, FB; Perreau, M; Stalder, JM; Nicod, LP; Cavassini, M; Calandra, T; Blanchet, CL; Jaton, K; Faouzi, M; Day, CL; Hanekom, WA; Bart, PA; Pantaleo, G				Harari, Alexandre; Rozot, Virginie; Enders, Felicitas Bellutti; Perreau, Matthieu; Stalder, Jesica Mazza; Nicod, Laurent P.; Cavassini, Matthias; Calandra, Thierry; Blanchet, Catherine Lazor; Jaton, Katia; Faouzi, Mohamed; Day, Cheryl L.; Hanekom, Willem A.; Bart, Pierre-Alexandre; Pantaleo, Giuseppe			Dominant TNF-alpha(+) Mycobacterium tuberculosis-specific CD4(+) T cell responses discriminate between latent infection and active disease	NATURE MEDICINE			English	Article							NECROSIS-FACTOR-ALPHA; FUNCTIONAL SIGNATURES; RHEUMATOID-ARTHRITIS; IMMUNOLOGY; DIAGNOSIS; IMMUNITY; ASSAY	Rapid diagnosis of active Mycobacterium tuberculosis (Mtb) infection remains a clinical and laboratory challenge. We have analyzed the cytokine profile (interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha) and interleukin-2 (IL-2)) of Mtb-specific T cells by polychromatic flow cytometry. We studied Mtb-specific CD4(+) T cell responses in subjects with latent Mtb infection and active tuberculosis disease. The results showed substantial increase in the proportion of single-positive TNF-alpha Mtb-specific CD4(+) T cells in subjects with active disease, and this parameter was the strongest predictor of diagnosis of active disease versus latent infection. We validated the use of this parameter in a cohort of 101 subjects with tuberculosis diagnosis unknown to the investigator. The sensitivity and specificity of the flow cytometry-based assay were 67% and 92%, respectively, the positive predictive value was 80% and the negative predictive value was 92.4%. Therefore, the proportion of single-positive TNF-alpha Mtb-specific CD4(+) T cells is a new tool for the rapid diagnosis of active tuberculosis disease.	[Harari, Alexandre; Rozot, Virginie; Enders, Felicitas Bellutti; Perreau, Matthieu; Bart, Pierre-Alexandre; Pantaleo, Giuseppe] Univ Lausanne, Div Immunol & Allergy, CHU Vaudois, Lausanne, Switzerland; [Harari, Alexandre; Pantaleo, Giuseppe] Swiss Vaccine Res Inst, Lausanne, Switzerland; [Stalder, Jesica Mazza; Nicod, Laurent P.] Univ Lausanne, Div Pneumol, CHU Vaudois, Lausanne, Switzerland; [Cavassini, Matthias; Calandra, Thierry] Univ Lausanne, Div Infect Dis, CHU Vaudois, Lausanne, Switzerland; [Blanchet, Catherine Lazor] Univ Lausanne, Div Occupat Med, CHU Vaudois, Lausanne, Switzerland; [Jaton, Katia] Univ Lausanne, Inst Microbiol, CHU Vaudois, Lausanne, Switzerland; [Faouzi, Mohamed] Univ Lausanne, Ctr Clin Epidemiol, CHU Vaudois, Lausanne, Switzerland; [Day, Cheryl L.; Hanekom, Willem A.] Univ Cape Town, S African TB Vaccine Initiat, ZA-7925 Cape Town, South Africa	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Cape Town	Pantaleo, G (corresponding author), Univ Lausanne, Div Immunol & Allergy, CHU Vaudois, Lausanne, Switzerland.	giuseppe.pantaleo@chuv.ch	Rozot, Virginie/AAR-7789-2020; Nicod, Laurent/ABD-3360-2020; Calandra, Thierry/D-9017-2015; Pantaleo, Giuseppe/K-6163-2016; Jaton, Katia/A-2828-2016; Day, Cheryl L/J-9844-2012; Perreau, Matthieu/D-6309-2017; Day, Cheryl/GQQ-9720-2022; Enders, Felicitas Bellutti/AAB-8916-2020; cavassini, matthias/F-8987-2017	Rozot, Virginie/0000-0001-9757-1501; Calandra, Thierry/0000-0003-3051-1285; Day, Cheryl L/0000-0002-6497-4846; Hanekom, Willem/0000-0003-3070-6154; MAZZA-STALDER, JESICA/0000-0002-5693-7156; cavassini, matthias/0000-0003-0933-7833; Jaton, Katia/0000-0001-8944-7295; Nicod, Laurent P/0000-0002-0905-916X; Harari, Alexandre/0000-0002-1055-2090	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was partially conducted as part of the Vaccine Immune Monitoring Consortium under the Collaboration for AIDS Vaccine Discovery with support from the Bill & Melinda Gates Foundation. Furthermore, we thank N. Rettby, D. Bonnet and K. Ellefsen Lavoie for logistic coordination. We also thank many additional members of the South African Tuberculosis Vaccine Initiative team who helped with enrollment and evaluation of participants and, finally, the participants themselves.	Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Griner P F, 1981, Ann Intern Med, V94, P557; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Meier T, 2005, EUR J CLIN MICROBIOL, V24, P529, DOI 10.1007/s10096-005-1377-8; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102; ZWEIG MH, 1993, CLIN CHEM, V39, P561	22	295	314	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2011	17	3					372	U174		10.1038/nm.2299	http://dx.doi.org/10.1038/nm.2299			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21336285	Green Accepted			2022-12-25	WOS:000288070000049
J	Kreuzaler, PA; Staniszewska, AD; Li, WJ; Omidvar, N; Kedjouar, B; Turkson, J; Poli, V; Flavell, RA; Clarkson, RWE; Watson, CJ				Kreuzaler, Peter A.; Staniszewska, Anna D.; Li, Wenjing; Omidvar, Nader; Kedjouar, Blandine; Turkson, James; Poli, Valeria; Flavell, Richard A.; Clarkson, Richard W. E.; Watson, Christine J.			Stat3 controls lysosomal-mediated cell death in vivo	NATURE CELL BIOLOGY			English	Article							MAMMARY-GLAND INVOLUTION; TUMOR-NECROSIS-FACTOR; EPITHELIAL-CELLS; KAPPA-B; CASPASE ACTIVATION; GENE-EXPRESSION; DOWN-REGULATION; APOPTOSIS; CATHEPSIN; PATHWAY	It is well established that lysosomes play an active role during the execution of cell death(1). A range of stimuli can lead to lysosomal membrane permeabilization (LMP), thus inducing programmed cell death without involvement of the classical apoptotic programme(2,3). However, these lysosomal pathways of cell death have mostly been described in vitro or under pathological conditions(4-7). Here we show that the physiological process of post-lactational regression of the mammary gland is accomplished through a non-classical, lysosomal-mediated pathway of cell death. We found that, during involution, lysosomes in the mammary epithelium undergo widespread LMP. Furthermore, although cell death through LMP is independent of executioner caspases 3, 6 and 7, it requires Stat3, which upregulates the expression of lysosomal proteases cathepsin B and L, while downregulating their endogenous inhibitor Spi2A (ref. 8). Our findings report a previously unknown, Stat3-regulated lysosomal-mediated pathway of cell death under physiological circumstances. We anticipate that these findings will be of major importance in the design of treatments for cancers such as breast, colon and liver, where cathepsins and Stat3 are commonly overexpressed and/or hyperactivated respectively(1,9,10).	[Kreuzaler, Peter A.; Staniszewska, Anna D.; Li, Wenjing; Kedjouar, Blandine; Watson, Christine J.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Omidvar, Nader; Clarkson, Richard W. E.] Univ Cardiff, Sch Biosci, Cardiff CF10 3US, S Glam, Wales; [Turkson, James] Univ Cent Florida, Orlando, FL 32826 USA; [Poli, Valeria] Univ Turin, Dept Genet Biol & Biochem, Mol Biotechnol Ctr MBC, I-10126 Turin, Italy; [Flavell, Richard A.] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	University of Cambridge; Cardiff University; State University System of Florida; University of Central Florida; University of Turin; Yale University	Watson, CJ (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	cjw53@mole.bio.cam.ac.uk	Poli, Valeria/A-9215-2012; watson, Christine J/B-1431-2012; Clarkson, Richard/A-7505-2010	Poli, Valeria/0000-0002-3739-3966; Kreuzaler, Peter/0000-0001-8684-9424; Staniszewska, Anna/0000-0003-1328-1959; clarkson, richard/0000-0001-7389-8673	Pathology Department, University of Cambridge; Breast Cancer Campaign PhD studentship; Italian Cancer Research Association; Biotechnology and Biological Sciences Research Council [BB/C006836/1]	Pathology Department, University of Cambridge(University of Cambridge); Breast Cancer Campaign PhD studentship; Italian Cancer Research Association(Fondazione AIRC per la ricerca sul cancro); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank J. Skepper for help with the electron microscopy and B. Potter for histological preparations. We thank also P. Came for the TUNEL data and W. Khaled for discussions. This work has been supported by a PhD studentship from the Pathology Department, University of Cambridge (P.A.K.), Breast Cancer Campaign PhD studentship (A.D.S. and W.L.), Italian Cancer Research Association (V.P.) and Biotechnology and Biological Sciences Research Council grant no. BB/C006836/1 (R.W.E.C. and N.O.).	Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Baxter FO, 2007, J MAMMARY GLAND BIOL, V12, P3, DOI 10.1007/s10911-007-9033-9; Baxter FO, 2006, DEVELOPMENT, V133, P3485, DOI 10.1242/dev.02502; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Clarkson RWE, 2000, J BIOL CHEM, V275, P12737, DOI 10.1074/jbc.275.17.12737; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; Fehrenbacher N, 2008, CANCER RES, V68, P6623, DOI 10.1158/0008-5472.CAN-08-0463; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Guicciardi ME, 2001, AM J PATHOL, V159, P2045, DOI 10.1016/S0002-9440(10)63056-8; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; INGLIS JD, 1991, EMBO J, V10, P255, DOI 10.1002/j.1460-2075.1991.tb07945.x; Kagedal K, 2001, BIOCHEM J, V359, P335, DOI 10.1042/0264-6021:3590335; Khaled WT, 2007, DEVELOPMENT, V134, P2739, DOI 10.1242/dev.003194; Kritikou EA, 2003, DEVELOPMENT, V130, P3459, DOI 10.1242/dev.00578; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; LASCELLES AK, 1978, LACTATION COMPREHENS, V4; Liu N, 2003, EMBO J, V22, P5313, DOI 10.1093/emboj/cdg510; Liu N, 2004, NAT IMMUNOL, V5, P919, DOI 10.1038/ni1107; Lockshin RA, 2004, ONCOGENE, V23, P2766, DOI 10.1038/sj.onc.1207514; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; Lund LR, 1996, DEVELOPMENT, V122, P181; Marti A, 2001, MECH DEVELOP, V104, P89, DOI 10.1016/S0925-4773(01)00381-1; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nakayama M, 2002, J IMMUNOL, V168, P734, DOI 10.4049/jimmunol.168.2.734; Nguyen AV, 2000, DEVELOPMENT, V127, P3107; Nylandsted J, 2002, CANCER RES, V62, P7139; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Reinhardt TA, 2009, BIOCHEM BIOPH RES CO, V378, P99, DOI 10.1016/j.bbrc.2008.11.004; Selbert S, 1998, TRANSGENIC RES, V7, P387, DOI 10.1023/A:1008848304391; Thangaraju M, 2005, DEVELOPMENT, V132, P4675, DOI 10.1242/dev.02050; Tiffen PG, 2008, MOL ENDOCRINOL, V22, P2677, DOI 10.1210/me.2008-0097; Vasiljeva O, 2008, ONCOGENE, V27, P4191, DOI 10.1038/onc.2008.59; WARLEY A, 1995, DIABETOLOGIA, V38, P413, DOI 10.1007/s001250050300; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588; Zaragoza R, 2009, BIOCHEM J, V419, P279, DOI 10.1042/BJ20081746; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343; Zhou Q, 1998, BIOCHEMISTRY-US, V37, P10757, DOI 10.1021/bi980893w	44	210	213	3	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2011	13	3					303	U263		10.1038/ncb2171	http://dx.doi.org/10.1038/ncb2171			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	728BB	21336304				2022-12-25	WOS:000287847600018
J	Maison, C; Bailly, D; Roche, D; de Oca, RM; Probst, AV; Vassias, I; Dingli, F; Lombard, B; Loew, D; Quivy, JP; Almouzni, G				Maison, Christele; Bailly, Delphine; Roche, Daniele; de Oca, Rocio Montes; Probst, Aline V.; Vassias, Isabelle; Dingli, Florent; Lombard, Berengere; Loew, Damarys; Quivy, Jean-Pierre; Almouzni, Genevieve			SUMOylation promotes de novo targeting of HP1 alpha to pericentric heterochromatin	NATURE GENETICS			English	Article							HISTONE H3; CONSTITUTIVE HETEROCHROMATIN; MASS-SPECTROMETRY; SATELLITE REPEATS; RNA-BINDING; LYSINE 9; CHROMATIN; CELLS; HP1; PROTEIN	HP1 enrichment at pericentric heterochromatin is considered important for centromere function. Although HP1 binding to H3K9me3 can explain its accumulation at pericentric heterochromatin, how it is initially targeted there remains unclear. Here, in mouse cells, we reveal the presence of long nuclear noncoding transcripts corresponding to major satellite repeats at the periphery of pericentric heterochromatin. Furthermore, we find that major transcripts in the forward orientation specifically associate with SUMO-modified HP1 proteins. We identified this modification as SUMO-1 and mapped it in the hinge domain of HP1 alpha. Notably, the hinge domain and its SUMOylation proved critical to promote the initial targeting of HP1a to pericentric domains using de novo localization assays, whereas they are dispensable for maintenance of HP1 domains. We propose that SUMO-HP1, through a specific association with major forward transcript, is guided at the pericentric heterochromatin domain to seed further HP1 localization.	[Maison, Christele; Bailly, Delphine; Roche, Daniele; de Oca, Rocio Montes; Probst, Aline V.; Vassias, Isabelle; Dingli, Florent; Lombard, Berengere; Loew, Damarys; Quivy, Jean-Pierre; Almouzni, Genevieve] Inst Curie, Ctr Rech, Paris, France; [Maison, Christele; Bailly, Delphine; Roche, Daniele; de Oca, Rocio Montes; Probst, Aline V.; Vassias, Isabelle; Quivy, Jean-Pierre; Almouzni, Genevieve] CNRS, Lab Nucl Dynam & Genome Plast, Unite Mixte Rech UMR218, Paris, France; [Dingli, Florent; Lombard, Berengere; Loew, Damarys] Lab Prote Mass Spectrometry, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS)	Quivy, JP (corresponding author), Inst Curie, Ctr Rech, Paris, France.	jpquivy@curie.fr; genevieve.almouzni@curie.fr	Almouzni, Genevieve/ABG-1029-2021; , Probst/F-2267-2015	Almouzni, Genevieve/0000-0001-5570-0723; , Probst/0000-0001-9534-8058; Damarys, Loew/0000-0002-9111-8842; quivy, jean-pierre/0000-0001-6557-7204	la Ligue Nationale contre le Cancer (Equipe labellisee la Ligue); Curie Programme Incitatif et Collaboratif (PIC); European Network of Excellence Epigenome [LSHG-CT-2004-503433]; ACI-2007-Canceropole IdF 'Breast cancer and Epigenetics'; Agence Nationale de la Recherche (ANR) 'EcenS' [ANR-09-BLAN-0257-01]; INCa 'GepiG'; European Research Council (ERC) [2009-AdG-20090506]; le Canceropole Ile-de-France; l'INCA	la Ligue Nationale contre le Cancer (Equipe labellisee la Ligue); Curie Programme Incitatif et Collaboratif (PIC); European Network of Excellence Epigenome; ACI-2007-Canceropole IdF 'Breast cancer and Epigenetics'; Agence Nationale de la Recherche (ANR) 'EcenS'(French National Research Agency (ANR)); INCa 'GepiG'; European Research Council (ERC)(European Research Council (ERC)); le Canceropole Ile-de-France; l'INCA	We thank A. Bird, D. Shapiro, R. Hay, T. Jenuwein, R. Losson and J. Seeler for constructs and reagents. We thank W. Faigle for mass spectrometry support, G. Cappello for helpful discussions, A. Cook for critical reading and P. Le Baccon at the Curie Imaging Platform. G.A.'s laboratory is funded by la Ligue Nationale contre le Cancer (Equipe labellisee la Ligue), Curie Programme Incitatif et Collaboratif (PIC) Programs, the European Network of Excellence Epigenome (LSHG-CT-2004-503433), ACI-2007-Canceropole IdF 'Breast cancer and Epigenetics', Agence Nationale de la Recherche (ANR) 'EcenS' ANR-09-BLAN-0257-01, INCa 'GepiG', European Research Council (ERC) Advanced Grant 2009-AdG-20090506, and D.L.'s laboratory was funded by le Canceropole Ile-de-France and l'INCA.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Blankenship JT, 2001, DEVELOPMENT, V128, P5129; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Dodson RE, 1997, J BIOL CHEM, V272, P12249, DOI 10.1074/jbc.272.19.12249; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; HAAF T, 1995, EXP CELL RES, V219, P604, DOI 10.1006/excr.1995.1270; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Heard E, 2007, CURR OPIN CELL BIOL, V19, P311, DOI 10.1016/j.ceb.2007.04.016; Irvine K, 2004, INT J DEV BIOL, V48, P1065, DOI 10.1387/ijdb.041893ki; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; KURODA MI, 1991, CELL, V66, P935, DOI 10.1016/0092-8674(91)90439-6; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Lu J, 2007, J CELL BIOL, V179, P411, DOI 10.1083/jcb.200706176; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Martini E, 1998, J CELL BIOL, V143, P563, DOI 10.1083/jcb.143.3.563; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Mayer R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-44; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Park-Sarge Ok-Kyong, 2008, V464, P255; Peng HZ, 2009, J BIOL CHEM, V284, P35670, DOI 10.1074/jbc.M109.032086; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Poullet P, 2007, PROTEOMICS, V7, P2553, DOI 10.1002/pmic.200600784; Probst AV, 2010, DEV CELL, V19, P625, DOI 10.1016/j.devcel.2010.09.002; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Quivy JP, 2004, EMBO J, V23, P3516, DOI 10.1038/sj.emboj.7600362; RUDERT F, 1995, MAMM GENOME, V6, P76, DOI 10.1007/BF00303248; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Savarese F, 2006, MOL CELL BIOL, V26, P7167, DOI 10.1128/MCB.00810-06; Shin JA, 2005, MOL CELL, V19, P817, DOI 10.1016/j.molcel.2005.08.021; Smothers JF, 2001, MOL CELL BIOL, V21, P2555, DOI 10.1128/MCB.21.7.2555-2569.2001; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Terranova R, 2005, EXP CELL RES, V310, P344, DOI 10.1016/j.yexcr.2005.07.031; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang QQ, 2005, CURR BIOL, V15, P384, DOI 10.1016/j.cub.2005.01.046; [No title captured]	55	165	167	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2011	43	3					220	U65		10.1038/ng.765	http://dx.doi.org/10.1038/ng.765			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726BR	21317888	Green Submitted			2022-12-25	WOS:000287693800012
J	Song, WJ; Chen, J; Petrilli, A; Liot, G; Klinglmayr, E; Zhou, Y; Poquiz, P; Tjong, J; Pouladi, MA; Hayden, MR; Masliah, E; Ellisman, M; Rouiller, I; Schwarzenbacher, R; Bossy, B; Perkins, G; Bossy-Wetzel, E				Song, Wenjun; Chen, Jin; Petrilli, Alejandra; Liot, Geraldine; Klinglmayr, Eva; Zhou, Yue; Poquiz, Patrick; Tjong, Jonathan; Pouladi, Mahmoud A.; Hayden, Michael R.; Masliah, Eliezer; Ellisman, Mark; Rouiller, Isabelle; Schwarzenbacher, Robert; Bossy, Blaise; Perkins, Guy; Bossy-Wetzel, Ella			Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity	NATURE MEDICINE			English	Article							S-NITROSYLATION; NITRIC-OXIDE; MOUSE MODEL; CELL-DEATH; SUSCEPTIBILITY; FRAGMENTATION; DISEASE; FUSION; DRP1; DYSFUNCTION	Huntington's disease is an inherited and incurable neurodegenerative disorder caused by an abnormal polyglutamine (polyQ) expansion in huntingtin (encoded by HTT). PolyQ length determines disease onset and severity, with a longer expansion causing earlier onset. The mechanisms of mutant huntingtin-mediated neurotoxicity remain unclear; however, mitochondrial dysfunction is a key event in Huntington's disease pathogenesis(1,2). Here we tested whether mutant huntingtin impairs the mitochondrial fission-fusion balance and thereby causes neuronal injury. We show that mutant huntingtin triggers mitochondrial fragmentation in rat neurons and fibroblasts of individuals with Huntington's disease in vitro and in a mouse model of Huntington's disease in vivo before the presence of neurological deficits and huntingtin aggregates. Mutant huntingtin abnormally interacts with the mitochondrial fission GTPase dynamin-related protein-1 (DRP1) in mice and humans with Huntington's disease, which, in turn, stimulates its enzymatic activity. Mutant huntingtin-mediated mitochondrial fragmentation, defects in anterograde and retrograde mitochondrial transport and neuronal cell death are all rescued by reducing DRP1 GTPase activity with the dominant-negative DRP1 K38A mutant. Thus, DRP1 might represent a new therapeutic target to combat neurodegeneration in Huntington's disease.	[Song, Wenjun; Chen, Jin; Petrilli, Alejandra; Liot, Geraldine; Zhou, Yue; Bossy, Blaise; Bossy-Wetzel, Ella] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA; [Klinglmayr, Eva; Schwarzenbacher, Robert] Salzburg Univ, Struct Biol Grp, Dept Mol Biol, A-5020 Salzburg, Austria; [Poquiz, Patrick; Tjong, Jonathan; Ellisman, Mark; Perkins, Guy] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, San Diego, CA 92103 USA; [Pouladi, Mahmoud A.; Hayden, Michael R.] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Masliah, Eliezer] Univ Calif San Diego, La Jolla, CA 92093 USA; [Rouiller, Isabelle] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada	State University System of Florida; University of Central Florida; Salzburg University; University of California System; University of California San Diego; University of British Columbia; University of California System; University of California San Diego; McGill University	Bossy-Wetzel, E (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32816 USA.	ebossywe@mail.ucf.edu	Klinglmayr, Eva/L-2967-2015; Hayden, Michael R/D-8581-2011; Rouiller, Isabelle/AAE-9637-2019; rouiller, isabelle/K-7679-2012; Chen, Jin/M-1837-2019; Pouladi, Mahmoud A/B-8743-2016; Song, Wenjun/HGB-4891-2022	Hayden, Michael R/0000-0001-5159-1419; rouiller, isabelle/0000-0002-1288-8575; Chen, Jin/0000-0001-7617-1664; Pouladi, Mahmoud A/0000-0002-9030-0976; Liot, Geraldine/0000-0002-4784-7693; Song, Wenjun/0000-0002-6355-2983; Perkins, Guy/0000-0002-1834-6646	NIH [R01EY016164, R01NS055193, P41RR004050]; Hereditary Disease Foundation; Canadian Institutes of Health Research; CHDI; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055193, R01NS047456] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hereditary Disease Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CHDI; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Finkbeiner (University of California-San Francisco) for the pGW1 plasmids encoding huntingtin<SUP>ex1</SUP>-Q<INF>17</INF>-GFP, huntingtine<SUP>x1-</SUP>Q<INF>46</INF>-GFP, huntingtin<SUP>ex1</SUP>-Q<INF>97-</INF>GFP; L. Thompson (University of California-Irvine) for the huntingtin plasmids pcDNA3.1-Q25-GFP and pcDNA3.1-Q97-GFP; U. Hartl (Max Planck Institute of Biochemistry) for the GST-huntingtin<SUP>ex1</SUP>-Q<INF>20</INF> and -Q<INF>53</INF> constructs; A. van der Bliek (University of California-Los Angeles) for the DRP1 K38A cDNA in baculovirus expression vector (US National Center for Biotechnology Information accession number NM_005690.3); R. Youle (US National Institutes of Health (NIH)) for the YFP-DRP1 plasmid; R. Slack (University of Ottawa) for the MFN2 RasG12V (p82-FzoRV12pECFP-C1) expression plasmid; S. Strack (University of Iowa) for his pcDNA3.1 beta-DRP1shRNA vector; S. Lubitz, J. Johnson, V. DeAssis, C. Eldon and B. Kincaid for technical assistance; and A. Knott for manuscript development and editing. This work is supported by NIH grants to E.B.-W. (R01EY016164 and R01NS055193), a fellowship from the Hereditary Disease Foundation (to G. L.), grants to I. R., M. A. P. and M. R. H. from the Canadian Institutes of Health Research, and support from CHDI to M. R. H. The electron microscope tomography work was carried out in facilities of the US National Center for Microscopy and Imaging Research, supported by NIH grant P41RR004050 awarded to M. E.	Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Bossy B, 2010, J ALZHEIMERS DIS, V20, pS513, DOI 10.3233/JAD-2010-100552; Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Fan J, 2009, J NEUROSCI, V29, P10928, DOI 10.1523/JNEUROSCI.2491-09.2009; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Graham RK, 2009, J NEUROSCI, V29, P2193, DOI 10.1523/JNEUROSCI.5473-08.2009; Hodgson JG, 1996, HUM MOL GENET, V5, P1875, DOI 10.1093/hmg/5.12.1875; Ingerman E, 2005, METHOD ENZYMOL, V404, P611, DOI 10.1016/S0076-6879(05)04053-X; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Knott AB, 2008, ANN NY ACAD SCI, V1147, P283, DOI 10.1196/annals.1427.030; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liot G, 2009, CELL DEATH DIFFER, V16, P899, DOI 10.1038/cdd.2009.22; Mears JA, 2008, METHOD CELL BIOL, V88, P237, DOI 10.1016/S0091-679X(08)00413-5; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; Orr AL, 2008, J NEUROSCI, V28, P2783, DOI 10.1523/JNEUROSCI.0106-08.2008; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Perkins GA, 2001, EUR J CELL BIOL, V80, P139, DOI 10.1078/0171-9335-00149; Perkins GA, 2008, J STRUCT BIOL, V161, P469, DOI 10.1016/j.jsb.2007.10.005; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wang HM, 2009, HUM MOL GENET, V18, P737, DOI 10.1093/hmg/ddn404; Yuan H, 2007, CELL DEATH DIFFER, V14, P462, DOI 10.1038/sj.cdd.4402046	33	373	379	3	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2011	17	3					377	U181		10.1038/nm.2313	http://dx.doi.org/10.1038/nm.2313			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21336284	Green Accepted, Green Submitted			2022-12-25	WOS:000288070000050
J	Argout, X; Salse, J; Aury, JM; Guiltinan, MJ; Droc, G; Gouzy, J; Allegre, M; Chaparro, C; Legavre, T; Maximova, SN; Abrouk, M; Murat, F; Fouet, O; Poulain, J; Ruiz, M; Roguet, Y; Rodier-Goud, M; Barbosa-Neto, JF; Sabot, F; Kudrna, D; Ammiraju, JSS; Schuster, SC; Carlson, JE; Sallet, E; Schiex, T; Dievart, A; Kramer, M; Gelley, L; Shi, Z; Berard, A; Viot, C; Boccara, M; Risterucci, AM; Guignon, V; Sabau, X; Axtell, MJ; Ma, ZR; Zhang, YF; Brown, S; Bourge, M; Golser, W; Song, XA; Clement, D; Rivallan, R; Tahi, M; Akaza, JM; Pitollat, B; Gramacho, K; D'Hont, A; Brunel, D; Infante, D; Kebe, I; Costet, P; Wing, R; McCombie, WR; Guiderdoni, E; Quetier, F; Panaud, O; Wincker, P; Bocs, S; Lanaud, C				Argout, Xavier; Salse, Jerome; Aury, Jean-Marc; Guiltinan, Mark J.; Droc, Gaetan; Gouzy, Jerome; Allegre, Mathilde; Chaparro, Cristian; Legavre, Thierry; Maximova, Siela N.; Abrouk, Michael; Murat, Florent; Fouet, Olivier; Poulain, Julie; Ruiz, Manuel; Roguet, Yolande; Rodier-Goud, Maguy; Barbosa-Neto, Jose Fernandes; Sabot, Francois; Kudrna, Dave; Ammiraju, Jetty Siva S.; Schuster, Stephan C.; Carlson, John E.; Sallet, Erika; Schiex, Thomas; Dievart, Anne; Kramer, Melissa; Gelley, Laura; Shi, Zi; Berard, Aurelie; Viot, Christopher; Boccara, Michel; Risterucci, Ange Marie; Guignon, Valentin; Sabau, Xavier; Axtell, Michael J.; Ma, Zhaorong; Zhang, Yufan; Brown, Spencer; Bourge, Mickael; Golser, Wolfgang; Song, Xiang; Clement, Didier; Rivallan, Ronan; Tahi, Mathias; Akaza, Joseph Moroh; Pitollat, Bertrand; Gramacho, Karina; D'Hont, Angelique; Brunel, Dominique; Infante, Diogenes; Kebe, Ismael; Costet, Pierre; Wing, Rod; McCombie, W. Richard; Guiderdoni, Emmanuel; Quetier, Francis; Panaud, Olivier; Wincker, Patrick; Bocs, Stephanie; Lanaud, Claire			The genome of Theobroma cacao	NATURE GENETICS			English	Article							COCOA; GENE; SEQUENCE; PLANTS; BIOSYNTHESIS; RESISTANCE; EVOLUTION; PATHOGEN; ORIGIN; MODEL	We sequenced and assembled the draft genome of Theobroma cacao, an economically important tropical-fruit tree crop that is the source of chocolate. This assembly corresponds to 76% of the estimated genome size and contains almost all previously described genes, with 82% of these genes anchored on the 10 T. cacao chromosomes. Analysis of this sequence information highlighted specific expansion of some gene families during evolution, for example, flavonoid-related genes. It also provides a major source of candidate genes for T. cacao improvement. Based on the inferred paleohistory of the T. cacao genome, we propose an evolutionary scenario whereby the ten T. cacao chromosomes were shaped from an ancestor through eleven chromosome fusions.	[Argout, Xavier; Droc, Gaetan; Allegre, Mathilde; Legavre, Thierry; Fouet, Olivier; Ruiz, Manuel; Roguet, Yolande; Rodier-Goud, Maguy; Dievart, Anne; Viot, Christopher; Boccara, Michel; Risterucci, Ange Marie; Guignon, Valentin; Sabau, Xavier; Clement, Didier; Rivallan, Ronan; Pitollat, Bertrand; D'Hont, Angelique; Guiderdoni, Emmanuel; Bocs, Stephanie; Lanaud, Claire] Ctr Cooperat Int Rech Agron Dev CIRAD, Biol Syst Dept, UMR DAP, F-34398 Montpellier, France; [Salse, Jerome; Abrouk, Michael; Murat, Florent] INRA, UMR 1095, Clermont Ferrand, France; [Aury, Jean-Marc; Poulain, Julie; Wincker, Patrick] CEA, IG, Evry, France; [Aury, Jean-Marc; Poulain, Julie; Wincker, Patrick] CNRS, UMR 8030, CP5706, Evry, France; [Aury, Jean-Marc; Poulain, Julie; Wincker, Patrick] Univ Evry, Evry, France; Penn State Univ, Dept Hort, University Pk, PA 16802 USA; [Guiltinan, Mark J.; Maximova, Siela N.; Carlson, John E.; Shi, Zi; Zhang, Yufan] Huck Inst Life Sci, University Pk, PA USA; [Shi, Zi; Zhang, Yufan] Penn State Univ, Plant Biol Grad Program, University Pk, PA 16802 USA; [Gouzy, Jerome; Sallet, Erika] CNRS, INRA, LIPM, Castanet Tolosan, France; [Chaparro, Cristian; Barbosa-Neto, Jose Fernandes; Sabot, Francois; Panaud, Olivier] UPVD, CNRS, IRD, UMR 5096,Lab Genome & Dev Plantes, Perpignan, France; Univ Arizona, Arizona Genom Inst, Tucson, AZ USA; [Kudrna, Dave; Ammiraju, Jetty Siva S.; Golser, Wolfgang; Song, Xiang; Wing, Rod] Univ Arizona, Sch Plant Sci, Tucson, AZ USA; [Schuster, Stephan C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Carlson, John E.] Penn State Univ, Sch Forest Resources, University Pk, PA 16802 USA; [Carlson, John E.] Chonnam Natl Univ, Dept Bioenergy Sci & Technol WCU, Kwangju, South Korea; [Schiex, Thomas] INRA, UR875, UBIA, F-31326 Castanet Tolosan, France; [Kramer, Melissa; Gelley, Laura; Zhang, Yufan; McCombie, W. Richard] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Berard, Aurelie; Brunel, Dominique] CP5724, Ctr Natl Genotypage, UR Etud Polymorphisme Genomes Vegetaux 1279, Inst Genom,INRA,CEA, Evry, France; [Axtell, Michael J.; Ma, Zhaorong] Penn State Univ, Bioinformat & Genom PhD Program, University Pk, PA 16802 USA; [Axtell, Michael J.; Ma, Zhaorong] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Brown, Spencer; Bourge, Mickael; Kebe, Ismael] CNRS, Inst Sci Vegetal, UPR 2355, Gif Sur Yvette, France; [Tahi, Mathias; Akaza, Joseph Moroh] CNRA, Divo, Cote Ivoire; [Gramacho, Karina] CEPLAC, Itabuna Bahia, Brazil; [Infante, Diogenes] IDEA, Ctr Nacl Biotecnol Agr, Caracas, Venezuela; [Costet, Pierre] Chocolaterie VALRHONA, Tain Lhermitage, France; [Quetier, Francis] Univ Evry Val Essonne, Dept Biol, Evry, France	CIRAD; INRAE; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Perpignan Via Domitia; Institut de Recherche pour le Developpement (IRD); University of Arizona; University of Arizona; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Chonnam National University; INRAE; Cold Spring Harbor Laboratory; CEA; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Argout, X (corresponding author), Ctr Cooperat Int Rech Agron Dev CIRAD, Biol Syst Dept, UMR DAP, TA A 96-03, F-34398 Montpellier, France.	xavier.argout@cirad.fr	Abrouk, Michael/W-1972-2017; Chaparro, Cristian/D-1427-2015; Gouzy, Jerome/AAH-4977-2020; GRAMACHO, KARINA PERES/AAO-8862-2020; song, xiang/A-2336-2012; Sabot, Francois/B-7820-2010; Abrouk, Michael/F-8516-2014; BROWN, Spencer/B-6878-2014; Ruiz, Manuel/E-6171-2010; GRAMACHO, KARINA PERES/J-3868-2014; Viot, Christopher/AAE-8789-2022; Gaetan, DROC/AAH-2616-2021; Aury, Jean-Marc/N-1621-2019; Wing, Rod A/Z-2885-2019; DHONT, Angélique/AAL-8074-2021; Infante, Diogenes/M-5488-2019; Quetier, Francis/J-7923-2017; Infante, Diogenes/A-8444-2015	Abrouk, Michael/0000-0001-9082-1432; Chaparro, Cristian/0000-0002-5162-349X; Gouzy, Jerome/0000-0001-5695-4557; GRAMACHO, KARINA PERES/0000-0003-4037-1554; Sabot, Francois/0000-0002-8522-7583; Abrouk, Michael/0000-0001-9082-1432; GRAMACHO, KARINA PERES/0000-0003-4037-1554; Viot, Christopher/0000-0001-6321-4741; Gaetan, DROC/0000-0003-1849-1269; Aury, Jean-Marc/0000-0003-1718-3010; Wing, Rod A/0000-0001-6633-6226; Quetier, Francis/0000-0003-4388-9287; Ruiz, Manuel/0000-0001-8153-276X; Lanaud, Claire/0000-0001-6411-7310; Infante, Diogenes/0000-0002-8312-2198; CLEMENT, Didier/0000-0002-7602-6472; Sallet, Erika/0000-0003-4637-473X; Dievart, Anne/0000-0001-9460-4638; Poulain, Julie/0000-0002-8744-3116; Murat, Florent/0000-0003-2116-2511	National Science Foundation [DBI0923128]; CIRAD; Agropolis foundation; Region Languedoc Roussillon; Agence Nationale de la Recherche (ANR); Valrhona and the Venezuelan Ministry of Science, Technology and Industry; Schatz Center for Tree Molecular Genetics in the School of Forest Resources	National Science Foundation(National Science Foundation (NSF)); CIRAD; Agropolis foundation; Region Languedoc Roussillon(Region OccitanieRegion Ile-de-France); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Valrhona and the Venezuelan Ministry of Science, Technology and Industry; Schatz Center for Tree Molecular Genetics in the School of Forest Resources	We would like to thank CIRAD, the Agropolis foundation, the Region Languedoc Roussillon, Agence Nationale de la Recherche (ANR), Valrhona and the Venezuelan Ministry of Science, Technology and Industry for their financial contribution to this project. We thank the Toulouse Midi-Pyrenees bioinformatic platform for providing us with computational resources. Activities at Pennsylvania State University were supported by a gift from the Hershey Corp. and through support from the Schatz Center for Tree Molecular Genetics in the School of Forest Resources. Acquisition of an Illumina sequencer by the Cold Spring Harbor Laboratory was supported by the National Science Foundation grant DBI0923128 to W. R. M. We would like to thank F. C. Baurens, Y. Jiao, O. Garsmeur and C. dePamphilis for helpful advice and assistance with bioinformatics. We would like to express our special appreciation to V. Mooleedhar, who collected the cacao accession in Belize and made it available to us for our analysis.	Abrouk M, 2010, TRENDS PLANT SCI, V15, P479, DOI 10.1016/j.tplants.2010.06.001; Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; ALLEGRE M, HIGH DENSIT IN PRESS; Ammiraju JSS, 2006, GENOME RES, V16, P140, DOI 10.1101/gr.3766306; Araujo IS, 2009, PLANT MOL BIOL REP, V27, P177, DOI 10.1007/s11105-008-0069-9; Argout X, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-512; Aury JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-603; Beisson F, 2003, PLANT PHYSIOL, V132, P681, DOI 10.1104/pp.103.022988; CHANLIAU S, 1996, 12 INT COC RES C SAL, P959; Coe Sophie D., 1996, TRUE HIST CHOCOLATE; DAVIE J. H., 1935, Genetica, V17, P487, DOI 10.1007/BF01508190; Degroeve S, 2005, BIOINFORMATICS, V21, P1332, DOI 10.1093/bioinformatics/bti166; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; DHont A, 1996, MOL GEN GENET, V250, P405, DOI [10.1007/BF02174028, 10.1007/s004380050092]; Dievart A, 2004, DEVELOPMENT, V131, P251, DOI 10.1242/dev.00998; Foissac S, 2008, CURR BIOINFORM, V3, P87, DOI 10.2174/157489308784340702; FOUET O, STRUCTURAL IN PRESS; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; GRIFFITHS G, 1991, PLANTA, V184, P279, DOI [10.1007/BF01102429, 10.1007/BF00197958]; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Henderson JS, 2007, P NATL ACAD SCI USA, V104, P18937, DOI 10.1073/pnas.0708815104; *ICCO MARK COMM, 2007, 10 M EBRD OFF LOND M, V10, P16; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lanaud C, 2009, MOL BREEDING, V24, P361, DOI 10.1007/s11032-009-9297-4; LANAUD C, 2003, P 14 INT COC RES C, P13; Lehmann Przemyslaw, 2002, Journal of Applied Genetics, V43, P403; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu Y, 2005, J INTEGR PLANT BIOL, V47, P769, DOI 10.1111/j.1744-7909.2005.00111.x; LIU YS, 2010, TECTONIC EVOLUTION P, P1; MARIE D, 1993, BIOL CELL, V78, P41, DOI 10.1016/0248-4900(93)90113-S; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Maximova SN, 2006, PLANTA, V224, P740, DOI 10.1007/s00425-005-0188-6; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Mooleedhar V., 1995, Cocoa Growers' Bulletin, P26; Motamayor JC, 2003, HEREDITY, V91, P322, DOI 10.1038/sj.hdy.6800298; Motamayor JC, 2002, HEREDITY, V89, P380, DOI 10.1038/sj.hdy.6800156; Mukhtar MS, 2009, CELL, V137, P804, DOI 10.1016/j.cell.2009.05.010; Murat F, 2010, GENOME RES, V20, P1545, DOI 10.1101/gr.109744.110; Pan QL, 2000, J MOL EVOL, V50, P203, DOI 10.1007/s002399910023; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pourcel L, 2007, TRENDS PLANT SCI, V12, P29, DOI 10.1016/j.tplants.2006.11.006; Pugh T, 2004, THEOR APPL GENET, V108, P1151, DOI 10.1007/s00122-003-1533-4; Rimbach G, 2009, INT J MOL SCI, V10, P4290, DOI 10.3390/ijms10104290; Salse J, 2009, BRIEF BIOINFORM, V10, P619, DOI 10.1093/bib/bbp037; Salse J, 2009, P NATL ACAD SCI USA, V106, P14908, DOI 10.1073/pnas.0902350106; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shi Z, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-248; Spencer JPE, 2009, GENES NUTR, V4, P243, DOI 10.1007/s12263-009-0136-3; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tarr D Ellen K, 2009, BMC Res Notes, V2, P197, DOI 10.1186/1756-0500-2-197; Tomas-Barberan FA, 2007, J AGR FOOD CHEM, V55, P3926, DOI 10.1021/jf070121j; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wolfgruber TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000743; ZIEGLEDER G, 1990, Z LEBENSM UNTERS FOR, V191, P306, DOI 10.1007/BF01202432	59	469	577	6	127	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2011	43	2					101	108		10.1038/ng.736	http://dx.doi.org/10.1038/ng.736			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	711XD	21186351				2022-12-25	WOS:000286623800006
J	McLeod, BW; Hayman, ML; Purcell, AL; Marcus, JS; Veitenheimer, E				McLeod, Bonnie W.; Hayman, Mark L.; Purcell, Angela L.; Marcus, Joshua S.; Veitenheimer, Erich			The 'real world' utility of miRNA patents: lessons learned from expressed sequence tags	NATURE BIOTECHNOLOGY			English	Editorial Material							MICRORNAS; RNA	Strategies are needed for drafting miRNA patent applications, in light of the existing patent landscape and genomic patent strategies of the past decades.	[McLeod, Bonnie W.; Hayman, Mark L.; Purcell, Angela L.; Marcus, Joshua S.; Veitenheimer, Erich] Cooley LLP, Washington, DC USA		McLeod, BW (corresponding author), Cooley LLP, Washington, DC USA.	bweissmcleod@cooley.com						Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; *AI GEORG INC, 1984, EVN, P221; Almanza G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011243; Cho WCS, 2010, BBA-REV CANCER, V1805, P209, DOI 10.1016/j.bbcan.2009.11.003; Davis PK, 2005, NAT BIOTECHNOL, V23, P1227, DOI 10.1038/nbt1005-1227; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hime GR, 2009, CELL ADHES MIGR, V3, P425, DOI 10.4161/cam.3.4.9913; Huang ZP, 2010, J CARDIOVASC TRANSL, V3, P212, DOI 10.1007/s12265-010-9165-y; Jones CI, 2010, BIOCHEM SOC T, V38, P1137, DOI 10.1042/BST0381137; Kunin Stephen G, 2002, Am Univ Law Rev, V51, P609; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Letzen BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010480; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Reynolds T, 2000, J NATL CANCER I, V92, P96, DOI 10.1093/jnci/92.2.96; SCHULTZ JD, SPE ART UNIT, V1635; Smalheiser Neil R., 2006, V342, P115, DOI 10.1385/1-59745-123-1:115; STORELLA J, 2005, AM C I 5 ADV FOR BIO; Sullivan CS, 2005, MOL CELL, V20, P3, DOI 10.1016/j.molcel.2005.09.012; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; US Patent and Trademark Office, 2001, FED REGISTER, V66, P1092; Weber M, 2010, BIOCHEM BIOPH RES CO, V393, P643, DOI 10.1016/j.bbrc.2010.02.045; Yu ZR, 2010, AM J PATHOL, V176, P1058, DOI 10.2353/ajpath.2010.090664; Zheng K, 2010, J NEUROSCI, V30, P8245, DOI 10.1523/JNEUROSCI.1169-10.2010; 2010, Patent No. 7838662; 2009, Patent No. 02782801; 2010, Patent No. 7838661; 2010, Patent No. 7838663; 2005, RASMUSSON SMITHKLINE, P1297; 2005, CF RE FISHER 421 F 3; 2010, Patent No. 7838660; 2005, FISHER 421 3D 1376; 2010, Patent No. 7838664; 2009, Patent No. 11747409	37	14	20	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2011	29	2					129	134		10.1038/nbt.1765	http://dx.doi.org/10.1038/nbt.1765			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	717DJ	21301436				2022-12-25	WOS:000287023000017
J	Liu, JB; Ma, J				Liu, Junbo; Ma, Jun			Fates-shifted is an F-box protein that targets Bicoid for degradation and regulates developmental fate determination in Drosophila embryos	NATURE CELL BIOLOGY			English	Article							MORPHOGEN GRADIENT; POSITIONAL INFORMATION; GENE-EXPRESSION; ANTERIOR PATTERN; TRANSCRIPTION; UBIQUITIN; RNA; MECHANISMS; PROTEASOME; HUNCHBACK	Bicoid (Bcd) is a morphogenetic protein that instructs patterning along the anterior-posterior (A-P) axis in Drosophila melanogaster embryos. Despite extensive studies, what controls the formation of a normal concentration gradient of Bcd remains an unresolved and controversial question. Here, we show that Bcd protein degradation is mediated by the ubiquitin-proteasome pathway. We have identified an F-box protein, encoded by fates-shifted (fsd), that has an important role in Bcd protein degradation by targeting it for ubiquitylation. Embryos from females lacking fsd have an altered Bcd gradient profile, resulting in a shift of the fatemap along the A-P axis. Our study is an experimental demonstration that, contrary to an alternative hypothesis, Bcd protein degradation is required for normal gradient formation and developmental fate determination.	[Liu, Junbo; Ma, Jun] Cincinnati Childrens Res Fdn, Div Biomed Informat, Cincinnati, OH 45229 USA; [Ma, Jun] Cincinnati Childrens Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Ma, J (corresponding author), Cincinnati Childrens Res Fdn, Div Biomed Informat, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	jun.ma@cchmc.org	Liu, junbo/H-5141-2011; Ma, Jun/GLT-4809-2022	Ma, Jun/0000-0002-1609-3294	NIH; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072812] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of our groups at CCHMC, in particular F.He, D. Cheung, W. Dui, and J. Deng, for discussion and assistance, and we thank Xinhua Lin's lab for some of the primers used in our dsRNAi screening. This work was supported in part by grants from NIH and NSF (to J.M.).	Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bergmann S, 2007, PLOS BIOL, V5, P232, DOI 10.1371/journal.pbio.0050046; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Coppey M, 2007, DEV BIOL, V312, P623, DOI 10.1016/j.ydbio.2007.09.058; Crauk O, 2005, CURR BIOL, V15, P1888, DOI 10.1016/j.cub.2005.09.046; CREVEL G, 1991, EMBO J, V10, P4361, DOI 10.1002/j.1460-2075.1991.tb05014.x; Deng JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010275; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1990, DEVELOPMENT, V109, P811; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Forler D, 2003, NAT BIOTECHNOL, V21, P89, DOI 10.1038/nbt773; FROHNHOFER HG, 1986, NATURE, V324, P120, DOI 10.1038/324120a0; Fu DC, 2005, NUCLEIC ACIDS RES, V33, P3985, DOI 10.1093/nar/gki691; Fu DC, 2004, J BIOL CHEM, V279, P48725, DOI 10.1074/jbc.M407066200; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Gregor T, 2008, DEV BIOL, V316, P350, DOI 10.1016/j.ydbio.2008.01.039; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Grimm O, 2010, DEVELOPMENT, V137, P2857, DOI 10.1242/dev.052589; He F, 2008, DEV CELL, V15, P558, DOI 10.1016/j.devcel.2008.09.004; He F, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-80; He F, 2010, BIOPHYS J, V99, P697, DOI 10.1016/j.bpj.2010.04.073; Hecht I, 2009, P NATL ACAD SCI USA, V106, P1710, DOI 10.1073/pnas.0807655106; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; HERSHKO A, 1991, J BIOL CHEM, V266, P16376; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Hsu T, 2001, NAT CELL BIOL, V3, P538, DOI 10.1038/35078508; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kerszberg M, 2007, CELL, V130, P205, DOI 10.1016/j.cell.2007.06.038; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; KORNITZER D, 1994, EMBO J, V13, P6021, DOI 10.1002/j.1460-2075.1994.tb06948.x; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Lattin J., 2003, ANAL MULTIVARIATE DA; Lucchetta EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003651; Manu, 2009, PLOS BIOL, V7, P591, DOI 10.1371/journal.pbio.1000049; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Perkins TJ, 2006, PLOS COMPUT BIOL, V2, P417, DOI 10.1371/journal.pcbi.0020051; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Porcher A, 2010, DEVELOPMENT, V137, P2795, DOI 10.1242/dev.051300; RiveraPomar R, 1996, TRENDS GENET, V12, P478, DOI 10.1016/0168-9525(96)10044-5; RIVERAPOMAR R, 1995, NATURE, V376, P253, DOI 10.1038/376253a0; Schaeffer V, 1999, P NATL ACAD SCI USA, V96, P4461, DOI 10.1073/pnas.96.8.4461; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; Spirov A, 2009, DEVELOPMENT, V136, P605, DOI 10.1242/dev.031195; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; Surkova S, 2008, DEV BIOL, V313, P844, DOI 10.1016/j.ydbio.2007.10.037; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wartlick O, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001255; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Zhao C, 2002, DEVELOPMENT, V129, P1669	64	33	33	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2011	13	1					22	U62		10.1038/ncb2141	http://dx.doi.org/10.1038/ncb2141			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697GV	21170036	Green Accepted			2022-12-25	WOS:000285502200007
J	Wagner, W; Brenowitz, SD; Hammer, JA				Wagner, Wolfgang; Brenowitz, Stephan D.; Hammer, John A., III			Myosin-Va transports the endoplasmic reticulum into the dendritic spines of Purkinje neurons	NATURE CELL BIOLOGY			English	Article							GLUTAMATE-RECEPTOR; CALCIUM-RELEASE; PROTEIN-KINASE; CEREBELLAR LTD; NECK LENGTH; LEVER ARM; CELLS; EXPRESSION; TYPE-1; MOTILITY	Extension of the endoplasmic reticulum (ER) into dendritic spines of Purkinje neurons is required for cerebellar synaptic plasticity and is disrupted in animals with null mutations in Myo5a, the gene encoding myosin-Va. We show here that myosin-Va acts as a point-to-point organelle transporter to pull ER as cargo into Purkinje neuron spines. Specifically, myosin-Va accumulates at the ER tip as the organelle moves into spines, and hydrolysis of ATP by myosin-Va is required for spine ER targeting. Moreover, myosin-Va is responsible for almost all of the spine ER insertion events. Finally, attenuation of the ability of myosin-Va to move along actin filaments reduces the maximum velocity of ER movement into spines, providing direct evidence that myosin-Va drives ER motility. Thus, we have established that an actin-based motor moves ER within animal cells, and have uncovered the mechanism for ER localization to Purkinje neuron spines, a prerequisite for synaptic plasticity.	[Wagner, Wolfgang; Hammer, John A., III] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Brenowitz, Stephan D.] Natl Inst Deafness & Other Commun Disorders, Sect Synapt Transmiss, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Hammer, JA (corresponding author), NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	hammerj@nhlbi.nih.gov		Wagner, Wolfgang/0000-0003-1187-2990	Intramural NIH HHS [Z01 DC000072-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006123, ZIAHL000514] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000072] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alami NH, 2009, J NEUROSCI, V29, P6625, DOI 10.1523/JNEUROSCI.3829-08.2009; Altan-Bonnet N, 2006, MOL BIOL CELL, V17, P990, DOI 10.1091/mbc.E05-02-0155; Bannai H, 2004, J CELL SCI, V117, P163, DOI 10.1242/jcs.00854; Bittins CM, 2009, CELL MOL NEUROBIOL, V29, P597, DOI 10.1007/s10571-009-9352-z; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Desnos C, 2007, J NEUROSCI, V27, P10636, DOI 10.1523/JNEUROSCI.1228-07.2007; English AR, 2009, CURR OPIN CELL BIOL, V21, P596, DOI 10.1016/j.ceb.2009.04.004; Estrada P, 2003, J CELL BIOL, V163, P1255, DOI 10.1083/jcb.200304030; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Forgacs E, 2009, J BIOL CHEM, V284, P2138, DOI 10.1074/jbc.M805530200; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; HARRIS KM, 1988, J NEUROSCI, V8, P4455; Hartmann J, 2009, ACTA PHYSIOL, V195, P79, DOI 10.1111/j.1748-1716.2008.01923.x; Hisatsune C, 2006, J NEUROSCI, V26, P10916, DOI 10.1523/JNEUROSCI.3269-06.2006; Holbro N, 2009, P NATL ACAD SCI USA, V106, P15055, DOI 10.1073/pnas.0905110106; Hu XD, 2008, J NEUROSCI, V28, P13094, DOI 10.1523/JNEUROSCI.3074-08.2008; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Johnson HW, 2009, MOL BIOL CELL, V20, P5166, DOI 10.1091/mbc.E09-01-0083; Jung G, 2009, J CELL BIOL, V186, P555, DOI 10.1083/jcb.200810147; Kano M, 2008, PHILOS T R SOC B, V363, P2173, DOI 10.1098/rstb.2008.2270; LANGFORD GM, 1995, CURR OPIN CELL BIOL, V7, P82, DOI 10.1016/0955-0674(95)80048-4; Linden DJ, 1999, J NEUROSCI, V19, P10221; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; McCroskery S, 2006, MOL CELL NEUROSCI, V33, P15, DOI 10.1016/j.mcn.2006.06.004; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; MOORE KJ, 1988, P NATL ACAD SCI USA, V85, P8131, DOI 10.1073/pnas.85.21.8131; Petralia RS, 2001, EUR J NEUROSCI, V13, P1722, DOI 10.1046/j.0953-816x.2001.01553.x; Provance DW, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-44; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Schott DH, 2002, J CELL BIOL, V156, P35, DOI 10.1083/jcb.200110086; Sellers J. R., 2008, MYOSINS SUPERFAMILY; SEPERACK PK, 1995, EMBO J, V14, P2326, DOI 10.1002/j.1460-2075.1995.tb07227.x; Serinagaoglu Y, 2007, MOL CELL NEUROSCI, V34, P324, DOI 10.1016/j.mcn.2006.11.013; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; Shiraishi Y, 2004, J COMP NEUROL, V473, P582, DOI 10.1002/cne.20116; Shiraishi-Yamaguchi Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-206; Sparkes I, 2009, PLANT CELL, V21, P3937, DOI 10.1105/tpc.109.072249; Street VA, 1997, J NEUROSCI, V17, P635; STROBEL MC, 1990, MOL CELL BIOL, V10, P501, DOI 10.1128/MCB.10.2.501; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Tabata T, 2000, J NEUROSCI METH, V104, P45, DOI 10.1016/S0165-0270(00)00323-X; Tabb JS, 1998, J CELL SCI, V111, P3221; Takagishi Y, 1996, NEUROSCI LETT, V215, P169, DOI 10.1016/S0304-3940(96)12967-0; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Tilelli CQ, 2003, NEUROSCIENCE, V121, P573, DOI 10.1016/S0306-4522(03)00546-3; Toresson H, 2005, EUR J NEUROSCI, V22, P1793, DOI 10.1111/j.1460-9568.2005.04342.x; Ueda H, 2010, P NATL ACAD SCI USA, V107, P6894, DOI 10.1073/pnas.0911482107; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Watanabe M, 2005, MOL BIOL CELL, V16, P4519, DOI 10.1091/mbc.E05-03-0252; Wollert T, 2002, J CELL BIOL, V159, P571, DOI 10.1083/jcb.200204065; Woolner S, 2009, TRENDS CELL BIOL, V19, P245, DOI 10.1016/j.tcb.2009.03.003; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Yengo CM, 2002, BIOCHEMISTRY-US, V41, P8508, DOI 10.1021/bi015969u; Yokota E, 2009, J EXP BOT, V60, P197, DOI 10.1093/jxb/ern280	63	135	138	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2011	13	1					40	U101		10.1038/ncb2132	http://dx.doi.org/10.1038/ncb2132			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697GV	21151132	Green Accepted			2022-12-25	WOS:000285502200009
J	Burgess, P; Hutt, PB; Farokhzad, OC; Langer, R; Minick, S; Zale, S				Burgess, Paul; Hutt, Peter Barton; Farokhzad, Omid C.; Langer, Robert; Minick, Scott; Zale, Stephen			On firm ground: IP protection of therapeutic nanoparticles	NATURE BIOTECHNOLOGY			English	Editorial Material									[Burgess, Paul; Minick, Scott; Zale, Stephen] BIND Biosci, Cambridge, MA USA; [Hutt, Peter Barton] Covington & Burling Associates, Washington, DC USA; [Farokhzad, Omid C.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Farokhzad, Omid C.] Harvard Univ, Sch Med, Boston, MA USA; [Langer, Robert] MIT, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Burgess, P (corresponding author), BIND Biosci, Cambridge, MA USA.	paulburgess@bindbio.com		Farokhzad, Omid/0000-0003-2009-270X				DAVIS M, 2006, NANOTECHNOL LAW  SEP, P255; Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m; *ORTH PROD LP, 2008, DOX PROD INF; U. S. Food and Drug Administration Department of Health and Human Services Office of Generic Drugs, 2010, DRAFT GUID DOX HYDR; U.S. Food & Drug Administration, 2003, GUID IND BIOAV BIOEQ; *US FDA, 2007, CRIT PATH OPP GEN DR; US Food & Drug Administration, OR BOOK APPR DRUG PR	7	62	65	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2010	28	12					1267	1271		10.1038/nbt.1725	http://dx.doi.org/10.1038/nbt.1725			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	691NP	21139609				2022-12-25	WOS:000285088400017
J	Lam, HM; Xu, X; Liu, X; Chen, WB; Yang, GH; Wong, FL; Li, MW; He, WM; Qin, N; Wang, B; Li, J; Jian, M; Wang, JA; Shao, GH; Wang, J; Sun, SSM; Zhang, GY				Lam, Hon-Ming; Xu, Xun; Liu, Xin; Chen, Wenbin; Yang, Guohua; Wong, Fuk-Ling; Li, Man-Wah; He, Weiming; Qin, Nan; Wang, Bo; Li, Jun; Jian, Min; Wang, Jian; Shao, Guihua; Wang, Jun; Sun, Samuel Sai-Ming; Zhang, Gengyun			Resequencing of 31 wild and cultivated soybean genomes identifies patterns of genetic diversity and selection	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; SEQUENCE; DOMESTICATION; HYPOTHESIS; MODEL; MAP	We report a large-scale analysis of the patterns of genome-wide genetic variation in soybeans. We re-sequenced a total of 17 wild and 14 cultivated soybean genomes to an average of approximately x5 depth and > 90% coverage using the Illumina Genome Analyzer II platform. We compared the patterns of genetic variation between wild and cultivated soybeans and identified higher allelic diversity in wild soybeans. We identified a high level of linkage disequilibrium in the soybean genome, suggesting that marker-assisted breeding of soybean will be less challenging than map-based cloning. We report linkage disequilibrium block location and distribution, and we identified a set of 205,614 tag SNPs that may be useful for QTL mapping and association studies. The data here provide a valuable resource for the analysis of wild soybeans and to facilitate future breeding and quantitative trait analysis.	[Lam, Hon-Ming; Liu, Xin; Wong, Fuk-Ling; Li, Man-Wah; Shao, Guihua; Sun, Samuel Sai-Ming] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China; [Xu, Xun; Zhang, Gengyun] BGI Shenzhen, Key Lab Genom, Minist Agr, Shenzhen, Peoples R China; [Shao, Guihua] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Lam, Hon-Ming; Liu, Xin; Wong, Fuk-Ling; Li, Man-Wah; Shao, Guihua; Sun, Samuel Sai-Ming] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Beijing Genomics Institute (BGI); Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; University of Copenhagen; Chinese University of Hong Kong	Lam, HM (corresponding author), Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China.	honming@cuhk.edu.hk; wangj@genomics.cn; ssun@cuhk.edu.hk; zhanggengyun@genomics.cn	Xu, Xun/AAI-6763-2020; Li, Man-Wah/AAZ-5631-2021; Lam, Hon-Ming/A-9866-2008; wang, jian/GVS-0711-2022; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Xu, Xun/0000-0002-5338-5173; Li, Man-Wah/0000-0003-4859-5683; Lam, Hon-Ming/0000-0002-6673-8740; Wang, Jun/0000-0002-2113-5874; Liu, Xin/0000-0003-3256-2940; Wang, Jun/0000-0002-8540-8931	Hong Kong RGC [468610]; Hong Kong UGC AoE Center for Plant and Agricultural Biotechnology [AoE-B-07/09]; Resource Allocation Committee; Chinese University of Hong Kong; National Natural Science Foundation of China [30725008]; Chinese 973 program [2007CB815703, 2007CB815705]; Chinese Ministry of Agriculture; Shenzhen Municipal Government of China; Shenzhen Bureau of Science Technology & Information, China [ZYC200903240077A, CXB200903110066A]	Hong Kong RGC(Hong Kong Research Grants Council); Hong Kong UGC AoE Center for Plant and Agricultural Biotechnology; Resource Allocation Committee; Chinese University of Hong Kong(Chinese University of Hong Kong); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 973 program(National Basic Research Program of China); Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); Shenzhen Municipal Government of China; Shenzhen Bureau of Science Technology & Information, China	T. Han, X. Yan, H. Liao, B. Zhuang and Y.-K. Lau provided valuable advice, information and other aid. This work was partially supported by the Hong Kong RGC General Research Fund 468610 (to H.-M.L.), the Hong Kong UGC AoE Center for Plant and Agricultural Biotechnology Project AoE-B-07/09 and a special fund from the Resource Allocation Committee, The Chinese University of Hong Kong (to H.-M.L. and S. S.-M.S.). We also acknowledge the funding support from the National Natural Science Foundation of China (30725008), the Chinese 973 program (2007CB815703; 2007CB815705), Chinese Ministry of Agriculture (948 program), the Shenzhen Municipal Government of China and grants from Shenzhen Bureau of Science Technology & Information, China (ZYC200903240077A; CXB200903110066A). We thank L. Goodman for assistance in editing the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hernandez RD, 2007, SCIENCE, V316, P240, DOI 10.1126/science.1140462; Huang ZhongWen, 2008, Acta Agronomica Sinica, V34, P944, DOI 10.3724/SP.J.1006.2008.00944; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HYMOWITZ T, 1983, ECON BOT, V37, P371, DOI 10.1007/BF02904196; HYMOWITZ T, 1970, ECON BOT, V24, P408, DOI 10.1007/BF02860745; Hyten DL, 2007, GENETICS, V175, P1937, DOI 10.1534/genetics.106.069740; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li HY, 2010, THEOR APPL GENET, V120, P1405, DOI 10.1007/s00122-010-1264-2; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu B, 2007, ANN BOT-LONDON, V100, P1027, DOI 10.1093/aob/mcm149; Lu J, 2006, TRENDS GENET, V22, P126, DOI 10.1016/j.tig.2006.01.004; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Pritchard JK, 2000, GENETICS, V155, P945; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005	47	726	796	6	282	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2010	42	12					1053	U41		10.1038/ng.715	http://dx.doi.org/10.1038/ng.715			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684UZ	21076406				2022-12-25	WOS:000284578800007
J	Martins, PAD; Salic, K; Gladka, MM; Armand, AS; Leptidis, S; el Azzouzit, H; Hansen, A; Coenen-de Roo, CJ; Bierhuizen, MF; van der Nagel, R; van Kuik, J; de Weger, R; de Bruin, A; Condorelli, G; Arbones, ML; Eschenhagen, T; De Windt, LJ				Martins, Paula A. da Costa; Salic, Kanita; Gladka, Monika M.; Armand, Anne-Sophie; Leptidis, Stefanos; el Azzouzit, Hamid; Hansen, Arne; Coenen-de Roo, Christina J.; Bierhuizen, Marti F.; van der Nagel, Roel; van Kuik, Joyce; de Weger, Roel; de Bruin, Alain; Condorelli, Gianluigi; Arbones, Maria L.; Eschenhagen, Thomas; De Windt, Leon J.			MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling	NATURE CELL BIOLOGY			English	Article							HYPERTROPHY IN-VIVO; CARDIAC-HYPERTROPHY; HEART-FAILURE; NFAT; EXPRESSION; CARDIOMYOCYTES; PROLIFERATION; ANTAGOMIRS; PROTEIN; MODEL	MicroRNAs (miRs) are a class of single-stranded, non-coding RNAs of about 22 nucleotides in length(1,2). Increasing evidence implicates miRs in myocardial disease processes(3-11). Here we show that miR-199b is a direct calcineurin/NFAT target gene that increases in expression in mouse and human heart failure, and targets the nuclear NFAT kinase dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1a (Dyrk1a), constituting a pathogenic feed forward mechanism that affects calcineurin-responsive gene expression. Mutant mice overexpressing miR-199b, or haploinsufficient for Dyrk1a, are sensitized to calcineurin/NFAT signalling or pressure overload and show stress-induced cardiomegaly through reduced Dyrk1a expression. In vivo inhibition of miR-199b by a specific antagomir normalized Dyrk1a expression, reduced nuclear NFAT activity and caused marked inhibition and even reversal of hypertrophy and fibrosis in mouse models of heart failure. Our results reveal that microRNAs affect cardiac cellular signalling and gene expression, and implicate miR-199b as a therapeutic target in heart failure.	[Martins, Paula A. da Costa; Salic, Kanita; Leptidis, Stefanos; el Azzouzit, Hamid; De Windt, Leon J.] Maastricht Univ, Dept Cardiol, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Martins, Paula A. da Costa; Salic, Kanita; Gladka, Monika M.; Leptidis, Stefanos; el Azzouzit, Hamid] Royal Netherlands Acad Sci, Hubrecht Inst, Utrecht, Netherlands; [Martins, Paula A. da Costa; Salic, Kanita; Gladka, Monika M.; Leptidis, Stefanos; el Azzouzit, Hamid] Royal Netherlands Acad Sci, Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Armand, Anne-Sophie] Univ Paris 05, CNRS, Ctr Etud Sensori Motricite, UMR 8194, F-75270 Paris 06, France; [Hansen, Arne] Univ Med Ctr Hamburg Eppendorf, Inst Expt & Clin Pharmacol & Toxicol, D-20246 Hamburg, Germany; [Coenen-de Roo, Christina J.] Harlan Labs, Horst, Netherlands; [Bierhuizen, Marti F.; van der Nagel, Roel] Univ Med Ctr Utrecht, Dept Med Physiol, Utrecht, Netherlands; [van Kuik, Joyce; de Weger, Roel] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [de Bruin, Alain] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [Condorelli, Gianluigi] CNR, Inst Biomed Technol, I-20090 Milan, Italy; [Arbones, Maria L.] Ctr Genom Regulat CRG, Barcelona 08003, Spain; [Arbones, Maria L.] Ctr Regulacio Genom, CIBERER, Barcelona 08003, Spain	Maastricht University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Hamburg; University Medical Center Hamburg-Eppendorf; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	De Windt, LJ (corresponding author), Maastricht Univ, Dept Cardiol, Cardiovasc Res Inst Maastricht, POB 616, Maastricht, Netherlands.	l.dewindt@maastrichtuniversity.nl	Leptidis, Stefanos/D-1455-2016; de Windt, Leon/AAO-6395-2020; Arbones, Maria/D-4668-2016; de Bruin, Alain/AAL-9195-2020; Condorelli, Gianluigi/Q-6736-2017	Leptidis, Stefanos/0000-0003-0172-4193; de Windt, Leon/0000-0002-7793-2856; Arbones, Maria/0000-0002-6035-0235; el Azzouzi, Hamid/0000-0003-1242-9691; Armand, Anne-Sophie/0000-0002-0291-6421; de Bruin, Alain/0000-0001-8579-2649; Gladka, Monika/0000-0002-4094-4335; Condorelli, Gianluigi/0000-0003-0481-6843	European Society of Cardiology; Netherlands Organization for Health Research and Development [912-04-054, 912-04-017, 917-863-72]; Netherlands Heart Foundation [NHS2007B167]; Fondation Leducq Transatlantic [08-CVD-03]	European Society of Cardiology; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Heart Foundation(Netherlands Heart Foundation); Fondation Leducq Transatlantic	We gratefully acknowledge T. Seidler and J. Molkentin for adenoviruses; R. Hesdahl and D. Bogaert for logistical and technical support; and members of the De Windt laboratory for technical support and helpful discussions. P.D.C.M. was supported by a Heart Failure Association Research Fellowship from the European Society of Cardiology. L.D.W. was supported by grants 912-04-054, 912-04-017 and a VIDI award 917-863-72 from the Netherlands Organization for Health Research and Development and the Netherlands Heart Foundation program grant NHS2007B167. G.C. and L.D.W were supported by the Fondation Leducq Transatlantic Network of Excellence program 08-CVD-03.	Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bourajjaj M, 2008, J BIOL CHEM, V283, P22295, DOI 10.1074/jbc.M801296200; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; De Windt LJ, 2000, J BIOL CHEM, V275, P13571, DOI 10.1074/jbc.275.18.13571; De Windt LJ, 2000, CIRC RES, V86, P255, DOI 10.1161/01.RES.86.3.255; De Windt LJ, 2001, P NATL ACAD SCI USA, V98, P3322, DOI 10.1073/pnas.031371998; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Gurda GT, 2008, MOL BIOL CELL, V19, P198, DOI 10.1091/mbc.E07-05-0430; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hoshijima M, 2002, J CLIN INVEST, V109, P849, DOI 10.1172/JCI15380; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Kuhn C, 2009, J BIOL CHEM, V284, P17320, DOI 10.1074/jbc.M109.006759; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Martins PADC, 2008, CIRCULATION, V118, P1567, DOI 10.1161/CIRCULATIONAHA.108.769984; MATKOVICH SJ, CIRC RES, V106, P166; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Rybkin II, 2003, J BIOL CHEM, V278, P15927, DOI 10.1074/jbc.M213102200; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van Rooij E, 2004, CIRC RES, V94, pE18, DOI 10.1161/01.RES.0000118597.54416.00; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wilkins BJ, 2002, MOL CELL BIOL, V22, P7603, DOI 10.1128/MCB.22.21.7603-7613.2002; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569	33	215	222	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2010	12	12					1220	U231		10.1038/ncb2126	http://dx.doi.org/10.1038/ncb2126			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	688DY	21102440				2022-12-25	WOS:000284831200014
J	Xiong, YY; Chen, XS; Chen, ZD; Wang, XZ; Shi, SH; Wang, XQ; Zhang, JZ; He, XL				Xiong, Yuanyan; Chen, Xiaoshu; Chen, Zhidong; Wang, Xunzhang; Shi, Suhua; Wang, Xueqin; Zhang, Jianzhi; He, Xionglei			RNA sequencing shows no dosage compensation of the active X-chromosome	NATURE GENETICS			English	Article							GENE-EXPRESSION; UP-REGULATION; MOUSE; SEX; REPRODUCIBILITY; TRANSCRIPTOME; EVOLUTION	Mammalian cells from both sexes typically contain one active X chromosome but two sets of autosomes. It has previously been hypothesized that X-linked genes are expressed at twice the level of autosomal genes per active allele to balance the gene dose between the X chromosome and autosomes (termed 'Ohno's hypothesis'). This hypothesis was supported by the observation that microarray-based gene expression levels were indistinguishable between one X chromosome and two autosomes (the X to two autosomes ratio (X:AA) similar to 1). Here we show that RNA sequencing (RNA-Seq) is more sensitive than microarray and that RNA-Seq data reveal an X: AA ratio of similar to 0.5 in human and mouse. In Caenorhabditis elegans hermaphrodites, the X:AA ratio reduces progressively from similar to 1 in larvae to similar to 0.5 in adults. Proteomic data are consistent with the RNA-Seq results and further suggest the lack of X upregulation at the protein level. Together, our findings reject Ohno's hypothesis, necessitating a major revision of the current model of dosage compensation in the evolution of sex chromosomes.	[Zhang, Jianzhi] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Xiong, Yuanyan; Chen, Xiaoshu; Chen, Zhidong; Wang, Xunzhang; Shi, Suhua; He, Xionglei] Sun Yat Sen Univ, Coll Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Xueqin] Sun Yat Sen Univ, Sch Math & Computat Sci, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Xueqin] Sun Yat Sen Univ, Zhongshan Med Sch, Guangzhou 510275, Guangdong, Peoples R China; [He, Xionglei] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China	University of Michigan System; University of Michigan; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Sciences; Kunming Institute of Zoology	Zhang, JZ (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	jianzhi@umich.edu; hexiongl@mail.sysu.edu.cn		xiong, yuanyan/0000-0002-3227-5215	US National Institutes of Health; National Natural Science Foundation of China [90717115, 30871371, 11001280]; Tianyuan Fund for Mathematics [10926200]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianyuan Fund for Mathematics(National Natural Science Foundation of China (NSFC))	We thank B.-Y. Liao for sharing his processed mouse proteomic data, Y. Jiang for assistance in statistical analysis and B.-Y. Liao, J. Lu, O. Podlaha, P. Shi, W. Qian, C.-I. Wu and Y. Xing for valuable comments. Part of the work was conducted in the laboratory of Peng Shi at the State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology. This work was supported by research grants from the US National Institutes of Health (to J.Z.), the National Natural Science Foundation of China (90717115 and 30871371 to X. H.; 11001280 to Xueqin Wang) and the Tianyuan Fund for Mathematics (10926200 to Xueqin Wang).	Adler DA, 1997, P NATL ACAD SCI USA, V94, P9244, DOI 10.1073/pnas.94.17.9244; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Ellegren H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-40; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; GUPTA V, 2006, J BIOL-LONDON, V5, pNIL8; Held GA, 2003, P NATL ACAD SCI USA, V100, P7575, DOI 10.1073/pnas.0832500100; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Itoh Y., 2007, J BIOL, V6; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Lahn BT, 2001, NAT REV GENET, V2, P207, DOI 10.1038/35056058; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Lin H, 2007, PLOS BIOL, V5, P2809, DOI 10.1371/journal.pbio.0050326; Mank JE, 2009, TRENDS GENET, V25, P226, DOI 10.1016/j.tig.2009.03.005; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Meyer BJ, 2004, COLD SPRING HARB SYM, V69, P71, DOI 10.1101/sqb.2004.69.71; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nacher JC, 2007, CELL BIOCHEM BIOPHYS, V49, P37, DOI 10.1007/s12013-007-0040-7; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Ohno S., 1967, SEX CHROMOSOMES SEX; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Qian WF, 2008, GENETICS, V179, P2319, DOI 10.1534/genetics.108.090936; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; Smith AM, 2009, GENOME RES, V19, P1836, DOI 10.1101/gr.093955.109; Straub T, 2007, NAT REV GENET, V8, P47, DOI 10.1038/nrg2013; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Vicoso B, 2006, NAT REV GENET, V7, P645, DOI 10.1038/nrg1914; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zha XF, 2009, INSECT BIOCHEM MOLEC, V39, P315, DOI 10.1016/j.ibmb.2008.12.003	38	151	152	0	68	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2010	42	12					1043	U29		10.1038/ng.711	http://dx.doi.org/10.1038/ng.711			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684UZ	21102464				2022-12-25	WOS:000284578800005
J	Thorne, CA; Hanson, AJ; Schneider, J; Tahinci, E; Orton, D; Cselenyi, CS; Jernigan, KK; Meyers, KC; Hang, BI; Waterson, AG; Kim, K; Melancon, B; Ghidu, VP; Sulikowski, GA; LaFleur, B; Salic, A; Lee, LA; Miller, DM; Lee, E				Thorne, Curtis A.; Hanson, Alison J.; Schneider, Judsen; Tahinci, Emilios; Orton, Darren; Cselenyi, Christopher S.; Jernigan, Kristin K.; Meyers, Kelly C.; Hang, Brian I.; Waterson, Alex G.; Kim, Kwangho; Melancon, Bruce; Ghidu, Victor P.; Sulikowski, Gary A.; LaFleur, Bonnie; Salic, Adrian; Lee, Laura A.; Miller, David M., III; Lee, Ethan			Small-molecule inhibition of Wnt signaling through activation of casein kinase 1 alpha	NATURE CHEMICAL BIOLOGY			English	Article							BETA-CATENIN; NEGATIVE REGULATOR; C-ELEGANS; ANTITUMOR-ACTIVITY; PYRVINIUM PAMOATE; COLORECTAL-CANCER; XENOPUS EMBRYOS; I FAMILY; PATHWAY; AXIN	Wnt/beta-catenin signaling is critically involved in metazoan development, stem cell maintenance and human disease. Using Xenopus laevis egg extract to screen for compounds that both stabilize Axin and promote beta-catenin turnover, we identified an FDA-approved drug, pyrvinium, as a potent inhibitor of Wnt signaling (EC(50) of similar to 10 nM). We show pyrvinium binds all casein kinase 1 (CK1) family members in vitro at low nanomolar concentrations and pyrvinium selectively potentiates casein kinase 1 alpha (CK1 alpha) kinase activity. CK1 alpha knockdown abrogates the effects of pyrvinium on the Wnt pathway. In addition to its effects on Axin and beta-catenin levels, pyrvinium promotes degradation of Pygopus, a Wnt transcriptional component. Pyrvinium treatment of colon cancer cells with mutation of the gene for adenomatous polyposis coli (APC) or beta-catenin inhibits both Wnt signaling and proliferation. Our findings reveal allosteric activation of CK1 alpha as an effective mechanism to inhibit Wnt signaling and highlight a new strategy for targeted therapeutics directed against the Wnt pathway.	[Thorne, Curtis A.; Hanson, Alison J.; Schneider, Judsen; Tahinci, Emilios; Cselenyi, Christopher S.; Jernigan, Kristin K.; Meyers, Kelly C.; Hang, Brian I.; Lee, Laura A.; Miller, David M., III; Lee, Ethan] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37203 USA; [Orton, Darren; Waterson, Alex G.; Kim, Kwangho; Melancon, Bruce; Ghidu, Victor P.; Sulikowski, Gary A.; Lee, Ethan] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN USA; [Orton, Darren] StemSynergy Therapeut Inc, Lauderdale By The Sea, FL USA; [LaFleur, Bonnie] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Lee, Laura A.; Lee, Ethan] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Salic, Adrian] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Harvard University; Harvard Medical School	Thorne, CA (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37203 USA.	ethan.lee@vanderbilt.edu	Salic, Adrian/GXG-1611-2022; LaFleur, Bonnie J/GPJ-9592-2022	LaFleur, Bonnie J/0000-0002-4939-9337	American Cancer Society [RSG-05-126-01, IRG-58-009-46]; National Cancer Institute [GI SPORE P50 CA95103]; Mouse Models of Human Cancers Consortium [5U01 CA084239]; US National Institutes of Health [1 R01 GM081635-01, 1 R01 NS26115, T32 CA09592]; American Heart Association [0615279B, 0615162B]; Molecular Endocrinology [5 T 32 DK007563]; Training Program in Developmental Biology (National Institute of Child Health and Human Development) [5 T32 HD007502]; US National Institute of General Medical Studies [T32 GM007347]; Pew Scholarship in the Biomedical Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007502] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485, P50CA095103, T32CA009592, R33CA086243, U01CA084239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, T32DK007563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081635, T32GM007347, P50GM015431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026115] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mouse Models of Human Cancers Consortium; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Molecular Endocrinology; Training Program in Developmental Biology (National Institute of Child Health and Human Development)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); US National Institute of General Medical Studies; Pew Scholarship in the Biomedical Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Lee laboratory, K. Gould, V. Siegel and R. Roberts-Galbraith for critical reading of the manuscript; J. Merkle for help with Drosophila S2 cell culture; members of the Institute of Chemistry and Cell Biology-Longwood for assistance with screening; M. Beinz, K. Basler, J. Nathans, R. Nusse, S. Hiebert, R. Coffey, B. Gumbiner and M. Lenardo for reagents. Nematode strains were obtained from the C. elegans Genetics Center, which is supported by the US National Institutes of Health National Center for Research Resources. This work was supported by American Cancer Society Research Scholar Grant RSG-05-126-01, American Cancer Society Institutional Research Grant IRG-58-009-46, National Cancer Institute Grant GI SPORE P50 CA95103, Mouse Models of Human Cancers Consortium (US National Institutes of Health-National Cancer Institute) 5U01 CA084239, US National Institutes of Health Grant 1 R01 GM081635-01 (E.L.); US National Institutes of Health Grant 1 R01 NS26115 (D.M.M.); American Heart Association Predoctoral Fellowship 0615279B, Molecular Endocrinology Training Grant 5 T 32 DK007563, Training Program in Developmental Biology 5 T32 HD007502 (National Institute of Child Health and Human Development) (C.A.T.); US National Institute of General Medical Studies Medical-Scientist Training Grant 5 T32 GM007347 (C.S.C. and A.J.H.); American Heart Association Predoctoral Fellowships 0615162B, US National Institutes of Health Cancer Biology Training Grant T32 CA09592 (K.K.J.). E.L. is a recipient of a Pew Scholarship in the Biomedical Sciences.	Aoki M, 1999, P NATL ACAD SCI USA, V96, P139, DOI 10.1073/pnas.96.1.139; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; de la Roche M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-199; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Downey AS, 2008, ANTIMICROB AGENTS CH, V52, P3106, DOI 10.1128/AAC.00207-08; Esumi H, 2004, CANCER SCI, V95, P685, DOI 10.1111/j.1349-7006.2004.tb03330.x; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Gleason JE, 2002, GENE DEV, V16, P1281, DOI 10.1101/gad.981602; Goenka S, 2006, P NATL ACAD SCI USA, V103, P4210, DOI 10.1073/pnas.0506981103; Hammerlein A, 2005, CELL MOL LIFE SCI, V62, P606, DOI 10.1007/s00018-005-4507-7; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hempelmann E, 2007, PARASITOL RES, V100, P671, DOI 10.1007/s00436-006-0313-x; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jones JO, 2009, P NATL ACAD SCI USA, V106, P7233, DOI 10.1073/pnas.0807282106; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Kofron M, 2007, DEVELOPMENT, V134, P503, DOI 10.1242/dev.02739; Korswagen HC, 2002, GENE DEV, V16, P1291, DOI 10.1101/gad.981802; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; LEWIS JA, 1980, GENETICS, V95, P905; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; Mithani SK, 2004, J SURG RES, V117, P296, DOI 10.1016/S0022-4804(03)00335-4; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; Parker DS, 2002, DEVELOPMENT, V129, P2565; PIERRE M, 1983, BIOCHEM BIOPH RES CO, V115, P212, DOI 10.1016/0006-291X(83)90991-9; Polakis P, 2000, GENE DEV, V14, P1837; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Rosenbluth JM, 2008, MOL CELL BIOL, V28, P5951, DOI 10.1128/MCB.00305-08; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Sparks AB, 1998, CANCER RES, V58, P1130; Thompson B, 2002, NAT CELL BIOL, V4, P367, DOI 10.1038/ncb786; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Whangbo J, 1999, MOL CELL, V4, P851, DOI 10.1016/S1097-2765(00)80394-9; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Yu DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003951	50	360	374	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2010	6	11					829	836		10.1038/NCHEMBIO.453	http://dx.doi.org/10.1038/NCHEMBIO.453			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	667MP	20890287	Green Accepted			2022-12-25	WOS:000283197800012
J	Feinberg, AP				Feinberg, Andrew P.			Epigenomics reveals a functional genome anatomy and a new approach to common disease	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; CPG ISLAND SHORES; DNA METHYLATION; ANTISENSE RNA; CANCER; CHROMATIN; GENES; TRANSCRIPTION; ORGANIZATION; PLURIPOTENT		[Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD 21218 USA; [Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Feinberg, AP (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD 21218 USA.	afeinberg@jhu.edu	Feinberg, Andrew/AAY-7666-2020	Feinberg, Andrew/0000-0002-8364-1991	NCI NIH HHS [R37 CA054358, R37 CA054358-19, R01 CA054358, 5R37CA054358] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA054358, R37CA054358] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barton N. H., 2007, EVOLUTION; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bjornsson HT, 2004, TRENDS GENET, V20, P350, DOI 10.1016/j.tig.2004.06.009; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; CROSSLEY M, 1993, CURR OPIN GENET DEV, V3, P232, DOI 10.1016/0959-437X(93)90028-N; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gondor A, 2009, NATURE, V461, P212, DOI 10.1038/nature08453; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jiang YH, 2004, ANNU REV GENOM HUM G, V5, P479, DOI 10.1146/annurev.genom.5.061903.180014; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; MacFarlane LA, 2010, MOL ENDOCRINOL, V24, P800, DOI 10.1210/me.2009-0367; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McKusick VA, 2001, JAMA-J AM MED ASSOC, V286, P2289, DOI 10.1001/jama.286.18.2289; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Petronis A, 1999, SCHIZOPHRENIA BULL, V25, P639, DOI 10.1093/oxfordjournals.schbul.a033408; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; PROUDFOOT NJ, 1980, SCIENCE, V209, P1329, DOI 10.1126/science.6158093; Sandhu KS, 2009, GENE DEV, V23, P2598, DOI 10.1101/gad.552109; Satterlee JS, 2010, NAT BIOTECHNOL, V28, P1039, DOI 10.1038/nbt1010-1039; Schwartz YB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000805; Smith ST, 2009, DEV BIOL, V328, P518, DOI 10.1016/j.ydbio.2008.12.039; VANSTEENSEL B, 2010, J NAT BIOTECHNOL, V28, P1089; Vesalius Andreas, 1543, HUMANI CORPORIFABR; VIVILLE S, 1995, BIOESSAYS, V17, P835, DOI 10.1002/bies.950171004; Wade N., 2010, NY TIMES        0612; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468	42	88	91	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2010	28	10					1049	1052		10.1038/nbt1010-1049	http://dx.doi.org/10.1038/nbt1010-1049			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	663GF	20944596	Green Accepted			2022-12-25	WOS:000282870500026
J	Greten, FR; Karin, M				Greten, Florian R.; Karin, Michael			JAKi rips STAT3 in cancer	NATURE MEDICINE			English	Editorial Material							NF-KAPPA-B; INFLAMMATION; IMMUNITY; TUMORIGENESIS; PROGRESSION		[Greten, Florian R.] Tech Univ Munich, Dept Med 2, Klinikum Rechts Isar, Munich, Germany; [Karin, Michael] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Technical University of Munich; University of California System; University of California San Diego	Greten, FR (corresponding author), Tech Univ Munich, Dept Med 2, Klinikum Rechts Isar, Munich, Germany.	florian.greten@lrz.tum.de; karinoffice@ucsd.edu	Greten, Florian R/AAF-5196-2020	Greten, Florian R/0000-0002-3928-6080				Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; O'Shea JJ, 2005, CURR OPIN RHEUMATOL, V17, P305, DOI 10.1097/01.bor.0000160781.07174.db; Pardanani A, 2008, LEUKEMIA, V22, P23, DOI 10.1038/sj.leu.2404948; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	13	11	11	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2010	16	10					1085	1087		10.1038/nm1010-1085	http://dx.doi.org/10.1038/nm1010-1085			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20930749				2022-12-25	WOS:000282644800035
J	Zhou, DW; Liu, KM; Sun, CW; Pawlik, KM; Townes, TM				Zhou, Dewang; Liu, Kaimao; Sun, Chiao-Wang; Pawlik, Kevin M.; Townes, Tim M.			KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching	NATURE GENETICS			English	Article							KRUPPEL-LIKE FACTOR; TRANSGENIC MICE; FACTOR EKLF; REGION	We show that knockdown of KLF1 in human and mouse adult erythroid progenitors markedly reduces BCL11A levels and increases human. gamma-globin/beta-globin expression ratios. These results suggest that KLF1 controls globin gene switching by directly activating beta-globin and indirectly repressing gamma-globin gene expression. Controlled knockdown of KLF1 in adult erythroid progenitors may provide a method to activate fetal hemoglobin expression in individuals with. beta-thalassemia or sickle cell disease.	[Townes, Tim M.] Univ Alabama, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; Univ Alabama, Sch Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; Univ Alabama, Sch Med, Stem Cell Inst, Birmingham, AL USA; Univ Alabama, Sch Dent, Stem Cell Inst, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Townes, TM (corresponding author), Univ Alabama, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA.	ttownes@uab.edu			US National Institutes of Health [1R01 DK073391]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073391] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank L. Lamb for purification of CD34+ cells from mobilized peripheral blood mononuclear cells, T. Ley for the human beta-globin BAC and S. McConnell for help with qRT-PCR. This work was supported by a grant from the US National Institutes of Health (1R01 DK073391).	BEHRINGER RR, 1990, GENE DEV, V4, P380, DOI 10.1101/gad.4.3.380; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; DONZE D, 1995, J BIOL CHEM, V270, P1955, DOI 10.1074/jbc.270.4.1955; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; ENVER T, 1990, NATURE, V344, P309, DOI 10.1038/344309a0; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Perkins AC, 1996, P NATL ACAD SCI USA, V93, P12267, DOI 10.1073/pnas.93.22.12267; Ryan TM, 2000, NUCLEIC ACIDS RES, V28, P2736, DOI 10.1093/nar/28.14.2736; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Tewari R, 1998, EMBO J, V17, P2334, DOI 10.1093/emboj/17.8.2334; TOWNES TM, 1990, TRENDS GENET, V6, P219, DOI 10.1016/0168-9525(90)90182-6; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Xue L, 2004, BLOOD, V103, P4078, DOI 10.1182/blood-2003-09-3231; Zhou DW, 2006, J BIOL CHEM, V281, P16052, DOI 10.1074/jbc.M601182200	15	265	277	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					742	744		10.1038/ng.637	http://dx.doi.org/10.1038/ng.637			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20676097				2022-12-25	WOS:000281388400006
J	Ullrich, SJ; Hellmich, UA; Ullrich, S; Glaubitz, C				Ullrich, Sandra J.; Hellmich, Ute A.; Ullrich, Stefan; Glaubitz, Clemens			Interfacial enzyme kinetics of a membrane bound kinase analyzed by real-time MAS-NMR	NATURE CHEMICAL BIOLOGY			English	Article							COLI DIACYLGLYCEROL KINASE; ESCHERICHIA-COLI; SN-1,2-DIACYLGLYCEROL KINASE; PHOSPHOROTHIOATE ANALOGS; TRANSITION-STATE; PROTEIN; ATP; HYDROLYSIS; SITES; LOCALIZATION	The simultaneous observation of interdependent reactions within different phases as catalyzed by membrane-bound enzymes is still a challenging task. One such enzyme, the Escherichia coli integral membrane protein diacylglycerol kinase (DGK), is a key player in lipid regulation. It catalyzes the generation of phosphatidic acid within the membrane through the transfer of the gamma-phosphate from soluble MgATP to membrane-bound diacylglycerol. We demonstrate that time-resolved P-31 magic angle spinning NMR offers a unique opportunity to simultaneously and directly detect both ATP hydrolysis and diacylglycerol phosphorylation. This experiment demonstrates that solid-state NMR provides a general approach for the kinetic analysis of coupled reactions at the membrane interface regardless of their compartmentalization. The enzymatic activity of DGK was probed with different lipid substrates as well as ATP analogs. Our data yield conclusions about intersubunit cooperativity, reaction stoichiometries and phosphoryl transfer mechanism and are discussed in the context of known structural data.	[Ullrich, Sandra J.; Hellmich, Ute A.; Glaubitz, Clemens] Goethe Univ Frankfurt, Inst Biophys Chem, Frankfurt, Germany; [Ullrich, Sandra J.; Hellmich, Ute A.; Glaubitz, Clemens] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Frankfurt, Germany; [Ullrich, Stefan] Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Glaubitz, C (corresponding author), Goethe Univ Frankfurt, Inst Biophys Chem, Frankfurt, Germany.	glaubitz@em.uni-frankfurt.de	Glaubitz, Clemens/D-5714-2011	Glaubitz, Clemens/0000-0002-3554-6586; Hellmich, Ute/0000-0001-7162-285X	Lipid Signalling Forschungszentrum Frankfurt (LiFF); SFB [807]; EU; Cluster of Excellence Macromolecular Complexes Frankfurt; Studienstiftung des deutschen Volkes	Lipid Signalling Forschungszentrum Frankfurt (LiFF); SFB(Austrian Science Fund (FWF)); EU(European Commission); Cluster of Excellence Macromolecular Complexes Frankfurt; Studienstiftung des deutschen Volkes	We are grateful to J. Becker Baldus, L. Buchner, S. Holper, C. Kaiser, N. Pfleger and L. Reggie for technical assistance. Plasmids were kindly provided by C. R. Sanders (Vanderbilt University). We thank D. O'Donovan and J.J. Lopez for initial help with data analysis. We thank M. Gobel for enabling access to his laboratory for substrate synthesis and B. Ludwig for helpful discussions. M. Lorch is acknowledged for valuable comments to the manuscript. The work was supported by the Lipid Signalling Forschungszentrum Frankfurt (LiFF) and by SFB 807 "Membrane Transport." Further support by the EU consortium Lipid-PRISM and the Cluster of Excellence Macromolecular Complexes Frankfurt is acknowledged. S.J.U. is grateful for a stipend from the "Studienstiftung des deutschen Volkes."	ALBERY WJ, 1977, ANGEW CHEM INT EDIT, V16, P285, DOI 10.1002/anie.197702851; Badola P, 1997, J BIOL CHEM, V272, P24176, DOI 10.1074/jbc.272.39.24176; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Bienkiewicz EA, 1999, J BIOMOL NMR, V15, P203, DOI 10.1023/A:1008375029746; Catrina IE, 1999, J AM CHEM SOC, V121, P2156, DOI 10.1021/ja983862x; Chen P, 1998, J BACTERIOL, V180, P167, DOI 10.1128/JB.180.1.167-170.1998; Cherepanov AV, 2008, P NATL ACAD SCI USA, V105, P8563, DOI 10.1073/pnas.0709140105; Cherepanov AV, 2004, BBA-BIOENERGETICS, V1656, P1, DOI 10.1016/j.bbabio.2004.02.006; Clarke K, 1996, J BIOL CHEM, V271, P21142, DOI 10.1074/jbc.271.35.21142; COHN M, 1962, J BIOL CHEM, V237, P176; COHN M, 1982, ACCOUNTS CHEM RES, V15, P326, DOI 10.1021/ar00082a005; CREPEAU RH, 1994, BIOPHYS J, V66, P1489, DOI 10.1016/S0006-3495(94)80940-3; Czerski L, 2000, ANAL BIOCHEM, V284, P327, DOI 10.1006/abio.2000.4720; Daly CJ, 2003, PHARMACOL THERAPEUT, V100, P101, DOI 10.1016/j.pharmthera.2003.08.001; ECKSTEIN F, 1983, ANGEW CHEM INT EDIT, V22, P423, DOI 10.1002/anie.198304233; ECKSTEIN F, 1985, ANNU REV BIOCHEM, V54, P367, DOI 10.1146/annurev.bi.54.070185.002055; Forneris F, 2008, SCIENCE, V321, P213, DOI 10.1126/science.1151118; FREY PA, 1985, SCIENCE, V228, P541, DOI 10.1126/science.2984773; Goni FM, 2002, FEBS LETT, V531, P38, DOI 10.1016/S0014-5793(02)03482-8; GOODNO CC, 1982, P NATL ACAD SCI-BIOL, V79, P21, DOI 10.1073/pnas.79.1.21; GOODNO CC, 1979, P NATL ACAD SCI USA, V76, P2620, DOI 10.1073/pnas.76.6.2620; Gribble FM, 2000, J BIOL CHEM, V275, P30046, DOI 10.1074/jbc.M001010200; Hellmich UA, 2008, FEBS LETT, V582, P3557, DOI 10.1016/j.febslet.2008.09.033; HOLLFELDER F, 1995, BIOCHEMISTRY-US, V34, P12255, DOI 10.1021/bi00038a021; Hurley JH, 1997, CURR OPIN STRUC BIOL, V7, P557, DOI 10.1016/S0959-440X(97)80122-4; KANOH H, 1990, TRENDS BIOCHEM SCI, V15, P47, DOI 10.1016/0968-0004(90)90172-8; KENNEDY EP, 1982, P NATL ACAD SCI-BIOL, V79, P1092, DOI 10.1073/pnas.79.4.1092; Koehler J, 2010, BIOCHEMISTRY-US, V49, P7089, DOI 10.1021/bi100575s; Lau FW, 1999, BIOCHEMISTRY-US, V38, P5521, DOI 10.1021/bi982763t; Maly T, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2833582; McDermott A, 2007, CURR OPIN STRUC BIOL, V17, P617, DOI 10.1016/j.sbi.2007.10.001; Nagy JK, 2000, BIOCHEMISTRY-US, V39, P4154, DOI 10.1021/bi991781n; Omote H, 2002, J BIOL CHEM, V277, P45688, DOI 10.1074/jbc.M206479200; Oxenoid K, 2002, BIOCHEMISTRY-US, V41, P12876, DOI 10.1021/bi020335o; RAETZ CRH, 1979, J BACTERIOL, V137, P860, DOI 10.1128/JB.137.2.860-868.1979; Rozovsky S, 2007, P NATL ACAD SCI USA, V104, P2080, DOI 10.1073/PNAS.0608876104; Sanders CR, 1996, BIOCHEMISTRY-US, V35, P8610, DOI 10.1021/bi9604892; SCHAAP D, 1994, BIOCHEM J, V304, P661, DOI 10.1042/bj3040661; SCHELLENBERGER A, 1989, ENZYMKATALYSE EINFUH; Smith CA, 1996, BIOPHYS J, V70, P1590, DOI 10.1016/S0006-3495(96)79745-X; Sperling LJ, 2010, J MOL BIOL, V399, P268, DOI 10.1016/j.jmb.2010.04.012; STRATER N, 1996, ANGEW CHEM, V108, P2158; TAKAHASHI K, 1987, J BIOCHEM-TOKYO, V101, P1107, DOI 10.1093/oxfordjournals.jbchem.a121975; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716; Vann LR, 1997, BIOCHEM J, V327, P569; WALSH JP, 1990, J BIOL CHEM, V265, P4374; WALSH JP, 1986, J BIOL CHEM, V261, P6239; Wattenberg BW, 2006, J LIPID RES, V47, P1128, DOI 10.1194/jlr.R600003-JLR200; YAMASHITA Y, 1993, J BACTERIOL, V175, P6220, DOI 10.1128/JB.175.19.6220-6228.1993; Zhang YL, 1999, BIOCHEMISTRY-US, V38, P12111, DOI 10.1021/bi990836i	50	37	37	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2011	7	5					263	270		10.1038/nchembio.543	http://dx.doi.org/10.1038/nchembio.543			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751KZ	21423170				2022-12-25	WOS:000289617800009
J	Alvarez-Erviti, L; Seow, YQ; Yin, HF; Betts, C; Lakhal, S; Wood, MJA				Alvarez-Erviti, Lydia; Seow, Yiqi; Yin, HaiFang; Betts, Corinne; Lakhal, Samira; Wood, Matthew J. A.			Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes	NATURE BIOTECHNOLOGY			English	Article							GENE DELIVERY; BACE1; RNA; PERSPECTIVES; VECTORS; NEURONS; GROWTH; CELLS; MICE	To realize the therapeutic potential of RNA drugs, efficient, tissue-specific and nonimmunogenic delivery technologies must be developed. Here we show that exosomes-endogenous nano-vesicles that transport RNAs and proteins(1,2)-can deliver short interfering (si) RNA to the brain in mice. To reduce immunogenicity, we used self-derived dendritic cells for exosome production. Targeting was achieved by engineering the dendritic cells to express Lamp2b, an exosomal membrane protein, fused to the neuron-specific RVG peptide(3). Purified exosomes were loaded with exogenous siRNA by electroporation. Intravenously injected RVG-targeted exosomes delivered GAPDH siRNA specifically to neurons, microglia, oligodendrocytes in the brain, resulting in a specific gene knockdown. Pre-exposure to RVG exosomes did not attenuate knockdown, and non-specific uptake in other tissues was not observed. The therapeutic potential of exosome-mediated siRNA delivery was demonstrated by the strong mRNA (60%) and protein (62%) knockdown of BACE1, a therapeutic target in Alzheimer's disease, in wild-type mice.	[Alvarez-Erviti, Lydia; Seow, Yiqi; Yin, HaiFang; Betts, Corinne; Lakhal, Samira; Wood, Matthew J. A.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	University of Oxford	Wood, MJA (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	matthew.wood@dpag.ox.ac.uk	Alvarez-Erviti, Lydia/AAW-5850-2021; Seow, Yiqi/ABF-7704-2020; Wood, Matthew/HDN-1469-2022; Alvarez-Erviti, Lydia/B-4353-2011	Betts, Corinne/0000-0003-0579-8843; Alvarez-Erviti, Lydia/0000-0002-1238-9442; Wood, Matthew/0000-0002-5436-6011; Seow, Yiqi/0000-0001-7040-3006	Muscular Dystrophy Ireland; Muscular Dystrophy Campaign (UK); Agency for Science, Technology and Research (Singapore); MRC [G0900887] Funding Source: UKRI; Medical Research Council [G0900887] Funding Source: researchfish; Parkinson&quot;s UK [J-0901, G-0904] Funding Source: researchfish	Muscular Dystrophy Ireland; Muscular Dystrophy Campaign (UK)(Muscular Dystrophy Association); Agency for Science, Technology and Research (Singapore)(Agency for Science Technology & Research (A*STAR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK)	The authors would like to thank I. Sargent and his group, especially A. Brooks, for their assistance with the LM10-HS system, J. Morris for his help with the electron microscopy, D. Morrissey and his laboratory at Novartis, Basel, for supplying the RVG-9R peptide and the Wood laboratory members for critical reading of the manuscript. L. A.-E., C. B. and H. Y. are funded by the Muscular Dystrophy Ireland and the Muscular Dystrophy Campaign (UK). Y. S. is funded by the Agency for Science, Technology and Research (Singapore).	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Flint PW, 2005, LARYNGOSCOPE, V115, P1930, DOI 10.1097/01.mlg.0000172273.98418.8d; Gonzalez SC, 2007, NEUROREPORT, V18, P1609, DOI 10.1097/WNR.0b013e3282f03fe5; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kao SC, 2004, J BIOL CHEM, V279, P1942, DOI 10.1074/jbc.M309219200; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Larson SD, 2007, SURGERY, V142, P262, DOI 10.1016/j.surg.2007.03.011; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nishitomi K, 2006, J NEUROCHEM, V99, P1555, DOI 10.1111/j.1471-4159.2006.04178.x; Nunes FA, 1999, HUM GENE THER, V10, P2515, DOI 10.1089/10430349950016852; Quah BJC, 2005, BLOOD CELL MOL DIS, V35, P94, DOI 10.1016/j.bcmd.2005.05.002; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Seow Y, 2009, MOL THER, V17, P767, DOI 10.1038/mt.2009.41; Simhadri VR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003377; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Yin HF, 2009, HUM MOL GENET, V18, P4405, DOI 10.1093/hmg/ddp395	21	2744	2944	83	1394	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2011	29	4					341	U179		10.1038/nbt.1807	http://dx.doi.org/10.1038/nbt.1807			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	746XY	21423189				2022-12-25	WOS:000289284900019
J	Kuo, JC; Han, XM; Hsiao, CT; Yates, JR; Waterman, CM				Kuo, Jean-Cheng; Han, Xuemei; Hsiao, Cheng-Te; Yates, John R., III; Waterman, Clare M.			Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for beta-Pix in negative regulation of focal adhesion maturation	NATURE CELL BIOLOGY			English	Article							MIGRATING CELLS; EXCHANGE FACTOR; ALPHA-ACTININ; PAXILLIN PHOSPHORYLATION; INTEGRIN ACTIVATION; SHOTGUN PROTEOMICS; LEADING-EDGE; F-ACTIN; DYNAMICS; RHO	Focal adhesions undergo myosin-II-mediated maturation wherein they grow and change composition to modulate integrin signalling for cell migration, growth and differentiation. To determine how focal adhesion composition is affected by myosin II activity, we performed proteomic analysis of isolated focal adhesions and compared protein abundance in focal adhesions from cells with and without myosin II inhibition. We identified 905 focal adhesion proteins, 459 of which changed in abundance with myosin II inhibition, defining the myosin-II-responsive focal adhesion proteome. The abundance of 73% of the proteins in the myosin-II-responsive focal adhesion proteome was enhanced by contractility, including proteins involved in Rho-mediated focal adhesion maturation and endocytosis-and calpain-dependent focal adhesion disassembly. During myosin II inhibition, 27% of proteins in the myosin-II-responsive focal adhesion proteome, including proteins involved in Rac-mediated lamellipodial protrusion, were enriched in focal adhesions, establishing that focal adhesion protein recruitment is also negatively regulated by contractility. We focused on the Rac guanine nucleotide exchange factor beta-Pix, documenting its role in the negative regulation of focal adhesion maturation and the promotion of lamellipodial protrusion and focal adhesion turnover to drive cell migration.	[Kuo, Jean-Cheng; Waterman, Clare M.] NHLBI, Cell Biol & Physiol Ctr, NIH, Bethesda, MD 20892 USA; [Han, Xuemei; Yates, John R., III] Scripps Res Inst, La Jolla, CA 92037 USA; [Hsiao, Cheng-Te] NIA, Prote & Analyt Biochem Unit, Res Resources Branch, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Waterman, CM (corresponding author), NHLBI, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	jyates@scripps.edu; watermancm@nhlbi.nih.gov		Waterman, Clare/0000-0001-6142-6775	NHLBI; NIH [P41 RR011823]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Hildebrand (University of Pittsburgh), J. Peterson (Fox Chase Cancer Centre), M. Davidson (Florida State), R.H. Chen (Academia Sinica) and M. Beckerle (University of Utah) for reagents, the NHLBI proteomics and flow cytometry facilities, W. Shin and I. Schneider for help with imaging and analysis, and A. Aslanian. C.M.W. is supported by NHLBI, J.R.Y. by NIH P41 RR011823.	Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Ambatipudi KS, 2009, J PROTEOME RES, V8, P5093, DOI 10.1021/pr900478h; Bai CY, 2007, J CELL SCI, V120, P2828, DOI 10.1242/jcs.03477; Ballestrem C, 2006, J CELL SCI, V119, P866, DOI 10.1242/jcs.02794; Bern M, 2004, BIOINFORMATICS, V20, P49, DOI 10.1093/bioinformatics/bth947; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Bertling E, 2004, MOL BIOL CELL, V15, P2324, DOI 10.1091/mbc.E04-01-0048; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chen EI, 2007, CANCER RES, V67, P1472, DOI 10.1158/0008-5472.CAN-06-3137; Chen Y, 2003, J BIOL CHEM, V278, P46094, DOI 10.1074/jbc.M305311200; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; DesMarais V, 2002, J CELL SCI, V115, P4649, DOI 10.1242/jcs.00147; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Galbraith CG, 1997, P NATL ACAD SCI USA, V94, P9114, DOI 10.1073/pnas.94.17.9114; Griffith E, 2005, CELL MOTIL CYTOSKEL, V60, P140, DOI 10.1002/cm.20052; Harris BZ, 2001, J CELL SCI, V114, P3219; Hoffert JD, 2004, AM J PHYSIOL-RENAL, V286, pF170, DOI 10.1152/ajprenal.00223.2003; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Koh CG, 2001, J CELL SCI, V114, P4239; KUO JC, 2010, METHODS MOL IN PRESS; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Lee CS, 2010, J CELL BIOL, V190, P663, DOI 10.1083/jcb.201003057; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; O'Connor KL, 2001, J BIOL CHEM, V276, P47895, DOI 10.1074/jbc.M107235200; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pletjushkina OJ, 1998, CELL ADHES COMMUN, V5, P121, DOI 10.3109/15419069809040286; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Rendon BE, 2007, J BIOL CHEM, V282, P29910, DOI 10.1074/jbc.M704898200; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; Schroeter MM, 2008, BIOSCIENCE REP, V28, P195, DOI 10.1042/BSR20080079; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shi Q, 2003, MOL BIOL CELL, V14, P4306, DOI 10.1091/mbc.E03-01-0046; Shin W., 2010, LIVE CELL IMAGING LA, P119; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takahashi H, 2005, BIOCHEM BIOPH RES CO, V336, P239, DOI 10.1016/j.bbrc.2005.08.064; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wiseman PW, 2004, J CELL SCI, V117, P5521, DOI 10.1242/jcs.01416; Wulfkuhle JD, 1999, J CELL SCI, V112, P2125; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zamir E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001901; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013	75	410	414	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2011	13	4					383	U109		10.1038/ncb2216	http://dx.doi.org/10.1038/ncb2216			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	744CK	21423176	Green Accepted			2022-12-25	WOS:000289070900010
J	Sato, A; Nagasaka, S; Furihata, K; Nagata, S; Arai, I; Saruwatari, K; Kogure, T; Sakuda, S; Nagasawa, H				Sato, Ai; Nagasaka, Seiji; Furihata, Kazuo; Nagata, Shinji; Arai, Isao; Saruwatari, Kazuko; Kogure, Toshihiro; Sakuda, Shohei; Nagasawa, Hiromichi			Glycolytic intermediates induce amorphous calcium carbonate formation in crustaceans	NATURE CHEMICAL BIOLOGY			English	Article							PROCAMBARUS-CLARKII; MATRIX PROTEIN; BIOMINERALIZATION; CRAYFISH	It has been thought that phosphorus in biominerals made of amorphous calcium carbonate (ACC) might be related to ACC formation, but no such phosphorus-containing compounds have ever been identified. Crustaceans use ACC biominerals in exoskeleton and gastroliths so that they will have easy access to calcium carbonate inside the body before and after molting. We have identified phosphoenolpyruvate and 3-phosphoglycerate, intermediates of the glycolytic pathway, in exoskeleton and gastroliths and found them important for stabilizing ACC.	[Sato, Ai; Nagasaka, Seiji; Furihata, Kazuo; Nagata, Shinji; Sakuda, Shohei; Nagasawa, Hiromichi] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo, Japan; [Nagasaka, Seiji] Toyo Univ, Grad Sch Life Sci, Itakura, Gunma, Japan; [Arai, Isao; Saruwatari, Kazuko; Kogure, Toshihiro] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Tokyo 113, Japan; [Arai, Isao] Mitsubishi Mat Corp, Cent Res Inst, Naka, Ibaraki, Japan; [Saruwatari, Kazuko] Natl Inst Mat Sci, Soft Chem Grp, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki, Japan	University of Tokyo; Toyo University; University of Tokyo; Mitsubishi Materials Corporation; National Institute for Materials Science	Sato, A (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo, Japan.	anagahi@mail.ecc.u-tokyo.ac.jp	Kogure, Toshihiro/K-7857-2015	Kogure, Toshihiro/0000-0002-3494-8989; Sakuda, Shohei/0000-0001-7966-1167	Japan Society for the Promotion of Science [17GS0311, 22248037, 22228006]; Grants-in-Aid for Scientific Research [22228006] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to J.J. Hull for critical reading of the manuscript. We also thank Y. Kagayama (Fisheries Station of Yamagata Prefecture, Japan) for supplying us with the mitten crab. This work was supported by Grants-in-Aid for Scientific Research (nos. 17GS0311, 22248037 and 22228006) from the Japan Society for the Promotion of Science.	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Aizenberg J, 2002, J AM CHEM SOC, V124, P32, DOI 10.1021/ja016990l; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Bentov S, 2010, J STRUCT BIOL, V171, P207, DOI 10.1016/j.jsb.2010.04.007; BRECEVIC L, 1989, J CRYST GROWTH, V98, P504, DOI 10.1016/0022-0248(89)90168-1; Faatz M, 2004, ADV MATER, V16, P996, DOI 10.1002/adma.200306565; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Hikida T., 2003, BIOMINERALIATION FOR, P81; HOUSE WA, 1987, J COLLOID INTERF SCI, V119, P505, DOI 10.1016/0021-9797(87)90296-7; Inoue H, 2001, BIOSCI BIOTECH BIOCH, V65, P1840, DOI 10.1271/bbb.65.1840; Kato T, 2002, ADV MATER, V14, P869, DOI 10.1002/1521-4095(20020618)14:12<869::AID-ADMA869>3.0.CO;2-E; Koga N, 1998, THERMOCHIM ACTA, V318, P239, DOI 10.1016/S0040-6031(98)00348-7; Levi-Kalisman Y, 2002, ADV FUNCT MATER, V12, P43, DOI 10.1002/1616-3028(20020101)12:1<43::AID-ADFM43>3.0.CO;2-C; Loste E, 2001, CHEM COMMUN, P901, DOI 10.1039/b101563j; Luquet G, 2004, CR PALEVOL, V3, P515, DOI 10.1016/j.crpv.2004.07.015; Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; Pouget EM, 2009, SCIENCE, V323, P1455, DOI 10.1126/science.1169434; Raz S, 2002, BIOL BULL-US, V203, P269, DOI 10.2307/1543569; Sawada K, 2003, DALTON T, P342, DOI 10.1039/b209758n; Shechter A, 2008, P NATL ACAD SCI USA, V105, P7129, DOI 10.1073/pnas.0800193105; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Tohse H, 2009, CRYST GROWTH DES, V9, P4897, DOI 10.1021/cg9006857; Tsutsui N, 1999, ZOOL SCI, V16, P619, DOI 10.2108/zsj.16.619; WEINER S, 1984, AM ZOOL, V24, P945	25	65	65	3	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					197	199		10.1038/NCHEMBIO.532	http://dx.doi.org/10.1038/NCHEMBIO.532			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21336282				2022-12-25	WOS:000288545000005
J	Inobe, T; Fishbain, S; Prakash, S; Matouschek, A				Inobe, Tomonao; Fishbain, Susan; Prakash, Sumit; Matouschek, Andreas			Defining the geometry of the two-component proteasome degron	NATURE CHEMICAL BIOLOGY			English	Article							UBIQUITIN-LIKE DOMAIN; 26S PROTEASOME; TAGGING SYSTEM; DIHYDROFOLATE-REDUCTASE; PROTEIN-BINDING; DNA-REPAIR; IN-VITRO; DEGRADATION; RECOGNITION; SUBUNIT	The eukaryotic 26S proteasome controls cellular processes by degrading specific regulatory proteins. Most proteins are targeted for degradation by a signal or degron that consists of two parts: a proteasome-binding tag, typically covalently attached polyubiquitin chains, and an unstructured region that serves as the initiation region for proteasomal proteolysis. Here we have characterized how the arrangement of the two degron parts in a protein affects degradation. We found that a substrate is degraded efficiently only when its initiation region is of a certain minimal length and is appropriately separated in space from the proteasome-binding tag. Regions that are located too close or too far from the proteasome-binding tag cannot access the proteasome and induce degradation. These spacing requirements are different for a polyubiquitin chain and a ubiquitin-like domain. Thus, the arrangement and location of the proteasome initiation region affect a protein's fate and are important in selecting proteins for proteasome-mediated degradation.	[Inobe, Tomonao; Fishbain, Susan; Prakash, Sumit; Matouschek, Andreas] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Inobe, Tomonao; Fishbain, Susan; Prakash, Sumit; Matouschek, Andreas] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA; [Inobe, Tomonao] RIKEN Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama, Japan	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; RIKEN	Inobe, T (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	matouschek@northwestern.edu	Prakash, Sumit/B-2679-2009; Matouschek, Andreas/L-9379-2013	Prakash, Sumit/0000-0002-0608-3420; Matouschek, Andreas/0000-0001-6016-2341; Inobe, Tomonao/0000-0002-5864-6889	US National Institutes of Health [R01GM063004, U54CA143869]; Ministry of Education, Culture, Sports, Science and Technology of Japan [22770137]; Robert H. Lurie Comprehensive Cancer Center at Northwestern University; Japan Society for the Promotion of Science; NATIONAL CANCER INSTITUTE [U54CA143869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063004] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Robert H. Lurie Comprehensive Cancer Center at Northwestern University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Elsasser (Harvard University Medical School), D. Finley (Harvard University Medical School), B. S. Glick (University of Chicago) and Y. Saeki (Tokyo Metropolitan Institute of Medical Science) for providing plasmids and yeast strains and members of the Matouschek lab for advice and comments. The authors greatly appreciate and gratefully acknowledge N. Nukina (RIKEN) for his support and the use of his laboratory equipment. We also thank G. Leigh for editing the manuscript. The work was supported by grants R01GM063004 and U54CA143869 from the US National Institutes of Health, by Ministry of Education, Culture, Sports, Science and Technology of Japan Grant-in-Aid 22770137 (T. I.) and by the Robert H. Lurie Comprehensive Cancer Center at Northwestern University. T. I. also gratefully acknowledges a Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad and the RIKEN Special Postdoctoral Researchers Program.	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Beskow A, 2009, J MOL BIOL, V394, P732, DOI 10.1016/j.jmb.2009.09.050; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Djuranovic S, 2009, MOL CELL, V34, P580, DOI 10.1016/j.molcel.2009.04.030; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Gonzalez M, 1998, GENE DEV, V12, P3889, DOI 10.1101/gad.12.24.3889; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Heessen S, 2005, MOL CELL, V18, P225, DOI 10.1016/j.molcel.2005.03.015; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; JOHNSON ES, 1990, NATURE, V346, P287, DOI 10.1038/346287a0; JOHNSTON JA, 1995, J BIOL CHEM, V270, P8172, DOI 10.1074/jbc.270.14.8172; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Klotzbucher A, 1996, EMBO J, V15, P3053, DOI 10.1002/j.1460-2075.1996.tb00668.x; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Larsen CN, 1997, CELL, V91, P431, DOI 10.1016/S0092-8674(00)80427-4; Levchenko I, 2005, NAT STRUCT MOL BIOL, V12, P520, DOI 10.1038/nsmb934; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; McGinness KE, 2007, J BIOL CHEM, V282, P11465, DOI 10.1074/jbc.M610671200; MILLER WG, 1968, BIOCHEMISTRY-US, V7, P3925, DOI 10.1021/bi00851a021; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; POLITOU AS, 1994, BIOCHEMISTRY-US, V33, P4730, DOI 10.1021/bi00181a604; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; ROOD JI, 1980, GENE, V8, P255, DOI 10.1016/0378-1119(80)90003-7; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V296, P813, DOI 10.1016/S0006-291X(02)02002-8; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Stack JH, 2000, NAT BIOTECHNOL, V18, P1298, DOI 10.1038/82422; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Verhoef LGGC, 2009, FASEB J, V23, P123, DOI 10.1096/fj.08-115055; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; Von Castelmur E, 2008, P NATL ACAD SCI USA, V105, P1186, DOI 10.1073/pnas.0707163105; WATKINS JF, 1993, MOL CELL BIOL, V13, P7757, DOI 10.1128/MCB.13.12.7757; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592; Zhang F, 2009, MOL CELL, V34, P485, DOI 10.1016/j.molcel.2009.04.022	50	121	121	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2011	7	3					161	167		10.1038/NCHEMBIO.521	http://dx.doi.org/10.1038/NCHEMBIO.521			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	720UH	21278740	Green Accepted			2022-12-25	WOS:000287307600009
J	Hsu, JM; Chen, CT; Chou, CK; Kuo, HP; Li, LY; Lin, CY; Lee, HJ; Wang, YN; Liu, M; Liao, HW; Shi, B; Lai, CC; Bedford, MT; Tsai, CH; Hung, MC				Hsu, Jung-Mao; Chen, Chun-Te; Chou, Chao-Kai; Kuo, Hsu-Ping; Li, Long-Yuan; Lin, Chun-Yi; Lee, Hong-Jen; Wang, Ying-Nai; Liu, Mo; Liao, Hsin-Wei; Shi, Bin; Lai, Chien-Chen; Bedford, Mark T.; Tsai, Chang-Hai; Hung, Mien-Chie			Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation	NATURE CELL BIOLOGY			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN ARGININE METHYLTRANSFERASES; TYROSINE-PHOSPHATASE SHP-1; FACTOR RECEPTOR; ERBB RECEPTORS; BINDING-SITES; SHC; ASSOCIATION; SUPPRESSION; CANCER	Epidermal growth factor receptor (EGFR)can undergo post-translational modifications, including phosphorylation, glycosylation and ubiquitylation, leading to diverse physiological consequences and modulation of its biological activity. There is increasing evidence that methylation may parallel other post-translational modifications in the regulation of various biological processes. It is still not known, however, whether EGFR is regulated by this post-translational event. Here, we show that EGFR Arg 1175 is methylated by an arginine methyltransferase, PRMT5. Arg 1175 methylation positively modulates EGF-induced EGFR trans-autophosphorylation at Tyr 1173, which governs ERK activation. Abolishment of Arg 1175 methylation enhances EGF-stimulated ERK activation by reducing SHP1 recruitment to EGFR, resulting in augmented cell proliferation, migration and invasion of EGFR-expressing cells. Therefore, we propose a model in which the regulatory crosstalk between PRMT5-mediated Arg 1175 methylation and EGF-induced Tyr 1173 phosphorylation attenuates EGFR-mediated ERK activation.	[Hsu, Jung-Mao; Chen, Chun-Te; Chou, Chao-Kai; Kuo, Hsu-Ping; Lee, Hong-Jen; Wang, Ying-Nai; Liu, Mo; Liao, Hsin-Wei; Shi, Bin; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Hsu, Jung-Mao; Chen, Chun-Te; Chou, Chao-Kai; Kuo, Hsu-Ping; Lee, Hong-Jen; Liu, Mo; Liao, Hsin-Wei; Hung, Mien-Chie] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Li, Long-Yuan; Lin, Chun-Yi; Hung, Mien-Chie] China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan; [Li, Long-Yuan; Lin, Chun-Yi; Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 404, Taiwan; [Li, Long-Yuan; Tsai, Chang-Hai; Hung, Mien-Chie] Asia Univ, Dept Biotechnol, Taichung 413, Taiwan; [Lai, Chien-Chen; Tsai, Chang-Hai] China Med Univ Hosp, Dept Med Res, Taichung 404, Taiwan; [Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Sci Pk Res Div, Smithville, TX 78957 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Texas System; UTMD Anderson Cancer Center	Hung, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	mhung@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021; Hsu, Jung-Mao/AAC-9527-2019; Bedford, Mark T/E-7856-2011; /AGZ-4617-2022; liu, mo/E-2087-2014; Hsu, Jung-Mao/AAP-8045-2020	Hung, Mien-Chie/0000-0003-4317-4740; /0000-0002-7133-8266; Li, Long-Yuan/0000-0001-7472-8318; Wang, Ying-Nai/0000-0002-5275-6729; CHOU, CHAO-KAI/0000-0001-5231-5264	National Institute of Health [RO1 109311, PO1 099031]; National Breast Cancer Foundation; China Medical University; Hospital/MD Anderson Cancer Center; National Science Council [NSC 96-3111-B-039, NSC 95-2311-B-039-002, NSC 99-2632-B-039-001]; National Health Research Institutes [NHRI-EX97-9603BC]; Department of Health of Taiwan [DOH97-TD-G-111-041, DOH97-TD-I-111-TM003, DOH100-TD-C-111-005]; NATIONAL CANCER INSTITUTE [R01CA109311, P01CA099031] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Breast Cancer Foundation; China Medical University(China Medical University); Hospital/MD Anderson Cancer Center; National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); Department of Health of Taiwan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institute of Health (RO1 109311 and PO1 099031), the National Breast Cancer Foundation, The Sister Institution Fund of China Medical University and Hospital/MD Anderson Cancer Center, and grants from the National Science Council (NSC 96-3111-B-039, NSC 95-2311-B-039-002 and NSC 99-2632-B-039-001), the National Health Research Institutes (NHRI-EX97-9603BC), and Department of Health (DOH97-TD-G-111-041, DOH97-TD-I-111-TM003 and DOH100-TD-C-111-005) of Taiwan. In memoriam, S. Lin-Guo for her courageous fight against breast cancer.	Anne J, 2005, DEVELOPMENT, V132, P2167, DOI 10.1242/dev.01809; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; BATZER AG, 1994, MOL CELL BIOL, V14, P5192, DOI 10.1128/MCB.14.8.5192; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bogdan S, 2001, CURR BIOL, V11, pR292, DOI 10.1016/S0960-9822(01)00167-1; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chang JY, 1997, ONCOGENE, V14, P561, DOI 10.1038/sj.onc.1200861; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Keilhack H, 1998, J BIOL CHEM, V273, P24839, DOI 10.1074/jbc.273.38.24839; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Li SG, 2001, EMBO J, V20, P6793, DOI 10.1093/emboj/20.23.6793; Linggi B, 2006, TRENDS CELL BIOL, V16, P649, DOI 10.1016/j.tcb.2006.10.008; LIU Q, 1995, MOL CELL BIOL, V15, P2800; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; Montano X, 2009, ONCOGENE, V28, P3787, DOI 10.1038/onc.2009.143; OKABAYASHI Y, 1994, J BIOL CHEM, V269, P18674; OKUTANI T, 1994, J BIOL CHEM, V269, P31310; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Peng Y, 2010, J CELL MOL MED, V14, P2780, DOI 10.1111/j.1582-4934.2009.00936.x; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Sini P, 2004, NAT CELL BIOL, V6, P268, DOI 10.1038/ncb1096; SOLER C, 1994, ONCOGENE, V9, P2207; TOMIC S, 1995, J BIOL CHEM, V270, P21277, DOI 10.1074/jbc.270.36.21277; You M, 1997, J BIOL CHEM, V272, P23376, DOI 10.1074/jbc.272.37.23376	30	160	175	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2011	13	2					174	U151		10.1038/ncb2158	http://dx.doi.org/10.1038/ncb2158			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714JM	21258366	Green Accepted			2022-12-25	WOS:000286805900012
J	Griffiths, DS; Li, JA; Dawson, MA; Trotter, MWB; Cheng, YH; Smith, AM; Mansfield, W; Liu, PT; Kouzarides, T; Nichols, J; Bannister, AJ; Green, AR; Gottgens, B				Griffiths, Dean S.; Li, Juan; Dawson, Mark A.; Trotter, Matthew W. B.; Cheng, Yi-Han; Smith, Aileen M.; Mansfield, William; Liu, Pentao; Kouzarides, Tony; Nichols, Jennifer; Bannister, Andrew J.; Green, Anthony R.; Goettgens, Berthold			LIF-independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease	NATURE CELL BIOLOGY			English	Article							LEUKEMIA INHIBITORY FACTOR; TYROSINE KINASE JAK2; SELF-RENEWAL; MYELOPROLIFERATIVE DISORDERS; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; STAT3; PLURIPOTENT; ACTIVATION; MUTATION	Activating mutations in the tyrosine kinase Janus kinase 2 (JAK2) cause myeloproliferative neoplasms, clonal blood stem cell disorders with a propensity for leukaemic transformation. Leukaemia inhibitory factor (LIF) signalling through the JAK-signal transducer and activator of transcription (STAT) pathway enables self-renewal of embryonic stem (ES) cells. Here we show that mouse ES cells carrying the human JAK2V617F mutation were able to self-renew in chemically defined conditions without cytokines or small-molecule inhibitors, independently of JAK signalling through the STAT3 or phosphatidylinositol-3-OH kinase pathways. Phosphorylation of histone H3 tyrosine 41 (H3Y41) by JAK2 was recently shown to interfere with binding of heterochromatin protein 1 alpha (HP1 alpha). Levels of chromatin-bound HP1 alpha were lower in JAK2V617F ES cells but increased following inhibition of JAK2, coincident with a global reduction in histone H3Y41 phosphorylation. JAK2 inhibition reduced levels of the pluripotency regulator Nanog, with a reduction in H3Y41 phosphorylation and concomitant increase in HP1 alpha levels at the Nanog promoter. Furthermore, Nanog was required for factor independence of JAK2V617F ES cells. Taken together, these results uncover a previously unrecognized role for direct signalling to chromatin by JAK2 as an important mediator of ES cell self-renewal.	[Griffiths, Dean S.; Li, Juan; Dawson, Mark A.; Cheng, Yi-Han; Smith, Aileen M.; Green, Anthony R.; Goettgens, Berthold] Univ Cambridge, Inst Med Res, Dept Haematol & Cambridge, Cambridge CB2 0XY, England; [Dawson, Mark A.; Green, Anthony R.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0QQ, England; [Trotter, Matthew W. B.] Anne McLaren Lab Regenerat Med, Cambridge CB2 0SZ, England; [Trotter, Matthew W. B.] Dept Surg, Cambridge CB2 0SZ, England; [Mansfield, William; Nichols, Jennifer] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Liu, Pentao] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Dawson, Mark A.; Kouzarides, Tony; Bannister, Andrew J.] Gurdon Inst, Cambridge CB2 1QN, England; [Dawson, Mark A.; Kouzarides, Tony; Bannister, Andrew J.] Dept Pathol, Cambridge CB2 1QN, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute	Griffiths, DS (corresponding author), Univ Cambridge, Inst Med Res, Dept Haematol & Cambridge, Cambridge CB2 0XY, England.	dsg29@cam.ac.uk; bg200@cam.ac.uk	Dawson, Mark A/B-9317-2017	Dawson, Mark A/0000-0002-5464-5029; Trotter, Matthew/0000-0003-3702-915X; Gottgens, Berthold/0000-0001-6302-5705; Bannister, Andrew/0000-0002-6312-4436; Nichols, Jennifer/0000-0002-8650-1388; Green, Anthony/0000-0002-9795-0218; Kouzarides, Tony/0000-0002-8918-4162	Cancer Research UK; Leukaemia and Lymphoma Research; The Leukaemia and Lymphoma Society; Medical Research Council; Medical Research Council [G0600275, G0800784, G0800784B, G1000847] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish; MRC [G1000847, G0800784, G0600275] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Leukaemia and Lymphoma Research; The Leukaemia and Lymphoma Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We gratefully acknowledge the assistance of S. Kinston for technical support, M. Anderson and T. Hamilton for 8-cell-stage injections, K. Griffiths and A. Johnston for assistance with statistics, N. Ivanova for the Nanog shRNA vector, S. Pollard for use of Incucyte, A. Smith for STAT3-null and Nanog-overexpressing ES cells and for helpful discussions and A. Bradley for helpful discussions. Research in the authors' laboratories is supported by Cancer Research UK, Leukaemia and Lymphoma Research, The Leukaemia and Lymphoma Society and Medical Research Council.	Batlle-Morera L, 2008, GENESIS, V46, P758, DOI 10.1002/dvg.20442; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Ernst M, 1996, J BIOL CHEM, V271, P30136, DOI 10.1074/jbc.271.47.30136; Grebien F, 2008, BLOOD, V111, P4511, DOI 10.1182/blood-2007-07-102848; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; Li JA, 2010, BLOOD, V116, P1528, DOI 10.1182/blood-2009-12-259747; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lu CW, 2008, NAT GENET, V40, P921, DOI 10.1038/ng.173; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; MOREAU JF, 1988, NATURE, V336, P690, DOI 10.1038/336690a0; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; OHASHI T, 1995, BLOOD, V85, P1454, DOI 10.1182/blood.V85.6.1454.bloodjournal8561454; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Papanayotou C, 2008, PLOS BIOL, V6, P109, DOI 10.1371/journal.pbio.0060002; Pardanani A, 2007, LEUKEMIA, V21, P1658, DOI 10.1038/sj.leu.2404750; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; SCHNEIDER H, 1992, INT IMMUNOL, V4, P447, DOI 10.1093/intimm/4.4.447; Shi S, 2008, NAT CELL BIOL, V10, P491, DOI 10.1038/ncb1713; Shi S, 2006, NAT GENET, V38, P1071, DOI 10.1038/ng1860; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tchirkov A, 2007, BRIT J CANCER, V96, P474, DOI 10.1038/sj.bjc.6603586; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wood AD, 2009, BLOOD, V114, P1820, DOI 10.1182/blood-2009-02-206573; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yuan P, 2009, GENE DEV, V23, P2507, DOI 10.1101/gad.1831909	53	78	79	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2011	13	1					13	21		10.1038/ncb2135	http://dx.doi.org/10.1038/ncb2135			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697GV	21151131	Green Accepted			2022-12-25	WOS:000285502200006
J	Zou, WG; Chen, X; Shim, JH; Huang, ZW; Brady, N; Hu, D; Drapp, R; Sigrist, K; Glimcher, LH; Jones, D				Zou, Weiguo; Chen, Xi; Shim, Jae-Hyuck; Huang, Zhiwei; Brady, Nicholas; Hu, Dorothy; Drapp, Rebecca; Sigrist, Kirsten; Glimcher, Laurie H.; Jones, Dallas			The E3 ubiquitin ligase Wwp2 regulates craniofacial development through mono-ubiquitylation of Goosecoid	NATURE CELL BIOLOGY			English	Article							STEM-CELLS; TRANSCRIPTION; CARTILAGE; EXPRESSION; SOX6	Craniofacial anomalies (CFAs) are the most frequently occurring human congenital disease, and a major cause of infant mortality and childhood morbidity. Although CFAs seems to arise from a combination of genetic factors and environmental influences, the underlying gene defects and pathophysiological mechanisms for most CFAs are currently unknown. Here we reveal a role for the E3 ubiquitin ligase Wwp2 in regulating craniofacial patterning. Mice deficient in Wwp2 develop malformations of the craniofacial region. Wwp2 is present in cartilage where its expression is controlled by Sox9. Our studies demonstrate that Wwp2 influences craniofacial patterning through its interactions with Goosecoid (Gsc), a paired-like homeobox transcription factor that has an important role in craniofacial development. We show that Wwp2-associated Gsc is a transcriptional activator of the key cartilage regulatory protein Sox6. Wwp2 interacts with Gsc to facilitate its mono-ubiquitylation, a post-translational modification required for optimal transcriptional activation of Gsc. Our results identify for the first time a physiological pathway regulated by Wwp2 in vivo, and also a unique non-proteolytic mechanism through which Wwp2 controls craniofacial development.	[Zou, Weiguo; Chen, Xi; Shim, Jae-Hyuck; Huang, Zhiwei; Brady, Nicholas; Hu, Dorothy; Drapp, Rebecca; Sigrist, Kirsten; Glimcher, Laurie H.; Jones, Dallas] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02163 USA; [Glimcher, Laurie H.; Jones, Dallas] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Glimcher, Laurie H.] Ragon Inst MIT MGH & Harvard, Boston, MA 02129 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Jones, D (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02163 USA.	djones@hsph.harvard.edu	Huang, Zhiwei/AAF-6846-2019; Chen, Xi/C-6889-2012; Brady, Nicholas/AAB-2888-2019	Brady, Nicholas/0000-0002-2928-0232; Chen, Xi/0000-0002-7995-6202; Glimcher, Laurie/0000-0001-9537-3456; Shim, Jae-Hyuck/0000-0002-4947-3293	NIH [HD055601, K99AR055668]; Merck Pharmaceuticals; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR055668] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Pharmaceuticals(Merck & Company); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Dong-Er Zhang, Wei Gu, Tatsuya Kobayashi, Nakamura Yukio and Jian Xu for providing reagents. We also thank Marc Wein for thoughtful comments on the manuscript. The study was supported by NIH grants HD055601 (L.H.G.), K99AR055668 (D.J.) and a grant from Merck Pharmaceuticals. W.G.Z. is a Yerby Fellow at the Harvard School of Public Health.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dhananjayan SC, 2005, ESSAYS BIOCHEM, V41, P69, DOI 10.1042/EB0410069; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; Latinkic BV, 1999, DEVELOPMENT, V126, P1769; Lefebvre W, 2002, J BONE MINER METAB, V20, P121, DOI 10.1007/s007740200017; Li H, 2007, MOL CELL BIOL, V27, P5296, DOI 10.1128/MCB.01667-06; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; McDonald FJ, 2002, AM J PHYSIOL-RENAL, V283, pF431, DOI 10.1152/ajprenal.00080.2002; Rivera-Perez JA, 1999, DEVELOPMENT, V126, P3811; RIVERAPEREZ JA, 1995, DEVELOPMENT, V121, P3005; Shim JH, 2009, EMBO J, V28, P2028, DOI 10.1038/emboj.2009.162; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Xiong W, 2009, DEV BIOL, V330, P131, DOI 10.1016/j.ydbio.2009.03.021; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; YAMADA G, 1995, DEVELOPMENT, V121, P2917	17	79	82	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2011	13	1					59	U139		10.1038/ncb2134	http://dx.doi.org/10.1038/ncb2134			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697GV	21170031	Green Accepted			2022-12-25	WOS:000285502200011
J	Speliotes, EK; Willer, CJ; Berndt, SI; Monda, KL; Thorleifsson, G; Jackson, AU; Allen, HL; Lindgren, CM; Luan, J; Magi, R; Randall, JC; Vedantam, S; Winkler, TW; Qi, L; Workalemahu, T; Heid, IM; Steinthorsdottir, V; Stringham, HM; Weedon, MN; Wheeler, E; Wood, AR; Ferreira, T; Weyant, RJ; Segre, AV; Estrada, K; Liang, LM; Nemesh, J; Park, JH; Gustafsson, S; Kilpelanen, TO; Yang, JA; Bouatia-Naji, N; Esko, T; Feitosa, MF; Kutalik, Z; Mangino, M; Raychaudhuri, S; Scherag, A; Smith, AV; Welch, R; Zhao, JH; Aben, KK; Absher, DM; Amin, N; Dixon, AL; Fisher, E; Glazer, NL; Goddard, ME; Heard-Costa, NL; Hoesel, V; Hottenga, JJ; Johansson, A; Johnson, T; Ketkar, S; Lamina, C; Li, SX; Moffatt, MF; Myers, RH; Narisu, N; Perry, JRB; Peters, MJ; Preuss, M; Ripatti, S; Rivadeneira, F; Sandholt, C; Scott, LJ; Timpson, NJ; Tyrer, JP; van Wingerden, S; Watanabe, RM; White, CC; Wiklund, F; Barlassina, C; Chasman, DI; Cooper, MN; Jansson, JO; Lawrence, RW; Pellikka, N; Prokopenko, I; Shi, JX; Thiering, E; Alavere, H; Alibrandi, MTS; Almgren, P; Arnold, AM; Aspelund, T; Atwood, LD; Balkau, B; Balmforth, AJ; Bennett, AJ; Ben-Shlomo, Y; Bergman, RN; Bergmann, S; Biebermann, H; Blakemore, AIF; Boes, T; Bonnycastle, LL; Bornstein, SR; Brown, MJ; Buchanan, TA; Busonero, F; Campbell, H; Cappuccio, FP; Cavalcanti-Proenca, C; Chen, YDI; Chen, CM; Chines, PS; Clarke, R; Coin, L; Connell, J; Day, INM; den Heijer, M; Duan, JB; Ebrahim, S; Elliott, P; Elosua, R; Eiriksdottir, G; Erdos, MR; Eriksson, JG; Facheris, MF; Felix, SB; Fischer-Posovszky, P; Folsom, AR; Friedrich, N; Freimer, NB; Fu, M; Gaget, S; Gejman, PV; Geus, EJC; Gieger, C; Gjesing, AP; Goel, A; Goyette, P; Grallert, H; Grassler, J; Greenawalt, DM; Groves, CJ; Gudnason, V; Guiducci, C; Hartikainen, AL; Hassanali, N; Hall, AS; Havulinna, AS; Hayward, C; Heath, AC; Hengstenberg, C; Hicks, AA; Hinney, A; Hofman, A; Homuth, G; Hui, J; Igl, W; Iribarren, C; Isomaa, B; Jacobs, KB; Jarick, I; Jewell, E; John, U; Jorgensen, T; Jousilahti, P; Jula, A; Kaakinen, M; Kajantie, E; Kaplan, LM; Kathiresan, S; Kettunen, J; Kinnunen, L; Knowles, JW; Kolcic, I; Konig, IR; Koskinen, S; Kovacs, P; Kuusisto, J; Kraft, P; Kvaloy, K; Laitinen, J; Lantieri, O; Lanzani, C; Launer, LJ; Lecoeur, C; Lehtimaki, T; Lettre, G; Liu, JJ; Lokki, ML; Lorentzon, M; Luben, RN; Ludwig, B; Manunta, P; Marek, D; Marre, M; Martin, NG; McArdle, WL; McCarthy, A; McKnight, B; Meitinger, T; Melander, O; Meyre, D; Midthjell, K; Montgomery, GW; Morken, MA; Morris, AP; Mulic, R; Ngwa, JS; Nelis, M; Neville, MJ; Nyholt, DR; O'Donnell, CJ; O'Rahilly, S; Ong, KK; Oostra, B; Pare, G; Parker, AN; Perola, M; Pichler, I; Pietilainen, KH; Platou, CGP; Polasek, O; Pouta, A; Rafelt, S; Raitakari, O; Rayner, NW; Ridderstrale, M; Rief, W; Ruokonen, A; Robertson, NR; Rzehak, P; Salomaa, V; Sanders, AR; Sandhu, MS; Sanna, S; Saramies, J; Savolainen, MJ; Scherag, S; Schipf, S; Schreiber, S; Schunkert, H; Silander, K; Sinisalo, J; Siscovick, DS; Smit, JH; Soranzo, N; Sovio, U; Stephens, J; Surakka, I; Swift, AJ; Tammesoo, ML; Tardif, JC; Teder-Laving, M; Teslovich, TM; Thompson, JR; Thomson, B; Tonjes, A; Tuomi, T; van Meurs, JBJ; van Ommen, GJ; Vatin, V; Viikari, J; Visvikis-Siest, S; Vitart, V; Vogel, CIG; Voight, BF; Waite, LL; Wallaschofski, H; Walters, GB; Widen, E; Wiegand, S; Wild, SH; Willemsen, G; Witte, DR; Witteman, JC; Xu, JF; Zhang, QY; Zgaga, L; Ziegler, A; Zitting, P; Beilby, JP; Farooqi, IS; Hebebrand, J; Huikuri, HV; James, AL; Kahonen, M; Levinson, DF; Macciardi, F; Nieminen, MS; Ohlsson, C; Palmer, LJ; Ridker, PM; Stumvoll, M; Beckmann, JS; Boeing, H; Boerwinkle, E; Boomsma, DI; Caulfield, MJ; Chanock, SJ; Collins, FS; Cupples, LA; Smith, GD; Erdmann, J; Froguel, P; Gronberg, H; Gyllensten, U; Hall, P; Hansen, T; Harris, TB; Hattersley, AT; Hayes, RB; Heinrich, J; Hu, FB; Hveem, K; Illig, T; Jarvelin, MR; Kaprio, J; Karpe, F; Khaw, KT; Kiemeney, LA; Krude, H; Laakso, M; Lawlor, DA; Metspalu, A; Munroe, PB; Ouwehand, WH; Pedersen, O; Penninx, BW; Peters, A; Pramstaller, PP; Quertermous, T; Reinehr, T; Rissanen, A; Rudan, I; Samani, NJ; Schwarz, PEH; Shuldiner, AR; Spector, TD; Tuomilehto, J; Uda, M; Uitterlinden, A; Valle, TT; Wabitsch, M; Waeber, G; Wareham, NJ; Watkins, H; Wilson, JF; Wright, AF; Zillikens, MC; Chatterjee, N; McCarroll, SA; Purcell, S; Schadt, EE; Visscher, PM; Assimes, TL; Borecki, IB; Deloukas, P; Fox, CS; Groop, LC; Haritunians, T; Hunter, DJ; Kaplan, RC; Mohlke, KL; O'Connell, JR; Peltonen, L; Schlessinger, D; Strachan, DP; van Duijn, CM; Wichmann, HE; Frayling, TM; Thorsteinsdottir, U; Abecasis, GR; Barroso, I; Boehnke, M; Stefansson, K; North, KE; McCarthy, MI; Hirschhorn, JN; Ingelsson, E; Loos, RJF				Speliotes, Elizabeth K.; Willer, Cristen J.; Berndt, Sonja I.; Monda, Keri L.; Thorleifsson, Gudmar; Jackson, Anne U.; Allen, Hana Lango; Lindgren, Cecilia M.; Luan, Jian'an; Maegi, Reedik; Randall, Joshua C.; Vedantam, Sailaja; Winkler, Thomas W.; Qi, Lu; Workalemahu, Tsegaselassie; Heid, Iris M.; Steinthorsdottir, Valgerdur; Stringham, Heather M.; Weedon, Michael N.; Wheeler, Eleanor; Wood, Andrew R.; Ferreira, Teresa; Weyant, Robert J.; Segre, Ayellet V.; Estrada, Karol; Liang, Liming; Nemesh, James; Park, Ju-Hyun; Gustafsson, Stefan; Kilpelaenen, Tuomas O.; Yang, Jian; Bouatia-Naji, Nabila; Esko, Tonu; Feitosa, Mary F.; Kutalik, Zoltan; Mangino, Massimo; Raychaudhuri, Soumya; Scherag, Andre; Smith, Albert Vernon; Welch, Ryan; Zhao, Jing Hua; Aben, Katja K.; Absher, Devin M.; Amin, Najaf; Dixon, Anna L.; Fisher, Eva; Glazer, Nicole L.; Goddard, Michael E.; Heard-Costa, Nancy L.; Hoesel, Volker; Hottenga, Jouke-Jan; Johansson, Asa; Johnson, Toby; Ketkar, Shamika; Lamina, Claudia; Li, Shengxu; Moffatt, Miriam F.; Myers, Richard H.; Narisu, Narisu; Perry, John R. B.; Peters, Marjolein J.; Preuss, Michael; Ripatti, Samuli; Rivadeneira, Fernando; Sandholt, Camilla; Scott, Laura J.; Timpson, Nicholas J.; Tyrer, Jonathan P.; van Wingerden, Sophie; Watanabe, Richard M.; White, Charles C.; Wiklund, Fredrik; Barlassina, Christina; Chasman, Daniel I.; Cooper, Matthew N.; Jansson, John-Olov; Lawrence, Robert W.; Pellikka, Niina; Prokopenko, Inga; Shi, Jianxin; Thiering, Elisabeth; Alavere, Helene; Alibrandi, Maria T. S.; Almgren, Peter; Arnold, Alice M.; Aspelund, Thor; Atwood, Larry D.; Balkau, Beverley; Balmforth, Anthony J.; Bennett, Amanda J.; Ben-Shlomo, Yoav; Bergman, Richard N.; Bergmann, Sven; Biebermann, Heike; Blakemore, Alexandra I. F.; Boes, Tanja; Bonnycastle, Lori L.; Bornstein, Stefan R.; Brown, Morris J.; Buchanan, Thomas A.; Busonero, Fabio; Campbell, Harry; Cappuccio, Francesco P.; Cavalcanti-Proenca, Christine; Chen, Yii-Der Ida; Chen, Chih-Mei; Chines, Peter S.; Clarke, Robert; Coin, Lachlan; Connell, John; Day, Ian N. M.; den Heijer, Martin; Duan, Jubao; Ebrahim, Shah; Elliott, Paul; Elosua, Roberto; Eiriksdottir, Gudny; Erdos, Michael R.; Eriksson, Johan G.; Facheris, Maurizio F.; Felix, Stephan B.; Fischer-Posovszky, Pamela; Folsom, Aaron R.; Friedrich, Nele; Freimer, Nelson B.; Fu, Mao; Gaget, Stefan; Gejman, Pablo V.; Geus, Eco J. C.; Gieger, Christian; Gjesing, Anette P.; Goel, Anuj; Goyette, Philippe; Grallert, Harald; Graessler, Juergen; Greenawalt, Danielle M.; Groves, Christopher J.; Gudnason, Vilmundur; Guiducci, Candace; Hartikainen, Anna-Liisa; Hassanali, Neelam; Hall, Alistair S.; Havulinna, Aki S.; Hayward, Caroline; Heath, Andrew C.; Hengstenberg, Christian; Hicks, Andrew A.; Hinney, Anke; Hofman, Albert; Homuth, Georg; Hui, Jennie; Igl, Wilmar; Iribarren, Carlos; Isomaa, Bo; Jacobs, Kevin B.; Jarick, Ivonne; Jewell, Elizabeth; John, Ulrich; Jorgensen, Torben; Jousilahti, Pekka; Jula, Antti; Kaakinen, Marika; Kajantie, Eero; Kaplan, Lee M.; Kathiresan, Sekar; Kettunen, Johannes; Kinnunen, Leena; Knowles, Joshua W.; Kolcic, Ivana; Koenig, Inke R.; Koskinen, Seppo; Kovacs, Peter; Kuusisto, Johanna; Kraft, Peter; Kvaloy, Kirsti; Laitinen, Jaana; Lantieri, Olivier; Lanzani, Chiara; Launer, Lenore J.; Lecoeur, Cecile; Lehtimaeki, Terho; Lettre, Guillaume; Liu, Jianjun; Lokki, Marja-Liisa; Lorentzon, Mattias; Luben, Robert N.; Ludwig, Barbara; Manunta, Paolo; Marek, Diana; Marre, Michel; Martin, Nicholas G.; McArdle, Wendy L.; McCarthy, Anne; McKnight, Barbara; Meitinger, Thomas; Melander, Olle; Meyre, David; Midthjell, Kristian; Montgomery, Grant W.; Morken, Mario A.; Morris, Andrew P.; Mulic, Rosanda; Ngwa, Julius S.; Nelis, Mari; Neville, Matt J.; Nyholt, Dale R.; O'Donnell, Christopher J.; O'Rahilly, Stephen; Ong, Ken K.; Oostra, Ben; Pare, Guillaume; Parker, Alex N.; Perola, Markus; Pichler, Irene; Pietilaeinen, Kirsi H.; Platou, Carl G. P.; Polasek, Ozren; Pouta, Anneli; Rafelt, Suzanne; Raitakari, Olli; Rayner, Nigel W.; Ridderstrale, Martin; Rief, Winfried; Ruokonen, Aimo; Robertson, Neil R.; Rzehak, Peter; Salomaa, Veikko; Sanders, Alan R.; Sandhu, Manjinder S.; Sanna, Serena; Saramies, Jouko; Savolainen, Markku J.; Scherag, Susann; Schipf, Sabine; Schreiber, Stefan; Schunkert, Heribert; Silander, Kaisa; Sinisalo, Juha; Siscovick, David S.; Smit, Jan H.; Soranzo, Nicole; Sovio, Ulla; Stephens, Jonathan; Surakka, Ida; Swift, Amy J.; Tammesoo, Mari-Liis; Tardif, Jean-Claude; Teder-Laving, Maris; Teslovich, Tanya M.; Thompson, John R.; Thomson, Brian; Toenjes, Anke; Tuomi, Tiinamaija; van Meurs, Joyce B. J.; van Ommen, Gert-Jan; Vatin, Vincent; Viikari, Jorma; Visvikis-Siest, Sophie; Vitart, Veronique; Vogel, Carla I. G.; Voight, Benjamin F.; Waite, Lindsay L.; Wallaschofski, Henri; Walters, G. Bragi; Widen, Elisabeth; Wiegand, Susanna; Wild, Sarah H.; Willemsen, Gonneke; Witte, Daniel R.; Witteman, Jacqueline C.; Xu, Jianfeng; Zhang, Qunyuan; Zgaga, Lina; Ziegler, Andreas; Zitting, Paavo; Beilby, John P.; Farooqi, I. Sadaf; Hebebrand, Johannes; Huikuri, Heikki V.; James, Alan L.; Kaehoenen, Mika; Levinson, Douglas F.; Macciardi, Fabio; Nieminen, Markku S.; Ohlsson, Claes; Palmer, Lyle J.; Ridker, Paul M.; Stumvoll, Michael; Beckmann, Jacques S.; Boeing, Heiner; Boerwinkle, Eric; Boomsma, Dorret I.; Caulfield, Mark J.; Chanock, Stephen J.; Collins, Francis S.; Cupples, L. Adrienne; Smith, George Davey; Erdmann, Jeanette; Froguel, Philippe; Greonberg, Henrik; Gyllensten, Ulf; Hall, Per; Hansen, Torben; Harris, Tamara B.; Hattersley, Andrew T.; Hayes, Richard B.; Heinrich, Joachim; Hu, Frank B.; Hveem, Kristian; Illig, Thomas; Jarvelin, Marjo-Riitta; Kaprio, Jaakko; Karpe, Fredrik; Khaw, Kay-Tee; Kiemeney, Lambertus A.; Krude, Heiko; Laakso, Markku; Lawlor, Debbie A.; Metspalu, Andres; Munroe, Patricia B.; Ouwehand, Willem H.; Pedersen, Oluf; Penninx, Brenda W.; Peters, Annette; Pramstaller, Peter P.; Quertermous, Thomas; Reinehr, Thomas; Rissanen, Aila; Rudan, Igor; Samani, Nilesh J.; Schwarz, Peter E. H.; Shuldiner, Alan R.; Spector, Timothy D.; Tuomilehto, Jaakko; Uda, Manuela; Uitterlinden, Andre; Valle, Timo T.; Wabitsch, Martin; Waeber, Gerard; Wareham, Nicholas J.; Watkins, Hugh; Wilson, James F.; Wright, Alan F.; Zillikens, M. Carola; Chatterjee, Nilanjan; McCarroll, Steven A.; Purcell, Shaun; Schadt, Eric E.; Visscher, Peter M.; Assimes, Themistocles L.; Borecki, Ingrid B.; Deloukas, Panos; Fox, Caroline S.; Groop, Leif C.; Haritunians, Talin; Hunter, David J.; Kaplan, Robert C.; Mohlke, Karen L.; O'Connell, Jeffrey R.; Peltonen, Leena; Schlessinger, David; Strachan, David P.; van Duijn, Cornelia M.; Wichmann, H-Erich; Frayling, Timothy M.; Thorsteinsdottir, Unnur; Abecasis, Goncalo R.; Barroso, Ines; Boehnke, Michael; Stefansson, Kari; North, Kari E.; McCarthy, Mark I.; Hirschhorn, Joel N.; Ingelsson, Erik; Loos, Ruth J. F.		MAGIC	Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GASTRIC-INHIBITORY POLYPEPTIDE; COMMON VARIANTS; EARLY-ONSET; FTO GENE; FAT MASS; OBESITY; GLUCOSE; METAANALYSIS; WEIGHT	Obesity is globally prevalent and highly heritable, but its underlying genetic factors remain largely elusive. To identify genetic loci for obesity susceptibility, we examined associations between body mass index and similar to 2.8 million SNPs in up to 123,865 individuals with targeted follow up of 42 SNPs in up to 125,931 additional individuals. We confirmed 14 known obesity susceptibility loci and identified 18 new loci associated with body mass index (P < 5 x 10(-8)), one of which includes a copy number variant near GPRC5B. Some loci (at MC4R, POMC, SH2B1 and BDNF) map near key hypothalamic regulators of energy balance, and one of these loci is near GIPR, an incretin receptor. Furthermore, genes in other newly associated loci may provide new insights into human body weight regulation.	[Brown, Morris J.] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge, England; [Speliotes, Elizabeth K.; Vedantam, Sailaja; Guiducci, Candace; Thomson, Brian; Hirschhorn, Joel N.] Broad Inst, Metab Initiat & Program Med & Populat Genet, Cambridge, MA USA; [Speliotes, Elizabeth K.; Kaplan, Lee M.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Willer, Cristen J.; Jackson, Anne U.; Stringham, Heather M.; Weyant, Robert J.; Welch, Ryan; Scott, Laura J.; Jewell, Elizabeth; Teslovich, Tanya M.; Abecasis, Goncalo R.; Boehnke, Michael] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Berndt, Sonja I.; Park, Ju-Hyun; Shi, Jianxin; Chanock, Stephen J.; Chatterjee, Nilanjan] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Monda, Keri L.; North, Kari E.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Thorleifsson, Gudmar; Steinthorsdottir, Valgerdur; Walters, G. Bragi; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland; [Allen, Hana Lango; Weedon, Michael N.; Wood, Andrew R.; Perry, John R. B.; Hattersley, Andrew T.; Frayling, Timothy M.] Univ Exeter, Peninsula Coll Med & Dent, Exeter, Devon, England; [Lindgren, Cecilia M.; Maegi, Reedik; Randall, Joshua C.; Ferreira, Teresa; Prokopenko, Inga; Goel, Anuj; Morris, Andrew P.; Rayner, Nigel W.; Robertson, Neil R.; Watkins, Hugh; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Lindgren, Cecilia M.; Prokopenko, Inga; Bennett, Amanda J.; Groves, Christopher J.; Hassanali, Neelam; Neville, Matt J.; Rayner, Nigel W.; Robertson, Neil R.; Karpe, Fredrik; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Luan, Jian'an; Kilpelaenen, Tuomas O.; Zhao, Jing Hua; Ong, Ken K.; Sandhu, Manjinder S.; Wareham, Nicholas J.; Loos, Ruth J. F.] Addenbrookes Hosp, MRC, Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Vedantam, Sailaja; Hirschhorn, Joel N.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Vedantam, Sailaja; Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Vedantam, Sailaja; Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Winkler, Thomas W.; Heid, Iris M.] Univ Regensburg, Med Ctr, Dept Epidemiol & Prevent Med, Regensburg, Germany; [Qi, Lu; Workalemahu, Tsegaselassie; Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Qi, Lu; Hu, Frank B.; Hunter, David J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Qi, Lu; Chasman, Daniel I.; Kaplan, Lee M.; Ridker, Paul M.; Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Med, Boston, MA USA; [Heid, Iris M.; Lamina, Claudia; Thiering, Elisabeth; Chen, Chih-Mei; Gieger, Christian; Grallert, Harald; Rzehak, Peter; Heinrich, Joachim; Illig, Thomas; Peters, Annette; Wichmann, H-Erich] Helmholtz Zentrum Munchen, German Res Ctr, Inst Epidemiol, Neuherberg, Germany; [Wheeler, Eleanor; Sandhu, Manjinder S.; Soranzo, Nicole; Ouwehand, Willem H.; Deloukas, Panos; Peltonen, Leena; Barroso, Ines] Wellcome Trust Sanger Inst, Cambridge, England; [Segre, Ayellet V.; Kathiresan, Sekar; Voight, Benjamin F.; McCarroll, Steven A.; Purcell, Shaun] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Segre, Ayellet V.; Nemesh, James; Raychaudhuri, Soumya; Kathiresan, Sekar] Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Nemesh, James; Raychaudhuri, Soumya; Kathiresan, Sekar] MIT, Cambridge, MA 02139 USA; [Segre, Ayellet V.; Voight, Benjamin F.; McCarroll, Steven A.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Estrada, Karol; Amin, Najaf; Rivadeneira, Fernando; van Wingerden, Sophie; Hofman, Albert; van Meurs, Joyce B. J.; Witteman, Jacqueline C.; Uitterlinden, Andre; van Duijn, Cornelia M.] Erasmus Med Ctr MC, Dept Epidemiol, Rotterdam, Netherlands; [Estrada, Karol; Peters, Marjolein J.; Rivadeneira, Fernando; van Meurs, Joyce B. J.; Uitterlinden, Andre; Zillikens, M. Carola] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Estrada, Karol; Peters, Marjolein J.; Rivadeneira, Fernando; Hofman, Albert; van Meurs, Joyce B. J.; Witteman, Jacqueline C.; Uitterlinden, Andre; Zillikens, M. Carola; van Duijn, Cornelia M.] Netherlands Consortium Healthy Aging NCHA, Netherlands Genom Initiat NGI Sponsored, Rotterdam, Netherlands; [Liang, Liming; Kraft, Peter; Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Liang, Liming; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Gustafsson, Stefan; Wiklund, Fredrik; Greonberg, Henrik; Hall, Per; Ingelsson, Erik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Yang, Jian; Visscher, Peter M.] Queensland Inst Med Res, Queensland Stat Genet Lab, Brisbane, Qld 4006, Australia; [Bouatia-Naji, Nabila; Cavalcanti-Proenca, Christine; Gaget, Stefan; Lecoeur, Cecile; Meyre, David; Vatin, Vincent; Froguel, Philippe] Inst Pasteur, CNRS, UMR8199, IBL, F-59019 Lille, France; [Bouatia-Naji, Nabila; Cavalcanti-Proenca, Christine; Gaget, Stefan; Lecoeur, Cecile; Meyre, David; Nelis, Mari; Vatin, Vincent; Froguel, Philippe] Univ Lille Nord France, Lille, France; [Esko, Tonu; Alavere, Helene; Nelis, Mari; Tammesoo, Mari-Liis; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Teder-Laving, Maris; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Esko, Tonu; Nelis, Mari; Teder-Laving, Maris; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Feitosa, Mary F.; Ketkar, Shamika; Zhang, Qunyuan; Borecki, Ingrid B.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Kutalik, Zoltan; Johnson, Toby; Bergmann, Sven; Folsom, Aaron R.; Marek, Diana; Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Kutalik, Zoltan; Johnson, Toby; Bergmann, Sven; Marek, Diana] Swiss Inst Bioinformat, Lausanne, Switzerland; [Mangino, Massimo; Soranzo, Nicole; Spector, Timothy D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Raychaudhuri, Soumya] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA USA; [Scherag, Andre; Boes, Tanja] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Smith, Albert Vernon; Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert Vernon; Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Aben, Katja K.; Kiemeney, Lambertus A.] Comprehens Canc Ctr E, Nijmegen, Netherlands; [Absher, Devin M.; Waite, Lindsay L.] Hudson Alpha Inst Biotechnol, Huntsville, AL USA; [Dixon, Anna L.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Fisher, Eva; Boeing, Heiner] German Inst Human Nutr, Dept Epidemiol, Potsdam, Nuthetal, Germany; [Glazer, Nicole L.] Univ Washington, Dept Med, Seattle, WA USA; [Glazer, Nicole L.; Siscovick, David S.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Goddard, Michael E.] Univ Melbourne, Parkville, Vic 3052, Australia; [Goddard, Michael E.] Dept Primary Ind, Melbourne, Australia; [Heard-Costa, Nancy L.; Atwood, Larry D.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Hoesel, Volker] Tech Univ Munich, Chair Biomath, D-8046 Garching, Germany; [Hottenga, Jouke-Jan; Geus, Eco J. C.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ VU Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Johansson, Asa; Igl, Wilmar; Gyllensten, Ulf] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Uppsala, Sweden; [Johansson, Asa] Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Canc Res & Mol Med, Trondheim, Norway; [Johnson, Toby] Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Johnson, Toby; Caulfield, Mark J.; Munroe, Patricia B.] Queen Mary Univ London, Barts & London Genome Ctr, London, England; [Johnson, Toby; Caulfield, Mark J.; Munroe, Patricia B.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Lamina, Claudia] Innsbruck Med Univ3, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, Innsbruck, Austria; [Moffatt, Miriam F.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Myers, Richard H.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Narisu, Narisu; Bonnycastle, Lori L.; Chines, Peter S.; Erdos, Michael R.; Morken, Mario A.; Swift, Amy J.; Collins, Francis S.] NHGRI, NIH, Bethesda, MD 20892 USA; [Preuss, Michael; Koenig, Inke R.; Ziegler, Andreas] Univ Klinikum Schleswig Holstein, Univ Lubeck, Inst Med Biometrie & Stat, D-23538 Lubeck, Germany; [Ripatti, Samuli; Pellikka, Niina; Kettunen, Johannes; Perola, Markus; Silander, Kaisa; Surakka, Ida; Widen, Elisabeth; Kaprio, Jaakko; Peltonen, Leena] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Ripatti, Samuli; Pellikka, Niina; Kettunen, Johannes; Perola, Markus; Silander, Kaisa; Surakka, Ida; Peltonen, Leena] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Unit Publ Hlth Genom, Helsinki, Finland; [Sandholt, Camilla; Gjesing, Anette P.; Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Timpson, Nicholas J.; Day, Ian N. M.; Smith, George Davey; Lawlor, Debbie A.] MRC Ctr Causal Anal Translat Epidemiol, Dept Social Med, Bristol, Avon, England; [Tyrer, Jonathan P.] Univ Cambridge, Dept Oncol, Cambridge, England; [Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Watanabe, Richard M.; Bergman, Richard N.; Buchanan, Thomas A.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [White, Charles C.; Ngwa, Julius S.; Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Barlassina, Christina; Macciardi, Fabio] Univ Milan, Dept Med Surg & Dent, Milan, Italy; [Chasman, Daniel I.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Cooper, Matthew N.; Lawrence, Robert W.; Hui, Jennie; Palmer, Lyle J.] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Crawley, WA, Australia; [Jansson, John-Olov] Univ Gothenburg, Dept Physiol, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Alibrandi, Maria T. S.; Lanzani, Chiara; Manunta, Paolo] Univ Vita Salute San Raffaele, Div Nephrol & Dialysis, Milan, Italy; [Almgren, Peter; Groop, Leif C.] Lund Univ, Dept Clin Sci, Ctr Diabet, Malmo, Sweden; [Arnold, Alice M.; McKnight, Barbara] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Arnold, Alice M.] Collaborat Hlth Studies Coordinating Ctr, Seattle, WA USA; [Balkau, Beverley] Ctr Res Epidemiol & Publ Hlth, INSERM, Ctr Rech Epidimiol & Sante Populat CESP, U1018, Villejuif, France; [Balkau, Beverley] Univ Paris 11, UMRS 1018, Villejuif, France; [Balmforth, Anthony J.; Hall, Alistair S.] Univ Leeds, LIGHT, MCRC, Leeds, W Yorkshire, England; [Ben-Shlomo, Yoav] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Biebermann, Heike; Wiegand, Susanna; Krude, Heiko] Charite, Inst Expt Paediat Endocrinol, D-13353 Berlin, Germany; [Blakemore, Alexandra I. F.; Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Bornstein, Stefan R.; Ludwig, Barbara] Univ Dresden, Dept Med 3, Dresden, Germany; [Buchanan, Thomas A.] Univ So Calif, Keck Sch Med, Div Endocrinol, Los Angeles, CA 90033 USA; [Busonero, Fabio; Sanna, Serena; Uda, Manuela] CNR, Ist Neurogenet & Neurofarmacol, Cagliari, Italy; [Campbell, Harry; Wild, Sarah H.; Rudan, Igor; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Cappuccio, Francesco P.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Chen, Yii-Der Ida; Haritunians, Talin] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Clarke, Robert] Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; [Coin, Lachlan; Elliott, Paul; Sovio, Ulla; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Fac Med, Dept Epidemiol & Biostat, London, England; [Connell, John] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; [den Heijer, Martin; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands; [den Heijer, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, NL-6525 ED Nijmegen, Netherlands; [Duan, Jubao; Gejman, Pablo V.; Sanders, Alan R.] Northshore Univ Healthsyst, Evanston, IL USA; [Ebrahim, Shah] London Sch Hyg & Trop Med, London WC1, England; [Ebrahim, Shah] S Asia Network Chron Dis, New Delhi, India; [Elliott, Paul] Ctr Environm & Hlth, MRC Hlth Protect Agcy HPA, London, England; [Elosua, Roberto] Ctr Invest Biomed Red CIBER Epidemiol & Salud Pub, Barcelona, Spain; [Elosua, Roberto] Inst Municipal Invest Med, E-08003 Barcelona, Spain; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Isomaa, Bo; Tuomi, Tiinamaija] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland; [Facheris, Maurizio F.; Hicks, Andrew A.; Pichler, Irene; Pramstaller, Peter P.] European Acad Bozen Bolzano EURAC, Inst Med Genet, Bolzano, Italy; [Facheris, Maurizio F.; Hicks, Andrew A.; Pichler, Irene; Pramstaller, Peter P.] Univ Lubeck, Lubeck, Germany; [Facheris, Maurizio F.; Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Felix, Stephan B.] Ernst Moritz Arndt Univ Greifswald, Dept Internal Med B, Greifswald, Germany; [Fischer-Posovszky, Pamela; Wabitsch, Martin] Dept Pediat & Adolescent Med, Pediat Endocrinol Diabet & Obes Unit, Ulm, Germany; [Folsom, Aaron R.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Friedrich, Nele; Schipf, Sabine; Wallaschofski, Henri] Ernst Moritz Arndt Univ Greifswald, Inst Klin Chem & Lab Med, Greifswald, Germany; [Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [Fu, Mao; Shuldiner, Alan R.; O'Connell, Jeffrey R.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Goel, Anuj; Watkins, Hugh] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England; [Goyette, Philippe; Lettre, Guillaume; Tardif, Jean-Claude] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Graessler, Juergen] Univ Dresden, Dept Med 3, Dresden, Germany; [Greenawalt, Danielle M.] Merck & Co Inc, Merck Res Labs, Boston, MA USA; [Hartikainen, Anna-Liisa; Pouta, Anneli] Univ Oulu, Dept Clin Sci Obstet & Gynecol, Oulu, Finland; [Havulinna, Aki S.; Jousilahti, Pekka; Koskinen, Seppo; Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Chron Dis Epidemiol & Prevent Unit, Helsinki, Finland; [Hayward, Caroline; Vitart, Veronique; Wright, Alan F.] Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Heath, Andrew C.] Washington Univ, Sch Med, Dept Psychiat & Midwest Alcoholism Res Ctr, St Louis, MO USA; [Hengstenberg, Christian] Univ Regensburg, Klin & Poliklin Innere Med 2, Regensburg, Germany; [Hengstenberg, Christian] Univ Regensburg, Med Ctr, Regensburg, Germany; [Hinney, Anke; Scherag, Susann; Vogel, Carla I. G.; Hebebrand, Johannes] Univ Duisburg Essen, Dept Child & Adolescent Psychiat, Essen, Germany; [Homuth, Georg] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Hui, Jennie; Beilby, John P.; Stumvoll, Michael] PathWest Lab Western Australia, Dept Mol Genet, QEII Med Ctr, Nedlands, WA, Australia; [Hui, Jennie; Beilby, John P.; James, Alan L.; Palmer, Lyle J.] Sir Charles Gairdner Hosp, Busselton Populat Med Res Fdn Inc, Nedlands, WA 6009, Australia; [Iribarren, Carlos] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Iribarren, Carlos] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Isomaa, Bo] Dept Social Serv & Hlth Care, Pietarsaari, Finland; [Jacobs, Kevin B.] NCI, SAIC Frederick Inc, Core Genotyping Facil, Frederick, MD 21701 USA; [Jarick, Ivonne] Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany; [John, Ulrich] Ernst Moritz Arndt Univ Greifswald, Inst Epidemiol & Sozialmed, Greifswald, Germany; [Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Jula, Antti] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Populat Studies Unit, Turku, Finland; [Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Kajantie, Eero] Univ Helsinki, Cent Hosp, Hosp Children & Adolescents, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Hosp Dist Helsinki & Uusimaa HUS, Helsinki, Finland; [Kaplan, Lee M.] Massachusetts Gen Hosp, Massachusetts Gen Hosp MGH Weight Ctr, Boston, MA 02114 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Kathiresan, Sekar] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [O'Donnell, Christopher J.] Boston Univ, Framingham, MA USA; [Kathiresan, Sekar; O'Donnell, Christopher J.] NHLBI, Framingham, MA USA; [Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Kinnunen, Leena; Tuomilehto, Jaakko; Valle, Timo T.] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland; [Knowles, Joshua W.; Quertermous, Thomas; Assimes, Themistocles L.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Kolcic, Ivana; Polasek, Ozren; Zgaga, Lina] Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Zagreb 41000, Croatia; [Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res, Leipzig, Germany; [Kuusisto, Johanna; Laakso, Markku] Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Kvaloy, Kirsti; Midthjell, Kristian; Platou, Carl G. P.; Hveem, Kristian] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Nord Trondelag Hlth Study HUNT Res Ctr, Levanger, Norway; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Oulu, Finland; [Lantieri, Olivier] Inst Interreg Sante IRSA, La Riche, France; [Launer, Lenore J.; Harris, Tamara B.] NIA, Lab Epidemiol, NIH, Bethesda, MD 20892 USA; [Lehtimaeki, Terho] Univ Tampere, Dept Clin Chem, FIN-33101 Tampere, Finland; [Lehtimaeki, Terho] Tampere Univ Hosp, Tampere, Finland; [Lettre, Guillaume; Tardif, Jean-Claude] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Liu, Jianjun] Genome Inst Singapore, Singapore, Singapore; [Lokki, Marja-Liisa] Univ Helsinki, Transplantat Lab, Haartman Inst, Helsinki, Finland; [Lorentzon, Mattias; Ohlsson, Claes] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Internal Med, Gothenburg, Sweden; [Luben, Robert N.; Sandhu, Manjinder S.; Khaw, Kay-Tee] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Marre, Michel] Bichat Claude Bernard Univ Hosp, AP HP, Dept Endocrinol Diabetol & Nutr, Paris, France; [Marre, Michel] Univ Nancy 1, Cardiovasc Genet Res Unit, Nancy, France; [Martin, Nicholas G.] Queensland Inst Med Res, Genet Epidemiol Lab, Brisbane, Qld 4006, Australia; [McArdle, Wendy L.] Univ Bristol, Dept Social Med, Avon Longitudinal Study Parents & Children ALSPAC, Bristol, Avon, England; [McCarthy, Anne] Bord Taighde Slainte, Res Board, Div Hlth, Dublin, Ireland; [Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-8000 Munich, Germany; [Meitinger, Thomas] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Human Genet, Neuherberg, Germany; [Melander, Olle; Ridderstrale, Martin] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Montgomery, Grant W.] Queensland Inst Med Res, Mol Epidemiol Lab, Brisbane, Qld 4006, Australia; [Mulic, Rosanda; Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia; [Nyholt, Dale R.] Queensland Inst Med Res, Neurogenet Lab, Brisbane, Qld 4006, Australia; [O'Donnell, Christopher J.] NHLBI, NIH, Framingham, MA USA; [O'Rahilly, Stephen; Farooqi, I. Sadaf] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England; [Oostra, Ben] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Pare, Guillaume] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Parker, Alex N.] Amgen Inc, Cambridge, MA USA; [Pietilaeinen, Kirsi H.; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Pietilaeinen, Kirsi H.; Rissanen, Aila] Univ Helsinki, Cent Hosp, Dept Psychiat, Obes Res Unit, Helsinki, Finland; [Platou, Carl G. P.] Nord Trondelag Hlth Trust, Levanger Hosp, Dept Med, Levanger, Norway; [Polasek, Ozren] Gen Info Ltd, Zagreb, Croatia; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Oulu, Finland; [Rafelt, Suzanne; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol, FIN-20520 Turku, Finland; [Rief, Winfried] Univ Marburg, Marburg, Germany; [Ruokonen, Aimo] Univ Oulu, Dept Clin Sci & Clin Chem, Oulu, Finland; [Rzehak, Peter; Wichmann, H-Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Saramies, Jouko] S Karelia Cent Hosp, Lappeenranta, Finland; [Savolainen, Markku J.] Univ Oulu, Dept Clin Sci & Internal Med, Oulu, Finland; [Schipf, Sabine] Inst Community Med, Greifswald, Germany; [Schreiber, Stefan] Univ Kiel, Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, Kiel, Germany; [Schreiber, Stefan] Univ Kiel, Dept Internal Med 1, Kiel, Germany; [Schunkert, Heribert; Erdmann, Jeanette] Univ Lubeck, Med Klin 2, Lubeck, Germany; [Sinisalo, Juha; Nieminen, Markku S.] Univ Helsinki, Cent Hosp, Cardiovasc Lab, Div Cardiol, Helsinki, Finland; [Siscovick, David S.] Univ Washington, Dept Med, Seattle, WA USA; [Siscovick, David S.] Univ Washington, Dept Epidemiol, Seattle, WA USA; [Smit, Jan H.; Penninx, Brenda W.] Vrije Univ Amsterdam Med Ctr, Inst Extramuraal Geneeskundig Onderzoek EMGO Inst, Dept Psychiat, Amsterdam, Netherlands; [Stephens, Jonathan; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge, England; [Stephens, Jonathan; Ouwehand, Willem H.] Natl Hlth Serv NHS Blood & Transplant, Cambridge Ctr, Cambridge, England; [Thompson, John R.; Samani, Nilesh J.] Glenfield Hosp, Leicester NIHR Biomed Res Unit Cardiovasc, Leicester, Leics, England; [Toenjes, Anke; Stumvoll, Michael] Univ Leipzig, Dept Med, Leipzig, Germany; [Thompson, John R.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Toenjes, Anke] Univ Leipzig, Coordinat Ctr Clin Trials, Leipzig, Germany; [Tuomi, Tiinamaija] Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland; [Tuomi, Tiinamaija] Univ Helsinki, Res Program Mol Med, Helsinki, Finland; [van Ommen, Gert-Jan] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [van Ommen, Gert-Jan] Leiden Univ, Med Ctr, Ctr Med Syst Biol, Leiden, Netherlands; [Viikari, Jorma] Univ Turku, Dept Med, Turku, Finland; [Viikari, Jorma] Turku Univ Hosp, FIN-20520 Turku, Finland; [Visvikis-Siest, Sophie] INSERM, Cardiovasc Genet team, CIC 9501, Nancy, France; [Witte, Daniel R.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Xu, Jianfeng] Wake Forest Univ, Ctr Human Genom, Winston Salem, NC 27109 USA; [Zitting, Paavo] Lapland Cent Hosp, Dept Physiatr, Rovaniemi, Finland; [Beilby, John P.] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Huikuri, Heikki V.] Univ Oulu, Dept Internal Med, SF-90220 Oulu, Finland; [James, Alan L.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Kaehoenen, Mika] Univ Tampere, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Kaehoenen, Mika] Tampere Univ Hosp, Tampere, Finland; [Levinson, Douglas F.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Macciardi, Fabio] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; Univ Leipzig, Leipziger Interdisziplinarer Forsch Komplex Mol U, Leipzig, Germany; [Beckmann, Jacques S.] Univ Hosp, CHUV, Serv Med Genet, Lausanne, Switzerland; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Inst Mol Med, Houston, TX USA; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark; [Hayes, Richard B.] NYU, Med Ctr, New York, NY 10016 USA; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Dept Mental Hlth & Substance Abuse Serv, Unit Child & Adolescent Mental Hlth, Helsinki, Finland; [Karpe, Fredrik; McCarthy, Mark I.] Churchill Hosp, NIHR Oxford Biomed Res Ctr, Oxford OX3 7LJ, England; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Pedersen, Oluf] Univ Copenhagen, Inst Biomed Sci, Copenhagen, Denmark; [Penninx, Brenda W.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Penninx, Brenda W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands; [Pramstaller, Peter P.] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Reinehr, Thomas] Univ Witten Herdecke, Vest Hosp Children & Adolescents, Inst Paediat Nutr Med, Datteln, Germany; [Schwarz, Peter E. H.] Univ Dresden, Dept Med 3, Dresden, Germany; [Tuomilehto, Jaakko] Baltimore Vet Adm, Geriatr Res & Educ Clin Ctr, Med Ctr, Baltimore, MD USA; [Tuomilehto, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Tuomilehto, Jaakko] S Ostrobothnia Cent Hosp, Seinajoki, Finland; [Shuldiner, Alan R.; Waeber, Gerard] Univ Hosp, CHUV, Dept Internal Med, Lausanne, Switzerland; [Purcell, Shaun; Peltonen, Leena] MIT, Cambridge, MA 02139 USA; [Purcell, Shaun; Peltonen, Leena] Broad Inst Harvard, Cambridge, MA 02139 USA; [Purcell, Shaun] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Schadt, Eric E.] Pacific Biosci, Menlo Pk, CA USA; [Schadt, Eric E.] Sage Bionetworks, Seattle, WA USA; [Borecki, Ingrid B.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Fox, Caroline S.] NHLBI, Div Intramural Res, Framingham, MA USA; [Kaplan, Robert C.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, New York, NY USA; [Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Peltonen, Leena] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA; [Strachan, David P.] Univ London, Div Community Hlth Sci, London, England; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Barroso, Ines] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England; [North, Kari E.] Univ N Carolina, Sch Publ Hlth, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill; University of Exeter; University of Plymouth; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Regensburg; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Wellcome Trust Sanger Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet; QIMR Berghofer Medical Research Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; University of Tartu; University of Tartu; University of Tartu; Washington University (WUSTL); University of Lausanne; Swiss Institute of Bioinformatics; University of London; King's College London; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Duisburg Essen; Icelandic Heart Association; University of Iceland; University of Bath; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Melbourne; Boston University; Technical University of Munich; Vrije Universiteit Amsterdam; Uppsala University; Norwegian University of Science & Technology (NTNU); University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; Medical University of Innsbruck; Imperial College London; Boston University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Helsinki; Finland National Institute for Health & Welfare; Novo Nordisk; Hagedorn Research Institute; University of Bristol; University of Cambridge; University of Southern California; University of Southern California; Boston University; University of Milan; Harvard University; Brigham & Women's Hospital; University of Western Australia; University of Gothenburg; Vita-Salute San Raffaele University; Lund University; University of Washington; University of Washington Seattle; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Leeds; University of Bristol; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Imperial College London; Technische Universitat Dresden; University of Southern California; Consiglio Nazionale delle Ricerche (CNR); University of Edinburgh; University of Warwick; Cedars Sinai Medical Center; Radcliffe Infirmary; University of Oxford; Imperial College London; University of Dundee; Radboud University Nijmegen; Radboud University Nijmegen; NorthShore University Health System; University of London; London School of Hygiene & Tropical Medicine; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Vaasa Central Hospital; European Academy of Bozen-Bolzano; University of Lubeck; Krankenhaus Bozen; Ernst Moritz Arndt Universitat Greifswald; University of Minnesota System; University of Minnesota Twin Cities; Ernst Moritz Arndt Universitat Greifswald; University of California System; University of California Los Angeles; University System of Maryland; University of Maryland Baltimore; University of Oxford; Universite de Montreal; Technische Universitat Dresden; Merck & Company; University of Oulu; Finland National Institute for Health & Welfare; University of Edinburgh; Washington University (WUSTL); University of Regensburg; University of Regensburg; University of Duisburg Essen; Ernst Moritz Arndt Universitat Greifswald; University of Western Australia; University of Western Australia; Kaiser Permanente; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Philipps University Marburg; Ernst Moritz Arndt Universitat Greifswald; University of Copenhagen; University of Copenhagen; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Harvard Medical School; Finland National Institute for Health & Welfare; Stanford University; University of Zagreb; Leipzig University; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Norwegian University of Science & Technology (NTNU); Finnish Institute of Occupational Health; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Tampere University; Tampere University; Tampere University Hospital; Universite de Montreal; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Helsinki; University of Gothenburg; University of Cambridge; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lorraine; QIMR Berghofer Medical Research Institute; University of Bristol; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Lund University; QIMR Berghofer Medical Research Institute; University of Split; QIMR Berghofer Medical Research Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Erasmus University Rotterdam; Erasmus MC; McMaster University; Amgen; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Turku; University of Turku; Philipps University Marburg; University of Oulu; University of Munich; University of Oulu; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Helsinki; Helsinki University Central Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Cambridge; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Leipzig University; University of Leicester; Leipzig University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Turku; University of Turku; Institut National de la Sante et de la Recherche Medicale (Inserm); Steno Diabetes Center; Wake Forest University; University of Western Australia; University of Oulu; University of Western Australia; Tampere University; Tampere University; Tampere University Hospital; Stanford University; University of California System; University of California Irvine; Leipzig University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Southern Denmark; New York University; Finland National Institute for Health & Welfare; University of Oxford; Radboud University Nijmegen; Aarhus University; University of Copenhagen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; University of Lubeck; Witten Herdecke University; Technische Universitat Dresden; Geriatric Research Education & Clinical Center; University System of Maryland; University of Maryland Baltimore; University of Helsinki; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Yeshiva University; University of North Carolina; University of North Carolina Chapel Hill; University of Helsinki; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University of Munich; University of Iceland; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School	Brown, MJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge, England.	boehnke@umich.edu; kstefans@decode.is; kari_north@unc.edu; mark.mccarthy@drl.ox.ac.uk; joelh@broadinstitute.org; erik.ingelsson@ki.se; ruth.loos@mrc-epid.cam.ac.uk	Erdmann, Jeanette/P-7513-2014; Yang, Jian/A-5852-2010; Kutalik, Zoltan/HHZ-5697-2022; O'Rahilly, Stephen/ABF-6509-2020; Luben, Robert N/H-5519-2015; Voight, Benjamin/F-1775-2011; Grallert, Harald/B-3424-2013; Aspelund, Thor/C-5983-2008; Gjesing, Anette/ACC-7521-2022; Wood, Andrew R/AAB-3807-2019; Coin, Lachlan JM/A-9001-2014; Narisu, Narisu/T-6908-2019; Ripatti, Samuli/H-9446-2014; BOUATIA-NAJI, NABILA/D-5863-2013; Peters, Annette/A-6117-2011; Amin, Najaf N/D-1859-2012; Hinney, Anke/D-6953-2011; Rivadeneira, Fernando/O-5385-2015; Kaprio, Jaakko/A-1820-2008; Lehtimäki, Terho/AAD-1094-2022; Mägi, Reedik/AAJ-9679-2021; Loos, Ruth J F/Q-2862-2016; Johansson, Åsa/AAG-6799-2021; Pramstaller, Peter P/C-2357-2008; FROGUEL, Philippe/O-6799-2017; Hicks, Andrew Anthony/E-9518-2017; Erdmann, Jeanette/A-4417-2009; de Geus, Eco J.C./M-9318-2015; Coin, Lachlan/O-4976-2019; Hui, Jennie/A-9543-2013; Penninx, Brenda WJH/S-7627-2017; Loos, Ruth/GON-5877-2022; Deloukas, Panos/B-2922-2013; Farooqi, Ismaa Sadaf/AAZ-3046-2020; Kiemeney, Lambertus A./D-3357-2009; Meitinger, Thomas/O-1318-2015; Hall, Alistair/K-1953-2019; Thiering, Elisabeth/B-3342-2013; Wichmann, Heinz Erich/AAA-5695-2022; Wilson, James F/A-5704-2009; Lamina, Claudia/F-7608-2010; Witte, Daniel/AAF-9535-2019; Spector, Tim D/F-6533-2012; Feitosa, Mary F/K-8044-2012; Palmer, Lyle John/K-3196-2014; Stumvoll, Michael/ABE-1121-2021; Raitakari, Olli/AAQ-7389-2021; Ohlsson, Claes/AGP-3544-2022; Timpson, Nicholas John/O-7548-2015; Scherag, Andre/B-3805-2014; Fox, Laura J/C-6249-2016; Walters, G. Bragi/L-4215-2013; Macciardi, Fabio/N-3768-2014; Cooper, Matthew N/J-4420-2014; Vogel, Carla Ivane/X-3419-2019; Colaus, PsyColaus/K-6607-2013; Abecasis, Goncalo R/B-7840-2010; Smith, Albert Vernon/K-5150-2015; Jørgensen, Torben/Z-1335-2018; Montgomery, Grant W/B-7148-2008; Davey Smith, George/A-7407-2013; Stefansson, Kari/AAE-7187-2019; Campbell, Harry/E-2959-2010; Meyre, David/D-7315-2011; Gudnason, Vilmundur/K-6885-2015; Khaw, Kay-Tee/AAZ-3209-2021; Attrill, Lauren/V-1688-2018; Witte, Daniel R/C-1722-2008; Allen, Hana Lango/G-9026-2012; Ben-Shlomo, Yoav/ABD-2004-2021; Mulic, Rosanda/D-6914-2017; Beckmann, Jacques S/A-9772-2008; Cappuccio, Francesco Paolo/ABF-1094-2020; Sovio, Ulla/H-8532-2019; Heinrich, Joachim/N-1720-2013; Zgaga, Lina/Q-9415-2018; Rudan, Igor/I-1467-2012; Nelis, Mari/ABG-7775-2020; Brown, Matthew A/E-5749-2010; Lanzani, Chiara Livia/AAN-2284-2020; Boomsma, Dorret I/AAX-4470-2020; Visscher, Peter/ABB-6151-2020; Blakemore, Alexandra I F/D-2253-2009; Kolcic, Ivana/E-2713-2017; Manunta, Paolo/ABH-5476-2020; Polasek, Ozren/B-6002-2011; Lorentzon, Mattias/W-7878-2019; Assimes, Themistocles Leonard/D-9696-2015; Bouatia-Naji, Nabila/AGF-1400-2022; Palmer, Lyle John/N-1948-2019; Rief, Winfried/ABD-4994-2021; Pare, Guillaume/T-9631-2018; Kinnunen, Leena/B-7059-2012; Aben, Katja KH/G-9686-2016; König, Inke R/A-4544-2009; Havulinna, Aki/AAM-4769-2021; Aspelund, Thor/F-4826-2011; Segre, Ayellet V/E-9800-2010; Johansson, Åsa/G-5270-2011; Prokopenko, Inga/AAU-9895-2020; Visvikis-Siest, Sophie/H-2324-2014; Kilpeläinen, Tuomas/F-8569-2012; Berndt, Sonja I/J-8423-2016; Ridderstråle, Martin/F-7678-2012; Hayward, Caroline/M-8818-2016; Prokopenko, Inga/H-3241-2014; Gudnason, Vilmundur/AAE-7126-2019; Hveem, Kristian/AFV-4683-2022; Liu, Jianjun/AAK-4989-2020; Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Hengstenberg, Christian/U-5485-2019; Tuluc, Petronel/C-2527-2011; sanna, serena/H-3009-2019; Uda, Manuela/AAC-2645-2019; Kaplan, Robert/A-2526-2011; Li, Shengxu/D-8915-2012; Mangino, Massimo/F-5134-2011; Aspelund, Thor/K-7022-2019; Nyholt, Dale Robert/J-3174-2017; Ziegler, Andreas/G-4246-2012; den Heijer, Martin/J-8036-2015	Erdmann, Jeanette/0000-0002-4486-6231; Yang, Jian/0000-0003-2001-2474; Kutalik, Zoltan/0000-0001-8285-7523; O'Rahilly, Stephen/0000-0003-2199-4449; Luben, Robert N/0000-0002-5088-6343; Aspelund, Thor/0000-0002-7998-5433; Gjesing, Anette/0000-0003-4580-1576; Wood, Andrew R/0000-0003-1726-948X; Coin, Lachlan JM/0000-0002-4300-455X; Ripatti, Samuli/0000-0002-0504-1202; Peters, Annette/0000-0001-6645-0985; Hinney, Anke/0000-0001-5659-0706; Rivadeneira, Fernando/0000-0001-9435-9441; Kaprio, Jaakko/0000-0002-3716-2455; Lehtimäki, Terho/0000-0002-2555-4427; Loos, Ruth J F/0000-0002-8532-5087; Johansson, Åsa/0000-0002-2915-4498; FROGUEL, Philippe/0000-0003-2972-0784; Hicks, Andrew Anthony/0000-0001-6320-0411; de Geus, Eco J.C./0000-0001-6022-2666; Coin, Lachlan/0000-0002-4300-455X; Hui, Jennie/0000-0002-1653-2496; Penninx, Brenda WJH/0000-0001-7779-9672; Deloukas, Panos/0000-0001-9251-070X; Kiemeney, Lambertus A./0000-0002-2368-1326; Wilson, James F/0000-0001-5751-9178; Lamina, Claudia/0000-0002-5398-5806; Witte, Daniel/0000-0002-0769-2922; Feitosa, Mary F/0000-0002-0933-2410; Palmer, Lyle John/0000-0002-1628-3055; Stumvoll, Michael/0000-0001-6225-8240; Ohlsson, Claes/0000-0002-9633-2805; Timpson, Nicholas John/0000-0002-7141-9189; Walters, G. Bragi/0000-0002-5415-6487; Macciardi, Fabio/0000-0003-0537-4266; Cooper, Matthew N/0000-0003-1139-3682; Smith, Albert Vernon/0000-0003-1942-5845; Montgomery, Grant W/0000-0002-4140-8139; Davey Smith, George/0000-0002-1407-8314; Campbell, Harry/0000-0002-6169-6262; Meyre, David/0000-0003-4850-7444; Gudnason, Vilmundur/0000-0001-5696-0084; Witte, Daniel R/0000-0002-0769-2922; Allen, Hana Lango/0000-0002-7803-8688; Ben-Shlomo, Yoav/0000-0001-6648-3007; Beckmann, Jacques S/0000-0002-9741-1900; Cappuccio, Francesco Paolo/0000-0002-7842-5493; Sovio, Ulla/0000-0002-0799-1105; Heinrich, Joachim/0000-0002-9620-1629; Zgaga, Lina/0000-0003-4089-9703; Rudan, Igor/0000-0001-6993-6884; Nelis, Mari/0000-0001-9748-1020; Brown, Matthew A/0000-0003-0538-8211; Lanzani, Chiara Livia/0000-0002-5332-4012; Visscher, Peter/0000-0002-2143-8760; Blakemore, Alexandra I F/0000-0003-0661-564X; Kolcic, Ivana/0000-0001-7918-6052; Manunta, Paolo/0000-0003-3976-9696; Polasek, Ozren/0000-0002-5765-1862; Lorentzon, Mattias/0000-0003-0749-1431; Assimes, Themistocles Leonard/0000-0003-2349-0009; Bouatia-Naji, Nabila/0000-0001-5424-2134; Palmer, Lyle John/0000-0002-1628-3055; Rief, Winfried/0000-0002-7019-2250; Pare, Guillaume/0000-0002-6795-4760; Kinnunen, Leena/0000-0001-8739-4812; Aben, Katja KH/0000-0002-0214-2147; König, Inke R/0000-0003-0504-6465; Johansson, Åsa/0000-0002-2915-4498; Visvikis-Siest, Sophie/0000-0001-8104-8425; Kilpeläinen, Tuomas/0000-0002-8349-3028; Hayward, Caroline/0000-0002-9405-9550; Prokopenko, Inga/0000-0003-1624-7457; Gudnason, Vilmundur/0000-0001-5696-0084; Liu, Jianjun/0000-0002-3255-3019; Pedersen, Oluf/0000-0002-3321-3972; sanna, serena/0000-0002-3768-1749; Uda, Manuela/0000-0002-4890-6456; Mangino, Massimo/0000-0002-2167-7470; Aspelund, Thor/0000-0002-7998-5433; Nyholt, Dale Robert/0000-0001-7159-3040; Marre, Michel/0000-0002-3071-1837; Scherag, Andre/0000-0002-9406-4704; Hattersley, Andrew/0000-0001-5620-473X; Weedon, Michael/0000-0002-6174-6135; Workalemahu, Tsegaselassie/0000-0003-4571-9740; Cupples, L. Adrienne/0000-0003-0273-7965; Esko, Tonu/0000-0003-1982-6569; Kahonen, Mika/0000-0002-4510-7341; Van Duijn, Cornelia/0000-0002-2374-9204; Elliott, Paul/0000-0002-7511-5684; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Wheeler, Eleanor/0000-0002-8616-6444; Wiegand, Susanna/0000-0001-8341-9533; Schwarz, Peter/0000-0002-0483-8594; Farooqi, Sadaf/0000-0001-7609-3504; Kaakinen, Marika/0000-0002-9228-0462; Eriksson, Johan/0000-0002-2516-2060; John, Ulrich/0000-0003-0587-5298; Vogel, Carla/0000-0003-1715-2556; Pichler, Irene/0000-0001-8251-0757; Pramstaller, Peter P/0000-0002-9831-8302; Hall, Alistair/0000-0003-0306-7887; Lindgren, Cecilia/0000-0002-4903-9374; bennett, amanda/0000-0003-2140-8710; Bergman, Richard/0000-0003-1539-4471; Raychaudhuri, Soumya/0000-0002-1901-8265; Sinisalo, Juha/0000-0002-0169-5137; Ouwehand, Willem/0000-0002-7744-1790; North, Kari/0000-0002-8903-0366; Hansen, Torben/0000-0001-8748-3831; Caulfield, Mark/0000-0001-9295-3594; Soranzo, Nicole/0000-0003-1095-3852; Bergmann, Sven/0000-0002-6785-9034; Biebermann, Heike/0000-0002-2024-7778; Magi, Reedik/0000-0002-2964-6011; Barroso, Ines/0000-0001-5800-4520; Hayes, Richard/0000-0002-0918-661X; Ziegler, Andreas/0000-0002-8386-5397; Voight, Benjamin/0000-0002-6205-9994; s, hema/0000-0002-3440-9475; Peters, Marjolein/0000-0003-3167-9063; Quertermous, Thomas/0000-0002-7645-9067; Melander, Olle/0000-0002-2581-484X; Willer, Cristen/0000-0001-5645-4966; Heard-Costa, Nancy/0000-0001-9730-0306; Pietilainen, Kirsi/0000-0002-8522-1288; Martin, Nicholas/0000-0003-4069-8020; Preuss, Michael/0000-0001-5266-8465; Munroe, Patricia/0000-0002-4176-2947; Fischer-Posovszky, Pamela/0000-0003-3402-9840; Barlassina, Cristina/0000-0001-7407-2697; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Kovacs, Peter/0000-0002-0290-5423; van Meurs, Joyce/0000-0001-6245-2123; Abecasis, Goncalo/0000-0003-1509-1825; Gieger, Christian/0000-0001-6986-9554; Surakka, Ida/0000-0002-6669-5541; Jacobs, Kevin/0000-0002-4657-6473; Karpe, Fredrik/0000-0002-2751-1770; Willemsen, Gonneke/0000-0003-3755-0236; Shuldiner, Alan/0000-0001-9921-4305; Weyant, Robert/0000-0002-5252-9120; Perola, Markus/0000-0003-4842-1667; Goel, Anuj/0000-0003-2307-4021; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Watkins, Hugh/0000-0002-5287-9016; Meitinger, Thomas/0000-0002-8838-8403; Beilby, John/0000-0002-4915-2254; Thiering, Elisabeth/0000-0002-5429-9584; Goddard, Michael/0000-0001-9917-7946; Morris, Andrew/0000-0002-6805-6014; Lawlor, Debbie A/0000-0002-6793-2262; Jones, Lindsay/0000-0002-4219-8356; Johnson, Toby/0000-0002-5998-3270; Mulic, Rosanda/0000-0003-3334-9658; den Heijer, Martin/0000-0003-3620-5617; Tuomi, Tiinamaija/0000-0002-8306-6202; Amin, Najaf/0000-0002-8944-1771; Jorgensen, Torben/0000-0001-9453-2830; Waeber, Gerard/0000-0003-4193-788X; Myers, Richard/0000-0002-8365-2674; Randall, Joshua/0000-0003-1540-203X; Glazer, Nicole/0000-0002-6397-609X	Academy of Finland [10404, 77299, 104781, 114382, 117797, 120315]; ADA; Amgen; Agency for Science, Technology and Research of Singapore (A<SUP>star</SUP>STAR); ALF/LUA; Althingi (the Icelandic Parliament); AstraZeneca; Augustinus Foundation; Australian National Health and Medical Research Council [241944, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 496688, 552485, 613672]; Australian Research Council (ARC) [DP0770096]; Becket Foundation; Biocenter (Finland); Biomedicum Helsinki Foundation; Boston Obesity Nutrition Research Center; British Diabetes Association [1192]; British Heart Foundation [97020, PG/02/128]; Busselton Population Medical Research Foundation; Cambridge Institute for Medical Research; Cambridge National Institute of Health Research (NIHR) Comprehensive Biomedical Research Centre; CamStrad (UK); Cancer Research UK; Centre for Medical Systems Biology (The Netherlands); Centre for Neurogenomics and Cognitive Research (The Netherlands); Chief Scientist Office of the Scottish Government; Contrat Plan Etat Region (France); Danish Centre for Health Technology Assessment; Danish Diabetes Association; Danish Heart Foundation; Danish Pharmaceutical Association; Danish Research Council; Deutsche Forschungsgemeinschaft (DFG) [HE 1446/4-1]; Department of Health (UK); Diabetes UK; Diabetes and Inflammation Laboratory; Donald W. Reynolds Foundation; Dresden University of Technology; Emil and Vera Cornell Foundation; Erasmus Medical Center (Rotterdam); Erasmus University (Rotterdam); European Commission [QLG1-CT-2000-01643, QLG2-CT-2002-01254, LSHC-CT-2005, LSHG-CT-2006-018947, LSHG-CT-2004-518153, LSH-2006-037593, LSHM-CT-2007-037273, HEALTH- F2-2008-ENGAGE, HEALTH-F4-2007-201413, HEALTH-F4-2007-201550, 205419, 212111, 245536, SOC 9520140805F02, WLRT-2001-01254]; Federal Ministry of Education and Research (Germany) [01AK803, 01EA9401, 01GI0823, 01GI0826, 01GP0209, 01GP0259, 01GS0820, 01GS0823, 01GS0824, 01GS0825, 01GS0830, 01GS0831, 01IG07015, 01KU0903, 01ZZ9603, 01ZZ0103, 01ZZ0403, 03ZIK012]; Federal State of Mecklenburg-West Pomerania; European Social Fund; Eve Appeal; Finnish Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Finnish Foundation for Pediatric Research, Finnish Medical Society; Finska Lakaresallskapet, Paivikki and Sakari Sohlberg Foundation, Folkhalsan Research Foundation; Fond Europeen pour le Developpement Regional (France); Fondation LeDucq (Paris, France); Foundation for Life and Health in Finland; Foundation for Strategic Research (Sweden); Genetic Association Information Network; German Research Council [KFO-152]; German National Genome Research Net 'NGFNplus' [FKZ 01GS0823]; German Research Center for Environmental Health; Giorgi-Cavaglieri Foundation; GlaxoSmithKline; Goteborg Medical Society; Great Wine Estates Auctions; Gyllenberg Foundation; Health Care Centers in Vasa, Narpes and Korsholm; Healthway, Western Australia; Helmholtz Center Munich; Helsinki University Central Hospital, Hjartavernd (the Icelandic Heart Association); INSERM (France); Ib Henriksen Foundation; Interdisziplinares Zentrum fur Klinische Forschung (IZKF) [B27]; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Juvenile Diabetes Research Foundation International (JDRF); Karolinska Institute; Knut and Alice Wallenberg Foundation; Leenaards Foundation; Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LUCAMP); Lundberg Foundation; Marie Curie Intra-European Fellowship; Medical Research Council (UK) [G0000649, G0000934, G9521010D, G0500539, G0600331, G0601261]; Ministry of Cultural Affairs and Social Ministry of the Federal State of Mecklenburg-West Pomerania; Ministry for Health, Welfare and Sports (The Netherlands); Ministry of Education (Finland); Ministry of Education, Culture and Science (The Netherlands); Ministry of Internal Affairs and Health (Denmark); Ministry of Science, Education and Sport of the Republic of Croatia [216-1080315-0302]; Ministry of Science, Research and the Arts Baden-Wurttemberg; Montreal Heart Institute Foundation; Municipal Health Care Center and Hospital in Jakobstad; Municipality of Rotterdam; Narpes Health Care Foundation; National Cancer Institute; National Health and Medical Research Council of Australia; National Institute for Health Research Cambridge Biomedical Research Centre; National Institute for Health Research Oxford Biomedical Research Centre; MRC [G0600705, G9521010, G0501184, MC_U106179472, G0601261, MC_U106188470, G0801056, MC_U137686857, MC_U127561128, G9824984, G0701863, G0000934, G0900554, MC_qA137934, G0600331] Funding Source: UKRI; Medical Research Council [MC_U106179472, G0601261, MC_qA137934, MC_U106188470, MC_U106179471, MC_U127561128, G9824984, G0801056B, G0000934, G0600705, G9521010, MC_U137686857, G0900554, G0600331, G0401527, G0501184, G0801056, G0701863] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195, N01HC075150, N01HC055016, N01HC055222, N01HC085085, N01HC045133, N01HC085082, N01HC035129, N01HC055020, N01HC085080, N01HC055019, N01HC085083, N01HC085084, N01HC085079, N01HC015103, N01HC055021, N01HC085081, N01HC055022, N01HC055018, N01HC085086, N01HC055015] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA067262, R01CA050385, R01CA047988, R01CA065725, U01CA049449, R01CA049449, U01CA098233, U01CA067262, P01CA087969] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005, U54RR020278, M01RR000425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL094535, R41HL055018, U01HL072515, U01HL054527, R01HL064278, R01HL071981, R01HL059367, U01HL084756, R01HL087652, ZIAHL006002, U01HL084729, R01HL085083, U01HL080295, R01HL087647, ZIAHL006094, R01HL088119, R01HL087641, K99HL094535, R01HL087679, R01HL087700, R42HL055018, R01HL086694, R01HL087676, R41HL055019] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004399, ZIAHG000024, N01HG065403, R01HG002651, Z01HG000024, T32HG000040, U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK073490, R01DK058845, K23DK080145, U01DK062370, U01DK062418, R56DK062370, P30DK072488, P30DK046200, F32DK079466, R01DK075787, R01DK075681, R01DK072193, R01DK062370, R01DK068336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060870, U01MH079470, R01MH059571, U01MH079469, R01MH061675, R01MH084698, R01MH067257, R01MH059588, R01MH059565, R01MH059160, R01MH060879, R01MH081800, R01MH059566, RL1MH083268, R01MH059586, R01MH063706, R01MH059587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG006000, N01AG012100, ZIAAG000675, R01AG031890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA017688, R01AA013321, R01AA007535, R01AA013320, R01AA014041, R01AA013326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012854, R56DA012854] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); ADA(American Diabetes Association); Amgen(Amgen); Agency for Science, Technology and Research of Singapore (A<SUP>star</SUP>STAR); ALF/LUA; Althingi (the Icelandic Parliament); AstraZeneca(AstraZeneca); Augustinus Foundation; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Becket Foundation; Biocenter (Finland); Biomedicum Helsinki Foundation; Boston Obesity Nutrition Research Center; British Diabetes Association(Diabetes UK); British Heart Foundation(British Heart Foundation); Busselton Population Medical Research Foundation; Cambridge Institute for Medical Research; Cambridge National Institute of Health Research (NIHR) Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); CamStrad (UK); Cancer Research UK(Cancer Research UK); Centre for Medical Systems Biology (The Netherlands)(Netherlands Government); Centre for Neurogenomics and Cognitive Research (The Netherlands)(Netherlands Government); Chief Scientist Office of the Scottish Government; Contrat Plan Etat Region (France); Danish Centre for Health Technology Assessment; Danish Diabetes Association; Danish Heart Foundation; Danish Pharmaceutical Association; Danish Research Council(Det Frie Forskningsrad (DFF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Department of Health (UK); Diabetes UK(Diabetes UK); Diabetes and Inflammation Laboratory; Donald W. Reynolds Foundation; Dresden University of Technology; Emil and Vera Cornell Foundation; Erasmus Medical Center (Rotterdam); Erasmus University (Rotterdam); European Commission(European CommissionEuropean Commission Joint Research Centre); Federal Ministry of Education and Research (Germany)(Federal Ministry of Education & Research (BMBF)); Federal State of Mecklenburg-West Pomerania; European Social Fund(European Social Fund (ESF)); Eve Appeal; Finnish Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Finnish Foundation for Pediatric Research, Finnish Medical Society; Finska Lakaresallskapet, Paivikki and Sakari Sohlberg Foundation, Folkhalsan Research Foundation; Fond Europeen pour le Developpement Regional (France); Fondation LeDucq (Paris, France)(Leducq Foundation); Foundation for Life and Health in Finland; Foundation for Strategic Research (Sweden)(Swedish Foundation for Strategic Research); Genetic Association Information Network; German Research Council(German Research Foundation (DFG)); German National Genome Research Net 'NGFNplus'; German Research Center for Environmental Health; Giorgi-Cavaglieri Foundation; GlaxoSmithKline(GlaxoSmithKline); Goteborg Medical Society; Great Wine Estates Auctions; Gyllenberg Foundation; Health Care Centers in Vasa, Narpes and Korsholm; Healthway, Western Australia; Helmholtz Center Munich(Helmholtz Association); Helsinki University Central Hospital, Hjartavernd (the Icelandic Heart Association); INSERM (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ib Henriksen Foundation; Interdisziplinares Zentrum fur Klinische Forschung (IZKF); Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); Karolinska Institute(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Leenaards Foundation; Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LUCAMP); Lundberg Foundation(European Commission); Marie Curie Intra-European Fellowship(European Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Cultural Affairs and Social Ministry of the Federal State of Mecklenburg-West Pomerania; Ministry for Health, Welfare and Sports (The Netherlands)(Netherlands Government); Ministry of Education (Finland); Ministry of Education, Culture and Science (The Netherlands)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Netherlands Government); Ministry of Internal Affairs and Health (Denmark); Ministry of Science, Education and Sport of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Ministry of Science, Research and the Arts Baden-Wurttemberg; Montreal Heart Institute Foundation; Municipal Health Care Center and Hospital in Jakobstad; Municipality of Rotterdam; Narpes Health Care Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by Academy of Finland (10404, 77299, 104781, 114382, 117797, 120315, 121584, 124243, 126775, 126925, 127437, 129255, 129269, 129306, 129494, 129680, 130326, 209072, 210595, 213225, 213506 and 216374); ADA Mentor-Based Postdoctoral Fellowship; Amgen; Agency for Science, Technology and Research of Singapore (A*STAR); ALF/LUA research grant in Gothenburg; Althingi (the Icelandic Parliament); AstraZeneca; Augustinus Foundation; Australian National Health and Medical Research Council (241944, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 496688, 552485 and 613672); Australian Research Council (ARC grant DP0770096); Becket Foundation; Biocenter (Finland); Biomedicum Helsinki Foundation; Boston Obesity Nutrition Research Center; British Diabetes Association (1192); British Heart Foundation (97020; PG/02/128); Busselton Population Medical Research Foundation; Cambridge Institute for Medical Research; Cambridge National Institute of Health Research (NIHR) Comprehensive Biomedical Research Centre; CamStrad (UK); Cancer Research UK; Centre for Medical Systems Biology (The Netherlands); Centre for Neurogenomics and Cognitive Research (The Netherlands); Chief Scientist Office of the Scottish Government; Contrat Plan Etat Rrgion (France); Danish Centre for Health Technology Assessment; Danish Diabetes Association; Danish Heart Foundation; Danish Pharmaceutical Association; Danish Research Council; Deutsche Forschungsgemeinschaft (DFG; HE 1446/4-1); Department of Health (UK); Diabetes UK; Diabetes and Inflammation Laboratory; Donald W.; Reynolds Foundation; Dresden University of Technology Funding Grant; Emil and Vera Cornell Foundation; Erasmus Medical Center (Rotterdam); Erasmus University (Rotterdam); European Commission (DG XII; QLG1-CT-2000-01643, QLG2-CT-2002-01254, LSHC-CT-2005, LSHG-CT-2006-018947, LSHG-CT-2004-518153, LSH-2006-037593, LSHM-CT-2007-037273, HEALTH-F2-2008ENGAGE, HEALTH-F4-2007-201413, HEALTH-F4-2007-201550, FP7/2007-2013, 205419, 212111, 245536, SOC 95201408 05F02 and WLRT-2001-01254); Federal Ministry of Education and Research (Germany) (01AK803, 01EA9401, 01GI0823, 01GI0826, 01GP0209, 01GP0259, 01GS0820, 01GS0823, 01GS0824, 01GS0825, 01GS0830, 01GS0831, 01IG07015, 01KU0903, 01ZZ9603, 01ZZ0103, 01ZZ0403 and 03ZIK012); Federal State of Mecklenburg-West Pomerania; European Social Fund; Eve Appeal; Finnish Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Finnish Foundation for Pediatric Research, Finnish Medical Society; Finska Lakaresallskapet, Paivikki and Sakari Sohlberg Foundation, Folkhalsan Research Foundation; Fond Europeen pour le Developpement Regional (France); Fondation LeDucq (Paris, France); Foundation for Life and Health in Finland; Foundation for Strategic Research (Sweden); Genetic Association Information Network; German Research Council (KFO-152); German National Genome Research Net 'NGFNplus' (FKZ 01GS0823); German Research Center for Environmental Health; Giorgi-Cavaglieri Foundation; GlaxoSmithKline; Goteborg Medical Society; Great Wine Estates Auctions; Gyllenberg Foundation; Health Care Centers in Vasa, Narpes and Korsholm; Healthway, Western Australia; Helmholtz Center Munich; Helsinki University Central Hospital, Hjartavernd (the Icelandic Heart Association); INSERM (France); Ib Henriksen Foundation; Interdisziplinares Zentrum fur Klinische Forschung (IZKF) (B27); Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Juvenile Diabetes Research Foundation International (JDRF); Karolinska Institute; Knut and Alice Wallenberg Foundation; Leenards Foundation; Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LUCAMP); Lundberg Foundation; Marie Curie Intra-European Fellowship; Medical Research Council (UK) (G0000649, G0000934, G9521010D, G0500539, G0600331 and G0601261, PrevMetSyn); Ministry of Cultural Affairs and Social Ministry of the Federal State of Mecklenburg-West Pomerania; Ministry for Health, Welfare and Sports (The Netherlands); Ministry of Education (Finland); Ministry of Education, Culture and Science (The Netherlands); Ministry of Internal Affairs and Health (Denmark); Ministry of Science, Education and Sport of the Republic of Croatia (216-1080315-0302); Ministry of Science, Research and the Arts Baden-Wurttemberg; Montreal Heart Institute Foundation; Municipal Health Care Center and Hospital in Jakobstad; Municipality of Rotterdam; Narpes Health Care Foundation; National Cancer Institute; National Health and Medical Research Council of Australia; National Institute for Health Research Cambridge Biomedical Research Centre; National Institute for Health Research Oxford Biomedical Research Centre; National Institute for Health Research comprehensive Biomedical Research Centre; US National Institutes of Health (263-MA-410953, AA07535, AA10248, AA014041, AA13320, AA13321, AA13326, CA047988, CA65725, CA87969, CA49449, CA67262, CA50385, DA12854, DK58845, DK46200, DK062370, DK063491, DK072193, HG002651, HL084729, HHSN268200625226C, HL71981, K23-DK080145, K99-HL094535, M01-RR00425, MH084698, N01-AG12100, NO1-AG12109, N01-H; 15103, N01-HC25195, N01-HC35129, N01-HC45133, N01-HC55015, N01-HC55016, N01-HC55018, N01-HC55019, N01-HC55020, N01-N01HC-55021, N01-HC55022, N01-HC55222, N01-HC75150, N01-HC85079, N01-HC85080, N01-HG-65403, N01-HC85081, N01-HC85082, N01-HC85083, N01-HC85084, N01-HC85085, N01-HC85086, N02-HL64278, P30-DK072488, R01-AG031890, R01-DK073490, R01-DK075787, R01DK068336, R01DK075681, R01-HL59367, R01-HL086694, R01-HL087641, R01-HL087647, R01-HL087652, R01-HL087676, R01-HL087679, R01-HL087700, R01-HL088119, R01-MH59160, R01-MH59565, R01-MH59566, R01-MH59571, R01-MH59586, R01-MH59587, R01-MH59588, R01-MH60870, R01-MH60879, R01-MH61675, R01-MH63706, R01-MH67257, R01-MH79469, R01-MH79470, R01-MH81800, RL1-MH083268, UO1-CA098233, U01-DK062418, U01-GM074518, U01-HG004402, U01-HG004399, U01-HL72515, U01-HL080295, U01-HL084756, U54-RR020278, T32-HG00040, UL1-RR025005 and Z01-HG000024); National Alliance for Research on Schizophrenia and Depression (NARSAD); Netherlands Genomics Initiative/Netherlands Consortium for Healthy Aging (050-060-810); Netherlands Organisation for Scientific Research (NWO) (904-61-090, 904-61-193, 480-04-004, 400-05-717, SPI 56-464-1419, 175.010.2005.011 and 911-03-012); Nord-Trondelag County Council; Nordic Center of Excellence in Disease Genetics; Novo Nordisk Foundation; Norwegian Institute of Public Health; Ollqvist Foundation; Oxford NIHR Biomedical Research Centre; Organization for the Health Research and Development (10-000-1002); Paavo Nurmi Foundation; Paul Michael Donovan Charitable Foundation; Perklen Foundation; Petrus and Augusta Hedlunds Foundation; Pew Scholar for the Biomedical Sciences; Public Health and Risk Assessment, Health and Consumer Protection (2004310); Research Foundation of Copenhagen County; Research Institute for Diseases in the Elderly (014-93-015; RIDE2); Robert Dawson Evans Endowment; Royal Society (UK); Royal Swedish Academy of Science; Sahlgrenska Center for Cardiovascular and Metabolic Research (CMR, no. A305: 188); Siemens Healthcare, Erlangen, Germany; Sigrid Juselius Foundation; Signe and Ane Gyllenberg Foundation; Science Funding programme (UK); Social Insurance Institution of Finland; Sderberg's Foundation; South Tyrol Ministry of Health; South Tyrolean Sparkasse Foundation; State of Bavaria; Stockholm County Council (560183); Susan G. Komen Breast Cancer Foundation; Swedish Cancer Society; Swedish Cultural Foundation in Finland; Swedish Foundation for Strategic Research; Swedish Heart-Lung Foundation; Swedish Medical Research Council (8691, K2007-66X-20270-01-3, K2010-54X-09894-19-3, K2010-54X-09894-19-3 and 2006-3832); Swedish Research Council; Swedish Society of Medicine; Swiss National Science Foundation (33CSCO-122661, 310000-112552 and 3100AO-116323/1); Torsten and Ragnar Soderberg's Foundation; Universite Henri Poincare-Nancy 1, Region Lorraine, Communaute Urbaine du Grand Nancy; University Hospital Medical funds to Tampere; University Hospital Oulu, Finland; University of Oulu, Finland (75617); Vastra Gotaland Foundation; Walter E. Nichols, M. D., and Eleanor Nichols endowments; Wellcome Trust (068545, 072960, 075491, 076113, 077016, 079557, 079895, 081682, 083270, 085301 and 086596); Western Australian DNA Bank; Western Australian Genetic Epidemiology Resource; and Yrjo Jahnsson Foundation.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Coll AP, 2009, MOL CELL ENDOCRINOL, V300, P147, DOI 10.1016/j.mce.2008.09.007; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Farooqi IS, 2006, DIABETES, V55, P2549, DOI 10.2337/db06-0214; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Krude H, 2003, J CLIN ENDOCR METAB, V88, P4633, DOI 10.1210/jc.2003-030502; Lemmens VEPP, 2008, OBES REV, V9, P446, DOI 10.1111/j.1467-789X.2008.00468.x; Lewis CE, 2009, CIRCULATION, V119, P3263, DOI 10.1161/CIRCULATIONAHA.109.192574; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Li ZQ, 2007, MOL ENDOCRINOL, V21, P2270, DOI 10.1210/me.2007-0111; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marsh DJ, 1999, NAT GENET, V21, P119, DOI 10.1038/5070; McIntosh CHS, 2009, VITAM HORM, V80, P409, DOI 10.1016/S0083-6729(08)00615-8; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; O'Rahilly S, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.239; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Stutzmann F, 2007, HUM MOL GENET, V16, P1837, DOI 10.1093/hmg/ddm132; Taylor AE, 2010, AM J CLIN NUTR, V91, P547, DOI 10.3945/ajcn.2009.28757; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yeo GSH, 2003, HUM MOL GENET, V12, P561, DOI 10.1093/hmg/ddg057; Young EH, 2007, INT J OBESITY, V31, P1437, DOI 10.1038/sj.ijo.0803609; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhong H, 2010, AM J HUM GENET, V86, P581, DOI 10.1016/j.ajhg.2010.02.020; 1998, OBES RES, V6, P461; 1998, OBES RES, V6, P464	54	2083	2136	9	506	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					937	U53		10.1038/ng.686	http://dx.doi.org/10.1038/ng.686			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20935630	Green Submitted, Green Accepted			2022-12-25	WOS:000283540500010
J	Henry, CS; DeJongh, M; Best, AA; Frybarger, PM; Linsay, B; Stevens, RL				Henry, Christopher S.; DeJongh, Matthew; Best, Aaron A.; Frybarger, Paul M.; Linsay, Ben; Stevens, Rick L.			High-throughput generation, optimization and analysis of genome-scale metabolic models	NATURE BIOTECHNOLOGY			English	Article							RECONSTRUCTION; ANNOTATION; PHENOTYPE; NETWORKS; MUTANTS; GENES; SEED; KEGG	Genome-scale metabolic models have proven to be valuable for predicting organism phenotypes from genotypes. Yet efforts to develop new models are failing to keep pace with genome sequencing. To address this problem, we introduce the Model SEED, a web-based resource for high-throughput generation, optimization and analysis of genome-scale metabolic models. The Model SEED integrates existing methods and introduces techniques to automate nearly every step of this process, taking similar to 48 h to reconstruct a metabolic model from an assembled genome sequence. We apply this resource to generate 130 genome-scale metabolic models representing a taxonomically diverse set of bacteria. Twenty-two of the models were validated against available gene essentiality and Biolog data, with the average model accuracy determined to be 66% before optimization and 87% after optimization.	[Henry, Christopher S.] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA; [DeJongh, Matthew; Frybarger, Paul M.] Hope Coll, Dept Comp Sci, Holland, MI 49423 USA; [Best, Aaron A.; Frybarger, Paul M.] Hope Coll, Dept Biol, Holland, MI 49423 USA; [Linsay, Ben; Stevens, Rick L.] Univ Chicago, Dept Comp Sci, Chicago, IL 60637 USA; [Linsay, Ben; Stevens, Rick L.] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Stevens, Rick L.] Argonne Natl Lab, Comp Environm & Life Sci Directorate, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory; Hope College; Hope College; University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Henry, CS (corresponding author), Argonne Natl Lab, Div Math & Comp Sci, 9700 S Cass Ave, Argonne, IL 60439 USA.	chenry@mcs.anl.gov			US Department of Energy [DE-ACO2-06CH11357]; National Institute of Allergy and Infectious Diseases [HHSN266200400042C]; National Science Foundation [MCB-0745100, CCF-0829929, DBI-0850546]; Argonne National Laboratory Guest Faculty; United States Fulbright Scholarship Program; Div Of Biological Infrastructure [0850546] Funding Source: National Science Foundation	US Department of Energy(United States Department of Energy (DOE)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF)); Argonne National Laboratory Guest Faculty; United States Fulbright Scholarship Program; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the US Department of Energy under contract DE-ACO2-06CH11357, by the National Institute of Allergy and Infectious Diseases under contract HHSN266200400042C and by the National Science Foundation under grants MCB-0745100, CCF-0829929 and DBI-0850546. M.D. was also supported by the Argonne National Laboratory Guest Faculty Program and the United States Fulbright Scholarship Program. We acknowledge the SEED annotators and development team for producing the annotations and computational infrastructure that make this work possible. We thank R. Overbeek, V. Vonstein, R. Olson, T. Disz, S. Devoid, F. Xia and T. Paczian for assistance with the use of the SEED genome annotation and analysis tools.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Becker SA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-8; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; DeJongh M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-139; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Durot M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-85; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100046; Gerdes S, 2006, CURR OPIN BIOTECH, V17, P448, DOI 10.1016/j.copbio.2006.08.006; Goelzer A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-20; Henry CS, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r69; Jamshidi N, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-26; Jankowski MD, 2008, BIOPHYS J, V95, P1487, DOI 10.1529/biophysj.107.124784; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P59, DOI 10.1093/nar/30.1.59; Keymer DP, 2007, APPL ENVIRON MICROB, V73, P3705, DOI 10.1128/AEM.02736-06; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; Kumar VS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-212; KUMAR VS, 2009, PLOS COMPUT BIOL, V5, DOI DOI 10.1371/JOURNAL.PCBI.1000308; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nakahigashi K, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.65; Nogales J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-79; Notebaart RA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-296; Oh YK, 2007, J BIOL CHEM, V282, P28791, DOI 10.1074/jbc.M703759200; Oliveira AP, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-39; Overbeek R, 2004, COMMUN ACM, V47, P46, DOI 10.1145/1029496.1029525; Pramanik J, 1998, BIOTECHNOL BIOENG, V60, P230, DOI 10.1002/(SICI)1097-0290(19981020)60:2<230::AID-BIT10>3.0.CO;2-Q; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Schilling CH, 2002, J BACTERIOL, V184, P4582, DOI 10.1128/JB.184.16.4582-4593.2002; Suthers PF, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000285; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Tsoka Sophia, 2004, Archaea, V1, P223, DOI 10.1155/2004/324925; von Eiff C, 2006, J BACTERIOL, V188, P687, DOI 10.1128/JB.188.2.687-693.2006; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263; Zhang R, 2004, NUCLEIC ACIDS RES, V32, pD271, DOI 10.1093/nar/gkh024	39	649	662	8	174	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2010	28	9					977	U22		10.1038/nbt.1672	http://dx.doi.org/10.1038/nbt.1672			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	648UF	20802497				2022-12-25	WOS:000281719100025
J	Tooze, SA; Yoshimori, T				Tooze, Sharon A.; Yoshimori, Tamotsu			The origin of the autophagosomal membrane	NATURE CELL BIOLOGY			English	Article							FREEZE-FRACTURE; INDUCED AUTOPHAGOCYTOSIS; MOUSE-LIVER; GOLGI; PHAGOPHORE; STARVATION; LYSOSOMES; PROTEINS; VACUOLES; BECLIN-1	Macroautophagy is initiated by the formation of the phagophore (also called the isolation membrane). This membrane can both selectively and non-selectively engulf cytosolic components, grow and close around the sequestered components and then deliver them to a degradative organelle, the lysosome. Where this membrane comes from and how it grows is not well understood. Since the discovery of autophagy in the 1950s the source of the membrane has been investigated, debated and re-investigated, with the consensus view oscillating between a de novo assembly mechanism or formation from the membranes of the endoplasmic reticulum (ER) or the Golgi. In recent months, new information has emerged that both the ER and mitochondria may provide a membrane source, enlightening some older findings and revealing how complex the initiation of autophagy may be in mammalian cells.	[Tooze, Sharon A.] London Res Inst Canc Res UK, Secretory Pathways Lab, London WC2A 3PX, England; [Yoshimori, Tamotsu] Osaka Univ, Dept Genet, Grad Sch Med, Osaka 5650871, Japan	University of London; Institute of Cancer Research - UK; Osaka University	Tooze, SA (corresponding author), London Res Inst Canc Res UK, Secretory Pathways Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	sharon.tooze@cancer.org.uk	Yoshimori, Tamotsu/K-9626-2014	Yoshimori, Tamotsu/0000-0001-9787-3788; Tooze, Sharon/0000-0002-2182-3116	Cancer Research U.K.; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Takeda Science Foundation	Cancer Research U.K.(Cancer Research UK); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	S.A.T. would like to thank Cancer Research U.K. for funding. T.Y. was supported by Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and by the Takeda Science Foundation.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Chan EY, 2009, AUTOPHAGY, V5, P758, DOI 10.4161/auto.8709; Fengsrud M, 2000, EUR J CELL BIOL, V79, P871, DOI 10.1078/0171-9335-00125; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Geng JF, 2010, MOL BIOL CELL, V21, P2257, DOI 10.1091/mbc.E09-11-0969; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hamasaki M, 2010, FEBS LETT, V584, P1296, DOI 10.1016/j.febslet.2010.02.061; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; HIRSIMAKI Y, 1982, EUR J CELL BIOL, V27, P298; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; MARI M, 2010, J CELL BIOL, DOI DOI 10.1080/JCB200912089; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; NOVIKOFF PM, 1971, J CELL BIOL, V50, P859, DOI 10.1083/jcb.50.3.859; Orsi A, 2010, CURR OPIN CELL BIOL, V22, P150, DOI 10.1016/j.ceb.2009.11.013; Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331; PUNNONEN EL, 1989, CELL TISSUE RES, V258, P269; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Reggiori F, 2009, DEV CELL, V17, P747, DOI 10.1016/j.devcel.2009.12.004; REUNANEN H, 1985, HISTOCHEMISTRY, V83, P513, DOI 10.1007/BF00492453; REZ G, 1980, LAB INVEST, V43, P269; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Stromhaug PE, 1998, BIOCHEM J, V335, P217, DOI 10.1042/bj3350217; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; van der Vaart A, 2010, MOL BIOL CELL, V21, P2270, DOI 10.1091/mbc.E09-04-0345; Webber JL, 2010, FEBS LETT, V584, P1319, DOI 10.1016/j.febslet.2010.01.020; Yen WL, 2010, J CELL BIOL, V188, P101, DOI 10.1083/jcb.200904075; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	36	412	431	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					831	835		10.1038/ncb0910-831	http://dx.doi.org/10.1038/ncb0910-831			5	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20811355				2022-12-25	WOS:000281561900004
J	Bicknell, LS; Walker, S; Klingseisen, A; Stiff, T; Leitch, A; Kerzendorfer, C; Martin, CA; Yeyati, P; Al Sanna, N; Bober, M; Johnson, D; Wise, C; Jackson, AP; O'Driscoll, M; Jeggo, PA				Bicknell, Louise S.; Walker, Sarah; Klingseisen, Anna; Stiff, Tom; Leitch, Andrea; Kerzendorfer, Claudia; Martin, Carol-Anne; Yeyati, Patricia; Al Sanna, Nouriya; Bober, Michael; Johnson, Diana; Wise, Carol; Jackson, Andrew P.; O'Driscoll, Mark; Jeggo, Penny A.			Mutations in ORC1, encoding the largest subunit of the origin recognition complex, cause microcephalic primordial dwarfism resembling Meier-Gorlin syndrome	NATURE GENETICS			English	Article							II MOPD-II; SECKEL-SYNDROME; CELL-CYCLE; REPLICATION; PERICENTRIN; PROTEIN; DNA; CHECKPOINT; DEFECT; PCNT	Studies into disorders of extreme growth failure (for example, Seckel syndrome and Majewski osteodysplastic primordial dwarfism type II) have implicated fundamental cellular processes of DNA damage response signaling and centrosome function in the regulation of human growth. Here we report that mutations in ORC1, encoding a subunit of the origin recognition complex, cause microcephalic primordial dwarfism resembling Meier-Gorlin syndrome. We establish that these mutations disrupt known ORC1 functions including pre-replicative complex formation and origin activation. ORC1 deficiency perturbs S-phase entry and S-phase progression. Additionally, we show that Orc1 depletion in zebrafish is sufficient to markedly reduce body size during rapid embryonic growth. Our data suggest a model in which ORC1 mutations impair replication licensing, slowing cell cycle progression and consequently impeding growth during development, particularly at times of rapid proliferation. These findings establish a novel mechanism for the pathogenesis of microcephalic dwarfism and show a surprising but important developmental impact of impaired origin licensing.	[Kerzendorfer, Claudia; O'Driscoll, Mark] Univ Sussex, Genome Damage & Stabil Ctr, Human DNA Damage Response Disorders Grp, Brighton, E Sussex, England; [Bicknell, Louise S.; Klingseisen, Anna; Leitch, Andrea; Martin, Carol-Anne; Yeyati, Patricia; Jackson, Andrew P.] Western Gen Hosp, Inst Genet & Mol Med, HGU, MRC, Edinburgh EH4 2XU, Midlothian, Scotland; [Walker, Sarah; Stiff, Tom] Univ Sussex, Genome Damage & Stabil Ctr, DNA Double Strand Break Repair Lab, Brighton, E Sussex, England; [Al Sanna, Nouriya] Dhahran Hlth Ctr, Pediat Serv Div, Dhahran, Saudi Arabia; [Bober, Michael] Alfred I DuPont Hosp Children, Dept Pediat, Div Genet, Wilmington, DE USA; [Johnson, Diana] Sheffield Childrens Hosp, Sheffield, S Yorkshire, England; [Wise, Carol] Texas Scottish Rite Hosp Children, Sarah M & Charles E Seay Ctr Musculoskeletal Res, Dallas, TX 75219 USA	University of Sussex; University of Edinburgh; University of Sussex; Nemours Alfred I. duPont Hospital for Children; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Texas Scottish Rite Hospital for Children	O'Driscoll, M (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Human DNA Damage Response Disorders Grp, Brighton, E Sussex, England.	andrew.jackson@hgu.mrc.ac.uk; m.o-driscoll@sussex.ac.uk	Bicknell, Louise/GLR-4215-2022; Jackson, Andrew P/D-3442-2009; Bober, Michael/AAH-4553-2021; Bicknell, Louise/AAL-8003-2020	Bicknell, Louise/0000-0001-6899-9322; Jackson, Andrew P/0000-0002-8739-2646; Wise, Carol/0000-0002-6790-2194; Mason, Sarah/0000-0002-0065-1503; Bober, Michael/0000-0002-6178-1264; O'Driscoll, Mark/0000-0003-2765-316X; Martin, Carol-Anne/0000-0001-5914-2757	MRC; Lister Insitute for Preventive Medicine; Cancer Research UK; Association for International Cancer Research; Wellcome Research Trust; Medical Research Council [G0500897, G0700733, G0801130B, MC_U127580972] Funding Source: researchfish; MRC [G0700733, G0500897, MC_U127580972] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lister Insitute for Preventive Medicine; Cancer Research UK(Cancer Research UK); Association for International Cancer Research; Wellcome Research Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the families and clinicians for their involvement; S. McKay, K. Erskine and the MRC HGU core sequencing service for advice and technical support; D. Fitzpatrick, J. Blow, E. Patton, V. van Heyningen, N. Hastie and T. Carr for discussions and comments; A. Sinclair for p294(oriP); A. Oliver for structural modeling; and S. Devroy for subject enrollment and sample collection. The A.P.J. laboratory is funded by the MRC and the Lister Insitute for Preventive Medicine, the M.O'D. laboratory is funded by Cancer Research UK and the MRC, and the P.A.J. laboratory is funded by the MRC, Association for International Cancer Research and the Wellcome Research Trust. A.P.J. is an MRC Senior Clinical Fellow and Lister Institute Prize fellow. M.O'D. is a CRUK Senior Cancer Research Fellow.	Al-Dosari MS, 2010, J MED GENET, V47, P411, DOI 10.1136/jmg.2009.076646; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bicknell LS, 2011, NAT GENET, V43, P356, DOI 10.1038/ng.775; Blow JJ, 2008, NAT REV CANCER, V8, P799, DOI 10.1038/nrc2500; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; Ge XQ, 2009, CELL CYCLE, V8, P2320; GORLIN RJ, 1992, J MED GENET, V29, P516; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Hall JG, 2004, AM J MED GENET A, V130A, P55, DOI 10.1002/ajmg.a.30203; Hemerly AS, 2009, SCIENCE, V323, P789, DOI 10.1126/science.1166745; MAJEWSKI F, 1982, AM J MED GENET, V12, P7, DOI 10.1002/ajmg.1320120103; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Noguchi K, 2006, EMBO J, V25, P5372, DOI 10.1038/sj.emboj.7601396; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Ryu S, 2005, P NATL ACAD SCI USA, V102, P18467, DOI 10.1073/pnas.0506187102; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Teer JK, 2006, J BIOL CHEM, V281, P6253, DOI 10.1074/jbc.M507150200; Tibelius A, 2009, J CELL BIOL, V185, P1149, DOI 10.1083/jcb.200810159; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Willems M, 2010, J MED GENET, V47, P797, DOI 10.1136/jmg.2009.067298	23	148	153	4	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2011	43	4					350	U103		10.1038/ng.776	http://dx.doi.org/10.1038/ng.776			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	741YL	21358633				2022-12-25	WOS:000288903700016
J	Jordan, SD; Kruger, M; Willmes, DM; Redemann, N; Wunderlich, FT; Bronneke, HS; Merkwirth, C; Kashkar, H; Olkkonen, VM; Bottger, T; Braun, T; Seibler, J; Bruning, JC				Jordan, Sabine D.; Krueger, Markus; Willmes, Diana M.; Redemann, Nora; Wunderlich, F. Thomas; Broenneke, Hella S.; Merkwirth, Carsten; Kashkar, Hamid; Olkkonen, Vesa M.; Boettger, Thomas; Braun, Thomas; Seibler, Jost; Bruening, Jens C.			Obesity-induced over expression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism	NATURE CELL BIOLOGY			English	Article							TYPE-2 DIABETES-MELLITUS; GENOME-WIDE ASSOCIATION; AKT/PROTEIN-KINASE-B; RECEPTOR SUBSTRATE-1; DOWN-REGULATION; ADIPOSE-TISSUE; SMALL RNAS; MICRORNAS; RESISTANCE; MUTATION	The contribution of altered post-transcriptional gene silencing to the development of insulin resistance and type2 diabetes mellitus so far remains elusive. Here, we demonstrate that expression of microRNA (miR)-143 and 145 is upregulated in the liver of genetic and dietary mouse models of obesity. Induced transgenic overexpression of miR-143, but not miR-145, impairs insulin-stimulated AKT activation and glucose homeostasis. Conversely, mice deficient for the miR-143-145 cluster are protected from the development of obesity-associated insulin resistance. Quantitative-mass-spectrometry-based analysis of hepatic protein expression in miR-143-overexpressing mice revealed miR-143-dependent downregulation of oxysterol-binding-protein-related protein (ORP) 8. Reduced ORP8 expression in cultured liver cells impairs the ability of insulin to induce AKT activation, revealing an ORP8-dependent mechanism of AKT regulation. Our experiments provide direct evidence that dysregulated post-transcriptional gene silencing contributes to the development of obesity-induced insulin resistance, and characterize the miR-143-ORP8 pathway as a potential target for the treatment of obesity-associated diabetes.	[Jordan, Sabine D.; Willmes, Diana M.; Redemann, Nora; Wunderlich, F. Thomas; Bruening, Jens C.] Univ Cologne, Dept Mouse Genet & Metab, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Jordan, Sabine D.; Willmes, Diana M.; Redemann, Nora; Wunderlich, F. Thomas; Merkwirth, Carsten; Kashkar, Hamid; Bruening, Jens C.] Univ Cologne, CMMC, D-50674 Cologne, Germany; [Jordan, Sabine D.; Willmes, Diana M.; Redemann, Nora; Wunderlich, F. Thomas; Bruening, Jens C.] Univ Hosp Cologne, Max Planck Inst Neurol Res, Ctr Endocrinol Diabet & Prevent Med CEDP, D-50674 Cologne, Germany; [Krueger, Markus; Boettger, Thomas; Braun, Thomas] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany; [Broenneke, Hella S.] Cologne Excellence Cluster Cellular Stress Respon, Phenotyping Facil, D-50674 Cologne, Germany; [Kashkar, Hamid] Univ Cologne, Inst Med Microbiol Immunol & Hyg, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Seibler, Jost] TaconicArtemis Pharmaceut GmbH, D-51063 Cologne, Germany; [Olkkonen, Vesa M.] Minerva Fdn, Biomedicum, FI-00290 Helsinki, Finland	University of Cologne; University of Cologne; Max Planck Society; University of Cologne; Max Planck Society; University of Cologne; University of Cologne; University of Helsinki	Bruning, JC (corresponding author), Univ Cologne, Dept Mouse Genet & Metab, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany.	jens.bruening@uni-koeln.de	Merkwirth, Carsten/H-5992-2012; Xie, Huangming/B-2260-2012; Braun, Thomas/B-2310-2008; Boettger, Thomas/E-3406-2012	Merkwirth, Carsten/0000-0001-8895-3495; Boettger, Thomas/0000-0003-4280-8449; Olkkonen, Vesa/0000-0001-5553-7997; Braun, Thomas/0000-0002-6165-4804	ZMMK; European Community [FP7/2007-2013, 201608]; DFG [1492-7]; Academy of Finland [121457]; Sigrid Juselius Foundation; Novo Nordisk Fonden [NNF11OC1014724] Funding Source: researchfish	ZMMK; European Community(European Commission); DFG(German Research Foundation (DFG)); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank G. Schmall and T. Rayle for secretarial assistance and B. Hampel, S. Irlenbusch and J. Alber for technical assistance. We thank B. Schumacher, M. C. Vogt and P. Frommolt for support with the bioinformatics analysis of gene expression and SILAC data. This work was supported by the ZMMK (J.C.B.), the European Community's Seventh Framework Programme (grant FP7/2007-2013, no 201608 to J.C.B.), the DFG (grant 1492-7 to J.C.B.), the Academy of Finland (grant 121457 to V.M.O.) and the Sigrid Juselius Foundation (V.M.O.).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; ALMIND K, 1993, LANCET, V342, P828, DOI 10.1016/0140-6736(93)92694-O; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; FROGUEL P, 1993, DIABETES METAB, V19, P1; Gallagher IJ, 2010, GENOME MED, V2, DOI 10.1186/gm130; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li SJ, 2009, J LIPID RES, V50, P1756, DOI 10.1194/jlr.M800509-JLR200; Liu J, 2009, ARCH BIOCHEM BIOPHYS, V487, P54, DOI 10.1016/j.abb.2009.05.004; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; Mauer J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000938; Michael MZ, 2003, MOL CANCER RES, V1, P882; MOLLER DE, 1990, J BIOL CHEM, V265, P14979; Olkkonen VM, 2006, BIOCHEM SOC T, V34, P389, DOI 10.1042/BST0340389; PFEFFER S, 2005, CURRENT PROTOCOLS MO, V24; Plum L, 2007, CELL METAB, V6, P431, DOI 10.1016/j.cmet.2007.10.012; Poy MN, 2007, DIABETES OBES METAB, V9, P67, DOI 10.1111/j.1463-1326.2007.00775.x; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Rusinol AE, 2004, J BIOL CHEM, V279, P1392, DOI 10.1074/jbc.M308619200; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Takanabe R, 2008, BIOCHEM BIOPH RES CO, V376, P728, DOI 10.1016/j.bbrc.2008.09.050; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; Vejux A, 2009, J NUTR BIOCHEM, V20, P45, DOI 10.1016/j.jnutbio.2007.12.001; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yan D, 2008, J BIOL CHEM, V283, P332, DOI 10.1074/jbc.M705313200; Zhande R, 2002, MOL CELL BIOL, V22, P1016, DOI 10.1128/MCB.22.4.1016-1026.2002; Zhou LN, 2009, CURR DIABETES REV, V5, P171, DOI 10.2174/157339909788920938	55	382	406	2	89	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2011	13	4					434	U208		10.1038/ncb2211	http://dx.doi.org/10.1038/ncb2211			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	744CK	21441927				2022-12-25	WOS:000289070900015
J	Staton, AA; Knaut, H; Giraldez, AJ				Staton, Alison A.; Knaut, Holger; Giraldez, Antonio J.			miRNA regulation of Sdf1 chemokine signaling provides genetic robustness to germ cell migration	NATURE GENETICS			English	Article							ZEBRAFISH GASTRULATION; MESSENGER-RNAS; MICRORNAS; EXPRESSION; EVOLUTION; TARGET; DROSOPHILA; SPECIFICATION; CONSEQUENCES; CANALIZATION	microRNAs (miRNAs) function as genetic rheostats to control gene output. Based on their role as modulators, it has been postulated that miRNAs canalize development and provide genetic robustness. Here, we uncover a previously unidentified regulatory layer of chemokine signaling by miRNAs that confers genetic robustness on primordial germ cell (PGC) migration. In zebrafish, PGCs are guided to the gonad by the ligand Sdf1a, which is regulated by the sequestration receptor Cxcr7b. We find that miR-430 regulates sdf1a and cxcr7 mRNAs. Using target protectors, we demonstrate that miR-430-mediated regulation of endogenous sdf1a (also known as cxcl12a) and cxcr7b (i) facilitates dynamic expression of sdf1a by clearing its mRNA from previous expression domains, (ii) modulates the levels of the decoy receptor Cxcr7b to avoid excessive depletion of Sdf1a and (iii) buffers against variation in gene dosage of chemokine signaling components to ensure accurate PGC migration. Our results indicate that losing miRNA-mediated regulation can expose otherwise buffered genetic lesions leading to developmental defects.	[Staton, Alison A.; Giraldez, Antonio J.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Knaut, Holger] NYU, Sch Med, Dev Genet Program, Skirball Inst Biomol Med, New York, NY USA; [Giraldez, Antonio J.] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT USA	Yale University; New York University; Yale University	Giraldez, AJ (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	antonio.giraldez@yale.edu		Giraldez, Antonio/0000-0002-6823-137X; Knaut, Holger/0000-0002-8399-8720	US National Institutes of Health (NIH)/National Institute of General Medicine Sciences [T32 GM007223]; NIH [R01GM081602-03/03S1]; Yale Scholar program; Pew Scholars Program in Biomedical Sciences; Whitehead Fellowship Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081602, T32GM007223] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)/National Institute of General Medicine Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Scholar program; Pew Scholars Program in Biomedical Sciences; Whitehead Fellowship Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Patnode for fish husbandry, C. Takacs and C. Stahlhut for discussion and critical reading of the manuscript, H. Xue for analysis of the Sdf1a 3' UTR and D. Stemple for cxcr7b mutant zebrafish. This work was supported by the National Research Service Award US National Institutes of Health (NIH)/National Institute of General Medicine Sciences T32 GM007223 Training Grant (A. A. S.), NIH grants R01GM081602-03/03S1, the Yale Scholar program, the Pew Scholars Program in Biomedical Sciences (A.J.G.) and a Whitehead Fellowship Award (H.K.).	Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Broxmeyer HE, 2003, J IMMUNOL, V170, P421, DOI 10.4049/jimmunol.170.1.421; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Fenyes F., 2010, ZFIN DIRECT DA UNPUB; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; Hilgers V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000396; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Knaut H, 2005, NEURON, V47, P653, DOI 10.1016/j.neuron.2005.07.014; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mizoguchi T, 2008, DEVELOPMENT, V135, P2521, DOI 10.1242/dev.020107; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nair S, 2008, SCIENCE, V322, P89, DOI 10.1126/science.1160038; Nakahara K, 2005, P NATL ACAD SCI USA, V102, P12023, DOI 10.1073/pnas.0500053102; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; Raz E, 2009, DEVELOPMENT, V136, P1223, DOI 10.1242/dev.022418; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105; Siekmann AF, 2009, GENE DEV, V23, P2272, DOI 10.1101/gad.1813509; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Svoboda P, 2010, EMBO REP, V11, P590, DOI 10.1038/embor.2010.102; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; Wall ME, 2005, J MOL BIOL, V349, P501, DOI 10.1016/j.jmb.2005.04.022; Weidinger G, 2002, DEVELOPMENT, V129, P25; Wu CI, 2009, GENOME RES, V19, P734, DOI 10.1101/gr.084640.108; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	46	91	95	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2011	43	3					204	U45		10.1038/ng.758	http://dx.doi.org/10.1038/ng.758			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726BR	21258340	Green Accepted			2022-12-25	WOS:000287693800010
J	[Anonymous]				[Anonymous]			Cancer's top papers	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2011	17	3					278	279		10.1038/nm0311-278	http://dx.doi.org/10.1038/nm0311-278			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21383734				2022-12-25	WOS:000288070000031
J	Barretto, RPJ; Ko, TH; Jung, JC; Wang, TJ; Capps, G; Waters, AC; Ziv, Y; Attardo, A; Recht, L; Schnitzer, MJ				Barretto, Robert P. J.; Ko, Tony H.; Jung, Juergen C.; Wang, Tammy J.; Capps, George; Waters, Allison C.; Ziv, Yaniv; Attardo, Alessio; Recht, Lawrence; Schnitzer, Mark J.			Time-lapse imaging of disease progression in deep brain areas using fluorescence microendoscopy	NATURE MEDICINE			English	Article							IN-VIVO; MULTIPHOTON MICROSCOPY; CRANIAL WINDOWS; ADULT CORTEX; SPINAL-CORD; HIGH-SPEED; MICE; GLIOMAS; CELLS; ANGIOGENESIS	The combination of intravital microscopy and animal models of disease has propelled studies of disease mechanisms and treatments. However, many disorders afflict tissues inaccessible to light microscopy in live subjects. Here we introduce cellular-level time-lapse imaging deep within the live mammalian brain by one-and two-photon fluorescence microendoscopy over multiple weeks. Bilateral imaging sites allowed longitudinal comparisons within individual subjects, including of normal and diseased tissues. Using this approach, we tracked CA1 hippocampal pyramidal neuron dendrites in adult mice, revealing these dendrites' extreme stability and rare examples of their structural alterations. To illustrate disease studies, we tracked deep lying gliomas by observing tumor growth, visualizing three-dimensional vasculature structure and determining microcirculatory speeds. Average erythrocyte speeds in gliomas declined markedly as the disease advanced, notwithstanding significant increases in capillary diameters. Time-lapse microendoscopy will be applicable to studies of numerous disorders, including neurovascular, neurological, cancerous and trauma-induced conditions.	[Barretto, Robert P. J.; Ko, Tony H.; Jung, Juergen C.; Wang, Tammy J.; Capps, George; Waters, Allison C.; Ziv, Yaniv; Attardo, Alessio; Schnitzer, Mark J.] Stanford Univ, James H Clark Ctr Biomed Engn & Sci, Stanford, CA 94305 USA; [Recht, Lawrence] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Recht, Lawrence] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, CNC Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Schnitzer, MJ (corresponding author), Stanford Univ, James H Clark Ctr Biomed Engn & Sci, Stanford, CA 94305 USA.	mschnitz@stanford.edu	Attardo, Alessio/ABE-5208-2021	Attardo, Alessio/0000-0003-0665-6011	National Institute of Neurological Disorders and Stroke [R01NS050533]; National Institute of Neurological Disorders and Stroke, National Cancer Institute [P50CA114747]; Mauna Kea Technologies; Stanford-US National Institutes of Health; Machiah postdoctoral fellowship; NATIONAL CANCER INSTITUTE [P50CA114747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA017895] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Neurological Disorders and Stroke, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Neurological Disorders & Stroke (NINDS)); Mauna Kea Technologies; Stanford-US National Institutes of Health; Machiah postdoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was initiated under National Institute on Drug Abuse CEBRA DA017895 and further supported by National Institute of Neurological Disorders and Stroke R01NS050533, National Cancer Institute P50CA114747 and a research contract with Mauna Kea Technologies. We gratefully acknowledge support from the Stanford-US National Institutes of Health Biophysics Program (R.P.J.B.) and a Machiah postdoctoral fellowship (Y.Z.). We thank M. Lim and J. Weimann for help with GL261 cells, S. Kim, T. Jang, A. Lui, J. Li and M. Ramkumar for technical assistance with histology and image processing, E. Mukamel for helpful conversations and B. Colyear and B. Wilt for help with graphic illustration.	Bareyre FM, 2005, NAT MED, V11, P1355, DOI 10.1038/nm1331; Barretto RPJ, 2009, NAT METHODS, V6, P511, DOI 10.1038/nmeth.1339; Chow DK, 2009, NAT NEUROSCI, V12, P116, DOI 10.1038/nn.2255; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Flusberg BA, 2005, NAT METHODS, V2, P941, DOI 10.1038/NMETH820; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Garkavtsev I, 2004, NATURE, V428, P328, DOI 10.1038/nature02329; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hsiung PL, 2008, NAT MED, V14, P454, DOI 10.1038/nm1692; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jang T, 2008, J NEUROSURG, V108, P782, DOI 10.3171/JNS/2008/108/4/0782; Jung JC, 2004, J NEUROPHYSIOL, V92, P3121, DOI 10.1152/jn.00234.2004; Jung JC, 2003, OPT LETT, V28, P902, DOI 10.1364/OL.28.000902; Kashiwagi S, 2008, NAT MED, V14, P255, DOI 10.1038/nm1730; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Larjavaara S, 2007, NEURO-ONCOLOGY, V9, P319, DOI 10.1215/15228517-2007-016; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Levene MJ, 2004, J NEUROPHYSIOL, V91, P1908, DOI 10.1152/jn.01007.2003; Li P, 2008, J NEUROSCI, V28, P11970, DOI 10.1523/JNEUROSCI.3724-08.2008; Li Y, 2009, CURR TOP DEV BIOL, V87, P149, DOI 10.1016/S0070-2153(09)01205-8; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; Lim DA, 2007, NEURO-ONCOLOGY, V9, P424, DOI 10.1215/15228517-2007-023; Llewellyn ME, 2008, NATURE, V454, P784, DOI 10.1038/nature07104; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; McLellan ME, 2003, J NEUROSCI, V23, P2212; MELDER RJ, 1995, MICROVASC RES, V50, P35, DOI 10.1006/mvre.1995.1036; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Misgeld T, 2006, NAT REV NEUROSCI, V7, P449, DOI 10.1038/nrn1905; Mizrahi A, 2004, J NEUROSCI, V24, P3147, DOI 10.1523/JNEUROSCI.5218-03.2004; Murayama M, 2007, J NEUROPHYSIOL, V98, P1791, DOI 10.1152/jn.00082.2007; Pyapali GK, 1998, J COMP NEUROL, V391, P335, DOI 10.1002/(SICI)1096-9861(19980216)391:3<335::AID-CNE4>3.0.CO;2-2; Ramnarayan R, 2007, J NEUROL SCI, V260, P49, DOI 10.1016/j.jns.2007.04.003; Shapiro LA, 2008, EPILEPSIA, V49, P13, DOI 10.1111/j.1528-1167.2008.01633.x; Szatmari T, 2006, CANCER SCI, V97, P546, DOI 10.1111/j.1349-7006.2006.00208.x; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; YUAN F, 1994, CANCER RES, V54, P4564	40	172	184	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					223	U120		10.1038/nm.2292	http://dx.doi.org/10.1038/nm.2292			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21240263	Green Accepted			2022-12-25	WOS:000286969900032
J	Vandanmagsar, B; Youm, YH; Ravussin, A; Galgani, JE; Stadler, K; Mynatt, RL; Ravussin, E; Stephens, JM; Dixit, VD				Vandanmagsar, Bolormaa; Youm, Yun-Hee; Ravussin, Anthony; Galgani, Jose E.; Stadler, Krisztian; Mynatt, Randall L.; Ravussin, Eric; Stephens, Jacqueline M.; Dixit, Vishwa Deep			The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance	NATURE MEDICINE			English	Article							ADIPOSE-TISSUE; URIC-ACID; T-CELLS; NALP3 INFLAMMASOME; ACTIVATION; MECHANISMS; LINKS; MICE; DIET; FAT	The emergence of chronic inflammation during obesity in the absence of overt infection or well-defined autoimmune processes is a puzzling phenomenon. The Nod-like receptor (NLR) family of innate immune cell sensors, such as the nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (Nlrp3, but also known as Nalp3 or cryopyrin) inflammasome are implicated in recognizing certain nonmicrobial originated 'danger signals' leading to caspase-1 activation and subsequent interleukin-1 beta (IL-1 beta) and IL-18 secretion. We show that calorie restriction and exercise-mediated weight loss in obese individuals with type 2 diabetes is associated with a reduction in adipose tissue expression of Nlrp3 as well as with decreased inflammation and improved insulin sensitivity. We further found that the Nlrp3 inflammasome senses lipotoxicity-associated increases in intracellular ceramide to induce caspase-1 cleavage in macrophages and adipose tissue. Ablation of Nlrp3 in mice prevents obesity-induced inflammasome activation in fat depots and liver as well as enhances insulin signaling. Furthermore, elimination of Nlrp3 in obese mice reduces IL-18 and adipose tissue interferon-gamma (IFN-gamma) expression, increases naive T cell numbers and reduces effector T cell numbers in adipose tissue. Collectively, these data establish that the Nlrp3 inflammasome senses obesity-associated danger signals and contributes to obesity-induced inflammation and insulin resistance.	[Vandanmagsar, Bolormaa; Youm, Yun-Hee; Ravussin, Anthony; Dixit, Vishwa Deep] Louisiana State Univ, Lab Neuroendocrine Immunol, Baton Rouge, LA 70803 USA; [Vandanmagsar, Bolormaa; Youm, Yun-Hee; Ravussin, Anthony; Galgani, Jose E.; Stadler, Krisztian; Mynatt, Randall L.; Ravussin, Eric; Dixit, Vishwa Deep] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA; [Galgani, Jose E.; Ravussin, Eric] Louisiana State Univ, Human Physiol Lab, Baton Rouge, LA 70803 USA; [Stadler, Krisztian] Louisiana State Univ, Oxidat Stress & Dis Lab, Baton Rouge, LA 70803 USA; [Stephens, Jacqueline M.] Louisiana State Univ Syst, Dept Biol Sci, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Dixit, VD (corresponding author), Louisiana State Univ, Lab Neuroendocrine Immunol, Baton Rouge, LA 70803 USA.	vishwa.dixit@pbrc.edu	Stadler, Krisztian/N-1992-2017; Mynatt, Randall L/N-1980-2017; Stephens, Jacqueline M/R-5217-2018; Ravussin, Eric/N-1985-2017; Vandanmagsar, Bolormaa/R-4565-2018	Mynatt, Randall L/0000-0003-4399-0019; Ravussin, Eric/0000-0003-2129-547X; Youm, Yun-Hee/0000-0002-8098-8527; Ravussin, Anthony/0000-0003-4237-3190	Nutrition and Obesity Research Center (US National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK072476]; NIH [R01AG31797, DK083615, 1 P20 RR02/1945]; Coypu Foundation; Pennington Biomedical Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090556, R00DK083615, P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031797] Funding Source: NIH RePORTER	Nutrition and Obesity Research Center (US National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coypu Foundation; Pennington Biomedical Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Vishva M. Dixit at Genentech for providing caspase-1-specific antibody and Nlrp3<SUP>-/-</SUP> mice and J. Suttles from the University of Louisville for L929 media. We also thank S. Bond for expert technical assistance and D. H. Ryan, C. Bouchard and J. M. Salbaum for helpful discussions. This work was supported in part by pilot grants to B. V. and V. D. D. from the Nutrition and Obesity Research Center (US National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases grant P30 DK072476). The research in the Dixit laboratory is supported in part by the NIH (R01AG31797), the Coypu Foundation and the Pennington Biomedical Research Foundation. K. S. was partially supported by the NIH (DK083615). This work used the facilities of the Genomics and Cell Biology & Bioimaging Core supported by NIH grant 1 P20 RR02/1945.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dixit VD, 2008, J LEUKOCYTE BIOL, V84, P882, DOI 10.1189/jlb.0108028; Dominguez H, 2005, J VASC RES, V42, P517, DOI 10.1159/000088261; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Duffaut C, 2009, ARTERIOSCL THROM VAS, V29, P1608, DOI 10.1161/ATVBAHA.109.192583; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Galgani JE, 2008, DIABETES, V57, P841, DOI 10.2337/db08-0043; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Haversen L, 2009, ATHEROSCLEROSIS, V202, P382, DOI 10.1016/j.atherosclerosis.2008.05.033; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Joosten LAB, 2009, ARTHRITIS RHEUM, V60, P3651, DOI 10.1002/art.25006; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Li HF, 2009, J IMMUNOL, V183, P1528, DOI 10.4049/jimmunol.0901080; Luchsinger JA, 2009, J ALZHEIMERS DIS, V16, P693, DOI 10.3233/JAD-2009-1022; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McGonagle D, 2006, PLOS MED, V3, P1242, DOI 10.1371/journal.pmed.0030297; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2008, NAT CLIN PRACT ENDOC, V4, P619, DOI 10.1038/ncpendmet0976; Osborn O, 2008, CYTOKINE, V44, P141, DOI 10.1016/j.cyto.2008.07.004; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Prieur X, 2010, BBA-MOL CELL BIOL L, V1801, P327, DOI 10.1016/j.bbalip.2009.09.017; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Shah C, 2008, J BIOL CHEM, V283, P13538, DOI 10.1074/jbc.M709950200; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Strissel KJ, 2010, OBESITY, V18, P1918, DOI 10.1038/oby.2010.1; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Watanabe A, 2009, AM J PHYSIOL-GASTR L, V296, pG1248, DOI 10.1152/ajpgi.90223.2008; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Yang H, 2009, BLOOD, V114, P3803, DOI 10.1182/blood-2009-03-213595; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	60	1726	1791	9	304	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					179	U214		10.1038/nm.2279	http://dx.doi.org/10.1038/nm.2279			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21217695	Green Accepted, Green Submitted			2022-12-25	WOS:000286969900025
J	Becker-Heck, A; Zohn, IE; Okabe, N; Pollock, A; Lenhart, KB; Sullivan-Brown, J; McSheene, J; Loges, NT; Olbrich, H; Haeffner, K; Fliegauf, M; Horvath, J; Reinhardt, R; Nielsen, KG; Marthin, JK; Baktai, G; Anderson, KV; Geisler, R; Niswander, L; Omran, H; Burdine, RD				Becker-Heck, Anita; Zohn, Irene E.; Okabe, Noriko; Pollock, Andrew; Lenhart, Kari Baker; Sullivan-Brown, Jessica; McSheene, Jason; Loges, Niki T.; Olbrich, Heike; Haeffner, Karsten; Fliegauf, Manfred; Horvath, Judith; Reinhardt, Richard; Nielsen, Kim G.; Marthin, June K.; Baktai, Gyorgy; Anderson, Kathryn V.; Geisler, Robert; Niswander, Lee; Omran, Heymut; Burdine, Rebecca D.			The coiled-coil domain containing protein CCDC40 is essential for motile cilia function and left-right axis formation	NATURE GENETICS			English	Article							DYNEIN REGULATORY COMPLEX; AXONEMAL DYNEINS; NEURAL-TUBE; MUTATIONS; DYSKINESIA; ZEBRAFISH; MECHANISM; DEFECTS; MOUSE; EXPRESSION	Primary ciliary dyskinesia (PCD) is a genetically heterogeneous autosomal recessive disorder characterized by recurrent infections of the respiratory tract associated with the abnormal function of motile cilia. Approximately half of individuals with PCD also have alterations in the left-right organization of their internal organ positioning, including situs inversus and situs ambiguous (Kartagener's syndrome). Here, we identify an uncharacterized coiled-coil domain containing a protein, CCDC40, essential for correct left-right patterning in mouse, zebrafish and human. In mouse and zebrafish, Ccdc40 is expressed in tissues that contain motile cilia, and mutations in Ccdc40 result in cilia with reduced ranges of motility. We further show that CCDC40 mutations in humans result in a variant of PCD characterized by misplacement of the central pair of microtubules and defective assembly of inner dynein arms and dynein regulatory complexes. CCDC40 localizes to motile cilia and the apical cytoplasm and is required for axonemal recruitment of CCDC39, disruption of which underlies a similar variant of PCD.	[Zohn, Irene E.; Pollock, Andrew; Niswander, Lee] Univ Colorado Denver, Dept Pediat, Howard Hughes Med Inst, Aurora, CO USA; [Becker-Heck, Anita; Loges, Niki T.; Haeffner, Karsten; Fliegauf, Manfred; Horvath, Judith; Omran, Heymut] Univ Hosp Freiburg, Dept Pediat, Freiburg, Germany; [Becker-Heck, Anita; Loges, Niki T.; Olbrich, Heike; Omran, Heymut] Univ Klinikum Munster, Klin & Poliklin Kinder & Jugendmed Allgemeine Ped, Munster, Germany; [Becker-Heck, Anita] Univ Freiburg, Fac Biol, Freiburg, Germany; [Zohn, Irene E.] Childrens Natl Med Ctr, Childrens Res Inst, Neurosci Res Ctr, Washington, DC 20010 USA; [Okabe, Noriko; Lenhart, Kari Baker; Sullivan-Brown, Jessica; McSheene, Jason; Burdine, Rebecca D.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Horvath, Judith] Natl Med Ctr, Budapest, Hungary; [Reinhardt, Richard] Max Planck Inst Plant Breeding Res, Genome Ctr Cologne, Cologne, Germany; [Nielsen, Kim G.; Marthin, June K.] Copenhagen Univ Hosp, Pediat Pulm Serv, Copenhagen, Denmark; [Nielsen, Kim G.; Marthin, June K.] Copenhagen Univ Hosp, Cyst Fibrosis Ctr, Copenhagen, Denmark; [Baktai, Gyorgy] Pediat Inst Svabhegy, Budapest, Hungary; [Anderson, Kathryn V.] Sloan Kettering Inst, Dev Biol Program, New York, NY USA; [Geisler, Robert] Max Planck Inst Dev Biol, Dept Genet, Tubingen, Germany	Children's Hospital Colorado; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Freiburg; University of Munster; University of Freiburg; Children's National Health System; Princeton University; Max Planck Society; University of Copenhagen; University of Copenhagen; Memorial Sloan Kettering Cancer Center; Max Planck Society	Niswander, L (corresponding author), Univ Colorado Denver, Dept Pediat, Howard Hughes Med Inst, Aurora, CO USA.	lee.niswander@ucdenver.edu; heymut.omran@ukmuenster.de; rburdine@princeton.edu	Niswander, Lee/D-3976-2013; Nielsen, KG/AAE-6575-2020; Geisler, Robert/K-6201-2013; Pollock, Andrew/I-4564-2012	Niswander, Lee/0000-0002-9959-0594; Nielsen, KG/0000-0001-5906-9449; Geisler, Robert/0000-0002-3909-8311; Zohn, Irene/0000-0001-7688-682X; Anderson, Kathryn/0000-0003-1657-2161; Burdine, Rebecca/0000-0001-6620-5015; Pollock, Andrew/0000-0002-4849-6514; Reinhardt, Richard/0000-0001-9376-2132; Omran, Heymut/0000-0003-0282-6765	Sloan-Kettering Institute [R37-HD035455]; March of Dimes; Spina Bifida Association; German Human Genome Project DHGP [01 KW9919]; Howard Hughes Medical Institute; 'Deutsche Forschungsgemeinschaft' DFG [Om 6/4, GRK1104, SFB592]; NICHD [R01HD048584];  [R01-HD058629]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD035455, R01HD058629, R01HD048584, R37HD035455] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R55HD035455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044385] Funding Source: NIH RePORTER	Sloan-Kettering Institute; March of Dimes(March of Dimes); Spina Bifida Association; German Human Genome Project DHGP; Howard Hughes Medical Institute(Howard Hughes Medical Institute); 'Deutsche Forschungsgemeinschaft' DFG(German Research Foundation (DFG)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the German subject support group 'Kartagener Syndrom und Primaere Ciliaere Dyskinesie e.V.', S. Glaser for the initial genomic mapping of lok, J. Liu for help with imaging Ccdc40 protein expression in the mouse node, L. Bulwith, A. Heer, C. Kopp, D. Nergenau and K. Sutter for excellent technical assistance, and D. Bosco for zebrafish facility maintenance. We also thank M. Griese (Munich), E. v. Mutius (Munich), T. Nuesslein (Koblenz), N. Schwerk (Hannover), S. Reithmayr (Vienna), H. Seithe (Nuernberg) and M. Stern (Tuebingen) for supporting the study. The lnks mutant mouse line was established as part of the Sloan-Kettering Institute Mouse Project (R37-HD035455). This work was supported by the Basil O'Connor Award from the March of Dimes, the Young Investigator Award from the Spina Bifida Association and R01-HD058629 to I.E.Z.; the German Human Genome Project DHGP grant 01 KW9919 to R.G.; the Howard Hughes Medical Institute to L.N.; 'Deutsche Forschungsgemeinschaft' DFG Om 6/4, GRK1104 and the SFB592 to H.O.; and NICHD-R01HD048584 to R.D.B.	Barbato A, 2009, EUR RESPIR J, V34, P1264, DOI 10.1183/09031936.00176608; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Colantonio JR, 2006, TRAFFIC, V7, P538, DOI 10.1111/j.1600-0854.2006.00411.x; Duquesnoy P, 2009, AM J HUM GENET, V85, P890, DOI 10.1016/j.ajhg.2009.11.008; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Garcia-Garcia MJ, 2005, P NATL ACAD SCI USA, V102, P5913, DOI 10.1073/pnas.0501071102; Holmes G, 2001, DEV DYNAM, V222, P301, DOI 10.1002/dvdy.1182; HUANG B, 1982, CELL, V28, P115, DOI 10.1016/0092-8674(82)90381-6; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Jaffe KM, 2010, METHOD CELL BIOL, V97, P415, DOI 10.1016/S0091-679X(10)97022-2; Kamiya R, 2002, INT REV CYTOL, V219, P115; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; PIPERNO G, 1994, J CELL BIOL, V125, P1109, DOI 10.1083/jcb.125.5.1109; PIPERNO G, 1992, J CELL BIOL, V118, P1455, DOI 10.1083/jcb.118.6.1455; Schottenfeld J, 2007, DEVELOPMENT, V134, P1605, DOI 10.1242/dev.02827; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; Sullivan-Brown J, 2008, DEV BIOL, V314, P261, DOI 10.1016/j.ydbio.2007.11.025; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Timmer JR, 2002, DEVELOPMENT, V129, P2459; van Rooijen E, 2008, J AM SOC NEPHROL, V19, P1128, DOI 10.1681/ASN.2007080917; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zhao CT, 2007, MECH DEVELOP, V124, P605, DOI 10.1016/j.mod.2007.04.004; Zohn IE, 2005, BIRTH DEFECTS RES A, V73, P583, DOI 10.1002/bdra.20164	27	194	200	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2011	43	1					79	U105		10.1038/ng.727	http://dx.doi.org/10.1038/ng.727			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	699SQ	21131974	Green Accepted			2022-12-25	WOS:000285683500020
J	Sharma, M; Burre, J; Sudhof, TC				Sharma, Manu; Burre, Jacqueline; Suedhof, Thomas C.			CSP alpha promotes SNARE-complex assembly by chaperoning SNAP-25 during synaptic activity	NATURE CELL BIOLOGY			English	Article							CYSTEINE-STRING PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; MEMBRANE-FUSION; QUALITY-CONTROL; SECRETORY PATHWAY; IN-VITRO; EXOCYTOSIS; DEGENERATION; RELEASE; NEURONS	A neuron forms thousands of presynaptic nerve terminals on its axons, far removed from the cell body. The protein CSP alpha resides in presynaptic terminals, where it forms a chaperone complex with Hsc70 and SGT. Deletion of CSP alpha results in massive neurodegeneration that impairs survival in mice and flies. In CSP alpha-knockout mice, levels of presynaptic SNARE complexes and the SNARE protein SNAP-25 are reduced, suggesting that CSP alpha may chaperone SNARE proteins, which catalyse synaptic vesicle fusion. Here, we show that the CSP alpha-Hsc70-SGT complex binds directly to monomeric SNAP-25 to prevent its aggregation, enabling SNARE-complex formation. Deletion of CSP alpha produces an abnormal SNAP-25 conformer that inhibits SNARE-complex formation, and is subject to ubiquitylation and proteasomal degradation. Even in wild-type mouse terminals, SNAP-25 degradation is regulated by synaptic activity; this degradation is decreased by CSP alpha overexpression, and enhanced by CSP alpha deletion. Thus, SNAP-25 function is maintained during rapid SNARE cycles by equilibrium between CSP alpha-dependent chaperoning and ubiquitin-dependent degradation, revealing unique protein quality-control machinery within the presynaptic compartment.	[Sharma, Manu; Burre, Jacqueline; Suedhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA; [Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94304 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Sharma, M (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, SIM1,265 Campus Dr, Palo Alto, CA 94304 USA.	sharma11@stanford.edu; tcs1@stanford.edu			National Institute on Aging (NIH) [RC2AG036614]; Human Frontiers Program [LT00527/2006-L]; Deutsche Akademie der Naturforscher Leopoldina [BMBF-LPD 9901/8-161]; NATIONAL INSTITUTE ON AGING [RC2AG036614] Funding Source: NIH RePORTER	National Institute on Aging (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Human Frontiers Program; Deutsche Akademie der Naturforscher Leopoldina; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Chandra for discussions, and J. Mitchell, A. Roth and I. Kornblum for technical support. This work was supported by National Institute on Aging (NIH grant RC2AG036614 to T.C.S.), and fellowships from the Human Frontiers Program (LT00527/2006-L to M.S.) and the 'Deutsche Akademie der Naturforscher Leopoldina' (BMBF-LPD 9901/8-161 to J.B.).	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Buchner E, 1997, TRENDS NEUROSCI, V20, P223, DOI 10.1016/S0166-2236(96)10082-5; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chamberlain LH, 1998, MOL BIOL CELL, V9, P2259, DOI 10.1091/mbc.9.8.2259; Chamberlain LH, 2000, J NEUROCHEM, V74, P1781, DOI 10.1046/j.1471-4159.2000.0741781.x; Chamberlain LH, 1997, J BIOL CHEM, V272, P31420, DOI 10.1074/jbc.272.50.31420; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chomczynski P, 1993, BIOTECHNIQUES, V15, P536; CHOMCZYNSKI PA, 1993, BIOTECHNIQUES, V536, P532; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; Garcia-Junco-Clemente P, 2010, J NEUROSCI, V30, P7377, DOI 10.1523/JNEUROSCI.0924-10.2010; GUNDERSEN CB, 1994, J BIOL CHEM, V269, P19197; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Ho A, 2008, J NEUROSCI, V28, P14392, DOI 10.1523/JNEUROSCI.2481-08.2008; JAHN R, 1993, J NEUROCHEM, V61, P12, DOI 10.1111/j.1471-4159.1993.tb03533.x; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Johnson JN, 2010, BIOCHEM CELL BIOL, V88, P157, DOI [10.1139/O09-124, 10.1139/o09-124]; KATZ B, 1969, RELEASE NEURONAL TRA; Kushmerick C, 2006, J NEUROSCI, V26, P1366, DOI 10.1523/JNEUROSCI.3889-05.2006; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Ruiz R, 2008, EUR J NEUROSCI, V27, P3118, DOI 10.1111/j.1460-9568.2008.06301.x; Schmitz F, 2006, P NATL ACAD SCI USA, V103, P2926, DOI 10.1073/pnas.0510060103; Segref A, 2009, EMBO REP, V10, P44, DOI 10.1038/embor.2008.229; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sugita S, 2000, BIOCHEMISTRY-US, V39, P2940, DOI 10.1021/bi9920984; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; UMBACH JA, 1994, NEURON, V13, P899, DOI 10.1016/0896-6273(94)90255-0; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhang H, 2002, J BIOL CHEM, V277, P28948, DOI 10.1074/jbc.M111706200; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	47	177	180	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	JAN	2011	13	1					30	U74		10.1038/ncb2131	http://dx.doi.org/10.1038/ncb2131			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697GV	21151134				2022-12-25	WOS:000285502200008
J	He, CA				He, Chuan			RNA epigenetics?	NATURE CHEMICAL BIOLOGY			English	Article							OXIDATIVE DEMETHYLATION; ESCHERICHIA-COLI; ADULT OBESITY; FTO GENE; DNA; CONTRIBUTES; DAMAGE; METHYLATION; CHILDHOOD; HOMOLOG	Post-transcriptional RNA modifications can be dynamic and might have functions beyond fine-tuning the structure and function of RNA. Understanding these RNA modification pathways and their functions may allow researchers to identify new layers of gene regulation at the RNA level.	[He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago	He, CA (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	chuanhe@uchicago.edu						Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Anderson J, 1998, GENE DEV, V12, P3650, DOI 10.1101/gad.12.23.3650; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; GROSJEAN H, 2005, TOPICS CURRENT GENET, V12; Hong X, 2010, P NATL ACAD SCI USA, V107, P14568, DOI 10.1073/pnas.1008832107; Saikia M, 2010, RNA, V16, P1317, DOI 10.1261/rna.2057810; Schaefer M, 2010, CHROMOSOMA, V119, P35, DOI 10.1007/s00412-009-0240-6; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shimada K, 2008, CANCER SCI, V99, P39, DOI 10.1111/j.1349-7006.2007.00655.x; Shimada K, 2009, CANCER RES, V69, P3157, DOI 10.1158/0008-5472.CAN-08-3530; Toh SM, 2007, MOL MICROBIOL, V64, P1506, DOI 10.1111/j.1365-2958.2007.05744.x; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y; Yi CQ, 2009, ACCOUNTS CHEM RES, V42, P519, DOI 10.1021/ar800178j	20	288	308	4	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					863	865		10.1038/nchembio.482	http://dx.doi.org/10.1038/nchembio.482			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079590				2022-12-25	WOS:000284214700006
J	Mardin, BR; Lange, C; Baxter, JE; Hardy, T; Scholz, SR; Fry, AM; Schiebel, E				Mardin, Balca R.; Lange, Cornelia; Baxter, Joanne E.; Hardy, Tara; Scholz, Sebastian R.; Fry, Andrew M.; Schiebel, Elmar			Components of the Hippo pathway cooperate with Nek2 kinase to regulate centrosome disjunction	NATURE CELL BIOLOGY			English	Article							TUMOR-SUPPRESSOR; PROTEIN-KINASE; SIZE-CONTROL; ORGAN SIZE; AURORA-A; C-NAP1; PHOSPHORYLATION; DROSOPHILA; MECHANISM; SUBSTRATE	During interphase, centrosomes are held together by a proteinaceous linker that connects the proximal ends of the mother and daughter centriole. This linker is disassembled at the onset of mitosis in a process known as centrosome disjunction, thereby facilitating centrosome separation and bipolar spindle formation. The NIMA (never in mitosis A)-related kinase Nek2A is implicated in disconnecting the centrosomes through disjoining the linker proteins C-Nap1 and rootletin. However, the mechanisms controlling centrosome disjunction remain poorly understood. Here, we report that two Hippo pathway components, the mammalian sterile 20-like kinase 2 (Mst2) and the scaffold protein Salvador (hSav1), directly interact with Nek2A and regulate its ability to localize to centrosomes, and phosphorylate C-Nap l and rootletin. Furthermore, we demonstrate that the hSav1-Mst2-Nek2A centrosome disjunction pathway becomes essential for bipolar spindle formation on partial inhibition of the kinesin-5 Eg5. We propose that hSav1-Mst2-Nek2A and Eg5 have distinct, but complementary functions, in centrosome disjunction.	[Mardin, Balca R.; Lange, Cornelia; Scholz, Sebastian R.; Schiebel, Elmar] Univ Heidelberg, Zentrum Mol Biol, DKFZ ZMBH Allianz, D-69117 Heidelberg, Germany; [Baxter, Joanne E.; Hardy, Tara; Fry, Andrew M.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Leicester	Schiebel, E (corresponding author), Univ Heidelberg, Zentrum Mol Biol, DKFZ ZMBH Allianz, Neuenheimer Feld 282, D-69117 Heidelberg, Germany.	e.schiebel@zmbh.uni-heidelberg.de		Mardin, Balca R/0000-0002-3903-9354	DFG [Schi295/3]; Wellcome Trust; Cancer Research UK; Association for International Cancer Research (AICR)	DFG(German Research Foundation (DFG)); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Association for International Cancer Research (AICR)	This work was supported by DFG grant Schi295/3. A.M.F. acknowledges support from the Wellcome Trust, Cancer Research UK and the Association for International Cancer Research (AICR). We acknowledge A. Khodjakov for the RPE-1 centrin-GFP cell line, T. Hyman for the LAP-Nek2A cell line and T. Mayer for Eg5 antibodies and VS83 inhibitor. We are grateful to O. Gruss and G. Pereira for helpful comments and A. Khmelinskii for critical reading of the manuscript. We thank T. Ruppert for MS/MS analysis and the Nikon Imaging Center (Heidelberg, Germany) for FRAP experiments. We also thank E. Eroglu and G. Bozkurt for their help with protein purification, and E. Ercan for help with cell culture.	Bahe S, 2005, J CELL BIOL, V171, P27, DOI 10.1083/jcb.200504107; Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Chiba S, 2009, CURR BIOL, V19, P675, DOI 10.1016/j.cub.2009.02.054; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Faragher AJ, 2003, MOL BIOL CELL, V14, P2876, DOI 10.1091/mbc.E03-02-0108; Fletcher L, 2004, RADIAT RES, V162, P128, DOI 10.1667/RR3211; Fry AM, 2002, ONCOGENE, V21, P6184, DOI 10.1038/sj.onc.1205711; Fry AM, 1999, J BIOL CHEM, V274, P16304, DOI 10.1074/jbc.274.23.16304; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; FRY AM, 1995, J BIOL CHEM, V270, P12899, DOI 10.1074/jbc.270.21.12899; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Godinho S, 2009, CANCER METAST REV, V28, P85, DOI 10.1007/s10555-008-9163-6; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Hames RS, 2005, MOL BIOL CELL, V16, P1711, DOI 10.1091/mbc.E04-08-0688; Hames RS, 2002, BIOCHEM J, V361, P77, DOI 10.1042/0264-6021:3610077; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Hergovich A, 2009, CURR BIOL, V19, P1692, DOI 10.1016/j.cub.2009.09.020; Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; Lee JH, 2008, EMBO J, V27, P1231, DOI 10.1038/emboj.2008.63; Liu L, 2008, ONCOGENE, V27, P6175, DOI 10.1038/onc.2008.220; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837; Mayor T, 2002, J CELL SCI, V115, P3275; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Oh H, 2010, TRENDS CELL BIOL, V20, P410, DOI 10.1016/j.tcb.2010.04.005; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Sarli V, 2005, CHEMBIOCHEM, V6, P2005, DOI 10.1002/cbic.200500168; SAWIN KE, 1992, NATURE, V359, P540, DOI 10.1038/359540a0; Sonn S, 2004, J CELL SCI, V117, P5557, DOI 10.1242/jcs.01476; Toji S, 2004, GENES CELLS, V9, P383, DOI 10.1111/j.1356-9597.2004.00732.x; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Valverde P, 2000, BIOCHEM BIOPH RES CO, V276, P990, DOI 10.1006/bbrc.2000.3582; Vanneste D, 2009, CURR BIOL, V19, P1712, DOI 10.1016/j.cub.2009.09.019; Wei X, 2007, EMBO J, V26, P1772, DOI 10.1038/sj.emboj.7601630; Yabuta N, 2007, J BIOL CHEM, V282, P19259, DOI 10.1074/jbc.M608562200; Yang J, 2006, MOL BIOL CELL, V17, P1033, DOI 10.1091/mbc.E05-10-0943; Yang XL, 2004, NAT CELL BIOL, V6, P609, DOI 10.1038/ncb1140; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	45	136	143	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2010	12	12					1166	U106		10.1038/ncb2120	http://dx.doi.org/10.1038/ncb2120			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	688DY	21076410	Green Accepted, Green Submitted			2022-12-25	WOS:000284831200008
J	Witte, MD; Kallemeijn, WW; Aten, J; Li, KY; Strijland, A; Donker-Koopman, WE; van den Nieuwendijk, AMCH; Bleijlevens, B; Kramer, G; Florea, BI; Hooibrink, B; Hollak, CEM; Ottenhoff, R; Boot, RG; van der Marel, GA; Overkleeft, HS; Aerts, JMFG				Witte, Martin D.; Kallemeijn, Wouter W.; Aten, Jan; Li, Kah-Yee; Strijland, Anneke; Donker-Koopman, Wilma E.; van den Nieuwendijk, Adrianus M. C. H.; Bleijlevens, Boris; Kramer, Gertjan; Florea, Bogdan I.; Hooibrink, Berend; Hollak, Carla E. M.; Ottenhoff, Roelof; Boot, Rolf G.; van der Marel, Gijsbert A.; Overkleeft, Herman S.; Aerts, Johannes M. F. G.			Ultrasensitive in situ visualization of active glucocerebrosidase molecules	NATURE CHEMICAL BIOLOGY			English	Article							ACID BETA-GLUCOSIDASE; TYPE-1 GAUCHER-DISEASE; N-BUTYLDEOXYNOJIRIMYCIN; ISOFAGOMINE INCREASES; CHAPERONES INCREASE; REPLACEMENT THERAPY; ENZYME; FIBROBLASTS; BIOSYNTHESIS; INHIBITORS	Deficiency of glucocerebrosidase (GBA) underlies Gaucher disease, a common lysosomal storage disorder. Carriership for Gaucher disease has recently been identified as major risk for parkinsonism. Presently, no method exists to visualize active GBA molecules in situ. We here report the design, synthesis and application of two fluorescent activity-based probes allowing highly specific labeling of active GBA molecules in vitro and in cultured cells and mice in vivo. Detection of in vitro labeled recombinant GBA on slab gels after electrophoresis is in the low attomolar range. Using cell or tissue lysates, we obtained exclusive labeling of GBA molecules. We present evidence from fluorescence-activated cell sorting analysis, fluorescence microscopy and pulse-chase experiments of highly efficient labeling of GBA molecules in intact cells as well as tissues of mice. In addition, we illustrate the use of the fluorescent probes to study inhibitors and tentative chaperones in living cells.	[Witte, Martin D.; Li, Kah-Yee; van den Nieuwendijk, Adrianus M. C. H.; Florea, Bogdan I.; van der Marel, Gijsbert A.; Overkleeft, Herman S.] Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands; [Kallemeijn, Wouter W.; Strijland, Anneke; Donker-Koopman, Wilma E.; Bleijlevens, Boris; Kramer, Gertjan; Ottenhoff, Roelof; Boot, Rolf G.; Aerts, Johannes M. F. G.] Univ Amsterdam, Acad Med Ctr, Dept Biochem Med, NL-1105 AZ Amsterdam, Netherlands; [Aten, Jan] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Kramer, Gertjan] Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Hooibrink, Berend] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Hollak, Carla E. M.] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Witte, MD (corresponding author), Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands.	h.s.overkleeft@chem.LeidenUniv.nl; j.m.aerts@amc.uva.nl	Kallemeijn, W. W./P-2768-2019; Aerts, Johannes/A-1028-2009; Florea, Bogdan I./AAM-9975-2020; Kallemeijn, Wouter W./F-6801-2014	Kallemeijn, W. W./0000-0002-3660-2930; Aerts, Johannes/0000-0001-8168-2565; Kallemeijn, Wouter W./0000-0002-3660-2930; Aten, Jan/0000-0002-0997-6777; Kramer, Gertjan/0000-0002-8541-0337; Hollak, Carla/0000-0003-0464-1078; Overkleeft, Herman/0000-0001-6976-7005; Florea, Bogdan Iulius/0000-0001-7114-2266; Boot, Rolf/0000-0002-7031-3390	The Netherlands Organization for Scientific Research (NWO-CW); The Netherlands Proteomics Centre	The Netherlands Organization for Scientific Research (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); The Netherlands Proteomics Centre	Funding from The Netherlands Organization for Scientific Research (NWO-CW, to M.D.W., W.W.K., R.G.B., G.v.d.M., H.S.O. and J.M.F.G.A.) and The Netherlands Proteomics Centre (to B.I.F. and H.S.O.) is acknowledged.	AERTS JMFG, 1986, ANAL BIOCHEM, V154, P655, DOI 10.1016/0003-2697(86)90043-6; AERTS JMFG, 1988, BIOCHIM BIOPHYS ACTA, V964, P303, DOI 10.1016/0304-4165(88)90030-X; Aerts JMFG, 2006, J INHERIT METAB DIS, V29, P449, DOI 10.1007/s10545-006-0272-5; Andersson U, 2000, BIOCHEM PHARMACOL, V59, P821, DOI 10.1016/S0006-2952(99)00384-6; Arribas JCD, 2000, EUR J BIOCHEM, V267, P6996, DOI 10.1046/j.1432-1327.2000.01784.x; ATSUMI S, 1993, ARCH BIOCHEM BIOPHYS, V304, P302, DOI 10.1006/abbi.1993.1353; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; Boot RG, 1997, HUM MUTAT, V10, P348, DOI 10.1002/(SICI)1098-1004(1997)10:5<348::AID-HUMU3>3.0.CO;2-B; BRADY RO, 1966, J CLIN INVEST, V45, P1112, DOI 10.1172/JCI105417; Brumshtein B, 2007, J BIOL CHEM, V282, P29052, DOI 10.1074/jbc.M705005200; Chang HH, 2006, FEBS J, V273, P4082, DOI 10.1111/j.1742-4658.2006.05410.x; Gloster TM, 2007, ORG BIOMOL CHEM, V5, P444, DOI 10.1039/b616590g; Goker-Alpan O, 2008, ARCH NEUROL-CHICAGO, V65, P1353, DOI 10.1001/archneur.65.10.1353; GRABOWSKI GA, 1995, ANN INTERN MED, V122, P33, DOI 10.7326/0003-4819-122-1-199501010-00005; Grabowski GA, 2008, LANCET, V372, P1263, DOI 10.1016/S0140-6736(08)61522-6; Hansen FG, 2005, J ORG CHEM, V70, P10139, DOI 10.1021/jo051645q; JONSSON LMV, 1987, EUR J BIOCHEM, V164, P171, DOI 10.1111/j.1432-1033.1987.tb11008.x; Kacher Y, 2008, BIOL CHEM, V389, P1361, DOI 10.1515/BC.2008.163; Kornhaber GJ, 2008, CHEMBIOCHEM, V9, P2643, DOI 10.1002/cbic.200800249; Lachmann RH, 2004, QJM-INT J MED, V97, P199, DOI 10.1093/qjmed/hch036; Lieberman RL, 2007, NAT CHEM BIOL, V3, P101, DOI 10.1038/nchembio850; Liou B, 2009, MOL GENET METAB, V97, P65, DOI 10.1016/j.ymgme.2009.01.006; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; OHASHI T, 1991, J BIOL CHEM, V266, P3661; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Phenix CP, 2010, P NATL ACAD SCI USA, V107, P10842, DOI 10.1073/pnas.1003247107; PLATT FM, 1994, J BIOL CHEM, V269, P8362; Rempel BP, 2008, GLYCOBIOLOGY, V18, P570, DOI 10.1093/glycob/cwn041; Ron I, 2005, HUM MOL GENET, V14, P2387, DOI 10.1093/hmg/ddi240; Rudensky B, 2003, BLOOD CELL MOL DIS, V30, P97, DOI 10.1016/S1079-9796(03)00010-X; Sawkar AR, 2005, CHEM BIOL, V12, P1235, DOI 10.1016/j.chembiol.2005.09.007; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Shen JS, 2008, BIOCHEM BIOPH RES CO, V369, P1071, DOI 10.1016/j.bbrc.2008.02.125; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; VANWEELY S, 1991, BIOCHIM BIOPHYS ACTA, V1096, P301, DOI 10.1016/0925-4439(91)90066-I; VANWEELY S, 1993, J CLIN INVEST, V91, P1167, DOI 10.1172/JCI116276; Yu ZQ, 2007, J MED CHEM, V50, P94, DOI 10.1021/jm060677i; Zechel DL, 2003, J AM CHEM SOC, V125, P14313, DOI 10.1021/ja036833h	38	167	195	0	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					907	913		10.1038/NCHEMBIO.466	http://dx.doi.org/10.1038/NCHEMBIO.466			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079602	Green Submitted, Green Published			2022-12-25	WOS:000284214700020
J	Lang, AE				Lang, Anthony E.			Clinical trials of disease-modifying therapies for neurodegenerative diseases: the challenges and the future	NATURE MEDICINE			English	Article							NEUROIMAGING INITIATIVE PROGRESS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; DELAYED-START; DOUBLE-BLIND; ANIMAL-MODELS; NEUROPROTECTION; ONSET; TRANSPLANTATION; RASAGILINE	Neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease represent a crucial and exponentially increasing challenge to health care systems throughout the world. There is an urgent need for effective treatments that will both delay their onset and slow their inexorable progression. Many obstacles stand in the way of realizing these goals. It is expected that future advances will have a major impact on how and when the diagnosis will be made. It is hoped that these will eventually make it possible to initiate effective disease-modifying therapies long before the neurodegenerative process becomes established and symptomatic.	Univ Toronto, Dept Med Neurol, Toronto, ON, Canada	University of Toronto	Lang, AE (corresponding author), Univ Toronto, Dept Med Neurol, Toronto, ON, Canada.	lang@uhnresearch.ca	Lang, Anthony/ABF-8114-2021	Lang, Anthony/0000-0003-1229-3667				Aarsland D, 2007, J NEUROL, V254, P38, DOI 10.1007/s00415-006-0234-8; Aisen PS, 2010, ALZHEIMERS DEMENT, V6, P239, DOI 10.1016/j.jalz.2010.03.006; Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Blennow K, 2010, NAT MED, V16, P1218, DOI 10.1038/nm.2221; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Brooks DJ, 1998, ANN NEUROL, V44, pS10, DOI 10.1002/ana.410440704; Broussolle E, 2000, NEUROLOGY, V55, P877, DOI 10.1212/WNL.55.6.877; Clarke CE, 2008, MOVEMENT DISORD, V23, P784, DOI 10.1002/mds.21918; D'Agostino RB, 2009, NEW ENGL J MED, V361, P1304, DOI 10.1056/NEJMsm0904209; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Dekosky ST, 2003, SCIENCE, V302, P830, DOI 10.1126/science.1090349; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Eckert T, 2007, LANCET NEUROL, V6, P926, DOI 10.1016/S1474-4422(07)70245-4; Epis R, 2010, EUR J PHARMACOL, V626, P57, DOI 10.1016/j.ejphar.2009.10.020; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Francis PT, 2005, TRENDS PHARMACOL SCI, V26, P104, DOI 10.1016/j.tips.2004.12.010; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Haehner A, 2007, MOVEMENT DISORD, V22, P839, DOI 10.1002/mds.21413; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Huang P, 2009, MOVEMENT DISORD, V24, P1732, DOI 10.1002/mds.22645; Jenner P, 2008, ANN NEUROL, V64, pS16, DOI 10.1002/ana.21489; Jucker M, 2010, NAT MED, V16, P1210, DOI 10.1038/nm.2224; Kieburtz K, 2006, NEUROLOGY, V66, pS50, DOI 10.1212/WNL.66.10_suppl_4.S50; Kieburtz K, 2007, NEUROLOGY, V68, P20; Kokjohn TA, 2009, ALZHEIMERS DEMENT, V5, P340, DOI 10.1016/j.jalz.2009.03.002; Lang AE, 2006, LANCET NEUROL, V5, P990, DOI 10.1016/S1474-4422(06)70605-6; Leber P, 1997, ALZ DIS ASSOC DIS, V11, pS10; Levy G, 2005, ARCH NEUROL-CHICAGO, V62, P467, DOI 10.1001/archneur.62.3.467; Levy G, 2007, ARCH NEUROL-CHICAGO, V64, P1242, DOI 10.1001/archneur.64.9.1242; *LEW GROUP, 2004, SAV LIV SAV MON DIV; Lim SY, 2009, ARCH NEUROL-CHICAGO, V66, P167, DOI 10.1001/archneurol.2008.561; Marek K, 2002, JAMA-J AM MED ASSOC, V287, P1653; Olanow CW, 2008, ANN NEUROL, V64, pS3; Olanow CW, 2006, LANCET NEUROL, V5, P1013, DOI 10.1016/S1474-4422(06)70602-0; Olanow CW, 2008, MOVEMENT DISORD, V23, P2194, DOI 10.1002/mds.22218; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Philipson O, 2010, FEBS J, V277, P1389, DOI 10.1111/j.1742-4658.2010.07564.x; Ploeger BA, 2009, PHARM STAT, V8, P225, DOI 10.1002/pst.355; Ponsen MM, 2009, MOVEMENT DISORD, V24, P1060, DOI 10.1002/mds.22534; Ravina B, 2009, MOVEMENT DISORD, V24, P2081, DOI 10.1002/mds.22690; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Scherzer CR, 2009, NEUROBIOL DIS, V35, P148, DOI 10.1016/j.nbd.2009.02.016; SHOULSON I, 1989, NEW ENGL J MED, V321, P1364; Shoulson I, 2007, NEUROLOGY, V69, P1480, DOI 10.1212/01.wnl.0000277648.63931.c0; Siderowf A, 2008, ANN NEUROL, V64, pS139, DOI 10.1002/ana.21462; Tang CC, 2010, J NEUROSCI, V30, P1049, DOI 10.1523/JNEUROSCI.4188-09.2010; Trojanowski JQ, 2010, ALZHEIMERS DEMENT, V6, P230, DOI 10.1016/j.jalz.2010.03.008; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007; Whone AL, 2003, ANN NEUROL, V54, P93, DOI 10.1002/ana.10609	52	59	60	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1223	1226		10.1038/nm.2220	http://dx.doi.org/10.1038/nm.2220			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21052078				2022-12-25	WOS:000283860100030
J	Stuart, PE; Nair, RP; Ellinghaus, E; Ding, J; Tejasvi, T; Gudjonsson, JE; Li, Y; Weidinger, S; Eberlein, B; Gieger, C; Wichmann, HE; Kunz, M; Ike, R; Krueger, GG; Bowcock, AM; Mrowietz, U; Lim, HW; Voorhees, JJ; Abecasis, GR; Weichenthal, M; Franke, A; Rahman, P; Gladman, DD; Elder, JT				Stuart, Philip E.; Nair, Rajan P.; Ellinghaus, Eva; Ding, Jun; Tejasvi, Trilokraj; Gudjonsson, Johann E.; Li, Yun; Weidinger, Stephan; Eberlein, Bernadette; Gieger, Christian; Wichmann, H. Erich; Kunz, Manfred; Ike, Robert; Krueger, Gerald G.; Bowcock, Anne M.; Mrowietz, Ulrich; Lim, Henry W.; Voorhees, John J.; Abecasis, Goncalo R.; Weichenthal, Michael; Franke, Andre; Rahman, Proton; Gladman, Dafna D.; Elder, James T.			Genome-wide association analysis identifies three psoriasis susceptibility loci	NATURE GENETICS			English	Article							NF-KAPPA-B; EXPRESSION; ARTHRITIS; MAP	We carried out a meta-analysis of two recent psoriasis genome-wide association studies(1,2) with a combined discovery sample of 1,831 affected individuals (cases) and 2,546 controls. One hundred and two loci selected based on P value rankings were followed up in a three-stage replication study including 4,064 cases and 4,685 controls from Michigan, Toronto, Newfoundland and Germany. In the combined meta-analysis, we identified three new susceptibility loci, including one at NOS2 (rs4795067, combined P = 4 x 10(-11)), one at FBXL19 (rs10782001, combined P = 9 x 10(-10)) and one near PSMA6-NFKBIA (rs12586317, combined P = 2 x 10(-8)). All three loci were also associated with psoriatic arthritis (rs4795067, combined P = 1 x 10(-5); rs10782001, combined P = 4 x 10-8; and rs12586317, combined P = 6 x 10-5) and purely cutaneous psoriasis (rs4795067, combined P = 1 x 10-8; rs10782001, combined P = 2 x 10(-6); and rs12586317, combined P = 1 x 10-6). We also replicated a recently identified(3) association signal near RNF114 (rs495337, combined P = 2 x 10(-7)).	[Stuart, Philip E.; Nair, Rajan P.; Tejasvi, Trilokraj; Gudjonsson, Johann E.; Voorhees, John J.; Elder, James T.] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA; [Ellinghaus, Eva; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Ding, Jun; Li, Yun; Abecasis, Goncalo R.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Weidinger, Stephan; Eberlein, Bernadette] Tech Univ Munich, Dept Dermatol & Allergy, Munich, Germany; [Gieger, Christian; Wichmann, H. Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Kunz, Manfred] Univ Lubeck, Comprehens Ctr Inflammat Med, Lubeck, Germany; [Ike, Robert] Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48104 USA; [Krueger, Gerald G.] Univ Utah, Dept Dermatol, Salt Lake City, UT USA; [Bowcock, Anne M.] Washington Univ, Dept Genet, Div Human Genet, St Louis, MO 63110 USA; [Mrowietz, Ulrich; Weichenthal, Michael] Univ Kiel, Dept Dermatol, D-2300 Kiel, Germany; [Lim, Henry W.] Henry Ford Hosp, Dept Dermatol, Detroit, MI 48202 USA; [Rahman, Proton] Mem Univ Newfoundland, Dept Med, St John, NF, Canada; [Gladman, Dafna D.] Univ Toronto, Dept Rheumatol, Toronto, ON, Canada; [Elder, James T.] Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Kiel; University of Michigan System; University of Michigan; Technical University of Munich; University of Munich; University of Lubeck; University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; Washington University (WUSTL); University of Kiel; Henry Ford Health System; Henry Ford Hospital; Memorial University Newfoundland; University of Toronto; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Elder, JT (corresponding author), Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA.	jelder@umich.edu	Weichenthal, Michael/A-5692-2009; Ike, Robert William/AAC-3582-2021; Wichmann, Heinz Erich/AAA-5695-2022; Ding, Jun/G-3918-2011; Ellinghaus, Eva/E-6490-2012; Weidinger, Stephan/C-8461-2011; Voorhees, John/AAM-9966-2020; Abecasis, Goncalo R/B-7840-2010; Franke, Andre/B-2151-2010; Lim, HW/GRY-3517-2022	Ellinghaus, Eva/0000-0003-2914-3382; Weidinger, Stephan/0000-0003-3944-252X; Voorhees, John/0000-0003-1856-785X; Franke, Andre/0000-0003-1530-5811; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Bowcock, Anne/0000-0001-8691-9090	US National Institutes of Health, by the Ann Arbor Veterans Affairs Hospital, by the German Ministry of Education [R01AR42742, R01AR050511, R01AR054966, R01AR050266, R01HG002651, U01HG005214]; National Genome Research Network [BMFT 01GS 0171, BMBF NUW-S23T10]; Krembil Foundation; Canadian Institutes of Health Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002651, U01HG005214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050511, R01AR042742, R01AR050266, R01AR054966] Funding Source: NIH RePORTER	US National Institutes of Health, by the Ann Arbor Veterans Affairs Hospital, by the German Ministry of Education(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Genome Research Network; Krembil Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors wish to thank the many psoriasis and PsA cases and normal controls who participated in this study and to acknowledge the key contributions of K. Callis Duffin, D. Goldgar and B. Jian Feng of the University of Utah and C. Helms of Washington University at St. Louis to the CASP study. This research was supported by grants R01AR42742, R01AR050511, R01AR054966, R01AR050266, R01HG002651 and U01HG005214 from the US National Institutes of Health, by the Ann Arbor Veterans Affairs Hospital, by the German Ministry of Education and Research through the National Genome Research Network (BMFT 01GS 0171/BMBF NUW-S23T10) and by the Krembil Foundation and the Canadian Institutes of Health Research.	Abu Bakar S, 2009, P NATL ACAD SCI USA, V106, P853, DOI 10.1073/pnas.0809073106; Cal Santiago, 2006, BMC Biochem, V7, P9, DOI 10.1186/1471-2091-7-9; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Chandran V, 2008, J RHEUMATOL, V35, P2069; Chung JS, 2009, EUR J IMMUNOL, V39, P965, DOI 10.1002/eji.200838990; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Elder JT, 2010, J INVEST DERMATOL, V130, P1213, DOI 10.1038/jid.2009.319; ELLINGHAUS E, 2010, NAT GENET IN PRESS; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gladman DD, 2009, MODERATE SEVERE PSOR, P239; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lu T, 2010, P NATL ACAD SCI USA, V107, P46, DOI 10.1073/pnas.0912493107; Makredes M, 2009, J AM ACAD DERMATOL, V61, P405, DOI 10.1016/j.jaad.2009.02.015; Melchiorri C, 1998, ARTHRITIS RHEUM-US, V41, P2165, DOI 10.1002/1529-0131(199812)41:12<2165::AID-ART11>3.3.CO;2-F; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; RUSSELL TJ, 1972, NEW ENGL J MED, V287, P738, DOI 10.1056/NEJM197210122871503; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; TIILIKAINEN A, 1980, BRIT J DERMATOL, V102, P179, DOI 10.1111/j.1365-2133.1980.tb05690.x; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Zaba LC, 2009, J INVEST DERMATOL, V129, P302, DOI 10.1038/jid.2008.225	31	225	238	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					1000	U125		10.1038/ng.693	http://dx.doi.org/10.1038/ng.693			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20953189	Green Accepted			2022-12-25	WOS:000283540500019
J	Krawitz, PM; Schweiger, MR; Rodelsperger, C; Marcelis, C; Kolsch, U; Meisel, C; Stephani, F; Kinoshita, T; Murakami, Y; Bauer, S; Isau, M; Fischer, A; Dahl, A; Kerick, M; Hecht, J; Kohler, S; Jager, M; Grunhagen, J; de Condor, BJ; Doelken, S; Brunner, HG; Meinecke, P; Passarge, E; Thompson, MD; Cole, DE; Horn, D; Roscioli, T; Mundlos, S; Robinson, PN				Krawitz, Peter M.; Schweiger, Michal R.; Roedelsperger, Christian; Marcelis, Carlo; Koelsch, Uwe; Meisel, Christian; Stephani, Friederike; Kinoshita, Taroh; Murakami, Yoshiko; Bauer, Sebastian; Isau, Melanie; Fischer, Axel; Dahl, Andreas; Kerick, Martin; Hecht, Jochen; Koehler, Sebastian; Jaeger, Marten; Gruenhagen, Johannes; de Condor, Birgit Jonske; Doelken, Sandra; Brunner, Han G.; Meinecke, Peter; Passarge, Eberhard; Thompson, Miles D.; Cole, David E.; Horn, Denise; Roscioli, Tony; Mundlos, Stefan; Robinson, Peter N.			Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome	NATURE GENETICS			English	Article							GLYCOSYLPHOSPHATIDYLINOSITOL; DEFICIENCY; ANOMALIES; SEIZURES	Hyperphosphatasia mental retardation (HPMR) syndrome is an autosomal recessive form of mental retardation with distinct facial features and elevated serum alkaline phosphatase. We performed whole-exome sequencing in three siblings of a nonconsanguineous union with HPMR and performed computational inference of regions identical by descent in all siblings to establish PIGV, encoding a member of the GPI-anchor biosynthesis pathway, as the gene mutated in HPMR. We identified homozygous or compound heterozygous mutations in PIGV in three additional families.	[Krawitz, Peter M.; Schweiger, Michal R.; Roedelsperger, Christian; Isau, Melanie; Fischer, Axel; Dahl, Andreas; Kerick, Martin; Hecht, Jochen; Mundlos, Stefan; Robinson, Peter N.] Max Planck Inst Mol Genet, Berlin, Germany; [Krawitz, Peter M.; Schweiger, Michal R.; Bauer, Sebastian; Koehler, Sebastian; Jaeger, Marten; Gruenhagen, Johannes; de Condor, Birgit Jonske; Doelken, Sandra; Horn, Denise; Mundlos, Stefan; Robinson, Peter N.] Charite Univ Med Berlin, Inst Med Genet, Berlin, Germany; [Krawitz, Peter M.; Roedelsperger, Christian; Hecht, Jochen; Mundlos, Stefan; Robinson, Peter N.] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies BCRI, Berlin, Germany; [Marcelis, Carlo; Stephani, Friederike; Brunner, Han G.; Roscioli, Tony] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Koelsch, Uwe; Meisel, Christian] Charite Univ Med Berlin, Inst Med Immunol, Berlin, Germany; [Kinoshita, Taroh; Murakami, Yoshiko] Osaka Univ, Microbial Dis Res Inst, Dept Immunoregulat, Osaka, Japan; [Meinecke, Peter] Altonaer Kinderkrankenhaus, Hamburg, Germany; [Passarge, Eberhard] Univ Klinikum Essen, Inst Humangenet, Essen, Germany; [Thompson, Miles D.; Cole, David E.] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON, Canada; [Roscioli, Tony] Univ Sydney, Dept Mol & Clin Genet, Sydney, NSW 2006, Australia	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Radboud University Nijmegen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Osaka University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Duisburg Essen; University of Toronto; University of Sydney	Mundlos, S (corresponding author), Max Planck Inst Mol Genet, Berlin, Germany.	stefan.mundlos@charite.de; peter.robinson@charite.de	Dahl, Andreas/E-3783-2017; Kerick, Martin/AAD-8303-2022; Mundlos, Stefan/ABH-9585-2020; , roedelsberg/Q-3831-2019; Krawitz, Peter M/F-3142-2012; Köhler, Sebastian/H-3301-2019; Brunner, Han/C-9928-2013; Kinoshita, Taroh/C-7353-2009; Bauer, Sebastian/HHR-9319-2022; Köhler, Sebastian/A-2029-2012; Schweiger, Michal R/H-5270-2015; Marcelis, C.L.M./L-4504-2015	Dahl, Andreas/0000-0002-2668-8371; , roedelsberg/0000-0002-7905-9675; Krawitz, Peter M/0000-0002-3194-8625; Köhler, Sebastian/0000-0002-5316-1399; Köhler, Sebastian/0000-0002-5316-1399; Schweiger, Michal R/0000-0002-4672-0623; Marcelis, C.L.M./0000-0001-7095-4641; Robinson, Peter/0000-0002-0736-9199; Mundlos, Stefan/0000-0002-9788-3166; Kerick, Martin/0000-0002-6298-4514; Fischer, Axel/0000-0001-6130-6984; Meisel, Christian/0000-0003-0222-991X	Deutsche Forschungsgemeinschaft [SFB 665]; Bundesministerium fur Bildung und Forschung (BMBF) [0313911]; Australian National Health and Medical Research Council; Canadian Institutes of Health Research; Epilepsy Canada	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Epilepsy Canada	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 665) to S.M., by a grant from Bundesministerium fur Bildung und Forschung (BMBF, project number 0313911) and an Australian National Health and Medical Research Council international research training fellowship to T. R., and by a grant of the Canadian Institutes of Health Research and Epilepsy Canada to M. D. T. We thank B. Fischer, U. Kornak, M. Ralser, E. van Beusekom, U. Marchfelder and D. Lefeber for their assistance in this project.	Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Horn D, 2010, EUR J MED GENET, V53, P85, DOI 10.1016/j.ejmg.2010.01.002; Kang JY, 2005, J BIOL CHEM, V280, P9489, DOI 10.1074/jbc.M413867200; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; KRUSE K, 1988, J PEDIATR-US, V112, P436, DOI 10.1016/S0022-3476(88)80331-7; MABRY CC, 1970, J PEDIATR-US, V77, P74, DOI 10.1016/S0022-3476(70)80047-6; Marcelis CL, 2007, CLIN DYSMORPHOL, V16, P73, DOI 10.1097/MCD.0b013e3280147130; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nozaki M, 1999, LAB INVEST, V79, P293; RABE P, 1991, AM J MED GENET, V41, P350, DOI 10.1002/ajmg.1320410317; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; Thompson MD, 2010, AM J MED GENET A, V152A, P1661, DOI 10.1002/ajmg.a.33438	15	223	232	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2010	42	10					827	829		10.1038/ng.653	http://dx.doi.org/10.1038/ng.653			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	655UO	20802478	Green Published			2022-12-25	WOS:000282276600010
J	Liu, DP; Ou, LD; Clemenson, GD; Chao, C; Lutske, ME; Zambetti, GP; Gage, FH; Xu, Y				Liu, Dongping; Ou, Linda; Clemenson, Gregory D., Jr.; Chao, Connie; Lutske, Marshall Eli; Zambetti, Gerard P.; Gage, Fred H.; Xu, Yang			Puma is required for p53-induced depletion of adult stem cells	NATURE CELL BIOLOGY			English	Article							DNA-DAMAGE; TUMOR SUPPRESSION; P53; PHOSPHORYLATION; MICE; APOPTOSIS; AGE; EXPRESSION; RESPONSES; PATHWAY	Mammalian ageing is accompanied by accumulation of genomic DNA damage and progressive decline in the ability of tissues to regenerate(1). DNA damage activates the tumour suppressor p53, which leads to cell-cycle arrest, senescence or apoptosis. The stability and activity of p53 are induced by DNA damage through posttranslational modifications such as phosphorylation of Thr 21 and Ser 23 (refs 2-5). To investigate the roles of DNA damage and p53 in tissue-regenerative capability, two phosphorylation-site mutations (T21D and S23D) were introduced into the endogenous p53 gene in mice, so that the synthesized protein mimics phosphorylated p53. The knock-in mice exhibit constitutive p53 activation and segmental progeria that is correlated with the depletion of adult stem cells in multiple tissues, including bone marrow, brain and testes. Furthermore, a deficiency of Puma, which is required for p53-dependent apoptosis after DNA damage(6), rescues segmental progeria and prevents the depletion of adult stem cells. These findings suggest a key role of p53-dependent apoptosis in depleting adult stem cells after the accumulation of DNA damage, which leads to a decrease in tissue regeneration.	[Liu, Dongping; Ou, Linda; Chao, Connie; Lutske, Marshall Eli; Xu, Yang] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Clemenson, Gregory D., Jr.; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Zambetti, Gerard P.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA	University of California System; University of California San Diego; Salk Institute; St Jude Children's Research Hospital	Xu, Y (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yangxu@ucsd.edu	Zambetti, Gerard/N-8093-2018	Zambetti, Gerard/0000-0002-0929-5007; Xu, Yang/0000-0001-5574-921X	National Institutes of Health (NIH) [CA094254]; NATIONAL CANCER INSTITUTE [R01CA094254] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank H. Tian and O. Gaidarenko for technical support, and N. Varki for help with mouse pathology. This work is supported by a National Institutes of Health (NIH) grant to Y.X. (CA094254).	Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Brinster RL, 2007, SCIENCE, V316, P404, DOI 10.1126/science.1137741; Chao C, 2003, J BIOL CHEM, V278, P41028, DOI 10.1074/jbc.M306938200; Chao C, 2006, EMBO J, V25, P2615, DOI 10.1038/sj.emboj.7601167; Craig AL, 1999, BIOCHEM J, V342, P133, DOI 10.1042/0264-6021:3420133; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Mendrysa SM, 2006, GENE DEV, V20, P16, DOI 10.1101/gad.1378506; Michalak E, 2005, BIOCHEM BIOPH RES CO, V331, P786, DOI 10.1016/j.bbrc.2005.03.183; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Xu Y, 2003, CELL DEATH DIFFER, V10, P1213, DOI 10.1038/sj.cdd.4401292; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	28	86	91	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					993	998		10.1038/ncb2100	http://dx.doi.org/10.1038/ncb2100			6	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20818388	Green Accepted			2022-12-25	WOS:000282363500014
J	Velasco, R; Zharkikh, A; Affourtit, J; Dhingra, A; Cestaro, A; Kalyanaraman, A; Fontana, P; Bhatnagar, SK; Troggio, M; Pruss, D; Salvi, S; Pindo, M; Baldi, P; Castelletti, S; Cavaiuolo, M; Coppola, G; Costa, F; Cova, V; Dal Ri, A; Goremykin, V; Komjanc, M; Longhi, S; Magnago, P; Malacarne, G; Malnoy, M; Micheletti, D; Moretto, M; Perazzolli, M; Si-Ammour, A; Vezzulli, S; Zini, E; Eldredge, G; Fitzgerald, LM; Gutin, N; Lanchbury, J; Macalma, T; Mitchell, JT; Reid, J; Wardell, B; Kodira, C; Chen, Z; Desany, B; Niazi, F; Palmer, M; Koepke, T; Jiwan, D; Schaeffer, S; Krishnan, V; Wu, C; Chu, VT; King, ST; Vick, J; Tao, Q; Mraz, A; Stormo, A; Stormo, K; Bogden, R; Ederle, D; Stella, A; Vecchietti, A; Kater, MM; Masiero, S; Lasserre, P; Lespinasse, Y; Allan, AC; Bus, V; Chagne, D; Crowhurst, RN; Gleave, AP; Lavezzo, E; Fawcett, JA; Proost, S; Rouze, P; Sterck, L; Toppo, S; Lazzari, B; Hellens, RP; Durel, CE; Gutin, A; Bumgarner, RE; Gardiner, SE; Skolnick, M; Egholm, M; Van de Peer, Y; Salamini, F; Viola, R				Velasco, Riccardo; Zharkikh, Andrey; Affourtit, Jason; Dhingra, Amit; Cestaro, Alessandro; Kalyanaraman, Ananth; Fontana, Paolo; Bhatnagar, Satish K.; Troggio, Michela; Pruss, Dmitry; Salvi, Silvio; Pindo, Massimo; Baldi, Paolo; Castelletti, Sara; Cavaiuolo, Marina; Coppola, Giuseppina; Costa, Fabrizio; Cova, Valentina; Dal Ri, Antonio; Goremykin, Vadim; Komjanc, Matteo; Longhi, Sara; Magnago, Pierluigi; Malacarne, Giulia; Malnoy, Mickael; Micheletti, Diego; Moretto, Marco; Perazzolli, Michele; Si-Ammour, Azeddine; Vezzulli, Silvia; Zini, Elena; Eldredge, Glenn; Fitzgerald, Lisa M.; Gutin, Natalia; Lanchbury, Jerry; Macalma, Teresita; Mitchell, Jeff T.; Reid, Julia; Wardell, Bryan; Kodira, Chinnappa; Chen, Zhoutao; Desany, Brian; Niazi, Faheem; Palmer, Melinda; Koepke, Tyson; Jiwan, Derick; Schaeffer, Scott; Krishnan, Vandhana; Wu, Changjun; Chu, Vu T.; King, Stephen T.; Vick, Jessica; Tao, Quanzhou; Mraz, Amy; Stormo, Aimee; Stormo, Keith; Bogden, Robert; Ederle, Davide; Stella, Alessandra; Vecchietti, Alberto; Kater, Martin M.; Masiero, Simona; Lasserre, Pauline; Lespinasse, Yves; Allan, Andrew C.; Bus, Vincent; Chagne, David; Crowhurst, Ross N.; Gleave, Andrew P.; Lavezzo, Enrico; Fawcett, Jeffrey A.; Proost, Sebastian; Rouze, Pierre; Sterck, Lieven; Toppo, Stefano; Lazzari, Barbara; Hellens, Roger P.; Durel, Charles-Eric; Gutin, Alexander; Bumgarner, Roger E.; Gardiner, Susan E.; Skolnick, Mark; Egholm, Michael; Van de Peer, Yves; Salamini, Francesco; Viola, Roberto			The genome of the domesticated apple (Malus x domestica Borkh.)	NATURE GENETICS			English	Article							SORBITOL TRANSPORTERS; GENUS MALUS; SEQUENCE; EVOLUTION; CLASSIFICATION; GENES; FRUIT; MILL.; MICROSATELLITES; IDENTIFICATION	We report a high-quality draft genome sequence of the domesticated apple (Malus x domestica). We show that a relatively recent (> 50 million years ago) genome-wide duplication (GWD) has resulted in the transition from nine ancestral chromosomes to 17 chromosomes in the Pyreae. Traces of older GWDs partly support the monophyly of the ancestral paleohexaploidy of eudicots. Phylogenetic reconstruction of Pyreae and the genus Malus, relative to major Rosaceae taxa, identified the progenitor of the cultivated apple as M. sieversii. Expansion of gene families reported to be involved in fruit development may explain formation of the pome, a Pyreae-specific false fruit that develops by proliferation of the basal part of the sepals, the receptacle. In apple, a subclade of MADS-box genes, normally involved in flower and fruit development, is expanded to include 15 members, as are other gene families involved in Rosaceae-specific metabolism, such as transport and assimilation of sorbitol.	[Velasco, Riccardo; Cestaro, Alessandro; Fontana, Paolo; Troggio, Michela; Salvi, Silvio; Pindo, Massimo; Baldi, Paolo; Castelletti, Sara; Cavaiuolo, Marina; Coppola, Giuseppina; Costa, Fabrizio; Cova, Valentina; Dal Ri, Antonio; Goremykin, Vadim; Komjanc, Matteo; Longhi, Sara; Magnago, Pierluigi; Malacarne, Giulia; Malnoy, Mickael; Micheletti, Diego; Moretto, Marco; Perazzolli, Michele; Si-Ammour, Azeddine; Vezzulli, Silvia; Zini, Elena; Viola, Roberto] Ist Agrario San Michele Adige Res, Trento, Italy; [Zharkikh, Andrey; Bhatnagar, Satish K.; Pruss, Dmitry; Eldredge, Glenn; Fitzgerald, Lisa M.; Gutin, Natalia; Lanchbury, Jerry; Macalma, Teresita; Mitchell, Jeff T.; Reid, Julia; Wardell, Bryan; Gutin, Alexander; Skolnick, Mark] Myriad Genet, Salt Lake City, UT USA; [Velasco, Riccardo; Cestaro, Alessandro; Fontana, Paolo; Troggio, Michela; Salvi, Silvio; Pindo, Massimo; Baldi, Paolo; Castelletti, Sara; Cavaiuolo, Marina; Coppola, Giuseppina; Costa, Fabrizio; Cova, Valentina; Dal Ri, Antonio; Goremykin, Vadim; Komjanc, Matteo; Longhi, Sara; Magnago, Pierluigi; Malacarne, Giulia; Malnoy, Mickael; Micheletti, Diego; Moretto, Marco; Perazzolli, Michele; Si-Ammour, Azeddine; Vezzulli, Silvia; Zini, Elena; Salamini, Francesco; Viola, Roberto] Fdn Edmund Mach, Innovat Ctr, Trento, Italy; [Affourtit, Jason; Kodira, Chinnappa; Chen, Zhoutao; Desany, Brian; Niazi, Faheem; Palmer, Melinda; Egholm, Michael] Roche Co, Branford, CT USA; [Koepke, Tyson; Jiwan, Derick; Schaeffer, Scott] Washington State Univ, Dept Hort & Landscape Architecture, Pullman, WA 99164 USA; [Kalyanaraman, Ananth; Krishnan, Vandhana; Wu, Changjun] Washington State Univ, Sch Elect Engn & Comp Sci, Pullman, WA USA; [Salvi, Silvio] Univ Bologna, Dept Agroenvironm Sci & Technol, Bologna, Italy; [Chu, Vu T.; King, Stephen T.; Vick, Jessica] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Tao, Quanzhou; Mraz, Amy; Stormo, Aimee; Stormo, Keith; Bogden, Robert] Amplicon Express, Pullman, WA USA; [Ederle, Davide; Stella, Alessandra; Vecchietti, Alberto] Parco Tecnol Padano, Lodi, Italy; [Kater, Martin M.] Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy; [Masiero, Simona] Univ Milan, Dept Biol, Milan, Italy; [Lasserre, Pauline; Lespinasse, Yves; Durel, Charles-Eric] INRA, French Natl Inst Agr Res Angers Nantes, UMR1259 Genet & Hort, IFR149 QUASAV, Beaucouze, France; [Allan, Andrew C.; Crowhurst, Ross N.; Gleave, Andrew P.; Hellens, Roger P.] New Zealand Inst Plant Food Res, Mt Albert Res Ctr, Auckland, New Zealand; [Bus, Vincent] New Zealand Inst Plant Food Res, Hawkes Bay Res Ctr, Havelock N, New Zealand; [Chagne, David] New Zealand Inst Plant Food Res, Palmerston N Res Ctr, Palmerston North, New Zealand; [Lavezzo, Enrico] Univ Padua, Padua, Italy; [Fawcett, Jeffrey A.; Proost, Sebastian; Rouze, Pierre; Sterck, Lieven; Van de Peer, Yves] Univ Ghent VIB, Dept Plant Syst Biol, Bioinformat & Syst Biol Div, Ghent, Belgium; [Fawcett, Jeffrey A.; Proost, Sebastian; Rouze, Pierre; Sterck, Lieven; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Genet, Ghent, Belgium; [Toppo, Stefano] Univ Padua, Dept Biol Chem, Padua, Italy	Fondazione Edmund Mach; Myriad Genetics, Inc; Fondazione Edmund Mach; Roche Holding; Washington State University; Washington State University; University of Bologna; University of Washington; University of Washington Seattle; University of Milan; University of Milan; INRAE; New Zealand Institute for Plant & Food Research Ltd; New Zealand Institute for Plant & Food Research Ltd; New Zealand Institute for Plant & Food Research Ltd; University of Padua; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of Padua	Velasco, R (corresponding author), Ist Agrario San Michele Adige Res, Trento, Italy.	riccardo.velasco@iasma.it	Dhingra, Amit/AAX-9566-2020; Bumgarner, Roger E/K-3531-2015; Malacarne, Giulia/N-4244-2015; Sterck, Lieven/A-9439-2016; stella, Alessandra/ABB-1952-2021; Fawcett, Jeffrey/B-4145-2008; Bumgarner, Roger/AAA-6846-2020; Van de Peer, Yves/AAE-7666-2019; Toppo, Stefano/Z-5479-2019; Malacarne, Giulia/A-5349-2012; Proost, Sebastian/AAB-9845-2022; Crowhurst, Ross N/N-8892-2017; Allan, Andrew C/L-3253-2016; cavaiuolo, marina/ABF-7831-2020; Perazzolli, Michele/B-3636-2012; Baldi, Paolo/AAJ-1041-2020; Dhingra, Amit/E-7369-2010; Bus, Vincent/B-1318-2011; Gardiner, Susan Elizabeth/A-2477-2010; stella, Alessandra/AAG-6401-2021; Van de Peer, Yves/D-4388-2009; Krishnan, Vandhana/AAP-7826-2020; Malnoy, Mickael/AAO-5431-2021; Viola, Roberto/D-2277-2010; Lavezzo, Enrico/K-7962-2016; Chagne, David/A-2596-2010; malnoy, mickael/C-5007-2012; Stella, Alessandra/AAY-7322-2020; Troggio, Michela/GPG-4116-2022; Kater, Martin M/M-9381-2017; Viola, Roberto/F-3657-2014	Dhingra, Amit/0000-0002-4464-2502; Bumgarner, Roger E/0000-0002-8168-6985; Malacarne, Giulia/0000-0003-1439-5958; Sterck, Lieven/0000-0001-7116-4000; stella, Alessandra/0000-0003-2850-3964; Van de Peer, Yves/0000-0003-4327-3730; Toppo, Stefano/0000-0002-0246-3119; Proost, Sebastian/0000-0002-6792-9442; Crowhurst, Ross N/0000-0003-0608-2134; Allan, Andrew C/0000-0003-1944-7067; cavaiuolo, marina/0000-0002-8580-6462; Perazzolli, Michele/0000-0001-7218-9963; Bus, Vincent/0000-0003-4071-4457; Gardiner, Susan Elizabeth/0000-0002-4884-8743; stella, Alessandra/0000-0003-2850-3964; Van de Peer, Yves/0000-0003-4327-3730; Krishnan, Vandhana/0000-0002-6475-8019; Malnoy, Mickael/0000-0002-5158-534X; Lavezzo, Enrico/0000-0002-3902-8356; Chagne, David/0000-0003-4018-0694; malnoy, mickael/0000-0002-5158-534X; Troggio, Michela/0000-0002-5858-7874; Kater, Martin M/0000-0003-1155-2575; Castelletti, Sara/0000-0003-0543-8303; Velasco, Riccardo/0000-0002-8760-5031; Micheletti, Diego/0000-0001-9175-9853; Cestaro, Alessandro/0000-0003-1439-5165; Viola, Roberto/0000-0002-8202-8503; Longhi, Sara/0000-0003-1086-0883; masiero, simona/0000-0002-7563-7634; Ederle, Davide/0000-0002-2425-975X; Si Ammour, Azeddine/0000-0002-5504-4444; Pindo, Massimo/0000-0002-8516-9010; Gleave, Andrew/0000-0002-0105-1737; Hellens, Roger/0000-0003-2094-0887; Zini, Elena/0000-0003-0807-8331; Costa, Fabrizio/0000-0003-1416-1078; Schaeffer, Scott/0000-0002-8904-2594; Fawcett, Jeffrey/0000-0003-3907-2135; Moretto, Marco/0000-0003-4555-7243; Vezzulli, Silvia/0000-0002-1447-486X	research office of the Provincia Autonoma di Trento; Washington State University Agriculture Research Center, Washington Tree Fruit Research Commission; US Department of Agriculture National Research Initiative (USDA-NRI) [2008-35300-04676]; US National Institutes of Health Protein Biotechnology Training Program; Achievement Rewards for College Scientists; New Zealand Foundation for Research Science and Technology [C06X0812]	research office of the Provincia Autonoma di Trento; Washington State University Agriculture Research Center, Washington Tree Fruit Research Commission; US Department of Agriculture National Research Initiative (USDA-NRI)(United States Department of Agriculture (USDA)); US National Institutes of Health Protein Biotechnology Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Achievement Rewards for College Scientists; New Zealand Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology)	The Italian apple genome project was supported by the research office of the Provincia Autonoma di Trento. The US apple genome project was supported by Washington State University Agriculture Research Center, Washington Tree Fruit Research Commission and US Department of Agriculture National Research Initiative (USDA-NRI) grant 2008-35300-04676 to A. D., A. K. and R. E. B. V. K. and C. W. received support from the USDA-NRI grant. S. Schaeffer and T. K. were supported by the US National Institutes of Health Protein Biotechnology Training Program and an Achievement Rewards for College Scientists fellowship. A. C. A., V. B., D. C., A. P. G., S. E. G., R. P. H. and R.N.C. were partially supported by the New Zealand Foundation for Research Science and Technology, contract no. C06X0812. We thank S. Attiya, E. Buglione and C. Celone from 454 Life Sciences-Roche Company as well as E. Stefani, A. Castelli and E. Potenza for technical support and V. Sgaramella for critical reading of the manuscript. Fosmid and shotgun libraries were prepared following the method developed by R. Meilan (Oregon State University).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1996, FRUIT BREEDING; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; BIELESKI RL, 1982, ENCY PLANT PHYSL A, V13, P158; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Cartwright DA, 2007, GENETICS, V176, P2521, DOI 10.1534/genetics.106.063982; Celton JM, 2009, TREE GENET GENOMES, V5, P93, DOI 10.1007/s11295-008-0171-z; CHEVREAU E, 1985, THEOR APPL GENET, V71, P268, DOI 10.1007/BF00252066; Coart E, 2006, MOL ECOL, V15, P2171, DOI 10.1111/j.1365-294X.2006.02924.x; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Evans RC, 2002, AM J BOT, V89, P1478, DOI 10.3732/ajb.89.9.1478; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Fontana P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004619; Forsline P. L., 2003, Horticultural Reviews, V29, P1, DOI 10.1002/9780470650868.ch1; Gao ZF, 2003, PLANT PHYSIOL, V131, P1566, DOI 10.1104/pp.102.016725; GHARGHANI A, 2009, GENET RESOUR CROP EV, V56, P829, DOI [10.1007/s10722-008-9404-0, DOI 10.1007/S10722-008-9404-0]; Gianfranceschi L, 1998, THEOR APPL GENET, V96, P1069, DOI 10.1007/s001220050841; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Griffiths S, 2006, NATURE, V439, P749, DOI 10.1038/nature04434; Guilford P, 1997, THEOR APPL GENET, V94, P249, DOI 10.1007/s001220050407; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hummer Kim E., 2009, V6, P1, DOI 10.1007/978-0-387-77491-6_1; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Janssen BJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-16; KORBAN SS, 1986, HORTSCIENCE, V21, P41; KORBAN SS, 1984, HORTSCIENCE, V19, P177; Korf I, 2001, Bioinformatics, V17 Suppl 1, pS140; LESPINASSE Y, 1999, ACTA HORTIC, V538, P49; Liebhard R, 2002, MOL BREEDING, V10, P217, DOI 10.1023/A:1020525906332; LOESCHER WH, 1982, PLANT PHYSIOL, V70, P335, DOI 10.1104/pp.70.2.335; Luby James J., 2003, P1, DOI 10.1079/9780851995922.0001; Luo MC, 2009, P NATL ACAD SCI USA, V106, P15780, DOI 10.1073/pnas.0908195106; Mabberley, 2006, STORY APPLE; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Maliepaard C, 1998, THEOR APPL GENET, V97, P60, DOI 10.1007/s001220050867; Masiero S, 2004, DEVELOPMENT, V131, P5981, DOI 10.1242/dev.01517; Mulder Nicola, 2007, V396, P59; Newcomb RD, 2006, PLANT PHYSIOL, V141, P147, DOI 10.1104/pp.105.076208; Ng M, 2001, PLANT CELL, V13, P739, DOI 10.1105/tpc.13.4.739; Noiton DAM, 1996, J AM SOC HORTIC SCI, V121, P773, DOI 10.21273/JASHS.121.5.773; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PHIPPS JB, 1991, SYST BOT, V16, P303, DOI 10.2307/2419283; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; Rieseberg LH, 1996, SCIENCE, V272, P741, DOI 10.1126/science.272.5262.741; Robinson JP, 2001, PLANT SYST EVOL, V226, P35, DOI 10.1007/s006060170072; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Shan HY, 2009, MOL BIOL EVOL, V26, P2229, DOI 10.1093/molbev/msp129; Silfverberg-Dilworth E, 2006, TREE GENET GENOMES, V2, P202, DOI 10.1007/s11295-006-0045-1; Simillion C, 2008, BIOINFORMATICS, V24, P127, DOI 10.1093/bioinformatics/btm449; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tao Q, 2002, THEOR APPL GENET, V105, P1058, DOI 10.1007/s00122-002-1057-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van de Peer Y, 2009, TRENDS PLANT SCI, V14, P680, DOI 10.1016/j.tplants.2009.09.001; Vavilov N. I., 1930, Report. and Proc. 9th Int. Hort. Congr., P271; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Watari J, 2004, PLANT CELL PHYSIOL, V45, P1032, DOI 10.1093/pcp/pch121; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; WOLFE J A, 1988, Aliso, V12, P177; Wright S., 1978, EVOLUTION GENETICS P, V4; Yamamoto T, 2004, ACTA HORTIC, P51, DOI 10.17660/ActaHortic.2004.663.2; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zharkikh A, 2008, J BIOTECHNOL, V136, P38, DOI 10.1016/j.jbiotec.2008.04.013; ZOHARY D, 1975, SCIENCE, V187, P319, DOI 10.1126/science.187.4174.319; Zohary D., 1994, DOMESTICATION PLANTS, V2	71	1486	1676	20	427	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2010	42	10					833	+		10.1038/ng.654	http://dx.doi.org/10.1038/ng.654			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	655UO	20802477	Bronze			2022-12-25	WOS:000282276600012
J	Hor, H; Kutalik, Z; Dauvilliers, Y; Valsesia, A; Lammers, GJ; Donjacour, CEHM; Iranzo, A; Santamaria, J; Adrados, RP; Vicario, JL; Overeem, S; Arnulf, I; Theodorou, I; Jennum, P; Knudsen, S; Bassetti, C; Mathis, J; Lecendreux, M; Mayer, G; Geisler, P; Beneto, A; Petit, B; Pfister, C; Burki, JV; Didelot, G; Billiard, M; Ercilla, G; Verduijn, W; Claas, FHJ; Vollenwider, P; Waeber, G; Waterworth, DM; Mooser, V; Heinzer, R; Beckmann, JS; Bergmann, S; Tafti, M				Hor, Hyun; Kutalik, Zoltan; Dauvilliers, Yves; Valsesia, Armand; Lammers, Gert J.; Donjacour, Claire E. H. M.; Iranzo, Alex; Santamaria, Joan; Adrados, Rosa Peraita; Vicario, Jose L.; Overeem, Sebastiaan; Arnulf, Isabelle; Theodorou, Ioannis; Jennum, Poul; Knudsen, Stine; Bassetti, Claudio; Mathis, Johannes; Lecendreux, Michel; Mayer, Geert; Geisler, Peter; Beneto, Antonio; Petit, Brice; Pfister, Corinne; Buerki, Julie Vienne; Didelot, Gerard; Billiard, Michel; Ercilla, Guadalupe; Verduijn, Willem; Claas, Frans H. J.; Vollenwider, Peter; Waeber, Gerard; Waterworth, Dawn M.; Mooser, Vincent; Heinzer, Raphael; Beckmann, Jacques S.; Bergmann, Sven; Tafti, Mehdi			Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy	NATURE GENETICS			English	Article							COPY NUMBER VARIATION; SLEEP-DISORDERS; CATAPLEXY; GENETICS; DISEASES; RISK; 2ND	Narcolepsy is a rare sleep disorder with the strongest human leukocyte antigen (HLA) association ever reported. Since the associated HLA-DRB1*1501-DQB1*0602 haplotype is common in the general population (15-25%), it has been suggested that it is almost necessary but not sufficient for developing narcolepsy. To further define the genetic basis of narcolepsy risk, we performed a genome-wide association study (GWAS) in 562 European individuals with narcolepsy (cases) and 702 ethnically matched controls, with independent replication in 370 cases and 495 controls, all heterozygous for DRB1*1501-DQB1*0602. We found association with a protective variant near HLA-DQA2 (rs2858884; P < 3 x 10(-8)). Further analysis revealed that rs2858884 is strongly linked to DRB1*03DQB1*02 (P < 4 x 10(-43)) and DRB1*1301-DQB1*0603 (P < 3 x 10(-7)). Cases almost never carried a trans DRB1*1301-DQB1*0603 haplotype (odds ratio = 0.02; P < 6 x 10(-14)). This unexpected protective HLA haplotype suggests a virtually causal involvement of the HLA region in narcolepsy susceptibility.	[Hor, Hyun; Petit, Brice; Pfister, Corinne; Buerki, Julie Vienne; Didelot, Gerard; Tafti, Mehdi] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Hor, Hyun; Dauvilliers, Yves] INSERM, U888, Montpellier, France; [Kutalik, Zoltan; Valsesia, Armand; Beckmann, Jacques S.; Bergmann, Sven] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Kutalik, Zoltan; Valsesia, Armand; Bergmann, Sven] Swiss Inst Bioinformat, Lausanne, Switzerland; [Dauvilliers, Yves; Billiard, Michel] Gui de Chauliac Hosp, Dept Neurol, Natl Reference Network Orphan Dis Narcolepsy & Id, Montpellier, France; [Valsesia, Armand] Ludwig Inst Canc Res, Lausanne, Switzerland; [Lammers, Gert J.; Donjacour, Claire E. H. M.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Iranzo, Alex; Santamaria, Joan] Hosp Clin Barcelona, Neurol Serv, Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain; [Iranzo, Alex; Santamaria, Joan] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain; [Adrados, Rosa Peraita] Gregorio Maranon Univ Hosp, Sleep & Epilepsy Unit, Dept Clin Neurophysiol, Madrid, Spain; [Vicario, Jose L.] Blood Ctr Community Madrid, Madrid, Spain; [Overeem, Sebastiaan] Sleep Med Ctr Kempenhaeghe, Heeze, Netherlands; [Overeem, Sebastiaan] Radboud Univ Nijmegen, Dept Neurol, Donders Inst Neurosci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Arnulf, Isabelle] Hop La Pitie Salpetriere, Sleep Disorders Unit, Natl Reference Network Orphan Dis Narcolepsy & Id, Paris, France; [Theodorou, Ioannis] Hop La Pitie Salpetriere, INSERM, U543, Paris, France; [Jennum, Poul; Knudsen, Stine] Univ Copenhagen, Dept Clin Neurophysiol, Glostrup, Denmark; [Bassetti, Claudio] Osped Civico, Neuroctr Ente Osped Cantonale Svizzera Italiana, Lugano, Switzerland; [Mathis, Johannes] Univ Bern, Inselspital, Abt Klin Neurophysiol, CH-3010 Bern, Switzerland; [Lecendreux, Michel] Univ Paris 07, Pediat Sleep Ctr, Natl Reference Network Orphan Dis Narcolepsy & Id, Dept Child & Adolescent Psychopathol,Robert Debre, Paris, France; [Mayer, Geert] Hephata Clin Neurol, Schwalmstadt, Germany; [Geisler, Peter] Univ Hosp Regensburg, Sleep Disorders & Res Ctr, Dept Psychiat & Psychotherapy, Regensburg, Germany; [Beneto, Antonio] Hosp Univ La Fe, Unidad Sueno, Serv Neurofisiol Clin, Valencia, Spain; [Ercilla, Guadalupe] Hosp Clin Barcelona, Serv Immunol, Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain; [Verduijn, Willem; Claas, Frans H. J.] Leiden Univ, Med Ctr, Dept Immunohaematol & Blood Transfus, Leiden, Netherlands; [Vollenwider, Peter; Waeber, Gerard] CHU Vaudois, Dept Med, Lausanne, Switzerland; [Waterworth, Dawn M.; Mooser, Vincent] GlaxoSmithKline Inc, Div Genet Res & Dev, King Of Prussia, PA USA; [Heinzer, Raphael; Tafti, Mehdi] CHU Vaudois, Ctr Invest & Res Sleep, Lausanne, Switzerland; [Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, Lausanne, Switzerland	University of Lausanne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Lausanne; Swiss Institute of Bioinformatics; Universite de Montpellier; CHU de Montpellier; Ludwig Institute for Cancer Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBERNED; General University Gregorio Maranon Hospital; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Copenhagen; University of Bern; University Hospital of Bern; UDICE-French Research Universities; Universite Paris Cite; University of Regensburg; Hospital Universitari i Politecnic La Fe; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); GlaxoSmithKline; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Tafti, M (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	mehdi.tafti@unil.ch	Colaus, PsyColaus/K-6607-2013; Tafti, Mehdi/A-8887-2017; Kutalik, Zoltan/HHZ-5697-2022; Beckmann, Jacques S/A-9772-2008; Overeem, Sebastiaan/D-2139-2010; Valsesia, Armand/F-1724-2010; Knudsen, Stine/O-2358-2017	Tafti, Mehdi/0000-0002-6997-3914; Kutalik, Zoltan/0000-0001-8285-7523; Beckmann, Jacques S/0000-0002-9741-1900; Knudsen, Stine/0000-0003-1946-1125; Dauvilliers, yves/0000-0003-0683-6506; Valsesia, Armand/0000-0003-0746-9664; Arnulf, Isabelle/0000-0002-2240-2516; Bassetti, Claudio/0000-0002-4535-0245; Geisler, Peter/0000-0002-1790-4909; Peraita-Adrados, Rosa/0000-0002-4172-4000; Overeem, Sebastiaan/0000-0002-6445-9836; Heinzer, Raphael/0000-0002-3215-7788; Waeber, Gerard/0000-0003-4193-788X; Bergmann, Sven/0000-0002-6785-9034; Lammers, Gert Jan/0000-0003-4755-7060	French Ministry of Research and Higher Education; Agence Nationale de la Recherche-07-MRAR (France) [PHRC 2007-P070138]; European Narcolepsy Network; UCB Pharma S.A. (Belgium); University and the State of Vaud (Switzerland); Swiss National Science Foundation [3100AO-108478/2, 3100AO-116323/1, 310000-112552/1]; European Framework Project 6; GlaxoSmithKline; Giorgi-Cavaglieri Foundation; Leenaards Foundation	French Ministry of Research and Higher Education; Agence Nationale de la Recherche-07-MRAR (France)(French National Research Agency (ANR)); European Narcolepsy Network; UCB Pharma S.A. (Belgium)(UCB Pharma SA); University and the State of Vaud (Switzerland); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Framework Project 6; GlaxoSmithKline(GlaxoSmithKline); Giorgi-Cavaglieri Foundation; Leenaards Foundation	We thank all the subjects for their generous participation in this study; our colleagues K. Harshman and O. Hagenbuchle and the staff of the Lausanne DNA array facility for their expert technical assistance; and F. Canellas from the University Hospital Son Dureta, Palma-Spain and P. Young from the Department of Neurology, University Hospital Muenster-Germany for providing additional data on narcolepsy patients. Support for this research was provided by the French Ministry of Research and Higher Education, Project Agence Nationale de la Recherche-07-MRAR (France), PHRC 2007-P070138 (France), European Narcolepsy Network, an unrestricted grant from UCB Pharma S. A. (Belgium), the University and the State of Vaud (Switzerland), the Swiss National Science Foundation (grants 3100AO-108478/2, 3100AO-116323/1 and 310000-112552/1), the European Framework Project 6 (EuroDia and the AnEuploidy projects) and GlaxoSmithKline (which sponsored in part the CoLaus study). S. B. is funded by the Giorgi-Cavaglieri Foundation and the Leenaards Foundation. Special thanks to T. Johnson for his valuable advice on data analysis. The computations were performed in part at the Vital-IT center for high-performance computing of the Swiss Institute of Bioinformatics. This study was conducted on behalf of the European Narcolepsy Network.	Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Billiard M, 2007, SLEEP MED REV, V11, P377, DOI 10.1016/j.smrv.2007.04.001; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Cvetkovic-Lopes V, 2010, J CLIN INVEST, V120, P713, DOI 10.1172/JCI41366; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Klein J, 2000, NEW ENGL J MED, V343, P782, DOI 10.1056/NEJM200009143431106; Korbel JO, 2007, P NATL ACAD SCI USA, V104, P10110, DOI 10.1073/pnas.0703834104; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Mignot E, 1997, TISSUE ANTIGENS, V49, P329, DOI 10.1111/j.1399-0039.1997.tb02761.x; MIGNOT E, 1994, SLEEP, V17, P60; Miyagawa T, 2008, NAT GENET, V40, P1324, DOI 10.1038/ng.231; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Perry GH, 2008, GENOME RES, V18, P1698, DOI 10.1101/gr.082016.108; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Tafti M, 2007, CURR OPIN GENET DEV, V17, P222, DOI 10.1016/j.gde.2007.04.007; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Weir BS, 2006, NAT REV GENET, V7, P771, DOI 10.1038/nrg1960; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560	25	127	128	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					786	U80		10.1038/ng.647	http://dx.doi.org/10.1038/ng.647			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20711174				2022-12-25	WOS:000281388400016
J	Li, LP; Lampert, JC; Chen, XJ; Leitao, C; Popovic, J; Muller, W; Blankenstein, T				Li, Liang-Ping; Lampert, J. Christoph; Chen, Xiaojing; Leitao, Catarina; Popovic, Jelena; Mueller, Werner; Blankenstein, Thomas			Transgenic mice with a diverse human T cell antigen receptor repertoire	NATURE MEDICINE			English	Article							ALPHA-BETA; GAMMA-DELTA; THYMOCYTE DEVELOPMENT; NEGATIVE SELECTION; POSITIVE SELECTION; AMINO-ACIDS; RECOGNITION; GENE; LYMPHOCYTES; THYMUS	Because of tolerance mechanisms, it has been hard to identify the T cell receptors (TCRs) of high-avidity T cells against self (for example, tumor) antigens. TCRs that are specific for foreign human antigens from the nontolerant T cell repertoire can be identified in mice. Moreover, if mice are constructed to express the human TCR repertoire, they can be used to analyze the unskewed repertoire against human self antigens. Here we generated transgenic mice with the entire human TCR alpha beta gene loci (1.1 and 0.7 Mb), whose T cells express a diverse human TCR repertoire that compensates for mouse TCR deficiency. A human major histocompatibility class I transgene increases the generation of CD8(+) T cells with human compared to mouse TCRs. Functional CD8(+) T cells against several human tumor antigens were induced, and those against the Melan-A melanoma antigen used similar TCRs to those that have been detected in T cell clones from individuals with autoimmune vitiligo or melanoma. These mice will allow researchers to identify pathogenic and therapeutic human TCRs.	[Li, Liang-Ping; Lampert, J. Christoph; Chen, Xiaojing; Leitao, Catarina; Popovic, Jelena; Blankenstein, Thomas] Max Delbruck Ctr Mol Med, Berlin, Germany; [Li, Liang-Ping; Lampert, J. Christoph; Chen, Xiaojing; Leitao, Catarina; Popovic, Jelena; Blankenstein, Thomas] Charite Campus Benjamin Franklin, Inst Immunol, Berlin, Germany; [Mueller, Werner] Univ Manchester, Fac Life Sci, Bill Ford Chair Cellular Immunol, Manchester, Lancs, England	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Manchester	Blankenstein, T (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	tblanke@mdc-berlin.de	Muller, Werner/B-9044-2008	Muller, Werner/0000-0002-1297-9725; Leitao, Catarina/0000-0001-9884-2983	Deutsche Forschungsgemeinschaft; Helmholtz-Gemeinschaft Deutscher Forschungszentren [HA-202]; European Commission [CT-2005-005203]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz-Gemeinschaft Deutscher Forschungszentren(Helmholtz Association); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank M. Textor, M. Rosch, A. Gartner and C. Westen for technical assistance; A. Garratt, E. Rohde and A. Samuels for help with ES cell culture; M. Hafner and M. Ebel for ES cell injection; H.-P. Rahn for FACS sorting; M. Gong for help with spectratyping and statistical analysis; F. Lemonier (Institut Pasteur) for HHDII mice; E. Mcintyre (Hopital Necker) and E. Green (US National Institutes of Health) for YACs; and D. Schendel and D. Busch for critically reading the manuscript. This work was supported by grants from the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich TR36) and the Helmholtz-Gemeinschaft Deutscher Forschungszentren (HA-202). W. M. was supported by the European Commission program MUGEN LSHG-CT-2005-005203 at the Helmholtz Centre for Infection Research, Braunschweig, Germany.	Alexander J, 1997, J IMMUNOL, V159, P4753; Almeida ARM, 2001, J EXP MED, V194, P591, DOI 10.1084/jem.194.5.591; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; BLACKMAN M, 1986, CELL, V47, P349, DOI 10.1016/0092-8674(86)90591-X; Burtrum DB, 1996, J IMMUNOL, V157, P4293; Casrouge A, 2000, J IMMUNOL, V164, P5782, DOI 10.4049/jimmunol.164.11.5782; CHIEN YH, 1984, NATURE, V309, P322, DOI 10.1038/309322a0; Dietrich PY, 2001, CANCER RES, V61, P2047; DUDLEY EC, 1995, CURR BIOL, V5, P659, DOI 10.1016/S0960-9822(95)00131-X; Engels B, 2003, HUM GENE THER, V14, P1155, DOI 10.1089/104303403322167993; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; Joachims ML, 2006, J IMMUNOL, V176, P1543, DOI 10.4049/jimmunol.176.3.1543; Kang J, 2001, J EXP MED, V193, P689, DOI 10.1084/jem.193.6.689; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; Kreslavsky T, 2008, J EXP MED, V205, P1173, DOI 10.1084/jem.20072425; Kreslavsky T, 2010, CURR OPIN IMMUNOL, V22, P185, DOI 10.1016/j.coi.2009.12.006; LONBERG N, 1994, NATURE, V368, P856, DOI 10.1038/368856a0; Mantovani S, 2003, J INVEST DERMATOL, V121, P308, DOI 10.1046/j.1523-1747.2003.12368.x; Mantovani S, 2002, J IMMUNOL, V169, P6253, DOI 10.4049/jimmunol.169.11.6253; MARKIE D, 1995, METH MOL BIOL, V54; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Schumacher TNM, 2002, NAT REV IMMUNOL, V2, P512, DOI 10.1038/nri841; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; SENSI M, 1995, P NATL ACAD SCI USA, V92, P5674, DOI 10.1073/pnas.92.12.5674; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; Sherman LA, 1998, CRIT REV IMMUNOL, V18, P47, DOI 10.1615/CritRevImmunol.v18.i1-2.60; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; Trautmann L, 2002, EUR J IMMUNOL, V32, P3181, DOI 10.1002/1521-4141(200211)32:11<3181::AID-IMMU3181>3.0.CO;2-2; YANAGI Y, 1984, NATURE, V308, P145, DOI 10.1038/308145a0; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	35	84	113	3	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2010	16	9					1029	U127		10.1038/nm.2197	http://dx.doi.org/10.1038/nm.2197			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20693993				2022-12-25	WOS:000281622900033
J	Massberg, S; Grahl, L; von Bruehl, ML; Manukyan, D; Pfeiler, S; Goosmann, C; Brinkmann, V; Lorenz, M; Bidzhekov, K; Khandagale, AB; Konrad, I; Kennerknecht, E; Reges, K; Holdenrieder, S; Braun, S; Reinhardt, C; Spannagl, M; Preissner, KT; Engelmann, B				Massberg, Steffen; Grahl, Lenka; von Bruehl, Marie-Luise; Manukyan, Davit; Pfeiler, Susanne; Goosmann, Christian; Brinkmann, Volker; Lorenz, Michael; Bidzhekov, Kiril; Khandagale, Avinash B.; Konrad, Ildiko; Kennerknecht, Elisabeth; Reges, Katja; Holdenrieder, Stefan; Braun, Siegmund; Reinhardt, Christoph; Spannagl, Michael; Preissner, Klaus T.; Engelmann, Bernd			Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases	NATURE MEDICINE			English	Article							FACTOR PATHWAY INHIBITOR; TISSUE FACTOR; EXTRACELLULAR TRAPS; PLATELETS SECRETE; IN-VIVO; ELASTASE; THROMBOSIS; FIBRIN; MICE; MACROPHAGES	Blood neutrophils provide the first line of defense against pathogens but have also been implicated in thrombotic processes. This dual function of neutrophils could reflect an evolutionarily conserved association between blood coagulation and antimicrobial defense, although the molecular determinants and in vivo significance of this association remain unclear. Here we show that major microbicidal effectors of neutrophils, the serine proteases neutrophil elastase and cathepsin G, together with externalized nucleosomes, promote coagulation and intravascular thrombus growth in vivo. The serine proteases and extracellular nucleosomes enhance tissue factor- and factor XII-dependent coagulation in a process involving local proteolysis of the coagulation suppressor tissue factor pathway inhibitor. During systemic infection, activation of coagulation fosters compartmentalization of bacteria in liver microvessels and reduces bacterial invasion into tissue. In the absence of a pathogen challenge, neutrophil-derived serine proteases and nucleosomes can contribute to large-vessel thrombosis, the main trigger of myocardial infarction and stroke. The ability of coagulation to suppress pathogen dissemination indicates that microvessel thrombosis represents a physiological tool of host defense.	[Grahl, Lenka; Manukyan, Davit; Pfeiler, Susanne; Bidzhekov, Kiril; Khandagale, Avinash B.; Reges, Katja; Holdenrieder, Stefan; Reinhardt, Christoph; Engelmann, Bernd] Univ Munich, Inst Klin Chem, Munich, Germany; [Massberg, Steffen; von Bruehl, Marie-Luise; Lorenz, Michael; Konrad, Ildiko; Kennerknecht, Elisabeth; Braun, Siegmund] Tech Univ Munich, Deutsch Herzzentrum, Munich, Germany; [Goosmann, Christian; Brinkmann, Volker] Max Planck Inst Infekt Biol, Berlin, Germany; [Preissner, Klaus T.] Univ Giessen, Inst Biochem, Giessen, Germany	University of Munich; German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; Max Planck Society; Justus Liebig University Giessen	Engelmann, B (corresponding author), Univ Munich, Inst Klin Chem, Munich, Germany.	bernd.engelmann@med.uni-muenchen.de	Brinkmann, Volker/A-6015-2009; Massberg, Steffen/AAN-6054-2021	Pfeiler, Susanne/0000-0002-8591-6186	Deutsche Forschungsgemeinschaft-Forschergruppe [440]; Rudolf-Marx-Stipendium from Gesellschaft fur Thrombose-und Hamostaseforschung	Deutsche Forschungsgemeinschaft-Forschergruppe(German Research Foundation (DFG)); Rudolf-Marx-Stipendium from Gesellschaft fur Thrombose-und Hamostaseforschung	We acknowledge support of Deutsche Forschungsgemeinschaft and Wilhelm Sander-Stiftung to B.E. and S.M. We are grateful to W. Bode, J. Roes, Peter Lohse, Pia Lohse and A. Moseman for helpful suggestions and comments. We thank G. Langst (University of Regensburg) and K. Rippe (University of Heidelberg) for preparation of isolated nucleosomes, M. Monestier (Temple University), H. Wardemann and R. Hurwitz (Max-Planck-Institut fur Infektionsbiologie) for providing H2A-H2B-DNA-specific antibody, DNA-specific antibody and human neutrophil elastase-specific antibody, K. Schledzewski (University of Heidelberg) for supplying the stabilin-2-positive antibody, L. Petersen (NovoNordisk) for donating rVIIa and D. Kirchhofer (Genentech) for providing mouse tissue factor-specific antibody. L.G. was supported by Deutsche Forschungsgemeinschaft-Forschergruppe 440 and by Rudolf-Marx-Stipendium from Gesellschaft fur Thrombose-und Hamostaseforschung. K.B. and C.R. were participants of Deutsche Forschungsgemeinschaft-Graduiertenkolleg 438.	Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Belaaouaj AA, 2000, J BIOL CHEM, V275, P27123; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BROWER MS, 1982, J BIOL CHEM, V257, P9849; Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Day SM, 2005, BLOOD, V105, P192, DOI 10.1182/blood-2004-06-2225; de la Barre AE, 2001, EMBO J, V20, P6383, DOI 10.1093/emboj/20.22.6383; Delvaeye M, 2009, BLOOD, V114, P2367, DOI 10.1182/blood-2009-05-199208; Esmon CT, 2004, TRENDS IMMUNOL, V25, P536, DOI 10.1016/j.it.2004.08.003; Falanga A, 2005, SEMIN HEMATOL, V42, P239, DOI 10.1053/j.seminhematol.2005.05.023; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Hickey MJ, 2009, NAT REV IMMUNOL, V9, P364, DOI 10.1038/nri2532; HIGUCHI DA, 1992, BLOOD, V79, P1712; Hirahashi J, 2006, IMMUNITY, V25, P271, DOI 10.1016/j.immuni.2006.05.014; Horne BD, 2005, J AM COLL CARDIOL, V45, P1638, DOI 10.1016/j.jacc.2005.02.054; JOCHUM M, 1981, H-S Z PHYSIOL CHEM, V362, P103, DOI 10.1515/bchm2.1981.362.1.103; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Kepert JF, 2005, J BIOL CHEM, V280, P34063, DOI 10.1074/jbc.M507322200; KIRSCHNER MW, 2005, PLAUSIBILITY LIFE RE, P133; KLEIN A, 1994, J LEUKOCYTE BIOL, V55, P248, DOI 10.1002/jlb.55.2.248; Komorowicz E, 1998, CIRC RES, V82, P1102, DOI 10.1161/01.RES.82.10.1102; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lefer DJ, 1999, AM J PHYSIOL-HEART C, V276, pH1943, DOI 10.1152/ajpheart.1999.276.6.H1943; LOSMAN MJ, 1992, J IMMUNOL, V148, P1561; Lu G, 2004, J BIOL CHEM, V279, P17241, DOI 10.1074/jbc.M312827200; Machovich R, 1990, Blood Coagul Fibrinolysis, V1, P79, DOI 10.1097/00001721-199003000-00011; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Maroney SA, 2008, J THROMB HAEMOST, V6, P1344, DOI 10.1111/j.1538-7836.2008.03033.x; Maroney SA, 2009, J THROMB HAEMOST, V7, P1106, DOI 10.1111/j.1538-7836.2009.03454.x; Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; Maugeri N, 2006, J THROMB HAEMOST, V4, P1323, DOI 10.1111/j.1538-7836.2006.01968.x; MEIER HL, 1989, INFLAMMATION, V13, P295, DOI 10.1007/BF00914396; Muller I, 2003, FASEB J, V17, P476, DOI 10.1096/fj.02-0574fje; NOVOTNY WF, 1988, BLOOD, V72, P2020; Opal SM, 2000, CRIT CARE MED, V28, pS77, DOI 10.1097/00003246-200009001-00017; OSTERUD B, 1977, P NATL ACAD SCI USA, V74, P5260, DOI 10.1073/pnas.74.12.5260; PALABRICA T, 1992, NATURE, V359, P848, DOI 10.1038/359848a0; Pawlinski R, 2004, THROMB HAEMOSTASIS, V92, P444, DOI 10.1160/TH04-05-0309; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; PLOW EF, 1980, BIOCHIM BIOPHYS ACTA, V630, P47, DOI 10.1016/0304-4165(80)90136-1; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; PRATT CW, 1990, J BIOL CHEM, V265, P6092; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Si-Tahar M, 1997, J BIOL CHEM, V272, P11636; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; Tzoulaki I, 2007, CIRCULATION, V115, P2119, DOI 10.1161/CIRCULATIONAHA.106.635029; WELBOURN CRB, 1992, BRIT J SURG, V79, P998, DOI 10.1002/bjs.1800791006; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Zillmann A, 2001, BIOCHEM BIOPH RES CO, V281, P603, DOI 10.1006/bbrc.2001.4399	58	751	780	2	72	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2010	16	8					887	U87		10.1038/nm.2184	http://dx.doi.org/10.1038/nm.2184			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20676107				2022-12-25	WOS:000280649200028
J	Deng, XM; Dzamko, N; Prescott, A; Davies, P; Liu, QS; Yang, QK; Lee, JD; Patricelli, MP; Nomanbhoy, TK; Alessi, DR; Gray, NS				Deng, Xianming; Dzamko, Nicolas; Prescott, Alan; Davies, Paul; Liu, Qingsong; Yang, Qingkai; Lee, Jiing-Dwan; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Alessi, Dario R.; Gray, Nathanael S.			Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2	NATURE CHEMICAL BIOLOGY			English	Article							CYTOPLASMIC LOCALIZATION; 14-3-3 BINDING; MUTATIONS; MAP	Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly associated with late-onset autosomal dominant Parkinson's disease. We employed a new, parallel, compound-centric approach to identify a potent and selective LRRK2 inhibitor, LRRK2-IN-1, and demonstrated that inhibition of LRRK2 induces dephosphorylation of Ser910 and Ser935 and accumulation of LRRK2 within aggregate structures. LRRK2-IN-1 will serve as a versatile tool to pharmacologically interrogate LRRK2 biology and study its role in Parkinson's disease.	[Deng, Xianming; Liu, Qingsong; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Deng, Xianming; Liu, Qingsong; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Dzamko, Nicolas; Davies, Paul; Alessi, Dario R.] Univ Dundee, MRC Prot Phosphorylat Unit, Coll Life Sci, Dundee, Scotland; [Prescott, Alan] Univ Dundee, Div Cell Biol & Immunol, Coll Life Sci, Dundee, Scotland; [Yang, Qingkai; Lee, Jiing-Dwan] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.] ActivX Biosci, La Jolla, CA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Dundee; University of Dundee; Scripps Research Institute; Kyorin Pharmaceutical Co Ltd	Deng, XM (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	r.alessi@dundee.ac.uk; nathanael_gray@dfci.harvard.edu	Yang, Qingkai/AAK-5111-2021; Prescott, Alan/Y-5956-2018; Dzamko, Nicolas/AAD-6922-2019; Liu, Qingsong/AFS-0714-2022; 刘, 青松/AEM-1932-2022	Yang, Qingkai/0000-0001-6628-5393; Prescott, Alan/0000-0002-0747-7317; Liu, Qingsong/0000-0002-7829-2547; 刘, 青松/0000-0002-7829-2547; Dzamko, Nicolas/0000-0002-9121-0294; Alessi, Dario/0000-0002-2140-9185; Deng, Xianming/0000-0002-9354-5864; Davies, Paul/0000-0001-8022-2719	US National Institutes of Health [P41 GM079575-03, CA079871, CA114059]; Medical Research Council; National Health and Medical Research Council; Michael J. Fox Foundation for Parkinson's Disease Research; University of California [19XT-0084]; Medical Research Council [MC_U127070193, G0700656] Funding Source: researchfish; MRC [G0700656, MC_U127070193] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA079871, R01CA114059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM079575] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Michael J. Fox Foundation for Parkinson's Disease Research; University of California(University of California System); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank staff at the National Centre for Protein Kinase Profiling (http://www.kinase-screen.mrc.ac.uk) for undertaking Dundee kinase specificity screening, F. Hentati (Institut National de Neurologie, Tunisia) and A. Reith (GlaxoSmithKline Pharmaceuticals Research and Development) for providing EBV immortalized human lymphoblastoid cells, P. Bamborough (GlaxoSmithKline Pharmaceuticals Research and Development) for providing LRRK2 homology model and the antibody purification teams (Division of Signal Transduction Therapy (DSTT), University of Dundee) coordinated by H. McLauchlan and J. Hastie for generation of antibodies. This work was supported by US National Institutes of Health grant P41 GM079575-03 (N.S.G.), the Medical Research Council Technology Industry Collaboration Award and a National Health and Medical Research Council postdoctoral fellowship (N.D.), the Medical Research Council (D. R. A.), the Michael J. Fox Foundation for Parkinson's Disease Research (D. R. A.), the pharmaceutical companies supporting the DSTT (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck KgaA and Pfizer) (D. R. A.), the US National Institutes of Health grants CA079871 and CA114059 (J.-D.L.) and funds from the Tobacco-Related Disease Research Program of the University of California, 19XT-0084, (J.-D.L.).	Alegre-Abarrategui J, 2009, HUM MOL GENET, V18, P4022, DOI 10.1093/hmg/ddp346; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Covy JP, 2009, BIOCHEM BIOPH RES CO, V378, P473, DOI 10.1016/j.bbrc.2008.11.048; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Dachsel JC, 2010, ARCH NEUROL-CHICAGO, V67, P542, DOI 10.1001/archneurol.2010.79; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Gandhi PN, 2009, J NEUROSCI RES, V87, P1283, DOI 10.1002/jnr.21949; Goldstein DM, 2008, NAT REV DRUG DISCOV, V7, P391, DOI 10.1038/nrd2541; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	22	327	345	0	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					203	205		10.1038/NCHEMBIO.538	http://dx.doi.org/10.1038/NCHEMBIO.538			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21378983	Green Accepted			2022-12-25	WOS:000288545000007
J	Chang, CJ; Chao, CH; Xia, WY; Yang, JY; Xiong, Y; Li, CW; Yu, WH; Rehman, SK; Hsu, JL; Lee, HH; Liu, M; Chen, CT; Yu, DH; Hung, MC				Chang, Chun-Ju; Chao, Chi-Hong; Xia, Weiya; Yang, Jer-Yen; Xiong, Yan; Li, Chia-Wei; Yu, Wen-Hsuan; Rehman, Sumaiyah K.; Hsu, Jennifer L.; Lee, Heng-Huan; Liu, Mo; Chen, Chun-Te; Yu, Dihua; Hung, Mien-Chie			p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs	NATURE CELL BIOLOGY			English	Article							WILD-TYPE P53; CANCER; MUTATIONS; SPECTRUM; ZEB1; EMT	The epithelial-mesenchymal transition (EMT) has recently been linked to stem cell phenotype(1,2). However, the molecular mechanism underlying EMT and regulation of stemness remains elusive. Here, using genomic approaches, we show that tumour suppressor p53 has a role in regulating both EMT and EMT-associated stem cell properties through transcriptional activation of the microRNA miR-200c. p53 transactivates miR-200c through direct binding to the miR-200c promoter. Loss of p53 in mammary epithelial cells leads to decreased expression of miR-200c and activates the EMT programme, accompanied by an increased mammary stem cell population. Re-expressing miR-200c suppresses genes that mediate EMT and stemness properties(3,4) and thereby reverts the mesenchymal and stem-cell-like phenotype caused by loss of p53 to a differentiated epithelial cell phenotype. Furthermore, loss of p53 correlates with a decrease in the level of miR-200c, but an increase in the expression of EMT and stemness markers, and development of a high tumour grade in a cohort of breast tumours. This study elucidates a role for p53 in regulating EMT-MET (mesenchymal-epithelial transition) and stemness or differentiation plasticity, and reveals a potential therapeutic implication to suppress EMT-associated cancer stem cells through activation of the p53-miR-200c pathway.	[Chang, Chun-Ju; Chao, Chi-Hong; Xia, Weiya; Yang, Jer-Yen; Xiong, Yan; Li, Chia-Wei; Yu, Wen-Hsuan; Rehman, Sumaiyah K.; Hsu, Jennifer L.; Lee, Heng-Huan; Liu, Mo; Chen, Chun-Te; Yu, Dihua; Hung, Mien-Chie] Univ Texas Houston, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Hung, Mien-Chie] China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan; [Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 404, Taiwan; [Hung, Mien-Chie] Asian Univ, Taichung 413, Taiwan	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan	Hung, MC (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mhung@mdanderson.org	Li, Chia-Wei/AAC-8660-2019; Hung, Mien-Chie/ABD-5911-2021; liu, mo/E-2087-2014	Li, Chia-Wei/0000-0002-2531-2866; Hung, Mien-Chie/0000-0003-4317-4740; Yu, Wen-Hsuan/0000-0002-0816-7409; Chang, Chunju/0000-0003-2887-9603; Chao, Chi-Hong/0000-0001-9890-4902; Yu, Dihua/0000-0001-6231-9381	National Breast Cancer Foundation, Inc.; Breast Cancer Research Foundation; China Medical University Hospital; MD Anderson Cancer Center; National Science Council of Taiwan [NSC-96-3111-B-039, NSC97-2917-I-564-107, NSC-2632-B-039]; Cancer Research Center for Excellence, Taiwan Department of Health [DOH99-TD-C-111-005];  [RO1 CA109311];  [PO1 CA099031];  [P50 CA116199];  [CA16672]; NATIONAL CANCER INSTITUTE [P50CA116199, R01CA109311, P30CA016672, P01CA099031] Funding Source: NIH RePORTER	National Breast Cancer Foundation, Inc.; Breast Cancer Research Foundation; China Medical University Hospital; MD Anderson Cancer Center; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Cancer Research Center for Excellence, Taiwan Department of Health; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. A. Weinberg and S. Mani for providing HMEC and HMEC-Snail cells, E. Flores for providing the p53 knockout mice and J. Lang for technical assistance. This study was supported by RO1 CA109311, PO1 CA099031, Breast SPORE P50 CA116199, Cancer Center Support Grant CA16672, the National Breast Cancer Foundation, Inc., the Breast Cancer Research Foundation, the Sister Institution Fund of China Medical University Hospital and MD Anderson Cancer Center, the National Science Council of Taiwan (grants NSC-96-3111-B-039, NSC97-2917-I-564-107 and NSC-2632-B-039) and the Cancer Research Center for Excellence, Taiwan Department of Health (grant DOH99-TD-C-111-005 to M-C. H.). In memoriam, Ms. Serena Lin-Guo for her courageous fight against cancer.	Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Araki S, 2010, J CLIN INVEST, V120, P290, DOI 10.1172/JCI39194; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cadwell C, 2001, GENE, V277, P15, DOI 10.1016/S0378-1119(01)00696-5; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Junk DJ, 2008, NEOPLASIA, V10, P450, DOI 10.1593/neo.08120; Kim JS, 2007, MOL CELL BIOL, V27, P662, DOI 10.1128/MCB.00537-06; Kramata P, 2005, CANCER RES, V65, P3577, DOI 10.1158/0008-5472.CAN-04-4537; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MILNER J, 1991, MOL CELL BIOL, V11, P12, DOI 10.1128/MCB.11.1.12; Muret J, 2008, ANN ONCOL, V19, P793, DOI 10.1093/annonc/mdm559; Nielsen LL, 1997, CANCER GENE THER, V4, P129; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Xia WY, 2004, CLIN CANCER RES, V10, P3815, DOI 10.1158/1078-0432.CCR-03-0527; Xirodimas DP, 1999, J BIOL CHEM, V274, P28042, DOI 10.1074/jbc.274.39.28042	20	576	601	2	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2011	13	3					317	U296		10.1038/ncb2173	http://dx.doi.org/10.1038/ncb2173			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	728BB	21336307	Green Accepted			2022-12-25	WOS:000287847600020
J	Majewski, IJ; Bernards, R				Majewski, Ian J.; Bernards, Rene			Taming the dragon: genomic biomarkers to individualize the treatment of cancer	NATURE MEDICINE			English	Article							CELL LUNG-CANCER; GENE-EXPRESSION SIGNATURE; CHRONIC MYELOGENOUS LEUKEMIA; ANAPLASTIC LYMPHOMA KINASE; METASTATIC BREAST-CANCER; EML4-ALK FUSION GENE; DNA-REPAIR DEFECT; COLORECTAL-CANCER; ACTIVATING MUTATIONS; TYROSINE KINASE	The gradual shift from cytotoxic drugs to highly selective, targeted therapeutic agents for cancer requires a parallel effort to characterize cancers at the molecular level to guide the choice of therapy for the individual patient. Here we review the genomic technologies that can be used to develop these drug response indicators, or biomarkers. We also discuss hurdles in their development and the implementation of biomarkers in clinical practice.	[Bernards, Rene] Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, Amsterdam, Netherlands; Netherlands Canc Inst, Canc Genom Ctr, Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, Amsterdam, Netherlands.	r.bernards@nki.nl		Bernards, Rene/0000-0001-8677-3423; Majewski, Ian/0000-0002-6087-635X	Dutch Cancer Society; The Netherlands Organisation for Scientific Research; European Research Council; National Health and Medical Research Council of Australia	Dutch Cancer Society(KWF Kankerbestrijding); The Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Our work was supported by grants from the Dutch Cancer Society, The Netherlands Organisation for Scientific Research and the European Research Council. I.M. was supported by a fellowship from the National Health and Medical Research Council of Australia.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Andersen JN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001065; Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Astsaturov I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001083; Baggerly KA, 2009, ANN APPL STAT, V3, P1309, DOI 10.1214/09-AOAS291; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Borst P, 2010, CELL CYCLE, V9, P4836, DOI 10.4161/cc.9.24.14326; Cameron D, 2008, BREAST CANCER RES TR, V112, P533, DOI 10.1007/s10549-007-9885-0; Cardoso F, 2008, J CLIN ONCOL, V26, P729, DOI 10.1200/JCO.2007.14.3222; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Clark G M, 1983, Prog Clin Biol Res, V132E, P183; Coombes KR, 2007, NAT MED, V13, P1276, DOI 10.1038/nm1107-1276b; Creighton CJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2594; Dagher R, 2002, CLIN CANCER RES, V8, P3034; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Etemadmoghadam D, 2009, CLIN CANCER RES, V15, P1417, DOI 10.1158/1078-0432.CCR-08-1564; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fojo T, 2009, JNCI-J NATL CANCER I, V101, P1044, DOI 10.1093/jnci/djp177; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Giagounidis AAN, 2006, CLIN CANCER RES, V12, P5, DOI 10.1158/1078-0432.CCR-05-1437; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Gomez HL, 2008, J CLIN ONCOL, V26, P2999, DOI 10.1200/JCO.2007.14.0590; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Hanash S, 2010, NAT REV CANCER, V10, P652, DOI 10.1038/nrc2918; Hazarika M, 2008, CLIN CANCER RES, V14, P5325, DOI 10.1158/1078-0432.CCR-08-0308; Hede K, 2008, J NATL CANCER I, V100, P836, DOI 10.1093/jnci/djn200; Hochhaus A, 2008, LEUKEMIA, V22, P1200, DOI 10.1038/leu.2008.84; Holzel M, 2010, CELL, V142, P218, DOI 10.1016/j.cell.2010.06.004; Hoskins JM, 2009, NAT REV CANCER, V9, P576, DOI 10.1038/nrc2683; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Ihle NT, 2009, CANCER RES, V69, P143, DOI 10.1158/0008-5472.CAN-07-6656; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Joosse SA, 2012, BREAST CANCER RES TR, V132, P379, DOI 10.1007/s10549-010-1016-7; Joosse SA, 2009, BREAST CANCER RES TR, V116, P479, DOI 10.1007/s10549-008-0117-z; Jordan VC, 2003, NAT REV DRUG DISCOV, V2, P205, DOI 10.1038/nrd1031; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Lee Adam, 2004, Clin Adv Hematol Oncol, V2, P527; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li M, 2006, NAT METHODS, V3, P95, DOI 10.1038/NMETH850; Lo YMD, 2009, CLIN CHEM, V55, P607, DOI 10.1373/clinchem.2009.123661; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Maheswaran S, 2010, CURR OPIN GENET DEV, V20, P96, DOI 10.1016/j.gde.2009.12.002; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Marty B, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2204; McBride DJ, 2010, GENE CHROMOSOME CANC, V49, P1062, DOI 10.1002/gcc.20815; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Monzon FA, 2010, ARCH PATHOL LAB MED, V134, P216, DOI 10.1043/1543-2165-134.2.216; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Moroni M, 2005, ANN ONCOL, V16, P1848, DOI 10.1093/annonc/mdi356; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Nkoy FL, 2010, ARCH PATHOL LAB MED, V134, P606, DOI 10.1043/1543-2165-134.4.606; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pantel K, 2010, TRENDS MOL MED, V16, P398, DOI 10.1016/j.molmed.2010.07.001; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; RAVDIN PM, 1992, J CLIN ONCOL, V10, P1284, DOI 10.1200/JCO.1992.10.8.1284; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Santos FPS, 2010, BLOOD, V115, P1131, DOI 10.1182/blood-2009-10-246363; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Shah NP, 2007, J CLIN INVEST, V117, P2562, DOI 10.1172/JCI30890; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Singer JB, 2007, LEUKEMIA, V21, P2311, DOI 10.1038/sj.leu.2404827; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sparano JA, 2006, CLIN BREAST CANCER, V7, P347, DOI 10.3816/CBC.2006.n.051; Spurrier B, 2008, NAT PROTOC, V3, P1796, DOI 10.1038/nprot.2008.179; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Turner N, 2005, CURR OPIN PHARMACOL, V5, P388, DOI 10.1016/j.coph.2005.03.006; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Van Kuilenburg ABP, 2002, INT J CANCER, V101, P253, DOI 10.1002/ijc.10599; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	124	62	65	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2011	17	3					304	312		10.1038/nm.2311	http://dx.doi.org/10.1038/nm.2311			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21386834				2022-12-25	WOS:000288070000041
J	Makowski, MR; Wiethoff, AJ; Blume, U; Cuello, F; Warley, A; Jansen, CHP; Nagel, E; Razavi, R; Onthank, DC; Cesati, RR; Marber, MS; Schaeffter, T; Smith, A; Robinson, SP; Botnar, RM				Makowski, Marcus R.; Wiethoff, Andrea J.; Blume, Ulrike; Cuello, Friederike; Warley, Alice; Jansen, Christian H. P.; Nagel, Eike; Razavi, Reza; Onthank, David C.; Cesati, Richard R.; Marber, Michael S.; Schaeffter, Tobias; Smith, Alberto; Robinson, Simon P.; Botnar, Rene M.			Assessment of atherosclerotic plaque burden with an elastin-specific magnetic resonance contrast agent	NATURE MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; INTRAVASCULAR ULTRASOUND; VESSEL WALL; PROGNOSTIC VALUE; CAROTID-ARTERY; ANGIOGRAPHY; COLLAGEN; ACQUISITION; TOMOGRAPHY; EXPRESSION	Atherosclerosis and its consequences remain the main cause of mortality in industrialized and developing nations. Plaque burden and progression have been shown to be independent predictors for future cardiac events by intravascular ultrasound. Routine prospective imaging is hampered by the invasive nature of intravascular ultrasound. A noninvasive technique would therefore be more suitable for screening of atherosclerosis in large populations. Here we introduce an elastin-specific magnetic resonance contrast agent (ESMA) for noninvasive quantification of plaque burden in a mouse model of atherosclerosis. The strong signal provided by ESMA allows for imaging with high spatial resolution, resulting in accurate assessment of plaque burden. Additionally, plaque characterization by quantifying intraplaque elastin content using signal intensity measurements is possible. Changes in elastin content and the high abundance of elastin during plaque development, in combination with the imaging properties of ESMA, provide potential for noninvasive assessment of plaque burden by molecular magnetic resonance imaging (MRI).	[Makowski, Marcus R.; Wiethoff, Andrea J.; Blume, Ulrike; Jansen, Christian H. P.; Nagel, Eike; Razavi, Reza; Schaeffter, Tobias; Botnar, Rene M.] Kings Coll London, Div Imaging Sci & Biomed Engn, London WC2R 2LS, England; [Makowski, Marcus R.; Cuello, Friederike; Nagel, Eike; Razavi, Reza; Marber, Michael S.; Schaeffter, Tobias; Botnar, Rene M.] Kings Coll London, British Heart Fdn BHF Ctr Excellence, London WC2R 2LS, England; [Makowski, Marcus R.] Charite, Dept Radiol, Berlin, Germany; [Wiethoff, Andrea J.] Philips Healthcare, Guildford, Surrey, England; [Cuello, Friederike; Marber, Michael S.; Smith, Alberto] Kings Coll London, Div Cardiovasc, London WC2R 2LS, England; [Warley, Alice] Kings Coll London, Ctr Ultrastruct Imaging, London WC2R 2LS, England; [Nagel, Eike; Razavi, Reza; Schaeffter, Tobias; Botnar, Rene M.] Kings Coll London, Wellcome Trust, London WC2R 2LS, England; [Nagel, Eike; Razavi, Reza; Schaeffter, Tobias; Botnar, Rene M.] Kings Coll London, Engn & Phys Sci Res Council, Med Engn Ctr, London WC2R 2LS, England; [Nagel, Eike; Razavi, Reza; Marber, Michael S.; Schaeffter, Tobias; Smith, Alberto; Botnar, Rene M.] Kings Coll London, Natl Inst Hlth Res, Biomed Res Ctr, London WC2R 2LS, England; [Smith, Alberto] Kings Coll London, Acad Surg, London WC2R 2LS, England; [Onthank, David C.; Cesati, Richard R.; Robinson, Simon P.] Lantheus Med Imaging, N Billerica, MA USA	University of London; King's College London; University of London; King's College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Philips; Philips Healthcare; University of London; King's College London; University of London; King's College London; University of London; King's College London; University College London; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of London; King's College London; University of London; King's College London; University of London; King's College London	Makowski, MR (corresponding author), Kings Coll London, Div Imaging Sci & Biomed Engn, London WC2R 2LS, England.	marcus.makowski@kcl.ac.uk	Schaeffter, Tobias/AAI-6826-2020; Nagel, Eike/C-6903-2008; Makowski, Marcus R/Q-7957-2018; marber, michael/AAW-7916-2021; Botnar, Rene Michael/AAZ-2112-2020; Cuello, Friederike/A-9642-2016; Botnar, Rene M/E-6875-2012	Schaeffter, Tobias/0000-0003-1310-2631; Nagel, Eike/0000-0002-6044-950X; Botnar, Rene M/0000-0003-2811-2509; Razavi, Reza/0000-0003-1065-3008; Marber, Michael/0000-0002-3463-7128; Botnar, Rene/0000-0002-9447-4367	BHF [PG/09/061]; Medical Research Council [G0600698B] Funding Source: researchfish	BHF(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by a BHF project grant (PG/09/061) awarded to R. M. B. M. R. M. was partly funded by a BHF studentship awarded to R. M. B. ESMA (BMS753951) was provided by Lantheus Medical Imaging. Supporting data for the in vitro rabbit competition and in vivo mouse distribution studies were provided by P. Yalamanchili, M. Kavosi and P. Silva from Lantheus Medical Imaging.	Botnar RM, 2000, CIRCULATION, V102, P2582; Botnar RM, 2004, CIRCULATION, V110, P1463, DOI 10.1161/01.CIR.0000134960.31304.87; Botnar RM, 2001, MAGNET RESON MED, V46, P848, DOI 10.1002/mrm.1268; Brasselet C, 2005, AM J PHYSIOL-HEART C, V289, pH2228, DOI 10.1152/ajpheart.00410.2005; Brooke BS, 2003, TRENDS CARDIOVAS MED, V13, P176, DOI 10.1016/S1050-1738(03)00065-3; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Fayad ZA, 2000, CIRCULATION, V102, P506; Finn AV, 2010, CIRCULATION, V121, P1165, DOI 10.1161/CIR.0b013e3181d83b4f; Firbank MJ, 2000, BRIT J RADIOL, V73, P376, DOI 10.1259/bjr.73.868.10844863; Hadamitzky M, 2010, DIABETES CARE, V33, P1358, DOI 10.2337/dc09-2104; Helm PA, 2008, RADIOLOGY, V247, P788, DOI 10.1148/radiol.2473070975; Ibrahim T, 2009, JACC-CARDIOVASC IMAG, V2, P580, DOI 10.1016/j.jcmg.2008.12.029; ISIK FF, 1994, TRANSPLANTATION, V58, P1246, DOI 10.1097/00007890-199412270-00019; Jang IK, 2002, J AM COLL CARDIOL, V39, P604, DOI 10.1016/S0735-1097(01)01799-5; Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223; Katsuda Shogo, 2003, J Atheroscler Thromb, V10, P267; KAUFMAN L, 1989, RADIOLOGY, V173, P265, DOI 10.1148/radiology.173.1.2781018; Kawasaki M, 2005, J AM COLL CARDIOL, V45, P1946, DOI 10.1016/j.jacc.2004.09.081; Kim WY, 2002, CIRCULATION, V106, P296, DOI 10.1161/01.CIR.0000025629.85631.1E; Krettek A, 2003, ARTERIOSCL THROM VAS, V23, P582, DOI 10.1161/01.ATV.0000064372.78561.A5; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Masuda H, 1999, ARTERIOSCL THROM VAS, V19, P2298, DOI 10.1161/01.ATV.19.10.2298; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; MOCK MB, 1982, CIRCULATION, V66, P562, DOI 10.1161/01.CIR.66.3.562; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nicholls SJ, 2010, J AM COLL CARDIOL, V55, P2399, DOI 10.1016/j.jacc.2010.02.026; NIKKARI ST, 1994, AM J PATHOL, V144, P1348; Nili NF, 2002, CARDIOVASC PATHOL, V11, P272, DOI 10.1016/S1054-8807(02)00119-9; Onthank D, 2007, CIRCULATION, V116, P411; RINGQVIST I, 1983, J CLIN INVEST, V71, P1854, DOI 10.1172/JCI110941; Rosenfeld ME, 2000, ARTERIOSCL THROM VAS, V20, P2587, DOI 10.1161/01.ATV.20.12.2587; Schoenhagen P, 2000, CIRCULATION, V101, P598, DOI 10.1161/01.CIR.101.6.598; SENIOR RM, 1980, J CLIN INVEST, V66, P859, DOI 10.1172/JCI109926; Wasserman BA, 2002, RADIOLOGY, V223, P566, DOI 10.1148/radiol.2232010659; Yeon SB, 2007, J AM COLL CARDIOL, V50, P441, DOI 10.1016/j.jacc.2007.03.052	36	130	131	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2011	17	3					383	U188		10.1038/nm.2310	http://dx.doi.org/10.1038/nm.2310			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21336283				2022-12-25	WOS:000288070000051
J	Gangaraju, VK; Yin, H; Weiner, MM; Wang, JQ; Huang, XA; Lin, HF				Gangaraju, Vamsi K.; Yin, Hang; Weiner, Molly M.; Wang, Jianquan; Huang, Xiao A.; Lin, Haifan			Drosophila Piwi functions in Hsp90-mediated suppression of phenotypic variation	NATURE GENETICS			English	Article							ACQUIRED CHARACTERS; MORPHOLOGICAL EVOLUTION; EPIGENETIC MECHANISM; HSP90; PROTEIN; INHIBITION; CAPACITOR; PIRNAS; CELLS; INHERITANCE	Canalization, also known as developmental robustness, describes an organism's ability to produce the same phenotype despite genotypic variations and environmental influences(1,2). In Drosophila, Hsp90, the trithorax-group proteins and transposon silencing have been previously implicated in canalization(3,4). Despite this, the molecular mechanism underlying canalization remains elusive. Here using a Drosophila eye-outgrowth assay sensitized by the dominant Krirregular facets-1(KrIf-1) allele(3), we show that the Piwi-interacting RNA (piRNA) pathway, but not the short interfering RNA or micro RNA pathway, is involved in canalization. Furthermore, we isolated a protein complex composed of Hsp90, Piwi and Hop, the Hsp70/Hsp90 organizing protein homolog, and we demonstrated the function of this complex in canalization. Our data indicate that Hsp90 and Hop regulate the piRNA pathway through Piwi to mediate canalization. Moreover, they point to epigenetic silencing of the expression of existing genetic variants and the suppression of transposon-induced new genetic variation as two major mechanisms underlying piRNA pathway-mediated canalization.	[Gangaraju, Vamsi K.; Weiner, Molly M.; Wang, Jianquan; Huang, Xiao A.; Lin, Haifan] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06520 USA; [Gangaraju, Vamsi K.; Weiner, Molly M.; Wang, Jianquan; Huang, Xiao A.; Lin, Haifan] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Yale University; Yale University	Lin, HF (corresponding author), Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06520 USA.	haifan.lin@yale.edu	Yin, Hang/J-3613-2019	Yin, Hang/0000-0002-9621-0138	US National Institutes of Health [R01HD33760]; G. Harold and Leila Mathers Foundation; Connecticut Stem Cell Research Fund [06SCD01, 06SCE01, 08SCD-Yale-004]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Mathers Foundation; Connecticut Stem Cell Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Siomi Lab for Piwi, Aub, and Ago 3 antibodies; R. Carthew and Y. Sik-Lee for FRT-dcr-1/2 flies and M. Chinkers for the Hop antibody. We would also like to thank L. Liu and V. Shteyn for technical assistance; A. Szakmary for Piwi position effect variegation (PEV) assay (Supplementary Fig. 3b), the Lin lab members for their valuable comments and A. Horwich for stimulating discussion. This work is supported by the US National Institutes of Health Grant R01HD33760, the G. Harold and Leila Mathers Foundation and the Connecticut Stem Cell Research Fund (06SCD01, 06SCE01 and 08SCD-Yale-004) to H.L.	Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Camphausen K, 2007, CLIN CANCER RES, V13, P4326, DOI 10.1158/1078-0432.CCR-07-0632; Carrera P, 1998, P NATL ACAD SCI USA, V95, P10779, DOI 10.1073/pnas.95.18.10779; Carrigan PE, 2005, J BIOL CHEM, V280, P8906, DOI 10.1074/jbc.M414245200; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Dote H, 2006, CANCER RES, V66, P9211, DOI 10.1158/0008-5472.CAN-06-2181; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Hermisson J, 2004, GENETICS, V168, P2271, DOI 10.1534/genetics.104.029173; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lin H, 2008, COLD SH Q B, V73, P273, DOI 10.1101/sqb.2008.73.056; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Mittelman D, 2010, CELL STRESS CHAPERON, V15, P753, DOI 10.1007/s12192-010-0191-0; Noguchi M, 2006, BIOCHEM BIOPH RES CO, V351, P658, DOI 10.1016/j.bbrc.2006.10.094; Odunuga OO, 2004, BIOESSAYS, V26, P1058, DOI 10.1002/bies.20107; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Ruden DM, 2003, SEMIN CELL DEV BIOL, V14, P301, DOI 10.1016/j.semcdb.2003.09.024; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Rutherford SL, 2003, NAT GENET, V33, P6, DOI 10.1038/ng0103-6; Sangster TA, 2004, BIOESSAYS, V26, P348, DOI 10.1002/bies.20020; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263	32	116	120	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2011	43	2					153	U107		10.1038/ng.743	http://dx.doi.org/10.1038/ng.743			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	711XD	21186352	Green Accepted			2022-12-25	WOS:000286623800015
J	Kim, J; Kundu, M; Viollet, B; Guan, KL				Kim, Joungmok; Kundu, Mondira; Viollet, Benoit; Guan, Kun-Liang			AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1	NATURE CELL BIOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; DIRECT TARGET; COMPLEX; ATG1; TSC2; MECHANISMS; GROWTH; ROLES; YEAST; RHEB	Autophagy is a process by which components of the cell are degraded to maintain essential activity and viability in response to nutrient limitation. Extensive genetic studies have shown that the yeast ATG1 kinase has an essential role in autophagy induction. Furthermore, autophagy is promoted by AMP activated protein kinase (AMPK), which is a key energy sensor and regulates cellular metabolism to maintain energy homeostasis. Conversely, autophagy is inhibited by the mammalian target of rapamycin (mTOR), a central cell-growth regulator that integrates growth factor and nutrient signals. Here we demonstrate a molecular mechanism for regulation of the mammalian autophagy-initiating kinase Ulk1, a homologue of yeast ATG1. Under glucose starvation, AMPK promotes autophagy by directly activating Ulk1 through phosphorylation of Ser 317 and Ser 777. Under nutrient sufficiency, high mTOR activity prevents Ulk1 activation by phosphorylating Ulk1 Ser 757 and disrupting the interaction between Ulk1 and AMPK. This coordinated phosphorylation is important for Ulk1 in autophagy induction. Our study has revealed a signalling mechanism for Ulk1 regulation and autophagy induction in response to nutrient signalling.	[Kim, Joungmok; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92130 USA; [Kim, Joungmok; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92130 USA; [Kundu, Mondira] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Viollet, Benoit] Univ Paris 05, INSERM, Inst Cochin, CNRS,UMR 8104,U1016, Paris, France	University of California System; University of California San Diego; University of California System; University of California San Diego; St Jude Children's Research Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92130 USA.	kuguan@ucsd.edu	Kundu, Mondira/N-8139-2018; Viollet, Benoit/O-6927-2017; Viollet, Benoit/N-2397-2019; Guan, Kun-Liang/ADK-7088-2022	Kundu, Mondira/0000-0001-9946-2472; Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; 	NIH [GM51586, GM62694]; NATIONAL CANCER INSTITUTE [R01CA108941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051586, R01GM062694] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Guan lab for discussions and reagents. We would especially like to thank I. Lian and C. Fang for technical assistance, and M. Farquhar, K. Kudicka and T. Meerloo for help with the electron microscopy. This work was supported by NIH grants GM51586 and GM62694 (to K.-L.G.).	Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Cadwell K, 2009, CURR TOP MICROBIOL, V335, P141, DOI 10.1007/978-3-642-00302-8_7; Chan EY, 2009, AUTOPHAGY, V5, P758, DOI 10.4161/auto.8709; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Funakoshi T, 1997, GENE, V192, P207, DOI 10.1016/S0378-1119(97)00031-0; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Hosokawa N, 2009, AUTOPHAGY, V5, P973, DOI 10.4161/auto.5.7.9296; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Huang J, 2007, CELL CYCLE, V6, P1837, DOI 10.4161/cc.6.15.4511; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoue Y, 2010, SEMIN CELL DEV BIOL, V21, P664, DOI 10.1016/j.semcdb.2010.03.009; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.e04-08-0669; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Koren I, 2010, CURR BIOL, V20, P1093, DOI 10.1016/j.cub.2010.04.041; Lee JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015394; Lerena MC, 2010, CELL MICROBIOL, V12, P10, DOI 10.1111/j.1462-5822.2009.01403.x; Liang CY, 2010, CURR OPIN CELL BIOL, V22, P226, DOI 10.1016/j.ceb.2009.11.003; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Sarkar S, 2008, FEBS J, V275, P4263, DOI 10.1111/j.1742-4658.2008.06562.x; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Stipanuk MH, 2009, NUTR REV, V67, P677, DOI 10.1111/j.1753-4887.2009.00252.x; Sudarsanam S, 2010, CURR OPIN DRUG DISC, V13, P31; Tal MC, 2009, CURR TOP MICROBIOL, V335, P107, DOI 10.1007/978-3-642-00302-8_5; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	51	4310	4529	55	849	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2011	13	2					132	U71		10.1038/ncb2152	http://dx.doi.org/10.1038/ncb2152			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714JM	21258367	Green Accepted			2022-12-25	WOS:000286805900007
J	Kornum, BR; Kawashima, M; Faraco, J; Lin, L; Rico, TJ; Hesselson, S; Axtell, RC; Kuipers, H; Weiner, K; Hamacher, A; Kassack, MU; Han, F; Knudsen, S; Li, J; Dong, XS; Winkelmann, J; Plazzi, G; Nevsimalova, S; Hong, SC; Honda, Y; Honda, M; Hogl, B; Ton, TGN; Montplaisir, J; Bourgin, P; Kemlink, D; Huang, YS; Warby, S; Einen, M; Eshragh, JL; Miyagawa, T; Desautels, A; Ruppert, E; Hesla, PE; Poli, F; Pizza, F; Frauscher, B; Jeong, JH; Lee, SP; Strohl, KP; Longstreth, WT; Kvale, M; Dobrovolna, M; Ohayon, MM; Nepom, GT; Wichmann, HE; Rouleau, GA; Gieger, C; Levinson, DF; Gejman, PV; Meitinger, T; Peppard, P; Young, T; Jennum, P; Steinman, L; Tokunaga, K; Kwok, PY; Risch, N; Hallmayer, J; Mignot, E				Kornum, Birgitte R.; Kawashima, Minae; Faraco, Juliette; Lin, Ling; Rico, Thomas J.; Hesselson, Stephanie; Axtell, Robert C.; Kuipers, Hedwich; Weiner, Karin; Hamacher, Alexandra; Kassack, Matthias U.; Han, Fang; Knudsen, Stine; Li, Jing; Dong, Xiaosong; Winkelmann, Juliane; Plazzi, Giuseppe; Nevsimalova, Sona; Hong, Seung-Chul; Honda, Yutaka; Honda, Makoto; Hogl, Birgit; Ton, Thanh G. N.; Montplaisir, Jacques; Bourgin, Patrice; Kemlink, David; Huang, Yu-Shu; Warby, Simon; Einen, Mali; Eshragh, Jasmin L.; Miyagawa, Taku; Desautels, Alex; Ruppert, Elisabeth; Hesla, Per Egil; Poli, Francesca; Pizza, Fabio; Frauscher, Birgit; Jeong, Jong-Hyun; Lee, Sung-Pil; Strohl, Kingman P.; Longstreth, William T., Jr.; Kvale, Mark; Dobrovolna, Marie; Ohayon, Maurice M.; Nepom, Gerald T.; Wichmann, H-Erich; Rouleau, Guy A.; Gieger, Christian; Levinson, Douglas F.; Gejman, Pablo V.; Meitinger, Thomas; Peppard, Paul; Young, Terry; Jennum, Poul; Steinman, Lawrence; Tokunaga, Katsushi; Kwok, Pui-Yan; Risch, Neil; Hallmayer, Joachim; Mignot, Emmanuel			Common variants in P2RY11 are associated with narcolepsy	NATURE GENETICS			English	Article							P2Y(11) RECEPTOR; ENDOTHELIAL-CELLS; DENDRITIC CELLS; T-LYMPHOCYTES; ATP; ACTIVATION; ONSET; AUTOANTIBODIES; SUSCEPTIBILITY; INFLAMMATION	Growing evidence supports the hypothesis that narcolepsy with cataplexy is an autoimmune disease. We here report genome-wide association analyses for narcolepsy with replication and fine mapping across three ethnic groups (3,406 individuals of European ancestry, 2,414 Asians and 302 African Americans). We identify a SNP in the 3' untranslated region of P2RY11, the purinergic receptor subtype P2Y(11) gene, which is associated with narcolepsy (rs2305795, combined P = 6.1 x 10(-10), odds ratio = 1.28, 95% CI 1.19-1.39, n = 5689). The disease-associated allele is correlated with reduced expression of P2RY11 in CD8(+) T lymphocytes (339% reduced, P = 0.003) and natural killer (NK) cells (P = 0.031), but not in other peripheral blood mononuclear cell types. The low expression variant is also associated with reduced P2RY11-mediated resistance to ATP-induced cell death in T lymphocytes (P = 0.0007) and natural killer cells (P = 0.001). These results identify P2RY11 as an important regulator of immune-cell survival, with possible implications in narcolepsy and other autoimmune diseases.	[Kornum, Birgitte R.; Kawashima, Minae; Faraco, Juliette; Lin, Ling; Rico, Thomas J.; Weiner, Karin; Warby, Simon; Einen, Mali; Ohayon, Maurice M.; Levinson, Douglas F.; Hallmayer, Joachim; Mignot, Emmanuel] Stanford Univ, Sch Med, Ctr Sleep Sci, Palo Alto, CA 94304 USA; [Kornum, Birgitte R.; Kawashima, Minae; Faraco, Juliette; Lin, Ling; Rico, Thomas J.; Weiner, Karin; Warby, Simon; Einen, Mali; Ohayon, Maurice M.; Levinson, Douglas F.; Hallmayer, Joachim; Mignot, Emmanuel] Stanford Univ, Sch Med, Dept Psychiat, Palo Alto, CA 94304 USA; [Kornum, Birgitte R.; Knudsen, Stine; Jennum, Poul] Univ Copenhagen, Glostrup Hosp, Danish Ctr Sleep Med, Glostrup, Denmark; [Kawashima, Minae; Miyagawa, Taku; Tokunaga, Katsushi] Univ Tokyo, Dept Human Genet, Tokyo, Japan; [Hesselson, Stephanie; Eshragh, Jasmin L.; Kvale, Mark; Kwok, Pui-Yan; Risch, Neil] Univ Calif San Francisco, Sch Med, Inst Human Genet, San Francisco, CA USA; [Axtell, Robert C.; Kuipers, Hedwich; Steinman, Lawrence] Stanford Univ, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA; [Hamacher, Alexandra; Kassack, Matthias U.] Univ Dusseldorf, Inst Pharmaceut & Med Chem, Dusseldorf, Germany; [Han, Fang; Li, Jing; Dong, Xiaosong] Beijing Univ, Peoples Hosp, Dept Pulm Med, Beijing 100871, Peoples R China; [Winkelmann, Juliane; Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Winkelmann, Juliane; Meitinger, Thomas] Tech Univ Munich, Dept Neurol, Munich, Germany; [Winkelmann, Juliane; Meitinger, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Plazzi, Giuseppe; Poli, Francesca; Pizza, Fabio] Univ Bologna, Dept Neurol Sci, Bologna, Italy; [Nevsimalova, Sona; Kemlink, David] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Nevsimalova, Sona; Kemlink, David] Gen Univ Hosp, Prague, Czech Republic; [Hong, Seung-Chul; Jeong, Jong-Hyun; Lee, Sung-Pil] Catholic Univ Korea, St Vincents Hosp, Dept Neuropsychiat, Suwon, South Korea; [Honda, Yutaka] Japan Sornnol Ctr, Neuropsychiat Res Inst, Tokyo, Japan; [Honda, Makoto] Tokyo Metropolitan Org Med Res, Tokyo Inst Psychiat, Tokyo, Japan; [Hogl, Birgit; Frauscher, Birgit] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria; [Ton, Thanh G. N.; Longstreth, William T., Jr.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Ton, Thanh G. N.; Longstreth, William T., Jr.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Montplaisir, Jacques; Desautels, Alex] Univ Montreal, Sleep Disorders Ctr, Montreal, PQ, Canada; [Bourgin, Patrice; Ruppert, Elisabeth] Univ Strasbourg, Hop Civil, Sleep Clin, Strasbourg, France; [Huang, Yu-Shu] Chang Gung Mem Univ Hosp, Dept Child Psychiat, Taipei, Taiwan; [Huang, Yu-Shu] Chang Gung Mem Univ Hosp, Dept Sleep Med, Taipei, Taiwan; [Hesla, Per Egil] Coliseum Majorstua Clin, Med Sect, Electroencephalog EEG Lab, Oslo, Norway; [Strohl, Kingman P.] Vet Adm Med Ctr, Div Pulm & Crit Care Med, Cleveland, OH 44106 USA; [Dobrovolna, Marie] Inst Hematol & Blood Transfus, Natl Reference Lab DNA Diagnost, HLA Typing Lab, CR-12820 Prague, Czech Republic; [Nepom, Gerald T.] Benaroya Res Inst Virginia Mason, Seattle, WA USA; [Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Munich, Germany; [Wichmann, H-Erich; Gieger, Christian] Univ Munich, Inst Med Informat Biometry & Epidemiol, D-80539 Munich, Germany; [Rouleau, Guy A.] Ctr Hosp Univ Montreal, Ctr Rech, Ctr Excellence Neurom, Montreal, PQ, Canada; [Rouleau, Guy A.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Gejman, Pablo V.] Evanston NW Healthcare Res Inst, Dept Psychiat & Behav Sci, Evanston, IL USA; [Peppard, Paul; Young, Terry] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI USA; [Risch, Neil] Kaiser Permanente No Calif Div Res, Oakland, CA USA; [Risch, Neil] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Stanford University; Stanford University; University of Copenhagen; University of Tokyo; University of California System; University of California San Francisco; Stanford University; Heinrich Heine University Dusseldorf; Peking University; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bologna; Charles University Prague; General University Hospital Prague; Catholic University of Korea; Tokyo Institute of Psychiatry; Tokyo Metropolitan Institute of Medical Science; Medical University of Innsbruck; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Universite de Montreal; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Institute of Hematology Prague; Benaroya Research Institute; Virginia Mason Medical Center; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Universite de Montreal; Universite de Montreal; University of Wisconsin System; University of Wisconsin Madison; Kaiser Permanente; University of California System; University of California San Francisco	Mignot, E (corresponding author), Stanford Univ, Sch Med, Ctr Sleep Sci, Palo Alto, CA 94304 USA.	mignot@stanford.edu	Axtell, Robert/AAJ-5053-2021; Pizza, Fabio/AAC-1794-2020; Kornum, Birgitte Rahbek/K-9193-2015; Nevšímalová, Soňa/H-3533-2017; Kwok, Pui-Yan/F-7725-2014; Knudsen, Stine/O-2358-2017; Ruppert, Elisabeth/G-5577-2014; Meitinger, Thomas/O-1318-2015; Kemlink, David/F-9567-2017; Kuipers, Hedwich F./AAF-1925-2021; Kemlink, David/Q-3019-2019; Wichmann, Heinz Erich/AAA-5695-2022; Plazzi, Giuseppe/AAB-9627-2020; Ohayon, Maurice M/A-1338-2007	Kornum, Birgitte Rahbek/0000-0002-2515-9451; Nevšímalová, Soňa/0000-0003-0083-3742; Kwok, Pui-Yan/0000-0002-5087-3059; Knudsen, Stine/0000-0003-1946-1125; Kemlink, David/0000-0003-1398-5796; Kuipers, Hedwich F./0000-0002-7275-5889; Gieger, Christian/0000-0001-6986-9554; Winkelmann, Juliane/0000-0003-2667-9691; PIZZA, FABIO/0000-0003-2294-9551; Jeong, Jong-Hyun/0000-0003-3570-7607; Hogl, Birgit/0000-0003-1894-7641; Steinman, Lawrence/0000-0002-2437-2250; Meitinger, Thomas/0000-0002-8838-8403; Ohayon, Maurice/0000-0002-2757-5440; Nepom, Gerald/0000-0002-8063-1464; Plazzi, Giuseppe/0000-0002-1051-0472	National Institutes of neurological Disease [P50 NS2372]; Danish Medical Council [09-066348/FSS, 5 T32 AI07290]; National Institutes of Mental Health [R01 MH080957, 5U01 MH079470]; US National Institutes of Health [NS-044199]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH079470, R01MH080957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS023724, R01NS044199] Funding Source: NIH RePORTER	National Institutes of neurological Disease; Danish Medical Council(Danish Medical Research Council); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are indebted to all the participants of the study, most notably the individuals with narcolepsy. Without their contributions, this study would not have been possible. This study was supported by National Institutes of neurological Disease and Stroke grant P50 NS2372. Additional funding was from the Danish Medical Council 09-066348/FSS to B.R.K., a Stanford training grant: Molecular and Cellular Immunobiology grant 5 T32 AI07290 to K.W., National Institutes of Mental Health grant R01 MH080957 to E.M., grant 5U01 MH079470 to D.L., and US National Institutes of Health NS-044199 to M.M.O. We are also grateful to GAIN (the Genetic Association Information Network, National Institutes of Health) and KORA (Kooperative Gesundheitsforschung in der Region Augsburg, Germany). The authors extend their thanks to P. Chang, A. Voros and J. Zhang for technical assistance and C. Grumet for brainstorming and constant support.	Amisten S, 2007, EUR HEART J, V28, P13, DOI 10.1093/eurheartj/ehl410; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Aswad F, 2005, J IMMUNOL, V175, P3075, DOI 10.4049/jimmunol.175.5.3075; Aswad F, 2006, CELL IMMUNOL, V243, P58, DOI 10.1016/j.cellimm.2006.12.003; Ben Yebdri F, 2009, EUR J IMMUNOL, V39, P2885, DOI 10.1002/eji.200939347; Bodin P, 1998, INFLAMM RES, V47, P351, DOI 10.1007/s000110050341; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Communi D, 2001, J BIOL CHEM, V276, P16561, DOI 10.1074/jbc.M009609200; Communi D, 1997, J BIOL CHEM, V272, P31969, DOI 10.1074/jbc.272.51.31969; Cvetkovic-Lopes V, 2010, J CLIN INVEST, V120, P713, DOI 10.1172/JCI41366; Di Virgilio F, 2009, CURR OPIN PHARMACOL, V9, P507, DOI 10.1016/j.coph.2009.06.021; Duhant X, 2002, J IMMUNOL, V169, P15, DOI 10.4049/jimmunol.169.1.15; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Gorini S, 2010, BLOOD, V116, P4492, DOI 10.1182/blood-2009-12-260828; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Hong SC, 2007, HUM IMMUNOL, V68, P59, DOI 10.1016/j.humimm.2006.10.006; Hor H, 2010, NAT GENET, V42, P786, DOI 10.1038/ng.647; Kawashima M, 2010, SLEEP, V33, P869, DOI 10.1093/sleep/33.7.869; Marteau F, 2004, J LEUKOCYTE BIOL, V76, P796, DOI 10.1189/jlb.0104032; MATSUKI K, 1992, LANCET, V339, P1052, DOI 10.1016/0140-6736(92)90571-J; Meis S, 2010, J PHARMACOL EXP THER, V332, P238, DOI 10.1124/jpet.109.157750; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Moore DJ, 2001, BBA-GENE STRUCT EXPR, V1521, P107, DOI 10.1016/S0167-4781(01)00291-3; Peng LM, 1999, CHINESE MED J-PEKING, V112, P356; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Schnurr M, 2003, BLOOD, V102, P613, DOI 10.1182/blood-2002-12-3745; Taylor SRJ, 2008, J IMMUNOL, V180, P300, DOI 10.4049/jimmunol.180.1.300; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Toyoda H, 2010, SLEEP, V33, P875, DOI 10.1093/sleep/33.7.875; Ullmann H, 2005, J MED CHEM, V48, P7040, DOI 10.1021/jm050301p; Vaughan KR, 2007, J IMMUNOL, V179, P8544, DOI 10.4049/jimmunol.179.12.8544; Wilkin F, 2001, J IMMUNOL, V166, P7172, DOI 10.4049/jimmunol.166.12.7172	33	167	170	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2011	43	1					66	U90		10.1038/ng.734	http://dx.doi.org/10.1038/ng.734			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	699SQ	21170044	Green Accepted, Green Submitted			2022-12-25	WOS:000285683500018
J	Parra, A; Madrid, R; Echevarria, D; del Olmo, S; Morenilla-Palao, C; Acosta, MC; Gallar, J; Dhaka, A; Viana, F; Belmonte, C				Parra, Andres; Madrid, Rodolfo; Echevarria, Diego; del Olmo, Susana; Morenilla-Palao, Cruz; Carmen Acosta, M.; Gallar, Juana; Dhaka, Ajay; Viana, Felix; Belmonte, Carlos			Ocular surface wetness is regulated by TRPM8-dependent cold thermoreceptors of the cornea	NATURE MEDICINE			English	Article							TEAR SECRETION; DRY EYE; TRPM8; STIMULATION; CHANNELS; NEURONS; TRPA1	Basal tearing is crucial to maintaining ocular surface wetness. Corneal cold thermoreceptors sense small oscillations in ambient temperature and change their discharge accordingly. Deletion of the cold-transducing ion channel Transient receptor potential cation channel subfamily M member 8 (TRPM8) in mice abrogates cold responsiveness and reduces basal tearing without affecting nociceptor-mediated irritative tearing. Warming of the cornea in humans also decreases tearing rate. These findings indicate that TRPM8-dependent impulse activity in corneal cold receptors contributes to regulating basal tear flow. (C) 2010 Nature America, Inc. All rights reserved.	[Parra, Andres; Madrid, Rodolfo; Echevarria, Diego; Morenilla-Palao, Cruz; Carmen Acosta, M.; Gallar, Juana; Viana, Felix; Belmonte, Carlos] Univ Miguel Hernandez, Inst Neurociencias Alicante, CSIC, Alacant, Spain; [Madrid, Rodolfo] Univ Santiago Chile, Dept Biol, Fac Quim & Biol, Santiago, Chile; [del Olmo, Susana; Belmonte, Carlos] Fdn Invest Oftalmol, Inst Oftalmol Fernandez Vega, Oviedo, Spain; [Dhaka, Ajay] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad de Santiago de Chile; University of Washington; University of Washington Seattle	Belmonte, C (corresponding author), Univ Miguel Hernandez, Inst Neurociencias Alicante, CSIC, Alacant, Spain.	carlos.belmonte@umh.es	Acosta, M.Carmen/K-1313-2014; Gallar, Juana/B-4563-2011; del Olmo Aguado, Susana/AAY-3497-2021; Echevarria, Diego/P-7391-2019; Viana, Felix/U-8533-2017; Echevarria, Diego/E-6386-2016	Gallar, Juana/0000-0002-3559-3649; del Olmo Aguado, Susana/0000-0002-2867-7254; Echevarria, Diego/0000-0002-0938-7470; Viana, Felix/0000-0003-1439-949X; Echevarria, Diego/0000-0002-0938-7470; parra martin, andres/0000-0003-3389-5288; Madrid, Rodolfo/0000-0002-8623-5761; Acosta, M. Carmen/0000-0002-1759-068X; Morenilla-Palao, Cruz/0000-0002-8159-1206	Spanish MICINN [BFU2008-04425, BFU2007-61855, SAF2008-00529, SAF2008-01004, CSD2007-00023]; Fundacion de Investigacion Oftalmologica, Instituto de Oftalmologia Fernandez-Vega; FONDECYT [1100983]; Fundacion M. C.-Masadeu-Peterson	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion de Investigacion Oftalmologica, Instituto de Oftalmologia Fernandez-Vega; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fundacion M. C.-Masadeu-Peterson	We thank E. Quintero, A. Miralles, M. Bayonas, A. Estirado, S. Ingham and A. Perez-Vegara for skillful technical assistance and P. Orio for help with the spike frequency analysis. The Trpa1<SUP>-/-</SUP> mice were a generous gift from D. Corey (Harvard Medical School). This work was supported by the Spanish MICINN: projects BFU2008-04425 to C. B., BFU2007-61855 to F. V., SAF2008-00529 to J.G., SAF2008-01004 to D. E. and CONSOLIDER-INGENIO 2010 CSD2007-00023, and by the Fundacion de Investigacion Oftalmologica, Instituto de Oftalmologia Fernandez-Vega and Fundacion M. C.-Masadeu-Peterson. R. M. thanks the support of FONDECYT-1100983.	Acosta MC, 2004, INVEST OPHTH VIS SCI, V45, P2333, DOI 10.1167/iovs.03-1366; Acosta MC, 2001, J PHYSIOL-LONDON, V534, P511, DOI 10.1111/j.1469-7793.2001.t01-1-00511.x; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Belmonte C, 2007, J REFRACT SURG, V23, P598, DOI 10.3928/1081-597X-20070601-11; Belmonte C, 2009, EXP BRAIN RES, V196, P13, DOI 10.1007/s00221-009-1797-2; Brock JA, 1998, J PHYSIOL-LONDON, V512, P211, DOI 10.1111/j.1469-7793.1998.211bf.x; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Dartt DA, 2009, PROG RETIN EYE RES, V28, P155, DOI 10.1016/j.preteyeres.2009.04.003; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; LEHRER S, 1994, AM J OBSTET GYNECOL, V170, P835, DOI 10.1016/S0002-9378(94)70294-2; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; Madrid R, 2009, J NEUROSCI, V29, P3120, DOI 10.1523/JNEUROSCI.4778-08.2009; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Moss SE, 2008, OPTOMETRY VISION SCI, V85, P668, DOI 10.1097/OPX.0b013e318181a947; Niederer RL, 2007, BRIT J OPHTHALMOL, V91, P1165, DOI 10.1136/bjo.2006.112656; Purslow C, 2007, OPTOMETRY VISION SCI, V84, P197, DOI 10.1097/OPX.0b013e3180339f6e; Tsubota K, 1998, PROG RETIN EYE RES, V17, P565, DOI 10.1016/S1350-9462(98)00004-4; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Wolkoff P, 2005, OCCUP ENVIRON MED, V62, P4, DOI 10.1136/oem.2004.016030	20	213	220	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1396	1399		10.1038/nm.2264	http://dx.doi.org/10.1038/nm.2264			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21076394				2022-12-25	WOS:000285048900032
J	Spiegel, DA				Spiegel, David A.			Synthetic immunology to engineer human immunity	NATURE CHEMICAL BIOLOGY			English	Article							SMALL MOLECULES; CELLS; DIFFERENTIATION; THERAPY; VACCINE; CANCER	Rationally designing new strategies to control the human immune response stands as a key challenge for the scientific community. Chemical biologists have the opportunity to address specific issues in this area that have important implications for both basic science and clinical medicine.	[Spiegel, David A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Spiegel, David A.] Yale Univ, Dept Pharmacol, New Haven, CT USA	Yale University; Yale University	Spiegel, DA (corresponding author), Yale Univ, Dept Chem, New Haven, CT 06520 USA.	david.spiegel@yale.edu						Adams MM, 2010, J AM CHEM SOC, V132, P1939, DOI 10.1021/ja9082842; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Budynek P, 2010, ARCH MICROBIOL, V192, P315, DOI 10.1007/s00203-010-0559-7; Carlson CB, 2007, ACS CHEM BIOL, V2, P119, DOI 10.1021/cb6003788; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Grunewald J, 2009, P NATL ACAD SCI USA, V106, P4337, DOI 10.1073/pnas.0900507106; Kaiser A, 2009, ANGEW CHEM INT EDIT, V48, P7551, DOI 10.1002/anie.200902564; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kodadek T, 2010, CURR OPIN CHEM BIOL, V14, P721, DOI 10.1016/j.cbpa.2010.07.002; Liu SC, 2008, CANCER RES, V68, P7995, DOI 10.1158/0008-5472.CAN-08-1698; Low PS, 2008, ACCOUNTS CHEM RES, V41, P120, DOI 10.1021/ar7000815; Nelson JW, 2010, ACS CHEM BIOL, V5, P1147, DOI 10.1021/cb100195d; Popkov M, 2009, P NATL ACAD SCI USA, V106, P4378, DOI 10.1073/pnas.0900147106; Puffer EB, 2007, ACS CHEM BIOL, V2, P252, DOI 10.1021/cb600489g; Shaha SP, 2009, CLIN EXP IMMUNOL, V158, P186, DOI 10.1111/j.1365-2249.2009.04003.x; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Zhang AX, 2010, J AM CHEM SOC, V132, P12711, DOI 10.1021/ja104591m; Zhou HY, 2010, CURR OPIN HEMATOL, V17, P276, DOI 10.1097/MOH.0b013e328339f2ee; Zhu JL, 2009, EXPERT REV VACCINES, V8, P1399, DOI 10.1586/ERV.09.95; Zhu ST, 2010, FUTURE MED CHEM, V2, P965, DOI [10.4155/fmc.10.190, 10.4155/FMC.10.190]	20	17	22	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					871	872		10.1038/nchembio.477	http://dx.doi.org/10.1038/nchembio.477			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079593				2022-12-25	WOS:000284214700009
J	Wagner, BK				Wagner, Bridget K.			Chemical transdifferentiation and regenerative medicine	NATURE CHEMICAL BIOLOGY			English	Article							TRANSCRIPTIONAL CONTROL; BETA-CELLS; EXPRESSION; FIBROBLASTS; INDUCERS; ALPHA	The ability to alter cell identity with small molecules represents a powerful approach to restore biological function lost because of cellular deficiency. Developing this capability through advances in chemical biology could have an enormous impact on human health.	[Wagner, Bridget K.] Broad Inst Harvard, Chem Biol Program, Cambridge, MA USA; [Wagner, Bridget K.] MIT, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Wagner, BK (corresponding author), Broad Inst Harvard, Chem Biol Program, Cambridge, MA USA.	bwagner@broadinstitute.org						Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105; Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Fomina-Yadlin D, 2010, P NATL ACAD SCI USA, V107, P15099, DOI 10.1073/pnas.1010018107; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Koehler AN, 2003, J AM CHEM SOC, V125, P8420, DOI 10.1021/ja0352698; Koehler AN, 2010, CURR OPIN CHEM BIOL, V14, P331, DOI 10.1016/j.cbpa.2010.03.022; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; Morgan CT, 2010, NAT CHEM BIOL, V6, P102, DOI [10.1038/nchembio.282, 10.1038/NCHEMBIO.282]; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	15	6	7	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					877	879		10.1038/nchembio.472	http://dx.doi.org/10.1038/nchembio.472			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079596				2022-12-25	WOS:000284214700012
J	Li, YR; Vinckenbosch, N; Tian, G; Huerta-Sanchez, E; Jiang, T; Jiang, H; Albrechtsen, A; Andersen, G; Cao, HZ; Korneliussen, T; Grarup, N; Guo, YR; Hellman, I; Jin, X; Li, QB; Liu, JT; Liu, XA; Sparso, T; Tang, MF; Wu, HL; Wu, RH; Yu, C; Zheng, HC; Astrup, A; Bolund, L; Holmkvist, J; Jorgensen, T; Kristiansen, K; Schmitz, O; Schwartz, TW; Zhang, XQ; Li, RQ; Yang, HM; Wang, JA; Hansen, T; Pedersen, O; Nielsen, R; Wang, J				Li, Yingrui; Vinckenbosch, Nicolas; Tian, Geng; Huerta-Sanchez, Emilia; Jiang, Tao; Jiang, Hui; Albrechtsen, Anders; Andersen, Gitte; Cao, Hongzhi; Korneliussen, Thorfinn; Grarup, Niels; Guo, Yiran; Hellman, Ines; Jin, Xin; Li, Qibin; Liu, Jiangtao; Liu, Xiao; Sparso, Thomas; Tang, Meifang; Wu, Honglong; Wu, Renhua; Yu, Chang; Zheng, Hancheng; Astrup, Arne; Bolund, Lars; Holmkvist, Johan; Jorgensen, Torben; Kristiansen, Karsten; Schmitz, Ole; Schwartz, Thue W.; Zhang, Xiuqing; Li, Ruiqiang; Yang, Huanming; Wang, Jian; Hansen, Torben; Pedersen, Oluf; Nielsen, Rasmus; Wang, Jun			Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants	NATURE GENETICS			English	Article							GENOME; SELECTION; NUCLEOTIDE; INFERENCE; PATTERNS; GENES; POLYMORPHISM; DIVERSITY; EVOLUTION; CAPTURE	Targeted capture combined with massively parallel exome sequencing is a promising approach to identify genetic variants implicated in human traits. We report exome sequencing of 200 individuals from Denmark with targeted capture of 18,654 coding genes and sequence coverage of each individual exome at an average depth of 12-fold. On average, about 95% of the target regions were covered by at least one read. We identified 121,870 SNPs in the sample population, including 53,081 coding SNPs (cSNPs). Using a statistical method for SNP calling and an estimation of allelic frequencies based on our population data, we derived the allele frequency spectrum of cSNPs with a minor allele frequency greater than 0.02. We identified a 1.8-fold excess of deleterious, non-syonomyous cSNPs over synonymous cSNPs in the low-frequency range (minor allele frequencies between 2% and 5%). This excess was more pronounced for X-linked SNPs, suggesting that deleterious substitutions are primarily recessive.	[Li, Yingrui; Tian, Geng; Jiang, Tao; Jiang, Hui; Cao, Hongzhi; Guo, Yiran; Jin, Xin; Li, Qibin; Liu, Jiangtao; Liu, Xiao; Tang, Meifang; Wu, Honglong; Wu, Renhua; Yu, Chang; Zheng, Hancheng; Bolund, Lars; Kristiansen, Karsten; Zhang, Xiuqing; Li, Ruiqiang; Yang, Huanming; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Vinckenbosch, Nicolas; Huerta-Sanchez, Emilia; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Huerta-Sanchez, Emilia; Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Albrechtsen, Anders; Korneliussen, Thorfinn; Kristiansen, Karsten; Li, Ruiqiang; Nielsen, Rasmus; Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Andersen, Gitte; Grarup, Niels; Sparso, Thomas; Holmkvist, Johan; Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Copenhagen, Denmark; [Hellman, Ines] Univ Vienna, Dept Math, Vienna, Austria; [Jin, Xin; Zheng, Hancheng] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou, Guangdong, Peoples R China; [Astrup, Arne] Univ Copenhagen, Fac Life Sci, Dept Human Nutr, Copenhagen, Denmark; [Bolund, Lars] Univ Aarhus, Inst Human Genet, Aarhus, Denmark; [Bolund, Lars] Danish Ctr Translat Breast Canc Res, Copenhagen, Denmark; [Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Schmitz, Ole] Aarhus Univ Hosp, Dept Endocrinol & Diabet, DK-8000 Aarhus, Denmark; [Schmitz, Ole] Univ Aarhus, Dept Clin Pharmacol, Aarhus, Denmark; [Schwartz, Thue W.] Univ Copenhagen, Mol Pharmacol Lab, Copenhagen, Denmark; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Pedersen, Oluf] Univ Copenhagen, Inst Biomed Sci, Copenhagen, Denmark	Beijing Genomics Institute (BGI); University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Copenhagen; Novo Nordisk; Hagedorn Research Institute; University of Vienna; South China University of Technology; University of Copenhagen; Aarhus University; University of Copenhagen; University of Copenhagen; Aarhus University; Aarhus University; University of Copenhagen; University of Southern Denmark; Aarhus University; University of Copenhagen	Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	oluf@hagedorn.dk; rasmus_nielsen@berkeley.edu; wangj@genomics.org.cn	Jin, Xin/ABF-1329-2020; Jørgensen, Torben/Z-1335-2018; Korneliussen, Thorfinn Sand/F-6421-2014; Kristiansen, Karsten/J-5148-2014; Wang, Jun/A-7261-2013; Li, Yingrui/K-1064-2015; Pedersen, Oluf/Z-1731-2019; wang, jian/GVS-0711-2022; Yu, Chang/AAE-8538-2019; Pedersen, Oluf/AAG-8015-2020; Guo, Yiran/H-4120-2011; Albrechtsen, Anders/K-4281-2013; Nielsen, Rasmus/D-4405-2009; Korneliussen, Thorfinn Sand/ABB-7656-2021; Grarup, Niels/K-2807-2015; Astrup, Arne/B-1407-2015; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Jin, Xin/0000-0001-7554-4975; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Kristiansen, Karsten/0000-0002-6024-0917; Pedersen, Oluf/0000-0002-3321-3972; Albrechtsen, Anders/0000-0001-7306-031X; Nielsen, Rasmus/0000-0003-0513-6591; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Grarup, Niels/0000-0001-5526-1070; Astrup, Arne/0000-0001-8968-8996; Jorgensen, Torben/0000-0001-9453-2830; Wang, Jun/0000-0002-8540-8931; Schwartz, Thue W./0000-0002-0261-6904; Hansen, Torben/0000-0001-8748-3831; Wang, Jun/0000-0002-2113-5874	Lundbeck Foundation; National Basic Research Program of China [2011CB809200, 2007CB815703, 2007CB815705, 2006AA02Z177, 2006AA02Z334, 2006AA02A302, 2009AA022707]; Chinese Academy of Science [GJHZ0701-6]; National Natural Science Foundation of China [30725008, 30890032, 30811130531, 30221004]; Danish Natural Science Research Council; Yantian District Local Government of Shenzhen [JC200903190767A, JC200903190772A, ZYC200903240076A, CXB200903110066A, ZYC200903240077A, ZYC200903240080A]; Shenzhen Municipal Government; Swiss National Science Foundation; American National Science Foundation; Chinese 863 program [2006AA02Z177]; Danish Platform for Integrative Biology; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER	Lundbeck Foundation(Lundbeckfonden); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Science(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Danish Natural Science Research Council(Danish Natural Science Research Council); Yantian District Local Government of Shenzhen; Shenzhen Municipal Government; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); American National Science Foundation(National Science Foundation (NSF)); Chinese 863 program(National High Technology Research and Development Program of China); Danish Platform for Integrative Biology; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This project was funded by the Lundbeck Foundation and produced by The Lundbeck Foundation Centre for Applied Medical Genomics in Personalised Disease Prediction, Prevention and Care (LuCAMP). The project was also supported by a National Basic Research Program of China (973 program no. 2011CB809200; 2007CB815703; 2007CB815705; and 863 program no. 2006AA02Z177; 2006AA02Z334; 2006AA02A302; 2009AA022707), the Chinese Academy of Science (GJHZ0701-6), the National Natural Science Foundation of China (30725008; 30890032; 30811130531; 30221004), the Chinese Academy of Science (GJHZ0701-6), the Chinese 973 program (2007CB815703; 2007CB815705), the Chinese 863 program (2006AA02Z177), the Danish Platform for Integrative Biology and the Ole Romer grant from the Danish Natural Science Research Council. The Shenzhen Municipal Government and the Yantian District Local Government of Shenzhen additionally funded the project (grants JC200903190767A; JC200903190772A; ZYC200903240076A; CXB200903110066A; ZYC200903240077A; ZYC200903240076A and ZYC200903240080A). N.V. and E. H.-S. were supported with fellowships from the Swiss and American National Science Foundations. We are indebted to T. Lauritzen and K. Borch-Johnsen for their contribution to LuCAMP.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Hammer MF, 2004, GENETICS, V167, P1841, DOI 10.1534/genetics.103.025361; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Johnson PLF, 2008, MOL BIOL EVOL, V25, P199, DOI 10.1093/molbev/msm239; Johnson PLF, 2006, GENOME RES, V16, P1320, DOI 10.1101/gr.5431206; Keightley PD, 2007, GENETICS, V177, P2251, DOI 10.1534/genetics.107.080663; Leabman MK, 2003, P NATL ACAD SCI USA, V100, P5896, DOI 10.1073/pnas.0730857100; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lynch M, 2008, MOL BIOL EVOL, V25, P2409, DOI 10.1093/molbev/msn185; Lynch M, 2009, GENETICS, V182, P295, DOI 10.1534/genetics.109.100479; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meunier J, 2004, MOL BIOL EVOL, V21, P984, DOI 10.1093/molbev/msh070; Nachman MW, 2000, GENETICS, V156, P297; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nielsen R, 2009, GENOME RES, V19, P838, DOI 10.1101/gr.088336.108; SAWYER SA, 1992, GENETICS, V132, P1161; Sunyaev SR, 2000, TRENDS GENET, V16, P335, DOI 10.1016/S0168-9525(00)02058-8; Vicoso B, 2006, NAT REV GENET, V7, P645, DOI 10.1038/nrg1914; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102	27	243	262	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					969	U82		10.1038/ng.680	http://dx.doi.org/10.1038/ng.680			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20890277				2022-12-25	WOS:000283540500013
J	Masterson, LR; Cheng, C; Yu, T; Tonelli, M; Kornev, A; Taylor, SS; Veglia, G				Masterson, Larry R.; Cheng, Cecilia; Yu, Tao; Tonelli, Marco; Kornev, Alexandr; Taylor, Susan S.; Veglia, Gianluigi			Dynamics connect substrate recognition to catalysis in protein kinase A	NATURE CHEMICAL BIOLOGY			English	Article							CONFORMATIONAL ENTROPY; BACKBONE DYNAMICS; NMR-SPECTROSCOPY; DRUG-BINDING; RELAXATION; MECHANISM; MOTION; DOMAIN; FLEXIBILITY; REVEALS	Atomic resolution studies of protein kinases have traditionally been carried out in the inhibitory state, limiting our current knowledge on the mechanisms of substrate recognition and catalysis. Using NMR, X-ray crystallography and thermodynamic measurements, we analyzed the substrate recognition process of cAMP-dependent protein kinase (PKA), finding that entropy and protein dynamics play a prominent role. The nucleotide acts as a dynamic and allosteric activator by coupling the two lobes of apo PKA, enhancing the enzyme dynamics synchronously and priming it for catalysis. The formation of the ternary complex is entropically driven, and NMR spin relaxation data reveal that both substrate and PKA are dynamic in the closed state. Our results show that the enzyme toggles between open and closed states, which indicates that a conformational selection rather than an induced-fit mechanism governs substrate recognition.	[Masterson, Larry R.; Veglia, Gianluigi] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Masterson, Larry R.; Yu, Tao; Veglia, Gianluigi] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Cheng, Cecilia; Kornev, Alexandr; Taylor, Susan S.] Univ San Diego, Dept Chem & Biochem, San Diego, CA 92110 USA; [Tonelli, Marco] Univ Wisconsin, Dept Biochem, Natl Magnet Resonance Facil Madison, Madison, WI 53705 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of San Diego; University of Wisconsin System; University of Wisconsin Madison	Masterson, LR (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	staylor@ucsd.edu; vegli001@umn.edu	Kornev, Alexandr Petrovich/O-7826-2015; Yu, Tao/F-5732-2014	Kornev, Alexandr Petrovich/0000-0002-1543-3795; 	US National Institutes of Health [GM64742, HL080081, GM19301]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002781, P41RR002301, S10RR008438] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL080081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072701, P41GM066326, R01GM019301, R01GM064742, R37GM019301] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health (GM64742 and HL080081 to G. V. and GM19301 to S. S. T.). NMR data were collected at the National Magnetic Resonance Facility at Madison (NMRFAM) (US National Institutes of Health: P41RR02301, P41GM66326, RR02781 and RR08438; US National Science Foundation: DMB-8415048, OIA-9977486 and BIR-9214394) and the University of Minnesota NMR Facility (US National Science Foundation BIR-961477). We thank J.P. Loria (Yale University) for providing the TROSY Hahn echo pulse sequence, and we would also like to thank J.P. Loria, E.E. Metcalfe and G. Melacini for critical analysis of the paper.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Beach H, 2005, J AM CHEM SOC, V127, P9167, DOI 10.1021/ja0514949; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Das R, 2009, J BIOL CHEM, V284, P23682, DOI 10.1074/jbc.M109.011700; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fenwick MK, 2008, J MOL BIOL, V378, P673, DOI 10.1016/j.jmb.2008.03.012; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; Grunberg R, 2006, STRUCTURE, V14, P683, DOI 10.1016/j.str.2006.01.014; Gsponer J, 2008, STRUCTURE, V16, P736, DOI 10.1016/j.str.2008.02.017; Hammes GG, 2002, BIOCHEMISTRY-US, V41, P8221, DOI 10.1021/bi0260839; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hyeon C, 2009, P NATL ACAD SCI USA, V106, P3023, DOI 10.1073/pnas.0813266106; Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kamerlin SCL, 2010, PROTEINS, V78, P1339, DOI 10.1002/prot.22654; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Kumar S, 2000, PROTEIN SCI, V9, P10; Lew J, 1997, BIOCHEMISTRY-US, V36, P6717, DOI 10.1021/bi963164u; Li F, 2002, J MOL BIOL, V315, P459, DOI 10.1006/jmbi.2001.5256; Mao DYL, 2008, MOL CELL, V29, P535, DOI 10.1016/j.molcel.2008.02.009; Marlow MS, 2010, NAT CHEM BIOL, V6, P352, DOI 10.1038/nchembio.347; Massi F, 2006, BIOCHEMISTRY-US, V45, P10787, DOI 10.1021/bi060764c; Masterson LR, 2008, P NATL ACAD SCI USA, V105, P506, DOI 10.1073/pnas.0709214104; Masterson LR, 2009, BIOMOL NMR ASSIGN, V3, P115, DOI 10.1007/s12104-009-9154-8; Masterson LR, 2009, PROTEIN EXPRES PURIF, V64, P231, DOI 10.1016/j.pep.2008.10.016; Mauldin RV, 2009, STRUCTURE, V17, P386, DOI 10.1016/j.str.2009.01.005; Minor W, 2000, STRUCTURE, V8, pR105, DOI 10.1016/S0969-2126(00)00139-8; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Schwartz SD, 2009, NAT CHEM BIOL, V5, P552, DOI 10.1038/nchembio.202; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Tjandra N, 1996, J BIOMOL NMR, V8, P273, DOI 10.1007/BF00410326; Traaseth NJ, 2008, BIOCHEMISTRY-US, V47, P3, DOI 10.1021/bi701668v; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; WALSH DA, 1994, FASEB J, V8, P1227, DOI 10.1096/fasebj.8.15.8001734; Wang CY, 2003, J AM CHEM SOC, V125, P8968, DOI 10.1021/ja035139z; Wu J, 2005, PROTEIN SCI, V14, P2871, DOI 10.1110/ps.051715205; Yang J, 2005, J MOL BIOL, V346, P191, DOI 10.1016/j.jmb.2004.11.030; Yao XL, 2008, NAT CHEM BIOL, V4, P491, DOI 10.1038/nchembio.99	50	165	167	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2010	6	11					821	828		10.1038/NCHEMBIO.452	http://dx.doi.org/10.1038/NCHEMBIO.452			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	667MP	20890288	Green Accepted			2022-12-25	WOS:000283197800011
J	McCullagh, E; Seshan, A; El-Samad, H; Madhani, HD				McCullagh, Emma; Seshan, Anupama; El-Samad, Hana; Madhani, Hiten D.			Coordinate control of gene expression noise and interchromosomal interactions in a MAP kinase pathway	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; DNA-BINDING; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; INVASIVE GROWTH; YEAST; REPRESSOR; STE12; PHEROMONE; KSS1	In the Saccharomyces cerevisiae pheromone-response pathway, the transcription factor Ste12 is inhibited by two mitogen-activated protein (MAP)-kinase-responsive regulators, Dig1 and Dig2. These two related proteins bind to distinct regions of Ste12 but are redundant in their inhibition of Ste12-dependent gene expression. Here we describe three functions for Dig1 that are non-redundant with those of Dig2. First, the removal of Dig1 results in a specific increase in intrinsic and extrinsic noise in the transcriptional outputs of the mating pathway. Second, in dig1 Delta cells, Ste12 relocalizes from the nucleoplasmic distribution seen in wild-type cells into discrete subnuclear foci. Third, genome-wide insertional chromatin immunoprecipitation studies revealed that Ste12-dependent genes have increased interchromosomal interactions in dig1 Delta cells. These findings suggest that the regulation of gene expression through long-range gene interactions, a widely observed phenomenon, comes at the cost of increased noise. Consequently, cells may have evolved mechanisms to suppress noise by controlling these interactions.	[McCullagh, Emma; Seshan, Anupama; El-Samad, Hana; Madhani, Hiten D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 600 16th St, San Francisco, CA 94158 USA.	Hana.El-Samad@ucsf.edu; hitenmadhani@gmail.com		seshan, anupama/0000-0002-7713-8599; Madhani, Hiten/0000-0001-7400-6657	Genentech Fellowship; National Science Foundation; National Institutes of Health (NIH) [R01 GM086379]; University of California, San Francisco; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086379] Funding Source: NIH RePORTER	Genentech Fellowship; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Francisco(University of California System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. S. Weissman, E. K. O'Shea, J. E. Haber, W. A. Lim, A. D. Johnson and D. J. Sherratt for plasmids and protocols; C. D. Chun and P.D. Hartley for help in conducting and analysing the ChIP-chip experiments; W. F. Marshall and K. Wemmer for assistance with microscopy; and A. D. Johnson, S. Komili, W.F. Marshall and S. Shankar for helpful comments on the manuscript. This work was supported by a Genentech Fellowship and a National Science Foundation Predoctoral Fellowship to E.M., a National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Award to A.S., and funding from the University of California, San Francisco, Program for Breakthrough Biomedical Research and a NIH grant (R01 GM086379) to H.D.M. and H.E.-S.	Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Bardwell L, 1998, P NATL ACAD SCI USA, V95, P15400, DOI 10.1073/pnas.95.26.15400; Baur M, 1997, MOL CELL BIOL, V17, P4330, DOI 10.1128/MCB.17.8.4330; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bollenbach T, 2008, DEVELOPMENT, V135, P1137, DOI 10.1242/dev.012062; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Chou S, 2006, MOL CELL BIOL, V26, P4794, DOI 10.1128/MCB.02053-05; Cockell M, 1999, CURR OPIN GENET DEV, V9, P199, DOI 10.1016/S0959-437X(99)80030-6; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Cook JG, 1996, GENE DEV, V10, P2831, DOI 10.1101/gad.10.22.2831; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; DeGregori J, 2006, CURR MOL MED, V6, P739; Dodd IB, 2001, GENE DEV, V15, P3013, DOI 10.1101/gad.937301; DOLAN JW, 1990, GENE DEV, V4, P492, DOI 10.1101/gad.4.4.492; EISMANN E, 1987, J MOL BIOL, V195, P949, DOI 10.1016/0022-2836(87)90499-2; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; ERREDE B, 1989, GENE DEV, V3, P1349, DOI 10.1101/gad.3.9.1349; FIELDS S, 1988, MOL CELL BIOL, V8, P551, DOI 10.1128/MCB.8.2.551; Gordon JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000485; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hoshino A, 2009, J BIOSCI BIOENG, V108, P446, DOI 10.1016/j.jbiosc.2009.05.005; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; KRAMER H, 1987, EMBO J, V6, P1481, DOI 10.1002/j.1460-2075.1987.tb02390.x; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Meister P, 2006, CELL, V125, P1233, DOI 10.1016/j.cell.2006.06.014; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; MOSSING MC, 1985, J MOL BIOL, V186, P295, DOI 10.1016/0022-2836(85)90106-8; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Olson KA, 2000, MOL CELL BIOL, V20, P4199, DOI 10.1128/MCB.20.12.4199-4209.2000; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pi HW, 1997, MOL CELL BIOL, V17, P6410, DOI 10.1128/MCB.17.11.6410; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Revet B, 1999, CURR BIOL, V9, P151, DOI 10.1016/S0960-9822(99)80069-4; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Shock TR, 2009, EUKARYOT CELL, V8, P606, DOI 10.1128/EC.00005-09; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; STEVENSON BJ, 1992, GENE DEV, V6, P1293, DOI 10.1101/gad.6.7.1293; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; Vilar JMG, 2003, J MOL BIOL, V331, P981, DOI 10.1016/S0022-2836(03)00764-2; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281; WHITSON PA, 1987, J BIOL CHEM, V262, P14592; WHITSON PA, 1987, J BIOL CHEM, V262, P4943; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513; YUAN YLO, 1991, MOL CELL BIOL, V11, P5910, DOI 10.1128/MCB.11.12.5910; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	65	48	48	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					954	962		10.1038/ncb2097	http://dx.doi.org/10.1038/ncb2097			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20852627	Green Accepted			2022-12-25	WOS:000282363500010
J	Ryan, MA; Nattamai, KJ; Xing, E; Schleimer, D; Daria, D; Sengupta, A; Kohler, A; Liu, W; Gunzer, M; Jansen, M; Ratner, N; Le Cras, TD; Waterstrat, A; Van Zant, G; Cancelas, JA; Zheng, Y; Geiger, H				Ryan, Marnie A.; Nattamai, Kalpana J.; Xing, Ellen; Schleimer, David; Daria, Deidre; Sengupta, Amitava; Koehler, Anja; Liu, Wei; Gunzer, Matthias; Jansen, Michael; Ratner, Nancy; Le Cras, Timothy D.; Waterstrat, Amanda; Van Zant, Gary; Cancelas, Jose A.; Zheng, Yi; Geiger, Hartmut			Pharmacological inhibition of EGFR signaling enhances G-CSF-induced hematopoietic stem cell mobilization	NATURE MEDICINE			English	Article							COLONY-STIMULATING FACTOR; PROGENITOR CELLS; CDC42; RECEPTOR; ADHESION; GTPASES; ACTIVATION; EXPRESSION; MIGRATION; MURINE	Mobilization of hematopoietic stem and progenitor cells (HSPCs) from bone marrow into peripheral blood by the cytokine granulocyte colony-stimulating factor (G-CSF) has become the preferred source of HSPCs for stem cell transplants(1-9). However, G-CSF fails to mobilize sufficient numbers of stem cells in up to 10% of donors, precluding autologous transplantation in those donors or substantially delaying transplant recovery time(2). Consequently, new regimens are needed to increase the number of stem cells in peripheral blood upon mobilization. Using a forward genetic approach in mice, we mapped the gene encoding the epidermal growth factor receptor (Egfr) to a genetic region modifying G-CSF-mediated HSPC mobilization. Amounts of EGFR in HSPCs inversely correlated with the cells' ability to be mobilized by G-CSF, implying a negative role for EGFR signaling in mobilization. In combination with G-CSF treatment, genetic reduction of EGFR activity in HSPCs (in waved-2 mutant mice) or treatment with the EGFR inhibitor erlotinib increased mobilization. Increased mobilization due to suppression of EGFR activity correlated with reduced activity of cell division control protein-42 (Cdc42), and genetic Cdc42 deficiency in vivo also enhanced G-CSF-induced mobilization. Our findings reveal a previously unknown signaling pathway regulating stem cell mobilization and provide a new pharmacological approach for improving HSPC mobilization and thereby transplantation outcomes.	[Ryan, Marnie A.; Nattamai, Kalpana J.; Xing, Ellen; Schleimer, David; Daria, Deidre; Sengupta, Amitava; Liu, Wei; Jansen, Michael; Ratner, Nancy; Cancelas, Jose A.; Zheng, Yi; Geiger, Hartmut] CCHMC, Div Expt Hematol & Canc Biol, Cincinnati, OH USA; [Daria, Deidre; Geiger, Hartmut] Univ Ulm, Dept Dermatol & Allerg Dis, Ulm, Germany; [Koehler, Anja; Gunzer, Matthias] Otto VonGuericke Univ Magdegurg, Inst Mol & Clin Immunol, D-39016 Magdeburg, Germany; [Le Cras, Timothy D.] CCHMC, Div Pulm Biol, Cincinnati, OH USA; [Waterstrat, Amanda] Eastern Kentucky Univ, Dept Biol Sci, Richmond, KY 40475 USA; [Van Zant, Gary] Univ Kentucky, Dept Internal Med, Markey Canc Ctr, Div Hematol Oncol, Lexington, KY USA; [Cancelas, Jose A.] Univ Cincinnati, Coll Med, Hoxworth Blood Ctr, Cincinnati, OH USA	Ulm University; Otto von Guericke University; University of Kentucky; University System of Ohio; University of Cincinnati	Geiger, H (corresponding author), CCHMC, Div Expt Hematol & Canc Biol, Cincinnati, OH USA.	hartmut.geiger@cchmc.org	Gunzer, Matthias/AAW-7026-2021; Zheng, Yi/J-7235-2015; Cancelas, Jose/AAR-9324-2020	Gunzer, Matthias/0000-0002-5534-6055; Zheng, Yi/0000-0001-7089-6074; RATNER, NANCY/0000-0001-5030-9354; Le Cras, Timothy/0000-0001-8538-2703	US National Institutes of Health [HL076604, DK077762, AG024950, HD060915]; American Heart Association [0740069N]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060915] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024950] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Cincinnati Children's Hospital Medical Center Translational Research Initiative Award to H. G. and M. A. R., grants from the US National Institutes of Health, HL076604 and DK077762 to H. G., AG024950 and HD060915 to G.V.Z. and an American Heart Association established investigator award to T. D. L. C. (0740069N). H. G. is a New Investigator in Aging, and G.V.Z. is a Senior Scholar in Aging of The Ellison Medical Foundation. A. S. is a recipient of the Lady Tata Memorial Trust Fellowship Award. We would like to thank T. Weaver and M.-D. Filippi for discussions and critical comments on the manuscript. We would like to thank B. Hardie for advice on the erlotinib experiments and the Comprehensive Mouse and Cancer Core as well as the Flow Cytometry Core at CCHMC for help with the experiments and OSI Pharmaceuticals for providing erlotinib.	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Bonig H, 2008, BLOOD, V111, P3439, DOI 10.1182/blood-2007-09-112052; Breems DA, 1996, BLOOD, V87, P5370, DOI 10.1182/blood.V87.12.5370.bloodjournal87125370; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Buerger H, 2000, CANCER RES, V60, P854; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Carlo-Stella C, 2004, BLOOD, V103, P3287, DOI 10.1182/blood-2003-07-2428; Christopher MJ, 2009, BLOOD, V114, P1331, DOI 10.1182/blood-2008-10-184754; Christopherson KW, 2003, BLOOD, V101, P4680, DOI 10.1182/blood-2002-12-3893; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Flomenberg N, 2005, BLOOD, V106, P1867, DOI 10.1182/blood-2005-02-0468; Geiger H, 2004, EXP HEMATOL, V32, P60, DOI 10.1016/j.exphem.2003.09.015; Giet O, 2002, BLOOD, V99, P2023, DOI 10.1182/blood.V99.6.2023; Glimm H, 2000, BLOOD, V96, P4185, DOI 10.1182/blood.V96.13.4185.h8004185_4185_4193; GRIGG AP, 1995, BLOOD, V86, P4437, DOI 10.1182/blood.V86.12.4437.bloodjournal86124437; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hasegawa M, 2000, BLOOD, V95, P1872, DOI 10.1182/blood.V95.5.1872.005k26_1872_1874; Huygen S, 2002, BLOOD, V100, P2744, DOI 10.1182/blood.V100.8.2744; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; LEVESQUE JP, 1995, J EXP MED, V181, P1805, DOI 10.1084/jem.181.5.1805; Levesque JP, 2001, BLOOD, V98, P1289, DOI 10.1182/blood.V98.5.1289; Liu FL, 2000, BLOOD, V95, P3025, DOI 10.1182/blood.V95.10.3025.010k32_3025_3031; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; Malliri A, 1998, J CELL BIOL, V143, P1087, DOI 10.1083/jcb.143.4.1087; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; Papayannopoulou T, 2008, BLOOD, V111, P3923, DOI 10.1182/blood-2007-08-078147; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Roberts AW, 1997, BLOOD, V89, P2736, DOI 10.1182/blood.V89.8.2736; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Seo MR, 2004, J BIOL CHEM, V279, P17366, DOI 10.1074/jbc.M312442200; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; Wang L, 2006, BLOOD, V107, P98, DOI 10.1182/blood-2005-05-2171; Wang L, 2007, P NATL ACAD SCI USA, V104, P1248, DOI 10.1073/pnas.0609149104; Waterstrat A, 2010, BLOOD, V115, P408, DOI 10.1182/blood-2008-03-143370; Xing ZL, 2006, BLOOD, V108, P2190, DOI 10.1182/blood-2005-12-010272; Yamaguchi M, 1998, BLOOD, V92, P842; Yang FC, 2001, P NATL ACAD SCI USA, V98, P5614, DOI 10.1073/pnas.101546898; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; Yuan R, 2005, EXP HEMATOL, V33, P243, DOI 10.1016/j.exphem.2004.10.014	40	47	49	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2010	16	10					1141	U121		10.1038/nm.2217	http://dx.doi.org/10.1038/nm.2217			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20871610	Green Accepted			2022-12-25	WOS:000282644800045
J	Wang, LD; Zhou, FY; Li, XM; Sun, LD; Song, X; Jin, Y; Li, JM; Kong, GQ; Qi, H; Cui, JA; Zhang, LQ; Yang, JZ; Li, JL; Li, XC; Ren, JL; Liu, ZC; Gao, WJ; Yuan, L; Wei, W; Zhang, YR; Wang, WP; Sheyhidin, I; Li, F; Chen, BP; Ren, SW; Liu, B; Li, D; Ku, JW; Fan, ZM; Zhou, SL; Guo, ZG; Zhao, XK; Liu, N; Ai, YH; Shen, FF; Cui, WY; Song, SA; Guo, T; Huang, J; Yuan, C; Huang, J; Wu, Y; Yue, WB; Feng, CW; Li, HL; Wang, Y; Tian, JY; Lu, Y; Yuan, Y; Zhu, WL; Liu, M; Fu, WJ; Yang, X; Wang, HJ; Han, SL; Chen, J; Han, M; Wang, HY; Zhang, P; Li, XM; Dong, JC; Xing, GL; Wang, R; Guo, M; Chang, ZW; Liu, HL; Guo, L; Yuan, ZQ; Liu, H; Lu, Q; Yang, LQ; Zhu, FG; Yang, XF; Feng, XS; Wang, Z; Li, Y; Gao, SG; Qige, QRW; Bai, LT; Yang, WJ; Lei, GY; Shen, ZY; Chen, LQ; Li, EM; Xu, LY; Wu, ZY; Cao, WK; Wang, JP; Bao, ZQ; Chen, JL; Ding, GC; Zhuang, XA; Zhou, YF; Zheng, HF; Zhang, Z; Zuo, XB; Dong, ZM; Fan, DM; He, X; Wang, J; Zhou, Q; Zhang, QX; Jiao, XY; Lian, SY; Ji, AF; Lu, XM; Wang, JS; Chang, FB; Lu, CD; Chen, ZG; Miao, JJ; Fan, ZL; Lin, RB; Liu, TJ; Wei, JC; Kong, QP; Lan, Y; Fan, YJ; Gao, FS; Wang, TY; Xie, D; Chen, SQ; Yang, WC; Hong, JY; Wang, LA; Qiu, SL; Cai, ZM; Zhang, XJ				Wang, Li-Dong; Zhou, Fu-You; Li, Xue-Min; Sun, Liang-Dan; Song, Xin; Jin, Yan; Li, Jiang-Man; Kong, Guo-Qiang; Qi, Hong; Cui, Juan; Zhang, Lian-Qun; Yang, Jie-Zhi; Li, Ji-Lin; Li, Xing-Chuan; Ren, Jing-Li; Liu, Zhi-Cai; Gao, Wen-Jun; Yuan, Ling; Wei, Wu; Zhang, Yan-Rui; Wang, Wei-Peng; Sheyhidin, Ilyar; Li, Feng; Chen, Bao-Ping; Ren, Shu-Wei; Liu, Bin; Li, Dan; Ku, Jian-Wei; Fan, Zong-Min; Zhou, Sheng-Li; Guo, Zhi-Gang; Zhao, Xue-Ke; Liu, Na; Ai, Yong-Hong; Shen, Fang-Fang; Cui, Wen-Yan; Song, Shuang; Guo, Tao; Huang, Jing; Yuan, Chao; Huang, Jia; Wu, Yue; Yue, Wen-Bin; Feng, Chang-Wei; Li, Hong-Lei; Wang, Yan; Tian, Jin-Ya; Lu, Yue; Yuan, Yi; Zhu, Wen-Liang; Liu, Min; Fu, Wen-Jing; Yang, Xia; Wang, Han-Jing; Han, Suo-Li; Chen, Jie; Han, Min; Wang, Hai-Yan; Zhang, Peng; Li, Xiu-Min; Dong, Jin-Cheng; Xing, Guo-Lan; Wang, Ran; Guo, Ming; Chang, Zhi-Wei; Liu, Hai-Lin; Guo, Li; Yuan, Zhi-Qing; Liu, Hai; Lu, Qin; Yang, Liu-Qin; Zhu, Fu-Guo; Yang, Xiu-Feng; Feng, Xiao-Shan; Wang, Zhou; Li, Yin; Gao, She-Gan; Qige, Qirenwang; Bai, Long-Tang; Yang, Wen-Jun; Lei, Guang-Yan; Shen, Zhong-Ying; Chen, Long-Qi; Li, En-Min; Xu, Li-Yan; Wu, Zhi-Yong; Cao, Wei-Ke; Wang, Jian-Po; Bao, Zhi-Qin; Chen, Ji-Li; Ding, Guang-Cheng; Zhuang, Xiang; Zhou, Ying-Fa; Zheng, Hou-Feng; Zhang, Zheng; Zuo, Xian-Bo; Dong, Zi-Ming; Fan, Dong-Mei; He, Xin; Wang, Jin; Zhou, Qi; Zhang, Qin-Xian; Jiao, Xin-Ying; Lian, Shi-Yong; Ji, Ai-Fang; Lu, Xiao-Mei; Wang, Jin-Sheng; Chang, Fu-Bao; Lu, Chang-Dong; Chen, Zhi-Guo; Miao, Jian-Jun; Fan, Zeng-Lin; Lin, Ruo-Bai; Liu, Tai-Jiang; Wei, Jin-Chang; Kong, Qing-Peng; Lan, Yu; Fan, Yu-Jing; Gao, Fu-Sheng; Wang, Tian-Yun; Xie, Dong; Chen, Shu-Qing; Yang, Wan-Cai; Hong, Jun-Yan; Wang, Liang; Qiu, Song-Liang; Cai, Zhi-Ming; Zhang, Xue-Jun			Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54	NATURE GENETICS			English	Article							PHOSPHOLIPASE-C-EPSILON; HIGH-INCIDENCE AREA; FUNCTIONAL-CHARACTERIZATION; NORTHERN CHINA; RISK-FACTORS; HAN CHINESE; CANCER	We performed a genome-wide association study of esophageal squamous cell carcinoma (ESCC) by genotyping 1,077 individuals with ESCC and 1,733 control subjects of Chinese Han descent. We selected 18 promising SNPs for replication in an additional 7,673 cases of ESCC and 11,013 control subjects of Chinese Han descent and 303 cases of ESCC and 537 control subjects of Chinese Uygur-Kazakh descent. We identified two previously unknown susceptibility loci for ESCC: PLCE1 at 10q23 (P-Han combined (for ESCC) = 7.46 x 10(-56), odds ratio (OR) = 1.43; PUygur-Kazakh for ESCC = 5.70 x 10(-4), OR = 1.53) and C20orf54 at 20p13 (P-Han combined (for ESCC) = 1.21 x 10(-11), OR = 0.86; PUygur-Kazakh for ESCC = 7.88 x 10(-3), OR = 0.66). We also confirmed association in 2,766 cases of gastric cardia adenocarcinoma cases and the same 11,013 control subjects (PLCE1, P-Han for GCA = 1.74 x 10(-39), OR = 1.55 and C20orf54, P-Han for GCA = 3.02 x 10(-3), OR = 0.91). PLCE1 and C20orf54 have important biological implications for both ESCC and GCA. PLCE1 might regulate cell growth, differentiation, apoptosis and angiogenesis. C20orf54 is responsible for transporting riboflavin, and deficiency of riboflavin has been documented as a risk factor for ESCC and GCA.	[Wang, Li-Dong; Song, Xin; Jin, Yan; Li, Jiang-Man; Zhang, Lian-Qun; Li, Dan; Zhou, Sheng-Li; Guo, Zhi-Gang; Zhao, Xue-Ke; Liu, Na; Ai, Yong-Hong; Shen, Fang-Fang; Cui, Wen-Yan; Yuan, Yi; Wang, Hai-Yan; Zhang, Peng; Li, Xiu-Min; Liu, Hai-Lin; Yuan, Zhi-Qing; Chen, Zhi-Guo; Wang, Tian-Yun; Yang, Wan-Cai; Wang, Liang] Xinxiang Med Univ, Canc Res Ctr, Xinxiang, Henan, Peoples R China; [Wang, Li-Dong; Zhou, Fu-You; Li, Xue-Min; Song, Xin; Li, Jiang-Man; Kong, Guo-Qiang; Qi, Hong; Cui, Juan; Yang, Jie-Zhi; Li, Xing-Chuan; Ren, Jing-Li; Yuan, Ling; Wang, Wei-Peng; Li, Dan; Fan, Zong-Min; Song, Shuang; Guo, Tao; Huang, Jing; Yuan, Chao; Huang, Jia; Wu, Yue; Feng, Chang-Wei; Li, Hong-Lei; Wang, Yan; Tian, Jin-Ya; Lu, Yue; Zhu, Wen-Liang; Liu, Min; Fu, Wen-Jing; Yang, Xia; Wang, Han-Jing; Han, Suo-Li; Chen, Jie; Dong, Jin-Cheng; Xing, Guo-Lan; Wang, Ran; Guo, Ming; Chang, Zhi-Wei; Guo, Li; Lu, Qin; Wang, Jian-Po; Ding, Guang-Cheng; Zhuang, Xiang; Zhou, Ying-Fa; Dong, Zi-Ming; Fan, Dong-Mei; He, Xin; Wang, Jin; Zhou, Qi; Zhang, Qin-Xian; Qiu, Song-Liang] Zhengzhou Univ, Henan Key Lab Esophageal Canc Res, Dept Basic Oncol & Pathol, Coll Med,Affiliated Hosp 1& 2, Zhengzhou, Henan, Peoples R China; [Zhou, Fu-You; Wang, Jian-Po; Lu, Chang-Dong] Anyang Tumor Hosp, Dept Thorac Surg & Tumor Prevent Treatment, Anyang, Henan, Peoples R China; [Li, Xue-Min; Wang, Wei-Peng; Bao, Zhi-Qin; Chen, Ji-Li; Miao, Jian-Jun; Fan, Zeng-Lin] Cixian Hosp, Dept Pathol & Thorac Surg, Ctr Hlth Screening & Endoscopy, Cixian, Hebei, Peoples R China; [Sun, Liang-Dan; Zheng, Hou-Feng; Zhang, Zheng; Zuo, Xian-Bo; Zhang, Xue-Jun] Anhui Med Univ, Minist Educ, Key Lab Dermatol, Hefei, Anhui, Peoples R China; [Li, Ji-Lin; Jiao, Xin-Ying; Wei, Jin-Chang] Linzhou Esophageal Canc Hosp, Dept Pathol & Thorac Surg, Linzhou, Henan, Peoples R China; [Liu, Zhi-Cai; Lian, Shi-Yong] Tumor Hosp Linzhou, Dept Thorac Surg, Linzhou, Henan, Peoples R China; [Gao, Wen-Jun; Chang, Fu-Bao] Peoples Hosp & Chinese Med Hosp Linzhou, Dept Thorac Surg, Linzhou, Henan, Peoples R China; [Yuan, Ling; Li, Yin] Canc Hosp Henan Prov, Dept Thorac Surg & Radiotherapy, Zhengzhou, Henan, Peoples R China; [Wei, Wu; Ji, Ai-Fang; Wang, Jin-Sheng] Changzhi Med Univ, Inst Hematol Dis, Changzhi, Shanxi, Peoples R China; [Wei, Wu; Ji, Ai-Fang; Wang, Jin-Sheng] Changzhi Med Univ, Dept Pathol, Changzhi, Shanxi, Peoples R China; [Zhang, Yan-Rui] Henan Prov Peoples Hosp, Dept Gastroenterol, Zhengzhou, Henan, Peoples R China; [Sheyhidin, Ilyar; Lu, Xiao-Mei] Xinjiang Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Urumqi, Xinjiang, Peoples R China; [Sheyhidin, Ilyar; Lu, Xiao-Mei] Xinjiang Med Univ, Affiliated Hosp 1, Med Res Ctr, Urumqi, Xinjiang, Peoples R China; [Li, Feng] Shihezi Univ, Sch Med, Dept Pathol, Shihezi, Xinjiang, Peoples R China; [Chen, Bao-Ping] Henan Univ, Huaihe Hosp, Dept Nephrol, Kaifeng, Henan, Peoples R China; [Ren, Shu-Wei] Xinyang Cent Hosp, Dept Oncol, Xinyang, Henan, Peoples R China; [Liu, Bin; Gao, Fu-Sheng] Capital Med Univ, Beijing Tongren Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Ku, Jian-Wei] Nanyang Med Coll, Affiliated Hosp 1, Dept Oncol, Nanyang, Henan, Peoples R China; [Yue, Wen-Bin] Peoples Hosp Puyang, Dept Oncol, Puyang, Henan, Peoples R China; [Han, Min; Zhu, Fu-Guo] First Peoples Hosp Shangqiu, Dept Gastroenterol & Thorac Surg, Shangqiu, Henan, Peoples R China; [Liu, Hai] Third Peoples Hosp Yunnan Prov, Dept Gastroenterol, Kunming, Yunnan, Peoples R China; [Yang, Liu-Qin] Cent Hosp Xinxiang, Dept Radiotherapy, Xinxiang, Henan, Peoples R China; [Yang, Xiu-Feng] Hebi Dahejian Hosp, Dept Surg, Hebi, Henan, Peoples R China; [Feng, Xiao-Shan; Gao, She-Gan] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Oncol, Luoyang, Henan, Peoples R China; [Wang, Zhou] Shandong Univ, Dept Thorac Surg, Prov Hosp, Jinan 250100, Shandong, Peoples R China; [Qige, Qirenwang; Bai, Long-Tang] Inner Mongolia Med Coll, Affiliated Hosp, Dept Internal Mongolia Med, Hohhot, Inner Mongolia, Peoples R China; [Yang, Wen-Jun] Ningxia Med Univ, Dept Biotechnol, Ningxia, Peoples R China; [Lei, Guang-Yan] Tumor Hosp Shaanxi Prov, Dept Thorac Surg, Xian, Shaanxi, Peoples R China; [Shen, Zhong-Ying; Li, En-Min; Xu, Li-Yan; Wu, Zhi-Yong] Shantou Univ, Coll Med, Dept Oncol Pathol, Shantou, Guangdong, Peoples R China; [Shen, Zhong-Ying; Li, En-Min; Xu, Li-Yan; Wu, Zhi-Yong] Shantou Univ, Coll Med, Dept Biochem & Mol Biol, Shantou, Guangdong, Peoples R China; [Chen, Long-Qi] Sichuan Univ, W China Hosp, Dept Thorac & Cardiovasc Surg, Chengdu 610064, Sichuan, Peoples R China; [Cao, Wei-Ke] Nanjing Med Univ, Huaian Hosp 1, Cent Lab, Huaian, Jiangsu, Peoples R China; [Lin, Ruo-Bai] Fujian Med Univ, Dept Thorac Surg, Union Hosp, Fuzhou, Fujian, Peoples R China; [Liu, Tai-Jiang] Red Cross Hosp Huojia, Dept Surg, Xinxiang, Henan, Peoples R China; [Kong, Qing-Peng] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resource & Evolut, Kunming, Yunnan, Peoples R China; [Lan, Yu; Fan, Yu-Jing] Peking Univ, Med Coll 4, Beijing Jishuitan Hosp, Dept Gastroenterol, Beijing 100871, Peoples R China; [Xie, Dong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Chen, Shu-Qing; Hong, Jun-Yan] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Cai, Zhi-Ming] Peking Univ, Shenzhen Hosp, Guangdong Key Lab Male Reprod Med & Genet, Shenzhen, Guangdong, Peoples R China	Xinxiang Medical University; Zhengzhou University; Anhui Medical University; Changzhi Medical College; Changzhi Medical College; Zhengzhou University; Xinjiang Medical University; Xinjiang Medical University; Shihezi University; Henan University; Capital Medical University; Nanyang Medical College; Henan University of Science & Technology; Shandong University; Inner Mongolia Medical University; Ningxia Medical University; Shantou University; Shantou University; Sichuan University; Nanjing Medical University; Fujian Medical University; Chinese Academy of Sciences; Kunming Institute of Zoology; Peking University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang University; Peking University	Wang, LD (corresponding author), Xinxiang Med Univ, Canc Res Ctr, Xinxiang, Henan, Peoples R China.	ldwang@xxmu.edu.cn	Chen, Shu/Z-2943-2019; zhou, sheng/GYJ-6012-2022; zhang, lianqun/HGF-1713-2022; li, xiu/GXV-1745-2022; Yang, Wancai/G-3750-2010; Zheng, Houfeng/K-4424-2012; xu, li/GNH-3667-2022; Pillay, Nischalan/F-9536-2012; Yang, Wancai/O-7655-2019; Chen, Gang/G-2722-2010	Zheng, Houfeng/0000-0001-5681-8598; Yang, Wancai/0000-0001-7437-9197; Xie, Dong/0000-0002-1150-8657; Zhou, Fu-You/0000-0002-6548-4099; ren, jingli/0000-0001-9891-0579; Wang, Li Dong/0000-0002-7933-0410; Yang, Wenjun/0000-0001-5671-1344	Xinxiang Medical University [2009-5]; National Natural Science Foundations [30670956, 30971133]; 863 HighTech Key Projects [2006AA02A403, 2007AA02Z161]; China Key Program on Basic Research [2007CB516812]; Science and Technology Department of Henan Province [2009-8]; Health Department of Henan Province [2009-10]; Education Department of Henan Province [2008-7]; Anhui Provincial Special Scientific Program [2007-7]	Xinxiang Medical University; National Natural Science Foundations(National Natural Science Foundation of China (NSFC)); 863 HighTech Key Projects(National High Technology Research and Development Program of China); China Key Program on Basic Research; Science and Technology Department of Henan Province; Health Department of Henan Province; Education Department of Henan Province; Anhui Provincial Special Scientific Program	We thank all the patients and their family members whose contributions made this work possible; medical students from Xinxiang Medical University for sample and data collections; Y. Xing (Xinxiang Medical University) for organizing field work for sample collections and finding financial support for this study; the genotyping at Key Laboratory of Dermatology (Anhui Medical University), Ministry of Education, China, Hefei, Anhui for genotyping and statistical and bioinformatic analyses; B. G. Ma (Henan Provincial People's Hospital), W. Huang (Health Department of Henan Province), S. Y. Lian (Tumor Hospital of Linzhou), Z. Wang (Anyang Tumor Hospital), W. Zhang and J.T. Zhao (both People's Hospital of Heibi) for field work organization; J.H. Bian (Shantou University), J.J. Liu (Human Genetics, Genome Institute of Singapore) and I. Ding (National Cancer Institute, NIH) for discussions about the manuscript. Supported by Xinxiang Medical University Key Scientific Program (2009-5), the National Natural Science Foundations (30670956, 30971133), 863 HighTech Key Projects (2006AA02A403, 2007AA02Z161), China Key Program on Basic Research (2007CB516812), Special Scientific Programs from Science and Technology Department (2009-8), Health Department (2009-10) and Education Department (2008-7) of Henan Province and Anhui Provincial Special Scientific Program (2007-7).	Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; Brown LM, 2001, AM J EPIDEMIOL, V153, P114, DOI 10.1093/aje/153.2.114; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Bunney TD, 2009, ADV ENZYME REGUL, V49, P54, DOI 10.1016/j.advenzreg.2009.01.004; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Cheung WY, 2009, GASTROENTEROL CLIN N, V38, P75, DOI 10.1016/j.gtc.2009.01.009; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; He YT, 2009, ASIAN PAC J CANCER P, V10, P619; Hongo M, 2009, J GASTROEN HEPATOL, V24, P729, DOI 10.1111/j.1440-1746.2009.05824.x; Hu N, 2005, CANCER RES, V65, P2542, DOI 10.1158/0008-5472.CAN-04-3247; Kamangar F, 2009, GASTROENTEROL CLIN N, V38, P27, DOI 10.1016/j.gtc.2009.01.004; Li K, 2002, INT J CANCER, V102, P271, DOI [10.1002/ijc.10706, 10.1002/jhc.10706]; Li MZ, 2009, CARCINOGENESIS, V30, P1424, DOI 10.1093/carcin/bgp125; Messmann H, 2001, BEST PRACT RES CL GA, V15, P249, DOI 10.1053/bega.2000.0172; Morita M, 2010, INT J CLIN ONCOL, V15, P126, DOI 10.1007/s10147-010-0056-7; Munoz N, 1996, CANC EPIDEMIOLOGY PR, P681; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Siassi F, 2005, CANCER DETECT PREV, V29, P464, DOI 10.1016/j.cdp.2005.08.001; Sun G, 2007, FOOD ADDIT CONTAM A, V24, P181, DOI 10.1080/02652030601013471; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; WANG LD, 1993, CANCER RES, V53, P1783; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yamamoto S, 2009, J BIOCHEM, V145, P437, DOI 10.1093/jb/mvn181; Yang Chun-xia, 2005, Asian Pac J Cancer Prev, V6, P48; Yonezawa A, 2008, AM J PHYSIOL-CELL PH, V295, pC632, DOI 10.1152/ajpcell.00019.2008; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang GH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009668; Zhang WH, 2000, AM J HUM GENET, V67, P110, DOI 10.1086/302970	32	349	392	4	595	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					759	U46		10.1038/ng.648	http://dx.doi.org/10.1038/ng.648			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20729853				2022-12-25	WOS:000281388400010
J	Jouvenet, N; Zhadina, M; Bieniasz, PD; Simon, SM				Jouvenet, Nolwenn; Zhadina, Maria; Bieniasz, Paul D.; Simon, Sanford M.			Dynamics of ESCRT protein recruitment during retroviral assembly	NATURE CELL BIOLOGY			English	Article							LATE-BUDDING DOMAINS; SORTING COMPLEX; HIV-1; TSG101; MACHINERY; ALIX; CYTOKINESIS; BIOGENESIS; ALIX/AIP1; MEMBRANE	The ESCRT (endosomal sorting complex required for transport) complexes and associated proteins mediate membrane scission reactions, such as multivesicular body formation, the terminal stages of cytokinesis and retroviral particle release. These proteins are believed to be sequentially recruited to the site of membrane scission, and then complexes are disassembled by the ATPase Vps4A. However, these events have never been observed in living cells, and their dynamics are unknown. By quantifying the recruitment of several ESCRT and associated proteins during the assembly of two retroviruses, we show that Alix progressively accumulated at viral assembly sites, coincident with the accumulation of the main viral structural protein, Gag, and was not recycled after assembly. In contrast, ESCRT-III and Vps4A were transiently recruited only when the accumulation of Gag was complete. These data indicate that the rapid and transient recruitment of proteins that act late in the ESCRT pathway and carry out membrane fission is triggered by prior and progressive accumulation of proteins that bridge viral proteins and the late-acting ESCRT proteins.	[Jouvenet, Nolwenn; Zhadina, Maria; Bieniasz, Paul D.] Rockefeller Univ, Lab Retrovirol, Aaron Diamond AIDS Res Ctr, New York, NY 10065 USA; [Jouvenet, Nolwenn] CNRS, UMR 5236, CPBS, F-34293 Montpellier, France; [Bieniasz, Paul D.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Simon, Sanford M.] Rockefeller Univ, Lab Cellular Biophys, New York, NY 10065 USA	Rockefeller University; Centre National de la Recherche Scientifique (CNRS); Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Bieniasz, PD (corresponding author), Rockefeller Univ, Lab Retrovirol, Aaron Diamond AIDS Res Ctr, New York, NY 10065 USA.	pbienias@adarc.org; simon@rockefeller.edu		jouvenet, nolwenn/0000-0001-6103-6048; Simon, Sanford/0000-0002-8615-4224	NIH [K99AI87368, R01AI50111, R01AI52774, GM87977, R01AI089844]; NSF [BES-0620813]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050111, K99AI087368, R01AI052774, R01AI089844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087977] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Sundquist for reagents, J. Martin-Serrano for discussions, V. Sahi for fluorescence-activated cell sorting analysis and A. Mattheyses for TIR-FM settings. This work was supported by NIH grant K99AI87368 (to N.J.), NIH grant R01AI50111 and R01AI52774 (to P.D.B.) and NSF grant BES-0620813 and NIH GM87977 and R01AI089844 (to S.M.S.). P.D.B. is a Howard Hughes Medical Institute investigator.	Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Dussupt V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000339; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Goila-Gaur R, 2003, J VIROL, V77, P6507, DOI 10.1128/JVI.77.11.6507-6519.2003; Howard TL, 2001, J CELL SCI, V114, P2395; Ivanchenko S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000652; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; McDonald B, 2009, J CELL SCI, V122, P2167, DOI 10.1242/jcs.028308; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Morita E, 2010, P NATL ACAD SCI USA, V107, P12889, DOI 10.1073/pnas.1005938107; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Popov S, 2009, J VIROL, V83, P7185, DOI 10.1128/JVI.00198-09; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Simon SM, 2009, TRENDS CELL BIOL, V19, P661, DOI 10.1016/j.tcb.2009.08.003; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Stuchell MD, 2004, J BIOL CHEM, V279, P36059, DOI 10.1074/jbc.M405226200; Usami Y, 2007, J VIROL, V81, P6614, DOI 10.1128/JVI.00314-07; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, J CELL SCI, V122, P2163, DOI 10.1242/jcs.029884; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103; Zhai Q, 2008, NAT STRUCT MOL BIOL, V15, P43, DOI 10.1038/nsmb1319	43	156	156	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2011	13	4					394	U124		10.1038/ncb2207	http://dx.doi.org/10.1038/ncb2207			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	744CK	21394083	Green Accepted			2022-12-25	WOS:000289070900011
J	Whitney, MA; Crisp, JL; Nguyen, LT; Friedman, B; Gross, LA; Steinbach, P; Tsien, RY; Nguyen, QT				Whitney, Michael A.; Crisp, Jessica L.; Linda T Nguyen; Friedman, Beth; Gross, Larry A.; Steinbach, Paul; Tsien, Roger Y.; Nguyen, Quyen T.			Fluorescent peptides highlight peripheral nerves during surgery in mice	NATURE BIOTECHNOLOGY			English	Article							RECURRENT LARYNGEAL NERVE; FACIAL-NERVE; CELL; SUPPRESSION; TRACERS; CANCER	Nerve preservation is an important goal during surgery because accidental transection or injury leads to significant morbidity, including numbness, pain, weakness or paralysis. Nerves are usually identified by their appearance and relationship to nearby structures or detected by local electrical stimulation (electromyography), but thin or buried nerves are sometimes overlooked. Here, we use phage display to select a peptide that binds preferentially to nerves. After systemic injection of a fluorescently labeled version of the peptide in mice, all peripheral nerves are clearly delineated within 2 h. Contrast between nerve and adjacent tissue is up to tenfold, and useful contrast lasts up to 8 h. No changes in behavior or activity are observed after treatment, indicating a lack of obvious toxicity. The fluorescent probe also labels nerves in human tissue samples. Fluorescence highlighting is independent of axonal integrity, suggesting that the probe could facilitate surgical repair of injured nerves and help prevent accidental transection.	[Linda T Nguyen; Nguyen, Quyen T.] Univ Calif San Diego, Div Otolaryngol Head & Neck Surg, La Jolla, CA 92093 USA; [Whitney, Michael A.; Friedman, Beth; Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Crisp, Jessica L.; Tsien, Roger Y.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Gross, Larry A.; Steinbach, Paul; Tsien, Roger Y.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Nguyen, QT (corresponding author), Univ Calif San Diego, Div Otolaryngol Head & Neck Surg, La Jolla, CA 92093 USA.	quyennguyen@ucsd.edu			Howard Hughes Medical Institute; Burrough-Wellcome Fund; National Institutes of Health (NIH) [5K08EB008122, NS27177]; NATIONAL CANCER INSTITUTE [R01CA158448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014929, K08EB008122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027177, R37NS027177] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burrough-Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are indebted to members of our laboratory for discussions and comments on the manuscript. Results described here are being used in support of a patent filing by the University of California, San Diego. This work was supported by the Howard Hughes Medical Institute, grants from the Burrough-Wellcome Fund (Career Award for Medical Scientists) and National Institutes of Health (NIH, 5K08EB008122) to Q.T.N. and NIH grant NS27177 to R.Y.T.	Berger S, 2007, MICROBES INFECT, V9, P963, DOI 10.1016/j.micinf.2007.03.016; DAVIS WE, 1979, OTOLARYNG HEAD NECK, V87, P330, DOI 10.1177/019459987908700309; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GANTZ BJ, 1985, AM J OTOL, P58; Jiang YQ, 2006, MOL MED, V12, P81, DOI 10.2119/2006-00011.Jiang; Kim GS, 2006, BIOCHEM BIOPH RES CO, V343, P1165, DOI 10.1016/j.bbrc.2006.03.029; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Kubler HR, 2007, J UROLOGY, V178, P488, DOI 10.1016/j.juro.2007.03.100; Marangos N, 2001, HEARING RES, V162, P48, DOI 10.1016/S0378-5955(01)00368-9; Miller MC, 2008, SURG ONCOL CLIN N AM, V17, P121, DOI 10.1016/j.soc.2007.10.008; Nguyen QT, 2010, P NATL ACAD SCI USA, V107, P4317, DOI 10.1073/pnas.0910261107; O'Malley MR, 2006, LARYNGOSCOPE, V116, P1792, DOI 10.1097/01.mlg.0000231344.92917.9c; Olson ES, 2010, P NATL ACAD SCI USA, V107, P4311, DOI 10.1073/pnas.0910283107; Osuchowski MF, 2009, MUSCLE NERVE, V40, P610, DOI 10.1002/mus.21284; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; RICHMOND FJR, 1994, J NEUROSCI METH, V53, P35, DOI 10.1016/0165-0270(94)90142-2; Shtatland T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-280; Walz J, 2007, WORLD J UROL, V25, P31, DOI 10.1007/s00345-007-0159-6; Walz J, 2010, EUR UROL, V57, P179, DOI 10.1016/j.eururo.2009.11.009; Zhivov A, 2010, BRIT J OPHTHALMOL, V94, P1133, DOI 10.1136/bjo.2009.175489; Zysk AM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2793736	21	147	163	2	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	APR	2011	29	4					352	U181		10.1038/nbt.1764	http://dx.doi.org/10.1038/nbt.1764			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	746XY	21297616	Green Accepted			2022-12-25	WOS:000289284900021
J	Krajcovic, M; Johnson, NB; Sun, QA; Normand, G; Hoover, N; Yao, E; Richardson, AL; King, RW; Cibas, ES; Schnitt, SJ; Brugge, JS; Overholtzer, M				Krajcovic, Matej; Johnson, Nicole B.; Sun, Qiang; Normand, Guillaume; Hoover, Nicholas; Yao, Evelyn; Richardson, Andrea L.; King, Randall W.; Cibas, Edmund S.; Schnitt, Stuart J.; Brugge, Joan S.; Overholtzer, Michael			A non-genetic route to aneuploidy in human cancers	NATURE CELL BIOLOGY			English	Article							CYTOKINESIS FAILURE; MITOTIC SPINDLE; CHROMOSOMAL INSTABILITY; ENDOMETRIAL CARCINOMA; BREAST-CANCER; TUMOR-CELLS; DNA-DAMAGE; TETRAPLOIDY; CANNIBALISM; CHECKPOINT	Aneuploidy is common in human tumours and is often indicative of aggressive disease. Aneuploidy can result from cytokinesis failure, which produces binucleate cells that generate aneuploid offspring with subsequent divisions. In cancers, disruption of cytokinesis is known to result from genetic perturbations to mitotic pathways or checkpoints. Here we describe a non-genetic mechanism of cytokinesis failure that occurs as a direct result of cell-in-cell formation by entosis. Live cells internalized by entosis, which can persist through the cell cycle of host cells, disrupt formation of the contractile ring during host cell division. As a result, cytokinesis frequently fails, generating binucleate cells that produce aneuploid cell lineages. In human breast tumours, multinucleation is associated with cell-in-cell structures. These data define a previously unknown mechanism of cytokinesis failure and aneuploid cell formation that operates in human cancers.	[Krajcovic, Matej; Sun, Qiang; Yao, Evelyn; Overholtzer, Michael] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; [Krajcovic, Matej; Yao, Evelyn; Overholtzer, Michael] Weill Cornell Med Coll, BCMB Allied Program, New York, NY 10065 USA; [Johnson, Nicole B.; Schnitt, Stuart J.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; [Normand, Guillaume] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA; [Hoover, Nicholas; Richardson, Andrea L.; Cibas, Edmund S.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [King, Randall W.; Brugge, Joan S.; Overholtzer, Michael] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Harvard University; Beth Israel Deaconess Medical Center; Memorial Sloan Kettering Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Overholtzer, M (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA.	overhom1@mskcc.org		Overholtzer, Michael/0000-0003-3007-4986; Sun, Qiang/0000-0002-5342-0637; Normand, Guillaume/0000-0003-1228-3813	National Cancer Institute; NIH [GM66492]; Geoffrey Beene Cancer Research Center at MSKCC; NATIONAL CANCER INSTITUTE [R01CA105134, P01CA080111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM066492, R01GM066492] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geoffrey Beene Cancer Research Center at MSKCC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Cancer Institute (J.S.B.), NIH GM66492 (R.W.K.) and a grant from the Geoffrey Beene Cancer Research Center at MSKCC (MD.).	Abodief WT, 2006, CYTOPATHOLOGY, V17, P304, DOI 10.1111/j.1365-2303.2006.00326.x; Guerrero AA, 2010, P NATL ACAD SCI USA, V107, P4159, DOI 10.1073/pnas.0912143106; Araujo SEA, 2007, DIS COLON RECTUM, V50, P1800, DOI 10.1007/s10350-007-9013-6; Boveri T, 1929, ORIGIN MALIGNANT TUM; Casenghi M, 1999, EXP CELL RES, V250, P339, DOI 10.1006/excr.1999.4554; Cibas E.S., 2019, CYTOLOGY DIAGNOSTIC; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; Duelli D, 2003, CANCER CELL, V3, P445, DOI 10.1016/S1535-6108(03)00114-4; Duelli DM, 2005, J CELL BIOL, V171, P493, DOI 10.1083/jcb.200507069; Fais S, 2007, CANCER LETT, V258, P155, DOI 10.1016/j.canlet.2007.09.014; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Huang HM, 2008, CANCER RES, V68, P3724, DOI 10.1158/0008-5472.CAN-08-0479; Jensen CG, 1996, CARCINOGENESIS, V17, P2013, DOI 10.1093/carcin/17.9.2013; KERBEL RS, 1983, MOL CELL BIOL, V3, P523, DOI 10.1128/MCB.3.4.523; King RW, 2008, BBA-REV CANCER, V1786, P4, DOI 10.1016/j.bbcan.2008.07.007; Larkins BA, 2001, J EXP BOT, V52, P183, DOI 10.1093/jexbot/52.355.183; Lugini L, 2006, CANCER RES, V66, P3629, DOI 10.1158/0008-5472.CAN-05-3204; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; Minn AJ, 1996, GENE DEV, V10, P2621, DOI 10.1101/gad.10.20.2621; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Nadler Y, 2008, CLIN CANCER RES, V14, P4455, DOI 10.1158/1078-0432.CCR-07-5268; Overholtzer M, 2008, NAT REV MOL CELL BIO, V9, P796, DOI 10.1038/nrm2504; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Pinto AE, 2005, INT J BIOL MARKER, V20, P249, DOI 10.1177/172460080502000408; Pinto AE, 2006, PATHOBIOLOGY, V73, P63, DOI 10.1159/000094490; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; RAPPAPORT R, 1961, J EXP ZOOL, V148, P81, DOI 10.1002/jez.1401480107; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Suehiro Y, 2008, CLIN CANCER RES, V14, P3354, DOI 10.1158/1078-0432.CCR-07-4609; Susini T, 2007, CANCER-AM CANCER SOC, V109, P882, DOI 10.1002/cncr.22465; Talos F, 2010, ADV EXP MED BIOL, V676, P73; Tsuiki H, 2001, ONCOGENE, V20, P420, DOI 10.1038/sj.onc.1204126; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Vinciguerra P, 2010, J CLIN INVEST, V120, P3834, DOI 10.1172/JCI43391; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Wong C, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-6	40	121	129	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAR	2011	13	3					324	U307		10.1038/ncb2174	http://dx.doi.org/10.1038/ncb2174			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	728BB	21336303	Green Accepted			2022-12-25	WOS:000287847600021
J	Ling, YB; Pong, T; Vassiliou, CC; Huang, PL; Cima, MJ				Ling, Yibo; Pong, Terrence; Vassiliou, Christophoros C.; Huang, Paul L.; Cima, Michael J.			Implantable magnetic relaxation sensors measure cumulative exposure to cardiac biomarkers	NATURE BIOTECHNOLOGY			English	Article							UNRECOGNIZED MYOCARDIAL-INFARCTION; MOLECULAR-INTERACTIONS; CONTRAST AGENTS; MODELS; DEVICE; ASSAYS	Molecular biomarkers can be used as objective indicators of pathologic processes. Although their levels often change over time, their measurement is often constrained to a single time point. Cumulative biomarker exposure would provide a fundamentally different kind of measurement to what is available in the clinic. Magnetic resonance relaxometry can be used to noninvasively monitor changes in the relaxation properties of antibody-coated magnetic particles when they aggregate upon exposure to a biomarker of interest. We used implantable devices containing such sensors to continuously profile changes in three clinically relevant cardiac biomarkers at physiological levels for up to 72 h. Sensor response differed between experimental and control groups in a mouse model of myocardial infarction and correlated with infarct size. Our prototype for a biomarker monitoring device also detected doxorubicin-induced cardiotoxicity and can be adapted to detect other molecular biomarkers with a sensitivity as low as the pg/ml range.	[Ling, Yibo; Pong, Terrence] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Ling, Yibo; Vassiliou, Christophoros C.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Ling, Yibo; Vassiliou, Christophoros C.; Cima, Michael J.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Pong, Terrence; Huang, Paul L.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Pong, Terrence] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Huang, Paul L.] Harvard Univ, Sch Med, Div Cardiol, Boston, MA USA; [Cima, Michael J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Cima, MJ (corresponding author), MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.	mjcima@mit.edu		Huang, Paul/0000-0002-5436-8658	National Cancer Institute Centers of Cancer Nanotechnology Excellence [5 U54 CA119349-12, CA151844]; National Science Foundation Division of Materials Research [0746264]; National Defense Science and Engineering; American Heart Association; NATIONAL CANCER INSTITUTE [U54CA119349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033335] Funding Source: NIH RePORTER	National Cancer Institute Centers of Cancer Nanotechnology Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation Division of Materials Research(National Science Foundation (NSF)); National Defense Science and Engineering; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Cancer Institute Centers of Cancer Nanotechnology Excellence no. 5 U54 CA119349-12 and CA151844 grants and National Science Foundation Division of Materials Research Award no. 0746264. Y.L. was supported by a National Defense Science and Engineering Graduate fellowship. T. P. was supported by an American Heart Association fellowship.	Ammar KA, 2004, AM HEART J, V148, P277, DOI 10.1016/j.ahj.2004.03.019; Bello D, 2005, J AM COLL CARDIOL, V45, P1104, DOI 10.1016/j.jacc.2004.12.057; Daniel KD, 2007, LAB CHIP, V7, P1288, DOI 10.1039/b705143c; Daniel KD, 2009, BIOSENS BIOELECTRON, V24, P3252, DOI 10.1016/j.bios.2009.04.010; Gutterman DD, 2009, CIRC J, V73, P785, DOI 10.1253/circj.CJ-08-1209; Jaffe AS, 2006, J AM COLL CARDIOL, V48, P1, DOI 10.1016/j.jacc.2006.02.056; Josephson L, 1999, BIOCONJUGATE CHEM, V10, P186, DOI 10.1021/bc980125h; Kim GY, 2007, BIOCONJUGATE CHEM, V18, P2024, DOI 10.1021/bc070110w; Perez JM, 2004, CHEMBIOCHEM, V5, P261, DOI 10.1002/cbic.200300730; Perez JM, 2002, J AM CHEM SOC, V124, P2856, DOI 10.1021/ja017773n; Perez JM, 2002, NAT BIOTECHNOL, V20, P816, DOI 10.1038/nbt720; Robert J, 2007, CARDIOVASC TOXICOL, V7, P135, DOI 10.1007/s12012-007-0022-4; Roes SD, 2007, AM J CARDIOL, V100, P930, DOI 10.1016/j.amjcard.2007.04.029; Scherrer-Crosbie M, 2007, ECHOCARDIOGR-J CARD, V24, P90, DOI 10.1111/j.1540-8175.2007.00357.x; Shapiro MG, 2006, MAGN RESON IMAGING, V24, P449, DOI 10.1016/j.mri.2005.12.033; Sheifer SE, 2001, ANN INTERN MED, V135, P801, DOI 10.7326/0003-4819-135-9-200111060-00010; Sun EY, 2006, SMALL, V2, P1144, DOI 10.1002/smll.200600204; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Taktak S, 2007, ANAL CHEM, V79, P8863, DOI 10.1021/ac701976p; Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Tsourkas A, 2004, ANGEW CHEM INT EDIT, V43, P2395, DOI 10.1002/anie.200352998; Wallace KB, 2004, TOXICOL PATHOL, V32, P106, DOI 10.1080/01926230490261302; Wunderbaldinger P, 2002, ACAD RADIOL, V9, pS304, DOI 10.1016/S1076-6332(03)80210-6; Zhao M, 2003, ANGEW CHEM INT EDIT, V42, P1375, DOI 10.1002/anie.200390352	25	44	52	2	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2011	29	3					273	U137		10.1038/nbt.1780	http://dx.doi.org/10.1038/nbt.1780			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	732RL	21317907				2022-12-25	WOS:000288206700023
J	Jiang, H; Pritchard, JR; Williams, RT; Lauffenburger, DA; Hemann, MT				Jiang, Hai; Pritchard, Justin R.; Williams, Richard T.; Lauffenburger, Douglas A.; Hemann, Michael T.			A mammalian functional-genetic approach to characterizing cancer therapeutics	NATURE CHEMICAL BIOLOGY			English	Article							RNA-POLYMERASE-II; CELL-DEATH; BIOACTIVE COMPOUNDS; MISMATCH REPAIR; STRESS-RESPONSE; SMALL MOLECULES; IN-VIVO; P53; YEAST; DNA	Identifying mechanisms of drug action remains a fundamental impediment to the development and effective use of chemotherapeutics. Here we describe an RNA interference (RNAi)-based strategy to characterize small-molecule function in mammalian cells. By examining the response of cells expressing short hairpin RNAs (shRNAs) to a diverse selection of chemotherapeutics, we could generate a functional shRNA signature that was able to accurately group drugs into established biochemical modes of action. This, in turn, provided a diversely sampled reference set for high-resolution prediction of mechanisms of action for poorly characterized small molecules. We could further reduce the predictive shRNA target set to as few as eight genes and, by using a newly derived probability-based nearest-neighbors approach, could extend the predictive power of this shRNA set to characterize additional drug categories. Thus, a focused shRNA phenotypic signature can provide a highly sensitive and tractable approach for characterizing new anticancer drugs.	[Jiang, Hai; Pritchard, Justin R.; Lauffenburger, Douglas A.; Hemann, Michael T.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Williams, Richard T.] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; [Lauffenburger, Douglas A.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); St Jude Children's Research Hospital; Massachusetts Institute of Technology (MIT)	Jiang, H (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hemann@mit.edu	Pritchard, Justin/AAI-2475-2021	Pritchard, Justin/0000-0001-7749-4473; jiang, hai/0000-0002-2508-5413	US National Institutes of Health [RO1 CA128803-03]; Massachusetts Institute of Technology Department of Biology; American Association for Cancer Research; Integrated Cancer Biology Program [1-U54-CA112967]; NATIONAL CANCER INSTITUTE [R01CA128803, U54CA112967] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Institute of Technology Department of Biology; American Association for Cancer Research; Integrated Cancer Biology Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The MM1S cell line was a generous gift from S. Rosen (Northwestern University). CY190602 and Hsp90 inhibitors were kindly provided by Nextwave Biotech. We thank L. Gilbert, H. Criscione, Stephanie Wu, S. Alford and Shan Wu for their experimental or analytical assistance. We are grateful to L. Samson, C. Pallasch and C. Meacham for critically reading the manuscript and the entire Hemann lab for helpful discussions. M. T. H. is a Rita Allen Fellow, and M. T. H. and H.J. are supported by US National Institutes of Health grant RO1 CA128803-03. J.R.P. is supported by the Massachusetts Institute of Technology Department of Biology training grant. R. T. W. is the recipient of an American Association for Cancer Research Career Development Award. Additional funding was provided by the Integrated Cancer Biology Program grant 1-U54-CA112967 to D. A. L. and M.T.H.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hillenmeyer ME, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r30; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lindemann RK, 2007, P NATL ACAD SCI USA, V104, P8071, DOI 10.1073/pnas.0702294104; Ljungman M, 2001, MOL PHARMACOL, V60, P785; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Lu C, 2009, APOPTOSIS, V14, P597, DOI 10.1007/s10495-009-0330-1; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; Mojas N, 2007, GENE DEV, V21, P3342, DOI 10.1101/gad.455407; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Pearce AK, 2001, TRENDS CELL BIOL, V11, P426, DOI 10.1016/S0962-8924(01)02119-5; Pritchard JR, 2009, MOL CANCER THER, V8, P2183, DOI 10.1158/1535-7163.MCT-08-1203; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Sato S, 2010, CHEM BIOL, V17, P616, DOI 10.1016/j.chembiol.2010.05.015; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Williams RT, 2006, P NATL ACAD SCI USA, V103, P6688, DOI 10.1073/pnas.0602030103; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	37	73	77	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2011	7	2					92	100		10.1038/NCHEMBIO.503	http://dx.doi.org/10.1038/NCHEMBIO.503			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	707XM	21186347	Green Published, Green Accepted			2022-12-25	WOS:000286324600009
J	Pier, G; Prince, A; Cantin, A				Pier, Gerald; Prince, Alice; Cantin, Andre			Cystic fibrosis: an-ion transport issue?	NATURE MEDICINE			English	Editorial Material								Cystic fibrosis can manifest in many organs, but infection and inflammation of the airways cause the most severe morbidity and mortality. Early studies suggested that increased epithelial Na+ reabsorption may be a key initiating event in cystic fibrosis lung disease. However, the importance of Na+ hyperabsorption and the consequent depletion of pericellular airway liquid in cystic fibrosis lung disease has been called into question by a recent study by Jeng-Haur Chen et al.(1). Newborn pigs lacking cystic fibrosis transmembrane conductance regulator (CFTR-/- pigs) developed lung pathology reminiscent of human cystic fibrosis. Although epithelia from these pigs had reduced Cl- and HCO3- transport, there were no alterations in Na+ or liquid absorption, suggesting that defective anion transport is responsible for cystic fibrosis lung disease. Here three experts comment on how these findings might affect our understanding of cystic fibrosis lung pathogenesis and strategies for cystic fibrosis therapy. [GRAPHICS] .	[Pier, Gerald] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Pier, Gerald] Brigham & Womens Hosp, Boston, MA 02115 USA; [Prince, Alice] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Cantin, Andre] CHU Sherbrooke, Clin Res Ctr Etienne Le Bel, Sherbrooke, PQ J1H 5N4, Canada	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Columbia University; University of Sherbrooke	Pier, G (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.		Pier, Gerald/AAO-2692-2021	Pier, Gerald/0000-0002-9112-2331	NHLBI NIH HHS [R01 HL073989] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073989] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Carnpodonico VL, 2008, TRENDS MOL MED, V14, P120, DOI 10.1016/j.molmed.2008.01.002; Chen EYT, 2010, AM J PHYSIOL-LUNG C, V299, pL542, DOI 10.1152/ajplung.00180.2010; Chen JH, 2010, CELL, V143, P911, DOI 10.1016/j.cell.2010.11.029; Farrell PM, 2009, RADIOLOGY, V252, P534, DOI 10.1148/radiol.2522081882; KNOWLES M, 1983, J CLIN INVEST, V71, P1410, DOI 10.1172/JCI110894; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928	7	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					166	167		10.1038/nm0211-166	http://dx.doi.org/10.1038/nm0211-166			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21297610	Green Accepted			2022-12-25	WOS:000286969900021
J	Tian, F; Bradbury, PJ; Brown, PJ; Hung, H; Sun, Q; Flint-Garcia, S; Rocheford, TR; McMullen, MD; Holland, JB; Buckler, ES				Tian, Feng; Bradbury, Peter J.; Brown, Patrick J.; Hung, Hsiaoyi; Sun, Qi; Flint-Garcia, Sherry; Rocheford, Torbert R.; McMullen, Michael D.; Holland, James B.; Buckler, Edward S.			Genome-wide association study of leaf architecture in the maize nested association mapping population	NATURE GENETICS			English	Article							GENETIC ARCHITECTURE; FLOWERING-TIME; EXPRESSION; DIVERSITY; TRAITS; YIELD; SELECTION; ENHANCER; ENCODES; MODEL	US maize yield has increased eight-fold in the past 80 years, with half of the gain attributed to selection by breeders. During this time, changes in maize leaf angle and size have altered plant architecture, allowing more efficient light capture as planting density has increased. Through a genome-wide association study (GWAS) of the maize nested association mapping panel, we determined the genetic basis of important leaf architecture traits and identified some of the key genes. Overall, we demonstrate that the genetic architecture of the leaf traits is dominated by small effects, with little epistasis, environmental interaction or pleiotropy. In particular, GWAS results show that variations at the liguleless genes have contributed to more upright leaves. These results demonstrate that the use of GWAS with specially designed mapping populations is effective in uncovering the basis of key agronomic traits.	[Tian, Feng; Brown, Patrick J.; Buckler, Edward S.] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Bradbury, Peter J.; Buckler, Edward S.] USDA ARS, Ithaca, NY 14853 USA; [Brown, Patrick J.; Rocheford, Torbert R.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Hung, Hsiaoyi; Holland, James B.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Sun, Qi] Cornell Univ, Computat Biol Serv Unit, Ithaca, NY USA; [Flint-Garcia, Sherry; McMullen, Michael D.] USDA ARS, Columbia, MO USA; [Flint-Garcia, Sherry; McMullen, Michael D.] Univ Missouri, Div Plant Sci, Columbia, MO USA; [Rocheford, Torbert R.] Purdue Univ, Dept Agron, Urbana, IL USA; [Holland, James B.] USDA ARS, Raleigh, NC 27695 USA; [Buckler, Edward S.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY USA	Cornell University; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of North Carolina; North Carolina State University; Cornell University; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; Purdue University System; Purdue University; United States Department of Agriculture (USDA); Cornell University	Buckler, ES (corresponding author), Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA.	esb33@cornell.edu	Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019	Buckler, Edward/0000-0002-3100-371X; Holland, James/0000-0002-4341-9675; Flint-Garcia, Sherry/0000-0003-4156-5318	US National Science Foundation [DBI-0820619, 0321467, 0703908, 0638566]; USDA-ARS; Division Of Integrative Organismal Systems [0820619] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank L. Rigamer Lirette and S. Myles for editing the manuscript. This work was supported by US National Science Foundation grants (DBI-0820619, 0321467, 0703908 and 0638566) and USDA-ARS.	BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Chopra S, 1998, MOL GEN GENET, V260, P372, DOI 10.1007/s004380050906; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; DUNCAN WG, 1971, CROP SCI, V11, P482, DOI 10.2135/cropsci1971.0011183X001100040006x; Duvick DN, 2005, MAYDICA, V50, P193; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Gilmour A., 2006, ASREML USER GUIDE RE; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Huang GJ, 2009, GENOME RES, V19, P1133, DOI 10.1101/gr.088120.108; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; LAMBERT RJ, 1978, CROP SCI, V18, P499, DOI 10.2135/cropsci1978.0011183X001800030037x; Laurie CC, 2004, GENETICS, V168, P2141, DOI 10.1534/genetics.104.029686; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Mickelson SM, 2002, CROP SCI, V42, P1902, DOI 10.2135/cropsci2002.1902; Moreno MA, 1997, GENE DEV, V11, P616, DOI 10.1101/gad.11.5.616; Palaisa KA, 2003, PLANT CELL, V15, P1795, DOI 10.1105/tpc.012526; PENDLETON JW, 1968, AGRON J, V60, P422, DOI 10.2134/agronj1968.00021962006000040027x; PEPPER GE, 1977, CROP SCI, V17, P883, DOI 10.2135/cropsci1977.0011183X001700060017x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Sinclair TR, 1999, SCIENCE, V283, P1456; Swanson-Wagner RA, 2010, GENOME RES, V20, P1689, DOI 10.1101/gr.109165.110; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Valdar W, 2009, GENETICS, V182, P1263, DOI 10.1534/genetics.109.100727; Walsh J, 1998, GENE DEV, V12, P208, DOI 10.1101/gad.12.2.208	36	690	755	7	353	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2011	43	2					159	U113		10.1038/ng.746	http://dx.doi.org/10.1038/ng.746			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	711XD	21217756				2022-12-25	WOS:000286623800016
J	Chen, ZJ; Zhao, H; He, L; Shi, YH; Qin, YY; Shi, YY; Li, ZQ; You, L; Zhao, JL; Liu, JY; Liang, XY; Zhao, XM; Zhao, JZ; Sun, YP; Zhang, B; Jiang, H; Zhao, DN; Bian, YH; Gao, XA; Geng, L; Li, YR; Zhu, DY; Sun, XQ; Xu, JE; Hao, CF; Ren, CE; Zhang, YJ; Chen, SL; Zhang, W; Yang, AJ; Yan, JH; Li, YA; Ma, JL; Zhao, YR				Chen, Zi-Jiang; Zhao, Han; He, Lin; Shi, Yuhua; Qin, Yingying; Shi, Yongyong; Li, Zhiqiang; You, Li; Zhao, Junli; Liu, Jiayin; Liang, Xiaoyan; Zhao, Xiaoming; Zhao, Junzhao; Sun, Yingpu; Zhang, Bo; Jiang, Hong; Zhao, Dongni; Bian, Yuehong; Gao, Xuan; Geng, Ling; Li, Yiran; Zhu, Dongyi; Sun, Xiuqin; Xu, Jin-e; Hao, Cuifang; Ren, Chun-e; Zhang, Yajie; Chen, Shiling; Zhang, Wei; Yang, Aijun; Yan, Junhao; Li, Yuan; Ma, Jinlong; Zhao, Yueran			Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3	NATURE GENETICS			English	Article							HORMONE RECEPTOR GENE; CHINESE WOMEN; POLYMORPHISMS; MUTATIONS; DISEASE; GLUCOSE; METAANALYSIS; PREVALENCE; PROMOTER; FAILURE	Polycystic ovary syndrome (PCOS) is a common metabolic disorder in women. To identify causative genes, we conducted a genome-wide association study (GWAS) of PCOS in Han Chinese. The discovery set included 744 PCOS cases and 895 controls; subsequent replications involved two independent cohorts (2,840 PCOS cases and 5,012 controls from northern Han Chinese; 498 cases and 780 controls from southern and central Han Chinese). We identified strong evidence of associations between PCOS and three loci: 2p16.3 (rs13405728; combined P-value by meta-analysis P-meta = 7.55 x 10(-21), odds ratio (OR) 0.71); 2p21 (rs13429458, P-meta = 1.73 x 10(-23), OR 0.67); and 9q33.3 (rs2479106, P-meta = 8.12 x 10(-19), OR 1.34). These findings provide new insight into the pathogenesis of PCOS. Follow-up studies of the candidate genes in these regions are recommended.	[Chen, Zi-Jiang; Zhao, Han; Shi, Yuhua; Qin, Yingying; You, Li; Bian, Yuehong; Gao, Xuan; Geng, Ling; Yan, Junhao; Li, Yuan; Ma, Jinlong; Zhao, Yueran] Shandong Univ, Shandong Prov Hosp, Ctr Reprod Med, Jinan 250100, Shandong, Peoples R China; [Chen, Zi-Jiang; Zhao, Han; Shi, Yuhua; Qin, Yingying; You, Li; Bian, Yuehong; Gao, Xuan; Geng, Ling; Yan, Junhao; Li, Yuan; Ma, Jinlong; Zhao, Yueran] Shandong Key Lab Reprod Med, Jinan, Shandong, Peoples R China; [He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [He, Lin; Shi, Yongyong; Li, Zhiqiang] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Ctr, Shanghai 200030, Peoples R China; [He, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Zhao, Junli] Ningxia Med Univ, Affiliated Hosp, Ningxia, Peoples R China; [Liu, Jiayin] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Liang, Xiaoyan] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Guangdong, Peoples R China; [Zhao, Xiaoming] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai 200030, Peoples R China; [Zhao, Junzhao] Wenzhou Med Coll, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China; [Sun, Yingpu] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China; [Zhang, Bo] Maternal & Child Hlth Hosp Guangxi, Guangxi, Peoples R China; [Zhao, Dongni] China Med Univ, Shengjing Hosp, Liaoning, Peoples R China; [Li, Yiran] Qingdao Women & Children Med Healthcare Ctr, Qingdao, Shandong, Peoples R China; [Li, Yiran; Ren, Chun-e] Affiliated Hosp, Weifang Med Coll, Weifang, Shandong, Peoples R China; [Zhu, Dongyi] Linyi Peoples Hosp, Linyi, Shandong, Peoples R China; [Sun, Xiuqin] Shandong Jingning First Peoples Hosp, Jingning, Shandong, Peoples R China; [Xu, Jin-e] Qingdao Univ, Coll Med, Affiliated Hosp, Qingdao, Shandong, Peoples R China; [Hao, Cuifang] Yantai Yuhuangding Hosp, Yantai, Shandong, Peoples R China; [Zhang, Yajie] Jinan Hlth Inst Matern & Infant, Jinan, Shandong, Peoples R China; [Chen, Shiling] Nanfang Hosp, Nanfang, Guangdong, Peoples R China; [Zhang, Wei] Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China; [Yang, Aijun] Jining Med Coll, Affiliated Hosp, Jining, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Fudan University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Ningxia Medical University; Nanjing Medical University; Sun Yat Sen University; Shanghai Jiao Tong University; Wenzhou Medical University; Zhengzhou University; Weifang Medical University; Qingdao University; Southern Medical University - China; Fudan University; Jining Medical University	Chen, ZJ (corresponding author), Shandong Univ, Shandong Prov Hosp, Ctr Reprod Med, Jinan 250100, Shandong, Peoples R China.	zjchen59@yahoo.com; shiyongyong@gmail.com	Li, Yuan/GXV-1310-2022; Yan, Junhao/AAH-8310-2019; liang, xiaoyan/GYJ-5006-2022; Li, Zhiqiang/AAI-4003-2021; Shi, Yongyong/GSO-1627-2022; Chen, Zi-Jiang/GOE-6119-2022	Li, Zhiqiang/0000-0002-0174-9254; Shi, Yongyong/0000-0003-1710-1505; Chen, Zi-Jiang/0000-0001-6637-6631	National Basic Research Program of China (973 Program) [2006CB944004, 2010CB945000, 2007CB947403, 2007CB914703, 2007CB947300, 2010CB529600]; National 863 Project of China [2006AA02A407, 2009AA022701]; National Natural Science Foundation of China [30973170]; Shanghai Municipal Commission of Science and Technology [09DJ1400601]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National 863 Project of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Science and Technology	We thank all participants involved in this study. We thank J. Simpson for revising this manuscript and X. Xu, X. Xing, T. Li, M. Guo, L. Cui, Q. Zheng, C. Li, J. Zhang, D. Wu, C. Zhang, X. Yan, W. He, Y. Cui, M. Xia, J. Li, P. Wang, H. Lv, S. Xu and L. Wang for subject recruitment. This study was supported by grants from the National Basic Research Program of China (973 Program-2006CB944004, 2010CB945000, 2007CB947403, 2007CB914703, 2007CB947300, 2010CB529600), the National 863 Project of China grants (2006AA02A407, 2009AA022701), the National Natural Science Foundation of China (30973170) and the Shanghai Municipal Commission of Science and Technology Program (09DJ1400601).	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Carmina E, 2009, CLIMACTERIC, V12, P22, DOI 10.1080/13697130903003842; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chen Zi-jiang, 2004, Zhonghua Fu Chan Ke Za Zhi, V39, P582; Del Villar K, 2004, P NATL ACAD SCI USA, V101, P4210, DOI 10.1073/pnas.0307349101; Drieschner N, 2006, THYROID, V16, P1091, DOI 10.1089/thy.2006.16.1091; Du J, 2010, MOL GENET METAB, V100, P292, DOI 10.1016/j.ymgme.2010.03.018; Ehrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141; Espinos-Gomez JJ, 2009, GYNECOL ENDOCRINOL, V25, P199, DOI 10.1080/09513590802585597; FERRIMAN D, 1961, J CLIN ENDOCR METAB, V21, P1440, DOI 10.1210/jcem-21-11-1440; Goodarzi MO, 2006, BEST PRACT RES CL EN, V20, P193, DOI 10.1016/j.beem.2006.02.005; Hu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007643; Huang M, 2006, INT J MOL MED, V17, P599; Kandaraki E, 2009, ARQ BRAS ENDOCRINOL, V53, P227, DOI 10.1590/S0004-27302009000200014; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kulshreshtha B, 2008, GYNECOL ENDOCRINOL, V24, P637, DOI 10.1080/09513590802342858; Latronico AC, 2000, CLIN ENDOCRINOL, V53, P609, DOI 10.1046/j.1365-2265.2000.01135.x; Latronico AC, 1998, MOL ENDOCRINOL, V12, P442, DOI 10.1210/me.12.3.442; MANTEL N, 1959, J NATL CANCER I, V22, P719; Olszanecka-Glinianowicz M, 2007, EUR J OBSTET GYN R B, V133, P197, DOI 10.1016/j.ejogrb.2006.10.037; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Radziuk J, 2000, J CLIN ENDOCR METAB, V85, P4426, DOI 10.1210/jc.85.12.4426; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shi YH, 2008, FERTIL STERIL, V90, P1139, DOI 10.1016/j.fertnstert.2007.07.1375; Shi YH, 2007, NEUROENDOCRINOL LETT, V28, P807; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Sudo S, 2002, MOL HUM REPROD, V8, P893, DOI 10.1093/molehr/8.10.893; Thomas G, 2004, ELECTROPHORESIS, V25, P1668, DOI 10.1002/elps.200405886; Toledo SPA, 1996, J CLIN ENDOCR METAB, V81, P3850, DOI 10.1210/jc.81.11.3850; Tong Y, 2001, HORM METAB RES, V33, P221, DOI 10.1055/s-2001-14941; Valkenburg O, 2009, HUM REPROD, V24, P2014, DOI 10.1093/humrep/dep113; Villuendas G, 2002, J CLIN ENDOCR METAB, V87, P1134, DOI 10.1210/jc.87.3.1134; Wang Y, 2006, FERTIL STERIL, V86, P223, DOI 10.1016/j.fertnstert.2005.12.037; Wild Sarah, 2000, Hum Fertil (Camb), V3, P101, DOI 10.1080/1464727002000198781; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yi P, 2009, PRENATAL DIAG, V29, P217, DOI 10.1002/pd.2072; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	39	474	512	3	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2011	43	1					55	U75		10.1038/ng.732	http://dx.doi.org/10.1038/ng.732			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	699SQ	21151128				2022-12-25	WOS:000285683500016
J	Zhang, ZH; Tan, MJ; Xie, ZY; Dai, LZ; Chen, Y; Zhao, YM				Zhang, Zhihong; Tan, Minjia; Xie, Zhongyu; Dai, Lunzhi; Chen, Yue; Zhao, Yingming			Identification of lysine succinylation as a new post-translational modification	NATURE CHEMICAL BIOLOGY			English	Article							DEFICIENCY; PROPIONYLATION; BUTYRYLATION; ACETYLATION; HISTONES; SOFTWARE	Of the 20 ribosomally coded amino acid residues, lysine is the most frequently post-translationally modified, which has important functional and regulatory consequences. Here we report the identification and verification of a previously unreported form of protein post-translational modification (PTM): lysine succinylation. The succinyllysine residue was initially identified by mass spectrometry and protein sequence alignment. The identified succinyllysine peptides derived from in vivo proteins were verified by western blot analysis, in vivo labeling with isotopic succinate, MS/MS and HPLC coelution of their synthetic counterparts. We further show that lysine succinylation is evolutionarily conserved and that this PTM responds to different physiological conditions. Our study also implies that succinyl-CoA might be a cofactor for lysine succinylation. Given the apparent high abundance of lysine succinylation and the significant structural changes induced by this PTM, it is expected that lysine succinylation has important cellular functions.	[Zhang, Zhihong; Tan, Minjia; Xie, Zhongyu; Dai, Lunzhi; Chen, Yue; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	University of Chicago	Zhao, YM (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	yingming.zhao@uchicago.edu	Tan, Minjia/C-4491-2014; zhang, zh/GWV-4677-2022	Tan, Minjia/0000-0002-6784-9653; Dai, Lunzhi/0000-0002-3003-8910; Xie, Zhongyu/0000-0001-5394-8282	US National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA126832] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Z. Cheng and Z. Wang for their assistance during the course of this study. This work was supported by US National Institutes of Health grants to Y.Z.	ALLIS CD, 1985, P NATL ACAD SCI USA, V82, P8048, DOI 10.1073/pnas.82.23.8048; Bandeira N, 2007, P NATL ACAD SCI USA, V104, P6140, DOI 10.1073/pnas.0701130104; BERGMEYER HU, 1974, METHOD ENZYMAT AN, P624; Berry GT, 2001, J INHERIT METAB DIS, V24, P587, DOI 10.1023/A:1012419911789; BONNEFONT JP, 1992, J PEDIATR-US, V121, P255, DOI 10.1016/S0022-3476(05)81199-0; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Chen Y, 2009, P NATL ACAD SCI USA, V106, P761, DOI 10.1073/pnas.0811739106; Cheng ZY, 2009, MOL CELL PROTEOMICS, V8, P45, DOI 10.1074/mcp.M800224-MCP200; Hake S B, 2007, Br J Cancer, V96 Suppl, pR31; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; NELSON DL, 2005, LEHNINGER PRINCIPLES, P200; Norris KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.297pe76; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Ostergaard E, 2008, J INHERIT METAB DIS, V31, P226, DOI 10.1007/s10545-008-0828-7; Sadygov RG, 2004, NAT METHODS, V1, P195, DOI 10.1038/NMETH725; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang K, 2009, J PROTEOME RES, V8, P900, DOI 10.1021/pr8005155	23	535	568	12	225	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2011	7	1					58	63		10.1038/NCHEMBIO.495	http://dx.doi.org/10.1038/NCHEMBIO.495			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	695PA	21151122	Green Accepted			2022-12-25	WOS:000285383400013
J	Kritzer, JA				Kritzer, Joshua A.			Beyond discovery: probes that see, grab and poke	NATURE CHEMICAL BIOLOGY			English	Article							CHEMICAL GENETICS; IN-VIVO; CHEMISTRY; PEPTIDES; BIOLOGY	Chemical biology is now able to discover molecules that manipulate virtually any biological target or process. It remains a grand challenge to leverage these molecules into useful probes that can be used to address unsolved problems in biology.	Tufts Univ, Dept Chem, Medford, MA 02155 USA	Tufts University	Kritzer, JA (corresponding author), Tufts Univ, Dept Chem, Medford, MA 02155 USA.	joshua.kritzer@tufts.edu						Ahn YH, 2007, ACCOUNTS CHEM RES, V40, P1025, DOI 10.1021/ar700030k; Behlke MA, 2006, MOL THER, V13, P644, DOI 10.1016/j.ymthe.2006.01.001; Burdine L, 2004, CHEM BIOL, V11, P593, DOI 10.1016/j.chembiol.2004.05.001; Chang PV, 2010, P NATL ACAD SCI USA, V107, P1821, DOI 10.1073/pnas.0911116107; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Kritzer JA, 2009, NAT CHEM BIOL, V5, P655, DOI 10.1038/nchembio.193; Lee LW, 2010, J BIOL CHEM, V285, P11033, DOI 10.1074/jbc.R109.075044; McNaughton BR, 2009, P NATL ACAD SCI USA, V106, P6111, DOI 10.1073/pnas.0807883106; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Nielsen TE, 2008, ANGEW CHEM INT EDIT, V47, P48, DOI 10.1002/anie.200703073; Oprea TI, 2007, NAT CHEM BIOL, V3, P447, DOI 10.1038/nchembio0807-447; Pollock R, 2002, CURR OPIN BIOTECH, V13, P459, DOI 10.1016/S0958-1669(02)00373-7; Raina K, 2010, J BIOL CHEM, V285, P11057, DOI 10.1074/jbc.R109.078105; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Rothman DM, 2005, TRENDS CELL BIOL, V15, P502, DOI 10.1016/j.tcb.2005.07.003; Stewart KM, 2008, ORG BIOMOL CHEM, V6, P2242, DOI 10.1039/b719950c; Terreno E, 2010, CHEM REV, V110, P3019, DOI 10.1021/cr100025t; Vegas AJ, 2008, CHEM SOC REV, V37, P1385, DOI 10.1039/b703568n; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walsh DP, 2006, CHEM REV, V106, P2476, DOI 10.1021/cr0404141	20	6	6	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					868	870		10.1038/nchembio.469	http://dx.doi.org/10.1038/nchembio.469			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079592				2022-12-25	WOS:000284214700008
J	Herker, E; Harris, C; Hernandez, C; Carpentier, A; Kaehlcke, K; Rosenberg, AR; Farese, RV; Ott, M				Herker, Eva; Harris, Charles; Hernandez, Celine; Carpentier, Arnaud; Kaehlcke, Katrin; Rosenberg, Arielle R.; Farese, Robert V., Jr.; Ott, Melanie			Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1	NATURE MEDICINE			English	Article							LIPID DROPLETS; CORE PROTEIN; CELL-CULTURE; VIRAL GENOME; REPLICATION; LOCALIZATION; SECRETION; DGAT; MICE	Hepatitis C virus (HCV) infection is closely tied to the lipid metabolism of liver cells. Here we identify the triglyceride-synthesizing enzyme diacylglycerol acyltransferase-1 (DGAT1) as a key host factor for HCV infection. DGAT1 interacts with the viral nucleocapsid core and is required for the trafficking of core to lipid droplets. Inhibition of DGAT1 activity or RNAi-mediated knockdown of DGAT1 severely impairs infectious virion production, implicating DGAT1 as a new target for antiviral therapy.	[Herker, Eva; Kaehlcke, Katrin; Ott, Melanie] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA; [Herker, Eva; Harris, Charles; Farese, Robert V., Jr.; Ott, Melanie] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA; [Herker, Eva; Harris, Charles; Farese, Robert V., Jr.; Ott, Melanie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Harris, Charles; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Hernandez, Celine; Carpentier, Arnaud; Rosenberg, Arielle R.] Univ Paris 05, EA Virol Hepatite C 4474, Paris, France; [Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Francisco	Ott, M (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA.	mott@gladstone.ucsf.edu	Herker, Eva/AAQ-1944-2021; Herker, Eva/B-9699-2014	Herker, Eva/0000-0001-9644-2484; Carpentier, Arnaud/0000-0002-6994-4689; Rosenberg, Arielle/0000-0003-2085-8146; Ott, Melanie/0000-0002-5697-1274	Gladstone Institutes; Hellman Family Foundation; US National Institutes of Health [R03 AI069090, R01 DK056084, P30 DK026743]; Human Frontiers Science Program; Agence nationale de recherches sur le sida et les hepatites virales; US National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI069090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, R01DK056084] Funding Source: NIH RePORTER	Gladstone Institutes(University of California System); Hellman Family Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Agence nationale de recherches sur le sida et les hepatites virales(ANRSFrench National Research Agency (ANR)); US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. Yen (University of North Carolina-Chapel Hill) for Sf9 cell lysates, R. Bartenschlager (University of Heidelberg) for Luc-Jc1, Luc-JFH1, Jc1 constructs and Huh7 Lunet cells, C. M. Rice (Rockefeller University) for Huh7.5 cells, F.V. Chisari (Scripps Research Institute) for Huh7.5.1 cells, J. McLauchlan (Medical Research Council Virology Unit) for JFH1, JFH1 GND and JFH1 Delta E1E2, T. Wakita (National Institute of Infectious Diseases, Japan) for the JFH1 construct and M. Spindler (Gladstone Institute of Cardiovascular Disease) for the pSicoRMS. We thank the members of the Ott and Farese laboratories for support. This work was supported by funds from the Gladstone Institutes, the Hellman Family Foundation (M.O.) and the US National Institutes of Health (R03 AI069090 (M.O.); R01 DK056084 (R.V.F. Jr.); P30 DK026743 (University of California-San Francisco Liver Center)). We gratefully acknowledge support through fellowships from the Human Frontiers Science Program (E.H.), the Agence nationale de recherches sur le sida et les hepatites virales (C. Hernandez and A.C.), and a training grant from the US National Institute of Diabetes and Digestive and Kidney Diseases (C. Harris).	Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; Roingeard P, 2008, HISTOCHEM CELL BIOL, V130, P561, DOI 10.1007/s00418-008-0447-2; SELBY MJ, 1993, J GEN VIROL, V74, P1103, DOI 10.1099/0022-1317-74-6-1103; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Targett-Adams P, 2008, J VIROL, V82, P2182, DOI 10.1128/JVI.01565-07; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	20	237	248	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1295	1298		10.1038/nm.2238	http://dx.doi.org/10.1038/nm.2238			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	20935628	Green Accepted, Green Submitted			2022-12-25	WOS:000283860100041
J	Lai, JS; Li, RQ; Xu, X; Jin, WW; Xu, ML; Zhao, HN; Xiang, ZK; Song, WB; Ying, K; Zhang, M; Jiao, YP; Ni, PX; Zhang, JG; Li, D; Guo, XS; Ye, KX; Jian, M; Wang, B; Zheng, HS; Liang, HQ; Zhang, XQ; Wang, SC; Chen, SJ; Li, JS; Fu, Y; Springer, NM; Yang, HM; Wang, JA; Dai, JR; Schnable, PS; Wang, J				Lai, Jinsheng; Li, Ruiqiang; Xu, Xun; Jin, Weiwei; Xu, Mingliang; Zhao, Hainan; Xiang, Zhongkai; Song, Weibin; Ying, Kai; Zhang, Mei; Jiao, Yinping; Ni, Peixiang; Zhang, Jianguo; Li, Dong; Guo, Xiaosen; Ye, Kaixiong; Jian, Min; Wang, Bo; Zheng, Huisong; Liang, Huiqing; Zhang, Xiuqing; Wang, Shoucai; Chen, Shaojiang; Li, Jiansheng; Fu, Yan; Springer, Nathan M.; Yang, Huanming; Wang, Jian; Dai, Jingrui; Schnable, Patrick S.; Wang, Jun			Genome-wide patterns of genetic variation among elite maize inbred lines	NATURE GENETICS			English	Article							SSP MAYS L.; DIVERSITY; SEQUENCE; ARABIDOPSIS; RECOMBINATION; POLYMORPHISMS; CHROMOSOME-1; SELECTION; WHOLE	We have resequenced a group of six elite maize inbred lines, including the parents of the most productive commercial hybrid in China. This effort uncovered more than 1,000,000 SNPs, 30,000 indel polymorphisms and 101 low-sequence-diversity chromosomal intervals in the maize genome. We also identified several hundred complete genes that show presence/absence variation among these resequenced lines. We discuss the potential roles of complementation of presence/absence variations and other deleterious mutations in contributing to heterosis. High-density SNP and indel polymorphism markers reported here are expected to be a valuable resource for future genetic studies and the molecular breeding of this important crop.	[Lai, Jinsheng; Zhao, Hainan; Xiang, Zhongkai; Song, Weibin; Zhang, Mei; Jiao, Yinping] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Lai, Jinsheng; Jin, Weiwei; Xu, Mingliang; Zhao, Hainan; Xiang, Zhongkai; Song, Weibin; Zhang, Mei; Jiao, Yinping; Wang, Shoucai; Chen, Shaojiang; Li, Jiansheng; Dai, Jingrui] China Agr Univ, Natl Maize Improvement Ctr, Beijing 100094, Peoples R China; [Li, Ruiqiang; Xu, Xun; Ni, Peixiang; Zhang, Jianguo; Li, Dong; Guo, Xiaosen; Ye, Kaixiong; Jian, Min; Wang, Bo; Zheng, Huisong; Liang, Huiqing; Zhang, Xiuqing; Yang, Huanming; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Ying, Kai; Fu, Yan; Schnable, Patrick S.] Iowa State Univ, Ctr Plant Genom, Ames, IA USA; [Springer, Nathan M.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	China Agricultural University; China Agricultural University; Beijing Genomics Institute (BGI); Iowa State University; University of Minnesota System; University of Minnesota Twin Cities; University of Copenhagen	Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Peoples R China.	jlai@cau.edu.cn; schnable@iastate.edu; wangj@genomics.cn	Springer, Nathan/F-2680-2013; wang, jian/GVS-0711-2022; Ye, Kaixiong/C-2297-2017; Xu, Xun/AAI-6763-2020; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Springer, Nathan/0000-0002-7301-4759; Ye, Kaixiong/0000-0003-4658-7292; Xu, Xun/0000-0002-5338-5173; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; Zhang, Jianguo/0000-0003-0723-1701; Schnable, Patrick/0000-0001-9169-5204	973 program [2009CB118400, 2007CB815703, 2007CB815705, 2007CB109000]; 863 project [2010AA10A106]; National Natural Science Foundation of China [30725008]; Shenzhen Bureau of Science Technology AMP; Information, China [ZYC200903240077A, CXB200903110066A]; Chinese Academy of Science [GJHZ0701-6]; Danish Natural Science Research Council; US National Science Foundation [DBI-0527192]	973 program(National Basic Research Program of China); 863 project(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Bureau of Science Technology AMP; Information, China; Chinese Academy of Science(Chinese Academy of Sciences); Danish Natural Science Research Council(Danish Natural Science Research Council); US National Science Foundation(National Science Foundation (NSF))	Supported by the 973 program (2009CB118400; 2007CB815703; 2007CB815705; 2007CB109000), the 863 project (2010AA10A106), the National Natural Science Foundation of China (30725008), the Shenzhen Bureau of Science Technology & Information, China (ZYC200903240077A; CXB200903110066A), the Chinese Academy of Science (GJHZ0701-6), the Ole Romer grant from the Danish Natural Science Research Council and the US National Science Foundation (DBI-0527192). We thank L. Goodman for editing the manuscript.	Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Everitt B S, 1996, Stat Methods Med Res, V5, P107, DOI 10.1177/096228029600500202; Fu HH, 2002, P NATL ACAD SCI USA, V99, P9573, DOI 10.1073/pnas.132259199; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Grant MR, 1998, P NATL ACAD SCI USA, V95, P15843, DOI 10.1073/pnas.95.26.15843; Lai JS, 2005, P NATL ACAD SCI USA, V102, P9068, DOI 10.1073/pnas.0502923102; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Messing J, 2004, P NATL ACAD SCI USA, V101, P14349, DOI 10.1073/pnas.0406163101; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Springer NM, 2007, GENOME RES, V17, P264, DOI 10.1101/gr.5347007; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; TAJIMA F, 1983, GENETICS, V105, P437; Tenaillon MI, 2002, GENETICS, V162, P1401; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Whitelaw CA, 2003, SCIENCE, V302, P2118, DOI 10.1126/science.1090047; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620	32	327	369	3	175	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					1027	+		10.1038/ng.684	http://dx.doi.org/10.1038/ng.684			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20972441				2022-12-25	WOS:000283540500024
J	Watanabe, R; Iino, R; Noji, H				Watanabe, Rikiya; Iino, Ryota; Noji, Hiroyuki			Phosphate release in F-1-ATPase catalytic cycle follows ADP release	NATURE CHEMICAL BIOLOGY			English	Article							TEMPERATURE-SENSITIVE REACTION; SINGLE-MOLECULE; ATP SYNTHESIS; F-1 MOTOR; MECHANISM; ROTATION; SYNTHASE; SITE; RESOLUTION; SUBUNITS	F-1-ATPase is an ATP-driven rotary motor protein in which the gamma-subunit rotates against the catalytic stator ring. Although the reaction scheme of F-1 has mostly been revealed, the timing of inorganic phosphate (P-i) release remains controversial. Here we addressed this issue by verifying the reversibility of ATP hydrolysis on arrested F-1 with magnetic tweezers. ATP hydrolysis was found to be essentially reversible, implying that P-i is released after the gamma rotation and ADP release, although extremely slow P-i release was found at the ATP hydrolysis angle as an uncoupling side reaction. On the basis of this finding, we deduced the chemomechanical coupling scheme of F-1. We found that the affinity for P-i was strongly angle dependent, implying a large contribution by P-i release to torque generation. These findings imply that under ATP synthesis conditions, P-i binds to an empty catalytic site, preventing solution ATP (though not ADP) from binding. Thus, this supports the concept of selective ADP binding for efficient ATP synthesis.	[Watanabe, Rikiya; Iino, Ryota; Noji, Hiroyuki] Osaka Univ, Inst Sci & Ind Res, Osaka, Japan; [Noji, Hiroyuki] Univ Tokyo, Sch Engn, Dept Appl Chem, Tokyo, Japan	Osaka University; University of Tokyo	Watanabe, R (corresponding author), Osaka Univ, Inst Sci & Ind Res, Osaka, Japan.	hnoji@sanken.osaka-u.ac.jp	Watanabe, Rikiya/AAO-1390-2021; Iino, Ryota/B-7746-2011	Watanabe, Rikiya/0000-0001-7146-2745; Iino, Ryota/0000-0003-0110-5704	Ministry of Education, Culture, Sports, Science and Technology, Japan [18074005]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank K. Hayashi for critical discussion, H. Ueno for sample preparation and all members of Noji laboratory for technical support. This work was partially supported by the Grant-in-Aid for Scientific Research No. 18074005 to H.N. and by special education and research expenses (to H.N.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Ahmad Z, 2005, J BIOENERG BIOMEMBR, V37, P437, DOI 10.1007/s10863-005-9486-8; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Braig K, 2000, STRUCTURE, V8, P567, DOI 10.1016/S0969-2126(00)00145-3; Dong K, 2002, J BIOL CHEM, V277, P9540, DOI 10.1074/jbc.M106911200; Enoki S, 2009, J BIOL CHEM, V284, P23169, DOI 10.1074/jbc.M109.026401; GRUBMEYER C, 1982, J BIOL CHEM, V257, P2092; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Iko Y, 2009, FEBS LETT, V583, P3187, DOI 10.1016/j.febslet.2009.08.042; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; Masaike T, 2002, J BIOL CHEM, V277, P21643, DOI 10.1074/jbc.M110297200; Masaike T, 2008, NAT STRUCT MOL BIOL, V15, P1326, DOI 10.1038/nsmb.1510; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; OHTSUBO M, 1987, BIOCHEM BIOPH RES CO, V146, P705, DOI 10.1016/0006-291X(87)90586-9; Okuno D, 2008, P NATL ACAD SCI USA, V105, P20722, DOI 10.1073/pnas.0805828106; Ono S, 2003, BBA-BIOENERGETICS, V1607, P35, DOI 10.1016/j.bbabio.2003.08.006; PARK MY, 1994, J BIOCHEM-TOKYO, V116, P1139, DOI 10.1093/oxfordjournals.jbchem.a124640; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Shimo-Kon R, 2010, BIOPHYS J, V98, P1227, DOI 10.1016/j.bpj.2009.11.050; Ueno H, 2010, BIOPHYS J, V98, P2014, DOI 10.1016/j.bpj.2010.01.011; Watanabe R, 2008, EMBO REP, V9, P84, DOI 10.1038/sj.embor.7401135; Weber J, 1996, J BIOL CHEM, V271, P18711, DOI 10.1074/jbc.271.31.18711; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; YOUNT RG, 1995, BIOPHYS J, V68, pS44	35	113	113	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2010	6	11					814	820		10.1038/NCHEMBIO.443	http://dx.doi.org/10.1038/NCHEMBIO.443			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	667MP	20871600				2022-12-25	WOS:000283197800010
J	Yu, TW; Mochida, GH; Tischfield, DJ; Sgaier, SK; Flores-Sarnat, L; Sergi, CM; Topcu, M; McDonald, MT; Barry, BJ; Felie, JM; Sunu, C; Dobyns, WB; Folkerth, RD; Barkovich, AJ; Walsh, CA				Yu, Timothy W.; Mochida, Ganeshwaran H.; Tischfield, David J.; Sgaier, Sema K.; Flores-Sarnat, Laura; Sergi, Consolato M.; Topcu, Meral; McDonald, Marie T.; Barry, Brenda J.; Felie, Jillian M.; Sunu, Christine; Dobyns, William B.; Folkerth, Rebecca D.; Barkovich, A. James; Walsh, Christopher A.			Mutations in WDR62, encoding a centrosome-associated protein, cause microcephaly with simplified gyri and abnormal cortical architecture	NATURE GENETICS			English	Article							CHROMOSOME SEGREGATION; SPINDLE; GENE; ASPM; CDK5RAP2; LOCUS; LIS1	Genes associated with human microcephaly, a condition characterized by a small brain, include critical regulators of proliferation, cell fate and DNA repair. We describe a syndrome of congenital microcephaly and diverse defects in cerebral cortical architecture. Genome-wide linkage analysis in two families identified a 7.5-Mb locus on chromosome 19q13.12 containing 148 genes. Targeted high throughput sequence analysis of linked genes in each family yielded > 4,000 DNA variants and implicated a single gene, WDR62, as harboring potentially deleterious changes. We subsequently identified additional WDR62 mutations in four other families. Magnetic resonance imaging and postmortem brain analysis supports important roles for WDR62 in the proliferation and migration of neuronal precursors. WDR62 is a WD40 repeat-containing protein expressed in neuronal precursors as well as in postmitotic neurons in the developing brain and localizes to the spindle poles of dividing cells. The diverse phenotypes of WDR62 suggest it has central roles in many aspects of cerebral cortical development.	[Yu, Timothy W.; Mochida, Ganeshwaran H.; Tischfield, David J.; Sgaier, Sema K.; Barry, Brenda J.; Felie, Jillian M.; Sunu, Christine; Walsh, Christopher A.] Childrens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Yu, Timothy W.; Mochida, Ganeshwaran H.; Tischfield, David J.; Sgaier, Sema K.; Barry, Brenda J.; Felie, Jillian M.; Sunu, Christine; Walsh, Christopher A.] Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Yu, Timothy W.; Mochida, Ganeshwaran H.; Tischfield, David J.; Sgaier, Sema K.; Barry, Brenda J.; Felie, Jillian M.; Sunu, Christine; Walsh, Christopher A.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Yu, Timothy W.; Mochida, Ganeshwaran H.; Tischfield, David J.; Sgaier, Sema K.; Barry, Brenda J.; Felie, Jillian M.; Sunu, Christine; Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Yu, Timothy W.; Mochida, Ganeshwaran H.; Walsh, Christopher A.] MIT, Broad Inst, Cambridge, MA 02139 USA; [Yu, Timothy W.; Mochida, Ganeshwaran H.] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp,Div Child Neurol, Boston, MA 02115 USA; [Sgaier, Sema K.] Bill & Melinda Gates Fdn, New Delhi, India; [Flores-Sarnat, Laura] Univ Calgary, Fac Med, Alberta Childrens Hosp, Dept Clin Neurosci,Div Paediat Neurol, Calgary, AB, Canada; [Sergi, Consolato M.] Univ Alberta Hosp, Dept Lab Med & Pathol, Walter Mackenzie Hlth Sci Ctr, Edmonton, AB T6G 2R7, Canada; [Sergi, Consolato M.] Med Univ Innsbruck, Inst Pathol, Innsbruck, Austria; [Topcu, Meral] Hacettepe Univ, Fac Med, Ihsan Dogramaci Childrens Hosp, Dept Pediat,Sect Pediat Neurol, TR-06100 Ankara, Turkey; [McDonald, Marie T.] Duke Univ, Dept Pediat, Div Med Genet, Durham, NC 27706 USA; [Dobyns, William B.] Univ Washington, Div Genet, Seattle, WA 98195 USA; [Folkerth, Rebecca D.] Brigham & Womens Hosp, Div Neuropathol, Boston, MA 02115 USA; [Barkovich, A. James] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Alberta Childrens Hospital; University of Calgary; University of Alberta; Medical University of Innsbruck; Hacettepe University; Duke University; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco	Walsh, CA (corresponding author), Childrens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu	Yu, Timothy W./AAF-5738-2019; Dobyns, William/AAI-2768-2020; Dobyns, William Brian/ABC-6525-2021; Sergi, Consolato/A-1126-2009	Yu, Timothy W./0000-0003-2988-7701; Dobyns, William/0000-0002-7681-2844; Sergi, Consolato/0000-0002-2779-7879; Walsh, Christopher/0000-0002-0156-2238; Mochida, Ganeshwaran/0000-0001-7912-4097; Tischfield, David/0000-0002-1338-2517	US National Institutes of Health (NIH) [P30-HD-18655]; Fidelity Foundation; NIH [T32 NS007484-08, HHSN268200782096C, N01-HG-65403]; Harvard- Massachusetts Institute of Technology Health Sciences and Technology; Beth Israel Deaconess Medical Center; Pfizer, Inc; Merck and Company, Inc.; Nancy Lurie Marks; National Alliance for Research on Schizophrenia and Depression (NARSAD); National Institute of Neurological Disorders and Stroke (NINDS) [RO1 NSR01-35129]; Fogarty International Center [R21 NS061772]; Dubai Harvard Foundation for Medical Research; Manton Center for Orphan Disease Research; Intellectual and Developmental Disabilities Research Centers [CHB DDRC, P30 HD18655]; National Human Genome Research Institute (NHGRI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R21TW008223] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001032] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007484, R01NS035129, R01NS032457] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fidelity Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard- Massachusetts Institute of Technology Health Sciences and Technology; Beth Israel Deaconess Medical Center; Pfizer, Inc(Pfizer); Merck and Company, Inc.(Merck & Company); Nancy Lurie Marks; National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Dubai Harvard Foundation for Medical Research; Manton Center for Orphan Disease Research; Intellectual and Developmental Disabilities Research Centers; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the many families and researchers who participated in this study; B. Chang and A. Poduri for expert review of MRI imaging findings; S. Lizarraga for contributions to genetic mapping; M. Aita and the In situ Hybridization Core Facility, University of North Carolina Neuroscience Center, Chapel Hill, North Carolina for performing in situ hybridizations; C. G. Woods for helpful discussions and for sharing data before publication; A. von Deimling from the Institut fur Pathologie, Heidelberg, for sectioning of the LIS-2601 brain; A. Nicholas and M. Khurshid for advice regarding immunohistochemistry; A. Hill and L. Bu at the MRDDRC (Mental Retardation Developmental Disability Research Center) Imaging Core for assistance with confocal microscopy (US National Institutes of Health (NIH) grant P30-HD-18655 and Fidelity Foundation); and R. Sean Hill for assistance with linkage analysis and helpful discussions. We are indebted to the members of the Microcephaly Collaborative (Supplementary Table 1) for contributing to the cohort from which these families were drawn. T.W.Y. was supported by a NIH T32 grant (T32 NS007484-08), the Clinical Investigator Training Program (CITP) at Harvard- Massachusetts Institute of Technology Health Sciences and Technology and Beth Israel Deaconess Medical Center in collaboration with Pfizer, Inc. and Merck and Company, Inc., and the Nancy Lurie Marks Junior Faculty MeRIT Fellowship. G.H.M. was supported by the Young Investigator Award of National Alliance for Research on Schizophrenia and Depression (NARSAD) as a NARSAD Lieber Investigator. Research was supported by grants from the National Institute of Neurological Disorders and Stroke (NINDS) (RO1 NSR01-35129) and the Fogarty International Center (R21 NS061772) to C. A. W., the Dubai Harvard Foundation for Medical Research and the Manton Center for Orphan Disease Research. Genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is funded through a federal contract from the NIH to Johns Hopkins University, contract number HHSN268200782096C and NIH N01-HG-65403. Genotyping at Children's Hospital Boston was supported by the Intellectual and Developmental Disabilities Research Centers (CHB DDRC, P30 HD18655). Genotyping at the Broad Institute was supported by National Human Genome Research Institute (NHGRI). C.A.W. is an investigator of the Howard Hughes Medical Institute.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gul A, 2006, NEUROGENETICS, V7, P105, DOI 10.1007/s10048-006-0042-4; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kouprina N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/hmg/ddi220; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Major JE, 2007, BIOINFORMATICS, V23, P3091, DOI 10.1093/bioinformatics/btm339; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Roberts E, 1999, EUR J HUM GENET, V7, P815, DOI 10.1038/sj.ejhg.5200385; Roberts E, 2002, J MED GENET, V39, P718, DOI 10.1136/jmg.39.10.718; Saunders RDC, 1997, J CELL BIOL, V137, P881, DOI 10.1083/jcb.137.4.881; Sergi C, 2000, PRENATAL DIAG, V20, P505; Sheen VL, 2006, ANN NEUROL, V60, P137, DOI 10.1002/ana.20843; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Tucker ES, 2008, J NEUROSCI, V28, P9504, DOI 10.1523/JNEUROSCI.2341-08.2008; van der Voet M, 2009, NAT CELL BIOL, V11, P269, DOI 10.1038/ncb1834; Wasserman T, 2010, MOL BIOL CELL, V21, P117, DOI 10.1091/mbc.E09-06-0512	30	217	225	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					1015	U145		10.1038/ng.683	http://dx.doi.org/10.1038/ng.683			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20890278	Green Published, Green Accepted			2022-12-25	WOS:000283540500022
J	Tsuchiya, Y; Vidaurre, D; Toh, S; Hanada, A; Nambara, E; Kamiya, Y; Yamaguchi, S; McCourt, P				Tsuchiya, Yuichiro; Vidaurre, Danielle; Toh, Shigeo; Hanada, Atsushi; Nambara, Eiji; Kamiya, Yuji; Yamaguchi, Shinjiro; McCourt, Peter			A small-molecule screen identifies new functions for the plant hormone strigolactone	NATURE CHEMICAL BIOLOGY			English	Article							PHYTOCHROME-CHROMOPHORE BIOSYNTHESIS; ARABIDOPSIS-THALIANA; ABSCISIC-ACID; GROWTH; COP1; PHOTOMORPHOGENESIS; INHIBITION; REGULATOR; ENCODES; RICE	Parasitic weeds of the genera Striga and Orobanche are considered the most damaging agricultural agents in the developing world. An essential step in parasitic seed germination is sensing a group of structurally related compounds called strigolactones that are released by host plants. Although this makes strigolactone synthesis and action a major target of biotechnology, little fundamental information is known about this hormone. Chemical genetic screening using Arabidopsis thaliana as a platform identified a collection of related small molecules, cotylimides, which perturb strigolactone accumulation. Suppressor screens against select cotylimides identified light-signaling genes as positive regulators of strigolactone levels. Molecular analysis showed strigolactones regulate the nuclear localization of the COP1 ubiquitin ligase, which in part determines the levels of light regulators such as HY5. This information not only uncovers new functions for strigolactones but was also used to identify rice cultivars with reduced capacity to germinate parasitic seed.	[Tsuchiya, Yuichiro; Vidaurre, Danielle; Toh, Shigeo; Nambara, Eiji; McCourt, Peter] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Vidaurre, Danielle; Nambara, Eiji; McCourt, Peter] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada; [Tsuchiya, Yuichiro; Hanada, Atsushi; Nambara, Eiji; Kamiya, Yuji; Yamaguchi, Shinjiro] RIKEN, Plant Sci Ctr, Yokohama, Kanagawa, Japan	University of Toronto; University of Toronto; RIKEN	Tsuchiya, Y (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	peter.mccourt@utoronto.ca	Toh, Shigeo/ABB-9441-2021; Kamiya, Yuji/F-9420-2010; Nambara, Eiji/E-5533-2012; Tsuchiya, Yuichiro/D-9777-2015; Toh, Shigeo/E-4438-2014; Yamaguchi, Shinjiro/F-9684-2010	Kamiya, Yuji/0000-0003-4415-520X; Tsuchiya, Yuichiro/0000-0002-4599-1069; Toh, Shigeo/0000-0002-6077-4556; 				Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davis SJ, 1999, P NATL ACAD SCI USA, V96, P6541, DOI 10.1073/pnas.96.11.6541; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Franklin KA, 2005, INT J DEV BIOL, V49, P653, DOI 10.1387/ijdb.051989kf; Gazzarrini S, 2004, DEV CELL, V7, P373, DOI 10.1016/j.devcel.2004.06.017; Goldwasser Y, 2008, PLANT GROWTH REGUL, V55, P21, DOI 10.1007/s10725-008-9253-z; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Govindarajulu M, 2005, NATURE, V435, P819, DOI 10.1038/nature03610; Humphrey AJ, 2006, NAT PROD REP, V23, P592, DOI 10.1039/b512776a; Huq E, 2004, SCIENCE, V305, P1937, DOI 10.1126/science.1099728; Izawa T, 2000, PLANT J, V22, P391, DOI 10.1046/j.1365-313X.2000.00753.x; Joel D. M., 2007, Horticultural Reviews, V33, P267, DOI 10.1002/9780470168011.ch4; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; Lopez-Raez JA, 2009, PEST MANAG SCI, V65, P471, DOI 10.1002/ps.1692; Muramoto T, 1999, PLANT CELL, V11, P335, DOI 10.1105/tpc.11.3.335; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Sakamoto T, 2006, TRANSGENIC RES, V15, P399, DOI 10.1007/s11248-006-0024-1; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Savaldi-Goldstein S, 2008, P NATL ACAD SCI USA, V105, P15190, DOI 10.1073/pnas.0806324105; Scholes JD, 2008, CURR OPIN PLANT BIOL, V11, P180, DOI 10.1016/j.pbi.2008.02.004; Seo M, 2009, PLANT MOL BIOL, V69, P463, DOI 10.1007/s11103-008-9429-y; Shen H, 2007, PLANT PHYSIOL, V145, P1471, DOI 10.1104/pp.107.107227; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Stirnberg P, 2007, PLANT J, V50, P80, DOI 10.1111/j.1365-313X.2007.03032.x; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; VONARNIM AG, 1994, CELL, V79, P1035, DOI 10.1016/0092-8674(94)90034-5; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007	34	157	163	3	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2010	6	10					741	749		10.1038/NCHEMBIO.435	http://dx.doi.org/10.1038/NCHEMBIO.435			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	651YM	20818397				2022-12-25	WOS:000281964100011
J	Antonacci, F; Kidd, JM; Marques-Bonet, T; Teague, B; Ventura, M; Girirajan, S; Alkan, C; Campbell, CD; Vives, L; Malig, M; Rosenfeld, JA; Ballif, BC; Shaffer, LG; Graves, TA; Wilson, RK; Schwartz, DC; Eichler, EE				Antonacci, Francesca; Kidd, Jeffrey M.; Marques-Bonet, Tomas; Teague, Brian; Ventura, Mario; Girirajan, Santhosh; Alkan, Can; Campbell, Catarina D.; Vives, Laura; Malig, Maika; Rosenfeld, Jill A.; Ballif, Blake C.; Shaffer, Lisa G.; Graves, Tina A.; Wilson, Richard K.; Schwartz, David C.; Eichler, Evan E.			A large and complex structural polymorphism at 16p12.1 underlies microdeletion disease risk	NATURE GENETICS			English	Article							SEGMENTAL DUPLICATIONS; MOLECULAR-MECHANISMS; GENOME ARCHITECTURE; COMMON INVERSION; DNA-SEQUENCE; DISORDERS; REARRANGEMENTS; DISCOVERY; DELETIONS; SELECTION	There is a complex relationship between the evolution of segmental duplications and rearrangements associated with human disease. We performed a detailed analysis of one region on chromosome 16p12.1 associated with neurocognitive disease and identified one of the largest structural inconsistencies in the human reference assembly. Various genomic analyses show that all examined humans are homozygously inverted relative to the reference genome for a 1.1-Mb region on 16p12.1. We determined that this assembly discrepancy stems from two common structural configurations with worldwide frequencies of 17.6% (S1) and 82.4% (S2). This polymorphism arose from the rapid integration of segmental duplications, precipitating two local inversions within the human lineage over the last 10 million years. The two human haplotypes differ by 333 kb of additional duplicated sequence present in S2 but not in S1. Notably, we show that the S2 configuration harbors directly oriented duplications, specifically predisposing this chromosome to disease-associated rearrangement.	[Antonacci, Francesca; Kidd, Jeffrey M.; Marques-Bonet, Tomas; Girirajan, Santhosh; Alkan, Can; Campbell, Catarina D.; Vives, Laura; Malig, Maika; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Marques-Bonet, Tomas] Inst Biol Evolut UPF CSIC, Barcelona, Catalonia, Spain; [Teague, Brian] Univ Wisconsin, Dept Chem, Lab Mol & Computat Genom, Genet Lab, Madison, WI 53706 USA; [Teague, Brian] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53705 USA; [Ventura, Mario; Schwartz, David C.] Univ Bari, Dept Genet & Microbiol, Bari, Italy; [Alkan, Can; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Rosenfeld, Jill A.; Ballif, Blake C.; Shaffer, Lisa G.] Signature Genom Labs, Spokane, WA USA; [Graves, Tina A.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO USA	University of Washington; University of Washington Seattle; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Universita degli Studi di Bari Aldo Moro; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Washington University (WUSTL)	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Alkan, Can/D-2982-2009; Marques-Bonet, Tomas/I-4618-2014; Antonacci, Francesca/F-5457-2013; Wilson, Richard K./AAF-4139-2019; Marques-Bonet, Tomas/ABF-3734-2020; Ventura, Mario/E-6420-2011	Alkan, Can/0000-0002-5443-0706; Marques-Bonet, Tomas/0000-0002-5597-3075; Antonacci, Francesca/0000-0002-5833-6186; Wilson, Richard K./0000-0002-1992-1358; Marques-Bonet, Tomas/0000-0002-5597-3075; Ventura, Mario/0000-0001-7762-8777; /0000-0002-9833-2817; Kidd, Jeffrey/0000-0002-9631-1465	US National Science Foundation; US National Institutes of Health [T32 GM07215, 5T15 LM007359, HG000225, HG002385]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000225, R01HG002385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007359] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank P. Sudmant for useful discussions, G. M. Cooper and T. Brown for critical review of the manuscript and L. Zhou, Y. Fu, R. Shi, J. Wu, S. Shaull and B. A. Roe for sequencing of clone AC120780. This work was supported by a US National Science Foundation Graduate Research Fellowship (to J. M. K.) and a Marie Curie fellowship (FP7 to T.M.-B.), and by the US National Institutes of Health (grants T32 GM07215 and 5T15 LM007359 to B. T., HG000225 to D. C. S. and HG002385 to E. E. E.). E. E. E. is an investigator of the Howard Hughes Medical Institute.	Antonacci F, 2009, HUM MOL GENET, V18, P2555, DOI 10.1093/hmg/ddp187; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Ballif BC, 2007, NAT GENET, V39, P1071, DOI 10.1038/ng2107; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Caceres M, 2007, P NATL ACAD SCI USA, V104, P18571, DOI 10.1073/pnas.0706604104; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; Fan JB, 2002, GENOMICS, V79, P58, DOI 10.1006/geno.2001.6676; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Hannes FD, 2009, J MED GENET, V46, P223, DOI 10.1136/jmg.2007.055202; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; Jiang ZS, 2008, GENOME RES, V18, P1362, DOI 10.1101/gr.078477.108; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Kehrer-Sawatzki H, 2008, CHROMOSOME RES, V16, P41, DOI 10.1007/s10577-007-1207-1; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; LAAN M, 1995, GENOME RES, V5, P13, DOI 10.1101/gr.5.1.13; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; Martin J, 2004, NATURE, V432, P988, DOI 10.1038/nature03187; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Murphy WJ, 2005, GENOMICS, V86, P383, DOI 10.1016/j.ygeno.2005.05.013; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Scherer SW, 2003, SCIENCE, V300, P767, DOI 10.1126/science.1083423; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Teague B, 2010, P NATL ACAD SCI USA, V107, P10848, DOI 10.1073/pnas.0914638107; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Ullmann R, 2007, HUM MUTAT, V28, P674, DOI 10.1002/humu.20546; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Zhou S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-278; Zhou SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000711; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193	52	71	72	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					745	U29		10.1038/ng.643	http://dx.doi.org/10.1038/ng.643			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20729854	Green Accepted			2022-12-25	WOS:000281388400007
J	Jahnke, W; Rondeau, JM; Cotesta, S; Marzinzik, A; Pelle, X; Geiser, M; Strauss, A; Gotte, M; Bitsch, F; Hemmig, R; Henry, C; Lehmann, S; Glickman, JF; Roddy, TP; Stout, SJ; Green, JR				Jahnke, Wolfgang; Rondeau, Jean-Michel; Cotesta, Simona; Marzinzik, Andreas; Pelle, Xavier; Geiser, Martin; Strauss, Andre; Goette, Marjo; Bitsch, Francis; Hemmig, Rene; Henry, Chrystele; Lehmann, Sylvie; Glickman, J. Fraser; Roddy, Thomas P.; Stout, Steven J.; Green, Jonathan R.			Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery	NATURE CHEMICAL BIOLOGY			English	Article							NITROGEN-CONTAINING BISPHOSPHONATES; BIOLOGICAL EVALUATION; DIFFRACTION DATA; ZOLEDRONIC ACID; X-RAY; DRUG; SYNTHASE; AFFINITY; STATINS; ANALOGS	Bisphosphonates are potent inhibitors of farnesyl pyrophosphate synthase (FPPS) and are highly efficacious in the treatment of bone diseases such as osteoporosis, Paget's disease and tumor-induced osteolysis. In addition, the potential for direct antitumor effects has been postulated on the basis of in vitro and in vivo studies and has recently been demonstrated clinically in early breast cancer patients treated with the potent bisphosphonate zoledronic acid. However, the high affinity of bisphosphonates for bone mineral seems suboptimal for the direct treatment of soft-tissue tumors. Here we report the discovery of the first potent non-bisphosphonate FPPS inhibitors. These new inhibitors bind to a previously unknown allosteric site on FPPS, which was identified by fragment-based approaches using NMR and X-ray crystallography. This allosteric and druggable pocket allows the development of a new generation of FPPS inhibitors that are optimized for direct antitumor effects in soft tissue.	[Jahnke, Wolfgang; Rondeau, Jean-Michel; Cotesta, Simona; Marzinzik, Andreas; Pelle, Xavier; Geiser, Martin; Strauss, Andre; Goette, Marjo; Bitsch, Francis; Hemmig, Rene; Henry, Chrystele; Lehmann, Sylvie; Glickman, J. Fraser; Roddy, Thomas P.; Stout, Steven J.; Green, Jonathan R.] Novartis Inst Biomed Res, Ctr Prote Chem & Global Discovery Chem, Basel, Switzerland	Novartis	Jahnke, W (corresponding author), Novartis Inst Biomed Res, Ctr Prote Chem & Global Discovery Chem, Basel, Switzerland.	wolfgang.jahnke@novartis.com	Glickman, Joseph/H-3021-2013	Glickman, Joseph/0000-0002-6706-4039				Abad-Zapatero C, 2005, DRUG DISCOV TODAY, V10, P464, DOI 10.1016/S1359-6446(05)03386-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Davignon J, 2005, VASC HEALTH RISK MAN, V1, P29, DOI 10.2147/vhrm.1.1.29.58937; Docampo Roberto, 2001, Current Drug Targets - Infectious Disorders, V1, P51, DOI 10.2174/1568005013343191; Dunford JE, 2008, J MED CHEM, V51, P2187, DOI 10.1021/jm7015733; Faller B, 2006, EXPERT OPIN DRUG MET, V2, P823, DOI 10.1517/17425255.2.6.823; Fournier PGJ, 2008, CANCER RES, V68, P8945, DOI 10.1158/0008-5472.CAN-08-2195; Glickman JF, 2007, ASSAY DRUG DEV TECHN, V5, P205, DOI 10.1089/adt.2007.057; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Gozzetti A, 2008, CALCIFIED TISSUE INT, V82, P258, DOI 10.1007/s00223-008-9123-8; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Jahnke W, 2002, ANGEW CHEM INT EDIT, V41, P3420, DOI 10.1002/1521-3773(20020916)41:18<3420::AID-ANIE3420>3.0.CO;2-E; Jahnke W, 2006, FRAGMENT BASED APPRO; Jahnke W, 2010, CHEMMEDCHEM, V5, P770, DOI 10.1002/cmdc.201000016; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kavanagh KL, 2006, P NATL ACAD SCI USA, V103, P7829, DOI 10.1073/pnas.0601643103; Kroemer M, 2004, ACTA CRYSTALLOGR D, V60, P1679, DOI 10.1107/S0907444904015215; Marma MS, 2007, J MED CHEM, V50, P5967, DOI 10.1021/jm0702884; Montagnani A, 2003, BONE, V32, P15, DOI 10.1016/S8756-3282(02)00924-9; Murray CW, 2009, NAT CHEM, V1, P187, DOI [10.1038/NCHEM.217, 10.1038/nchem.217]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poynter JN, 2005, NEW ENGL J MED, V352, P2184, DOI 10.1056/NEJMoa043792; REBOLLO A, 2008, AGING HLTH, V4, P171; Roddy TP, 2007, ANAL CHEM, V79, P8207, DOI 10.1021/ac062421q; Rogers Michael J., 2003, Current Pharmaceutical Design, V9, P2643, DOI 10.2174/1381612033453640; Rondeau JM, 2006, CHEMMEDCHEM, V1, P267, DOI 10.1002/cmdc.200500059; Simonen M, 2008, J BIOMOL SCREEN, V13, P456, DOI 10.1177/1087057108318757; Simoni D, 2008, J MED CHEM, V51, P6800, DOI 10.1021/jm801003y; Stockman BJ, 2002, PROG NUCL MAG RES SP, V41, P187, DOI 10.1016/S0079-6565(02)00049-3; Stresing V, 2007, CANCER LETT, V257, P16, DOI 10.1016/j.canlet.2007.07.007; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Wohnsland F, 2001, J MED CHEM, V44, P923, DOI 10.1021/jm001020e; Zhang YH, 2009, J AM CHEM SOC, V131, P5153, DOI 10.1021/ja808285e	35	104	105	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2010	6	9					660	666		10.1038/NCHEMBIO.421	http://dx.doi.org/10.1038/NCHEMBIO.421			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	640WO	20711197				2022-12-25	WOS:000281084900009
J	Kotz, KT; Xiao, W; Miller-Graziano, C; Qian, WJ; Russom, A; Warner, EA; Moldawer, LL; De, A; Bankey, PE; Petritis, BO; Camp, DG; Rosenbach, AE; Goverman, J; Fagan, SP; Brownstein, BH; Irimia, D; Xu, WH; Wilhelmy, J; Mindrinos, MN; Smith, RD; Davis, RW; Tompkins, RG; Toner, M				Kotz, Kenneth T.; Xiao, Wenzong; Miller-Graziano, Carol; Qian, Wei-Jun; Russom, Aman; Warner, Elizabeth A.; Moldawer, Lyle L.; De, Asit; Bankey, Paul E.; Petritis, Brianne O.; Camp, David G., II; Rosenbach, Alan E.; Goverman, Jeremy; Fagan, Shawn P.; Brownstein, Bernard H.; Irimia, Daniel; Xu, Weihong; Wilhelmy, Julie; Mindrinos, Michael N.; Smith, Richard D.; Davis, Ronald W.; Tompkins, Ronald G.; Toner, Mehmet		Inflammation Host Response Injury	Clinical microfluidics for neutrophil genomics and proteomics	NATURE MEDICINE			English	Article							T-CELL; EXPRESSION; LIPOPOLYSACCHARIDE; MASS; ACTIVATION; BLOOD; CHALLENGES; APOPTOSIS; SUBSETS; PATHWAY	Neutrophils have key roles in modulating the immune response. We present a robust methodology for rapidly isolating neutrophils directly from whole blood with 'on-chip' processing for mRNA and protein isolation for genomics and proteomics. We validate this device with an ex vivo stimulation experiment and by comparison with standard bulk isolation methodologies. Last, we implement this tool as part of a near-patient blood processing system within a multi-center clinical study of the immune response to severe trauma and burn injury. The preliminary results from a small cohort of subjects in our study and healthy controls show a unique time-dependent gene expression pattern clearly demonstrating the ability of this tool to discriminate temporal transcriptional events of neutrophils within a clinical setting.	[Kotz, Kenneth T.; Xiao, Wenzong; Russom, Aman; Rosenbach, Alan E.; Goverman, Jeremy; Fagan, Shawn P.; Irimia, Daniel; Tompkins, Ronald G.; Toner, Mehmet] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Shriners Hosp Children,Dept Surg, Boston, MA 02115 USA; [Xiao, Wenzong; Xu, Weihong; Wilhelmy, Julie; Mindrinos, Michael N.; Davis, Ronald W.] Stanford Genome Technol Ctr, Palo Alto, CA USA; [Miller-Graziano, Carol; De, Asit; Bankey, Paul E.] Univ Rochester, Sch Med, Dept Surg, Rochester, NY USA; [Qian, Wei-Jun; Petritis, Brianne O.; Camp, David G., II; Smith, Richard D.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Qian, Wei-Jun; Petritis, Brianne O.; Camp, David G., II; Smith, Richard D.] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA; [Warner, Elizabeth A.; Moldawer, Lyle L.] Univ Florida, Coll Med, Dept Surg, Gainesville, FL USA; [Brownstein, Bernard H.] Washington Univ, Dept Radiat Oncol, St Louis, MO USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Stanford University; University of Rochester; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; State University System of Florida; University of Florida; Washington University (WUSTL)	Kotz, KT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Shriners Hosp Children,Dept Surg, Boston, MA 02115 USA.	kkotz@partners.org; mtoner@hms.harvard.edu	Xu, Weihong/C-4175-2012; Qian, Wei-Jun/C-6167-2011; Russom, Aman/B-1675-2012; Smith, Richard D/J-3664-2012; Irimia, Daniel/A-4095-2008; Goverman, Jeremy/AAZ-6769-2020; QIAN, Wei-Jun/AAC-1907-2021; Irimia, Daniel/S-5404-2019	Xu, Weihong/0000-0002-3988-3571; Smith, Richard D/0000-0002-2381-2349; Irimia, Daniel/0000-0001-7347-2082; QIAN, Wei-Jun/0000-0002-5393-2827; Irimia, Daniel/0000-0001-7347-2082; Russom, Aman/0000-0002-0242-358X; Moldawer, Lyle/0000-0002-9041-9838; West, Michaela A/0000-0002-6598-4114; xiao, wenzhong/0000-0003-4944-6380	US National Institutes of Health (NIH) [T32 GM-007035-32]; US NIH Inflammation; NATIONAL CANCER INSTITUTE [R33CA094304] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036214, U54GM062119, R01GM040586, T32GM007035] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH Inflammation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Hurtado, K. Eken, K. Richter and A. Gupta for microfabrication support. We thank C. Vanderburg for help with nucleic acid analysis and the use of the Harvard NeuroDiscovery Center Agilent Bioanalyzer 2100. We thank the University of Florida technical staff (A. Abouhamze, C. Tannahill and R. Ungaro) for managing clinical implementation of the microfluidic devices. K. T. K. was supported by a US National Institutes of Health (NIH) training grant T32 GM-007035-32. These studies were supported by the US NIH Inflammation and the Host Response to Injury Large Scale Collaborative Project, U54 GM-062119, BioMEMS Resource Center P41 EB-002503 and Proteomics Research Resource for Integrative Biology RR018522. The ex vivo stimulation studies and genomics protocol development were partially supported by US National Institutes of Health grants R01-GM-36214 and P01 HG000205, respectively. The proteomics work was performed in the Environmental Molecular Sciences Laboratory, a US Department of Energy Office of Biological and Environmental Research national scientific user facility on the Pacific Northwest National Laboratory (PNNL) campus. PNNL is multiprogram national laboratory operated by Battelle for the Department of Energy under contract number DE-AC05-76RLO 1830.	Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Burczynski ME, 2006, PHARMACOGENOMICS, V7, P187, DOI 10.2217/14622416.7.2.187; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cassatella MA, 1997, ANN NY ACAD SCI, V832, P233, DOI 10.1111/j.1749-6632.1997.tb46251.x; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; Cheng XH, 2007, JAIDS-J ACQ IMM DEF, V45, P257; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; De AK, 2005, J IMMUNOL, V175, P6155, DOI 10.4049/jimmunol.175.9.6155; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; DEFORGE LE, 1992, J IMMUNOL, V148, P2133; Elghetany MT, 2005, CYTOM PART B-CLIN CY, V65B, P1, DOI 10.1002/cyto.b.20051; Fessler MB, 2002, J BIOL CHEM, V277, P31291, DOI 10.1074/jbc.M200755200; GOSSELIN EJ, 1993, J IMMUNOL, V151, P1482; Kobayashi SD, 2005, J LEUKOCYTE BIOL, V78, P1408, DOI 10.1189/jlb.0605289; Kobayashi SD, 2003, J IMMUNOL, V170, P3357, DOI 10.4049/jimmunol.170.6.3357; Kotz Kenneth, 2007, J Vis Exp, P319, DOI 10.3791/319; Kotz Kenneth, 2007, J Vis Exp, P320, DOI 10.3791/320; Laudanski K, 2006, P NATL ACAD SCI USA, V103, P15564, DOI 10.1073/pnas.0607028103; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lyons PA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-64; Malcolm KC, 2003, AM J PHYSIOL-LUNG C, V284, pL663, DOI 10.1152/ajplung.00094.2002; McDonald PP, 1997, BLOOD, V89, P3421, DOI 10.1182/blood.V89.9.3421; MEHEUS LA, 1993, J IMMUNOL, V151, P1535; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nauseef William M., 2007, V412, P15, DOI 10.1007/978-1-59745-467-4_2; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Petyuk VA, 2007, GENOME RES, V17, P328, DOI 10.1101/gr.5799207; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Qian WJ, 2006, MOL CELL PROTEOMICS, V5, P1727, DOI 10.1074/mcp.M600162-MCP200; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Singh R, 2005, AM J PHYSIOL-CELL PH, V288, pC1179, DOI 10.1152/ajpcell.00258.2004; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Zhang XL, 2006, ELECTROPHORESIS, V27, P1659, DOI 10.1002/elps.200500736; Zhang XQ, 2004, J LEUKOCYTE BIOL, V75, P358, DOI 10.1189/jlb.0903412; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	39	127	134	0	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2010	16	9					1042	U142		10.1038/nm.2205	http://dx.doi.org/10.1038/nm.2205			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20802500	Green Accepted			2022-12-25	WOS:000281622900035
J	Luciani, A; Villella, VR; Esposito, S; Brunetti-Pierri, N; Medina, D; Settembre, C; Gavina, M; Pulze, L; Giardino, I; Pettoello-Mantovani, M; D'Apolito, M; Guido, S; Masliah, E; Spencer, B; Quaratino, S; Raia, V; Ballabio, A; Maiuri, L				Luciani, Alessandro; Villella, Valeria Rachela; Esposito, Speranza; Brunetti-Pierri, Nicola; Medina, Diego; Settembre, Carmine; Gavina, Manuela; Pulze, Laura; Giardino, Ida; Pettoello-Mantovani, Massimo; D'Apolito, Maria; Guido, Stefano; Masliah, Eliezer; Spencer, Brian; Quaratino, Sonia; Raia, Valeria; Ballabio, Andrea; Maiuri, Luigi			Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition	NATURE CELL BIOLOGY			English	Article							TISSUE TRANSGLUTAMINASE; BECLIN 1; NEURODEGENERATIVE DISEASES; NA+ ABSORPTION; GENE-TRANSFER; APOPTOSIS; UBIQUITIN; DELTA-F508-CFTR; ACCUMULATION; ACTIVATION	Accumulation of unwanted/misfolded proteins in aggregates has been observed in airways of patients with cystic fibrosis (CF), a life-threatening genetic disorder caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). Here we show how defective CFTR results in defective autophagy and decreases the clearance of aggresomes. Defective CFTR-induced upregulation of reactive oxygen species (ROS) and tissue transglutaminase (TG2) drive the crosslinking of beclin 1, leading to sequestration of phosphatidylinositol-3-kinase (PI(3)K) complex III and accumulation of p62, which regulates aggresome formation. Both CFTR knockdown and the overexpression of green fluorescent protein (GFP)-tagged-CFTRF508del induce beclin 1 downregulation and defective autophagy in non-CF airway epithelia through the ROS-TG2 pathway. Restoration of beclin 1 and autophagy by either beclin 1 overexpression, cystamine or antioxidants rescues the localization of the beclin 1 interactome to the endoplasmic reticulum and reverts the CF airway phenotype in vitro, in vivo in Scnn1b-transgenic and Cftr(F508del) homozygous mice, and in human CF nasal biopsies. Restoring beclin 1 or knocking down p62 rescued the trafficking of CFTRF508del to the cell surface. These data link the CFTR defect to autophagy deficiency, leading to the accumulation of protein aggregates and to lung inflammation.	[Luciani, Alessandro; Gavina, Manuela; Pulze, Laura; Maiuri, Luigi] Ist Sci San Raffaele, European Inst Res Cyst Fibrosis, I-20132 Milan, Italy; [Luciani, Alessandro; Villella, Valeria Rachela; Esposito, Speranza; Guido, Stefano] Univ Naples Federico II, Dept Chem Engn, I-80125 Naples, Italy; [Esposito, Speranza; Pettoello-Mantovani, Massimo; D'Apolito, Maria; Maiuri, Luigi] Univ Foggia, Inst Pediat, I-71100 Foggia, Italy; [Brunetti-Pierri, Nicola; Medina, Diego; Settembre, Carmine; Ballabio, Andrea] Telethon Inst Genet & Med TIGEM, I-80131 Naples, Italy; [Raia, Valeria] Univ Naples Federico II, Dept Pediat, Cyst Fibrosis Unit, I-80131 Naples, Italy; [Giardino, Ida] Univ Foggia, Dept Lab Med, I-71100 Foggia, Italy; [Masliah, Eliezer; Spencer, Brian] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Quaratino, Sonia] Univ Southampton, Canc Res UK Oncol Unit, Southampton SO16 6YD, Hants, England	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Naples Federico II; University of Foggia; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; University of Foggia; University of California System; University of California San Diego; University of Southampton	Maiuri, L (corresponding author), Ist Sci San Raffaele, European Inst Res Cyst Fibrosis, I-20132 Milan, Italy.	raia@unina.it; ballabio@tigem.it; maiuri@unina.it	MANTOVANI, Massimo PETTOELLO/AAC-1990-2019; BALLABIO, Andrea/AAL-2672-2020; esposito, speranza/AFT-9322-2022; Settembre, Carmine/AIA-9170-2022; Brunetti-Pierri, Nicola/K-8465-2016; Medina, Diego/AAC-9622-2020; Guido, Stefano/B-9928-2011; Villella, Valeria Rachela/AAC-1075-2019; Raia, Valeria/AAC-3029-2022; d'Apolito, Maria/AAQ-9290-2021	MANTOVANI, Massimo PETTOELLO/0000-0002-0688-1131; BALLABIO, Andrea/0000-0003-1381-4604; Brunetti-Pierri, Nicola/0000-0002-6895-8819; Medina, Diego/0000-0002-7347-2645; Guido, Stefano/0000-0002-9247-6852; Villella, Valeria Rachela/0000-0003-4858-4853; SETTEMBRE, Carmine/0000-0002-5829-8589; Luciani, Alessandro/0000-0001-7219-3719; esposito, speranza/0000-0003-0269-4029	European Institute for Research in Cystic Fibrosis; Cancer Research UK; Rothschild Trust; Coeliac UK; Regione Campania [L. 229/99]; Fondazione Telethon Funding Source: Custom	European Institute for Research in Cystic Fibrosis; Cancer Research UK(Cancer Research UK); Rothschild Trust; Coeliac UK; Regione Campania(Regione Campania); Fondazione Telethon(Fondazione Telethon)	We thank Noboru Mizushima for the gift of the pEGFP-LC3 and pcDNA3-HA-beclin 1 expression vectors; Ron Kopito for the gift of the pGFP-F508del-CFTR expression vector; Michael Bownlee for the gift of the adenoviral vectors; Clan Maria Fimia for the gift of the TG2 plasmid; Dieter C. Gruenert for the gift of CFBE41o<SUP>-</SUP> and 16HBE14o<SUP>-</SUP> cell lines; Maria Carla Panzeri for support in electron microscopy and in the analysis of the data; Rosarita Tate for technical support in confocal microscopy; and Ilaria Russo for technical support in histology. Cftrtm1EUR (F508del (FVB/129) mice were obtained from Bob Scholte under European Economic Community European Coordination Action for Research in Cystic Fibrosis program EU FP6 LSHM-CT-2005-018932. This work was supported by the European Institute for Research in Cystic Fibrosis, Cancer Research UK, Rothschild Trust, Coeliac UK and Regione Campania (L. 229/99).	Akar U, 2007, MOL CANCER RES, V5, P241, DOI 10.1158/1541-7786.MCR-06-0229; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bartoszewski R, 2008, AM J RESP CELL MOL, V39, P448, DOI 10.1165/rcmb.2008-0065OC; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; Dohm CP, 2008, NEURODEGENER DIS, V5, P321, DOI 10.1159/000119459; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Frizzell RA, 2004, NAT MED, V10, P452, DOI 10.1038/nm0504-452; Fu LW, 2009, EUR J CELL BIOL, V88, P215, DOI 10.1016/j.ejcb.2008.11.003; Ghavami S, 2010, CELL RES, V20, P314, DOI 10.1038/cr.2009.129; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Legssyer R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-134; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Luciani A, 2009, J IMMUNOL, V183, P2775, DOI 10.4049/jimmunol.0900993; Maiuri L, 2008, J IMMUNOL, V180, P7697, DOI 10.4049/jimmunol.180.11.7697; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Martinez A, 2010, BRAIN PATHOL, V20, P281, DOI 10.1111/j.1750-3639.2009.00326.x; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Muma NA, 2007, J NEUROPATH EXP NEUR, V66, P258, DOI 10.1097/nen.0b013e31803d3b02; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Raia V, 2005, THORAX, V60, P773, DOI 10.1136/thx.2005.042564; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Rochat T, 2004, J CELL PHYSIOL, V201, P106, DOI 10.1002/jcp.20066; Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Schessl J, 2008, J CLIN INVEST, V118, P904, DOI 10.1172/JCI34450; Scott-Ward TS, 2009, FEBS J, V276, P7097, DOI 10.1111/j.1742-4658.2009.07421.x; Sha YB, 2009, MOL CELL BIOL, V29, P116, DOI 10.1128/MCB.00829-08; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Skach WR, 2006, CELL, V127, P673, DOI 10.1016/j.cell.2006.11.002; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Stocker AG, 2009, J GENE MED, V11, P861, DOI 10.1002/jgm.1368; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; TEBBENKAMP ATN, 2009, METH MOL B, V566, P85; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Trudel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006075; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	65	361	370	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					863	875		10.1038/ncb2090	http://dx.doi.org/10.1038/ncb2090			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20711182				2022-12-25	WOS:000281561900010
J	Reddy, ST; Ge, X; Miklos, AE; Hughes, RA; Kang, SH; Hoi, KH; Chrysostomou, C; Hunicke-Smith, SP; Iverson, BL; Tucker, PW; Ellington, AD; Georgiou, G				Reddy, Sai T.; Ge, Xin; Miklos, Aleksandr E.; Hughes, Randall A.; Kang, Seung Hyun; Hoi, Kam Hon; Chrysostomou, Constantine; Hunicke-Smith, Scott P.; Iverson, Brent L.; Tucker, Philip W.; Ellington, Andrew D.; Georgiou, George			Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells	NATURE BIOTECHNOLOGY			English	Article							MEMORY B-CELLS; DISPLAY; LIBRARIES; EXPRESSION; GENERATION; FRAGMENTS; SELECTION; CLONING	Isolation of antigen-specific monoclonal antibodies (mAbs) and antibody fragments relies on high-throughput screening of immortalized B cells(1,2) or recombinant antibody libraries(3-6). We bypassed the screening step by using high-throughput DNA sequencing and bioinformatic analysis to mine antibody variable region (V)-gene repertoires from bone marrow plasma cells (BMPC) of immunized mice. BMPCs, which cannot be immortalized, produce the vast majority of circulating antibodies. We found that the V-gene repertoire of BMPCs becomes highly polarized after immunization, with the most abundant sequences represented at frequencies between similar to 1% and >10% of the total repertoire. We paired the most abundant variable heavy (VH) and variable light (VL) genes based on their relative frequencies, reconstructed them using automated gene synthesis, and expressed recombinant antibodies in bacteria or mammalian cells. Antibodies generated in this manner from six mice, each immunized with one of three antigens were overwhelmingly antigen specific (21/27 or 78%). Those generated from a mouse with high serum titers had nanomolar binding affinities. (C) 2010 Nature America, Inc. All rights reserved.	[Reddy, Sai T.; Ge, Xin; Kang, Seung Hyun; Chrysostomou, Constantine; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Reddy, Sai T.; Hoi, Kam Hon; Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Miklos, Aleksandr E.; Hughes, Randall A.; Hunicke-Smith, Scott P.; Iverson, Brent L.; Tucker, Philip W.; Ellington, Andrew D.; Georgiou, George] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Miklos, Aleksandr E.; Hughes, Randall A.; Ellington, Andrew D.] Univ Texas Austin, Appl Res Labs, Austin, TX 78713 USA; [Iverson, Brent L.; Ellington, Andrew D.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Tucker, Philip W.; Georgiou, George] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Georgiou, G (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.	gg@che.utexas.edu	Ge, Xin/I-8181-2013; Reddy, Sai/B-4190-2012	Ge, Xin/0000-0001-7491-7805; Reddy, Sai/0000-0002-9177-0857; Hoi, Kam Hon/0000-0003-4158-0446; Miklos, Aleksandr/0000-0001-6375-2304	Clayton Foundation; Cockrell Chair in Engineering; Natural Sciences and Engineering Research Council of Canada	Clayton Foundation; Cockrell Chair in Engineering; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank C. Das for her invaluable technical assistance on mammalian cell culture and transfection and M. Byrom for assistance with mouse experiments. This work was funded by grants from the Clayton Foundation, the Cockrell Chair in Engineering (to G.G.) and by a fellowship from Natural Sciences and Engineering Research Council of Canada (to X.G.).	Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Carlson R, 2009, NAT BIOTECHNOL, V27, P1091, DOI 10.1038/nbt1209-1091; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; Cobaugh CW, 2008, J MOL BIOL, V378, P622, DOI 10.1016/j.jmb.2008.02.037; Cox JC, 2007, PROTEIN SCI, V16, P379, DOI 10.1110/ps.062591607; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Gao XX, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng143; Ge X, 2010, BIOTECHNOL BIOENG, V106, P347, DOI 10.1002/bit.22712; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Harvey BR, 2004, P NATL ACAD SCI USA, V101, P9193, DOI 10.1073/pnas.0400187101; Hayhurst A, 2003, J IMMUNOL METHODS, V276, P185, DOI 10.1016/S0022-1759(03)00100-5; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Mazor Y, 2007, NAT BIOTECHNOL, V25, P563, DOI 10.1038/nbt1296; Mazor Y, 2007, J IMMUNOL METHODS, V321, P41, DOI 10.1016/j.jim.2007.01.008; Meijer PJ, 2006, J MOL BIOL, V358, P764, DOI 10.1016/j.jmb.2006.02.040; Persson H, 2006, J MOL BIOL, V357, P607, DOI 10.1016/j.jmb.2006.01.004; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Schaffitzel C, 1999, J IMMUNOL METHODS, V231, P119, DOI 10.1016/S0022-1759(99)00149-0; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890	32	207	277	2	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2010	28	9					965	U20		10.1038/nbt.1673	http://dx.doi.org/10.1038/nbt.1673			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	648UF	20802495				2022-12-25	WOS:000281719100023
J	Vickers, KC; Palmisano, BT; Shoucri, BM; Shamburek, RD; Remaley, AT				Vickers, Kasey C.; Palmisano, Brian T.; Shoucri, Bassem M.; Shamburek, Robert D.; Remaley, Alan T.			MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins	NATURE CELL BIOLOGY			English	Article							APOLIPOPROTEIN-A-I; MESSENGER-RNAS; EXPRESSION; MECHANISM; BINDING; DNA; DIAGNOSIS; PROTEINS; INSIGHTS; GENES	Circulating microRNAs (miRNA) are relatively stable in plasma and are a new class of disease biomarkers. Here we present evidence that high-density lipoprotein (HDL) transports endogenous miRNAs and delivers them to recipient cells with functional targeting capabilities. Cellular export of miRNAs to HDL was demonstrated to be regulated by neutral sphingomyelinase. Reconstituted HDL injected into mice retrieved distinct miRNA profiles from normal and atherogenic models. HDL delivery of both exogenous and endogenous miRNAs resulted in the direct targeting of messenger RNA reporters. Furthermore, HDL-mediated delivery of miRNAs to recipient cells was demonstrated to be dependent on scavenger receptor class B type I. The human HDL-miRNA profile of normal subjects is significantly different from that of familial hypercholesterolemia subjects. Notably, HDL-miRNA from atherosclerotic subjects induced differential gene expression, with significant loss of conserved mRNA targets in cultured hepatocytes. Collectively, these observations indicate that HDL participates in a mechanism of intercellular communication involving the transport and delivery of miRNAs.	[Vickers, Kasey C.; Palmisano, Brian T.; Shoucri, Bassem M.; Shamburek, Robert D.; Remaley, Alan T.] NHLBI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Vickers, KC (corresponding author), NHLBI, NIH, 10 Ctr Dr,Bldg 10 8N222, Bethesda, MD 20892 USA.	vickerskc@nhlbi.nih.gov	ravegnini, gloria/K-1330-2016	ravegnini, gloria/0000-0002-7774-402X; Palmisano, Brian T./0000-0002-2140-1060	NIH, NHLBI DIR; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006091] Funding Source: NIH RePORTER	NIH, NHLBI DIR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was helped by the NHLBI Electron Microscopy Core, Genomics Core and Proteomics Core Facilities. Special thanks are extended to P. Sethupathy, PhD, for target prediction and discussion, M. Sampson for her work on patient lipid profiles and A. Loncarich for statistical analysis. This research was supported in total by the Intramural Research Program of the NIH, NHLBI DIR.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887; Cui XD, 2010, INT J CANCER, V126, P940, DOI 10.1002/ijc.24798; Eyholzer M, 2010, LEUKEMIA RES, V34, P672, DOI 10.1016/j.leukres.2009.11.019; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Ferracin M, 2010, EXPERT REV MOL DIAGN, V10, P297, DOI 10.1586/ERM.10.11; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gromelski S, 2006, LANGMUIR, V22, P6293, DOI 10.1021/la0531796; Heinecke JW, 2009, J LIPID RES, V50, pS167, DOI 10.1194/jlr.R800097-JLR200; Heneghan HM, 2010, J ONCOL, V2010, DOI 10.1155/2010/950201; Huang L, 2005, PROTEOMICS, V5, P3314, DOI 10.1002/pmic.200401277; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Iida H, 2005, GUT, V54, P843, DOI 10.1136/gut.2004.049486; Janas T, 2006, NUCLEIC ACIDS RES, V34, P2128, DOI 10.1093/nar/gkl220; Kim SI, 2007, MOL THER, V15, P1145, DOI 10.1038/sj.mt.6300168; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lee H, 2009, BIOCHEM BIOPH RES CO, V378, P192, DOI 10.1016/j.bbrc.2008.11.029; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lima ES, 2004, CLIN CHEM, V50, P1086, DOI 10.1373/clinchem.2004.032383; Lu DM, 2002, BBA-BIOMEMBRANES, V1563, P45, DOI 10.1016/S0005-2736(02)00384-X; Lu H, 2010, CARDIOVASC RES, V86, P410, DOI 10.1093/cvr/cvq010; Lund-Katz S, 2010, SUBCELL BIOCHEM, V51, P183, DOI 10.1007/978-90-481-8622-8_7; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Manavbasi Y, 2007, ARCH PHARM RES, V30, P1027, DOI 10.1007/BF02993973; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; MATZ CE, 1982, J BIOL CHEM, V257, P4535; McManus JJ, 2003, J PHYS CHEM B, V107, P9869, DOI 10.1021/jp034463d; Mengistu DH, 2009, J PHYS CHEM B, V113, P12277, DOI 10.1021/jp904986j; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moreno PR, 2006, CIRCULATION, V113, P2245, DOI 10.1161/CIRCULATIONAHA.105.578955; Nieuwland R, 2000, BLOOD, V95, P930, DOI 10.1182/blood.V95.3.930.003k46_930_935; Podrez EA, 2010, CLIN EXP PHARMACOL P, V37, P719, DOI 10.1111/j.1440-1681.2010.05380.x; Pulikkan JA, 2010, BLOOD, V115, P1768, DOI 10.1182/blood-2009-08-240101; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; Ramakrishnan SN, 2005, J BIOL CHEM, V280, P8651, DOI 10.1074/jbc.M413949200; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Rothblat GH, 2010, CURR OPIN LIPIDOL, V21, P229, DOI 10.1097/MOL.0b013e328338472d; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Sugatani T, 2007, J CELL BIOCHEM, V101, P996, DOI 10.1002/jcb.21335; Suleymanoglu Erhan, 2006, PDA J Pharm Sci Technol, V60, P232; Sun GH, 2010, NUCLEIC ACIDS RES, V38, P239, DOI 10.1093/nar/gkp870; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; Wolfrum C, 2007, NAT BIOTECHNOL, V25, P1149, DOI 10.1038/nbt1339; Yao YC, 2008, ARTERIOSCL THROM VAS, V28, P2266, DOI 10.1161/ATVBAHA.108.176958; Yu CH, 2009, DIGEST DIS SCI, V54, P2362, DOI 10.1007/s10620-008-0629-8	62	1956	2059	5	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2011	13	4					423	U182		10.1038/ncb2210	http://dx.doi.org/10.1038/ncb2210			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	744CK	21423178	Green Accepted			2022-12-25	WOS:000289070900014
J	Schramek, D; Kotsinas, A; Meixner, A; Wada, T; Elling, U; Pospisilik, JA; Neely, GG; Zwick, RH; Sigl, V; Forni, G; Serrano, M; Gorgoulis, VG; Penninger, JM				Schramek, Daniel; Kotsinas, Athanassios; Meixner, Arabella; Wada, Teiji; Elling, Ulrich; Pospisilik, J. Andrew; Neely, G. Gregory; Zwick, Ralf-Harun; Sigl, Verena; Forni, Guido; Serrano, Manuel; Gorgoulis, Vassilis G.; Penninger, Josef M.			The stress kinase MKK7 couples oncogenic stress to p53 stability and tumor suppression	NATURE GENETICS			English	Article							SIGNAL-TRANSDUCTION PATHWAY; DNA-DAMAGE RESPONSE; JUN NH2-TERMINAL KINASE; C-JUN; K-RAS; LUNG-CANCER; PRECANCEROUS LESIONS; INDUCED SENESCENCE; BREAST-CANCER; MICE	Most preneoplastic lesions are quiescent and do not progress to form overt tumors. It has been proposed that oncogenic stress activates the DNA damage response and the key tumor suppressor p53, which prohibits tumor growth. However, the molecular pathways by which cells sense a premalignant state in vivo are largely unknown. Here we report that tissue-specific inactivation of the stress signaling kinase MKK7 in KRas(G12D)-driven lung carcinomas and NeuT-driven mammary tumors markedly accelerates tumor onset and reduces overall survival. Mechanistically, MKK7 acts through the kinases JNK1 and JNK2, and this signaling pathway directly couples oncogenic and genotoxic stress to the stability of p53, which is required for cell cycle arrest and suppression of epithelial cancers. These results show that MKK7 functions as a major tumor suppressor in lung and mammary cancer in mouse and identify MKK7 as a vital molecular sensor to set a cellular anti-cancer barrier.	[Schramek, Daniel; Meixner, Arabella; Wada, Teiji; Elling, Ulrich; Pospisilik, J. Andrew; Sigl, Verena; Penninger, Josef M.] Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna, Austria; [Kotsinas, Athanassios; Gorgoulis, Vassilis G.] Univ Athens, Sch Med, Dept Histol & Embryol, GR-11527 Athens, Greece; [Neely, G. Gregory] Garvan Inst Med Res, Sydney, NSW, Australia; [Zwick, Ralf-Harun] Otto Wagner Hosp, Dept Resp & Crit Care Med, Vienna, Austria; [Forni, Guido] Univ Turin, Dept Clin & Biol Sci, Ctr Mol Biotechnol, Turin, Italy; [Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Madrid, Spain	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Athens Medical School; National & Kapodistrian University of Athens; Garvan Institute of Medical Research; University of Turin; Centro Nacional de Investigaciones Oncologicas (CNIO)	Penninger, JM (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, Vienna, Austria.	josef.penninger@imba.oeaw.ac.at	Schramek, Daniel/J-5792-2014; Neely, Greg/AAB-4642-2020; Schramek, Daniel/AAL-1470-2020; Penninger, Josef M/I-6860-2013; Serrano, Manuel/H-2634-2015; Gorgoulis, Vassilis/AAD-3630-2019; neely, graham/A-6511-2011	Neely, Greg/0000-0002-1957-9732; Schramek, Daniel/0000-0001-9977-2104; Penninger, Josef M/0000-0002-8194-3777; Serrano, Manuel/0000-0001-7177-9312; Gorgoulis, Vassilis/0000-0001-9001-4112; 	EU INFLA-CARE network; IMBA; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU (AustroMouse); EU ERC; EU	EU INFLA-CARE network; IMBA; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU (AustroMouse); EU ERC(European Research Council (ERC)European Commission); EU(European Commission)	We thank all members of our laboratories for discussions; H. Scheuch and M. Radolf for microarray support; and E. Wagner for reading the manuscript. D. S. is supported by the EU INFLA-CARE network. J.M.P. is supported by grants from IMBA, the Austrian Ministry of Sciences, the Austrian Academy of Sciences, GEN-AU (AustroMouse) and an EU ERC Advanced Grant. V. G. G. and A. K. are supported by the EU-grants INFLA-CARE and GENICA.	Aas T, 1996, NAT MED, V2, P811, DOI 10.1038/nm0796-811; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Boggio K, 1998, J EXP MED, V188, P589, DOI 10.1084/jem.188.3.589; Bortnick AE, 2003, AM J PHYSIOL-LUNG C, V285, pL869, DOI 10.1152/ajplung.00077.2003; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Chen NY, 2001, CANCER RES, V61, P3908; COLES C, 1992, CANCER RES, V52, P5291; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Costa A, 2008, NAT CLIN PRACT ONCOL, V5, P700, DOI 10.1038/ncponc1239; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Efeyan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005475; Fata JE, 2007, DEV BIOL, V306, P193, DOI 10.1016/j.ydbio.2007.03.013; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hu MCT, 1997, ONCOGENE, V15, P2277, DOI 10.1038/sj.onc.1201401; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kennedy NJ, 2003, GENE DEV, V17, P629, DOI 10.1101/gad.1062903; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; Kissil JL, 2007, CANCER RES, V67, P8089, DOI 10.1158/0008-5472.CAN-07-2300; LEHMAN TA, 1991, CANCER RES, V51, P4090; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Oleinik NV, 2007, ONCOGENE, V26, P7222, DOI 10.1038/sj.onc.1210526; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Sancho R, 2009, EMBO J, V28, P1843, DOI 10.1038/emboj.2009.153; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; She QB, 2002, CANCER RES, V62, P1343; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Weston CR, 2004, P NATL ACAD SCI USA, V101, P14114, DOI 10.1073/pnas.0406061101; Young NP, 2010, P NATL ACAD SCI USA, V107, P10184, DOI 10.1073/pnas.1004796107; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721; Zhou YH, 2010, NAT BIOTECHNOL, V28, P71, DOI 10.1038/nbt.1595	50	79	81	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2011	43	3					212	U55		10.1038/ng.767	http://dx.doi.org/10.1038/ng.767			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726BR	21317887				2022-12-25	WOS:000287693800011
J	Hurtado, A; Holmes, KA; Ross-Innes, CS; Schmidt, D; Carroll, JS				Hurtado, Antoni; Holmes, Kelly A.; Ross-Innes, Caryn S.; Schmidt, Dominic; Carroll, Jason S.			FOXA1 is a key determinant of estrogen receptor function and endocrine response	NATURE GENETICS			English	Article							BREAST-CANCER CELLS; GENE-EXPRESSION; ER-ALPHA; HUMAN CHROMATIN; BINDING-SITES; MCF-7 CELLS; TRANSCRIPTION; TAMOXIFEN; LINES; BETA	Estrogen receptor-alpha (ER) is the key feature of most breast cancers and binding of ER to the genome correlates with expression of the Forkhead protein FOXA1 (also called HNF3 alpha). Here we show that FOXA1 is a key determinant that can influence differential interactions between ER and chromatin. Almost all ER-chromatin interactions and gene expression changes depended on the presence of FOXA1 and FOXA1 influenced genome-wide chromatin accessibility. Furthermore, we found that CTCF was an upstream negative regulator of FOXA1-chromatin interactions. In estrogen-responsive breast cancer cells, the dependency on FOXA1 for tamoxifen-ER activity was absolute; in tamoxifen-resistant cells, ER binding was independent of ligand but depended on FOXA1. Expression of FOXA1 in non-breast cancer cells can alter ER binding and function. As such, FOXA1 is a major determinant of estrogen-ER activity and endocrine response in breast cancer cells.	[Hurtado, Antoni; Holmes, Kelly A.; Ross-Innes, Caryn S.; Schmidt, Dominic; Carroll, Jason S.] Canc Res UK, Li Ka Shing Ctr, Cambridge Res Inst, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Carroll, JS (corresponding author), Canc Res UK, Li Ka Shing Ctr, Cambridge Res Inst, Cambridge, England.	jason.carroll@cancer.org.uk		Carroll, Jason/0000-0003-3643-0080; Hurtado, Antoni/0000-0002-0145-4763	The University of Cambridge; Cancer Research UK; Hutchison Whampoa Limited; Commonwealth fellowship; Breast Cancer Campaign; ERC; Cancer Research UK [15602] Funding Source: researchfish	The University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); Hutchison Whampoa Limited; Commonwealth fellowship; Breast Cancer Campaign; ERC(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK)	We thank G. Brown, R. Russell and R. Stark for bioinformatics support; J. Hadfield for genomic help; S. Vowler for statistical advice; and T. Spelsberg and I. Hutcheson for cell lines. We acknowledge support from The University of Cambridge, Cancer Research UK and Hutchison Whampoa Limited. C.S.R.-I. is supported by a Commonwealth fellowship, K. A. H. is supported by a Breast Cancer Campaign grant and J.S.C. and A.H. are supported by an ERC Starting Grant.	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Badve S, 2007, CLIN CANCER RES, V13, P4415, DOI 10.1158/1078-0432.CCR-07-0122; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Carroll JS, 2000, J BIOL CHEM, V275, P38221, DOI 10.1074/jbc.M004424200; Chan CS, 2008, CANCER RES, V68, P9041, DOI 10.1158/0008-5472.CAN-08-2632; Charn TH, 2010, MOL ENDOCRINOL, V24, P47, DOI 10.1210/me.2009-0252; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; Clarke R, 2001, PHARMACOL REV, V53, P25; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Deblois G, 2008, MOL ENDOCRINOL, V22, P1999, DOI 10.1210/me.2007-0546; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; Eeckhoute J, 2009, GENOME RES, V19, P372, DOI 10.1101/gr.084582.108; Frasor J, 2004, CANCER RES, V64, P1522, DOI 10.1158/0008-5472.CAN-03-3326; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Glass CK, 2000, GENE DEV, V14, P121; Jordan VC, 2003, NAT REV DRUG DISCOV, V2, P205, DOI 10.1038/nrd1031; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Martin LA, 2003, J BIOL CHEM, V278, P30458, DOI 10.1074/jbc.M305226200; Monroe DG, 2005, MOL ENDOCRINOL, V19, P1555, DOI 10.1210/me.2004-0381; Monroe DG, 2003, J CELL BIOCHEM, V90, P315, DOI 10.1002/jcb.10633; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Y, 2010, J BIOL CHEM, V285, P28604, DOI 10.1074/jbc.M110.149658	40	600	618	2	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2011	43	1					27	U42		10.1038/ng.730	http://dx.doi.org/10.1038/ng.730			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	699SQ	21151129	Green Submitted, Green Accepted			2022-12-25	WOS:000285683500011
J	Ni, QA; Ganesan, A; Aye-Han, NN; Gao, XX; Allen, MD; Levchenko, A; Zhang, J				Ni, Qiang; Ganesan, Ambhighainath; Aye-Han, Nwe-Nwe; Gao, Xinxin; Allen, Michael D.; Levchenko, Andre; Zhang, Jin			Signaling diversity of PKA achieved via a Ca2+-cAMP-PKA oscillatory circuit	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-KINASE-A; PANCREATIC BETA-CELL; INSULIN-SECRETION; GENE-EXPRESSION; CALCIUM OSCILLATIONS; CA2+ CHANNEL; CYCLIC-AMP; CAMP; PHOSPHORYLATION; GLUCOSE	Many protein kinases are key nodal signaling molecules that regulate a wide range of cellular functions. These functions may require complex spatiotemporal regulation of kinase activities. Here, we show that protein kinase A (PKA), Ca2+ and cyclic AMP (cAMP) oscillate in sync in insulin-secreting MIN6 beta cells, forming a highly integrated oscillatory circuit. We found that PKA activity was essential for this oscillatory circuit and was capable of not only initiating the signaling oscillations but also modulating their frequency, thereby diversifying the spatiotemporal control of downstream signaling. Our findings suggest that exquisite temporal control of kinase activity, mediated via signaling circuits resulting from cross-regulation of signaling pathways, can encode diverse inputs into temporal parameters such as oscillation frequency, which in turn contribute to proper regulation of complex cellular functions in a context-dependent manner.	[Ni, Qiang; Aye-Han, Nwe-Nwe; Gao, Xinxin; Allen, Michael D.; Zhang, Jin] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Ganesan, Ambhighainath; Levchenko, Andre] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Zhang, Jin] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Zhang, Jin] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Zhang, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	alev@jhu.edu; jzhang32@jhmi.edu			US National Institutes of Health [R01 DK073368, DP1OD006419, GM072024, RR020839]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072024] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006419] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J.-I. Miyazaki (Osaka University), G. G. Holz (SUNY Upstate Medical University) and G. H. Hart (Johns Hopkins University) for providing cell lines. We also thank X. Li (Johns Hopkins University) for initial technical assistance. This work was supported by US National Institutes of Health grants R01 DK073368 and DP1OD006419 (to J.Z.) and GM072024 and RR020839 (to A.L.).	Allen MD, 2008, ANGEW CHEM INT EDIT, V47, P500, DOI 10.1002/anie.200703493; Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; BERGSTEN P, 1994, J BIOL CHEM, V269, P8749; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; BORODINSKY LN, 2006, SCI STKE, pPE22; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Bugrim AE, 1999, CELL CALCIUM, V25, P219, DOI 10.1054/ceca.1999.0027; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; CHAY TR, 1983, BIOPHYS J, V42, P181, DOI 10.1016/S0006-3495(83)84384-7; Delmeire D, 2003, DIABETOLOGIA, V46, P1383, DOI 10.1007/s00125-003-1203-8; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Gromada J, 2004, BASIC CLIN PHARMACOL, V95, P252, DOI 10.1111/j.1742-7843.2004.t01-1-pto950502.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hatakeyama H, 2006, J PHYSIOL-LONDON, V570, P271, DOI 10.1113/jphysiol.2005.096560; HENQUIN JC, 1984, ENDOCRINOLOGY, V115, P1125, DOI 10.1210/endo-115-3-1125; Hilioti Z, 2008, CURR BIOL, V18, P1700, DOI 10.1016/j.cub.2008.09.027; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Leiser M, 1996, DIABETES, V45, P1412, DOI 10.2337/diabetes.45.10.1412; Lester LB, 2001, ENDOCRINOLOGY, V142, P1218, DOI 10.1210/en.142.3.1218; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Markoulaki S, 2004, DEV BIOL, V272, P15, DOI 10.1016/j.ydbio.2004.04.008; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Neves SR, 2008, CELL, V133, P666, DOI 10.1016/j.cell.2008.04.025; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Putney JW, 2008, J PHYSIOL-LONDON, V586, P3055, DOI 10.1113/jphysiol.2008.153221; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; VAAG A, 1995, J CLIN INVEST, V95, P690, DOI 10.1172/JCI117715; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; Zaccolo M, 2003, TRENDS NEUROSCI, V26, P53, DOI 10.1016/S0166-2236(02)00017-6; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	44	84	86	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2011	7	1					34	40		10.1038/NCHEMBIO.478	http://dx.doi.org/10.1038/NCHEMBIO.478			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	695PA	21102470	Green Accepted			2022-12-25	WOS:000285383400010
J	Alcazar, R; Garcia, AV; Kronholm, I; de Meaux, J; Koornneef, M; Parker, JE; Reymond, M				Alcazar, Ruben; Garcia, Ana V.; Kronholm, Ilkka; de Meaux, Juliette; Koornneef, Maarten; Parker, Jane E.; Reymond, Matthieu			Natural variation at Strubbelig Receptor Kinase 3 drives immune-triggered incompatibilities between Arabidopsis thaliana accessions	NATURE GENETICS			English	Article							MPK4 ACTIVATION; RESISTANCE; EDS1; MEKK1	Accumulation of genetic incompatibilities within species can lead to reproductive isolation and, potentially, speciation. In this study, we show that allelic variation at SRF3 (Strubbelig Receptor Family 3), encoding a receptor-like kinase, conditions the occurrence of incompatibility between Arabidopsis thaliana accessions. The geographical distribution of SRF3 alleles reveals that allelic forms causing epistatic incompatibility with a Landsberg erecta allele at the RPP1 resistance locus are present in A. thaliana accessions in central Asia. Incompatible SRF3 alleles condition for an enhanced early immune response to pathogens as compared to the resistance-dampening effect of compatible SRF3 forms in isogenic backgrounds. Variation in disease susceptibility suggests a basis for the molecular patterns of a recent selective sweep detected at the SRF3 locus in central Asian populations.	[Alcazar, Ruben; Kronholm, Ilkka; de Meaux, Juliette; Koornneef, Maarten; Reymond, Matthieu] Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany; [Garcia, Ana V.; Parker, Jane E.] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany	Max Planck Society; Max Planck Society	Reymond, M (corresponding author), INRA AgroParisTech, Ctr Versailles Grignon, Inst Jean Pierre Bourgin, UMR1318, Route St Cyr,RD10, Versailles, France.	reymond@mpiz-koeln.mpg.de	Alcazar, Ruben/S-6391-2019; Alcazar, Ruben/E-7720-2010	Kronholm, Ilkka/0000-0002-4126-0250; Koornneef, Maarten/0000-0002-7759-4869; Alcazar, Ruben/0000-0002-3567-7586; de Meaux, Juliette/0000-0002-2942-4750				Aarts N, 1998, P NATL ACAD SCI USA, V95, P10306, DOI 10.1073/pnas.95.17.10306; Alcazar R, 2009, P NATL ACAD SCI USA, V106, P334, DOI 10.1073/pnas.0811734106; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Bechtold N, 1998, METH MOL B, V82, P259; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Bomblies K, 2010, ANNU REV PLANT BIOL, V61, P109, DOI 10.1146/annurev-arplant-042809-112146; Bomblies K, 2010, PHILOS T R SOC B, V365, P1815, DOI 10.1098/rstb.2009.0304; Brodersen P, 2006, PLANT J, V47, P532, DOI 10.1111/j.1365-313X.2006.02806.x; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Dobzhansky T., 1937; El-Lithy ME, 2006, GENETICS, V172, P1867, DOI 10.1534/genetics.105.050617; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Eyuboglu B, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-16; Fay JC, 2000, GENETICS, V155, P1405; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; Feys BJ, 2001, EMBO J, V20, P5400, DOI 10.1093/emboj/20.19.5400; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Ichimura K, 2006, J BIOL CHEM, V281, P36969, DOI 10.1074/jbc.M605319200; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Mishina TE, 2007, PLANT J, V50, P500, DOI 10.1111/j.1365-313X.2007.03067.x; Muller HJ, 1942, BIOL S, V6, P71; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Pritchard JK, 2000, GENETICS, V155, P945; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Suarez-Rodriguez MC, 2007, PLANT PHYSIOL, V143, P661, DOI 10.1104/pp.106.091389; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tornero P, 2001, PLANT J, V28, P475, DOI 10.1046/j.1365-313X.2001.01136.x; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Wakeley J, 2001, GENETICS, V159, P893; Yuan J, 1996, J BACTERIOL, V178, P6399, DOI 10.1128/jb.178.21.6399-6402.1996; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432	37	94	97	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2010	42	12					1135	+		10.1038/ng.704	http://dx.doi.org/10.1038/ng.704			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684UZ	21037570				2022-12-25	WOS:000284578800019
J	Conko, G; Miller, HI				Conko, Gregory; Miller, Henry I.			The environmental impact subterfuge	NATURE BIOTECHNOLOGY			English	Article									[Conko, Gregory] Competit Enterprise Inst, Washington, DC USA; [Miller, Henry I.] Stanford Univ, Hoover Inst, Stanford, CA 94305 USA	Stanford University	Conko, G (corresponding author), Competit Enterprise Inst, Washington, DC USA.	henry.miller@stanford.edu							0	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2010	28	12					1256	1258		10.1038/nbt.1730	http://dx.doi.org/10.1038/nbt.1730			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	691NP	21139607				2022-12-25	WOS:000285088400015
J	Tanaka, H; Kono, E; Tran, CP; Miyazaki, H; Yamashiro, J; Shimomura, T; Fazli, L; Wada, R; Huang, JT; Vessella, RL; An, JB; Horvath, S; Gleave, M; Rettig, MB; Wainberg, ZA; Reiter, RE				Tanaka, Hiroshi; Kono, Evelyn; Tran, Chau P.; Miyazaki, Hideyo; Yamashiro, Joyce; Shimomura, Tatsuya; Fazli, Ladan; Wada, Robert; Huang, Jiaoti; Vessella, Robert L.; An, Jaibin; Horvath, Steven; Gleave, Martin; Rettig, Matthew B.; Wainberg, Zev A.; Reiter, Robert E.			Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance	NATURE MEDICINE			English	Article							MESENCHYMAL TRANSITION; ANDROGEN RECEPTOR; ANTITUMOR-ACTIVITY; STEM-CELLS; PROGRESSION; THERAPY; INDEPENDENCE; INCREASES; PATHWAY; BIOLOGY	The transition from androgen-dependent to castration-resistant prostate cancer (CRPC) is a lethal event of uncertain molecular etiology. Comparing gene expression in isogenic androgen-dependent and CRPC xenografts, we found a reproducible increase in N-cadherin expression, which was also elevated in primary and metastatic tumors of individuals with CRPC. Ectopic expression of N-cadherin in nonmetastatic, androgen-dependent prostate cancer models caused castration resistance, invasion and metastasis. Monoclonal antibodies against the ectodomain of N-cadherin reduced proliferation, adhesion and invasion of prostate cancer cells in vitro. In vivo, these antibodies slowed the growth of multiple established CRPC xenografts, blocked local invasion and metastasis and, at higher doses, led to complete regression. N-cadherin-specific antibodies markedly delayed the time to emergence of castration resistance, markedly affected tumor histology and angiogenesis, and reduced both AKT serine-threonine kinase activity and serum interleukin-8 (IL-8) secretion. These data indicate that N-cadherin is a major cause of both prostate cancer metastasis and castration resistance. Therapeutic targeting of this factor with monoclonal antibodies may have considerable clinical benefit. (C) 2010 Nature America, Inc. All rights reserved.	[Tanaka, Hiroshi; Kono, Evelyn; Tran, Chau P.; Yamashiro, Joyce; Shimomura, Tatsuya; Wada, Robert; An, Jaibin; Rettig, Matthew B.; Reiter, Robert E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA; [Tanaka, Hiroshi; Kono, Evelyn; Tran, Chau P.; Yamashiro, Joyce; Shimomura, Tatsuya; Huang, Jiaoti; Rettig, Matthew B.; Wainberg, Zev A.; Reiter, Robert E.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Miyazaki, Hideyo] Univ Tokyo, Dept Urol, Tokyo, Japan; [Fazli, Ladan; Gleave, Martin] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V5Z 1M9, Canada; [Huang, Jiaoti] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; [Vessella, Robert L.] Univ Washington, Med Ctr, Dept Urol, Puget Sound Vet Hlth Care Adm, Seattle, WA 98195 USA; [An, Jaibin; Rettig, Matthew B.] Vet Affairs Greater Los Angeles Healthcare Syst W, Dept Med, Los Angeles, CA USA; [Horvath, Steven] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Horvath, Steven] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA; [Wainberg, Zev A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Reiter, Robert E.] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Tokyo; University of British Columbia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Reiter, RE (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA.	rreiter@mednet.ucla.edu	Tran, Chau/GRX-4633-2022	Huang, Jiaoti/0000-0003-1195-1998	US National Cancer Institute Prostate Cancer SPORE at the University of California-Los Angeles [P50CA092131-09]; US Department of Defense [W81XWH-06-1-0324, W81XWH-09-1-0630, PC061456]; Takeda Pharmaceuticals; Jean Perkins Foundation; American Cancer Society [RSG-07-092-01-TBE]; NATIONAL CANCER INSTITUTE [P50CA092131] Funding Source: NIH RePORTER	US National Cancer Institute Prostate Cancer SPORE at the University of California-Los Angeles(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Defense(United States Department of Defense); Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Jean Perkins Foundation; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in parts by the US National Cancer Institute Prostate Cancer SPORE at the University of California-Los Angeles (P50CA092131-09 to R. E. R.), US Department of Defense Prostate Cancer Research grants (W81XWH-06-1-0324 to Z.A.W., W81XWH-09-1-0630 to R. E. R. and M. B. R., PC061456 to J.H.), Takeda Pharmaceuticals, the Jean Perkins Foundation and the American Cancer Society (RSG-07-092-01-TBE to J.H.). We also thank S. and L. Resnick, the Prostate Cancer Foundation and the Luskin Foundation for generous support and J. Said and N. Doan for immunohistochemical assessments. LNCaP-CL1 cells were provided by C. L. Tso (University of California-Los Angeles). Plasmid p Delta VPR was provided by I. Chen (University of California-Los Angeles).	Araki S, 2007, CANCER RES, V67, P6854, DOI 10.1158/0008-5472.CAN-07-1162; Attard G, 2009, CANCER RES, V69, P4937, DOI 10.1158/0008-5472.CAN-08-4531; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Domingo-Domenech J, 2006, CLIN CANCER RES, V12, P5578, DOI 10.1158/1078-0432.CCR-05-2767; Gleave M, 2005, CANCER CHEMOTH PHARM, V56, pS47, DOI 10.1007/s00280-005-0098-0; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Gu Z, 2000, ONCOGENE, V19, P1288, DOI 10.1038/sj.onc.1203426; Gu ZN, 2005, CLIN CANCER RES, V11, P2237, DOI 10.1158/1078-0432.CCR-04-0356; Hara T, 2008, CANCER RES, V68, P1128, DOI 10.1158/0008-5472.CAN-07-1929; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Isaacs JT, 1999, UROL CLIN N AM, V26, P263, DOI 10.1016/S0094-0143(05)70066-5; Jaggi M, 2006, PROSTATE, V66, P193, DOI 10.1002/pros.20334; Kim JB, 2000, J CELL BIOL, V151, P1193, DOI 10.1083/jcb.151.6.1193; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Lassi K, 2009, CURR OPIN ONCOL, V21, P260, DOI 10.1097/CCO.0b013e32832a1868; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mason MJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-327; Mellado B, 2009, CLIN TRANSL ONCOL, V11, P5, DOI 10.1007/s12094-009-0304-3; Rizzi F, 2008, J PHYSIOL PHARMACOL, V59, P265; Roudier MP, 2003, HUM PATHOL, V34, P646, DOI 10.1016/S0046-8177(03)00190-4; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Sharifi N, 2006, CANCER BIOL THER, V5, P901, DOI 10.4161/cbt.5.8.2949; Suzuki H, 2003, ENDOCR-RELAT CANCER, V10, P209, DOI 10.1677/erc.0.0100209; Tomita K, 2000, CANCER RES, V60, P3650; Tran NL, 2002, J BIOL CHEM, V277, P32905, DOI 10.1074/jbc.M200300200; Tso CL, 2000, CANCER J, V6, P220	28	240	259	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2010	16	12					1414	U96		10.1038/nm.2236	http://dx.doi.org/10.1038/nm.2236			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21057494	Green Accepted			2022-12-25	WOS:000285048900035
J	Vissers, LELM; de Ligt, J; Gilissen, C; Janssen, I; Steehouwer, M; de Vries, P; van Lier, B; Arts, P; Wieskamp, N; del Rosario, M; van Bon, BWM; Hoischen, A; de Vries, BBA; Brunner, HG; Veltman, JA				Vissers, Lisenka E. L. M.; de Ligt, Joep; Gilissen, Christian; Janssen, Irene; Steehouwer, Marloes; de Vries, Petra; van Lier, Bart; Arts, Peer; Wieskamp, Nienke; del Rosario, Marisol; van Bon, Bregje W. M.; Hoischen, Alexander; de Vries, Bert B. A.; Brunner, Han G.; Veltman, Joris A.			A de novo paradigm for mental retardation	NATURE GENETICS			English	Article							MUTATIONS; DYNEIN; GENE; MICE	The per-generation mutation rate in humans is high. De novo mutations may compensate for allele loss due to severely reduced fecundity in common neurodevelopmental and psychiatric diseases, explaining a major paradox in evolutionary genetic theory. Here we used a family based exome sequencing approach to test this de novo mutation hypothesis in ten individuals with unexplained mental retardation. We identified and validated unique non-synonymous de novo mutations in nine genes. Six of these, identified in six different individuals, are likely to be pathogenic based on gene function, evolutionary conservation and mutation impact. Our findings provide strong experimental support for a de novo paradigm for mental retardation. Together with de novo copy number variation, de novo point mutations of large effect could explain the majority of all mental retardation cases in the population.	[Vissers, Lisenka E. L. M.; de Ligt, Joep; Gilissen, Christian; Janssen, Irene; Steehouwer, Marloes; de Vries, Petra; van Lier, Bart; Arts, Peer; Wieskamp, Nienke; del Rosario, Marisol; van Bon, Bregje W. M.; Hoischen, Alexander; de Vries, Bert B. A.; Brunner, Han G.; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Vissers, Lisenka E. L. M.; de Ligt, Joep; Gilissen, Christian; Janssen, Irene; Steehouwer, Marloes; de Vries, Petra; van Lier, Bart; Arts, Peer; Wieskamp, Nienke; del Rosario, Marisol; van Bon, Bregje W. M.; Hoischen, Alexander; de Vries, Bert B. A.; Brunner, Han G.; Veltman, Joris A.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Disorders, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Brunner, HG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands.	h.brunner@antrg.umcn.nl; j.veltman@antrg.umcn.nl	Janssen, Irene M/V-3667-2018; Arts, Peer/Q-4139-2019; Vissers, Lisenka ELM/A-2598-2015; Hoischen, Alexander/AGF-7293-2022; Hoischen, Alexander/D-1282-2013; van Bon, Bregje/Q-2445-2015; Gilissen, Christian/E-5246-2012; Veltman, Joris A/F-5128-2010; Brunner, Han/C-9928-2013; van Bon, Bregje/D-3720-2013	Arts, Peer/0000-0002-6742-6239; Vissers, Lisenka ELM/0000-0001-6470-5497; Hoischen, Alexander/0000-0002-8072-4476; Hoischen, Alexander/0000-0002-8072-4476; van Bon, Bregje/0000-0003-2234-0105; Gilissen, Christian/0000-0003-1693-9699; Veltman, Joris A/0000-0002-3218-8250; de Ligt, Joep/0000-0002-0348-419X				Chen XJ, 2007, J NEUROSCI, V27, P14515, DOI 10.1523/JNEUROSCI.4338-07.2007; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Forlani G, 2010, HUM MOL GENET, V19, P3114, DOI 10.1093/hmg/ddq214; Giannandrea M, 2010, AM J HUM GENET, V86, P185, DOI 10.1016/j.ajhg.2010.01.011; Hahm KM, 2004, MOL CELL BIOL, V24, P2074, DOI 10.1128/MCB.24.5.2074-2082.2004; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; He Y, 2008, J NEUROCHEM, V106, P1493, DOI 10.1111/j.1471-4159.2008.05486.x; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Keller MC, 2006, BEHAV BRAIN SCI, V29, P385, DOI 10.1017/S0140525X06009095; Lee CJ, 2002, MOL BRAIN RES, V106, P151, DOI 10.1016/S0169-328X(02)00439-4; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Mulero JJ, 2002, IMMUNOGENETICS, V54, P293, DOI 10.1007/s00251-002-0467-3; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Sobreira NLM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000991; TAGGART RT, 1986, AM J HUM GENET, V38, P848; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Tsujikawa M, 2007, P NATL ACAD SCI USA, V104, P14819, DOI 10.1073/pnas.0700178104; Uher R, 2009, MOL PSYCHIATR, V14, P1072, DOI 10.1038/mp.2009.85; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Veraksa A, 2002, GENESIS, V33, P67, DOI 10.1002/gene.10090; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Whibley AC, 2010, AM J HUM GENET, V87, P173, DOI 10.1016/j.ajhg.2010.06.017	31	584	601	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2010	42	12					1109	+		10.1038/ng.712	http://dx.doi.org/10.1038/ng.712			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684UZ	21076407				2022-12-25	WOS:000284578800014
J	Huang, XH; Wei, XH; Sang, T; Zhao, QA; Feng, Q; Zhao, Y; Li, CY; Zhu, CR; Lu, TT; Zhang, ZW; Li, M; Fan, DL; Guo, YL; Wang, A; Wang, L; Deng, LW; Li, WJ; Lu, YQ; Weng, QJ; Liu, KY; Huang, T; Zhou, TY; Jing, YF; Li, W; Lin, Z; Buckler, ES; Qian, QA; Zhang, QF; Li, JY; Han, B				Huang, Xuehui; Wei, Xinghua; Sang, Tao; Zhao, Qiang; Feng, Qi; Zhao, Yan; Li, Canyang; Zhu, Chuanrang; Lu, Tingting; Zhang, Zhiwu; Li, Meng; Fan, Danlin; Guo, Yunli; Wang, Ahong; Wang, Lu; Deng, Liuwei; Li, Wenjun; Lu, Yiqi; Weng, Qijun; Liu, Kunyan; Huang, Tao; Zhou, Taoying; Jing, Yufeng; Li, Wei; Lin, Zhang; Buckler, Edward S.; Qian, Qian; Zhang, Qi-Fa; Li, Jiayang; Han, Bin			Genome-wide association studies of 14 agronomic traits in rice landraces	NATURE GENETICS			English	Article							ARABIDOPSIS-THALIANA; HAPLOTYPE MAP; CULTIVATED RICE; ORYZA-SATIVA; MAIZE; GENE; DOMESTICATION; PHENOTYPES; VARIETIES; SEQUENCE	Uncovering the genetic basis of agronomic traits in crop landraces that have adapted to various agro-climatic conditions is important to world food security. Here we have identified similar to 3.6 million SNPs by sequencing 517 rice landraces and constructed a high-density haplotype map of the rice genome using a novel data-imputation method. We performed genome-wide association studies (GWAS) for 14 agronomic traits in the population of Oryza sativa indica subspecies. The loci identified through GWAS explained similar to 36% of the phenotypic variance, on average. The peak signals at six loci were tied closely to previously identified genes. This study provides a fundamental resource for rice genetics research and breeding, and demonstrates that an approach integrating second-generation genome sequencing and GWAS can be used as a powerful complementary strategy to classical biparental cross-mapping for dissecting complex traits in rice.	[Huang, Xuehui; Zhao, Qiang; Feng, Qi; Zhao, Yan; Li, Canyang; Zhu, Chuanrang; Lu, Tingting; Fan, Danlin; Guo, Yunli; Wang, Ahong; Wang, Lu; Deng, Liuwei; Li, Wenjun; Lu, Yiqi; Weng, Qijun; Liu, Kunyan; Huang, Tao; Zhou, Taoying; Jing, Yufeng; Li, Wei; Lin, Zhang; Han, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Ctr Gene Res, Shanghai, Peoples R China; [Huang, Xuehui; Zhao, Qiang; Han, Bin] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Wei, Xinghua; Qian, Qian] Chinese Acad Agr Sci, China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Zhiwu; Li, Meng; Buckler, Edward S.] Cornell Univ, Inst Genom Divers, Ithaca, NY USA; [Sang, Tao] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Li, Meng] Nanjing Agr Univ, Coll Agr, State Key Lab Crop Genet & Germplasm Enhancement, Natl Ctr Soybean Improvement, Nanjing, Peoples R China; [Buckler, Edward S.] USDA ARS, Ithaca, NY 14853 USA; [Zhang, Qi-Fa] Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Li, Jiayang] Chinese Acad Sci, Natl Ctr Plant Gene Res, Inst Genet & Dev Biol, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Cornell University; Michigan State University; Nanjing Agricultural University; United States Department of Agriculture (USDA); Huazhong Agricultural University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Han, B (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Ctr Gene Res, Shanghai, Peoples R China.	bhan@ncgr.ac.cn	Buckler, Edward/L-7651-2019; Zhang, Zhiwu/P-6156-2016; Zhang, zs/GXN-3521-2022; qian, qian/AAH-8708-2021; , 叮当๑/AAZ-9709-2020; Buckler, Edward/GPS-4932-2022; Li, Jiayang/AAG-4377-2020	Buckler, Edward/0000-0002-3100-371X; Zhang, Zhiwu/0000-0002-5784-9684; Huang, Xuehui/0000-0003-0529-1532	Chinese Academy of Sciences [KSCX2-YW-N-024]; China's Ministry of Science and Technology [2006AA10A102]; Ministry of Agriculture [2008ZX08009-002]; National Natural Science Foundation of China [30821004]	Chinese Academy of Sciences(Chinese Academy of Sciences); China's Ministry of Science and Technology(Ministry of Science and Technology, China); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank the China National Rice Research Institute for providing the landrace samples, R. A. Wing for critical reading of the manuscript, P. Hu for helping assay rice grain quality and Z. Ning for assistance with sequence alignment. This work was supported by the Chinese Academy of Sciences (KSCX2-YW-N-024), China's Ministry of Science and Technology (2006AA10A102) and Ministry of Agriculture (2008ZX08009-002) and the National Natural Science Foundation of China (30821004) to B.H.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Cui JJ, 2007, J INTEGR PLANT BIOL, V49, P678, DOI 10.1111/j.1744-7909.2007.00467.x; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gao ZY, 2003, SCI CHINA SER C, V46, P661, DOI 10.1360/03yc0099; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Huang XH, 2008, PLANT PHYSIOL, V148, P25, DOI 10.1104/pp.108.121491; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Juliano BO, 1985, CRITERIA TEST RICE G, P443; Kim SL, 2007, PLANT PHYSIOL, V145, P1484, DOI 10.1104/pp.107.103291; LITTLE RR, 1958, CEREAL CHEM, V35, P111; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Roberts A, 2007, BIOINFORMATICS, V23, pI401, DOI 10.1093/bioinformatics/btm220; Saitoh K, 2004, GENETICS, V168, P997, DOI 10.1534/genetics.103.018390; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; TAJIMA F, 1983, GENETICS, V105, P437; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; WANG ZY, 1995, PLANT J, V7, P613, DOI 10.1046/j.1365-313X.1995.7040613.x; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang DL, 2009, THEOR APPL GENET, V119, P1105, DOI 10.1007/s00122-009-1112-4; Zhang QF, 2008, MOL PLANT, V1, P715, DOI 10.1093/mp/ssn043; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005; Zong Y, 2007, NATURE, V449, P459, DOI 10.1038/nature06135	42	1298	1440	48	795	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					961	U76		10.1038/ng.695	http://dx.doi.org/10.1038/ng.695			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20972439				2022-12-25	WOS:000283540500012
J	Van Broeckhoven, C				Van Broeckhoven, Christine			The future of genetic research on neurodegeneration	NATURE MEDICINE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; MISSENSE MUTATIONS; TARDBP MUTATIONS; LOCUS; PROGRANULIN; DEMENTIA	Why, with all the progress in the field of neurodegeneration, do we still lack disease-modifying drugs that tackle the primary defect of severe cell loss? How much progress has been made toward this goal? Have we spent our time and resources wisely? And, most important, is there room for improvement? This commentary highlights several problems faced by researchers in studying the genetic etiology of neurodegenerative diseases and seeks to provide direction in overcoming some of these obstacles.	[Van Broeckhoven, Christine] VIB, Neurodegenerat Brain Dis Grp, Dept Mol Genet, Antwerp, Belgium; [Van Broeckhoven, Christine] Univ Antwerp, Neurogenet Lab, Inst Born Bunge, B-2020 Antwerp, Belgium	Flanders Institute for Biotechnology (VIB); University of Antwerp	Van Broeckhoven, C (corresponding author), VIB, Neurodegenerat Brain Dis Grp, Dept Mol Genet, Antwerp, Belgium.	christine.vanbroeckhoven@molgen.vib-ua.be	Van Broeckhoven, Christine/G-8362-2017; Van Broeckhoven, Christine/M-7853-2019	Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665	Flemish and Federal governments of Belgium; VIB; Institute Born-Bunge; University of Antwerp	Flemish and Federal governments of Belgium; VIB; Institute Born-Bunge; University of Antwerp	A number of the issues identified in this commentary were discussed in a session on genetics at the Herrenhausen Symposium on Neurodegeneration with P. St. George-Hyslop, P. Heutink and B. De Strooper, with added discussion points and commentary provided by the attendees at the conference. The research in my group has been funded by the Flemish and Federal governments of Belgium, the VIB, the Institute Born-Bunge and the University of Antwerp, as well as by many national and international governmental research funding agencies and charity organizations. The main contributors, however, are the many people with neurodegenerative disease and their families that generously participate in research and the efforts of researchers to pave the way toward new therapeutics.	Aisen PS, 2002, LANCET NEUROL, V1, P279, DOI 10.1016/S1474-4422(02)00133-3; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; BEECHAM GW, 2010, ALZHEIMERS DEMENT, V6, pS113; Bertram L, 2004, HUM MOL GENET, V13, pR135, DOI 10.1093/hmg/ddh077; Bettens K, 2010, HUM MOL GENET, V19, pR4, DOI 10.1093/hmg/ddq142; Brouwers N, 2008, NEUROLOGY, V71, P656, DOI 10.1212/01.wnl.0000319688.89790.7a; Clarimon J, 2009, NEUROBIOL AGING, V30, P1986, DOI 10.1016/j.neurobiolaging.2008.02.008; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Dermaut B, 2004, ANN NEUROL, V55, P617, DOI 10.1002/ana.20083; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Gijselinck I, 2008, HUM MUTAT, V29, P53, DOI 10.1002/humu.20651; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Jones L., 2012, ALZHEIMERS DEMENT, V6, pS113, DOI [10.1016/j.jalz.2010.05.350, DOI 10.1016/J.JALZ.2010.05.350]; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kauwe JSK, 2010, J ALZHEIMERS DIS, V21, P833, DOI 10.3233/JAD-2010-091711; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lambert JC, 2010, J ALZHEIMERS DIS, V20, P1107, DOI 10.3233/JAD-2010-100018; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Nalls MA, 2009, NEUROGENETICS, V10, P183, DOI 10.1007/s10048-009-0182-4; Nuytemans K, 2010, HUM MUTAT, V31, P763, DOI 10.1002/humu.21277; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Rademakers R, 2003, HUM MUTAT, V22, P409, DOI 10.1002/humu.10269; Rademakers R, 2005, AM J HUM GENET, V77, P643, DOI 10.1086/491749; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Rovelet-Lecrux A, 2010, J ALZHEIMERS DIS, V21, P897, DOI 10.3233/JAD-2010-100441; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shulman JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011244; Sleegers K, 2010, ANNU REV NEUROSCI, V33, P71, DOI 10.1146/annurev-neuro-060909-153144; Sleegers K, 2010, TRENDS GENET, V26, P84, DOI 10.1016/j.tig.2009.12.004; Sleegers K, 2009, NATURE, V458, P415, DOI 10.1038/458415a; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Theuns J, 2006, AM J HUM GENET, V78, P936, DOI 10.1086/504044; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Trompet S, 2010, J NEUROL, V257, P85, DOI 10.1007/s00415-009-5271-7; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; van der Zee J, 2007, HUM MUTAT, V28, P416, DOI 10.1002/humu.9484; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; ZUCHNER S, 2010, ALZHEIMERS DEMENT, V6, pS74	50	16	16	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2010	16	11					1215	1217		10.1038/nm.2225	http://dx.doi.org/10.1038/nm.2225			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21052076				2022-12-25	WOS:000283860100028
J	Quigley, M; Pereyra, F; Nilsson, B; Porichis, F; Fonseca, C; Eichbaum, Q; Julg, B; Jesneck, JL; Brosnahan, K; Imam, S; Russell, K; Toth, I; Piechocka-Trocha, A; Dolfi, D; Angelosanto, J; Crawford, A; Shin, H; Kwon, DS; Zupkosky, J; Francisco, L; Freeman, GJ; Wherry, EJ; Kaufmann, DE; Walker, BD; Ebert, B; Haining, WN				Quigley, Michael; Pereyra, Florencia; Nilsson, Bjoern; Porichis, Filippos; Fonseca, Catia; Eichbaum, Quentin; Julg, Boris; Jesneck, Jonathan L.; Brosnahan, Kathleen; Imam, Sabrina; Russell, Kate; Toth, Ildiko; Piechocka-Trocha, Alicja; Dolfi, Douglas; Angelosanto, Jill; Crawford, Alison; Shin, Haina; Kwon, Douglas S.; Zupkosky, Jennifer; Francisco, Loise; Freeman, Gordon J.; Wherry, E. John; Kaufmann, Daniel E.; Walker, Bruce D.; Ebert, Benjamin; Haining, W. Nicholas			Transcriptional analysis of HIV-specific CD8(+) T cells shows that PD-1 inhibits T cell function by upregulating BATF	NATURE MEDICINE			English	Article							CHRONIC VIRAL-INFECTION; MEMORY DIFFERENTIATION; NEGATIVE REGULATOR; GENE-EXPRESSION; ACTIVATION; EXHAUSTION; AP-1; NONPROGRESSORS; PERSISTENCE; RECEPTORS	CD8(+) T cells in chronic viral infections such as HIV develop functional defects including loss of interleukin-2 (IL-2) secretion and decreased proliferative potential that are collectively termed 'exhaustion' 1. Exhausted T cells express increased amounts of multiple inhibitory receptors, such as programmed death-1 (PD-1)(2,3), that contribute to impaired virus-specific T cell function. Although reversing PD-1 inhibition is therefore an attractive therapeutic strategy, the cellular mechanisms by which PD-1 ligation results in T cell inhibition are not fully understood. PD-1 is thought to limit T cell activation by attenuating T cell receptor (TCR) signaling(4,5). It is not known whether PD-1 also acts by upregulating genes in exhausted T cells that impair their function. Here we analyzed gene expression profiles from HIV-specific CD8(+) T cells in individuals with HIV and show that PD-1 coordinately upregulates a program of genes in exhausted CD8(+) T cells from humans and mice. This program includes upregulation of basic leucine transcription factor, ATF-like (BATF), a transcription factor in the AP-1 family. Enforced expression of BATF was sufficient to impair T cell proliferation and cytokine secretion, whereas BATF knockdown reduced PD-1 inhibition. Silencing BATF in T cells from individuals with chronic viremia rescued HIV-specific T cell function. Thus, inhibitory receptors can cause T cell exhaustion by upregulating genes-such as BATF-that inhibit T cell function. Such genes may provide new therapeutic opportunities to improve T cell immunity to HIV.	[Pereyra, Florencia; Porichis, Filippos; Eichbaum, Quentin; Julg, Boris; Toth, Ildiko; Piechocka-Trocha, Alicja; Kwon, Douglas S.; Zupkosky, Jennifer; Kaufmann, Daniel E.; Walker, Bruce D.] Massachusetts Gen Hosp, Ragon Inst, MIT, Charlestown, MA USA; [Pereyra, Florencia; Porichis, Filippos; Eichbaum, Quentin; Julg, Boris; Toth, Ildiko; Piechocka-Trocha, Alicja; Kwon, Douglas S.; Zupkosky, Jennifer; Kaufmann, Daniel E.; Walker, Bruce D.] Harvard Univ, Charlestown, MA USA; [Quigley, Michael; Fonseca, Catia; Jesneck, Jonathan L.; Brosnahan, Kathleen; Imam, Sabrina; Russell, Kate; Haining, W. Nicholas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Jesneck, Jonathan L.; Ebert, Benjamin] Broad Inst, Canc Program, Cambridge, MA USA; [Dolfi, Douglas; Angelosanto, Jill; Crawford, Alison; Shin, Haina; Wherry, E. John] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Dolfi, Douglas; Angelosanto, Jill; Crawford, Alison; Shin, Haina; Wherry, E. John] Univ Penn, Inst Immunol, Philadelphia, PA 19104 USA; [Francisco, Loise] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Freeman, Gordon J.] Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA USA; [Kaufmann, Daniel E.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Ebert, Benjamin] Harvard Univ, Sch Med, Div Hematol, Brigham & Womens Hosp, Boston, MA USA; [Haining, W. Nicholas] Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Pennsylvania; University of Pennsylvania; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Walker, BD (corresponding author), Massachusetts Gen Hosp, Ragon Inst, MIT, Charlestown, MA USA.	bwalker@partners.org; nicholas_haining@dfci.harvard.edu	crawford, alison/AAS-3155-2020; Wherry, John/ABI-1280-2020; Freeman, Gordon/AAC-5380-2019; Juelg, Boris/ABA-1955-2020; Crawford, Alison/N-3234-2014	Freeman, Gordon/0000-0002-7210-5616; Juelg, Boris/0000-0002-4687-9626; Crawford, Alison/0000-0002-4591-6341; Shin, Haina/0000-0002-1014-1451; Woodworth, Kate/0000-0001-9343-3355	US National Institutes of Health [AI082630, AI56299, HHSN26620050030C, HL092565]; International HIV Controllers Study; Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; NATIONAL CANCER INSTITUTE [R21CA129670] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030914, U19AI090023, P01AI056299, P01AI080192, U19AI082630, U19AI057266] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International HIV Controllers Study; Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank the subjects for taking part in the study; E. Cutrell, B. Baker, K. Moss, A. Rathod and C. Brume for coordinating sample management; and A. Sharpe, T. Golub, G. Lauer, M. Altfeld and H. Joffe for valuable discussions. This work was supported by US National Institutes of Health grants AI082630, AI56299, HHSN26620050030C and HL092565, the International HIV Controllers Study and the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Chemnitz JM, 2007, BLOOD, V110, P3226, DOI 10.1182/blood-2006-12-064360; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Clark GJ, 2009, TRENDS IMMUNOL, V30, P209, DOI 10.1016/j.it.2009.02.003; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Echlin DR, 2000, ONCOGENE, V19, P1752, DOI 10.1038/sj.onc.1203491; Foletta VC, 1998, J LEUKOCYTE BIOL, V63, P139, DOI 10.1002/jlb.63.2.139; Haining WN, 2008, J IMMUNOL, V181, P1859, DOI 10.4049/jimmunol.181.3.1859; Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001; Haining WN, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-44; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Nilsson B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r74; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Williams KL, 2001, EUR J IMMUNOL, V31, P1620, DOI 10.1002/1521-4141(200105)31:5<1620::AID-IMMU1620>3.0.CO;2-3; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	30	334	354	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2010	16	10					1147	U127		10.1038/nm.2232	http://dx.doi.org/10.1038/nm.2232			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20890291	Green Accepted			2022-12-25	WOS:000282644800046
J	Goetz, KB; Pfleiderer, M; Schneider, CK				Goetz, Karen B.; Pfleiderer, Michael; Schneider, Christian K.			First-in-human clinical trials with vaccines-what regulators want	NATURE BIOTECHNOLOGY			English	Article							MOLECULAR MIMICRY; VACCINATION; MEASLES		[Goetz, Karen B.; Pfleiderer, Michael; Schneider, Christian K.] Paul Ehrlich Inst, Fed Inst Vaccines & Biomed, D-6070 Langen, Germany; [Schneider, Christian K.] Twincore Ctr Expt & Clin Infect Res, Hannover, Germany	Paul Ehrlich Institute; Helmholtz Association; Helmholtz-Center for Infection Research	Goetz, KB (corresponding author), Paul Ehrlich Inst, Fed Inst Vaccines & Biomed, D-6070 Langen, Germany.	goeka@pei.de						A, 1997, CPMPSWP46595 EMA; Aguilar JC, 2007, VACCINE, V25, P3752, DOI 10.1016/j.vaccine.2007.01.111; *EMA, 1998, CPMPICH30295 EMA; EMA, 2006, EMACHMPVWP2448942006; *EMA, 2008, EMACHMPBWP4731912006; *EMA, 2009, EMACHMPEWP6927022008; *EMA, 2006, CHMPVWP16465305; EMA, 2005, EMACHMPVEG1347162004; *EMA, 2007, CHMPBMWP1016952006 E; *EUR MED AG, 2007, CHMPSWP2836707 EMA; Gibson GG, 2007, XENOBIOTICA, V37, P1013, DOI 10.1080/00498250701649873; Gran B, 1999, ANN NEUROL, V45, P559, DOI 10.1002/1531-8249(199905)45:5<559::AID-ANA3>3.0.CO;2-Q; Hughes RAC, 1999, J NEUROIMMUNOL, V100, P74, DOI 10.1016/S0165-5728(99)00195-2; *ICH, 2008, TOP E 5 R1 ETHN FACT; *ICH, 1997, GUID E8 GEN CONS CLI; Knudsen KM, 1996, INT J EPIDEMIOL, V25, P665, DOI 10.1093/ije/25.3.665; Marth E, 2001, VACCINE, V20, P532, DOI 10.1016/S0264-410X(01)00329-2; NATHANSON N, 1963, AM J HYG, V78, P16, DOI 10.1093/oxfordjournals.aje.a120327; Neuenschwander B, 2008, STAT MED, V27, P2420, DOI 10.1002/sim.3230; Plotkin S.VidorE, 2009, VACCINES; Polack FP, 2007, PEDIATR RES, V62, P111, DOI 10.1203/PDR.0b013e3180686ce0; Schneider Christian K, 2008, Expert Rev Clin Pharmacol, V1, P327, DOI 10.1586/17512433.1.3.327; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Thall PF, 2003, INT J GYNECOL CANCER, V13, P251, DOI 10.1046/j.1525-1438.2003.13202.x; U.S. Food and Drug Administration, 2002, GUID IND REV EST SAF; Wucherpfennig KW, 2001, J AUTOIMMUN, V16, P293, DOI 10.1006/jaut.2000.0499; Yang ZY, 2005, P NATL ACAD SCI USA, V102, P797, DOI 10.1073/pnas.0409065102; 2006, OFFICIAL J EUR UNION, V27	28	18	18	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2010	28	9					910	916		10.1038/nbt0910-910	http://dx.doi.org/10.1038/nbt0910-910			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	648UF	20829825	Green Published, Bronze			2022-12-25	WOS:000281719100013
J	Cahalan, SM; Gonzalez-Cabrera, PJ; Sarkisyan, G; Nguyen, N; Schaeffer, MT; Huang, LM; Yeager, A; Clemons, B; Scott, F; Rosen, H				Cahalan, Stuart M.; Gonzalez-Cabrera, Pedro J.; Sarkisyan, Gor; Nhan Nguyen; Schaeffer, Marie-Therese; Huang, Liming; Yeager, Adam; Clemons, Bryan; Scott, Fiona; Rosen, Hugh			Actions of a picomolar short-acting S1P(1) agonist in S1P(1)-eGFP knock-in mice	NATURE CHEMICAL BIOLOGY			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; PROTEIN-COUPLED RECEPTOR; ORAL FINGOLIMOD FTY720; LYMPHOCYTE EGRESS; T-CELLS; CONTROLLED-TRIAL; PHASE-II; SPHINGOSINE-1-PHOSPHATE; ACTIVATION; EDG-1	Sphingosine 1-phosphate receptor 1 (S1P(1)) is critical for lymphocyte recirculation and is a clinical target for treatment of multiple sclerosis. By generating a short-duration S1P(1) agonist and mice in which fluorescently tagged S1P(1) replaces wild-type receptor, we elucidate physiological and agonist-perturbed changes in expression of S1P(1) at a subcellular level in vivo. We demonstrate differential downregulation of S1P(1) on lymphocytes and endothelia after agonist treatment.	[Cahalan, Stuart M.; Gonzalez-Cabrera, Pedro J.; Nhan Nguyen; Schaeffer, Marie-Therese; Rosen, Hugh] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Cahalan, Stuart M.; Sarkisyan, Gor; Rosen, Hugh] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; [Huang, Liming; Yeager, Adam; Clemons, Bryan; Scott, Fiona] Receptos Pharmaceut Inc, La Jolla, CA USA	Scripps Research Institute; Scripps Research Institute	Rosen, H (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.	hrosen@scripps.edu			US National Institutes of Health Immunology [T32 AI007606]; US National Institutes of Health [NIH U01 AI074564, R01 AI055509, U54 MH084512]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055509, U01AI074564, T32AI007606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH074404, U54MH084512] Funding Source: NIH RePORTER	US National Institutes of Health Immunology; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We acknowledge R. Proia and M. Capecchi for providing plasmids used in the generation of the Edg1<SUP>eGFP</SUP> targeting construct. We thank G. Martin and S. Kupriyanov for aid in generating Edg1<SUP>eGFP/eGFP</SUP> mice. We thank B. Webb for aid with mass spectrometry. S. M. C. is supported by a US National Institutes of Health Immunology Training Grant T32 AI007606. H. R. is supported by US National Institutes of Health Grants NIH U01 AI074564, R01 AI055509 and U54 MH084512.	Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Allende ML, 2002, BBA-MOL CELL BIOL L, V1582, P222, DOI 10.1016/S1388-1981(02)00175-0; Comi G, 2010, MULT SCLER, V16, P197, DOI 10.1177/1352458509357065; Gonzalez-Cabrera PJ, 2008, MOL PHARMACOL, V74, P1308, DOI 10.1124/mol.108.049783; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Grigorova IL, 2009, NAT IMMUNOL, V10, P58, DOI 10.1038/ni.1682; Igarashi J, 2000, J BIOL CHEM, V275, P32363, DOI 10.1074/jbc.M003075200; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Marsolais D, 2008, MOL PHARMACOL, V74, P896, DOI 10.1124/mol.108.048769; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; O'Connor P, 2009, NEUROLOGY, V72, P73, DOI 10.1212/01.wnl.0000338569.32367.3d; Okamoto H, 1998, J BIOL CHEM, V273, P27104, DOI 10.1074/jbc.273.42.27104; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Salvadori M, 2006, AM J TRANSPLANT, V6, P2912, DOI 10.1111/j.1600-6143.2006.01552.x; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Thangada S, 2010, J EXP MED, V207, P1475, DOI 10.1084/jem.20091343; Van Doorn R, 2010, GLIA, V58, P1465, DOI 10.1002/glia.21021; Wang WG, 2007, J IMMUNOL, V178, P4885, DOI 10.4049/jimmunol.178.8.4885; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269	25	57	59	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2011	7	5					254	256		10.1038/nchembio.547	http://dx.doi.org/10.1038/nchembio.547			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751KZ	21445057	Green Accepted			2022-12-25	WOS:000289617800006
J	Rooryck, C; Diaz-Font, A; Osborn, DPS; Chabchoub, E; Hernandez-Hernandez, V; Shamseldin, H; Kenny, J; Waters, A; Jenkins, D; Al Kaissi, A; Leal, GF; Dallapiccola, B; Carnevale, F; Bitner-Glindzicz, M; Lees, M; Hennekam, R; Stanier, P; Burns, AJ; Peeters, H; Alkuraya, FS; Beales, PL				Rooryck, Caroline; Diaz-Font, Anna; Osborn, Daniel P. S.; Chabchoub, Elyes; Hernandez-Hernandez, Victor; Shamseldin, Hanan; Kenny, Joanna; Waters, Aoife; Jenkins, Dagan; Al Kaissi, Ali; Leal, Gabriela F.; Dallapiccola, Bruno; Carnevale, Franco; Bitner-Glindzicz, Maria; Lees, Melissa; Hennekam, Raoul; Stanier, Philip; Burns, Alan J.; Peeters, Hilde; Alkuraya, Fowzan S.; Beales, Philip L.			Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome	NATURE GENETICS			English	Article							UMBILICAL ANOMALIES; ANTERIOR-CHAMBER; ACTIVATION; SKELETAL; PROTEIN; SIBS; CARNEVALE; COLLECTIN; MALPUECH; PTOSIS	3MC syndrome has been proposed as a unifying term encompassing the overlapping Carnevale, Mingarelli, Malpuech and Michels syndromes. These rare autosomal recessive disorders exhibit a spectrum of developmental features, including characteristic facial dysmorphism, cleft lip and/or palate, craniosynostosis, learning disability and genital, limb and vesicorenal anomalies. Here we studied 11 families with 3MC syndrome and identified two mutated genes, COLEC11 and MASP1, both of which encode proteins in the lectin complement pathway (collectin kidney 1 (CL-K1) and MASP-1 and MASP-3, respectively). CL-K1 is highly expressed in embryonic murine craniofacial cartilage, heart, bronchi, kidney and vertebral bodies. Zebrafish morphants for either gene develop pigmentary defects and severe craniofacial abnormalities. Finally, we show that CL-K1 serves as a guidance cue for neural crest cell migration. Together, these findings demonstrate a role for complement pathway factors in fundamental developmental processes and in the etiology of 3MC syndrome.	[Rooryck, Caroline; Diaz-Font, Anna; Osborn, Daniel P. S.; Hernandez-Hernandez, Victor; Waters, Aoife; Jenkins, Dagan; Beales, Philip L.] UCL, Inst Child Hlth, Mol Med Unit, London, England; [Chabchoub, Elyes; Peeters, Hilde] Univ Hosp Leuven, Ctr Human Genet, Louvain, Belgium; [Shamseldin, Hanan; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dev Genet Unit, Dept Genet, Riyadh 11211, Saudi Arabia; [Kenny, Joanna; Bitner-Glindzicz, Maria; Lees, Melissa] Great Ormond St Hosp Sick Children, Dept Clin Genet, London, England; [Leal, Gabriela F.] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil; [Dallapiccola, Bruno] Bambino Gesu Children Hosp, IRCCS, Rome, Italy; [Carnevale, Franco] Univ Bari, Dept Pediat, Bari, Italy; [Stanier, Philip; Burns, Alan J.] UCL, Neural Dev Unit, Inst Child Hlth, London, England; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh, Saudi Arabia; [Alkuraya, Fowzan S.] King Khalid Univ Hosp, Dept Pediat, Riyadh 11472, Saudi Arabia; [Alkuraya, Fowzan S.] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia; [Al Kaissi, Ali] Hanusch Hosp, Ludwig Boltzmann Inst Osteol, Meidlin Med Dept 4, Hanusch Hosp WGKK & AUVA Trauma Ctr, Vienna, Austria	University of London; University College London; KU Leuven; University Hospital Leuven; King Faisal Specialist Hospital & Research Center; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Instituto de Medicina Integral Professor Fernando Figueira (IMIP); IRCCS Bambino Gesu; Universita degli Studi di Bari Aldo Moro; University of London; University College London; Alfaisal University; King Saud University; King Khalid University Hospital; King Saud University; Ludwig Boltzmann Institute; WGKK - Hanusch Hospital	Beales, PL (corresponding author), UCL, Inst Child Hlth, Mol Med Unit, London, England.	p.beales@ucl.ac.uk	Alkuraya, Fowzan S./A-1542-2009; Stanier, Philip/C-1593-2008; ROORYCK, Caroline/M-4565-2014; Beales, Philip L/C-7367-2009; Kaissi, Ali Abdul Salam Awni Al/H-2804-2019; Burns, Alan J/C-4988-2008; Osborn, Daniel/ABG-6699-2020; Peeters, Hilde/AAA-7338-2020; Bitner-Glindzicz, Maria/A-4231-2009; Burns, Alan/AAC-1266-2022; Dallapiccola, Bruno/K-8692-2016	Alkuraya, Fowzan S./0000-0003-4158-341X; Stanier, Philip/0000-0001-9340-8117; Kaissi, Ali Abdul Salam Awni Al/0000-0003-1599-6050; Chabchoub, Elyes/0000-0001-9512-4476; Burns, Alan/0000-0002-1725-1071; Osborn, Daniel/0000-0002-5266-404X; Dallapiccola, Bruno/0000-0002-5031-1013; Peeters, Hilde/0000-0002-7295-3375; Kenny, Joanna/0000-0002-2271-1941; Rooryck, Caroline/0000-0002-9789-3591	NEWLIFE; Wellcome Trust; Dubai Harvard Foundation for Medical Research; University Hospital of Bordeaux; UK Medical Research Council; EU [201804-EUCILIA]; MRC [G0801843, G0802138] Funding Source: UKRI; Medical Research Council [G0801843, G0802138] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1241, V1239] Funding Source: researchfish	NEWLIFE; Wellcome Trust(Wellcome TrustEuropean Commission); Dubai Harvard Foundation for Medical Research; University Hospital of Bordeaux; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity	This work was supported in part by grants from NEWLIFE (P. L. B., A.D.-F. and C. R.), the Wellcome Trust (P. L. B.), Dubai Harvard Foundation for Medical Research (F. S. A.), the University Hospital of Bordeaux (C. R.), the UK Medical Research Council (A. W.) and EU-FP7 (201804-EUCILIA) (V. H.-H., D.J. and D.P.S.O.). P. L. B. is a Wellcome Trust Senior Research Fellow.	Al Kaissi A, 2007, AM J MED GENET A, V143A, P349, DOI 10.1002/ajmg.a.31610; CARNEVALE F, 1989, AM J MED GENET, V33, P186, DOI 10.1002/ajmg.1320330210; Cortesio CL, 2006, ARCH BIOCHEM BIOPHYS, V449, P164, DOI 10.1016/j.abb.2006.02.006; Dahl MR, 2001, IMMUNITY, V15, P127, DOI 10.1016/S1074-7613(01)00161-3; Degn SE, 2007, IMMUNOBIOLOGY, V212, P301, DOI 10.1016/j.imbio.2006.12.004; Degn SE, 2009, J IMMUNOL, V183, P7371, DOI 10.4049/jimmunol.0902388; Delalande JM, 2008, DEV BIOL, V313, P279, DOI 10.1016/j.ydbio.2007.10.028; EZEKOWITZ RAB, 1988, J EXP MED, V167, P1034, DOI 10.1084/jem.167.3.1034; Hansen S, 2010, J IMMUNOL, V185, P6096, DOI 10.4049/jimmunol.1002185; Keshi H, 2006, MICROBIOL IMMUNOL, V50, P1001, DOI 10.1111/j.1348-0421.2006.tb03868.x; Leal GF, 2008, AM J MED GENET A, V146A, P1059, DOI 10.1002/ajmg.a.32252; Leal GF, 2007, AM J MED GENET A, V143A, P2747, DOI 10.1002/ajmg.a.32029; Lynch NJ, 2005, J IMMUNOL, V174, P4998, DOI 10.4049/jimmunol.174.8.4998; MALPUECH G, 1983, AM J MED GENET, V16, P475, DOI 10.1002/ajmg.1320160405; MICHELS VV, 1978, J PEDIATR-US, V93, P444, DOI 10.1016/S0022-3476(78)81154-8; Mingarelli R, 1996, J MED GENET, V33, P884, DOI 10.1136/jmg.33.10.884; Moller-Kristensen M, 2007, INT IMMUNOL, V19, P141, DOI 10.1093/intimm/dxl131; Priolo M, 2007, EUR J MED GENET, V50, P139, DOI 10.1016/j.ejmg.2006.10.004; Sirmaci A, 2010, AM J HUM GENET, V87, P679, DOI 10.1016/j.ajhg.2010.09.018; Skjoedt MO, 2010, J BIOL CHEM, V285, P8234, DOI 10.1074/jbc.M109.065805; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Zundel S, 2004, J IMMUNOL, V172, P4342, DOI 10.4049/jimmunol.172.7.4342	22	172	181	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2011	43	3					197	U36		10.1038/ng.757	http://dx.doi.org/10.1038/ng.757			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726BR	21258343	Green Accepted, Green Submitted			2022-12-25	WOS:000287693800009
J	Gupta, RD; Goldsmith, M; Ashani, Y; Simo, Y; Mullokandov, G; Bar, H; Ben-David, M; Leader, H; Margalit, R; Silman, I; Sussman, JL; Tawfik, DS				Gupta, Rinkoo D.; Goldsmith, Moshe; Ashani, Yacov; Simo, Yair; Mullokandov, Gavriel; Bar, Hagit; Ben-David, Moshe; Leader, Haim; Margalit, Raanan; Silman, Israel; Sussman, Joel L.; Tawfik, Dan S.			Directed evolution of hydrolases for prevention of G-type nerve agent intoxication	NATURE CHEMICAL BIOLOGY			English	Article							STEREOSELECTIVE HYDROLYSIS; ENZYME LIBRARIES; ORGANOPHOSPHATES; TOXICITY; PROPHYLAXIS; PROTECTION; VARIANTS; ANALOGS; PON1	Organophosphate nerve agents are extremely lethal compounds. Rapid in vivo organophosphate clearance requires bioscavenging enzymes with catalytic efficiencies of >10(7) (M-1 min(-1)). Although serum paraoxonase (PON1) is a leading candidate for such a treatment, it hydrolyzes the toxic S-p isomers of G-agents with very slow rates. We improved PON1's catalytic efficiency by combining random and targeted mutagenesis with high-throughput screening using fluorogenic analogs in emulsion compartments. We thereby enhanced PON1's activity toward the coumarin analog of S-p-cyclosarin by similar to 10(5)-fold. We also developed a direct screen for protection of acetylcholinesterase from inactivation by nerve agents and used it to isolate variants that degrade the toxic isomer of the coumarin analog and cyclosarin itself with k(cat)/K-M similar to 10(7) M-1 min(-1). We then demonstrated the in vivo prophylactic activity of an evolved variant. These evolved variants and the newly developed screens provide the basis for engineering PON1 for prophylaxis against other G-type agents.	[Gupta, Rinkoo D.; Goldsmith, Moshe; Simo, Yair; Mullokandov, Gavriel; Bar, Hagit; Tawfik, Dan S.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Ashani, Yacov; Ben-David, Moshe; Sussman, Joel L.] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Ashani, Yacov; Silman, Israel] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Leader, Haim] Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel; [Margalit, Raanan] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Gupta, RD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tawfik@weizmann.ac.il	Gupta, Rinkoo Devi/AAI-9528-2021	Gupta, Rinkoo Devi/0000-0003-1156-9596; Sussman, Joel/0000-0003-0306-3878	US National Institutes of Health [W81XWH-07-2-0020]; Defense Threat Reduction Agency [HDTRA 1-07-C-0024]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS058183] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Financial support by US National Institutes of Health (W81XWH-07-2-0020) and the Defense Threat Reduction Agency (HDTRA 1-07-C-0024) is gratefully acknowledged. We thank D. Tal and the Israel Structural Proteomics Centre for assistance with protein production and T. Magliery, D. Lenz and D. Cerasoli for a fruitful collaboration.	Aharoni A, 2005, CHEM BIOL, V12, P1281, DOI 10.1016/j.chembiol.2005.09.012; Aharoni A, 2004, P NATL ACAD SCI USA, V101, P482, DOI 10.1073/pnas.2536901100; Amitai G, 2006, FEBS J, V273, P1906, DOI 10.1111/j.1742-4658.2006.05198.x; Amitai G, 2007, TOXICOLOGY, V233, P187, DOI 10.1016/j.tox.2006.09.020; Ashani Y, 2004, TOXICOL SCI, V77, P358, DOI 10.1093/toxsci/kfh012; Ashani Y, 2010, CHEM-BIOL INTERACT, V187, P362, DOI 10.1016/j.cbi.2010.02.039; ASHANI Y, 1991, LIFE SCI, V49, P367, DOI 10.1016/0024-3205(91)90444-G; BROOMFIELD CA, 1993, CHEM-BIOL INTERACT, V87, P279, DOI 10.1016/0009-2797(93)90055-4; Cho CMH, 2006, PROTEIN ENG DES SEL, V19, P99, DOI 10.1093/protein/gzj007; Ditargiani RC, 2010, CHEM-BIOL INTERACT, V187, P349, DOI 10.1016/j.cbi.2010.02.021; Doctor BP, 2005, CHEM-BIOL INTERACT, V157, P167, DOI 10.1016/j.cbi.2005.10.024; Fox RJ, 2007, NAT BIOTECHNOL, V25, P338, DOI 10.1038/nbt1286; Gaidukov Leonid, 2009, BMC Clin Pharmacol, V9, P18, DOI 10.1186/1472-6904-9-18; Ghanem Eman, 2005, Toxicol Appl Pharmacol, V207, P459, DOI 10.1016/j.taap.2005.02.025; Gupta RD, 2008, NAT METHODS, V5, P939, DOI 10.1038/nmeth.1262; Harvey SP, 2005, ENZYME MICROB TECH, V37, P547, DOI 10.1016/j.enzmictec.2005.04.004; Herman A, 2007, PROTEIN ENG DES SEL, V20, P219, DOI 10.1093/protein/gzm014; Kassa J, 2009, TOXICOL MECH METHOD, V19, P547, DOI 10.3109/15376510903350371; Lenz DE, 2007, TOXICOLOGY, V233, P31, DOI 10.1016/j.tox.2006.11.066; LI WF, 1995, TOXICOL LETT, V76, P219, DOI 10.1016/0378-4274(95)80006-Y; Li WS, 2001, BIOORGAN MED CHEM, V9, P2083, DOI 10.1016/S0968-0896(01)00113-4; Luo CY, 2010, CHEM-BIOL INTERACT, V187, P185, DOI 10.1016/j.cbi.2010.01.018; Mastrobattista E, 2005, CHEM BIOL, V12, P1291, DOI 10.1016/j.chembiol.2005.09.016; Melzer M, 2009, J AM CHEM SOC, V131, P17226, DOI 10.1021/ja905444g; Reetz MT, 2008, CHEMBIOCHEM, V9, P1797, DOI 10.1002/cbic.200800298; Romano J. A., 2008, CHEM WARFARE AGENTS; Shapiro MG, 2010, NAT BIOTECHNOL, V28, P264, DOI 10.1038/nbt.1609; Tsai PC, 2010, BIOCHEMISTRY-US, V49, P7978, DOI 10.1021/bi101056m	28	156	165	3	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2011	7	2					120	125		10.1038/NCHEMBIO.510	http://dx.doi.org/10.1038/NCHEMBIO.510			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	707XM	21217689				2022-12-25	WOS:000286324600013
J	Paragas, N; Qiu, AD; Zhang, QY; Samstein, B; Deng, SX; Schmidt-Ott, KM; Viltard, M; Yu, WQ; Forster, CS; Gong, GL; Liu, YD; Kulkarni, R; Mori, K; Kalandadze, A; Ratner, AJ; Devarajan, P; Landry, DW; D'Agati, V; Lin, CS; Barasch, J				Paragas, Neal; Qiu, Andong; Zhang, Qingyin; Samstein, Benjamin; Deng, Shi-Xian; Schmidt-Ott, Kai M.; Viltard, Melanie; Yu, Wenqiang; Forster, Catherine S.; Gong, Gangli; Liu, Yidong; Kulkarni, Ritwij; Mori, Kiyoshi; Kalandadze, Avtandil; Ratner, Adam J.; Devarajan, Prasad; Landry, Donald W.; D'Agati, Vivette; Lin, Chyuan-Sheng; Barasch, Jonathan			The Ngal reporter mouse detects the response of the kidney to injury in real time	NATURE MEDICINE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; GLOMERULAR-FILTRATION-RATE; EARLY URINARY BIOMARKER; INNATE IMMUNE-RESPONSE; CARDIAC-SURGERY; ESCHERICHIA-COLI; EPITHELIAL-CELLS; SERUM CREATININE; RENAL INJURY; RAT-KIDNEY	Many proteins have been proposed to act as surrogate markers of organ damage, yet for many candidates the essential biomarker characteristics that link the protein to the injured organ have not yet been described. We generated an Ngal reporter mouse by inserting a double-fusion reporter gene encoding luciferase-2 and mCherry (Luc2-mC) into the Ngal (Lcn2) locus. The Ngal-Luc2-mC reporter accurately recapitulated the endogenous message and illuminated injuries in vivo in real time. In the kidney, Ngal-Luc2-mC imaging showed a sensitive, rapid, dose-dependent, reversible, and organ-and cell-specific relationship with tubular stress, which correlated with the level of urinary Ngal (uNgal). Unexpectedly, specific cells of the distal nephron were the source of uNgal. Cells isolated from Ngal-Luc2-mC mice also revealed both the onset and the resolution of the injury, and the actions of NF-kappa B inhibitors and antibiotics during infection. Thus, imaging of Ngal-Luc2-mC mice and cells identified injurious and reparative agents that affect kidney damage.	[Paragas, Neal; Qiu, Andong; Zhang, Qingyin; Samstein, Benjamin; Deng, Shi-Xian; Viltard, Melanie; Yu, Wenqiang; Forster, Catherine S.; Gong, Gangli; Liu, Yidong; Kulkarni, Ritwij; Kalandadze, Avtandil; Ratner, Adam J.; Landry, Donald W.; D'Agati, Vivette; Lin, Chyuan-Sheng; Barasch, Jonathan] Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA; [Schmidt-Ott, Kai M.] Max Delbruck Ctr Mol Med Berlin Buch, Berlin, Germany; [Mori, Kiyoshi] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Devarajan, Prasad] Cincinnati Childrens Hosp, Cincinnati, OH USA	Columbia University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Kyoto University; Cincinnati Children's Hospital Medical Center	Barasch, J (corresponding author), Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA.	jmb4@columbia.edu	Qiu, Andong/AAY-1179-2021; Mori, Kiyoshi/N-1267-2014; Samstein, Benjamin/AAJ-5846-2020; Schmidt-Ott, Kai/F-4588-2011	Mori, Kiyoshi/0000-0002-7285-8351; Samstein, Benjamin/0000-0002-3934-2564; Schmidt-Ott, Kai/0000-0002-7700-7142; Paragas, Neal/0000-0001-6084-8220; Ratner, Adam/0000-0003-1761-794X; Devarajan, Prasad/0000-0002-7847-8552; Forster, Catherine/0000-0002-6233-1070	Office of Columbia University Technology Ventures; US National Institute of Diabetes and Digestive and Kidney Diseases [DK-55388, DK-58872]; March of Dimes for Birth Defects; Glomerular Center of Columbia University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK055388, R01DK058872, R01DK073462] Funding Source: NIH RePORTER	Office of Columbia University Technology Ventures; US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); March of Dimes for Birth Defects(March of Dimes); Glomerular Center of Columbia University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful for the advice of Q. Al-Awqati and J.A. Oliver. This work was supported by a grant from the Office of Columbia University Technology Ventures. J.B., N.P. and A. Q. are supported by grants from the US National Institute of Diabetes and Digestive and Kidney Diseases (DK-55388 and DK-58872) and the March of Dimes for Birth Defects. Additional funding to J.B. was provided by the Glomerular Center of Columbia University.	Barasch J, 2004, NATURE, V432, P811, DOI 10.1038/432811a; Bennett M, 2008, CLIN J AM SOC NEPHRO, V3, P665, DOI 10.2215/CJN.04010907; Bolignano D, 2007, AM J NEPHROL, V27, P373, DOI 10.1159/000103912; BOSCH JP, 1983, AM J MED, V75, P943, DOI 10.1016/0002-9343(83)90873-2; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; Brzuszkiewicz E, 2006, P NATL ACAD SCI USA, V103, P12879, DOI 10.1073/pnas.0603038103; Chassin C, 2006, J IMMUNOL, V177, P4773, DOI 10.4049/jimmunol.177.7.4773; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Christensen EI, 2008, KIDNEY INT, V74, P1233, DOI 10.1038/ki.2008.421; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; Damman K, 2009, EUR J HEART FAIL, V11, P847, DOI 10.1093/eurjhf/hfp108; Di Mari JF, 1999, AM J PHYSIOL-RENAL, V277, pF195, DOI 10.1152/ajprenal.1999.277.2.F195; El-Achkar TM, 2006, AM J PHYSIOL-RENAL, V290, pF1034, DOI 10.1152/ajprenal.00414.2005; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Gong GL, 2009, BIOORG MED CHEM LETT, V19, P1191, DOI 10.1016/j.bmcl.2008.12.086; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Haase M, 2009, CRIT CARE MED, V37, P39, DOI 10.1097/CCM.0b013e318193216f; Haase-Fielitz A, 2009, NEPHROL DIAL TRANSPL, V24, P3349, DOI 10.1093/ndt/gfp234; Hall IE, 2010, J AM SOC NEPHROL, V21, P189, DOI 10.1681/ASN.2009030264; HAN KH, 2008, J AM SOC NEPHROL, V19, P1538; Heyman SN, 2010, KIDNEY INT, V77, P9, DOI 10.1038/ki.2009.347; Klausen P, 2005, EUR J HAEMATOL, V75, P332, DOI 10.1111/j.1600-0609.2005.00511.x; Kollisch G, 2005, IMMUNOLOGY, V114, P531, DOI 10.1111/j.1365-2567.2005.02122.x; Kumpers P, 2010, CRIT CARE, V14, DOI 10.1186/cc8861; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Li X, 2009, CURR OPIN CRIT CARE, V15, P481, DOI 10.1097/MCC.0b013e328332f69e; Lysenko ES, 2005, PLOS PATHOG, V1, P3, DOI 10.1371/journal.ppat.0010001; Mishra J, 2004, AM J NEPHROL, V24, P307, DOI 10.1159/000078452; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Newby LK, 1998, CIRCULATION, V98, P1853, DOI 10.1161/01.CIR.98.18.1853; Nickolas TL, 2008, ANN INTERN MED, V148, P810, DOI 10.7326/0003-4819-148-11-200806030-00003; Ramphal R, 2008, J IMMUNOL, V181, P586, DOI 10.4049/jimmunol.181.1.586; Rice BW, 2001, J BIOMED OPT, V6, P432, DOI 10.1117/1.1413210; Rosenberger C, 2008, KIDNEY INT, V73, P34, DOI 10.1038/sj.ki.5002567; Steen H, 2006, J AM COLL CARDIOL, V48, P2192, DOI 10.1016/j.jacc.2006.06.002; Supavekin S, 2003, KIDNEY INT, V63, P1714, DOI 10.1046/j.1523-1755.2003.00928.x; Waikar SS, 2010, KIDNEY INT, V78, P486, DOI 10.1038/ki.2010.165; Xie YL, 2008, BIOORG MED CHEM LETT, V18, P329, DOI 10.1016/j.bmcl.2007.10.100; ZHANG Z, 1995, MICROSURG, V16, P103, DOI 10.1002/micr.1920160212	42	298	323	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					216	U113		10.1038/nm.2290	http://dx.doi.org/10.1038/nm.2290			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21240264	Green Accepted			2022-12-25	WOS:000286969900031
J	Furuyama, K; Kawaguchi, Y; Akiyama, H; Horiguchi, M; Kodama, S; Kuhara, T; Hosokawa, S; Elbahrawy, A; Soeda, T; Koizumi, M; Masui, T; Kawaguchi, M; Takaori, K; Doi, R; Nishi, E; Kakinoki, R; Deng, JM; Behringer, RR; Nakamura, T; Uemoto, S				Furuyama, Kenichiro; Kawaguchi, Yoshiya; Akiyama, Haruhiko; Horiguchi, Masashi; Kodama, Sota; Kuhara, Takeshi; Hosokawa, Shinichi; Elbahrawy, Ashraf; Soeda, Tsunemitsu; Koizumi, Masayuki; Masui, Toshihiko; Kawaguchi, Michiya; Takaori, Kyoichi; Doi, Ryuichiro; Nishi, Eiichiro; Kakinoki, Ryosuke; Deng, Jian Min; Behringer, Richard R.; Nakamura, Takashi; Uemoto, Shinji			Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR SOX9; AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; BETA-CELLS; CAMPOMELIC DYSPLASIA; DUCT CELLS; STEM-CELLS; MOUSE; DIFFERENTIATION; FATE	The liver and exocrine pancreas share a common structure, with functioning units ( hepatic plates and pancreatic acini) connected to the ductal tree. Here we show that Sox9 is expressed throughout the biliary and pancreatic ductal epithelia, which are connected to the intestinal stem-cell zone. Cre-based lineage tracing showed that adult intestinal cells, hepatocytes and pancreatic acinar cells are supplied physiologically from Sox9-expressing progenitors. Combination of lineage analysis and hepatic injury experiments showed involvement of Sox9-positive precursors in liver regeneration. Embryonic pancreatic Sox9-expressing cells differentiate into all types of mature cells, but their capacity for endocrine differentiation diminishes shortly after birth, when endocrine cells detach from the epithelial lining of the ducts and form the islets of Langerhans. We observed a developmental switch in the hepatic progenitor cell type from Sox9-negative to Sox9-positive progenitors as the biliary tree develops. These results suggest interdependence between the structure and homeostasis of endodermal organs, with Sox9 expression being linked to progenitor status.	[Furuyama, Kenichiro; Kawaguchi, Yoshiya; Horiguchi, Masashi; Kodama, Sota; Kuhara, Takeshi; Hosokawa, Shinichi; Elbahrawy, Ashraf; Koizumi, Masayuki; Masui, Toshihiko; Kawaguchi, Michiya; Takaori, Kyoichi; Doi, Ryuichiro; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan; [Akiyama, Haruhiko; Soeda, Tsunemitsu; Kakinoki, Ryosuke; Nakamura, Takashi] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan; [Nishi, Eiichiro] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Deng, Jian Min; Behringer, Richard R.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	Kyoto University; Kyoto University; Kyoto University; University of Texas System; UTMD Anderson Cancer Center	Kawaguchi, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan.	yoshiyak@kuhp.kyoto-u.ac.jp; hakiyama@kuhp.kyoto-u.ac.jp	Nishi, Eiichiro/A-8246-2019; Elbahrawy, Ashraf/ADH-9281-2022	Nishi, Eiichiro/0000-0002-8188-8026; Elbahrawy, Ashraf/0000-0002-6798-4468; FURUYAMA, Kenichiro/0000-0003-4878-2841; Doi, Ryuichiro/0000-0002-7298-2301	Ministry of Education, Culture, Sports, Science and Technology of Japan; US National Institutes of Health; Grants-in-Aid for Scientific Research [21249078] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A. Fukuda and M. Gannon for critical discussions and reading of the manuscript, Y. Ishiura and K. Fukazawa for technical help, C.V.E. Wright for Pdx1 antibody, P. Soriano for Rosa26R mice and the staff of the Institute of Laboratory Animals of Kyoto University for animal care. This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the US National Institutes of Health.	Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x; Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Formeister EJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1108, DOI 10.1152/ajpgi.00004.2009; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kawaguchi Y, 2011, J HEPATO-BIL-PAN SCI, V18, P1, DOI 10.1007/s00534-010-0307-z; Kushner JA, 2010, CELL METAB, V11, P2, DOI 10.1016/j.cmet.2009.12.005; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Nel-Themaat L, 2009, DEV DYNAM, V238, P1100, DOI 10.1002/dvdy.21954; Oshima Y, 2007, GASTROENTEROLOGY, V132, P720, DOI 10.1053/j.gastro.2006.11.027; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Poche RA, 2008, J COMP NEUROL, V510, P237, DOI 10.1002/cne.21746; Raynaud P, 2011, INT J BIOCHEM CELL B, V43, P245, DOI 10.1016/j.biocel.2009.07.020; Sackett SD, 2009, HEPATOLOGY, V49, P920, DOI 10.1002/hep.22705; Sell S, 2008, TUMOR BIOL, V29, P161, DOI 10.1159/000143402; Seymour PA, 2008, DEV BIOL, V323, P19, DOI 10.1016/j.ydbio.2008.07.034; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Soeda T., 2010, GENESIS         1007, DOI [10.1002/dvg.20667, DOI 10.1002/DVG.20667]; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Swenson ES, 2008, STEM CELLS, V26, P1768, DOI 10.1634/stemcells.2008-0148; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yang L, 2008, STEM CELLS, V26, P2104, DOI 10.1634/stemcells.2008-0115; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318	35	586	618	0	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2011	43	1					34	U52		10.1038/ng.722	http://dx.doi.org/10.1038/ng.722			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	699SQ	21113154	Green Submitted			2022-12-25	WOS:000285683500012
J	Bayer, TS				Bayer, Travis S.			Transforming biosynthesis into an information science	NATURE CHEMICAL BIOLOGY			English	Article							ACID	Engineering biosynthetic pathways to natural products is a challenging endeavor that promises to provide new therapeutics and tools to manipulate biology. Information-guided design strategies and tools could unlock the creativity of a wide spectrum of scientists and engineers by decoupling expertise from implementation.	Univ London Imperial Coll Sci Technol & Med, Ctr Synthet Biol & Innovat, London, England	Imperial College London	Bayer, TS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Synthet Biol & Innovat, London, England.	t.bayer@imperial.ac.uk						Arkin A, 2008, NAT BIOTECHNOL, V26, P771, DOI 10.1038/nbt0708-771; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Bachmann BO, 2010, NAT CHEM BIOL, V6, P390, DOI 10.1038/nchembio.377; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Cheng Q, 2007, NAT CHEM BIOL, V3, P557, DOI 10.1038/nchembio.2007.22; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jung YK, 2010, BIOTECHNOL BIOENG, V105, P161, DOI 10.1002/bit.22548; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Villalobos A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-285; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318	13	3	4	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					859	861		10.1038/nchembio.487	http://dx.doi.org/10.1038/nchembio.487			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079588				2022-12-25	WOS:000284214700004
J	Haass, C				Haass, Christian			Initiation and propagation of neurodegeneration	NATURE MEDICINE			English	Article							AMYLOID-BETA-PROTEIN; AMYOTROPHIC-LATERAL-SCLEROSIS; CELLULAR PRION PROTEIN; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; SYNAPTIC PLASTICITY; MOUSE MODEL; IN-VIVO; MUTATIONS	Although substantial progress has been made in understanding the molecular and pathological bases of neurodegeneration, there have been few successes in the clinic and a number of fundamental questions remain unanswered. Is this skepticism misplaced, or do the words of Sir Isaac Newton hold true, that "what we know is a drop, what we don't know is an ocean"?	[Haass, Christian] DZNE German Ctr Neurodegenerat Dis, Munich, Germany; [Haass, Christian] Univ Munich, Adolf Butenandt Inst, Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich	Haass, C (corresponding author), DZNE German Ctr Neurodegenerat Dis, Munich, Germany.	chaass@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This article reports on some of the main points raised at the Herrenhausen Symposium on Neurodegeneration in Seeon, Germany (May 2010) during the session on the initiation and propagation of neurodegeneration. I thank A. Aguzzi, D. Rubinsztein, S. Sisodia, D. Edbauer and M. Meyer-Luhmann for reading this manuscript. This work was supported by the Deutsche Forschungsgemeinschaft.	Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Aguzzi A, 2009, NATURE, V459, P924, DOI 10.1038/459924a; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Cataldo AM, 1996, J NEUROSCI, V16, P186; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Di Monte DA, 2002, NEUROTOXICOLOGY, V23, P487, DOI 10.1016/S0161-813X(02)00099-2; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Falsig J, 2008, NAT NEUROSCI, V11, P109, DOI 10.1038/nn2028; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Iacono D, 2009, NEUROLOGY, V73, P665, DOI 10.1212/WNL.0b013e3181b01077; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Paquet D, 2009, J CLIN INVEST, V119, P1382, DOI 10.1172/JCI37537; Podlisny MB, 1998, BIOCHEMISTRY-US, V37, P3602, DOI 10.1021/bi972029u; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; ROHRER JD, 2010, NEUROIMAGE      0104, DOI DOI 10.1016/J.NEUROIMAGE.2009.12.088; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schenk D, 2004, CURR OPIN IMMUNOL, V16, P599, DOI 10.1016/j.coi.2004.07.012; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; THAL DR, 2006, SCI AGING KNOWLEDGE, pRE1, DOI DOI 10.1126/SAGEKE.2006.6.RE1; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Veeraraghavalu K, 2010, J NEUROSCI, V30, P6903, DOI 10.1523/JNEUROSCI.0527-10.2010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930	52	36	39	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2010	16	11					1201	1204		10.1038/nm.2223	http://dx.doi.org/10.1038/nm.2223			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21052073				2022-12-25	WOS:000283860100025
J	Haglund, CM; Choe, JE; Skau, CT; Kovar, DR; Welch, MD				Haglund, Cat M.; Choe, Julie E.; Skau, Colleen T.; Kovar, David R.; Welch, Matthew D.			Rickettsia Sca2 is a bacterial formin-like mediator of actin-based motility	NATURE CELL BIOLOGY			English	Article							SPOTTED-FEVER; FISSION YEAST; FLUORESCENCE MICROSCOPY; CYTOSKELETAL PROTEINS; HOMOLOGY-2 DOMAIN; ARP2/3 COMPLEX; PROFILIN; CONORII; POLYMERIZATION; NUCLEATION	Diverse intracellular pathogens subvert the host actin-polymerization machinery to drive movement within and between cells during infection. Rickettsia in the spotted fever group (SFG) are Gram-negative, obligate intracellular bacterial pathogens that undergo actin-based motility and assemble distinctive 'comet tails' that consist of long, unbranched actin filaments(1,2). Despite this distinct organization, it was proposed that actin in Rickettsia comet tails is nucleated by the host Arp2/3 complex and the bacterial protein RickA, which assemble branched actin networks (3,4). However, a second bacterial gene, sca2, was recently implicated in actin-tail formation by R. rickettsii(5). Here, we demonstrate that Sca2 is a bacterial actin-assembly factor that functionally mimics eukaryotic formin proteins. Sca2 nucleates unbranched actin filaments, processively associates with growing barbed ends, requires profilin for efficient elongation, and inhibits the activity of capping protein, all properties shared with formins. Sca2 localizes to the Rickettsia surface and is sufficient to promote the assembly of actin filaments in cytoplasmic extract. These results suggest that Sca2 mimics formins to determine the unique organization of actin filaments in Rickettsia tails and drive bacterial motility, independently of host nucleators.	[Haglund, Cat M.; Choe, Julie E.; Welch, Matthew D.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Skau, Colleen T.; Kovar, David R.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of California System; University of California Berkeley; University of Chicago	Welch, MD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	welch@berkeley.edu			NIH-NIAID [R01 AI074760]; NIH [R01 GM079265]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079265] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Hackstadt and T. Clark for reagents, C. Paddock for the R. parkeri strain, the R. Heald lab for Xenopus egg extracts, B. Scott for help with alignments, Y. Li for technical assistance, and E. Benanti, K. Campellone, A. Serio, S. Reed and T. Ohkawa for comments on the manuscript. This work was funded by NIH-NIAID grant R01 AI074760 (to M.D.W.) and NIH grant R01 GM079265 (to D.R.K.).	ANACKER RL, 1987, J CLIN MICROBIOL, V25, P167, DOI 10.1128/JCM.25.1.167-171.1987; Barko S, 2010, J BIOL CHEM, V285, P13154, DOI 10.1074/jbc.M109.093914; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Cardwell MM, 2009, INFECT IMMUN, V77, P5272, DOI 10.1128/IAI.00201-09; Chalkia D, 2008, MOL BIOL EVOL, V25, P2717, DOI 10.1093/molbev/msn215; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Dominguez R, 2007, ANN NY ACAD SCI, V1112, P86, DOI 10.1196/annals.1415.011; Gillespie JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002018; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Gouin E, 1999, J CELL SCI, V112, P1697; HACKSTADT T, 1992, INFECT IMMUN, V60, P159, DOI 10.1128/IAI.60.1.159-165.1992; Harlander RS, 2003, INFECT IMMUN, V71, P1551, DOI 10.1128/IAI.71.3.1551-1556.2003; Heindl JE, 2010, INFECT IMMUN, V78, P193, DOI 10.1128/IAI.00252-09; Heinzen RA, 2003, ANN NY ACAD SCI, V990, P535, DOI 10.1111/j.1749-6632.2003.tb07424.x; HEINZEN RA, 1993, INFECT IMMUN, V61, P1926, DOI 10.1128/IAI.61.5.1926-1935.1993; Holt MR, 2001, TRENDS CELL BIOL, V11, P38, DOI 10.1016/S0962-8924(00)01876-6; JANMEY PA, 1991, METHOD ENZYMOL, V196, P92; Jeng RL, 2004, CELL MICROBIOL, V6, P761, DOI 10.1111/j.1462-5822.2004.00402.x; Jewett TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000997; Kleba B, 2010, INFECT IMMUN, V78, P2240, DOI 10.1128/IAI.00100-10; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Liverman ADB, 2007, P NATL ACAD SCI USA, V104, P17117, DOI 10.1073/pnas.0703196104; Martinez JJ, 2004, J CELL SCI, V117, P5097, DOI 10.1242/jcs.01382; McLeod MP, 2004, J BACTERIOL, V186, P5842, DOI 10.1128/JB.186.17.5842-5855.2004; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Moseley JB, 2006, METHOD ENZYMOL, V406, P215, DOI 10.1016/S0076-6879(06)06016-2; Neidt EM, 2008, J BIOL CHEM, V283, P23872, DOI 10.1074/jbc.M803734200; Ngwamidiba M, 2005, ANN NY ACAD SCI, V1063, P94, DOI 10.1196/annals.1355.015; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Paddock CD, 2004, CLIN INFECT DIS, V38, P805, DOI 10.1086/381894; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Serio AW, 2010, CELL HOST MICROBE, V7, P388, DOI 10.1016/j.chom.2010.04.008; Simser JA, 2005, MOL MICROBIOL, V58, P71, DOI 10.1111/j.1365-2958.2005.04806.x; Skau CT, 2009, MOL BIOL CELL, V20, P2160, DOI 10.1091/mbc.E08-12-1201; Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320; Tam VC, 2007, CELL HOST MICROBE, V1, P95, DOI 10.1016/j.chom.2007.03.005; Van Kirk LS, 2000, INFECT IMMUN, V68, P4706, DOI 10.1128/IAI.68.8.4706-4713.2000; Walker DH, 2005, ANN NY ACAD SCI, V1063, P13, DOI 10.1196/annals.1355.003; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	47	118	123	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2010	12	11					1057	U40		10.1038/ncb2109	http://dx.doi.org/10.1038/ncb2109			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	674CO	20972427	Green Accepted, Green Published			2022-12-25	WOS:000283711500008
J	Kornberg, MD; Sen, N; Hara, MR; Juluri, KR; Nguyen, JVK; Snowman, AM; Law, L; Hester, LD; Snyder, SH				Kornberg, Michael D.; Sen, Nilkantha; Hara, Makoto R.; Juluri, Krishna R.; Nguyen, Judy Van K.; Snowman, Adele M.; Law, Lindsey; Hester, Lynda D.; Snyder, Solomon H.			GAPDH mediates nitrosylation of nuclear proteins	NATURE CELL BIOLOGY			English	Article							NITRIC-OXIDE SYNTHASE; S-NITROSYLATION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; COMPLEX; NITROSATION; DENITROSYLATION; THIOREDOXIN; PGC-1-ALPHA; INHIBITION; ACTIVATION	S-nitrosylation of proteins by nitric oxide is a major mode of signalling in cells'. S-nitrosylation can mediate the regulation of a range of proteins, including prominent nuclear proteins, such as HDAC2 (ref. 2) and PARP1 (ref. 3). The high reactivity of the nitric oxide group with protein thiols, but the selective nature of nitrosylation within the cell, implies the existence of targeting mechanisms. Specificity of nitric oxide signalling is often achieved by the binding of nitric oxide synthase (NOS) to target proteins, either directly(4) or through scaffolding proteins such as PSD-95 (ref. 5) and CAPON(6). As the three principal isoforms of NOS-neuronal NOS (nNOS), endothelial NOS (eNOS) and inducible NOS (iNOS)-are primarily non-nuclear, the mechanisms by which nuclear proteins are selectively nitrosylated have been elusive. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is physiologically nitrosylated at its Cys 150 residue. Nitrosylated GAPDH (SNO-GAPDH) binds to Siah1, which possesses a nuclear localization signal, and is transported to the nucleus(7). Here, we show that SNO-GAPDH physiologically transnitrosylates nuclear proteins, including the deacetylating enzyme sirtuin-1 (SIRT1), histone deacetylase-2 (HDAC2) and DNA-activated protein kinase (DNA-PK). Our findings reveal a novel mechanism for targeted nitrosylation of nuclear proteins and suggest that protein-protein transfer of nitric oxide groups may be a general mechanism in cellular signal transduction.	[Kornberg, Michael D.; Sen, Nilkantha; Hara, Makoto R.; Juluri, Krishna R.; Nguyen, Judy Van K.; Snowman, Adele M.; Law, Lindsey; Hester, Lynda D.; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu	Sen, Nilkantha/AAW-9788-2020; Kornberg, Michael Davin/K-3329-2019	Kornberg, Michael Davin/0000-0003-2588-7325	USPHS [DA-000266]; Research Scientist Award [DA-00074]; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000074, P50DA000266] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Research Scientist Award; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful to M. Koldobskiy, B. Selvakumar, S.F. Kim, P. Kim, K. Werner and all members of the Snyder laboratory for insight and discussion. We thank P. Puigserver for SIRT1 and PGC1 alpha plasmids. We thank B. Ziegler for organizing the manuscript. This work was supported by USPHS grant DA-000266 and Research Scientist Award DA-00074 to SHS.	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; CHANG K, 2006, 2006 ANN M AM SOC AN; Chen L, 2010, J INORG BIOCHEM, V104, P180, DOI 10.1016/j.jinorgbio.2009.10.021; Doi Hideyuki, 2007, Ecological Society of America Annual Meeting Abstracts; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Giordano A, 2002, FEBS LETT, V514, P135, DOI 10.1016/S0014-5793(02)02245-7; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gobeil F, 2006, J BIOL CHEM, V281, P16058, DOI 10.1074/jbc.M602219200; Grasselli A, 2008, CIRC RES, V103, P34, DOI 10.1161/CIRCRESAHA.107.169037; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jagnandan D, 2005, AM J PHYSIOL-CELL PH, V289, pC1024, DOI 10.1152/ajpcell.00162.2005; Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Lipton SA, 2002, TRENDS NEUROSCI, V25, P474, DOI 10.1016/S0166-2236(02)02245-2; Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y; MEYERSIEGLER K, 1992, CARCINOGENESIS, V13, P2127, DOI 10.1093/carcin/13.11.2127; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Mitchell DA, 2007, P NATL ACAD SCI USA, V104, P11609, DOI 10.1073/pnas.0704898104; Nakamura T, 2010, MOL CELL, V39, P184, DOI 10.1016/j.molcel.2010.07.002; North BJ, 2005, METHODS, V36, P338, DOI 10.1016/j.ymeth.2005.03.004; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Parsons XH, 2003, P NATL ACAD SCI USA, V100, P1609, DOI 10.1073/pnas.0434064100; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; Yasinska IM, 2003, FEBS LETT, V549, P105, DOI 10.1016/S0014-5793(03)00807-X; Yu ZY, 2006, J BIOL CHEM, V281, P9101, DOI 10.1074/jbc.M511049200; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X; Zhou Y, 2008, MOL CANCER RES, V6, P1375, DOI 10.1158/1541-7786.MCR-07-2170	42	293	307	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2010	12	11					1094	U89		10.1038/ncb2114	http://dx.doi.org/10.1038/ncb2114			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	674CO	20972425	Green Accepted			2022-12-25	WOS:000283711500013
J	Mohammad, HP; Baylin, SB				Mohammad, Helai P.; Baylin, Stephen B.			Linking cell signaling and the epigenetic machinery	NATURE BIOTECHNOLOGY			English	Article							NOVO DNA METHYLATION; SELF-RENEWAL; STEM-CELLS; NEURONAL DIFFERENTIATION; RETINOIC ACID; POLYCOMB; CANCER; PLURIPOTENT; PATHWAY; REPRESSION		[Mohammad, Helai P.; Baylin, Stephen B.] Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Mohammad, HP (corresponding author), Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA.	sbaylin@jhmi.edu						ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Athanasiadou R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009937; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Barski A, 2009, J CELL BIOCHEM, V107, P11, DOI 10.1002/jcb.22077; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baylin S. B., 2009, STEMBOOK; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bertrand N, 2006, TRENDS CELL BIOL, V16, P597, DOI 10.1016/j.tcb.2006.09.007; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Biddie SC, 2010, TRENDS ENDOCRIN MET, V21, P3, DOI 10.1016/j.tem.2009.08.006; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Bryant GO, 2008, PLOS BIOL, V6, P2928, DOI 10.1371/journal.pbio.0060317; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chi AS, 2009, SCIENCE, V323, P220, DOI 10.1126/science.1166261; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Dang CV, 2009, EMBO J, V28, P3065, DOI 10.1038/emboj.2009.293; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Gil J, 2005, DNA CELL BIOL, V24, P117, DOI 10.1089/dna.2005.24.117; Guenther MG, 2010, SCIENCE, V329, P150, DOI 10.1126/science.1193995; Gunhaga L, 2003, NAT NEUROSCI, V6, P701, DOI 10.1038/nn1068; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Kirmizis A, 2003, MOL CANCER THER, V2, P113; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Liefke R, 2010, GENE DEV, V24, P590, DOI 10.1101/gad.563210; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohammad HP, 2009, CANCER RES, V69, P6322, DOI 10.1158/0008-5472.CAN-09-0065; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Ohm JE, 2007, CELL CYCLE, V6, P1040, DOI 10.4161/cc.6.9.4210; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Opavsky R, 2007, PLOS GENET, V3, P1757, DOI 10.1371/journal.pgen.0030167; Pajcini KV, 2010, CELL STEM CELL, V7, P198, DOI 10.1016/j.stem.2010.05.022; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Ptashne M, 2009, CURR BIOL, V19, pR234, DOI 10.1016/j.cub.2009.02.015; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Richly H, 2010, BIOESSAYS, V32, P669, DOI 10.1002/bies.201000016; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Satterlee JS, 2010, NAT BIOTECHNOL, V28, P1039, DOI 10.1038/nbt1010-1039; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Toyota M, 2005, SEMIN ONCOL, V32, P521, DOI 10.1053/j.seminoncol.2005.07.003; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; VICENT GP, 2010, MOL ENDOCRINOL, V3, P1; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Ying Y, 2009, EPIGENETICS-US, V4, P307, DOI 10.4161/epi.4.5.9371; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015	92	59	61	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2010	28	10					1033	1038		10.1038/nbt1010-1033	http://dx.doi.org/10.1038/nbt1010-1033			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	663GF	20944593				2022-12-25	WOS:000282870500023
J	Ng, CT; Jaworski, JP; Jayaraman, P; Sutton, WF; Delio, P; Kuller, L; Anderson, D; Landucci, G; Richardson, BA; Burton, DR; Forthal, DN; Haigwood, NL				Ng, Cherie T.; Jaworski, J. Pablo; Jayaraman, Pushpa; Sutton, William F.; Delio, Patrick; Kuller, LaRene; Anderson, David; Landucci, Gary; Richardson, Barbra A.; Burton, Dennis R.; Forthal, Donald N.; Haigwood, Nancy L.			Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques	NATURE MEDICINE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; HIV-1/SIV CHIMERIC VIRUS; MONOCLONAL-ANTIBODIES; PROTECTION; TRANSMISSION; TYPE-1; BROAD	Maternal HIV-1-specific antibodies are efficiently transferred to newborns, but their role in disease control is unknown. We administered neutralizing IgG, including the human neutralizing monoclonal IgG1b12, at levels insufficient to block infection, to six newborn macaques before oral challenge with simian-HIV strain SF162P3 (SHIVSF162P3). All of the macaques rapidly developed neutralizing antibodies and had significantly reduced plasma viremia for six months. These studies support the use of neutralizing antibodies in enhancing B cell responses and viral control in perinatal settings.	[Ng, Cherie T.; Jayaraman, Pushpa; Haigwood, Nancy L.] Univ Washington, Dept Global Hlth, Pathobiol Program, Seattle, WA 98195 USA; [Ng, Cherie T.; Jayaraman, Pushpa] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Jaworski, J. Pablo; Sutton, William F.; Haigwood, Nancy L.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Jaworski, J. Pablo; Sutton, William F.; Haigwood, Nancy L.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA; [Delio, Patrick; Kuller, LaRene; Anderson, David] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; [Landucci, Gary; Forthal, Donald N.] Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92717 USA; [Richardson, Barbra A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Burton, Dennis R.] Massachusetts Gen Hosp, Ragon Inst, MIT, Boston, MA 02114 USA; [Burton, Dennis R.] Harvard Univ, Boston, MA 02115 USA	University of Washington; University of Washington Seattle; Center for Infectious Disease Research; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; University of Washington; University of Washington Seattle; University of California System; University of California Irvine; University of Washington; University of Washington Seattle; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University	Haigwood, NL (corresponding author), Univ Washington, Dept Global Hlth, Pathobiol Program, Seattle, WA 98195 USA.	haigwoon@ohsu.edu	Haigwood, Nancy Logan/AAV-7484-2020; Jaworski, Juan/ABA-4503-2020	Jaworski, Juan/0000-0002-1311-060X; Haigwood, Nancy/0000-0002-1477-9575	US National Institutes of Health [R01HD038653, R01AI33292, R01AI052039]; Elizabeth Glaser Pediatric AIDS Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033292, R01AI052039] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth Glaser Pediatric AIDS Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank Z. Brower for technical support, D. Morris and K. Filer for manuscript preparation, M. L. Marthas and K. K. A. Van Rompay for advice on subcutaneous dosing of IgG and oral inoculation of infants, J. Overbaugh (Fred Hutchinson Cancer Research Center) for the Env-deleted viral backbone plasmid Q23 Delta Env, S. Barnett and I. Srinivasan (Novartis) for recombinant gp120-SF162 and V. Planelles (University of Utah) for the plasmid pEMC*. M. Piatak and J. D. Lifson (Science Applications International Corporation) kindly provided RNA standards and advice on real-time PCR. SHIV<INF>SF162P3</INF> was supplied by N. Miller (US National Institutes of Health Division of AIDS) and R. Pal (Advanced Bioscience Labs). TZM-bl were supplied by the US National Institutes of Health AIDS Research Reference Reagent Program. This study was supported by grants from the US National Institutes of Health R01HD038653 (N. L. H.), R01AI33292 (D. R. B.) and R01AI052039 (D. N. F.) and from the Elizabeth Glaser Pediatric AIDS Foundation (N. L. H.).	Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Forthal DN, 2005, J VIROL, V79, P2042, DOI 10.1128/JVI.79.4.2042-2049.2005; Forthal DN, 2006, J VIROL, V80, P9217, DOI 10.1128/JVI.02746-05; Haigwood NL, 2004, J VIROL, V78, P5983, DOI 10.1128/JVI.78.11.5983-5995.2004; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Jayaraman P, 2007, J VIROL, V81, P822, DOI 10.1128/JVI.01759-06; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; STEIMER KS, 1991, SCIENCE, V254, P105, DOI 10.1126/science.1718036; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yamamoto H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000540	19	115	119	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2010	16	10					1117	1119		10.1038/nm.2233	http://dx.doi.org/10.1038/nm.2233			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20890292	Green Accepted, Green Submitted			2022-12-25	WOS:000282644800041
J	Schroder, R; Janssen, N; Schmidt, J; Kebig, A; Merten, N; Hennen, S; Muller, A; Blattermann, S; Mohr-Andra, M; Zahn, S; Wenzel, J; Smith, NJ; Gomeza, J; Drewke, C; Milligan, G; Mohr, K; Kostenis, E				Schroeder, Ralf; Janssen, Nicole; Schmidt, Johannes; Kebig, Anna; Merten, Nicole; Hennen, Stephanie; Mueller, Anke; Blaettermann, Stefanie; Mohr-Andrae, Marion; Zahn, Sabine; Wenzel, Joerg; Smith, Nicola J.; Gomeza, Jesus; Drewke, Christel; Milligan, Graeme; Mohr, Klaus; Kostenis, Evi			Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements	NATURE BIOTECHNOLOGY			English	Article							DRUG DISCOVERY; 7-TRANSMEMBRANE RECEPTORS; OPTICAL BIOSENSOR; FATTY-ACIDS; ACTIVATION; LIGANDS; AGONIST; GPR55; ASSAY; PHARMACOLOGY	Label-free biosensor technology based on dynamic mass redistribution (DMR) of cellular constituents promises to translate GPCR signaling into complex optical 'fingerprints' in real time in living cells. Here we present a strategy to map cellular mechanisms that define label-free responses, and we compare DMR technology with traditional second-messenger assays that are currently the state of the art in GPCR drug discovery. The holistic nature of DMR measurements enabled us to (i) probe GPCR functionality along all four G-protein signaling pathways, something presently beyond reach of most other assay platforms; (ii) dissect complex GPCR signaling patterns even in primary human cells with unprecedented accuracy; (iii) define heterotrimeric G proteins as triggers for the complex optical fingerprints; and (iv) disclose previously undetected features of GPCR behavior. Our results suggest that DMR technology will have a substantial impact on systems biology and systems pharmacology as well as for the discovery of drugs with novel mechanisms. (C) 2010 Nature America, Inc. All rights reserved.	[Schroeder, Ralf; Schmidt, Johannes; Merten, Nicole; Hennen, Stephanie; Mueller, Anke; Blaettermann, Stefanie; Gomeza, Jesus; Drewke, Christel; Kostenis, Evi] Univ Bonn, Inst Pharmazeut Biol, Mol Cellular & Pharmacobiol Sect, D-5300 Bonn, Germany; [Janssen, Nicole; Kebig, Anna; Mohr-Andrae, Marion; Mohr, Klaus] Univ Bonn, Pharmacol & Toxicol Sect, Inst Pharm, D-5300 Bonn, Germany; [Zahn, Sabine; Wenzel, Joerg] Univ Bonn, Dept Dermatol, D-5300 Bonn, Germany; [Smith, Nicola J.; Milligan, Graeme] Univ Glasgow, Mol Pharmacol Grp, Fac Biomed & Life Sci, Glasgow, Lanark, Scotland	University of Bonn; University of Bonn; University of Bonn; University of Glasgow	Kostenis, E (corresponding author), Univ Bonn, Inst Pharmazeut Biol, Mol Cellular & Pharmacobiol Sect, Nussallee 6, D-5300 Bonn, Germany.	k.mohr@uni-bonn.de; kostenis@uni-bonn.de	Milligan, Graeme/F-9426-2011; Wenzel, Jörg/AAX-2644-2020	Milligan, Graeme/0000-0002-6946-3519; Wenzel, Jörg/0000-0002-4744-5993; Smith, Nicola J/0000-0002-7247-9562	DFG (Deutsche Forschungsgemeinschaft) [KO 1582/3-1, MO 821/2-1, WE 4428/1-1, GRK 677]; Dr. Hilmer Foundation	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Dr. Hilmer Foundation	We thank U. Rick, M. Vasmer-Ehses and T. Kogler for expert technical assistance and Corning Inc. for providing us with the Epic system. This work was supported by the DFG (Deutsche Forschungsgemeinschaft) grants KO 1582/3-1 to E.K., MO 821/2-1 to K.M. and WE 4428/1-1 to J.W. and by the Dr. Hilmer Foundation (PhD fellowship to S.H.). A.K. is a member of the DFG-funded Research Training School GRK 677. N.J.S is an NHMRC/NHF of Australia Overseas Research Fellow. We thank M. De Amici and U. Holzgrabe (University of Milan and University of Wurzburg) for kindly providing Hybrid 1 (ref. 47), T. Ulven (University of Southern Denmark) for TUG424 (ref. 38) and Astellas Pharma Inc. (Osaka, Japan) for providing us with YM-254890 (ref. 30).	Antony J, 2009, FASEB J, V23, P442, DOI 10.1096/fj.08-114751; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baker JG, 2007, TRENDS PHARMACOL SCI, V28, P374, DOI 10.1016/j.tips.2007.06.011; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bosier B, 2007, TRENDS PHARMACOL SCI, V28, P438, DOI 10.1016/j.tips.2007.06.001; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; BURFORD NT, 1995, J PHARMACOL EXP THER, V274, P134; Christiansen E, 2008, J MED CHEM, V51, P7061, DOI 10.1021/jm8010178; Dodgson K, 2009, J RECEPT SIG TRANSD, V29, P163, DOI 10.1080/10799890903079844; Eglen RM, 2005, COMB CHEM HIGH T SCR, V8, P311, DOI 10.2174/1386207054020813; Fang Y, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-24; Fang Ye, 2007, Journal of Pharmacological and Toxicological Methods, V55, P314, DOI 10.1016/j.vascn.2006.11.001; Fang Y, 2006, BIOPHYS J, V91, P1925, DOI [10.1529/biophysj.105.077818, 10.1529/biophysj.105.007818]; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Gaspard N, 2009, NAT PROTOC, V4, P1454, DOI 10.1038/nprot.2009.157; Hamdan FF, 2005, J BIOMOL SCREEN, V10, P463, DOI 10.1177/1087057105275344; Hansen JL, 2004, J BIOL CHEM, V279, P24108, DOI 10.1074/jbc.M400092200; Henstridge CM, 2010, BRIT J PHARMACOL, V160, P604, DOI 10.1111/j.1476-5381.2009.00625.x; Henstridge CM, 2009, FASEB J, V23, P183, DOI 10.1096/fj.08-108670; Hoffmann C, 2008, J BIOL CHEM, V283, P30933, DOI 10.1074/jbc.M801472200; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jager D, 2007, J BIOL CHEM, V282, P34968, DOI 10.1074/jbc.M705563200; James D, 2010, NAT BIOTECHNOL, V28, P161, DOI 10.1038/nbt.1605; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P232, DOI 10.1016/S0165-6147(00)89032-X; Kenakin TP, 2009, NAT REV DRUG DISCOV, V8, P617, DOI 10.1038/nrd2838; Lee PH, 2008, ASSAY DRUG DEV TECHN, V6, P83, DOI 10.1089/adt.2007.126; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; McGraw DW, 2003, J CLIN INVEST, V112, P619, DOI 10.1172/JCI200318193; McGuinness R, 2007, CURR OPIN PHARMACOL, V7, P535, DOI 10.1016/j.coph.2007.08.004; McGuinness RP, 2009, COMB CHEM HIGH T SCR, V12, P812, DOI 10.2174/138620709789104861; Olson KR, 2007, ASSAY DRUG DEV TECHN, V5, P137, DOI 10.1089/adt.2006.052; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pantaloni C, 1996, J BIOL CHEM, V271, P22146, DOI 10.1074/jbc.271.36.22146; Peters MF, 2010, ASSAY DRUG DEV TECHN, V8, P219, DOI 10.1089/adt.2009.0232; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Rocheville M, 2009, CURR OPIN PHARMACOL, V9, P643, DOI 10.1016/j.coph.2009.06.015; Ross RA, 2009, TRENDS PHARMACOL SCI, V30, P156, DOI 10.1016/j.tips.2008.12.004; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Schmidt M, 1996, MOL PHARMACOL, V50, P1038; Schroder R, 2009, J BIOL CHEM, V284, P1324, DOI 10.1074/jbc.M806867200; Smith NJ, 2009, J BIOL CHEM, V284, P17527, DOI 10.1074/jbc.M109.012849; Stoddart LA, 2007, MOL PHARMACOL, V71, P994, DOI 10.1124/mol.106.031534; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Verkaar F, 2008, BIOTECHNOL ANN REV, V14, P253, DOI 10.1016/S1387-2656(08)00010-0; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Williams C, 2004, NAT REV DRUG DISCOV, V3, P125, DOI 10.1038/nrd1306; Willoughby D, 2008, NAT METHODS, V5, P29, DOI 10.1038/NMETH1135; Zhang J Z, 1994, Exp Dermatol, V3, P164, DOI 10.1111/j.1600-0625.1994.tb00273.x	50	208	210	2	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2010	28	9					943	950		10.1038/nbt.1671	http://dx.doi.org/10.1038/nbt.1671			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	648UF	20711173	Green Accepted			2022-12-25	WOS:000281719100020
J	Kobayashi, Y; Imamura, S; Hanaoka, M; Tanaka, K				Kobayashi, Yuki; Imamura, Sousuke; Hanaoka, Mitsumasa; Tanaka, Kan			A tetrapyrrole-regulated ubiquitin ligase controls algal nuclear DNA replication	NATURE CELL BIOLOGY			English	Article							MG-PROTOPORPHYRIN IX; BOX PROTEIN TIR1; CYANIDIOSCHYZON-MEROLAE; F-BOX; CYCLE; MITOCHONDRIA; SEQUENCE; REVEALS; GENOME	In plant cells, organelle DNA replication (ODR) is coordinated with nuclear DNA replication (NDR), with ODR preceding NDR during cell cycle progression. We previously showed that the occurrence of ODR is signalled by a tetrapyrrole compound, most likely Mg-protoporphyrin IX (Mg-ProtoIX), resulting in the activation of cyclin-dependent kinase A (CDKA) and consequent initiation of NDR (refs 1-3). Here we identify an F-box protein of SCF-type E3 ubiquitin ligase (Fbx3) in the red alga Cyanidioschyzon merolae, which inhibits CDKA by ubiquitylating the relevant cyclin and inducing its degradation. Mg-ProtoIX binds to Fbx3 and inhibits cyclin ubiquitylation. Thus, these observations indicate that Fbx3 serves as the receptor for the plastid-to-nucleus retrograde signal Mg-ProtoIX and thereby contributes to a checkpoint mechanism ensuring coordination of ODR and NDR.	[Kobayashi, Yuki; Hanaoka, Mitsumasa; Tanaka, Kan] Chiba Univ, Grad Sch Hort, Chiba 2718510, Japan; [Imamura, Sousuke] Chuo Univ, Fac Sci & Engn, Dept Biol Sci, Bunkyo Ku, Tokyo 1128551, Japan	Chiba University; Chuo University	Tanaka, K (corresponding author), Chiba Univ, Grad Sch Hort, 648 Matsudo, Chiba 2718510, Japan.	kntanaka@faculty.chiba-u.jp	Imamura, Sousuke/D-3638-2015; Kobayashi, Yuki/F-2844-2014; Hanaoka, Mitsumasa/M-9904-2015; Tanaka, Kan/E-3724-2015; Imamura, Sousuke/N-6703-2019	Imamura, Sousuke/0000-0002-3040-4757; Kobayashi, Yuki/0000-0001-6200-964X; Tanaka, Kan/0000-0001-7560-7884; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [16GS0304]; Japan Society for the Promotion of Science (JSPS) [21370015]; Chiba University	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Chiba University	We thank T. Kuroiwa and H. Kuroiwa for help with microscopic analysis. This study was supported by a Grant-in-Aid for Creative Scientific Research (16GS0304) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K.T.), a Grant-in-Aid for Scientific Research (B) (21370015) from the Japan Society for the Promotion of Science (JSPS) (to K.T.), COE StartUp Program from Chiba University (to K.T.), and by a Special Coordination Fund for Promoting Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M.H.).	Ariyoshi M, 2003, GENE DEV, V17, P1909, DOI 10.1101/gad.266203; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Finkel T, 2009, P NATL ACAD SCI USA, V106, P11825, DOI 10.1073/pnas.0906430106; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; GOUGH NR, 2009, SCI SIGNAL, V2, pEC27; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Imamura S, 2008, EMBO J, V27, P2317, DOI 10.1038/emboj.2008.151; Imamura S, 2010, PLANT CELL PHYSIOL, V51, P707, DOI 10.1093/pcp/pcq043; Itoh R, 1997, EUR J CELL BIOL, V73, P252; Jung T, 2009, MOL ASPECTS MED, V30, P191, DOI 10.1016/j.mam.2009.04.001; Kanesaki Y, 2009, PLANT SIGNAL BEHAV, V4, P1190, DOI 10.4161/psb.4.12.10061; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kobayashi Y, 2009, P NATL ACAD SCI USA, V106, P803, DOI 10.1073/pnas.0804270105; Kuroiwa T, 1998, BIOESSAYS, V20, P344, DOI 10.1002/(SICI)1521-1878(199804)20:4<344::AID-BIES11>3.3.CO;2-L; Leister D, 2005, GENE, V354, P110, DOI 10.1016/j.gene.2005.03.039; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Mochizuki N, 2008, P NATL ACAD SCI USA, V105, P15184, DOI 10.1073/pnas.0803245105; Moulin M, 2008, P NATL ACAD SCI USA, V105, P15178, DOI 10.1073/pnas.0803054105; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Nozaki H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-28; Ohta N, 2003, DNA RES, V10, P67, DOI 10.1093/dnares/10.2.67; Ohta N, 1998, NUCLEIC ACIDS RES, V26, P5190, DOI 10.1093/nar/26.22.5190; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Reed Steven I., 2006, V42, P147, DOI 10.1007/b136681; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Somers DE, 2009, TRENDS PLANT SCI, V14, P206, DOI 10.1016/j.tplants.2009.01.003; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333	28	43	43	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2011	13	4					483	U307		10.1038/ncb2203	http://dx.doi.org/10.1038/ncb2203			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	744CK	21378982				2022-12-25	WOS:000289070900021
J	Ruf, S; Symmons, O; Uslu, VV; Dolle, D; Hot, C; Ettwiller, L; Spitz, F				Ruf, Sandra; Symmons, Orsolya; Uslu, Veli Vural; Dolle, Dirk; Hot, Chloe; Ettwiller, Laurence; Spitz, Francois			Large-scale analysis of the regulatory architecture of the mouse genome with a transposon-associated sensor	NATURE GENETICS			English	Article							THUMB-POLYSYNDACTYLY SYNDROME; SLEEPING-BEAUTY TRANSPOSON; LONG-RANGE ENHANCERS; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; NONCODING ELEMENTS; SHH ENHANCER; HOXD CLUSTER; MICE; DUPLICATIONS	We present here a Sleeping Beauty-based transposition system that offers a simple and efficient way to investigate the regulatory architecture of mammalian chromosomes in vivo. With this system, we generated several hundred mice and embryos, each with a regulatory sensor inserted at a random genomic position. This large sampling of the genome revealed the widespread presence of long-range regulatory activities along chromosomes, forming overlapping blocks with distinct tissue-specific expression potentials. The presence of tissue-restricted regulatory activities around genes with widespread expression patterns challenges the gene-centric view of genome regulation and suggests that most genes are modulated in a tissue-specific manner. The local hopping property of Sleeping Beauty provides a dynamic approach to map these regulatory domains at high resolution and, combined with Cre-mediated recombination, allows for the determination of their functions by engineering mice with specific chromosomal rearrangements.	[Ruf, Sandra; Symmons, Orsolya; Uslu, Veli Vural; Hot, Chloe; Spitz, Francois] Dev Biol Unit, European Mol Biol Lab, Heidelberg, Germany; [Dolle, Dirk; Ettwiller, Laurence] Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg	Spitz, F (corresponding author), Dev Biol Unit, European Mol Biol Lab, Heidelberg, Germany.	spitz@embl.de	Symmons, Orsolya/AAZ-8219-2021	Symmons, Orsolya/0000-0003-2435-4236; Ettwiller, Laurence/0000-0002-3957-6539; Dolle, Dirk-Dominik/0000-0003-1786-6452; Spitz, Francois/0000-0002-1960-829X	Louis-Jeantet Foundation; European Molecular Biology Laboratory; European Community [FP7/2007-2013, FP7-211868]	Louis-Jeantet Foundation; European Molecular Biology Laboratory; European Community(European Commission)	We thank all the members of the EMBL mouse and transgenic facilities for pronuclear injections of the transgenes and mouse husbandry, particularly C. Klasen, A. Schultz and S. Feller; B. Fletcher (University of Florida) for the Sleeping Beauty transposon and transposase plasmids; A. Ephrussi and A. Aulehla for discussions and comments on the manuscript; and A. Hermelin and EMBL information technology service for helping with the TRACER website. We are grateful to all the members of the Spitz lab and students of the EMBL PhD classes of 2008 and 2009 who contributed to embryo dissection and staining. O.S. is funded by a Louis-Jeantet Foundation PhD fellowship. This work was supported by funding from the European Molecular Biology Laboratory (to F.S.) and from the European Community's Seventh Framework Programme (FP7/2007-2013) under the grant agreement noFP7-211868 (to L.E. and F.S.).	Baus J, 2005, MOL THER, V12, P1148, DOI 10.1016/j.ymthe.2005.06.484; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; D'haene B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000522; Dathe K, 2009, AM J HUM GENET, V84, P483, DOI 10.1016/j.ajhg.2009.03.001; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Geurts AM, 2006, PLOS GENET, V2, P1413, DOI 10.1371/journal.pgen.0020156; Geurts AM, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-30; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Horie K, 2003, MOL CELL BIOL, V23, P9189, DOI 10.1128/MCB.23.24.9189-9207.2003; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Jeong Y, 2008, NAT GENET, V40, P1348, DOI 10.1038/ng.230; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kleinjan DA, 2006, DEV BIOL, V299, P563, DOI 10.1016/j.ydbio.2006.08.060; Klopocki E, 2008, J MED GENET, V45, P370, DOI 10.1136/jmg.2007.055699; Kokubu C, 2009, NAT GENET, V41, P946, DOI 10.1038/ng.397; Kondo T, 1999, CELL, V97, P407, DOI 10.1016/S0092-8674(00)80749-7; KORN R, 1992, MECH DEVELOP, V39, P95, DOI 10.1016/0925-4773(92)90029-J; Kurth I, 2009, NAT GENET, V41, P862, DOI 10.1038/ng0809-862; Lefevre C, 2008, DEV DYNAM, V237, P1082, DOI 10.1002/dvdy.21482; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Luo GB, 1998, P NATL ACAD SCI USA, V95, P10769, DOI 10.1073/pnas.95.18.10769; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; PESCHON JJ, 1989, ANN NY ACAD SCI, V564, P186, DOI 10.1111/j.1749-6632.1989.tb25897.x; Reymond A, 2002, NATURE, V420, P582, DOI 10.1038/nature01178; Sagai T, 2009, DEVELOPMENT, V136, P1665, DOI 10.1242/dev.032714; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Spitz F, 2005, NAT GENET, V37, P889, DOI 10.1038/ng1597; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Sumiyama K, 2002, P NATL ACAD SCI USA, V99, P780, DOI 10.1073/pnas.012584999; Sun M, 2008, J MED GENET, V45, P589, DOI 10.1136/jmg.2008.057646; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wu S, 2007, NAT GENET, V39, P922, DOI 10.1038/ng2060; Wunderle VM, 1998, P NATL ACAD SCI USA, V95, P10649, DOI 10.1073/pnas.95.18.10649; WURST W, 1995, GENETICS, V139, P889; Yae K, 2006, MOL CELL BIOL, V26, P6185, DOI 10.1128/MCB.00018-06; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277	50	114	117	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2011	43	4					379	U141		10.1038/ng.790	http://dx.doi.org/10.1038/ng.790			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	741YL	21423180				2022-12-25	WOS:000288903700021
J	Kuhlbrodt, K; Janiesch, PC; Kevei, E; Segref, A; Barikbin, R; Hoppe, T				Kuhlbrodt, Kirsten; Janiesch, Philipp Christoph; Kevei, Eva; Segref, Alexandra; Barikbin, Roja; Hoppe, Thorsten			The Machado-Joseph disease deubiquitylase ATX-3 couples longevity and proteostasis	NATURE CELL BIOLOGY			English	Article							RESTRICTION-INDUCED LONGEVITY; ELEGANS LIFE-SPAN; CAENORHABDITIS-ELEGANS; PROTEIN-DEGRADATION; UBIQUITIN LIGASE; DAF-16; CHAIN; PATHWAY; COMPLEX; STRESS	Protein ubiquitylation is a key post-translational control mechanism contributing to different physiological processes, such as signal transduction and ageing. The size and linkage of a ubiquitin chain, which determines whether a substrate is efficiently targeted for proteasomal degradation, is determined by the interplay between ubiquitylation and deubiquitylation. A conserved factor that orchestrates distinct substrate-processing co-regulators in diverse species is the ubiquitin-selective chaperone CDC-48 (also known as p97). Several deubiquitylation enzymes (DUBs) have been shown to interact with CDC-48/p97, but the mechanistic and physiological relevance of these interactions remained elusive. Here we report a synergistic cooperation between CDC-48 and ATX-3 (the Caenorhabditis elegans orthologue of ataxin-3) in ubiquitin-mediated proteolysis and ageing regulation. Surprisingly, worms deficient for both cdc-48.1 and atx-3 demonstrated extended lifespan by up to 50%, mediated through the insulin-insulin-like growth factor 1 (IGF-1) signalling pathway. As lifespan extension specifically depends on the deubiquitylation activity of ATX-3, our findings identify a mechanistic link between protein degradation and longevity through editing of the ubiquitylation status of substrates involved in insulin-IGF-1 signalling.	[Kevei, Eva; Segref, Alexandra; Hoppe, Thorsten] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Kevei, Eva; Segref, Alexandra; Hoppe, Thorsten] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Kuhlbrodt, Kirsten; Janiesch, Philipp Christoph; Barikbin, Roja] Univ Hamburg, Ctr Mol Neurobiol ZMNH, D-20251 Hamburg, Germany	University of Cologne; University of Cologne; University of Hamburg	Hoppe, T (corresponding author), Univ Cologne, Inst Genet, Zulpicher Str 47A, D-50674 Cologne, Germany.	thorsten.hoppe@uni-koeln.de	Hoppe, Thorsten/AAC-7880-2020; Kevei, Eva/J-4828-2016; Segref, Alexandra/C-8325-2011	Kevei, Eva/0000-0002-0560-9208; Segref, Alexandra/0000-0001-8095-4469; Hoppe, Thorsten/0000-0002-4734-9352	Rubicon European Union Network of Excellence; Hans & Ilse Breuer Foundation; Deutsche Forschungsgemeinschaft; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases and the Research Unit [FOR885]; NIH National Center for Research Resources	Rubicon European Union Network of Excellence; Hans & Ilse Breuer Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases and the Research Unit; NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Y. Kohara, the Caenorhabditis Genetics Center (funded by the NIH National Center for Research Resources), the Dana-Farber Cancer Institute and Gene service Ltd for antibodies, plasmids, cDNAs and strains and we thank S. Hohenberger for technical help. We also thank A. Antebi, I. Dikic, and B. Schumacher for reading the manuscript. This work is supported by grants of the Deutsche Forschungsgemeinschaft (especially the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases and the Research Unit FOR885), and the Rubicon European Union Network of Excellence to T.H., and a doctoral fellowship of the Hans & Ilse Breuer Foundation to R.B. T.H. is an EMBO Young Investigator.	Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; BRENNER S, 1974, GENETICS, V77, P71; Carrano AC, 2009, NATURE, V460, P396, DOI 10.1038/nature08130; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; Choe KP, 2009, MOL CELL BIOL, V29, P2704, DOI 10.1128/MCB.01811-08; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Ghazi A, 2007, P NATL ACAD SCI USA, V104, P5947, DOI 10.1073/pnas.0700638104; Gidalevitz T, 2010, CURR OPIN STRUC BIOL, V20, P23, DOI 10.1016/j.sbi.2009.11.001; Henis-Korenblit S, 2010, P NATL ACAD SCI USA, V107, P9730, DOI 10.1073/pnas.1002575107; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hoppe T, 2005, TRENDS BIOCHEM SCI, V30, P183, DOI 10.1016/j.tibs.2005.02.004; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Johnson TE, 2002, J INHERIT METAB DIS, V25, P197, DOI 10.1023/A:1015677828407; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim HT, 2009, EMBO J, V28, P1867, DOI 10.1038/emboj.2009.115; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Kulkarni M., 2008, PLOS GENET, V4, DOI [10.1371/journal.pgen.1000131, DOI 10.1371/JOURNAL.PGEN.1000131]; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Li WS, 2007, DEV CELL, V12, P235, DOI 10.1016/j.devcel.2006.12.002; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Mehta R, 2009, SCIENCE, V324, P1196, DOI 10.1126/science.1173507; Mouysset J, 2008, P NATL ACAD SCI USA, V105, P12879, DOI 10.1073/pnas.0805944105; Mouysset J, 2006, J STRUCT BIOL, V156, P41, DOI 10.1016/j.jsb.2006.02.015; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Praitis V, 2001, GENETICS, V157, P1217; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rodrigues AJ, 2009, BIOCHEM BIOPH RES CO, V386, P575, DOI 10.1016/j.bbrc.2009.06.092; Saeki Y, 2004, BIOCHEM BIOPH RES CO, V320, P840, DOI 10.1016/j.bbrc.2004.05.216; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Tonoki A, 2009, MOL CELL BIOL, V29, P1095, DOI 10.1128/MCB.01227-08; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Vernace VA, 2007, AGING CELL, V6, P599, DOI 10.1111/j.1474-9726.2007.00329.x; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Yamauchi S, 2006, BIOCHEM BIOPH RES CO, V345, P746, DOI 10.1016/j.bbrc.2006.04.160; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105; Zhang DN, 2009, MOL CELL, V36, P1018, DOI 10.1016/j.molcel.2009.11.012	53	66	72	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2011	13	3					273	U455		10.1038/ncb2200	http://dx.doi.org/10.1038/ncb2200			30	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	728BB	21317884				2022-12-25	WOS:000287847600015
J	Monsalvo, AC; Batalle, JP; Lopez, MF; Krause, JC; Klemenc, J; Hernandez, JZ; Maskin, B; Bugna, J; Rubinstein, C; Aguilar, L; Dalurzo, L; Libster, R; Savy, V; Baumeister, E; Aguilar, L; Cabral, G; Font, J; Solari, L; Weller, KP; Johnson, J; Echavarria, M; Edwards, KM; Chappell, JD; Crowe, JE; Williams, JV; Melendi, GA; Polack, FP				Clara Monsalvo, Ana; Batalle, Juan P.; Florencia Lopez, M.; Krause, Jens C.; Klemenc, Jennifer; Zea Hernandez, Johanna; Maskin, Bernardo; Bugna, Jimena; Rubinstein, Carlos; Aguilar, Leandro; Dalurzo, Liliana; Libster, Romina; Savy, Vilma; Baumeister, Elsa; Aguilar, Liliana; Cabral, Graciela; Font, Julia; Solari, Liliana; Weller, Kevin P.; Johnson, Joyce; Echavarria, Marcela; Edwards, Kathryn M.; Chappell, James D.; Crowe, James E., Jr.; Williams, John V.; Melendi, Guillermina A.; Polack, Fernando P.			Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes	NATURE MEDICINE			English	Article							PNEUMONIA; INFECTION; RESPONSES; CHILDREN; VIRUSES; DEATH	Pandemic influenza viruses often cause severe disease in middle-aged adults without preexisting comorbidities. The mechanism of illness associated with severe disease in this age group is not well understood(1-10). Here we find preexisting serum antibodies that cross-react with, but do not protect against, 2009 H1N1 influenza virus in middle-aged adults. Nonprotective antibody is associated with immune complex-mediated disease after infection. We detected high titers of serum antibody of low avidity for H1-2009 antigen, and low-avidity pulmonary immune complexes against the same protein, in severely ill individuals. Moreover, C4d deposition-a marker of complement activation mediated by immune complexes-was present in lung sections of fatal cases. Archived lung sections from middle-aged adults with confirmed fatal influenza 1957 H2N2 infection revealed a similar mechanism of illness. These observations provide a previously unknown biological mechanism for the unusual age distribution of severe cases during influenza pandemics.	[Clara Monsalvo, Ana; Batalle, Juan P.; Florencia Lopez, M.; Zea Hernandez, Johanna; Bugna, Jimena; Libster, Romina; Melendi, Guillermina A.; Polack, Fernando P.] Fdn INFANT, Buenos Aires, DF, Argentina; [Krause, Jens C.; Klemenc, Jennifer; Zea Hernandez, Johanna; Weller, Kevin P.; Edwards, Kathryn M.; Crowe, James E., Jr.; Williams, John V.; Melendi, Guillermina A.; Polack, Fernando P.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Maskin, Bernardo; Aguilar, Liliana; Cabral, Graciela; Font, Julia; Solari, Liliana] Hosp Nacl Prof Alejandro Posadas, Buenos Aires, DF, Argentina; [Rubinstein, Carlos; Aguilar, Leandro] Hosp Dr Federico Abete, Buenos Aires, DF, Argentina; [Dalurzo, Liliana] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina; [Savy, Vilma; Baumeister, Elsa] Adm Nacl Labs, Buenos Aires, DF, Argentina; [Savy, Vilma; Baumeister, Elsa] Inst Salud Dr Carlos G Malbran, Buenos Aires, DF, Argentina; [Johnson, Joyce; Chappell, James D.] Vanderbilt Univ, Dept Pathol, Nashville, TN USA; [Echavarria, Marcela] Ctr Educ Med & Invest Clin, Dept Microbiol, Buenos Aires, DF, Argentina	Vanderbilt University; Hospital Italiano de Buenos Aires; University of Buenos Aires; Vanderbilt University; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC)	Polack, FP (corresponding author), Fdn INFANT, Buenos Aires, DF, Argentina.	gmelendi@infant.org.ar; fernando.p.polack@vanderbilt.edu	Williams, John/F-6962-2010; Williams, John/ABE-3227-2020; Crowe, James/B-5549-2009; Echavarria, Marcela/AAQ-2897-2021	Williams, John/0000-0001-8377-5175; Williams, John/0000-0001-8377-5175; Crowe, James/0000-0002-0049-1079; Echavarria, Marcela/0000-0001-6987-8397	Fundacion INFANT 2008 Fundraising Campaign [AI-054952]; Thrasher Research Fund Early Career Award and Fogarty International Center International Clinical Research Fellows Program at Vanderbilt [R24 TW007988]; US Department of Defense [HDTRA1-08-10-BRCWMD-BAA]; US National Institutes of Health [P01 AI058113]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI058113, R01AI054952] Funding Source: NIH RePORTER	Fundacion INFANT 2008 Fundraising Campaign; Thrasher Research Fund Early Career Award and Fogarty International Center International Clinical Research Fellows Program at Vanderbilt(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); US Department of Defense(United States Department of Defense); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the Fundacion INFANT 2008 Fundraising Campaign and AI-054952 (F. P. P.), the Thrasher Research Fund Early Career Award and Fogarty International Center International Clinical Research Fellows Program at Vanderbilt (R24 TW007988) (G. A. M. and J.P.B.), US Department of Defense grant HDTRA1-08-10-BRCWMD-BAA and US National Institutes of Health grant P01 AI058113 (J.E.C. Jr.). Doctoral awards from the Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (A. C. M. and J.P.B.).	Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; HALL CB, 1978, J PEDIATR-US, V93, P28, DOI 10.1016/S0022-3476(78)80594-0; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Johnson TR, 1998, J VIROL, V72, P2871, DOI 10.1128/JVI.72.4.2871-2880.1998; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; LEWIS DE, 1986, J IMMUNOL, V137, P3777; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Polack FP, 2002, J EXP MED, V196, P859, DOI 10.1084/jem.20020781; Regele H, 2001, NEPHROL DIAL TRANSPL, V16, P2058, DOI 10.1093/ndt/16.10.2058; REICHERT T, 2010, AM J RESP CRIT CARE, V181, P72; Salomon R, 2007, P NATL ACAD SCI USA, V104, P12479, DOI 10.1073/pnas.0705289104; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481	29	188	193	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					195	U225		10.1038/nm.2262	http://dx.doi.org/10.1038/nm.2262			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21131958	Bronze, Green Accepted, Green Published			2022-12-25	WOS:000286969900027
J	Hakkim, A; Fuchs, TA; Martinez, NE; Hess, S; Prinz, H; Zychlinsky, A; Waldmann, H				Hakkim, Abdul; Fuchs, Tobias A.; Martinez, Nancy E.; Hess, Simone; Prinz, Heino; Zychlinsky, Arturo; Waldmann, Herbert			Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-KINASE; INHIBITOR; RESPONSES; SURVIVAL; MCL-1	The signaling mechanisms leading to the formation of neutrophil extracellular traps (NETs), relevant in infections, sepsis and autoimmune diseases, are poorly understood. Neutrophils are not amenable to studies with conventional genetic techniques. Using a new chemical genetic analysis we show that the Raf-MEK-ERK pathway is involved in NET formation through activation of NADPH oxidase and upregulation of antiapoptotic proteins. We identify potential targets for drugs addressing NET-associated diseases.	[Hakkim, Abdul; Fuchs, Tobias A.; Zychlinsky, Arturo] Max Planck Inst Infect Biol, Dept Cellular Microbiol, Berlin, Germany; [Martinez, Nancy E.; Prinz, Heino; Waldmann, Herbert] Max Planck Inst Mol Physiol, Dept Biol Chem, D-44139 Dortmund, Germany; [Martinez, Nancy E.; Waldmann, Herbert] Tech Univ Dortmund, Fac Chem, Dortmund, Germany; [Hess, Simone] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany	Max Planck Society; Max Planck Society; Dortmund University of Technology; Max Planck Society	Hakkim, A (corresponding author), Max Planck Inst Infect Biol, Dept Cellular Microbiol, Berlin, Germany.	zychlinsky@mpiib-berlin.mpg.de; herbert.waldmann@mpi-dortmund.mpg.de	Fuchs, Tobias/F-1189-2013; Waldmann, Herbert/B-7406-2017	Waldmann, Herbert/0000-0002-9606-7247				Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; ElBenna J, 1996, ARCH BIOCHEM BIOPHYS, V334, P395; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; GAY JC, 1986, BLOOD, V67, P931; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; MAUER AM, 1960, J CLIN INVEST, V39, P1481, DOI 10.1172/JCI104167; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; Moulding DA, 1998, BLOOD, V92, P2495, DOI 10.1182/blood.V92.7.2495.2495_2495_2502; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nguyen UTT, 2009, NAT CHEM BIOL, V5, P227, DOI 10.1038/nchembio.149; Nishioka H, 2003, EUR J IMMUNOL, V33, P840, DOI 10.1002/eji.200323726; O'Donnell BV, 1993, BIOCH J 1, V290, P41; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003; Yost CC, 2010, BIOCHIMIE, V92, P692, DOI 10.1016/j.biochi.2010.02.011	25	448	474	3	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2011	7	2					75	77		10.1038/NCHEMBIO.496	http://dx.doi.org/10.1038/NCHEMBIO.496			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	707XM	21170021				2022-12-25	WOS:000286324600006
J	Zhou, KX; Bellenguez, C; Spencer, CCA; Bennett, AJ; Coleman, RL; Tavendale, R; Hawley, SA; Donnelly, LA; Schofield, C; Groves, CJ; Burch, L; Carr, F; Strange, A; Freeman, C; Blackwell, JM; Bramon, E; Brown, MA; Casas, JP; Corvin, A; Craddock, N; Deloukas, P; Dronov, S; Duncanson, A; Edkins, S; Gray, E; Hunt, S; Jankowski, J; Langford, C; Markus, HS; Mathew, CG; Plomin, R; Rautanen, A; Sawcer, SJ; Samani, NJ; Trembath, R; Viswanathan, AC; Wood, NW; Harries, LW; Hattersley, AT; Doney, ASF; Colhoun, H; Morris, AD; Sutherland, C; Hardie, DG; Peltonen, L; McCarthy, MI; Holman, RR; Palmer, CNA; Donnelly, P; Pearson, ER				Zhou, Kaixin; Bellenguez, Celine; Spencer, Chris C. A.; Bennett, Amanda J.; Coleman, Ruth L.; Tavendale, Roger; Hawley, Simon A.; Donnelly, Louise A.; Schofield, Chris; Groves, Christopher J.; Burch, Lindsay; Carr, Fiona; Strange, Amy; Freeman, Colin; Blackwell, Jenefer M.; Bramon, Elvira; Brown, Matthew A.; Casas, Juan P.; Corvin, Aiden; Craddock, Nicholas; Deloukas, Panos; Dronov, Serge; Duncanson, Audrey; Edkins, Sarah; Gray, Emma; Hunt, Sarah; Jankowski, Janusz; Langford, Cordelia; Markus, Hugh S.; Mathew, Christopher G.; Plomin, Robert; Rautanen, Anna; Sawcer, Stephen J.; Samani, Nilesh J.; Trembath, Richard; Viswanathan, Ananth C.; Wood, Nicholas W.; Harries, Lorna W.; Hattersley, Andrew T.; Doney, Alex S. F.; Colhoun, Helen; Morris, Andrew D.; Sutherland, Calum; Hardie, D. Grahame; Peltonen, Leena; McCarthy, Mark I.; Holman, Rury R.; Palmer, Colin N. A.; Donnelly, Peter; Pearson, Ewan R.		GoDARTS UKPDS Diabet Pharmacogenet; Wellcome Trust Case Control Consor; MAGIC Investigators	Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes	NATURE GENETICS			English	Article							ACTIVATED PROTEIN-KINASE; GENOME-WIDE ASSOCIATION; ATAXIA-TELANGIECTASIA; CANCER; CELLS; RISK; AMPK; IDENTIFICATION; HOMEOSTASIS; REDUCTASE	Metformin is the most commonly used pharmacological therapy for type 2 diabetes. We report a genome-wide association study for glycemic response to metformin in 1,024 Scottish individuals with type 2 diabetes with replication in two cohorts including 1,783 Scottish individuals and 1,113 individuals from the UK Prospective Diabetes Study. In a combined meta-analysis, we identified a SNP, rs11212617, associated with treatment success (n = 3,920, P = 2.9 x 10(-9), odds ratio = 1.35, 95% CI 1.22-1.49) at a locus containing ATM, the ataxia telangiectasia mutated gene. In a rat hepatoma cell line, inhibition of ATM with KU-55933 attenuated the phosphorylation and activation of AMP-activated protein kinase in response to metformin. We conclude that ATM, a gene known to be involved in DNA repair and cell cycle control, plays a role in the effect of metformin upstream of AMP-activated protein kinase, and variation in this gene alters glycemic response to metformin.	[Zhou, Kaixin; Tavendale, Roger; Donnelly, Louise A.; Schofield, Chris; Burch, Lindsay; Carr, Fiona; Colhoun, Helen; Morris, Andrew D.; Sutherland, Calum; Palmer, Colin N. A.; Pearson, Ewan R.] Univ Dundee, Biomed Res Inst, Dundee, Scotland; [Bellenguez, Celine; Spencer, Chris C. A.; Strange, Amy; Freeman, Colin; Rautanen, Anna; McCarthy, Mark I.; Donnelly, Peter] UK Wellcome Trust Ctr Human Genet, Oxford, England; [Bennett, Amanda J.; Coleman, Ruth L.; Groves, Christopher J.; McCarthy, Mark I.; Holman, Rury R.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Coleman, Ruth L.; Holman, Rury R.] Univ Oxford, Diabet Trials Unit, Oxford, England; [Hawley, Simon A.; Hardie, D. Grahame] Univ Dundee, Coll Life Sci, Dundee, Scotland; [Blackwell, Jenefer M.] Univ Western Australia, Ctr Child Hlth Res, Inst Child Hlth Res, Subiaco, WA, Australia; [Blackwell, Jenefer M.] Univ Cambridge, Sch Clin Med, Cambridge Inst Med Res, Cambridge, England; [Bramon, Elvira] Kings Coll London, Dept Psychosis Studies, Natl Inst Hlth Res, Biomed Res Ctr Mental Hlth,Inst Psychiat, London WC2R 2LS, England; [Bramon, Elvira] S London & Maudsley Natl Hlth Serv Fdn Trust, London, England; [Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld, Australia; [Casas, Juan P.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Casas, Juan P.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Corvin, Aiden] Trinity Coll Dublin, Inst Mol Med, Neuropsychiat Genet Res Grp, Dublin, Ireland; [Craddock, Nicholas] Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff, S Glam, Wales; [Deloukas, Panos; Dronov, Serge; Edkins, Sarah; Gray, Emma; Hunt, Sarah; Langford, Cordelia; Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge, England; [Duncanson, Audrey] Wellcome Trust Res Labs, Mol & Physiol Sci, London, England; [Jankowski, Janusz] Queen Mary Univ London, Ctr Digest Dis, London, England; [Jankowski, Janusz] Leicester Royal Infirm, Ctr Digest Dis, Leicester, Leics, England; [Jankowski, Janusz] Univ Oxford, Dept Clin Pharmacol, Oxford, England; [Markus, Hugh S.] St Georges Univ London, London, England; [Mathew, Christopher G.; Trembath, Richard] Kings Coll London, Sch Med, Guys Hosp, Dept Med & Mol Genet, London WC2R 2LS, England; [Plomin, Robert] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat, London WC2R 2LS, England; [Sawcer, Stephen J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Viswanathan, Ananth C.] Moorfields Eye Hosp Natl Hlth Serv Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr Ophthalmol, London, England; [Viswanathan, Ananth C.] UCL, Inst Ophthalmol, London, England; [Wood, Nicholas W.] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Harries, Lorna W.; Hattersley, Andrew T.] Univ Exeter, Peninsula Coll Med & Dent, Exeter, Devon, England; [Doney, Alex S. F.] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; [McCarthy, Mark I.] Churchill Hosp, UK Oxford Natl Inst Hlth Res, Biomed Res Ctr, Oxford OX3 7LJ, England; [Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Dundee; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; University of Dundee; Telethon Kids Institute; University of Western Australia; University of Cambridge; University of London; King's College London; South London & Maudsley NHS Trust; University of Queensland; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Trinity College Dublin; Cardiff University; Wellcome Trust Sanger Institute; University of London; Queen Mary University London; University of Leicester; University of Oxford; St Georges University London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; University of Exeter; University of Plymouth; University of Dundee; University of Oxford; University of Oxford	Pearson, ER (corresponding author), Univ Dundee, Biomed Res Inst, Dundee, Scotland.	e.pearson@cpse.dundee.ac.uk	Doney, Alexander SF/P-7437-2017; Brown, Matthew A/E-5749-2010; Hardie, David/Z-1979-2019; Bellenguez, Céline/X-4004-2019; Blackwell, Jenefer M/H-3015-2015; Wood, Nicholas W/C-2505-2009; Bramon, Elvira/A-9463-2011; Bramon, Elvira/HHC-3809-2022; Jankowski, Janusz/H-2706-2012; Harries, Lorna/D-2241-2014; Study, GoDARTS/K-9448-2016; Belllenguez, Céline/Y-3183-2018; Plomin, Robert/B-8911-2008; Mathew, Christopher G/G-3434-2015; Deloukas, Panos/B-2922-2013; Palmer, Colin NA/C-7053-2008; McCarthy, Mark/M-3763-2015	Doney, Alexander SF/0000-0002-6210-5620; Brown, Matthew A/0000-0003-0538-8211; Bellenguez, Céline/0000-0002-1240-7874; Wood, Nicholas W/0000-0002-9500-3348; Bramon, Elvira/0000-0003-1369-5983; Jankowski, Janusz/0000-0003-2130-9181; Belllenguez, Céline/0000-0002-1240-7874; Mathew, Christopher G/0000-0003-4178-1838; Deloukas, Panos/0000-0001-9251-070X; Palmer, Colin NA/0000-0002-6415-6560; Pearson, Ewan/0000-0001-9237-8585; Hattersley, Andrew/0000-0001-5620-473X; Corvin, Aiden/0000-0001-6717-4089; Hardie, Grahame/0000-0002-8373-7379; McCarthy, Mark/0000-0002-4393-0510; Coleman, Ruth/0000-0002-5194-8550; Hunt, Sarah/0000-0002-8350-1235; Plomin, Robert/0000-0002-0756-3629; bennett, amanda/0000-0003-2140-8710; Colhoun, Helen/0000-0002-8345-3288; Walters, James/0000-0002-6980-4053; Sutherland, Calum/0000-0003-4398-7434; Trembath, Richard/0000-0003-0550-3400	Wellcome Trust [084726/Z/08/Z, 085475/Z/08/Z, 085475/B/08/Z]; Diabetes UK [07/0003525]; MRC [G0601261]; National Institute for Health Research; Wolfson-Royal Society Merit Award; Henry Wellcome Post-Doctoral Fellowship; European Commission [LSHM-CT-2004-005272]; MRC [G0901310, G19/2] Funding Source: UKRI; Medical Research Council [G0901310, G0601261, G9817803B, G19/2] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10379, PDA/02/06/016] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Diabetes UK(Diabetes UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wolfson-Royal Society Merit Award(Royal Society of London); Henry Wellcome Post-Doctoral Fellowship; European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We are grateful to all the participants who took part in this study, to the general practitioners, to the Scottish School of Primary Care for their help in recruiting the participants, and to the whole team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. The Wellcome Trust provides support for the Wellcome Trust United Kingdom Type 2 Diabetes Case Control Collection (GoDARTS) and informatics support was provided by the Chief Scientist Office. The Wellcome Trust funds the Scottish Health Informatics Programme, provides core support for the Wellcome Trust Centre for Human Genetics in Oxford and funds the Wellcome Trust Case Control Consortium 2. This research was specifically funded by Diabetes UK (07/0003525), MRC (G0601261) and the Wellcome Trust (084726/Z/08/Z, 085475/Z/08/Z, 085475/B/08/Z). We also acknowledge support from the National Institute for Health Research award to Moorfields Eye Hospital National Health Service Foundation Trust and University College London Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology (to A. C. V.). P. Donnelly was supported in part by a Wolfson-Royal Society Merit Award. K.Z. holds a Henry Wellcome Post-Doctoral Fellowship. S. A. H. and D. G. H. were supported by the EXGENESIS consortium (LSHM-CT-2004-005272) funded by the European Commission.	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; BAR RS, 1978, NEW ENGL J MED, V298, P1164, DOI 10.1056/NEJM197805252982103; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; BODER E, 1985, ATAXIA TELANGIECTASI, V19, P1; Crescenzi E, 2008, CLIN CANCER RES, V14, P1877, DOI 10.1158/1078-0432.CCR-07-4298; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; Donnelly LA, 2006, DIABETIC MED, V23, P128, DOI 10.1111/j.1464-5491.2005.01755.x; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604; Fu XA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002009; Fukao T, 1999, BLOOD, V94, P1998; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Hardie DG, 2000, METH MOL B, V99, P63; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Miles PD, 2007, AM J PHYSIOL-ENDOC M, V293, pE70, DOI 10.1152/ajpendo.00259.2006; Morris AD, 1997, BMJ-BRIT MED J, V315, P524, DOI 10.1136/bmj.315.7107.524; *NAT I HLTH CLIN E, 2009, NICE CLIN GUID 87 TY; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sanli T, 2010, INT J RADIAT ONCOL, V78, P221, DOI 10.1016/j.ijrobp.2010.03.005; Savitsky K, 1997, NUCLEIC ACIDS RES, V25, P1678, DOI 10.1093/nar/25.9.1678; SCHALCH DS, 1970, NEW ENGL J MED, V282, P1396, DOI 10.1056/NEJM197006182822503; Schneider JG, 2006, CELL METAB, V4, P377, DOI 10.1016/j.cmet.2006.10.002; Sun Y, 2007, MOL CELL BIOCHEM, V306, P239, DOI 10.1007/s11010-007-9575-6; Trinklein ND, 2003, GENOME RES, V13, P308, DOI 10.1101/gr.794803; UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P854; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	36	306	316	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2011	43	2					117	U57		10.1038/ng.735	http://dx.doi.org/10.1038/ng.735			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	711XD	21186350	Green Accepted, Green Submitted			2022-12-25	WOS:000286623800008
J	Maeda, H; Yoo, HJ; Dudareva, N				Maeda, Hiroshi; Yoo, Heejin; Dudareva, Natalia			Prephenate aminotransferase directs plant phenylalanine biosynthesis via arogenate	NATURE CHEMICAL BIOLOGY			English	Article							ASPARTATE-AMINOTRANSFERASE; TYROSINE BIOSYNTHESIS; PURIFICATION; PATHWAY; IDENTIFICATION; ACCUMULATION	The aromatic amino acids L-phenylalanine and L-tyrosine and their plant-derived natural products are essential in human and plant metabolism and physiology. Here we identified Petunia hybrida and Arabidopsis thaliana genes encoding prephenate aminotransferases (PPA-ATs), thus completing the identification of the genes involved in phenylalanine and tyrosine biosyntheses. Biochemical and genetic characterization of enzymes showed that PPA-AT directs carbon flux from prephenate toward arogenate, making the arogenate pathway predominant in plant phenylalanine biosynthesis.	[Maeda, Hiroshi; Yoo, Heejin; Dudareva, Natalia] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Dudareva, N (corresponding author), Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA.	dudareva@purdue.edu	Yoo, Heejin/L-3207-2019; Dudareva, Natalia/S-8710-2017	Dudareva, Natalia/0000-0003-0777-7763; Yoo, Heejin/0000-0002-9630-8207	US Agriculture and Food Research Initiative, US Department of Agriculture National Institute of Food and Agriculture [2010-65115-20385]; US National Science Foundation [MCB-0615700]; Japan Society for the Promotion of Science	US Agriculture and Food Research Initiative, US Department of Agriculture National Institute of Food and Agriculture; US National Science Foundation(National Science Foundation (NSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank J. Zheng and C. M. Kish (Purdue University) for technical assistance in the quantitative real-time PCR experiments, G. Taguchi and E. Pichersky (University of Michigan) for the pLISG vector and N. Bonawitz, D. Rhodes (Purdue University) and members of Dudareva laboratory for critical reading of the manuscript. This work was supported by the US Agriculture and Food Research Initiative competitive grant no. 2010-65115-20385 from US Department of Agriculture National Institute of Food and Agriculture and by grant MCB-0615700 from the US National Science Foundation to N. D. H. M. was supported in part by the Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad.	BICKEL H, 1979, PHYTOCHEMISTRY, V18, P498, DOI 10.1016/S0031-9422(00)81902-0; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; BONNER CA, 1985, ARCH BIOCHEM BIOPHYS, V238, P237, DOI 10.1016/0003-9861(85)90161-4; Bramley PM, 2000, J SCI FOOD AGR, V80, P913, DOI [10.1002/(SICI)1097-0010(20000515)80:7<913::AID-JSFA600>3.0.CO;2-3, 10.1002/(SICI)1097-0010(20000515)80:7&lt;913::AID-JSFA600&gt;3.0.CO;2-3]; Cho MH, 2007, J BIOL CHEM, V282, P30827, DOI 10.1074/jbc.M702662200; de la Torre F, 2006, PLANT J, V46, P414, DOI 10.1111/j.1365-313X.2006.02713.x; DEEKNAMKUL W, 1988, ARCH BIOCHEM BIOPHYS, V267, P87, DOI 10.1016/0003-9861(88)90011-2; FAZEL AM, 1979, J BACTERIOL, V138, P805, DOI 10.1128/JB.138.3.805-815.1979; GORLACH J, 1995, P NATL ACAD SCI USA, V92, P3166, DOI 10.1073/pnas.92.8.3166; KUTCHAN TM, 1998, ALKALOIDS, V50, P257; Maeda H, 2010, PLANT CELL, V22, P832, DOI 10.1105/tpc.109.073247; MARINO G, 1988, J BIOL CHEM, V263, P12305; Nakai T, 1999, BIOCHEMISTRY-US, V38, P2413, DOI 10.1021/bi9819881; Nobe Y, 1998, J BIOL CHEM, V273, P29554, DOI 10.1074/jbc.273.45.29554; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; REDKINA TV, 1969, BIOCHEMISTRY-MOSCOW+, V34, P247; Rippert P, 2002, EUR J BIOCHEM, V269, P4753, DOI 10.1046/j.1432-1033.2002.03172.x; RUBIN JL, 1979, PLANT PHYSIOL, V64, P727, DOI 10.1104/pp.64.5.727; SIEHL DL, 1986, PLANT PHYSIOL, V81, P711, DOI 10.1104/pp.81.2.711; SIEHL DL, 1986, Z NATURFORSCH C, V41, P79; Siehl DL, 1999, BOOK SOIL P, P171; Verdonk JC, 2003, PHYTOCHEMISTRY, V62, P997, DOI 10.1016/S0031-9422(02)00707-0; WIGHTMAN F, 1978, PHYTOCHEMISTRY, V17, P1455, DOI 10.1016/S0031-9422(00)94622-3; Yamada T, 2008, PLANT CELL, V20, P1316, DOI 10.1105/tpc.107.057455; ZAMIR LO, 1983, TETRAHEDRON LETT, V24, P2815, DOI 10.1016/S0040-4039(00)88031-4	25	104	112	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2011	7	1					19	21		10.1038/NCHEMBIO.485	http://dx.doi.org/10.1038/NCHEMBIO.485			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	695PA	21102469				2022-12-25	WOS:000285383400006
J	Borgel, J; Guibert, S; Li, YF; Chiba, H; Schubeler, D; Sasaki, H; Forne, T; Weber, M				Borgel, Julie; Guibert, Sylvain; Li, Yufeng; Chiba, Hatsune; Schuebeler, Dirk; Sasaki, Hiroyuki; Forne, Thierry; Weber, Michael			Targets and dynamics of promoter DNA methylation during early mouse development	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; DE-NOVO METHYLATION; MAMMALIAN DEVELOPMENT; PREIMPLANTATION DEVELOPMENT; METHYLTRANSFERASES DNMT3A; PATERNAL GENOME; GERM-CELL; PLURIPOTENT; DEMETHYLATION; POLYCOMB	DNA methylation is extensively reprogrammed during the early phases of mammalian development, yet genomic targets of this process are largely unknown. We optimized methylated DNA immunoprecipitation for low numbers of cells and profiled DNA methylation during early development of the mouse embryonic lineage in vivo. We observed a major epigenetic switch during implantation at the transition from the blastocyst to the postimplantation epiblast. During this period, DNA methylation is primarily targeted to repress the germline expression program. DNA methylation in the epiblast is also targeted to promoters of lineage-specific genes such as hematopoietic genes, which are subsequently demethylated during terminal differentiation. De novo methylation during early embryogenesis is catalyzed by Dnmt3b, and absence of DNA methylation leads to ectopic gene activation in the embryo. Finally, we identify nonimprinted genes that inherit promoter DNA methylation from parental gametes, suggesting that escape of post-fertilization DNA methylation reprogramming is prevalent in the mouse genome.	[Borgel, Julie; Guibert, Sylvain; Forne, Thierry; Weber, Michael] Univ Montpellier I, Univ Montpellier 2, CNRS, Inst Mol Genet,UMR 5535, Montpellier, France; [Li, Yufeng; Chiba, Hatsune; Sasaki, Hiroyuki] Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Higashi Ku, Fukuoka 812, Japan; [Schuebeler, Dirk] Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Kyushu University; Friedrich Miescher Institute for Biomedical Research	Weber, M (corresponding author), Univ Montpellier I, Univ Montpellier 2, CNRS, Inst Mol Genet,UMR 5535, Montpellier, France.	michael.weber@igmm.cnrs.fr	Forne, Thierry/D-3718-2013; Weber, Michael/P-1914-2016	Forne, Thierry/0000-0002-9179-1551; Weber, Michael/0000-0003-3484-5821	Epigenome NoE [LSHG-CT-2006-037415]; Novartis Research Foundation; Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche [ANR-07-BLAN-0052-02]; Association pour la Recherche sur le Cancer (ARC) [4868]; European Chemical Industry Council (CEFIC) [LRI-EMSG49-CNRS-08]	Epigenome NoE; Novartis Research Foundation; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); European Chemical Industry Council (CEFIC)	We thank R. Vicente for assistance with the flow cytometry, T. Gostan for help with R programming, and E. Posfai and R. Hirasawa for advice on embryo dissection. This research was supported by the Epigenome NoE (LSHG-CT-2006-037415), Novartis Research Foundation, Centre National de la Recherche Scientifique (CNRS), Agence Nationale de la Recherche (ANR-07-BLAN-0052-02), Association pour la Recherche sur le Cancer (ARC contract 4868) and European Chemical Industry Council (CEFIC) Long Research Initiative (LRI-EMSG49-CNRS-08).	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; BHULANI N, 2009, NATURE, V463, P1042; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Dahl JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009150; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lei H, 1996, DEVELOPMENT, V122, P3195; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Oda M, 2006, GENE DEV, V20, P3382, DOI 10.1101/gad.1470906; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Skinner MK, 2009, EPIGENOMICS-UK, V1, P111, DOI 10.2217/EPI.09.11; Smith RJ, 2002, GENE, V292, P101, DOI 10.1016/S0378-1119(02)00666-2; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; Waterland RA, 2009, HUM MOL GENET, V18, P3026, DOI 10.1093/hmg/ddp241; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990	50	437	449	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2010	42	12					1093	U90		10.1038/ng.708	http://dx.doi.org/10.1038/ng.708			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684UZ	21057502				2022-12-25	WOS:000284578800012
J	Jagani, Z; Mora-Blanco, EL; Sansam, CG; McKenna, ES; Wilson, B; Chen, DS; Klekota, J; Tamayo, P; Nguyen, PTL; Tolstorukov, M; Park, PJ; Cho, YJ; Hsiao, K; Buonamici, S; Pomeroy, SL; Mesirov, JP; Ruffner, H; Bouwmeester, T; Luchansky, SJ; Murtie, J; Kelleher, JF; Warmuth, M; Sellers, WR; Roberts, CWM; Dorsch, M				Jagani, Zainab; Mora-Blanco, E. Lorena; Sansam, Courtney G.; McKenna, Elizabeth S.; Wilson, Boris; Chen, Dongshu; Klekota, Justin; Tamayo, Pablo; Nguyen, Phuong T. L.; Tolstorukov, Michael; Park, Peter J.; Cho, Yoon-Jae; Hsiao, Kathy; Buonamici, Silvia; Pomeroy, Scott L.; Mesirov, Jill P.; Ruffner, Heinz; Bouwmeester, Tewis; Luchansky, Sarah J.; Murtie, Joshua; Kelleher, Joseph F.; Warmuth, Markus; Sellers, William R.; Roberts, Charles W. M.; Dorsch, Marion			Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway	NATURE MEDICINE			English	Article							SWI/SNF COMPLEX; SONIC-HEDGEHOG; GENE; MUTATIONS; CHROMATIN; IDENTIFICATION; EXPRESSION; HSNF5/INI1; INHIBITORS; TARGET	Aberrant activation of the Hedgehog (Hh) pathway can drive tumorigenesis(1). To investigate the mechanism by which glioma-associated oncogene family zinc finger-1 (GLI1), a crucial effector of Hh signaling(2), regulates Hh pathway activation, we searched for GLI1-interacting proteins. We report that the chromatin remodeling protein SNF5 (encoded by SMARCB1, hereafter called SNF5), which is inactivated in human malignant rhabdoid tumors (MRTs), interacts with GLI1. We show that Snf5 localizes to Gli1-regulated promoters and that loss of Snf5 leads to activation of the Hh-Gli pathway. Conversely, re-expression of SNF5 in MRT cells represses GLI1. Consistent with this, we show the presence of a Hh-Gli-activated gene expression profile in primary MRTs and show that GLI1 drives the growth of SNF5-deficient MRT cells in vitro and in vivo. Therefore, our studies reveal that SNF5 is a key mediator of Hh signaling and that aberrant activation of GLI1 is a previously undescribed targetable mechanism contributing to the growth of MRT cells.	[Mora-Blanco, E. Lorena; Sansam, Courtney G.; McKenna, Elizabeth S.; Wilson, Boris; Nguyen, Phuong T. L.; Roberts, Charles W. M.] Childrens Hosp Boston, Dept Pediat Oncol, Dana Farber Canc Inst, Div Hematol Oncol, Boston, MA USA; [Tamayo, Pablo; Cho, Yoon-Jae; Mesirov, Jill P.] Broad Inst Harvard, Cambridge, MA USA; [Tamayo, Pablo; Cho, Yoon-Jae; Mesirov, Jill P.] MIT, Cambridge, MA 02139 USA; [Tolstorukov, Michael; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA USA; [Cho, Yoon-Jae; Pomeroy, Scott L.] Childrens Hosp Boston, Dept Neurol, Boston, MA USA; [Ruffner, Heinz; Bouwmeester, Tewis] Novartis Inst BioMed Res, Basel, Switzerland; [Jagani, Zainab; Chen, Dongshu; Klekota, Justin; Hsiao, Kathy; Buonamici, Silvia; Luchansky, Sarah J.; Murtie, Joshua; Kelleher, Joseph F.; Warmuth, Markus; Sellers, William R.; Dorsch, Marion] Novartis Inst BioMed Res, Cambridge, MA USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Novartis; Novartis	Dorsch, M (corresponding author), Sanofi Aventis, Cambridge, MA USA.	charles_roberts@dfci.harvard.edu; marion.dorsch@sanofi-aventis.com	Mesirov, Jill/AGF-7626-2022; Roberts, Charles/N-2541-2018	Roberts, Charles/0000-0003-1135-1896; Park, Peter/0000-0001-9378-960X; Sansam, Courtney/0000-0002-0253-8643	NCI NIH HHS [R01 CA109467, R01 CA113794, R01 CA121941] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA121941, R01CA109467, R01CA113794] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Biegel JA, 1999, CANCER RES, V59, P74; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Chai JJ, 2005, CANCER RES, V65, P10192, DOI 10.1158/0008-5472.CAN-05-1896; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Hyman JM, 2009, P NATL ACAD SCI USA, V106, P14132, DOI 10.1073/pnas.0907134106; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Isakoff MS, 2005, P NATL ACAD SCI USA, V102, P17745, DOI 10.1073/pnas.0509014102; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Lee J, 1997, DEVELOPMENT, V124, P2537; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Martin JF, 2000, GENESIS, V26, P225, DOI 10.1002/(SICI)1526-968X(200004)26:4<225::AID-GENE10>3.0.CO;2-F; McKenna ES, 2008, MOL CELL BIOL, V28, P6223, DOI 10.1128/MCB.00658-08; McKenna ES, 2009, CELL CYCLE, V8, P23, DOI 10.4161/cc.8.1.7290; Nagl NG, 2006, CANCER RES, V66, P1289, DOI 10.1158/0008-5472.CAN-05-3427; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Pan SF, 2010, ACS MED CHEM LETT, V1, P130, DOI 10.1021/ml1000307; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Raffel C, 1997, CANCER RES, V57, P842; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Sevenet N, 1999, AM J HUM GENET, V65, P1342, DOI 10.1086/302639; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Theil T, 1999, CELL TISSUE RES, V296, P75, DOI 10.1007/s004410051268; Tsikitis M, 2005, P NATL ACAD SCI USA, V102, P12129, DOI 10.1073/pnas.0505300102; Turner FB, 2006, METH MOL B, V325, P261; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wang X, 2009, CANCER RES, V69, P8094, DOI 10.1158/0008-5472.CAN-09-0733; Weissman B, 2009, CANCER RES, V69, P8223, DOI 10.1158/0008-5472.CAN-09-2166; Wisniewski D, 2002, CANCER RES, V62, P4244; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009	39	170	178	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1429	U112		10.1038/nm.2251	http://dx.doi.org/10.1038/nm.2251			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21076395	Green Accepted			2022-12-25	WOS:000285048900037
J	Blennow, K				Blennow, Kaj			Biomarkers in Alzheimer's disease drug development	NATURE MEDICINE			English	Article							MILD COGNITIVE IMPAIRMENT; BETA IMMUNIZATION AN1792; PLACEBO-CONTROLLED TRIAL; A-BETA; CEREBROSPINAL-FLUID; CSF BIOMARKERS; GAMMA-SECRETASE; DOUBLE-BLIND; FOLLOW-UP; IN-VIVO	Biomarkers may be of great value in Alzheimer's disease drug development to select the most optimal drug candidates for large and expensive phase 3 clinical trials. Biomarkers will also be important to provide evidence that a drug affects the underlying pathophysiology of the disease, which, together with a beneficial effect on the clinical course, will be essential for labeling the drug as having a disease-modifying effect.	Univ Gothenburg, Clin Neurochem Lab, Inst Neurosci & Physiol, Dept Psychiat & Neurochem,Sahlgrenska Acad, Molndal, Sweden	University of Gothenburg	Blennow, K (corresponding author), Univ Gothenburg, Clin Neurochem Lab, Inst Neurosci & Physiol, Dept Psychiat & Neurochem,Sahlgrenska Acad, Molndal, Sweden.	kaj.blennow@neuro.gu.se						Bateman RJ, 2009, ANN NEUROL, V66, P48, DOI 10.1002/ana.21623; Blennow K, 2007, NEUROSCI LETT, V419, P18, DOI 10.1016/j.neulet.2007.03.064; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Chen XY, 2006, J NEUROPSYCH CLIN N, V18, P178, DOI 10.1176/appi.neuropsych.18.2.178; Cook JJ, 2010, J NEUROSCI, V30, P6743, DOI 10.1523/JNEUROSCI.1381-10.2010; Davidsson P, 1998, Int Psychogeriatr, V10, P11, DOI 10.1017/S1041610298005110; Davidsson P, 1999, ELECTROPHORESIS, V20, P431; DeCarli C, 2003, LANCET NEUROL, V2, P15, DOI 10.1016/S1474-4422(03)00262-X; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fleisher AS, 2008, ARCH NEUROL-CHICAGO, V65, P1031, DOI 10.1001/archneur.65.8.1031; Fox NC, 2005, NEUROLOGY, V64, P1563, DOI 10.1212/01.WNL.0000159743.08996.99; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; Galasko DR, 2007, ALZ DIS ASSOC DIS, V21, P292, DOI 10.1097/WAD.0b013e31815d1048; Garcia-Alloza M, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-19; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Green RC, 2009, JAMA-J AM MED ASSOC, V302, P2557, DOI 10.1001/jama.2009.1866; Gunnarsson MD, 2010, DEMENT GERIATR COGN, V29, P204, DOI 10.1159/000281832; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hashimoto M, 2005, AM J PSYCHIAT, V162, P676, DOI 10.1176/appi.ajp.162.4.676; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Kotzbauer PT, 2001, J MOL NEUROSCI, V17, P225, DOI 10.1385/JMN:17:2:225; Krishnan KRR, 2003, AM J PSYCHIAT, V160, P2003, DOI 10.1176/appi.ajp.160.11.2003; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; Nelson PT, 2010, J NEUROPATH EXP NEUR, V69, P449, DOI 10.1097/NEN.0b013e3181d8db07; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; PORTELIUS E, 2010, J ALZHEIMERS DI 0715, DOI DOI 10.3233/JALZHEIMER'SDISEASE-2010-100573; Portelius E, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt30; Portelius E, 2009, NEURODEGENER DIS, V6, P258, DOI 10.1159/000264639; Portelius E, 2011, NEUROBIOL AGING, V32, P1090, DOI 10.1016/j.neurobiolaging.2009.06.002; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Tune L, 2003, AM J GERIAT PSYCHIAT, V11, P169, DOI 10.1176/appi.ajgp.11.2.169; Visser PJ, 2009, LANCET NEUROL, V8, P619, DOI 10.1016/S1474-4422(09)70139-5; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wilcock GK, 2008, LANCET NEUROL, V7, P483, DOI 10.1016/S1474-4422(08)70090-5; Zetterberg H, 2007, J ALZHEIMERS DIS, V12, P255, DOI 10.3233/jad-2007-12307	45	103	104	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2010	16	11					1218	1222		10.1038/nm.2221	http://dx.doi.org/10.1038/nm.2221			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21052077				2022-12-25	WOS:000283860100029
J	Duric, V; Banasr, M; Licznerski, P; Schmidt, HD; Stockmeier, CA; Simen, AA; Newton, SS; Duman, RS				Duric, Vanja; Banasr, Mounira; Licznerski, Pawel; Schmidt, Heath D.; Stockmeier, Craig A.; Simen, Arthur A.; Newton, Samuel S.; Duman, Ronald S.			A negative regulator of MAP kinase causes depressive behavior	NATURE MEDICINE			English	Article							POSTMORTEM BRAIN; PATHWAY CONTRIBUTES; HIPPOCAMPAL ATROPHY; SUICIDE VICTIMS; ECONOMIC BURDEN; STRESS SYSTEM; EXPRESSION; PHOSPHATASE-1; GENE; MODELS	The lifetime prevalence (similar to 16%)(1) and the economic burden ($100 billion annually)(2,3) associated with major depressive disorder (MDD) make it one of the most common and debilitating neurobiological illnesses. To date, the exact cellular and molecular mechanisms underlying the pathophysiology of MDD have not been identified. Here we use whole-genome expression profiling of postmortem tissue and show significantly increased expression of mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1, encoded by DUSP1, but hereafter called MKP-1) in the hippocampal subfields of subjects with MDD compared to matched controls. MKP-1, also known as dual-specificity phosphatase-1 (DUSP1), is a member of a family of proteins that dephosphorylate both threonine and tyrosine residues and thereby serves as a key negative regulator of the MAPK cascade(4), a major signaling pathway involved in neuronal plasticity, function and survival(5,6). We tested the role of altered MKP-1 expression in rat and mouse models of depression and found that increased hippocampal MKP-1 expression, as a result of stress or viral-mediated gene transfer, causes depressive behaviors. Conversely, chronic antidepressant treatment normalizes stress-induced MKP-1 expression and behavior, and mice lacking MKP-1 are resilient to stress. These postmortem and preclinical studies identify MKP-1 as a key factor in MDD pathophysiology and as a new target for therapeutic interventions.	[Duric, Vanja; Banasr, Mounira; Licznerski, Pawel; Schmidt, Heath D.; Simen, Arthur A.; Newton, Samuel S.; Duman, Ronald S.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Stockmeier, Craig A.] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA; [Stockmeier, Craig A.] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA	Yale University; University of Mississippi; University of Mississippi Medical Center; Case Western Reserve University	Duman, RS (corresponding author), Yale Univ, Dept Psychiat, New Haven, CT 06520 USA.	ronald.duman@yale.edu	Yan, Shuo/B-8381-2009	Licznerski, Pawel/0000-0003-2761-8428	US Public Health Service [MH45481, 2 P01 MH25642, MH67996, P20 RR17701]; Connecticut Mental Health Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH025642, R29MH045481, R01MH045481, R37MH045481, R01MH067996] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Connecticut Mental Health Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by US Public Health Service grants MH45481 (R.S.D.), 2 P01 MH25642 (R.S.D.), MH67996 (C.A.S.) and P20 RR17701 (C.A.S.) and the Connecticut Mental Health Center (R.S.D.). We acknowledge the invaluable contributions made by the families consenting to donate brain tissue and be interviewed. We also thank the Cuyahoga County Coroner and staff for their willing assistance. We are grateful for the contributions of J. Overholser, G. Jurjus, H. Meltzer, L. Konick, L. Dieter, N. Herbst, G. Mahajan, H. Kooiman and J. Cobb in the psychiatric assessment and human tissue dissection and preparation. We also thank R. Terwilliger and H.J. Kang for technical assistance with gene expression analysis, A. Bennett (Yale University School of Medicine) for Mkp-1<SUP>-/-</SUP> mice, X.Y. Li for assistance in breeding and genotyping Mkp-1<SUP>-/-</SUP> mice and R. DiLeone (Yale University School of Medicine) for generously donating AAV-CMV-GFP plasmid used to generate recombinant AAVs.	Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Creson TK, 2009, BIPOLAR DISORD, V11, P339, DOI 10.1111/j.1399-5618.2009.00697.x; Dorfman K, 1996, ONCOGENE, V13, P925; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Drevets WC, 2000, PROG BRAIN RES, V126, P413; Duman CH, 2007, BIOL PSYCHIAT, V61, P661, DOI 10.1016/j.biopsych.2006.05.047; Dwivedi Y, 2006, MOL PSYCHIATR, V11, P86, DOI 10.1038/sj.mp.4001744; Dwivedi Y, 2005, BIOL PSYCHIAT, V58, P315, DOI 10.1016/j.biopsych.2005.04.014; Dwivedi Y, 2001, J NEUROCHEM, V77, P916, DOI 10.1046/j.1471-4159.2001.00300.x; Dwivedi Y, 2003, ARCH GEN PSYCHIAT, V60, P804, DOI 10.1001/archpsyc.60.8.804; Einat H, 2003, J NEUROSCI, V23, P7311; Engel SR, 2009, MOL PSYCHIATR, V14, P448, DOI 10.1038/sj.mp.4002135; Fukunaga K, 1998, MOL NEUROBIOL, V16, P79, DOI 10.1007/BF02740604; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Greenberg PE, 2003, J CLIN PSYCHIAT, V64, P1465, DOI 10.4088/JCP.v64n1211; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Hsiung S, 2003, J NEUROCHEM, V87, P182, DOI 10.1046/j.1471-4159.2003.01987.x; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Laderoute KR, 1999, J BIOL CHEM, V274, P12890, DOI 10.1074/jbc.274.18.12890; Magarinos AM, 1999, EUR J PHARMACOL, V371, P113, DOI 10.1016/S0014-2999(99)00163-6; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Neumeister A, 2005, BIOL PSYCHIAT, V57, P935, DOI 10.1016/j.biopsych.2005.01.016; Qi XL, 2009, BEHAV BRAIN RES, V199, P203, DOI 10.1016/j.bbr.2008.11.051; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; Seta KA, 2001, J BIOL CHEM, V276, P44405, DOI 10.1074/jbc.M103346200; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Simon GE, 2003, BIOL PSYCHIAT, V54, P208, DOI 10.1016/S0006-3223(03)00420-7; Stockmeier CA, 2004, BIOL PSYCHIAT, V56, P640, DOI 10.1016/j.biopsych.2004.08.022; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; VERKHRATSKY NS, 1995, EXP GERONTOL, V30, P415, DOI 10.1016/0531-5565(94)00056-9; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010	40	299	312	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1328	U36		10.1038/nm.2219	http://dx.doi.org/10.1038/nm.2219			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	20953200	Green Accepted			2022-12-25	WOS:000283860100046
J	Mao, HY; Graziano, JJ; Chase, TMA; Bentley, CA; Bazirgan, OA; Reddy, NP; Song, BD; Smider, VV				Mao, Hongyuan; Graziano, James J.; Chase, Tyson M. A.; Bentley, Cornelia A.; Bazirgan, Omar A.; Reddy, Neil P.; Song, Byeong Doo; Smider, Vaughn V.			Spatially addressed combinatorial protein libraries for recombinant antibody discovery and optimization	NATURE BIOTECHNOLOGY			English	Article							AFFINITY HUMAN-ANTIBODIES; SINGLE-CHAIN ANTIBODIES; PHAGE-DISPLAY LIBRARY; INHIBITS TUMOR-GROWTH; IN-VITRO; NOTCH LIGAND; MOLECULAR RECOGNITION; UP-REGULATION; BINDING-SITE; CELL LINES	Antibody discovery typically uses hybridoma- or display-based selection approaches, which lack the advantages of directly screening spatially addressed compound libraries as in small-molecule discovery. Here we apply the latter strategy to antibody discovery, using a library of similar to 10,000 human germline antibody Fabs created by de novo DNA synthesis and automated protein expression and purification. In multiplexed screening assays, we obtained specific hits against seven of nine antigens. Using sequence-activity relationships and iterative mutagenesis, we optimized the binding affinities of two hits to the low nanomolar range. The matured Fabs showed full and partial antagonism activities in cell-based assays. Thus, protein drug leads can be discovered using surprisingly small libraries of proteins with known sequences, questioning the requirement for billions of members in an antibody discovery library. This methodology also provides sequence, expression and specificity information at the first step of the discovery process, and could enable novel antibody discovery in functional screens.	[Mao, Hongyuan; Graziano, James J.; Chase, Tyson M. A.; Bentley, Cornelia A.; Bazirgan, Omar A.; Reddy, Neil P.; Song, Byeong Doo; Smider, Vaughn V.] Fabrus LLC, La Jolla, CA USA; [Smider, Vaughn V.] Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Smider, VV (corresponding author), Fabrus LLC, La Jolla, CA USA.	vvsmider@scripps.edu		Smider, Vaughn/0000-0003-3488-6383				Babor M, 2009, PROTEINS, V75, P846, DOI 10.1002/prot.22293; BACHMANN MF, 1994, J IMMUNOL, V152, P4235; BARBAS CF, 1994, P NATL ACAD SCI USA, V91, P3809, DOI 10.1073/pnas.91.9.3809; Beerli RR, 2008, P NATL ACAD SCI USA, V105, P14336, DOI 10.1073/pnas.0805942105; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Brezinschek HP, 1997, J CLIN INVEST, V99, P2488, DOI 10.1172/JCI119433; Brooks CL, 2008, J MOL BIOL, V377, P450, DOI 10.1016/j.jmb.2008.01.018; Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018; COHN M, 1990, IMMUNOL REV, V115, P7, DOI 10.1111/j.1600-065X.1990.tb00783.x; Corbett SJ, 1997, J MOL BIOL, V270, P587, DOI 10.1006/jmbi.1997.1141; Cumbers SJ, 2002, NAT BIOTECHNOL, V20, P1129, DOI 10.1038/nbt752; DEKRUIF J, 1995, J MOL BIOL, V248, P97, DOI 10.1006/jmbi.1995.0204; Diller DJ, 2008, CURR OPIN DRUG DISC, V11, P346; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Gilfillan S, 1995, IMMUNOL REV, V148, P201, DOI 10.1111/j.1600-065X.1995.tb00099.x; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; Hanes J, 1998, P NATL ACAD SCI USA, V95, P14130, DOI 10.1073/pnas.95.24.14130; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; Ho M, 2006, P NATL ACAD SCI USA, V103, P9637, DOI 10.1073/pnas.0603653103; Hoey T, 2009, CELL STEM CELL, V5, P168, DOI 10.1016/j.stem.2009.05.019; Holt L J, 2000, Nucleic Acids Res, V28, pE72, DOI 10.1093/nar/28.15.e72; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; HUSE WD, 1989, SCIENCE, V246, P1275, DOI 10.1126/science.2531466; JACKSON JR, 1995, J IMMUNOL, V154, P3310; Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966; Joachimiak A, 2009, CURR OPIN STRUC BIOL, V19, P573, DOI 10.1016/j.sbi.2009.08.002; Kauffman S. A., 1993, ORIGINS ORDER; Kim D, 2005, J MOL BIOL, V351, P763, DOI 10.1016/j.jmb.2005.06.051; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Leonard B, 2006, J IMMUNOL METHODS, V317, P56, DOI 10.1016/j.jim.2006.09.006; Levitan B, 1998, J MOL BIOL, V277, P893, DOI 10.1006/jmbi.1997.1555; Li JL, 2007, CANCER RES, V67, P11244, DOI 10.1158/0008-5472.CAN-07-0969; Liu ZH, 2007, BLOOD, V110, P2408, DOI 10.1182/blood-2007-04-083998; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Mao SL, 1999, P NATL ACAD SCI USA, V96, P6953, DOI 10.1073/pnas.96.12.6953; MARKS JD, 1992, BIO-TECHNOL, V10, P779, DOI 10.1038/nbt0792-779; Matsuda F, 1998, J EXP MED, V188, P2151, DOI 10.1084/jem.188.11.2151; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; McCall AM, 1999, MOL IMMUNOL, V36, P433, DOI 10.1016/S0161-5890(99)00057-7; MILLER DJ, 1995, J IMMUNOL, V154, P2460; Nefedova Y, 2004, BLOOD, V103, P3503, DOI 10.1182/blood-2003-07-2340; Nguyen HP, 2003, NAT STRUCT BIOL, V10, P1019, DOI 10.1038/nsb1014; Patel NS, 2006, CLIN CANCER RES, V12, P4836, DOI 10.1158/1078-0432.CCR-06-0285; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Patten PA, 1996, SCIENCE, V271, P1086, DOI 10.1126/science.271.5252.1086; Polinsky A, 1999, Curr Opin Drug Discov Devel, V2, P197; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Segarra M, 2008, BLOOD, V112, P1904, DOI 10.1182/blood-2007-11-126045; Sethi DK, 2006, IMMUNITY, V24, P429, DOI 10.1016/j.immuni.2006.02.010; Sheets MD, 1998, P NATL ACAD SCI USA, V95, P6157, DOI 10.1073/pnas.95.11.6157; Shutter JR, 2000, GENE DEV, V14, P1313; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; Smider V, 1997, Semin Immunol, V9, P189, DOI 10.1006/smim.1997.0070; SMIDER V, 2009, Patent No. 2009063299; Thielges MC, 2008, BIOCHEMISTRY-US, V47, P7237, DOI 10.1021/bi800374q; Thomson CA, 2008, EMBO J, V27, P2592, DOI 10.1038/emboj.2008.179; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; Wang J, 2008, CELL MOL IMMUNOL, V5, P55, DOI 10.1038/cmi.2008.7; Wang LY, 2009, J PHARMACOL EXP THER, V331, P340, DOI 10.1124/jpet.109.156380; Wollerton M.C., 2006, JALA, V11, P291; Wu HR, 1998, P NATL ACAD SCI USA, V95, P6037, DOI 10.1073/pnas.95.11.6037; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Yan MH, 2010, NATURE, V463, pE6, DOI 10.1038/nature08751; Yin J, 2003, J MOL BIOL, V330, P651, DOI 10.1016/S0022-2836(03)00631-4; Yoneya T, 2001, J BIOCHEM-TOKYO, V129, P27, DOI 10.1093/oxfordjournals.jbchem.a002832; Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114; Zimmermann J, 2006, P NATL ACAD SCI USA, V103, P13722, DOI 10.1073/pnas.0603282103	69	20	27	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2010	28	11					1195	U90		10.1038/nbt.1694	http://dx.doi.org/10.1038/nbt.1694			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	676PI	20972421				2022-12-25	WOS:000283924100022
J	Flach, TL; Ng, G; Hari, A; Desrosiers, MD; Zhang, P; Ward, SM; Seamone, ME; Vilaysane, A; Mucsi, AD; Fong, Y; Prenner, E; Ling, CC; Tschopp, J; Muruve, DA; Amrein, MW; Shi, Y				Flach, Tracy L.; Ng, Gilbert; Hari, Aswin; Desrosiers, Melanie D.; Zhang, Ping; Ward, Sandra M.; Seamone, Mark E.; Vilaysane, Akosua; Mucsi, Ashley D.; Fong, Yin; Prenner, Elmar; Ling, Chang Chun; Tschopp, Jurg; Muruve, Daniel A.; Amrein, Matthias W.; Shi, Yan			Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity	NATURE MEDICINE			English	Article							MONOSODIUM URATE CRYSTALS; NALP3 INFLAMMASOME; NLRP3 INFLAMMASOME; CROSS-PRESENTATION; VACCINE ADJUVANTS; IMMUNE-RESPONSES; SOLID-SURFACES; URIC-ACID; ACTIVATION; PHAGOCYTOSIS	As an approved vaccine adjuvant for use in humans, alum has vast health implications, but, as it is a crystal, questions remain regarding its mechanism. Furthermore, little is known about the target cells, receptors, and signaling pathways engaged by alum. Here we report that, independent of inflammasome and membrane proteins, alum binds dendritic cell (DC) plasma membrane lipids with substantial force. Subsequent lipid sorting activates an abortive phagocytic response that leads to antigen uptake. Such activated DCs, without further association with alum, show high affinity and stable binding with CD4(+) T cells via the adhesion molecules intercellular adhesion molecule-1 (ICAM-1) and lymphocyte function-associated antigen-1 (LFA-1). We propose that alum triggers DC responses by altering membrane lipid structures. This study therefore suggests an unexpected mechanism for how this crystalline structure interacts with the immune system and how the DC plasma membrane may behave as a general sensor for solid structures.	[Flach, Tracy L.; Ng, Gilbert; Hari, Aswin; Desrosiers, Melanie D.; Mucsi, Ashley D.; Fong, Yin; Shi, Yan] Univ Calgary, Dept Microbiol & Infect Dis, Immunol Res Grp, Calgary, AB, Canada; [Flach, Tracy L.; Ng, Gilbert; Hari, Aswin; Desrosiers, Melanie D.; Mucsi, Ashley D.; Fong, Yin; Shi, Yan] Univ Calgary, Snyder Inst, Calgary, AB, Canada; [Zhang, Ping; Ward, Sandra M.; Ling, Chang Chun] Univ Calgary, Dept Chem, Calgary, AB T2N 1N4, Canada; [Zhang, Ping; Ward, Sandra M.; Ling, Chang Chun] Univ Calgary, Alberta Ingenu Ctr Carbohydrate Sci, Calgary, AB, Canada; [Seamone, Mark E.; Vilaysane, Akosua; Muruve, Daniel A.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Prenner, Elmar] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Tschopp, Jurg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Amrein, Matthias W.] Univ Calgary, Dept Biol & Anat, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Lausanne; University of Calgary	Shi, Y (corresponding author), Univ Calgary, Dept Microbiol & Infect Dis, Immunol Res Grp, Calgary, AB, Canada.	yshi@ucalgary.ca	Shi, Yan/Y-6642-2019; Prenner, Elmar J/E-5549-2011		US National Institutes of Health; JPK instruments; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI089963] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPK instruments; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Lanier and C. Lowell (University of California-San Francisco) for providing mouse bone marrows; P. Kubes (University of Calgary) for ICAM-1-, LFA-1- and TLR4-knockout mice; K. Rock (University of Massachusetts Medical School), P. Cresswell (Yale University), G. Dranoff (Harvard Medical School) and R. Yates and J. Deans (University of Calgary) for cell lines, L. J. Shen, M. Ho, Y. Yang and P. Santamaria for manuscript review; C. Olson and T. Fung for statistical software and advice; E. Chau for manuscript editing; F. Oskouie for cell culture assistance; and M. Schoel and W.-D. Xiang for SEM and transmission electron microscopy technical assistance. This work was supported by grants from the US National Institutes of Health to Y. S. and equipment donation from JPK instruments to M. W. A.	Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; COLIGAN JE, 2005, SHORT PROTOCOLS IMMU, pCH1; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Dai RY, 2009, INT J ONCOL, V34, P1749, DOI 10.3892/ijo_00000306; De Gregorio E, 2009, CURR OPIN IMMUNOL, V21, P339, DOI 10.1016/j.coi.2009.05.003; Desrosiers MD, 2007, J IMMUNOL, V179, P1884, DOI 10.4049/jimmunol.179.3.1884; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fitzer-Attas CJ, 2000, J EXP MED, V191, P669, DOI 10.1084/jem.191.4.669; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; GARRY VF, 1993, J LAB CLIN MED, V122, P739; Glenny AT, 1931, J PATHOL BACTERIOL, V34, P267, DOI 10.1002/path.1700340214; GOLDSTEIN J, 2003, SCANNING ELECT MICRO, pCH7; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Harlow E., 1988, ANTIBODIES; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Jiang K, 2002, J IMMUNOL, V168, P3155, DOI 10.4049/jimmunol.168.7.3155; Jordan MB, 2004, SCIENCE, V304, P1808, DOI 10.1126/science.1089926; Kanevets U, 2009, J IMMUNOL, V182, P1912, DOI 10.4049/jimmunol.0803777; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Kovjazin R, 2003, FASEB J, V17, P467, DOI 10.1096/fj.02-0558fje; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Leonenko Z, 2007, ULTRAMICROSCOPY, V107, P948, DOI 10.1016/j.ultramic.2007.02.036; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2008, J LEUKOCYTE BIOL, V83, P507, DOI 10.1189/jlb.0607362; Mathur RK, 2004, NAT MED, V10, P540, DOI 10.1038/nm1045; Mckee AS, 2009, J IMMUNOL, V183, P4403, DOI 10.4049/jimmunol.0900164; Newton R, 2000, BRIT J PHARMACOL, V130, P1353, DOI 10.1038/sj.bjp.0703431; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013; NOLLERT P, 1995, BIOPHYS J, V69, P1447, DOI 10.1016/S0006-3495(95)80014-7; PARHAM P, 2004, IMMUNE SYSTEM, pCH12; Richter R, 2003, BIOPHYS J, V85, P3035, DOI 10.1016/S0006-3495(03)74722-5; Rimaniol AC, 2004, VACCINE, V22, P3127, DOI 10.1016/j.vaccine.2004.01.061; Rock KL, 2006, IMMUNITY, V25, P523, DOI 10.1016/j.immuni.2006.09.003; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Ruland J, 2008, ANN NY ACAD SCI, V1143, P35, DOI 10.1196/annals.1443.024; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Shi Y, 2006, J IMMUNOL, V176, P3905, DOI 10.4049/jimmunol.176.7.3905; Shi Y, 2010, IMMUNOL REV, V233, P203, DOI 10.1111/j.0105-2896.2009.00851.x; Shio MT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000559; Shiratsuchi H, 2004, AM J PHYSIOL-CELL PH, V286, pC1358, DOI 10.1152/ajpcell.00553.2003; Sun HF, 2003, VACCINE, V21, P849, DOI 10.1016/S0264-410X(02)00531-5; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551	50	273	279	6	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2011	17	4					479	U121		10.1038/nm.2306	http://dx.doi.org/10.1038/nm.2306			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21399646				2022-12-25	WOS:000289245100039
J	Wang, YF; Fisher, JC; Mathew, R; Ou, L; Otieno, S; Sublet, J; Xiao, LM; Chen, JH; Roussel, MF; Kriwacki, RW				Wang, Yuefeng; Fisher, John C.; Mathew, Rose; Ou, Li; Otieno, Steve; Sublet, Jack; Xiao, Limin; Chen, Jianhan; Roussel, Martine F.; Kriwacki, Richard W.			Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21	NATURE CHEMICAL BIOLOGY			English	Article							CYCLIN-DEPENDENT KINASES; UNSTRUCTURED PROTEINS; CRYSTAL-STRUCTURE; CHEMICAL-SHIFTS; CELL-DIVISION; P27(KIP1); COMPLEX; BINDING; FLEXIBILITY; ACTIVATION	Traditionally, well-defined three-dimensional structure has been thought to be essential for protein function. However, myriad biological functions are performed by highly dynamic, intrinsically disordered proteins (IDPs). IDPs often fold upon binding their biological targets and frequently show 'binding diversity' by targeting multiple ligands. We sought to understand the physical basis of IDP binding diversity and report here that the cyclin-dependent kinase (Cdk) inhibitor p21(Cip1) adaptively binds to and inhibits the various Cdk-cyclin complexes that regulate eukaryotic cell division. Using results from NMR spectroscopy and biochemical and cellular assays, we show that structural adaptability of a helical subdomain within p21, termed LH, enables two other subdomains, D1 and D2, to specifically bind conserved surface features of the cyclin and Cdk subunits, respectively, within otherwise structurally distinct Cdk-cyclin complexes. Adaptive folding upon binding is likely to mediate the diverse biological functions of the thousands of IDPs present in eukaryotes.	[Wang, Yuefeng; Fisher, John C.; Ou, Li; Otieno, Steve; Xiao, Limin; Kriwacki, Richard W.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Fisher, John C.; Roussel, Martine F.; Kriwacki, Richard W.] Univ Tennessee, Hlth Sci Ctr, Integrated Program Biomed Sci, Memphis, TN USA; [Fisher, John C.] Univ Tennessee, Hlth Sci Ctr, Coll Med, Memphis, TN USA; [Chen, Jianhan] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Roussel, Martine F.; Kriwacki, Richard W.] Univ Tennessee, Dept Microbiol Immunol & Biochem, Hlth Sci Ctr, Memphis, TN USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Kansas State University; University of Tennessee System; University of Tennessee Health Science Center	Wang, YF (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.	richard.kriwacki@stjude.org	Roussel, Martine F/F-1469-2016; Kriwacki, Richard/N-8154-2018; Chen, Jianhan/C-7680-2009; WANG, YUE/GWQ-9256-2022; Ou, Li/F-8416-2012	Roussel, Martine F/0000-0002-1740-8139; Kriwacki, Richard/0000-0002-9798-6018; 	US National Institutes of Health [P30CA21765, 5R01CA082491, R01CA71907]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; US National Science Foundation [NSF MCB 0952514]; NATIONAL CANCER INSTITUTE [P01CA071907, P30CA021765, R01CA082491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK007405] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); US National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors gratefully acknowledge S. I. Reed (Scripps Research Institute) for providing a vector to express a cyclin D1-Cdk4 fusion protein, L. Hengst (Innsbruck Medical University) for providing baculoviruses that coexpress Cdk6 and cyclin D1, B. Schulman (St. Jude Children's Research Hospital) and P. D. Adams (Fox Chase Cancer Center) for providing Rb constructs, C.J. Sherr (St. Jude Children's Research Hospital) for providing anti-sera for Cdk2 and Cdk4 and for stimulating discussions, M. Assem (St. Jude Children's Research Hospital) for technical assistance with cell cycle assays, C.-G. Park (St. Jude Children's Research Hospital) for preparation of Cdk-cyclin complexes for kinase assays, N. Pytel (St. Jude Children's Research Hospital) for preparation of p21-KID protein samples, E. Tuomanen (St. Jude Children's Research Hospital) for assistance with kinase assays and R. Ashmun (St. Jude Children's Research Hospital) for FACS analysis. The authors acknowledge support from US National Institutes of Health core grant P30CA21765 (St. Jude Children's Research Hospital), 5R01CA082491 (to R. W. K.), R01CA71907 (to M. F. R.), the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital and a US National Science Foundation CAREER Award (NSF MCB 0952514 to J.C.).	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bowman P, 2006, BBA-PROTEINS PROTEOM, V1764, P182, DOI 10.1016/j.bbapap.2005.12.016; Brown NR, 2007, CELL CYCLE, V6, P1350, DOI 10.4161/cc.6.11.4278; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Creighton T. E., 1993, PROTEINS STRUCTURES; CREIGHTON TE, 1989, PROTEIN STRUCTURE PR; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Galea CA, 2008, J MOL BIOL, V376, P827, DOI 10.1016/j.jmb.2007.12.016; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; HARPER JW, 1993, CELL, V75, P805; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; Honda R, 2005, EMBO J, V24, P452, DOI 10.1038/sj.emboj.7600554; HUI Z, 1993, MOL BIOL CELL, V4, P897, DOI 10.1091/mbc.4.9.897; Kriwacki RW, 1996, J AM CHEM SOC, V118, P5320, DOI 10.1021/ja960752m; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Lacy ER, 2005, J MOL BIOL, V349, P764, DOI 10.1016/j.jmb.2005.04.019; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; Martin AC, 1998, STRUCTURE, V6, P875, DOI 10.1016/S0969-2126(98)00089-6; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sivakolundu SG, 2005, J MOL BIOL, V353, P1118, DOI 10.1016/j.jmb.2005.08.074; Takaki T, 2009, P NATL ACAD SCI USA, V106, P4171, DOI 10.1073/pnas.0809674106; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Wang YF, 2005, CHEMBIOCHEM, V6, P2242, DOI 10.1002/cbic.200500260; WEINBEG RA, 2006, BIOL CANC; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	46	102	106	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					214	221		10.1038/NCHEMBIO.536	http://dx.doi.org/10.1038/NCHEMBIO.536			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21358637	Green Accepted			2022-12-25	WOS:000288545000009
J	Weiss, IM				Weiss, Ingrid M.			BIOMATERIALS Metabolites empowering minerals	NATURE CHEMICAL BIOLOGY			English	News Item							AMORPHOUS CALCIUM-CARBONATE; BIOMINERALIZATION		Leibniz Inst New Mat, Dept Mat Biol, Saarbrucken, Germany	Leibniz Institut fur Neue Materialien (INM)	Weiss, IM (corresponding author), Leibniz Inst New Mat, Dept Mat Biol, Saarbrucken, Germany.	ingrid.weiss@inm-gmbh.de		Weiss, Ingrid/0000-0002-7345-341X				Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; Cornish-Bowden A., 1997, NEW BEER OLD BOTTLE; HOROWITZ NH, 1945, P NATL ACAD SCI USA, V31, P153, DOI 10.1073/pnas.31.6.153; Lippmann F, 1973, SEDIMENTARY CARBONAT; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; Oparin AI., 1957, ORIGIN LIFE EARTH; Radha AV, 2010, P NATL ACAD SCI USA, V107, P16438, DOI 10.1073/pnas.1009959107; Sato A, 2011, NAT CHEM BIOL, V7, P197, DOI 10.1038/NCHEMBIO.532; Weiner S, 2008, J STRUCT BIOL, V163, P229, DOI 10.1016/j.jsb.2008.02.001	10	2	2	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					192	193		10.1038/nchembio.550	http://dx.doi.org/10.1038/nchembio.550			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21423159				2022-12-25	WOS:000288545000001
J	Davis, EE; Zhang, Q; Liu, Q; Diplas, BH; Davey, LM; Hartley, J; Stoetzel, C; Szymanska, K; Ramaswami, G; Logan, CV; Muzny, DM; Young, AC; Wheeler, DA; Cruz, P; Morgan, M; Lewis, LR; Cherukuri, P; Maskeri, B; Hansen, NF; Mullikin, JC; Blakesley, RW; Bouffard, GG; Gyapay, G; Rieger, S; Tonshoff, B; Kern, I; Soliman, NA; Neuhaus, TJ; Swoboda, KJ; Kayserili, H; Gallagher, TE; Lewis, RA; Bergmann, C; Otto, EA; Saunier, S; Scambler, PJ; Beales, PL; Gleeson, JG; Maher, ER; Attie-Bitach, T; Dollfus, H; Johnson, CA; Green, ED; Gibbs, RA; Hildebrandt, F; Pierce, EA; Katsanis, N				Davis, Erica E.; Zhang, Qi; Liu, Qin; Diplas, Bill H.; Davey, Lisa M.; Hartley, Jane; Stoetzel, Corinne; Szymanska, Katarzyna; Ramaswami, Gokul; Logan, Clare V.; Muzny, Donna M.; Young, Alice C.; Wheeler, David A.; Cruz, Pedro; Morgan, Margaret; Lewis, Lora R.; Cherukuri, Praveen; Maskeri, Baishali; Hansen, Nancy F.; Mullikin, James C.; Blakesley, Robert W.; Bouffard, Gerard G.; Gyapay, Gabor; Rieger, Susanne; Toenshoff, Burkhard; Kern, Ilse; Soliman, Neveen A.; Neuhaus, Thomas J.; Swoboda, Kathryn J.; Kayserili, Hulya; Gallagher, Tomas E.; Lewis, Richard A.; Bergmann, Carsten; Otto, Edgar A.; Saunier, Sophie; Scambler, Peter J.; Beales, Philip L.; Gleeson, Joseph G.; Maher, Eamonn R.; Attie-Bitach, Tania; Dollfus, Helene; Johnson, Colin A.; Green, Eric D.; Gibbs, Richard A.; Hildebrandt, Friedhelm; Pierce, Eric A.; Katsanis, Nicholas		NISC Comparative Sequencing Progra	TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum	NATURE GENETICS			English	Article							BARDET-BIEDL-SYNDROME; RETROGRADE INTRAFLAGELLAR TRANSPORT; JOUBERT-SYNDROME; RETINAL DEGENERATION; CENTROSOMAL PROTEIN; MECKEL-SYNDROME; IN-VIVO; MUTATIONS; GENE; NEPHRONOPHTHISIS	Ciliary dysfunction leads to a broad range of overlapping phenotypes, collectively termed ciliopathies. This grouping is underscored by genetic overlap, where causal genes can also contribute modifier alleles to clinically distinct disorders. Here we show that mutations in TTC21B, which encodes the retrograde intraflagellar transport protein IFT139, cause both isolated nephronophthisis and syndromic Jeune asphyxiating thoracic dystrophy. Moreover, although resequencing of TTC21B in a large, clinically diverse ciliopathy cohort and matched controls showed a similar frequency of rare changes, in vivo and in vitro evaluations showed a significant enrichment of pathogenic alleles in cases (P < 0.003), suggesting that TTC21B contributes pathogenic alleles to similar to 5% of ciliopathy cases. Our data illustrate how genetic lesions can be both causally associated with diverse ciliopathies and interact in trans with other disease-causing genes and highlight how saturated resequencing followed by functional analysis of all variants informs the genetic architecture of inherited disorders.	[Davis, Erica E.; Diplas, Bill H.; Davey, Lisa M.; Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Davis, Erica E.; Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Zhang, Qi; Liu, Qin; Pierce, Eric A.] Univ Penn, Sch Med, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Hartley, Jane; Maher, Eamonn R.] Univ Birmingham, Inst Biomed Res, Dept Med & Mol Genet, Birmingham, W Midlands, England; [Stoetzel, Corinne; Dollfus, Helene] Univ Strasbourg, Avenir INSERM, Lab Genet Med EA3949, Strasbourg, France; [Szymanska, Katarzyna; Logan, Clare V.; Johnson, Colin A.] St James Univ Hosp, Sect Ophthalmol & Neurosci, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Ramaswami, Gokul; Otto, Edgar A.; Hildebrandt, Friedhelm] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Muzny, Donna M.; Wheeler, David A.; Morgan, Margaret; Lewis, Lora R.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Young, Alice C.; Cruz, Pedro; Cherukuri, Praveen; Maskeri, Baishali; Hansen, Nancy F.; Mullikin, James C.; Blakesley, Robert W.; Bouffard, Gerard G.; Green, Eric D.; NISC Comparative Sequencing Progra] NHGRI, NIH, Intramural Sequencing Ctr, Bethesda, MD 20892 USA; [Gyapay, Gabor] Genoscope Ctr Natl Sequencage, Evry, France; [Rieger, Susanne; Toenshoff, Burkhard] Univ Childrens Hosp, Heidelberg, Germany; [Kern, Ilse] Univ Hosp Geneva, Dept Pediat, Geneva, Switzerland; [Soliman, Neveen A.] Cairo Univ, Dept Pediat, Kasralainy Sch Med, Cairo, Egypt; [Neuhaus, Thomas J.] Univ Childrens Hosp Zurich, Div Nephrol, Zurich, Switzerland; [Swoboda, Kathryn J.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Swoboda, Kathryn J.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Kayserili, Hulya] Istanbul Univ, Istanbul Fac Med, Istanbul, Turkey; [Gallagher, Tomas E.] Univ Hawaii Manoa, Honolulu, HI 96822 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Bergmann, Carsten] Bioscientia, Ctr Human Genet, Ingelheim, Germany; [Bergmann, Carsten] Rhein Westfal TH Aachen, Dept Human Genet, Aachen, Germany; [Saunier, Sophie] Univ Paris 05, Hop Necker Enfants Malades, INSERM, U983, Paris, France; [Scambler, Peter J.; Beales, Philip L.] UCL, Mol Med Unit, Inst Child Hlth, London, England; [Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, La Jolla, CA 92093 USA; [Attie-Bitach, Tania] Univ Paris 05, Hop Necker Enfants Malades, INSERM, U781, Paris, France; [Attie-Bitach, Tania] Univ Paris 05, Hop Necker Enfants Malades, Dept Genet, Paris, France; [Hildebrandt, Friedhelm] Howard Hughes Med Inst, Ann Arbor, MI USA; [Hildebrandt, Friedhelm] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Katsanis, Nicholas] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Katsanis, Nicholas] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Duke University; Duke University; University of Pennsylvania; Pennsylvania Medicine; University of Birmingham; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Saint James's University Hospital; University of Leeds; University of Michigan System; University of Michigan; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Geneva; Egyptian Knowledge Bank (EKB); Cairo University; University Children's Hospital Zurich; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Istanbul University; University of Hawaii System; University of Hawaii Manoa; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; RWTH Aachen University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Howard Hughes Medical Institute; University of California System; University of California San Diego; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Katsanis, N (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27710 USA.	katsanis@cellbio.duke.edu	ATTIE-BITACH, Tania/K-1453-2017; Soliman, Neveen/Y-1583-2019; Soliman, Neveen A/T-2687-2018; Scambler, Peter/AAZ-6026-2020; Beales, Philip L/C-7367-2009; Katsanis, Nicholas/E-1837-2012; Wheeler, David A/M-9740-2018; Saunier, Sophie/G-6044-2015; Kayserili, Hülya/AAA-5593-2021; MAHER, EAMONN R/A-9507-2008; Cherukuri, Praveen/AFU-2005-2022; Scambler, Peter J/C-4998-2008	ATTIE-BITACH, Tania/0000-0002-1155-3626; Soliman, Neveen/0000-0002-8942-1973; Soliman, Neveen A/0000-0002-8942-1973; Scambler, Peter/0000-0002-1487-4628; Wheeler, David A/0000-0002-9056-6299; Saunier, Sophie/0000-0002-1069-0047; Kayserili, Hülya/0000-0003-0376-499X; MAHER, EAMONN R/0000-0002-6226-6918; Cherukuri, Praveen/0000-0002-9509-1245; Scambler, Peter J/0000-0002-1487-4628; Otto, Edgar/0000-0002-2387-9973; Diplas, Bill/0000-0001-9248-7351; Dollfus, Helene/0000-0002-2249-895X; Davis, Erica/0000-0002-2412-8397; Johnson, Colin/0000-0002-2979-8234; Pierce, Eric/0000-0002-2354-4102; Swoboda, Kathryn/0000-0002-4593-6342; Logan, Clare/0000-0003-4323-1602; Katsanis, Nicholas/0000-0002-2480-0171	US National Institutes of Health [R01HD04260]; National Institute of Child Health and Development [R01DK072301, R01DK075972, R01DK068306, R01DK064614, R01DK069274]; National Institute of Diabetes, Digestive and Kidney disorders [F32 DK079541]; National Eye Institute [RO1EY12910]; Macular Vision Research Foundation; Foundation Fighting Blindness; F.M. Kirby Foundation; Rosanne Silbermann Foundation; Polycystic Kidney Disease (PKD) Foundation; German Kidney Foundation; German Research Foundation (DFG) [BE 3910/5-1, SFB/TRR57]; UNADEV; Retina France; Programme Hospitalier de Recherche Clinique; L'Agence nationale de la recherche; Medical Research Council (MRC); National Human Genome Research Institute; British Heart Foundation [RG/10/13/28570] Funding Source: researchfish; Medical Research Council [G0801843, G0700073, G0601347, G9901217] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; MRC [G0601347, G0700073, G9901217, G0801843] Funding Source: UKRI; NATIONAL EYE INSTITUTE [R01EY012910] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, ZIBHG000196, U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306, R01DK075972, F32DK079541, R01DK069274, R01DK072301, R01DK064614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052455, R01NS048453] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Diabetes, Digestive and Kidney disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Macular Vision Research Foundation; Foundation Fighting Blindness(European Commission); F.M. Kirby Foundation; Rosanne Silbermann Foundation; Polycystic Kidney Disease (PKD) Foundation; German Kidney Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); UNADEV; Retina France; Programme Hospitalier de Recherche Clinique; L'Agence nationale de la recherche(French National Research Agency (ANR)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the individuals affected with ciliopathies and their families for their continued participation and enthusiasm. We thank N. Elkhartoufi for technical assistance, P. Parvex for subject recruitment, D. Parker for critical reading of the manuscript and Yorkshire Regional Genetics Service for help in obtaining control DNA samples. This research was supported by funds from the US National Institutes of Health grant R01HD04260 from the National Institute of Child Health and Development (N. K.), R01DK072301, R01DK075972 (N. K.), R01DK068306, R01DK064614, R01DK069274 (F. H.) and National Research Service Award (NRSA) fellowship F32 DK079541 (E. E. D.) from the National Institute of Diabetes, Digestive and Kidney disorders, RO1EY12910 from the National Eye Institute (E. A. P.), the Macular Vision Research Foundation (N. K.) the Foundation Fighting Blindness (N. K., R. A. L., E. A. P. and Q. L.), the F.M. Kirby Foundation (E. A. P.), the Rosanne Silbermann Foundation (E. A. P.), the Polycystic Kidney Disease (PKD) Foundation (C. B.), German Kidney Foundation (C. B.), German Research Foundation (DFG BE 3910/5-1 and SFB/TRR57; C. B.), UNADEV, Retina France, Programme Hospitalier de Recherche Clinique 2007, L'Agence nationale de la recherche 2009 (H. D.) and a Medical Research Council (MRC) research training fellowship (J.H.). This work was also supported in part by the Intramural Research Program of the National Human Genome Research Institute. R. A. L. is a Senior Scientific Investigator of Research to Prevent Blindness, New York, New York. P. L. B. is a Wellcome Trust Senior Research Fellow. F. H. is an Investigator of the Howard Hughes Medical Institute, a Doris Duke Distinguished Clinical Scientist and the Frederick G. L. Huetwell Professor. N. K. is a Distinguished George W. Brumley Professor.	Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Beales PL, 1999, J MED GENET, V36, P437; Bergmann C, 2008, AM J HUM GENET, V82, P959, DOI 10.1016/j.ajhg.2008.02.017; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Gorden NT, 2008, AM J HUM GENET, V83, P559, DOI 10.1016/j.ajhg.2008.10.002; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Hoefele J, 2007, J AM SOC NEPHROL, V18, P2789, DOI 10.1681/ASN.2007020243; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Louie CM, 2010, NAT GENET, V42, P175, DOI 10.1038/ng.519; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Neuhaus TJ, 1997, EUR J PEDIATR, V156, P723, DOI 10.1007/s004310050699; Otto EA, 2009, J MED GENET, V46, P663, DOI 10.1136/jmg.2009.066613; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594; Wolf MTF, 2007, KIDNEY INT, V72, P1520, DOI 10.1038/sj.ki.5002630; Zaghloul NA, 2010, P NATL ACAD SCI USA, V107, P10602, DOI 10.1073/pnas.1000219107; Zaghloul NA, 2010, TRENDS GENET, V26, P168, DOI 10.1016/j.tig.2010.01.006	31	254	270	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2011	43	3					189	U28		10.1038/ng.756	http://dx.doi.org/10.1038/ng.756			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726BR	21258341	Green Accepted			2022-12-25	WOS:000287693800008
J	Titov, DV; Gilman, B; He, QL; Bhat, S; Low, WK; Dang, YJ; Smeaton, M; Demain, AL; Miller, PS; Kugel, JF; Goodrich, JA; Liu, JO				Titov, Denis V.; Gilman, Benjamin; He, Qing-Li; Bhat, Shridhar; Low, Woon-Kai; Dang, Yongjun; Smeaton, Michael; Demain, Arnold L.; Miller, Paul S.; Kugel, Jennifer F.; Goodrich, James A.; Liu, Jun O.			XPB, a subunit of TFIIH, is a target of the natural product triptolide	NATURE CHEMICAL BIOLOGY			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION FACTOR IIH; TRIPTERYGIUM-WILFORDII; COMMON TARGET; INHIBITION; PROTEIN; CYTOTOXICITY; CHEMOTHERAPY; TRANSLATION; INITIATION	Triptolide (1) is a structurally unique diterpene triepoxide isolated from a traditional Chinese medicinal plant with anti-inflammatory, immunosuppressive, contraceptive and antitumor activities. Its molecular mechanism of action, however, has remained largely elusive to date. We report that triptolide covalently binds to human XPB (also known as ERCC3), a subunit of the transcription factor TFIIH, and inhibits its DNA-dependent ATPase activity, which leads to the inhibition of RNA polymerase II-mediated transcription and likely nucleotide excision repair. The identification of XPB as the target of triptolide accounts for the majority of the known biological activities of triptolide. These findings also suggest that triptolide can serve as a new molecular probe for studying transcription and, potentially, as a new type of anticancer agent through inhibition of the ATPase activity of XPB.	[Titov, Denis V.; He, Qing-Li; Bhat, Shridhar; Low, Woon-Kai; Dang, Yongjun; Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Gilman, Benjamin; Kugel, Jennifer F.; Goodrich, James A.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Smeaton, Michael; Miller, Paul S.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD USA; [Demain, Arnold L.] Drew Univ, Charles A Dana Res Inst Scientists Emeriti, Madison, NJ 07940 USA; [Liu, Jun O.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; University of Colorado System; University of Colorado Boulder; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Drew University; Johns Hopkins University	Titov, DV (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	joliu@jhu.edu	Titov, Denis/AAI-1600-2021; Titov, Denis/L-5943-2015; dang, yongjun/M-6531-2016; dang, yongjun/A-8095-2011; Bhat, Shridhar/C-5412-2012	Titov, Denis/0000-0001-5677-0651; Titov, Denis/0000-0001-5677-0651; dang, yongjun/0000-0001-7237-1132; He, Qing-Li/0000-0001-9417-8958; Low, Woon-Kai/0000-0003-2207-9509	NATIONAL CANCER INSTITUTE [T32CA009243] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009243] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALONSO MA, 1980, EUR J BIOCHEM, V109, P535, DOI 10.1111/j.1432-1033.1980.tb04825.x; Aoyagi Y, 2006, BIOORG MED CHEM LETT, V16, P1947, DOI 10.1016/j.bmcl.2005.12.098; Aoyagi Y, 2008, BIOORG MED CHEM LETT, V18, P2459, DOI 10.1016/j.bmcl.2008.02.039; Chang WT, 2001, J BIOL CHEM, V276, P2221, DOI 10.1074/jbc.M009713200; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; CONAWAY RC, 1989, P NATL ACAD SCI USA, V86, P7356, DOI 10.1073/pnas.86.19.7356; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fidler JM, 2003, MOL CANCER THER, V2, P855; Gilman B, 2009, J BIOL CHEM, V284, P9093, DOI 10.1074/jbc.M900019200; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; Griffith EC, 1997, CHEM BIOL, V4, P461, DOI 10.1016/S1074-5521(97)90198-8; Gu WZ, 1998, INT J IMMUNOPHARMACO, V20, P389, DOI 10.1016/S0192-0561(98)00035-6; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hieb AR, 2006, EMBO J, V25, P3100, DOI 10.1038/sj.emboj.7601197; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kitzen JJEM, 2009, EUR J CANCER, V45, P1764, DOI 10.1016/j.ejca.2009.01.026; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Kugel JF, 2002, MOL CELL BIOL, V22, P762, DOI 10.1128/MCB.22.3.762-773.2002; KUPCHAN SM, 1972, J AM CHEM SOC, V94, P7194, DOI 10.1021/ja00775a078; KUPCHAN SM, 1974, SCIENCE, V185, P791, DOI 10.1126/science.185.4153.791; LeRoy G, 1998, J BIOL CHEM, V273, P7134, DOI 10.1074/jbc.273.12.7134; Leuenroth SJ, 2008, CANCER RES, V68, P5257, DOI 10.1158/0008-5472.CAN-07-6207; Leuenroth SJ, 2007, P NATL ACAD SCI USA, V104, P4389, DOI 10.1073/pnas.0700499104; Li Z, 2009, J MED CHEM, V52, P5115, DOI 10.1021/jm900342g; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Low WK, 2005, MOL CELL, V20, P709, DOI 10.1016/j.molcel.2005.10.008; Mason TM, 2008, BIOCONJUGATE CHEM, V19, P1064, DOI 10.1021/bc7004363; Matsui Y, 2008, ONCOGENE, V27, P4603, DOI 10.1038/onc.2008.89; McCallum C., 2005, THERAPY, V2, P261; McCallum C, 2007, IMMUNOBIOLOGY, V212, P549, DOI 10.1016/j.imbio.2007.02.002; MIESFELD R, 1982, NUCLEIC ACIDS RES, V10, P3933, DOI 10.1093/nar/10.13.3933; Ning LL, 2003, PLANTA MED, V69, P804, DOI 10.1055/s-2003-43220; Pan JX, 2010, CANCER LETT, V292, P149, DOI 10.1016/j.canlet.2009.11.018; Pugh B F, 1995, Methods Mol Biol, V37, P349; Qiu DM, 1999, J BIOL CHEM, V274, P13443, DOI 10.1074/jbc.274.19.13443; REICH E, 1961, SCIENCE, V134, P556, DOI 10.1126/science.134.3478.556; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; Shamon LA, 1997, CANCER LETT, V112, P113, DOI 10.1016/S0304-3835(96)04554-5; SISODIA SS, 1987, MOL CELL BIOL, V7, P3602, DOI 10.1128/MCB.7.10.3602; Smeaton MB, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm974; Takagi Y, 2005, MOL CELL, V18, P237, DOI 10.1016/j.molcel.2005.03.007; Vispe S, 2009, MOL CANCER THER, V8, P2780, DOI 10.1158/1535-7163.MCT-09-0549; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; Yakovchuk P, 2010, J MOL BIOL, V397, P57, DOI 10.1016/j.jmb.2010.01.025; YANG SX, 1992, INT J IMMUNOPHARMACO, V14, P963; ZANDOMENI R, 1986, J BIOL CHEM, V261, P3414; ZHAO XM, 1965, SUPPLEMENT MAT MED	50	316	338	5	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2011	7	3					182	188		10.1038/NCHEMBIO.522	http://dx.doi.org/10.1038/NCHEMBIO.522			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	720UH	21278739	Green Accepted			2022-12-25	WOS:000287307600012
J	Bassat, Q; Alonso, PL				Bassat, Quique; Alonso, Pedro L.			Defying malaria Fathoming severe Plasmodium vivax disease	NATURE MEDICINE			English	Editorial Material							CLINICAL-FEATURES; CHILDREN; BIKANER; PAPUA; INDIA		[Bassat, Quique; Alonso, Pedro L.] Univ Barcelona, Barcelona Ctr Int Hlth Res, Hosp Clin, Barcelona, Spain; [Bassat, Quique; Alonso, Pedro L.] Ctr Invest Saude Manhica, Maputo, Mozambique	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica	Bassat, Q (corresponding author), Univ Barcelona, Barcelona Ctr Int Hlth Res, Hosp Clin, Barcelona, Spain.	quique.bassat@cresib.cat	Alonso, Pedro L/AAZ-3645-2020; Bassat, Quique/P-2341-2016	Alonso, Pedro L/0000-0003-3292-3443; Bassat, Quique/0000-0003-0875-7596				Alexandre MA, 2010, EMERG INFECT DIS, V16, P1611, DOI 10.3201/eid1610.100685; Andrade BB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-13; Anstey NM, 2007, J INFECT DIS, V195, P589, DOI 10.1086/510756; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815; Clark IA, 1999, PARASITOL TODAY, V15, P458, DOI 10.1016/S0169-4758(99)01535-5; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Kochar DK, 2009, AM J TROP MED HYG, V80, P194, DOI 10.4269/ajtmh.2009.80.194; Kochar DK, 2010, AM J TROP MED HYG, V83, P981, DOI 10.4269/ajtmh.2010.09-0633; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Muhlberger N, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-5; Poespoprodjo JR, 2009, CLIN INFECT DIS, V48, P1704, DOI 10.1086/599041; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128	16	50	50	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2011	17	1					48	49		10.1038/nm0111-48	http://dx.doi.org/10.1038/nm0111-48			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21217683				2022-12-25	WOS:000285994000034
J	van der Zanden, LFM; van Rooij, IALM; Feitz, WFJ; Knight, J; Donders, ART; Renkema, KY; Bongers, EMHF; Vermeulen, SHHM; Kiemeney, LALM; Veltman, JA; Arias-Vasquez, A; Zhang, XF; Markljung, E; Qiao, LA; Baskin, LS; Nordenskjold, A; Roeleveld, N; Franke, B; Knoers, NVAM				van der Zanden, Loes F. M.; van Rooij, Iris A. L. M.; Feitz, Wout F. J.; Knight, Jo; Donders, A. Rogier T.; Renkema, Kirsten Y.; Bongers, Ernie M. H. F.; Vermeulen, Sita H. H. M.; Kiemeney, Lambertus A. L. M.; Veltman, Joris A.; Arias-Vasquez, Alejandro; Zhang, Xufeng; Markljung, Ellen; Qiao, Liang; Baskin, Laurence S.; Nordenskjold, Agneta; Roeleveld, Nel; Franke, Barbara; Knoers, Nine V. A. M.			Common variants in DGKK are strongly associated with risk of hypospadias	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ANDROGEN RECEPTOR GENE; POLYMORPHISM; DNA; IDENTIFICATION; CRYPTORCHIDISM; MICROARRAYS; LINKAGE	Hypospadias is a common congenital malformation of the male external genitalia. We performed a genome-wide association study using pooled DNA from 436 individuals with hypospadias (cases) and 494 controls of European descent and selected the highest ranked SNPs for individual genotyping in the discovery sample, an additional Dutch sample of 133 cases and their parents, and a Swedish series of 266 cases and 402 controls. Individual genotyping of two SNPs (rs1934179 and rs7063116) in DGKK, encoding diacylglycerol kinase., produced compelling evidence for association with hypospadias in the discovery sample (allele-specific odds ratio (OR) = 2.5, P = 2.5 x 10(-11) and OR = 2.3, P = 2.9 x 10(-9), respectively) and in the Dutch (OR = 3.9, P = 2.4 x 10(-5) and OR = 3.8, P = 3.4 x 10(-5)) and Swedish (OR = 2.5, P = 2.6 x 10(-8) and OR = 2.2, P = 2.7 x 10(-6)) replication samples. Expression studies showed expression of DGKK in preputial tissue of cases and controls, which was lower in carriers of the risk allele of rs1934179 (P = 0.047). We propose DGKK as a major risk gene for hypospadias.	[van der Zanden, Loes F. M.; Renkema, Kirsten Y.; Bongers, Ernie M. H. F.; Vermeulen, Sita H. H. M.; Veltman, Joris A.; Arias-Vasquez, Alejandro; Franke, Barbara; Knoers, Nine V. A. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [van der Zanden, Loes F. M.; van Rooij, Iris A. L. M.; Donders, A. Rogier T.; Vermeulen, Sita H. H. M.; Kiemeney, Lambertus A. L. M.; Roeleveld, Nel] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands; [Feitz, Wout F. J.; Kiemeney, Lambertus A. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Knight, Jo] Kings Coll London, Sch Med, Div Genet & Mol Med, London WC2R 2LS, England; [Knight, Jo] Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, Biomed Res Ctr, NIHR, London, England; [Arias-Vasquez, Alejandro; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands; [Zhang, Xufeng; Markljung, Ellen; Nordenskjold, Agneta] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Zhang, Xufeng; Markljung, Ellen; Nordenskjold, Agneta] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Qiao, Liang; Baskin, Laurence S.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Nordenskjold, Agneta] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Dept Pediat Surg, Stockholm, Sweden	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of London; King's College London; University of London; King's College London; Radboud University Nijmegen; Karolinska Institutet; Karolinska Institutet; University of California System; University of California San Francisco; Karolinska Institutet; Karolinska University Hospital	Franke, B (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.	b.franke@antrg.umcn.nl	Veltman, Joris A/F-5128-2010; zhang, xian/GYA-0290-2022; Vasquez, Alejandro Arias/E-4762-2012; Bongers, M.H.F./L-4214-2015; zhang, xu/GYE-3558-2022; Iris ALM Rooij, van/A-5705-2014; Zhang, xiaoyu/GXA-3206-2022; Franke, Barbara/D-4836-2009; zhang, xu/GRX-9733-2022; Vermeulen, Sita H./L-4716-2015; Knight, Jo/F-4946-2011; Donders, A.R.T./L-4277-2015; Kiemeney, Lambertus A./D-3357-2009; Renkema, Kirsten Y./V-2385-2019; Vasquez, A. Arias/L-4175-2015; Feitz, W.F.J./H-8028-2014; van der Zanden, Loes/M-4795-2015; Roeleveld, Nel/B-4242-2008	Veltman, Joris A/0000-0002-3218-8250; Vasquez, Alejandro Arias/0000-0002-4786-0169; Iris ALM Rooij, van/0000-0002-9519-966X; Franke, Barbara/0000-0003-4375-6572; Vermeulen, Sita H./0000-0003-4913-8601; Donders, A.R.T./0000-0002-0484-1419; Kiemeney, Lambertus A./0000-0002-2368-1326; van der Zanden, Loes/0000-0003-3914-7491; Roeleveld, Nel/0000-0002-3390-4466; Nordenskjold, Agneta/0000-0001-6638-4631; Renkema, Kirsten/0000-0003-3922-9382; Knight, Joanne/0000-0002-7148-1660	Radboud University Nijmegen Medical Centre; Urology Foundation; Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; King's College London; King's College Hospital NHS Foundation Trust	Radboud University Nijmegen Medical Centre; Urology Foundation; Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London; King's College Hospital NHS Foundation Trust	We thank all cases and parents for their cooperation in this study. We are grateful to the Microarray Facility Nijmegen of the Department of Human Genetics (RUNMC), in particular to M. Steehouwer, for performing the microarray experiments, and to T. Vrijenhoek and J. Hehir-Kwa for their assistance in data analysis. We would also like to thank everyone involved in the data collection, S. van der Velde-Visser, C. Beumer, K. Kwak, J. Knoll, R. de Gier, B. Kortmann, A. Paauwen, K. Kho, J. Driessen and the anesthesiologists of OR 18. Finally, we are grateful to M. Coenen, J. Groothuismink, R. Makkinje and M. Schijvenaars for their practical guidance. This research is performed within a PhD project supported by the Radboud University Nijmegen Medical Centre and with extra budget from the Urology Foundation 1973. J. Knight is funded by the Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St. Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust.	Aschim EL, 2004, J CLIN ENDOCR METAB, V89, P5105, DOI 10.1210/jc.2004-0293; Ban S, 2008, HUM REPROD, V23, P1466, DOI 10.1093/humrep/den098; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beleza-Meireles A, 2006, J ENDOCRINOL INVEST, V29, P5, DOI 10.1007/BF03349170; Beleza-Meireles A, 2008, EUR J ENDOCRINOL, V158, P729, DOI 10.1530/EJE-07-0793; Beleza-Meireles A, 2007, J CLIN ENDOCR METAB, V92, P3712, DOI 10.1210/jc.2007-0543; Brouwers MM, 2010, BJU INT, V105, P254, DOI 10.1111/j.1464-410X.2009.08772.x; Butcher LM, 2008, GENES BRAIN BEHAV, V7, P435, DOI 10.1111/j.1601-183X.2007.00368.x; Davis OSP, 2009, BIOINFORMATICS, V25, P281, DOI 10.1093/bioinformatics/btn587; Franke B, 2010, BIOL PSYCHIAT, V68, P586, DOI 10.1016/j.biopsych.2010.05.037; Fredell L, 2002, J UROLOGY, V167, P1423, DOI 10.1016/S0022-5347(05)65334-7; Hoogendoorn EH, 2006, CLIN CHEM, V52, P104, DOI 10.1373/clinchem.2005.055194; Imai S, 2005, J BIOL CHEM, V280, P39870, DOI 10.1074/jbc.M500669200; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Macgregor S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1060; Pearson JV, 2007, AM J HUM GENET, V80, P126, DOI 10.1086/510686; Radpour R, 2007, J ANDROL, V28, P164, DOI 10.2164/jandrol.106.000927; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Schnack TH, 2008, AM J EPIDEMIOL, V167, P251, DOI 10.1093/aje/kwm317; Shifman S, 2008, MOL PSYCHIATR, V13, P302, DOI 10.1038/sj.mp.4002048; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Thai HTT, 2005, J CLIN ENDOCR METAB, V90, P6695, DOI 10.1210/jc.2005-0446; van der Zanden LFM, 2010, J CLIN ENDOCR METAB, V95, P2384, DOI 10.1210/jc.2009-2101; Wang YP, 2004, EUR J HUM GENET, V12, P706, DOI 10.1038/sj.ejhg.5201232; Watanabe M, 2007, HUM REPROD, V22, P1279, DOI 10.1093/humrep/del513	26	81	82	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2011	43	1					48	U63		10.1038/ng.721	http://dx.doi.org/10.1038/ng.721			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	699SQ	21113153	Green Submitted			2022-12-25	WOS:000285683500014
J	Wei, YK; Chen, YH; Li, LY; Lang, JY; Yeh, SP; Shi, B; Yang, CC; Yang, JY; Lin, CY; Lai, CC; Hung, MC				Wei, Yongkun; Chen, Ya-Huey; Li, Long-Yuan; Lang, Jingyu; Yeh, Su-Peng; Shi, Bin; Yang, Cheng-Chieh; Yang, Jer-Yen; Lin, Chun-Yi; Lai, Chien-Chen; Hung, Mien-Chie			CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells	NATURE CELL BIOLOGY			English	Article							CYCLIN-DEPENDENT KINASES; DEVELOPMENTAL REGULATORS; HISTONE H3; POLYCOMB; BREAST; CANCER; PROLIFERATION; LYSINE-27; PROSTATE; RECEPTOR	Enhancer of zeste homologue 2 (EZH2) is the catalytic subunit of Polycomb repressive complex 2 (PRC2) and catalyses the trimethylation of histone H3 on Lys 27 (H3K27), which represses gene transcription. EZH2 enhances cancer-cell invasiveness and regulates stem cell differentiation. Here, we demonstrate that EZH2 can be phosphorylated at Thr 487 through activation of cyclin-dependent kinase 1 (CDK1). The phosphorylation of EZH2 at Thr 487 disrupted EZH2 binding with the other PRC2 components SUZ12 and EED, and thereby inhibited EZH2 methyltransferase activity, resulting in inhibition of cancer-cell invasion. In human mesenchymal stem cells, activation of CDK1 promoted mesenchymal stem cell differentiation into osteoblasts through phosphorylation of EZH2 at Thr 487. These findings define a signalling link between CDK1 and EZH2 that may have an important role in diverse biological processes, including cancer-cell invasion and osteogenic differentiation of mesenchymal stem cells.	[Chen, Ya-Huey; Li, Long-Yuan; Lin, Chun-Yi; Hung, Mien-Chie] China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan; [Wei, Yongkun; Lang, Jingyu; Shi, Bin; Yang, Cheng-Chieh; Yang, Jer-Yen; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Li, Long-Yuan; Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 404, Taiwan; [Li, Long-Yuan; Hung, Mien-Chie] Asia Univ, Taichung 413, Taiwan; [Yeh, Su-Peng] China Med Univ & Hosp, Dept Med, Div Hematol & Oncol, Taichung 404, Taiwan; [Lai, Chien-Chen] China Med Univ, Grad Inst Chinese Med Sci, Taichung 404, Taiwan; [Lai, Chien-Chen] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan; [Hung, Mien-Chie] Univ Texas Houston, Grad Sch Biomed Sci Houston, Program Canc Biol, Houston, TX 77030 USA	China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Chung Hsing University; University of Texas System; University of Texas Health Science Center Houston	Li, LY (corresponding author), China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan.	lyl@mail.cmu.edu.tw; mhung@mdanderson.org	/AGZ-4617-2022; Hung, Mien-Chie/ABD-5911-2021	/0000-0002-7133-8266; Hung, Mien-Chie/0000-0003-4317-4740; Li, Long-Yuan/0000-0001-7472-8318	National Institutes of Health [R01 CA109311]; Kadoorie Charitable Foundations; National Breast Cancer Foundation Inc.; M.D. Anderson Cancer Center/China Medical University and Hospital;  [NSC 96-3111-B-039];  [NSC 97-3111-B-039];  [NHRI-EX98-9603BC];  [DOH97-TD-I-111-TM003];  [DOH98-TD-I-111-TM002];  [DOH97-TD-G-111-041];  [DOH99-TD-C-111-005];  [NSC99-2632-B-039-001-MY3]; NATIONAL CANCER INSTITUTE [R01CA109311, P01CA099031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kadoorie Charitable Foundations; National Breast Cancer Foundation Inc.; M.D. Anderson Cancer Center/China Medical University and Hospital(China Medical University); ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S.A. Miller and J. Hsu for editorial assistance. We thank A.M. Labaff for characterization of EED antibody. This work was supported by grants from National Institutes of Health (grant R01 CA109311), Kadoorie Charitable Foundations, National Breast Cancer Foundation Inc. and the M.D. Anderson Cancer Center/China Medical University and Hospital Sister Foundation Funds (to M.-C.H), NSC 96-3111-B-039 and NSC 97-3111-B-039 (to M.-C.H., L.-Y.L. and S.-P.Y), NHRI-EX98-9603BC, DOH97-TD-I-111-TM003, DOH98-TD-I-111-TM002 (to L.-Y.L.), DOH97-TD-G-111-041 (to M.-C.H.), DOH99-TD-C-111-005, NSC99-2632-B-039-001-MY3 (to L.-Y.L. and M.-C.H.). In memory of Mrs Serena Lin-Guo for her courageous battle against breast cancer.	Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Gonzalez ME, 2009, ONCOGENE, V28, P843, DOI 10.1038/onc.2008.433; Imbach P, 1999, BIOORG MED CHEM LETT, V9, P91, DOI 10.1016/S0960-894X(98)00691-X; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781	23	281	286	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2011	13	1					87	U211		10.1038/ncb2139	http://dx.doi.org/10.1038/ncb2139			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697GV	21131960	Green Accepted			2022-12-25	WOS:000285502200015
J	Church, C; Moir, L; McMurray, F; Girard, C; Banks, GT; Teboul, L; Wells, S; Bruning, JC; Nolan, PM; Ashcroft, FM; Cox, RD				Church, Chris; Moir, Lee; McMurray, Fiona; Girard, Christophe; Banks, Gareth T.; Teboul, Lydia; Wells, Sara; Bruening, Jens C.; Nolan, Patrick M.; Ashcroft, Frances M.; Cox, Roger D.			Overexpression of Fto leads to increased food intake and results in obesity	NATURE GENETICS			English	Article							BODY-MASS INDEX; ENERGY-EXPENDITURE; PHYSICAL-ACTIVITY; GENE-EXPRESSION; ADULT OBESITY; FAT; VARIANTS; CHILDREN; MOUSE; POLYMORPHISMS	Genome-wide association studies have identified SNPs within FTO, the human fat mass and obesity-associated gene, that are strongly associated with obesity. Individuals homozygous for the at-risk rs9939609 A allele weigh, on average, similar to 3 kg more than individuals with the low-risk T allele. Mice that lack FTO function and/or Fto expression display increased energy expenditure and a lean phenotype. We show here that ubiquitous overexpression of Fto leads to a dose-dependent increase in body and fat mass, irrespective of whether mice are fed a standard or a high-fat diet. Our results suggest that increased body mass results primarily from increased food intake. Mice with increased Fto expression on a high-fat diet develop glucose intolerance. This study provides the first direct evidence that increased Fto expression causes obesity in mice.	[Church, Chris; Moir, Lee; McMurray, Fiona; Banks, Gareth T.; Teboul, Lydia; Wells, Sara; Nolan, Patrick M.; Cox, Roger D.] MRC Harwell, Metab & Inflammat, Harwell, Berks, England; [Girard, Christophe; Ashcroft, Frances M.] Univ Oxford, Dept Physiol Anat & Genet, Henry Wellcome Ctr Gene Funct, Oxford, England; [Bruening, Jens C.] Univ Cologne, CMMC, Cologne, Germany	MRC Harwell; University of Oxford; University of Cologne	Cox, RD (corresponding author), MRC Harwell, Metab & Inflammat, Harwell Sci & Innovat Campus, Harwell, Berks, England.	r.cox@har.mrc.ac.uk	Girard, Christophe/O-8455-2016; Nolan, Patrick/W-3918-2019; Teboul, Lydia/P-2428-2019	Girard, Christophe/0000-0002-4560-4479; Nolan, Patrick/0000-0001-5550-0334; Teboul, Lydia/0000-0002-2789-8637; Moir, Lee/0000-0003-4829-3597; Cox, Roger/0000-0001-7170-5014; Banks, Gareth/0000-0002-8647-667X; McMurray, Fiona/0000-0003-4147-5064	UK Medical Research Council (MRC); UK Royal Society; MRC; Wellcome Trust; Medical Research Council [MC_U142661184, MC_UP_1502/1, MC_U142684173] Funding Source: researchfish; MRC [MC_U142684173, MC_U142661184, MC_UP_1502/1] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the UK Medical Research Council (MRC) (to L.M., L.T., S.W., P.M.N., G.T.B., R.D.C.and studentships to C.C.and F.M.) and the UK Royal Society (research professorship to F.M.A.) for personnel support, and the MRC and Wellcome Trust for financing the research (R.D.C.and F.M.A.).We thank C. Holmes, G. Nicholson and O. Espinosa for help with multiple regression analysis using R.	Bacon Y, 2004, GENES BRAIN BEHAV, V3, P196, DOI 10.1111/j.1601-183X.2004.00070.x; Berentzen T, 2008, J CLIN ENDOCR METAB, V93, P2904, DOI 10.1210/jc.2008-0007; Berulava T, 2010, EUR J HUM GENET, V18, P1054, DOI 10.1038/ejhg.2010.71; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Do R, 2008, DIABETES, V57, P1147, DOI 10.2337/db07-1267; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Girard CA, 2009, J CLIN INVEST, V119, P80, DOI 10.1172/JCI35772; Goossens GH, 2009, INT J OBESITY, V33, P669, DOI 10.1038/ijo.2009.59; Grunnet LG, 2009, DIABETES, V58, P2402, DOI 10.2337/db09-0205; Hakanen M, 2009, J CLIN ENDOCR METAB, V94, P1281, DOI 10.1210/jc.2008-1199; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Haupt A, 2009, EXP CLIN ENDOCR DIAB, V117, P194, DOI 10.1055/s-0028-1087176; Haupt A, 2008, OBESITY, V16, P1969, DOI 10.1038/oby.2008.283; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hough TA, 2002, MAMM GENOME, V13, P595, DOI 10.1007/s00335-002-2188-1; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jonsson A, 2009, DIABETOLOGIA, V52, P1334, DOI 10.1007/s00125-009-1355-2; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kloting N, 2008, DIABETOLOGIA, V51, P641, DOI 10.1007/s00125-008-0928-9; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Olszewski PK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-129; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Sonestedt E, 2009, AM J CLIN NUTR, V90, P1418, DOI 10.3945/ajcn.2009.27958; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Tanofsky-Kraff M, 2009, AM J CLIN NUTR, V90, P1483, DOI 10.3945/ajcn.2009.28439; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Villalobos-Comparan M, 2008, OBESITY, V16, P2296, DOI 10.1038/oby.2008.367; Vimaleswaran KS, 2009, AM J CLIN NUTR, V90, P425, DOI 10.3945/ajcn.2009.27652; Wahlen K, 2008, J LIPID RES, V49, P607, DOI 10.1194/jlr.M700448-JLR200; Wardle J, 2009, INT J OBESITY, V33, P42, DOI 10.1038/ijo.2008.174; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Zabena C, 2009, OBES SURG, V19, P87, DOI 10.1007/s11695-008-9727-0	42	486	516	0	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2010	42	12					1086	U147		10.1038/ng.713	http://dx.doi.org/10.1038/ng.713			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684UZ	21076408	Green Accepted			2022-12-25	WOS:000284578800011
J	Jenkins, LMM; Ott, DE; Hayashi, R; Coren, LV; Wang, DY; Xu, Q; Schito, ML; Inman, JK; Appella, DH; Appella, E				Jenkins, Lisa M. Miller; Ott, David E.; Hayashi, Ryo; Coren, Lori V.; Wang, Deyun; Xu, Qun; Schito, Marco L.; Inman, John K.; Appella, Daniel H.; Appella, Ettore			Small-molecule inactivation of HIV-1 NCp7 by repetitive intracellular acyl transfer	NATURE CHEMICAL BIOLOGY			English	Article							VIRAL NUCLEOCAPSID PROTEIN; DRUG-RESISTANCE; INHIBITORS; SPECIFICITY; THIOESTERS; INFECTION; TARGET	The zinc fingers of the HIV-1 nucleocapsid protein, NCp7, are prime targets for antiretroviral therapeutics. Here we show that S-acyl-2-mercaptobenzamide thioester (SAMT) chemotypes inhibit HIV by modifying the NCp7 region of Gag in infected cells, thereby blocking Gag processing and reducing infectivity. The thiol produced by SAMT reaction with NCp7 is acetylated by cellular enzymes to regenerate active SAMTs via a recycling mechanism unique among small-molecule inhibitors of HIV.	[Jenkins, Lisa M. Miller; Hayashi, Ryo; Schito, Marco L.; Appella, Ettore] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Ott, David E.; Coren, Lori V.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21701 USA; [Wang, Deyun; Xu, Qun; Appella, Daniel H.] NIDDKD, Bioorgan Chem Lab, Bethesda, MD 20892 USA; [Inman, John K.] NIAID, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jenkins, LMM (corresponding author), NCI, Cell Biol Lab, NIH, Bldg 37, Bethesda, MD 20892 USA.	appellae@mail.nih.gov	Xu, Qun/C-6996-2011; Jenkins, Lisa/AAI-2490-2021	Wang, Deyun/0000-0002-0356-2848	US National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; US National Cancer Institute [HHSN261200800001E, N01-CO-12400]; NATIONAL CANCER INSTITUTE [ZIABC009101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK031124] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank T. Hartman (ImQuest Biosciences) for antiviral assays, E. Chertova (US National Cancer Institute at Frederick) for HPLC separation of Gag and P. Srivastava (US National Cancer Institute) for synthesis of <SUP>14</SUP>C-SAMT-247. The authors thank J.A. Turpin and P.F. Kiser for helpful discussion. This research was supported by the US National Institutes of Health Intramural AIDS Targeted Antiretroviral Program (L.M.M.J., R.H., M.L.S., E.A.), the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (D.W., Q.X., D.H.A.) and with federal funds from the US National Cancer Institute under Contracts No. HHSN261200800001E and No. N01-CO-12400 (D.E.O., L.V.C.).	COFFIN JM, 1997, RETROVIRUSES, V843; Darlix JL, 2007, ADV PHARMACOL, V55, P299, DOI 10.1016/S1054-3589(07)55009-X; de Rocquigny H, 2008, MINI-REV MED CHEM, V8, P24; Goldschmidt Valerie, 2010, HIV Therapy, V4, P179, DOI 10.2217/HIV.10.3; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hosokawa M, 2008, MOLECULES, V13, P412, DOI 10.3390/molecules13020412; Jenkins LMM, 2006, J AM CHEM SOC, V128, P11964, DOI 10.1021/ja063329e; Jenkins LMM, 2007, J AM CHEM SOC, V129, P11067, DOI 10.1021/ja071254o; Jenkins LMM, 2005, J MED CHEM, V48, P2847, DOI 10.1021/jm0492195; KAPLAN AH, 1993, J VIROL, V67, P4050, DOI 10.1128/JVI.67.7.4050-4055.1993; Muller B, 2009, J BIOL CHEM, V284, P29692, DOI 10.1074/jbc.M109.027144; Rahim S, 2009, HIV CLIN TRIALS, V10, P94, DOI 10.1310/hct1002-94; Rustin P, 1997, BBA-MOL BASIS DIS, V1361, P185, DOI 10.1016/S0925-4439(97)00035-5; Schito ML, 2003, AIDS RES HUM RETROV, V19, P91, DOI 10.1089/088922203762688595; Sprinz E, 2009, AIDS RES HUM RETROV, V25, P861, DOI 10.1089/aid.2009.0012; Srivastava P, 2004, BIOORGAN MED CHEM, V12, P6437, DOI 10.1016/j.bmc.2004.09.032; Thomas JA, 2008, VIRUS RES, V134, P39, DOI 10.1016/j.virusres.2007.12.006; Turpin JA, 1996, J VIROL, V70, P6180, DOI 10.1128/JVI.70.9.6180-6189.1996; Turpin JA, 1999, J MED CHEM, V42, P67, DOI 10.1021/jm9802517; Turpin Jim A, 2003, Expert Rev Anti Infect Ther, V1, P97, DOI 10.1586/14787210.1.1.97; Turpin JA, 2008, ADV PHARMACOL, V56, P229, DOI 10.1016/S1054-3589(07)56008-4; Wallace GS, 2009, J VIROL, V83, P9175, DOI 10.1128/JVI.00820-09; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; Yovandich JL, 2001, J VIROL, V75, P115, DOI 10.1128/JVI.75.1.115-124.2001	24	35	37	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					887	889		10.1038/NCHEMBIO.456	http://dx.doi.org/10.1038/NCHEMBIO.456			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	20953192	Green Accepted			2022-12-25	WOS:000284214700017
J	Ridky, TW; Chow, JM; Wong, DJ; Khavari, PA				Ridky, Todd W.; Chow, Jennifer M.; Wong, David J.; Khavari, Paul A.			Invasive three-dimensional organotypic neoplasia from multiple normal human epithelia	NATURE MEDICINE			English	Article							EXTRACELLULAR-MATRIX; CANCER PROGRESSION; BASEMENT-MEMBRANE; CELLS; RAS; TRANSFORMATION; GENOME; TISSUE; REQUIREMENTS; ASSOCIATION	Refined cancer models are required if researchers are to assess the burgeoning number of potential targets for cancer therapeutics in a clinically relevant context that allows a fast turnaround. Here we use tumor-associated genetic pathways to transform primary human epithelial cells from the epidermis, oropharynx, esophagus and cervix into genetically defined tumors in a human three-dimensional (3D) tissue environment that incorporates cell-populated stroma and intact basement membrane. These engineered organotypic tissues recapitulated natural features of tumor progression, including epithelial invasion through basement membrane, a complex process that is necessary for biological malignancy in 90% of human cancers. Invasion was rapid and was potentiated by stromal cells. Oncogenic signals in 3D tissue, but not 2D culture, resembled gene expression profiles from spontaneous human cancers. We screened 3D organotypic neoplasia with well-characterized signaling pathway inhibitors to distill a clinically faithful cancer gene signature. Multitissue 3D human tissue cancer models may provide an efficient and relevant complement to current approaches to characterizing cancer progression.	[Ridky, Todd W.; Chow, Jennifer M.; Wong, David J.; Khavari, Paul A.] Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA; [Ridky, Todd W.; Chow, Jennifer M.; Wong, David J.; Khavari, Paul A.] Stanford Univ, Program Canc Biol, Stanford, CA 94305 USA; [Khavari, Paul A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Khavari, PA (corresponding author), Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA.	khavari@stanford.edu		Ridky, Todd/0000-0001-8482-1284	National Institutes of Health [AR43799, K08AR053195]; NATIONAL CANCER INSTITUTE [R01CA163566, F32CA099473, R01CA142635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR053195, R01AR043799, R29AR043799, R01AR049737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grant AR43799 to P. A. K. We thank A. Oro, P. Marinkovich, H. Chang, D. Felsher, S. Artandi, A. Sweet-Cordero, M. Scott, G. Sen, Z. Siprashvili, M. Kretz and J. Reuter for presubmission review of the manuscript. T. W. R. is the recipient of career development award National Institutes of Health K08AR053195.	Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Cox AD, 2010, CANCER CELL, V17, P221, DOI 10.1016/j.ccr.2010.02.029; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Egeblad M, 2005, COLD SH Q B, V70, P383, DOI 10.1101/sqb.2005.70.007; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Forbes SA, 2008, CURR PROTOC HUM GENE, V57, DOI DOI 10.11.1-10.11.26; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Horner MJ, 2010, SEER CANC STAT REV 1; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Kao WT, 2008, ANTICANCER RES, V28, P2109; Khavari PA, 2006, NAT REV CANCER, V6, P270, DOI 10.1038/nrc1838; Kuriakose MA, 2004, CELL MOL LIFE SCI, V61, P1372, DOI 10.1007/s00018-004-4069-0; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; Lee TL, 2007, CLIN CANCER RES, V13, P5680, DOI 10.1158/1078-0432.CCR-07-0670; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; MARINKOVICH MP, 1993, DEV DYNAM, V197, P255, DOI 10.1002/aja.1001970404; Marx J, 2008, SCIENCE, V320, P38, DOI 10.1126/science.320.5872.38; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Reuter JA, 2009, CANCER CELL, V15, P477, DOI 10.1016/j.ccr.2009.04.002; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tarutani M, 2003, CANCER RES, V63, P319; Toruner GA, 2004, CANCER GENET CYTOGEN, V154, P27, DOI 10.1016/j.cancergencyto.2004.01.026	28	157	165	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1450	U137		10.1038/nm.2265	http://dx.doi.org/10.1038/nm.2265			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21102459	Green Accepted			2022-12-25	WOS:000285048900041
J	Barry-Hamilton, V; Spangler, R; Marshall, D; McCauley, S; Rodriguez, HM; Oyasu, M; Mikels, A; Vaysberg, M; Ghermazien, H; Wai, C; Garcia, CA; Velayo, AC; Jorgensen, B; Biermann, D; Tsai, D; Green, J; Zaffryar-Eilot, S; Holzer, A; Ogg, S; Thai, D; Neufeld, G; Van Vlasselaer, P; Smith, V				Barry-Hamilton, Vivian; Spangler, Rhyannon; Marshall, Derek; McCauley, Scott; Rodriguez, Hector M.; Oyasu, Miho; Mikels, Amanda; Vaysberg, Maria; Ghermazien, Haben; Wai, Carol; Garcia, Carlos A.; Velayo, Arleene C.; Jorgensen, Brett; Biermann, Donna; Tsai, Daniel; Green, Jennifer; Zaffryar-Eilot, Shelly; Holzer, Alison; Ogg, Scott; Thai, Dung; Neufeld, Gera; Van Vlasselaer, Peter; Smith, Victoria			Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment	NATURE MEDICINE			English	Article							TUMOR-GROWTH; PULMONARY-FIBROSIS; HUMAN BREAST; IN-VIVO; DESMOPLASTIC REACTION; STROMAL FIBROBLASTS; MOLECULAR ROLE; CELL-LINES; CANCER; PROMOTES	We have identified a new role for the matrix enzyme lysyl oxidase-like-2 (LOXL2) in the creation and maintenance of the pathologic microenvironment of cancer and fibrotic disease. Our analysis of biopsies from human tumors and fibrotic lung and liver tissues revealed an increase in LOXL2 in disease-associated stroma and limited expression in healthy tissues. Targeting LOXL2 with an inhibitory monoclonal antibody (AB0023) was efficacious in both primary and metastatic xenograft models of cancer, as well as in liver and lung fibrosis models. Inhibition of LOXL2 resulted in a marked reduction in activated fibroblasts, desmoplasia and endothelial cells, decreased production of growth factors and cytokines and decreased transforming growth factor-beta (TGF-beta) pathway signaling. AB0023 outperformed the small-molecule lysyl oxidase inhibitor beta-aminoproprionitrile. The efficacy and safety of LOXL2-specific AB0023 represents a new therapeutic approach with broad applicability in oncologic and fibrotic diseases.	[Barry-Hamilton, Vivian; Spangler, Rhyannon; Marshall, Derek; McCauley, Scott; Rodriguez, Hector M.; Oyasu, Miho; Mikels, Amanda; Vaysberg, Maria; Ghermazien, Haben; Wai, Carol; Garcia, Carlos A.; Velayo, Arleene C.; Jorgensen, Brett; Biermann, Donna; Tsai, Daniel; Green, Jennifer; Holzer, Alison; Ogg, Scott; Thai, Dung; Van Vlasselaer, Peter; Smith, Victoria] Arresto BioSci, Palo Alto, CA USA; [Zaffryar-Eilot, Shelly; Neufeld, Gera] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc Res & Vasc Biol Ctr, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Smith, V (corresponding author), Arresto BioSci, Palo Alto, CA USA.	vsmith@arresto.com	Neufeld, Gera/F-1524-2019	McCauley, Scott/0000-0003-4549-5599				Akiri G, 2003, CANCER RES, V63, P1657; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Cardone A, 1997, PANMINERVA MED, V39, P174; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Constandinou C, 2005, METH MOLEC MED, V117, P237; Conti JA, 2008, CLIN CANCER RES, V14, P6405, DOI 10.1158/1078-0432.CCR-08-0816; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cunha GR, 2003, INT J CANCER, V107, P1, DOI 10.1002/ijc.11335; Dong JY, 2004, EMBO J, V23, P2800, DOI 10.1038/sj.emboj.7600289; Dornhofer N, 2006, CANCER RES, V66, P5816, DOI 10.1158/0008-5472.CAN-06-0081; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fong SFT, 2007, GENE CHROMOSOME CANC, V46, P644, DOI 10.1002/gcc.20444; Ge RR, 2006, CLIN CANCER RES, V12, P4315, DOI 10.1158/1078-0432.CCR-06-0162; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Guleng B, 2005, CANCER RES, V65, P5864, DOI 10.1158/0008-5472.CAN-04-3833; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; HLATKY L, 1994, CANCER RES, V54, P6083; Hollosi P, 2009, INT J CANCER, V125, P318, DOI 10.1002/ijc.24308; Inagaki Y, 2001, J CELL PHYSIOL, V187, P117, DOI 10.1002/1097-4652(2001)9999:9999<00::AID-JCP1059>3.0.CO;2-S; Jacobs TW, 1999, NEW ENGL J MED, V340, P430, DOI 10.1056/NEJM199902113400604; Jenkins DE, 2005, BREAST CANCER RES, V7, pR444, DOI 10.1186/bcr1026; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Khalil N, 2004, CAN MED ASSOC J, V171, P153, DOI 10.1503/cmaj.1030055; Kirschmann DA, 2002, CANCER RES, V62, P4478; Kleeff J, 2007, INT J CANCER, V121, P699, DOI 10.1002/ijc.22871; Lelievre E, 2008, EMBO J, V27, P1658, DOI 10.1038/emboj.2008.103; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Maeshima AM, 2002, CANCER, V95, P2546, DOI 10.1002/cncr.11006; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Moeller A, 2009, AM J RESP CRIT CARE, V179, P588, DOI 10.1164/rccm.200810-1534OC; Nam JS, 2008, CANCER RES, V68, P3835, DOI 10.1158/0008-5472.CAN-08-0215; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Orimo A, 2001, CLIN CANCER RES, V7, P3097; Park SH, 1997, AM J RESP CRIT CARE, V156, P600, DOI 10.1164/ajrccm.156.2.9607123; Payne SL, 2007, J CELL BIOCHEM, V101, P1338, DOI 10.1002/jcb.21371; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peng L, 2009, CARCINOGENESIS, V30, P1660, DOI 10.1093/carcin/bgp178; Pulichino AM, 2008, AM J RESP CELL MOL, V39, P324, DOI 10.1165/rcmb.2007-0186OC; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Rodriguez HM, 2010, J BIOL CHEM, V285, P20964, DOI 10.1074/jbc.M109.094136; SAPPINO AP, 1988, INT J CANCER, V41, P707, DOI 10.1002/ijc.2910410512; Suki B, 2005, J APPL PHYSIOL, V98, P1892, DOI 10.1152/japplphysiol.01087.2004; Tahashi Y, 2002, HEPATOLOGY, V35, P49, DOI 10.1053/jhep.2002.30083; TANG SS, 1983, J BIOL CHEM, V258, P4331; TRACKMAN PC, 1979, J BIOL CHEM, V254, P7831; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052; Van Aarsen LAK, 2008, CANCER RES, V68, P561, DOI 10.1158/0008-5472.CAN-07-2307; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Xu JG, 2007, AM J RESP CELL MOL, V37, P291, DOI 10.1165/rcmb.2006-0187OC; Yang F, 2005, CANCER RES, V65, P8887, DOI 10.1158/0008-5472.CAN-05-1702	58	609	643	5	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2010	16	9					1009	U107		10.1038/nm.2208	http://dx.doi.org/10.1038/nm.2208			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20818376				2022-12-25	WOS:000281622900030
J	Ng, SB; Bigham, AW; Buckingham, KJ; Hannibal, MC; McMillin, MJ; Gildersleeve, HI; Beck, AE; Tabor, HK; Cooper, GM; Mefford, HC; Lee, C; Turner, EH; Smith, JD; Rieder, MJ; Yoshiura, K; Matsumoto, N; Ohta, T; Niikawa, N; Nickerson, DA; Bamshad, MJ; Shendure, J				Ng, Sarah B.; Bigham, Abigail W.; Buckingham, Kati J.; Hannibal, Mark C.; McMillin, Margaret J.; Gildersleeve, Heidi I.; Beck, Anita E.; Tabor, Holly K.; Cooper, Gregory M.; Mefford, Heather C.; Lee, Choli; Turner, Emily H.; Smith, Joshua D.; Rieder, Mark J.; Yoshiura, Koh-ichiro; Matsumoto, Naomichi; Ohta, Tohru; Niikawa, Norio; Nickerson, Deborah A.; Bamshad, Michael J.; Shendure, Jay			Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome	NATURE GENETICS			English	Article							MENTAL-RETARDATION; ABNORMALITIES; CONSTRAINT; CAPTURE; GROWTH; GENES; EARS; ALR	We demonstrate the successful application of exome sequencing(1-3) to discover a gene for an autosomal dominant disorder, Kabuki syndrome (OMIM% 147920). We subjected the exomes of ten unrelated probands to massively parallel sequencing. After filtering against existing SNP databases, there was no compelling candidate gene containing previously unknown variants in all affected individuals. Less stringent filtering criteria allowed for the presence of modest genetic heterogeneity or missing data but also identified multiple candidate genes. However, genotypic and phenotypic stratification highlighted MLL2, which encodes a Trithorax-group histone methyltransferase(4): seven probands had newly identified nonsense or frameshift mutations in this gene. Follow-up Sanger sequencing detected MLL2 mutations in two of the three remaining individuals with Kabuki syndrome (cases) and in 26 of 43 additional cases. In families where parental DNA was available, the mutation was confirmed to be de novo (n = 12) or transmitted (n = 2) in concordance with phenotype. Our results strongly suggest that mutations in MLL2 are a major cause of Kabuki syndrome.	[Ng, Sarah B.; Cooper, Gregory M.; Lee, Choli; Turner, Emily H.; Smith, Joshua D.; Rieder, Mark J.; Nickerson, Deborah A.; Bamshad, Michael J.; Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Bigham, Abigail W.; Buckingham, Kati J.; Hannibal, Mark C.; McMillin, Margaret J.; Gildersleeve, Heidi I.; Beck, Anita E.; Tabor, Holly K.; Mefford, Heather C.; Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Hannibal, Mark C.; Beck, Anita E.; Tabor, Holly K.; Bamshad, Michael J.] Seattle Childrens Hosp, Seattle, WA USA; [Yoshiura, Koh-ichiro] Nagasaki Univ, Dept Human Genet, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa 232, Japan; [Ohta, Tohru; Niikawa, Norio] Hlth Sci Univ Hokkaido, Res Inst Personalized Hlth Sci, Sapporo, Hokkaido, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Nagasaki University; Yokohama City University; Health Sciences University of Hokkaido	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	mbamshad@u.washington.edu; shendure@u.washington.edu	Beck, Anita E./AAS-8775-2021; Pinheiro, Maísa/E-7424-2012; Shendure, Jay/AAU-3684-2021; Cooper, Gregory/D-6914-2011	Beck, Anita E./0000-0002-7965-0326; Cooper, Gregory/0000-0001-5509-9923; Turner, Emily/0000-0001-9040-9229; Shendure, Jay/0000-0002-1516-1865; Hannibal, Mark/0000-0002-9077-3837	Kabuki Syndrome Network; US National Institutes of Health (NIH)-National Heart, Lung, and Blood Institute [5R01HL094976]; NIH-National Human Genome Research Institute [5R21HG004749, 1RC2HG005608, 5RO1HG004316, T32HG00035]; NIH-National Institute of Environmental Health Sciences [HHSN273200800010C]; Ministry of Health, Labour and Welfare; Japan Science and Technology Agency; Society for the Promotion of Science; Life Sciences Discovery Fund [2065508, 0905001]; Washington Research Foundation; NIH-National Institute of Child Health and Human Development [1R01HD048895]; Agency for Science, Technology and Research, Singapore; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD048895] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102926, R01HL094976] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005608, R00HG004316, T32HG000035, R21HG004749, K99HG004316] Funding Source: NIH RePORTER	Kabuki Syndrome Network; US National Institutes of Health (NIH)-National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH-National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH-National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Life Sciences Discovery Fund; Washington Research Foundation; NIH-National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the families for their participation and the Kabuki Syndrome Network for their support. We thank J. Allanson, J. Carey and M. Golabi for referral of cases and M. Emond for helpful discussion. We thank the 1000 Genomes Project for early data release that proved useful for filtering out common variants. Our work was supported in part by grants from the US National Institutes of Health (NIH)-National Heart, Lung, and Blood Institute (5R01HL094976 to D.A.N. and J. S.), the NIH-National Human Genome Research Institute (5R21HG004749 to J. S., 1RC2HG005608 to M. J. B., D.A.N. and J. S.; and 5RO1HG004316 to H. K. T.), NIH-National Institute of Environmental Health Sciences (HHSN273200800010C to D.N. and M. J. R.), Ministry of Health, Labour and Welfare (K.Y., N.M., T.O. and N.N.), Japan Science and Technology Agency (N.M.), Society for the Promotion of Science (N.M.), the Life Sciences Discovery Fund (2065508 and 0905001), the Washington Research Foundation and the NIH-National Institute of Child Health and Human Development (1R01HD048895 to M. J. B.). S.B.N. is supported by the Agency for Science, Technology and Research, Singapore. A. W. B. is supported by a training fellowship from the NIH-National Human Genome Research Institute (T32HG00035).	Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; Courtens W, 2000, AM J MED GENET, V93, P244, DOI 10.1002/1096-8628(20000731)93:3<244::AID-AJMG17>3.0.CO;2-2; FitzGerald KT, 1999, GENOMICS, V59, P187, DOI 10.1006/geno.1999.5860; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; KUROKI Y, 1981, J PEDIATR-US, V99, P570, DOI 10.1016/S0022-3476(81)80256-9; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; NIIKAWA N, 1988, AM J MED GENET, V31, P565, DOI 10.1002/ajmg.1320310312; NIIKAWA N, 1981, J PEDIATR-US, V99, P565, DOI 10.1016/S0022-3476(81)80255-7; Prasad R, 1997, ONCOGENE, V15, P549, DOI 10.1038/sj.onc.1201211; Tonoki H, 1998, AM J MED GENET, V75, P416, DOI 10.1002/(SICI)1096-8628(19980203)75:4<416::AID-AJMG13>3.0.CO;2-R	14	889	930	0	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					790	U85		10.1038/ng.646	http://dx.doi.org/10.1038/ng.646			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20711175	Green Accepted			2022-12-25	WOS:000281388400017
J	Bujara, M; Schumperli, M; Pellaux, R; Heinemann, M; Panke, S				Bujara, Matthias; Schuemperli, Michael; Pellaux, Rene; Heinemann, Matthias; Panke, Sven			Optimization of a blueprint for in vitro glycolysis by metabolic real-time analysis	NATURE CHEMICAL BIOLOGY			English	Article							FLUX CONTROL COEFFICIENTS; ESCHERICHIA-COLI; MASS-SPECTROMETRY; DYNAMICS; GENOME; CELLS; TRANSCRIPTOME; EXPRESSION; EVOLUTION; PATHWAYS	Recruiting complex metabolic reaction networks for chemical synthesis has attracted considerable attention but frequently requires optimization of network composition and dynamics to reach sufficient productivity. As a design framework to predict optimal levels for all enzymes in the network is currently not available, state-of-the-art pathway optimization relies on high-throughput phenotype screening. We present here the development and application of a new in vitro real-time analysis method for the comprehensive investigation and rational programming of enzyme networks for synthetic tasks. We used this first to rationally and rapidly derive an optimal blueprint for the production of the fine chemical building block dihydroxyacetone phosphate (DHAP) via Escherichia coli's highly evolved glycolysis. Second, the method guided the three-step genetic implementation of the blueprint, yielding a synthetic operon with the predicted 2.5-fold-increased glycolytic flux toward DHAP. The new analytical setup drastically accelerates rational optimization of synthetic multienzyme networks.	[Bujara, Matthias; Pellaux, Rene; Panke, Sven] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Bujara, Matthias; Schuemperli, Michael; Pellaux, Rene; Heinemann, Matthias; Panke, Sven] Swiss Fed Inst Technol, Inst Proc Engn, Dept Mech & Proc Engn, Zurich, Switzerland; [Heinemann, Matthias] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Groningen	Panke, S (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland.	sven.panke@bsse.ethz.ch	Heinemann, Matthias/B-9421-2008	Heinemann, Matthias/0000-0002-5512-9077; Panke, Sven/0000-0002-9368-539X	EU	EU(European Commission)	We would like to thank N. Zamboni, U. Sauer, M. Oldiges and C. Wandrey for help with MS analyses. This work was supported by the EU-FP6 projects EUROBIOSYN and NANOMOT.	Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Anthony JR, 2009, METAB ENG, V11, P13, DOI 10.1016/j.ymben.2008.07.007; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625; Buscher JM, 2009, ANAL CHEM, V81, P2135, DOI 10.1021/ac8022857; Bujara M, 2010, BIOTECHNOL BIOENG, V106, P376, DOI 10.1002/bit.22666; Buziol S, 2002, BIOTECHNOL BIOENG, V80, P632, DOI 10.1002/bit.10427; Chassagnole C, 2002, BIOTECHNOL BIOENG, V79, P53, DOI 10.1002/bit.10288; Chen HW, 2008, NAT PROTOC, V3, P1467, DOI 10.1038/nprot.2008.109; Cho BK, 2009, NAT BIOTECHNOL, V27, P1043, DOI 10.1038/nbt.1582; DELGADO J, 1992, BIOCHEM J, V285, P965, DOI 10.1042/bj2850965; DELGADO J, 1992, BIOCHEM J, V282, P919, DOI 10.1042/bj2820919; Ehlde M, 1996, BIOCHEM J, V313, P721, DOI 10.1042/bj3130721; El Massaoudi M, 2003, METAB ENG, V5, P86, DOI 10.1016/S1096-7176(03)00004-1; Emmerling M, 2000, BIOTECHNOL BIOENG, V67, P623, DOI [10.1002/(SICI)1097-0290(20000305)67:5<623::AID-BIT13>3.0.CO;2-W, 10.1002/(SICI)1097-0290(20000305)67:5&lt;623::AID-BIT13&gt;3.0.CO;2-W]; Fell D., 1997, UNDERSTANDING CONTRO; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Hadlich F, 2009, METAB ENG, V11, P87, DOI 10.1016/j.ymben.2008.10.002; Holtz WJ, 2010, CELL, V140, P19, DOI 10.1016/j.cell.2009.12.029; Jamshidi N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000177; Jewett MC, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.57; Kotte O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.10; Kummel A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100074; Linshiz G, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.26; Meyer D, 1997, J BACTERIOL, V179, P1298, DOI 10.1128/jb.179.4.1298-1306.1997; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Schumperli M, 2007, APPL MICROBIOL BIOT, V75, P33, DOI 10.1007/s00253-007-0882-3; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Stephanopoulos G., 1998, METAB ENG; Teusink B, 1998, TRENDS BIOCHEM SCI, V23, P162, DOI 10.1016/S0968-0004(98)01205-5; van den Brink J, 2008, APPL ENVIRON MICROB, V74, P5710, DOI 10.1128/AEM.01121-08; van Eunen K, 2010, FEBS J, V277, P749, DOI 10.1111/j.1742-4658.2009.07524.x; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Woodward J, 2000, NATURE, V405, P1014, DOI 10.1038/35016633; Yokobayashi Y, 2002, P NATL ACAD SCI USA, V99, P16587, DOI 10.1073/pnas.252535999; Zhang YHP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000456; Zhu L, 2008, RAPID COMMUN MASS SP, V22, P2993, DOI 10.1002/rcm.3700	41	100	111	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2011	7	5					271	277		10.1038/nchembio.541	http://dx.doi.org/10.1038/nchembio.541			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	751KZ	21423171	Green Submitted, Green Published			2022-12-25	WOS:000289617800010
J	Burnette, DT; Manley, S; Sengupta, P; Sougrat, R; Davidson, MW; Kachar, B; Lippincott-Schwartz, J				Burnette, Dylan T.; Manley, Suliana; Sengupta, Prabuddha; Sougrat, Rachid; Davidson, Michael W.; Kachar, Bechara; Lippincott-Schwartz, Jennifer			A role for actin arcs in the leading-edge advance of migrating cells	NATURE CELL BIOLOGY			English	Article							NEURONAL GROWTH CONE; FOCAL ADHESIONS; NASCENT ADHESIONS; MOTILE CELLS; DYNAMICS; FILAMENTS; MICROTUBULE; PROTRUSION; NETWORKS; BUNDLES	Epithelial cell migration requires coordination of two actin modules at the leading edge: one in the lamellipodium and one in the lamella. How the two modules connect mechanistically to regulate directed edge motion is not understood. Using live-cell imaging and photoactivation approaches, we demonstrate that the actin network of the lamellipodium evolves spatio-temporally into the lamella. This occurs during the retraction phase of edge motion, when myosin II redistributes to the lamellipodial actin and condenses it into an actin arc parallel to the edge. The new actin arc moves rearward, slowing down at focal adhesions in the lamella. We propose that net edge extension occurs by nascent focal adhesions advancing the site at which new actin arcs slow down and form the base of the next protrusion event. The actin arc there by serves as a structural element underlying the temporal and spatial connection between the lamellipodium and the lamella during directed cell motion.	[Burnette, Dylan T.; Manley, Suliana; Sengupta, Prabuddha; Sougrat, Rachid; Lippincott-Schwartz, Jennifer] NICHHD, NIH, Bethesda, MD 20892 USA; [Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32310 USA; [Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Kachar, Bechara] Natl Inst Deafness & Other Commun Disorders, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); State University System of Florida; Florida State University; State University System of Florida; Florida State University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Lippincott-Schwartz, J (corresponding author), NICHHD, NIH, Bethesda, MD 20892 USA.	lippincj@mail.nih.gov	Manley, Suliana/D-3818-2012	Manley, Suliana/0000-0002-4755-4778; Sougrat, Rachid/0000-0001-6476-1886; Sengupta, Prabuddha/0000-0001-7094-6967	NIGMS, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609, ZIAHD008850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000002, ZIADC000009] Funding Source: NIH RePORTER	NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the members of the Lippincott-Schwartz Laboratory for helpful comments and suggestions. D.T.B. was supported by a Pharmacology Research Associate Fellowship from NIGMS, NIH during the course of these studies.	Alexandrova AY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003234; Aratyn-Schaus Y, 2010, CURR BIOL, V20, P1145, DOI 10.1016/j.cub.2010.05.049; Burnette DT, 2008, DEV CELL, V15, P163, DOI 10.1016/j.devcel.2008.05.016; Burnette DT, 2007, NAT CELL BIOL, V9, P1360, DOI 10.1038/ncb1655; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Danuser G, 2005, BIOCHEM SOC T, V33, P1250, DOI 10.1042/BST0331250; Danuser G, 2009, J CELL SCI, V122, P1959, DOI 10.1242/jcs.054379; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; HEATH JP, 1981, CELL BIOL INT REP, V5, P975, DOI 10.1016/0309-1651(81)90214-9; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Ji L, 2005, J MICROSC-OXFORD, V220, P150, DOI 10.1111/j.1365-2818.2005.01522.x; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mogilner A, 2009, CURR BIOL, V19, pR762, DOI 10.1016/j.cub.2009.06.053; Mongiu AK, 2007, J CELL SCI, V120, P1113, DOI 10.1242/jcs.03384; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Rafelski SM, 2004, ANNU REV BIOCHEM, V73, P209, DOI 10.1146/annurev.biochem.73.011303.073844; Rossier OM, 2010, EMBO J, V29, P1055, DOI 10.1038/emboj.2010.2; Shemesh T, 2009, BIOPHYS J, V97, P1254, DOI 10.1016/j.bpj.2009.05.065; Small JV, 2008, J MICROSC-OXFORD, V231, P479, DOI 10.1111/j.1365-2818.2008.02060.x; Svitkina T, 2007, METHOD CELL BIOL, V79, P295, DOI 10.1016/S0091-679X(06)79012-4; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Svitkina TM, 1995, J STRUCT BIOL, V115, P290, DOI 10.1006/jsbi.1995.1054; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Urban E, 2010, NAT CELL BIOL, V12, P429, DOI 10.1038/ncb2044; Vallotton P, 2009, J CELL SCI, V122, P1955, DOI 10.1242/jcs.042036; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Zhang XF, 2003, NEURON, V40, P931, DOI 10.1016/S0896-6273(03)00754-2	40	255	256	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	APR	2011	13	4					371	U88		10.1038/ncb2205	http://dx.doi.org/10.1038/ncb2205			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	744CK	21423177	Green Accepted, Green Published			2022-12-25	WOS:000289070900009
J	Nikic, I; Merkler, D; Sorbara, C; Brinkoetter, M; Kreutzfeldt, M; Bareyre, FM; Bruck, W; Bishop, D; Misgeld, T; Kerschensteiner, M				Nikic, Ivana; Merkler, Doron; Sorbara, Catherine; Brinkoetter, Mary; Kreutzfeldt, Mario; Bareyre, Florence M.; Brueck, Wolfgang; Bishop, Derron; Misgeld, Thomas; Kerschensteiner, Martin			A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis	NATURE MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; IN-VIVO; NITRIC-OXIDE; MITOCHONDRIAL DYSFUNCTION; SPINAL-CORD; DEGENERATION; MODEL; INFLAMMATION; LESIONS; MECHANISMS	In multiple sclerosis, a common inflammatory disease of the central nervous system, immune-mediated axon damage is responsible for permanent neurological deficits(1,2). How axon damage is initiated is not known. Here we use in vivo imaging to identify a previously undescribed variant of axon damage in a mouse model of multiple sclerosis. This process, termed 'focal axonal degeneration' (FAD), is characterized by sequential stages, beginning with focal swellings and progressing to axon fragmentation. Notably, most swollen axons persist unchanged for several days, and some recover spontaneously. Early stages of FAD can be observed in axons with intact myelin sheaths. Thus, contrary to the classical view(2-6), demyelination-a hallmark of multiple sclerosis-is not a prerequisite for axon damage. Instead, focal intra-axonal mitochondrial pathology is the earliest ultrastructural sign of damage, and it precedes changes in axon morphology. Molecular imaging and pharmacological experiments show that macrophage-derived reactive oxygen and nitrogen species (ROS and RNS) can trigger mitochondrial pathology and initiate FAD. Indeed, neutralization of ROS and RNS rescues axons that have already entered the degenerative process. Finally, axonal changes consistent with FAD can be detected in acute human multiple sclerosis lesions. In summary, our data suggest that inflammatory axon damage might be spontaneously reversible and thus a potential target for therapy.	[Nikic, Ivana; Sorbara, Catherine; Bareyre, Florence M.; Kerschensteiner, Martin] Univ Munich, Inst Clin Neuroimmunol, Res Unit Therapy Dev, Munich, Germany; [Merkler, Doron; Kreutzfeldt, Mario; Brueck, Wolfgang] Univ Gottingen, Inst Neuropathol, Gottingen, Germany; [Merkler, Doron; Kreutzfeldt, Mario] Univ Geneva, Dept Pathol & Immunol, CH-1211 Geneva 4, Switzerland; [Merkler, Doron; Kreutzfeldt, Mario] Univ Geneva, Univ Hosp Geneva, Div Clin Pathol, CH-1211 Geneva 4, Switzerland; [Brinkoetter, Mary; Bishop, Derron] Indiana Univ Sch Med, Dept Physiol, Muncie, IN USA; [Misgeld, Thomas] Tech Univ Munich, Inst Neurosci, Ctr Integrated Prot Sci Munich, Chair Biomol Sensors, Munich, Germany; [Misgeld, Thomas] Tech Univ Munich, Inst Adv Study, Munich, Germany	University of Munich; University of Gottingen; University of Geneva; University of Geneva; Indiana University System; Technical University of Munich; University of Munich; Technical University of Munich	Kerschensteiner, M (corresponding author), Univ Munich, Inst Clin Neuroimmunol, Res Unit Therapy Dev, Munich, Germany.	thomas.misgeld@lrz.tu-muenchen.de; martin.kerschensteiner@med.uni-muenchen.de	Merkler, Doron/N-9157-2016	Merkler, Doron/0000-0002-0247-2007; Nikic, Ivana/0000-0002-6666-3486; Kreutzfeldt, Mario/0000-0003-0335-2733	Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 571, Sonderforschungsbereich Transregio 43]; 'Verein Therapieforschung fur MS-Kranke e.V'. M. Kerschensteiner; German Federal Ministry of Education and Research; Institute for Advanced Study, Technische Universitat Munchen; Alexander von Humboldt Foundation; Center for Integrated Protein Science (Munich); Swiss National Science Foundation [PP00P3 128372]; US National Institutes of Health; Dana Foundation; Hertie Foundation; Christopher and Dana Reeve Foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); 'Verein Therapieforschung fur MS-Kranke e.V'. M. Kerschensteiner; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Institute for Advanced Study, Technische Universitat Munchen; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Center for Integrated Protein Science (Munich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; Hertie Foundation; Christopher and Dana Reeve Foundation	We would like to thank B. Fiedler, G. Heitmann, M. Schedensack, A. Schmalz and S. Knecht for excellent technical assistance; D. Matzek for animal husbandry; A. Dagkalis for help with immunizations; M. Krumbholz for advice on statistical analysis; and R. Hohlfeld, H. Wekerle, J. Sanes, J. Lichtman, L. Godinho, D. Kerschensteiner, P. Williams, T. Dick, E. Meinl and K. Dornmair for discussions or critical reading of the manuscript. Work in M. Kerschensteiner's laboratory is financed through grants from the Deutsche Forschungsgemeinschaft (DFG; Emmy Noether Program and Sonderforschungsbereich 571) and the 'Verein Therapieforschung fur MS-Kranke e.V'. M. Kerschensteiner and W. B. are supported by a grant from the German Federal Ministry of Education and Research (Competence Network Multiple Sclerosis). T. M. is supported by the Institute for Advanced Study, Technische Universitat Munchen, by the Alexander von Humboldt Foundation and by the Center for Integrated Protein Science (Munich). D. M. and W. B. are supported by grants from the DFG (Sonderforschungsbereich Transregio 43). D. M. is supported by the Swiss National Science Foundation (PP00P3 128372). D. B. is supported by the US National Institutes of Health. This project was further financed by grants to M. Kerschensteiner and T. M. from the Dana Foundation and the Hertie Foundation, and by a grant from the Christopher and Dana Reeve Foundation to T. M. and D. B.	Abdul-Majid KB, 2000, J NEUROIMMUNOL, V111, P23, DOI 10.1016/S0165-5728(00)00360-X; Aboul-Enein F, 2006, ACTA NEUROPATHOL, V111, P539, DOI 10.1007/s00401-006-0047-y; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Bittner S, 2009, BRAIN, V132, P2501, DOI 10.1093/brain/awp163; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Coman I, 2006, BRAIN, V129, P3186, DOI 10.1093/brain/awl144; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Das Sarma J, 2009, J NEUROSCI, V29, P10272, DOI 10.1523/JNEUROSCI.1975-09.2009; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Forte M, 2007, P NATL ACAD SCI USA, V104, P7558, DOI 10.1073/pnas.0702228104; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hooper DC, 2000, FASEB J, V14, P691, DOI 10.1096/fasebj.14.5.691; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kapoor R, 2003, ANN NEUROL, V53, P174, DOI 10.1002/ana.10443; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Kizelsztein P, 2009, J NEUROIMMUNOL, V213, P20, DOI 10.1016/j.jneuroim.2009.05.019; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lipton SA, 2007, NAT REV NEUROSCI, V8, P803, DOI 10.1038/nrn2229; Lo AC, 2003, J NEUROPHYSIOL, V90, P3566, DOI 10.1152/jn.00434.2003; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Mahad D, 2008, BRAIN, V131, P1722, DOI 10.1093/brain/awn105; Mahad DJ, 2009, BRAIN, V132, P1161, DOI 10.1093/brain/awp046; Mathey EK, 2007, J EXP MED, V204, P2363, DOI 10.1084/jem.20071053; Medana I, 2001, AM J PATHOL, V159, P809, DOI 10.1016/S0002-9440(10)61755-5; Misgeld T, 2007, NAT METHODS, V4, P559, DOI 10.1038/NMETH1055; Misgeld T, 2006, NAT REV NEUROSCI, V7, P449, DOI 10.1038/nrn1905; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Singbartl K, 2001, J IMMUNOL, V166, P7520, DOI 10.4049/jimmunol.166.12.7520; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3; Smith KJ, 2001, ANN NEUROL, V49, P470; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Trapp BD, 2009, LANCET NEUROL, V8, P280, DOI 10.1016/S1474-4422(09)70043-2; Waxman SG, 2006, NAT REV NEUROSCI, V7, P932, DOI 10.1038/nrn2023	40	483	486	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2011	17	4					495	U135		10.1038/nm.2324	http://dx.doi.org/10.1038/nm.2324			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21441916				2022-12-25	WOS:000289245100041
J	Obad, S; dos Santos, CO; Petri, A; Heidenblad, M; Broom, O; Ruse, C; Fu, CX; Lindow, M; Stenvang, J; Straarup, EM; Hansen, HF; Koch, T; Pappin, D; Hannon, GJ; Kauppinen, S				Obad, Susanna; dos Santos, Camila O.; Petri, Andreas; Heidenblad, Markus; Broom, Oliver; Ruse, Cristian; Fu, Cexiong; Lindow, Morten; Stenvang, Jan; Straarup, Ellen Marie; Hansen, Henrik Frydenlund; Koch, Troels; Pappin, Darryl; Hannon, Gregory J.; Kauppinen, Sakari			Silencing of microRNA families by seed-targeting tiny LNAs	NATURE GENETICS			English	Article							LOCKED NUCLEIC-ACID; IN-VIVO; ANTISENSE OLIGONUCLEOTIDES; MESSENGER-RNA; LET-7; EXPRESSION; MIR-21; MICE; DETERMINANTS; SPECIFICITY	The challenge of understanding the widespread biological roles of animal microRNAs (miRNAs) has prompted the development of genetic and functional genomics technologies for miRNA loss-of-function studies. However, tools for exploring the functions of entire miRNA families are still limited. We developed a method that enables antagonism of miRNA function using seed-targeting 8-mer locked nucleic acid (LNA) oligonucleotides, termed tiny LNAs. Transfection of tiny LNAs into cells resulted in simultaneous inhibition of miRNAs within families sharing the same seed with concomitant upregulation of direct targets. In addition, systemically delivered, unconjugated tiny LNAs showed uptake in many normal tissues and in breast tumors in mice, coinciding with long-term miRNA silencing. Transcriptional and proteomic profiling suggested that tiny LNAs have negligible off-target effects, not significantly altering the output from mRNAs with perfect tiny LNA complementary sites. Considered together, these data support the utility of tiny LNAs in elucidating the functions of miRNA families in vivo.	[Obad, Susanna; Petri, Andreas; Heidenblad, Markus; Broom, Oliver; Lindow, Morten; Stenvang, Jan; Straarup, Ellen Marie; Hansen, Henrik Frydenlund; Koch, Troels; Kauppinen, Sakari] Santaris Pharma, Horsholm, Denmark; [dos Santos, Camila O.; Ruse, Cristian; Fu, Cexiong; Pappin, Darryl; Hannon, Gregory J.] Cold Spring Harbor Lab, Cold Spring Harbor, NY USA; [Kauppinen, Sakari] Aalborg Univ, Copenhagen Inst Technol, Ballerup, Denmark	Cold Spring Harbor Laboratory; Aalborg University	Kauppinen, S (corresponding author), Santaris Pharma, Horsholm, Denmark.	sk@santaris.com	Ruse, Cristian/A-4609-2011; Hannon, Gregory/AAB-3568-2019	Ruse, Cristian/0000-0001-8237-6308; Pappin, Darryl/0000-0002-8981-8401; Stenvang, Jan/0000-0001-5647-4828	Danish National Advanced Technology Foundation; Danish Medical Research Council; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062534] Funding Source: NIH RePORTER	Danish National Advanced Technology Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to thank A. Koustrup, H. Brostrom, A. Konge, J.J. Jorgensen, M. R. Moller, L. Bang and M. Meldgaard for excellent technical assistance, and A. Lund and T. Bou-Kheir for reagents. This study was supported by grants from the Danish National Advanced Technology Foundation and the Danish Medical Research Council to S. K.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bantscheff M, 2008, MOL CELL PROTEOMICS, V7, P1702, DOI 10.1074/mcp.M800029-MCP200; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Broom OJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006371; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Horth P, 2006, MOL CELL PROTEOMICS, V5, P1968, DOI 10.1074/mcp.T600037-MCP200; Horwich MD, 2008, NAT PROTOC, V3, P1537, DOI 10.1038/nprot.2008.145; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu M, 2009, CELL RES, V19, P828, DOI 10.1038/cr.2009.72; Loya CM, 2009, NAT METHODS, V6, P897, DOI 10.1038/nmeth.1402; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Miyoshi Keita, 2008, V442, P29, DOI 10.1007/978-1-59745-191-8_3; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Pulaski BA, 2000, CANCER IMMUNOL IMMUN, V49, P34, DOI 10.1007/s002620050024; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Robertson Barbara, 2010, Silence, V1, P10, DOI 10.1186/1758-907X-1-10; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; Straarup EM, 2010, NUCLEIC ACIDS RES, V38, P7100, DOI 10.1093/nar/gkq457; Taylor P, 2009, J PROTEOME RES, V8, P1610, DOI 10.1021/pr800986c; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Worm J, 2009, NUCLEIC ACIDS RES, V37, P5784, DOI 10.1093/nar/gkp577; Zheng Genhua, 2010, Silence, V1, P9, DOI 10.1186/1758-907X-1-9	54	479	533	1	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2011	43	4					371	U160		10.1038/ng.786	http://dx.doi.org/10.1038/ng.786			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	741YL	21423181	Green Accepted			2022-12-25	WOS:000288903700020
J	Kume, K; Koyano, T; Kanai, M; Toda, T; Hirata, D				Kume, Kazunori; Koyano, Takayuki; Kanai, Muneyoshi; Toda, Takashi; Hirata, Dai			Calcineurin ensures a link between the DNA replication checkpoint and microtubule-dependent polarized growth	NATURE CELL BIOLOGY			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; CELL POLARITY; S-PHASE; GENE; ACTIVATION; TRACKING; KINASE; CYTOSKELETON; EFFICIENT	Microtubules are central to eukaryotic cell morphogenesis. Microtubule plus-end tracking proteins (+TIPs) transport polarity factors to the cell cortex, thereby playing a key role in both microtubule dynamics and cell polarity. However, the signalling pathway linking +TIPs to cell polarity control remains elusive. Here we show that the fission yeast checkpoint kinase Cds1 (Chk2 homologue) delays the transition of growth polarity from monopolar to bipolar (termed NETO; new-end take-off). The +TIPs CLIP170 homologue Tip1 and kinesin Tea2 are responsible for this delay, which is accompanied by a reduction in microtubule dynamics at the cell tip. Remarkably, microtubule stabilization occurs asymmetrically, prominently at the non-growing cell end, which induces abnormal accumulation of the polarity factor Teal. Importantly, NETO delay requires activation of calcineurin, which is carried out by Cdsl, resulting in Tip1 dephosphorylation. Thus, our study establishes a critical link between calcineurin and checkpoint-dependent cell morphogenesis.	[Kume, Kazunori; Koyano, Takayuki; Hirata, Dai] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Higashihiroshima 7398530, Japan; [Kanai, Muneyoshi] Natl Res Inst Brewing, Higashihiroshima 7390046, Japan; [Toda, Takashi] Canc Res UK, London Res Inst, Lab Cell Regulat, London WC2A 3LY, England	Hiroshima University; Cancer Research UK	Hirata, D (corresponding author), Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Higashihiroshima 7398530, Japan.	dhirata@hiroshima-u.ac.jp	Kume, Kazunori/T-4061-2018	Kume, Kazunori/0000-0002-0613-8081; Koyano, Takayuki/0000-0003-1675-2525	Ministry of Education, Science, and Culture of Japan; Cancer Research UK	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cancer Research UK(Cancer Research UK)	We thank D. Brunner, K. Kitamura, H. Murakami and P. Russell for strains and plasmids; K. Gull for antibody; E. Kinoshita for Phos-tag; Astellas Pharma for providing FK506; and all members of our laboratory for their help. We also thank D. Brunner, S. Martin, D. McCollum, K. Sawin, M. Yanagida and J. Hirata for discussions; and H. Iefuji, K. Ono, T. Miyakawa and K. Hirata for their support. This work was supported by grants from the Ministry of Education, Science, and Culture of Japan (to K.K. and D.H.), and by Cancer Research UK (to T.T.)	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Browning H, 2000, J CELL BIOL, V151, P15, DOI 10.1083/jcb.151.1.15; Browning H, 2003, NAT CELL BIOL, V5, P812, DOI 10.1038/ncb1034; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; DAMAGNEZ V, 1991, MOL GEN GENET, V226, P182, DOI 10.1007/BF00273602; Dantal J, 2005, NEW ENGL J MED, V352, P1371, DOI 10.1056/NEJMe058018; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; DURSO G, 1995, J CELL SCI, V108, P3109; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; KEENEY JB, 1994, GENETICS, V136, P849; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Martin SG, 2005, DEV CELL, V8, P479, DOI 10.1016/j.devcel.2005.02.008; Martin SG, 2009, TRENDS CELL BIOL, V19, P447, DOI 10.1016/j.tcb.2009.06.003; Martin-Garcia R, 2009, J CELL SCI, V122, P3862, DOI 10.1242/jcs.054460; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; MITCHISON JM, 1985, J CELL SCI, V75, P357; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nishiyama T, 2007, NATURE, V449, P341, DOI 10.1038/nature06136; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; Rhind N, 2000, J CELL SCI, V113, P3889; Roy J, 2007, MOL CELL, V25, P889, DOI 10.1016/j.molcel.2007.02.014; Rupes I, 1999, MOL BIOL CELL, V10, P1495, DOI 10.1091/mbc.10.5.1495; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; SMITH CL, 1987, NUCLEIC ACIDS RES, V15, P4481, DOI 10.1093/nar/15.11.4481; Snaith HA, 2003, NATURE, V423, P647, DOI 10.1038/nature01672; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Tatebe H, 2005, CURR BIOL, V15, P1006, DOI 10.1016/j.cub.2005.04.061; West RR, 1998, MOL BIOL CELL, V9, P2839, DOI 10.1091/mbc.9.10.2839; Wilson-Grady JT, 2008, J PROTEOME RES, V7, P1088, DOI 10.1021/pr7006335; YOSHIDA T, 1994, J CELL SCI, V107, P1725	43	31	31	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2011	13	3					234	U357		10.1038/ncb2166	http://dx.doi.org/10.1038/ncb2166			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	728BB	21336311				2022-12-25	WOS:000287847600011
J	[Anonymous]				[Anonymous]			Highly cited cancer papers, 2008-2010	NATURE MEDICINE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2011	17	3					280	282		10.1038/nm0311-280	http://dx.doi.org/10.1038/nm0311-280			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21383735				2022-12-25	WOS:000288070000032
J	Fierz, B; Chatterjee, C; McGinty, RK; Bar-Dagan, M; Raleigh, DP; Muir, TW				Fierz, Beat; Chatterjee, Champak; McGinty, Robert K.; Bar-Dagan, Maya; Raleigh, Daniel P.; Muir, Tom W.			Histone H2B ubiquitylation disrupts local and higher-order chromatin compaction	NATURE CHEMICAL BIOLOGY			English	Article							RNA-POLYMERASE-II; H4-K16 ACETYLATION; GENE-EXPRESSION; HUMAN-CELLS; NUCLEOSOME; FIBER; DYNAMICS; METHYLATION; UBIQUITIN; REVEALS	Regulation of chromatin structure involves histone posttranslational modifications that can modulate intrinsic properties of the chromatin fiber to change the chromatin state. We used chemically defined nucleosome arrays to demonstrate that H2B ubiquitylation (uH2B), a modification associated with transcription, interferes with chromatin compaction and leads to an open and biochemically accessible fiber conformation. Notably, these effects were specific for ubiquitin, as compaction of chromatin modified with a similar ubiquitin-sized protein, Hub1, was only weakly affected. Applying a fluorescence-based method, we found that uH2B acts through a mechanism distinct from H4 tail acetylation, a modification known to disrupt chromatin folding. Finally, incorporation of both uH2B and acetylated H4 resulted in synergistic inhibition of higher-order chromatin structure formation, possibly a result of their distinct modes of action.	[Fierz, Beat; Chatterjee, Champak; McGinty, Robert K.; Bar-Dagan, Maya; Muir, Tom W.] Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10021 USA; [Raleigh, Daniel P.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	Rockefeller University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Fierz, B (corresponding author), Rockefeller Univ, Lab Synthet Prot Chem, 1230 York Ave, New York, NY 10021 USA.	muirt@rockefeller.edu	Muir, Tom/AHD-0860-2022; Fierz, Beat/H-3143-2012; Chatterjee, Champak/R-7214-2017	Muir, Tom/0000-0001-9635-0344; Fierz, Beat/0000-0002-2991-3044; raleigh, daniel/0000-0003-3248-7493	US National Institutes of Health [RC2CA148354]; Starr Cancer Consortium; Swiss National Science Foundation [PBBSA-118839, PA00P3_129130/1]; Novartis Foundation; NATIONAL CANCER INSTITUTE [RC2CA148354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095880, T32GM007739] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Deng and H. Yu (The Rockefeller University) for mass spectrometric analysis of histones, J. Kim and R. Subramanian for assistance with preparing hDot1L, K. Chiang for help with DNA preparation, H. Yang and D. Montiel for help with fluorescence lifetime measurements and A. Ruthenburg, R. Sadeh, P. Moyle and M. Vila-Perello for assistance with cell experiments and discussions. This work was funded by the US National Institutes of Health (grant number RC2CA148354) and the Starr Cancer Consortium. B.F. was funded by the Swiss National Science Foundation (Nr. PBBSA-118839 and PA00P3_129130/1) and by the Novartis Foundation.	Bergstrom F, 1999, P NATL ACAD SCI USA, V96, P12477, DOI 10.1073/pnas.96.22.12477; Chandrasekharan MB, 2009, P NATL ACAD SCI USA, V106, P16686, DOI 10.1073/pnas.0907862106; Chatterjee C, 2010, NAT CHEM BIOL, V6, P267, DOI [10.1038/NCHEMBIO.315, 10.1038/nchembio.315]; Chodaparambil JV, 2007, NAT STRUCT MOL BIOL, V14, P1105, DOI 10.1038/nsmb1334; Cui Y, 2000, P NATL ACAD SCI USA, V97, P127, DOI 10.1073/pnas.97.1.127; DELCUVE GP, 1989, BIOCHEM J, V263, P179, DOI 10.1042/bj2630179; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; DEMELER B, 2009, ULTRASCAN VERSION 9; Dittmar GAG, 2002, SCIENCE, V295, P2442, DOI 10.1126/science.1069989; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Jason LJM, 2001, J BIOL CHEM, V276, P14597, DOI 10.1074/jbc.M011153200; KAWSKI A, 1983, PHOTOCHEM PHOTOBIOL, V38, P487, DOI 10.1111/j.1751-1097.1983.tb03372.x; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; KNOX RS, 1968, PHYSICA, V39, P361, DOI 10.1016/0031-8914(68)90090-6; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Kruithof M, 2009, NAT STRUCT MOL BIOL, V16, P534, DOI 10.1038/nsmb.1590; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lu X, 2008, NAT STRUCT MOL BIOL, V15, P1122, DOI 10.1038/nsmb.1489; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; McGinty RK, 2009, ACS CHEM BIOL, V4, P958, DOI 10.1021/cb9002255; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; NICKEL BE, 1989, BIOCHEMISTRY-US, V28, P958, DOI 10.1021/bi00429a006; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Poirier MG, 2008, J MOL BIOL, V379, P772, DOI 10.1016/j.jmb.2008.04.025; Poirier MG, 2009, NAT STRUCT MOL BIOL, V16, P938, DOI 10.1038/nsmb.1650; Ramelot Theresa A., 2003, Journal of Structural and Functional Genomics, V4, P25, DOI 10.1023/A:1024674220425; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; RUNNELS LW, 1995, BIOPHYS J, V69, P1569, DOI 10.1016/S0006-3495(95)80030-5; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Shema E, 2008, GENE DEV, V22, P2664, DOI 10.1101/gad.1703008; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sridhar VV, 2007, NATURE, V447, P735, DOI 10.1038/nature05864; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thaler C, 2009, P NATL ACAD SCI USA, V106, P6369, DOI 10.1073/pnas.0901913106; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; WEST MHP, 1980, NUCLEIC ACIDS RES, V8, P4671, DOI 10.1093/nar/8.20.4671; WOODCOCK CL, 1993, P NATL ACAD SCI USA, V90, P9021, DOI 10.1073/pnas.90.19.9021; WOODCOCK CL, 1995, TRENDS CELL BIOL, V5, P272, DOI 10.1016/S0962-8924(00)89038-8; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	50	309	322	1	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2011	7	2					113	119		10.1038/NCHEMBIO.501	http://dx.doi.org/10.1038/NCHEMBIO.501			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	707XM	21196936	Green Accepted, Green Submitted			2022-12-25	WOS:000286324600012
J	Terry, SJ; Zihni, C; Elbediwy, A; Vitiello, E; San, IVLC; Balda, MS; Matter, K				Terry, Stephen J.; Zihni, Ceniz; Elbediwy, Ahmed; Vitiello, Elisa; San, Isabelle V. Leefa Chong; Balda, Maria S.; Matter, Karl			Spatially restricted activation of RhoA signalling at epithelial junctions by p114RhoGEF drives junction formation and morphogenesis	NATURE CELL BIOLOGY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; CELL-CELL ADHESION; TIGHT JUNCTION; PARACELLULAR PERMEABILITY; FACTOR ZONAB/DBPA; FAMILY GTPASES; PROTEIN; IDENTIFICATION; EXPRESSION; GEF-H1	Signalling by the GTPase RhoA, a key regulator of epithelial cell behaviour, can stimulate opposing processes: RhoA can promote junction formation and apical constriction, and reduce adhesion and cell spreading(1,2). Molecular mechanisms are thus required that ensures spatially restricted and process-specific RhoA activation. For many fundamental processes, including assembly of the epithelial junctional complex, such mechanisms are still unknown. Here we show that p114RhoGEF is a junction-associated protein that drives RhoA signalling at the junctional complex and regulates tight-junction assembly and epithelial morphogenesis. p114RhoGEF is required for RhoA activation at cell-cell junctions, and its depletion stimulates non-junctional Rho signalling and induction of myosin phosphorylation along the basal domain. Depletion of GEF-H1, a RhoA activator inhibited by junctional recruitment(3), does not reduce junction-associated RhoA activation. p114RhoGEF associates with a complex containing myosin II, Rock II and the junctional adaptor cingulin, indicating that p114RhoGEF is a component of a junction-associated Rho signalling module that drives spatially restricted activation of RhoA to regulate junction formation and epithelial morphogenesis.	[Terry, Stephen J.; Zihni, Ceniz; Elbediwy, Ahmed; Vitiello, Elisa; San, Isabelle V. Leefa Chong; Balda, Maria S.; Matter, Karl] UCL, Dept Cell Biol, UCL Inst Ophthalmol, London EC1V 9EL, England	University of London; University College London	Balda, MS (corresponding author), UCL, Dept Cell Biol, UCL Inst Ophthalmol, Bath St, London EC1V 9EL, England.	m.balda@ucl.ac.uk; k.matter@ucl.ac.u	Terry, Stephen/AAC-8511-2019; Matter, Karl/C-4880-2008	Matter, Karl/0000-0001-8026-7220; Terry, Stephen/0000-0001-8195-898X; Elbediwy, Ahmed/0000-0002-2102-7339; zihni, ceniz/0000-0002-7961-5336; /0000-0002-8427-6746	Fight for Sight Studentship; Fight for Sight; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/H002294/1] Funding Source: researchfish; Medical Research Council [G0400678] Funding Source: researchfish; BBSRC [BB/H002294/1] Funding Source: UKRI; MRC [G0400678] Funding Source: UKRI	Fight for Sight Studentship; Fight for Sight; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	S.J.T. is supported by a Fight for Sight Studentship. This research was supported by Fight for Sight and the Wellcome Trust.	Abouhamed M, 2009, MOL BIOL CELL, V20, P5074, DOI 10.1091/mbc.E09-04-0291; Aijaz S, 2005, DEV CELL, V8, P777, DOI 10.1016/j.devcel.2005.03.003; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Benais-Pont G, 2003, J CELL BIOL, V160, P729, DOI 10.1083/jcb.200211047; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Blomquist A, 2000, BIOCHEM J, V352, P319, DOI 10.1042/0264-6021:3520319; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Cordenonsi M, 1999, J CELL BIOL, V147, P1569, DOI 10.1083/jcb.147.7.1569; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Guillemot L, 2006, MOL BIOL CELL, V17, P3569, DOI 10.1091/mbc.E06-02-0122; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Kakiashvili E, 2009, J BIOL CHEM, V284, P11454, DOI 10.1074/jbc.M805933200; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; MATTER K, 1989, J BIOL CHEM, V264, P13131; Matter K, 2003, METHODS, V30, P228, DOI 10.1016/S1046-2023(03)00029-X; Nagata KI, 2005, ONCOGENE, V24, P65, DOI 10.1038/sj.onc.1208101; Nie M, 2009, EMBO REP, V10, P1125, DOI 10.1038/embor.2009.182; Niu JX, 2003, CIRC RES, V93, P848, DOI 10.1161/01.RES.0000097607.14733.0C; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Noren NK, 2003, J BIOL CHEM, V278, P13615, DOI 10.1074/jbc.C200657200; NUSRAT A, 1995, P NATL ACAD SCI USA, V92, P10629, DOI 10.1073/pnas.92.23.10629; Osler ME, 2005, J CELL SCI, V118, P4667, DOI 10.1242/jcs.02588; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Samarin SN, 2007, MOL BIOL CELL, V18, P3429, DOI 10.1091/mbc.E07-04-0315; Sourisseau T, 2006, MOL CELL BIOL, V26, P2387, DOI 10.1128/MCB.26.6.2387-2398.2006; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Steed E, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-95; Sterpetti P, 1999, MOL CELL BIOL, V19, P1334; Terry S, 2010, PHYSIOLOGY, V25, P16, DOI 10.1152/physiol.00034.2009; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	38	155	158	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	FEB	2011	13	2					159	U120		10.1038/ncb2156	http://dx.doi.org/10.1038/ncb2156			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714JM	21258369	Green Accepted			2022-12-25	WOS:000286805900010
J	Dauwerse, JG; Dixon, J; Seland, S; Ruivenkamp, CAL; van Haeringen, A; Hoefsloot, LH; Peters, DJM; Boers, ACD; Daumer-Haas, C; Maiwald, R; Zweier, C; Kerr, B; Cobo, AM; Toral, JF; Hoogeboom, AJM; Lohmann, DR; Hehr, U; Dixon, MJ; Breuning, MH; Wieczorek, D				Dauwerse, Johannes G.; Dixon, Jill; Seland, Saskia; Ruivenkamp, Claudia A. L.; van Haeringen, Arie; Hoefsloot, Lies H.; Peters, Dorien J. M.; Boers, Agnes Clement-de; Daumer-Haas, Cornelia; Maiwald, Robert; Zweier, Christiane; Kerr, Bronwyn; Cobo, Ana M.; Toral, Joaquin F.; Hoogeboom, A. Jeannette M.; Lohmann, Dietmar R.; Hehr, Ute; Dixon, Michael J.; Breuning, Martijn H.; Wieczorek, Dagmar			Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome	NATURE GENETICS			English	Article							YEAST; REVEALS; TCOF1	We identified a deletion of a gene encoding a subunit of RNA polymerases I and III, POLR1D, in an individual with Treacher Collins syndrome (TCS). Subsequently, we detected 20 additional heterozygous mutations of POLR1D in 252 individuals with TCS. Furthermore, we discovered mutations in both alleles of POLR1C in three individuals with TCS. These findings identify two additional genes involved in TCS, confirm the genetic heterogeneity of TCS and support the hypothesis that TCS is a ribosomopathy.	[Dauwerse, Johannes G.; Ruivenkamp, Claudia A. L.; van Haeringen, Arie; Peters, Dorien J. M.; Breuning, Martijn H.] Leiden Univ Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands; [Dixon, Jill; Kerr, Bronwyn; Dixon, Michael J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci, Manchester, Lancs, England; [Seland, Saskia; Lohmann, Dietmar R.; Wieczorek, Dagmar] Univ Klinikum Essen, Inst Humangenet, Essen, Germany; [Hoefsloot, Lies H.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Boers, Agnes Clement-de] Med Ctr Haaglanden, Dept Pediat, The Hague, Netherlands; [Daumer-Haas, Cornelia] Praenatal Med Munchen, Munich, Germany; [Maiwald, Robert] Med Versorgungszentrum Lab Med Mikrobiol & Humang, Monchengladbach, Germany; [Zweier, Christiane] Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany; [Cobo, Ana M.] Hop Marin, AP HP, Ctr Reference Neuromusculaire, Hendaye, France; [Toral, Joaquin F.] Hosp Univ Cent Asturias, Oviedo, Spain; [Hoogeboom, A. Jeannette M.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Hehr, Ute] Univ Klinikum Regensburg, Zentrum Humangenet, Regensburg, Germany; [Dixon, Michael J.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Leiden University; Leiden University Medical Center (LUMC); University of Manchester; University of Duisburg Essen; Radboud University Nijmegen; Haaglanden Medical Center; University of Erlangen Nuremberg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Marin de Hendaye - APHP; Central University Hospital Asturias; Erasmus University Rotterdam; Erasmus MC; University of Regensburg; University of Manchester	Dauwerse, JG (corresponding author), Leiden Univ Med Ctr, Ctr Human & Clin Genet, Leiden, Netherlands.	dauw@lumc.nl	Lohmann, Dietmar R./X-4895-2019; Lohmann, Dietmar R/B-4041-2013; Peters, Dorien/AFH-8507-2022; Zweier, Christiane/F-2202-2015; Wieczorek, Dagmar/AAU-6008-2021	Lohmann, Dietmar R./0000-0002-2624-9889; Lohmann, Dietmar R/0000-0002-2624-9889; Peters, Dorien/0000-0001-6974-7143; Zweier, Christiane/0000-0001-8002-2020; Wieczorek, Dagmar/0000-0003-2812-6492	German Ministry of Research and Education [BMBF 01GM0802]; National Institutes of Health Research Manchester Biomedical Research Centre; Healing Foundation	German Ministry of Research and Education(Federal Ministry of Education & Research (BMBF)); National Institutes of Health Research Manchester Biomedical Research Centre; Healing Foundation	We express our sincere gratitude to the cases, their parents and other family members for their participation in this study, as well as to the clinicians for sending blood samples. We want to thank the Laboratory for Diagnostic Genome Analysis (LDGA) in Leiden and the Forensisch Laboratorium voor DNA Onderzoek (FLDO), as well as the TCS team in Essen and Regensburg for their excellent technical assistance and Ivo Fokkema for his help with constructing the Leiden Open Variation Databases (LOVD). This work was part of the CRANIRARE Network funded through a grant from the German Ministry of Research and Education to D.R.L. and D.W. (BMBF 01GM0802). The financial support of the National Institutes of Health Research Manchester Biomedical Research Centre and the Healing Foundation to J.D. and M.J.D. is gratefully acknowledged.	Cook DL, 1998, P NATL ACAD SCI USA, V95, P15641, DOI 10.1073/pnas.95.26.15641; Dixon J, 1996, NAT GENET, V12, P130; Dixon J, 2006, P NATL ACAD SCI USA, V103, P13403, DOI 10.1073/pnas.0603730103; Edwards SJ, 1997, AM J HUM GENET, V60, P515; Fokkema IFAC, 2005, HUM MUTAT, V26, P63, DOI 10.1002/humu.20201; Larkin RM, 1997, J BIOL CHEM, V272, P12824, DOI 10.1074/jbc.272.19.12824; Lin CI, 2009, BIOCHEM BIOPH RES CO, V386, P396, DOI 10.1016/j.bbrc.2009.06.050; LOWRY RB, 1985, AM J MED GENET, V22, P501, DOI 10.1002/ajmg.1320220308; MANN C, 1987, CELL, V48, P627, DOI 10.1016/0092-8674(87)90241-8; MARRES HAM, 1995, ARCH OTOLARYNGOL, V121, P509; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Splendore A, 2000, HUM MUTAT, V16, P315, DOI 10.1002/1098-1004(200010)16:4<315::AID-HUMU4>3.0.CO;2-H; Teber OA, 2004, EUR J HUM GENET, V12, P879, DOI 10.1038/sj.ejhg.5201260; Valdez BC, 2004, P NATL ACAD SCI USA, V101, P10709, DOI 10.1073/pnas.0402492101; Yao YQ, 1996, J BIOL CHEM, V271, P32881, DOI 10.1074/jbc.271.51.32881	15	211	236	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2011	43	1					20	22		10.1038/ng.724	http://dx.doi.org/10.1038/ng.724			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	699SQ	21131976				2022-12-25	WOS:000285683500009
J	Enciso-Mora, V; Broderick, P; Ma, Y; Jarrett, RF; Hjalgrim, H; Hemminki, K; van den Berg, A; Olver, B; Lloyd, A; Dobbins, SE; Lightfoot, T; van Leeuwen, FE; Forsti, A; Diepstra, A; Broeks, A; Vijayakrishnan, J; Shield, L; Lake, A; Montgomery, D; Roman, E; Engert, A; von Strandmann, EP; Reiners, KS; Nolte, IM; Smedby, KE; Adami, HO; Russell, NS; Glimelius, B; Hamilton-Dutoit, S; de Bruin, M; Ryder, LP; Molin, D; Sorensen, KM; Chang, ET; Taylor, M; Cooke, R; Hofstra, R; Westers, H; van Wezel, T; van Eijk, R; Ashworth, A; Rostgaard, K; Melbye, M; Swerdlow, AJ; Houlston, RS				Enciso-Mora, Victor; Broderick, Peter; Ma, Yussanne; Jarrett, Ruth F.; Hjalgrim, Henrik; Hemminki, Kari; van den Berg, Anke; Olver, Bianca; Lloyd, Amy; Dobbins, Sara E.; Lightfoot, Tracy; van Leeuwen, Flora E.; Foersti, Asta; Diepstra, Arjan; Broeks, Annegien; Vijayakrishnan, Jayaram; Shield, Lesley; Lake, Annette; Montgomery, Dorothy; Roman, Eve; Engert, Andreas; von Strandmann, Elke Pogge; Reiners, Katrin S.; Nolte, Ilja M.; Smedby, Karin E.; Adami, Hans-Olov; Russell, Nicola S.; Glimelius, Bengt; Hamilton-Dutoit, Stephen; de Bruin, Marieke; Ryder, Lars P.; Molin, Daniel; Sorensen, Karina Meden; Chang, Ellen T.; Taylor, Malcolm; Cooke, Rosie; Hofstra, Robert; Westers, Helga; van Wezel, Tom; van Eijk, Ronald; Ashworth, Alan; Rostgaard, Klaus; Melbye, Mads; Swerdlow, Anthony J.; Houlston, Richard S.			A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)	NATURE GENETICS			English	Article							KAPPA-B-ALPHA; INFECTIOUS-MONONUCLEOSIS; COLORECTAL-CANCER; NEOPLASTIC-CELLS; PROSTATE-CANCER; INCREASED RISK; C-MYC; DISEASE; GENE; VARIANT	To identify susceptibility loci for classical Hodgkin's lymphoma (cHL), we conducted a genome-wide association study of 589 individuals with cHL (cases) and 5,199 controls with validation in four independent samples totaling 2,057 cases and 3,416 controls. We identified three new susceptibility loci at 2p16.1 (rs1432295, REL, odds ratio (OR) = 1.22, combined P = 1.91 x 10(-8)), 8q24.21 (rs2019960, PVT1, OR = 1.33, combined P = 1.26 x 10(-13)) and 10p14 (rs501764, GATA3, OR = 1.25, combined P = 7.05 x 10(-8)). Furthermore, we confirmed the role of the major histocompatibility complex in disease etiology by revealing a strong human leukocyte antigen (HLA) association (rs6903608, OR = 1.70, combined P = 2.84 x 10(-50)). These data provide new insight into the pathogenesis of cHL.	[Enciso-Mora, Victor; Broderick, Peter; Ma, Yussanne; Olver, Bianca; Lloyd, Amy; Dobbins, Sara E.; Vijayakrishnan, Jayaram; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Jarrett, Ruth F.; Shield, Lesley; Lake, Annette; Montgomery, Dorothy] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Hjalgrim, Henrik; Rostgaard, Klaus; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Hemminki, Kari; Foersti, Asta] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Hemminki, Kari; Diepstra, Arjan] Lund Univ, Clin Res Ctr, Ctr Primary Hlth Care Res, Malmo, Sweden; [van den Berg, Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Lightfoot, Tracy; Roman, Eve] Univ York, Dept Hlth Sci, Epidemiol & Genet Unit, York YO10 5DD, N Yorkshire, England; [van Leeuwen, Flora E.; de Bruin, Marieke] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands; [Broeks, Annegien] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Expt Therapy, Amsterdam, Netherlands; [Engert, Andreas; von Strandmann, Elke Pogge; Reiners, Katrin S.] Univ Hosp Cologne, Dept Internal Med, Cologne, Germany; [Nolte, Ilja M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Unit Genet Epidemiol & Bioinformat, Groningen, Netherlands; [Smedby, Karin E.] Karolinska Univ Hosp, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Adami, Hans-Olov] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Adami, Hans-Olov] Harvard Univ, Sch Med, Dept Epidemiol, Boston, MA USA; [Russell, Nicola S.] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands; [Glimelius, Bengt] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden; [Glimelius, Bengt; Molin, Daniel] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden; [Hamilton-Dutoit, Stephen] Aarhus Univ Hosp, Inst Pathol, DK-8000 Aarhus, Denmark; [Ryder, Lars P.] Univ Copenhagen Hosp, Rigshosp, Dept Clin Immunol, DK-2100 Copenhagen, Denmark; [Sorensen, Karina Meden] Statens Serum Inst, Dept Clin Biochem, DK-2300 Copenhagen, Denmark; [Chang, Ellen T.; Swerdlow, Anthony J.] Canc Prevent Inst Calif, Fremont, CA USA; [Chang, Ellen T.] Stanford Univ, Sch Med, Div Epidemiol, Dept Hlth Res & Policy, Stanford, CA USA; [Taylor, Malcolm] Univ Manchester, St Marys Hosp, Sch Canc & Enabling Sci, Canc Immunogenet Grp, Manchester M13 0JH, Lancs, England; [Cooke, Rosie] Inst Canc Res, Epidemiol Sect, Sutton, Surrey, England; [Hofstra, Robert; Westers, Helga] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [van Wezel, Tom; van Eijk, Ronald] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Ashworth, Alan] Breakthrough Breast Canc Res Ctr, Inst Canc Res, London, England	University of London; Institute of Cancer Research - UK; University of Glasgow; Statens Serum Institut; Helmholtz Association; German Cancer Research Center (DKFZ); Lund University; University of Groningen; University of York - UK; Netherlands Cancer Institute; Netherlands Cancer Institute; University of Cologne; University of Groningen; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Harvard University; Harvard Medical School; Netherlands Cancer Institute; Karolinska Institutet; Uppsala University; Aarhus University; Rigshospitalet; University of Copenhagen; Statens Serum Institut; Cancer Prevention Institute of California; Stanford University; University of Manchester; University of London; Institute of Cancer Research - UK; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England.	richard.houlston@icr.ac.uk	van Wezel, Tom/Z-3092-2019; Hjalgrim, Henrik/AAG-4973-2021; van Wezel, Tom/AAL-5626-2021; ryder, lars p/Q-2060-2015; Chang, Ellen/G-5700-2010; van den Berg, Anke/H-1718-2011; Jarrett, Ruth F/A-5570-2012; De Bruin, Marie Louise/O-5349-2016; Molin, Daniel/ABC-2260-2021; Dutoit, Stephen Hamilton/E-1815-2013; van Wezel, Tom/A-9599-2008	van Wezel, Tom/0000-0001-5773-7730; ryder, lars p/0000-0002-4744-3496; van den Berg, Anke/0000-0002-8894-2638; De Bruin, Marie Louise/0000-0001-9197-7068; van Wezel, Tom/0000-0001-5773-7730; Broderick, Peter/0000-0002-8348-5829; Hamilton-Dutoit, Stephen/0000-0003-2158-3885; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Swerdlow, Anthony/0000-0001-5550-4159; Houlston, Richard/0000-0002-5268-0242; Hofstra, Robert/0000-0001-7498-3829; Jarrett, Ruth/0000-0003-0390-3478; Roman, Eve/0000-0001-7603-3704; van Eijk, Ronald/0000-0001-7955-6295; Rostgaard, Klaus/0000-0001-6220-9414; melbye, mads/0000-0001-8264-6785; Diepstra, Arjan/0000-0001-9239-1050	MRC [G0000934] Funding Source: UKRI; Cancer Research UK [C1298/A8362, A3351] Funding Source: Medline; Medical Research Council [G0000934] Funding Source: Medline; Wellcome Trust [085475, 068545/Z/02, 076113] Funding Source: Medline; Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Breast Cancer Now		Alexander FE, 2003, INT J CANCER, V107, P298, DOI 10.1002/ijc.11156; AMIEL JL, 1967, HISTOCOMPATIBILITY T; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Atayar C, 2005, AM J PATHOL, V166, P127, DOI 10.1016/S0002-9440(10)62238-9; BAKKUS MHC, 1990, ONCOGENE, V5, P1359; Barth TFE, 2003, BLOOD, V101, P3681, DOI 10.1182/blood-2002-08-2577; Beck-Engeser GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-4; Broeks A, 2000, INT J RADIAT BIOL, V76, P693, DOI 10.1080/095530000138367; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cabannes E, 1999, ONCOGENE, V18, P3063, DOI 10.1038/sj.onc.1202893; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; De Bruin ML, 2009, J CLIN ONCOL, V27, P4239, DOI 10.1200/JCO.2008.19.9174; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Emmerich F, 1999, BLOOD, V94, P3129, DOI 10.1182/blood.V94.9.3129.421k03_3129_3134; Faumont N, 2009, J VIROL, V83, P5014, DOI 10.1128/JVI.02264-08; Ferretti V, 2007, NUCLEIC ACIDS RES, V35, pD122, DOI 10.1093/nar/gkl879; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goldin LR, 2005, J MED GENET, V42, P595, DOI 10.1136/jmg.2004.027433; Goldin LR, 2004, CANCER-AM CANCER SOC, V100, P1902, DOI 10.1002/cncr.20189; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hjalgrim H, 2008, J INTERN MED, V264, P537, DOI 10.1111/j.1365-2796.2008.02031.x; Hjalgrim H, 2007, CANCER RES, V67, P2382, DOI 10.1158/0008-5472.CAN-06-3566; Hjalgrim H, 2010, P NATL ACAD SCI USA, V107, P6400, DOI 10.1073/pnas.0915054107; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; HUPPI K, 1990, P NATL ACAD SCI USA, V87, P6964, DOI 10.1073/pnas.87.18.6964; Jarrett RF, 2003, J CLIN PATHOL, V56, P811, DOI 10.1136/jcp.56.11.811; Joos S, 2003, INT J CANCER, V103, P489, DOI 10.1002/ijc.10845; Jundt F, 2002, BLOOD, V99, P3060, DOI 10.1182/blood.V99.8.3060; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; KLITZ W, 1994, AM J HUM GENET, V54, P497; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209; LA RF, 1994, MOL CELL BIOL, V14, P1039; Lake A, 2009, INT J CANCER, V125, P1334, DOI 10.1002/ijc.24502; Li J, 2009, INT IMMUNOPHARMACOL, V9, P590, DOI 10.1016/j.intimp.2009.01.015; MACK TM, 1995, NEW ENGL J MED, V332, P413, DOI 10.1056/NEJM199502163320701; Martin-Subero JI, 2002, BLOOD, V99, P1474, DOI 10.1182/blood.V99.4.1474; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maurice D, 2007, EMBO J, V26, P3629, DOI 10.1038/sj.emboj.7601801; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Niens M, 2007, BLOOD, V110, P3310, DOI 10.1182/blood-2007-05-086934; OZA AM, 1994, CANCER RES, V54, P5101; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Penegar S, 2007, BRIT J CANCER, V97, P1305, DOI 10.1038/sj.bjc.6603997; Pettiti D, 1994, METAANALYSIS DECISIO; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; RISCH N, 1987, AM J HUM GENET, V40, P1; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Smedby KE, 2005, JNCI-J NATL CANCER I, V97, P199, DOI 10.1093/jnci/dji022; Smith A, 2010, BRIT J HAEMATOL, V148, P739, DOI 10.1111/j.1365-2141.2009.08010.x; Sorensen KM, 2007, GENET TEST, V11, P65, DOI 10.1089/gte.2006.0503; Storlazzi CT, 2004, HUM MOL GENET, V13, P1479, DOI 10.1093/hmg/ddh164; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Swerdlow AJ, 2003, EUR J NUCL MED MOL I, V30, pS3, DOI 10.1007/s00259-003-1154-9; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; van Leeuwen FE, 2003, JNCI-J NATL CANCER I, V95, P971, DOI 10.1093/jnci/95.13.971; VILLENEUVE L, 1986, MOL CELL BIOL, V6, P1834, DOI 10.1128/MCB.6.5.1834; Willett EV, 2007, EPIDEMIOLOGY, V18, P130, DOI 10.1097/01.ede.0000248899.47399.78; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	67	143	146	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2010	42	12					1126	+		10.1038/ng.696	http://dx.doi.org/10.1038/ng.696			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684UZ	21037568	Green Accepted, Green Submitted			2022-12-25	WOS:000284578800017
J	Kay, MA; He, CY; Chen, ZY				Kay, Mark A.; He, Cheng-Yi; Chen, Zhi-Ying			A robust system for production of minicircle DNA vectors	NATURE BIOTECHNOLOGY			English	Article							EXPRESSION IN-VIVO; ESCHERICHIA-COLI; GENE-THERAPY; INTEGRATION; RECOMBINATION; TRANSPORTER; CHROMOSOME; PERSISTENT; PROMOTER; GENOME	Minicircle DNA vectors allow sustained transgene expression in quiescent cells and tissues. To improve minicircle production, we genetically modified Escherichia coli to construct a producer strain that stably expresses a set of inducible minicircle-assembly enzymes, Phi C31 integrase and I-SceI homing endonuclease. This bacterial strain produces purified minicircles in a time frame and quantity similar to those of routine plasmid DNA preparation, making it feasible to use minicircles in place of plasmids in mammalian transgene expression studies.	[Kay, Mark A.; He, Cheng-Yi; Chen, Zhi-Ying] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Kay, Mark A.; He, Cheng-Yi; Chen, Zhi-Ying] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Kay, Mark A.; He, Cheng-Yi; Chen, Zhi-Ying] Stanford Univ, Sch Med, Ctr Clin Sci Res, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Kay, MA (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.	markay@stanford.edu; zychen98@stanford.edu		Kay, Mark/0000-0002-2799-2615	US National Institutes of Health [HL064274]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064274] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors would like to thank P. Valdmanis for critical review of the manuscript. This work was supported by the US National Institutes of Health - HL064274 (M.A.K.). Bacterial strain BW27783 was a gift of Jay D. Keasling of the University of California at Berkeley. Plasmid placY A177C was obtained from John E. Cronan at the University of Illinois.	Bigger BW, 2001, J BIOL CHEM, V276, P23018, DOI 10.1074/jbc.M010873200; Chen ZY, 2005, HUM GENE THER, V16, P126, DOI 10.1089/hum.2005.16.126; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Darquet AM, 1997, GENE THER, V4, P1341, DOI 10.1038/sj.gt.3300540; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Huang M, 2009, CIRCULATION, V120, pS230, DOI 10.1161/CIRCULATIONAHA.108.841155; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Mayrhofer P, 2008, J GENE MED, V10, P1253, DOI 10.1002/jgm.1243; Minaeva NI, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-63; Morgan-Kiss RM, 2002, P NATL ACAD SCI USA, V99, P7373, DOI 10.1073/pnas.122227599; Riu ER, 2007, MOL THER, V15, P1348, DOI 10.1038/sj.mt.6300177; Sallam KI, 2010, APPL ENVIRON MICROB, V76, P2531, DOI 10.1128/AEM.02131-09; Stoll SM, 2002, J BACTERIOL, V184, P3657, DOI 10.1128/JB.184.13.3657-3663.2002; Tan YD, 1999, HUM GENE THER, V10, P2153, DOI 10.1089/10430349950017149; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	18	213	251	2	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2010	28	12					1287	U96		10.1038/nbt.1708	http://dx.doi.org/10.1038/nbt.1708			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	691NP	21102455	Green Accepted			2022-12-25	WOS:000285088400022
J	Matzas, M; Stahler, PF; Kefer, N; Siebelt, N; Boisguerin, V; Leonard, JT; Keller, A; Stahler, CF; Haberle, P; Gharizadeh, B; Babrzadeh, F; Church, GM				Matzas, Mark; Staehler, Peer F.; Kefer, Nathalie; Siebelt, Nicole; Boisguerin, Valesca; Leonard, Jack T.; Keller, Andreas; Staehler, Cord F.; Haeberle, Pamela; Gharizadeh, Baback; Babrzadeh, Farbod; Church, George M.			High-fidelity gene synthesis by retrieval of sequence-verified DNA identified using high-throughput pyrosequencing	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; AMPLIFICATION; GENOME; PCR; GLUCURONIDASE; POLYMERASE; REMOVAL	The construction of synthetic biological systems involving millions of nucleotides is limited by the lack of high-quality synthetic DNA. Consequently, the field requires advances in the accuracy and scale of chemical DNA synthesis and in the processing of longer DNA assembled from short fragments. Here we describe a highly parallel and miniaturized method, called megacloning, for obtaining high-quality DNA by using next-generation sequencing (NGS) technology as a preparative tool. We demonstrate our method by processing both chemically synthesized and microarray-derived DNA oligonucleotides with a robotic system for imaging and picking beads directly off of a high-throughput pyrosequencing platform. The method can reduce error rates by a factor of 500 compared to the starting oligonucleotide pool generated by microarray. We use DNA obtained by megacloning to assemble synthetic genes. In principle, millions of DNA fragments can be sequenced, characterized and sorted in a single megacloner run, enabling constructive biology up to the megabase scale.	[Church, George M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Matzas, Mark; Staehler, Peer F.; Kefer, Nathalie; Siebelt, Nicole; Boisguerin, Valesca; Leonard, Jack T.; Keller, Andreas; Staehler, Cord F.; Haeberle, Pamela] Febit Grp, Heidelberg, Germany; [Gharizadeh, Baback; Babrzadeh, Farbod] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Church, George M.] Wyss Inst Biol Inspired Engn, Boston, MA USA	Harvard University; Harvard Medical School; Stanford University	Church, GM (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	gmc@harvard.edu	Keller, Andreas/ABB-6412-2021	Keller, Andreas/0000-0002-5361-0895; church, george/0000-0001-6232-9969	NHGRI NIH HHS [P50 HG005550] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bang DH, 2008, NAT METHODS, V5, P37, DOI 10.1038/NMETH1136; Binkowski BF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni053; Carr PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh160; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; COUTEAUDIER Y, 1993, APPL ENVIRON MICROB, V59, P1767, DOI 10.1128/AEM.59.6.1767-1773.1993; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Fuhrmann M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni058; Gao XL, 2001, NUCLEIC ACIDS RES, V29, P4744, DOI 10.1093/nar/29.22.4744; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; JEFFERSON RA, 1986, P NATL ACAD SCI USA, V83, P8447, DOI 10.1073/pnas.83.22.8447; Kosuri S, 2010, NAT BIOTECHNOL, V28, P1295, DOI 10.1038/nbt.1716; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Menzella HG, 2005, NAT BIOTECHNOL, V23, P1171, DOI 10.1038/nbt1128; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Richmond KE, 2004, NUCLEIC ACIDS RES, V32, P5011, DOI 10.1093/nar/gkh793; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Smith J, 1997, P NATL ACAD SCI USA, V94, P6847, DOI 10.1073/pnas.94.13.6847; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; Willenbrock H, 2009, RNA, V15, P2028, DOI 10.1261/rna.1699809; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896	24	72	108	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2010	28	12					1291	U101		10.1038/nbt.1710	http://dx.doi.org/10.1038/nbt.1710			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	691NP	21113166	Green Submitted, Green Accepted			2022-12-25	WOS:000285088400023
J	Cohen, J; Looney, W				Cohen, Joshua; Looney, William			What is the value of oncology medicines?	NATURE BIOTECHNOLOGY			English	Article							OFF-LABEL USE; COST-EFFECTIVENESS; CANCER DRUGS; SURVIVAL; ACCESS; CHALLENGES	Coverage with evidence development (CED), rather than quality-adjusted-life-year (QALY) thresholds, offers the best way forward in balancing evidence-based policy for new oncology products with the needs of developers, payers, physicians and patients.	[Cohen, Joshua] Tufts Univ, Sch Med, Ctr Study Drug Dev, Boston, MA 02111 USA; [Looney, William] Pfizer, New York, NY USA	Tufts University; Pfizer	Cohen, J (corresponding author), Tufts Univ, Sch Med, Ctr Study Drug Dev, Boston, MA 02111 USA.							[Anonymous], NICE GUIDANCE; Clement FM, 2009, JAMA-J AM MED ASSOC, V302, P1437, DOI 10.1001/jama.2009.1409; Cohen J, 1996, J MED ETHICS, V22, P267, DOI 10.1136/jme.22.5.267; Cohen J, 2006, APPL HEALTH ECON HEA, V5, P177, DOI 10.2165/00148365-200605030-00004; Cohen J, 2009, MABS-AUSTIN, V1, P56, DOI 10.4161/mabs.1.1.7246; Cohen J, 2009, FOOD DRUG LAW J, V64, P391; DiMasi JA, 2007, J CLIN ONCOL, V25, P209, DOI 10.1200/JCO.2006.09.0803; Eckhouse S, 2008, MOL ONCOL, V2, P20, DOI 10.1016/j.molonc.2008.03.007; Eckhouse S, 2006, PLOS MED, V3, P994, DOI 10.1371/journal.pmed.0030267; Fojo T, 2009, JNCI-J NATL CANCER I, V101, P1044, DOI 10.1093/jnci/djp177; Gafni A, 2006, SOC SCI MED, V62, P2091, DOI 10.1016/j.socscimed.2005.10.023; Gatta G, 2000, CANCER-AM CANCER SOC, V89, P893, DOI 10.1002/1097-0142(20000815)89:4<893::AID-CNCR24>3.3.CO;2-0; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jonsson B, 2007, ANN ONCOL, V18, P2, DOI 10.1093/annonc/mdm096; Leighl NB, 2006, LUNG CANCER, V51, P115, DOI 10.1016/j.lungcan.2005.08.005; Leveque D, 2008, LANCET ONCOL, V9, P1102, DOI 10.1016/S1470-2045(08)70280-8; Markman M, 2008, J ONCOL PRACT, V4, P231, DOI 10.1200/JOP.0858505; Mason AR, 2009, EUR J CANCER, V45, P1188, DOI 10.1016/j.ejca.2008.11.040; Mohr PE, 2010, PHARMACOECONOMICS, V28, P153, DOI 10.2165/11531050-000000000-00000; MULCAHY N, 2009, TIME CONSIDER COST E; NORD E, 1995, MED DECIS MAKING, V15, P201, DOI 10.1177/0272989X9501500302; Raftery J, 1999, J EVAL CLIN PRACT, V5, P361, DOI 10.1046/j.1365-2753.1999.00179.x; REICHERT J, 2008, J DRUG DISCOV TODAY, V13, P30; Schiller JH, 2005, CLIN CANCER RES, V11, p5030S, DOI 10.1158/1078-0432.CCR-05-9003; SINGER P, 2009, NY TIMES MAGAZI 0719; Tangka FK, 2010, CANCER-AM CANCER SOC, V116, P3477, DOI 10.1002/cncr.25150; Teutsch SM, 2005, HEALTH AFFAIR, V24, P128, DOI 10.1377/hlthaff.24.1.128; Tsuchiya A, 2000, HEALTH ECON, V9, P57, DOI 10.1002/(SICI)1099-1050(200001)9:1<57::AID-HEC484>3.0.CO;2-N; Verdecchia A, 2008, EUR J PUBLIC HEALTH, V18, P527, DOI 10.1093/eurpub/ckn022; Verdecchia A, 2007, LANCET ONCOL, V8, P784, DOI 10.1016/S1470-2045(07)70246-2; Yabroff KR, 2009, JNCI-J NATL CANCER I, V101, P1161, DOI 10.1093/jnci/djp258; CDC FASTSTATS; 2009, PFIZERS SUTENT IS RE	33	12	12	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2010	28	11					1160	1163		10.1038/nbt1110-1160	http://dx.doi.org/10.1038/nbt1110-1160			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology	676PI	21057481				2022-12-25	WOS:000283924100013
J	Deshpande, DA; Wang, WCH; McIlmoyle, EL; Robinett, KS; Schillinger, RM; An, SS; Sham, JSK; Liggett, SB				Deshpande, Deepak A.; Wang, Wayne C. H.; McIlmoyle, Elizabeth L.; Robinett, Kathryn S.; Schillinger, Rachel M.; An, Steven S.; Sham, James S. K.; Liggett, Stephen B.			Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction	NATURE MEDICINE			English	Article							CELLS; CONTRACTILITY; HETEROGENEITY; RELAXATION; EXPRESSION; LACTONES; CHANNELS; SPARKS; ASTHMA	Bitter taste receptors (TAS2Rs) on the tongue probably evolved to evoke signals for avoiding ingestion of plant toxins. We found expression of TAS2Rs on human airway smooth muscle (ASM) and considered these to be avoidance receptors for inhalants that, when activated, lead to ASM contraction and bronchospasm. TAS2R agonists such as saccharin, chloroquine and denatonium evoked increased intracellular calcium ([Ca2+](i)) in ASM in a G beta gamma-, phospholipase C beta (PLC beta)-and inositol trisphosphate (IP3) receptor-dependent manner, which would be expected to evoke contraction. Paradoxically, bitter tastants caused relaxation of isolated ASM and dilation of airways that was threefold greater than that elicited by beta-adrenergic receptor agonists. The relaxation induced by TAS2Rs is associated with a localized [Ca2+](i) response at the cell membrane, which opens large-conductance Ca2+-activated K+ (BKCa) channels, leading to ASM membrane hyperpolarization. Inhaled bitter tastants decreased airway obstruction in a mouse model of asthma. Given the need for efficacious bronchodilators for treating obstructive lung diseases, this pathway can be exploited for therapy with the thousands of known synthetic and naturally occurring bitter tastants.	[Deshpande, Deepak A.; Wang, Wayne C. H.; McIlmoyle, Elizabeth L.; Robinett, Kathryn S.; Schillinger, Rachel M.; Liggett, Stephen B.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [An, Steven S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Sham, James S. K.] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; [Liggett, Stephen B.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore	Liggett, SB (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.	sligg001@umaryland.edu	liggett, stephen b/E-7453-2012; An, Steven/AAM-3848-2020	An, Steven/0000-0003-4723-1888; Liggett, Stephen B./0000-0002-0128-3669; Sham, James/0000-0002-3571-8712	US National Heart, Lung, and Blood Institute [HL104119, HL045967, HL071609, HL071835, HL075134, HL087560]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071835, R01HL045967, R01HL075134, R56HL071835, R37HL045967, R01HL104119, K99HL087560, R01HL071609, R00HL087560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041265] Funding Source: NIH RePORTER	US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by US National Heart, Lung, and Blood Institute grants HL104119 (to W.C.H.W.), HL045967 and HL071609 (to S.B.L.), HL071835 and HL075134 (to J.S.K.S.) and HL087560 (to D.A.D.).	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; An SS, 2006, AM J RESP CELL MOL, V35, P55, DOI 10.1165/rcmb.2005-0453OC; Baxter DF, 2002, J BIOMOL SCREEN, V7, P79, DOI 10.1177/108705710200700110; Billington CK, 2003, RESP RES, V4; Bosse Y, 2007, PHYSIOL GENOMICS, V29, P161, DOI 10.1152/physiolgenomics.00134.2006; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535; Einstein R, 2008, P NATL ACAD SCI USA, V105, P5230, DOI 10.1073/pnas.0801319105; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; GREEN SA, 1996, GENETICS ASTHMA, P67; Kotlikoff MI, 1996, ANNU REV PHYSIOL, V58, P115, DOI 10.1146/annurev.ph.58.030196.000555; LIGGETT SB, 1989, MOL PHARMACOL, V36, P641; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombardo LJ, 2000, ENVIRON HEALTH PERSP, V108, P697, DOI 10.2307/3454406; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; Martin G, 2008, EXP PHYSIOL, V93, P908, DOI 10.1113/expphysiol.2008.042432; McGraw DW, 2007, J CLIN INVEST, V117, P1391, DOI 10.1172/JCI30489; McGraw DW, 2006, J CLIN INVEST, V116, P1400, DOI 10.1172/JCI25840; Meyerhof W, 2005, REV PHYSIOL BIOCH P, V154, P37, DOI 10.1007/s10254-005-0041-0; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Misior AM, 2009, AM J RESP CELL MOL, V41, P24, DOI 10.1165/rcmb.2008-0266OC; Morin C, 2007, AM J PHYSIOL-LUNG C, V293, pL1037, DOI 10.1152/ajplung.00145.2007; Panebra A, 2007, AM J PHYSIOL-LUNG C, V293, pL453, DOI 10.1152/ajplung.00084.2007; Sbarbati A, 2009, ANAT REC, V292, P439, DOI 10.1002/ar.20866; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Small KM, 2004, P NATL ACAD SCI USA, V101, P13020, DOI 10.1073/pnas.0405074101; Vignola AM, 1998, LUNG BIOL HEALTH DIS, V115, P139; Yang XR, 2005, AM J PHYSIOL-LUNG C, V289, pL338, DOI 10.1152/ajplung.00328.2004; Zhang WM, 2003, AM J PHYSIOL-LUNG C, V285, pL680, DOI 10.1152/ajplung.00067.2003	33	436	469	6	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1299	U8		10.1038/nm.2237	http://dx.doi.org/10.1038/nm.2237			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	20972434	Green Accepted			2022-12-25	WOS:000283860100042
J	Fujimoto, A; Nakagawa, H; Hosono, N; Nakano, K; Abe, T; Boroevich, KA; Nagasaki, M; Yamaguchi, R; Shibuya, T; Kubo, M; Miyano, S; Nakamura, Y; Tsunoda, T				Fujimoto, Akihiro; Nakagawa, Hidewaki; Hosono, Naoya; Nakano, Kaoru; Abe, Tetsuo; Boroevich, Keith A.; Nagasaki, Masao; Yamaguchi, Rui; Shibuya, Tetsuo; Kubo, Michiaki; Miyano, Satoru; Nakamura, Yusuke; Tsunoda, Tatsuhiko			Whole-genome sequencing and comprehensive variant analysis of a Japanese individual using massively parallel sequencing	NATURE GENETICS			English	Article							COPY-NUMBER; SHORT-READ; RARE VARIANTS; GENE; SNPS; SUSCEPTIBILITY; ASSOCIATION; GENERATION; ALIGNMENT; ALLELE	We report the analysis of a Japanese male using high-throughput sequencing to x40 coverage. More than 99% of the sequence reads were mapped to the reference human genome. Using a Bayesian decision method, we identified 3,132,608 single nucleotide variations (SNVs). Comparison with six previously reported genomes revealed an excess of singleton nonsense and nonsynonymous SNVs, as well as singleton SNVs in conserved non-coding regions. We also identified 5,319 deletions smaller than 10 kb with high accuracy, in addition to copy number variations and rearrangements. De novo assembly of the unmapped sequence reads generated around 3 Mb of novel sequence, which showed high similarity to non-reference human genomes and the human herpesvirus 4 genome. Our analysis suggests that considerable variation remains undiscovered in the human genome and that whole-genome sequencing is an invaluable tool for obtaining a complete understanding of human genetic variation.	[Fujimoto, Akihiro; Nakagawa, Hidewaki; Hosono, Naoya; Nakano, Kaoru; Abe, Tetsuo; Boroevich, Keith A.; Kubo, Michiaki; Nakamura, Yusuke; Tsunoda, Tatsuhiko] RIKEN, Ctr Genom Med, Yokohama, Kanagawa, Japan; [Fujimoto, Akihiro; Miyano, Satoru; Tsunoda, Tatsuhiko] RIKEN, Computat Sci Res Program, Data Anal Fus Team, Tokyo, Japan; [Nagasaki, Masao; Yamaguchi, Rui; Shibuya, Tetsuo; Miyano, Satoru; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, Tokyo, Japan	RIKEN; RIKEN; University of Tokyo	Tsunoda, T (corresponding author), RIKEN, Ctr Genom Med, Yokohama, Kanagawa, Japan.	hidewaki@ims.u-tokyo.ac.jp; tsunoda@src.riken.jp	Kubo, Michiaki/N-7947-2015; Tsunoda, Tatsuhiko/K-2061-2014	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Boroevich, Keith/0000-0001-7095-7332; Nagasaki, Masao/0000-0002-4292-8785; Miyano, Satoru/0000-0002-1753-6616	Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank K.Misawa for comments on the manuscript. This study was supported in part by the National Project on 'Next-generation Integrated Living Matter Simulation' of the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The super-computing resource was provided by the Human Genome Center, University of Tokyo, Japan (http://sc.hgc.jp/shirokane.html).	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Hillier LW, 2005, NATURE, V434, P724, DOI 10.1038/nature03466; Hirayasu K, 2008, AM J HUM GENET, V82, P1075, DOI 10.1016/j.ajhg.2008.03.012; Hosono N, 2009, CLIN CHEM, V55, P1546, DOI 10.1373/clinchem.2009.123620; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Kruglyak L, 2008, NAT REV GENET, V9, P314, DOI 10.1038/nrg2316; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Menashe I, 2007, PLOS BIOL, V5, P2462, DOI 10.1371/journal.pbio.0050284; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qin J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn518; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Torkar M, 2000, EUR J IMMUNOL, V30, P3655, DOI 10.1002/1521-4141(200012)30:12<3655::AID-IMMU3655>3.0.CO;2-Y; Tsend-Ayush E, 2004, GENOMICS, V83, P193, DOI 10.1016/j.ygeno.2003.08.012; Tsunoda T, 2004, HUM MOL GENET, V13, P1623, DOI 10.1093/hmg/ddh177; Tucker T, 2009, AM J HUM GENET, V85, P142, DOI 10.1016/j.ajhg.2009.06.022; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang JZ, 2000, J MOL EVOL, V50, P56, DOI 10.1007/s002399910007	49	82	90	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					931	U39		10.1038/ng.691	http://dx.doi.org/10.1038/ng.691			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20972442				2022-12-25	WOS:000283540500009
J	Kobayashi, H; Butler, JM; O'Donnell, R; Kobayashi, M; Ding, BS; Bonner, B; Chiu, VK; Nolan, DJ; Shido, K; Benjamin, L; Rafii, S				Kobayashi, Hideki; Butler, Jason M.; O'Donnell, Rebekah; Kobayashi, Mariko; Ding, Bi-Sen; Bonner, Bryant; Chiu, Vi K.; Nolan, Daniel J.; Shido, Koji; Benjamin, Laura; Rafii, Shahin			Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells	NATURE CELL BIOLOGY			English	Article							EX-VIVO EXPANSION; VASCULAR NICHE; GROWTH-FACTOR; ANGIOGENESIS; REGENERATION	Endothelial cells establish an instructive vascular niche that reconstitutes haematopoietic stem and progenitor cells (HSPCs) through release of specific paracrine growth factors, known as angiocrine factors. However, the mechanism by which endothelial cells balance the rate of proliferation and lineage-specific differentiation of HSPCs is unknown. Here, we demonstrate that Akt activation in endothelial cells, through recruitment of mTOR, but not the FoxO pathway, upregulates specific angiocrine factors that support expansion of CD34-F1t3-KLS HSPCs with long-term haematopoietic stem cell (LT-HSC) repopulation capacity. Conversely, co-activation of Akt-stimulated endothelial cells with p42/44 MAPK shifts the balance towards maintenance and differentiation of the HSPCs. Selective activation of Akt1 in the endothelial cells of adult mice increased the number of colony forming units in the spleen and CD34-F1t3- KLS HSPCs with LT-HSC activity in the bone marrow, accelerating haematopoietic recovery. Therefore, the activation state of endothelial cells modulates reconstitution of HSPCs through the modulation of angiocrine factors, with Akt mTOR-activated endothelial cells supporting the self-renewal of LT-HSCs and expansion of HSPCs, whereas MAPK co-activation favours maintenance and lineagespecific differentiation of HSPCs.	[Kobayashi, Hideki; Butler, Jason M.; Kobayashi, Mariko; Ding, Bi-Sen; Bonner, Bryant; Chiu, Vi K.; Nolan, Daniel J.; Shido, Koji; Rafii, Shahin] Weill Cornell Med Coll, Howard Hughes Med Inst, Ansary Stem Cell Inst, Dept Med Genet, New York, NY 10065 USA; [O'Donnell, Rebekah; Benjamin, Laura] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Rafii, Shahin] Shahin Rafii MD Weill Cornell Med Coll, New York, NY 10065 USA	Cornell University; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Rafii, S (corresponding author), Weill Cornell Med Coll, Howard Hughes Med Inst, Ansary Stem Cell Inst, Dept Med Genet, New York, NY 10065 USA.	srafii@med.cornell.edu		O'Donnell, Rebekah/0000-0001-5878-7510	Howard Hughes Medical Institute; Ansary Stem Cell Institute; National Institute of Health [HL097797, U01 HL66592-03, RC1 AI080309]; Qatar National Priorities Research Program; Anbinder and Newmans Own Foundations; Empire State Stem Cell Board; New York State Department of Health [NYS C024180]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066952, P01HL059312, R01HL097797, P50HL084936, R01HL075234, R21HL083222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI080309] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ansary Stem Cell Institute; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Qatar National Priorities Research Program(Qatar National Research Fund (QNRF)); Anbinder and Newmans Own Foundations; Empire State Stem Cell Board; New York State Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	S.R. is supported by Howard Hughes Medical Institute; Ansary Stem Cell Institute; National Institute of Health grants HL097797, U01 HL66592-03, RC1 AI080309; Qatar National Priorities Research Program; Anbinder and Newmans Own Foundations; Empire State Stem Cell Board and the New York State Department of Health grant NYS C024180. We thank G. Lam (Weill Cornell Medical College) for HUVEC culture.	Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Dimmeler S, 2000, CIRC RES, V86, P4, DOI 10.1161/01.RES.86.1.4; DING B, 2010, NATURE; Fernandez L, 2008, EXP HEMATOL, V36, P545, DOI 10.1016/j.exphem.2007.12.012; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Goldman DC, 2009, BLOOD, V114, P4393, DOI 10.1182/blood-2009-02-206433; Han W, 2000, BLOOD, V95, P1616, DOI 10.1182/blood.V95.5.1616.005k31_1616_1625; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; Huynh HD, 2008, STEM CELLS, V26, P1628, DOI 10.1634/stemcells.2008-0064; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; KOL LET, 2006, Nat Med, V12, P657; Kopp HG, 2006, J CLIN INVEST, V116, P3277, DOI 10.1172/JCI29314; Kopp HG, 2005, BLOOD, V106, P505, DOI 10.1182/blood-2004-11-4269; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Matsunaga T, 1998, BLOOD, V92, P452, DOI 10.1182/blood.V92.2.452.414k09_452_461; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Pages G, 2000, ANN NY ACAD SCI, V902, P187; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; RAFII S, 1994, BLOOD, V84, P10; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Sun JF, 2005, P NATL ACAD SCI USA, V102, P128, DOI 10.1073/pnas.0403198102; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Yeoh JSG, 2006, STEM CELLS, V24, P1564, DOI 10.1634/stemcells.2005-0439; Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	39	275	286	3	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2010	12	11					1046	U32		10.1038/ncb2108	http://dx.doi.org/10.1038/ncb2108			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	674CO	20972423	Green Accepted			2022-12-25	WOS:000283711500007
J	Wong, CC; Loewke, KE; Bossert, NL; Behr, B; De Jonge, CJ; Baer, TM; Pera, RAR				Wong, Connie C.; Loewke, Kevin E.; Bossert, Nancy L.; Behr, Barry; De Jonge, Christopher J.; Baer, Thomas M.; Pera, Renee A. Reijo			Non-invasive imaging of human embryos before embryonic genome activation predicts development to the blastocyst stage	NATURE BIOTECHNOLOGY			English	Article							HUMAN PREIMPLANTATION EMBRYOS; CELL-FATE DECISIONS; GENE-EXPRESSION; ASSISTED REPRODUCTION; TIME; CLEAVAGE; QUALITY; RATES; PREGNANCY; RNA	We report studies of preimplantation human embryo development that correlate time-lapse image analysis and gene expression profiling. By examining a large set of zygotes from in vitro fertilization (IVF), we find that success in progression to the blastocyst stage can be predicted with >93% sensitivity and specificity by measuring three dynamic, noninvasive imaging parameters by day 2 after fertilization, before embryonic genome activation (EGA). These parameters can be reliably monitored by automated image analysis, confirming that successful development follows a set of carefully orchestrated and predictable events. Moreover, we show that imaging phenotypes reflect molecular programs of the embryo and of individual blastomeres. Single-cell gene expression analysis reveals that blastomeres develop cell autonomously, with some cells advancing to EGA and others arresting. These studies indicate that success and failure in human embryo development is largely determined before EGA. Our methods and algorithms may provide an approach for early diagnosis of embryo potential in assisted reproduction.	[Wong, Connie C.; Loewke, Kevin E.; Pera, Renee A. Reijo] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Wong, Connie C.; Loewke, Kevin E.; Behr, Barry; Pera, Renee A. Reijo] Stanford Univ, Dept Obstet & Gynecol, Sch Med, Stanford, CA 94305 USA; [Loewke, Kevin E.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Bossert, Nancy L.; De Jonge, Christopher J.] Univ Minnesota, Reprod Med Ctr, Minneapolis, MN USA; [Baer, Thomas M.] Stanford Univ, Dept Appl Phys, Stanford Photon Res Ctr, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; University of Minnesota System; University of Minnesota Twin Cities; Stanford University	Pera, RAR (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA.	reneer@stanford.edu		De Jonge, Christopher/0000-0002-4083-5833	Stanford Institute for Stem Cell Biology and Regenerative Medicine [6-FY06-326]	Stanford Institute for Stem Cell Biology and Regenerative Medicine	We thank R. Raja for help with the microarray analysis and early imaging experiments, the members of the Reijo Pera laboratory for technical assistance and discussions, S. Walker for advice regarding the cell tracking algorithm and K. Salisbury for providing K. E. L. with hardware and software resources. We acknowledge funding contributions from the Stanford Institute for Stem Cell Biology and Regenerative Medicine, a generous, anonymous donor and the March of Dimes (6-FY06-326).	Adjaye J, 1999, GENE, V237, P373, DOI 10.1016/S0378-1119(99)00329-7; Assou S, 2006, HUM REPROD, V21, P1705, DOI 10.1093/humrep/del065; Baltaci V, 2006, REPROD BIOMED ONLINE, V12, P77, DOI 10.1016/S1472-6483(10)60984-4; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Beaujean N, 2004, BIOL REPROD, V71, P185, DOI 10.1095/biolreprod.103.026559; Bermudez M, 2004, REPROD BIOMED ONLINE, V8, P325, DOI 10.1016/S1472-6483(10)60913-3; Bettegowda A, 2007, FRONT BIOSCI-LANDMRK, V12, P3713, DOI 10.2741/2346; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Cohen AR, 2010, NAT METHODS, V7, P213, DOI [10.1038/NMETH.1424, 10.1038/nmeth.1424]; Damario MA, 1999, FERTIL STERIL, V72, P1049, DOI 10.1016/S0015-0282(99)00444-6; Dobson AT, 2004, HUM MOL GENET, V13, P1461, DOI 10.1093/hmg/ddh157; Duranthon V, 2008, REPRODUCTION, V135, P141, DOI 10.1530/REP-07-0324; Evers JLH, 2002, LANCET, V360, P151, DOI 10.1016/S0140-6736(02)09417-5; Fenwick J, 2002, HUM REPROD, V17, P407, DOI 10.1093/humrep/17.2.407; Fino E, 2005, FERTIL STERIL, V84, pS98, DOI 10.1016/j.fertnstert.2005.07.237; Foygel K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004109; French DB, 2010, FERTIL STERIL, V93, P1097, DOI 10.1016/j.fertnstert.2008.10.051; Fulka H, 2004, REPRODUCTION, V128, P703, DOI 10.1530/rep.1.00217; Gardner David K, 2003, Reprod Biomed Online, V6, P470; Gardner DK, 2004, FERTIL STERIL, V81, P551, DOI 10.1016/j.fertnstert.2003.07.023; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Gardner DK, 2000, HUM REPROD, V15, P9; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hiiragi T, 2006, NATURE, V442, pE3, DOI 10.1038/nature04907; Horsthemke B, 2005, HUM REPROD UPDATE, V11, P473, DOI 10.1093/humupd/dmi022; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Kearns WG, 2006, FERTIL STERIL, V86, pS474, DOI 10.1016/j.fertnstert.2006.07.1309; Kiessling AA, 2009, J ASSIST REPROD GEN, V26, P187, DOI 10.1007/s10815-009-9306-x; Kimber SJ, 2008, REPRODUCTION, V135, P635, DOI 10.1530/REP-07-0359; Kocabas AM, 2006, P NATL ACAD SCI USA, V103, P14027, DOI 10.1073/pnas.0603227103; Lemmen JG, 2008, REPROD BIOMED ONLINE, V17, P385, DOI 10.1016/S1472-6483(10)60222-2; Liebermann Juergen, 2002, Reprod Biomed Online, V4, P146; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundin K, 2001, HUM REPROD, V16, P2652, DOI 10.1093/humrep/16.12.2652; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; Manipalviratn S, 2009, FERTIL STERIL, V91, P305, DOI 10.1016/j.fertnstert.2009.01.002; Memili E, 2000, ZYGOTE, V8, P87, DOI 10.1017/S0967199400000861; Milki AA, 2000, FERTIL STERIL, V73, P126, DOI 10.1016/S0015-0282(99)00485-9; MILLER KF, 1995, OBSTET GYNECOL, V85, P999, DOI 10.1016/0029-7844(95)00084-5; NAGY ZP, 1994, HUM REPROD, V9, P1743, DOI 10.1093/oxfordjournals.humrep.a138786; Niemitz EL, 2004, AM J HUM GENET, V74, P599, DOI 10.1086/382897; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; Payne D, 1997, HUM REPROD, V12, P532; Plusa B, 2005, NATURE, V434, P391, DOI 10.1038/nature03388; Racowsky C, 2002, THERIOGENOLOGY, V57, P87, DOI 10.1016/S0093-691X(01)00659-8; Rienzi L, 2005, REPROD BIOMED ONLINE, V10, P669, DOI 10.1016/S1472-6483(10)61676-8; Sathananthan AH, 1999, HUM REPROD UPDATE, V5, P553, DOI 10.1093/humupd/5.5.553; Schatten H, 2010, SEMIN CELL DEV BIOL, V21, P174, DOI 10.1016/j.semcdb.2010.01.012; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Tarin JJ, 1999, REPROD FERT DEVELOP, V11, P273, DOI 10.1071/RD99057; Vajta G, 2009, REPROD BIOMED ONLINE, V19, P1, DOI 10.1016/S1472-6483(10)60278-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; VEECK LL, 1993, FERTIL STERIL, V59, P1202; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038; Zernicka-Goetz M, 2002, DEVELOPMENT, V129, P815; Zernicka-Goetz M, 2006, CURR OPIN GENET DEV, V16, P406, DOI 10.1016/j.gde.2006.06.011; Zhang JQ, 2010, REPROD BIOMED ONLINE, V20, P510, DOI 10.1016/j.rbmo.2009.12.027	60	511	550	2	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2010	28	10					1115	U199		10.1038/nbt.1686	http://dx.doi.org/10.1038/nbt.1686			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	663GF	20890283				2022-12-25	WOS:000282870500034
J	Zhou, YF; Kawasaki, H; Hsu, SC; Lee, RT; Yao, X; Plunkett, B; Fu, JR; Yang, K; Lee, YC; Huang, SK				Zhou, Yufeng; Kawasaki, Hirokazu; Hsu, Shih-Chang; Lee, Reiko T.; Yao, Xu; Plunkett, Beverly; Fu, Jinrong; Yang, Kuender; Lee, Yuan C.; Huang, Shau-Ku			Oral tolerance to food-induced systemic anaphylaxis mediated by the C-type lectin SIGNR1	NATURE MEDICINE			English	Article							INTESTINAL LAMINA PROPRIA; MESENTERIC LYMPH-NODES; REGULATORY T-CELLS; DENDRITIC CELLS; DC-SIGN; PATHOGEN RECOGNITION; IMMUNE REGULATION; RETINOIC-ACID; ANTIGEN; INTERLEUKIN-10	We propose that a C-type lectin receptor, SIGNR-1 (also called Cd209b), helps to condition dendritic cells (DCs) in the gastrointestinal lamina propria (LPDCs) for the induction of oral tolerance in a model of food-induced anaphylaxis. Oral delivery of BSA bearing 51 molecules of mannoside (Man(51)-BSA) substantially reduced the BSA-induced anaphylactic response. Man(51)-BSA selectively targeted LPDCs that expressed SIGNR1 and induced the expression of interleukin-10 (IL-10), but not IL-6 or IL-12 p70. We found the same effects in IL-10-GFP knock-in (tiger) mice treated with Man(51)-BSA. The Man(51)-BSA-SIGNR1 axis in LPDCs, both in vitro and in vivo, promoted the generation of CD4(+) type 1 regulatory T (Tr1)-like cells that expressed IL-10 and interferon-gamma (IFN-gamma), in a SIGNR-1-and IL-10-dependent manner, but not of CD4(+)CD25(+)Foxp3(+) regulatory T cells. The Tr1-like cells could transfer tolerance. These results suggest that sugar-modified antigens might be used to induce oral tolerance by targeting SIGNR1 and LPDCs.	[Zhou, Yufeng; Kawasaki, Hirokazu; Hsu, Shih-Chang; Yao, Xu; Plunkett, Beverly; Fu, Jinrong; Huang, Shau-Ku] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA; [Lee, Reiko T.; Lee, Yuan C.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Yao, Xu] Chinese Acad Med Sci, Inst Dermatol, Nanjing, Peoples R China; [Yang, Kuender] Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Huang, Shau-Ku] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung, Taiwan; [Huang, Shau-Ku] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Chang Gung Memorial Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Huang, SK (corresponding author), Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA.	skhuang@jhmi.edu	zhou, yufeng/G-6429-2010; Huang, Shau-Ku/F-5509-2010; Hsu, Shih-Chang/I-4277-2012	Hsu, Shih-Chang/0000-0003-1010-1182; zhou, Yufeng/0000-0002-6050-4951	US National Institutes of Health [AI052468, AI073610]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052468, R21AI073610] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Myers and H. Rohde for technical assistance; K. Takahara (Kyoto University) for SIGNR1-transfectant cells; and the Consortium for Functional Glycomics for SIGNR1-deficient mice. This work was supported, in part, by US National Institutes of Health grants (AI052468 and AI073610).	Arslanoglu S, 2008, J NUTR, V138, P1091, DOI 10.1093/jn/138.6.1091; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Bashir MEH, 2002, J IMMUNOL, V169, P3284, DOI 10.4049/jimmunol.169.6.3284; Bilsborough J, 2003, IMMUNOLOGY, V108, P481, DOI 10.1046/j.1365-2567.2003.01606.x; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Cambi A, 2005, CURR OPIN IMMUNOL, V17, P345, DOI 10.1016/j.coi.2005.05.011; Chehade M, 2005, J ALLERGY CLIN IMMUN, V115, P3, DOI 10.1016/j.jaci.2004.11.008; Chirdo FG, 2005, EUR J IMMUNOL, V35, P1831, DOI 10.1002/eji.200425882; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P506, DOI 10.1016/j.jaci.2007.07.033; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Galustian C, 2004, INT IMMUNOL, V16, P853, DOI 10.1093/intimm/dxh089; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Hsu SC, 2010, J BIOL CHEM, V285, P7903, DOI 10.1074/jbc.M109.058370; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Koppel EA, 2005, CELL MICROBIOL, V7, P157, DOI 10.1111/J.1462-5822.2004.00480.x; LEE RT, 1997, GLYCOPROTEINS, V2, P601; McGreal EP, 2005, CURR OPIN IMMUNOL, V17, P18, DOI 10.1016/j.coi.2004.12.001; Mine Y, 2008, J AGR FOOD CHEM, V56, P4874, DOI 10.1021/jf8001153; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Numazaki M, 2009, BIOCHEM BIOPH RES CO, V386, P202, DOI 10.1016/j.bbrc.2009.06.011; Poulsen LK, 2005, ALLERGY, V60, P549, DOI 10.1111/j.1398-9995.2005.00821.x; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Roy K, 1999, NAT MED, V5, P387, DOI 10.1038/7385; Spahn TW, 2002, EUR J IMMUNOL, V32, P1109, DOI 10.1002/1521-4141(200204)32:4<1109::AID-IMMU1109>3.3.CO;2-B; Stowell C P, 1980, Adv Carbohydr Chem Biochem, V37, P225; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Taams LS, 2006, IMMUNOLOGY, V118, P1, DOI 10.1111/j.1365-2567.2006.02348.x; Takahara K, 2004, INT IMMUNOL, V16, P819, DOI 10.1093/intimm/dxh084; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016	39	101	102	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2010	16	10					1128	U105		10.1038/nm.2201	http://dx.doi.org/10.1038/nm.2201			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20835248	Green Accepted			2022-12-25	WOS:000282644800043
J	Ellis, LM; Fidler, IJ				Ellis, Lee M.; Fidler, Isaiah J.			Therapy fails, patients don't	NATURE MEDICINE			English	Editorial Material							METASTATIC COLORECTAL-CANCER; LUNG-CANCER; BEVACIZUMAB; TRIAL; CHEMOTHERAPY; MUTATIONS; GEFITINIB; CETUXIMAB; KINASE; TUMOR		[Ellis, Lee M.; Fidler, Isaiah J.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Ellis, Lee M.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ellis, LM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	lellis@mdanderson.org; ifidler@mdanderson.org						Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Hecht JR, 2009, J CLIN ONCOL, V27, P672, DOI 10.1200/JCO.2008.19.8135; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Saltz LB, 2007, J CLIN ONCOL, V25, P4557, DOI 10.1200/JCO.2007.12.0949; Shaheen RM, 2001, BRIT J CANCER, V85, P584, DOI 10.1054/bjoc.2001.1936; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; TALMADGE JE, 2010, J CANC RES, V70, P5649; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268	12	81	82	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2010	16	9					974	975		10.1038/nm0910-974	http://dx.doi.org/10.1038/nm0910-974			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20823880				2022-12-25	WOS:000281622900023
J	Hoffenberg, HL				Hoffenberg, Howard Leslie			Will the patentability of genes survive?	NATURE BIOTECHNOLOGY			English	Editorial Material									IP Law Off Howard L Hoffenberg, Los Angeles, CA USA		Hoffenberg, HL (corresponding author), IP Law Off Howard L Hoffenberg, Los Angeles, CA USA.	howard@ipcounselor.com							0	4	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	SEP	2010	28	9					925	927		10.1038/nbt0910-925	http://dx.doi.org/10.1038/nbt0910-925			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	648UF	20829827				2022-12-25	WOS:000281719100015
J	Delaval, B; Bright, A; Lawson, ND; Doxsey, S				Delaval, Benedicte; Bright, Alison; Lawson, Nathan D.; Doxsey, Stephen			The cilia protein IFT88 is required for spindle orientation in mitosis	NATURE CELL BIOLOGY			English	Article							POLYCYSTIC KIDNEY-DISEASE; PLANAR CELL POLARITY; INTRAFLAGELLAR TRANSPORT; CYTOPLASMIC DYNEIN; CYSTIC KIDNEY; GAMMA-TUBULIN; CHROMOSOME ALIGNMENT; MAMMALIAN-CELLS; MITOTIC SPINDLE; MOTOR PROTEINS	Cilia dysfunction has long been associated with cyst formation and ciliopathies(1). More recently, misoriented cell division has been observed in cystic kidneys(2), but the molecular mechanism leading to this abnormality remains unclear. Proteins of the intraflagellar transport (IFT) machinery are linked to cystogenesis and are required for cilia formation in non-cycling cells(3,4). Several IFT proteins also localize to spindle poles in mitosis(5-8), indicating uncharacterized functions for these proteins in dividing cells. Here, we show that IFT88 depletion induces mitotic defects in human cultured cells, in kidney cells from the IFT88 mouse mutant Tg737(orpk) and in zebrafish embryos. In mitosis, IFT88 is part of a dynein1-driven complex that transports peripheral microtubule clusters containing microtubule-nucleating proteins to spindle poles to ensure proper formation of astral microtubule arrays and thus proper spindle orientation. This work identifies a mitotic mechanism for a cilia protein in the orientation of cell division and has important implications for the etiology of ciliopathies.	[Delaval, Benedicte; Bright, Alison; Doxsey, Stephen] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Lawson, Nathan D.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Doxsey, S (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St,Suite 210, Worcester, MA 01605 USA.	Stephen.Doxsey@umassmed.edu		Lawson, Nathan/0000-0001-7788-9619	Diabetes Endocrinology Research Center [DK32520]; National Institutes of Health [GM51994]; Polycystic Kidney Disease Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM051994, R01GM051994] Funding Source: NIH RePORTER	Diabetes Endocrinology Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polycystic Kidney Disease Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Pazour, G. Witman and P. Wadsworth for thoughtful discussions on this work, and S. Redick for assistance with microscopy. We are particularly grateful to L. Covassin-Barberis in N.L. laboratory and N.L. Adkins in C. Peterson's laboratory for guidance on zebrafish experimental work and gel-filtration experiments, respectively. We thank G. Pazour for the gift of IFT88 antibody and GFP-IFT88 LLC-PK1, Flag-IFT52 IMCD stable cell lines, P. Wadsworth for the GFP-alpha-tubulin LLC-PK1 cell line and C. Desdouets, P. Denoulet and C. Janke for their gift of antibodies specific to IFT88 and polyglutamylated tubulin, respectively. Core resources supported by the Diabetes Endocrinology Research Center grant DK32520 were used; S.D. is a member of the UMass DERC (DK32520). This work was supported by financial support from the National Institutes of Health (GM51994) to S.D. and the Polycystic Kidney Disease Foundation to B.D.	CORTHESYTHEULAZ I, 1992, J CELL BIOL, V118, P1333, DOI 10.1083/jcb.118.6.1333; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Follit JA, 2009, CELL MOTIL CYTOSKEL, V66, P457, DOI 10.1002/cm.20346; Gaglio T, 1997, J CELL BIOL, V138, P1055, DOI 10.1083/jcb.138.5.1055; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Han YG, 2003, CURR BIOL, V13, P1679, DOI 10.1016/j.cub.2003.08.034; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; Haycraft CJ, 2001, DEVELOPMENT, V128, P1493; Hildebrandt F, 2005, NAT REV GENET, V6, P928, DOI 10.1038/nrg1727; Iomini C, 2004, J CELL BIOL, V164, P811, DOI 10.1083/jcb.200312133; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; Murcia NS, 2000, DEVELOPMENT, V127, P2347; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; Robert A, 2007, J CELL SCI, V120, P628, DOI 10.1242/jcs.03366; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Rusan NM, 2002, J CELL BIOL, V158, P997, DOI 10.1083/jcb.200204109; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Tulu US, 2006, CURR BIOL, V16, P536, DOI 10.1016/j.cub.2006.01.060; Tulu US, 2003, CURR BIOL, V13, P1894, DOI 10.1016/j.cub.2003.10.002; Vaisberg EA, 1996, J CELL BIOL, V133, P831, DOI 10.1083/jcb.133.4.831; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wheatley DN, 1995, PATHOBIOLOGY, V63, P222, DOI 10.1159/000163955; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	40	120	121	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2011	13	4					461	U262		10.1038/ncb2202	http://dx.doi.org/10.1038/ncb2202			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	744CK	21441926	Green Accepted, Green Submitted			2022-12-25	WOS:000289070900018
J	Bantscheff, M; Hopf, C; Savitski, MM; Dittmann, A; Grandi, P; Michon, AM; Schlegl, J; Abraham, Y; Becher, I; Bergamini, G; Boesche, M; Delling, M; Dumpelfeld, B; Eberhard, D; Huthmacher, C; Mathieson, T; Poeckel, D; Reader, V; Strunk, K; Sweetman, G; Kruse, U; Neubauer, G; Ramsden, NG; Drewes, G				Bantscheff, Marcus; Hopf, Carsten; Savitski, Mikhail M.; Dittmann, Antje; Grandi, Paola; Michon, Anne-Marie; Schlegl, Judith; Abraham, Yann; Becher, Isabelle; Bergamini, Giovanna; Boesche, Markus; Delling, Manja; Duempelfeld, Birgit; Eberhard, Dirk; Huthmacher, Carola; Mathieson, Toby; Poeckel, Daniel; Reader, Valerie; Strunk, Katja; Sweetman, Gavain; Kruse, Ulrich; Neubauer, Gitte; Ramsden, Nigel G.; Drewes, Gerard			Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes	NATURE BIOTECHNOLOGY			English	Article							HISTONE DEACETYLASE INHIBITORS; ORBITRAP MASS-SPECTROMETER; LYSINE ACETYLATION; CATALYTIC-ACTIVITY; PROTEIN COMPLEXES; SIN3 COMPLEX; IDENTIFICATION; CELL; PROTEOMICS; CHROMATIN	The development of selective histone deacetylase (HDAC) inhibitors with anti-cancer and anti-inflammatory properties remains challenging in large part owing to the difficulty of probing the interaction of small molecules with megadalton protein complexes. A combination of affinity capture and quantitative mass spectrometry revealed the selectivity with which 16 HDAC inhibitors target multiple HDAC complexes scaffolded by ELM-SANT domain subunits, including a novel mitotic deacetylase complex (MiDAC). Inhibitors clustered according to their target profiles with stronger binding of aminobenzamides to the HDAC NCoR complex than to the HDAC Sin3 complex. We identified several non-HDAC targets for hydroxamate inhibitors. HDAC inhibitors with distinct profiles have correspondingly different effects on downstream targets. We also identified the anti-inflammatory drug bufexamac as a class IIb (HDAC6, HDAC10) HDAC inhibitor. Our approach enables the discovery of novel targets and inhibitors and suggests that the selectivity of HDAC inhibitors should be evaluated in the context of HDAC complexes and not purified catalytic subunits.	[Bantscheff, Marcus; Hopf, Carsten; Savitski, Mikhail M.; Dittmann, Antje; Grandi, Paola; Michon, Anne-Marie; Schlegl, Judith; Abraham, Yann; Becher, Isabelle; Bergamini, Giovanna; Boesche, Markus; Delling, Manja; Duempelfeld, Birgit; Eberhard, Dirk; Huthmacher, Carola; Mathieson, Toby; Poeckel, Daniel; Strunk, Katja; Sweetman, Gavain; Kruse, Ulrich; Neubauer, Gitte; Drewes, Gerard] Cellzome AG, Heidelberg, Germany; [Reader, Valerie; Ramsden, Nigel G.] Cellzome Ltd, Cambridge, England	GlaxoSmithKline; Cellzome GmbH; GlaxoSmithKline; Cellzome GmbH	Bantscheff, M (corresponding author), Cellzome AG, Heidelberg, Germany.	marcus.bantscheff@cellzome.com; gerard.drewes@cellzome.com	Bantscheff, Marcus/AAQ-2903-2021; Hopf, Carsten/A-3275-2015	Bantscheff, Marcus/0000-0002-8343-8977; Hopf, Carsten/0000-0003-0802-6451; Drewes, Gerard/0000-0003-0575-6766; Becher, Isabelle/0000-0001-7170-2235; Abraham, Yann/0000-0001-5600-5896; Mathieson, Toby/0000-0002-6153-3113; Bergamini, Giovanna/0000-0002-9662-9502	German Bundesministerium fur Bildung und Forschung [INE-TP01]	German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the German Bundesministerium fur Bildung und Forschung (Spitzencluster BioRN, Verbundprojekt Inkubator/Teilprojekt INE-TP01) to Cellzome AG. We are grateful to N. Garcia-Altrieth, M. Jundt, M. Lottgers, J.-I. Huber, M. Klos-Hudak, J. Krause, B. Kroh, A. Podszuweit, T. Rudi and K. Weis for expert technical assistance, to C. Gemund and V. Wolowski for the development of software and database tools, and to F. Weisbrodt for help with the figures. We would like to thank T. Edwards, O. Rausch and D. Simmons for suggestions and support.	Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; Bantscheff M, 2008, MOL CELL PROTEOMICS, V7, P1702, DOI 10.1074/mcp.M800029-MCP200; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Bantscheff M, 2009, DRUG DISCOV TODAY, V14, P1021, DOI 10.1016/j.drudis.2009.07.001; Beckers T, 2007, INT J CANCER, V121, P1138, DOI 10.1002/ijc.22751; Blackwell L, 2008, LIFE SCI, V82, P1050, DOI 10.1016/j.lfs.2008.03.004; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Chou CJ, 2008, J BIOL CHEM, V283, P35402, DOI 10.1074/jbc.M807045200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cunliffe VT, 2008, CURR OPIN GENET DEV, V18, P404, DOI 10.1016/j.gde.2008.10.001; Farias EF, 2010, P NATL ACAD SCI USA, V107, P11811, DOI 10.1073/pnas.1006737107; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Jones P, 2008, BIOORG MED CHEM LETT, V18, P1814, DOI 10.1016/j.bmcl.2008.02.025; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Karberg S, 2009, CELL, V139, P1029, DOI 10.1016/j.cell.2009.11.038; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kocher T, 2009, J PROTEOME RES, V8, P4743, DOI 10.1021/pr900451u; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; Kubota T, 2007, GENES CELLS, V12, P941, DOI 10.1111/j.1365-2443.2007.01105.x; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Salisbury CM, 2007, P NATL ACAD SCI USA, V104, P1171, DOI 10.1073/pnas.0608659104; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Savitski MM, 2010, J PROTEOME RES, V9, P5511, DOI 10.1021/pr1006813; Savitski MM, 2010, J AM SOC MASS SPECTR, V21, P1668, DOI 10.1016/j.jasms.2010.01.012; Sharma K, 2009, NAT METHODS, V6, P741, DOI [10.1038/NMETH.1373, 10.1038/nmeth.1373]; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Smith KT, 2010, CHEM BIOL, V17, P65, DOI 10.1016/j.chembiol.2009.12.010; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Thingholm TE, 2010, J PROTEOME RES, V9, P4045, DOI 10.1021/pr100230q; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Trommer H, 2003, J PHARM PHARMACOL, V55, P1379, DOI 10.1211/002235703322461569; Wang L, 2008, EMBO REP, V9, P555, DOI 10.1038/embor.2008.67; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	50	487	520	10	170	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2011	29	3					255	U124		10.1038/nbt.1759	http://dx.doi.org/10.1038/nbt.1759			14	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	732RL	21258344				2022-12-25	WOS:000288206700021
J	Aagaard, C; Hoang, T; Dietrich, J; Cardona, PJ; Izzo, A; Dolganov, G; Schoolnik, GK; Cassidy, JP; Billeskov, R; Andersen, P				Aagaard, Claus; Hoang, Truc; Dietrich, Jes; Cardona, Pere-Joan; Izzo, Angelo; Dolganov, Gregory; Schoolnik, Gary K.; Cassidy, Joseph P.; Billeskov, Rolf; Andersen, Peter			A multistage tuberculosis vaccine that confers efficient protection before and after exposure	NATURE MEDICINE			English	Article							GUINEA-PIG MODEL; CD4 T-CELLS; MYCOBACTERIUM-TUBERCULOSIS; SUBUNIT VACCINE; GENE-EXPRESSION; ANTIGEN 85B; IMMUNE-RESPONSES; FUSION PROTEIN; HIV EPIDEMIC; BCG	All tuberculosis vaccines currently in clinical trials are designed as prophylactic vaccines based on early expressed antigens. We have developed a multistage vaccination strategy in which the early antigens Ag85B and 6-kDa early secretory antigenic target (ESAT-6) are combined with the latency-associated protein Rv2660c (H56 vaccine). In CB6F1 mice we show that Rv2660c is stably expressed in late stages of infection despite an overall reduced transcription. The H56 vaccine promotes a T cell response against all protein components that is characterized by a high proportion of polyfunctional CD4(+) T cells. In three different pre-exposure mouse models, H56 confers protective immunity characterized by a more efficient containment of late-stage infection than the Ag85B-ESAT6 vaccine (H1) and BCG. In two mouse models of latent tuberculosis, we show that H56 vaccination after exposure is able to control reactivation and significantly lower the bacterial load compared to adjuvant control mice.	[Aagaard, Claus; Hoang, Truc; Dietrich, Jes; Billeskov, Rolf; Andersen, Peter] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Cardona, Pere-Joan] Univ Autonoma Barcelona, Inst Invest Ciencies Salut Germans Trias & Pujol, Unitat TB Expt, Badalona, Catalonia, Spain; [Izzo, Angelo] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Dolganov, Gregory; Schoolnik, Gary K.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Cassidy, Joseph P.] Univ Coll Dublin, Sch Agr Food Sci & Vet Med, Vet Sci Ctr, Dublin 2, Ireland	Statens Serum Institut; Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Colorado State University; Stanford University; University College Dublin	Aagaard, C (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark.	caa@ssi.dk; pa@ssi.dk	Izzo, Angelo A/F-1229-2017; Cardona, Pere-Joan/A-5258-2011; Rivet, Catherine A/M-7978-2014	Izzo, Angelo A/0000-0003-3208-2330; Cardona, Pere-Joan/0000-0001-5623-7873; Andersen, Peter/0000-0002-5869-2551; Billeskov, Rolf/0000-0003-4533-7304; Cassidy, Joseph/0000-0002-9229-1831	Bill and Melinda Gates Foundation [37885]; EC [LSHP-CT-2003-503367]; US National Institutes of Health and National Institute of Allergy and Infectious Diseases [HHSN266200400091c]; TB Vaccine Testing and Research [NOI-AI-40091]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); EC(European CommissionEuropean Commission Joint Research Centre); US National Institutes of Health and National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); TB Vaccine Testing and Research	We thank the Bill and Melinda Gates Foundation (GC12 # 37885), EC-FP6: TB-VAC (LSHP-CT-2003-503367), the US National Institutes of Health and National Institute of Allergy and Infectious Diseases (HHSN266200400091c) and the TB Vaccine Testing and Research Materials Contract (NOI-AI-40091). Thanks to N. Caceres for her contribution on the model of latent tuberculosis, to L. Rasmussen, M. Henriksen, J. Brady and V. Andersen for excellent technical help and to E. M. Agger for critical reading of the manuscript.	Agger EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003116; Andersen P, 2007, NAT REV MICROBIOL, V5, P484, DOI 10.1038/nrmicro1703; Baldwin SL, 1998, INFECT IMMUN, V66, P2951, DOI 10.1128/IAI.66.6.2951-2959.1998; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Brandt L, 2000, INFECT IMMUN, V68, P791, DOI 10.1128/IAI.68.2.791-795.2000; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Butcher PD, 1998, METH MOL B, V101, P285, DOI 10.1385/0-89603-471-2:285; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Dietrich J, 2007, J IMMUNOL, V178, P3721, DOI 10.4049/jimmunol.178.6.3721; Doherty TM, 2007, EXPERT OPIN BIOL TH, V7, P1539, DOI 10.1517/14712598.7.10.1539; Dolganov GM, 2001, GENOME RES, V11, P1473, DOI 10.1101/gr.191301; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Fontan PA, 2008, J INFECT DIS, V198, P877, DOI 10.1086/591098; Govender L, 2010, VACCINE, V29, P51, DOI 10.1016/j.vaccine.2010.10.022; Heeney Jonathan L, 2006, Nat Immunol, V7, P1281, DOI 10.1038/ni1206-1281; HORWITZ MA, 1995, P NATL ACAD SCI USA, V92, P1530, DOI 10.1073/pnas.92.5.1530; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Lin MY, 2007, INFECT IMMUN, V75, P3523, DOI 10.1128/IAI.01999-06; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; MCCUNE RM, 1956, J EXP MED, V104, P763, DOI 10.1084/jem.104.5.763; Muttucumaru DGN, 2004, TUBERCULOSIS, V84, P239, DOI 10.1016/j.tube.2003.12.006; Olsen AW, 2001, INFECT IMMUN, V69, P2773, DOI 10.1128/IAI.69.5.2773-2778.2001; Olsen AW, 2004, INFECT IMMUN, V72, P6148, DOI 10.1128/IAI.72.10.6148-6150.2004; Palendira U, 2005, VACCINE, V23, P1680, DOI 10.1016/j.vaccine.2004.10.007; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Skeiky YAW, 2004, J IMMUNOL, V172, P7618, DOI 10.4049/jimmunol.172.12.7618; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wilkinson D, 1997, S AFR MED J, V87, P447; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433	39	401	430	3	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					189	U224		10.1038/nm.2285	http://dx.doi.org/10.1038/nm.2285			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21258338				2022-12-25	WOS:000286969900026
J	Kobayashi, SD; Deleo, FR				Kobayashi, Scott D.; Deleo, Frank R.			A MRSA-terious enemy among us	NATURE MEDICINE			English	Editorial Material							STAPHYLOCOCCUS-AUREUS INFECTIONS; VACCINE; MICE; INSIGHTS	Infection with methicillin-resistant Staphylococcus aureus (MRSA) can cause symptoms ranging from mild skin infections to more severe disease in various organs, even among healthy individuals. The ability of this pathogen to escape our immune arsenal and overcome antibiotic therapy poses a challenge to preventing their spread and treating the related symptoms. In 'Bench to Bedside', Scott Kobayashi and Frank DeLeo explore new approaches for vaccine development that focus on antigens required for establishment of disease. Studies with infected mice immunized against S. aureus coagulases-important for abscess formation and bloodstream infection-suggest such an approach may be used to reduce bacterial load and protect against severe disease in humans. In 'Bedside to Bench', Michael Otto examines a large human study where the presence of genes encoding Panton-Valentine leukocidin toxin (PVL) in community-associated MRSA did not correlate with complicated skin structure infections-a result opposing the widespread notion that PVL is the primary CA-MRSA virulence factor.	[Kobayashi, Scott D.; Deleo, Frank R.] US Natl Inst Allergy & Infect Dis, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kobayashi, SD (corresponding author), US Natl Inst Allergy & Infect Dis, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	fdeleo@niaid.nih.gov		Kobayashi, Scott/0000-0002-5705-1381; DeLeo, Frank/0000-0003-3150-2516	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001079] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Cheng AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001036; Clarke SR, 2006, J INFECT DIS, V193, P1098, DOI 10.1086/501471; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Harro C, 2010, CLIN VACCINE IMMUNOL, V17, P1868, DOI 10.1128/CVI.00356-10; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kim HK, 2010, J EXP MED, V207, P1863, DOI 10.1084/jem.20092514; Kim HK, 2010, VACCINE, V28, P6382, DOI 10.1016/j.vaccine.2010.02.097; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Projan SJ, 2008, DRUG DISCOV TODAY, V13, P279, DOI 10.1016/j.drudis.2008.03.010; Projan SJ, 2006, CURR OPIN PHARMACOL, V6, P473, DOI 10.1016/j.coph.2006.04.005; SMITH W, 1947, BRIT J EXP PATHOL, V28, P57; Spellberg B, 2010, HUM VACCINES, V6, P857, DOI 10.4161/hv.6.10.12469; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208	16	12	12	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					168	169		10.1038/nm0211-168	http://dx.doi.org/10.1038/nm0211-168			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21297611	Bronze			2022-12-25	WOS:000286969900022
J	Otto, M				Otto, Michael			End of the PVL controversy?	NATURE MEDICINE			English	Editorial Material							PANTON-VALENTINE LEUKOCIDIN; STAPHYLOCOCCUS-AUREUS; VIRULENCE DETERMINANT; SKIN; INFECTIONS; RESISTANCE		US Natl Inst Allergy & Infect Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Otto, M (corresponding author), US Natl Inst Allergy & Infect Dis, NIH, Bethesda, MD 20892 USA.	motto@niaid.nih.gov		Otto, Michael/0000-0002-2222-4115	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bae IG, 2009, J CLIN MICROBIOL, V47, P3952, DOI 10.1128/JCM.01643-09; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; Daum RS, 2002, J INFECT DIS, V186, P1344, DOI 10.1086/344326; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Hermos CR, 2010, CLIN INFECT DIS, V51, P1138, DOI 10.1086/656742; Jones RN, 2007, ANTIMICROB AGENTS CH, V51, P3381, DOI 10.1128/AAC.01588-06; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053	15	37	39	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					169	170		10.1038/nm0211-169	http://dx.doi.org/10.1038/nm0211-169			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21297612				2022-12-25	WOS:000286969900023
J	Ramsay, L; Comadran, J; Druka, A; Marshall, DF; Thomas, WTB; Macaulay, M; MacKenzie, K; Simpson, C; Fuller, J; Bonar, N; Hayes, PM; Lundqvist, U; Franckowiak, JD; Close, TJ; Muehlbauer, GJ; Waugh, R				Ramsay, Luke; Comadran, Jordi; Druka, Arnis; Marshall, David F.; Thomas, William T. B.; Macaulay, Malcolm; MacKenzie, Katrin; Simpson, Craig; Fuller, John; Bonar, Nicola; Hayes, Patrick M.; Lundqvist, Udda; Franckowiak, Jerome D.; Close, Timothy J.; Muehlbauer, Gary J.; Waugh, Robbie			INTERMEDIUM-C, a modifier of lateral spikelet fertility in barley, is an ortholog of the maize domestication gene TEOSINTE BRANCHED 1	NATURE GENETICS			English	Article							MOLECULAR EVOLUTION; PLANT; POPULATION; RESISTANCE; PATTERNS; MUTANTS; MODEL	The domestication of cereals has involved common changes in morphological features, such as seed size, seed retention and modification of vegetative and inflorescence architecture that ultimately contributed to an increase in harvested yield(1). In barley, this process has resulted in two different cultivated types, two-rowed and six-rowed forms, both derived from the wild two-rowed ancestor, with archaeo-botanical evidence indicating the origin of six-rowed barley early in the domestication of the species, some 8,600-8,000 years ago(2). Variation at SIX-ROWED SPIKE 1 (VRS1) is sufficient to control this phenotype. However, phenotypes imposed by VRS1 alleles are modified by alleles at the INTERMEDIUM-C (INT-C) locus. Here we show that INT-C is an ortholog of the maize domestication gene TEOSINTE BRANCHED 1 (TB1) and identify 17 coding mutations in barley TB1 correlated with lateral spikelet fertility phenotypes.	[Ramsay, Luke; Comadran, Jordi; Druka, Arnis; Marshall, David F.; Thomas, William T. B.; Macaulay, Malcolm; Simpson, Craig; Fuller, John; Bonar, Nicola; Waugh, Robbie] Scottish Crop Res Inst, Genet Programme, Dundee DD2 5DA, Scotland; [Hayes, Patrick M.] Oregon State Univ, Corvallis, OR 97331 USA; [Lundqvist, Udda] Nord Genet Resource Ctr, Alnarp, Sweden; [Franckowiak, Jerome D.] Hermitage Res Stn, Warwick, Qld, Australia; [Close, Timothy J.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Muehlbauer, Gary J.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA	James Hutton Institute; Oregon State University; University of California System; University of California Riverside; University of Minnesota System; University of Minnesota Twin Cities	Waugh, R (corresponding author), Scottish Crop Res Inst, Genet Programme, Dundee DD2 5DA, Scotland.	robbie.waugh@scri.ac.uk	Marshall, David F/F-2471-2011; Druka, Arnis/E-9701-2011; MacKenzie, Katrin M/N-2996-2013	Marshall, David F/0000-0001-9309-2570; 	UK Sustainable Arable LINK [302 /BB/D522003/1]; United States Department of Agriculture-Cooperative State Research, Education and Extension Service-National Research Institute (USDA-CSREES-NRI) [2006-55606-16722]; Biotechnology and Biological Sciences Research Council [BB/D522003/1] Funding Source: researchfish; BBSRC [BB/D522003/1] Funding Source: UKRI	UK Sustainable Arable LINK; United States Department of Agriculture-Cooperative State Research, Education and Extension Service-National Research Institute (USDA-CSREES-NRI)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by UK Sustainable Arable LINK 302 /BB/D522003/1 'Association Genetics of Elite UK Barleys' and United States Department of Agriculture-Cooperative State Research, Education and Extension Service-National Research Institute (USDA-CSREES-NRI) grant no. 2006-55606-16722 'Barley Coordinated Agricultural Project; leveraging Genomics, Genetics, and Breeding for Gene Discovery and Barley Improvement'. We thank A. Roberts and S. Chapman (Scottish Crop Research Institute) for technical advice and M. Boulton and T. Moore (John Innes Centre) for guidance on sequencing SLENDER1.	Buckler ES, 2001, GENET RES, V77, P213, DOI 10.1017/S0016672301005158; Caldwell KS, 2006, GENETICS, V172, P557, DOI 10.1534/genetics.104.038489; Camus-Kulandaivelu L, 2008, GENETICS, V180, P1107, DOI 10.1534/genetics.108.088849; Chandler PM, 2002, PLANT PHYSIOL, V129, P181, DOI 10.1104/pp.010917; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; DRUKA A, 2011, PLANT PHYSIOL, V155, P1; Fischbeck G, 2003, DEV PL GEN, V7, P29, DOI 10.1016/S0168-7972(03)80005-1; Forster BP, 2007, ANN BOT-LONDON, V100, P725, DOI 10.1093/aob/mcm183; HARLAN JR, 1979, USDA AGR HDB, V338, P10; Hubbard L, 2002, GENETICS, V162, P1927; KIRBY EJM, 1978, J AGR SCI, V91, P207, DOI 10.1017/S002185960005677X; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Lewis JM, 2008, PLANT CELL REP, V27, P1217, DOI 10.1007/s00299-008-0543-8; Lukens L, 2001, MOL BIOL EVOL, V18, P627, DOI 10.1093/oxfordjournals.molbev.a003843; LUNDQVIST U, 1988, HEREDITAS, V108, P13, DOI 10.1111/j.1601-5223.1988.tb00677.x; LUNDQVIST U, 1989, HEREDITAS, V110, P227, DOI 10.1111/j.1601-5223.1989.tb00785.x; LUNDQVIST U., 1997, BARLEY GENET NEWSL, V26, P22; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; PAYNE RW, 2007, GENSTAT REL, V3; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rostoks N, 2006, P NATL ACAD SCI USA, V103, P18656, DOI 10.1073/pnas.0606133103; Saisho D, 2007, GENETICS, V177, P1765, DOI 10.1534/genetics.107.079491; Takeda T, 2003, PLANT J, V33, P513, DOI 10.1046/j.1365-313X.2003.01648.x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhu H, 1999, THEOR APPL GENET, V99, P1221, DOI 10.1007/s001220051328; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	32	210	226	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2011	43	2					169	U125		10.1038/ng.745	http://dx.doi.org/10.1038/ng.745			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	711XD	21217754				2022-12-25	WOS:000286623800018
J	Ye, LL; Zeng, RY; Bai, Y; Roopenian, DC; Zhu, XP				Ye, Lilin; Zeng, Rongyu; Bai, Yu; Roopenian, Derry C.; Zhu, Xiaoping			Efficient mucosal vaccination mediated by the neonatal Fc receptor	NATURE BIOTECHNOLOGY			English	Article							SIMPLEX-VIRUS TYPE-2; PROTECTIVE IMMUNITY; CPG OLIGODEOXYNUCLEOTIDES; EPITHELIAL-CELLS; IGG TRANSPORT; GENITAL-TRACT; HERPES; IMMUNIZATION; RESPONSES; ADJUVANT	Almost all infectious diseases are initiated at mucosal surfaces, yet intramuscular or subcutaneous vaccination usually provides only minimal protection at sites of infection owing to suboptimal activation of the mucosal immune system. The neonatal Fc receptor (FcRn) mediates the transport of IgG across polarized epithelial cells lining mucosal surfaces. We mimicked this process by fusing a model antigen, herpes simplex virus type-2 (HSV-2) glycoprotein gD, to an IgG Fc fragment. Intranasal immunization, together with the adjuvant CpG, completely protected wild-type, but not FcRn knockout, mice after intravaginal challenge with virulent HSV-2 186. This immunization strategy induced efficient mucosal and systemic antibody, B-and T-cell immune responses, with stable protection for at least 6 months after vaccination in most of the immunized animals. The FcRn-IgG transcellular transport pathway may provide a general delivery route for subunit vaccines against many mucosal pathogens.	[Ye, Lilin; Zeng, Rongyu; Bai, Yu; Zhu, Xiaoping] Univ Maryland, Virginia Maryland Reg Coll Vet Med, Immunol Lab, College Pk, MD 20742 USA; [Roopenian, Derry C.] Jackson Lab, Bar Harbor, ME 04609 USA; [Zhu, Xiaoping] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; Jackson Laboratory; University System of Maryland; University of Maryland College Park	Zhu, XP (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, Immunol Lab, College Pk, MD 20742 USA.	xzhu1@umd.edu		Ye, Lilin/0000-0003-0778-3311	National Institutes of Health [AI65892, AI67965, AI73139, DK56597]; University of Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073139, R21AI067965, R01AI065892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank K. Rosenthal and A. Harandi for their discussions of mucosal antigen transport and immunization. We thank G.J. Letchworth for helpful discussions and critical reading of the manuscript. We are grateful to N.E. Simister, Brandeis University, for supplying us with inner medullary collecting duct-FcRn cell line. We acknowledge the receipt of HSV-2 186 strain from L.R. Stanberry, Columbia University, and HSV gD plasmids from P. Spear, Northwestern University. We also acknowledge the helpful discussions with D. Mosser, D. Perez, S. Samal and W. Song. We are most grateful for the technical help from Y. Wang, L. Lu, X. Liu, S. Palaniyandi and Z. Li. This work was supported in part by the National Institutes of Health grants AI65892, AI67965, AI73139 (to X.Z.), DK56597 (to D.C.R.) and MAES competitive grants from the University of Maryland (to X.Z.).	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Baker K, 2009, SEMIN IMMUNOPATHOL, V31, P223, DOI 10.1007/s00281-009-0160-9; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; ChangLai SP, 1999, RESPIRATION, V66, P506, DOI 10.1159/000029449; Dickinson BL, 1999, J CLIN INVEST, V104, P903, DOI 10.1172/JCI6968; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; Gallichan WS, 1998, J INFECT DIS, V177, P1155, DOI 10.1086/515286; Gallichan WS, 2001, J IMMUNOL, V166, P3451, DOI 10.4049/jimmunol.166.5.3451; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; He WZ, 2008, NATURE, V455, P542, DOI 10.1038/nature07255; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Kelsall Brian L, 2004, Nat Immunol, V5, P1091, DOI 10.1038/ni1104-1091; KIM JK, 1994, EUR J IMMUNOL, V24, P2429, DOI 10.1002/eji.1830241025; Kodama S, 2006, LARYNGOSCOPE, V116, P331, DOI 10.1097/01.mlg.0000194222.93067.f7; Kwant A, 2004, VACCINE, V22, P3098, DOI 10.1016/j.vaccine.2004.01.059; Lin HX, 2007, INT J PHARMACEUT, V330, P23, DOI 10.1016/j.ijpharm.2006.08.043; Lindqvist M, 2009, J IMMUNOL, V182, P6435, DOI 10.4049/jimmunol.0900136; Liu XD, 2008, J IMMUNOL, V181, P449, DOI 10.4049/jimmunol.181.1.449; McCarthy KM, 2000, J CELL SCI, V113, P1277; MCGHEE JR, 1992, VACCINE, V10, P75, DOI 10.1016/0264-410X(92)90021-B; Mestecky J, 2007, J IMMUNOL, V179, P5633, DOI 10.4049/jimmunol.179.9.5633; Mi WT, 2008, J IMMUNOL, V181, P7550, DOI 10.4049/jimmunol.181.11.7550; Milligan GN, 2004, VIROLOGY, V318, P507, DOI 10.1016/j.virol.2003.10.010; Milligan GN, 1998, J IMMUNOL, V160, P6093; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Nochi T, 2007, J EXP MED, V204, P2789, DOI 10.1084/jem.20070607; Parr EL, 1997, J VIROL, V71, P8109, DOI 10.1128/JVI.71.11.8109-8115.1997; Rawool DB, 2008, J IMMUNOL, V180, P5548, DOI 10.4049/jimmunol.180.8.5548; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Tengvall S, 2006, J VIROL, V80, P5283, DOI 10.1128/JVI.02013-05; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; van Duin D, 2006, TRENDS IMMUNOL, V27, P49, DOI 10.1016/j.it.2005.11.005; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367; Ye LL, 2008, J IMMUNOL, V181, P2572, DOI 10.4049/jimmunol.181.4.2572; Yoshida M, 2004, IMMUNITY, V20, P769, DOI 10.1016/j.immuni.2004.05.007; Yoshida M, 2006, J CLIN INVEST, V116, P2142, DOI 10.1172/JCI27821	40	116	125	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2011	29	2					158	U104		10.1038/nbt.1742	http://dx.doi.org/10.1038/nbt.1742			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	717DJ	21240266	Green Accepted, Bronze			2022-12-25	WOS:000287023000024
J	Han, DW; Greber, B; Wu, GM; Tapia, N; Arauzo-Bravo, MJ; Ko, K; Bernemann, C; Stehling, M; Scholer, HR				Han, Dong Wook; Greber, Boris; Wu, Guangming; Tapia, Natalia; Arauzo-Bravo, Marcos J.; Ko, Kinarm; Bernemann, Christof; Stehling, Martin; Schoeler, Hans R.			Direct reprogramming of fibroblasts into epiblast stem cells	NATURE CELL BIOLOGY			English	Article							MAMMALIAN EMBRYOS; MOUSE EMBRYOS; GROUND-STATE; SELF-RENEWAL; PLURIPOTENCY; GENERATION; GROWTH; CYCLE	Epiblast stem cells (EpiSCs) derived from epiblast tissue of post-implantation embryos are pluripotent and can give rise to all three germ layers in teratoma assays(1,2). Introduction of the four transcription factors Oct4, Sox2, Klf4 and c-Myc into somatic cells has been shown to generate induced pluripotent stem cells (iPSCs) that are very similar to embryonic stem cells (ESCs) in a number of characteristics(3-6). However, generation of EpiSCs by the direct reprogramming of somatic cells using these transcription factors has not been shown to date. Here, we show that these transcription factors can be used to directly generate induced EpiSCs (iEpiSCs) under EpiSC culture conditions. iEpiSCs resemble EpiSCs in morphology, gene expression pattern, epigenetic status and chimaera-forming capability. This study demonstrates that the culture environment in transcription factor-mediated reprogramming determines the cell fate of the reprogrammed cell. We therefore hypothesize that it will eventually be possible to shape the identity of a directly reprogrammed cell simply by modulating culture conditions.	[Han, Dong Wook; Greber, Boris; Wu, Guangming; Tapia, Natalia; Arauzo-Bravo, Marcos J.; Bernemann, Christof; Stehling, Martin; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Ko, Kinarm] Konkuk Univ, Ctr Stem Cell Res, Inst Biomed Sci & Technol, Seoul 143701, South Korea; [Ko, Kinarm] Konkuk Univ, Dept Neurosci, Sch Med, Seoul 143701, South Korea; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; Konkuk University; Konkuk University; Konkuk University Medical Center; University of Munster	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Rontgenstr 20, D-48149 Munster, Germany.	office@mpi-muenster.mpg.de	, HS/AAB-4434-2019; Marcos, Arauzo-Bravo/A-1706-2011; Han, Dong Wook/D-6041-2011; Tapia, Natalia/H-5500-2012	, HS/0000-0003-2643-5136; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Wu, Guangming/0000-0003-1923-7609; Tapia, Natalia/0000-0003-0226-1952; Greber, Boris/0000-0002-9404-7293	Max Planck Society; Federal Ministry of Education and Research (BMBF) [01GN0934]	Max Planck Society(Max Planck Society); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	We are indebted to all members of the Scholer laboratory for discussions on the results. We are especially grateful to P. Tesar for providing T9 EpiSCs and A. Malapetsas for editing the manuscript. We are also grateful to M. Sinn for technical assistance and I. M. Verma for providing the pBOB-CAG-iCRE-SD plasmid. This work was supported by funds of the Max Planck Society and the Federal Ministry of Education and Research (BMBF) (Grant 01GN0934).	Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hadjantonakis AK, 1998, NAT GENET, V19, P220, DOI 10.1038/896; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Yeom YI, 1996, DEVELOPMENT, V122, P881	28	92	96	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2011	13	1					66	U153		10.1038/ncb2136	http://dx.doi.org/10.1038/ncb2136			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697GV	21131959				2022-12-25	WOS:000285502200012
J	Kerbel, RS; Ebos, JML				Kerbel, Robert S.; Ebos, John M. L.			Peering into the aftermath	NATURE MEDICINE			English	Editorial Material							ANTIANGIOGENIC THERAPY; CELL MOBILIZATION; SUNITINIB; VEGF; ANGIOGENESIS; METASTASIS; INHIBITION; BIOMARKERS; RESISTANCE; TUMORS		[Kerbel, Robert S.; Ebos, John M. L.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Dept Mol & Cellular Biol, Toronto, ON M4N 3M5, Canada; [Kerbel, Robert S.; Ebos, John M. L.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Kerbel, RS (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Dept Mol & Cellular Biol, Toronto, ON M4N 3M5, Canada.	robert.kerbel@sri.utoronto.ca; jebos@sri.utoronto.ca						Ahn GO, 2010, P NATL ACAD SCI USA, V107, P8363, DOI 10.1073/pnas.0911378107; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; DePrimo SE, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-32; Desar IME, 2009, ACTA ONCOL, V48, P927, DOI 10.1080/02841860902974167; Ebos JML, 2007, P NATL ACAD SCI USA, V104, P17069, DOI 10.1073/pnas.0708148104; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Jain RK, 2009, NAT REV CLIN ONCOL, V6, P327, DOI 10.1038/nrclinonc.2009.63; Lindauer A, 2010, CLIN PHARMACOL THER, V87, P601, DOI 10.1038/clpt.2010.20; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Murukesh N, 2010, BRIT J CANCER, V102, P8, DOI 10.1038/sj.bjc.6605483; Nikolinakos PG, 2010, CANCER RES, V70, P2171, DOI 10.1158/0008-5472.CAN-09-2533; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Shaked Y, 2008, CANCER CELL, V14, P263, DOI 10.1016/j.ccr.2008.08.001; Shojaei F, 2009, P NATL ACAD SCI USA, V106, P6742, DOI 10.1073/pnas.0902280106	14	21	21	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2010	16	10					1084	1085		10.1038/nm1010-1084	http://dx.doi.org/10.1038/nm1010-1084			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20930748				2022-12-25	WOS:000282644800034
J	Lin, S; Hanson, RE; Cronan, JE				Lin, Steven; Hanson, Ryan E.; Cronan, John E.			Biotin synthesis begins by hijacking the fatty acid synthetic pathway	NATURE CHEMICAL BIOLOGY			English	Article							ACYL CARRIER PROTEIN; III POLYKETIDE SYNTHASE; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; TRANS-ACONITATE; IN-VIVO; BIOSYNTHESIS; BACTERIAL; BIOH; EXPRESSION	Although biotin is an essential enzyme cofactor found in all three domains of life, our knowledge of its biosynthesis remains fragmentary. Most of the carbon atoms of biotin are derived from pimelic acid, a seven-carbon dicarboxylic acid, but the mechanism whereby this intermediate is assembled remains unknown. Genetic analysis in Escherichia coli identified only two genes of unknown function required for pimelate synthesis, bioC and bioH. We report in vivo and in vitro evidence that the pimeloyl moiety is synthesized by a modified fatty acid synthetic pathway in which the omega-carboxyl group of a malonyl-thioester is methylated by BioC, which allows recognition of this atypical substrate by the fatty acid synthetic enzymes. The malonyl-thioester methyl ester enters fatty acid synthesis as the primer and undergoes two reiterations of the fatty acid elongation cycle to give pimeloyl-acyl carrier protein (ACP) methyl ester, which is hydrolyzed to pimeloyl-ACP and methanol by BioH.	[Lin, Steven; Hanson, Ryan E.; Cronan, John E.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Cronan, John/V-6626-2019; Lin, Steven/ABD-7821-2021; Lin, Steven/G-6142-2019	Lin, Steven/0000-0002-7542-4663; Lin, Steven/0000-0002-7542-4663	US National Institute of Allergy and Infectious Diseases, US National Institutes of Health [AI15650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015650, R01AI015650] Funding Source: NIH RePORTER	US National Institute of Allergy and Infectious Diseases, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US National Institutes of Health grant AI15650 from the US National Institute of Allergy and Infectious Diseases.	Austin MB, 2004, J BIOL CHEM, V279, P45162, DOI 10.1074/jbc.M406567200; Bower S, 1996, J BACTERIOL, V178, P4122, DOI 10.1128/jb.178.14.4122-4130.1996; Cai H, 2001, BIOCHEMISTRY-US, V40, P2210, DOI 10.1021/bi0022902; Cai H, 1999, J BIOL CHEM, V274, P13470, DOI 10.1074/jbc.274.19.13470; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; Chan DI, 2008, J BIOL CHEM, V283, P33620, DOI 10.1074/jbc.M805323200; Chapman-Smith A, 1999, TRENDS BIOCHEM SCI, V24, P359, DOI 10.1016/S0968-0004(99)01438-3; Choi KH, 2000, J BACTERIOL, V182, P365, DOI 10.1128/JB.182.2.365-370.2000; Choi-Rhee E, 2005, CHEM BIOL, V12, P461, DOI 10.1016/j.chembiol.2005.02.006; Choi-Rhee EJ, 2005, CHEM BIOL, V12, P589, DOI 10.1016/j.chembiol.2005.04.012; CLEARY PP, 1972, J BACTERIOL, V112, P830, DOI 10.1128/JB.112.2.830-839.1972; CRONAN JE, 1982, J BIOL CHEM, V257, P5013; Cronan JE, 2009, METHOD ENZYMOL, V459, P395, DOI 10.1016/S0076-6879(09)04617-5; Cryle MJ, 2008, P NATL ACAD SCI USA, V105, P15696, DOI 10.1073/pnas.0805983105; del Campillo-Campbell A, 1979, Methods Enzymol, V62, P379; EISENBERG MA, 1968, J BACTERIOL, V96, P1291, DOI 10.1128/JB.96.4.1291-1297.1968; IFUKU O, 1994, EUR J BIOCHEM, V220, P585, DOI 10.1111/j.1432-1033.1994.tb18659.x; Jiang YF, 2006, BIOCHEMISTRY-US, V45, P10008, DOI 10.1021/bi060842w; Jiang YF, 2010, BIOCHEMISTRY-US, V49, P718, DOI 10.1021/bi901890a; Kwon MA, 2009, J MICROBIOL BIOTECHN, V19, P147, DOI 10.4014/jmb.0804.287; Lemoine Y, 1996, MOL MICROBIOL, V19, P645, DOI 10.1046/j.1365-2958.1996.t01-4-442924.x; LENNARZ WJ, 1962, P NATL ACAD SCI USA, V48, P840, DOI 10.1073/pnas.48.5.840; LEZIUS A, 1963, BIOCHEM Z, V336, P510; Marquet A, 2001, VITAM HORM, V61, P51; Massengo-Tiasse RP, 2008, J BIOL CHEM, V283, P1308, DOI 10.1074/jbc.M708171200; Miller J.H., 1992, SHORT COURSE BACTERI, P150; OREGAN M, 1989, NUCLEIC ACIDS RES, V17, P8004, DOI 10.1093/nar/17.19.8004; PUGH CSG, 1978, J BIOL CHEM, V253, P4075; Rock C O, 1981, Methods Enzymol, V71 Pt C, P341; ROLFE B, 1968, J BACTERIOL, V96, P515, DOI 10.1128/JB.96.2.515-524.1968; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; Sanishvili R, 2003, J BIOL CHEM, V278, P26039, DOI 10.1074/jbc.M303867200; SANYAL I, 1994, J AM CHEM SOC, V116, P2637, DOI 10.1021/ja00085a061; Stok JE, 2000, ARCH BIOCHEM BIOPHYS, V384, P351, DOI 10.1006/abbi.2000.2067; Tomczyk NH, 2002, FEBS LETT, V513, P299, DOI 10.1016/S0014-5793(02)02342-6; Tseng CC, 2004, BIOCHEMISTRY-US, V43, P970, DOI 10.1021/bi035714b; Webb ME, 2007, NAT PROD REP, V24, P988, DOI 10.1039/b703105j; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Xie XK, 2007, METAB ENG, V9, P379, DOI 10.1016/j.ymben.2007.05.006	39	132	161	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	SEP	2010	6	9					682	688		10.1038/NCHEMBIO.420	http://dx.doi.org/10.1038/NCHEMBIO.420			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	640WO	20693992	Green Accepted			2022-12-25	WOS:000281084900012
J	Ruhrberg, C; De Palma, M				Ruhrberg, Christiana; De Palma, Michele			A double agent in cancer: Deciphering macrophage roles in human tumors	NATURE MEDICINE			English	Editorial Material							TIE2-EXPRESSING MONOCYTES; HODGKINS LYMPHOMA; ANGIOGENESIS; INFLAMMATION; PROGRESSION; POPULATION; EXPRESSION; SURVIVAL; BLOOD	Macrophages engulf microbes and cellular debris to protect us from disease and help repair wounded tissues. In cancer, they also infiltrate the tumor, but studies in humans and mice now uncover more sinister roles for these immune cells in cancer. In 'Bedside to Bench', Christiana Ruhrberg and Michele De Palma scrutinize a clinical study where the presence of macrophages correlates with a high risk of disease progression in people with Hodgkin's lymphoma, indicating a clinical value of macrophages as biomarkers of survival. The authors also emphasize how characterizing of the mechanisms by which subpopulations of macrophages promote tumor cell motility and angiogenesis might help in the development of antiangiogenic therapies to stop tumor progression. In 'Bench to Bedside', Joseph Qualls and Peter Murray examine a study that shows how stopping migration of macrophages into the tumor can impair tumor regrowth after radiation treatment.	[Ruhrberg, Christiana] UCL, UCL Inst Ophthalmol, London, England; [De Palma, Michele] Ist Sci San Raffaele, Div Regenerat Med, San Raffaele Telethon Inst Gene Therapy, I-20132 Milan, Italy	University of London; University College London; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Ruhrberg, C (corresponding author), UCL, UCL Inst Ophthalmol, London, England.	c.ruhrberg@ucl.ac.uk; depalma.michele@hsr.it	Ruhrberg, Christiana/C-6404-2009; De Palma, Michele/L-5350-2016	Ruhrberg, Christiana/0000-0002-3212-9381; De Palma, Michele/0000-0001-9128-5459				Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Birgersdotter A, 2009, BRIT J CANCER, V101, P1393, DOI 10.1038/sj.bjc.6605238; Coffelt SB, 2010, AM J PATHOL, V176, P1564, DOI 10.2353/ajpath.2010.090786; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; FANTIN A, 2010, BLOOD           0419, DOI DOI 10.1182/BLOOD-2009-12-257832; Kim DW, 2008, BRIT J CANCER, V98, P1118, DOI 10.1038/sj.bjc.6604256; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Nakayama Y, 2002, ANTICANCER RES, V22, P4291; Ojalvo LS, 2009, AM J PATHOL, V174, P1048, DOI 10.2353/ajpath.2009.080676; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Vacca A, 1999, BRIT J CANCER, V79, P965, DOI 10.1038/sj.bjc.6690154; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504	16	25	25	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2010	16	8					861	862		10.1038/nm0810-861	http://dx.doi.org/10.1038/nm0810-861			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	635IQ	20689550				2022-12-25	WOS:000280649200023
J	Witte, K; Schuh, AL; Hegermann, J; Sarkeshik, A; Mayers, JR; Schwarze, K; Yates, JR; Eimer, S; Audhya, A				Witte, Kristen; Schuh, Amber L.; Hegermann, Jan; Sarkeshik, Ali; Mayers, Jonathan R.; Schwarze, Katrin; Yates, John R., III; Eimer, Stefan; Audhya, Anjon			TFG-1 function in protein secretion and oncogenesis	NATURE CELL BIOLOGY			English	Article							EXIT SITES; SUBUNIT INTERACTIONS; COPII; TRANSPORT; ORGANIZATION; GENE; ER; RECEPTORS; SEC23A; DOMAIN	Export of proteins from the endoplasmic reticulum in COPII-coated vesicles occurs at defined sites that contain the scaffolding protein Sec 16. We identify TFG-1, a new conserved regulator of protein secretion that interacts directly with SEC-16 and controls the export of cargoes from the endoplasmic reticulum in Caenorhabditis elegans. Hydrodynamic studies indicate that TFG-1 forms hexamers that facilitate the co-assembly of SEC-16 with COPII subunits. Consistent with these findings, TFG-1 depletion leads to a marked decline in both SEC-16 and COPII levels at endoplasmic reticulum exit sites. The sequence encoding the amino terminus of human TFG has been previously identified in chromosome translocation events involving two protein kinases, which created a pair of oncogenes. We propose that fusion of these kinases to TFG relocalizes their activities to endoplasmic reticulum exit sites, where they prematurely phosphorylate substrates during endoplasmic reticulum export. Our findings provide a mechanism by which translocations involving TFG can result in cellular transformation and oncogenesis.	[Witte, Kristen; Schuh, Amber L.; Mayers, Jonathan R.; Audhya, Anjon] Univ Wisconsin Madison Med Sch, Dept Biomol Chem, Madison, WI 53706 USA; [Hegermann, Jan; Schwarze, Katrin; Eimer, Stefan] European Neurosci Inst, D-37077 Gottingen, Germany; [Hegermann, Jan; Schwarze, Katrin; Eimer, Stefan] CMPB, D-37077 Gottingen, Germany; [Sarkeshik, Ali; Yates, John R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of Wisconsin System; University of Wisconsin Madison; Scripps Research Institute	Audhya, A (corresponding author), Univ Wisconsin Madison Med Sch, Dept Biomol Chem, 1300 Univ Ave, Madison, WI 53706 USA.	audhya@wisc.edu	Eimer, Stefan/B-1865-2013		NIH [1R01GM088151-01A1, P41RR011823]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088151] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the NIH (1R01GM088151-01A1 to A.A. and P41RR011823 to J.R.Y.). We thank B. Weaver and P. Bertics for use of tissue culture facilities, R. Landick for use of a Gradient Master, K. Oegema for marker strains and antibodies, E. Chapman for use of Metamorph software and S. Koenig for help with RNAi. We also thank D. Stephens, P. Kiley and members of the Audhya laboratory for critically reading this manuscript.	Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bickford LC, 2004, CURR OPIN STRUC BIOL, V14, P147, DOI 10.1016/j.sbi.2004.02.002; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Diop SB, 2008, EMBO REP, V9, P260, DOI 10.1038/embor.2008.8; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; ESPENSHADE P, 1995, J CELL BIOL, V131, P311, DOI 10.1083/jcb.131.2.311; Farhan H, 2008, EMBO J, V27, P2043, DOI 10.1038/emboj.2008.136; Farhan H, 2010, J CELL BIOL, V189, P997, DOI 10.1083/jcb.200912082; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Gimeno RE, 1996, MOL BIOL CELL, V7, P1815, DOI 10.1091/mbc.7.11.1815; GRECO A, 1995, MOL CELL BIOL, V15, P6118; Greco A, 1998, ONCOGENE, V16, P809, DOI 10.1038/sj.onc.1201596; Heinzer S, 2008, J CELL SCI, V121, P55, DOI 10.1242/jcs.013383; Hernandez L, 1999, BLOOD, V94, P3265; Hughes H, 2008, HISTOCHEM CELL BIOL, V129, P129, DOI 10.1007/s00418-007-0363-x; Hughes H, 2009, J CELL SCI, V122, P2924, DOI 10.1242/jcs.044032; Klesse LJ, 1999, MICROSC RES TECHNIQ, V45, P210, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<210::AID-JEMT4>3.3.CO;2-6; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; MAINE EM, 1989, DEVELOPMENT, V106, P133; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Miller EA, 2010, CURR OPIN CELL BIOL, V22, P447, DOI 10.1016/j.ceb.2010.04.003; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; PERLAKY L, 1992, CANCER RES, V52, P428; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rostaing P, 2006, EUR J NEUROSCI, V24, P3463, DOI 10.1111/j.1460-9568.2006.05234.x; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Sato K, 2006, MOL BIOL CELL, V17, P3085, DOI 10.1091/mbc.E06-03-0211; Schecterson LC, 2010, DEV NEUROBIOL, V70, P332, DOI 10.1002/dneu.20767; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Shi AB, 2010, MOL BIOL CELL, V21, P2930, DOI 10.1091/mbc.E10-02-0149; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Supek F, 2002, J CELL BIOL, V158, P1029, DOI 10.1083/jcb.200207053; Trzcinska-Daneluti AM, 2009, MOL CELL PROTEOMICS, V8, P780, DOI 10.1074/mcp.M800268-MCP200; Whittle JRR, 2010, J CELL BIOL, V190, P347, DOI 10.1083/jcb.201003092; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180	45	123	131	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY 11	2011	13	5					550	U338		10.1038/ncb2225	http://dx.doi.org/10.1038/ncb2225			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	758FY	21478858	Green Accepted			2022-12-25	WOS:000290148700014
J	Chanda, B; Xia, Y; Mandal, MK; Yu, KS; Sekine, KT; Gao, QM; Selote, D; Hu, YL; Stromberg, A; Navarre, D; Kachroo, A; Kachroo, P				Chanda, Bidisha; Xia, Ye; Mandal, Mihir Kumar; Yu, Keshun; Sekine, Ken-Taro; Gao, Qing-ming; Selote, Devarshi; Hu, Yanling; Stromberg, Arnold; Navarre, Duroy; Kachroo, Aardra; Kachroo, Pradeep			Glycerol-3-phosphate is a critical mobile inducer of systemic immunity in plants	NATURE GENETICS			English	Article							ACQUIRED-RESISTANCE; SALICYLIC-ACID; ARABIDOPSIS-THALIANA; GLYCEROLIPID METABOLISM; METHYL SALICYLATE; DEHYDROGENASE; ACCUMULATION; PROTEIN; EXPRESSION; IDENTIFICATION	Glycerol-3-phosphate (G3P) is an important metabolite that contributes to the growth and disease-related physiologies of prokaryotes, plants, animals and humans alike. Here we show that G3P serves as the inducer of an important form of broad-spectrum immunity in plants, termed systemic acquired resistance (SAR). SAR is induced upon primary infection and protects distal tissues from secondary infections. Genetic mutants defective in G3P biosynthesis cannot induce SAR but can be rescued when G3P is supplied exogenously. Radioactive tracer experiments show that a G3P derivative is translocated to distal tissues, and this requires the lipid transfer protein, DIR1. Conversely, G3P is required for the translocation of DIR1 to distal tissues, which occurs through the symplast. These observations, along with the fact that dir1 plants accumulate reduced levels of G3P in their petiole exudates, suggest that the cooperative interaction of DIR1 and G3P orchestrates the induction of SAR in plants.	[Chanda, Bidisha; Xia, Ye; Mandal, Mihir Kumar; Yu, Keshun; Sekine, Ken-Taro; Gao, Qing-ming; Selote, Devarshi; Kachroo, Aardra; Kachroo, Pradeep] Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA; [Hu, Yanling; Stromberg, Arnold] Univ Kentucky, Dept Stat, Lexington, KY 40546 USA; [Navarre, Duroy] Washington State Univ, USDA, ARS, Prosser, WA USA	University of Kentucky; University of Kentucky; United States Department of Agriculture (USDA); Washington State University	Kachroo, P (corresponding author), Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA.	pk62@uky.edu	MANDAL, MIHIR KUMAR/S-9411-2019; Selote, Devarshi/F-1560-2015; Xia, Ye/B-8217-2016		National Science Foundation [0749731]; United Soybean Board [9444]	National Science Foundation(National Science Foundation (NSF)); United Soybean Board	We thank D. Smith and J. Shanklin for useful discussions, M. Goodin for providing the pSITE-2NA and TMV-MP30-GFP vectors and GFP antibodies and J. Johnson for help with gas chromatography. We thank L. Lapchyk for technical help and A. Crume for managing the plant growth facility. This work was supported by grants from the National Science Foundation (IOS#0749731) to A.K. and P.K. and United Soybean Board (#9444) to A.K.	ARGAST M, 1979, J BIOL CHEM, V254, P931; Attaran E, 2009, PLANT CELL, V21, P954, DOI 10.1105/tpc.108.063164; Chanda B, 2008, PLANT PHYSIOL, V147, P2017, DOI 10.1104/pp.108.121335; Chandra-Shekara AC, 2006, PLANT J, V45, P320, DOI 10.1111/j.1365-313X.2005.02618.x; Chaturvedi R, 2008, PLANT J, V54, P106, DOI 10.1111/j.1365-313X.2007.03400.x; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Fillinger S, 2001, MOL MICROBIOL, V39, P145, DOI 10.1046/j.1365-2958.2001.02223.x; Iriti M, 2007, MYCOPATHOLOGIA, V164, P57, DOI 10.1007/s11046-007-9026-7; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Kachroo A, 2004, P NATL ACAD SCI USA, V101, P5152, DOI 10.1073/pnas.0401315101; Kachroo P, 2005, PLANT PHYSIOL, V139, P1717, DOI 10.1104/pp.105.071662; Kang L, 2003, P NATL ACAD SCI USA, V100, P3519, DOI 10.1073/pnas.0637377100; Lascombe MB, 2008, PROTEIN SCI, V17, P1522, DOI 10.1110/ps.035972.108; Liu PP, 2010, MOL PLANT MICROBE IN, V23, P82, DOI 10.1094/MPMI-23-1-0082; Lu M, 2001, PLANT CELL, V13, P437, DOI 10.1105/tpc.13.2.437; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; Martin K, 2009, PLANT J, V59, P150, DOI 10.1111/j.1365-313X.2009.03850.x; Miquel M, 1998, PLANT PHYSIOL, V117, P923, DOI 10.1104/pp.117.3.923; Nandi A, 2004, PLANT CELL, V16, P465, DOI 10.1105/tpc.016907; Park SW, 2007, SCIENCE, V318, P113, DOI 10.1126/science.1147113; Quettier AL, 2008, PLANT PHYSIOL, V148, P519, DOI 10.1104/pp.108.123703; RASMUSSEN JB, 1991, PLANT PHYSIOL, V97, P1342, DOI 10.1104/pp.97.4.1342; Robert HS, 2009, NAT CHEM BIOL, V5, P325, DOI 10.1038/nchembio.170; Selote D, 2010, PLANT PHYSIOL, V153, P1199, DOI 10.1104/pp.110.158147; Shen WY, 2006, PLANT CELL, V18, P422, DOI 10.1105/tpc.105.039750; Shen WY, 2003, FEBS LETT, V536, P92, DOI 10.1016/S0014-5793(03)00033-4; Smith-Becker J, 1998, PLANT PHYSIOL, V116, P231, DOI 10.1104/pp.116.1.231; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; Truman WM, 2010, PLANT PHYSIOL, V152, P1562, DOI 10.1104/pp.109.152173; Venugopal SC, 2009, PLANT SIGNAL BEHAV, V4, P746, DOI 10.4161/psb.4.8.9111; Vlot AC, 2008, CURR OPIN PLANT BIOL, V11, P436, DOI 10.1016/j.pbi.2008.05.003; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Vlot AC, 2008, PLANT J, V56, P445, DOI 10.1111/j.1365-313X.2008.03618.x; Wei YD, 2001, PLANT PHYSIOL BIOCH, V39, P841, DOI 10.1016/S0981-9428(01)01308-0; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Xia Y, 2009, CELL HOST MICROBE, V5, P151, DOI 10.1016/j.chom.2009.01.001; Xia Y, 2010, PLANT PHYSIOL, V154, P833, DOI 10.1104/pp.110.161646	37	239	250	5	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2011	43	5					421	+		10.1038/ng.798	http://dx.doi.org/10.1038/ng.798			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	755XF	21441932				2022-12-25	WOS:000289972600010
J	Chen, GY; Chen, X; King, S; Cavassani, KA; Cheng, JS; Zheng, XC; Cao, HZ; Yu, H; Qu, JY; Fang, DX; Wu, W; Bai, XF; Liu, JQ; Woodiga, SA; Chen, C; Sun, L; Hogaboam, CM; Kunkel, SL; Zheng, P; Liu, Y				Chen, Guo-Yun; Chen, Xi; King, Samantha; Cavassani, Karen A.; Cheng, Jiansong; Zheng, Xincheng; Cao, Hongzhi; Yu, Hai; Qu, Jingyao; Fang, Dexing; Wu, Wei; Bai, Xue-Feng; Liu, Jin-Qing; Woodiga, Shireen A.; Chen, Chong; Sun, Lei; Hogaboam, Cory M.; Kunkel, Steven L.; Zheng, Pan; Liu, Yang			Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction	NATURE BIOTECHNOLOGY			English	Article							STREPTOCOCCUS-PNEUMONIAE; IMMUNE-SYSTEM; NALP3 INFLAMMASOME; DENDRITIC CELLS; IN-VIVO; NEURAMINIDASE; TOLERANCE; FAMILY; SPECIFICITY; ACTIVATION	Suppression of inflammation is critical for effective therapy of many infectious diseases. However, the high rates of mortality caused by sepsis attest to the need to better understand the basis of the inflammatory sequelae of sepsis and to develop new options for its treatment. In mice, inflammatory responses to host danger-associated molecular patterns (DAMPs), but not to microbial pathogen-associated molecular patterns (PAMPs), are repressed by the t interaction of CD24 and SiglecG (SIGLEC10 in human). Here we use an intestinal perforation model of sepsis to show that microbial sialidases target the sialic acid-based recognition of CD24 by SiglecG/10 to exacerbate inflammation. Sialidase inhibitors protect mice against sepsis by a mechanism involving both CD24 and Siglecg, whereas mutation of either gene exacerbates sepsis. Analysis of sialidase-deficient bacterial mutants confirms the key contribution of disrupting sialic acid-based pattern recognition to microbial virulence and supports the clinical potential of sialidase inhibition for dampening inflammation caused by infection.	[Chen, Guo-Yun; Chen, Chong; Zheng, Pan; Liu, Yang] Univ Michigan, Dept Surg, Div Immunotherapy, Ann Arbor, MI 48109 USA; [Chen, Xi; Cheng, Jiansong; Cao, Hongzhi; Yu, Hai; Qu, Jingyao] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [King, Samantha; Woodiga, Shireen A.] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH USA; [Cavassani, Karen A.; Sun, Lei; Hogaboam, Cory M.; Kunkel, Steven L.; Zheng, Pan] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Zheng, Xincheng; Fang, Dexing; Wu, Wei] OncoImmune Inc, Ann Arbor, MI USA; [Bai, Xue-Feng; Liu, Jin-Qing] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Liu, Yang] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of California System; University of California Davis; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Michigan System; University of Michigan; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan	Liu, Y (corresponding author), Univ Michigan, Dept Surg, Div Immunotherapy, Ann Arbor, MI 48109 USA.	panz@umich.edu; yangl@umich.edu	Zheng, Pan/E-8691-2011; hogaboam, cory/M-3578-2014; Chen, Xi/H-1811-2018; Hogaboam, Cory M./AAI-1433-2021; king, samantha/AAS-4813-2021; Bai, Xue-feng/E-2681-2011; Chen, Guo-yun/C-2436-2011; King, Samantha J/E-3386-2011; Bai, Xue-Feng/H-5164-2013	Zheng, Pan/0000-0003-2598-3544; Chen, Xi/0000-0002-3160-614X; Hogaboam, Cory M./0000-0003-3366-4850; Bai, Xue-Feng/0000-0001-9476-8376; Liu, Yang/0000-0002-9442-700X; CAO, HONGZHI/0000-0003-4736-3143	US National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA058033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064350, R21AI078286, R01AI076341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036690] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P.N. Boyaka for valuable advice, Y. Chen for critical reading of the manuscript and valuable discussions and D. Kroft for editorial assistance. This study is supported by grants from US National Institutes of Health.	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Blixt O, 2003, J BIOL CHEM, V278, P31007, DOI 10.1074/jbc.M304331200; Brocker T, 1997, ADV EXP MED BIOL, V417, P55; Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Ding C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000997; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Drzeniek R, 1972, Curr Top Microbiol Immunol, V59, P35; Duong BH, 2010, J EXP MED, V207, P173, DOI 10.1084/jem.20091873; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; Hoffmann A, 2007, NAT IMMUNOL, V8, P694, DOI 10.1038/ni1480; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Inohara N, 2002, CURR OPIN MICROBIOL, V5, P76, DOI 10.1016/S1369-5274(02)00289-8; JANEWAY C, 1989, IMMUNOL TODAY, V10, P283, DOI 10.1016/0167-5699(89)90081-9; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; King SJ, 2004, MOL MICROBIOL, V54, P159, DOI 10.1111/j.1365-2958.2004.04252.x; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; LEE LT, 1966, J BACTERIOL, V91, P1418, DOI 10.1128/JB.91.4.1418-1426.1966; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Li YH, 2008, APPL MICROBIOL BIOT, V79, P963, DOI 10.1007/s00253-008-1506-2; Li YH, 2011, MOL BIOSYST, V7, P1060, DOI 10.1039/c0mb00244e; Liu Y, 2009, TRENDS IMMUNOL, V30, P557, DOI 10.1016/j.it.2009.09.006; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mally M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000164; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Nielsen PJ, 1997, BLOOD, V89, P1058, DOI 10.1182/blood.V89.3.1058; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Peltola VT, 2005, J INFECT DIS, V192, P249, DOI 10.1086/430954; Piagnerelli M, 2009, CRIT CARE MED, V37, P1244, DOI 10.1097/CCM.0b013e31819cebbe; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Tong HH, 2000, INFECT IMMUN, V68, P921, DOI 10.1128/IAI.68.2.921-924.2000; Varki A, 2009, GLYCOCONJUGATE J, V26, P231, DOI 10.1007/s10719-008-9183-z; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Yu H, 2005, J AM CHEM SOC, V127, P17618, DOI 10.1021/ja0561690; Yu H, 2006, ANGEW CHEM INT EDIT, V45, P3938, DOI 10.1002/anie.200600572	46	128	134	2	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2011	29	5					428	U234		10.1038/nbt.1846	http://dx.doi.org/10.1038/nbt.1846			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	760CX	21478876	Green Accepted			2022-12-25	WOS:000290301700023
J	Isidor, B; Lindenbaum, P; Pichon, O; Bezieau, S; Dina, C; Jacquemont, S; Martin-Coignard, D; Thauvin-Robinet, C; Le Merrer, M; Mandel, JL; David, A; Faivre, L; Cormier-Daire, V; Redon, R; Le Caignec, C				Isidor, Bertrand; Lindenbaum, Pierre; Pichon, Olivier; Bezieau, Stephane; Dina, Christian; Jacquemont, Sebastien; Martin-Coignard, Dominique; Thauvin-Robinet, Christel; Le Merrer, Martine; Mandel, Jean-Louis; David, Albert; Faivre, Laurence; Cormier-Daire, Valerie; Redon, Richard; Le Caignec, Cedric			Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis	NATURE GENETICS			English	Article							ALAGILLE-SYNDROME; OSTEOBLAST DIFFERENTIATION; SIGNALING PATHWAY	Hajdu-Cheney syndrome is a rare autosomal dominant skeletal disorder with facial anomalies, osteoporosis and acro-osteolysis. We sequenced the exomes of six unrelated individuals with this syndrome and identified heterozygous nonsense and frameshift mutations in NOTCH2 in five of them. All mutations cluster to the last coding exon of the gene, suggesting that the mutant mRNA products escape nonsense-mediated decay and that the resulting truncated NOTCH2 proteins act in a gain-of-function manner.	[Isidor, Bertrand; Lindenbaum, Pierre; Pichon, Olivier; Bezieau, Stephane; David, Albert; Redon, Richard; Le Caignec, Cedric] CHU Nantes, Serv Genet Med, F-44035 Nantes 01, France; [Lindenbaum, Pierre; Dina, Christian; Redon, Richard; Le Caignec, Cedric] INSERM, Inst Thorax, UMR915, Nantes, France; [Lindenbaum, Pierre; Bezieau, Stephane; Dina, Christian; Redon, Richard; Le Caignec, Cedric] Univ Nantes, Nantes, France; [Dina, Christian; Le Caignec, Cedric] CNRS, ERL3147, Nantes, France; [Jacquemont, Sebastien] CHUV, Serv Genet Med, Lausanne, Switzerland; [Martin-Coignard, Dominique] Ctr Hosp Mans, Unit Genet Clin, Le Mans, France; [Thauvin-Robinet, Christel; Faivre, Laurence] CHU, Ctr Genet, Ctr Reference Malad Rares Anomalies Dev & Syndrom, Est Hop Enfants, Dijon, France; [Thauvin-Robinet, Christel; Faivre, Laurence] Univ Bourgogne, Dijon, France; [Le Merrer, Martine; Cormier-Daire, Valerie] INSERM, U781, Paris, France; [Le Merrer, Martine; Cormier-Daire, Valerie] Hop Necker Enfants Malad, Dept Genet, Paris, France; [Le Merrer, Martine; Cormier-Daire, Valerie] Univ Paris 05, Paris, France; [Mandel, Jean-Louis] Coll France, IGBMC, Translat Med & Neurogenet Program, Illkirch Graffenstaden, France; [Mandel, Jean-Louis] INSERM, U964, Illkirch Graffenstaden, France; [Mandel, Jean-Louis] CNRS, UMR 7104, Illkirch Graffenstaden, France; [Mandel, Jean-Louis] Univ Strasbourg, Illkirch Graffenstaden, France; [Mandel, Jean-Louis] CHU Strasbourg, F-67000 Strasbourg, France	Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; Centre National de la Recherche Scientifique (CNRS); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Centre Hospitalier Le Mans; CHU Dijon Bourgogne; Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Le Caignec, C (corresponding author), CHU Nantes, Serv Genet Med, F-44035 Nantes 01, France.	cedric.lecaignec@chu-nantes.fr	Dina, Christian R/D-3535-2015; Le Caignec, Cedric/K-8467-2015; Lindenbaum, Pierre/A-7154-2008; Isidor, Bertrand/AAJ-3456-2021; Redon, Richard/F-3303-2014; Isidor, Bertrand/L-2435-2015; Bézieau, stéphane/G-5621-2015; Jacquemont, Sebastien/AAS-5060-2021; Mandel, Jean Louis/Q-2668-2016; cormier-daire, valerie/H-6520-2017	Dina, Christian R/0000-0002-7722-7348; Le Caignec, Cedric/0000-0002-0598-653X; Lindenbaum, Pierre/0000-0003-0148-9787; Isidor, Bertrand/0000-0001-6480-126X; Redon, Richard/0000-0001-7751-2280; Isidor, Bertrand/0000-0001-6480-126X; Bézieau, stéphane/0000-0003-0095-1319; Jacquemont, Sebastien/0000-0001-6838-8767; Faivre, Laurence/0000-0001-9770-444X; Mandel, Jean Louis/0000-0002-0535-6589; cormier-daire, valerie/0000-0002-2839-9856	Inserm; Fondation pour la Recherche Medicale; Federation Francaise de Cardiologie; Region Pays-de-la-Loire; Direction Hospitaliere de l'Organisation des Soins (DHOS); bourse de releve academique de la Faculte de Biologie et Medecine de l'Universite de Lausanne	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Federation Francaise de Cardiologie; Region Pays-de-la-Loire(Region Pays de la Loire); Direction Hospitaliere de l'Organisation des Soins (DHOS); bourse de releve academique de la Faculte de Biologie et Medecine de l'Universite de Lausanne	We are grateful to the affected subjects and their families who participated in this study. We thank F. Gros, H. Eldjouzi, A. Briand, C. Beneteau and S. Lecointe for technical assistance, and R. Houlgatte and C. Chevalier from Biogenouest de Nantes. This research was funded by grants from Inserm, Fondation pour la Recherche Medicale, Federation Francaise de Cardiologie and Region Pays-de-la-Loire. P.L. is supported by the Direction Hospitaliere de l'Organisation des Soins (DHOS). S.J. is funded by the "bourse de releve academique de la Faculte de Biologie et Medecine de l'Universite de Lausanne."	Bales CB, 2010, J PEDIATR GASTR NUTR, V51, P66, DOI 10.1097/MPG.0b013e3181cb9629; Brennan AM, 2001, AM J MED GENET, V100, P292, DOI 10.1002/1096-8628(20010515)100:4<292::AID-AJMG1308>3.0.CO;2-4; Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kung AWC, 2010, AM J HUM GENET, V86, P229, DOI 10.1016/j.ajhg.2009.12.014; Lee SY, 2009, CANCER SCI, V100, P920, DOI 10.1111/j.1349-7006.2009.01130.x; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; McCright B, 2001, DEVELOPMENT, V128, P491; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140	15	131	140	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2011	43	4					306	308		10.1038/ng.778	http://dx.doi.org/10.1038/ng.778			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	741YL	21378989				2022-12-25	WOS:000288903700008
J	Metz, JT; Johnson, EF; Soni, NB; Merta, PJ; Kifle, L; Hajduk, PJ				Metz, James T.; Johnson, Eric F.; Soni, Niru B.; Merta, Philip J.; Kifle, Lemma; Hajduk, Philip J.			Navigating the kinome	NATURE CHEMICAL BIOLOGY			English	Article							DRUG-TARGET NETWORKS; SPACE; DESCRIPTOR; BIOLOGY	Although it is increasingly being recognized that drug-target interaction networks can be powerful tools for the interrogation of systems biology and the rational design of multitargeted drugs, there is no generalized, statistically validated approach to harmonizing sequence-dependent and pharmacology-dependent networks. Here we demonstrate the creation of a comprehensive kinome interaction network based not only on sequence comparisons but also on multiple pharmacology parameters derived from activity profiling data. The framework described for statistical interpretation of these network connections also enables rigorous investigation of chemotype-specific interaction networks, which is critical for multitargeted drug design.	[Metz, James T.; Johnson, Eric F.; Soni, Niru B.; Merta, Philip J.; Kifle, Lemma; Hajduk, Philip J.] Abbott Labs, Div Pharmaceut Discovery, Abbott Pk, IL 60064 USA	Abbott Laboratories	Metz, JT (corresponding author), Abbott Labs, Div Pharmaceut Discovery, Abbott Pk, IL 60064 USA.	philip.hajduk@abbott.com						Bamborough P, 2008, J MED CHEM, V51, P7898, DOI 10.1021/jm8011036; Frantz S, 2005, NATURE, V437, P942, DOI 10.1038/437942a; Godden JW, 2000, J MOL GRAPH MODEL, V18, P73; Godden JW, 2003, QSAR COMB SCI, V22, P487, DOI 10.1002/qsar.200310001; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Mestres J, 2008, NAT BIOTECHNOL, V26, P983, DOI 10.1038/nbt0908-983; Mestres J, 2009, MOL BIOSYST, V5, P1051, DOI 10.1039/b905821b; Metz JT, 2010, CURR OPIN CHEM BIOL, V14, P498, DOI 10.1016/j.cbpa.2010.06.166; Morphy R, 2010, J MED CHEM, V53, P1413, DOI 10.1021/jm901132v; Oprea TI, 2007, NAT CHEM BIOL, V3, P447, DOI 10.1038/nchembio0807-447; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Vieth M, 2005, DRUG DISCOV TODAY, V10, P839, DOI 10.1016/S1359-6446(05)03477-X; Vieth M, 2004, BBA-PROTEINS PROTEOM, V1697, P243, DOI 10.1016/j.bbapap.2003.11.028; Vogt I, 2010, MOL INFORM, V29, P10, DOI 10.1002/minf.200900069	16	187	193	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					200	202		10.1038/NCHEMBIO.530	http://dx.doi.org/10.1038/NCHEMBIO.530			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21336281				2022-12-25	WOS:000288545000006
J	Bartelt, A; Bruns, OT; Reimer, R; Hohenberg, H; Ittrich, H; Peldschus, K; Kaul, MG; Tromsdorf, UI; Weller, H; Waurisch, C; Eychmuller, A; Gordts, PLSM; Rinninger, F; Bruegelmann, K; Freund, B; Nielsen, P; Merkel, M; Heeren, J				Bartelt, Alexander; Bruns, Oliver T.; Reimer, Rudolph; Hohenberg, Heinz; Ittrich, Harald; Peldschus, Kersten; Kaul, Michael G.; Tromsdorf, Ulrich I.; Weller, Horst; Waurisch, Christian; Eychmueller, Alexander; Gordts, Philip L. S. M.; Rinninger, Franz; Bruegelmann, Karoline; Freund, Barbara; Nielsen, Peter; Merkel, Martin; Heeren, Joerg			Brown adipose tissue activity controls triglyceride clearance	NATURE MEDICINE			English	Article							LIPOPROTEIN-LIPASE; RICH LIPOPROTEINS; COLD-EXPOSURE; FATTY-ACID; METABOLISM; INSULIN; DYSLIPIDEMIA; INACTIVATION; HUMANS; PLASMA	Brown adipose tissue (BAT) burns fatty acids for heat production to defend the body against cold(1,2) and has recently been shown to be present in humans(3-5). Triglyceride-rich lipoproteins (TRLs) transport lipids in the bloodstream, where the fatty acid moieties are liberated by the action of lipoprotein lipase (LPL)(6). Peripheral organs such as muscle and adipose tissue take up the fatty acids, whereas the remaining cholesterol-rich remnant particles are cleared by the liver(6). Elevated plasma triglyceride concentrations and prolonged circulation of cholesterol-rich remnants, especially in diabetic dyslipidemia, are risk factors for cardiovascular disease(7-11). However, the precise biological role of BAT for TRL clearance remains unclear. Here we show that increased BAT activity induced by short-term cold exposure controls TRL metabolism in mice. Cold exposure drastically accelerated plasma clearance of triglycerides as a result of increased uptake into BAT, a process crucially dependent on local LPL activity and transmembrane receptor CD36. In pathophysiological settings, cold exposure corrected hyperlipidemia and improved deleterious effects of insulin resistance. In conclusion, BAT activity controls vascular lipoprotein homeostasis by inducing a metabolic program that boosts TRL turnover and channels lipids into BAT. Activation of BAT might be a therapeutic approach to reduce elevated triglyceride concentrations and combat obesity in humans.	[Bartelt, Alexander; Bruegelmann, Karoline; Freund, Barbara; Nielsen, Peter; Merkel, Martin; Heeren, Joerg] Univ Med Ctr Hamburg Eppendorf, Inst Biochem & Mol Biol Mol Cell Biol 2, Hamburg, Germany; [Bruns, Oliver T.; Reimer, Rudolph; Hohenberg, Heinz] Heinrich Pette Inst, Dept Electron Microscopy & Micro Technol, Hamburg, Germany; [Ittrich, Harald; Peldschus, Kersten; Kaul, Michael G.] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol, Hamburg, Germany; [Tromsdorf, Ulrich I.; Weller, Horst] Univ Hamburg, Inst Phys Chem, D-2000 Hamburg, Germany; [Waurisch, Christian; Eychmueller, Alexander] Tech Univ Dresden, Dresden, Germany; [Gordts, Philip L. S. M.] Univ Louvain, Dept Human Genet, Leuven, Belgium; [Rinninger, Franz] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med 3, Hamburg, Germany; [Merkel, Martin] Asklepios Clin St Georg, Dept Internal Med, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; Technische Universitat Dresden; University of Hamburg; University Medical Center Hamburg-Eppendorf; Asklepios Klinik St. Georg	Bartelt, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Biochem & Mol Biol Mol Cell Biol 2, Hamburg, Germany.	abartelt@uke.uni-hamburg.de; heeren@uke.uni-hamburg.de	Weller, Horst/B-5715-2014; Bruns, Oliver T/D-6735-2015; Bartelt, Alexander/ABC-2525-2020; Waurisch, Christian/A-4686-2012	Bruns, Oliver T/0000-0002-5738-0126; Waurisch, Christian/0000-0002-9058-3996; Merkel, Martin/0000-0002-2850-5110; Eychmuller, Alexander/0000-0001-9926-6279; Gordts, Philip/0000-0001-7224-4328	Graduiertenkolleg der Deutschen Forschungsgemeinschaft [1459]; Landesexzellenzinitiative Hamburg; Norgenta; Deutsche Forschungsgemeinschaft [ME1507]; Institute for the Promotion of Innovation through Science and Technology in Flanders; Bundesministerium fur Bildung und Forschung for the Tailored Magnetic Nanoparticles for Cancer Targeting (TOMCAT) [01 EZ 0824]	Graduiertenkolleg der Deutschen Forschungsgemeinschaft(German Research Foundation (DFG)); Landesexzellenzinitiative Hamburg; Norgenta; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Institute for the Promotion of Innovation through Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Bundesministerium fur Bildung und Forschung for the Tailored Magnetic Nanoparticles for Cancer Targeting (TOMCAT)(Federal Ministry of Education & Research (BMBF))	We thank S. Ehret, B. Henkel, E.-M. Azizi, W. Tauscher, C. Edeling, M. Warmer and M. Holthaus for excellent technical assistance. We thank U. Beisiegel for support and critical reading of the manuscript. We thank G. Adam for helpful discussions and support. We thank L. Scheja for helpful discussions and expert technical advice. We are grateful to K.J. Moore (New York University), A. Roebroeck (Katholieke Universiteit Leuven), E. M. Rubin (University of California Berkeley) and L. A. Pennacchio (University of California-Berkeley) for providing transgenic mouse models. A. B. is a fellow of the Ernst Schering Foundation and is supported by the Graduiertenkolleg der Deutschen Forschungsgemeinschaft 1459. This work was supported by the Landesexzellenzinitiative Hamburg, by Norgenta and by grants from the Deutsche Forschungsgemeinschaft to J.H. and M. M. (ME1507) and A. E. (Schwerpunktprogramm 1313), from the Institute for the Promotion of Innovation through Science and Technology in Flanders to P. L. S. M. G. and from the Bundesministerium fur Bildung und Forschung for the Tailored Magnetic Nanoparticles for Cancer Targeting project (TOMCAT, 01 EZ 0824) to H. H., H. I. and P.N. Intravital imaging was performed in collaboration with the Nikon-Applikationszentrum Norddeutschland (Nikon GmbH) at the Heinrich-Pette-Institute.	Augustus AS, 2003, AM J PHYSIOL-ENDOC M, V284, pE331, DOI 10.1152/ajpendo.00298.2002; Austin MA, 2000, CIRCULATION, V101, P2777, DOI 10.1161/01.CIR.101.24.2777; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Bruns OT, 2009, NAT NANOTECHNOL, V4, P193, DOI [10.1038/nnano.2008.405, 10.1038/NNANO.2008.405]; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; CARNEHEIM C, 1984, AM J PHYSIOL, V246, pE327, DOI 10.1152/ajpendo.1984.246.4.E327; Cullen P, 2000, AM J CARDIOL, V86, P943, DOI 10.1016/S0002-9149(00)01127-9; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DOLE VP, 1956, J CLIN INVEST, V35, P150, DOI 10.1172/JCI103259; Eiselein L, 2007, AM J PHYSIOL-HEART C, V292, pH2745, DOI 10.1152/ajpheart.00686.2006; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Gordts PLSM, 2009, ARTERIOSCL THROM VAS, V29, P1258, DOI 10.1161/ATVBAHA.109.192211; Goudriaan JR, 2005, J LIPID RES, V46, P2175, DOI 10.1194/jlr.M500112-JLR200; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Hohenberg H, 1996, J MICROSC-OXFORD, V183, P133, DOI 10.1046/j.1365-2818.1996.820642.x; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Merkel M, 2005, J BIOL CHEM, V280, P21553, DOI 10.1074/jbc.M411412200; Mooradian AD, 2009, NAT CLIN PRACT ENDOC, V5, P150, DOI 10.1038/ncpendmet1066; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Neuger Lucyna, 2004, BMC Physiol, V4, P13, DOI 10.1186/1472-6793-4-13; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Skarulis MC, 2010, J CLIN ENDOCR METAB, V95, P256, DOI 10.1210/jc.2009-0543; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; VALLERAND AL, 1987, AM J PHYSIOL, V253, pE179, DOI 10.1152/ajpendo.1987.253.2.E179; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; von Eckardstein A, 2005, CURR OPIN CLIN NUTR, V8, P147, DOI 10.1097/00075197-200503000-00007; Williams KJ, 2008, J CLIN INVEST, V118, P3247, DOI 10.1172/JCI35206; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	36	1104	1159	11	218	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					200	U93		10.1038/nm.2297	http://dx.doi.org/10.1038/nm.2297			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21258337				2022-12-25	WOS:000286969900028
J	Huh, D; Paulsson, J				Huh, Dann; Paulsson, Johan			Non-genetic heterogeneity from stochastic partitioning at cell division	NATURE GENETICS			English	Article							EUKARYOTIC GENE-EXPRESSION; SINGLE-CELL; PROTEIN EXPRESSION; NOISE; FLUCTUATIONS; NETWORKS; DYNAMICS; MOLECULE; CHLOROPLASTS; ARCHITECTURE	Gene expression involves inherently probabilistic steps that create fluctuations in protein abundances. The results from many in-depth analyses and genome-scale surveys have suggested how such fluctuations arise and spread, often in ways consistent with stochastic models of transcription and translation. But fluctuations also arise during cell division when molecules are partitioned stochastically between the two daughters. Here we mathematically demonstrate how stochastic partitioning contributes to the non-genetic heterogeneity. Our results show that partitioning errors are hard to correct, and that the resulting noise profiles are remarkably difficult to separate from gene expression noise. By applying these results to common experimental strategies and distinguishing between creation versus transmission of noise, we hypothesize that much of the cell-to-cell heterogeneity that has been attributed to various aspects of gene expression instead comes from random segregation at cell division. We propose experiments to separate between these two types of fluctuations and discuss future directions.	[Huh, Dann; Paulsson, Johan] Harvard Univ, Dept Syst Biol, Boston, MA 02115 USA; [Huh, Dann] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Paulsson, J (corresponding author), Harvard Univ, Dept Syst Biol, Boston, MA 02115 USA.	johan_paulsson@hms.harvard.edu			National Science Foundation [DMS-074876-0, CAREER 0720056]; US National Institutes of Health [GM081563-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081563] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported by the National Science Foundation grants DMS-074876-0 and CAREER 0720056 and by grant GM081563-02 from the US National Institutes of Health. We thank I. Golding for valuable comments on the manuscript.	Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; BERG OG, 1978, J THEOR BIOL, V71, P587, DOI 10.1016/0022-5193(78)90326-0; Bergeland T, 2001, CURR BIOL, V11, P644, DOI 10.1016/S0960-9822(01)00177-4; BIRKY CW, 1983, INT REV CYTOL, P49; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Cannon W.B., 1932, WISDOM BODY; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Cookson NA, 2010, NUCLEIC ACIDS RES, V38, P2676, DOI 10.1093/nar/gkp1069; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Grunwald D, 2008, METHOD ENZYMOL, V448, P553, DOI 10.1016/S0076-6879(08)02627-X; HENNIS AS, 1984, J CELL SCI, V70, P1; HOOD RD, 1972, CYTOBIOS, V5, P167; Kar S, 2009, P NATL ACAD SCI USA, V106, P6471, DOI 10.1073/pnas.0810034106; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Mantzaris NV, 2007, BIOPHYS J, V92, P4271, DOI 10.1529/biophysj.106.100271; Marshall WF, 2007, BIOPHYS J, V93, P1818, DOI 10.1529/biophysj.107.107052; Maxwell J.C., 1868, PROC RS, V16, P270, DOI [DOI 10.1098/RSPL.1867.0055, 10.1098/rspl.1867.0055]; MCAULEY PJ, 1990, PHILOS T ROY SOC B, V329, P47, DOI 10.1098/rstb.1990.0148; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; NORDSTROM K, 1989, ANNU REV GENET, V23, P37, DOI 10.1146/annurev.genet.23.1.37; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; PALSSON BO, 1985, J THEOR BIOL, V113, P279, DOI 10.1016/S0022-5193(85)80228-9; Paulsson J, 2000, P NATL ACAD SCI USA, V97, P7148, DOI 10.1073/pnas.110057697; Paulsson J, 2000, PHYS REV LETT, V84, P5447, DOI 10.1103/PhysRevLett.84.5447; Paulsson J, 2005, NAT GENET, V37, P925, DOI 10.1038/ng0905-925; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; RIGNEY DR, 1979, J THEOR BIOL, V76, P453, DOI 10.1016/0022-5193(79)90013-4; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Savage DF, 2010, SCIENCE, V327, P1258, DOI 10.1126/science.1186090; Sheahan MB, 2004, PLANT J, V37, P379, DOI 10.1046/j.1365-313X.2003.01967.x; Shima DT, 1997, J CELL BIOL, V137, P1211, DOI 10.1083/jcb.137.6.1211; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; WARREN G, 1993, ANNU REV BIOCHEM, V62, P323, DOI 10.1146/annurev.bi.62.070193.001543; Wilson EB, 1931, J MORPHOL, V52, P429, DOI 10.1002/jmor.1050520205; Wilson EB, 1916, P NATL ACAD SCI USA, V2, P321, DOI 10.1073/pnas.2.6.321; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	45	242	244	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2011	43	2					95	U32		10.1038/ng.729	http://dx.doi.org/10.1038/ng.729			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	711XD	21186354	Green Accepted			2022-12-25	WOS:000286623800005
J	Sainlos, M; Tigaret, C; Poujol, C; Olivier, NB; Bard, L; Breillat, C; Thiolon, K; Choquet, D; Imperiali, B				Sainlos, Matthieu; Tigaret, Cezar; Poujol, Christel; Olivier, Nelson B.; Bard, Lucie; Breillat, Christelle; Thiolon, Kevin; Choquet, Daniel; Imperiali, Barbara			Biomimetic divalent ligands for the acute disruption of synaptic AMPAR stabilization	NATURE CHEMICAL BIOLOGY			English	Article							ENVIRONMENT-SENSITIVE FLUOROPHORES; TANDEM PDZ DOMAINS; PROTEIN INTERACTIONS; CRYSTAL-STRUCTURES; BIVALENT PEPTIDES; RECEPTOR; STARGAZIN; PSD-95; BINDING; TRAFFICKING	The interactions of the AMPA receptor (AMPAR) auxiliary subunit Stargazin with PDZ domain-containing scaffold proteins such as PSD-95 are critical for the synaptic stabilization of AMPARs. To investigate these interactions, we have developed biomimetic competing ligands that are assembled from two Stargazin-derived PSD-95/DLG/ZO-1 (PDZ) domain-binding motifs using 'click' chemistry. Characterization of the ligands in vitro and in a cellular FRET-based model revealed an enhanced affinity for the multiple PDZ domains of PSD-95 compared to monovalent peptides. In cultured neurons, the divalent ligands competed with transmembrane AMPAR regulatory protein (TARP) for the intracellular membrane-associated guanylate kinase resulting in increased lateral diffusion and endocytosis of surface AMPARs, while showing strong inhibition of synaptic AMPAR currents. This provides evidence for a model in which the TARP-containing AMPARs are stabilized at the synapse by engaging in multivalent interactions. In light of the prevalence of PDZ domain clusters, these new biomimetic chemical tools could find broad application for acutely perturbing multivalent complexes.	[Sainlos, Matthieu; Olivier, Nelson B.; Imperiali, Barbara] MIT, Dept Chem, Cambridge, MA 02139 USA; [Sainlos, Matthieu; Olivier, Nelson B.; Imperiali, Barbara] MIT, Dept Biol, Cambridge, MA USA; [Sainlos, Matthieu; Tigaret, Cezar; Bard, Lucie; Breillat, Christelle; Thiolon, Kevin; Choquet, Daniel] CNRS, UMR 5091, Bordeaux, France; [Sainlos, Matthieu; Tigaret, Cezar; Poujol, Christel; Bard, Lucie; Breillat, Christelle; Thiolon, Kevin; Choquet, Daniel] Univ Bordeaux, Bordeaux, France; [Poujol, Christel] Bordeaux Imaging Ctr, Bordeaux, France	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Sainlos, M (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	dchoquet@u-bordeaux2.fr; imper@mit.edu	Choquet, Daniel/E-4203-2013; Tigaret, Cezar/AAS-6577-2021; Choquet, Daniel/GOJ-8825-2022; Sainlos, Matthieu/H-4253-2013; Choquet, Daniel/K-7893-2018	Tigaret, Cezar/0000-0001-5848-6697; Choquet, Daniel/0000-0003-4726-9763; Sainlos, Matthieu/0000-0001-5465-5641; Choquet, Daniel/0000-0003-4726-9763; Imperiali, Barbara/0000-0002-5749-7869; Poujol, Christel/0000-0002-5222-9064	Human Frontiers Science Program [RGP0007/2006]; European Commission; Agence Nationale pour la Recherche; Conseil Regional d'Aquitaine	Human Frontiers Science Program(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine)	This research was supported by the Human Frontiers Science Program (RGP0007/2006, M. S., D. C. and B. I.), the European Commission Marie Curie postdoctoral fellowship (PICK-CPP to M. S.), grants from the Agence Nationale pour la Recherche (ChemTraffic to M. S. and D. C) and the Conseil Regional d'Aquitaine. The microscopy was done in the Bordeaux Imaging Center of the Neurosciences Institute of the University of Bordeaux II. The help of P. Legros is acknowledged. We are grateful to the staff at the National Synchrotron Light Source beamline X6A for access via the General User program and especially to J. Jackonic for assistance in data collection and reduction.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Bach A, 2009, ANGEW CHEM INT EDIT, V48, P9685, DOI 10.1002/anie.200904741; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bedoukian MA, 2006, J BIOL CHEM, V281, P23908, DOI 10.1074/jbc.M600679200; Bertaso F, 2008, NAT NEUROSCI, V11, P940, DOI 10.1038/nn.2142; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; Dakoji S, 2003, NEUROPHARMACOLOGY, V45, P849, DOI 10.1016/S0028-3908(03)00267-3; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Diaz E, 2010, EUR J NEUROSCI, V32, P261, DOI 10.1111/j.1460-9568.2010.07357.x; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Elias GM, 2008, P NATL ACAD SCI USA, V105, P20953, DOI 10.1073/pnas.0811025106; Elkins JM, 2007, PROTEIN SCI, V16, P683, DOI 10.1110/ps.062657507; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Fourgeaud L, 2003, J BIOL CHEM, V278, P12222, DOI 10.1074/jbc.M205663200; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Goult BT, 2007, BIOCHEMISTRY-US, V46, P14117, DOI 10.1021/bi701257z; Hackeng TM, 1999, P NATL ACAD SCI USA, V96, P10068, DOI 10.1073/pnas.96.18.10068; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Ives JH, 2004, J BIOL CHEM, V279, P31002, DOI 10.1074/jbc.M402214200; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim KS, 2010, J NEUROSCI, V30, P1064, DOI 10.1523/JNEUROSCI.3909-09.2010; Klosi E, 2007, BIOORG MED CHEM LETT, V17, P6147, DOI 10.1016/j.bmcl.2007.09.035; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Marks DR, 2007, J NEUROCHEM, V103, P1608, DOI 10.1111/j.1471-4159.2007.04870.x; Medina I, 1999, EUR J NEUROSCI, V11, P2422, DOI 10.1046/j.1460-9568.1999.00664.x; Paduch M, 2007, CHEMBIOCHEM, V8, P443, DOI 10.1002/cbic.200600389; Pegan S, 2007, BIOCHEMISTRY-US, V46, P5315, DOI 10.1021/bi062228q; Petrini EM, 2009, NEURON, V63, P92, DOI 10.1016/j.neuron.2009.05.025; Piserchio A, 2002, J BIOL CHEM, V277, P6967, DOI 10.1074/jbc.M109453200; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Sainlos M, 2007, NAT PROTOC, V2, P3201, DOI 10.1038/nprot.2007.442; Sainlos M, 2007, NAT PROTOC, V2, P3219, DOI 10.1038/nprot.2007.444; Sainlos M, 2009, J AM CHEM SOC, V131, P6680, DOI 10.1021/ja900371q; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi Y, 2009, NEURON, V62, P633, DOI 10.1016/j.neuron.2009.05.016; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; Vazquez ME, 2004, ORG BIOMOL CHEM, V2, P1965, DOI 10.1039/b408001g; Wang W, 2009, J AM CHEM SOC, V131, P787, DOI 10.1021/ja8076022; Xu W, 2008, NEURON, V57, P248, DOI 10.1016/j.neuron.2007.11.027	50	81	83	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2011	7	2					81	91		10.1038/NCHEMBIO.498	http://dx.doi.org/10.1038/NCHEMBIO.498			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	707XM	21186349				2022-12-25	WOS:000286324600008
J	Shevtsov, SP; Dundr, M				Shevtsov, Sergey P.; Dundr, Miroslav			Nucleation of nuclear bodies by RNA	NATURE CELL BIOLOGY			English	Article							CAJAL BODIES; HUMAN-CELLS; SPLICING FACTORS; NONCODING RNAS; MESSENGER-RNAS; TRANSCRIPTION; LOCALIZATION; PARASPECKLES; ORGANELLES; PROTEIN	The biogenesis of the many functional compartments contained in the mammalian cell nucleus is poorly understood. More specifically, little is known regarding the initial nucleation step required for nuclear body formation. Here we show that RNA can function as a structural element and a nucleator of nuclear bodies. We find that several types of coding and noncoding RNAs are sufficient to de novo assemble, and are physiologically enriched in, histone locus bodies (with associated Cajal bodies), nuclear speckles, paraspeckles and nuclear stress bodies. Formation of nuclear bodies occurs through recruitment and accumulation of proteins resident in the nuclear bodies by nucleating RNA. These results demonstrate that transcription is a driving force in nuclear body formation and RNA transcripts can function as a scaffold in the formation of major nuclear bodies. Together, these data suggest that RNA-primed biogenesis of nuclear bodies is a general principle of nuclear organization.	[Shevtsov, Sergey P.; Dundr, Miroslav] Rosalind Franklin Univ Med & Sci, Dept Cell Biol, N Chicago, IL 60064 USA	Rosalind Franklin University Medical & Science	Dundr, M (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Cell Biol, N Chicago, IL 60064 USA.	mirek.dundr@rosalindfranklin.edu			Schweppe Foundation; Rosalind Franklin University of Medicine and Science	Schweppe Foundation; Rosalind Franklin University of Medicine and Science	We thank A. Belmont, M. Carmo-Fonseca, C. Clemson, V. De Laurenzi, A. Fox, J. Gall, M. Hastings, R. Intine, P. Kalab, A. Lamond, G. Matera, T. Misteli, D. Spector, E. Wagner and J. Zhao for reagents. We are particularly grateful to T. Misteli for helpful suggestions and critical reading of the manuscript and to V. Barr for help with the fast-spinning disc confocal microscope system. This research was supported by a Schweppe Career Development Award (the Schweppe Foundation) to M. D. and by startup funds from the Rosalind Franklin University of Medicine and Science to M.D.	Alastalo TP, 2003, J CELL SCI, V116, P3557, DOI 10.1242/jcs.00671; Biamonti G, 2009, TRENDS BIOCHEM SCI, V34, P146, DOI 10.1016/j.tibs.2008.11.004; Bongiorno-Borbone L, 2008, CELL CYCLE, V7, P2357, DOI 10.4161/cc.6344; Bubulya PA, 2004, J CELL BIOL, V167, P51, DOI 10.1083/jcb.200404120; CARMOFONSECA M, 1993, J CELL BIOL, V120, P841, DOI 10.1083/jcb.120.4.841; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Erkmann JA, 2005, MOL BIOL CELL, V16, P2960, DOI 10.1091/mbc.E04-11-1023; Fox AH, 2005, MOL BIOL CELL, V16, P5304, DOI 10.1091/mbc.E05-06-0587; Frey MR, 2001, J CELL BIOL, V154, P499, DOI 10.1083/jcb.200105084; Hall LL, 2006, ANAT REC PART A, V288A, P664, DOI 10.1002/ar.a.20336; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; Hu Y, 2009, J CELL BIOL, V185, P87, DOI 10.1083/jcb.200809196; Huang S, 1996, J CELL BIOL, V133, P719, DOI 10.1083/jcb.133.4.719; Kaiser TE, 2008, SCIENCE, V322, P1713, DOI 10.1126/science.1165216; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Leung AKL, 2004, J CELL BIOL, V166, P787, DOI 10.1083/jcb.200405013; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Matera AG, 2009, DEV CELL, V17, P639, DOI 10.1016/j.devcel.2009.10.017; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Valgardsdottir R, 2005, MOL BIOL CELL, V16, P2597, DOI 10.1091/mbc.E04-12-1078; Valgardsdottir R, 2008, NUCLEIC ACIDS RES, V36, P423, DOI 10.1093/nar/gkm1056	29	244	248	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2011	13	2					167	U134		10.1038/ncb2157	http://dx.doi.org/10.1038/ncb2157			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714JM	21240286				2022-12-25	WOS:000286805900011
J	[Anonymous]				[Anonymous]			The ART of preventing HIV	NATURE MEDICINE			English	Editorial Material							ANTIRETROVIRAL THERAPY; TRANSMISSION											Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Gallant JE, 2005, CLIN INFECT DIS, V40, P1194, DOI 10.1086/428840; Garcia-Lerma JG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000391; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Mellors J.W., 1996, NAT MED, V2, P1	9	0	0	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					46	47		10.1038/nm0111-46	http://dx.doi.org/10.1038/nm0111-46			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21217682				2022-12-25	WOS:000285994000033
J	Loewer, S; Cabili, MN; Guttman, M; Loh, YH; Thomas, K; Park, IH; Garber, M; Curran, M; Onder, T; Agarwal, S; Manos, PD; Datta, S; Lander, ES; Schlaeger, TM; Daley, GQ; Rinn, JL				Loewer, Sabine; Cabili, Moran N.; Guttman, Mitchell; Loh, Yuin-Han; Thomas, Kelly; Park, In Hyun; Garber, Manuel; Curran, Matthew; Onder, Tamer; Agarwal, Suneet; Manos, Philip D.; Datta, Sumon; Lander, Eric S.; Schlaeger, Thorsten M.; Daley, George Q.; Rinn, John L.			Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells	NATURE GENETICS			English	Article							DEVELOPMENTAL REGULATORS; EXPRESSION; GENERATION; POLYCOMB; TRANSCRIPTION; FIBROBLASTS; METHYLATION; COMPLEXES; NETWORK; TISSUE	The conversion of lineage-committed cells to induced pluripotent stem cells (iPSCs) by reprogramming is accompanied by a global remodeling of the epigenome(1-5), resulting in altered patterns of gene expression(2,6-9). Here we characterize the transcriptional reorganization of large intergenic non-coding RNAs (lincRNAs)(10,11) that occurs upon derivation of human iPSCs and identify numerous lincRNAs whose expression is linked to pluripotency. Among these, we defined ten lincRNAs whose expression was elevated in iPSCs compared with embryonic stem cells, suggesting that their activation may promote the emergence of iPSCs. Supporting this, our results indicate that these lincRNAs are direct targets of key pluripotency transcription factors. Using loss-of-function and gain-of-function approaches, we found that one such lincRNA (lincRNA-RoR) modulates reprogramming, thus providing a first demonstration for critical functions of lincRNAs in the derivation of pluripotent stem cells.	[Loewer, Sabine; Loh, Yuin-Han; Park, In Hyun; Curran, Matthew; Onder, Tamer; Agarwal, Suneet; Manos, Philip D.; Datta, Sumon; Schlaeger, Thorsten M.; Daley, George Q.] Childrens Hosp Boston, Manton Ctr Orphan Dis Res, Div Pediat Hematol & Oncol, Stem Cell Transplantat Program, Boston, MA USA; [Loewer, Sabine; Loh, Yuin-Han; Park, In Hyun; Curran, Matthew; Onder, Tamer; Agarwal, Suneet; Manos, Philip D.; Datta, Sumon; Schlaeger, Thorsten M.; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Loewer, Sabine; Loh, Yuin-Han; Park, In Hyun; Onder, Tamer; Agarwal, Suneet; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Loewer, Sabine; Loh, Yuin-Han; Park, In Hyun; Curran, Matthew; Onder, Tamer; Agarwal, Suneet; Manos, Philip D.; Datta, Sumon; Schlaeger, Thorsten M.; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA USA; [Loewer, Sabine; Loh, Yuin-Han; Park, In Hyun; Onder, Tamer; Manos, Philip D.; Datta, Sumon; Schlaeger, Thorsten M.; Daley, George Q.] Childrens Hosp Boston, Stem Cell Program, Boston, MA USA; [Cabili, Moran N.; Guttman, Mitchell; Thomas, Kelly; Garber, Manuel; Lander, Eric S.; Rinn, John L.] Harvard & Massachusetts Inst Technol, Broad Inst, Cambridge, MA USA; [Guttman, Mitchell; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA USA; [Cabili, Moran N.; Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Thomas, Kelly; Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Daley, George Q.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Boston, MA 02115 USA; [Rinn, John L.] Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Daley, GQ (corresponding author), Childrens Hosp Boston, Manton Ctr Orphan Dis Res, Div Pediat Hematol & Oncol, Stem Cell Transplantat Program, Boston, MA USA.	george.daley@childrens.harvard.edu	Loh, Yuin-Han/E-1096-2014; Onder, Tamer/O-3669-2019; Onder, Tamer T/H-3330-2013	Loh, Yuin-Han/0000-0002-4715-6454; Onder, Tamer/0000-0002-2372-9158; Onder, Tamer T/0000-0002-2372-9158; Rinn, John/0000-0002-7231-7539; Schlaeger, Thorsten/0000-0002-1599-9908	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102815, K08HL089150] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006670] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [1 RC2-HL102815, K08 HL089150, RC2 HL102815] Funding Source: Medline; NIH HHS [DP2 OD006670-01, DP2 OD006670, 1DP2OD00667-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Grant GR, 2005, BIOINFORMATICS, V21, P2684, DOI 10.1093/bioinformatics/bti407; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	35	737	793	1	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2010	42	12					1113	+		10.1038/ng.710	http://dx.doi.org/10.1038/ng.710			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684UZ	21057500	Green Accepted, Green Submitted			2022-12-25	WOS:000284578800015
J	Houlston, RS; Cheadle, J; Dobbins, SE; Tenesa, A; Jones, AM; Howarth, K; Spain, SL; Broderick, P; Domingo, E; Farrington, S; Prendergast, JGD; Pittman, AM; Theodoratou, E; Smith, CG; Olver, B; Walther, A; Barnetson, RA; Churchman, M; Jaeger, EEM; Penegar, S; Barclay, E; Martin, L; Gorman, M; Mager, R; Johnstone, E; Midgley, R; Niittymaki, I; Tuupanen, S; Colley, J; Idziaszczyk, S; Thomas, HJW; Lucassen, AM; Evans, DGR; Maher, ER; Maughan, T; Dimas, A; Dermitzakis, E; Cazier, JB; Aaltonen, LA; Pharoah, P; Kerr, DJ; Carvajal-Carmona, LG; Campbell, H; Dunlop, MG; Tomlinson, IPM				Houlston, Richard S.; Cheadle, Jeremy; Dobbins, Sara E.; Tenesa, Albert; Jones, Angela M.; Howarth, Kimberley; Spain, Sarah L.; Broderick, Peter; Domingo, Enric; Farrington, Susan; Prendergast, James G. D.; Pittman, Alan M.; Theodoratou, Evi; Smith, Christopher G.; Olver, Bianca; Walther, Axel; Barnetson, Rebecca A.; Churchman, Michael; Jaeger, Emma E. M.; Penegar, Steven; Barclay, Ella; Martin, Lynn; Gorman, Maggie; Mager, Rachel; Johnstone, Elaine; Midgley, Rachel; Niittymaki, Iina; Tuupanen, Sari; Colley, James; Idziaszczyk, Shelley; Thomas, Huw J. W.; Lucassen, Anneke M.; Evans, D. Gareth R.; Maher, Eamonn R.; Maughan, Timothy; Dimas, Antigone; Dermitzakis, Emmanouil; Cazier, Jean-Baptiste; Aaltonen, Lauri A.; Pharoah, Paul; Kerr, David J.; Carvajal-Carmona, Luis G.; Campbell, Harry; Dunlop, Malcolm G.; Tomlinson, Ian P. M.		COGENT Consortium; CORGI Consortium; COIN Collaborative Grp; COINB Collaborative Grp	Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33	NATURE GENETICS			English	Article							RISK; GENETICS; DISEASE; VARIANT; SCAN	Genome-wide association studies (GWAS) have identified ten loci harboring common variants that influence risk of developing colorectal cancer (CRC). To enhance the power to identify additional CRC risk loci, we conducted a meta-analysis of three GWAS from the UK which included a total of 3,334 affected individuals (cases) and 4,628 controls followed by multiple validation analyses including a total of 18,095 cases and 20,197 controls. We identified associations at four new CRC risk loci: 1q41 (rs6691170, odds ratio (OR) = 1.06, P = 9.55 x 10(-10) and rs6687758, OR = 1.09, P = 2.27 x 10(-9)), 3q26.2 (rs10936599, OR = 0.93, P = 3.39 x 10(-8)), 12q13.13 (rs11169552, OR = 0.92, P = 1.89 x 10(-10) and rs7136702, OR = 1.06, P = 4.02 x 10(-8)) and 20q13.33 (rs4925386, OR = 0.93, P = 1.89 x 10(-10)). In addition to identifying new CRC risk loci, this analysis provides evidence that additional CRC-associated variants of similar effect size remain to be discovered.	[Houlston, Richard S.; Dobbins, Sara E.; Broderick, Peter; Pittman, Alan M.; Olver, Bianca; Penegar, Steven] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Cheadle, Jeremy; Smith, Christopher G.; Colley, James; Idziaszczyk, Shelley] Cardiff Univ, Sch Med, Inst Med Genet, Cardiff, S Glam, Wales; [Tenesa, Albert; Farrington, Susan; Prendergast, James G. D.; Theodoratou, Evi; Barnetson, Rebecca A.; Dunlop, Malcolm G.] Univ Edinburgh, Inst Genet & Mol Med, Colon Canc Genet Grp, Edinburgh, Midlothian, Scotland; [Tenesa, Albert; Farrington, Susan; Prendergast, James G. D.; Theodoratou, Evi; Barnetson, Rebecca A.; Dunlop, Malcolm G.] MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Jones, Angela M.; Howarth, Kimberley; Spain, Sarah L.; Domingo, Enric; Walther, Axel; Churchman, Michael; Jaeger, Emma E. M.; Barclay, Ella; Martin, Lynn; Gorman, Maggie; Dimas, Antigone; Cazier, Jean-Baptiste; Carvajal-Carmona, Luis G.; Tomlinson, Ian P. M.] Wellcome Trust Ctr Human Genet, Oxford, England; [Mager, Rachel; Johnstone, Elaine; Midgley, Rachel; Kerr, David J.] Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HE, England; [Niittymaki, Iina; Tuupanen, Sari; Aaltonen, Lauri A.] Univ Helsinki, Biomedicum Helsinki, Genome Scale Biol Res Program, Dept Med Genet, Helsinki, Finland; [Thomas, Huw J. W.] St Marks Hosp, Colorectal Canc Unit, Harrow, Middx, England; [Lucassen, Anneke M.] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Evans, D. Gareth R.] St Marys Hosp, Manchester M13 0JH, Lancs, England; [Maher, Eamonn R.] Brigham & Womens Hosp, W Midlands Reg Genet Serv, Birmingham, W Midlands, England; [Maher, Eamonn R.] Univ Birmingham, Dept Med & Mol Genet, Sch Clin & Expt Med, Inst Biomed Res, Birmingham, W Midlands, England; [Maughan, Timothy] Cardiff Univ, Sch Med, Dept Oncol & Palliat Care, Cardiff, S Glam, Wales; [Dimas, Antigone; Dermitzakis, Emmanouil] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Pharoah, Paul] Univ Cambridge, Canc Res UK Labs, Strangeways Res Lab, Dept Oncol, Cambridge, England; [Kerr, David J.] Qatar Fdn, Sidra Med & Res Ctr, Doha, Qatar	University of London; Institute of Cancer Research - UK; Cardiff University; University of Edinburgh; University of Edinburgh; University of Oxford; Wellcome Centre for Human Genetics; Radcliffe Infirmary; University of Oxford; University of Helsinki; Imperial College London; University of Manchester; Birmingham Women's Hospital; University of Birmingham; Cardiff University; University of Geneva; Cancer Research UK; University of Cambridge; Qatar Foundation (QF); Sidra Medical & Research Center	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England.	richard.houlston@icr.ac.uk; malcolm.dunlop@hgu.mrc.ac.uk; iant@well.ox.ac.uk	Farrington, Susan M/C-7319-2013; Aaltonen, Lauri/A-5375-2010; Domingo, Enric/A-9099-2018; Cazier, Jean-Baptiste/F-2369-2010; Dunlop, Malcolm G/F-1973-2011; van Wezel, Tom/A-9599-2008; Campbell, Harry/E-2959-2010; Dermitzakis, Emmanouil/B-7687-2013; Pharoah, Paul/V-6658-2019; Pittman, Alan/AAP-2534-2020; Farrington, Susan M/Q-2710-2019; Theodoratou, Evropi/C-3430-2014; Carvajal-Carmona, Luis G/B-3882-2010; MAHER, EAMONN R/A-9507-2008; Maughan, Timothy/D-5032-2011; van Wezel, Tom/Z-3092-2019; GenePool, The/D-8812-2012; Evans, D Gareth/AAB-4308-2022; Pittman, Alan M/D-6231-2012; Cazier, Jean-Baptiste/GLR-2949-2022; Lucassen, Anneke/D-7764-2017; Spain, Sarah/G-1968-2010; Jones, Alan/F-3086-2015	Aaltonen, Lauri/0000-0001-6839-4286; Domingo, Enric/0000-0003-4390-8767; Cazier, Jean-Baptiste/0000-0001-7581-9051; Dunlop, Malcolm G/0000-0002-3033-5851; van Wezel, Tom/0000-0001-5773-7730; Campbell, Harry/0000-0002-6169-6262; Pharoah, Paul/0000-0001-8494-732X; Pittman, Alan/0000-0002-8112-2987; Farrington, Susan M/0000-0001-5955-7389; Theodoratou, Evropi/0000-0001-5887-9132; Carvajal-Carmona, Luis G/0000-0001-7129-2918; MAHER, EAMONN R/0000-0002-6226-6918; van Wezel, Tom/0000-0001-5773-7730; Evans, D Gareth/0000-0002-8482-5784; Pittman, Alan M/0000-0002-8112-2987; Cazier, Jean-Baptiste/0000-0001-7581-9051; Prendergast, James/0000-0001-8916-018X; Kerr, Rachel/0000-0002-7240-3269; Lucassen, Anneke/0000-0003-3324-4338; Spain, Sarah/0000-0002-7591-8364; Tenesa, Albert/0000-0003-4884-4475; Houlston, Richard/0000-0002-5268-0242; Broderick, Peter/0000-0002-8348-5829; Jones, Alan/0000-0002-3897-5626; churchman, Michael/0000-0003-1958-7692; Penegar, Steven/0000-0002-3768-0236	Cancer Research UK; Oxford Comprehensive Biomedical Research Centre; EU; Core infrastructure; Centre for Human Genetics, Oxford [075491/Z/04]; Medical Research Council [G0000657-53203]; CORE and Scottish Executive Chief Scientist's Office [K/OPR/2/2/D333, CZB/4/449]; Cancer Research UK [C31250/A10107]; Cancer Research Wales, Tenovus and Wales Gene Park; Academy of Finland; Finnish Cancer Society; Sigrid Juselius Foundation; MRC [MC_U122861325, G0301096, MC_U127527198] Funding Source: UKRI; Medical Research Council [MC_U127527198, G0301096, MC_U122861325] Funding Source: researchfish; Tenovus Cancer Care [PhD2009/L27] Funding Source: researchfish; Chief Scientist Office [CZB/4/449] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Oxford Comprehensive Biomedical Research Centre; EU(European Commission); Core infrastructure; Centre for Human Genetics, Oxford; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CORE and Scottish Executive Chief Scientist's Office; Cancer Research UK(Cancer Research UK); Cancer Research Wales, Tenovus and Wales Gene Park; Academy of Finland(Academy of Finland); Finnish Cancer Society; Sigrid Juselius Foundation(Sigrid Juselius Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Tenovus Cancer Care; Chief Scientist Office; The Francis Crick Institute	Cancer Research UK provided principal funding for this study individually to I.P.M.T., M.G.D., R.S.H., P.P. and J. Cheadle. Additional funding was provided by the Oxford Comprehensive Biomedical Research Centre (to E. Domingo and I.P.M.T.) and the EU FP7 CHIBCHA grant (to L.G.C.-C. and I.P.M.T.). Core infrastructure support to the Wellcome Trust Centre for Human Genetics, Oxford was provided by grant 075491/Z/04. We are grateful to many colleagues within UK Clinical Genetics Departments (for CORGI) and to many collaborators who participated in the VICTOR and QUASAR2 trials. We also thank colleagues from the UK National Cancer Research Network (for NSCCG). Additional funding (to M.G.D.) was provided by the Medical Research Council (G0000657-53203), CORE and Scottish Executive Chief Scientist's Office (K/OPR/2/2/D333, CZB/4/449). We (Edinburgh) gratefully acknowledge the work of the COGS and SOCCS administrative teams; R. Cetnarskyj and the research nurse teams, who all recruited subjects to the studies; the Wellcome Trust Clinical Research Facility for sample preparation; and to all clinicians and pathologists throughout Scotland at the collaborating centres. E.T. was funded by a Cancer Research UK Fellowship (C31250/A10107). The study used the biological and data resources of Generation Scotland. COIN and COINB were funded by the UK Medical Research Council. COIN sample analysis (J. Cheadle) was also funded by Cancer Research Wales, Tenovus and Wales Gene Park. For the Helsinki study, the work was supported by grants from Academy of Finland (Finnish Centre of Excellence Program 2006-2011), the Finnish Cancer Society and the Sigrid Juselius Foundation. For the Cambridge study, we thank the SEARCH study team and all the participants in the study. P.P. is a Cancer Research UK Senior Clinical Research Fellow. This study made use of genotyping data from the 1958 Birth Cohort and NBS samples, kindly made available by the Wellcome Trust Case Control Consortium 2. A full list of the investigators who contributed to the generation of the data is available at http://www.wtccc.org.uk/. Finally, we would like to thank all individuals who participated in the study.	Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Houlston RS, 1996, QJM-INT J MED, V89, P737, DOI 10.1093/qjmed/89.10.737; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x; Jones AM, 2005, ONCOGENE, V24, P118, DOI 10.1038/sj.onc.1208194; Petitti Diana B., 1994, Annals of Epidemiology, V4, P115; Power C, 2006, J PEDIATR-US, V148, P54, DOI 10.1016/j.jpeds.2005.07.028; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Tomlinson IPM, 2010, BRIT J CANCER, V102, P447, DOI 10.1038/sj.bjc.6605338; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; ZUCMAN J, 1993, NAT GENET, V4, P341, DOI 10.1038/ng0893-341	14	301	306	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					973	U89		10.1038/ng.670	http://dx.doi.org/10.1038/ng.670			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20972440	Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000283540500014
J	Bunnik, EM; Euler, Z; Welkers, MRA; Boeser-Nunnink, BDM; Grijsen, ML; Prins, JM; Schuitemaker, H				Bunnik, Evelien M.; Euler, Zelda; Welkers, Matthijs R. A.; Boeser-Nunnink, Brigitte D. M.; Grijsen, Marlous L.; Prins, Jan M.; Schuitemaker, Hanneke			Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level	NATURE MEDICINE			English	Article							NEUTRALIZING ANTIBODY-RESPONSE; TYPE-1 INFECTION; C INFECTION; VIRUS; SENSITIVITY; EVOLUTION; DOMAIN	By comparing HIV-1 variants from people who became infected at the beginning of the epidemic and from people who have recently contracted the virus, we observed an enhanced resistance of the virus to antibody neutralization over time, accompanied by an increase in the length of the variable loops and in the number of potential N-linked glycosylation sites on the HIV-1 envelope gp120 subunit. The enhanced neutralization resistance of HIV-1 in contemporary seroconverters coincided with the poorer elicitation of neutralizing antibody responses, which may have implications for vaccine design.	[Bunnik, Evelien M.; Euler, Zelda; Welkers, Matthijs R. A.; Boeser-Nunnink, Brigitte D. M.; Schuitemaker, Hanneke] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Ctr Infect & Immun Amsterdam,Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Grijsen, Marlous L.; Prins, Jan M.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Dept Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Schuitemaker, H (corresponding author), Crucell Holland BV, Leiden, Netherlands.	h.schuitemaker@amc.uva.nl	Prins, Jan M./AAF-4945-2020	Bunnik, Evelien/0000-0003-4003-3053; Welkers, Matthijs/0000-0002-2982-0278	Center for Infectious Disease Control of The Netherlands National Institute for Public Health and the Environment; Dutch AIDS fund [2004064]; Netherlands Organization for Scientific research [918.66.628]	Center for Infectious Disease Control of The Netherlands National Institute for Public Health and the Environment; Dutch AIDS fund; Netherlands Organization for Scientific research(Netherlands Organization for Scientific Research (NWO))	The Amsterdam Cohort Studies on HIV infection and AIDS, a collaboration between the Amsterdam Health Service, the Academic Medical Center of the University of Amsterdam, Sanquin Blood Supply Foundation, the University Medical Center Utrecht and the Jan van Goyen Clinic are part of The Netherlands HIV Monitoring Foundation and are financially supported by the Center for Infectious Disease Control of The Netherlands National Institute for Public Health and the Environment. This study was financially supported by the Dutch AIDS fund (grant 2004064), The Netherlands Organization for Scientific research (grant 918.66.628), an Academic Medical Center graduate school PhD scholarship (M. R. A. W.), the European Community's Six Framework Programme European HIV Enterprise (EUROPRISE; FP6/2007-2012) under grant agreement 037611 and the European Community's Seventh Framework Programme Next Generation HIV-1 Immunogens inducing broadly reactive Neutralizing antibodies (NGIN) (FP7/2007-2013) under grant agreement 201433. We thank the International Antiviral Therapy Evaluation Center for providing financial support for the follow-up of contemporary seroconverters, D. Burton and A. Hessell (The Scripps Research Institute) for their generous supply of IgG1b12, D. Katinger (Polymun, as a partner in EUROPRISE) for his supply of mAbs 2G12, 2F5 and 4E10, and D. Montefiori (Duke University Medical Center) for his supply of HIVIg. The following reagents were obtained through the US National Institutes of Health AIDS Research and Reference Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases: HIV-IG from North American Biologicals and the National Heart, Lung, and Blood Institute.	Bunnik EM, 2008, J VIROL, V82, P7932, DOI 10.1128/JVI.00757-08; Chackerian B, 1997, J VIROL, V71, P7719, DOI 10.1128/JVI.71.10.7719-7727.1997; Euler Z, 2010, J INFECT DIS, V201, P1045, DOI 10.1086/651144; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Laird ME, 2008, J VIROL, V82, P11054, DOI 10.1128/JVI.01341-08; Lambert JS, 1997, J INFECT DIS, V175, P283, DOI 10.1093/infdis/175.2.283; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rong R, 2007, J VIROL, V81, P1350, DOI 10.1128/JVI.01839-06; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470	14	87	91	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2010	16	9					995	997		10.1038/nm.2203	http://dx.doi.org/10.1038/nm.2203			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20802498				2022-12-25	WOS:000281622900027
J	Wu, M; Huang, B; Graham, M; Raimondi, A; Heuser, JE; Zhuang, XW; De Camilli, P				Wu, Min; Huang, Bo; Graham, Morven; Raimondi, Andrea; Heuser, John E.; Zhuang, Xiaowei; De Camilli, Pietro			Coupling between clathrin-dependent endocytic budding and F-BAR-dependent tubulation in a cell-free system	NATURE CELL BIOLOGY			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; WASP-WIP COMPLEX; MEDIATED ENDOCYTOSIS; COATED PITS; MEMBRANE INVAGINATION; ACTIN CYTOSKELETON; DYNAMIN; PROTEINS; CURVATURE; DOMAIN	Cell-free reconstitution of membrane traffic reactions and the morphological characterization of membrane intermediates that accumulate under these conditions have helped to elucidate the physical and molecular mechanisms involved in membrane transport(1-3). To gain a better understanding of endocytosis, we have reconstituted vesicle budding and fission from isolated plasma membrane sheets and imaged these events. Electron and fluorescence microscopy, including subdiffraction-limit imaging by stochastic optical reconstruction microscopy (STORM)(4-6), revealed F-BAR (FBP17) domain coated tubules nucleated by clathrin-coated buds when fission was blocked by GTP gamma S. Triggering fission by replacing GTP gamma S with GTP led not only to separation of clathrin-coated buds, but also to vesicle formation by fragmentation of the tubules. These results suggest a functional link between FBP17-dependent membrane tubulation and clathrin-dependent budding. They also show that clathrin spatially directs plasma membrane invaginations that lead to the generation of endocytic vesicles larger than those enclosed by the coat.	[Wu, Min; Huang, Bo; Raimondi, Andrea; Zhuang, Xiaowei; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Wu, Min; Graham, Morven; Raimondi, Andrea; De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [De Camilli, Pietro] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Raimondi, Andrea; De Camilli, Pietro] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06520 USA; [Huang, Bo; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Heuser, John E.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Harvard University; Harvard University; Washington University (WUSTL)	De Camilli, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA.	pietro.decamilli@yale.edu	Wu, Min/H-8048-2012; Raimondi, Andrea/AAN-2475-2020; Huang, Bo/D-4854-2009; Heuser, John/H-5940-2012; Wu, Min/AAK-8627-2020	Wu, Min/0000-0002-9161-7940; Wu, Min/0000-0002-9161-7940; Raimondi, Andrea/0000-0002-4563-386X	G. Harold and Leila Y. Mathers Charitable Foundation; W.M. Keck Foundation; National Institutes of Health [NS36251, DK45735, GM068518]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036251, R01NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Charitable Foundation; W.M. Keck Foundation(W.M. Keck Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Aurelien Roux and Yuxin Mao for advice and help; Lijun Liu, Frank Wilson and Christoph Rahner for critical technical assistance. This work was supported in part by the G. Harold and Leila Y. Mathers Charitable Foundation, the W.M. Keck Foundation and the National Institutes of Health grants (NS36251 and DK45735) to P.D.C., and National Institutes of Health grant (GM068518) to X.Z.; P.D.C. and X.Z. are Howard Hughes Medical Institute Investigators.	Anitei M, 2010, NAT CELL BIOL, V12, P330, DOI 10.1038/ncb2034; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Giuliani C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000675; He WZ, 2008, NATURE, V455, P542, DOI 10.1038/nature07255; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; MOORE MS, 1987, SCIENCE, V236, P558, DOI 10.1126/science.2883727; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; SCHMID SL, 1991, J CELL BIOL, V114, P869, DOI 10.1083/jcb.114.5.869; Sheetz MP, 1996, TRENDS CELL BIOL, V6, P85, DOI 10.1016/0962-8924(96)80993-7; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; SMYTHE E, 1989, J CELL BIOL, V108, P843, DOI 10.1083/jcb.108.3.843; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001; WILLINGHAM MC, 1981, J HISTOCHEM CYTOCHEM, V29, P1003, DOI 10.1177/29.9.6169759; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	30	115	118	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					902	908		10.1038/ncb2094	http://dx.doi.org/10.1038/ncb2094			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20729836	Green Accepted			2022-12-25	WOS:000281561900014
J	Lau, S; De Smet, I; Kolb, M; Meinhardt, H; Jurgens, G				Lau, Steffen; De Smet, Ive; Kolb, Martina; Meinhardt, Hans; Juergens, Gerd			Auxin triggers a genetic switch	NATURE CELL BIOLOGY			English	Article							ARABIDOPSIS EMBRYO; TRANSCRIPTION FACTOR; RESPONSE ELEMENTS; PLANT DEVELOPMENT; EXPRESSION; CELLS; EMBRYOGENESIS; THALIANA; PROTEINS; FAMILY	Cell specification in development requires robust gene-regulatory responses to transient signals. In plants, the small signalling molecule auxin has been implicated in diverse developmental processes(1,2). Auxin promotes the degradation of AUXIN/INDOLE-3-ACETIC ACID (AUX/IAA) inhibitors that prevent AUXIN RESPONSE FACTOR (ARF) transcription factors from regulating their target genes(1,3). However, the precise role of auxin in patterning has remained unclear, the view of auxin acting as a morphogen is controversial(4,5) and the transcriptional control of the ARF genes themselves is barely explored(6). Here, we demonstrate by experimental and computational analyses that the Arabidopsis ARF protein MONOPTEROS (MP) controls its own expression and the expression of its AUX/IAA inhibitor BODENLOS (BDL), with auxin acting as a threshold-specific trigger by promoting the degradation of the inhibitor. Our results suggest a general mechanism for how the transient accumulation of auxin activates self-sustaining or hysteretic feedback systems of interacting auxin-response proteins that, similarly to other genetic switches, result in unequivocal developmental responses.	[Lau, Steffen; De Smet, Ive; Kolb, Martina; Juergens, Gerd] Max Planck Inst Dev Biol, Dept Cell Biol, D-72076 Tubingen, Germany; [De Smet, Ive; Juergens, Gerd] Univ Tubingen, Ctr Plant Mol Biol, D-72076 Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen	Jurgens, G (corresponding author), Max Planck Inst Dev Biol, Dept Cell Biol, Spemannstr 35, D-72076 Tubingen, Germany.	gerd.juergens@zmbp.uni-tuebingen.de	De Smet, Ive/A-6583-2011; De Smet, Ive/E-6086-2011	De Smet, Ive/0000-0003-4607-8893; De Smet, Ive/0000-0003-4607-8893	Max Planck Society; Deutsche Forschungsgemeinschaft [SFB 446]; European Molecular Biology Organization [ALTF 108-2006]; Marie Curie Intra-European Fellowship [MEIF-CT-2007-041375]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Marie Curie Intra-European Fellowship(European Commission)	We thank C. Brancato for protoplast transfections, R. Kancheva and E. Ozdemir for help with plant work, M. Kientz for help with RNA in situ hybridizations, and D. Weijers and M. Bayer for critical reading of the manuscript. This work was supported by the Max Planck Society, a grant from the Deutsche Forschungsgemeinschaft to G.J. (SFB 446) and long-term postdoctoral fellowships to I.D.S. from the European Molecular Biology Organization (ALTF 108-2006) and the Marie Curie Intra-European Fellowship Scheme (FP6 MEIF-CT-2007-041375).	ABEL S, 1995, J MOL BIOL, V251, P533, DOI 10.1006/jmbi.1995.0454; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; BERLETH T, 1993, DEVELOPMENT, V118, P575; Bhalerao RP, 2003, NAT CELL BIOL, V5, P939, DOI 10.1038/ncb1103-939; Bowman JL, 2008, ANNU REV PLANT BIOL, V59, P67, DOI 10.1146/annurev.arplant.57.032905.105356; Calderon-Villalobos LIA, 2006, PLANT PHYSIOL, V141, P3, DOI 10.1104/pp.106.078097; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cole MF, 2008, COLD SH Q B, V73, P183, DOI 10.1101/sqb.2008.73.027; De Smet I, 2010, PLANT J, V61, P959, DOI 10.1111/j.1365-313X.2010.04143.x; De Smet I, 2010, P NATL ACAD SCI USA, V107, P2705, DOI 10.1073/pnas.0915001107; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Hamann T, 1999, DEVELOPMENT, V126, P1387; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hubbard KE, 2009, MOL BIOSYST, V5, P1502, DOI [10.1039/b907714f, 10.1039/B907714f]; KAUFFMAN SA, 1975, CELL PATTERNING, P201; Lau S, 2008, PLANT CELL, V20, P1738, DOI 10.1105/tpc.108.060418; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; MAYER U, 1993, DEVELOPMENT, V117, P149; MEINHARDT H, 1976, DIFFERENTIATION, V6, P117, DOI 10.1111/j.1432-0436.1976.tb01478.x; Meinhardt H., 1982, MODELS BIOL PATTERN; Moller B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001545; Sauer Michael, 2008, V427, P71, DOI 10.1007/978-1-59745-273-1_5; Schlereth A, 2010, NATURE, V464, P913, DOI 10.1038/nature08836; Schuetze Katia, 2009, V479, P189, DOI 10.1007/978-1-59745-289-2_12; Schwechheimer C, 1998, PLANT MOL BIOL, V36, P195, DOI 10.1023/A:1005990321918; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Takada S, 2007, DEVELOPMENT, V134, P1141, DOI 10.1242/dev.02803; Tian Q, 2002, PLANT CELL, V14, P301, DOI 10.1105/tpc.010283; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Weijers D, 2006, DEV CELL, V10, P265, DOI 10.1016/j.devcel.2005.12.001; Weijers D, 2005, EMBO J, V24, P1874, DOI 10.1038/sj.emboj.7600659	37	88	92	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392			NAT CELL BIOL	Nat. Cell Biol.	MAY 11	2011	13	5					611	U249		10.1038/ncb2212	http://dx.doi.org/10.1038/ncb2212			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	758FY	21478855				2022-12-25	WOS:000290148700020
J	Brest, P; Lapaquette, P; Souidi, M; Lebrigand, K; Cesaro, A; Vouret-Craviari, V; Mari, B; Barbry, P; Mosnier, JF; Hebuterne, X; Harel-Bellan, A; Mograbi, B; Darfeuille-Michaud, A; Hofman, P				Brest, Patrick; Lapaquette, Pierre; Souidi, Mouloud; Lebrigand, Kevin; Cesaro, Annabelle; Vouret-Craviari, Valerie; Mari, Bernard; Barbry, Pascal; Mosnier, Jean-Francois; Hebuterne, Xavier; Harel-Bellan, Annick; Mograbi, Baharia; Darfeuille-Michaud, Arlette; Hofman, Paul			A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease	NATURE GENETICS			English	Article							SEQUENCE VARIANTS; AUTOPHAGY; EXPRESSION; COLI	Susceptibility to Crohn's disease, a complex inflammatory disease, is influenced by common variants at many loci. The common exonic synonymous SNP (c.313C>T) in IRGM, found in strong linkage disequilibrium with a deletion polymorphism, has been classified as non-causative because of the absence of an alteration in the IRGM protein sequence or splice sites. Here we show that a family of microRNAs (miRNAs), miR-196, is overexpressed in the inflammatory intestinal epithelia of individuals with Crohn's disease and downregulates the IRGM protective variant (c.313C) but not the risk-associated allele (c.313T). Subsequent loss of tight regulation of IRGM expression compromises control of intracellular replication of Crohn's disease-associated adherent invasive Escherichia coli by autophagy. These results suggest that the association of IRGM with Crohn's disease arises from a miRNA-based alteration in IRGM regulation that affects the efficacy of autophagy, thereby implicating a synonymous polymorphism as a likely causal variant.	[Brest, Patrick; Cesaro, Annabelle; Vouret-Craviari, Valerie; Hebuterne, Xavier; Mograbi, Baharia; Hofman, Paul] Fac Med Nice, INSERM, ERI 21, EA4319, F-06034 Nice, France; [Brest, Patrick; Lebrigand, Kevin; Cesaro, Annabelle; Vouret-Craviari, Valerie; Mari, Bernard; Barbry, Pascal; Hebuterne, Xavier; Mograbi, Baharia; Hofman, Paul] Univ Nice Sophia Antipolis, Nice, France; [Lapaquette, Pierre; Darfeuille-Michaud, Arlette] Univ Auvergne, Clermont Univ, Jeune Equipe JE 2526, Clermont Ferrand, France; [Lapaquette, Pierre; Darfeuille-Michaud, Arlette] INRA, USC 2018, Clermont Ferrand, France; [Souidi, Mouloud; Harel-Bellan, Annick] Univ Paris 11, FRE 3239, Villejuif, France; [Souidi, Mouloud; Harel-Bellan, Annick] CNRS, Villejuif, France; [Lebrigand, Kevin; Mari, Bernard; Barbry, Pascal] CNRS, Inst Pharmacol Mol & Cellulaire, UMR 6097, F-06560 Valbonne, France; [Mosnier, Jean-Francois] Univ Nantes, EA4273, Nantes, France; [Hebuterne, Xavier] Hop Archet, Ctr Hosp Univ Nice, Serv Gastroenterol, Nice, France; [Hofman, Paul] Hop Louis Pasteur, Ctr Hosp Univ Nice, Ctr Ressource Biol, INSERM, F-06002 Nice, France; [Hofman, Paul] Hop Louis Pasteur, Ctr Hosp Univ Nice, Lab Pathol Clin & Expt, F-06002 Nice, France	CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Universite Clermont Auvergne (UCA); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Nantes Universite; CHU Nice; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice	Hofman, P (corresponding author), Fac Med Nice, INSERM, ERI 21, EA4319, U210, F-06034 Nice, France.	arlette.darfeuille-michaud@u-clermont1.fr; hofman@unice.fr	Hofman, Paul/P-7654-2018; Barbry, Pascal/O-5021-2016; Cesaro, Annabelle/AAX-3177-2020; Mari, Bernard P/D-7445-2015; Mari, Bernard P/F-8960-2013; SOUIDI, Mouloud/ABI-1444-2020; Harel-Bellan, Annick/M-9795-2015; Lapaquette, Pierre/AAF-5537-2020; brest, patrick/B-7311-2012; Mari, Bernard P/GVS-3100-2022; Mograbi, Baharia/Q-7953-2019; Mari, Bernard/Q-5832-2019; Mograbi, Baharia/N-5531-2018	Hofman, Paul/0000-0003-0431-9353; Barbry, Pascal/0000-0001-9632-6483; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; brest, patrick/0000-0002-1252-4747; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard/0000-0002-0422-9182; Harel-Bellan, Annick/0000-0002-2339-153X; Lapaquette, Pierre/0000-0002-2680-351X; Mograbi, Baharia/0000-0002-1025-3429	Ministere de la Recherche et de la Technologie [JE2526]; INRA [USC 2018]; Association F. Aupetit; Institut National du Cancer [07/3D1616/Pdoc-110-32/NG-NC, PL0079, INFLACOL]; European Community [MICROENVIMET, FP7-HEALTH-F2-2008-201279]; Association pour la Recherche sur le Cancer (ARC), Villejuif, France; Integrated Project SIROCCO [LSHG-CT-2006-037900]; French clinical research projects [PHRC-2010]; Infectiopole Sud PACA	Ministere de la Recherche et de la Technologie; INRA; Association F. Aupetit; Institut National du Cancer(Institut National du Cancer (INCA) France); European Community(European Commission); Association pour la Recherche sur le Cancer (ARC), Villejuif, France(Fondation ARC pour la Recherche sur le Cancer); Integrated Project SIROCCO; French clinical research projects; Infectiopole Sud PACA	This work was supported by grants from the Ministere de la Recherche et de la Technologie (JE2526, A. D.-M.), by INRA (USC 2018, A. D.-M.) by the Association F. Aupetit (A. D.-M. and V. V.-C.), by the Institut National du Cancer (07/3D1616/Pdoc-110-32/NG-NC (P. Brest), PL0079 (P. Barbry) and INFLACOL (P. H.)), the European Community (P. Barbry and B. Mari; MICROENVIMET, FP7-HEALTH-F2-2008-201279), Association pour la Recherche sur le Cancer (ARC), Villejuif, France (V. V.-C.), Integrated Project SIROCCO LSHG-CT-2006-037900 (A.H.-B.), French clinical research projects funding program 'MUTCROHN' (PHRC-2010) (X. H.) and the Infectiopole Sud PACA (P. H.). The confocal microscope was the property of the Universite d'Auvergne. The authors would like to thank E. Selva, V. Gavric-Tanga, K. Havet, O. Bordone, G. Cane, M. Ohanna and A. Chargui for their excellent technical assistance.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Bekpen C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000403; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Brest P, 2010, CURR MOL MED, V10, P486, DOI 10.2174/156652410791608252; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cesaro A, 2010, AM J PHYSIOL-GASTR L, V299, pG32, DOI 10.1152/ajpgi.00282.2009; Cesaro A, 2009, AM J PHYSIOL-GASTR L, V296, pG1332, DOI 10.1152/ajpgi.90641.2008; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Lapaquette P, 2010, CELL MICROBIOL, V12, P99, DOI 10.1111/j.1462-5822.2009.01381.x; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; MARY JY, 1989, GUT, V30, P983, DOI 10.1136/gut.30.7.983; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Nonne N, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1100; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Ogura Y, 2003, GUT, V52, P1591, DOI 10.1136/gut.52.11.1591; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Prescott NJ, 2010, HUM MOL GENET, V19, P1828, DOI 10.1093/hmg/ddq041; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681	24	422	441	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2011	43	3					242	U24		10.1038/ng.762	http://dx.doi.org/10.1038/ng.762			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726BR	21278745				2022-12-25	WOS:000287693800015
J	Jiang, P; Du, WJ; Wang, XW; Mancuso, A; Gao, XA; Wu, MA; Yang, XL				Jiang, Peng; Du, Wenjing; Wang, Xingwu; Mancuso, Anthony; Gao, Xiang; Wu, Mian; Yang, Xiaolu			p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase	NATURE CELL BIOLOGY			English	Article							NUCLEAR EXPORT; CANCER; DOMAIN; COMPLEX	Cancer cells consume large quantities of glucose and primarily use glycolysis for ATP production, even in the presence of adequate oxygen(1,2). This metabolic signature (aerobic glycolysis or the Warburg effect) enables cancer cells to direct glucose to biosynthesis, supporting their rapid growth and proliferation(3,4). However, both causes of the Warburg effect and its connection to biosynthesis are not well understood. Here we show that the tumour suppressor p53, the most frequently mutated gene in human tumours, inhibits the pentose phosphate pathway(5) (PPP). Through the PPP, p53 suppresses glucose consumption, NADPH production and biosynthesis. The p53 protein binds to glucose-6-phosphate dehydrogenase (G6PD), the first and rate-limiting enzyme of the PPP, and prevents the formation of the active dimer. Tumour-associated p53 mutants lack the G6PD-inhibitory activity. Therefore, enhanced PPP glucose flux due to p53 inactivation may increase glucose consumption and direct glucose towards biosynthesis in tumour cells.	[Jiang, Peng; Du, Wenjing; Wang, Xingwu; Wu, Mian] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Jiang, Peng; Du, Wenjing; Wang, Xingwu; Wu, Mian] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Jiang, Peng; Du, Wenjing; Mancuso, Anthony; Yang, Xiaolu] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19096 USA; [Jiang, Peng; Du, Wenjing; Mancuso, Anthony; Yang, Xiaolu] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19096 USA; [Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Nanjing University	Wu, MA (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	wumian@ustc.edu.cn; xyang@mail.med.upenn.edu	du, wenjing/A-2530-2013; Wu, Mian/H-2494-2018; Jiang, Peng/A-1946-2013	du, wenjing/0000-0002-3967-9984; Jiang, Peng/0000-0002-4218-0092; Wu, Mian/0000-0002-2714-0500	China National Natural Science Foundation [31030046]; Ministry of Science and Technology [2010CB912804, 2011CB966302]; Chinese Academy of Sciences [KSCX1-YW-R-57]; US National Institutes of Health [CA088868, GM060911]; Department of Defense [W81XWH-07-1-0336, W81XWH-10-1-0468]; NATIONAL CANCER INSTITUTE [R01CA088868, P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060911] Funding Source: NIH RePORTER	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chinese Academy of Sciences(Chinese Academy of Sciences); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Xie for isolating p53<SUP>+/+</SUP> and p53<SUP>-/-</SUP> MEF cells; X. Chen for SW480 cells; B. Vogelstein and W. El-Deiry for HCT116 cells; J. Cross, N. Li, J. Wu, Y. Mei, A. Stonestrom, W. Tan, H. Liu, Y. Hao, X. Zhao and Z. Lou for technical assistance; C. B. Thompson and J. Delikatny for helpful comments; and A. Stonestrom and E. Thompson for help with manuscript preparation. Supported by grants from the China National Natural Science Foundation (31030046), the Ministry of Science and Technology (2010CB912804 and 2011CB966302) and the Chinese Academy of Sciences (KSCX1-YW-R-57) to M.W. and the US National Institutes of Health (CA088868 and GM060911) and the Department of Defense (W81XWH-07-1-0336 and W81XWH-10-1-0468) to X.Y.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Au SWN, 2000, STRUCTURE, V8, P293, DOI 10.1016/S0969-2126(00)00104-0; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Berg J, 2006, BIOCHEMISTRY-US, P577; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Du W, 2009, CELL DEATH DIFFER, V16, P1493, DOI 10.1038/cdd.2009.89; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Inga A, 2001, ONCOGENE, V20, P3409, DOI 10.1038/sj.onc.1204457; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kondoh H, 2005, CANCER RES, V65, P177; MANCUSO A, 1994, BIOTECHNOL BIOENG, V44, P563, DOI 10.1002/bit.260440504; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; Roos D, 1999, BLOOD, V94, P2955; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1924, BIOCHEM Z, V152, P319; Yan WS, 2010, J BIOL CHEM, V285, P14229, DOI 10.1074/jbc.M109.097253; Zhang ZQ, 2000, ANAL BIOCHEM, V285, P163, DOI 10.1006/abio.2000.4701	30	487	524	8	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2011	13	3					310	U278		10.1038/ncb2172	http://dx.doi.org/10.1038/ncb2172			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	728BB	21336310	Green Accepted			2022-12-25	WOS:000287847600019
J	Kump, KL; Bradbury, PJ; Wisser, RJ; Buckler, ES; Belcher, AR; Oropeza-Rosas, MA; Zwonitzer, JC; Kresovich, S; McMullen, MD; Ware, D; Balint-Kurti, PJ; Holland, JB				Kump, Kristen L.; Bradbury, Peter J.; Wisser, Randall J.; Buckler, Edward S.; Belcher, Araby R.; Oropeza-Rosas, Marco A.; Zwonitzer, John C.; Kresovich, Stephen; McMullen, Michael D.; Ware, Doreen; Balint-Kurti, Peter J.; Holland, James B.			Genome-wide association study of quantitative resistance to southern leaf blight in the maize nested association mapping population	NATURE GENETICS			English	Article							INBRED LINE POPULATION; DISEASE RESISTANCE; TRANSCRIPTION FACTORS; TRAIT LOCI; GENETIC ARCHITECTURE; NEGATIVE REGULATOR; DEFENSE-RESPONSE; ARABIDOPSIS NPR1; PROTEIN-KINASES; FLOWERING TIME	Nested association mapping (NAM) offers power to resolve complex, quantitative traits to their causal loci. The maize NAM population, consisting of 5,000 recombinant inbred lines (RILs) from 25 families representing the global diversity of maize, was evaluated for resistance to southern leaf blight (SLB) disease. Joint-linkage analysis identified 32 quantitative trait loci (QTLs) with predominantly small, additive effects on SLB resistance. Genome-wide association tests of maize HapMap SNPs were conducted by imputing founder SNP genotypes onto the NAM RILs. SNPs both within and outside of QTL intervals were associated with variation for SLB resistance. Many of these SNPs were within or near sequences homologous to genes previously shown to be involved in plant disease resistance. Limited linkage disequilibrium was observed around some SNPs associated with SLB resistance, indicating that the maize NAM population enables high-resolution mapping of some genome regions.	[Kump, Kristen L.; Oropeza-Rosas, Marco A.; Holland, James B.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Bradbury, Peter J.; Buckler, Edward S.] Cornell Univ, USDA ARS, Ithaca, NY 14853 USA; [Bradbury, Peter J.; Buckler, Edward S.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA; [Bradbury, Peter J.; Buckler, Edward S.; Kresovich, Stephen; Ware, Doreen] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Wisser, Randall J.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19717 USA; [Belcher, Araby R.; Zwonitzer, John C.; Balint-Kurti, Peter J.] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [McMullen, Michael D.] Univ Missouri, USDA ARS, Columbia, MO 65211 USA; [McMullen, Michael D.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Balint-Kurti, Peter J.; Holland, James B.] USDA ARS, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; Cornell University; United States Department of Agriculture (USDA); Cornell University; Cornell University; University of Delaware; University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA)	Holland, JB (corresponding author), N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA.	jim.holland@ars.usda.gov	Buckler, Edward/L-7651-2019; Buckler, Edward/GPS-4932-2022; Balint-kurti, Peter/AES-0111-2022	Buckler, Edward/0000-0002-3100-371X; Balint-Kurti, Peter/0000-0002-3916-194X; Holland, James/0000-0002-4341-9675	US National Science Foundation [DBI-0321467, IOS-0820619]; USDA-ARS; Pioneer Hi-Bred International; Direct For Biological Sciences [0820619] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Pioneer Hi-Bred International; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank M. Eller, D. Rhyne, D. Stephens, G. Van Esbroek, C. Herring and the staffs of the North Carolina Central Crops Research Station and 27 Farms, Homestead, Florida, USA, for assistance in the field. We also thank J. Green and C.-R. Shyu for providing the photographs for Supplementary Figure 1. This research was supported by the US National Science Foundation (DBI-0321467 and IOS-0820619) and funds were provided by USDA-ARS. K.L.K. is supported by Pioneer Hi-Bred International.	[Anonymous], 2010, R LANG ENV STAT COMP; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Balint-Kurti PJ, 2008, PHYTOPATHOLOGY, V98, P315, DOI 10.1094/PHYTO-98-3-0315; Balint-Kurti PJ, 2007, GENETICS, V176, P645, DOI 10.1534/genetics.106.067892; Balint-Kurti P J, 2006, Phytopathology, V96, P221, DOI 10.1094/PHYTO-96-0221; Balint-Kurti PJ, 2006, PHYTOPATHOLOGY, V96, P1067, DOI 10.1094/PHYTO-96-1067; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Boyle P, 2009, PLANT CELL, V21, P3700, DOI 10.1105/tpc.109.069971; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Broglie K.E., 2009, U.S. Patent, Patent No. 7619133; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; Chern M, 2005, PLANT J, V43, P623, DOI 10.1111/j.1365-313X.2005.02485.x; Chern M, 2005, MOL PLANT MICROBE IN, V18, P511, DOI 10.1094/MPMI-18-0511; Despres C, 2000, PLANT CELL, V12, P279, DOI 10.1105/tpc.12.2.279; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Gu YQ, 2002, PLANT CELL, V14, P817, DOI 10.1105/tpc.000794; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Haldane JBS, 1931, GENETICS, V16, P0357; HOLLEY RN, 1989, PLANT DIS, V73, P562, DOI 10.1094/PD-73-0562; HOOKER A L, 1972, Journal of Environmental Quality, V1, P244, DOI 10.2134/jeq1972.00472425000100030008x; Kou YJ, 2009, PLANT CELL REP, V28, P113, DOI 10.1007/s00299-008-0620-z; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Liu KJ, 2003, GENETICS, V165, P2117; LOH YT, 1995, PLANT PHYSIOL, V108, P1735, DOI 10.1104/pp.108.4.1735; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; Manosalva PM, 2009, PLANT PHYSIOL, V149, P286, DOI 10.1104/pp.108.128348; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; Morris ER, 2003, CURR OPIN PLANT BIOL, V6, P339, DOI 10.1016/S1369-5266(03)00055-4; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; Sacco MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000564; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shah J, 2005, ANNU REV PHYTOPATHOL, V43, P229, DOI 10.1146/annurev.phyto.43.040204.135951; Takemoto D, 1999, PLANT CELL PHYSIOL, V40, P1232, DOI 10.1093/oxfordjournals.pcp.a029511; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Valdar W, 2009, GENETICS, V182, P1263, DOI 10.1534/genetics.109.100727; Vogel JP, 2002, PLANT CELL, V14, P2095, DOI 10.1105/tpc.003509; Wisser RJ, 2006, PHYTOPATHOLOGY, V96, P120, DOI 10.1094/PHYTO-96-0120; Wisser RJ, 2005, GENETICS, V169, P2277, DOI 10.1534/genetics.104.036327; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171; Zhang YL, 1999, P NATL ACAD SCI USA, V96, P6523, DOI 10.1073/pnas.96.11.6523; ZHOU JM, 1995, CELL, V83, P925, DOI 10.1016/0092-8674(95)90208-2; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419; Zwonitzer JC, 2010, PHYTOPATHOLOGY, V100, P72, DOI 10.1094/PHYTO-100-1-0072; Zwonitzer JC, 2009, THEOR APPL GENET, V118, P911, DOI 10.1007/s00122-008-0949-2; [No title captured]; [No title captured]	55	373	409	4	202	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2011	43	2					163	U120		10.1038/ng.747	http://dx.doi.org/10.1038/ng.747			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	711XD	21217757				2022-12-25	WOS:000286623800017
J	Liu, CC; Qi, L; Yanofsky, C; Arkin, AP				Liu, Chang C.; Qi, Lei; Yanofsky, Charles; Arkin, Adam P.			Regulation of transcription by unnatural amino acids	NATURE BIOTECHNOLOGY			English	Article							ESCHERICHIA-COLI; GENETIC-CODE; NASCENT PEPTIDE; EXPRESSION; RIBOSOME; RIBOREGULATORS; BIOSYNTHESIS; ATTENUATION; GENERATION; EVOLUTION	Small-molecule regulation of gene expression is intrinsic to cellular function and indispensable to the construction of new biological sensing, control and expression systems(1,2). However, there are currently only a handful of strategies for engineering such regulatory components and fewer still that can give rise to an arbitrarily large set of inducible systems whose members respond to different small molecules, display uniformity and modularity in their mechanisms of regulation, and combine to actuate universal logics(3-8). Here we present an approach for small-molecule regulation of transcription based on the combination of cis-regulatory leader-peptide elements with genetically encoded unnatural amino acids (amino acids that have been artificially added to the genetic code). In our system, any genetically encoded unnatural amino acid (UAA) can be used as a small-molecule attenuator or activator of gene transcription, and the logics intrinsic to the network defined by expanded genetic codes can be actuated.	[Liu, Chang C.; Qi, Lei; Arkin, Adam P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Liu, Chang C.] Miller Inst Basic Res Sci, Berkeley, CA USA; [Yanofsky, Charles] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Arkin, Adam P.] Univ Calif Berkeley, Calif Inst Quantitat Biol Res QB3, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Liu, CC (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	ccliu@berkeley.edu; aparkin@lbl.gov	Arkin, Adam P/A-6751-2008; Arkin, Adam/M-9941-2019; Qi, Lei S/AAC-5088-2019	Arkin, Adam P/0000-0002-4999-2931; Arkin, Adam/0000-0002-4999-2931; Qi, Lei S/0000-0002-3965-3223; Liu, Chang/0000-0002-3290-2880	National Science Foundation as part of the Synthetic Biology Engineering Research Center; Miller Institute for Basic Scientific Research	National Science Foundation as part of the Synthetic Biology Engineering Research Center; Miller Institute for Basic Scientific Research	We thank P. Schultz (The Scripps Research Institute) for thoughtful comments and the gift of the pEVOL plasmids. We thank J. Lucks for helpful discussions and advice. This work was funded by the National Science Foundation as part of the Synthetic Biology Engineering Research Center (A.P.A.) and the Miller Institute for Basic Scientific Research (C.C.L.).	Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Anderson JC, 2004, P NATL ACAD SCI USA, V101, P7566, DOI 10.1073/pnas.0401517101; Callura JM, 2010, P NATL ACAD SCI USA, V107, P15898, DOI 10.1073/pnas.1009747107; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434; KOLTER R, 1982, ANNU REV GENET, V16, P113, DOI 10.1146/annurev.ge.16.120182.000553; LANDICK R, 1990, J MOL BIOL, V216, P25, DOI 10.1016/S0022-2836(05)80058-0; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Lovett PS, 1996, MICROBIOL REV, V60, P366, DOI 10.1128/MMBR.60.2.366-385.1996; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; Lucks JB, 2008, CURR OPIN MICROBIOL, V11, P567, DOI 10.1016/j.mib.2008.10.002; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Naville Magali, 2009, Briefings in Functional Genomics & Proteomics, V8, P482, DOI 10.1093/bfgp/elp025; Neumann H, 2010, J AM CHEM SOC, V132, P2142, DOI 10.1021/ja9068722; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; ROESSER JR, 1989, J BIOL CHEM, V264, P12284; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Sharma V, 2008, J AM CHEM SOC, V130, P16310, DOI 10.1021/ja805203w; Wan W, 2010, ANGEW CHEM INT EDIT, V49, P3211, DOI 10.1002/anie.201000465; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang L, 2003, P NATL ACAD SCI USA, V100, P56, DOI 10.1073/pnas.0234824100; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Yen L, 2004, NATURE, V431, P471, DOI 10.1038/nature02844; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Zhang KC, 2010, P NATL ACAD SCI USA, V107, P6234, DOI 10.1073/pnas.0912903107	30	30	32	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2011	29	2					164	U111		10.1038/nbt.1741	http://dx.doi.org/10.1038/nbt.1741			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	717DJ	21240267				2022-12-25	WOS:000287023000025
J	Liu, J; Gao, BB; Clermont, AC; Blair, P; Chilcote, TJ; Sinha, S; Flaumenhaft, R; Feener, EP				Liu, Jia; Gao, Ben-Bo; Clermont, Allen C.; Blair, Price; Chilcote, Tamie J.; Sinha, Sukanto; Flaumenhaft, Robert; Feener, Edward P.			Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein	NATURE MEDICINE			English	Article							SPONTANEOUS INTRACEREBRAL HEMORRHAGE; RECEPTOR GLYCOPROTEIN-VI; ACUTE STROKE; ADMISSION HYPERGLYCEMIA; VASCULAR-PERMEABILITY; PLATELET-COLLAGEN; ISCHEMIC-STROKE; MANAGEMENT; MORTALITY; GLUCOSE	Hyperglycemia is associated with greater hematoma expansion and poor clinical outcomes after intracerebral hemorrhage. We show that cerebral hematoma expansion triggered by intracerebral infusion of autologous blood is greater in diabetic rats and mice compared to nondiabetic controls and that this augmented expansion is ameliorated by plasma kallikrein (PK) inhibition or deficiency. Intracerebral injection of purified PK augmented hematoma expansion in both diabetic and acutely hyperglycemic rats, whereas injection of bradykinin, plasmin or tissue plasminogen activator did not elicit such a response. This response, which occurs rapidly, was prevented by co-injection of the glycoprotein VI agonist convulxin and was mimicked by glycoprotein VI inhibition or deficiency, implicating an effect of PK on inhibiting platelet aggregation. We show that PK inhibits collagen-induced platelet aggregation by binding collagen, a response enhanced by elevated glucose concentrations. The effect of hyperglycemia on hematoma expansion and PK-mediated inhibition of platelet aggregation could be mimicked by infusing mannitol. These findings suggest that hyperglycemia auguments cerebral hematoma expansion by PK-mediated osmotic-sensitive inhibition of hemostasis.	[Liu, Jia; Gao, Ben-Bo; Clermont, Allen C.; Feener, Edward P.] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Liu, Jia; Gao, Ben-Bo; Clermont, Allen C.; Feener, Edward P.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Blair, Price; Flaumenhaft, Robert] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Hemostasis & Thrombosis, Boston, MA 02215 USA; [Chilcote, Tamie J.; Sinha, Sukanto] ActiveSite Pharmaceut Inc, Berkeley, CA USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Feener, EP (corresponding author), Joslin Diabet Ctr, Div Res, 1 Joslin Pl, Boston, MA 02215 USA.	edward.feener@joslin.harvard.edu			US National Institutes of Health [EY19029, DK36836, HL090132, HL87203, HL07917]; American Heart Association [0855905D, 0840043N]; NATIONAL EYE INSTITUTE [R01EY019029] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL090132, T32HL007917, P01HL087203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the US National Institutes of Health (grants EY19029, DK36836, HL090132, HL87203 and HL07917) and the American Heart Association (0855905D and 0840043N).	Acar K, 2006, THROMB RES, V118, P765, DOI 10.1016/j.thromres.2005.12.003; Arboix A, 2000, DIABETES CARE, V23, P1527, DOI 10.2337/diacare.23.10.1527; Arthur JF, 2007, BRIT J HAEMATOL, V139, P363, DOI 10.1111/j.1365-2141.2007.06799.x; Asmis LM, 2002, THROMB RES, V105, P463, DOI 10.1016/S0049-3848(02)00045-2; Bhalla A, 2000, STROKE, V31, P2043, DOI 10.1161/01.STR.31.9.2043; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Broderick JP, 2007, STROKE, V38, P1072, DOI 10.1161/01.STR.0000258078.35316.30; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Bruno A, 2008, STROKE, V39, P384, DOI 10.1161/STROKEAHA.107.493544; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Demchuk AM, 1999, STROKE, V30, P34, DOI 10.1161/01.STR.30.1.34; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Fogelholm R, 2005, J NEUROL NEUROSUR PS, V76, P349, DOI 10.1136/jnnp.2003.034819; GALLIMORE MJ, 1978, THROMB RES, V12, P409, DOI 10.1016/0049-3848(78)90312-2; Gao BB, 2007, NAT MED, V13, P181, DOI 10.1038/nm1534; Godoy DA, 2008, NEUROCRIT CARE, V9, P217, DOI 10.1007/s12028-008-9063-1; Godoy DA, 2009, NEUROCRIT CARE, V10, P150, DOI 10.1007/s12028-008-9098-3; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; James ML, 2008, NEUROCRIT CARE, V9, P139, DOI 10.1007/s12028-007-9030-2; Kazui S, 1997, STROKE, V28, P2370, DOI 10.1161/01.STR.28.12.2370; Kehrel B, 1998, BLOOD, V91, P491; Kimura K, 2007, J NEUROL SCI, V255, P90, DOI 10.1016/j.jns.2007.02.005; Lee SH, 2010, DIABETOLOGIA, V53, P429, DOI 10.1007/s00125-009-1617-z; Lippi G, 2009, CLIN BIOCHEM, V42, P118, DOI 10.1016/j.clinbiochem.2008.10.012; McCormick MT, 2008, STROKE, V39, P2177, DOI 10.1161/STROKEAHA.107.496646; Miura Y, 2002, J BIOL CHEM, V277, P46197, DOI 10.1074/jbc.M204029200; Nieswandt B, 2005, J THROMB HAEMOST, V3, P1725, DOI 10.1111/j.1538-7836.2005.01488.x; Nieswandt B, 2000, J BIOL CHEM, V275, P23998, DOI 10.1074/jbc.M003803200; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Passero S, 2003, NEUROLOGY, V61, P1351, DOI 10.1212/01.WNL.0000094326.30791.2D; Phipps JA, 2009, HYPERTENSION, V53, P175, DOI 10.1161/HYPERTENSIONAHA.108.117663; Poppe AY, 2009, DIABETES CARE, V32, P617, DOI 10.2337/dc08-1754; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab; Schmaier AH, 2007, J THROMB HAEMOST, V5, P2323, DOI 10.1111/j.1538-7836.2007.02770.x; Scott JF, 1999, LANCET, V353, P376, DOI 10.1016/S0140-6736(05)74948-5; Stead LG, 2010, NEUROCRIT CARE, V13, P67, DOI 10.1007/s12028-010-9355-0; Stultz CM, 2003, BIOPHYS J, V85, P2198, DOI 10.1016/S0006-3495(03)74645-1; Toyoda K, 2005, NEUROLOGY, V65, P1000, DOI 10.1212/01.wnl.0000179178.37713.69; Walkowiak B, 1997, THROMB RES, V87, P95, DOI 10.1016/S0049-3848(97)00108-4	40	83	93	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					206	U99		10.1038/nm.2295	http://dx.doi.org/10.1038/nm.2295			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21258336	Green Accepted			2022-12-25	WOS:000286969900029
J	Oman, TJ; Boettcher, JM; Wang, HA; Okalibe, XN; van der Donk, WA				Oman, Trent J.; Boettcher, John M.; Wang, Huan; Okalibe, Xenia N.; van der Donk, Wilfred A.			Sublancin is not a lantibiotic but an S-linked glycopeptide	NATURE CHEMICAL BIOLOGY			English	Article							ACID-CONTAINING PEPTIDES; BACILLUS-SUBTILIS; SOLUTION-PHASE; PRODUCT; IDENTIFICATION; BIOSYNTHESIS; TOOLS	Sublancin is shown to be an S-linked glycopeptide containing a glucose attached to a cysteine residue, establishing a new post-translational modification. The activity of the S-glycosyl transferase was reconstituted in vitro, and the enzyme is shown to have relaxed substrate specificity, allowing the preparation of analogs of sublancin. Glycosylation is essential for its antimicrobial activity.	[Oman, Trent J.; Boettcher, John M.; Wang, Huan; van der Donk, Wilfred A.] Univ Illinois, Dept Chem, Urbana, IL USA; [Oman, Trent J.; Boettcher, John M.; Wang, Huan; van der Donk, Wilfred A.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL USA; [Okalibe, Xenia N.] Univ Michigan, Coll Literature Sci & Arts, Ann Arbor, MI 48109 USA	University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Michigan System; University of Michigan	Oman, TJ (corresponding author), Univ Illinois, Dept Chem, Urbana, IL USA.	vddonk@illinois.edu	van der Donk, Wilfred/K-2961-2015	van der Donk, Wilfred/0000-0002-5467-7071	US National Institutes of Health [GM58822]; US National Institutes of Health Cellular and Molecular Biology [T32 GM007283]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007283, R01GM058822] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health Cellular and Molecular Biology; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the US National Institutes of Health (GM58822 to W.A.v.d.D.) and a US National Institutes of Health Cellular and Molecular Biology Training Grant (T32 GM007283 to T.J.O.). X.N.O. was supported by the EXROP summer research program of the Howard Hughes Medical Institute.	BARAN E, 1978, POL J CHEM, V52, P941; Blanchard S, 2006, CURR OPIN CHEM BIOL, V10, P263, DOI 10.1016/j.cbpa.2006.04.001; Cohen SB, 2002, J AM CHEM SOC, V124, P2534, DOI 10.1021/ja011932l; Dorenbos R, 2002, J BIOL CHEM, V277, P16682, DOI 10.1074/jbc.M201158200; Driguez H, 2001, CHEMBIOCHEM, V2, P311; Dubois JYF, 2009, ANTIMICROB AGENTS CH, V53, P651, DOI 10.1128/AAC.01189-08; Fuller E, 2005, FEBS J, V272, P1727, DOI 10.1111/j.1742-4658.2005.04602.x; Galonic DP, 2004, J AM CHEM SOC, V126, P12712, DOI 10.1021/ja046793x; Galonic DP, 2003, CHEM-EUR J, V9, P5997, DOI 10.1002/chem.200305290; Galonic DP, 2005, J AM CHEM SOC, V127, P7359, DOI 10.1021/ja050304r; Goto Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000339; HEMPHILL HE, 1980, CAN J MICROBIOL, V26, P1328, DOI 10.1139/m80-220; Hili R, 2010, J AM CHEM SOC, V132, P2889, DOI 10.1021/ja910544p; Jahn M, 2003, ANGEW CHEM INT EDIT, V42, P352, DOI 10.1002/anie.200390114; Kodani S, 2004, P NATL ACAD SCI USA, V101, P11448, DOI 10.1073/pnas.0404220101; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LOTE CJ, 1971, FEBS LETT, V16, P81, DOI 10.1016/0014-5793(71)80337-X; McIntosh JA, 2009, NAT PROD REP, V26, P537, DOI 10.1039/b714132g; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Paik SH, 1998, J BIOL CHEM, V273, P23134, DOI 10.1074/jbc.273.36.23134; Siezen RJ, 1996, ANTON LEEUW INT J G, V69, P171, DOI 10.1007/BF00399422; Thibodeaux CJ, 2007, NATURE, V446, P1008, DOI 10.1038/nature05814; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501	25	159	170	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2011	7	2					78	80		10.1038/NCHEMBIO.509	http://dx.doi.org/10.1038/NCHEMBIO.509			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	707XM	21196935	Green Accepted			2022-12-25	WOS:000286324600007
J	Melum, E; Franke, A; Schramm, C; Weismuller, TJ; Gotthardt, DN; Offner, FA; Juran, BD; Laerdahl, JK; Labi, V; Bjornsson, E; Weersma, RK; Henckaerts, L; Teufel, A; Rust, C; Ellinghaus, E; Balschun, T; Boberg, KM; Ellinghaus, D; Bergquist, A; Sauer, P; Ryu, E; Hov, JR; Wedemeyer, J; Lindkvist, B; Wittig, M; Porte, RJ; Holm, K; Gieger, C; Wichmann, HE; Stokkers, P; Ponsioen, CY; Runz, H; Stiehl, A; Wijmenga, C; Sterneck, M; Vermeire, S; Beuers, U; Villunger, A; Schrumpf, E; Lazaridis, KN; Manns, MP; Schreiber, S; Karlsen, TH				Melum, Espen; Franke, Andre; Schramm, Christoph; Weismueller, Tobias J.; Gotthardt, Daniel Nils; Offner, Felix A.; Juran, Brian D.; Laerdahl, Jon K.; Labi, Verena; Bjoernsson, Einar; Weersma, Rinse K.; Henckaerts, Liesbet; Teufel, Andreas; Rust, Christian; Ellinghaus, Eva; Balschun, Tobias; Boberg, Kirsten Muri; Ellinghaus, David; Bergquist, Annika; Sauer, Peter; Ryu, Euijung; Hov, Johannes Roksund; Wedemeyer, Jochen; Lindkvist, Bjoern; Wittig, Michael; Porte, Robert J.; Holm, Kristian; Gieger, Christian; Wichmann, H-Erich; Stokkers, Pieter; Ponsioen, Cyriel Y.; Runz, Heiko; Stiehl, Adolf; Wijmenga, Cisca; Sterneck, Martina; Vermeire, Severine; Beuers, Ulrich; Villunger, Andreas; Schrumpf, Erik; Lazaridis, Konstantinos N.; Manns, Michael P.; Schreiber, Stefan; Karlsen, Tom H.			Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci	NATURE GENETICS			English	Article							BOWEL-DISEASE; PATHOGENESIS	Primary sclerosing cholangitis (PSC) is a chronic bile duct disease affecting 2.4-7.5% of individuals with inflammatory bowel disease. We performed a genome-wide association analysis of 2,466,182 SNPs in 715 individuals with PSC and 2,962 controls, followed by replication in 1,025 PSC cases and 2,174 controls. We detected non-HLA associations at rs3197999 in MST1 and rs6720394 near BCL2L11 (combined P = 1.1 x 10(-16) and P = 4.1 x 10(-8), respectively).	[Melum, Espen; Hov, Johannes Roksund; Holm, Kristian; Schrumpf, Erik; Karlsen, Tom H.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Clin Specialized Med & Surg,Norwegian PSC Res Ctr, N-0027 Oslo, Norway; [Melum, Espen; Hov, Johannes Roksund] Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway; [Franke, Andre; Ellinghaus, Eva; Balschun, Tobias; Ellinghaus, David; Wittig, Michael; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Schramm, Christoph; Sterneck, Martina] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [Weismueller, Tobias J.; Wedemeyer, Jochen; Manns, Michael P.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany; [Weismueller, Tobias J.; Wedemeyer, Jochen; Manns, Michael P.] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, D-3000 Hannover, Germany; [Gotthardt, Daniel Nils; Sauer, Peter; Stiehl, Adolf] Univ Heidelberg Hosp, Dept Med, Heidelberg, Germany; [Offner, Felix A.] Acad Teaching Hosp Feldkirch, Feldkirch, Austria; [Juran, Brian D.; Lazaridis, Konstantinos N.] Mayo Clin, Coll Med, Ctr Basic Res Digest Dis, Div Gastroenterol & Hepatol, Rochester, MN USA; [Laerdahl, Jon K.] Univ Oslo, Rikshosp, Oslo Univ Hosp, CMBN, N-0027 Oslo, Norway; [Laerdahl, Jon K.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Inst Med Microbiol, N-0027 Oslo, Norway; [Labi, Verena; Villunger, Andreas] Innsbruck Med Univ, Bioctr, Div Dev Immunol, Innsbruck, Austria; [Bjoernsson, Einar; Lindkvist, Bjoern] Sahlgrens Univ Hosp, Dept Internal Med, Sect Gastroenterol & Hepatol, Gothenburg, Sweden; [Weersma, Rinse K.] Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, NL-9713 AV Groningen, Netherlands; [Weersma, Rinse K.; Wijmenga, Cisca] Univ Groningen, Groningen, Netherlands; [Henckaerts, Liesbet] Univ Hosp Gasthuisberg, Dept Gastroenterol, B-3000 Louvain, Belgium; [Teufel, Andreas] Johannes Gutenberg Univ Mainz, Dept Med 1, D-6500 Mainz, Germany; [Rust, Christian] Univ Munich, Dept Med 2, Munich, Germany; [Bergquist, Annika] Karolinska Univ, Huddinge Hosp, Dept Gastroenterol & Hepatol, Stockholm, Sweden; [Ryu, Euijung] Mayo Clin, Coll Med, Div Biomed Stat & Informat, Rochester, MN USA; [Porte, Robert J.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Gieger, Christian; Wichmann, H-Erich] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Epidemiol, Neuherberg, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H-Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Stokkers, Pieter; Ponsioen, Cyriel Y.; Beuers, Ulrich] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [Runz, Heiko] Univ Heidelberg Hosp, Dept Human Genet, Heidelberg, Germany; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Schreiber, Stefan] Univ Kiel, Dept Gen Internal Med, Kiel, Germany	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Kiel; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; Hannover Medical School; Ruprecht Karls University Heidelberg; Mayo Clinic; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; Medical University of Innsbruck; Sahlgrenska University Hospital; University of Groningen; University of Groningen; KU Leuven; University Hospital Leuven; Johannes Gutenberg University of Mainz; University of Munich; Karolinska Institutet; Karolinska University Hospital; Mayo Clinic; University of Groningen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Amsterdam; Academic Medical Center Amsterdam; Ruprecht Karls University Heidelberg; University of Groningen; University of Kiel	Karlsen, TH (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Clin Specialized Med & Surg,Norwegian PSC Res Ctr, N-0027 Oslo, Norway.	t.h.karlsen@medisin.uio.no	Weersma, Rinse/ABE-3807-2021; Ellinghaus, Eva/E-6490-2012; Ellinghaus, David/G-4467-2012; Wichmann, Heinz Erich/AAA-5695-2022; Teufel, Andreas/ABD-8000-2021; Franke, Andre/B-2151-2010; Henckaerts, Liesbet/AAB-5706-2021; Weismüller, Tobias J./I-1879-2019; Labi, Verena/V-2766-2019; Wijmenga, Cisca/D-2173-2009; Hov, Johannes R/J-1480-2019; Ellinghaus, David/ABC-3610-2020; Wijmenga, Cisca/AAE-7719-2019	Ellinghaus, Eva/0000-0003-2914-3382; Franke, Andre/0000-0003-1530-5811; Weismüller, Tobias J./0000-0001-9736-1483; Labi, Verena/0000-0001-7538-1520; Hov, Johannes R/0000-0002-5900-8096; Ellinghaus, David/0000-0002-4332-6110; Wijmenga, Cisca/0000-0002-5635-1614; Henckaerts, Liesbet/0000-0003-2880-1400; Bergquist, Annika/0000-0002-3858-6241; Schramm, Christoph/0000-0002-4264-1928; Vermeire, Severine/0000-0001-9942-3019; Lindkvist, Bjorn/0000-0001-7485-0006; Gieger, Christian/0000-0001-6986-9554; Laerdahl, Jon Kristen/0000-0002-0826-9464	Norwegian PSC research center; German Federal Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN); PopGen biobank; Integrated Research and Treatment Center [01EO0802]; Palumbo Charitable Trust; Musette and Allen Morgan Jr. Foundation; Helmholtz Center Munich; German Research Center for Environmental Health; German Federal Ministry of Education and Research (BMBF); State of Bavaria; German National Genome Research Network [01GS0823]; Munich Center of Health Sciences (MC Health) as part of Ludwig-Maximilians-Universitat (LMU) innovativ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080670, R01DK084960] Funding Source: NIH RePORTER	Norwegian PSC research center; German Federal Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); PopGen biobank; Integrated Research and Treatment Center; Palumbo Charitable Trust; Musette and Allen Morgan Jr. Foundation; Helmholtz Center Munich(Helmholtz Association); German Research Center for Environmental Health; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; German National Genome Research Network; Munich Center of Health Sciences (MC Health) as part of Ludwig-Maximilians-Universitat (LMU) innovativ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors wish to thank all PSC cases and healthy controls for their participation. We also thank K. Cloppenborg-Schmidt, I. Urbach, I. Pauselis, T. Wesse, T. Henke, R. Vogler, B. Stade, T. Vennegerts, P.R. Berg, H.D. Sollid and B. Woldseth for expert technical help. We are grateful to M.K. Viken and M. Nothnagel for helpful discussions. We acknowledge B.A. Lie and the Norwegian Bone Marrow Donor Registry at Oslo University Hospital, Rikshospitalet for contributing the healthy Norwegian control population. We acknowledge F. Braun, W. Kreisel, T. Berg and R. Gunther for contributing German PSC cases. We acknowledge A. Strasser for generating and kindly providing the Bcl2l11<SUP>-/-</SUP> mouse model. We greatly acknowledge A. Kaser for managing the Bcl2l11<SUP>-/-</SUP> liver histology assessment and for helpful discussions on the functional implications of all findings. The study was supported by The Norwegian PSC research center, the German Federal Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN), the PopGen biobank, the Integrated Research and Treatment Center-Transplantation (reference number: 01EO0802), the Palumbo Charitable Trust, the Musette and Allen Morgan Jr. Foundation for the Study of PSC, PSC Partners Seeking a Cure and the Mayo Clinic College of Medicine. The project received infrastructure support through the Norwegian Functional Genomics Programme (FUGE) through the 'CIGENE' platform, the Research Computing Services at the University of Oslo and the Deutsche Forschungsgemeinschaft (DFG) excellence cluster 'Inflammation at Interfaces'. The Kooperative Gesundheitsforschung in der Region Augsburg (KORA) research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFN-2 and NGFNPlus: 01GS0823). This research was also supported within the Munich Center of Health Sciences (MC Health) as part of Ludwig-Maximilians-Universitat (LMU) innovativ.	Bergquist A, 2008, CLIN GASTROENTEROL H, V6, P939, DOI 10.1016/j.cgh.2008.03.016; Broome U, 2006, SEMIN LIVER DIS, V26, P31, DOI 10.1055/s-2006-933561; Goyette P, 2008, MUCOSAL IMMUNOL, V1, P131, DOI 10.1038/mi.2007.15; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Hsu W, 2009, HEPATOLOGY, V49, P133, DOI 10.1002/hep.22591; Karlsen TH, 2010, HEPATOLOGY, V51, P1833, DOI 10.1002/hep.23564; Karlsen TH, 2010, GASTROENTEROLOGY, V138, P1102, DOI 10.1053/j.gastro.2009.11.046; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	10	172	173	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2011	43	1					17	19		10.1038/ng.728	http://dx.doi.org/10.1038/ng.728			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	699SQ	21151127	Green Accepted			2022-12-25	WOS:000285683500008
J	Lee, H; Deng, JH; Kujawski, M; Yang, CM; Liu, Y; Herrmann, A; Kortylewski, M; Horne, D; Somlo, G; Forman, S; Jove, R; Yu, H				Lee, Heehyoung; Deng, Jiehui; Kujawski, Maciej; Yang, Chunmei; Liu, Yong; Herrmann, Andreas; Kortylewski, Marcin; Horne, David; Somlo, George; Forman, Stephen; Jove, Richard; Yu, Hua			STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors	NATURE MEDICINE			English	Article							LYMPHOCYTE EGRESS; SPHINGOSINE 1-PHOSPHATE; GROWTH-FACTOR; IMMUNE CELLS; CANCER; ANGIOGENESIS; RECEPTORS; SURVIVAL; SPHINGOSINE-1-PHOSPHATE; PHOSPHATE	Interleukin-6 (IL-6)-Janus kinase (JAK) signaling is viewed as crucial for persistent signal transducer and activator of transcription-3 (STAT3) activation in cancer. However, IL-6-induced STAT3 activation is normally transient. Here we identify a key mechanism for persistent STAT3 activation in tumor cells and the tumor microenvironment. We show that expression of sphingosine-1-phosphate receptor-1 (S1PR1), a G protein-coupled receptor for the lysophospholipid sphingosine-1-phosphate (S1P), is elevated in STAT3-positive tumors. STAT3 is a transcription factor for the S1pr1 gene. Reciprocally, enhanced S1pr1 expression activates STAT3 and upregulates II6 gene expression, thereby accelerating tumor growth and metastasis in a STAT3-dependent manner. Silencing S1pr1 in tumor cells or immune cells inhibits tumor STAT3 activity, tumor growth and metastasis. S1P-S1PR1-induced STAT3 activation is persistent, in contrast to transient STAT3 activation by IL-6. S1PR1 activates STAT3 in part by upregulating JAK2 tyrosine kinase activity. We show that STAT3-induced S1PR1 expression, as well as the S1P-S1PR1 pathway reciprocal regulation of STAT3 activity, is a major positive feedback loop for persistent STAT3 activation in cancer cells and the tumor microenvironment and for malignant progression. (C) 2010 Nature America, Inc. All rights reserved.	[Lee, Heehyoung; Deng, Jiehui; Kujawski, Maciej; Yang, Chunmei; Liu, Yong; Herrmann, Andreas; Kortylewski, Marcin; Yu, Hua] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA 91010 USA; [Lee, Heehyoung; Deng, Jiehui; Kujawski, Maciej; Yang, Chunmei; Liu, Yong; Herrmann, Andreas; Kortylewski, Marcin; Horne, David; Somlo, George; Forman, Stephen; Jove, Richard; Yu, Hua] City Hope Comprehens Canc Ctr, Duarte, CA USA; [Horne, David; Jove, Richard] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Somlo, George] City Hope Natl Med Ctr, Beckman Res Inst, Dept Med Oncol, Duarte, CA 91010 USA; [Forman, Stephen] City Hope Natl Med Ctr, Beckman Res Inst, Dept Hematopoiet Cell Transplantat, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Yu, H (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA 91010 USA.	Hyu@coh.org	Liu, Yong/A-2031-2013; Kortylewski, Marcin/H-8052-2019	Kortylewski, Marcin/0000-0002-6003-1816; Deng, Jiehui/0000-0001-7986-8643; YU, Hua/0000-0003-0931-1000	US National Institutes of Health [R01CA115815, R01CA115674, R01CA122976, P50CA107399]; National Cancer Institute [CA 33572]; American Bioscience; NATIONAL CANCER INSTITUTE [R01CA140692, P50CA107399, R01CA115674, P30CA033572, R01CA122976, R01CA115815] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Bioscience; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the flow cytometry core, light microscopy core, pathology core and translational research core, as well as the animal facility, of the Beckman Research Institute at City of Hope for their superb technical assistance. We would also like to thank P. Chu for evaluating histology of breast cancer tissue sections, R. L. Proia at US National Institutes of Health for generously providing the S1pr1<SUP>flox/flox</SUP> mice, V. Poli (University of Turin) for Stat3<SUP>-/-</SUP> MEF cells, T. Ratliff (University of Iowa) for MB49 mouse bladder transitional cell carcinoma cell line, A. Raubitschek (City of Hope Medical Center) for Jurkat human T cell leukemia and Karpas 299 human T cell lymphoma cell lines and S. Priceman for critical reading of this manuscript. This work is funded by US National Institutes of Health grants R01CA115815, R01CA115674, R01CA122976 and P50CA107399. Procurement of clinical specimens used in the study was supported by grants from the National Cancer Institute CA 33572 and American Bioscience.	Ara T, 2009, CANCER RES, V69, P329, DOI 10.1158/0008-5472.CAN-08-0613; Auernhammer CJ, 1999, P NATL ACAD SCI USA, V96, P6964, DOI 10.1073/pnas.96.12.6964; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chae SS, 2004, J CLIN INVEST, V114, P1082, DOI 10.1172/JCI200422716; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Ghoreschi K, 2009, NAT IMMUNOL, V10, P356, DOI 10.1038/ni.1701; Graeler M, 2002, J IMMUNOL, V169, P4084, DOI 10.4049/jimmunol.169.8.4084; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Halak BK, 1999, CANCER RES, V59, P911; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Igarashi J, 2003, P NATL ACAD SCI USA, V100, P10664, DOI 10.1073/pnas.1934494100; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kortylewski M, 2009, NAT BIOTECHNOL, V27, P925, DOI 10.1038/nbt.1564; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Okamoto H, 1998, J BIOL CHEM, V273, P27104, DOI 10.1074/jbc.273.42.27104; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Ram PT, 2000, SCIENCE, V287, P142, DOI 10.1126/science.287.5450.142; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sabbadini RA, 2006, BRIT J CANCER, V95, P1131, DOI 10.1038/sj.bjc.6603400; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	41	294	309	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1421	U105		10.1038/nm.2250	http://dx.doi.org/10.1038/nm.2250			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21102457	Green Accepted			2022-12-25	WOS:000285048900036
J	Nabel, GJ; Fauci, AS				Nabel, Gary J.; Fauci, Anthony S.			Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine	NATURE MEDICINE			English	Article							A VIRUS; MICE; NEUTRALIZATION; HEMAGGLUTININ; ANTIBODIES; INFECTION	The immune system normally responds to influenza virus by making neutralizing antibodies to regions of the viral spike, the hemagglutinin, that vary year to year. This natural response protects against circulating subtypes but necessitates production of new vaccines annually. Newer vaccine approaches have succeeded in eliciting broadly neutralizing antibodies to highly conserved yet vulnerable regions of the hemagglutinin and suggest potential pathways for the development of universal influenza vaccines. (C) 2010 Nature America, Inc. All rights reserved.	[Nabel, Gary J.; Fauci, Anthony S.] NIAID, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Nabel, Gary J.] US Natl Inst Hlth, Vaccine Res Ctr, Inst Allergy & Infect Dis, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nabel, GJ (corresponding author), NIAID, US Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA.	gnabel@nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005003] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Epstein SL, 1997, J IMMUNOL, V158, P1222; Gerhard W, 2006, EMERG INFECT DIS, V12, P569, DOI 10.3201/eid1204.051020; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kashyap AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000990; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; MBAWUIKE IN, 1990, J VIROL, V64, P1370, DOI 10.1128/JVI.64.3.1370-1374.1990; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Rao SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009812; Roose K, 2009, DRUG NEWS PERSPECT, V22, P80, DOI 10.1358/dnp.2009.22.2.1334451; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; SCHULMAN JL, 1965, J BACTERIOL, V89, P170, DOI 10.1128/JB.89.1.170-174.1965; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517	19	125	145	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1389	1391		10.1038/nm1210-1389	http://dx.doi.org/10.1038/nm1210-1389			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21135852				2022-12-25	WOS:000285048900030
J	Sirin, O; Lukov, GL; Mao, R; Conneely, OM; Goodell, MA				Sirin, Olga; Lukov, Georgi L.; Mao, Rui; Conneely, Orla M.; Goodell, Margaret A.			The orphan nuclear receptor Nurr1 restricts the proliferation of haematopoietic stem cells	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTION FACTOR; NGFI-B; GENE; QUIESCENCE; DIFFERENTIATION; IDENTIFICATION; P18(INK4C); SUBFAMILY; BINDING; ABSENCE	Successful haematopoiesis requires long-term retention of haematopoietic stem cells (HSCs) in a quiescent state. The transcriptional regulation of stem cell quiescence, especially by factors with specific functions in HSCs, is only beginning to be understood. Here, we demonstrate that Nurr1, a nuclear receptor transcription factor, has such a regulatory role. Overexpression of Nurr1 drives early haematopoietic progenitors into quiescence. When stem cells overexpressing Nurr1 are transplanted into lethally irradiated mice, they localize to the bone marrow, but do not contribute to regeneration of the blood system. Furthermore, the loss of only one allele of Nurr1 is sufficient to induce HSCs to enter the cell cycle and proliferate. Molecular analysis revealed an association between Nurr1 overexpression and upregulation of the cell-cycle inhibitor p18 (also known as INK4C), suggesting a mechanism by which Nurr1 could regulate HSC quiescence. Our findings provide critical insight into the transcriptional control mechanisms that determine whether HSCs remain dormant or enter the cell cycle and begin to proliferate.	[Sirin, Olga; Goodell, Margaret A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Sirin, Olga; Lukov, Georgi L.; Mao, Rui; Goodell, Margaret A.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Conneely, Orla M.; Goodell, Margaret A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Goodell, MA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	goodell@bcm.edu	Lukov, Georgi/AAI-8544-2021	Goodell, Margaret A./0000-0003-1111-2932	NIH [DK58192, CA111411, CA126752, EB005173, AG034451]; Ellison Foundation [AG-SS178706]; Dan L. Duncan Cancer Center; NATIONAL CANCER INSTITUTE [P50CA126752, R01CA111411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG034451] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Foundation(Lawrence Ellison Foundation); Dan L. Duncan Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank N. Boles, E. J. Dettman, and J. Gilbert for helpful discussion and suggestions, and T. Perlmann for comments on the manuscript. This work was supported by NIH grants DK58192, CA111411, CA126752, EB005173 and AG034451, as well as Ellison Foundation grant AG-SS178706, and the Dan L. Duncan Cancer Center. T. Cheng provided p18-null mice. We also thank S. Watowich for 32D cells.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Castro DS, 2001, J BIOL CHEM, V276, P43277, DOI 10.1074/jbc.M107013200; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Dykstra B, 2006, P NATL ACAD SCI USA, V103, P8185, DOI 10.1073/pnas.0602548103; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Feng CG, 2008, CELL STEM CELL, V2, P83, DOI 10.1016/j.stem.2007.10.007; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Ichikawa M, 2008, J IMMUNOL, V180, P4402, DOI 10.4049/jimmunol.180.7.4402; Jacobs FMJ, 2009, DEVELOPMENT, V136, P531, DOI 10.1242/dev.029769; Ke N, 2004, CANCER RES, V64, P8208, DOI 10.1158/0008-5472.CAN-04-2134; KOTANI H, 1994, HUM GENE THER, V5, P19, DOI 10.1089/hum.1994.5.1-19; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Kubota Y, 2009, BLOOD, V114, P4383, DOI 10.1182/blood-2009-07-230292; Lacorazza HD, 2006, CANCER CELL, V9, P175, DOI 10.1016/j.ccr.2006.02.017; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Maira M, 1999, MOL CELL BIOL, V19, P7549; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Martinat C, 2006, P NATL ACAD SCI USA, V103, P2874, DOI 10.1073/pnas.0511153103; Maruyama K, 1998, INT J ONCOL, V12, P1237; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Nsegbe E, 2004, J PHYSIOL-LONDON, V556, P43, DOI 10.1113/jphysiol.2003.058560; OHKURA N, 1994, BIOCHEM BIOPH RES CO, V205, P1959, DOI 10.1006/bbrc.1994.2900; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; Takeshita M, 2008, LEUKEMIA, V22, P1241, DOI 10.1038/leu.2008.53; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Wang YY, 2008, ACTA BIOCH BIOPH SIN, V40, P711, DOI 10.1111/j.1745-7270.2008.00448.x; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; WILSON TE, 1993, MOL CELL BIOL, V13, P5794, DOI 10.1128/MCB.13.9.5794; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Yu H, 2006, BLOOD, V107, P1200, DOI 10.1182/blood-2005-02-0685; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	43	72	73	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2010	12	12					1213	U210		10.1038/ncb2125	http://dx.doi.org/10.1038/ncb2125			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	688DY	21076412	Green Accepted			2022-12-25	WOS:000284831200013
J	Finkbeiner, S				Finkbeiner, Steven			Bridging the Valley of Death of therapeutics for neurodegeneration	NATURE MEDICINE			English	Article							NEUROIMAGING INITIATIVE PROGRESS; DRUG DEVELOPMENT	Neurodegenerative diseases are the sixth leading cause of death in the US. The market for disease-modifying drugs is enormous, but no drug exists. Academic scientists are increasingly pursuing the discovery and development of therapeutics. Their progress could potentially reduce the risk of failure sufficiently to warrant greater industry investment and movement of leads into clinical trials. Here we consider the many obstacles to the development of therapeutics for neurodegenerative disease within academia, with a special focus on organizational issues.	[Finkbeiner, Steven] Univ Calif San Francisco, Gladstone Inst Neurol Dis, Taube Koret Ctr Huntingtons Dis Res, Consortium Fronto Temporal Dementia Res, San Francisco, CA 94143 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Finkbeiner, S (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, Taube Koret Ctr Huntingtons Dis Res, Consortium Fronto Temporal Dementia Res, San Francisco, CA 94143 USA.	sfinkbeiner@gladstone.ucsf.edu			Taube-Koret Center for Huntington's Disease Research; NIH - National Institute of Neurological Disorders and Stroke [2R01 NS039074, 2R01 NS045091]; NIH - National Institute on Aging [2P01 AG022074]; J. David Gladstone Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045091, R01NS039074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	Taube-Koret Center for Huntington's Disease Research; NIH - National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH - National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); J. David Gladstone Institute(University of California System); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Taube-Koret Center for Huntington's Disease Research, by NIH - National Institute of Neurological Disorders and Stroke grants 2R01 NS039074 and 2R01 NS045091 and NIH - National Institute on Aging grant 2P01 AG022074, and by The J. David Gladstone Institutes. I thank S. Williams, S. Freedman, M. Sutherland, F. Dorey, M. Lopez, L. Bruijn, R. Blumenstein, R. Pacifici, N. Wexler, C. Johnson, C. Austin, L. Vetter, A. Grove, P. Lansbury, T. Reisine, G. Naeve and members of the Finkbeiner laboratory for helpful discussions and/or comments on an early version of this manuscript. I thank G. Howard and S. Ordway for editorial assistance, and K. Nelson for administrative assistance.	Acemoglu D, 2004, Q J ECON, V119, P1049, DOI 10.1162/0033553041502144; Adams CP, 2006, HEALTH AFFAIR, V25, P420, DOI 10.1377/hlthaff.25.2.420; Aisen PS, 2010, ALZHEIMERS DEMENT, V6, P239, DOI 10.1016/j.jalz.2010.03.006; *ALZH ASS, 2010, ALZHEIMERS DEMENT, V6, P158, DOI DOI 10.1016/J.JALZ.2010.01.009; BENEDETTI F, 2010, NEUROPSYCHOPHAR 0630, DOI DOI 10.1038/NPP.2010.81; Boettiger S, 2006, NAT BIOTECHNOL, V24, P320, DOI 10.1038/nbt0306-320; BYNUM J, 2009, 1 ALZH ASS; *CDCP, 2007, STAT HLTH AG AM; COCKBURN IM, 2000, NBER INNOVATION POLI, V1, P20; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Duggan M, 2005, J HEALTH ECON, V24, P1, DOI 10.1016/j.jhealeco.2004.08.001; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fraser J., 2009, TOMORROWS TECHNOLOGY, V1, P9; Friedman J, 2003, J TECHNOL TRANSFER, V28, P17, DOI [DOI 10.1023/A:1021674618658, 10.1023/A:1021674618658]; HANSON S, 2009, VENT PHIL STRAT SUPP; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Ioannidis JPA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010036; Lach S, 2004, J EUR ECON ASSOC, V2, P252, DOI 10.1162/154247604323067961; Lanjouw JO, 2001, WORLD DEV, V29, P265, DOI 10.1016/S0305-750X(00)00099-1; Link A. N., 2005, EUR J FINANC, V11, P169, DOI [10.1080/1351847042000254211, DOI 10.1080/1351847042000254211]; Lockett A, 2005, RES POLICY, V34, P1043, DOI 10.1016/j.respol.2005.05.006; Markman G., 2004, J TECHNOLOGY TRANSFE, V29, P353, DOI DOI 10.1023/B:JOTT.0000034127.01889.86; Mebane-Sims I, 2009, ALZHEIMERS DEMENT, V5, P234, DOI 10.1016/j.jalz.2009.03.001; National Institutes of Health, NIH BLUEPR NEUR RES; Reinhardt UE, 2001, HEALTH AFFAIR, V20, P136, DOI 10.1377/hlthaff.20.5.136; SPIEGEL A, 2010, NATL PUBLIC RADIO; THURSBY J, 2000, AUTM J, V12, P9; THURSBY JG, 2001, J TECHNOLOGY TRANSFE, V26, P59, DOI DOI 10.1023/A:1007884111883; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007; Young T. A., 2005, INT J INTELLECT PROP, V1, P13; 2010, ECONOMIST       0617, V395, P81	31	35	35	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1227	1232		10.1038/nm.2222	http://dx.doi.org/10.1038/nm.2222			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21052079				2022-12-25	WOS:000283860100031
J	Nakamura, M; Ehrhardt, DW; Hashimoto, T				Nakamura, Masayoshi; Ehrhardt, David W.; Hashimoto, Takashi			Microtubule and katanin-dependent dynamics of microtubule nucleation complexes in the acentrosomal Arabidopsis cortical array	NATURE CELL BIOLOGY			English	Article							GAMMA-TUBULIN COMPLEX; ORGANIZATION; CYTOSKELETON; FUSION; SITES	Microtubule nucleation in interphase plant cells primarily occurs through branching from pre-existing microtubules at dispersed sites in the cell cortex(1,2,3). The minus ends of new microtubules are often released from the sites of nucleation, and the free microtubules are then transported to new locations by polymer treadmilling(1). These nucleation-and-release events are characteristic features of plant arrays in interphase cells, but little is known about the spatiotemporal control of these events by nucleating protein complexes. We visualized the dynamics of two fluorescently-tagged gamma-tubulin complex proteins, GCP2 and GCP3, in Arabidopsis thaliana. These probes labelled motile complexes in the cytosol that transiently stabilized at fixed locations in the cell cortex. Recruitment of labelled complexes occurred preferentially along existing cortical microtubules, from which new microtubule was synthesized in a branching manner, or in parallel to the existing microtubule. Complexes localized to microtubules were approximately 10-fold more likely to display nucleation than were complexes recruited to other locations. Nucleating complexes remained stable until daughter microtubules were either completely depolymerized from their plus ends or released by katanin-dependent severing activity. These observations suggest that the nucleation complexes are primarily activated on association with microtubule lattices, and that nucleation complex stability depends on association with daughter microtubules and is regulated in part by katanin activity.	[Nakamura, Masayoshi; Hashimoto, Takashi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300192, Japan; [Ehrhardt, David W.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Ehrhardt, David W.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Nara Institute of Science & Technology; Carnegie Institution for Science; Stanford University	Hashimoto, T (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300192, Japan.	ehrhardt@stanford.edu; hasimoto@bs.naist.jp	Nakamura, Masayoshi/D-1979-2017	Nakamura, Masayoshi/0000-0002-7107-4942	JSPS; NAIST (Frontier Biosciences: strategies for survival and adaptation in a changing global environment), MEXT, Japan; Carnegie Institution for Science;  [20370023]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NAIST (Frontier Biosciences: strategies for survival and adaptation in a changing global environment), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Carnegie Institution for Science; 	We thank Y. Fukao and M. Fujiwara (The Plant Science Education Unit, NAIST) for the mass spectrometry analysis, T. Kato for providing the katanin alleles, and D. Moss and R. Gutierrez for helpful discussions. The Arabidopsis Biological Resource Center is acknowledged for providing the genomic clones. M.N. was supported by a JSPS Research Fellowship for Young Scientist. The work was partly supported by a grant (20370023) and Global CUE Program in NAIST (Frontier Biosciences: strategies for survival and adaptation in a changing global environment), MEXT, Japan, to T.H., and by endowment funds of the Carnegie Institution for Science to D.W.E.	Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Binarova P, 2006, PLANT CELL, V18, P1199, DOI 10.1105/tpc.105.038364; Bouquin T, 2003, J CELL SCI, V116, P791, DOI 10.1242/jcs.00274; Burk DH, 2001, PLANT CELL, V13, P807, DOI 10.1105/tpc.13.4.807; Chan J, 2003, NAT CELL BIOL, V5, P967, DOI 10.1038/ncb1057; Chan J, 2009, PLANT CELL, V21, P2298, DOI 10.1105/tpc.109.069716; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crowell EF, 2009, PLANT CELL, V21, P1141, DOI 10.1105/tpc.108.065334; Dixit R, 2004, PLANT CELL, V16, P3274, DOI 10.1105/tpc.104.026930; Ehrhardt DW, 2006, ANNU REV PLANT BIOL, V57, P859, DOI 10.1146/annurev.arplant.57.032905.105329; Erhardt M, 2002, J CELL SCI, V115, P2423; FU VGUV, 2005, ARABIDOPSIS */* CELL, V120, P687; Fujiwara M, 2009, PLANT CELL PHYSIOL, V50, P1191, DOI 10.1093/pcp/pcp077; Galatis B, 2004, NEW PHYTOL, V161, P613, DOI 10.1046/j.1469-8137.2003.00986.x; Gutierrez R, 2009, NAT CELL BIOL, V11, P797, DOI 10.1038/ncb1886; Janson ME, 2005, J CELL BIOL, V169, P297, DOI 10.1083/jcb.200410119; Kong ZS, 2010, PLANT CELL, V22, P191, DOI 10.1105/tpc.109.071191; LIU B, 1994, PLANT CELL, V6, P303, DOI 10.1105/tpc.6.2.303; MAZIA D, 1984, EXP CELL RES, V153, P1, DOI 10.1016/0014-4827(84)90442-7; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; Murata T, 2005, NAT CELL BIOL, V7, P961, DOI 10.1038/ncb1306; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nakamura M, 2004, PLANT CELL PHYSIOL, V45, P1330, DOI 10.1093/pcp/pch300; Nakamura M, 2009, J CELL SCI, V122, P2208, DOI 10.1242/jcs.044131; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Pastuglia M, 2006, PLANT CELL, V18, P1412, DOI 10.1105/tpc.105.039644; Roll-Mecak A, 2006, J CELL BIOL, V175, P849, DOI 10.1083/jcb.200611149; Rubio V, 2005, PLANT J, V41, P767, DOI 10.1111/j.1365-313X.2004.02328.x; Seltzer V, 2007, PLANT J, V52, P322, DOI 10.1111/j.1365-313X.2007.03240.x; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; Sheahan MB, 2004, PLANT PHYSIOL, V136, P3968, DOI 10.1104/pp.104.049411; Stoppin-Mellet V, 2006, PLANT J, V46, P1009, DOI 10.1111/j.1365-313X.2006.02761.x; WASTENEYS GO, 1989, J CELL SCI, V93, P705; Wasteneys GO, 2002, J CELL SCI, V115, P1345; Wiese C, 2000, NAT CELL BIOL, V2, P358, DOI 10.1038/35014051; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Zeng CJT, 2009, PLANT CELL, V21, P1129, DOI 10.1105/tpc.109.065953	39	161	164	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2010	12	11					1064	U49		10.1038/ncb2110	http://dx.doi.org/10.1038/ncb2110			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	674CO	20935636				2022-12-25	WOS:000283711500009
J	Hammer, MF; Woerner, AE; Mendez, FL; Watkins, JC; Cox, MP; Wall, JD				Hammer, Michael F.; Woerner, August E.; Mendez, Fernando L.; Watkins, Joseph C.; Cox, Murray P.; Wall, Jeffrey D.			The ratio of human X chromosome to autosome diversity is positively correlated with genetic distance from genes	NATURE GENETICS			English	Article							BACKGROUND SELECTION; PATTERNS; GENOME	The ratio of X-linked to autosomal diversity was estimated from an analysis of six human genome sequences and found to deviate from the expected value of 0.75. However, the direction of this deviation depends on whether a particular sequence is close to or far from the nearest gene. This pattern may be explained by stronger locally acting selection on X-linked genes compared with autosomal genes, combined with larger effective population sizes for females than for males.	[Hammer, Michael F.; Woerner, August E.; Cox, Murray P.] Univ Arizona, Arizona Res Labs, Div Biotechnol, Tucson, AZ 85721 USA; [Hammer, Michael F.; Mendez, Fernando L.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Wall, Jeffrey D.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Watkins, Joseph C.] Univ Arizona, Dept Math, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; University of California System; University of California San Francisco; University of Arizona	Hammer, MF (corresponding author), Univ Arizona, Arizona Res Labs, Div Biotechnol, Tucson, AZ 85721 USA.	mfh@email.arizona.edu	Cox, Murray/A-1459-2012	Cox, Murray/0000-0003-1936-0236; Mendez, Fernando/0000-0002-0879-3813	Direct For Social, Behav & Economic Scie [0813715] Funding Source: National Science Foundation	Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Betancourt AJ, 2004, GENETICS, V168, P2261, DOI 10.1534/genetics.104.030999; Bustamante CD, 2009, NAT GENET, V41, P8, DOI 10.1038/ng0109-8; Charlesworth B, 1996, GENET RES, V68, P131, DOI 10.1017/S0016672300034029; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Hammer MF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000202; HUDSON RR, 1995, GENETICS, V141, P1605; Keinan A, 2009, NAT GENET, V41, P66, DOI 10.1038/ng.303; Lu J, 2005, P NATL ACAD SCI USA, V102, P4063, DOI 10.1073/pnas.0500436102; Payseur BA, 2002, MOL BIOL EVOL, V19, P336, DOI 10.1093/oxfordjournals.molbev.a004086; Pool JE, 2007, EVOLUTION, V61, P3001, DOI 10.1111/j.1558-5646.2007.00238.x; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Tapper W, 2005, P NATL ACAD SCI USA, V102, P11835, DOI 10.1073/pnas.0505262102; Vicoso B, 2009, GENETICS, V181, P1699, DOI 10.1534/genetics.108.098004; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102	15	69	69	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2010	42	10					830	831		10.1038/ng.651	http://dx.doi.org/10.1038/ng.651			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	655UO	20802480				2022-12-25	WOS:000282276600011
J	Netz, DJA; Stumpfig, M; Dore, C; Muhlenhoff, U; Pierik, AJ; Lill, R				Netz, Daili J. A.; Stuempfig, Martin; Dore, Carole; Muehlenhoff, Ulrich; Pierik, Antonio J.; Lill, Roland			Tah18 transfers electrons to Dre2 in cytosolic iron-sulfur protein biogenesis	NATURE CHEMICAL BIOLOGY			English	Article							SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONE; METHIONINE SYNTHASE; MITOCHONDRIAL; SCAFFOLD; EXPRESSION; MATURATION; CLUSTERS; BIOSYNTHESIS; ACTIVATION	Cytosolic and nuclear iron-sulfur (Fe-S) proteins play key roles in processes such as ribosome maturation, transcription and DNA repair-replication. For biosynthesis of their Fe-S clusters, a dedicated cytosolic Fe-S protein assembly (CIA) machinery is required. Here, we identify the essential flavoprotein Tah18 as a previously unrecognized CIA component and show by cell biological, biochemical and spectroscopic approaches that the complex of Tah18 and the CIA protein Dre2 is part of an electron transfer chain functioning in an early step of cytosolic Fe-S protein biogenesis. Electrons are transferred from NADPH via the FAD- and FMN-containing Tah18 to the Fe-S clusters of Dre2. This electron transfer chain is required for assembly of target but not scaffold Fe-S proteins, suggesting a need for reduction in the generation of stably inserted Fe-S clusters. The pathway is conserved in eukaryotes, as human Ndor1-Ciapin1 proteins can functionally replace yeast Tah18-Dre2.	[Netz, Daili J. A.; Stuempfig, Martin; Dore, Carole; Muehlenhoff, Ulrich; Pierik, Antonio J.; Lill, Roland] Univ Marburg, Inst Zytobiol & Zytopathol, Marburg, Germany	Philipps University Marburg	Netz, DJA (corresponding author), Univ Marburg, Inst Zytobiol & Zytopathol, Marburg, Germany.	pierik@staff.uni-marburg.de; lill@staff.uni-marburg.de	Pierik, Antonio J/G-1108-2010	Pierik, Antonio J/0000-0002-1509-6370; Lill, Roland/0000-0002-8345-6518	Deutsche Forschungsgemeinschaft [SFB 593, GRK 1216]; Rhon Klinikum AG; von Behring-Rontgen Stiftung; LOEWE program of state Hessen; Max-Planck Gesellschaft; Fonds der chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Rhon Klinikum AG; von Behring-Rontgen Stiftung; LOEWE program of state Hessen; Max-Planck Gesellschaft(Max Planck Society); Fonds der chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	We thank S. Molik for plasmid construction and D. Vogel for help with cloning. We acknowledge generous support from the Deutsche Forschungsgemeinschaft (SFB 593, the Gottfried-Wilhelm Leibniz program and GRK 1216), Rhon Klinikum AG, von Behring-Rontgen Stiftung, LOEWE program of state Hessen, Max-Planck Gesellschaft and Fonds der chemischen Industrie.	Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; Chanet R, 2003, CURR GENET, V43, P337, DOI 10.1007/s00294-003-0407-2; Craig EA, 2002, CELL MOL LIFE SCI, V59, P1658, DOI 10.1007/PL00012493; Dutkiewicz R, 2006, J BIOL CHEM, V281, P7801, DOI 10.1074/jbc.M513301200; FAEDER EJ, 1973, ANAL BIOCHEM, V53, P332, DOI 10.1016/0003-2697(73)90442-9; Finn RD, 2005, PHARMACOGENET GENOM, V15, P381, DOI 10.1097/01213011-200506000-00002; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kim J, 2008, P NATL ACAD SCI USA, V105, P14551, DOI 10.1073/pnas.0805989105; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; Li J, 2001, J BIOL CHEM, V276, P1503, DOI 10.1074/jbc.M007198200; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Molik S, 2007, METHOD CELL BIOL, V80, P261, DOI 10.1016/S0091-679X(06)80013-0; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Murataliev MB, 2004, BBA-PROTEINS PROTEOM, V1698, P1, DOI 10.1016/j.bbapap.2003.10.003; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Olteanu H, 2003, J BIOL CHEM, V278, P38310, DOI 10.1074/jbc.M306282200; Paine MJI, 2000, J BIOL CHEM, V275, P1471, DOI 10.1074/jbc.275.2.1471; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; SANTOS MA, 1995, J BIOL CHEM, V270, P437, DOI 10.1074/jbc.270.1.437; Schwenkert S, 2010, BIOCHEM J, V425, P207, DOI 10.1042/BJ20091290; SHEN AL, 1995, J BIOL CHEM, V270, P27475, DOI 10.1074/jbc.270.46.27475; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Song DS, 2008, J BIOL CHEM, V283, P9231, DOI 10.1074/jbc.M708077200; Srinivasan V, 2007, STRUCTURE, V15, P1246, DOI 10.1016/j.str.2007.08.009; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Urzica E, 2009, BIOCHEMISTRY-US, V48, P4946, DOI 10.1021/bi900312x; Vernis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004376; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; Yamada K, 2006, P NATL ACAD SCI USA, V103, P9476, DOI 10.1073/pnas.0603694103; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	50	146	154	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2010	6	10					758	765		10.1038/NCHEMBIO.432	http://dx.doi.org/10.1038/NCHEMBIO.432			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	651YM	20802492				2022-12-25	WOS:000281964100013
J	Ray, NB; Durairaj, L; Chen, BB; McVerry, BJ; Ryan, AJ; Donahoe, M; Waltenbaugh, AK; O'Donnell, CP; Henderson, FC; Etscheidt, CA; Mccoy, DM; Agassandian, M; Hayes-Rowan, EC; Coon, TA; Butler, PL; Gakhar, L; Mathur, SN; Sieren, JC; Tyurina, YY; Kagan, VE; McLennan, G; Mallampalli, RK				Ray, Nancy B.; Durairaj, Lakshmi; Chen, Bill B.; McVerry, Bryan J.; Ryan, Alan J.; Donahoe, Michael; Waltenbaugh, Alisa K.; O'Donnell, Christopher P.; Henderson, Florita C.; Etscheidt, Christopher A.; Mccoy, Diann M.; Agassandian, Marianna; Hayes-Rowan, Emily C.; Coon, Tiffany A.; Butler, Phillip L.; Gakhar, Lokesh; Mathur, Satya N.; Sieren, Jessica C.; Tyurina, Yulia Y.; Kagan, Valerian E.; McLennan, Geoffrey; Mallampalli, Rama K.			Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumonia	NATURE MEDICINE			English	Article							PULMONARY-EDEMA; PROTEIN; SURFACE; GENE; PHOSPHOLIPIDS; EXPRESSION; RESPONSES; MEMBRANE; DISEASE; ENZYME	Pneumonia remains the leading cause of death from infection in the US, yet fundamentally new conceptual models underlying its pathogenesis have not emerged. We show that humans and mice with bacterial pneumonia have markedly elevated amounts of cardiolipin, a rare, mitochondrial-specific phospholipid, in lung fluid and find that it potently disrupts surfactant function. Intratracheal cardiolipin administration in mice recapitulates the clinical phenotype of pneumonia, including impaired lung mechanics, modulation of cell survival and cytokine networks and lung consolidation. We have identified and characterized the activity of a unique cardiolipin transporter, the P-type ATPase transmembrane lipid pump Atp8b1, a mutant version of which is associated with severe pneumonia in humans and mice. Atp8b1 bound and internalized cardiolipin from extracellular fluid via a basic residue-enriched motif. Administration of a peptide encompassing the cardiolipin binding motif or Atp8b1 gene transfer in mice lessened bacteria-induced lung injury and improved survival. The results unveil a new paradigm whereby Atp8b1 is a cardiolipin importer whose capacity to remove cardiolipin from lung fluid is exceeded during inflammation or when Atp8b1 is defective. This discovery opens the door for new therapeutic strategies directed at modulating the abundance or molecular interactions of cardiolipin in pneumonia.	[Chen, Bill B.; McVerry, Bryan J.; Donahoe, Michael; Waltenbaugh, Alisa K.; O'Donnell, Christopher P.; Hayes-Rowan, Emily C.; Coon, Tiffany A.; Mallampalli, Rama K.] Univ Pittsburgh, Dept Internal Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15260 USA; [Ray, Nancy B.; Durairaj, Lakshmi; Ryan, Alan J.; Henderson, Florita C.; Etscheidt, Christopher A.; Mccoy, Diann M.; Agassandian, Marianna; Mathur, Satya N.; Sieren, Jessica C.; McLennan, Geoffrey] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Butler, Phillip L.; Gakhar, Lokesh] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Tyurina, Yulia Y.; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Ctr Free Radl & Antioxidant Hlth, Pittsburgh, PA USA; [McLennan, Geoffrey] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA; [McLennan, Geoffrey] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Mallampalli, RK (corresponding author), Univ Pittsburgh, Dept Internal Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15260 USA.	mallampallirk@upmc.edu	McVerry, Bryan/AAS-7790-2021; Gakhar, Lokesh/P-8356-2019; Gakhar, Lokesh/F-2113-2010	McVerry, Bryan/0000-0002-1175-4874; Gakhar, Lokesh/0000-0002-3319-1902; Gakhar, Lokesh/0000-0002-3319-1902; O'Donnell, Christopher/0000-0002-9120-6850; Tyurina, Yulia/0000-0003-0287-2091; Durairaj, Lakshmi/0000-0002-8072-3430; Sieren, Jessica/0000-0002-1109-7886; Kagan, Valerian E./0000-0002-7245-1885	US Department of Veterans Affairs; US National Institutes of Health [R01 HL068135, HL080229, HL081784, HL096376, HL097376, HL098174, HL70755, HL094488, NIOSH OH008282, K23 HL075402, U01 HL102288]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007344, R01HL094488, U01HL102288, R01HL080229, K08HL083101, R01HL081784, R01HL098174, R01HL070755, R01HL097376, R01HL068135, R01HL096376, K23HL075402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH008282] Funding Source: NIH RePORTER	US Department of Veterans Affairs(US Department of Veterans Affairs); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	We thank M. E. Anderson, M.J. Welsh, J. Zabner and M. Gladwin for critical review of the manuscript and helpful suggestions. The Atp8b1<SUP>G308V/G308V</SUP> 129S1/SvlmJ mutant mice14 were a generous gift from L. Bull (University of California-San Francisco). Nontypable H. influenza strain 12 bacteria were kindly provided by D. Look (University of Iowa) 29. Antibodies to ATP8b1 were generous gifts from D. Ortiz (Tufts University) 30 and M. Ananthanarayanan (Mount Sinai School of Medicine) 31. This material is based upon work supported, in part, by the US Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. This work was supported by a Merit Review Award from the US Department of Veterans Affairs and US National Institutes of Health R01 grants HL068135, HL080229, HL081784, HL096376, HL097376 and HL098174 (to R. K. M.), HL70755, HL094488 and NIOSH OH008282 (to V. E. K.) and K23 HL075402 and U01 HL102288 (to L. D.). The contents do not represent the views of the Department of Veterans Affairs or the US government.	ALBERT RK, 1979, J CLIN INVEST, V63, P1015, DOI 10.1172/JCI109369; Benarafa C, 2007, J EXP MED, V204, P1901, DOI 10.1084/jem.20070494; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borron P, 2000, AM J PHYSIOL-LUNG C, V278, pL840, DOI 10.1152/ajplung.2000.278.4.L840; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Chen BB, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706472200; Dullforce P, 1998, NAT MED, V4, P88, DOI 10.1038/nm0198-088; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frankenberg T, 2008, HEPATOLOGY, V48, P1896, DOI 10.1002/hep.22431; Frick AG, 2000, J IMMUNOL, V164, P4185, DOI 10.4049/jimmunol.164.8.4185; Grossmann G, 1999, J APPL PHYSIOL, V86, P633, DOI 10.1152/jappl.1999.86.2.633; HUGHES DA, 1989, CHEST, V95, P82, DOI 10.1378/chest.95.1.82; Jirsa M, 2004, HEPATOL RES, V30, P1, DOI 10.1016/j.hepres.2004.05.001; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kaewsuya P, 2007, ANAL BIOANAL CHEM, V387, P2775, DOI 10.1007/s00216-007-1135-0; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; KENNEDY JI, 1990, J THORAC CARDIOV SUR, V100, P145; Koppelman CM, 2001, J BACTERIOL, V183, P6144, DOI 10.1128/JB.183.20.6144-6147.2001; Ksenzenko SM, 1997, J APPL PHYSIOL, V82, P2020, DOI 10.1152/jappl.1997.82.6.2020; LIAU DF, 1984, J LIPID RES, V25, P678; Mallampalli RK, 2000, J BIOL CHEM, V275, P9699, DOI 10.1074/jbc.275.13.9699; MCCORMACK FX, 1991, AM REV RESPIR DIS, V144, P160, DOI 10.1164/ajrccm/144.1.160; McCoy DM, 2006, AM J RESP CELL MOL, V35, P394, DOI 10.1165/rcmb.2005-0401OC; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Pawlikowska L, 2004, HUM MOL GENET, V13, P881, DOI 10.1093/hmg/ddh100; Pawlikowska L, 2010, J HEPATOL, V53, P170, DOI 10.1016/j.jhep.2010.01.034; Ritov VB, 2006, J CHROMATOGR B, V831, P63, DOI 10.1016/j.jchromb.2005.11.031; ROONEY SA, 1994, FASEB J, V8, P957, DOI 10.1096/fasebj.8.12.8088461; Sorice M, 2000, CLIN EXP IMMUNOL, V122, P277, DOI 10.1046/j.1365-2249.2000.01353.x; SUTRINA SL, 1976, J GEN MICROBIOL, V92, P410, DOI 10.1099/00221287-92-2-410; Ujhazy P, 2001, HEPATOLOGY, V34, P768, DOI 10.1053/jhep.2001.27663; van Mil SWC, 2001, SEMIN LIVER DIS, V21, P535, DOI 10.1055/s-2001-19034; Wang ZD, 1998, AM J RESP CRIT CARE, V158, P28, DOI 10.1164/ajrccm.158.1.9709041; WHITINGTON PF, 1994, J PEDIATR GASTR NUTR, V18, P134, DOI 10.1097/00005176-199402000-00003; Yamazoe M, 2008, J BIOL CHEM, V283, P35878, DOI 10.1074/jbc.M807268200; Zhou J, 2006, GENE THER, V13, P974, DOI 10.1038/sj.gt.3302746; 2008, AHRQ NEWS NUMBE 0702	38	106	110	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2010	16	10					1120	U1		10.1038/nm.2213	http://dx.doi.org/10.1038/nm.2213			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20852622	Green Accepted			2022-12-25	WOS:000282644800042
J	Baksh, MM; Kussrow, AK; Mileni, M; Finn, MG; Bornhop, DJ				Baksh, Michael M.; Kussrow, Amanda K.; Mileni, Mauro; Finn, M. G.; Bornhop, Darryl J.			Label-free quantification of membrane-ligand interactions using backscattering interferometry	NATURE BIOTECHNOLOGY			English	Article							ALPHA-KETOHETEROCYCLE INHIBITORS; ACID AMIDE HYDROLASE; BIOLOGICAL-ACTIVITY; CHEMOKINE RECEPTOR; PHOSPHINIC ACID; BINDING; POTENT; GANGLIOSIDES; MECHANISM; TARGET	Although membrane proteins are ubiquitous within all living organisms and represent the majority of drug targets, a general method for direct, label-free measurement of ligand binding to native membranes has not been reported. Here we show that backscattering interferometry (BSI) can accurately quantify ligand-receptor binding affinities in a variety of membrane environments. By detecting minute changes in the refractive index of a solution, BSI allows binding interactions of proteins with their ligands to be measured at picomolar concentrations. Equilibrium binding constants in the micromolar to picomolar range were obtained for small-and large-molecule interactions in both synthetic and cell-derived membranes without the use of labels or supporting substrates. The simple and low-cost hardware, high sensitivity and label-free nature of BSI should make it readily applicable to the study of many membrane-associated proteins of biochemical and pharmacological interest.	[Baksh, Michael M.; Finn, M. G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Mileni, Mauro] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Kussrow, Amanda K.; Bornhop, Darryl J.] Vanderbilt Univ, Dept Chem, Vanderbilt Inst Chem Biol, Nashville, TN USA	Scripps Research Institute; Scripps Research Institute; Vanderbilt University	Finn, MG (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	mgfinn@scripps.edu; darryl.bornhop@vanderbilt.edu		Staijen, Erik/0000-0001-8682-4366	US National Institutes of Health [RO1 EB003537-01A2, U01 MH069062]; Joint Center for Innovative Membrane Protein Technologies [GM073197]; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, T32GM065086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH069062] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joint Center for Innovative Membrane Protein Technologies; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the US National Institutes of Health (RO1 EB003537-01A2; U01 MH069062; and the Joint Center for Innovative Membrane Protein Technologies, Roadmap Grant GM073197) and The Skaggs Institute for Chemical Biology. We are grateful to J. Garfunkel and D. Boger of The Scripps Research Institute for samples of the FAAH inhibitors, R. Stevens of The Scripps Research Institute for samples of the FAAH protein, M. Hanes and T. Handel of the University of California, San Diego for the samples of the CXCL12 chemokine and K. Kaupmann of Novartis for the GABA<INF>B</INF>-transfected CHO cell line.	Boger DL, 2005, J MED CHEM, V48, P1849, DOI 10.1021/jm049614v; Bornhop DJ, 2007, SCIENCE, V317, P1732, DOI 10.1126/science.1146559; BOWERY NG, 1985, NEUROPHARMACOLOGY, V24, P207, DOI 10.1016/0028-3908(85)90075-9; BRIAN AA, 1984, P NATL ACAD SCI-BIOL, V81, P6159, DOI 10.1073/pnas.81.19.6159; BRUGGER F, 1993, EUR J PHARMACOL, V235, P153, DOI 10.1016/0014-2999(93)90836-7; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cannon B, 2005, LANGMUIR, V21, P9666, DOI 10.1021/la0502645; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cravatt BF, 2003, CURR OPIN CHEM BIOL, V7, P469, DOI 10.1016/S1367-5931(03)00079-6; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Fang Y, 2003, LANGMUIR, V19, P1500, DOI 10.1021/la026151s; FISHMAN PH, 1993, ADV LIPID RES, V25, P165; FROESTL W, 1995, J MED CHEM, V38, P3297, DOI 10.1021/jm00017a015; Garfunkle J, 2008, J MED CHEM, V51, P4392, DOI 10.1021/jm800136b; Hesselgesser J, 1998, J IMMUNOL, V160, P877; HOWSON W, 1993, BIOORG MED CHEM LETT, V3, P515, DOI 10.1016/S0960-894X(01)81218-X; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Krummel MF, 2002, CURR OPIN IMMUNOL, V14, P66, DOI 10.1016/S0952-7915(01)00299-0; Kussrow A, 2011, CHEMBIOCHEM, V12, P367, DOI 10.1002/cbic.201000671; Kussrow A, 2010, ANALYST, V135, P1535, DOI 10.1039/c0an00098a; Kussrow A, 2009, ANAL CHEM, V81, P4889, DOI 10.1021/ac900569c; Kuziemko GM, 1996, BIOCHEMISTRY-US, V35, P6375, DOI 10.1021/bi952314i; Latham JC, 2009, ANAL CHEM, V81, P1865, DOI 10.1021/ac802327h; Markov DA, 2004, J AM CHEM SOC, V126, P16659, DOI 10.1021/ja047820m; Mileni M, 2009, J AM CHEM SOC, V131, P10497, DOI 10.1021/ja902694n; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pin JP, 2004, BIOCHEM PHARMACOL, V68, P1565, DOI 10.1016/j.bcp.2004.06.035; Romero FA, 2007, J MED CHEM, V50, P1058, DOI 10.1021/jm0611509; Sonnino S, 2007, GLYCOBIOLOGY, V17, p1R, DOI 10.1093/glycob/cwl052; Sorensen HS, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2356380; Urwyler S, 2001, MOL PHARMACOL, V60, P963, DOI 10.1124/mol.60.5.963; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6	33	62	70	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2011	29	4					357	U173		10.1038/nbt.1790	http://dx.doi.org/10.1038/nbt.1790			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	746XY	21399645	Green Accepted			2022-12-25	WOS:000289284900022
J	Wagner, BK				Wagner, Bridget K.			SCREENING Low-fat worms on drugs	NATURE CHEMICAL BIOLOGY			English	News Item							C-ELEGANS; CAENORHABDITIS-ELEGANS; IDENTIFICATION; ZEBRAFISH; STORAGE; MODEL		Broad Inst Harvard & MIT, Chem Biol Program, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Wagner, BK (corresponding author), Broad Inst Harvard & MIT, Chem Biol Program, Cambridge, MA USA.	bwagner@broadinstitute.org						Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Lemieux GA, 2011, NAT CHEM BIOL, V7, P206, DOI [10.1038/nchembio.534, 10.1038/NCHEMBIO.534]; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; McKay RM, 2003, DEV CELL, V4, P131, DOI 10.1016/S1534-5807(02)00411-2; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; Petrascheck M, 2009, ANN NY ACAD SCI, V1170, P698, DOI 10.1111/j.1749-6632.2009.04377.x; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012	10	0	0	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	APR	2011	7	4					194	195		10.1038/nchembio.540	http://dx.doi.org/10.1038/nchembio.540			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CC	21423161				2022-12-25	WOS:000288545000003
J	Chin, L; Andersen, JN; Futreal, PA				Chin, Lynda; Andersen, Jannik N.; Futreal, P. Andrew			Cancer genomics: from discovery science to personalized medicine	NATURE MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; ANAPLASTIC LYMPHOMA KINASE; EML4-ALK FUSION GENE; SOMATIC MUTATIONS; ALK KINASE; ACTIVATING MUTATIONS; MONOCLONAL-ANTIBODY; FGFR2 MUTATIONS; PIK3CA GENE	Recent advances in genome technologies and the ensuing outpouring of genomic information related to cancer have accelerated the convergence of discovery science and clinical medicine. Successful examples of translating cancer genomics into therapeutics and diagnostics reinforce its potential to make possible personalized cancer medicine. However, the bottlenecks along the path of converting a genome discovery into a tangible clinical endpoint are numerous and formidable. In this Perspective, we emphasize the importance of establishing the biological relevance of a cancer genomic discovery in realizing its clinical potential and discuss some of the major obstacles to moving from the bench to the bedside.	[Chin, Lynda; Andersen, Jannik N.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Chin, Lynda] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Chin, Lynda] Broad Inst MIT & Harvard, Cambridge, MA USA; [Futreal, P. Andrew] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Wellcome Trust Sanger Institute	Chin, L (corresponding author), Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA.	lynda_chin@dfci.harvard.edu		Andersen, Jannik/0000-0003-4528-2120				Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; BOS JL, 1985, NATURE, V315, P726, DOI 10.1038/315726a0; Brachmann S, 2009, CURR OPIN CELL BIOL, V21, P194, DOI 10.1016/j.ceb.2008.12.011; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; CAPON DJ, 1983, NATURE, V304, P507, DOI 10.1038/304507a0; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dierks C, 2010, CANCER RES, V70, P6193, DOI 10.1158/0008-5472.CAN-08-3719; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Handolias D, 2010, BRIT J CANCER, V102, P1219, DOI 10.1038/sj.bjc.6605635; Haura EB, 2010, CLIN CANCER RES, V16, P2450, DOI 10.1158/1078-0432.CCR-09-1920; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Kwitkowski VE, 2010, ONCOLOGIST, V15, P428, DOI 10.1634/theoncologist.2009-0178; Kwong LN, 2010, CELL, V140, P180, DOI 10.1016/j.cell.2010.01.013; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; McEllin B, 2010, CANCER RES, V70, P5457, DOI 10.1158/0008-5472.CAN-09-4295; MCGRATH JP, 1983, NATURE, V304, P501, DOI 10.1038/304501a0; Mendes-Pereira AM, 2009, EMBO MOL MED, V1, P315, DOI 10.1002/emmm.200900041; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pechloff K, 2010, J EXP MED, V207, P1031, DOI 10.1084/jem.20092042; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Riccaboni M, 2010, DRUG DISCOV TODAY, V15, P517, DOI 10.1016/j.drudis.2010.05.001; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; SHIMIZU K, 1983, NATURE, V304, P497, DOI 10.1038/304497a0; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soda M, 2008, P NATL ACAD SCI USA, V105, P19893, DOI 10.1073/pnas.0805381105; Sousa SF, 2008, CURR MED CHEM, V15, P1478, DOI 10.2174/092986708784638825; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Turke AB, 2010, CLIN CANCER RES, V16, P3523, DOI 10.1158/1078-0432.CCR-10-1201; Uckun FM, 2010, BRIT J HAEMATOL, V149, P508, DOI 10.1111/j.1365-2141.2010.08106.x; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhao L, 2008, P NATL ACAD SCI USA, V105, P2652, DOI 10.1073/pnas.0712169105	67	410	421	1	109	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2011	17	3					297	303		10.1038/nm.2323	http://dx.doi.org/10.1038/nm.2323			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21383744				2022-12-25	WOS:000288070000040
J	Yang, JJ; Cheng, C; Devidas, M; Cao, XY; Fan, YP; Campana, D; Yang, WJ; Neale, G; Cox, NJ; Scheet, P; Borowitz, MJ; Winick, NJ; Martin, PL; Willman, CL; Bowman, WP; Camitta, BM; Carroll, A; Reaman, GH; Carroll, WL; Loh, M; Hunger, SP; Pui, CH; Evans, WE; Relling, MV				Yang, Jun J.; Cheng, Cheng; Devidas, Meenakshi; Cao, Xueyuan; Fan, Yiping; Campana, Dario; Yang, Wenjian; Neale, Geoff; Cox, Nancy J.; Scheet, Paul; Borowitz, Michael J.; Winick, Naomi J.; Martin, Paul L.; Willman, Cheryl L.; Bowman, W. Paul; Camitta, Bruce M.; Carroll, Andrew; Reaman, Gregory H.; Carroll, William L.; Loh, Mignon; Hunger, Stephen P.; Pui, Ching-Hon; Evans, William E.; Relling, Mary V.			Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia	NATURE GENETICS			English	Article							CHILDRENS-CANCER-GROUP; MINIMAL RESIDUAL DISEASE; ACUTE LYMPHOID LEUKEMIA; DELAYED INTENSIFICATION; CHILDHOOD-CANCER; WHITE-CHILDREN; ONCOLOGY-GROUP; SURVIVAL; THERAPY; TRIAL	Although five-year survival rates for childhood acute lymphoblastic leukemia (ALL) are now over 80% in most industrialized countries(1), not all children have benefited equally from this progress(2). Ethnic differences in survival after childhood ALL have been reported in many clinical studies(3-11), with poorer survival observed among African Americans or those with Hispanic ethnicity when compared with European Americans or Asians(3-5). The causes of ethnic differences remain uncertain, although both genetic and non-genetic factors are likely important(4,12). Interrogating genome-wide germline SNP genotypes in an unselected large cohort of children with ALL, we observed that the component of genomic variation that co-segregated with Native American ancestry was associated with risk of relapse (P = 0.0029) even after adjusting for known prognostic factors (P = 0.017). Ancestry-related differences in relapse risk were abrogated by the addition of a single extra phase of chemotherapy, indicating that modifications to therapy can mitigate the ancestry-related risk of relapse.	[Yang, Jun J.; Yang, Wenjian; Evans, William E.; Relling, Mary V.] St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Cheng, Cheng; Cao, Xueyuan] St Jude Childrens Hosp, Dept Biostat, Memphis, TN 38105 USA; [Devidas, Meenakshi] Univ Florida, Dept Epidemiol & Hlth Policy Res, Gainesville, FL USA; [Fan, Yiping; Neale, Geoff] St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Campana, Dario; Pui, Ching-Hon] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; [Cox, Nancy J.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Scheet, Paul] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Borowitz, Michael J.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Winick, Naomi J.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Martin, Paul L.] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Willman, Cheryl L.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Bowman, W. Paul] Cook Childrens Med Ctr, Ft Worth, TX USA; [Camitta, Bruce M.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Carroll, Andrew] Univ Alabama, Dept Genet, Birmingham, AL USA; [Reaman, Gregory H.] George Washington Univ, Childrens Natl Med Ctr, Washington, DC USA; [Carroll, William L.] NYU, Inst Canc, New York, NY USA; [Loh, Mignon] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Hunger, Stephen P.] Univ Colorado, Denver Sch Med, Aurora, CO USA; [Hunger, Stephen P.] Childrens Hosp, Aurora, CO USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; State University System of Florida; University of Florida; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Chicago; University of Texas System; UTMD Anderson Cancer Center; Johns Hopkins University; Johns Hopkins Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; Duke University; University of New Mexico; Cook Children's Medical Center; Medical College of Wisconsin; University of Alabama System; University of Alabama Birmingham; Children's National Health System; George Washington University; New York University; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado	Relling, MV (corresponding author), St Jude Childrens Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA.	mary.relling@stjude.org	Devidas, Meenakshi/H-1170-2019; Relling, Mary/N-5032-2018; Yang, Jun J./ABG-5646-2020; Pui, Ching-Hon/N-8076-2018; Yang, Jun/B-6976-2008; Cheng, Cheng/N-8075-2018; Evans, William E./C-2069-2012	Devidas, Meenakshi/0000-0002-1099-3478; Yang, Jun J./0000-0002-0770-9659; Pui, Ching-Hon/0000-0003-0303-5658; Yang, Jun/0000-0002-0770-9659; Evans, William E./0000-0002-9333-5322; Loh, Mignon/0000-0003-4099-4700	Jeffrey Pride Foundation; National Childhood Cancer Foundation; American Society of Clinical Pharmacology and Therapeutics; Alex Lemonade Stand Foundation for Childhood Cancer; National Cancer Institute of the National Institutes of Health [CA093552, CA78224, CA21765, R37CA36401, CA98543, CA114766, RC4CA156449, U10CA98413, U01GM 61393, U01GM 92666]; National Institute of General Medical Sciences of the National Institutes of Health [CA093552, CA78224, CA21765, R37CA36401, CA98543, CA114766, RC4CA156449, U10CA98413, U01GM 61393, U01GM 92666]; American Lebanese Syrian Associated Charities (ALSAC); CureSearch; NATIONAL CANCER INSTITUTE [U10CA098413, R01CA078224, RC4CA156449, U10CA098543, R37CA036401, U01CA157937, R01CA093552, P30CA021765, U24CA114766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092666, U01GM061393] Funding Source: NIH RePORTER	Jeffrey Pride Foundation; National Childhood Cancer Foundation; American Society of Clinical Pharmacology and Therapeutics; Alex Lemonade Stand Foundation for Childhood Cancer; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); CureSearch; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to all patients and their parents who participated in the St. Jude and COG protocols included in this study, the clinicians and research staff at the St. Jude and COG institutions and J. Pullen from the University of Mississippi at Jackson for assistance in classification of patients with ALL. Genome-wide genotyping of COG P9904/9905 samples was performed by the Center for Molecular Medicine with generous financial support from the Jeffrey Pride Foundation and the National Childhood Cancer Foundation. S. P. H. is the Ergen Family Chair in Pediatric Cancer, and J.J.Y. is supported by the American Society of Clinical Pharmacology and Therapeutics Young Investigator Award and Alex Lemonade Stand Foundation for Childhood Cancer Young Investigator Grant. We also thank M. Shriver at the Pennsylvania State University for sharing SNP genotype data of the Native American references. We are especially inspired by Damon Ingersoll, who bravely fought but lost his battle with ALL. This work was supported by the National Cancer Institute and National Institute of General Medical Sciences of the National Institutes of Health (grant numbers CA093552, CA78224, CA21765, R37CA36401, CA98543, CA114766, RC4CA156449, U10CA98413, U01GM 61393 and U01GM 92666), American Lebanese Syrian Associated Charities (ALSAC) and CureSearch.	Bhatia S, 2004, CURR OPIN PEDIATR, V16, P9, DOI 10.1097/00008480-200402000-00004; Bhatia S, 2002, BLOOD, V100, P1957, DOI 10.1182/blood-2002-02-0395; Borowitz MJ, 2008, BLOOD, V111, P5477, DOI 10.1182/blood-2008-01-132837; Carroll WL, 2003, JAMA-J AM MED ASSOC, V290, P2061, DOI 10.1001/jama.290.15.2061; Coustan-Smith E, 2000, BLOOD, V96, P2691, DOI 10.1182/blood.V96.8.2691; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; FOUCAR K, 1991, CANCER-AM CANCER SOC, V67, P2125, DOI 10.1002/1097-0142(19910415)67:8<2125::AID-CNCR2820670820>3.0.CO;2-A; GAYNON PS, 1988, AM J PEDIAT HEMATOL, V10, P42; Gaynon PS, 2001, J CLIN ONCOL, V19, P1916, DOI 10.1200/JCO.2001.19.7.1916; Hord MH, 1996, CANCER-AM CANCER SOC, V77, P563; Hutchinson RJ, 2003, J CLIN ONCOL, V21, P1790, DOI 10.1200/JCO.2003.03.009; Kadan-Lottick NS, 2003, JAMA-J AM MED ASSOC, V290, P2008, DOI 10.1001/jama.290.15.2008; Lange BJ, 2002, BLOOD, V99, P825, DOI 10.1182/blood.V99.3.825; Mao XY, 2007, AM J HUM GENET, V80, P1171, DOI 10.1086/518564; Pollock BH, 2000, J CLIN ONCOL, V18, P813, DOI 10.1200/JCO.2000.18.4.813; Powell JE, 2000, BRIT J CANCER, V82, P1568; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; PUI CH, 1995, JAMA-J AM MED ASSOC, V273, P633, DOI 10.1001/jama.273.8.633; Pui CH, 2004, BLOOD, V104, P2690, DOI 10.1182/blood-2004-04-1616; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Pui CH, 2003, JAMA-J AM MED ASSOC, V290, P2001, DOI 10.1001/jama.290.15.2001; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Sankararaman S, 2008, AM J HUM GENET, V82, P290, DOI 10.1016/j.ajhg.2007.09.022; Schrappe M, 2000, BLOOD, V95, P3310; Stiller CA, 2000, BRIT J CANCER, V82, P1339, DOI 10.1054/bjoc.1999.1101; TUBERGEN DG, 1993, J CLIN ONCOL, V11, P527, DOI 10.1200/JCO.1993.11.3.527; Yang JJ, 2009, JAMA-J AM MED ASSOC, V301, P393, DOI 10.1001/jama.2009.7; Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977	29	198	202	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2011	43	3					237	U30		10.1038/ng.763	http://dx.doi.org/10.1038/ng.763			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726BR	21297632	Green Accepted			2022-12-25	WOS:000287693800014
J	Atarashi, R; Satoh, K; Sano, K; Fuse, T; Yamaguchi, N; Ishibashi, D; Matsubara, T; Nakagaki, T; Yamanaka, H; Shirabe, S; Yamada, M; Mizusawa, H; Kitamoto, T; Klug, G; McGlade, A; Collins, SJ; Nishida, N				Atarashi, Ryuichiro; Satoh, Katsuya; Sano, Kazunori; Fuse, Takayuki; Yamaguchi, Naohiro; Ishibashi, Daisuke; Matsubara, Takehiro; Nakagaki, Takehiro; Yamanaka, Hitoki; Shirabe, Susumu; Yamada, Masahito; Mizusawa, Hidehiro; Kitamoto, Tetsuyuki; Klug, Genevieve; McGlade, Amelia; Collins, Steven J.; Nishida, Noriyuki			Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion	NATURE MEDICINE			English	Article							CREUTZFELDT-JAKOB-DISEASE; CYCLIC AMPLIFICATION; SEEDED CONVERSION; 14-3-3 PROTEIN; DIAGNOSIS	The development of technologies for the in vitro amplification of abnormal conformations of prion protein (PrPSc) has generated the potential for sensitive detection of prions. Here we developed a new PrPSc amplification assay, called real-time quaking-induced conversion (RT-QUIC), which allows the detection of >= 1 fg of PrPSc in diluted Creutzfeldt-Jakob disease (CJD) brain homogenate. Moreover, we assessed the technique first in a series of Japanese subjects and then in a blind study of 30 cerebrospinal fluid specimens from Australia, which achieved greater than 80% sensitivity and 100% specificity. These findings indicate the promising enhanced diagnostic capacity of RT-QUIC in the antemortem evaluation of suspected CJD.	[Atarashi, Ryuichiro; Satoh, Katsuya; Sano, Kazunori; Fuse, Takayuki; Yamaguchi, Naohiro; Ishibashi, Daisuke; Matsubara, Takehiro; Nakagaki, Takehiro; Nishida, Noriyuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki 852, Japan; [Atarashi, Ryuichiro] Nagasaki Univ, Res Ctr Genom Instabil & Carcinogenesis, Nagasaki 852, Japan; [Sano, Kazunori; Nishida, Noriyuki] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan; [Yamanaka, Hitoki] Nagasaki Univ, Ctr Frontier Life Sci, Div Comparat Med, Nagasaki 852, Japan; [Shirabe, Susumu] Nagasaki Univ Hosp, Org Rural Med & Residency Educ, Nagasaki, Japan; [Yamada, Masahito] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan; [Mizusawa, Hidehiro] Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Tokyo, Japan; [Kitamoto, Tetsuyuki] Tohoku Univ, Grad Sch Med, Dept Prion Res, Div Creutzfeldt Jakob Dis Sci & Technol, Sendai, Miyagi 980, Japan; [Klug, Genevieve; McGlade, Amelia; Collins, Steven J.] Univ Melbourne, Australian Natl Creutzfeldt Jakob Dis Registry, Dept Pathol, Melbourne, Vic, Australia	Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University; Kanazawa University; Tokyo Medical & Dental University (TMDU); Tohoku University; University of Melbourne	Atarashi, R (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki 852, Japan.	atarashi@nagasaki-u.ac.jp		Nakagaki, Takehiro/0000-0003-1960-8326	Global Centers of Excellence Program [F12]; Ministry of Education, Culture, Sports, Science and Technology of Japan [20390287]; Ministry of Health, Labor and Welfare of Japan	Global Centers of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	We thank the members of the CJD Surveillance Committee in Japan for their support of this work, K. Yamaguchi and K. Kuwata for helping with the circular dichroism analysis of rPrP-sen, M. Tsujihata (Nagasaki Kita Hospital) for providing CSF samples and information about subjects and A. Yamakawa and A. Matsuo for technical assistance. The work was supported by the Global Centers of Excellence Program (F12); a grant-in-aid for science research (B; grant no. 20390287) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a grant for bovine spongiform encephalopathy research and a grant-in-aid of the Research Committee of Prion disease and Slow Virus Infection, from the Ministry of Health, Labor and Welfare of Japan.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Hsich G, 1996, NEW ENGL J MED, V335, P924, DOI 10.1056/NEJM199609263351303; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; LANSBURY PT, 1995, CHEM BIOL, V2, P1, DOI 10.1016/1074-5521(95)90074-8; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Orru CD, 2009, PROTEIN ENG DES SEL, V22, P515, DOI 10.1093/protein/gzp031; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Satoh K, 2010, LAB INVEST, V90, P1637, DOI 10.1038/labinvest.2009.68; Toth SI, 2009, J PHARM SCI-US, V98, P3302, DOI 10.1002/jps.21676; Zerr I, 1998, ANN NEUROL, V43, P32, DOI 10.1002/ana.410430109	18	374	385	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					175	178		10.1038/nm.2294	http://dx.doi.org/10.1038/nm.2294			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21278748	Green Submitted			2022-12-25	WOS:000286969900024
J	Kormann, MSD; Hasenpusch, G; Aneja, MK; Nica, G; Flemmer, AW; Herber-Jonat, S; Huppmann, M; Mays, LE; Illenyi, M; Schams, A; Griese, M; Bittmann, I; Handgretinger, R; Hartl, D; Rosenecker, J; Rudolph, C				Kormann, Michael S. D.; Hasenpusch, Guenther; Aneja, Manish K.; Nica, Gabriela; Flemmer, Andreas W.; Herber-Jonat, Susanne; Huppmann, Marceline; Mays, Lauren E.; Illenyi, Marta; Schams, Andrea; Griese, Matthias; Bittmann, Iris; Handgretinger, Rupert; Hartl, Dominik; Rosenecker, Joseph; Rudolph, Carsten			Expression of therapeutic proteins after delivery of chemically modified mRNA in mice	NATURE BIOTECHNOLOGY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; HYDROPHOBIC SURFACTANT PROTEINS; NONVIRAL GENE DELIVERY; LUNG-DISEASE; CELLS; ERYTHROPOIETIN; IMPEDANCES; DEFICIENCY; EFFICACY; TOOL	Current viral vectors for gene therapy(1-3) are associated with serious safety concerns, including leukemogenesis(4), and nonviral vectors are limited by low gene transfer efficiency(5). Here we investigate the therapeutic utility of chemically modified mRNA as an alternative to DNA-based gene therapy. A combination of nucleotide modifications abrogates mRNA interaction with Toll-like receptor (TLR)3, TLR7, TLR8 and retinoid-inducible gene I (RIG-I), resulting in low immunogenicity and higher stability in mice. A single intramuscular injection of modified murine erythropoietin mRNA raises the average hematocrit in mice from 51.5% to 64.2% after 28 days. In a mouse model of a lethal congenital lung disease caused by a lack of surfactant protein B (SP-B), twice weekly local application of an aerosol of modified SP-B mRNA to the lung restored 71% of the wild-type SP-B expression, and treated mice survived until the predetermined end of the study after 28 days.	[Kormann, Michael S. D.; Hasenpusch, Guenther; Aneja, Manish K.; Nica, Gabriela; Illenyi, Marta; Schams, Andrea; Griese, Matthias; Rosenecker, Joseph; Rudolph, Carsten] Univ Munich, Dept Pediat, Munich, Germany; [Flemmer, Andreas W.; Herber-Jonat, Susanne; Huppmann, Marceline] Univ Munich, Childrens Hosp, Div Neonatol, D-8000 Munich, Germany; [Flemmer, Andreas W.; Herber-Jonat, Susanne; Huppmann, Marceline] Univ Munich, Perinatal Ctr, Munich, Germany; [Kormann, Michael S. D.; Mays, Lauren E.; Handgretinger, Rupert; Hartl, Dominik] Univ Tubingen, Childrens Hosp, Tubingen, Germany; [Kormann, Michael S. D.; Mays, Lauren E.; Handgretinger, Rupert; Hartl, Dominik] Univ Tubingen, Interdisciplinary Ctr Infect Dis, Tubingen, Germany; [Bittmann, Iris] Diakonien Hosp Rotenburg Wumme LTD, Inst Pathol, Rotenburg, Wumme, Germany	University of Munich; University of Munich; University of Munich; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen	Rudolph, C (corresponding author), Univ Munich, Dept Pediat, Munich, Germany.	michael.kormann@med.uni-tuebingen.de; carsten.rudolph@med.uni-muenchen.de	Kormann, Michael SD/C-7723-2014; Rosenecker, Joseph/AAA-7330-2020; W., Andreas Flemmer/AAQ-5654-2021; Rudolph, Carsten/B-9379-2011		German Federal Ministry of Education and Research [01GU0616, 13N9182, 0311898]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	We are grateful to J. Whitsett (Department of Pediatrics, Division of Pulmonary Biology, University of Cincinnati College of Medicine) for providing the conditional SP-B knockout mice. We thank R. Imker for technical assistance and A. Roscher for careful proofreading of the manuscript. This work was supported by the German Federal Ministry of Education and Research, grants 01GU0616, 13N9182, BioFuture (0311898) and LMUexcellent (Investitionsfonds). A T7 promoter containing pST1-2 beta-globin UTR-A(120) construct was kindly provided by U. Sahin (Department of Internal Medicine III, Division of Experimental and Translational Oncology, Johannes-Gutenberg University). Polyclonal rabbit antiserum directed against SP-B and anti-human/anti-mouse SP-B antibody were gifts of W. Steinhilber (Altana AG, Wesel, Germany).	ALLEYNE CM, 1989, J APPL PHYSIOL, V66, P542, DOI 10.1152/jappl.1989.66.2.542; Aneja MK, 2007, J GENE MED, V9, P967, DOI 10.1002/jgm.1090; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Dames P, 2007, NAT NANOTECHNOL, V2, P495, DOI 10.1038/nnano.2007.217; Ehrenreich H, 2004, MOL PSYCHIATR, V9, P42, DOI 10.1038/sj.mp.4001442; Elfinger M, 2009, J CONTROL RELEASE, V135, P234, DOI 10.1016/j.jconrel.2009.01.012; Griese M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-80; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; HANTOS Z, 1992, J APPL PHYSIOL, V73, P427, DOI 10.1152/jappl.1992.73.2.427; Holtkamp S, 2006, BLOOD, V108, P4009, DOI 10.1182/blood-2006-04-015024; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Macdougall IC, 1996, KIDNEY INT, V50, P1694, DOI 10.1038/ki.1996.487; McCormack MP, 2004, NEW ENGL J MED, V350, P913, DOI 10.1056/NEJMra032207; McKenna SA, 2007, NAT PROTOC, V2, P3270, DOI 10.1038/nprot.2007.480; Melton KR, 2003, AM J PHYSIOL-LUNG C, V285, pL543, DOI 10.1152/ajplung.00011.2003; NOGEE LM, 1993, NEW ENGL J MED, V328, P406, DOI 10.1056/NEJM199302113280606; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pillow JJ, 2001, J APPL PHYSIOL, V91, P2730, DOI 10.1152/jappl.2001.91.6.2730; Read ML, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni085; Rosenecker J, 2006, CURR OPIN MOL THER, V8, P439; Sanders N, 2009, ADV DRUG DELIVER REV, V61, P115, DOI 10.1016/j.addr.2008.09.011; SCHUESSLER TF, 1995, IEEE T BIO-MED ENG, V42, P860, DOI 10.1109/10.412653; Sly PD, 2003, J APPL PHYSIOL, V94, P1460, DOI 10.1152/japplphysiol.00596.2002; Van Tendeloo VF, 2007, CURR OPIN MOL THER, V9, P423; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; WEAVER TE, 1989, AM J PHYSIOL, V257, pL100, DOI 10.1152/ajplung.1989.257.2.L100; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387	27	467	705	9	140	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2011	29	2					154	U96		10.1038/nbt.1733	http://dx.doi.org/10.1038/nbt.1733			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	717DJ	21217696				2022-12-25	WOS:000287023000023
J	Stoepker, C; Hain, K; Schuster, B; Hilhorst-Hofstee, Y; Rooimans, MA; Steltenpool, J; Oostra, AB; Eirich, K; Korthof, ET; Nieuwint, AWM; Jaspers, NGJ; Bettecken, T; Joenje, H; Schindler, D; Rouse, J; de Winter, JP				Stoepker, Chantal; Hain, Karolina; Schuster, Beatrice; Hilhorst-Hofstee, Yvonne; Rooimans, Martin A.; Steltenpool, Jurgen; Oostra, Anneke B.; Eirich, Katharina; Korthof, Elisabeth T.; Nieuwint, Aggie W. M.; Jaspers, Nicolaas G. J.; Bettecken, Thomas; Joenje, Hans; Schindler, Detlev; Rouse, John; de Winter, Johan P.			SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype	NATURE GENETICS			English	Article							HOLLIDAY JUNCTION RESOLVASE; DNA-REPAIR; ERCC1	DNA interstrand crosslink repair requires several classes of proteins, including structure-specific endonucleases and Fanconi anemia proteins. SLX4, which coordinates three separate endonucleases, was recently recognized as an important regulator of DNA repair. Here we report the first human individuals found to have biallelic mutations in SLX4. These individuals, who were previously diagnosed as having Fanconi anemia, add SLX4 as an essential component to the FA-BRCA genome maintenance pathway.	[Stoepker, Chantal; Rooimans, Martin A.; Steltenpool, Jurgen; Oostra, Anneke B.; Nieuwint, Aggie W. M.; Joenje, Hans; de Winter, Johan P.] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Hain, Karolina; Rouse, John] Univ Dundee, Coll Life Sci, MRC, Prot Phosphorylat Unit, Dundee, Scotland; [Schuster, Beatrice; Eirich, Katharina; Schindler, Detlev] Univ Wurzburg, Biozentrum, Dept Human Genet, Wurzburg, Germany; [Hilhorst-Hofstee, Yvonne; Korthof, Elisabeth T.] Leiden Univ Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Jaspers, Nicolaas G. J.] Erasmus MC, Dept Genet, Rotterdam, Netherlands; [Bettecken, Thomas] Max Planck Inst Psychiat, Ctr Appl Genotyping Munich, D-80804 Munich, Germany	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Dundee; University of Wurzburg; Leiden University; Leiden University Medical Center (LUMC); Erasmus University Rotterdam; Erasmus MC; Max Planck Society	de Winter, JP (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands.	schindler@biozentrum.uni-wuerzburg.de; j.rouse@dundee.ac.uk; j.dewinter@vumc.nl	Hilhorst-Hofstee, Yvonne/AAC-5120-2022	Hilhorst-Hofstee, Yvonne/0000-0003-0951-6524	Cancer Center Amsterdam-VU Medisch Centrum Institute for Cancer and Immunology (CCA/V-ICI) Amsterdam; Dutch Cancer Society; Schroeder-Kurth-Fund; Medical Research Council UK; MRC [MC_U127070192] Funding Source: UKRI; Medical Research Council [MC_U127070192] Funding Source: researchfish	Cancer Center Amsterdam-VU Medisch Centrum Institute for Cancer and Immunology (CCA/V-ICI) Amsterdam; Dutch Cancer Society(KWF Kankerbestrijding); Schroeder-Kurth-Fund; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the affected individuals and their families for contributing to this study. We also thank A. Raams, R. Friedl, B. Gottwald and S. Darchinger for expert technical assistance. We acknowledge I. Carr for Phaser software, R. Kanaar for RAD51 antiserum and K.J. Patel for mouse Slx4 cDNA. Financial support was from the Cancer Center Amsterdam-VU Medisch Centrum Institute for Cancer and Immunology (CCA/V-ICI) Amsterdam (to C. S.), the Dutch Cancer Society (to H.J.), Schroeder-Kurth-Fund (to D. S.) and the Medical Research Council UK (to J.R.).	Ahmad A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000871; Andersen SL, 2009, MOL CELL, V35, P128, DOI 10.1016/j.molcel.2009.06.019; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; de Winter JP, 2009, MUTAT RES-FUND MOL M, V668, P11, DOI 10.1016/j.mrfmmm.2008.11.004; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; JOENJE H, 1995, BLOOD, V86, P2156, DOI 10.1182/blood.V86.6.2156.bloodjournal8662156; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Shimamura A, 2002, BLOOD, V100, P4649, DOI 10.1182/blood-2002-05-1399; Singh TR, 2009, BLOOD, V114, P174, DOI 10.1182/blood-2009-02-207811; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; VANVUUREN AJ, 1993, EMBO J, V12, P3693, DOI 10.1002/j.1460-2075.1993.tb06044.x; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570	13	224	228	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2011	43	2					138	U85		10.1038/ng.751	http://dx.doi.org/10.1038/ng.751			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	711XD	21240277				2022-12-25	WOS:000286623800012
J	Ramazzina, I; Costa, R; Cendron, L; Berni, R; Peracchi, A; Zanotti, G; Percudani, R				Ramazzina, Ileana; Costa, Roberto; Cendron, Laura; Berni, Rodolfo; Peracchi, Alessio; Zanotti, Giuseppe; Percudani, Riccardo			An aminotransferase branch point connects purine catabolism to amino acid recycling	NATURE CHEMICAL BIOLOGY			English	Article							ALANINE-GLYOXYLATE AMINOTRANSFERASE; BACILLUS-SUBTILIS; URIC-ACID; CRYSTAL-STRUCTURE; UREIDE PATHWAY; NITROGEN; IDENTIFICATION; UREIDOGLYCINE; (S)-ALLANTOIN; DEGRADATION	Although amino acids are known precursors of purines, a pathway for the direct recycling of amino acids from purines has never been described at the molecular level. We provide NMR and crystallographic evidence that the PucG protein from Bacillus subtilis catalyzes the transamination between an unstable intermediate ((S)-ureidoglycine) and the end product of purine catabolism (glyoxylate) to yield oxalurate and glycine. This activity enables soil and gut bacteria to use the animal purine waste as a source of carbon and nitrogen. The reaction catalyzed by (S)-ureidoglycine-glyoxylate aminotransferase (UGXT) illustrates a transamination sequence in which the same substrate provides both the amino group donor and, via its spontaneous decay, the amino group acceptor. Structural comparison and mutational analysis suggest a molecular rationale for the functional divergence between UGXT and peroxisomal alanine-glyoxylate aminotransferase, a fundamental enzyme for glyoxylate detoxification in humans.	[Ramazzina, Ileana; Costa, Roberto; Berni, Rodolfo; Peracchi, Alessio; Percudani, Riccardo] Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy; [Cendron, Laura; Zanotti, Giuseppe] Univ Padua, Dept Biol Chem, Padua, Italy; [Cendron, Laura; Zanotti, Giuseppe] Venetian Inst Mol Med, Padua, Italy	University of Parma; University of Padua; Veneto Institute Molecular Medicine	Ramazzina, I (corresponding author), Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy.	riccardo.percudani@unipr.it	percudani, riccardo/B-4872-2011; cendron, Laura/A-5202-2014; Peracchi, Alessio/G-5167-2012; Costa, Roberto/AAT-9140-2020; Peracchi, Alessio/Q-5173-2019	percudani, riccardo/0000-0001-8452-1062; Peracchi, Alessio/0000-0003-3254-4099; Costa, Roberto/0000-0001-7328-9018; Peracchi, Alessio/0000-0003-3254-4099; Berni, Rodolfo/0000-0002-1839-0479; Ramazzina, Ileana/0000-0003-1009-2917; Cendron, Laura/0000-0002-0125-0461; Zanotti, Giuseppe/0000-0002-0945-6501				Bowers PM, 2004, SCIENCE, V306, P2246, DOI 10.1126/science.1103330; Cellini B, 2007, BIOCHEM J, V408, P39, DOI 10.1042/BJ20070637; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; French JB, 2010, BIOCHEMISTRY-US, V49, P5975, DOI 10.1021/bi1006755; Gimisis T, 2006, EUR J ORG CHEM, V2006, P1351, DOI 10.1002/ejoc.200500581; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GUPTA SC, 1984, J BIOL CHEM, V259, P12; Han Q, 2006, J BIOL CHEM, V281, P37175, DOI 10.1074/jbc.M607032200; Hoa NT, 2000, APPL ENVIRON MICROB, V66, P5241, DOI 10.1128/AEM.66.12.5241-5247.2000; Kahn K, 1997, J AM CHEM SOC, V119, P5435, DOI 10.1021/ja970375t; Katsura Y, 2004, PROTEINS, V55, P487, DOI 10.1002/prot.20020; Kim K, 2007, J BIOL CHEM, V282, P23457, DOI 10.1074/jbc.M703211200; Nakano MM, 1998, ANNU REV MICROBIOL, V52, P165, DOI 10.1146/annurev.micro.52.1.165; Percudani R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-273; POTRIKUS CJ, 1981, P NATL ACAD SCI-BIOL, V78, P4601, DOI 10.1073/pnas.78.7.4601; RABINOWITZ JC, 1956, J BIOL CHEM, V218, P147; Ramazzina I, 2008, J BIOL CHEM, V283, P23295, DOI 10.1074/jbc.M801195200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALAS JA, 1985, BIOCHEM J, V229, P241, DOI 10.1042/bj2290241; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Schultz AC, 2001, J BACTERIOL, V183, P3293, DOI 10.1128/JB.183.11.3293-3302.2001; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Serventi F, 2010, ACS CHEM BIOL, V5, P203, DOI 10.1021/cb900248n; Singer MA, 2003, COMP BIOCHEM PHYS B, V134, P543, DOI 10.1016/S1096-4959(03)00027-7; SORENSEN LB, 1975, NEPHRON, V14, P7, DOI 10.1159/000180432; Tam NKM, 2006, J BACTERIOL, V188, P2692, DOI 10.1128/JB.188.7.2692-2700.2006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tipton PA, 2006, NAT CHEM BIOL, V2, P124, DOI 10.1038/nchembio0306-124; Todd CD, 2006, J EXP BOT, V57, P5, DOI 10.1093/jxb/erj013; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; Werner AK, 2010, NAT CHEM BIOL, V6, P19, DOI [10.1038/NCHEMBIO.265, 10.1038/nchembio.265]; Wilkins MR, 1999, METH MOL B, V112, P531; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430; Zhang XX, 2003, J MOL BIOL, V331, P643, DOI 10.1016/S0022-2836(03)00791-5	34	22	25	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2010	6	11					801	806		10.1038/NCHEMBIO.445	http://dx.doi.org/10.1038/NCHEMBIO.445			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	667MP	20852637				2022-12-25	WOS:000283197800008
J	Dumont, J; Oegema, K; Desai, A				Dumont, Julien; Oegema, Karen; Desai, Arshad			A kinetochore-independent mechanism drives anaphase chromosome separation during acentrosomal meiosis	NATURE CELL BIOLOGY			English	Article							AURORA-B KINASE; MEIOTIC SPINDLE; CAENORHABDITIS-ELEGANS; HOLOCENTRIC CHROMOSOMES; C-ELEGANS; SEGREGATION; COHESION; OOCYTES; MITOSIS	Although assembly of acentrosomal meiotic spindles has been extensively studied(1), little is known about the segregation of chromosomes on these spindles. Here, we show in Caenorhabditis elegans oocytes that the kinetochore protein, KNL-1, directs assembly of meiotic kinetochores that orient chromosomes. However, in contrast to mitosis, chromosome separation during meiotic anaphase is kinetochore-independent. Before anaphase, meiotic kinetochores and spindle poles disassemble along with the microtubules on the poleward side of chromosomes. During anaphase, microtubules then form between the separating chromosomes. Functional analysis implicated a set of proteins that localize to a ring-shaped domain between kinetochores during pre-anaphase spindle assembly and anaphase separation. These proteins are localized by the chromosomal passenger complex, which regulates the loss of meiotic chromosome cohesion(2-4). Thus, meiotic segregation in C. elegans is a two-stage process, where kinetochores orient chromosomes, but are then dispensable for their separation. We suggest that separation is controlled by a meiosis-specific chromosomal domain to coordinate cohesin removal and chromosome segregation.	[Dumont, Julien; Oegema, Karen; Desai, Arshad] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Desai, A (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	abdesai@ucsd.edu	Dumont, Julien/G-6624-2013	Dumont, Julien/0000-0001-5312-9770	EMBO long-term postdoctoral fellowship; Human Frontiers Science Program [RGY0084]; NIH [GM074215]; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074215] Funding Source: NIH RePORTER	EMBO long-term postdoctoral fellowship(European Molecular Biology Organization (EMBO)); Human Frontiers Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J. Canman and R. Green for critical reading of the manuscript. This work was supported by an EMBO long-term postdoctoral fellowship to J.D., grants from Human Frontiers Science Program (RGY0084) and the NIH (GM074215) to A.D., and funding from the Ludwig Institute for Cancer Research to A.D. and K.O.	Albertson DG, 1993, CHROMOSOME RES, V1, P15, DOI 10.1007/BF00710603; Brunet S, 1998, CURR BIOL, V8, P1231, DOI 10.1016/S0960-9822(07)00516-7; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; de Carvalho CE, 2008, GENE DEV, V22, P2869, DOI 10.1101/gad.1691208; Deng MQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005249; Dumont J, 2010, OOGENESIS UNIVERSAL, P269; Gilliland WD, 2007, PLOS GENET, V3, P1178, DOI 10.1371/journal.pgen.0030113; Hannak E, 2006, J CELL BIOL, V172, P19, DOI 10.1083/jcb.200508180; Howe M, 2001, J CELL BIOL, V153, P1227, DOI 10.1083/jcb.153.6.1227; Hunt PA, 2008, TRENDS GENET, V24, P86, DOI 10.1016/j.tig.2007.11.010; Jones KT, 2008, HUM REPROD UPDATE, V14, P143, DOI 10.1093/humupd/dmm043; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Maddox PS, 2004, CHROMOSOME RES, V12, P641, DOI 10.1023/B:CHRO.0000036588.42225.2f; Martinez-Perez E, 2008, GENE DEV, V22, P2886, DOI 10.1101/gad.1694108; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; Monen J, 2005, NAT CELL BIOL, V7, P1248, DOI 10.1038/ncb1331; Nabeshima K, 2005, J CELL BIOL, V168, P683, DOI 10.1083/jcb.200410144; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Ohsugi M, 2008, CELL, V132, P771, DOI 10.1016/j.cell.2008.01.029; Powers J, 2004, J CELL BIOL, V166, P991, DOI 10.1083/jcb.200403036; Rogers E, 2002, J CELL BIOL, V157, P219, DOI 10.1083/jcb.200110045; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Wignall SM, 2009, NAT CELL BIOL, V11, P839, DOI 10.1038/ncb1891; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013	26	131	138	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					894	901		10.1038/ncb2093	http://dx.doi.org/10.1038/ncb2093			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20729837	Green Accepted			2022-12-25	WOS:000281561900013
J	Lopez, M; Varela, L; Vazquez, MJ; Rodriguez-Cuenca, S; Gonzalez, CR; Velagapudi, VR; Morgan, DA; Schoenmakers, E; Agassandian, K; Lage, R; de Morentin, PBM; Tovar, S; Nogueiras, R; Carling, D; Lelliott, C; Gallego, R; Oresic, M; Chatterjee, K; Saha, AK; Rahmouni, K; Dieguez, C; Vidal-Puig, A				Lopez, Miguel; Varela, Luis; Vazquez, Maria J.; Rodriguez-Cuenca, Sergio; Gonzalez, Carmen R.; Velagapudi, Vidya R.; Morgan, Donald A.; Schoenmakers, Erik; Agassandian, Khristofor; Lage, Ricardo; Martinez de Morentin, Pablo Blanco; Tovar, Sulay; Nogueiras, Ruben; Carling, David; Lelliott, Christopher; Gallego, Rosalia; Oresic, Matej; Chatterjee, Krishna; Saha, Asish K.; Rahmouni, Kamal; Dieguez, Carlos; Vidal-Puig, Antonio			Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance	NATURE MEDICINE			English	Article							BROWN ADIPOSE-TISSUE; ACTIVATED PROTEIN-KINASE; ACETYL-COA CARBOXYLASE; FOOD-INTAKE; VENTROMEDIAL HYPOTHALAMUS; INSULIN SENSITIVITY; SKELETAL-MUSCLE; NERVOUS-SYSTEM; ADULT HUMANS; MALONYL-COA	Thyroid hormones have widespread cellular effects; however it is unclear whether their effects on the central nervous system (CNS) contribute to global energy balance. Here we demonstrate that either whole-body hyperthyroidism or central administration of triiodothyronine (T3) decreases the activity of hypothalamic AMP-activated protein kinase (AMPK), increases sympathetic nervous system (SNS) activity and upregulates thermogenic markers in brown adipose tissue (BAT). Inhibition of the lipogenic pathway in the ventromedial nucleus of the hypothalamus (VMH) prevents CNS-mediated activation of BAT by thyroid hormone and reverses the weight loss associated with hyperthyroidism. Similarly, inhibition of thyroid hormone receptors in the VMH reverses the weight loss associated with hyperthyroidism. This regulatory mechanism depends on AMPK inactivation, as genetic inhibition of this enzyme in the VMH of euthyroid rats induces feeding-independent weight loss and increases expression of thermogenic markers in BAT. These effects are reversed by pharmacological blockade of the SNS. Thus, thyroid hormone-induced modulation of AMPK activity and lipid metabolism in the hypothalamus is a major regulator of whole-body energy homeostasis.	[Lopez, Miguel; Varela, Luis; Vazquez, Maria J.; Gonzalez, Carmen R.; Lage, Ricardo; Martinez de Morentin, Pablo Blanco; Tovar, Sulay; Nogueiras, Ruben; Dieguez, Carlos] Univ Santiago de Compostela, Inst Invest Sanitaria, Sch Med, Dept Physiol, Santiago De Compostela, A Coruna, Spain; [Lopez, Miguel; Varela, Luis; Vazquez, Maria J.; Gonzalez, Carmen R.; Lage, Ricardo; Martinez de Morentin, Pablo Blanco; Tovar, Sulay; Nogueiras, Ruben; Dieguez, Carlos] Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, La Coruna, Spain; [Lopez, Miguel; Rodriguez-Cuenca, Sergio; Schoenmakers, Erik; Vidal-Puig, Antonio] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 2QQ, England; [Velagapudi, Vidya R.; Oresic, Matej] Tech Res Ctr Finland VTT, Espoo, Finland; [Morgan, Donald A.; Rahmouni, Kamal] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Agassandian, Khristofor] Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Iowa City, IA 52242 USA; [Carling, David] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Ctr Clin Sci, MRC,Cellular Stress Grp, London, England; [Lelliott, Christopher] AstraZeneca, Res & Dev, Dept Biosci, Molndal, Sweden; [Gallego, Rosalia] Univ Santiago de Compostela, Sch Med, Dept Morphol Sci, Santiago De Compostela, A Coruna, Spain; [Saha, Asish K.] Boston Med Ctr, Diabet Res Unit, Boston, MA USA	Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; VTT Technical Research Center Finland; University of Iowa; University of Iowa; Imperial College London; AstraZeneca; Universidade de Santiago de Compostela; Boston Medical Center	Lopez, M (corresponding author), Univ Santiago de Compostela, Inst Invest Sanitaria, Sch Med, Dept Physiol, Santiago De Compostela, A Coruna, Spain.	m.lopez@usc.es; ajv22@cam.ac.uk	Oresic, Matej/K-7673-2016; Morgan, Donald A/L-6907-2013; Carling, David/F-1943-2014; Oresic, Matej/AAV-3978-2020; López, Miguel/ABF-4844-2021; Rahmouni, Kamal/Y-1788-2019; Dieguez, Carmen Ruth Gonzalez/AAC-1339-2020; Velagapudi, Vidya/L-7278-2015; Tovar, Sulay/ABF-4037-2021; Nogueiras, Ruben/AAS-9427-2021; Lelliott, Christopher J/G-4620-2011; Varela, Luis/ABG-7581-2020; de Morentin, Pablo B Martinez/K-5403-2014; Rodriguez-Cuenca, Sergio/C-5901-2011	Oresic, Matej/0000-0002-2856-9165; Morgan, Donald A/0000-0003-3167-1643; Carling, David/0000-0002-2316-1830; López, Miguel/0000-0002-7823-1648; Dieguez, Carmen Ruth Gonzalez/0000-0001-9311-1866; Velagapudi, Vidya/0000-0002-8261-7164; Nogueiras, Ruben/0000-0002-9976-9930; Lelliott, Christopher J/0000-0001-8087-4530; Varela, Luis/0000-0001-7794-7241; de Morentin, Pablo B Martinez/0000-0002-0684-3215; Chatterjee, Vengalil Krishna/0000-0002-2654-8854; Lage Fernandez, Ricardo/0000-0002-8779-7723; Saha, Asish/0000-0003-1001-5110; Vidal-Puig, Antonio/0000-0003-4220-9577; Rosalia, Gallego/0000-0002-6015-4680; Tovar, Sulay/0000-0001-7813-6520; Rahmouni, Kamal/0000-0001-5136-6748	UK Medical Research Council [G0802051]; Wellcome Trust [080237, 065326/Z/01/Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL084207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067509, R01DK019514] Funding Source: NIH RePORTER; Medical Research Council [G0802051, MC_U120027537] Funding Source: researchfish; MRC [G0802051] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Adams and A. Whittle for discussion and editing and L. Casas, M. Portas and K. Burling for excellent technical assistance. This work has been supported by grants from the UK Medical Research Council (A. V.-P.: G0802051), the Wellcome Trust (K. C.: 080237; A. V.-P.: 065326/Z/01/Z), Xunta de Galicia (R. G.: PGIDITPXIB20811PR), Fondo Investigaciones Sanitarias (M. L.: PS09/01880), Ministerio de Ciencia e Innovacion (C. D.: BFU2008; M. L.: RyC-2007-00211; R.N.: RyC-2008-02219 and SAF2009-07049), the EU (A. V.-P. and M.O.: FP7MITIN; A. V.-P. and M. O.: LSHM-CT-2005-018734; C. D., M. L. and R. N.: Health-F2-2008223713; M. L.: Marie Curie Program QLK6-CT-2002-51671) and the US National Institutes of Health (A. K. S.: DK-19514 and DK-67509; K. R.: HL-084207). CIBER de Fisiopatolog a de la Obesidad y Nutricion is an initiative of Instituto de Salud Carlos III (ISCIII).	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Belgardt BF, 2008, CELL METAB, V7, P291, DOI 10.1016/j.cmet.2008.01.006; BEYLOT M, 1991, J CLIN ENDOCR METAB, V73, P42, DOI 10.1210/jcem-73-1-42; BLENNEMANN B, 1992, ENDOCRINOLOGY, V130, P637, DOI 10.1210/en.130.2.637; BLENNEMANN B, 1995, MOL CELL ENDOCRINOL, V110, P1, DOI 10.1016/0303-7207(95)03509-6; Branvold DJ, 2008, J APPL PHYSIOL, V105, P1218, DOI 10.1152/japplphysiol.00997.2007; Cachefo A, 2001, J CLIN ENDOCR METAB, V86, P5353, DOI 10.1210/jc.86.11.5353; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Commins SP, 2000, J BIOL CHEM, V275, P33059, DOI 10.1074/jbc.M006328200; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; Costanzo-Garvey DL, 2009, CELL METAB, V10, P366, DOI 10.1016/j.cmet.2009.09.010; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dulloo AG, 2002, SCIENCE, V297, P780, DOI 10.1126/science.1074923; Dzamko N, 2010, J BIOL CHEM, V285, P115, DOI 10.1074/jbc.M109.056762; Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104; GNONI GV, 1983, BIOCHIM BIOPHYS ACTA, V751, P271, DOI 10.1016/0005-2760(83)90284-9; HAGENFELDT L, 1981, J CLIN INVEST, V67, P1672, DOI 10.1172/JCI110204; HALVORSON I, 1990, BRAIN RES, V522, P76, DOI 10.1016/0006-8993(90)91579-6; He W, 2006, NAT NEUROSCI, V9, P227, DOI 10.1038/nn1626; Herwig A, 2008, OBESITY FACTS, V1, P71, DOI 10.1159/000123428; HOLT SJ, 1987, BRAIN RES, V405, P227, DOI 10.1016/0006-8993(87)90292-7; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Irrcher I, 2008, J APPL PHYSIOL, V104, P178, DOI 10.1152/japplphysiol.00643.2007; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kola B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001797; KRISHNA V, 1991, J CLIN INVEST, V87, P1977, DOI 10.1172/JCI115225; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Lage R, 2010, FASEB J, V24, P2670, DOI 10.1096/fj.09-150672; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Lam TKT, 2010, NAT MED, V16, P392, DOI 10.1038/nm0410-392; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Lopez M, 2006, DIABETES, V55, P1327, DOI 10.2337/db05-1356; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; McCrimmon RJ, 2008, DIABETES, V57, P444, DOI 10.2337/db07-0837; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; MORINI P, 1991, BIOCHEM MED METAB B, V46, P169, DOI 10.1016/0885-4505(91)90064-R; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; NIIJIMA A, 1984, AM J PHYSIOL, V247, pR650, DOI 10.1152/ajpregu.1984.247.4.R650; Nogueiras R, 2009, J NEUROSCI, V29, P5916, DOI 10.1523/JNEUROSCI.5977-08.2009; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Park SH, 2002, J APPL PHYSIOL, V93, P2081, DOI 10.1152/japplphysiol.00504.2002; Pijl H, 2001, J CLIN ENDOCR METAB, V86, P5848, DOI 10.1210/jc.86.12.5848; Plum L, 2009, NAT MED, V15, P1195, DOI 10.1038/nm.2026; Pocai A, 2006, J CLIN INVEST, V116, P1081, DOI 10.1172/JCI26640; Rahmouni K, 2004, J CLIN INVEST, V114, P652, DOI 10.1172/JCI200421737; Riis ALD, 2002, J CLIN ENDOCR METAB, V87, P4747, DOI 10.1210/jc.2002-020174; Sangiao-Alvarellos S, 2010, J NEUROENDOCRINOL, V22, P543, DOI 10.1111/j.1365-2826.2010.01994.x; Silva JE, 1995, THYROID, V5, P481, DOI 10.1089/thy.1995.5.481; Skarulis MC, 2010, J CLIN ENDOCR METAB, V95, P256, DOI 10.1210/jc.2009-0543; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; VOLPE JJ, 1972, J NEUROCHEM, V19, P737, DOI 10.1111/j.1471-4159.1972.tb01389.x; Winder WW, 2003, BIOCHEM SOC T, V31, P182, DOI 10.1042/bst0310182; Wolfgang MJ, 2006, P NATL ACAD SCI USA, V103, P7282, DOI 10.1073/pnas.0602205103	58	490	505	1	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2010	16	9					1001	U97		10.1038/nm.2207	http://dx.doi.org/10.1038/nm.2207			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	647MP	20802499	Green Accepted			2022-12-25	WOS:000281622900029
J	Takata, R; Akamatsu, S; Kubo, M; Takahashi, A; Hosono, N; Kawaguchi, T; Tsunoda, T; Inazawa, J; Kamatani, N; Ogawa, O; Fujioka, T; Nakamura, Y; Nakagawa, H				Takata, Ryo; Akamatsu, Shusuke; Kubo, Michiaki; Takahashi, Atsushi; Hosono, Naoya; Kawaguchi, Takahisa; Tsunoda, Tatsuhiko; Inazawa, Johji; Kamatani, Naoyuki; Ogawa, Osamu; Fujioka, Tomoaki; Nakamura, Yusuke; Nakagawa, Hidewaki			Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population	NATURE GENETICS			English	Article							MULTIPLE LOCI; 8Q24; VARIANTS; RISK	Prostate cancer is one of the most common malignancies in males throughout the world(1), and its incidence is increasing in Asian countries. We carried out a genome-wide association study and replication study using 4,584 Japanese men with prostate cancer and 8,801 control subjects. From the thirty-one associated SNPs reported in previous genome-wide association studies in European populations, we confirmed the association of nine SNPs at P < 1.0 x 10(-7) and ten SNPs at P < 0.05 in the Japanese population. The remaining 12 SNPs showed no association (P > 0.05). In addition, we report here five new loci for prostate cancer susceptibility, at 5p15 (lambda-corrected probability P-GC = 3.9 x 10(-18)), GPRC6A/RFX6 (P-GC = 1.6 x 10(-12)), 13q22 (P-GC = 2.8 x 10(-9)), C2orf43 (P-GC = 7.5 x 10(-8)) and FOXP4 (P-GC = 7.6 x 10(-8)). These findings advance our understanding of the genetic basis of prostate carcinogenesis and also highlight the genetic heterogeneity of prostate cancer susceptibility among different ethnic populations.	[Takata, Ryo; Akamatsu, Shusuke; Nakagawa, Hidewaki] RIKEN, Ctr Genom Med, Lab Biomarker Dev, Tokyo, Japan; [Takata, Ryo; Fujioka, Tomoaki] Iwate Med Univ, Dept Urol, Morioka, Iwate 020, Japan; [Akamatsu, Shusuke; Ogawa, Osamu] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan; [Kubo, Michiaki; Hosono, Naoya] RIKEN, Ctr Genom Med, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Ctr Genom Med, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Kawaguchi, Takahisa; Tsunoda, Tatsuhiko] RIKEN, Ctr Genom Med, Lab Med Informat, Yokohama, Kanagawa, Japan; [Inazawa, Johji] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Tokyo, Japan; [Inazawa, Johji] Tokyo Med & Dent Univ, Sch Biomed Sci, Tokyo, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan	RIKEN; Iwate Medical University; Kyoto University; RIKEN; RIKEN; RIKEN; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Tokyo	Nakagawa, H (corresponding author), RIKEN, Ctr Genom Med, Lab Biomarker Dev, Tokyo, Japan.	hidewaki@ims.u-tokyo.ac.jp	Kubo, Michiaki/N-7947-2015; Tsunoda, Tatsuhiko/K-2061-2014; Takata, Ryo/ABB-4430-2020	Tsunoda, Tatsuhiko/0000-0002-5439-7918; 	BioBank Japan; Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan; Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government	BioBank Japan; Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan; Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank K. Ashikawa, H. Amitani and other staff from the Laboratory for Genotyping Development, Center for Genomic Medicine, RIKEN for their contribution to SNP genotyping, K. Boroevich for comments on the manuscript, and members of the BioBank Japan project and the Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan for supporting our study. This work was conducted as a part of the BioBank Japan Project, which was supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government.	Aftab S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-226; Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Croucher PJP, 2003, EUR J HUM GENET, V11, P6, DOI 10.1038/sj.ejhg.5200897; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Kurahashi N, 2008, CANCER EPIDEM BIOMAR, V17, P930, DOI 10.1158/1055-9965.EPI-07-2681; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Matsuda T, 2009, JPN J CLIN ONCOL, V39, P435, DOI [10.1093/jjco/hyp047, 10.1093/jjco/hyp077]; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schaid DJ, 2004, HUM MOL GENET, V13, pR103, DOI 10.1093/hmg/ddh072; Teufel A, 2003, BBA-GENE STRUCT EXPR, V1627, P147, DOI 10.1016/S0167-4781(03)00074-5; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Witte JS, 2009, NAT REV GENET, V10, P77, DOI 10.1038/nrg2507; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444	29	222	233	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					751	U34		10.1038/ng.635	http://dx.doi.org/10.1038/ng.635			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20676098				2022-12-25	WOS:000281388400008
J	Pitcher, GM; Kalia, LV; Ng, D; Goodfellow, NM; Yee, KT; Lambe, EK; Salter, MW				Pitcher, Graham M.; Kalia, Lorraine V.; Ng, David; Goodfellow, Nathalie M.; Yee, Kathleen T.; Lambe, Evelyn K.; Salter, Michael W.			Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors	NATURE MEDICINE			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; TYROSINE KINASE SRC; PREFRONTAL CORTEX; IN-VIVO; ERBB4; EXPRESSION; HIPPOCAMPUS; PROTEIN; MICE	Hypofunction of the N-methyl D-aspartate subtype of glutamate receptor (NMDAR) is hypothesized to be a mechanism underlying cognitive dysfunction in individuals with schizophrenia. For the schizophrenia-linked genes NRG1 and ERBB4, NMDAR hypofunction is thus considered a key detrimental consequence of the excessive NRG1-ErbB4 signaling found in people with schizophrenia. However, we show here that neuregulin 1 beta-ErbB4 (NRG1 beta-ErbB4) signaling does not cause general hypofunction of NMDARs. Rather, we find that, in the hippocampus and prefrontal cortex, NRG1 beta-ErbB4 signaling suppresses the enhancement of synaptic NMDAR currents by the nonreceptor tyrosine kinase Src. NRG1 beta-ErbB4 signaling prevented induction of long-term potentiation at hippocampal Schaffer collateral-CA1 synapses and suppressed Src-dependent enhancement of NMDAR responses during theta-burst stimulation. Moreover, NRG1 beta-ErbB4 signaling prevented theta burst-induced phosphorylation of GluN2B by inhibiting Src kinase activity. We propose that NRG1-ErbB4 signaling participates in cognitive dysfunction in schizophrenia by aberrantly suppressing Src-mediated enhancement of synaptic NMDAR function.	[Pitcher, Graham M.; Kalia, Lorraine V.; Ng, David; Salter, Michael W.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Pitcher, Graham M.; Goodfellow, Nathalie M.; Lambe, Evelyn K.; Salter, Michael W.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A1, Canada; [Kalia, Lorraine V.; Salter, Michael W.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Yee, Kathleen T.] Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Boston, MA 02111 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Tufts University	Salter, MW (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	mike.salter@utoronto.ca	Lambe, Evelyn K/K-3699-2015	Lambe, Evelyn K/0000-0002-5994-6090; Kalia, Lorraine/0000-0002-9384-1305	Canadian Institutes of Health Research (CIHR) [MT-12682, MOP-89825]; Deafness Research Foundation; Merck Frosst Fellowship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Deafness Research Foundation; Merck Frosst Fellowship	We thank J. F. MacDonald, P. A. Frankland, L. Y. Wang, M. F. Jackson and M. H. Pitcher for critical reading of the manuscript, and Genentech and L. Mei for providing NRG1 beta. Src knockout mice were obtained as a gift from B. F. Boyce, University of Rochester Medical Center. This study was supported by grants from the Canadian Institutes of Health Research (CIHR) to M. W. S. (MT-12682) and to E. K. L. (MOP-89825), and from the Deafness Research Foundation to K. T. Y. M. W. S. holds a Canada research chair (tier I) in neuroplasticity and pain, and is an International Research Scholar of the Howard Hughes Medical Institute. E. K. L. holds a Canada research chair (tier II) in developmental cortical physiology. G. M. P. was a CIHR postdoctoral fellow and was supported by a Merck Frosst Fellowship award. D. N. held a CIHR doctoral research award, L. V. K. was a CIHR MD-PhD student, and N. M. G. holds a CIHR Canada Graduate Scholarship doctoral award. We thank D. Wong, J. Hicks and S. Singhroy for technical support.	Balu DT, 2011, NEUROSCI BIOBEHAV R, V35, P848, DOI 10.1016/j.neubiorev.2010.10.005; Benetti S, 2009, BRAIN, V132, P2426, DOI 10.1093/brain/awp098; Bjarnadottir M, 2007, J NEUROSCI, V27, P4519, DOI 10.1523/JNEUROSCI.4314-06.2007; Chen YJJ, 2008, J NEUROSCI, V28, P6872, DOI 10.1523/JNEUROSCI.1815-08.2008; Chong VZ, 2008, SCHIZOPHR RES, V100, P270, DOI 10.1016/j.schres.2007.12.474; Colantuoni C, 2008, BRAIN STRUCT FUNCT, V213, P255, DOI 10.1007/s00429-008-0181-5; Coyle JT, 2003, ANN NY ACAD SCI, V1003, P318, DOI 10.1196/annals.1300.020; Deakin IH, 2009, NEUROREPORT, V20, P1523, DOI 10.1097/WNR.0b013e328330f6e7; Dingledine R, 1999, PHARMACOL REV, V51, P7; Duffy L, 2010, NEUROSCIENCE, V170, P800, DOI 10.1016/j.neuroscience.2010.07.042; Eilam R, 1998, P NATL ACAD SCI USA, V95, P1888, DOI 10.1073/pnas.95.4.1888; Eisenberg DP, 2010, NEUROPSYCHOPHARMACOL, V35, P258, DOI 10.1038/npp.2009.111; Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012; Gao XM, 2000, AM J PSYCHIAT, V157, P1141, DOI 10.1176/appi.ajp.157.7.1141; Grant SGN, 2001, J NEUROSCI, V21, P8315, DOI 10.1523/JNEUROSCI.21-21-08315.2001; Gu ZL, 2005, J NEUROSCI, V25, P4974, DOI 10.1523/JNEUROSCI.1086-05.2005; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Hashimoto R, 2004, MOL PSYCHIATR, V9, P299, DOI 10.1038/sj.mp.4001434; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Iyengar SS, 2008, BRAIN RES, V1208, P67, DOI 10.1016/j.brainres.2008.02.045; Kalia LV, 2006, EMBO J, V25, P4971, DOI 10.1038/sj.emboj.7601342; Kato T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014185; Kim H, 2005, ONCOGENE, V24, P7599, DOI 10.1038/sj.onc.1208898; Kwon OB, 2005, J NEUROSCI, V25, P9378, DOI 10.1523/JNEUROSCI.2100-05.2005; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; Law AJ, 2007, HUM MOL GENET, V16, P129, DOI 10.1093/hmg/ddl449; Lei G, 2002, EMBO J, V21, P2977, DOI 10.1093/emboj/cdf292; Lindsley CW, 2006, CURR TOP MED CHEM, V6, P771, DOI 10.2174/156802606777057599; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; Liu XJ, 2008, NAT MED, V14, P1325, DOI 10.1038/nm.1883; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Ma L, 2003, J NEUROSCI, V23, P3164; Macdonald DS, 2005, J NEUROSCI, V25, P11374, DOI 10.1523/JNEUROSCI.3871-05.2005; MacDonald JF, 2001, CURR DRUG TARGETS, V2, P299, DOI 10.2174/1389450013348452; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; Nicodemus KK, 2006, MOL PSYCHIATR, V11, P1062, DOI 10.1038/sj.mp.4001878; Nicodemus KK, 2009, MOL PSYCHIATR, V14, P741, DOI 10.1038/mp.2008.150; Norton N, 2006, AM J MED GENET B, V141B, P96, DOI 10.1002/ajmg.b.30236; O'Tuathaigh CMP, 2008, PROG NEURO-PSYCHOPH, V32, P462, DOI 10.1016/j.pnpbp.2007.09.018; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Pelkey KA, 2002, NEURON, V34, P127, DOI 10.1016/S0896-6273(02)00633-5; Pilowsky LS, 2006, MOL PSYCHIATR, V11, P118, DOI 10.1038/sj.mp.4001751; Pitcher GM, 2008, NEUROREPORT, V19, P139, DOI 10.1097/WNR.0b013e3282f3da10; Rosenblum K, 1996, P NATL ACAD SCI USA, V93, P10457, DOI 10.1073/pnas.93.19.10457; Rostas JAP, 1996, P NATL ACAD SCI USA, V93, P10452, DOI 10.1073/pnas.93.19.10452; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Siekmeier PJ, 2007, SCHIZOPHR RES, V89, P177, DOI 10.1016/j.schres.2006.08.007; Silberberg G, 2006, AM J MED GENET B, V141B, P142, DOI 10.1002/ajmg.b.30275; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Tan W, 2007, J BIOL CHEM, V282, P24343, DOI 10.1074/jbc.M702953200; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Xu JD, 2008, J BIOL CHEM, V283, P17503, DOI 10.1074/jbc.M800917200; Yang JZ, 2003, MOL PSYCHIATR, V8, P706, DOI 10.1038/sj.mp.4001377; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zierhut K, 2010, PSYCHIAT RES-NEUROIM, V183, P187, DOI 10.1016/j.pscychresns.2010.03.007	60	123	127	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2011	17	4					470	U111		10.1038/nm.2315	http://dx.doi.org/10.1038/nm.2315			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21441918	Green Accepted			2022-12-25	WOS:000289245100038
J	Wang, TJ; Larson, MG; Vasan, RS; Cheng, S; Rhee, EP; McCabe, E; Lewis, GD; Fox, CS; Jacques, PF; Fernandez, C; O'Donnell, CJ; Carr, SA; Mootha, VK; Florez, JC; Souza, A; Melander, O; Clish, CB; Gerszten, RE				Wang, Thomas J.; Larson, Martin G.; Vasan, Ramachandran S.; Cheng, Susan; Rhee, Eugene P.; McCabe, Elizabeth; Lewis, Gregory D.; Fox, Caroline S.; Jacques, Paul F.; Fernandez, Celine; O'Donnell, Christopher J.; Carr, Stephen A.; Mootha, Vamsi K.; Florez, Jose C.; Souza, Amanda; Melander, Olle; Clish, Clary B.; Gerszten, Robert E.			Metabolite profiles and the risk of developing diabetes	NATURE MEDICINE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; AMINO-ACID; INSULIN-SECRETION; PROTEIN; PREDICTION; RESISTANCE; MIXTURES; MELLITUS; MUSCLE; OBESE	Emerging technologies allow the high-throughput profiling of metabolic status from a blood specimen (metabolomics). We investigated whether metabolite profiles could predict the development of diabetes. Among 2,422 normoglycemic individuals followed for 12 years, 201 developed diabetes. Amino acids, amines and other polar metabolites were profiled in baseline specimens by liquid chromatography-tandem mass spectrometry (LC-MS). Cases and controls were matched for age, body mass index and fasting glucose. Five branched-chain and aromatic amino acids had highly significant associations with future diabetes: isoleucine, leucine, valine, tyrosine and phenylalanine. A combination of three amino acids predicted future diabetes (with a more than fivefold higher risk for individuals in top quartile). The results were replicated in an independent, prospective cohort. These findings underscore the potential key role of amino acid metabolism early in the pathogenesis of diabetes and suggest that amino acid profiles could aid in diabetes risk assessment.	[Wang, Thomas J.; Rhee, Eugene P.; Lewis, Gregory D.; Gerszten, Robert E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA 02115 USA; [Wang, Thomas J.; Cheng, Susan; McCabe, Elizabeth; Lewis, Gregory D.; O'Donnell, Christopher J.; Gerszten, Robert E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Wang, Thomas J.; Larson, Martin G.; Vasan, Ramachandran S.; Cheng, Susan; McCabe, Elizabeth; Fox, Caroline S.; O'Donnell, Christopher J.] Boston Univ, Sch Med, Framingham, MA USA; [Wang, Thomas J.; Larson, Martin G.; Vasan, Ramachandran S.; Cheng, Susan; McCabe, Elizabeth; Fox, Caroline S.; O'Donnell, Christopher J.] NHLBI, Framingham Heart Study, Framingham, MA USA; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Boston Med Ctr, Cardiol Sect, Boston, MA 02118 USA; [Cheng, Susan] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiol, Boston, MA USA; [Rhee, Eugene P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Renal, Boston, MA USA; [Rhee, Eugene P.; Lewis, Gregory D.; O'Donnell, Christopher J.; Carr, Stephen A.; Mootha, Vamsi K.; Florez, Jose C.; Souza, Amanda; Clish, Clary B.; Gerszten, Robert E.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Fox, Caroline S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol, Boston, MA USA; [Fox, Caroline S.] NHLBI, Div Intramural Res, Bethesda, MD 20892 USA; [Jacques, Paul F.] Tufts Univ, Jean Mayer US Dept, Agr Human Nutr Res Ctr, Boston, MA 02111 USA; [Fernandez, Celine] Lund Univ, Dept Expt Med Sci, Malmo, Sweden; [Mootha, Vamsi K.; Florez, Jose C.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Diabet Unit, Boston, MA USA; [Mootha, Vamsi K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA; [Melander, Olle] Lund Univ, Dept Clin Sci, Malmo, Sweden	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston Medical Center; Boston University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Tufts University; Lund University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Lund University	Wang, TJ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA 02115 USA.	tjwang@partners.org; rgerszten@partners.org	Clish, Clary/AAB-7124-2019; Lorkiewicz, Pawel/A-2126-2011; Ramachandran, Vasan/Y-2527-2019; Carr, Steven A./AAH-8366-2019; Clish, Clary B/ABB-9374-2021; Fernandez, Celine/ABH-9332-2020	Lorkiewicz, Pawel/0000-0002-1755-9826; Ramachandran, Vasan/0000-0001-7357-5970; Clish, Clary B/0000-0001-8259-9245; Fernandez, Celine/0000-0003-1290-4982; Cheng, Susan/0000-0002-4977-036X; Melander, Olle/0000-0002-2581-484X; Wang, Thomas/0000-0003-4063-6508; Larson, Martin/0000-0002-9631-1254	US National Institutes of Health [NO1-HC-25195, R01-DK-HL081572]; Donald W. Reynolds Foundation; Leducq Foundation; American Heart Association; Ellison Foundation; Massachusetts General Hospital; Doris Duke Charitable Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006002, ZIAHL006094] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Foundation; Leducq Foundation(Leducq Foundation); American Heart Association(American Heart Association); Ellison Foundation(Lawrence Ellison Foundation); Massachusetts General Hospital(General Electric); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by US National Institutes of Health contract NO1-HC-25195, R01-DK-HL081572, the Donald W. Reynolds Foundation, the Leducq Foundation and the American Heart Association. S. C. is also supported by an award from the Ellison Foundation. J.C.F. is also supported by the Massachusetts General Hospital and a Clinical Scientist Development Award from the Doris Duke Charitable Foundation.	Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Diabetes Prevention Program Research Group, 2002, NEW ENGL J MED, V346, P393, DOI [10.1056/NEJMoa012512, DOI 10.1056/NEJMOA012512]; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; FLOYD JC, 1966, J CLIN INVEST, V45, P1487, DOI 10.1172/JCI105456; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Krebs M, 2002, DIABETES, V51, P599, DOI 10.2337/diabetes.51.3.599; Lewis GD, 2008, J AM COLL CARDIOL, V52, P117, DOI 10.1016/j.jacc.2008.03.043; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Nilsson M, 2007, AM J CLIN NUTR, V85, P996, DOI 10.1093/ajcn/85.4.996; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Persson M, 2007, ARTERIOSCL THROM VAS, V27, P1411, DOI 10.1161/ATVBAHA.107.142679; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; van Loon LJC, 2000, AM J CLIN NUTR, V72, P96; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Wopereis S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004525; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123; Zhao XJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE384, DOI 10.1152/ajpendo.90748.2008	31	2037	2109	18	642	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2011	17	4					448	U83		10.1038/nm.2307	http://dx.doi.org/10.1038/nm.2307			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21423183	Green Accepted			2022-12-25	WOS:000289245100035
J	Izawa, D; Pines, J				Izawa, Daisuke; Pines, Jonathon			How APC/C-Cdc20 changes its substrate specificity in mitosis	NATURE CELL BIOLOGY			English	Article							ANAPHASE-PROMOTING COMPLEX; SPINDLE ASSEMBLY CHECKPOINT; CYCLIN-A; CELL-CYCLE; DESTRUCTION BOX; DEPENDENT PROTEOLYSIS; ANTIMITOTIC DRUGS; MITOTIC CYCLINS; APC/C; CDC20	Progress through mitosis requires that the right protein be degraded at the right time. One ubiquitin ligase, the anaphase-promoting complex or cyclosome (APC/C) targets most of the crucial mitotic regulators by changing its substrate specificity throughout mitosis. The spindle assembly checkpoint (SAC) acts on the APC/C co-activator, Cdc20 (cell division cycle 20), to block the degradation of metaphase substrates (for example, cyclin B1 and securin), but not others (for example, cyclin A). How this is achieved is unclear. Here we show that Cdc20 binds to different sites on the APC/C depending on the SAC. Cdc20 requires APC3 and APC8 to bind and activate the APC/C when the SAC is satisfied, but requires only APC8 to bind the APC/C when the SAC is active. Moreover, APC10 is crucial for the destruction of cyclin B1 and securin, but not cyclin A. We conclude that the SAC causes Cdc20 to bind to different sites on the APC/C and this alters APC/C substrate specificity.	[Izawa, Daisuke; Pines, Jonathon] Gurdon Inst, Cambridge CB2 1QN, England; [Izawa, Daisuke; Pines, Jonathon] Dept Zool, Cambridge CB2 1QN, England		Pines, J (corresponding author), Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	jp103@cam.ac.uk		Pines, Jonathon/0000-0002-5227-6004	Japanese Society for the Promotion of Science; Association for International Cancer Research (AICR); Welcome Trust; Cancer Research UK	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Association for International Cancer Research (AICR); Welcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK)	We thank J-M. Peters for the anti-phospho APC1 antibody and S. Taylor for the HeLa-FRT cell line. We are grateful to D. Barford for discussing results before publication and all the members of our laboratory for comments and criticisms. D.I. was supported by a fellowship from the Japanese Society for the Promotion of Science and by the Association for International Cancer Research (AICR). The work was supported by core funding to the Gurdon Institute from the Welcome Trust and Cancer Research UK, by a project grant from the AICR and a programme grant from Cancer Research UK to J.P.	Blanco MA, 2000, EMBO J, V19, P3945, DOI 10.1093/emboj/19.15.3945; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Burton JL, 2000, MOL CELL BIOL, V20, P4614, DOI 10.1128/MCB.20.13.4614-4625.2000; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Deak P, 2003, J CELL SCI, V116, P4147, DOI 10.1242/jcs.00722; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Di Fiore B, 2010, J CELL BIOL, V190, P501, DOI 10.1083/jcb.201001083; Dube P, 2005, MOL CELL, V20, P867, DOI 10.1016/j.molcel.2005.11.008; Eytan E, 2006, P NATL ACAD SCI USA, V103, P2081, DOI 10.1073/pnas.0510695103; Floyd S, 2008, CURR BIOL, V18, P1649, DOI 10.1016/j.cub.2008.09.058; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Hames RS, 2001, EMBO J, V20, P7117, DOI 10.1093/emboj/20.24.7117; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; Kimata Y, 2008, DEV CELL, V14, P446, DOI 10.1016/j.devcel.2007.12.010; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Li M, 2008, NAT CELL BIOL, V10, P1083, DOI 10.1038/ncb1768; Mallory MJ, 2007, MOL CELL, V27, P951, DOI 10.1016/j.molcel.2007.08.019; Matyskiela ME, 2009, MOL CELL, V34, P68, DOI 10.1016/j.molcel.2009.02.027; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Passmore LA, 2005, EMBO REP, V6, P873, DOI 10.1038/sj.embor.7400482; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Sigrist SJ, 1997, CELL, V90, P671, DOI 10.1016/S0092-8674(00)80528-0; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Steen JAJ, 2008, P NATL ACAD SCI USA, V105, P6069, DOI 10.1073/pnas.0709807104; Sudo T, 2001, EMBO J, V20, P6499, DOI 10.1093/emboj/20.22.6499; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Summers MK, 2008, MOL CELL, V31, P544, DOI 10.1016/j.molcel.2008.07.014; Tang ZY, 2001, MOL BIOL CELL, V12, P3839, DOI 10.1091/mbc.12.12.3839; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; van Zon W, 2010, J CELL BIOL, V190, P587, DOI 10.1083/jcb.200912084; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Walker A, 2008, J CELL SCI, V121, P2319, DOI 10.1242/jcs.031591; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Zachariae W, 1996, MOL BIOL CELL, V7, P791, DOI 10.1091/mbc.7.5.791; Zhang ZG, 2010, J MOL BIOL, V397, P1316, DOI 10.1016/j.jmb.2010.02.045	56	85	87	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2011	13	3					223	U339		10.1038/ncb2165	http://dx.doi.org/10.1038/ncb2165			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	728BB	21336306	Green Accepted			2022-12-25	WOS:000287847600010
J	Schiffer, JT; Scott, J; Corey, L				Schiffer, Joshua T.; Scott, John; Corey, Lawrence			Fighting a defiant virus	NATURE MEDICINE			English	Editorial Material							HEPATITIS-C VIRUS; GENOTYPE 1 INFECTION; RIBAVIRIN; TELAPREVIR; PLACEBO; INTERFERON-ALPHA-2B; PEGINTERFERON; COMBINATION; TRIAL		[Schiffer, Joshua T.; Scott, John; Corey, Lawrence] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Schiffer, Joshua T.; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Schiffer, JT (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	jschiffe@fhcrc.org; lcorey@u.washington.edu	Corey, Lawrence/AAE-1796-2020	Corey, Lawrence/0000-0002-2179-2436				Cuevas JM, 2009, J VIROL, V83, P5760, DOI 10.1128/JVI.00201-09; Dahari H, 2009, J VIROL, V83, P6383, DOI 10.1128/JVI.02612-08; DAVIS GL, 2009, GASTROENTEROLOGY, V138; Fletcher NF, 2010, GASTROENTEROLOGY, V139, P1365, DOI 10.1053/j.gastro.2010.06.008; Gane EJ, 2010, LANCET, V376, P1467, DOI 10.1016/S0140-6736(10)61384-0; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Kieffer TL, 2007, HEPATOLOGY, V46, P631, DOI 10.1002/hep.21781; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; Roberts SK, 2008, HEPATOLOGY, V48, P398, DOI 10.1002/hep.22321; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; SCHUURMAN R, 1995, J INFECT DIS, V171, P1411, DOI 10.1093/infdis/171.6.1411	15	4	4	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2011	17	3					253	254		10.1038/nm0311-253	http://dx.doi.org/10.1038/nm0311-253			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21383719				2022-12-25	WOS:000288070000019
J	[Anonymous]				[Anonymous]			Towards a medical grade human genome sequence	NATURE GENETICS			English	Editorial Material								The substantial $10 million purse of the Archon Genomics X PRIZE (AGXP) is being offered for the generation of rapid, accurate and complete human DNA sequences. Because so many genomics researchers have a stake, we offer to help with a process of community consultation to help evolve fair and efficient methods to validate contestant data for the competition.											0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2011	43	3					173	173						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726BR	21350492	Bronze			2022-12-25	WOS:000287693800001
J	Dickinson, BC; Peltier, J; Stone, D; Schaffer, DV; Chang, CJ				Dickinson, Bryan C.; Peltier, Joseph; Stone, Daniel; Schaffer, David V.; Chang, Christopher J.			Nox2 redox signaling maintains essential cell populations in the brain	NATURE CHEMICAL BIOLOGY			English	Article							IMAGING HYDROGEN-PEROXIDE; CHRONIC GRANULOMATOUS-DISEASE; TUMOR-SUPPRESSOR PTEN; NEURAL STEM-CELLS; LIVING CELLS; FLUORESCENT-PROBES; REACTIVE OXYGEN; NADPH-OXIDASE; OXIDATIVE STRESS; NITRIC-OXIDE	Reactive oxygen species (ROS) are conventionally classified as toxic consequences of aerobic life, and the brain is particularly susceptible to ROS-induced oxidative stress and damage owing to its high energy and oxygen demands. NADPH oxidases (Nox) are a widespread source of brain ROS implicated in seizures, stroke and neurodegeneration. A physiological role for ROS generation in normal brain function has not been established, despite the fact that mice and humans lacking functional Nox proteins have cognitive deficits. Using molecular imaging with Peroxyfluor-6 (PF6), a new selective fluorescent indicator for hydrogen peroxide (H2O2), we show that adult hippocampal stem/progenitor cells (AHPs) generate H2O2 through Nox2 to regulate intracellular growth signaling pathways, which in turn maintains their normal proliferation in vitro and in vivo. Our results challenge the traditional view that brain ROS are solely deleterious by demonstrating that controlled ROS chemistry is needed for maintaining specific cell populations.	[Dickinson, Bryan C.; Chang, Christopher J.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Peltier, Joseph; Stone, Daniel; Schaffer, David V.] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; [Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Dickinson, BC (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	schaffer@berkeley.edu; chrischang@berkeley.edu		Stone, Daniel/0000-0003-1619-7541	Packard and Sloan Foundations; UC Berkeley Hellman Faculty Fund; Amgen; Astra Zeneca; Novartis; US National Institutes of Health [GM 79465, EB 007295, T32 GM066698)]; California Institute for Regenerative Medicine [T1-00007]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB007295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079465, T32GM066698] Funding Source: NIH RePORTER	Packard and Sloan Foundations; UC Berkeley Hellman Faculty Fund; Amgen(Amgen); Astra Zeneca(AstraZeneca); Novartis(Novartis); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Packard and Sloan Foundations (C.J.C.), the UC Berkeley Hellman Faculty Fund (C.J.C.), Amgen, Astra Zeneca and Novartis (C.J.C.) and the US National Institutes of Health (GM 79465 to C.J.C. and EB 007295 to D.V.S.) for providing funding for this work. C.J.C. is an Investigator with the Howard Hughes Medical Institute. B. C. D. was partially supported by a Chemical Biology Training Grant from the US National Institutes of Health. (T32 GM066698). J.P. was partially supported by a training grant fellowship from the California Institute for Regenerative Medicine (T1-00007). We thank M. Quinn (Montana State University) for generous donation of Nox2 antibodies and T. Kawahara for helpful advice.	Albers AE, 2008, BIOORG MED CHEM LETT, V18, P5948, DOI 10.1016/j.bmcl.2008.08.035; Albers AE, 2006, J AM CHEM SOC, V128, P9640, DOI 10.1021/ja063308k; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Chang MCY, 2004, J AM CHEM SOC, V126, P15392, DOI 10.1021/ja0441716; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dickinson BC, 2008, J AM CHEM SOC, V130, P9638, DOI 10.1021/ja802355u; Dickinson BC, 2010, J AM CHEM SOC, V132, P5906, DOI 10.1021/ja1014103; Dickinson BC, 2010, CURR OPIN CHEM BIOL, V14, P50, DOI 10.1016/j.cbpa.2009.10.014; FLOYD RA, 1991, SCIENCE, V254, P1597, DOI 10.1126/science.1684251; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Izumi S, 2009, J AM CHEM SOC, V131, P10189, DOI 10.1021/ja902511p; Kishida KT, 2006, MOL CELL BIOL, V26, P5908, DOI 10.1128/MCB.00269-06; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; McQuade LE, 2010, INORG CHEM, V49, P9535, DOI 10.1021/ic1012507; McQuade LE, 2010, P NATL ACAD SCI USA, V107, P8525, DOI 10.1073/pnas.0914794107; Miller EW, 2007, CURR OPIN CHEM BIOL, V11, P620, DOI 10.1016/j.cbpa.2007.09.018; Miller EW, 2007, NAT CHEM BIOL, V3, P263, DOI 10.1038/nchembio871; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Miller EW, 2005, J AM CHEM SOC, V127, P16652, DOI 10.1021/ja054474f; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Palmer TD, 1999, J NEUROSCI, V19, P8487; Pao M, 2004, PSYCHOSOMATICS, V45, P230, DOI 10.1176/appi.psy.45.3.230; Park L, 2008, P NATL ACAD SCI USA, V105, P1347, DOI 10.1073/pnas.0711568105; Park L, 2007, J CEREBR BLOOD F MET, V27, P1908, DOI 10.1038/sj.jcbfm.9600491; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Pluth MD, 2010, ORG LETT, V12, P2318, DOI 10.1021/ol1006289; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; Srikun D, 2008, J AM CHEM SOC, V130, P4596, DOI 10.1021/ja711480f; Srikun D, 2010, J AM CHEM SOC, V132, P4455, DOI 10.1021/ja100117u; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; Walder CE, 1997, STROKE, V28, P2252, DOI 10.1161/01.STR.28.11.2252; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Zhang W, 2004, FASEB J, V18, P589, DOI 10.1096/fj.03-0983fje; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	50	204	207	8	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2011	7	2					106	112		10.1038/NCHEMBIO.497	http://dx.doi.org/10.1038/NCHEMBIO.497			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	707XM	21186346	Green Accepted, Green Submitted			2022-12-25	WOS:000286324600011
J	van de Laar, IMBH; Oldenburg, RA; Pals, G; Roos-Hesselink, JW; de Graaf, BM; Verhagen, JMA; Hoedemaekers, YM; Willemsen, R; Severijnen, LA; Venselaar, H; Vriend, G; Pattynama, PM; Collee, M; Majoor-Krakauer, D; Poldermans, D; Frohn-Mulder, IME; Micha, D; Timmermans, J; Hilhorst-Hofstee, Y; Bierma-Zeinstra, SM; Willems, PJ; Kros, JM; Oei, EHG; Oostra, BA; Wessels, MW; Bertoli-Avella, AM				van de laar, Ingrid M. B. H.; Oldenburg, Rogier A.; Pals, Gerard; Roos-Hesselink, Jolien W.; de Graaf, Bianca M.; Verhagen, Judith M. A.; Hoedemaekers, Yvonne M.; Willemsen, Rob; Severijnen, Lies-Anne; Venselaar, Hanka; Vriend, Gert; Pattynama, Peter M.; Collee, Margriet; Majoor-Krakauer, Danielle; Poldermans, Don; Frohn-Mulder, Ingrid M. E.; Micha, Dimitra; Timmermans, Janneke; Hilhorst-Hofstee, Yvonne; Bierma-Zeinstra, Sita M.; Willems, Patrick J.; Kros, Johan M.; Oei, Edwin H. G.; Oostra, Ben A.; Wessels, Marja W.; Bertoli-Avella, Aida M.			Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis	NATURE GENETICS			English	Article							GROWTH-FACTOR-BETA; MARFAN-SYNDROME; RECEPTOR; INDIVIDUALS; ACTIVATION; DESIGN; DISC	Thoracic aortic aneurysms and dissections are a main feature of connective tissue disorders, such as Marfan syndrome and Loeys-Dietz syndrome. We delineated a new syndrome presenting with aneurysms, dissections and tortuosity throughout the arterial tree in association with mild craniofacial features and skeletal and cutaneous anomalies. In contrast with other aneurysm syndromes, most of these affected individuals presented with early-onset osteoarthritis. We mapped the genetic locus to chromosome 15q22.2-24.2 and show that the disease is caused by mutations in SMAD3. This gene encodes a member of the TGF-beta pathway that is essential for TGF-beta signal transmission(1-3). SMAD3 mutations lead to increased aortic expression of several key players in the TGF-beta pathway, including SMAD3. Molecular diagnosis will allow early and reliable identification of cases and relatives at risk for major cardiovascular complications. Our findings endorse the TGF-beta pathway as the primary pharmacological target for the development of new treatments for aortic aneurysms and osteoarthritis.	[van de laar, Ingrid M. B. H.; Oldenburg, Rogier A.; de Graaf, Bianca M.; Verhagen, Judith M. A.; Hoedemaekers, Yvonne M.; Willemsen, Rob; Severijnen, Lies-Anne; Collee, Margriet; Majoor-Krakauer, Danielle; Oostra, Ben A.; Wessels, Marja W.; Bertoli-Avella, Aida M.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Pals, Gerard; Micha, Dimitra] Vrije Univ Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Roos-Hesselink, Jolien W.] Erasmus MC, Dept Cardiol, Rotterdam, Netherlands; [Venselaar, Hanka; Vriend, Gert] Radboud Univ Nijmegen, Med Ctr, NCMLS, Nijmegen, Netherlands; [Venselaar, Hanka; Vriend, Gert] CMBI, Nijmegen, Netherlands; [Pattynama, Peter M.; Oei, Edwin H. G.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Poldermans, Don] Erasmus MC, Dept Vasc Surg, Rotterdam, Netherlands; [Frohn-Mulder, Ingrid M. E.] Erasmus MC, Dept Pediat Cardiol, Rotterdam, Netherlands; [Timmermans, Janneke] Radboud Univ Nijmegen, Med Ctr, Dept Cardiol, Nijmegen, Netherlands; [Hilhorst-Hofstee, Yvonne] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Bierma-Zeinstra, Sita M.] Erasmus MC, Dept Gen Practice, Rotterdam, Netherlands; [Willems, Patrick J.] GENDIA Network, Antwerp, Belgium; [Kros, Johan M.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Bertoli-Avella, AM (corresponding author), Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands.	a.bertoliavella@erasmusmc.nl	Timmermans, J./L-4693-2015; Venselaar, Hanka/D-2009-2016; Majoor-Krakauer, Danielle/AAC-3939-2020; Micha, Dimitra/U-4979-2019; Bierma-Zeinstra, Sita/AAF-2122-2019; Hilhorst-Hofstee, Yvonne/AAC-5120-2022; Vriend, Gert/D-6730-2011; Oei, Edwin HG/E-8174-2013; Vriend, G./H-8112-2014; Bertoli-Avella, Aida/AAW-2751-2020	Venselaar, Hanka/0000-0001-9824-6559; Micha, Dimitra/0000-0001-7890-4411; Hilhorst-Hofstee, Yvonne/0000-0003-0951-6524; Bertoli-Avella, Aida/0000-0001-9544-1877; Verhagen, Judith/0000-0002-0340-3433; Pals, Gerard/0000-0003-4091-7115	Erasmus Medical Center, The Netherlands; Center for Biomedical Genetics (CBG), The Netherlands	Erasmus Medical Center, The Netherlands(Netherlands Government); Center for Biomedical Genetics (CBG), The Netherlands(Netherlands Government)	This work was partially funded by an Erasmus Fellowship (Erasmus Medical Center, The Netherlands) to A.M.B.-A. and a grant from the Center for Biomedical Genetics (CBG), The Netherlands to B.A.O.	Bakker CE, 2000, EXP CELL RES, V258, P162, DOI 10.1006/excr.2000.4932; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Coucke PJ, 2006, NAT GENET, V38, P452, DOI 10.1038/ng1764; Datto MB, 1999, MOL CELL BIOL, V19, P2495; Faivre L, 2007, AM J HUM GENET, V81, P454, DOI 10.1086/520125; Gomez D, 2009, J PATHOL, V218, P131, DOI 10.1002/path.2516; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Lacro RV, 2007, AM HEART J, V154, P624, DOI 10.1016/j.ahj.2007.06.024; LANE NE, 1993, J RHEUMATOL, V20, P1911; Li CG, 2009, SPINE, V34, P1363, DOI 10.1097/BRS.0b013e3181a3c7c7; LILIENFELD DE, 1987, ARTERIOSCLEROSIS, V7, P637, DOI 10.1161/01.ATV.7.6.637; Lin Fay Y, 2008, J Cardiovasc Comput Tomogr, V2, P298, DOI 10.1016/j.jcct.2008.08.002; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Maleszewski JJ, 2009, AM J SURG PATHOL, V33, P194, DOI 10.1097/PAS.0b013e31817f3661; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Prokova V, 2007, BIOCHEMISTRY-US, V46, P13775, DOI 10.1021/bi701540u; ROMAN MJ, 1989, AM J CARDIOL, V64, P507, DOI 10.1016/0002-9149(89)90430-X; SILVERMAN DI, 1995, AM J CARDIOL, V75, P157, DOI 10.1016/S0002-9149(00)80066-1; van de Laar I, 2009, EUR HEART J, V30, P2485, DOI 10.1093/eurheartj/ehp271; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang XW, 2006, CIRCULATION, V114, pI200, DOI 10.1161/CIRCULATIONAHA.105.000240; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	28	450	455	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2011	43	2					121	U65		10.1038/ng.744	http://dx.doi.org/10.1038/ng.744			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	711XD	21217753				2022-12-25	WOS:000286623800009
J	Epping, MT; Meijer, LAT; Krijgsman, O; Bos, JL; Pandolfi, PP; Bernards, R				Epping, Mirjam T.; Meijer, Lars A. T.; Krijgsman, Oscar; Bos, Johannes L.; Pandolfi, Pier Paolo; Bernards, Rene			TSPYL5 suppresses p53 levels and function by physical interaction with USP7	NATURE CELL BIOLOGY			English	Article							BREAST-CANCER; EXPRESSION SIGNATURE; INDUCED SENESCENCE; GENE; HAUSP; UBIQUITINATION; RECURRENCE; ACTIVATION; PROGNOSIS; PATHWAY	We have previously reported a gene expression signature that is a powerful predictor of poor clinical outcome in breast cancer(1). Among the seventy genes in this expression profile is a gene of unknown function: TSPYL5 (TSPY-like 5, also known as KIAA1750). TSPYL5 is located within a small region at chromosome 8q22 that is frequently amplified in breast cancer, which suggests that TSPYL5 has a causal role in breast oncogenesis(2,3). Here, we report that high TSPYL5 expression is an independent marker of poor outcome in breast cancer. Mass spectrometric analysis revealed that TSPYL5 interacts with ubiquitin-specific protease 7 (USP7; also known as herpesvirus-associated ubiquitin-specific protease; HAUSP). USP7 is the deubiquitylase for the p53 tumour suppressor(4) and TSPYL5 reduces the activity of USP7 towards p53, resulting in increased p53 ubiquitylation. We demonstrate that TSPYL5 reduces p53 protein levels and inhibits activation of p53-target genes. Furthermore, expression of TSPYL5 overrides p53-dependent proliferation arrest and oncogene-induced senescence, and contributes to oncogenic transformation in multiple cell-based assays. Our data identify TSPYL5 as a suppressor of p53 function through its interaction with USP7.	[Epping, Mirjam T.; Bernards, Rene] Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Epping, Mirjam T.; Bernards, Rene] Netherlands Canc Inst, Canc Genom Ctr, NL-1066 CX Amsterdam, Netherlands; [Epping, Mirjam T.; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Med, Beth Israel Deaconess Canc Ctr,Canc Genet Program, Boston, MA 02215 USA; [Epping, Mirjam T.; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Pathol, Beth Israel Deaconess Canc Ctr,Canc Genet Program, Boston, MA 02215 USA; [Meijer, Lars A. T.; Bos, Johannes L.] Univ Med Ctr Utrecht, Ctr Biomed Genet, Dept Physiol Chem, NL-3584 CX Utrecht, Netherlands; [Meijer, Lars A. T.; Bos, Johannes L.] Univ Med Ctr Utrecht, Canc Genom Ctr, NL-3584 CX Utrecht, Netherlands; [Krijgsman, Oscar] Agendia BV, NL-1098 XH Amsterdam, Netherlands; [Krijgsman, Oscar] Vrije Univ Amsterdam Med Ctr, Dept Pathol, NL-1081 HV Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Agendia; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Ctr Biomed Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl		Pandolfi, Pier Paolo/0000-0002-5352-5295; Bernards, Rene/0000-0001-8677-3423	Dutch Cancer Society; Netherlands Genomics Initiative; Netherlands Proteomics Centre; NIH	Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Genomics Initiative; Netherlands Proteomics Centre; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Bishop and D. Beach for the gift of HMEC cells with inducible RAS<SUP>V12</SUP> and members of the Bernards and Pandolfi laboratories for discussions and critical reading of the manuscript. This work was supported by grants from the Dutch Cancer Society and the Netherlands Genomics Initiative to R.B., by grants from the Netherlands Proteomics Centre and the Netherlands Genomics Initiative to J.L.B. and by NIH grants to P.P.P.	Borgdorff V, 2010, ONCOGENE, V29, P2262, DOI 10.1038/onc.2009.497; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Brummelkamp TR, 2002, J BIOL CHEM, V277, P6567, DOI 10.1074/jbc.M110492200; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Flatt PM, 2000, CANCER LETT, V156, P63, DOI 10.1016/S0304-3835(00)00441-9; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Holowaty MN, 2003, J BIOL CHEM, V278, P47753, DOI 10.1074/jbc.M307200200; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Kon N, 2010, ONCOGENE, V29, P1270, DOI 10.1038/onc.2009.427; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147	32	87	102	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2011	13	1					102	U249		10.1038/ncb2142	http://dx.doi.org/10.1038/ncb2142			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697GV	21170034				2022-12-25	WOS:000285502200017
J	Galarneau, G; Palmer, CD; Sankaran, VG; Orkin, SH; Hirschhorn, JN; Lettre, G				Galarneau, Genevieve; Palmer, Cameron D.; Sankaran, Vijay G.; Orkin, Stuart H.; Hirschhorn, Joel N.; Lettre, Guillaume			Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; EXPRESSION; HBS1L-MYB; VARIANTS; BCL11A	We used resequencing and genotyping in African Americans with sickle cell anemia (SCA) to characterize associations with fetal hemoglobin (HbF) levels at the BCL11A, HBS1L-MYB and beta-globin loci. Fine-mapping of HbF association signals at these loci confirmed seven SNPs with independent effects and increased the explained heritable variation in HbF levels from 38.6% to 49.5%. We also identified rare missense variants that causally implicate MYB in HbF production.	[Sankaran, Vijay G.; Orkin, Stuart H.] Childrens Hosp Boston, Div Hematol & Oncol, Boston, MA 02115 USA; [Galarneau, Genevieve; Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Palmer, Cameron D.; Hirschhorn, Joel N.] Childrens Hosp Boston, Div Genet, Boston, MA USA; [Palmer, Cameron D.; Hirschhorn, Joel N.] Childrens Hosp Boston, Div Endocrinol, Boston, MA USA; [Palmer, Cameron D.; Hirschhorn, Joel N.] Childrens Hosp Boston, Program Genom, Boston, MA USA; [Palmer, Cameron D.; Hirschhorn, Joel N.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Sankaran, Vijay G.; Orkin, Stuart H.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Lettre, Guillaume] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Harvard University; Boston Children's Hospital; Universite de Montreal; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Universite de Montreal	Orkin, SH (corresponding author), Childrens Hosp Boston, Div Hematol & Oncol, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu; joelh@broadinstitute.org; guillaume.lettre@mhi-humangenetics.org			Fondation de l'Institut de Cardiologie de Montreal; Doris Duke Charitable Foundation; National Heart, Lung, and Blood Institute [N01-HV-48194]	Fondation de l'Institut de Cardiologie de Montreal; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank all the individuals who participated in this study, and T. Nguyen and M. Beaudoin for DNA genotyping support. We thank S. Raychaudhuri for critical reading of the manuscript, G. Boucher for statistical advice and the CARe Sickle Cell Disease working group for providing the Cooperative Study of Sickle Cell Disease (CSSCD) principal components. This work was funded by the Fondation de l'Institut de Cardiologie de Montreal (to G.L.) and was supported by an Innovations in Clinical Research Award grant from the Doris Duke Charitable Foundation (to G.L. and J.N.H.). Resequencing services were provided by the University of Washington, Department of Genome Sciences, under US Federal Government contract number N01-HV-48194 from the National Heart, Lung, and Blood Institute.	Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Embury SH, 1994, SICKLE CELL DIS BASI; Galanello R, 2009, BLOOD, V114, P3935, DOI 10.1182/blood-2009-04-217901; LABIE D, 1985, P NATL ACAD SCI USA, V82, P2111, DOI 10.1073/pnas.82.7.2111; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nuinoon M, 2010, HUM GENET, V127, P303, DOI 10.1007/s00439-009-0770-2; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Solovieff N, 2010, BLOOD, V115, P1815, DOI 10.1182/blood-2009-08-239517; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105	15	185	190	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2010	42	12					1049	1051		10.1038/ng.707	http://dx.doi.org/10.1038/ng.707			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684UZ	21057501	Green Accepted			2022-12-25	WOS:000284578800006
J	Smith, FD; Langeberg, LK; Cellurale, C; Pawson, T; Morrison, DK; Davis, RJ; Scott, JD				Smith, F. Donelson; Langeberg, Lorene K.; Cellurale, Cristina; Pawson, Tony; Morrison, Deborah K.; Davis, Roger J.; Scott, John D.			AKAP-Lbc enhances cyclic AMP control of the ERK1/2 cascade	NATURE CELL BIOLOGY			English	Article							PROTEIN-KINASE-A; SIGNALING PATHWAYS; IN-VIVO; B-RAF; ACTIVATION; CAMP; SCAFFOLD; INHIBITION; KSR	Mitogen-activated protein kinase (MAPK) cascades propagate a variety of cellular activities(1). Processive relay of signals through RAF-MEK-ERK modulates cell growth and proliferation(2,3). Signalling through this ERK cascade is frequently amplified in cancers, and drugs such as sorafenib (which is prescribed to treat renal and hepatic carcinomas) and PLX4720 (which targets melanomas) inhibit RAF kinases(4,5). Natural factors that influence ERK1/2 signalling include the second messenger cyclic AMP(6,7). However, the mechanisms underlying this cascade have been difficult to elucidate. We demonstrate that the A-kinase-anchoring protein AKAP-Lbc and the scaffolding protein kinase suppressor of Ras (KSR-1) form the core of a signalling network that efficiently relay signals from RAF, through MEK, and on to ERK1/2. AKAP-Lbc functions as an enhancer of ERK signalling by securing RAF in the vicinity of MEK1 and synchronizing protein kinase A (PKA)-mediated phosphorylation of Ser 838 on KSR-1. This offers mechanistic insight into cAMP-responsive control of ERK signalling events.	[Smith, F. Donelson; Langeberg, Lorene K.; Scott, John D.] Univ Washington, Sch Med, Dept Pharmacol, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Cellurale, Cristina; Davis, Roger J.] Univ Massachusetts, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA; [Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Morrison, Deborah K.] NCI, Lab Cell & Dev Signalling, Frederick, MD 21702 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Scott, JD (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Howard Hughes Med Inst, 1959 Pacific Ave NE, Seattle, WA 98195 USA.	scottjdw@u.washington.edu	Pawson, Tony J/E-4578-2013	Davis, Roger/0000-0002-0130-1652	 [HL088366]; NATIONAL CANCER INSTITUTE [ZIABC011107] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088366] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors wish to thank members of the Scott lab for critical evaluation of this work, M. Milnes for assistance in preparation of the manuscript, and K.L. Guan (UCSD) and R. Marais (ICR, London) for plasmids encoding KSR-1 and Flag-B-Raf. J.D.S. was supported in part by HL088366.	Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366	27	95	105	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2010	12	12					1242	U287		10.1038/ncb2130	http://dx.doi.org/10.1038/ncb2130			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	688DY	21102438	Green Accepted			2022-12-25	WOS:000284831200017
J	Strauss, E				Strauss, Erick			Exploiting single-cell variation for new antibiotics	NATURE CHEMICAL BIOLOGY			English	Article							TUBERCULOSIS; PERSISTENCE	Variations between single members of a bacterial population can lead to antibiotic resistance that is not gene based. The future of effective infectious disease management might depend on a better understanding of this phenomenon and the potential to manipulate both it and microbial population dynamics in general.	Univ Stellenbosch, Dept Biochem, ZA-7600 Stellenbosch, South Africa	Stellenbosch University	Strauss, E (corresponding author), Univ Stellenbosch, Dept Biochem, ZA-7600 Stellenbosch, South Africa.	estrauss@sun.ac.za	Strauss, Erick/G-1783-2010	Strauss, Erick/0000-0002-9898-8226				Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bigger JW, 1944, LANCET, V2, P497; Brehm-Stecher BF, 2004, MICROBIOL MOL BIOL R, V68, P538, DOI 10.1128/MMBR.68.3.538-559.2004; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Schmid A, 2010, CURR OPIN BIOTECH, V21, P12, DOI 10.1016/j.copbio.2010.01.007; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Spiller DG, 2010, NATURE, V465, P736, DOI 10.1038/nature09232; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Wang DJ, 2010, TRENDS BIOTECHNOL, V28, P281, DOI 10.1016/j.tibtech.2010.03.002; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461	20	2	2	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					873	875		10.1038/nchembio.483	http://dx.doi.org/10.1038/nchembio.483			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079594				2022-12-25	WOS:000284214700010
J	Bryant, DM; Datta, A; Rodriguez-Fraticelli, AE; Peranen, J; Martin-Belmonte, F; Mostov, KE				Bryant, David M.; Datta, Anirban; Rodriguez-Fraticelli, Alejo E.; Peranen, Johan; Martin-Belmonte, Fernando; Mostov, Keith E.			A molecular network for de novo generation of the apical surface and lumen	NATURE CELL BIOLOGY			English	Article							MITOTIC SPINDLE ORIENTATION; POLARIZED EPITHELIAL-CELLS; MDCK CELLS; PRIMARY CILIOGENESIS; EXCHANGE FACTOR; PRIMARY CILIUM; RAB GTPASES; CDC42 GEF; MORPHOGENESIS; TRAFFICKING	To form epithelial organs cells must polarize and generate de novo an apical domain and lumen. Epithelial polarization is regulated by polarity complexes that are hypothesized to direct downstream events, such as polarized membrane traffic, although this interconnection is not well understood. We have found that Rab11a regulates apical traffic and lumen formation through the Rab guanine nucleotide exchange factor (GEF), Rabin8, and its target, Rab8a. Rab8a and Rab11a function through the exocyst to target Par3 to the apical surface, and control apical Cdc42 activation through the Cdc42 GEF, Tuba. These components assemble at a transient apical membrane initiation site to form the lumen. This Rab11a-directed network directs Cdc42-dependent apical exocytosis during lumen formation, revealing an interaction between the machineries of vesicular transport and polarization.	[Bryant, David M.; Datta, Anirban; Mostov, Keith E.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Mostov, Keith E.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Rodriguez-Fraticelli, Alejo E.; Martin-Belmonte, Fernando] CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Peranen, Johan] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); University of Helsinki	Mostov, KE (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	keith.mostov@ucsf.edu	Bryant, David/AAH-5620-2019; Rodriguez-Fraticelli, Alejo/AAG-7462-2020; Martin-Belmonte, Fernando/J-8029-2014	Bryant, David/0000-0003-2721-5012; Rodriguez-Fraticelli, Alejo/0000-0002-4017-8714; mostov, keith/0000-0002-8123-6247; Martin-Belmonte, Fernando/0000-0002-2564-4430	Susan G Komen Foundation; DOD; NIH [R01DK074398, R01AI25144, P01AI53194]; Human Frontiers Science Program [HFSP-CDA00011/2009]; MICINN [BFU2008-01916, CSD2009-00016]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI053194, R01AI025144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074398, R01DK067153] Funding Source: NIH RePORTER	Susan G Komen Foundation(Susan G. Komen Breast Cancer Foundation); DOD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank F. Barr, E. Brown, J. Stow, W Guo, I. Macara, K. Simons, J. Wilson, T. Weimbs, and A. Zahraoui for gifts of reagents and unpublished data, and the Mostov lab for kind assistance. Supported by a Susan G Komen Foundation Fellowship (D.M.B.), a DOD Breast Cancer Concept Award (A.D.), NIH grants R01DK074398, R01AI25144 and P01AI53194 (K.E.M.), grants of the Human Frontiers Science Program (HFSP-CDA00011/2009), Marie Curie (IRG-209382), MICINN (BFU2008-01916) and (CONSOLIDER CSD2009-00016) to F.M.-B.; and a JAE fellowship (MICINN) to A.E.R.F.	Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; BRIGNONI M, 1993, EXP CELL RES, V205, P171, DOI 10.1006/excr.1993.1072; Brown PS, 2000, TRAFFIC, V1, P124, DOI 10.1034/j.1600-0854.2000.010205.x; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Casanova JE, 1999, MOL BIOL CELL, V10, P47, DOI 10.1091/mbc.10.1.47; Desclozeaux M, 2008, AM J PHYSIOL-CELL PH, V295, pC545, DOI 10.1152/ajpcell.00097.2008; Ferrari A, 2008, J CELL SCI, V121, P3649, DOI 10.1242/jcs.018648; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Hayes MJ, 2009, J BIOL CHEM, V284, P10202, DOI 10.1074/jbc.M807043200; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; Lalli G, 2009, J CELL SCI, V122, P1499, DOI 10.1242/jcs.044339; Li BX, 2007, J CELL BIOL, V177, P659, DOI 10.1083/jcb.200610157; Liu KD, 2007, AM J PHYSIOL-RENAL, V293, pF1633, DOI 10.1152/ajprenal.00053.2007; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Mangravite LM, 2001, AM J PHYSIOL-RENAL, V280, pF879, DOI 10.1152/ajprenal.2001.280.5.F879; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Matheson J, 2005, BIOCHEM SOC T, V33, P1290, DOI 10.1042/BST0331290; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morais-de-Sa E, 2010, CELL, V141, P509, DOI 10.1016/j.cell.2010.02.040; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Oztan A, 2007, MOL BIOL CELL, V18, P3978, DOI 10.1091/mbc.E07-02-0097; Pohl C, 2008, CELL, V132, P832, DOI 10.1016/j.cell.2008.01.012; Qin Y, 2010, J CELL BIOL, V189, P661, DOI 10.1083/jcb.201002097; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Sato Y, 2007, STRUCTURE, V15, P245, DOI 10.1016/j.str.2007.01.003; Schluter MA, 2009, MOL BIOL CELL, V20, P4652, DOI 10.1091/mbc.E09-02-0137; Schuck S, 2004, P NATL ACAD SCI USA, V101, P4912, DOI 10.1073/pnas.0401285101; Sfakianos J, 2007, J CELL BIOL, V179, P1133, DOI 10.1083/jcb.200709111; Shaye DD, 2008, NAT CELL BIOL, V10, P964, DOI 10.1038/ncb1756; Shivas JM, 2010, TRENDS CELL BIOL, V20, P445, DOI 10.1016/j.tcb.2010.04.003; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tanimizu N, 2009, MOL BIOL CELL, V20, P2486, DOI 10.1091/mbc.E08-02-0177; Walther RF, 2010, CURR BIOL, V20, P1065, DOI 10.1016/j.cub.2010.04.049; WANG AZ, 1994, AM J PHYSIOL, V267, pC473, DOI 10.1152/ajpcell.1994.267.2.C473; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Yu W, 2007, MOL BIOL CELL, V18, P1693, DOI 10.1091/mbc.E06-11-1052; Zhang HN, 2008, MOL BIOL CELL, V19, P2553, DOI 10.1091/mbc.E07-09-0862; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021; Zobiack N, 2003, MOL BIOL CELL, V14, P4896, DOI 10.1091/mbc.E03-06-0387; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	53	402	413	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2010	12	11					1035	U24		10.1038/ncb2106	http://dx.doi.org/10.1038/ncb2106			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	674CO	20890297	Green Accepted			2022-12-25	WOS:000283711500006
J	Endele, S; Rosenberger, G; Geider, K; Popp, B; Tamer, C; Stefanova, I; Milh, M; Kortum, F; Fritsch, A; Pientka, FK; Hellenbroich, Y; Kalscheuer, VM; Kohlhase, J; Moog, U; Rappold, G; Rauch, A; Ropers, HH; von Spiczak, S; Tonnies, H; Villeneuve, N; Villard, L; Zabel, B; Zenker, M; Laube, B; Reis, A; Wieczorek, D; Van Maldergem, L; Kutsche, K				Endele, Sabine; Rosenberger, Georg; Geider, Kirsten; Popp, Bernt; Tamer, Ceyhun; Stefanova, Irina; Milh, Mathieu; Kortuem, Fanny; Fritsch, Angela; Pientka, Friederike K.; Hellenbroich, Yorck; Kalscheuer, Vera M.; Kohlhase, Juergen; Moog, Ute; Rappold, Gudrun; Rauch, Anita; Ropers, Hans-Hilger; von Spiczak, Sarah; Toennies, Holger; Villeneuve, Nathalie; Villard, Laurent; Zabel, Bernhard; Zenker, Martin; Laube, Bodo; Reis, Andre; Wieczorek, Dagmar; Van Maldergem, Lionel; Kutsche, Kerstin			Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes	NATURE GENETICS			English	Article							LONG-TERM POTENTIATION; MOLECULAR DETERMINANTS; GENETIC ENHANCEMENT; EPSILON-1 SUBUNIT; MICE LACKING; SITE; DISCRIMINATION; REFINEMENT; DISEASE; PATTERN	N-methyl-D-aspartate (NMDA) receptors mediate excitatory neurotransmission in the mammalian brain. Two glycine-binding NR1 subunits and two glutamate-binding NR2 subunits each form highly Ca2+-permeable cation channels which are blocked by extracellular Mg2+ in a voltage-dependent manner(1). Either GRIN2B or GRIN2A, encoding the NMDA receptor subunits NR2B and NR2A, was found to be disrupted by chromosome translocation breakpoints in individuals with mental retardation and/or epilepsy. Sequencing of GRIN2B in 468 individuals with mental retardation revealed four de novo mutations: a frameshift, a missense and two splice-site mutations. In another cohort of 127 individuals with idiopathic epilepsy and/or mental retardation, we discovered a GRIN2A nonsense mutation in a three-generation family. In a girl with early-onset epileptic encephalopathy, we identified the de novo GRIN2A mutation c.1845C>A predicting the amino acid substitution p.N615K. Analysis of NR1-NR2A(N615K) (NR2A subunit with the p.N615K alteration) receptor currents revealed a loss of the Mg2+ block and a decrease in Ca2+ permeability. Our findings suggest that disturbances in the neuronal electrophysiological balance during development result in variable neurological phenotypes depending on which NR2 subunit of NMDA receptors is affected.	[Rosenberger, Georg; Kortuem, Fanny; Fritsch, Angela; Pientka, Friederike K.; Kutsche, Kerstin] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany; [Endele, Sabine; Popp, Bernt; Rauch, Anita; Zenker, Martin; Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany; [Geider, Kirsten; Tamer, Ceyhun; Laube, Bodo] Tech Univ Darmstadt, Abt Mol & Zellulare Neurophysiol, Darmstadt, Germany; [Stefanova, Irina; Hellenbroich, Yorck] Univ Lubeck, Inst Humangenet, Lubeck, Germany; [Milh, Mathieu; Villard, Laurent] Fac Med Timone, U910, INSERM, Marseille, France; [Milh, Mathieu] Hop Enfants La Timone, Dept Paediat Neurol, Marseille, France; [Kalscheuer, Vera M.; Ropers, Hans-Hilger] Max Planck Inst Mol Genet, Dept Human Mol Genet, Berlin, Germany; [Kohlhase, Juergen] Ctr Human Genet, Freiburg, Germany; [Moog, Ute] Univ Heidelberg, Inst Human Genet, Heidelberg, Germany; [Rappold, Gudrun] Univ Heidelberg, Dept Human Mol Genet, Heidelberg, Germany; [von Spiczak, Sarah] Univ Med Ctr Schleswig Holstein, Dept Neuropaediat, Kiel, Germany; [Toennies, Holger] Univ Med Ctr Schleswig Holstein, Inst Human Genet, Kiel, Germany; [Villeneuve, Nathalie] Hop Henri Gastaut, Ctr St Paul, Marseille, France; [Villard, Laurent] Univ Aix Marseille 2, Marseille, France; [Zabel, Bernhard] Univ Hosp Freiburg, Ctr Pediat & Adolescent Med, Freiburg, Germany; [Zabel, Bernhard] Inst Human Genet, Freiburg, Germany; [Wieczorek, Dagmar] Univ Klinikum Essen, Inst Humangenet, Essen, Germany; [Van Maldergem, Lionel] Univ Liege, Ctr Genet Humaine, Liege, Belgium	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Erlangen Nuremberg; Technical University of Darmstadt; University of Lubeck; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Max Planck Society; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; UDICE-French Research Universities; Aix-Marseille Universite; University of Freiburg; University of Duisburg Essen; University of Liege	Kutsche, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany.	kkutsche@uke.de	Van Maldergem, Lionel/G-9849-2017; Popp, Bernt/M-2157-2019; Rauch, Anita/C-5568-2014; milh, mathieu/F-9165-2013; Reis, André/D-2309-2009; Wieczorek, Dagmar/AAU-6008-2021; Van Maldergem, Lionel/O-3242-2019; Villard, Laurent/E-3941-2016	Van Maldergem, Lionel/0000-0001-8880-5214; Popp, Bernt/0000-0002-3679-1081; Rauch, Anita/0000-0003-2930-3163; Reis, André/0000-0002-6301-6363; Wieczorek, Dagmar/0000-0003-2812-6492; Van Maldergem, Lionel/0000-0001-8880-5214; Villard, Laurent/0000-0001-6657-5008; Kalscheuer, Vera/0000-0001-6898-3259	German Ministry of Research and Education [01GS08160, 01GS08168- 9, 01GS08161, 01GS08164]; Fondation Fran aise pour la Recherche sur l'Epilepsie; Gemeinnutzige HertieStiftung; Deutsche Forschungsgemeinschaft [FOR 885/IRP5]	German Ministry of Research and Education(Federal Ministry of Education & Research (BMBF)); Fondation Fran aise pour la Recherche sur l'Epilepsie; Gemeinnutzige HertieStiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank all subjects and healthy (control) individuals for their participation in this study; P. De Jonghe for providing DNA samples of individuals with idiopathic epilepsy; A. Gal and B. Horsthemke for continuous support; H.-H. Richardt and H. Petri for clinical evaluation of subjects 3 and 1; A. Tzschach and M. Hoeltzenbein for initial help with collecting clinical data of subject 2; S. Fuchs for chromosome analysis; B. Lubker and C. Menzel for FISH analysis; R. Ullmann and A. Ahmed for array comparative genomic hybridization (CGH) on subject 2, O. Riess and M. Bonin for copy number variation analysis on subjects 8 and 9, and I. Gohring and A. B. Ekici for microarray analysis of the Erlanger cohort; S. Berkel, J. Hoyer and K. Cremer for support with data maintenance; and A. Diem, S. Freier, I. Jantke, S. Meien and K. Ziegler for skillfull technical assistance. This work was part of the German Mental Retardation Network (MRNET) funded through a grant from the German Ministry of Research and Education to A. Rauch and A. Reis (01GS08160), G. Rappold (01GS08168- 9), H.- H. R. (01GS08161) and D. W. (01GS08164). M. M. was supported by the Fondation Fran aise pour la Recherche sur l'Epilepsie, B. L. was supported by the Gemeinnutzige HertieStiftung, and G. Rosenberger and K. K. were supported by a grant from the Deutsche Forschungsgemeinschaft (FOR 885/IRP5).	Akashi K, 2009, J NEUROSCI, V29, P10869, DOI 10.1523/JNEUROSCI.5531-08.2009; Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Chen W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-85; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Ding YX, 2010, DEV MED CHILD NEUROL, V52, P1028, DOI 10.1111/j.1469-8749.2010.03746.x; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Kiyama Y, 1998, J NEUROSCI, V18, P6704; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Laube B, 2004, NEUROPHARMACOLOGY, V47, P994, DOI 10.1016/j.neuropharm.2004.07.041; Madry C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00006; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; REUTLINGER C, 2010, EPILEPSIA       0402, DOI DOI 10.1111/J.1528-1167.2010.02555.X; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Schuler T, 2008, J BIOL CHEM, V283, P37, DOI 10.1074/jbc.M703539200; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Spitz R, 2006, GENE CHROMOSOME CANC, V45, P1130, DOI 10.1002/gcc.20376; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Wang DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007486; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wollmuth LP, 1998, J PHYSIOL-LONDON, V506, P13, DOI 10.1111/j.1469-7793.1998.013bx.x; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046	38	344	354	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					1021	U153		10.1038/ng.677	http://dx.doi.org/10.1038/ng.677			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20890276				2022-12-25	WOS:000283540500023
J	Sakurai, M; Yano, T; Kawabata, H; Ueda, H; Suzuki, T				Sakurai, Masayuki; Yano, Takanori; Kawabata, Hitomi; Ueda, Hiroki; Suzuki, Tsutomu			Inosine cyanoethylation identifies A-to-I RNA editing sites in the human transcriptome	NATURE CHEMICAL BIOLOGY			English	Article							MITOCHONDRIAL TRANSFER-RNAS; MESSENGER-RNA; ADENOSINE DEAMINATION; GLUR-B; PSEUDOURIDINE; ADAR1; GENE; TARGETS; NUCLEOTIDES; NUCLEOSIDES	Adenosine-to-inosine (A-to-I) RNA editing is a post-transcriptional processing event involved in diversifying the transcriptome responsible for various biological processes. Although bioinformatic approaches have predicted a number of A-to-I editing sites in cDNAs, the human transcriptome is thought to still harbor large numbers of as-yet-unknown editing sites. Exploring new editing sites requires a biochemical method to accurately identify inosines on RNA strands. We here describe a chemical method to identify inosines, called inosine chemical erasing (ICE), that is based on cyanoethylation combined with reverse transcription. We carried out a large-scale verification of the ICE method focusing on 642 regions in human cDNA and identified 5,072 editing sites, including 4,395 new sites. Functional study revealed that A-to-I intronic editing in the SARS gene mediated by ADAR1 is involved in preventing aberrant exonization of Alu sequence into mature mRNA.	[Sakurai, Masayuki; Yano, Takanori; Kawabata, Hitomi; Ueda, Hiroki; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan	University of Tokyo	Sakurai, M (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan.	ts@chembio.t.u-tokyo.ac.jp	Suzuki, Tsutomu/J-1776-2015; Sakurai, Masayuki/AAR-8939-2021	Suzuki, Tsutomu/0000-0002-9731-1731; Sakurai, Masayuki/0000-0002-6920-1746	Ministry of Education, Science, Sports and Culture of Japan; New Energy and Industrial Technology Development Organization	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	We are grateful to the members of the Suzuki laboratory, especially to S. Okada and to H. Terajima for his experimental assistance and fruitful discussions on this study. Special thanks are due to Maze, Inc. for their support of computational work. This work was supported by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports and Culture of Japan and by a grant from the New Energy and Industrial Technology Development Organization (to T. S.).	Agranat L, 2008, P NATL ACAD SCI USA, V105, P5028, DOI 10.1073/pnas.0710576105; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bass BL, 2006, COLD SPRING HARB SYM, V71, P285, DOI 10.1101/sqb.2006.71.037; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Borchert GM, 2009, HUM MOL GENET, V18, P4801, DOI 10.1093/hmg/ddp443; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; CHAMBERS RW, 1963, BIOCHEMISTRY-US, V2, P1192, DOI 10.1021/bi00906a003; CHAMBERS RW, 1965, BIOCHEMISTRY-US, V4, P219, DOI 10.1021/bi00878a007; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; George CX, 2005, J BIOL CHEM, V280, P15020, DOI 10.1074/jbc.M500476200; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Hundley HA, 2008, RNA, V14, P2050, DOI 10.1261/rna.1165008; Jepson JEC, 2008, BBA-GENE REGUL MECH, V1779, P459, DOI 10.1016/j.bbagrm.2007.11.009; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Levanon K, 2005, EMBO REP, V6, P831, DOI 10.1038/sj.embor.7400507; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Maas Stefan, 2006, RNA Biol, V3, P1; Mengel-Jorgensen J, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf135; Morse DP, 1997, BIOCHEMISTRY-US, V36, P8429, DOI 10.1021/bi9709607; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Nishimoto Y, 2008, NEUROSCI RES, V61, P201, DOI 10.1016/j.neures.2008.02.009; Ohlson J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni169; Osenberg S, 2009, RNA, V15, P1632, DOI 10.1261/rna.1581809; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Sakurai M, 2005, FEBS LETT, V579, P2767, DOI 10.1016/j.febslet.2005.04.009; Schaefer M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn954; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; YOSHIDA M, 1968, BIOCHIM BIOPHYS ACTA, V157, P466, DOI 10.1016/0005-2787(68)90146-9; YOSHIDA M, 1968, BIOCHIM BIOPHYS ACTA, V157, P455, DOI 10.1016/0005-2787(68)90145-7	47	128	138	1	21	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2010	6	10					733	740		10.1038/nchembio.434	http://dx.doi.org/10.1038/nchembio.434			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	651YM	20835228				2022-12-25	WOS:000281964100010
J	Tawfik, DS				Tawfik, Dan S.			Messy biology and the origins of evolutionary innovations	NATURE CHEMICAL BIOLOGY			English	Article							STOCHASTIC GENE-EXPRESSION; SINGLE-CELL; EVOLVABILITY; ENZYME; NOISE; ROBUSTNESS; SURVIVAL; NETWORKS; CHANCE; GENOME		Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Tawfik, DS (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tawfik@weizmann.ac.il						Amitai G, 2007, HFSP J, V1, P67, DOI [10.2976/1.2739115/10.2976/1, 10.2976/1.2739115]; Austin MB, 2008, NAT CHEM BIOL, V4, P217, DOI 10.1038/nchembio0408-217; Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; D'Ari R, 1998, BIOESSAYS, V20, P181, DOI 10.1002/(SICI)1521-1878(199802)20:2<181::AID-BIES10>3.3.CO;2-6; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fraser D, 2009, MOL MICROBIOL, V71, P1333, DOI 10.1111/j.1365-2958.2009.06605.x; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Goldsmith M, 2009, P NATL ACAD SCI USA, V106, P6197, DOI 10.1073/pnas.0809506106; Gould S., 1980, PANDAS THUMB MORE RE; Greenspan RJ, 2001, NAT REV GENET, V2, P383, DOI 10.1038/35072018; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Kaneko K, 2006, J THEOR BIOL, V240, P78, DOI 10.1016/j.jtbi.2005.08.029; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kilfoil ML, 2009, HFSP J, V3, P379, DOI 10.2976/1.3223356; Kovacs K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000115; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Lehner B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009035; Lehner B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.11; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Masel J, 2003, EVOLUTION, V57, P1498; Masel J, 2010, TRENDS GENET, V26, P406, DOI 10.1016/j.tig.2010.06.002; McLoughlin SY, 2008, P NATL ACAD SCI USA, V105, P13497, DOI 10.1073/pnas.0804804105; Meyerovich M, 2010, P NATL ACAD SCI USA, V107, P11543, DOI 10.1073/pnas.0912989107; Milo R, 2007, P NATL ACAD SCI USA, V104, P16998, DOI 10.1073/pnas.0707673104; Radman M, 1999, ANN NY ACAD SCI, V870, P146, DOI 10.1111/j.1749-6632.1999.tb08874.x; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Robert L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.12; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Stern S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100147; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Wang DJ, 2010, TRENDS BIOTECHNOL, V28, P281, DOI 10.1016/j.tibtech.2010.03.002; Willensdorfer M, 2007, PLOS COMPUT BIOL, V3, P2058, DOI 10.1371/journal.pcbi.0030203; Zhang ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005686	36	146	149	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	OCT	2010	6	10					692	696		10.1038/nchembio.441	http://dx.doi.org/10.1038/nchembio.441			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	651YM	20852602				2022-12-25	WOS:000281964100002
J	Nakashima, M; Chung, S; Takahashi, A; Kamatani, N; Kawaguchi, T; Tsunoda, T; Hosono, N; Kubo, M; Nakamura, Y; Zembutsu, H				Nakashima, Mitsuko; Chung, Suyoun; Takahashi, Atsushi; Kamatani, Naoyuki; Kawaguchi, Takahisa; Tsunoda, Tatsuhiko; Hosono, Naoya; Kubo, Michiaki; Nakamura, Yusuke; Zembutsu, Hitoshi			A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population	NATURE GENETICS			English	Article							GENETIC SUSCEPTIBILITY; TGF-BETA; DISEASE; GROWTH; POLYMORPHISMS; DEGRADATION; TAMOXIFEN; RECEPTOR; PROTEIN	Keloid is a dermal fibroproliferative growth that results from dysfunction of the wound healing processes. Through a multistage genome-wide association study using 824 individuals with keloid (cases) and 3,205 unaffected controls in the Japanese population, we identified significant associations of keloid with four SNP loci in three chromosomal regions: 1q41, 3q22.3-23 and 15q21.3. The most significant association with keloid was observed at rs873549 (combined P = 5.89 x 10(-23), odds ratio (OR) = 1.77) on chromosome 1. Associations on chromosome 3 were observed at two separate linkage disequilibrium (LD) blocks: rs1511412 in the LD block including FOXL2 with P = 2.31 x 10(-13) (OR = 1.87) and rs940187 in another LD block with P = 1.80 x 10(-13) (OR = 1.98). Association of rs8032158 located in NEDD4 on chromosome 15 yielded P = 5.96 x 10(-13) (OR = 1.51). Our findings provide new insights into the pathophysiology of keloid formation.	[Nakashima, Mitsuko; Chung, Suyoun; Nakamura, Yusuke; Zembutsu, Hitoshi] Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan; [Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Ctr Genom Med, Lab Stat Anal, Wako, Kanagawa, Japan; [Kawaguchi, Takahisa; Tsunoda, Tatsuhiko] RIKEN, Ctr Genom Med, Lab Med Informat, Wako, Kanagawa, Japan; [Hosono, Naoya; Kubo, Michiaki] RIKEN, Ctr Genom Med, Lab Genotyping Dev, Wako, Kanagawa, Japan	University of Tokyo; RIKEN; RIKEN; RIKEN	Nakamura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan.	yusuke@ims.u-tokyo.ac.jp	Kubo, Michiaki/N-7947-2015; Tsunoda, Tatsuhiko/K-2061-2014	Tsunoda, Tatsuhiko/0000-0002-5439-7918	Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan; Ministry of Education, Culture, Sports, Science and Technology of the Japanese government	Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan; Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We express our heartfelt gratitude to all the subjects who participated in this study and the members of the Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan for supporting our study. We would like to thank S.-K. Low for her assistance in the statistical analysis. We also thank the technical staff of the Laboratory for Genotyping Development in RIKEN. We would like to express our gratefulness to T. Tamamoto and K. Matsuda for their outstanding technical assistance. This work was conducted as a part of the BioBank Japan Project that was supported by the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bayat A, 2005, BRIT J PLAST SURG, V58, P914, DOI 10.1016/j.bjps.2005.04.009; Bayat A, 2003, PLAST RECONSTR SURG, V111, P535, DOI 10.1097/01.PRS.0000041536.02524.A3; Bayat A, 2002, BRIT J PLAST SURG, V55, P283, DOI 10.1054/bjps.2002.3853; Bayat A, 2003, PLAST RECONSTR SURG, V111, P544; Bettinger DA, 1996, PLAST RECONSTR SURG, V98, P827, DOI 10.1097/00006534-199610000-00012; Brown JJ, 2008, EXP DERMATOL, V17, P610, DOI 10.1111/j.1600-0625.2007.00654.x; Chau D, 1998, ANN PLAS SURG, V40, P490, DOI 10.1097/00000637-199805000-00008; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Hu D, 1998, BRIT J PLAST SURG, V51, P462, DOI 10.1054/bjps.1997.0100; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Izzi L, 2006, NEOPLASIA, V8, P677, DOI 10.1593/neo.06472; Kelly AP, 2009, SEMIN CUTAN MED SURG, V28, P71, DOI 10.1016/j.sder.2009.04.002; KELLY AP, 1988, DERMATOL CLIN, V6, P413, DOI 10.1016/S0733-8635(18)30653-3; Kumar S, 1997, GENOMICS, V40, P435, DOI 10.1006/geno.1996.4582; LEONID L, 1999, NAT GENET, V22, P139; Marneros AG, 2001, ARCH DERMATOL, V137, P1429; Marneros AG, 2004, J INVEST DERMATOL, V122, P1126, DOI 10.1111/j.0022-202X.2004.22327.x; Marneros Alexander G, 2004, J Dtsch Dermatol Ges, V2, P905, DOI 10.1046/j.1439-0353.2004.04077.x; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; MOUSTAFA MFH, 1975, PLAST RECONSTR SURG, V56, P450, DOI 10.1097/00006534-197510000-00019; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Okada Y, 2010, HUM MOL GENET, V19, P2303, DOI 10.1093/hmg/ddq091; Pisarska MD, 2004, ENDOCRINOLOGY, V145, P3424, DOI 10.1210/en.2003-1141; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robles DT, 2007, CLIN DERMATOL, V25, P26, DOI 10.1016/j.clindermatol.2006.09.009; Saito A, 2002, J HUM GENET, V47, P360, DOI 10.1007/s100380200050; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Wang Y, 2007, PRION, V1, P128, DOI 10.4161/pri.1.2.4440; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019	33	124	130	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					768	U56		10.1038/ng.645	http://dx.doi.org/10.1038/ng.645			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20711176				2022-12-25	WOS:000281388400012
J	Patla, I; Volberg, T; Elad, N; Hirschfeld-Warneken, V; Grashoff, C; Fassler, R; Spatz, JP; Geiger, B; Medalia, O				Patla, Israel; Volberg, Tova; Elad, Nadav; Hirschfeld-Warneken, Vera; Grashoff, Carsten; Faessler, Reinhard; Spatz, Joachim P.; Geiger, Benjamin; Medalia, Ohad			Dissecting the molecular architecture of integrin adhesion sites by cryo-electron tomography	NATURE CELL BIOLOGY			English	Article							FOCAL ADHESIONS; STRESS FIBERS; DYNAMICS; FIBROBLASTS; CELLS; CYTOSKELETON; MATRIX; FORCE; ORGANIZATION; INHIBITION	Focal adhesions are integrin-based multiprotein complexes, several micrometres in diameter, that mechanically link the extracellular matrix with the termini of actin bundles. The molecular diversity of focal adhesions and their role in cell migration and matrix sensing has been extensively studied, but their ultrastructural architecture is still unknown. We present the first three-dimensional structural reconstruction of focal adhesions using cryo-electron tomography. Our analyses reveal that the membrane-cytoskeleton interaction at focal adhesions is mediated through particles located at the cell membrane and attached to actin fibres. The particles have diameters of 25 +/- 5 nm, and an average interspacing of approximately 45 nm. Treatment with the Rho-kinase inhibitor Y-27632 induces a rapid decrease in particle diameter, suggesting that they are highly mechanosensitive. Our findings clarify the internal architecture of focal adhesions at molecular resolution, and provide insights into their scaffolding and mechanosensory functions.	[Patla, Israel; Elad, Nadav; Medalia, Ohad] Ben Gurion Univ Negev, Dept Life Sci, IL-84120 Beer Sheva, Israel; [Patla, Israel; Elad, Nadav; Medalia, Ohad] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84120 Beer Sheva, Israel; [Volberg, Tova; Geiger, Benjamin] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Hirschfeld-Warneken, Vera; Spatz, Joachim P.] Max Planck Inst Met Res, Dept New Mat & Biosyst, D-70569 Stuttgart, Germany; [Hirschfeld-Warneken, Vera] Univ Heidelberg, Dept Biophys Chem, D-70569 Stuttgart, Germany; [Grashoff, Carsten; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany	Ben Gurion University; Ben Gurion University; Weizmann Institute of Science; Max Planck Society; Ruprecht Karls University Heidelberg; Max Planck Society	Medalia, O (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84120 Beer Sheva, Israel.	omedalia@bgu.ac.il	Spatz, Joachim P/A-1107-2017	Spatz, Joachim P/0000-0003-3419-9807; Medalia, Ohad/0000-0003-0994-2937; Elad, Nadav/0000-0001-6222-2280	German-Israeli Cooperation Project [DIP H.2.2]; National Institutes of Health Cell Migration Consortium [U54 GM64346]; ERC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	German-Israeli Cooperation Project; National Institutes of Health Cell Migration Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a grant from the German-Israeli Cooperation Project (DIP H.2.2) to O. M., R. F., J. S. and B. G., an NIGMS grant from the National Institutes of Health Cell Migration Consortium (Grant No. U54 GM64346) to B. G. and an ERC Starting Grant to O. M. The authors express gratitude to B. Morgenstern for help in editing the manuscript. B. G. holds the Erwin Neter Professorial Chair in Cell and Tumor Biology.	ABERCROMBIE M, 1975, EXP CELL RES, V92, P57, DOI 10.1016/0014-4827(75)90636-9; AVNUR Z, 1981, J MOL BIOL, V153, P361, DOI 10.1016/0022-2836(81)90283-7; Beningo KA, 2002, TRENDS CELL BIOL, V12, P79, DOI 10.1016/S0962-8924(01)02205-X; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Campbell ID, 2008, BIOCHEM SOC T, V36, P263, DOI 10.1042/BST0360263; Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013; FELTKAMP CA, 1991, J CELL SCI, V100, P579; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; FRANK J, 1992, ELECT TOMOGRAPHY, P1; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; GINSBERG M, 1985, J BIOL CHEM, V260, P3931; JIMENEZ J, 1986, SCIENCE, V232, P1113, DOI 10.1126/science.3754654; Katoh K, 2007, GENES CELLS, V12, P623, DOI 10.1111/j.1365-2443.2007.01073.x; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Lo SH, 2006, DEV BIOL, V294, P280, DOI 10.1016/j.ydbio.2006.03.029; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; NICOL A, 1987, J HISTOCHEM CYTOCHEM, V35, P499, DOI 10.1177/35.4.2880891; Nicolas A, 2008, BIOPHYS J, V95, P527, DOI 10.1529/biophysj.107.127399; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; RINNERTHALER G, 1988, J CELL BIOL, V106, P747, DOI 10.1083/jcb.106.3.747; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; SALGIA R, 1995, J BIOL CHEM, V270, P5039, DOI 10.1074/jbc.270.10.5039; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; SINGER II, 1979, CELL, V16, P675, DOI 10.1016/0092-8674(79)90040-0; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; TURNER CE, 1994, J CELL SCI, V107, P1583; VANHEEL M, 1984, ULTRAMICROSCOPY, V13, P165, DOI 10.1016/0304-3991(84)90066-4; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Waterman-Storer CM, 2000, MOL BIOL CELL, V11, P2471, DOI 10.1091/mbc.11.7.2471; Wiesner S, 2006, TRENDS CELL BIOL, V16, P327, DOI 10.1016/j.tcb.2006.05.002; Winograd-Katz SE, 2009, J CELL BIOL, V186, P423, DOI 10.1083/jcb.200901105; Wolfenson H, 2009, CELL MOTIL CYTOSKEL, V66, P1017, DOI 10.1002/cm.20410; Wolfenson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004304; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zamir E, 2001, J CELL SCI, V114, P3583; Zamir E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001901	40	170	172	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					909	915		10.1038/ncb2095	http://dx.doi.org/10.1038/ncb2095			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20694000				2022-12-25	WOS:000281561900015
J	Lukas, C; Savic, V; Bekker-Jensen, S; Doil, C; Neumann, B; Pedersen, RS; Grofte, M; Chan, KL; Hickson, ID; Bartek, J; Lukas, J				Lukas, Claudia; Savic, Velibor; Bekker-Jensen, Simon; Doil, Carsten; Neumann, Beate; Pedersen, Ronni Solvhoj; Grofte, Merete; Chan, Kok Lung; Hickson, Ian David; Bartek, Jiri; Lukas, Jiri			53BP1 nuclear bodies form around DNA lesions generated by mitotic transmission of chromosomes under replication stress	NATURE CELL BIOLOGY			English	Article							ONCOGENE-INDUCED SENESCENCE; DOUBLE-STRAND BREAKS; DAMAGE RESPONSE; GENOMIC INSTABILITY; FRAGILE SITES; ATM; CHECKPOINT; REVEALS; SEGREGATION; CONDENSIN	Completion of genome duplication is challenged by structural and topological barriers that impede progression of replication forks. Although this can seriously undermine genome integrity, the fate of DNA with unresolved replication intermediates is not known. Here, we show that mild replication stress increases the frequency of chromosomal lesions that are transmitted to daughter cells. Throughout G1, these lesions are sequestered in nuclear compartments marked by p53-binding protein 1 (53BP1) and other chromatin-associated genome caretakers. We show that the number of such 53BP1 nuclear bodies increases after genetic ablation of BLM, a DNA helicase associated with dissolution of entangled DNA. Conversely, 53BP1 nuclear bodies are partially suppressed by knocking down SMC2, a condensin subunit required for mechanical stability of mitotic chromosomes. Finally, we provide evidence that 53BP1 nuclear bodies shield chromosomal fragile sites sequestered in these compartments against erosion. Together, these data indicate that restoration of DNA or chromatin integrity at loci prone to replication problems requires mitotic transmission to the next cell generations.	[Lukas, Claudia; Savic, Velibor; Bekker-Jensen, Simon; Doil, Carsten; Pedersen, Ronni Solvhoj; Grofte, Merete; Bartek, Jiri; Lukas, Jiri] Danish Canc Soc, Inst Canc Biol, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; [Bekker-Jensen, Simon] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Neumann, Beate] European Mol Biol Lab EMBL, Adv Light Microscopy Facil, D-69117 Heidelberg, Germany; [Chan, Kok Lung; Hickson, Ian David] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9D5, England; [Chan, Kok Lung] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Hickson, Ian David] Univ Copenhagen, Dept Cellular & Mol Med, Ctr Healthy Aging, DK-2200 Copenhagen N, Denmark; [Bartek, Jiri] Palacky Univ, Inst Mol & Translat Med, Olomouc 77515, Czech Republic	Danish Cancer Society; University of Copenhagen; European Molecular Biology Laboratory (EMBL); University of Oxford; University of Oxford; University of Copenhagen; Palacky University Olomouc	Bartek, J (corresponding author), Danish Canc Soc, Inst Canc Biol, Ctr Genotox Stress Res, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.	jb@cancer.dk; jil@cancer.dk	Hickson, Ian/AAJ-7548-2020; Bartek, Jiri/G-5870-2014	Lukas, Jiri/0000-0001-9087-506X; Bekker-Jensen, Simon/0000-0002-7308-4597; chan, kok-lung/0000-0002-8796-8385; Neumann, Beate/0000-0002-6899-502X; Lukas, Claudia/0000-0001-7169-6883; Hickson, Ian/0000-0002-0583-566X; Savic, Velibor/0000-0002-4830-3591	Danish Cancer Society; Danish National Research Foundation; European Commission; Lunbeck Foundation; Danish Council for Independent Research-Medical Sciences; John and Birthe Meyer Foundation	Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); European Commission(European CommissionEuropean Commission Joint Research Centre); Lunbeck Foundation; Danish Council for Independent Research-Medical Sciences(Det Frie Forskningsrad (DFF)); John and Birthe Meyer Foundation	We thank J. Ellenberg and R. Pepperkok for help with the siRNA screen and for commenting on the manuscript. We also thank J. Chen, D. Durocher and R. Freire for reagents. This work was supported by grants from the Danish Cancer Society, Danish National Research Foundation, European Commission (projects GENICA, and Biomedreg), the Lunbeck Foundation, Danish Council for Independent Research-Medical Sciences, and the John and Birthe Meyer Foundation.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bothmer A, 2010, J EXP MED, V207, P855, DOI 10.1084/jem.20100244; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Chan KL, 2009, CELL CYCLE, V8, P3065, DOI 10.4161/cc.8.19.9513; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Dulev S, 2009, P NATL ACAD SCI USA, V106, P14466, DOI 10.1073/pnas.0900190106; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Gerlich D, 2006, CURR BIOL, V16, P333, DOI 10.1016/j.cub.2005.12.040; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Helmink BA, 2011, NATURE, V469, P245, DOI 10.1038/nature09585; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; Mochan TA, 2004, DNA REPAIR, V3, P945, DOI 10.1016/j.dnarep.2004.03.017; Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883; Nelson G, 2009, CELL CYCLE, V8, P3379, DOI 10.4161/cc.8.20.9857; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Royou A, 2010, CELL, V140, P235, DOI 10.1016/j.cell.2009.12.043; Savic V, 2009, MOL CELL, V34, P298, DOI 10.1016/j.molcel.2009.04.012; Schwob E, 2004, CURR OPIN MICROBIOL, V7, P680, DOI 10.1016/j.mib.2004.10.017; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Szilard RK, 2010, NAT STRUCT MOL BIOL, V17, P299, DOI 10.1038/nsmb.1754; Torres-Rosell J, 2007, SCIENCE, V315, P1411, DOI 10.1126/science.1134025; Tuduri S, 2009, NAT CELL BIOL, V11, P1315, DOI 10.1038/ncb1984; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	50	466	470	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2011	13	3					243	U380		10.1038/ncb2201	http://dx.doi.org/10.1038/ncb2201			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	728BB	21317883				2022-12-25	WOS:000287847600012
J	Liu, C; Kelnar, K; Liu, BG; Chen, X; Calhoun-Davis, T; Li, HW; Patrawala, L; Yan, H; Jeter, C; Honorio, S; Wiggins, JF; Bader, AG; Fagin, R; Brown, D; Tang, DAG				Liu, Can; Kelnar, Kevin; Liu, Bigang; Chen, Xin; Calhoun-Davis, Tammy; Li, Hangwen; Patrawala, Lubna; Yan, Hong; Jeter, Collene; Honorio, Sofia; Wiggins, Jason F.; Bader, Andreas G.; Fagin, Randy; Brown, David; Tang, Dean G.			The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44	NATURE MEDICINE			English	Article							TUMOR-INITIATING CELLS; SELF-RENEWAL; PROSPECTIVE IDENTIFICATION; PROGENITOR CELLS; MARKER CD44; APOPTOSIS; POPULATION; ACTIVATION; EXPRESSION; CARCINOMA	Cancer stem cells (CSCs), or tumor-initiating cells, are involved in tumor progression and metastasis(1). MicroRNAs (miRNAs) regulate both normal stem cells and CSCs2-5, and dysregulation of miRNAs has been implicated in tumorigenesis(6). CSCs in many tumors-including cancers of the breast(7), pancreas(8), head and neck(9), colon(10,11), small intestine(12), liver(13), stomach(14), bladder(15) and ovary(16)-have been identified using the adhesion molecule CD44, either individually or in combination with other marker(s). Prostate CSCs with enhanced clonogenic(17) and tumor-initiating and metastatic(18,19) capacities are enriched in the CD44(+) cell population, but whether miRNAs regulate CD44(+) prostate cancer cells and prostate cancer metastasis remains unclear. Here we show, through expression analysis, that miR-34a, a p53 target(20-24), was underexpressed in CD44(+) prostate cancer cells purified from xenograft and primary tumors. Enforced expression of miR-34a in bulk or purified CD44(+) prostate cancer cells inhibited clonogenic expansion, tumor regeneration, and metastasis. In contrast, expression of miR-34a antagomirs in CD44(-) prostate cancer cells promoted tumor development and metastasis. Systemically delivered miR-34a inhibited prostate cancer metastasis and extended survival of tumor-bearing mice. We identified and validated CD44 as a direct and functional target of miR-34a and found that CD44 knockdown phenocopied miR-34a overexpression in inhibiting prostate cancer regeneration and metastasis. Our study shows that miR-34a is a key negative regulator of CD44(+) prostate cancer cells and establishes a strong rationale for developing miR-34a as a novel therapeutic agent against prostate CSCs.	[Liu, Can; Liu, Bigang; Chen, Xin; Calhoun-Davis, Tammy; Li, Hangwen; Yan, Hong; Jeter, Collene; Honorio, Sofia; Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA; [Liu, Can; Chen, Xin; Patrawala, Lubna; Tang, Dean G.] Univ Texas Grad Sch Biomed Sci GSBS, Program Mol Carcinogenesis, Houston, TX USA; [Kelnar, Kevin; Wiggins, Jason F.; Bader, Andreas G.; Brown, David] Mirna Therapeut Inc, Austin, TX USA; [Fagin, Randy] Hosp Westlake, Austin, TX USA	University of Texas System; UTMD Anderson Cancer Center	Tang, DAG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Sci Pk, Smithville, TX 78957 USA.	dtang@mdanderson.org	Tang, Dean/AAI-3457-2020; Jackson, Benjamin L/C-4297-2012	Tang, Dean/0000-0001-5029-1174; Jeter, Collene/0000-0002-9627-4529; Chen, Xin/0000-0002-0566-7678	US National Institutes of Health [R01-AG023374, R01-ES015888, R21-ES015893, R21-CA150009]; US Department of Defense [W81XWH-07-1-0616, W81XWH-08-1-0472]; Elsa Pardee Foundation; M. D. Anderson Cancer Center [CCSG-5 P30 CA016672-34, ES007784]; NATIONAL CANCER INSTITUTE [P30CA016672, R21CA150009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES015893, R01ES015888, P30ES007784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023374] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Elsa Pardee Foundation; M. D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank K. Claypool and P. Whitney for FACS, the Histology Core for help with immunohistochemistry, K. Lin for statistical analysis, G. Calin for critically reading the manuscript and other members of the Tang lab for support and discussions. We also thank G. Hannon (Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA) for the MSCV-PIG vector. This work was supported in part by grants from the US National Institutes of Health (R01-AG023374, R01-ES015888, R21-ES015893, R21-CA150009), the US Department of Defense (W81XWH-07-1-0616, W81XWH-08-1-0472) and Elsa Pardee Foundation (D. G. T.) and by two M. D. Anderson Cancer Center grants (CCSG-5 P30 CA016672-34 and ES007784). C. Liu and H. Li were supported in part by predoctoral fellowships from the US Department of Defense.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bhatia B, 2008, J BIOL CHEM, V283, P27957, DOI 10.1074/jbc.M803467200; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Li H, 2009, METHODS MOL BIOL, V568, P85, DOI 10.1007/978-1-59745-280-9_7; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	39	1108	1176	1	260	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2011	17	2					211	U105		10.1038/nm.2284	http://dx.doi.org/10.1038/nm.2284			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	716LK	21240262	Green Accepted			2022-12-25	WOS:000286969900030
J	Neukomm, LJ; Frei, AP; Cabello, J; Kinchen, JM; Zaidel-Bar, R; Ma, Z; Haney, LB; Hardin, J; Ravichandran, KS; Moreno, S; Hengartner, MO				Neukomm, Lukas J.; Frei, Andreas P.; Cabello, Juan; Kinchen, Jason M.; Zaidel-Bar, Ronen; Ma, Zhong; Haney, Lisa B.; Hardin, Jeff; Ravichandran, Kodi S.; Moreno, Sergio; Hengartner, Michael O.			Loss of the RhoGAP SRGP-1 promotes the clearance of dead and injured cells in Caenorhabditis elegans	NATURE CELL BIOLOGY			English	Article							C-ELEGANS; APOPTOTIC CELLS; CORPSE ENGULFMENT; PROTEIN; PHAGOCYTOSIS; MIGRATION; RECEPTOR; REMOVAL; PATHWAY; DOMAIN	Multicellular animals rapidly clear dying cells from their bodies. Many of the pathways that mediate this cell removal are conserved through evolution. Here, we identify srgp-1 as a negative regulator of cell clearance in both Caenorhabditis elegans and mammalian cells. Loss of srgp-1 function results in improved engulfment of apoptotic cells, whereas srgp-1 overexpression inhibits apoptotic cell corpse removal. We show that SRGP-1 functions in engulfing cells and functions as a GTPase activating protein (GAP) for CED-10 (Rac1). Interestingly, loss of srgp-1 function promotes not only the clearance of already dead cells, but also the removal of cells that have been brought to the verge of death through sublethal apoptotic, necrotic or cytotoxic insults. In contrast, impaired engulfment allows damaged cells to escape clearance, which results in increased long-term survival. We propose that C. elegans uses the engulfment machinery as part of a primitive, but evolutionarily conserved, survey mechanism that identifies and removes unfit cells within a tissue.	[Neukomm, Lukas J.; Frei, Andreas P.; Hengartner, Michael O.] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Frei, Andreas P.] Univ Zurich, ETH, PhD Program Mol Life Sci MLS, CH-8057 Zurich, Switzerland; [Cabello, Juan; Moreno, Sergio] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Salamanca 37007, Spain; [Cabello, Juan] Ctr Biomed Res La Rioja CIBIR, Logrono 26006, Spain; [Kinchen, Jason M.; Ma, Zhong; Haney, Lisa B.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22902 USA; [Kinchen, Jason M.; Ma, Zhong; Haney, Lisa B.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22902 USA; [Zaidel-Bar, Ronen; Hardin, Jeff] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Virginia; University of Virginia; University of Wisconsin System; University of Wisconsin Madison	Hengartner, MO (corresponding author), Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland.	michael.hengartner@imls.uzh.ch	Kinchen, Jason/ABC-5663-2021; Neukomm, Lukas/I-8636-2019; Hengartner, Michael O/E-6235-2011; Moreno, Sergio/K-3671-2014; Cabello, Juan/AAM-1683-2020	Neukomm, Lukas/0000-0002-5007-3959; Moreno, Sergio/0000-0002-8039-1413; Cabello, Juan/0000-0002-3835-0116; Kinchen, Jason/0000-0001-8430-2265; Ravichandran, Kodi/0000-0001-9049-1410; Zaidel-Bar, Ronen/0000-0002-1374-5007; Hengartner, Michael/0000-0002-7584-596X	American Heart Association; American Cancer Society; NIGMS/NIH; Junta de Castilla y Leon [CSI03A08, GR265]; Spanish Ministry of Science and Innovation [BFU2010-21794, BFU200801808, CSD200700015]; Riojasalud Foundation; NIH [GM078747]; Machiah Foundation; Swiss National Science Foundation; The Ernst Hadorn Foundation; European Union; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM078747, R01GM064709, R01GM058038] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); NIGMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Junta de Castilla y Leon(Junta de Castilla y Leon); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Riojasalud Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Machiah Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); The Ernst Hadorn Foundation; European Union(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Hengartner lab members for comments and discussions, M. Weiss for statistical advice and M. Jovanovic for assistance with in vivo pulldown experiments. Some strains were supplied by the Caenorhabditis Genetic Center (CGC), the C. elegans knock-out consortium (Oklahoma, USA) and the National Bioresource Project (Japan). This work was supported by grants from the American Heart Association and American Cancer Society (to J.M.K.), the NIGMS/NIH (to K.S.R., a William Benter Senior Fellow of the American Asthma Foundation), the Junta de Castilla y Leon (grant CSI03A08), the Spanish Ministry of Science and Innovation (grant BFU2010-21794) and the Riojasalud Foundation (to J.C.), the Junta de Castilla y Leon (Grupo de Excelencia GR265) and the Spanish Ministry of Science and Innovation (grants BFU200801808 and Consolider CSD200700015 to S.M.), the NIH postdoctoral training grant GM078747 and the fellowship from the Machiah Foundation (to R.Z.-B.), the Swiss National Science Foundation, The Ernst Hadorn Foundation and the European Union (FP5 project APOCLEAR to M.O.H.).	Akakura S, 2005, J CELL PHYSIOL, V204, P344, DOI 10.1002/jcp.20288; Bar RZ, 2010, J CELL BIOL, V191, P761, DOI 10.1083/jcb.201005082; Barrett T, 1997, NATURE, V385, P458, DOI 10.1038/385458a0; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BRENNER S, 1974, GENETICS, V77, P71; Cabello J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000297; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Debatin KM, 2004, CANCER IMMUNOL IMMUN, V53, P153, DOI 10.1007/s00262-003-0474-8; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Fullard JF, 2009, APOPTOSIS, V14, P1029, DOI 10.1007/s10495-009-0335-9; Galvin BD, 2008, GENETICS, V179, P403, DOI 10.1534/genetics.108.087221; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Hsu TY, 2010, CURR BIOL, V20, P477, DOI 10.1016/j.cub.2010.01.062; Hurwitz ME, 2009, PLOS BIOL, V7, P876, DOI 10.1371/journal.pbio.1000099; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Kinchen JM, 2007, J CELL SCI, V120, P2143, DOI 10.1242/jcs.03463; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Li W, 2007, CELL, V129, P1215, DOI 10.1016/j.cell.2007.03.054; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Patel FB, 2008, DEV BIOL, V324, P297, DOI 10.1016/j.ydbio.2008.09.023; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Savill J, 2003, SCIENCE, V302, P1516, DOI 10.1126/science.1092533; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Suetsugu S, 2010, SEMIN CELL DEV BIOL, V21, P340, DOI 10.1016/j.semcdb.2009.12.002; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tosello-Trampont AC, 2007, CELL DEATH DIFFER, V14, P963, DOI 10.1038/sj.cdd.4402094; Tosello-Trampont AC, 2003, J BIOL CHEM, V278, P49911, DOI 10.1074/jbc.M306079200; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; Yang YY, 2006, GENETICS, V174, P1917, DOI 10.1534/genetics.106.063115; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhang W, 2008, CELL DEATH DIFFER, V15, P1794, DOI 10.1038/cdd.2008.114; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Zou W, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000679	47	46	52	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2011	13	1					79	U193		10.1038/ncb2138	http://dx.doi.org/10.1038/ncb2138			28	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697GV	21170032	Green Accepted			2022-12-25	WOS:000285502200014
J	Zhang, YJ; Dai, YB; Wen, JM; Zhang, WR; Grenz, A; Sun, H; Tao, LJ; Lu, GX; Alexander, DC; Milburn, MV; Carter-Dawson, L; Lewis, DE; Zhang, WZ; Eltzschig, HK; Kellems, RE; Blackburn, MR; Juneja, HS; Xia, Y				Zhang, Yujin; Dai, Yingbo; Wen, Jiaming; Zhang, Weiru; Grenz, Almut; Sun, Hong; Tao, Lijian; Lu, Guangxiu; Alexander, Danny C.; Milburn, Michael V.; Carter-Dawson, Louvenia; Lewis, Dorothy E.; Zhang, Wenzheng; Eltzschig, Holger K.; Kellems, Rodney E.; Blackburn, Michael R.; Juneja, Harinder S.; Xia, Yang			Detrimental effects of adenosine signaling in sickle cell disease	NATURE MEDICINE			English	Article							ENZYME REPLACEMENT THERAPY; PULMONARY INFLAMMATION; DEAMINASE DEFICIENCY; KNOCKOUT MICE; 2,3-BISPHOSPHOGLYCERATE; 2,3-DIPHOSPHOGLYCERATE; HEMOGLOBIN; ADA; PATHOPHYSIOLOGY; POLYMERIZATION	Hypoxia can act as an initial trigger to induce erythrocyte sickling and eventual end organ damage in sickle cell disease (SCD). Many factors and metabolites are altered in response to hypoxia and may contribute to the pathogenesis of the disease. Using metabolomic profiling, we found that the steady-state concentration of adenosine in the blood was elevated in a transgenic mouse model of SCD. Adenosine concentrations were similarly elevated in the blood of humans with SCD. Increased adenosine levels promoted sickling, hemolysis and damage to multiple tissues in SCD transgenic mice and promoted sickling of human erythrocytes. Using biochemical, genetic and pharmacological approaches, we showed that adenosine A(2B) receptor (A(2B)R)-mediated induction of 2,3-diphosphoglycerate, an erythrocyte-specific metabolite that decreases the oxygen binding affinity of hemoglobin, underlies the induction of erythrocyte sickling by excess adenosine both in cultured human red blood cells and in SCD transgenic mice. Thus, excessive adenosine signaling through the A(2B)R has a pathological role in SCD. These findings may provide new therapeutic possibilities for this disease.	[Zhang, Yujin; Dai, Yingbo; Wen, Jiaming; Zhang, Weiru; Kellems, Rodney E.; Blackburn, Michael R.; Xia, Yang] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX 77225 USA; [Dai, Yingbo; Wen, Jiaming] Third Xiangya Hosp, Dept Urol, Changsha, Hunan, Peoples R China; [Zhang, Weiru; Tao, Lijian] First Xiangya Hosp, Dept Nephrol, Changsha, Hunan, Peoples R China; [Grenz, Almut; Eltzschig, Holger K.] Univ Colorado, Dept Anesthesiol, Denver, CO 80202 USA; [Sun, Hong] Third Xiangya Hosp, Dept Otorhinolaryngol, Changsha, Hunan, Peoples R China; [Lu, Guangxiu; Xia, Yang] Cent S Univ, Inst Reprod & Genet Med, Changsha, Hunan, Peoples R China; [Alexander, Danny C.; Milburn, Michael V.] Metabolon Inc, Durham, NC USA; [Carter-Dawson, Louvenia] Univ Texas Hlth Sci Ctr Houston, Dept Ophthalmol & Visual Sci, Houston, TX USA; [Lewis, Dorothy E.; Zhang, Wenzheng; Juneja, Harinder S.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Central South University; Central South University; University of Colorado System; University of Colorado Denver; Central South University; Central South University; Metabolon; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Xia, Y (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Houston, TX 77225 USA.	yang.xia@uth.tmc.edu		Blackburn, Michael/0000-0002-1394-9966	US National Institute of Health [DK077748, DK083559, HL070952, HL092188]; China National Science Foundation Scholarship Council [2008637068]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113574, R01HL070952, R01HL092188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077748, R01DK083559] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China National Science Foundation Scholarship Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by US National Institute of Health grants DK077748 (to Y.X.), DK083559 (to Y.X.), HL070952 (to M.R.B.) and HL092188 (to H.K.E.) and by China National Science Foundation Scholarship Council 2008637068 (to J.W.). We thank T. Krahn (Bayer HealthCare AG) for the adenosine receptor A<INF>2B</INF>R agonist BAY 60-6583. Adenosine receptor-deficient mice were obtained from the following sources: A<INF>1</INF>R-deficient mice (J. Schnermann, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health); A<INF>2A</INF>R-deficient mice (J.-F. Chen, Boston University School of Medicine); A<INF>2B</INF>R-deficient mice (M.R. Blackburn, University of Texas-Houston Medical School); and A<INF>3</INF>R-deficient mice (M. Jacobson, Merck Research Laboratories).	Ballas Samir K, 2007, Hematology Am Soc Hematol Educ Program, P97; Blackburn MR, 2000, J BIOL CHEM, V275, P32114, DOI 10.1074/jbc.M005153200; BUNN HF, 1982, P NATL ACAD SCI-BIOL, V79, P7527, DOI 10.1073/pnas.79.23.7527; Carbonaro DA, 2008, BLOOD, V111, P5745, DOI 10.1182/blood-2007-08-103663; Carbonaro DA, 2006, MOL THER, V13, P1110, DOI 10.1016/j.ymthe.2006.02.013; Chan B, 2005, CLIN IMMUNOL, V117, P133, DOI 10.1016/j.clim.2005.07.006; Chiba H, 1978, Curr Top Cell Regul, V14, P75; Christoph GW, 2005, BIOPHYS J, V88, P1371, DOI 10.1529/biophysj.104.051250; Chui DHK, 2001, CURR OPIN PEDIATR, V13, P22, DOI 10.1097/00008480-200102000-00004; de Montalembert M., 2008, B ACAD NATL MED, V192; de Montalembert M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1397; de Montalembert M, 2008, B ACAD NAT MED PARIS, V192, P1375, DOI 10.1016/S0001-4079(19)32687-1; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; ERICSON A, 1972, SCAND J CLIN LAB INV, V29, P85, DOI 10.3109/00365517209081059; Ferrone FA, 2004, MICROCIRCULATION, V11, P115, DOI 10.1080/10739680490278312; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fung EB, 2007, AM J HEMATOL, V82, P255, DOI 10.1002/ajh.20809; Hebbel RP, 2004, MICROCIRCULATION, V11, P129, DOI 10.1080/10739680490278402; HEBBEL RP, 1991, BLOOD, V77, P214; HERSHFIELD MS, 1995, CLIN IMMUNOL IMMUNOP, V76, pS228, DOI 10.1016/S0090-1229(95)90306-2; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; KNUDSEN TB, 1992, TERATOLOGY, V45, P91, DOI 10.1002/tera.1420450109; Lanzkron S, 2006, AM J HEMATOL, V81, P927, DOI 10.1002/ajh.20703; Madigan Catherine, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010659; Mi T, 2008, J CLIN INVEST, V118, P1491, DOI 10.1172/JCI33467; NARITA H, 1981, J BIOL CHEM, V256, P7059; Palmer TM, 1997, BIOCHEMISTRY-US, V36, P832, DOI 10.1021/bi962290v; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Paszty C, 1997, Curr Opin Hematol, V4, P88; Perumbeti A, 2009, BLOOD, V114, P1174, DOI 10.1182/blood-2009-01-201863; POILLON WN, 1986, ARCH BIOCHEM BIOPHYS, V249, P301, DOI 10.1016/0003-9861(86)90006-8; POILLON WN, 1995, BLOOD, V85, P3289, DOI 10.1182/blood.V85.11.3289.bloodjournal85113289; POILLON WN, 1990, BLOOD, V76, P1028; Sasaki R, 1983, Tanpakushitsu Kakusan Koso, V28, P957; SASAKI R, 1983, MOL CELL BIOCHEM, V53-4, P247; Scheinman JI, 2009, NAT CLIN PRACT NEPHR, V5, P78, DOI 10.1038/ncpneph1008; Sebastiani P, 2007, BLOOD, V110, P2727, DOI 10.1182/blood-2007-04-084921; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stiles Gary L., 1997, P29; Urbinati Fabrizia, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010805; Wallace KL, 2010, BLOOD, V116, P5010, DOI 10.1182/blood-2010-06-290643; Wallace KL, 2009, BLOOD, V114, P667, DOI 10.1182/blood-2009-02-205492; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856	45	139	139	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					79	U252		10.1038/nm.2280	http://dx.doi.org/10.1038/nm.2280			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21170046	Green Accepted			2022-12-25	WOS:000285994000039
J	Dandapani, S; Marcaurelle, LA				Dandapani, Sivaraman; Marcaurelle, Lisa A.			Accessing new chemical space for 'undruggable' targets	NATURE CHEMICAL BIOLOGY			English	Article							DIVERSITY-ORIENTED SYNTHESIS; SMALL-MOLECULE; DISCOVERY; CHEMISTRY	The synthesis and biological annotation of small molecules from underexplored chemical space will play a central role in the development of drugs for challenging targets currently being identified in frontier areas of biological research such as human genetics.				sivaram@broadinstitute.org; lisa@broadinstitute.org						Blake JF, 2004, CURR OPIN CHEM BIOL, V8, P407, DOI 10.1016/j.cbpa.2004.04.017; Clemons PA, 2010, P NATL ACAD SCI USA, V107, P18787, DOI 10.1073/pnas.1012741107; Dandapani S, 2010, CURR OPIN CHEM BIOL, V14, P362, DOI 10.1016/j.cbpa.2010.03.018; Danishefsky S, 2010, NAT PROD REP, V27, P1114, DOI 10.1039/c003211p; Drewry DH, 2010, CURR OPIN CHEM BIOL, V14, P289, DOI 10.1016/j.cbpa.2010.03.024; Francotte E, 2006, CHIRALITY DRUG RES; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; Marcaurelle LA, 2009, BIOORG MED CHEM LETT, V19, P2500, DOI 10.1016/j.bmcl.2009.03.037; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Shelat AA, 2007, CURR OPIN CHEM BIOL, V11, P244, DOI 10.1016/j.cbpa.2007.05.003; Stanton BZ, 2009, NAT CHEM BIOL, V5, P154, DOI 10.1038/nchembio.142; Tan DS, 2005, NAT CHEM BIOL, V1, P74, DOI 10.1038/nchembio0705-74; Tepper RI, 2009, GENOMIC AND PERSONALIZED MEDICINE, VOL 1, P335; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013	15	166	166	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450			NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2010	6	12					861	863		10.1038/nchembio.479	http://dx.doi.org/10.1038/nchembio.479			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	680EH	21079589				2022-12-25	WOS:000284214700005
J	Kosuri, S; Eroshenko, N; LeProust, EM; Super, M; Way, J; Li, JB; Church, GM				Kosuri, Sriram; Eroshenko, Nikolai; LeProust, Emily M.; Super, Michael; Way, Jeffrey; Li, Jin Billy; Church, George M.			Scalable gene synthesis by selective amplification of DNA pools from high-fidelity microchips	NATURE BIOTECHNOLOGY			English	Article							GENOME; OLIGONUCLEOTIDES; DESIGN	Development of cheap, high-throughput and reliable gene synthesis methods will broadly stimulate progress in biology and biotechnology(1). Currently, the reliance on column-synthesized oligonucleotides as a source of DNA limits further cost reductions in gene synthesis(2). Oligonucleotides from DNA microchips can reduce costs by at least an order of magnitude(3-5), yet efforts to scale their use have been largely unsuccessful owing to the high error rates and complexity of the oligonucleotide mixtures. Here we use high-fidelity DNA microchips, selective oligonucleotide pool amplification, optimized gene assembly protocols and enzymatic error correction to develop a method for highly parallel gene synthesis. We tested our approach by assembling 47 genes, including 42 challenging therapeutic antibody sequences, encoding a total of similar to 35 kilobase pairs of DNA. These assemblies were performed from a complex background containing 13,000 oligonucleotides encoding similar to 2.5 megabases of DNA, which is at least 50 times larger than in previously published attempts.	[Kosuri, Sriram; Eroshenko, Nikolai; Super, Michael; Way, Jeffrey; Church, George M.] Wyss Inst Biol Inspired Engn, Boston, MA USA; [Kosuri, Sriram; Li, Jin Billy; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Eroshenko, Nikolai] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [LeProust, Emily M.] Agilent Technol, Santa Clara, CA USA	Harvard University; Harvard Medical School; Harvard University; Agilent Technologies	Kosuri, S (corresponding author), Wyss Inst Biol Inspired Engn, Boston, MA USA.	sri.kosuri@wyss.harvard.edu; eroshenk@wyss.harvard.edu	Super, Michael/AAW-7952-2021; Eroshenko, Nikolai/F-6231-2011	church, george/0000-0001-6232-9969; Kosuri, Sriram/0000-0002-4661-0600	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003170, P50HG005550] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG005550-01, P50 HG005550, P50 HG003170] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bang DH, 2008, NAT METHODS, V5, P37, DOI 10.1038/NMETH1136; Carr PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh160; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2009, NUCLEIC ACIDS RES, V37, P6984, DOI 10.1093/nar/gkp687; Huston J S, 1993, Int Rev Immunol, V10, P195, DOI 10.3109/08830189309061696; Kim C, 2006, MICROELECTRON ENG, V83, P1613, DOI 10.1016/j.mee.2006.01.143; Lee CC, 2010, NUCLEIC ACIDS RES, V38, P2514, DOI 10.1093/nar/gkq092; LeProust EM, 2010, NUCLEIC ACIDS RES, V38, P2522, DOI 10.1093/nar/gkq163; LI H, 2010, MAQ MAPPING ASSEMBLY; Li JB, 2009, GENOME RES, V19, P1606, DOI 10.1101/gr.092213.109; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; NIRENBERG M, 1961, P NATL ACAD SCI USA, V47, P1588, DOI 10.1073/pnas.47.10.1588; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Richmond KE, 2004, NUCLEIC ACIDS RES, V32, P5011, DOI 10.1093/nar/gkh793; Schlabach MR, 2010, P NATL ACAD SCI USA, V107, P2538, DOI 10.1073/pnas.0914803107; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; SOLL D, 1965, P NATL ACAD SCI USA, V54, P1378, DOI 10.1073/pnas.54.5.1378; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151; Tian JD, 2009, MOL BIOSYST, V5, P714, DOI 10.1039/b822268c; Xu QK, 2009, P NATL ACAD SCI USA, V106, P2289, DOI 10.1073/pnas.0812506106; Zhou XC, 2004, NUCLEIC ACIDS RES, V32, P5409, DOI 10.1093/nar/gkh879	26	168	249	1	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2010	28	12					1295	U108		10.1038/nbt.1716	http://dx.doi.org/10.1038/nbt.1716			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	691NP	21113165	Green Accepted, Green Submitted			2022-12-25	WOS:000285088400024
J	Bruning, JB; Parent, AA; Gil, G; Zhao, M; Nowak, J; Pace, MC; Smith, CL; Afonine, PV; Adams, PD; Katzenellenbogen, JA; Nettles, KW				Bruning, John B.; Parent, Alexander A.; Gil, German; Zhao, Min; Nowak, Jason; Pace, Margaret C.; Smith, Carolyn L.; Afonine, Pavel V.; Adams, Paul D.; Katzenellenbogen, John A.; Nettles, Kendall W.			Coupling of receptor conformation and ligand orientation determine graded activity	NATURE CHEMICAL BIOLOGY			English	Article							STRUCTURAL BASIS; MOLECULAR-BASIS; HIGH-THROUGHPUT; BINDING; AGONISTS; AUTOINHIBITION; SPECIFICITY; ANTAGONISM; MODULATION; MODE	Small molecules stabilize specific protein conformations from a larger ensemble, enabling molecular switches that control diverse cellular functions. We show here that the converse also holds true: the conformational state of the estrogen-receptor can direct distinct orientations of the bound ligand. 'Gain-of-allostery' mutations that mimic the effects of ligand in driving protein conformation allowed crystallization of the partial agonist ligand WAY-169916 with both the canonical active and inactive-conformations of the estrogen receptor. The intermediate transcriptional activity induced by WAY-169916 is-associated with the ligand binding differently to the active and inactive conformations of the receptor. Analyses of a series of chemical derivatives demonstrated that altering the ensemble of ligand binding orientations changes signaling output. The coupling of different ligand binding orientations to distinct active and inactive protein conformations defines a new mechanism for titrating allosteric signaling activity.	[Bruning, John B.; Gil, German; Zhao, Min; Nowak, Jason; Nettles, Kendall W.] Scripps Florida, Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Parent, Alexander A.; Katzenellenbogen, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Pace, Margaret C.; Smith, Carolyn L.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Afonine, Pavel V.; Adams, Paul D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	Scripps Research Institute; State University System of Florida; University of Florida; University of Illinois System; University of Illinois Urbana-Champaign; Baylor College of Medicine; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bruning, JB (corresponding author), Scripps Florida, Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA.	knettles@scripps.edu	Adams, Paul David/A-1977-2013; GIL, GERMAN A./T-3018-2019; Bruning, John/AAW-8567-2020	Adams, Paul David/0000-0001-9333-8219; GIL, GERMAN A./0000-0001-6714-2693; Bruning, John/0000-0002-6919-1824	US National Institutes of Health [PHS R37 DK15556, DK53002, CA132022, DK077085]; Frenchman's Creek Women for Cancer Research; NATIONAL CANCER INSTITUTE [R33CA132022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053002, R37DK015556, R01DK077085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS056998] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frenchman's Creek Women for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the US National Institutes of Health PHS R37 DK15556 (J.A.K.), DK53002 (C.L.S.), CA132022 and DK077085 (K.W.N.) and the Frenchman's Creek Women for Cancer Research (G.G.). We would like to thank J. Cleveland for comments on the manuscript, L. Potterton and S. McNicholas (University of York) for help with CCP4MG and K. Carlson (University of Illinois) for performing the ER alpha ligand-binding assays.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Angell RM, 2008, BIOORG MED CHEM LETT, V18, P4433, DOI 10.1016/j.bmcl.2008.06.028; Atwell S, 2004, J BIOL CHEM, V279, P55827, DOI 10.1074/jbc.M409792200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhavnani BR, 1998, P SOC EXP BIOL MED, V217, P6; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Bramlett KS, 2003, J PHARMACOL EXP THER, V307, P291, DOI 10.1124/jpet.103.052852; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Chadwick CC, 2005, P NATL ACAD SCI USA, V102, P2543, DOI 10.1073/pnas.0405841102; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gelman L, 2007, BBA-MOL CELL BIOL L, V1771, P1094, DOI 10.1016/j.bbalip.2007.03.004; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Lewis JA, 2008, CURR OPIN CHEM BIOL, V12, P269, DOI 10.1016/j.cbpa.2008.02.014; Love JD, 2002, J BIOL CHEM, V277, P11385, DOI 10.1074/jbc.M110869200; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nettles KW, 2008, NAT CHEM BIOL, V4, P241, DOI 10.1038/nchembio.76; Nettles KW, 2007, EMBO REP, V8, P563, DOI 10.1038/sj.embor.7400963; Norman BH, 2006, J MED CHEM, V49, P6155, DOI 10.1021/jm060491j; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Sablin EP, 2001, CURR OPIN STRUC BIOL, V11, P716, DOI 10.1016/S0959-440X(01)00265-2; Schacke H, 2004, P NATL ACAD SCI USA, V101, P227, DOI 10.1073/pnas.0300372101; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015; Shan L, 2004, MOL CELL, V16, P907, DOI 10.1016/S1097-2765(04)00728-2; Shiau AK, 2002, NAT STRUCT BIOL, V9, P359, DOI 10.1038/nsb787; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Steffan RJ, 2004, J MED CHEM, V47, P6435, DOI 10.1021/jm049194+; Steitz TA, 2006, EMBO J, V25, P3458, DOI 10.1038/sj.emboj.7601211; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Velyvis A, 2007, P NATL ACAD SCI USA, V104, P8815, DOI 10.1073/pnas.0703347104; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; WEBER G, 1972, BIOCHEMISTRY-US, V11, P864, DOI 10.1021/bi00755a028; Weis KE, 1996, MOL ENDOCRINOL, V10, P1388, DOI 10.1210/me.10.11.1388; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Yamasaki K, 2002, TOXICOLOGY, V170, P21, DOI 10.1016/S0300-483X(01)00505-4; Zhou HB, 2007, CHEM BIOL, V14, P659, DOI 10.1016/j.chembiol.2007.04.009	48	102	104	3	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2010	6	11					837	843		10.1038/NCHEMBIO.451	http://dx.doi.org/10.1038/NCHEMBIO.451			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	667MP	20924370	Green Accepted			2022-12-25	WOS:000283197800013
J	Ellinghaus, E; Ellinghaus, D; Stuart, PE; Nair, RP; Debrus, S; Raelson, JV; Belouchi, M; Fournier, H; Reinhard, C; Ding, J; Li, Y; Tejasvi, T; Gudjonsson, J; Stoll, SW; Voorhees, JJ; Lambert, S; Weidinger, S; Eberlein, B; Kunz, M; Rahman, P; Gladman, DD; Gieger, C; Wichmann, HE; Karlsen, TH; Mayr, G; Albrecht, M; Kabelitz, D; Mrowietz, U; Abecasis, GR; Elder, JT; Schreiber, S; Weichenthal, M; Franke, A				Ellinghaus, Eva; Ellinghaus, David; Stuart, Philip E.; Nair, Rajan P.; Debrus, Sophie; Raelson, John V.; Belouchi, Majid; Fournier, Helene; Reinhard, Claudia; Ding, Jun; Li, Yun; Tejasvi, Trilokraj; Gudjonsson, Johann; Stoll, Stefan W.; Voorhees, John J.; Lambert, Sylviane; Weidinger, Stephan; Eberlein, Bernadette; Kunz, Manfred; Rahman, Proton; Gladman, Dafna D.; Gieger, Christian; Wichmann, H. Erich; Karlsen, Tom H.; Mayr, Gabriele; Albrecht, Mario; Kabelitz, Dieter; Mrowietz, Ulrich; Abecasis, Goncalo R.; Elder, James T.; Schreiber, Stefan; Weichenthal, Michael; Franke, Andre			Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2	NATURE GENETICS			English	Article							NF-KAPPA-B; T-CELL; POPULATION; GENETICS; GENES; IL12B; IL23R; POLYMORPHISMS; ACTIVATION; AUTOIMMUNE	Psoriasis is a multifactorial skin disease characterized by epidermal hyperproliferation and chronic inflammation, the most common form of which is psoriasis vulgaris (PsV). We present a genome-wide association analysis of 2,339,118 SNPs in 472 PsV cases and 1,146 controls from Germany, with follow-up of the 147 most significant SNPs in 2,746 PsV cases and 4,140 controls from three independent replication panels. We identified an association at TRAF3IP2 on 6q21 and genotyped two SNPs at this locus in two additional replication panels (the combined discovery and replication panels consisted of 6,487 cases and 8,037 controls; combined P = 2.36 x 10(-10) for rs13210247 and combined P = 1.24 x 10(-16) for rs33980500). About 15% of psoriasis cases develop psoriatic arthritis (PsA). A stratified analysis of our datasets including only PsA cases (1,922 cases compared to 8,037 controls, P = 4.57 x 10(-12) for rs33980500) suggested that TRAF3IP2 represents a shared susceptibility for PsV and PsA. TRAF3IP2 encodes a protein involved in IL-17 signaling and which interacts with members of the Rel/NF-kappa B transcription factor family.	[Ellinghaus, Eva; Ellinghaus, David; Schreiber, Stefan; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Stuart, Philip E.; Nair, Rajan P.; Tejasvi, Trilokraj; Gudjonsson, Johann; Stoll, Stefan W.; Voorhees, John J.; Lambert, Sylviane; Elder, James T.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Debrus, Sophie; Raelson, John V.; Belouchi, Majid; Fournier, Helene; Reinhard, Claudia] Genizon BioSci Inc, St Laurent, PQ, Canada; [Ding, Jun; Li, Yun; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Weidinger, Stephan; Eberlein, Bernadette] Tech Univ Munich, Dept Dermatol & Allergy, Munich, Germany; [Weidinger, Stephan; Mrowietz, Ulrich; Weichenthal, Michael] Univ Kiel, Dept Dermatol, Univ Hosp Schleswig Holstein, D-2300 Kiel, Germany; [Kunz, Manfred] Univ Lubeck, Comprehens Ctr Inflammat Med, Lubeck, Germany; [Rahman, Proton] Mem Univ Newfoundland, Dept Med, St John, NF, Canada; [Gladman, Dafna D.] Univ Toronto, Div Rheumatol, Psoriat Arthrit Program, Univ Hlth Network, Toronto, ON, Canada; [Gieger, Christian; Wichmann, H. Erich] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Epidemiol, Neuherberg, Germany; [Wichmann, H. Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H. Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Karlsen, Tom H.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Clin Specialized Med & Surg, N-0027 Oslo, Norway; [Mayr, Gabriele; Albrecht, Mario] Max Planck Inst Informat, Saarbrucken, Germany; [Kabelitz, Dieter] Univ Kiel, Inst Immunol, Univ Hosp Schleswig Holstein, Kiel, Germany; [Elder, James T.] Ann Arbor Vet Affairs Hosp, Ann Arbor, MI USA	University of Kiel; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Technical University of Munich; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; Memorial University Newfoundland; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Oslo; National Hospital Norway; Max Planck Society; University of Kiel; Schleswig Holstein University Hospital	Franke, A (corresponding author), Univ Kiel, Inst Clin Mol Biol, Kiel, Germany.	mweichenthal@dermatology.uni-kiel.de; a.franke@mucosa.de	Ellinghaus, Eva/E-6490-2012; Ellinghaus, David/G-4467-2012; Albrecht, Mario/B-6694-2008; Voorhees, John/AAM-9966-2020; Kabelitz, Dieter/A-2757-2010; Kabelitz, Dieter/AAB-4199-2021; Franke, Andre/B-2151-2010; Ellinghaus, David/ABC-3610-2020; Wichmann, Heinz Erich/AAA-5695-2022; Ding, Jun/G-3918-2011; Weidinger, Stephan/C-8461-2011; Abecasis, Goncalo R/B-7840-2010; Weichenthal, Michael/A-5692-2009	Ellinghaus, Eva/0000-0003-2914-3382; Albrecht, Mario/0000-0002-3103-9624; Voorhees, John/0000-0003-1856-785X; Franke, Andre/0000-0003-1530-5811; Ellinghaus, David/0000-0002-4332-6110; Weidinger, Stephan/0000-0003-3944-252X; Abecasis, Goncalo/0000-0003-1509-1825; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Gieger, Christian/0000-0001-6986-9554	German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria and the Munich Center of Health Sciences (MC Health); US National Institutes of Health [R01-AR42742, R01-AR050511, R01-AR054966]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054966, R01AR042742, R01AR050511] Funding Source: NIH RePORTER	German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education, Science, Research and Technology; State of Bavaria and the Munich Center of Health Sciences (MC Health); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank all individuals with psoriasis who participated in this study, their families and their physicians for their cooperation. We acknowledge the cooperation of Genizon Biosciences. We wish to thank T. Wesse, T. Henke, C. Furstenau, S. Ehlers, M. Davids and R. Vogler for expert technical help. We thank J.R. Hov for helpful discussions. This study was supported by the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN), the PopGen biobank and the KORA (Cooperative Research in the Region of Augsburg) research platform. KORA was initiated and financed by the Helmholtz Zentrum Munchen-National Research Center for Environmental Health, which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria and the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. The project received infrastructure support through the Deutsche Forschungsgemeinschaft (DFG) clusters of excellence 'Multimodal Computing and Interaction' and 'Inflammation at Interfaces'. This research was also supported by grants R01-AR42742, R01-AR050511 and R01-AR054966 from the US National Institutes of Health.	Bhalerao J, 1998, HUM MOL GENET, V7, P1537, DOI 10.1093/hmg/7.10.1537; Bowcock AM, 2003, J AM ACAD DERMATOL, V49, pS51, DOI 10.1016/S0190-9622(03)01135-6; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chang M, 2008, GENES IMMUN, V9, P176, DOI 10.1038/sj.gene.6364451; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Dupont WD, 1997, CONTROL CLIN TRIALS, V18, P274, DOI 10.1016/S0197-2456(97)00074-3; ELDER JT, 1994, ARCH DERMATOL, V130, P216, DOI 10.1001/archderm.130.2.216; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gelfand JM, 2005, J AM ACAD DERMATOL, V53, P573, DOI 10.1016/j.jaad.2005.03.046; Gottlieb AB, 2005, NAT REV DRUG DISCOV, V4, P19, DOI 10.1038/nrd1607; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Hunter CA, 2007, NAT IMMUNOL, V8, P232, DOI 10.1038/ni0307-232; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; MOLL J M H, 1973, Seminars in Arthritis and Rheumatism, V3, P55, DOI 10.1016/0049-0172(73)90035-8; Nair RP, 2008, J INVEST DERMATOL, V128, P1653, DOI 10.1038/sj.jid.5701255; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Oudot T, 2009, J INVEST DERMATOL, V129, P2637, DOI 10.1038/jid.2009.157; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stoll SW, 2010, J INVEST DERMATOL, V130, P2031, DOI 10.1038/jid.2010.98; Stoll SW, 2010, J INVEST DERMATOL, V130, P295, DOI 10.1038/jid.2009.211; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Tsunemi Y, 2002, J DERMATOL SCI, V30, P161, DOI 10.1016/S0923-1811(02)00072-5; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Zaba LC, 2009, J ALLERGY CLIN IMMUN, V124, P1022, DOI 10.1016/j.jaci.2009.08.046; Zhang XJ, 2007, J INVEST DERMATOL, V127, P2544, DOI 10.1038/sj.jid.5700896; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	37	256	268	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					991	U113		10.1038/ng.689	http://dx.doi.org/10.1038/ng.689			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20953188	Green Accepted			2022-12-25	WOS:000283540500017
J	Hartman, IZ; Kim, A; Cotter, RJ; Walter, K; Dalai, SK; Boronina, T; Griffith, W; Lanar, DE; Schwenk, R; Krzych, U; Cole, RN; Sadegh-Nasseri, S				Hartman, Isamu Z.; Kim, AeRyon; Cotter, Robert J.; Walter, Kimberly; Dalai, Sarat K.; Boronina, Tatiana; Griffith, Wendell; Lanar, David E.; Schwenk, Robert; Krzych, Urszula; Cole, Robert N.; Sadegh-Nasseri, Scheherazade			A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopes	NATURE MEDICINE			English	Article							LIVER-STAGE ANTIGEN-1; COLLAGEN TYPE-II; HLA-DM; PLASMODIUM-FALCIPARUM; MASS-SPECTROMETRY; T-CELLS; REMNANT EPITOPES; MHC MOLECULES; GELATINASE-B; CATHEPSIN-S	Immunodominance is defined as restricted responsiveness of T cells to a few selected epitopes from complex antigens. Strategies currently used for elucidating CD4(+) T cell epitopes are inadequate. To understand the mechanism of epitope selection for helper T cells, we established a cell-free antigen processing system composed of defined proteins: human leukocyte antigen-DR1 (HLA-DR1), HLA-DM and cathepsins. Our reductionist system successfully identified the physiologically selected immunodominant epitopes of two model antigens: hemagglutinin-1 (HA1) from influenza virus (A/Texas/1/77) and type II collagen (CII). When applied for identification of new epitopes from a recombinant liver-stage antigen of malaria falciparum (LSA-NRC) or HA1 from H5N1 influenza virus ('avian flu'), the system selected single epitopes from each protein that were confirmed to be immunodominant by their capacity to activate CD4(+) T cells from H5N1-immunized HLA-DR1-transgenic mice and LSA-NRC-vaccinated HLA-DR1-positive human volunteers. Thus, we provide a new tool for the identification of physiologically relevant helper T cell epitopes from antigens.	[Hartman, Isamu Z.; Kim, AeRyon; Sadegh-Nasseri, Scheherazade] Johns Hopkins Univ, Sch Med, Grad Program Immunol, Baltimore, MD 21218 USA; [Cotter, Robert J.; Griffith, Wendell] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; [Walter, Kimberly; Dalai, Sarat K.; Sadegh-Nasseri, Scheherazade] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Boronina, Tatiana; Cole, Robert N.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Lanar, David E.; Schwenk, Robert; Krzych, Urszula] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD USA; [Cole, Robert N.] Johns Hopkins Univ, Sch Med, Mass Spectrometry & Prote Facil, Inst Basic Biomed Sci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Johns Hopkins University	Sadegh-Nasseri, S (corresponding author), Johns Hopkins Univ, Sch Med, Grad Program Immunol, Baltimore, MD 21218 USA.	ssadegh@jhmi.edu	Lanar, David E/B-3560-2011; Boronina, Tatiana/AAN-6332-2021; Griffith, Wendell/AAG-6193-2020	Sadegh-Nasseri, Scheherazade/0000-0002-8127-1720	Johns Hopkins Malaria Research Institute [AI063764, GM053549]; US National Science Foundation; Johns Hopkins University Rheumatology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI063764, R01AI063764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053549] Funding Source: NIH RePORTER	Johns Hopkins Malaria Research Institute; US National Science Foundation(National Science Foundation (NSF)); Johns Hopkins University Rheumatology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank S. Landry, A. Hamad, J. Pomerantz and K. Narayan for reading the manuscript and insightful discussions, S. Khoruzhenko for protein production, S. Kalb-Ramirez and D. Wang for the initial mass spectrometry, F. Korangy and D. Pardoll (Johns Hopkins University) for Escherichia coli transformed with an expression vector encoding influenza HA, D. Zaller (Merck) for the original DR1-transgenic mice, L. Rein for testing the human samples and the US National Institutes of Health Tetramer Facility for providing DR1 and CLIP monomers. This work was supported by R01 grants AI063764 and GM053549, a grant from Johns Hopkins Malaria Research Institute to S.S.-N., a US National Science Foundation predoctoral award to I.Z.H. and a Johns Hopkins University Rheumatology T32 Fellowship to A.K.	AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; Beltrami A, 2008, J BIOL CHEM, V283, P27189, DOI 10.1074/jbc.M802818200; Boja ES, 2001, ANAL CHEM, V73, P3576, DOI 10.1021/ac0103423; Chapman HA, 2006, CURR OPIN IMMUNOL, V18, P78, DOI 10.1016/j.coi.2005.11.011; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; Cummings JF, 2010, VACCINE, V28, P5135, DOI 10.1016/j.vaccine.2009.08.046; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; FIDOCK DA, 1994, J IMMUNOL, V153, P190; Gebe John A., 2007, V136, P39; Hillier CJ, 2005, INFECT IMMUN, V73, P2109, DOI 10.1128/IAI.73.4.2109-2115.2005; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; Ireland J, 2006, J IMMUNOL, V177, P1421, DOI 10.4049/jimmunol.177.3.1421; Jensen PE, 2007, NAT IMMUNOL, V8, P1041, DOI 10.1038/ni1516; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; KRZYCH U, 1995, J IMMUNOL, V155, P4072; LAMB JR, 1982, NATURE, V300, P66, DOI 10.1038/300066a0; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Narayan K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006188; Natarajan SK, 1999, J IMMUNOL, V162, P3463; Parker CE, 1996, J IMMUNOL, V157, P198; PISONI RL, 1990, J CELL BIOL, V110, P327, DOI 10.1083/jcb.110.2.327; Pluger EBE, 2002, EUR J IMMUNOL, V32, P467, DOI 10.1002/1521-4141(200202)32:2<467::AID-IMMU467>3.0.CO;2-Y; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Rosloniec EF, 1997, J EXP MED, V185, P1113, DOI 10.1084/jem.185.6.1113; Sadegh-Nasseri S, 2008, TRENDS IMMUNOL, V29, P141, DOI 10.1016/j.it.2008.01.001; Schey KL, 2000, ACCOUNTS CHEM RES, V33, P299, DOI 10.1021/ar9800744; Sercarz EE, 1998, IMMUNOL REV, V164, P5, DOI 10.1111/j.1600-065X.1998.tb01202.x; SERCARZ EE, 1993, ANNU REV IMMUNOL, V11, P729, DOI 10.1146/annurev.immunol.11.1.729; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; Strug I, 2008, J PROTEOME RES, V7, P2703, DOI 10.1021/pr700780x; Suri A, 2002, J IMMUNOL, V168, P1235, DOI 10.4049/jimmunol.168.3.1235; Van den Steen PE, 2004, BIOCHEMISTRY-US, V43, P10809, DOI 10.1021/bi0493665; Van Den Steen PE, 2002, FASEB J, V16, DOI 10.1096/fj.01-0688com	37	41	44	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1333	U192		10.1038/nm.2248	http://dx.doi.org/10.1038/nm.2248			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21037588	Bronze, Green Accepted			2022-12-25	WOS:000283860100047
J	Strange, A; Capon, F; Spencer, CCA; Knight, J; Weale, ME; Allen, MH; Barton, A; Band, G; Bellenguez, C; Bergboer, JGM; Blackwell, JM; Bramon, E; Bumpstead, SJ; Casas, JP; Cork, MJ; Corvin, A; Deloukas, P; Dilthey, A; Duncanson, A; Edkins, S; Estivill, X; Fitzgerald, O; Freeman, C; Giardina, E; Gray, E; Hofer, A; Huffmeier, U; Hunt, SE; Irvine, AD; Jankowski, J; Kirby, B; Langford, C; Lascorz, J; Leman, J; Leslie, S; Mallbris, L; Markus, HS; Mathew, CG; McLean, WHI; McManus, R; Mossner, R; Moutsianas, L; Naluai, AT; Nestle, FO; Novelli, G; Onoufriadis, A; Palmer, CNA; Perricone, C; Pirinen, M; Plomin, R; Potter, SC; Pujol, RM; Rautanen, A; Riveira-Munoz, E; Ryan, AW; Salmhofer, W; Samuelsson, L; Sawcer, SJ; Schalkwijk, J; Smith, CH; Stahle, M; Su, Z; Tazi-Ahnini, R; Traupe, H; Viswanathan, AC; Warren, RB; Weger, W; Wolk, K; Wood, N; Worthington, J; Young, HS; Zeeuwen, PLJM; Hayday, A; Burden, AD; Griffiths, CEM; Kere, J; Reis, A; McVean, G; Evans, DM; Brown, MA; Barker, JN; Peltonen, L; Donnelly, P; Trembath, RC				Strange, Amy; Capon, Francesca; Spencer, Chris C. A.; Knight, Jo; Weale, Michael E.; Allen, Michael H.; Barton, Anne; Band, Gavin; Bellenguez, Celine; Bergboer, Judith G. M.; Blackwell, Jenefer M.; Bramon, Elvira; Bumpstead, Suzannah J.; Casas, Juan P.; Cork, Michael J.; Corvin, Aiden; Deloukas, Panos; Dilthey, Alexander; Duncanson, Audrey; Edkins, Sarah; Estivill, Xavier; Fitzgerald, Oliver; Freeman, Colin; Giardina, Emiliano; Gray, Emma; Hofer, Angelika; Hueffmeier, Ulrike; Hunt, Sarah E.; Irvine, Alan D.; Jankowski, Janusz; Kirby, Brian; Langford, Cordelia; Lascorz, Jesus; Leman, Joyce; Leslie, Stephen; Mallbris, Lotus; Markus, Hugh S.; Mathew, Christopher G.; McLean, W. H. Irwin; McManus, Ross; Moessner, Rotraut; Moutsianas, Loukas; Naluai, Asa T.; Nestle, Frank O.; Novelli, Giuseppe; Onoufriadis, Alexandros; Palmer, Colin N. A.; Perricone, Carlo; Pirinen, Matti; Plomin, Robert; Potter, Simon C.; Pujol, Ramon M.; Rautanen, Anna; Riveira-Munoz, Eva; Ryan, Anthony W.; Salmhofer, Wolfgang; Samuelsson, Lena; Sawcer, Stephen J.; Schalkwijk, Joost; Smith, Catherine H.; Stahle, Mona; Su, Zhan; Tazi-Ahnini, Rachid; Traupe, Heiko; Viswanathan, Ananth C.; Warren, Richard B.; Weger, Wolfgang; Wolk, Katarina; Wood, Nicholas; Worthington, Jane; Young, Helen S.; Zeeuwen, Patrick L. J. M.; Hayday, Adrian; Burden, A. David; Griffiths, Christopher E. M.; Kere, Juha; Reis, Andre; McVean, Gilean; Evans, David M.; Brown, Matthew A.; Barker, Jonathan N.; Peltonen, Leena; Donnelly, Peter; Trembath, Richard C.		Genetic Anal Psoriasis Consortium; Wellcome Trust Case Control	A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1	NATURE GENETICS			English	Article							STATISTICAL-METHOD; DISEASES; GENE; VARIANTS; AUTOIMMUNITY; RESPONSES; PATHWAYS; COMPLEX; FAMILY; SCAN	To identify new susceptibility loci for psoriasis, we undertook a genome-wide association study of 594,224 SNPs in 2,622 individuals with psoriasis and 5,667 controls. We identified associations at eight previously unreported genomic loci. Seven loci harbored genes with recognized immune functions (IL28RA, REL, IFIH1, ERAP1, TRAF3IP2, NFKBIA and TYK2). These associations were replicated in 9,079 European samples (six loci with a combined P < 5 x 10(-8) and two loci with a combined P < 5 x 10(-7)). We also report compelling evidence for an interaction between the HLA-C and ERAP1 loci (combined P = 6.95 x 10(-6)). ERAP1 plays an important role in MHC class I peptide processing. ERAP1 variants only influenced psoriasis susceptibility in individuals carrying the HLA-C risk allele. Our findings implicate pathways that integrate epidermal barrier dysfunction with innate and adaptive immune dysregulation in psoriasis pathogenesis.	[Strange, Amy; Spencer, Chris C. A.; Band, Gavin; Bellenguez, Celine; Freeman, Colin; Pirinen, Matti; Rautanen, Anna; Su, Zhan; Donnelly, Peter] Wellcome Trust Ctr Human Genet, Oxford, England; [Capon, Francesca; Knight, Jo; Weale, Michael E.; Allen, Michael H.; Mathew, Christopher G.; Nestle, Frank O.; Onoufriadis, Alexandros; Smith, Catherine H.; Barker, Jonathan N.; Trembath, Richard C.] Kings Coll London, Div Genet & Mol Med, London WC2R 2LS, England; [Knight, Jo; Nestle, Frank O.; Trembath, Richard C.] Guys & St Thomas Natl Hlth Serv NHS Fdn Trust, Biomed Res Ctr, NIHR, London, England; [Barton, Anne] Univ Manchester, UK Epidemiol Unit, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Bergboer, Judith G. M.; Schalkwijk, Joost; Zeeuwen, Patrick L. J. M.] Radboud Univ Nijmegen Med Ctr, Dept Dermatol, Nijmegen, Netherlands; [Blackwell, Jenefer M.] Addenbrookes Hosp, Cambridge Inst Med Res, Genet & Infect Lab, Cambridge, England; [Bramon, Elvira] Kings Coll London, Div Psychol Med & Psychiat, Biomed Res Ctr Mental Hlth, Inst Psychiat, London WC2R 2LS, England; [Bramon, Elvira] S London & Maudsley NHS Fdn Trust, London, England; [Bumpstead, Suzannah J.; Deloukas, Panos; Edkins, Sarah; Gray, Emma; Hunt, Sarah E.; Langford, Cordelia; Potter, Simon C.; Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge, England; [Casas, Juan P.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Cork, Michael J.; Tazi-Ahnini, Rachid] Univ Sheffield, Dept Infect & Immun, Acad Unit Dermatol Res, Sheffield, S Yorkshire, England; [Corvin, Aiden] Trinity Coll Dublin, Inst Mol Med, Neuropsychiat Genet Res Grp, Dublin, Ireland; [Dilthey, Alexander; Leslie, Stephen; Moutsianas, Loukas; McVean, Gilean; Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Duncanson, Audrey] Wellcome Trust Res Labs, London, England; [Estivill, Xavier; Riveira-Munoz, Eva] CRG, Genes & Dis Programme, Barcelona, Spain; [Estivill, Xavier; Riveira-Munoz, Eva] Publ Hlth & Epidemiol Network Biomed Res Ctr CIBE, Barcelona, Spain; [Fitzgerald, Oliver; Kirby, Brian] St Vincents Univ Hosp, Dublin 4, Ireland; [Giardina, Emiliano; Novelli, Giuseppe] Univ Roma Tor Vergata, Sch Med, Dept Biopathol, Ctr Excellence Genom Risk Assessment Multifactori, Rome, Italy; [Hofer, Angelika; Salmhofer, Wolfgang; Weger, Wolfgang] Med Univ Graz, Dept Dermatol, Graz, Austria; [Hueffmeier, Ulrike; Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany; [Irvine, Alan D.] Our Ladys Childrens Hosp Crumlin, Trinity Coll Dublin, Dept Clin Med, Dublin, Ireland; [Jankowski, Janusz] Barts & London Queen Marys Sch Med & Dent, Ctr Gastroenterol, London, England; [Lascorz, Jesus] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Leman, Joyce; Burden, A. David] Western Infirm & Associated Hosp, Dept Dermatol, Glasgow, Lanark, Scotland; [Mallbris, Lotus; Stahle, Mona; Wolk, Katarina] Karolinska Inst, Dept Med, Dermatol Unit, Stockholm, Sweden; [Markus, Hugh S.] St Georges Univ London, London, England; [McLean, W. H. Irwin] Univ Dundee, Div Mol Med, Epithelial Genet Grp, Coll Life Sci & Med, Dundee, Scotland; [McLean, W. H. Irwin] Univ Dundee, Div Mol Med, Epithelial Genet Grp, Coll Dent, Dundee, Scotland; [McLean, W. H. Irwin] Univ Dundee, Div Mol Med, Epithelial Genet Grp, Coll Nursing, Dundee, Scotland; [McManus, Ross; Ryan, Anthony W.] St James Hosp, Trinity Coll Dublin, Dept Clin Med, Dublin, Ireland; [McManus, Ross; Ryan, Anthony W.] St James Hosp, Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland; [Moessner, Rotraut] Univ Gottingen, Dept Dermatol, Gottingen, Germany; [Naluai, Asa T.; Samuelsson, Lena] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med & Clin Genet, Gothenburg, Sweden; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Inst, Dundee DD1 9SY, Scotland; [Perricone, Carlo] Univ Roma La Sapienza, Rheumatol Unit, Dept Clin & Med Therapy, Rome, Italy; [Plomin, Robert] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Pujol, Ramon M.] Hosp del Mar, IMAS, Dermatol Serv, Barcelona, Spain; [Sawcer, Stephen J.; Hayday, Adrian] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Smith, Catherine H.; Barker, Jonathan N.] Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England; [Traupe, Heiko] Univ Munster, Dept Dermatol, D-4400 Munster, Germany; [Viswanathan, Ananth C.] Moorfields Eye Hosp NHS Fdn Trust, Glaucoma Res Unit, London, England; [Viswanathan, Ananth C.] UCL, Dept Genet, Inst Ophthalmol, London, England; [Warren, Richard B.; Young, Helen S.; Griffiths, Christopher E. M.] Univ Manchester, Salford Royal NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Wood, Nicholas] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Hayday, Adrian] Kings Coll London, Div Immunol Infect & Inflammatory Dis, London WC2R 2LS, England; [Hayday, Adrian] London Res Inst, Immuno Surveillance Lab, London, England; [Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Kere, Juha] Sci Life Lab, Stockholm, Sweden; [Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland; [Kere, Juha] Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; [Evans, David M.] Univ Bristol, Dept Social Med, MRC, Ctr Causal Analyses Translat Epidemiol, Bristol, Avon, England; [Evans, David M.; Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld, Australia	University of Oxford; Wellcome Centre for Human Genetics; University of London; King's College London; University of London; King's College London; University of Manchester; Radboud University Nijmegen; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; King's College London; South London & Maudsley NHS Trust; Wellcome Trust Sanger Institute; University of London; London School of Hygiene & Tropical Medicine; University of Sheffield; Trinity College Dublin; University of Oxford; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University College Dublin; Saint Vincent's University Hospital; University of Rome Tor Vergata; Medical University of Graz; University of Erlangen Nuremberg; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; University of London; Queen Mary University London; Helmholtz Association; German Cancer Research Center (DKFZ); Karolinska Institutet; St Georges University London; University of Dundee; University of Dundee; University of Dundee; Trinity College Dublin; Trinity College Dublin; University of Gottingen; University of Gothenburg; University of Dundee; Sapienza University Rome; University of London; King's College London; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; King's College London; University of Munster; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Salford Royal NHS Foundation Trust; University of Manchester; University of London; University College London; University of London; King's College London; Karolinska Institutet; University of Helsinki; University of Bristol; University of Queensland	Donnelly, P (corresponding author), Wellcome Trust Ctr Human Genet, Oxford, England.	peter.donnelly@well.ox.ac.uk; richard.trembath@kcl.ac.uk	Young, Helen/H-5247-2015; Giardina, Emiliano/J-1965-2012; Worthington, Jane/M-9770-2014; McLean, William HI/C-6352-2009; Irvine, Alan D/A-3982-2008; Novelli, Giuseppe/A-5195-2013; McManus, Ross/AAE-9236-2020; Smith, Catherine H./G-5268-2012; Griffiths, Christopher E.M./P-5448-2014; Schalkwijk, Joost/N-1774-2013; Warren, Richard B/G-4929-2015; Blackwell, Jenefer M/H-3015-2015; Ryan, Anthony W/A-1336-2010; Kere, Juha/A-9179-2008; Weale, Michael E/F-2587-2010; Wood, Nicholas W/C-2505-2009; Bramon, Elvira/A-9463-2011; Schalkwijk, Joost/R-7509-2019; Barton, Anne/N-2053-2014; Novelli, Giuseppe/GQB-3329-2022; Mathew, Christopher G/G-3434-2015; Plomin, Robert/B-8911-2008; Brown, Matthew A/E-5749-2010; Mallbris, Lotus/L-8607-2019; Estivill, Xavier/E-2957-2012; Capon, Francesca/F-4763-2011; Naluai, Åsa Torinsson/AAB-2166-2021; Huffmeier, Ulrike/D-2806-2013; Kere, Juha/AAX-9117-2021; Naluai, Åsa Torinsson/P-3269-2015; Deloukas, Panos/B-2922-2013; Knight, Jo/F-4946-2011; Reis, André/D-2309-2009; Belllenguez, Céline/Y-3183-2018; Bramon, Elvira/HHC-3809-2022; Evans, David M/H-6325-2013; Estivill, Xavier/A-3125-2013; Bellenguez, Céline/X-4004-2019; Zeeuwen, Patrick/N-1779-2013; Novelli, Giuseppe/T-8822-2019; Jankowski, Janusz/H-2706-2012; Palmer, Colin NA/C-7053-2008	Young, Helen/0000-0003-1538-445X; Worthington, Jane/0000-0003-0544-042X; Irvine, Alan D/0000-0002-9048-2044; Novelli, Giuseppe/0000-0002-7781-602X; Smith, Catherine H./0000-0001-9918-1144; Griffiths, Christopher E.M./0000-0001-5371-4427; Warren, Richard B/0000-0002-2918-6481; Kere, Juha/0000-0003-1974-0271; Weale, Michael E/0000-0003-4593-1186; Wood, Nicholas W/0000-0002-9500-3348; Schalkwijk, Joost/0000-0002-1308-1319; Barton, Anne/0000-0003-3316-2527; Novelli, Giuseppe/0000-0002-7781-602X; Mathew, Christopher G/0000-0003-4178-1838; Brown, Matthew A/0000-0003-0538-8211; Capon, Francesca/0000-0003-2432-5793; Naluai, Åsa Torinsson/0000-0002-0504-6492; Huffmeier, Ulrike/0000-0001-6448-4671; Kere, Juha/0000-0003-1974-0271; Naluai, Åsa Torinsson/0000-0002-0504-6492; Deloukas, Panos/0000-0001-9251-070X; Reis, André/0000-0002-6301-6363; Belllenguez, Céline/0000-0002-1240-7874; Bramon, Elvira/0000-0003-1369-5983; Evans, David M/0000-0003-0663-4621; Estivill, Xavier/0000-0002-0723-2256; Bellenguez, Céline/0000-0002-1240-7874; Zeeuwen, Patrick/0000-0002-6878-2438; Jankowski, Janusz/0000-0003-2130-9181; Palmer, Colin NA/0000-0002-6415-6560; Trembath, Richard/0000-0003-0550-3400; McManus, Ross/0000-0002-0529-9617; Perricone, Carlo/0000-0003-4771-6981; Cork, Michael/0000-0003-4428-2428; Barker, Jonathan/0000-0002-9030-183X; FitzGerald, Oliver/0000-0002-6607-6070; Ryan, Anthony/0000-0001-5005-3344; Knight, Joanne/0000-0002-7148-1660; HAYDAY, ADRIAN/0000-0002-9495-5793; Edkins, Sarah/0000-0003-0717-1972; Riveira Munoz, Eva/0000-0002-6396-1162; Hunt, Sarah/0000-0002-8350-1235; Donnelly, Peter/0000-0001-9495-3408; Pirinen, Matti/0000-0002-1664-1350; Plomin, Robert/0000-0002-0756-3629; Corvin, Aiden/0000-0001-6717-4089; Walters, James/0000-0002-6980-4053; giardina, emiliano/0000-0002-2741-5009; Potter, Simon/0000-0003-4208-4102; PUJOL, RAMON M/0000-0002-5622-6055; McLean, William Henry Irwin/0000-0001-5539-5757	Wellcome Trust [083948/Z/07/Z]; Netherlands Organization for Health Research and Development (P.L.J.M.Z.); Swedish Medical Research Council; Karolinska Institutet; Karolinska University Hospital; Psoriasis Foundation; AFA Insurance and Welander Finsen Foundation; Association for the Defence of Psoriasis Patients; Psoriasis Association and the Cecil King Memorial Foundation; Swedish Psoriasis Association; German Research Foundation [Tr 228/5-4, Re 679/104]; Interdisciplinary Centre for Clinical Research of the University of Erlangen-Nuremberg [IZKF B32/A8]; Spanish Ministry of Science and Innovation [SAF 2008-00357]; Departments of Health and Universities and Innovation; Genetic Repository in Ireland for Psoriasis and Psoriatic Arthritis; Irish Health Research Board; Wellcome Trust and Science Foundation Ireland [078173/Z/05/Z, 068545/Z/02]; National Institute for Health Research; Manchester Biomedical Research Centre; Arthritis Research UK [17552]; Wolfson-Royal Society; Generation Trust; UK Medical Research Council [G0601387]; Department of Health through the National Institute for Health Research (NIHR); St. Thomas' National Health Service (NHS) Foundation Trust; King's College London; Medical Research Council [G0000934]; Medical Research Council [G19/2, G9817803B, G0600705, G0901310, G0600698B, G0800582, G0601387, G0700314] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10379, CL-2008-06-002, PDA/02/06/016] Funding Source: researchfish; MRC [G19/2, G0700314, G0800582, G0000934, G0600705, G0901310, G0601387] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Netherlands Organization for Health Research and Development (P.L.J.M.Z.)(Netherlands Organization for Health Research and Development); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Karolinska Institutet(Karolinska Institutet); Karolinska University Hospital(Karolinska Institutet); Psoriasis Foundation; AFA Insurance and Welander Finsen Foundation; Association for the Defence of Psoriasis Patients; Psoriasis Association and the Cecil King Memorial Foundation; Swedish Psoriasis Association; German Research Foundation(German Research Foundation (DFG)); Interdisciplinary Centre for Clinical Research of the University of Erlangen-Nuremberg; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Departments of Health and Universities and Innovation; Genetic Repository in Ireland for Psoriasis and Psoriatic Arthritis; Irish Health Research Board; Wellcome Trust and Science Foundation Ireland(Science Foundation Ireland); National Institute for Health Research(National Institute for Health Research (NIHR)); Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Arthritis Research UK(Versus Arthritis); Wolfson-Royal Society(Royal Society of London); Generation Trust; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health through the National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); St. Thomas' National Health Service (NHS) Foundation Trust; King's College London(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The principal funding for this study was provided by the Wellcome Trust, as part of the Wellcome Trust Case Control Consortium 2 project (083948/Z/07/Z). We also thank S. Bertrand, J. Bryant, S.L. Clark, J.S. Conquer, T. Dibling, J.C. Eldred, S. Gamble, C. Hind, A. Wilk, C.R. Stribling and S. Taylor of the Wellcome Trust Sanger Institute's Sample and Genotyping Facilities for technical assistance. We thank D. Davison for making available his program 'Shellfish' for calculating principal components in large genetic datasets. Case collections were supported by the Netherlands Organization for Health Research and Development (P.L.J.M.Z.); the Swedish Medical Research Council, Karolinska Institutet, Karolinska University Hospital, Psoriasis Foundation, AFA Insurance and Welander Finsen Foundation (M. S.); the Association for the Defence of Psoriasis Patients (G.N.); Psoriasis Association and the Cecil King Memorial Foundation (M.J.C.); the Swedish Psoriasis Association (L.S.); the German Research Foundation (Tr 228/5-4 and Re 679/104) and The Interdisciplinary Centre for Clinical Research (IZKF B32/A8) of the University of Erlangen-Nuremberg (A. Reis); the Spanish Ministry of Science and Innovation (grant SAF 2008-00357) and the 'Generalitat de Catalunya' Departments of Health and Universities and Innovation (X. E.); the Genetic Repository in Ireland for Psoriasis and Psoriatic Arthritis (GRIPPsA), the Dublin Centre for Clinical Research (DCCR, funded by the Irish Health Research Board), The Wellcome Trust and Science Foundation Ireland (R. McManus); National Institute for Health Research, Manchester Biomedical Research Centre (J.W., C.E.M.G., R.B.W., H.S.Y.); and Arthritis Research UK (J.W., grant 17552). P.Donnelly was supported in part by a Wolfson-Royal Society Merit Award, and A.O. was supported by a PhD studentship from The Generation Trust. We also acknowledge support from the UK Medical Research Council (to R.C.T.,F.O.N., A.H. and J.N.B., grant G0601387), the Wellcome Trust (F.O.N., grant 078173/Z/05/Z) and the Department of Health through the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Guy's and St. Thomas' National Health Service (NHS) Foundation Trust in partnership with King's College London (J. Knight., M.E.W., C.G.M., F.O.N., A. Hayday and J.N.B.) and the NIHR award to Moorfields Eye Hospital NHS Foundation Trust and University College London Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology (A.C.V.). We acknowledge use of the British 1958 Birth Cohort DNA collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02, and of the UK National Blood Service controls funded by the Wellcome Trust. We thank W. Bodmer and B. Winney for use of the People of the British Isles DNA collection, which was funded by the Wellcome Trust.	[Anonymous], 2010, R LANG ENV STAT COMP; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jenisch S, 1998, AM J HUM GENET, V63, P191, DOI 10.1086/301899; Khan MA, 2002, ANN INTERN MED, V136, P896, DOI 10.7326/0003-4819-136-12-200206180-00011; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Leslie S, 2008, AM J HUM GENET, V82, P48, DOI 10.1016/j.ajhg.2007.09.001; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Orsmark-Pietras C, 2008, HUM MOL GENET, V17, P1673, DOI 10.1093/hmg/ddn058; Oyamada A, 2009, J IMMUNOL, V183, P7539, DOI 10.4049/jimmunol.0902740; Picard C, 2009, EUR J IMMUNOL, V39, P1966, DOI 10.1002/eji.200939385; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; SCHOUTEN EG, 1993, STAT MED, V12, P1733, DOI 10.1002/sim.4780121808; Smyth DJ, 2008, DIABETES, V57, P1730, DOI 10.2337/db07-1131; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Su Z, 2009, STAT SCI, V24, P430, DOI 10.1214/09-STS311; Veal CD, 2002, AM J HUM GENET, V71, P554, DOI 10.1086/342289; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	37	743	765	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2010	42	11					985	U106		10.1038/ng.694	http://dx.doi.org/10.1038/ng.694			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671VW	20953190	Green Accepted			2022-12-25	WOS:000283540500016
J	Davies, CC; Chakraborty, A; Cipriani, F; Haigh, K; Haigh, JJ; Behrens, A				Davies, Clare C.; Chakraborty, Atanu; Cipriani, Filippo; Haigh, Katharina; Haigh, Jody J.; Behrens, Axel			Identification of a co-activator that links growth factor signalling to c-Jun/AP-1 activation	NATURE CELL BIOLOGY			English	Article							CELL-CYCLE PROGRESSION; TRANSCRIPTION FACTOR AP-1; C-JUN; UBIQUITIN LIGASE; TERMINAL PHOSPHORYLATION; MAP KINASES; JNK; RAS; PROTEIN; FOS	The AP-1 transcription factor c-Jun is essential for cellular proliferation in many cell types, but the molecular link between growth factors and c-Jun activation has been enigmatic. In this study we identify a previously uncharacterized RING-domain-containing protein, RACO-1 (RING domain AP-1 co-activator-1), as a c-Jun co-activator that is regulated by growth factor signalling. RACO-1 interacted with c-Jun independently of amino-terminal phosphorylation, and was both necessary and sufficient for c-Jun/AP-1 activation. Growth factor-mediated stimulation of AP-1 was attributable to MEK/ERK-dependent stabilization of RACO-1 protein. Stimulation of the MEK/ERK pathway strongly promoted Lys 63-linked ubiquitylation of RACO-1, which antagonized Lys 48-linked degradative auto-ubiquitylation of the same Lys residues. RACO-1 depletion reduced cellular proliferation and decreased expression of several growth-associated AP-1 target genes, such as cdc2, cyclinD1 and hb-egf. Moreover, transgenic overexpression of RACO-1 augmented intestinal tumour formation triggered by aberrant Wnt signalling and cooperated with oncogenic Ras in colonic hyperproliferation. Thus RACO-1 is a co-activator that links c-Jun to growth factor signalling and is essential for AP-1 function in proliferation.	[Davies, Clare C.; Chakraborty, Atanu; Cipriani, Filippo; Behrens, Axel] Canc Res UK London Res Inst, Mammalian Genet Lab, Lincolns Inn Fields Labs, London WC2A 3PX, England; [Haigh, Katharina; Haigh, Jody J.] Univ Ghent VIB, Dept Mol Biomed Res, Vasc Cell Biol Unit, B-9052 Ghent, Belgium; [Haigh, Katharina; Haigh, Jody J.] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Cancer Research UK; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Behrens, A (corresponding author), Canc Res UK London Res Inst, Mammalian Genet Lab, Lincolns Inn Fields Labs, 44 Lincolns Inn Fields, London WC2A 3PX, England.	axel.behrens@cancer.org.uk		haigh, jody/0000-0002-7319-8922; Davies, Clare/0000-0003-3097-1791; Behrens, Axel/0000-0002-1557-1143	Cancer Research UK; Medical Research Council [G0901677] Funding Source: researchfish; MRC [G0901677] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to N. Ahn, M. Cobb and A. Hock for providing reagents. We thank B. Spencer-Dean, E. Nye and R. Mitter for technical support; the Molecular Biology Core Facility, Paterson Institute for Cancer Research, Manchester, UK for microarray analysis; and H. Walden for critical reading of the manuscript. The London Research Institute is funded by Cancer Research UK.	Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Behrens A, 2003, DEVELOPMENT, V130, P103, DOI 10.1242/dev.00186; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; Campanero MR, 1997, P NATL ACAD SCI USA, V94, P2221, DOI 10.1073/pnas.94.6.2221; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; DAbaco GM, 1996, MOL CELL BIOL, V16, P884; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Ruiter ND, 2000, MOL CELL BIOL, V20, P8480, DOI 10.1128/MCB.20.22.8480-8488.2000; DECESARE D, 1995, ONCOGENE, V11, P365; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; HU ED, 1994, EMBO J, V13, P3094, DOI 10.1002/j.1460-2075.1994.tb06608.x; Janssen KP, 2006, GASTROENTEROLOGY, V131, P1096, DOI 10.1053/j.gastro.2006.08.011; Johnson R, 1996, MOL CELL BIOL, V16, P4504; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Kennedy NJ, 2003, GENE DEV, V17, P629, DOI 10.1101/gad.1062903; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; Mansour SJ, 1996, CELL GROWTH DIFFER, V7, P243; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nyabi O, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp112; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Sancho R, 2009, EMBO J, V28, P1843, DOI 10.1038/emboj.2009.153; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911	47	33	42	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					963	972		10.1038/ncb2098	http://dx.doi.org/10.1038/ncb2098			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20852630				2022-12-25	WOS:000282363500011
J	Satterlee, JS; Schubeler, D; Ng, HH				Satterlee, John S.; Schuebeler, Dirk; Ng, Huck-Hui			Tackling the epigenome: challenges and opportunities for collaboration	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; DNA METHYLATION; HUMAN GENOME; DIFFERENTIATED CELLS; CHROMATIN; CANCER; EPIGENETICS; REVEALS; PLURIPOTENT; THERAPY		[Satterlee, John S.] US Natl Inst Drug Abuse, Bethesda, MD USA; [Schuebeler, Dirk] Friedrich Miescher Inst, CH-4002 Basel, Switzerland; [Ng, Huck-Hui] Genome Inst Singapore, Singapore, Singapore	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Friedrich Miescher Institute for Biomedical Research; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Satterlee, JS (corresponding author), US Natl Inst Drug Abuse, Bethesda, MD USA.	satterleej@nida.nih.gov	Ng, Huck Hui/A-1135-2009					Almeida AM, 2007, NEW ENGL J MED, V356, P1641, DOI 10.1056/NEJMoa063369; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Ammerpohl O, 2009, BBA-GEN SUBJECTS, V1790, P847, DOI 10.1016/j.bbagen.2009.02.001; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barski A, 2009, GENOME RES, V19, P1742, DOI 10.1101/gr.090951.109; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beck S, 2008, TRENDS GENET, V24, P231, DOI 10.1016/j.tig.2008.01.006; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bock C, 2008, BIOINFORMATICS, V24, P1, DOI 10.1093/bioinformatics/btm546; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Dindot SV, 2009, GENOME RES, V19, P1374, DOI 10.1101/gr.089185.108; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Goren A, 2010, NAT METHODS, V7, P47, DOI [10.1038/NMETH.1404, 10.1038/nmeth.1404]; Gronbaek K, 2007, APMIS, V115, P1039, DOI 10.1111/j.1600-0463.2007.apm_636.xml.x; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; HAYATSU H, 1979, BIOCHEMISTRY-US, V18, P632, DOI 10.1021/bi00571a013; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hon GC, 2009, HUM MOL GENET, V18, pR195, DOI 10.1093/hmg/ddp409; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Jones PA, 2005, CANCER RES, V65, P11241, DOI 10.1158/0008-5472.CAN-05-3865; Jones PA, 2008, NATURE, V454, P711, DOI 10.1038/454711a; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Li JB, 2009, GENOME RES, V19, P1606, DOI 10.1101/gr.092213.109; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Mack GS, 2006, J NATL CANCER I, V98, P1443, DOI 10.1093/jnci/djj447; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mulero-Navarro S, 2008, CRIT REV ONCOL HEMAT, V68, P1, DOI 10.1016/j.critrevonc.2008.03.001; Murrell A, 2005, HUM MOL GENET, V14, pR3, DOI 10.1093/hmg/ddi110; Nagano T, 2009, MAMM GENOME, V20, P557, DOI 10.1007/s00335-009-9218-1; Ng RK, 2008, CELL CYCLE, V7, P1173, DOI 10.4161/cc.7.9.5791; O'Neill LP, 2006, NAT GENET, V38, P835, DOI 10.1038/ng1820; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445; Zhang TY, 2010, ANNU REV PSYCHOL, V61, P439, DOI 10.1146/annurev.psych.60.110707.163625	63	58	60	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156			NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2010	28	10					1039	1044		10.1038/nbt1010-1039	http://dx.doi.org/10.1038/nbt1010-1039			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	663GF	20944594				2022-12-25	WOS:000282870500024
J	Yang, MH; Hsu, DSS; Wang, HW; Wang, HJ; Lan, HY; Yang, WH; Huang, CH; Kao, SY; Tzeng, CH; Tai, SK; Chang, SY; Lee, OKS; Wu, KJ				Yang, Muh-Hwa; Hsu, Dennis Shin-Shian; Wang, Hsei-Wei; Wang, Hsiao-Jung; Lan, Hsin-Yi; Yang, Wen-Hao; Huang, Chi-Hung; Kao, Shou-Yen; Tzeng, Cheng-Hwai; Tai, Shyh-Kuan; Chang, Shyue-Yih; Lee, Oscar Kuang-Sheng; Wu, Kou-Juey			Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition	NATURE CELL BIOLOGY			English	Article							CANCER STEM-CELLS; E-CADHERIN REPRESSION; NECK-CANCER; GENE-EXPRESSION; SELF-RENEWAL; METHYLTRANSFERASE ACTIVITY; IN-VIVO; KAPPA-B; HEAD; HYPOXIA	The epithelial-mesenchymal transition (EMT), one of the main mechanisms underlying development of cancer metastasis, induces stem-like properties in epithelial cells. Bmi1 is a polycomb-group protein that maintains self-renewal, and is frequently overexpressed in human cancers. Here, we show the direct regulation of BMI1 by the EMT regulator, Twist1. Furthermore, Twist1 and Bmi1 were mutually essential to promote EMT and tumour-initiating capability. Twist1 and Bmi1 act cooperatively to repress expression of both E-cadherin and p16INK4a. In patients with head and neck cancers, increased levels of both Twist1 and Bmi1 correlated with downregulation of E-cadherin and p16INK4a, and was associated with the worst prognosis. These results suggest that Twist1-induced EMT and tumour-initiating capability in cancer cells occurs through chromatin remodelling, which leads to unfavourable clinical outcomes.	[Yang, Muh-Hwa; Hsu, Dennis Shin-Shian; Wang, Hsei-Wei; Wang, Hsiao-Jung; Lan, Hsin-Yi; Yang, Wen-Hao; Lee, Oscar Kuang-Sheng] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Yang, Muh-Hwa] Natl Yang Ming Univ, Inst Biotechnol Med, Taipei 112, Taiwan; [Yang, Muh-Hwa; Huang, Chi-Hung; Tzeng, Cheng-Hwai] Taipei Vet Gen Hosp, Dept Med, Div Hematol Oncol, Taipei 112, Taiwan; [Yang, Muh-Hwa; Wang, Hsei-Wei; Chang, Shyue-Yih; Wu, Kou-Juey] Taipei Vet Gen Hosp, Genom Res Ctr, Taipei 112, Taiwan; [Wang, Hsei-Wei] Inst Microbiol & Immunol, Taipei 112, Taiwan; [Wu, Kou-Juey] Taiwan Adv Biopharm Inc, Xizhi City 221, Taipei County, Taiwan; [Kao, Shou-Yen] Taipei Vet Gen Hosp, Dept Dent, Taipei 112, Taiwan; [Tai, Shyh-Kuan; Chang, Shyue-Yih] Taipei Vet Gen Hosp, Dept Otolaryngol, Taipei 112, Taiwan; [Lee, Oscar Kuang-Sheng] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei 112, Taiwan; [Wu, Kou-Juey] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Yang, MH (corresponding author), Natl Yang Ming Univ, Inst Clin Med, 155,Sec 2,Li Nong St, Taipei 112, Taiwan.	mhyang2@vghtpe.gov.tw; kjwu2@ym.edu.tw	Yang, Muh-Hwa/AAE-4691-2020; Wu, Kou-Juey/P-4654-2015; Yang, wenhao/GXG-5965-2022		National Science Council [96-2314-B-075-013, 97-2314-B-010-003, 97-2320-B-010-029]; National Research Program for Genomic Medicine [DOH98-TD-G-111-027, DOH99-TD-G-111-024]; Ministry of Education [VGH 98-C1-050, 98-ER2-008, 99-C1-077, 99-ER2-007, 99-ER2-009]	National Science Council(Ministry of Science and Technology, Taiwan); National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); Ministry of Education	We would like to thank M. C. Hung (M. D. Anderson Cancer Center) for critical comments on the manuscript. We thank L. E. Huang (University of Utah) for pHA-HIF1 alpha(Delta ODD) plasmid. We are grateful to T.Y. Chou and W.Y. Li of the Department of Pathology, Taipei Veterans General Hospital for providing advice on IHC analysis. This work was supported in part by National Science Council grants to M.H.Y. (96-2314-B-075-013 and 97-2314-B-010-003) and K.J.W.(97-2320-B-010-029), National Research Program for Genomic Medicine grants to K.J.W (DOH98-TD-G-111-027 and DOH99-TD-G-111-024); Taipei Veterans General Hospital grants to M.H.Y (VGH 98-C1-050; 98-ER2-008, 99-C1-077 and 99-ER2-007) and K.J.W (99-ER2-009), grants from Ministry of Education, Aim for the Top University Plan to M.H.Y (98A-C-T510 and 99A-C-T509) and to K.J.W (99A-C-T508), National Health Research Institutes grants to K.J.W (NHRI-EX-98-9611BI and NHRI-EX-99-9931BI) and a grant from Department of Health, Center of Excellence for Cancer Research at Taipei Veterans General Hospital (DOH99-TD-C-111-007) to M.H.Y.	Ainbinder E, 2004, MOL CELL BIOL, V24, P2444, DOI 10.1128/MCB.24.6.2444-2454.2004; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Birnie R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r83; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Chen YC, 2009, BIOCHEM BIOPH RES CO, V385, P307, DOI 10.1016/j.bbrc.2009.05.048; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Foschini MP, 2008, HEAD NECK-J SCI SPEC, V30, P1475, DOI 10.1002/hed.20908; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Hoogsteen IJ, 2007, HEAD NECK-J SCI SPEC, V29, P591, DOI 10.1002/hed.20543; Hou ZY, 2008, MOL CELL BIOL, V28, P3198, DOI 10.1128/MCB.01435-07; Huang CH, 2009, NEOPLASIA, V11, P1371, DOI 10.1593/neo.91326; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Huang TS, 2008, STEM CELLS, V26, P1186, DOI 10.1634/stemcells.2007-0821; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Janssen HL, 2005, HEAD NECK-J SCI SPEC, V27, P622, DOI 10.1002/hed.20223; Kang MK, 2007, BRIT J CANCER, V96, P126, DOI 10.1038/sj.bjc.6603529; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kumar B, 2008, J CLIN ONCOL, V26, P3128, DOI 10.1200/JCO.2007.12.7662; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li J, 2010, AM J PATHOL, V176, P699, DOI 10.2353/ajpath.2010.090502; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Seiwert TY, 2005, BRIT J CANCER, V92, P1341, DOI 10.1038/sj.bjc.6602510; Tamura G, 2000, J NATL CANCER I, V92, P569, DOI 10.1093/jnci/92.7.569; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vormittag L, 2009, INT J RADIAT ONCOL, V73, P913, DOI 10.1016/j.ijrobp.2008.10.040; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2007, ONCOGENE, V26, P1459, DOI 10.1038/sj.onc.1209929; Yang MH, 2006, CLIN CANCER RES, V12, P507, DOI 10.1158/1078-0432.CCR-05-1231; Yang MH, 2008, CELL CYCLE, V7, P2090, DOI 10.4161/cc.7.14.6324; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691	51	511	529	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	OCT	2010	12	10					982	992		10.1038/ncb2099	http://dx.doi.org/10.1038/ncb2099			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	656UJ	20818389				2022-12-25	WOS:000282363500013
J	Santenard, A; Ziegler-Birling, C; Koch, M; Tora, L; Bannister, AJ; Torres-Padilla, ME				Santenard, Angele; Ziegler-Birling, Celine; Koch, Marc; Tora, Laszlo; Bannister, Andrew J.; Torres-Padilla, Maria-Elena			Heterochromatin formation in the mouse embryo requires critical residues of the histone variant H3.3	NATURE CELL BIOLOGY			English	Article							CHROMATIN MODIFICATIONS; MATERNAL CHROMATIN; DNA-REPLICATION; TRANSCRIPTION; ASYMMETRY; METHYLATION; ACTIVATION; COMPLEXES; PROTEINS	In mammals, oocyte fertilization by sperm initiates development. This is followed by epigenetic reprogramming of both parental genomes, which involves the de novo establishment of chromatin domains. In the mouse embryo, methylation of histone H3 establishes an epigenetic asymmetry and is predominant in the maternal pronucleus. However, the roles of differential incorporation of histone H3 variants in the parental chromatin, and of modified residues within specific histone variants, have not been addressed. Here we show that the histone variant H3.3, and in particular lysine 27, is required for the establishment of heterochromatin in the mouse embryo. H3.3 localizes to paternal pericentromeric chromatin during S phase at the time of transcription of pericentromeric repeats. Mutation of H3.3 K27, but not of H3.1 K27, results in aberrant accumulation of pericentromeric transcripts, HP1 mislocalization, dysfunctional chromosome segregation and developmental arrest. This phenotype is rescued by injection of double-stranded RNA (dsRNA) derived from pericentromeric transcripts, indicating a functional link between H3.3K27 and the silencing of such regions by means of an RNA-interference (RNAi) pathway. Our work demonstrates a role for a modifiable residue within a histone-variant-specific context during reprogramming and identifies a novel function for mammalian H3.3 in the initial formation of dsRNA-dependent heterochromatin.	[Santenard, Angele; Ziegler-Birling, Celine; Koch, Marc; Tora, Laszlo; Torres-Padilla, Maria-Elena] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM,U964, F-67404 Illkirch Graffenstaden, France; [Bannister, Andrew J.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Cambridge	Torres-Padilla, ME (corresponding author), Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM,U964, F-67404 Illkirch Graffenstaden, France.	metp@igbmc.fr	Tora, Laszlo/E-9999-2018	Tora, Laszlo/0000-0001-7398-2250; Koch, Marc/0000-0002-2678-235X; Bannister, Andrew/0000-0002-6312-4436	Cancer Research U.K.; Programme National de Recherche Reproduction Endocrinologie (PNRRE); INSERM;  [ANR-09-Blanc-0114]	Cancer Research U.K.(Cancer Research UK); Programme National de Recherche Reproduction Endocrinologie (PNRRE); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); 	We thank Kami Ahmad for providing H3.3 constructs, Florence Cammas and Tony Kouzarides for HP1 beta cDNAs, Natacha Dreumont and James Stevenin for advice on RNA-shift, and Olivier Pourquie for critical reading of the manuscript. A.J.B. acknowledges funding from Cancer Research U.K.; M.E.T.-P. acknowledges funding from Programme National de Recherche Reproduction Endocrinologie (PNRRE) and the Avenir programme from INSERM, and ANR-09-Blanc-0114.	Adenot PG, 1997, DEVELOPMENT, V124, P4615; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Arney KL, 2002, INT J DEV BIOL, V46, P317; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; BouniolBaly C, 1997, EXP CELL RES, V236, P201, DOI 10.1006/excr.1997.3708; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Hake SB, 2006, J BIOL CHEM, V281, P559, DOI 10.1074/jbc.M509266200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lepikhov Konstantin, 2004, BMC Developmental Biology, V4, P1; Lu J, 2007, J CELL BIOL, V179, P411, DOI 10.1083/jcb.200706176; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Mellone BG, 2003, CURR BIOL, V13, P1748, DOI 10.1016/j.cub.2003.09.031; Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026; Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; Probst AV, 2007, CHROMOSOMA, V116, P403, DOI 10.1007/s00412-007-0106-8; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Torres-Padilla ME, 2006, INT J DEV BIOL, V50, P455, DOI 10.1387/ijdb.052073mt; van der Heijden GW, 2005, MECH DEVELOP, V122, P1008, DOI 10.1016/j.mod.2005.04.009; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wiekowski M, 1997, J CELL SCI, V110, P1147; Wouters-Tyrou D, 1998, BIOCHIMIE, V80, P117, DOI 10.1016/S0300-9084(98)80018-7; Wright SJ, 1999, CURR TOP DEV BIOL, V46, P133, DOI 10.1016/S0070-2153(08)60328-2	28	216	228	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	SEP	2010	12	9					853	862		10.1038/ncb2089	http://dx.doi.org/10.1038/ncb2089			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	646SC	20676102	Green Accepted			2022-12-25	WOS:000281561900009
J	Gharavi, AG; Kiryluk, K; Choi, M; Li, YF; Hou, P; Xie, JY; Sanna-Cherchi, S; Men, CJ; Julian, BA; Wyatt, RJ; Novak, J; He, JC; Wang, HY; Lv, JC; Zhu, L; Wang, WM; Wang, ZH; Yasuno, K; Gunel, M; Mane, S; Umlauf, S; Tikhonova, I; Beerman, I; Savoldi, S; Magistroni, R; Ghiggeri, GM; Bodria, M; Lugani, F; Ravani, P; Ponticelli, C; Allegri, L; Boscutti, G; Frasca, G; Amore, A; Peruzzi, L; Coppo, R; Izzi, C; Viola, BF; Prati, E; Salvadori, M; Mignani, R; Gesualdo, L; Bertinetto, F; Mesiano, P; Amoroso, A; Scolari, F; Chen, N; Zhang, H; Lifton, RP				Gharavi, Ali G.; Kiryluk, Krzysztof; Choi, Murim; Li, Yifu; Hou, Ping; Xie, Jingyuan; Sanna-Cherchi, Simone; Men, Clara J.; Julian, Bruce A.; Wyatt, Robert J.; Novak, Jan; He, John C.; Wang, Haiyan; Lv, Jicheng; Zhu, Li; Wang, Weiming; Wang, Zhaohui; Yasuno, Kasuhito; Gunel, Murat; Mane, Shrikant; Umlauf, Sheila; Tikhonova, Irina; Beerman, Isabel; Savoldi, Silvana; Magistroni, Riccardo; Ghiggeri, Gian Marco; Bodria, Monica; Lugani, Francesca; Ravani, Pietro; Ponticelli, Claudio; Allegri, Landino; Boscutti, Giuliano; Frasca, Giovanni; Amore, Alessandro; Peruzzi, Licia; Coppo, Rosanna; Izzi, Claudia; Viola, Battista Fabio; Prati, Elisabetta; Salvadori, Maurizio; Mignani, Renzo; Gesualdo, Loreto; Bertinetto, Francesca; Mesiano, Paola; Amoroso, Antonio; Scolari, Francesco; Chen, Nan; Zhang, Hong; Lifton, Richard P.			Genome-wide association study identifies susceptibility loci for IgA nephropathy	NATURE GENETICS			English	Article							GALACTOSE-DEFICIENT IGA1; HLA-DR; RISK; VARIANTS; CFH; HAPLOTYPE; LINKAGE; GLOMERULONEPHRITIS; IMMUNOPROTEASOME; REPLICATION	We carried out a genome-wide association study of IgA nephropathy, a major cause of kidney failure worldwide. We studied 1,194 cases and 902 controls of Chinese Han ancestry, with targeted follow up in Chinese and European cohorts comprising 1,950 cases and 1,920 controls. We identified three independent loci in the major histocompatibility complex, as well as a common deletion of CFHR1 and CFHR3 at chromosome 1q32 and a locus at chromosome 22q12 that each surpassed genome-wide significance (P values for association between 1.59 x 10(-26) and 4.84 x 10(-9) and minor allele odds ratios of 0.63-0.80). These five loci explain 4-7% of the disease variance and up to a tenfold variation in interindividual risk. Many of the alleles that protect against IgA nephropathy impart increased risk for other autoimmune or infectious diseases, and IgA nephropathy risk allele frequencies closely parallel the variation in disease prevalence among Asian, European and African populations, suggesting complex selective pressures.	[Gharavi, Ali G.; Kiryluk, Krzysztof; Li, Yifu; Hou, Ping; Xie, Jingyuan; Sanna-Cherchi, Simone; Lugani, Francesca] Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY 10027 USA; [Choi, Murim; Men, Clara J.; Yasuno, Kasuhito; Gunel, Murat; Mane, Shrikant; Umlauf, Sheila; Tikhonova, Irina; Beerman, Isabel; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA; [Hou, Ping; Wang, Haiyan; Lv, Jicheng; Zhu, Li; Zhang, Hong] Peking Univ, Renal Div, Hosp 1, Inst Nephrol,Key Lab Renal Dis,Minist Hlth China, Beijing 100871, Peoples R China; [Xie, Jingyuan; Wang, Weiming; Wang, Zhaohui; Chen, Nan] Shanghai Jiao Tong Univ, Dept Nephrol, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Julian, Bruce A.; Novak, Jan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Julian, Bruce A.; Novak, Jan] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Wyatt, Robert J.] Bonheur Childrens Hosp, Childrens Fdn, Res Ctr, Memphis, TN USA; [Wyatt, Robert J.] Univ Tennessee, Ctr Hlth Sci, Div Pediat Nephrol, Memphis, TN 38163 USA; [He, John C.] Mt Sinai Sch Med, Dept Med, York, NY USA; [Mane, Shrikant; Umlauf, Sheila; Tikhonova, Irina] Yale Univ, Sch Med, Yale Ctr Genome Anal, New Haven, CT 06510 USA; [Savoldi, Silvana] Cirie Hosp, Nephrol & Dialysis Unit, Turin, Italy; [Magistroni, Riccardo] Univ Policlin Modena, Div Nefrol Dialisi & Trapianto, Azienda Osped, Modena, Italy; [Ghiggeri, Gian Marco; Bodria, Monica; Lugani, Francesca] Uremia Ist Giannina Gaslini, Lab Pathophysiol, Genoa, Italy; [Ravani, Pietro] Univ Calgary, Calgary, AB T2N 1N4, Canada; [Ponticelli, Claudio] Ist Sci Humanitas, Div Nefrol & Dialisi, Milan, Italy; [Allegri, Landino] Univ Parma, Nephrol Sect, Dept Clin Med Nephrol & Hlth Sci, I-43100 Parma, Italy; [Boscutti, Giuliano] Osped Gorizia, Dept Nephrol, Gorizia, Italy; [Frasca, Giovanni] Osped Riuniti, Nephrol & Dialysis Unit, Ancona, Italy; [Amore, Alessandro; Peruzzi, Licia; Coppo, Rosanna] Regina Margherita Univ Hosp, Turin, Italy; [Izzi, Claudia; Scolari, Francesco] Univ Brescia, Montichiari, Italy; [Izzi, Claudia; Scolari, Francesco] Montichiari Hosp, Div Nephrol 2, Montichiari, Italy; [Viola, Battista Fabio] Spedali Civil Brescia, Div Nephrol, I-25125 Brescia, Italy; [Prati, Elisabetta] Osped Desenzano, Dialysis Ctr, Desenzano Del Garda, Italy; [Salvadori, Maurizio] Careggi Univ Hosp, Renal Unit, Florence, Italy; [Mignani, Renzo] Osped Infermi, Div Nephrol, Rimini, Italy; [Gesualdo, Loreto] Univ Foggia, Dept Biomed Sci, Foggia, Italy; [Bertinetto, Francesca; Mesiano, Paola; Amoroso, Antonio] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy	Columbia University; Howard Hughes Medical Institute; Yale University; Peking University; Shanghai Jiao Tong University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Tennessee System; University of Tennessee Health Science Center; Icahn School of Medicine at Mount Sinai; Yale University; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Calgary; University of Parma; A.O.U. Citta della Salute e della Scienza di Torino; Ospedale Infantile Regina Margherita; University of Turin; University of Brescia; Hospital Spedali Civili Brescia; University of Florence; Azienda Ospedaliero Universitaria Careggi; Hospital of Rimini; University of Foggia; University of Turin	Gharavi, AG (corresponding author), Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY 10027 USA.	ag2239@columbia.edu; richard.lifton@yale.edu	Izzi, Claudia/GZG-8769-2022; Ghiggeri, Gian Marco/N-4712-2015; Magistroni, Riccardo/AAL-8753-2020; bodria, monica/K-2115-2016; scolari, francesco/AAC-5957-2022; Beerman, Isabel/Y-2555-2019; AMOROSO, ANTONIO/AAN-3884-2020; PERUZZI, LICIA/I-1873-2012; Boscutti, Giuliano/AAH-8559-2021; amoroso, antonio/AAL-1475-2020; Beerman, Isabel/AAN-4216-2020; Gesualdo, Loreto/K-7751-2016; Xie, Jingyuan/AAX-2708-2021; xie, jing/GRY-1689-2022; Ravani, Pietro/J-3050-2015; Izzi, Claudia/AAB-7004-2022; Choi, Murim/AAP-9120-2021; Yasuno, Katsuhito/E-1960-2012; Lugani, Francesca/J-7183-2016	Ghiggeri, Gian Marco/0000-0003-3659-9062; Magistroni, Riccardo/0000-0002-3319-0248; bodria, monica/0000-0001-9690-9945; amoroso, antonio/0000-0002-9437-9407; Gesualdo, Loreto/0000-0002-4861-0911; Ravani, Pietro/0000-0001-6973-8570; Yasuno, Katsuhito/0000-0002-3606-532X; Peruzzi, Licia/0000-0002-5704-3867; Lugani, Francesca/0000-0002-4189-8561; Izzi, Claudia/0000-0001-6253-3185; Scolari, Francesco/0000-0003-0233-9705; Beerman, Isabel/0000-0002-7758-8231; LI, YIFU/0000-0002-7077-7689; Wyatt, Robert/0000-0001-6077-0259	Center for Glomerular Diseases at Columbia University; Yale Center; Yale Center for Human Genetics and Genomics;  [RC1DK087445];  [R01DK082753];  [KL2 RR24157]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082753, K23DK090207, RC1DK087445, P30DK079310] Funding Source: NIH RePORTER	Center for Glomerular Diseases at Columbia University; Yale Center; Yale Center for Human Genetics and Genomics; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to all study participants for their contribution to this work. We also thank the staff of the Yale West Campus Center for Genome Analysis for their excellent support. We also appreciate the assistance of C.V. Barker and S.Y. Woodford with sample collection. This study was supported by RC1DK087445 (A.G.G., R.P.L.), R01DK082753 (A.G.G., J.N., B.A.J. and R.J.W.) and KL2 RR24157 (K.K.), the Center for Glomerular Diseases at Columbia University, the Yale Center Translational Science Award and the Yale Center for Human Genetics and Genomics. R.P.L. is an investigator of the Howard Hughes Medical Institute.	Atkinson JP, 2007, J EXP MED, V204, P1245, DOI 10.1084/jem.20070664; Barcellos LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000696; Barratt J, 2005, J AM SOC NEPHROL, V16, P2088, DOI 10.1681/ASN.2005020134; Begley GS, 2005, MOL IMMUNOL, V42, P137, DOI 10.1016/j.molimm.2004.07.005; Bisceglia L, 2006, AM J HUM GENET, V79, P1130, DOI 10.1086/510135; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton D, 2007, HUM HERED, V64, P45, DOI 10.1159/000101422; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Coppo R, 2009, KIDNEY INT, V75, P536, DOI 10.1038/ki.2008.579; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; DAMICO G, 1987, Q J MED, V64, P709; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Esashi E, 2009, EUR J IMMUNOL, V39, P1664, DOI 10.1002/eji.200839149; Feehally J, 2010, J AM SOC NEPHROL, V21, P1791, DOI 10.1681/ASN.2010010076; Ferreira RC, 2010, NAT GENET, V42, P777, DOI 10.1038/ng.644; Gesualdo L, 2004, KIDNEY INT, V66, P890, DOI 10.1111/j.1523-1755.2004.00831.x; Gharavi AG, 2000, NAT GENET, V26, P354, DOI 10.1038/81677; Gharavi AG, 2008, J AM SOC NEPHROL, V19, P1008, DOI 10.1681/ASN.2007091052; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Hastings MC, 2010, CLIN J AM SOC NEPHRO, V5, P2069, DOI 10.2215/CJN.03270410; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kiryluk Krzysztof, 2010, Pediatr Nephrol, V25, P2257, DOI 10.1007/s00467-010-1500-7; Lin XJ, 2009, NEPHROL DIAL TRANSPL, V24, P3372, DOI 10.1093/ndt/gfp294; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; MESTECKY J, 1993, CONTRIB NEPHROL, V104, P172; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Nair R, 2006, KIDNEY INT, V69, P1455, DOI 10.1038/sj.ki.5000292; Paterson AD, 2007, J AM SOC NEPHROL, V18, P2408, DOI 10.1681/ASN.2007020241; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2010, NAT GENET, V42, P553, DOI 10.1038/ng0710-553; Singer JB, 2010, NAT GENET, V42, P711, DOI 10.1038/ng.632; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Suzuki K, 2003, KIDNEY INT, V63, P2286, DOI 10.1046/j.1523-1755.63.6s.2.x; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; Tsukamoto Y, 2009, CLIN EXP NEPHROL, V13, P249, DOI 10.1007/s10157-009-0156-8; VARIS J, 1993, J CLIN PATHOL, V46, P607, DOI 10.1136/jcp.46.7.607; Wojtasz L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000702; Zhou XD, 2009, ARTHRITIS RHEUM-US, V60, P3807, DOI 10.1002/art.24982; Zipfel PF, 2007, PLOS GENET, V3, P387, DOI 10.1371/journal.pgen.0030041	50	424	452	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2011	43	4					321	U68		10.1038/ng.787	http://dx.doi.org/10.1038/ng.787			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	741YL	21399633	Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000288903700011
J	Maldonado, M; Kapoor, TM				Maldonado, Maria; Kapoor, Tarun M.			Constitutive Mad1 targeting to kinetochores uncouples checkpoint signalling from chromosome biorientation	NATURE CELL BIOLOGY			English	Article							AURORA-B KINASE; SPINDLE-ASSEMBLY CHECKPOINT; MICROTUBULE ATTACHMENT; ANAPHASE; MPS1; BUBR1; SEGREGATION; INHIBITION; COMPONENT; COMPLEX	Accurate chromosome segregation depends on biorientation, whereby sister chromatids attach to microtubules from opposite spindle poles. The spindle-assembly checkpoint is a surveillance mechanism in eukaryotes that inhibits anaphase until all chromosomes have bioriented(1-3). In present models, the recruitment of the spindle-assembly checkpoint protein Mad2, through Mad1, to non-bioriented kinetochores is needed to stop cell-cycle progression(3-6). However, it is unknown whether Mad1-Mad2 targeting to kinetochores is sufficient to block anaphase. Furthermore, it is unclear whether regulators of biorientation (for example, Aurorakinases(7)) have checkpoint functions downstream of Mad1-Mad2 recruitment or whether they act upstream to quench the primary error signal(8). Here, we engineered a Mad1 construct that localizes to bioriented kinetochores. We show that the kinetochore localization of Mad1 is sufficient for a metaphase arrest that depends on Mad1-Mad2 binding. By uncoupling the checkpoint from its primary error signal, we show that Aurora, Mps1 and BubR1 kinases, but not Polo-like kinase, are needed to maintain checkpoint arrest when Mad1 is present on kinetochores. Together, our data suggest a model in which the biorientation errors, which recruit Mad1-Mad2 to kinetochores, may be signalled not only through Mad2 template dynamics(9), but also through the activity of widely conserved kinases, to ensure the fidelity of cell division.	[Maldonado, Maria; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA	Rockefeller University	Kapoor, TM (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA.	kapoor@rockefeller.edu		Maldonado, Maria/0000-0002-3428-1053	NIH [GM65933]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065933] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Tan and E. A. Foley for the anti-mCherry antibody, reagents and experimental advice, S. Kawashima for comments on the manuscript and N. Gray for the inhibitor Mps1-IN-1. This work was supported by the NIH (GM65933). T.M.K. is a Leukemia and Lymphoma Society Scholar.	Burke DJ, 2008, DEV CELL, V14, P474, DOI 10.1016/j.devcel.2008.03.015; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Chen RH, 1998, J CELL BIOL, V143, P283, DOI 10.1083/jcb.143.2.283; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Emanuele MJ, 2008, J CELL BIOL, V181, P241, DOI 10.1083/jcb.200710019; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; Jablonski SA, 1998, CHROMOSOMA, V107, P386, DOI 10.1007/s004120050322; Jelluma N, 2010, J CELL BIOL, V191, P281, DOI 10.1083/jcb.201003038; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Kang J, 2009, J BIOL CHEM, V284, P15359, DOI 10.1074/jbc.R900005200; Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Lan WJ, 2010, J CELL BIOL, V190, P21, DOI 10.1083/jcb.201006080; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Luo XL, 2008, STRUCTURE, V16, P1616, DOI 10.1016/j.str.2008.10.002; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Petersen J, 2003, CURR BIOL, V13, P590, DOI 10.1016/S0960-9822(03)00205-7; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Simonetta M, 2009, PLOS BIOL, V7, P175, DOI 10.1371/journal.pbio.1000010; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Vanoosthuyse V, 2009, CURR BIOL, V19, P1176, DOI 10.1016/j.cub.2009.05.060; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035	36	127	130	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2011	13	4					475	U291		10.1038/ncb2223	http://dx.doi.org/10.1038/ncb2223			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	744CK	21394085	Green Accepted			2022-12-25	WOS:000289070900020
J	Zhang, D; Grode, KD; Stewman, SF; Diaz-Valencia, JD; Liebling, E; Rath, U; Riera, T; Currie, JD; Buster, DW; Asenjo, AB; Sosa, HJ; Ross, JL; Ma, A; Rogers, SL; Sharp, DJ				Zhang, Dong; Grode, Kyle D.; Stewman, Shannon F.; Diaz-Valencia, Juan Daniel; Liebling, Emily; Rath, Uttama; Riera, Tania; Currie, Joshua D.; Buster, Daniel W.; Asenjo, Ana B.; Sosa, Hernando J.; Ross, Jennifer L.; Ma, Ao; Rogers, Stephen L.; Sharp, David J.			Drosophila katanin is a microtubule depolymerase that regulates cortical-microtubule plus-end interactions and cell migration	NATURE CELL BIOLOGY			English	Article							MITOTIC SPINDLE; DYNAMIC INSTABILITY; SEVERING PROTEINS; IN-VITRO; BINDING; MITOSIS; GROWTH; LENGTH; MELANOGASTER; ARCHITECTURE	Regulation of microtubule dynamics at the cell cortex is important for cell motility, morphogenesis and division. Here we show that the Drosophila katanin Dm-Kat60 functions to generate a dynamic cortical-microtubule interface in interphase cells. Dm-Kat60 concentrates at the cell cortex of S2 Drosophila cells during interphase, where it suppresses the polymerization of microtubule plus-ends, there by preventing the formation of aberrantly dense cortical arrays. Dm-Kat60 also localizes at the leading edge of migratory D17 Drosophila cells and negatively regulates multiple parameters of their motility. Finally, in vitro, Dm-Kat60 severs and depolymerizes microtubules from their ends. On the basis of these data, we propose that Dm-Kat60 removes tubulin from microtubule lattice or microtubule ends that contact specific cortical sites to prevent stable and/or lateral attachments. The asymmetric distribution of such an activity could help generate regional variations in microtubule behaviours involved in cell migration.	[Zhang, Dong; Stewman, Shannon F.; Liebling, Emily; Rath, Uttama; Riera, Tania; Asenjo, Ana B.; Sosa, Hernando J.; Ma, Ao; Sharp, David J.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Grode, Kyle D.; Currie, Joshua D.; Rogers, Stephen L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Grode, Kyle D.; Currie, Joshua D.; Rogers, Stephen L.] Univ N Carolina, Ctr Carolina Genome Sci, Chapel Hill, NC 27599 USA; [Diaz-Valencia, Juan Daniel; Ross, Jennifer L.] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA; [Buster, Daniel W.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA; [Buster, Daniel W.] Univ Arizona, Dept Cell Biol & Anat, Tucson, AZ 85724 USA	Yeshiva University; Albert Einstein College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Massachusetts System; University of Massachusetts Amherst; Arizona Center Cancer Care; University of Arizona; University of Arizona	Sharp, DJ (corresponding author), Albert Einstein Coll Med, Dept Physiol & Biophys, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	david.sharp@einstein.yu.edu	Rath, Uttama/D-1197-2011; Ross, Jennifer L/D-7208-2012	Ross, Jennifer L/0000-0002-4838-3798; Currie, Josh/0000-0001-7402-4265	NIH [R01-GM065940, R01 GM081645, R01-GM086536, R01-GM083338]; March of Dimes [1-FY08-429, 5-FY09-47]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083338, R01GM065940, R01GM081645, R01GM086536] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D.J.S., U.R. and D.Z. were supported by NIH grant no. R01-GM065940 (to D.J.S.). S.L.R., K.D.G. and J.D.C. were supported by March of Dimes grant no. 1-FY08-429 and NIH grant no. R01 GM081645 (both to S.L.R.). S.F.S. and A.M. were supported by NIH grant no. R01-GM086536 (to A.M.). J.L.R. and J.D.D-V. were supported by March of Dimes grant no. 5-FY09-47 (to J.L.R.). H.J.S., A.B.A., E.L. and T.R. were supported by NIH grant no. R01-GM083338 (to H.J.S.).	Borghese L, 2006, DEV CELL, V10, P497, DOI 10.1016/j.devcel.2006.02.004; Burk DH, 2007, J INTEGR PLANT BIOL, V49, P1174, DOI 10.1111/j.1672-9072.2007.00544.x; Burk DH, 2001, PLANT CELL, V13, P807, DOI 10.1105/tpc.13.4.807; Buster D, 2002, J CELL SCI, V115, P1083; Casanova M, 2009, MOL MICROBIOL, V71, P1353, DOI 10.1111/j.1365-2958.2009.06594.x; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Gouveia SM, 2010, CURR BIOL, V20, P1717, DOI 10.1016/j.cub.2010.08.020; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Hudson AM, 2002, ANNU REV GENET, V36, P455, DOI 10.1146/annurev.genet.36.052802.114101; Jankovics F, 2006, DEV CELL, V11, P375, DOI 10.1016/j.devcel.2006.07.014; Jaworski J, 2008, INT J BIOCHEM CELL B, V40, P619, DOI 10.1016/j.biocel.2007.10.015; Karabay A, 2004, J NEUROSCI, V24, P5778, DOI 10.1523/JNEUROSCI.1382-04.2004; KURTTI TJ, 1970, EXP CELL RES, V61, P407, DOI 10.1016/0014-4827(70)90465-9; Lee H, 2004, NEURON, V42, P913, DOI 10.1016/j.neuron.2004.05.020; Martin SG, 2009, TRENDS CELL BIOL, V19, P447, DOI 10.1016/j.tcb.2009.06.003; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; McNally FJ, 1998, MOL BIOL CELL, V9, P1847, DOI 10.1091/mbc.9.7.1847; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; McNally KP, 2000, J CELL SCI, V113, P1623; Mennella V, 2005, NAT CELL BIOL, V7, P235, DOI 10.1038/ncb1222; Merchant D, 2008, J INSECT PHYSIOL, V54, P215, DOI 10.1016/j.jinsphys.2007.09.004; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; Nakamura M, 2010, NAT CELL BIOL, V12, P1064, DOI 10.1038/ncb2110; Ozon S, 2002, MOL BIOL CELL, V13, P698, DOI 10.1091/mbc.01-07-0362; Quarmby L, 2000, J CELL SCI, V113, P2821; Rasi MQ, 2009, MOL BIOL CELL, V20, P379, DOI 10.1091/mbc.E07-10-1007; Rath U, 2009, MOL BIOL CELL, V20, P4696, DOI 10.1091/mbc.E09-07-0557; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Roll-Mecak A, 2005, CURR BIOL, V15, P650, DOI 10.1016/j.cub.2005.02.029; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; Sharma N, 2007, J CELL BIOL, V178, P1065, DOI 10.1083/jcb.200704021; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Sonbuchner TM, 2010, CELL CYCLE, V9, P2403, DOI 10.4161/cc.9.12.11916; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Srayko M, 2006, CURR BIOL, V16, P1944, DOI 10.1016/j.cub.2006.08.029; Stoppin-Mellet V, 2007, PLANT PHYSIOL BIOCH, V45, P867, DOI 10.1016/j.plaphy.2007.09.005; Stoppin-Mellet V, 2006, PLANT J, V46, P1009, DOI 10.1111/j.1365-313X.2006.02761.x; Stramer B, 2010, J CELL BIOL, V189, P681, DOI 10.1083/jcb.200912134; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873; UI K, 1987, IN VITRO CELL DEV B, V23, P707; van der Vaart B, 2009, BIOCHEM SOC T, V37, P1007, DOI 10.1042/BST0371007; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Watanabe Takashi, 2005, Novartis Found Symp, V269, P92; Waterman-Storer C, 2000, J CELL BIOL, V150, P361, DOI 10.1083/jcb.150.2.361; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417; Yu WQ, 2008, MOL BIOL CELL, V19, P1485, DOI 10.1091/mbc.E07-09-0878; Yu WQ, 2005, J NEUROSCI, V25, P5573, DOI 10.1523/JNEUROSCI.0834-05.2005; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011	56	82	82	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2011	13	4					361	U71		10.1038/ncb2206	http://dx.doi.org/10.1038/ncb2206			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	744CK	21378981	Green Submitted, Green Accepted			2022-12-25	WOS:000289070900008
J	Zhang, Y; Li, XA; Carpinteiro, A; Goettel, JA; Soddemann, M; Gulbins, E				Zhang, Yang; Li, Xiang; Carpinteiro, Alexander; Goettel, Jeremy A.; Soddemann, Matthias; Gulbins, Erich			Kinase suppressor of Ras-1 protects against pulmonary Pseudomonas aeruginosa infections	NATURE MEDICINE			English	Article							NITRIC-OXIDE SYNTHASE; EPITHELIAL-CELLS; CYSTIC-FIBROSIS; MAPK SCAFFOLD; UP-REGULATION; IN-VIVO; ACTIVATION; MACROPHAGES; EXPRESSION; KSR	Pseudomonas aeruginosa is a Gram-negative pathogen that causes severe infections in immunocompromised individuals and individuals with cystic fibrosis or chronic obstructive pulmonary disease (COPD). Here we show that kinase suppressor of Ras-1 (Ksr1)-deficient mice are highly susceptible to pulmonary P. aeruginosa infection accompanied by uncontrolled pulmonary cytokine release, sepsis and death, whereas wild-type mice clear the infection. Ksr1 recruits and assembles inducible nitric oxide (NO) synthase (iNOS) and heat shock protein-90 (Hsp90) to enhance iNOS activity and to release NO upon infection. Ksr1 deficiency prevents lung alveolar macrophages and neutrophils from activating iNOS, producing NO and killing bacteria. Restoring NO production restores the bactericidal capability of Ksr1-deficient lung alveolar macrophages and neutrophils and rescues Ksr1-deficient mice from P. aeruginosa infection. Our findings suggest that Ksr1 functions as a previously unknown scaffold that enhances iNOS activity and is therefore crucial for the pulmonary response to P. aeruginosa infections.	[Zhang, Yang; Li, Xiang; Carpinteiro, Alexander; Soddemann, Matthias; Gulbins, Erich] Univ Duisburg Essen, Dept Mol Biol, Essen, Germany; [Goettel, Jeremy A.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Goettel, Jeremy A.] Monroe Carell Jr Childrens Hosp Vanderbilt, Nashville, TN USA	University of Duisburg Essen; Vanderbilt University; Vanderbilt University	Gulbins, E (corresponding author), Univ Duisburg Essen, Dept Mol Biol, Essen, Germany.	erich.gulbins@uni-due.de	Gulbins, Erich/L-6989-2014	Gulbins, Erich/0000-0002-3117-1342	Deutsche Forschungsgemeinschaft [Gu 335/13-3, Gu 335/16-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank R. Kolesnick (Memorial Sloan-Kettering Cancer Center) for providing us with Ksr1-deficient mice. This study was supported by Deutsche Forschungsgemeinschaft grants Gu 335/13-3 and Gu 335/16-2 to E.G.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Assis MC, 2006, INT J MOL MED, V18, P355; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; Currie AJ, 2003, SEM RESP CRIT CARE M, V24, P671, DOI 10.1055/s-2004-815663; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Fusello AM, 2006, J IMMUNOL, V177, P6152, DOI 10.4049/jimmunol.177.9.6152; Grassme H, 2000, SCIENCE, V290, P527, DOI 10.1126/science.290.5491.527; Koh AY, 2009, INFECT IMMUN, V77, P5300, DOI 10.1128/IAI.00501-09; Kolesnick R, 2004, J CLIN INVEST, V114, P1233, DOI 10.1172/JCI200423441; Kuncewicz T, 2001, AM J PHYSIOL-RENAL, V281, pF326, DOI 10.1152/ajprenal.2001.281.2.F326; Lozano J, 2003, CANCER RES, V63, P4232; Martin TR, 2000, AM J RESP CELL MOL, V23, P128, DOI 10.1165/ajrcmb.23.2.f189; Morrison DK, 2001, J CELL SCI, V114, P1609; Murphy TF, 2009, CURR OPIN PULM MED, V15, P138, DOI 10.1097/MCP.0b013e328321861a; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Peshes-Yaloz N, 2007, IMMUNOLOGY, V120, P502, DOI 10.1111/j.1365-2567.2006.02521.x; Poch DS, 2009, SEMIN RESP CRIT CARE, V30, P26, DOI 10.1055/s-0028-1119806; Rao S, 2006, ARCH DIS CHILD, V91, P786, DOI 10.1136/adc.2004.069419; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Satoh S, 2001, CLIN EXP IMMUNOL, V126, P266, DOI 10.1046/j.1365-2249.2001.01656.x; Stewart S, 1999, MOL CELL BIOL, V19, P5523; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Xing HR, 2003, NAT MED, V9, P1266, DOI 10.1038/nm927; Yan F, 2004, J CLIN INVEST, V114, P1272, DOI 10.1172/JCI200421022; Yan F, 2001, CANCER RES, V61, P963; Yoshida M, 2003, J BIOL CHEM, V278, P36953, DOI 10.1074/jbc.M305214200; Yu H, 2000, INFECT IMMUN, V68, P2142, DOI 10.1128/IAI.68.4.2142-2147.2000; Zhang Y, 2008, J IMMUNOL, V181, P4247, DOI 10.4049/jimmunol.181.6.4247; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X	31	46	47	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2011	17	3					341	U140		10.1038/nm.2296	http://dx.doi.org/10.1038/nm.2296			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21297617				2022-12-25	WOS:000288070000045
J	Zheng, M; Wang, YH; Wu, XN; Wu, SQ; Lu, BJ; Dong, MQ; Zhang, HB; Sun, PQ; Lin, SC; Guan, KL; Han, JH				Zheng, Min; Wang, Yan-Hai; Wu, Xiao-Nan; Wu, Su-Qin; Lu, Bao-Ju; Dong, Meng-Qiu; Zhang, Hongbing; Sun, Peiqing; Lin, Sheng-Cai; Guan, Kun-Liang; Han, Jiahuai			Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1	NATURE CELL BIOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; P38 MAP-KINASES; CELL-GROWTH; DIRECT TARGET; PATHWAY; COMPLEX; STRESS; GTPASE; CASCADE; MEMBER	Cell growth can be suppressed by stressful environments, but the role of stress pathways in this process is largely unknown. Here we show that a cascade of p38 beta mitogen-activated protein kinase (MAPK) and p38-regulated/activated kinase (PRAK) plays a role in energy-starvation-induced suppression of mammalian target of rapamycin (mTOR), and that energy starvation activates the p38 beta-PRAK cascade. Depletion of p38 beta or PRAK diminishes the suppression of mTOR complex 1 (mTORC1) and reduction of cell size induced by energy starvation. We show that p38 beta-PRAK operates independently of the known mTORC1 inactivation pathways-phosphorylation of tuberous sclerosis protein 2 (TSC2) and Raptor by AMP-activated protein kinase (AMPK)-and surprisingly, that PRAK directly regulates Ras homologue enriched in brain (Rheb), a key component of the mTORC1 pathway, by phosphorylation. Phosphorylation of Rheb at Ser 130 by PRAK impairs the nucleotide-binding ability of Rheb and inhibits Rheb-mediated mTORC1 activation. The direct regulation of Rheb by PRAK integrates a stress pathway with the mTORC1 pathway in response to energy depletion.	[Zheng, Min; Wang, Yan-Hai; Wu, Xiao-Nan; Wu, Su-Qin; Lin, Sheng-Cai; Han, Jiahuai] Xiamen Univ, Sch Life Sci, Key Lab Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Fujian, Peoples R China; [Lu, Bao-Ju; Dong, Meng-Qiu] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Zhang, Hongbing] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Dept Physiol, Beijing 100005, Peoples R China; [Zhang, Hongbing] Peking Union Med Coll, Beijing 100005, Peoples R China; [Sun, Peiqing] Scripps Res Inst, La Jolla, CA 92037 USA; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Xiamen University; National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Han, JH (corresponding author), Xiamen Univ, Sch Life Sci, Key Lab Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Fujian, Peoples R China.	jhan@scripps.edu	Lin, SC/G-4666-2010; Guan, Kun-Liang/ADK-7088-2022; Han, J/G-4671-2010		NSF China [30830092, 30921005, 30828219]; 973 program [2009CB22200]; National Institutes of Health [AI41637, AI68896]; NATIONAL CANCER INSTITUTE [R01CA106768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041637, R01AI068896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062694] Funding Source: NIH RePORTER	NSF China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank H. Jiang (Boehringer Ingelheim Pharmaceuticals) for providing p38 conditional knockout mice, B. Viollet (Universite Paris Descartes) and K. R. Laderoute (Stanford University School of Medicine) for AMPK alpha 1/alpha 2<SUP>-/-</SUP> cells. This work was supported by grants from NSF China 30830092, 30921005, 30828219, 973 program 2009CB22200, National Institutes of Health AI41637 and AI68896.	Anderson JC, 2008, PLANT J, V55, P881, DOI 10.1111/j.1365-313X.2008.03550.x; Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Cully M, 2010, MOL CELL BIOL, V30, P481, DOI 10.1128/MCB.00688-09; English JM, 2002, TRENDS PHARMACOL SCI, V23, P40, DOI 10.1016/S0165-6147(00)01865-4; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kwong J, 2009, J BIOL CHEM, V284, P11237, DOI 10.1074/jbc.M808327200; Li QX, 2008, J BIOL CHEM, V283, P11014, DOI 10.1074/jbc.M709682200; Li Y, 2003, J BIOL CHEM, V278, P13663, DOI 10.1074/jbc.M300862200; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; New L, 2003, MOL BIOL CELL, V14, P2603, DOI 10.1091/mbc.E02-08-0538; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Potter CJ, 2001, CURR OPIN GENET DEV, V11, P279, DOI 10.1016/S0959-437X(00)00191-X; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Yu YD, 2005, J BIOL CHEM, V280, P17093, DOI 10.1074/jbc.M501253200; Yuan J, 2005, MOL BIOL REP, V32, P205, DOI 10.1007/s11033-005-0984-x; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	55	96	107	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2011	13	3					263	U425		10.1038/ncb2168	http://dx.doi.org/10.1038/ncb2168			29	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	728BB	21336308	Green Accepted			2022-12-25	WOS:000287847600014
J	Kim, Y; Lach, FP; Desetty, R; Hanenberg, H; Auerbach, AD; Smogorzewska, A				Kim, Yonghwan; Lach, Francis P.; Desetty, Rohini; Hanenberg, Helmut; Auerbach, Arleen D.; Smogorzewska, Agata			Mutations of the SLX4 gene in Fanconi anemia	NATURE GENETICS			English	Article							CANCER SUSCEPTIBILITY GENE; CROSS-LINK REPAIR; HOLLIDAY JUNCTION RESOLVASE; DNA-REPAIR; MONOUBIQUITINATED FANCD2; IDENTIFICATION; BREAST; NUCLEASE; PATHWAY; DAMAGE	Fanconi anemia is a rare recessive disorder characterized by genome instability, congenital malformations, progressive bone marrow failure and predisposition to hematologic malignancies and solid tumors(1). At the cellular level, hypersensitivity to DNA interstrand crosslinks is the defining feature in Fanconi anemia(2). Mutations in thirteen distinct Fanconi anemia genes(3) have been shown to interfere with the DNA-replication-dependent repair of lesions involving crosslinked DNA at stalled replication forks(4). Depletion of SLX4, which interacts with multiple nucleases and has been recently identified as a Holliday junction resolvase(5-7), results in increased sensitivity of the cells to DNA crosslinking agents. Here we report the identification of biallelic SLX4 mutations in two individuals with typical clinical features of Fanconi anemia and show that the cellular defects in these individuals' cells are complemented by wildtype SLX4, demonstrating that biallelic mutations in SLX4 (renamed here as FANCP) cause a new subtype of Fanconi anemia, Fanconi anemia-P.	[Kim, Yonghwan; Lach, Francis P.; Desetty, Rohini; Smogorzewska, Agata] Rockefeller Univ, Lab Genome Maintenance, New York, NY 10021 USA; [Hanenberg, Helmut] Indiana Univ Sch Med, Riley Hosp Children, Herman B Wells Ctr Pediat Res, Div Pediat Hematol Oncol, Indianapolis, IN USA; [Hanenberg, Helmut] Univ Dusseldorf, Dept Otorhinolaryngol, Dusseldorf, Germany	Rockefeller University; Indiana University System; Indiana University Bloomington; James Whitcomb Riley Hospital Children; Heinrich Heine University Dusseldorf	Smogorzewska, A (corresponding author), Rockefeller Univ, Lab Genome Maintenance, 1230 York Ave, New York, NY 10021 USA.	asmogorzewska@rockefeller.edu	Smogorzewska, Agata/B-8891-2011	Lach, Francis/0000-0003-3708-7122; Smogorzewska, Agata/0000-0001-6285-1562; Auerbach, Arleen/0000-0002-6911-8379	Deutsche Forschungsgemeinschaft [SPP1230]; Bundesministerium fur Bildung und Forschung network for Bone Marrow failure Syndrome; FoneFA; Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE [R01CA155294] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung network for Bone Marrow failure Syndrome; FoneFA; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We are grateful to the affected individuals and their families for their participation in this study. We thank the Harper Lab, Harvard Medical School, Boston, Massachusetts, USA for reagents, E. Foley for advice and J. de Winter for communicating unpublished results. H. H. is supported by the Deutsche Forschungsgemeinschaft SPP1230, the Bundesministerium fur Bildung und Forschung network for Bone Marrow failure Syndrome, and FoneFA. A.S. is supported by the Burroughs Wellcome Fund Career Award for Medical Scientists and is a Rita Allen Foundation and an Irma T. Hirschl Scholar.	AUERBACH AD, 1976, NATURE, V261, P494, DOI 10.1038/261494a0; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942	26	253	257	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2011	43	2					142	U91		10.1038/ng.750	http://dx.doi.org/10.1038/ng.750			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	711XD	21240275	Green Accepted			2022-12-25	WOS:000286623800013
J	Holland, WL; Miller, RA; Wang, ZV; Sun, K; Barth, BM; Bui, HH; Davis, KE; Bikman, BT; Halberg, N; Rutkowski, JM; Wade, MR; Tenorio, VM; Kuo, MS; Brozinick, JT; Zhang, BB; Birnbaum, MJ; Summers, SA; Scherer, PE				Holland, William L.; Miller, Russell A.; Wang, Zhao V.; Sun, Kai; Barth, Brian M.; Bui, Hai H.; Davis, Kathryn E.; Bikman, Benjamin T.; Halberg, Nils; Rutkowski, Joseph M.; Wade, Mark R.; Tenorio, Vincent M.; Kuo, Ming-Shang; Brozinick, Joseph T.; Zhang, Bei B.; Birnbaum, Morris J.; Summers, Scott A.; Scherer, Philipp E.			Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin	NATURE MEDICINE			English	Article							PROTEIN-KINASE; INSULIN SENSITIVITY; FATTY-ACIDS; MOUSE MODEL; PKC-ZETA; CELL; SPHINGOSINE; RESISTANCE; INHIBITION; APOPTOSIS	The adipocyte-derived secretory factor adiponectin promotes insulin sensitivity, decreases inflammation and promotes cell survival. No unifying mechanism has yet explained how adiponectin can exert such a variety of beneficial systemic effects. Here, we show that adiponectin potently stimulates a ceramidase activity associated with its two receptors, AdipoR1 and AdipoR2, and enhances ceramide catabolism and formation of its antiapoptotic metabolite-sphingosine-1-phosphate (S1P)-independently of AMP-dependent kinase (AMPK). Using models of inducible apoptosis in pancreatic beta cells and cardiomyocytes, we show that transgenic overproduction of adiponectin decreases caspase-8-mediated death, whereas genetic ablation of adiponectin enhances apoptosis in vivo through a sphingolipid-mediated pathway. Ceramidase activity is impaired in cells lacking both adiponectin receptor isoforms, leading to elevated ceramide levels and enhanced susceptibility to palmitate-induced cell death. Combined, our observations suggest a unifying mechanism of action for the beneficial systemic effects exerted by adiponectin, with sphingolipid metabolism as its core upstream signaling component.	[Holland, William L.; Wang, Zhao V.; Sun, Kai; Davis, Kathryn E.; Halberg, Nils; Rutkowski, Joseph M.; Tenorio, Vincent M.; Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Touchstone Diabet Ctr, Dallas, TX 75390 USA; [Miller, Russell A.; Birnbaum, Morris J.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Barth, Brian M.; Summers, Scott A.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Bui, Hai H.; Wade, Mark R.; Kuo, Ming-Shang; Brozinick, Joseph T.] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; [Bikman, Benjamin T.; Summers, Scott A.] Duke Natl Univ Singapore, Grad Sch Med, Program Cardiovasc & Metab Dis, Singapore, Singapore; [Halberg, Nils] Univ Copenhagen, Dept Biomed Sci, Fac Hlth Sci, Copenhagen, Denmark; [Zhang, Bei B.] Merck Res Labs, Dept Metab Disorders, Rahway, NJ USA; [Summers, Scott A.] Duke Univ, Med Ctr, Stedman Ctr Nutr & Metab Res, Durham, NC USA; [Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania; Colorado State University; Eli Lilly; National University of Singapore; University of Copenhagen; Merck & Company; Duke University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Scherer, PE (corresponding author), Univ Texas SW Med Ctr Dallas, Touchstone Diabet Ctr, Dallas, TX 75390 USA.	philipp.scherer@utsouthwestern.edu	Scherer, Philipp E/K-7819-2012; /AAE-5384-2020; Bikman, Benjamin/AAT-9606-2021; Halberg, Nils/AAF-8153-2019	Scherer, Philipp E/0000-0003-0680-3392; Halberg, Nils/0000-0002-2943-3147; Rutkowski, Joseph/0000-0002-4197-0236; Sun, Kai/0000-0002-4778-4549; Birnbaum, Morris/0000-0001-9972-8680; Barth, Brian/0000-0002-3542-1804; Wang, Zhao/0000-0002-9904-9538	US National Institutes of Health [R01-DK55758, R01-CA112023, RC1-DK086629, P01-DK088761, R01-DK56886, P01-DK49210, R21-DK073181]; National Research Service Award [F32-DK083866, TL1-DK081181]; University of Copenhagen;  [F32-DK085935];  [T32-HL007360];  [F32-DK081279]; NATIONAL CANCER INSTITUTE [R01CA112023] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK073181, R01DK056886, R01DK055758, F32DK085935, R01DK081456, F32DK083866, P01DK049210, F32DK081279, TL1DK081181, P01DK088761, RC1DK086629] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Copenhagen; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Scherer and Summers laboratories for comments. We would like to thank R. Kitsis for discussions regarding the generation of HEART-ATTAC mice. We thank B. Hammer and the Transgenic Core Facility at UT Southwestern for the generation of the mouse models used in this study and the Metabolic Core Facility at UT Southwestern for help with phenotyping of the mice. Lkb1<SUP>-/-</SUP> mice and cells were a kind gift from R. DePinho, Massachusetts General Hospital. INS-1 832/13 cells were generously provided by C. Newgard, Duke University Medical Center. We thank Ariad Pharmaceuticals for providing the dimerization kit and compound AP20187. This work was supported by US National Institutes of Health grants R01-DK55758, R01-CA112023, RC1-DK086629 and P01-DK088761 (P.E.S.); R01-DK56886 and P01-DK49210 (M.J.B.); as well as R21-DK073181 (S.A.S.). W.L.H. was supported by National Research Service Award F32-DK083866 and TL1-DK081181. J.M.R. was supported by F32-DK085935 and T32-HL007360 and K.E.D. was supported by F32-DK081279. N.H. was funded by a grant from University of Copenhagen.	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Asterholm IW, 2010, AM J PATHOL, V176, P1364, DOI 10.2353/ajpath.2010.090647; Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Bourbon NA, 2001, AM J PHYSIOL-CELL PH, V280, pC1403, DOI 10.1152/ajpcell.2001.280.6.C1403; Brakch N, 2010, EUR HEART J, V31, P67, DOI 10.1093/eurheartj/ehp387; Burger D, 2006, CARDIOVASC RES, V72, P51, DOI 10.1016/j.cardiores.2006.06.026; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; El Bawab S, 2002, J LIPID RES, V43, P141; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; Halberg N, 2009, DIABETES, V58, P1961, DOI 10.2337/db08-1750; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; He LS, 1997, EXP CELL RES, V232, P64, DOI 10.1006/excr.1997.3494; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hohmeier HE, 2003, INT J OBESITY, V27, pS12, DOI 10.1038/sj.ijo.0802493; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holland WL, 2009, MOL PHARMACOL, V75, P740, DOI 10.1124/mol.109.054817; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Karliner JS, 2009, J CARDIOVASC PHARM, V53, P189, DOI 10.1097/FJC.0b013e3181926706; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; King CC, 2000, J BIOL CHEM, V275, P18108, DOI 10.1074/jbc.M909663199; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Kupchak BR, 2007, BBA-MOL CELL RES, V1773, P1124, DOI 10.1016/j.bbamcr.2007.04.003; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Li ZQ, 2009, J BIOL CHEM, V284, P27010, DOI 10.1074/jbc.M109.042028; Mao CG, 2001, J BIOL CHEM, V276, P26577, DOI 10.1074/jbc.M102818200; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Mukhopadhyay A, 2009, FASEB J, V23, P751, DOI 10.1096/fj.08-120550; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Olivera A, 2007, IMMUNITY, V26, P287, DOI 10.1016/j.immuni.2007.02.008; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Perry DK, 2000, METHOD ENZYMOL, V312, P22; Powell DJ, 2003, MOL CELL BIOL, V23, P7794, DOI 10.1128/MCB.23.21.7794-7808.2003; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schraw T, 2008, ENDOCRINOLOGY, V149, P2270, DOI 10.1210/en.2007-1561; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stein DT, 1997, J CLIN INVEST, V100, P398, DOI 10.1172/JCI119546; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Van Veldhoven PP, 2000, BBA-MOL CELL BIOL L, V1487, P128, DOI 10.1016/S1388-1981(00)00079-2; Villa NY, 2009, MOL PHARMACOL, V75, P866, DOI 10.1124/mol.108.049809; Wang ZV, 2008, DIABETES, V57, P2137, DOI 10.2337/db07-1631; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719	60	631	664	1	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					55	U226		10.1038/nm.2277	http://dx.doi.org/10.1038/nm.2277			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21186369	Green Accepted			2022-12-25	WOS:000285994000036
J	Purdue, MP; Johansson, M; Zelenika, D; Toro, JR; Scelo, G; Moore, LE; Prokhortchouk, E; Wu, XF; Kiemeney, LA; Gaborieau, V; Jacobs, KB; Chow, WH; Zaridze, D; Matveev, V; Lubinski, J; Trubicka, J; Szeszenia-Dabrowska, N; Lissowska, J; Rudnai, P; Fabianova, E; Bucur, A; Bencko, V; Foretova, L; Janout, V; Boffetta, P; Colt, JS; Davis, FG; Schwartz, KL; Banks, RE; Selby, PJ; Harnden, P; Berg, CD; Hsing, AW; Grubb, RL; Boeing, H; Vineis, P; Clavel-Chapelon, F; Palli, D; Tumino, R; Krogh, V; Panico, S; Duell, EJ; Quiros, JR; Sanchez, MJ; Navarro, C; Ardanaz, E; Dorronsoro, M; Khaw, KT; Allen, NE; Bueno-De-Mesquita, HB; Peeters, PHM; Trichopoulos, D; Linseisen, J; Ljungberg, B; Overvad, K; Tjonneland, A; Romieu, I; Riboli, E; Mukeria, A; Shangina, O; Stevens, VL; Thun, MJ; Diver, WR; Gapstur, SM; Pharoah, PD; Easton, DF; Albanes, D; Weinstein, SJ; Virtamo, J; Vatten, L; Hveem, K; Njolstad, I; Tell, GS; Stoltenberg, C; Kumar, R; Koppova, K; Cussenot, O; Benhamou, S; Oosterwijk, E; Vermeulen, SH; Aben, KKH; van der Marel, SL; Ye, YQ; Wood, CG; Pu, X; Mazur, AM; Boulygina, ES; Chekanov, NN; Foglio, M; Lechner, D; Gut, I; Heath, S; Blanche, H; Hutchinson, A; Thomas, G; Wang, ZM; Yeager, M; Fraumeni, JF; Skryabin, KG; McKay, JD; Rothman, N; Chanock, SJ; Lathrop, M; Brennan, P				Purdue, Mark P.; Johansson, Mattias; Zelenika, Diana; Toro, Jorge R.; Scelo, Ghislaine; Moore, Lee E.; Prokhortchouk, Egor; Wu, Xifeng; Kiemeney, Lambertus A.; Gaborieau, Valerie; Jacobs, Kevin B.; Chow, Wong-Ho; Zaridze, David; Matveev, Vsevolod; Lubinski, Jan; Trubicka, Joanna; Szeszenia-Dabrowska, Neonila; Lissowska, Jolanta; Rudnai, Peter; Fabianova, Eleonora; Bucur, Alexandru; Bencko, Vladimir; Foretova, Lenka; Janout, Vladimir; Boffetta, Paolo; Colt, Joanne S.; Davis, Faith G.; Schwartz, Kendra L.; Banks, Rosamonde E.; Selby, Peter J.; Harnden, Patricia; Berg, Christine D.; Hsing, Ann W.; Grubb, Robert L., III; Boeing, Heiner; Vineis, Paolo; Clavel-Chapelon, Francoise; Palli, Domenico; Tumino, Rosario; Krogh, Vittorio; Panico, Salvatore; Duell, Eric J.; Quiros, Jose Ramon; Sanchez, Maria-Jose; Navarro, Carmen; Ardanaz, Eva; Dorronsoro, Miren; Khaw, Kay-Tee; Allen, Naomi E.; Bueno-de-Mesquita, H. Bas; Peeters, Petra H. M.; Trichopoulos, Dimitrios; Linseisen, Jakob; Ljungberg, Borje; Overvad, Kim; Tjonneland, Anne; Romieu, Isabelle; Riboli, Elio; Mukeria, Anush; Shangina, Oxana; Stevens, Victoria L.; Thun, Michael J.; Diver, W. Ryan; Gapstur, Susan M.; Pharoah, Paul D.; Easton, Douglas F.; Albanes, Demetrius; Weinstein, Stephanie J.; Virtamo, Jarmo; Vatten, Lars; Hveem, Kristian; Njolstad, Inger; Tell, Grethe S.; Stoltenberg, Camilla; Kumar, Rajiv; Koppova, Kvetoslava; Cussenot, Olivier; Benhamou, Simone; Oosterwijk, Egbert; Vermeulen, Sita H.; Aben, Katja K. H.; van der Marel, Saskia L.; Ye, Yuanqing; Wood, Christopher G.; Pu, Xia; Mazur, Alexander M.; Boulygina, Eugenia S.; Chekanov, Nikolai N.; Foglio, Mario; Lechner, Doris; Gut, Ivo; Heath, Simon; Blanche, Helene; Hutchinson, Amy; Thomas, Gilles; Wang, Zhaoming; Yeager, Meredith; Fraumeni, Joseph F., Jr.; Skryabin, Konstantin G.; McKay, James D.; Rothman, Nathaniel; Chanock, Stephen J.; Lathrop, Mark; Brennan, Paul			Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3	NATURE GENETICS			English	Article							DENSITY-LIPOPROTEIN HDL; FAMILY-HISTORY; KIDNEY CANCER; RISK; TRANSCRIPTION; EPIDEMIOLOGY; CHOLESTEROL; DISEASE	We conducted a two-stage genome-wide association study of renal cell carcinoma (RCC) in 3,772 affected individuals (cases) and 8,505 controls of European background from 11 studies and followed up 6 SNPs in 3 replication studies of 2,198 cases and 4,918 controls. Two loci on the regions of 2p21 and 11q13.3 were associated with RCC susceptibility below genome-wide significance. Two correlated variants (r(2) = 0.99 in controls), rs11894252 (P = 1.8 x 10(-8)) and rs7579899 (P = 2.3 x 10(-9)), map to EPAS1 on 2p21, which encodes hypoxia-inducible-factor-2 alpha, a transcription factor previously implicated in RCC. The second locus, rs7105934, at 11q13.3, contains no characterized genes (P = 7.8 x 10(-14)). In addition, we observed a promising association on 12q24.31 for rs4765623, which maps to SCARB1, the scavenger receptor class B, member 1 gene (P = 2.6 x 10(-8)). Our study reports previously unidentified genomic regions associated with RCC risk that may lead to new etiological insights.	[Purdue, Mark P.; Toro, Jorge R.; Moore, Lee E.; Jacobs, Kevin B.; Chow, Wong-Ho; Colt, Joanne S.; Hsing, Ann W.; Albanes, Demetrius; Weinstein, Stephanie J.; Hutchinson, Amy; Thomas, Gilles; Wang, Zhaoming; Yeager, Meredith; Fraumeni, Joseph F., Jr.; Rothman, Nathaniel; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Johansson, Mattias; Scelo, Ghislaine; Gaborieau, Valerie; Romieu, Isabelle; McKay, James D.; Brennan, Paul] Int Agcy Res Canc, F-69372 Lyon, France; [Zelenika, Diana; Foglio, Mario; Lechner, Doris; Gut, Ivo; Heath, Simon; Lathrop, Mark] Ctr Natl Genotypage, Inst Genom, CEA, Evry, France; [Prokhortchouk, Egor; Mazur, Alexander M.; Chekanov, Nikolai N.; Skryabin, Konstantin G.] Russian Acad Sci, Ctr Bioengn, Moscow, Russia; [Prokhortchouk, Egor; Mazur, Alexander M.; Boulygina, Eugenia S.; Skryabin, Konstantin G.] Kurchatov Sci Ctr, Moscow, Russia; [Wu, Xifeng; Ye, Yuanqing; Pu, Xia] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Div Canc Prevent & Populat Sci, Houston, TX 77030 USA; [Kiemeney, Lambertus A.; Vermeulen, Sita H.; Aben, Katja K. H.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A.; Oosterwijk, Egbert] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Jacobs, Kevin B.; Hutchinson, Amy; Thomas, Gilles; Wang, Zhaoming; Yeager, Meredith] NCI, Core Genotyping Facil, SAIC Frederick Inc, Frederick, MD 21701 USA; [Zaridze, David; Matveev, Vsevolod; Mukeria, Anush; Shangina, Oxana] Russian NN Blokhin Canc Res Ctr, Moscow, Russia; [Lubinski, Jan; Trubicka, Joanna] Pomeranian Med Univ, Dept Genet & Pathomorphol, Int Hereditary Canc Ctr, Szczecin, Poland; [Szeszenia-Dabrowska, Neonila] Inst Occupat Med, Dept Epidemiol, Lodz, Poland; [Lissowska, Jolanta] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Rudnai, Peter] Natl Inst Environm Hlth, Dept Environm Epidemiol, Budapest, Hungary; [Fabianova, Eleonora] Reg Author Publ Hlth, Banska Bystrica, Slovakia; [Bucur, Alexandru] Inst Publ Hlth, Bucharest, Romania; [Bencko, Vladimir] Charles Univ Prague, Fac Med 1, Inst Hyg & Epidemiol, Prague, Czech Republic; [Foretova, Lenka] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; [Janout, Vladimir] Palacky Univ, CR-77147 Olomouc, Czech Republic; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Davis, Faith G.] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA; [Schwartz, Kendra L.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Schwartz, Kendra L.] Wayne State Univ, Dept Family Med, Detroit, MI USA; [Banks, Rosamonde E.; Selby, Peter J.] St James Univ Hosp, Leeds Inst Mol Med, Canc Res UK Ctr, Leeds, W Yorkshire, England; [Harnden, Patricia] St James Univ Hosp, Dept Pathol, Leeds, W Yorkshire, England; [Berg, Christine D.] NCI, Canc Prevent Div, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Grubb, Robert L., III] Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63110 USA; [Boeing, Heiner] German Inst Human Nutr, Dept Epidemiol, Potsdam, Nuthetal, Germany; [Vineis, Paolo; Peeters, Petra H. M.; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, Ctr Environm & Hlth, MRC HPA, London, England; [Vineis, Paolo] Human Genet Fdn HuGeF, Turin, Italy; [Clavel-Chapelon, Francoise] Inst Gustave Roussy, Ctr Res Epidemiol & Populat Hlth, INSERM, Villejuif, France; [Clavel-Chapelon, Francoise] Paris S Univ, UMRS 1018, Villejuif, France; [Palli, Domenico] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Tumino, Rosario] Azienda Osped Civile MP Arezzo, Canc Registry, Ragusa, Italy; [Krogh, Vittorio] Ist Nazl Tumori, Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Nutr Epidemiol Unit, I-20133 Milan, Italy; [Panico, Salvatore] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; [Duell, Eric J.] Catalan Inst Oncol ICO IDIBELL, Canc Epidemiol Res Program, Unit Nutr Environm & Canc, Barcelona, Spain; [Quiros, Jose Ramon] Consejeria Serv Sociales, Jefe Secc Informac Sanitaria, Oviedo, Spain; [Sanchez, Maria-Jose] Andalusian Sch Publ Hlth, Granada, Spain; [Sanchez, Maria-Jose; Navarro, Carmen; Ardanaz, Eva; Dorronsoro, Miren] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Navarro, Carmen] Reg Council Hlth & Consumer Affairs, Dept Epidemiol, Murcia, Spain; [Ardanaz, Eva] Publ Hlth Inst Navarra, Pamplona, Spain; [Dorronsoro, Miren] Basque Reg Hlth Dept, Publ Hlth Div Gipuzkoa, San Sebastian, Spain; [Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Dept Gerontol, Cambridge, England; [Allen, Naomi E.] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford, England; [Bueno-de-Mesquita, H. Bas] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Peeters, Petra H. M.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Trichopoulos, Dimitrios] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Trichopoulos, Dimitrios] Acad Athens, Bur Epidemiol Res, Athens, Greece; [Linseisen, Jakob] German Canc Res Ctr, Div Canc Epidemiol, D-6900 Heidelberg, Germany; [Linseisen, Jakob] Helmholtz Ctr Munich, Inst Epidemiol, Munich, Germany; [Ljungberg, Borje] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden; [Overvad, Kim; Stevens, Victoria L.; Diver, W. Ryan] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Tjonneland, Anne] Inst Canc Epidemiol, Danish Canc Soc, Copenhagen, Denmark; [Thun, Michael J.; Gapstur, Susan M.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Pharoah, Paul D.; Easton, Douglas F.] Univ Cambridge, Dept Oncol, Cambridge, England; [Pharoah, Paul D.; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Vatten, Lars; Hveem, Kristian] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, N-7034 Trondheim, Norway; [Njolstad, Inger] Univ Tromso, Dept Community Med, Tromso, Norway; [Tell, Grethe S.] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Stoltenberg, Camilla] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany; [Koppova, Kvetoslava] Reg Author Publ Hlth, Dept Environm Hyg, Banska Bystrica, Slovakia; [Cussenot, Olivier] Univ Paris 06, Tenon Hosp, APHP, CeRePP,ER2, Paris, France; [Benhamou, Simone] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, INSERM, U946, Paris, France; [Benhamou, Simone] Inst Gustave Roussy, CNRS, UMR8200, Villejuif, France; [Vermeulen, Sita H.; van der Marel, Saskia L.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Aben, Katja K. H.] Comprehens Canc Ctr E, Dept Canc Registry & Res, Nijmegen, Netherlands; [Wood, Christopher G.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); World Health Organization; International Agency for Research on Cancer (IARC); CEA; UDICE-French Research Universities; Universite Paris Saclay; Research Center of Biotechnology RAS; Russian Academy of Sciences; National Research Centre - Kurchatov Institute; University of Texas System; UTMD Anderson Cancer Center; Radboud University Nijmegen; Radboud University Nijmegen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; N.N. Blokhin Russian Cancer Research Center; Pomeranian Medical University; Nofer Institute of Occupational Medicine; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Regional Authority of Public Health Banska Bystrica; Charles University Prague; Masaryk Memorial Cancer Institute; Palacky University Olomouc; Icahn School of Medicine at Mount Sinai; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Cancer Research UK; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Imperial College London; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Civile M.P. Arezzo Hospital; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Naples Federico II; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Escuela Andaluza de Salud Publica; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Public Health Institute of Navarra; University of Cambridge; University of Oxford; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; Academy of Athens; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Umea University; Aarhus University; Danish Cancer Society; American Cancer Society; University of Cambridge; University of Cambridge; Finland National Institute for Health & Welfare; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; University of Bergen; Norwegian Institute of Public Health (NIPH); Helmholtz Association; German Cancer Research Center (DKFZ); Regional Authority of Public Health Banska Bystrica; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Gustave Roussy; Radboud University Nijmegen; University of Texas System; UTMD Anderson Cancer Center	Chanock, SJ (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, US Dept HHS, Bethesda, MD 20892 USA.	chanocks@mail.nih.gov; brennan@iarc.fr	Janout, Vladimir/M-5133-2014; Foglio, mary A./B-9149-2012; Clavel-Chapelon, Francoise/G-6733-2014; Yeager, Meredith/AAA-5322-2020; Diver, Ryan/AAG-3469-2019; Johansson, Mattias/ABF-3365-2020; Matveev, Vsevolod B/O-7476-2017; Tell, Grethe/G-5639-2015; Hveem, Kristian/AFV-4683-2022; Szeszenia-Dabrowska, Neonila/F-7190-2010; Scelo, Ghislaine/CAF-8077-2022; Krogh, Vittorio/AAA-9171-2019; Bucur, Alexandru/H-3074-2016; Krogh, Vittorio/K-2628-2016; Wang, Zhaoming/R-5527-2018; Weinstein, Stephanie J/P-1627-2017; Vermeulen, Sita H./L-4716-2015; Khaw, Kay-Tee/AAZ-3209-2021; Albanes, Demetrius/B-9749-2015; Vatten, Lars/AFK-2073-2022; Linseisen, Jakob/B-5353-2014; Pu, Xia/H-2670-2012; Berg, Christine/K-1047-2014; Purdue, Mark P/C-9228-2016; Benhamou, Simone/ABD-2590-2020; Gut, Ivo/ABF-3188-2020; Heath, Simon C/J-4138-2012; Trubicka, Joanna/R-1215-2018; Kumar, Rajiv/H-6431-2019; Panico, Salvatore/K-6506-2016; Bencko, Vladimir/H-8598-2017; Prokhortchouk, Egor/I-9108-2014; Benhamou, Simone/K-6554-2015; Aben, Katja KH/G-9686-2016; Pharoah, Paul/V-6658-2019; Njolstad, Inger/X-3784-2019; Zaridze, David/K-5605-2013; Boulygina, Eugenia S./I-8665-2014; Vatten, Lars/AAF-9380-2022; Lissowska, Jolanta/AAH-3252-2020; Boffetta, Paolo/AAI-7767-2021; Sánchez, Maria-José/D-1087-2011; Stoltenberg, Camilla/G-5090-2017; Oosterwijk, Egbert/P-5466-2014; Kiemeney, Lambertus A./D-3357-2009	Foglio, mary A./0000-0001-7715-4452; Diver, Ryan/0000-0002-5418-9000; Matveev, Vsevolod B/0000-0001-7748-9527; Tell, Grethe/0000-0003-1386-1638; Krogh, Vittorio/0000-0003-0122-8624; Krogh, Vittorio/0000-0003-0122-8624; Wang, Zhaoming/0000-0001-7556-3869; Weinstein, Stephanie J/0000-0002-3834-1535; Vermeulen, Sita H./0000-0003-4913-8601; Linseisen, Jakob/0000-0002-9386-382X; Purdue, Mark P/0000-0003-1177-3108; Gut, Ivo/0000-0001-7219-632X; Heath, Simon C/0000-0002-9550-0897; Trubicka, Joanna/0000-0002-9848-3674; Kumar, Rajiv/0000-0002-6093-0395; Panico, Salvatore/0000-0002-5498-8312; Bencko, Vladimir/0000-0003-1935-2228; Aben, Katja KH/0000-0002-0214-2147; Pharoah, Paul/0000-0001-8494-732X; Lissowska, Jolanta/0000-0003-2695-5799; Boffetta, Paolo/0000-0002-3811-2791; Sánchez, Maria-José/0000-0003-4817-0757; Kiemeney, Lambertus A./0000-0002-2368-1326; Tjonneland, Anne/0000-0003-4385-2097; Banks, Rosamonde/0000-0002-0042-8715; cussenot, olivier/0000-0002-9912-0533; tumino, rosario/0000-0003-2666-414X; Foretova, Lenka/0000-0003-0494-2620; Jacobs, Kevin/0000-0002-4657-6473; Navarro, Carmen/0000-0001-8896-7483; Duell, Eric J/0000-0001-5256-0163; Chekanov, Nikolay/0000-0003-1131-3195; PALLI, Domenico/0000-0002-5558-2437; Lubinski, Jan/0000-0003-2931-3003; Riboli, Elio/0000-0001-6795-6080; BENHAMOU, Simone/0000-0001-5853-8047; Overvad, Kim/0000-0001-6429-7921; Ljungberg, Borje/0000-0002-4121-3753; Johansson, Mattias/0000-0002-3116-5081	French Institut National du Cancer (INCa); National Cancer Institute (NCI), US National Institutes of Health (NIH); NATIONAL CANCER INSTITUTE [ZIACP010201] Funding Source: NIH RePORTER; Cancer Research UK [10118, 11022, 11021] Funding Source: researchfish; Medical Research Council [G1000143, G0801056B, G0401527] Funding Source: researchfish; The Francis Crick Institute [10124, 10119] Funding Source: researchfish	French Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); National Cancer Institute (NCI), US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	The authors thank all of the participants who took part in this research and the funders and support staff who made this study possible. Funding for the genome-wide genotyping was provided by the French Institut National du Cancer (INCa) for those studies coordinated by IARC/CNG, and by the intramural research program of the National Cancer Institute (NCI), US National Institutes of Health (NIH) for those studies coordinated by the NCI. Additional acknowledgments can be found in the Supplementary Note.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chanock S, 2009, NAT GENET, V41, P765, DOI 10.1038/ng0709-765; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Ferlay J, 2004, IARC CANC BASE; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gago-Dominguez M, 2001, CANCER EPIDEM BIOMAR, V10, P1001; Gunaratnam L, 2009, J AM SOC NEPHROL, V20, P1877, DOI 10.1681/ASN.2008070804; Higgins JPT, 2003, AM J PATHOL, V162, P925, DOI 10.1016/S0002-9440(10)63887-4; Hung RJ, 2007, CANCER EPIDEM BIOMAR, V16, P1287, DOI 10.1158/1055-9965.EPI-06-0963; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Linehan WM, 2009, CANCER-AM CANCER SOC, V115, P2252, DOI 10.1002/cncr.24230; MCLAUGHLIN JK, 1984, JNCI-J NATL CANCER I, V72, P275; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Peto J, 2001, EUR J CANCER, V37, pS88; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Scelo G, 2007, NAT CLIN PRACT UROL, V4, P205, DOI 10.1038/ncpuro0760; Schlehofer B, 1996, INT J CANCER, V66, P723, DOI 10.1002/(SICI)1097-0215(19960611)66:6<723::AID-IJC2>3.3.CO;2-V; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sowter HM, 2003, CANCER RES, V63, P6130; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Ueda Y, 1999, J BIOL CHEM, V274, P7165, DOI 10.1074/jbc.274.11.7165; Xia GB, 2001, CANCER-AM CANCER SOC, V91, P1429, DOI 10.1002/1097-0142(20010415)91:8<1429::AID-CNCR1149>3.0.CO;2-V; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551; Zimmer M, 2004, MOL CANCER RES, V2, P89	37	190	199	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2011	43	1					60	U83		10.1038/ng.723	http://dx.doi.org/10.1038/ng.723			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	699SQ	21131975	Green Accepted, Green Submitted			2022-12-25	WOS:000285683500017
J	Zhou, L; Li, F; Xu, HB; Luo, CX; Wu, HY; Zhu, MM; Lu, W; Ji, X; Zhou, QG; Zhu, DY				Zhou, Li; Li, Fei; Xu, Hai-Bing; Luo, Chun-Xia; Wu, Hai-Yin; Zhu, Ming-Mei; Lu, Wei; Ji, Xing; Zhou, Qi-Gang; Zhu, Dong-Ya			Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95	NATURE MEDICINE			English	Article							NITRIC-OXIDE SYNTHASE; MICE LACKING; SUBCELLULAR-LOCALIZATION; PROTEIN INTERACTIONS; BRAIN-INJURY; PDZ DOMAIN; NEUROPROTECTION; EXCITOTOXICITY; NEUROTOXICITY; ANTAGONISTS	Stroke is a major public health problem leading to high rates of death and disability in adults(1,2). Excessive stimulation of N-methyl-D-aspartate receptors (NMDARs) and the resulting neuronal nitric oxide synthase (nNOS) activation are crucial for neuronal injury after stroke insult(3-7). However, directly inhibiting NMDARs or nNOS can cause severe side effects because they have key physiological functions in the CNS5,8-12. Here we show that cerebral ischemia induces the interaction of nNOS with postsynaptic density protein-95 (PSD-95). Disrupting nNOS-PSD-95 interaction via overexpressing the N-terminal amino acid residues 1-133 of nNOS (nNOS-N1-133) prevented glutamate-induced excitotoxicity and cerebral ischemic damage. Given the mechanism of nNOS-PSD-95 interaction, we developed a series of compounds and discovered a small-molecular inhibitor of the nNOS-PSD-95 interaction, ZL006. This drug blocked the ischemia-induced nNOS-PSD-95 association selectively, had potent neuroprotective activity in vitro and ameliorated focal cerebral ischemic damage in mice and rats subjected to middle cerebral artery occlusion (MCAO) and reperfusion. Moreover, it readily crossed the blood-brain barrier, did not inhibit NMDAR function, catalytic activity of nNOS or spatial memory, and had no effect on aggressive behaviors. Thus, this new drug may serve as a treatment for stroke, perhaps without major side effects.	[Zhou, Li; Xu, Hai-Bing; Luo, Chun-Xia; Wu, Hai-Yin; Zhu, Ming-Mei; Zhou, Qi-Gang; Zhu, Dong-Ya] Nanjing Med Univ, Sch Pharm, Dept Pharmacol, Nanjing, Peoples R China; [Li, Fei; Ji, Xing] Nanjing Med Univ, Sch Pharm, Dept Med Chem, Nanjing, Peoples R China; [Luo, Chun-Xia; Wu, Hai-Yin; Zhou, Qi-Gang; Zhu, Dong-Ya] Nanjing Med Univ, Lab Cerebrovasc Dis, Nanjing, Peoples R China; [Lu, Wei] Nanjing Med Univ, Dept Neurobiol, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Zhu, DY (corresponding author), Nanjing Med Univ, Sch Pharm, Dept Pharmacol, Nanjing, Peoples R China.	chunxialuo@njmu.edu.cn; dyzhu@njmu.edu.cn			National Natural Science Foundation of China [30971021, 81030023, 30901550]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China ((30971021, 81030023) (D.-Y.Z.) and (30901550) (C.-X. L.)). We thank X. Jin, Q.-P. Li, C.-C. Cao, H.-H. Zhou, W.-X. Sun, D.-L. Wu, Y. Hu and J. Zhang for technical assistance.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Cao J, 2005, J CELL BIOL, V168, P117, DOI 10.1083/jcb.200407024; Cappuccio Jenny A., 2009, V498, P273, DOI 10.1007/978-1-59745-196-3_18; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; Dawson VL, 1996, J NEUROSCI, V16, P2479; Flynn RWV, 2008, NEUROPHARMACOLOGY, V55, P250, DOI 10.1016/j.neuropharm.2008.05.031; Gallego J, 2009, CEREBROVASC DIS, V27, P88, DOI 10.1159/000200445; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; HECKER M, 1994, J NEUROCHEM, V62, P1524; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Kelley JB, 2009, LEARN MEMORY, V16, P371, DOI 10.1101/lm.1329209; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Koroshetz WJ, 1996, TRENDS PHARMACOL SCI, V17, P227, DOI 10.1016/0165-6147(96)10020-1; Lea PM, 2005, BRIT J PHARMACOL, V145, P527, DOI 10.1038/sj.bjp.0706219; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Lipton SA, 2007, NAT REV NEUROSCI, V8, P803, DOI 10.1038/nrn2229; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Moghaddam B, 2003, NEURON, V40, P881, DOI 10.1016/S0896-6273(03)00757-8; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; NELSON RJ, 1995, NATURE, V378, P383, DOI 10.1038/378383a0; Qoronfleh MW, 2003, J BIOMED BIOTECHNOL, P249; Quintana E, 2004, FASEB J, V18, P531, DOI 10.1096/fj.03-0596fje; Rothe F, 1998, NEUROSCIENCE, V83, P259, DOI 10.1016/S0306-4522(97)00373-4; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Smith Paul F, 2003, Curr Opin Investig Drugs, V4, P826; Takagi N, 2000, J NEUROCHEM, V74, P169, DOI 10.1046/j.1471-4159.2000.0740169.x; Tanda K, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-19; Tochio H, 2000, J MOL BIOL, V303, P359, DOI 10.1006/jmbi.2000.4148; Tochio H, 2000, J MOL BIOL, V295, P225, DOI 10.1006/jmbi.1999.3350; Zhou L, 2009, NITRIC OXIDE-BIOL CH, V20, P223, DOI 10.1016/j.niox.2009.03.001	34	276	306	2	166	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2010	16	12					1439	U123		10.1038/nm.2245	http://dx.doi.org/10.1038/nm.2245			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	690ZH	21102461				2022-12-25	WOS:000285048900039
J	Tardat, M; Brustel, J; Kirsh, O; Lefevbre, C; Callanan, M; Sardet, C; Julien, E				Tardat, Mathieu; Brustel, Julien; Kirsh, Olivier; Lefevbre, Christine; Callanan, Mary; Sardet, Claude; Julien, Eric			The histone H4 Lys 20 methyltransferase PR-Set7 regulates replication origins in mammalian cells	NATURE CELL BIOLOGY			English	Article							S-PHASE; METHYLATION; UBIQUITYLATION; REREPLICATION; TRANSCRIPTION; LOCALIZATION; DEGRADATION; INITIATION; REGIONS; PREVENT	The initiation of DNA synthesis is governed by the licensing of replication origins, which consists of assembling a pre-replication complex (pre-RC) on origins during late M- and G1-phases(1,2). In metazoans, functional replication origins do not show defined DNA consensus sequences, thus evoking the involvement of chromatin determinants in the selection of these origins(3). Here, we show that the onset of licensing in mammalian cells coincides with an increase in histone H4 Lys 20 monomethylation (H4K20me1) at replication origins by the methyltransferase PR-Set7 (also known as Set8 or KMT5A). Indeed, tethering PR-Set7 methylase activity to a specific genomic locus promotes the loading of pre-RC proteins on chromatin. In addition, we demonstrate that PR-Set7 undergoes a PCNA- and Cul4-Ddb1-driven degradation during S phase that contributes to the disappearance of H4K20me1 at origins and the inhibition of replication licensing. Strikingly, expression of a PR-Set7 mutant insensitive to this degradation causes the maintenance of H4K20me1 and repeated DNA replication at origins. These results elucidate a critical role for PR-Set7 and H4K20me1 in the chromatin events that regulate replication origins.	[Tardat, Mathieu; Brustel, Julien; Kirsh, Olivier; Sardet, Claude; Julien, Eric] CNRS, IGMM, UMR 5535, Montpellier, France; [Tardat, Mathieu; Brustel, Julien; Kirsh, Olivier; Sardet, Claude; Julien, Eric] Univ Montpellier 2, Montpellier, France; [Tardat, Mathieu; Brustel, Julien; Kirsh, Olivier; Sardet, Claude; Julien, Eric] Univ Montpellier I, Montpellier, France; [Lefevbre, Christine; Callanan, Mary] Inst Albert Bonniot, INSERM, U823, Grenoble, France; [Lefevbre, Christine; Callanan, Mary] Univ Grenoble 1, Grenoble, France; [Lefevbre, Christine; Callanan, Mary] CHU Grenoble, Oncohematol Unit, Dept Hematol Oncogenet & Immunol, F-38043 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Sardet, C (corresponding author), CNRS, IGMM, UMR 5535, Montpellier, France.	claude.sardet@igmm.cnrs.fr; eric.julien@igmm.cnrs.fr	JULIEN, ERIC/Y-5873-2019; mary, CALLANAN/M-5193-2013; Lefebvre, Christine/G-7280-2014	JULIEN, ERIC/0000-0003-2976-666X; mary, CALLANAN/0000-0003-0210-9600; Callanan, Mary/0000-0002-9088-0720; Kirsh, Olivier/0000-0001-6200-5681; Tardat, Mathieu/0000-0001-6689-7373	Ministere de la Recherche; Association de la Recherche contre le Cancer (ARC); Fondation pour la Recherche Medicale (FRM); Agence Nationale de la Recherche (ANR); CNRS; Institut National du Cancer Canceropole Grand Sud-Ouest; ANR [ANR-09-JCJC-0014-01]; INSERM; University Joseph Fourier; Fondation de France	Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Association de la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut National du Cancer Canceropole Grand Sud-Ouest; ANR(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Joseph Fourier; Fondation de France(Fondation de France)	We thank K. Helin, C. S. Sorensen, S. Jorgensen, K. Hansen, M. DePamphilis, D. Tempe and G. Bossis for providing reagents, L. Linares for technical help with ubiquitylation assay, P. Coulombe for technical help with the CsCl gradient centrifugation experiments, and G. Pawlak, E. Fabbrizio, R. Hipskind, and E. Schwob for critical reading of the manuscript. M.T. was supported by a fellowship from Ministere de la Recherche and from Association de la Recherche contre le Cancer (ARC). J.B. was supported by a fellowship from Fondation pour la Recherche Medicale (FRM). O.K. was supported by a fellowship from Agence Nationale de la Recherche (ANR). This work was supported by the institutional support of the CNRS and a grant from the Institut National du Cancer Canceropole Grand Sud-Ouest to C.S. and E.J., by an ANR grant (ANR-09-JCJC-0014-01) to ET, and by institutional grants from INSERM, the University Joseph Fourier, and the Fondation de France to C.L. and M.C.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cadoret JC, 2008, P NATL ACAD SCI USA, V105, P15837, DOI 10.1073/pnas.0805208105; Cayrou C, 2010, CHROMOSOME RES, V18, P137, DOI 10.1007/s10577-009-9105-3; Congdon LM, 2010, J CELL BIOCHEM, V110, P609, DOI 10.1002/jcb.22570; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; FOUNIER A, 2010, EMBO MOL MED, V2, P159; Goren A, 2008, GENE DEV, V22, P1319, DOI 10.1101/gad.468308; Gruber S, 2009, CELL, V137, P685, DOI 10.1016/j.cell.2009.02.035; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Huen MSY, 2008, J BIOL CHEM, V283, P11073, DOI 10.1074/jbc.C700242200; I I, 2006, REGULATION */* HBOL, V26, P1098; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Julien E, 2004, MOL CELL, V14, P713, DOI 10.1016/j.molcel.2004.06.008; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Kakino S, 1996, CYTOMETRY, V24, P49, DOI 10.1002/(SICI)1097-0320(19960501)24:1<49::AID-CYTO6>3.0.CO;2-D; Karnani N, 2010, MOL BIOL CELL, V21, P393, DOI 10.1091/mbc.E09-08-0707; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Lovejoy CA, 2006, MOL CELL BIOL, V26, P7977, DOI 10.1128/MCB.00819-06; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; MIOTTO B, 2010, DNA REPLICATION */*, V57; Miotto B, 2008, GENE DEV, V22, P2633, DOI 10.1101/gad.1674108; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Saha T, 2006, J CELL SCI, V119, P1371, DOI 10.1242/jcs.02851; Stielow B, 2008, EMBO REP, V9, P899, DOI 10.1038/embor.2008.127; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Unnikrishnan A, 2010, NAT STRUCT MOL BIOL, V17, P430, DOI 10.1038/nsmb.1780; Wang BD, 2005, MOL CELL BIOL, V25, P7216, DOI 10.1128/MCB.25.16.7216-7225.2005	39	207	210	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2010	12	11					1086	U82		10.1038/ncb2113	http://dx.doi.org/10.1038/ncb2113			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	674CO	20953199				2022-12-25	WOS:000283711500012
J	Solit, DB; Mellinghoff, IK				Solit, David B.; Mellinghoff, Ingo K.			Tracing cancer networks with phosphoproteomics	NATURE BIOTECHNOLOGY			English	Editorial Material							PATHWAY; ACTIVATION; MTOR		[Solit, David B.; Mellinghoff, Ingo K.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Solit, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	solitd@mskcc.org; mellingi@mskcc.org	Solit, David B./AAC-5309-2019					Andersen JN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001065; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Varmus H, 2006, SCIENCE, V312, P1162, DOI 10.1126/science.1126758; Wallin JJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000630	13	11	13	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2010	28	10					1028	1029		10.1038/nbt1010-1028	http://dx.doi.org/10.1038/nbt1010-1028			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	663GF	20944590				2022-12-25	WOS:000282870500021
J	Thye, T; Vannberg, FO; Wong, SH; Owusu-Dabo, E; Osei, I; Gyapong, J; Sirugo, G; Sisay-Joof, F; Enimil, A; Chinbuah, MA; Floyd, S; Warndorff, DK; Sichali, L; Malema, S; Crampin, AC; Ngwira, B; Teo, YY; Small, K; Rockett, K; Kwiatkowski, D; Fine, PE; Hill, PC; Newport, M; Lienhardt, C; Adegbola, RA; Corrah, T; Ziegler, A; Morris, AP; Meyer, CG; Horstmann, RD; Hill, AVS				Thye, Thorsten; Vannberg, Fredrik O.; Wong, Sunny H.; Owusu-Dabo, Ellis; Osei, Ivy; Gyapong, John; Sirugo, Giorgio; Sisay-Joof, Fatou; Enimil, Anthony; Chinbuah, Margaret A.; Floyd, Sian; Warndorff, David K.; Sichali, Lifted; Malema, Simon; Crampin, Amelia C.; Ngwira, Bagrey; Teo, Yik Y.; Small, Kerrin; Rockett, Kirk; Kwiatkowski, Dominic; Fine, Paul E.; Hill, Philip C.; Newport, Melanie; Lienhardt, Christian; Adegbola, Richard A.; Corrah, Tumani; Ziegler, Andreas; Morris, Andrew P.; Meyer, Christian G.; Horstmann, Rolf D.; Hill, Adrian V. S.		African TB Genetics Consortium; Wellcome Trust Case Control Consor	Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2	NATURE GENETICS			English	Article								We combined two tuberculosis genome-wide association studies from Ghana and The Gambia with subsequent replication in a combined 11,425 individuals. rs4331426, located in a gene-poor region on chromosome 18q11.2, was associated with disease (combined P = 6.8 x 10(-9), odds ratio = 1.19, 95% CI = 1.13-1.27). Our study demonstrates that genome-wide association studies can identify new susceptibility loci for infectious diseases, even in African populations, in which levels of linkage disequilibrium are particularly low.	[Thye, Thorsten; Meyer, Christian G.; Horstmann, Rolf D.] Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany; [Thye, Thorsten; Ziegler, Andreas] Univ Hosp Schleswig Holstein, Inst Med Biometry & Stat, Lubeck, Germany; [Vannberg, Fredrik O.; Wong, Sunny H.; Teo, Yik Y.; Small, Kerrin; Rockett, Kirk; Kwiatkowski, Dominic; Morris, Andrew P.; Hill, Adrian V. S.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Owusu-Dabo, Ellis; Enimil, Anthony] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Owusu-Dabo, Ellis] Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Dept Community Hlth, Kumasi, Ghana; [Osei, Ivy; Gyapong, John; Chinbuah, Margaret A.] Ghana Hlth Serv, Hlth Res Unit, Accra, Ghana; [Sirugo, Giorgio; Sisay-Joof, Fatou; Hill, Philip C.; Newport, Melanie; Lienhardt, Christian; Adegbola, Richard A.; Corrah, Tumani] Med Res Ctr Labs, Banjul, Gambia; [Enimil, Anthony] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Floyd, Sian; Crampin, Amelia C.; Fine, Paul E.] London Sch Hyg & Trop Med, London WC1, England; [Warndorff, David K.; Sichali, Lifted; Malema, Simon; Ngwira, Bagrey; Fine, Paul E.] Karonga Prevent Study, Chilumba, Karonga Dist, Malawi	Bernhard Nocht Institut fur Tropenmedizin; University of Kiel; Schleswig Holstein University Hospital; University of Oxford; Wellcome Centre for Human Genetics; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; Ghana Health Service; Kwame Nkrumah University Science & Technology; University of London; London School of Hygiene & Tropical Medicine; Malawi Epidemiology and Intervention Research Unit	Horstmann, RD (corresponding author), Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany.	horstmann@bnitm.de; adrian.hill@well.ox.ac.uk	Lienhardt, Christian/AAU-4969-2021; Enimil, Anthony/AAV-2595-2021; Wong, Sunny H/N-3754-2015; Sirugo, Giorgio/N-9056-2019; Sirugo, Giorgio/L-1628-2016; Clark, Taane G./AAM-2570-2020; Ziegler, Andreas/G-4246-2012	Lienhardt, Christian/0000-0003-0233-893X; Wong, Sunny H/0000-0002-3354-9310; Clark, Taane G./0000-0001-8985-9265; Ziegler, Andreas/0000-0002-8386-5397; Small, Kerrin/0000-0003-4566-0005; Newport, Melanie/0000-0002-8946-7525; Gyapong, John/0000-0002-8415-1468; Kwiatkowski, Dominic/0000-0002-5023-0176; Crampin, Amelia/0000-0002-1513-4330	Medical Research Council [G0600718B] Funding Source: researchfish; MRC [MC_U190071468, G19/9] Funding Source: UKRI; Medical Research Council [MC_U190071468, G19/9] Funding Source: Medline; Wellcome Trust [079828, 084818, 076438] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		[Anonymous], 2003, Wkly Epidemiol Rec, V78, P122; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fitness J, 2004, AM J TROP MED HYG, V71, P341, DOI 10.4269/ajtmh.2004.71.341; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Lienhardt C, 2002, AM J EPIDEMIOL, V155, P1066, DOI 10.1093/aje/155.11.1066; STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702; Thye T, 2009, HUM MOL GENET, V18, P381, DOI 10.1093/hmg/ddn352; *WHO, 2009, LANCET, V373, P1145; Ziegler A, 2009, GENET EPIDEMIOL, V33, pS45, DOI 10.1002/gepi.20472	13	263	274	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					739	741		10.1038/ng.639	http://dx.doi.org/10.1038/ng.639			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20694014	Green Submitted, Green Accepted			2022-12-25	WOS:000281388400005
J	Baumgartel, V; Ivanchenko, S; Dupont, A; Sergeev, M; Wiseman, PW; Krausslich, HG; Brauchle, C; Muller, B; Lamb, DC				Baumgaertel, Viola; Ivanchenko, Sergey; Dupont, Aurelie; Sergeev, Mikhail; Wiseman, Paul W.; Kraeusslich, Hans-Georg; Braeuchle, Christoph; Mueller, Barbara; Lamb, Don C.			Live-cell visualization of dynamics of HIV budding site interactions with an ESCRT component	NATURE CELL BIOLOGY			English	Article							IMAGE CORRELATION SPECTROSCOPY; AAA-ATPASE VPS4; PROTEINS; BIOGENESIS; DISTRIBUTIONS; MACHINERY; COMPLEXES; MECHANISM	HIV (human immunodeficiency virus) diverts the cellular ESCRT (endosomal sorting complex required for transport) machinery to promote virion release from infected cells. The ESCRT consists of four heteromeric complexes (ESCRT-0 to ESCRT-III), which mediate different membrane abscission processes, most importantly formation of intralumenal vesicles at multivesicular bodies. The ATPase VPS4 (vacuolar protein sorting 4) acts at a late stage of ESCRT function, providing energy for ESCRT dissociation. Recruitment of ESCRT by late-domain motifs in the viral Gag polyprotein and a role of ESCRT in HIV release are firmly established, but the order of events, their kinetics and the mechanism of action of individual ESCRT components in HIV budding are unclear at present. Using live-cell imaging, we show late-domain-dependent recruitment of VPS4A to nascent HIV particles at the host cell plasma membrane. Recruitment of VPS4A was transient, resulting in a single or a few bursts of at least two to five VPS4 dodecamers assembling at HIV budding sites. Bursts lasted for similar to 35?s and appeared with variable delay before particle release. These results indicate that VPS4A has a direct role in membrane scission leading to HIV-1 release.	[Kraeusslich, Hans-Georg; Mueller, Barbara] Univ Klinikum Heidelberg, Dept Infect Dis, D-69120 Heidelberg, Germany; [Baumgaertel, Viola; Ivanchenko, Sergey; Dupont, Aurelie; Braeuchle, Christoph; Lamb, Don C.] Univ Munich, Dept Chem & Biochem, Munich Ctr Integrated Prot Sci CiPSM, D-81377 Munich, Germany; [Baumgaertel, Viola; Ivanchenko, Sergey; Dupont, Aurelie; Braeuchle, Christoph; Lamb, Don C.] Univ Munich, Ctr NanoSci, D-81377 Munich, Germany; [Sergeev, Mikhail; Wiseman, Paul W.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada	Ruprecht Karls University Heidelberg; University of Munich; University of Munich; McGill University	Muller, B (corresponding author), Univ Klinikum Heidelberg, Dept Infect Dis, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	Barbara.mueller@med.uni-heidelberg.de; Don.Lamb@cup.uni-muenchen.de	Lamb, Don C/G-9501-2014; Muller, Barbara/AAC-4483-2020	Lamb, Don C/0000-0002-0232-1903; Muller, Barbara/0000-0001-5726-5585; Sergeev, Mikhail/0000-0001-7047-2378	DFG [SPP1175, SFB638, MU885/4-2]; German Excellence Initiative through 'Nanosystems Initiative Munich (NIM)'; Ludwig-Maximilians-University Munich (LMUInnovativ BioImaging Network); EU [HEALTH-F3-2008-201095]; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research	DFG(German Research Foundation (DFG)); German Excellence Initiative through 'Nanosystems Initiative Munich (NIM)'; Ludwig-Maximilians-University Munich (LMUInnovativ BioImaging Network); EU(European Commission); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank W. Sundquist (University of Utah, Salt Lake City) and R. Tsien (University of California, San Diego) for plasmids. We appreciate the assistance of M. Franke, M. Anders-Osswein, A. M. Heuser, W. Schrimpf, D. Schupp and M. Eckhardt and tracking support from M. Preiner, F. Kohler and S. A. Rahman. We thank J. Hurley for helpful comments, A. Godin for Matlab masking algorithms and W. Godinez, J. P. Bergeestand, K. Rohr for support with the single-particle tracking algorithm. We gratefully acknowledge financial support of the DFG through SPP1175 (D.C.L., C.B., H-G.K.), SFB638 (H-G.K.) and grant MU885/4-2 (B.M.), the German Excellence Initiative through 'Nanosystems Initiative Munich (NIM)' (D.C.L., C.B.) and 'CellNetworks' (H-G. K.), the Ludwig-Maximilians-University Munich (LMUInnovativ BioImaging Network, D.C.L., C.B.), the EU (HIV-ACE network HEALTH-F3-2008-201095; B.M., H-G.K.), the Natural Sciences and Engineering Research Council of Canada (P.W.W.) and the Canadian Institutes of Health Research (P.W.W.).	Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Carlton JG, 2009, BIOCHEM SOC T, V37, P195, DOI 10.1042/BST0370195; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Fujita H, 2004, J CELL SCI, V117, P2997, DOI 10.1242/jcs.01170; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Godinez WJ, 2009, MED IMAGE ANAL, V13, P325, DOI 10.1016/j.media.2008.12.004; Gonciarz MD, 2008, J MOL BIOL, V384, P878, DOI 10.1016/j.jmb.2008.09.066; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hanson PI, 2009, CURR OPIN CELL BIOL, V21, P568, DOI 10.1016/j.ceb.2009.06.002; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Ivanchenko S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000652; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Lampe M, 2007, VIROLOGY, V360, P92, DOI 10.1016/j.virol.2006.10.005; Landsberg MJ, 2009, STRUCTURE, V17, P427, DOI 10.1016/j.str.2008.12.020; Lange S, 2008, TRAFFIC, V9, P1256, DOI 10.1111/j.1600-0854.2008.00763.x; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; PETERSEN NO, 1993, BIOPHYS J, V65, P1135, DOI 10.1016/S0006-3495(93)81173-1; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Scheuring S, 2001, J MOL BIOL, V312, P469, DOI 10.1006/jmbi.2001.4917; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Sergeev M, 2006, BIOPHYS J, V91, P3884, DOI 10.1529/biophysj.106.091181; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Ward DMV, 2005, J BIOL CHEM, V280, P10548, DOI 10.1074/jbc.M413734200; Wiseman PW, 1999, BIOPHYS J, V76, P963, DOI 10.1016/S0006-3495(99)77260-7; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, J CELL SCI, V122, P2163, DOI 10.1242/jcs.029884; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yang D, 2010, STRUCTURE, V18, P976, DOI 10.1016/j.str.2010.04.014; Yu ZH, 2008, J MOL BIOL, V377, P364, DOI 10.1016/j.jmb.2008.01.009	38	141	141	1	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2011	13	4					469	U277		10.1038/ncb2215	http://dx.doi.org/10.1038/ncb2215			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	744CK	21394086				2022-12-25	WOS:000289070900019
J	Luxenburg, C; Pasolli, HA; Williams, SE; Fuchs, E				Luxenburg, Chen; Pasolli, H. Amalia; Williams, Scott E.; Fuchs, Elaine			Developmental roles for Srf, cortical cytoskeleton and cell shape in epidermal spindle orientation	NATURE CELL BIOLOGY			English	Article							SERUM RESPONSE FACTOR; STEM-CELLS; PLANAR DIVISIONS; PAR PROTEINS; ACTIN; POLARITY; DIFFERENTIATION; H2-CALPONIN; EXPRESSION; MYOSIN	During development, a polarized epidermal sheet undergoes stratification and differentiation to produce the skin barrier. Through mechanisms that are poorly understood, the process involves actin dynamics, spindle reorientation and Notch signalling. To elucidate how epidermal embryogenesis is governed, we conditionally targeted serum response factor (Sri), a transcription factor that is essential for epidermal differentiation. Unexpectedly, previously ascribed causative defects are not responsible for profoundly perturbed embryonic epidermis. Seeking the mechanism for this, we identified actins and their regulators that were downregulated after ablation. Without Sri, cells exhibit a diminished cortical network and in mitosis, they fail to round up, features we recapitulate with low-dose actin inhibitors in vivo and shRNA-knockdown in vitro. Altered concomitantly are phosphorylated ERM and cortical myosin-IIA, shown in vitro to establish a rigid cortical actomyosin network and elicit critical shape changes. We provide a link between these features and Sri loss, and we show that the process is physiologically relevant in skin, as reflected by defects in spindle orientation, asymmetric cell divisions, stratification and differentiation.	[Luxenburg, Chen; Pasolli, H. Amalia; Williams, Scott E.; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Williams, Scott/0000-0001-9975-7334; Pasolli, Hilda Amalia/0000-0003-3899-3530	National Institutes of Health [R01AR27883]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883, R37AR027883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the RU Facilities for Bioimaging (A. North) and FACS (S. Mazes) staff for their technical support; we thank N. Stokes for her assistance in the mouse facility and the Comparative Biology Center (CBC) staff for their help in veterinary care and health of our mice. We are grateful to E. Ezratty, S. Beronja, A. R. Folgueras, M. Nikolova and other members of the Fuchs laboratory for helpful discussions, critical reading of the manuscript and experimental assistance. C.L. is a Tri-Institutional Starr Stem Cell Scholars Posdoctoral Fellow. saw. is an American Cancer Society Postdoctoral Fellow. Work in the Fuchs laboratory was supported by a grant from the National Institutes of Health (E.F. R01AR27883).	Alberti S, 2005, P NATL ACAD SCI USA, V102, P6148, DOI 10.1073/pnas.0501191102; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Cabernard C, 2010, NATURE, V467, P91, DOI 10.1038/nature09334; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Chai J, 2002, J PHYSIOL PHARMACOL, V53, P147; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; Coulombe PA, 2009, J CLIN INVEST, V119, P1784, DOI 10.1172/JCI38177; Cramer LP, 1997, MOL BIOL CELL, V8, P109, DOI 10.1091/mbc.8.1.109; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Demehri S, 2009, DEVELOPMENT, V136, P891, DOI 10.1242/dev.030700; Effler JC, 2006, CURR BIOL, V16, P1962, DOI 10.1016/j.cub.2006.08.027; Fang Min, 2007, Genomic Med, V1, P75, DOI 10.1007/s11568-007-9010-9; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Franco CA, 2008, DEV CELL, V15, P448, DOI 10.1016/j.devcel.2008.07.019; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; Fujibuchi T, 2005, BIOCHEM BIOPH RES CO, V327, P268, DOI 10.1016/j.bbrc.2004.11.156; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Hossain MM, 2006, BIOCHEMISTRY-US, V45, P15670, DOI 10.1021/bi061718f; Hossain MM, 2005, J BIOL CHEM, V280, P42442, DOI 10.1074/jbc.M509952200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang QQ, 2008, J BIOL CHEM, V283, P25887, DOI 10.1074/jbc.M801163200; Kaji N, 2008, J BIOL CHEM, V283, P4983, DOI 10.1074/jbc.M708644200; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Koegel H, 2009, J CLIN INVEST, V119, P899, DOI 10.1172/JCI37771; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kubosaki A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r41; Kumbrink J, 2010, J CELL BIOCHEM, V111, P207, DOI 10.1002/jcb.22690; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Larson SM, 2010, MOL BIOL CELL, V21, P3182, DOI 10.1091/mbc.E10-01-0066; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Ou GS, 2010, SCIENCE, V330, P677, DOI 10.1126/science.1196112; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Severson AF, 2003, J CELL BIOL, V161, P21, DOI 10.1083/jcb.200210171; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2008, HFSP J, V2, P65, DOI 10.2976/1.2895661; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Thyss R, 2005, EMBO J, V24, P128, DOI 10.1038/sj.emboj.7600501; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; Verdoni AM, 2010, MAMM GENOME, V21, P64, DOI 10.1007/s00335-009-9245-y; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021	63	123	123	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2011	13	3					203	U51		10.1038/ncb2163	http://dx.doi.org/10.1038/ncb2163			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	728BB	21336301	Green Accepted			2022-12-25	WOS:000287847600008
J	Wu, H; Pomeroy, SL; Ferreira, M; Teider, N; Mariani, J; Nakayama, KI; Hatakeyama, S; Tron, VA; Saltibus, LF; Spyracopoulos, L; Leng, RP				Wu, Hong; Pomeroy, Scott L.; Ferreira, Manuel; Teider, Natalia; Mariani, Juliana; Nakayama, Keiichi I.; Hatakeyama, Shigetsugu; Tron, Victor A.; Saltibus, Linda F.; Spyracopoulos, Leo; Leng, Roger P.			UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53	NATURE MEDICINE			English	Article							EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; NEGATIVE REGULATOR; UBIQUITIN; LIGASE; MDM2; MUTATIONS; GENE; POLYUBIQUITINATION; MEDULLOBLASTOMA	The TP53 gene (encoding the p53 tumor suppressor) is rarely mutated, although frequently inactivated, in medulloblastoma and ependymoma. Recent work in mouse models showed that the loss of p53 accelerated the development of medulloblastoma. The mechanism underlying p53 inactivation in human brain tumors is not completely understood. We show that ubiquitination factor E4B (UBE4B), an E3 and E4 ubiquitin ligase, physically interacts with p53 and Hdm2 (also known as Mdm2 in mice). UBE4B promotes p53 polyubiquitination and degradation and inhibits p53-dependent transactivation and apoptosis. Notably, silencing UBE4B expression impairs xenotransplanted tumor growth in a p53-dependent manner and overexpression of UBE4B correlates with decreased expression of p53 in these tumors. We also show that UBE4B overexpression is often associated with amplification of its gene in human brain tumors. Our data indicate that amplification and overexpression of UBE4B represent previously undescribed molecular mechanisms of inactivation of p53 in brain tumors.	[Wu, Hong; Leng, Roger P.] Univ Alberta, Heritage Med Res Ctr, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Pomeroy, Scott L.; Teider, Natalia; Mariani, Juliana] Harvard Univ, Sch Med, Dept Neurol, Childrens Hosp Boston, Boston, MA 02115 USA; [Ferreira, Manuel] Harvard Univ, Dept Neurosurg, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 812, Japan; [Hatakeyama, Shigetsugu] Hokkaido Univ, Dept Mol Biochem, Grad Sch Med, Kita Ku, Sapporo, Hokkaido, Japan; [Tron, Victor A.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Saltibus, Linda F.; Spyracopoulos, Leo] Univ Alberta, Dept Biochem, Edmonton, AB, Canada	University of Alberta; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Kyushu University; Hokkaido University; McMaster University; Queens University - Canada; University of Alberta	Leng, RP (corresponding author), Univ Alberta, Heritage Med Res Ctr, Dept Lab Med & Pathol, Edmonton, AB, Canada.	rleng@ualberta.ca	Hatakeyama, Shigetsugu/C-8333-2012	Hatakeyama, Shigetsugu/0000-0002-2150-9979; Leng, Roger/0000-0001-9652-4703	Alberta Heritage Foundation for Medical Research; Canadian Institutes of Health Research; US National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA109467] Funding Source: NIH RePORTER	Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge W. Gu (Columbia University) for the His-ubiquitin (wild-type) and His-Ub-ko plasmids, A.G. Jochemsen (Erasmus University Medical Center) for the Myc-Mdm2 plasmid, C. Blattner (Universitat Heidelberg) for pSuper.neo.gpf-Mdm2 siRNA plasmid, J.A. Mahoney (Johns Hopkins University) for pEF-DEST51-Flag-UBE4B plasmid, B. Vogelstein (Johns Hopkins University) for HCT116 TP53<SUP>-/-</SUP> cells, S. Benchimol (York University) for BJT and BJT/DD cell lines and G. Lozano (University of Texas, M. D. Anderson Cancer Center) for Mdm2<SUP>-/-</SUP> Trp53<SUP>-/-</SUP> MEFs as described in the text. We thank T. Turner for technical help in making the figures. This work was supported by grants from the Alberta Heritage Foundation for Medical Research and Canadian Institutes of Health Research (to R.P.L.) and from the US National Institutes of Health (to S.L.P.). R.P.L. is an Alberta Heritage Foundation for Medical Research scholar.	ADESINA AM, 1994, CANCER RES, V54, P5649; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Crawford JR, 2007, LANCET NEUROL, V6, P1073, DOI 10.1016/S1474-4422(07)70289-2; CROOK T, 1992, EMBO J, V11, P3935, DOI 10.1002/j.1460-2075.1992.tb05487.x; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; FARRELL PJ, 1991, EMBO J, V10, P2879, DOI 10.1002/j.1460-2075.1991.tb07837.x; FINLAY CA, 1993, MOL CELL BIOL, V13, P301, DOI 10.1128/MCB.13.1.301; Gaspar N, 2006, PEDIATR BLOOD CANCER, V46, P604, DOI 10.1002/pbc.20532; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hosoda M, 2005, ONCOGENE, V24, P7156, DOI 10.1038/sj.onc.1208872; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kaneko-Oshikawa C, 2005, MOL CELL BIOL, V25, P10953, DOI 10.1128/MCB.25.24.10953-10964.2005; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; LUNA RMD, 1995, NATURE, V378, P203; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; McCurrach ME, 1997, P NATL ACAD SCI USA, V94, P2345, DOI 10.1073/pnas.94.6.2345; Okumura F, 2004, J BIOL CHEM, V279, P53533, DOI 10.1074/jbc.M402916200; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; SAYLORS RL, 1991, CANCER RES, V51, P4721; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sheng Y, 2008, NAT STRUCT MOL BIOL, V15, P1334, DOI 10.1038/nsmb.1521; Shi DD, 2009, P NATL ACAD SCI USA, V106, P16275, DOI 10.1073/pnas.0904305106; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tu D, 2007, P NATL ACAD SCI USA, V104, P15599, DOI 10.1073/pnas.0701369104; Uziel T, 2005, GENE DEV, V19, P2656, DOI 10.1101/gad.1368605; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Waldman T, 1997, NAT MED, V3, P1034, DOI 10.1038/nm0997-1034	42	78	86	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2011	17	3					347	U150		10.1038/nm.2283	http://dx.doi.org/10.1038/nm.2283			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	730XF	21317885				2022-12-25	WOS:000288070000046
J	Tang, WQ; Yuan, M; Wang, RJ; Yang, YH; Wang, CM; Oses-Prieto, JA; Kim, TW; Zhou, HW; Deng, ZP; Gampala, SS; Gendron, JM; Jonassen, EM; Lillo, C; DeLong, A; Burlingame, AL; Sun, Y; Wang, ZY				Tang, Wenqiang; Yuan, Min; Wang, Ruiju; Yang, Yihong; Wang, Chunming; Oses-Prieto, Juan A.; Kim, Tae-Wuk; Zhou, Hong-Wei; Deng, Zhiping; Gampala, Srinivas S.; Gendron, Joshua M.; Jonassen, Else M.; Lillo, Cathrine; DeLong, Alison; Burlingame, Alma L.; Sun, Ying; Wang, Zhi-Yong			PP2A activates brassinosteroid-responsive gene expression and plant growth by dephosphorylating BZR1	NATURE CELL BIOLOGY			English	Article							PROTEIN PHOSPHATASE 2A; RECEPTOR KINASE BRI1; SIGNAL-TRANSDUCTION; BETA-CATENIN; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; REGULATORY SUBUNIT; PLASMA-MEMBRANE; MECHANISMS; MODULATE	When brassinosteroid levels are low, the GSK3-like kinase BIN2 phosphorylates and in activates the BZR1 transcription factor to inhibit growth in plants. Brassinosteroid promotes growth by inducing dephosphorylation of BZR1, but the phosphatase that dephosphorylates BZR1 has remained unknown. Here, using tandem affinity purification, we identified protein phosphatase 2A (PP2A) as a BZR1-interacting protein. Genetic analyses demonstrated a positive role for PP2A in brassinosteroid signalling an BZR1 dephosphorylation. Members of the B' regulatory subunits of PP2A directly interact with BZR1's putative PEST domain containing the site of the bzr1-1D mutation. Interaction with and dephosphorylation by PP2A are enhanced by the bzr1-1D mutation, reduced by two intragenic bzr1-1D suppress or mutations, and abolished by deletion of the PEST domain. This study reveals a crucial function for PP2A in dephosphorylating and activating BZR1 and completes the set of core components of the brassinosteroid-signalling cascade from cell surface receptor kinase to gene regulation in the nucleus.	[Tang, Wenqiang; Yuan, Min; Yang, Yihong; Wang, Chunming; Sun, Ying] Hebei Normal Univ, Coll Life Sci, Inst Mol Cell Biol, Shijiazhuang 050016, Hebei, Peoples R China; [Tang, Wenqiang; Yuan, Min; Wang, Ruiju; Kim, Tae-Wuk; Deng, Zhiping; Gampala, Srinivas S.; Gendron, Joshua M.; Sun, Ying; Wang, Zhi-Yong] Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA; [Wang, Ruiju] Nankai Univ, Inst Mol Biol, Coll Life Sci, Tianjin 300071, Peoples R China; [Oses-Prieto, Juan A.; Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Zhou, Hong-Wei; DeLong, Alison] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Jonassen, Else M.; Lillo, Cathrine] Univ Stavanger, Ctr Organelle Res, N-4036 Stavanger, Norway	Hebei Normal University; Carnegie Institution for Science; Nankai University; University of California System; University of California San Francisco; Brown University; Universitetet i Stavanger	Sun, Y (corresponding author), Hebei Normal Univ, Coll Life Sci, Inst Mol Cell Biol, Shijiazhuang 050016, Hebei, Peoples R China.	yingsun@mail.hebtu.edu.cn; zywang24@stanford.edu	Wang, Zhi-Yong/E-3810-2012	Wang, Zhi-Yong/0000-0003-4602-3390; Deng, zhiping/0000-0001-9663-3088; Oses-Prieto, Juan/0000-0003-4759-2341; Tang, Wenqiang/0000-0002-2972-5748; Lillo, Cathrine/0000-0002-8470-8983	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy [DE-FG02-08ER15973]; NIH [R01GM066258]; National Science Foundation of China [30870213, 90917008]; NSF [IOS-0724688, IOS-0846282]; Herman Frasch Foundation; China Scholarship Council; Division Of Integrative Organismal Systems [0846282] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614, S10RR019934, S10RR012961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066258] Funding Source: NIH RePORTER	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSF(National Science Foundation (NSF)); Herman Frasch Foundation; China Scholarship Council(China Scholarship Council); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was financially supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy through Grant DE-FG02-08ER15973, and by NIH (R01GM066258), National Science Foundation of China (30870213, 90917008), NSF (IOS-0724688 and IOS-0846282), and the Herman Frasch Foundation. R.W and M.Y. were supported by the China Scholarship Council. The UCSF Mass Spectrometry Facility (A.L.B., Director) is supported by the Biomedical Research Technology Program of the National Centre for Research Resources, NIH NCRR RR01614, RR012961 and RR019934.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bai MY, 2007, P NATL ACAD SCI USA, V104, P13839, DOI 10.1073/pnas.0706386104; Blakeslee JJ, 2008, PLANT PHYSIOL, V146, P539, DOI 10.1104/pp.107.112995; Clouse SD, 2002, VITAM HORM, V65, P195, DOI 10.1016/S0083-6729(02)65065-4; De Rybel B, 2009, CHEM BIOL, V16, P594, DOI 10.1016/j.chembiol.2009.04.008; Farkas I, 2007, TRENDS PLANT SCI, V12, P169, DOI 10.1016/j.tplants.2007.03.003; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Gendron JM, 2007, CURR OPIN PLANT BIOL, V10, P436, DOI 10.1016/j.pbi.2007.08.015; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; IANG W, 2010, CURR OPIN PLANT BIOL, V23, P27; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Mora-Garcia S, 2004, GENE DEV, V18, P448, DOI 10.1101/gad.1174204; Muday GK, 2006, PLANT PHYSIOL, V141, P1617, DOI 10.1104/pp.106.083212; Mumby M, 2007, ACS CHEM BIOL, V2, P99, DOI 10.1021/cb700021z; Rashotte AM, 2001, PLANT CELL, V13, P1683, DOI 10.1105/tpc.13.7.1683; Ryu H, 2007, PLANT CELL, V19, P2749, DOI 10.1105/tpc.107.053728; Ryu H, 2010, MOL CELLS, V29, P291, DOI 10.1007/s10059-010-0034-y; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023; Sun Y, 2010, DEV CELL, V19, P765, DOI 10.1016/j.devcel.2010.10.010; Tang WQ, 2008, SCIENCE, V321, P557, DOI 10.1126/science.1156973; Tang WQ, 2008, MOL CELL PROTEOMICS, V7, P728, DOI 10.1074/mcp.M700358-MCP200; Terol J, 2002, PLANT PHYSIOL, V129, P808, DOI 10.1104/pp.020004; Thummel CS, 2002, GENE DEV, V16, P3113, DOI 10.1101/gad.1042102; Tseng TS, 2010, PLANT CELL, V22, P392, DOI 10.1105/tpc.109.066423; Vert G, 2006, NATURE, V441, P96, DOI 10.1038/nature04681; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang XY, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2938732; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; Zhang W, 2009, J BIOL CHEM, V284, P22649, DOI 10.1074/jbc.M109.013698	40	306	340	12	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2011	13	2					124	U49		10.1038/ncb2151	http://dx.doi.org/10.1038/ncb2151			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714JM	21258370	Green Submitted, Green Accepted			2022-12-25	WOS:000286805900006
J	Hidalgo-Carcedo, C; Hooper, S; Chaudhry, SI; Williamson, P; Harrington, K; Leitinger, B; Sahai, E				Hidalgo-Carcedo, Cristina; Hooper, Steven; Chaudhry, Shahid I.; Williamson, Peter; Harrington, Kevin; Leitinger, Birgit; Sahai, Erik			Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6	NATURE CELL BIOLOGY			English	Article							TIGHT JUNCTION; COLLAGEN-BINDING; CARCINOMA-CELLS; MORPHOGENESIS; ACTIVATION; PROTEIN; CANCER; TUMOR; IDENTIFICATION; EXPRESSION	Collective cell migration occurs in a range of contexts: cancer cells frequently invade in cohorts while retaining cell-cell junctions. Here we show that collective invasion by cancer cells depends on decreasing actomyosin contractility at sites of cell-cell contact. When actomyosin is not downregulated at cell-cell contacts, migrating cells lose cohesion. We provide a molecular mechanism for this downregulation. Depletion of discoidin domain receptor 1 (DDR1) blocks collective cancer-cell invasion in a range of two-dimensional, three-dimensional and 'organotypic' models. DDR1 coordinates the Par3/Par6 cell-polarity complex through its carboxy terminus, binding PDZ domains in Par3 and Par6. The DDR1-Par3/Par6 complex controls the localization of RhoE to cell-cell contacts, where it antagonizes ROCK-driven actomyosin contractility. Depletion of DDR1, Par3, Par6 or RhoE leads to increased actomyosin contactility at cell-cell contacts, a loss of cell-cell cohesion and defective collective cell invasion.	[Hidalgo-Carcedo, Cristina; Hooper, Steven; Chaudhry, Shahid I.; Sahai, Erik] Canc Res UK London Res Inst, Tumour Cell Biol Lab, London WC2A 3PX, England; [Williamson, Peter] Univ London St Georges Hosp, London SW17 0QT, England; [Harrington, Kevin] Inst Canc Res, London SW3 6JB, England; [Leitinger, Birgit] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England	Cancer Research UK; St Georges University London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Imperial College London	Sahai, E (corresponding author), Canc Res UK London Res Inst, Tumour Cell Biol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	erik.sahai@cancer.org.uk	Hidalgo-Carcedo, Cristina/K-8876-2017; hidalgo carcedo, cristina/M-6908-2015	Hidalgo-Carcedo, Cristina/0000-0003-3571-2449; hidalgo carcedo, cristina/0000-0003-3571-2449; Sahai, Erik/0000-0002-3932-5086; Harrington, Kevin/0000-0002-6014-348X	Cancer Research UK; EMBO	Cancer Research UK(Cancer Research UK); EMBO(European Molecular Biology Organization (EMBO))	We thank Cancer Research UK and EMBO for funding and B. Thompson, N. Tapon and lab members for comments and discussion. We also thank the Experimental Pathology lab for technical help.	Abdulhussein R, 2004, J BIOL CHEM, V279, P31462, DOI 10.1074/jbc.M400651200; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Croft DR, 2004, CANCER RES, V64, P8994, DOI 10.1158/0008-5472.CAN-04-2052; Danjo Y, 1998, J CELL SCI, V111, P3323; DICOSTANZO D, 1990, AM J SURG PATHOL, V14, P12, DOI 10.1097/00000478-199001000-00002; Dow LE, 2007, ONCOGENE, V26, P2272, DOI 10.1038/sj.onc.1210016; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Foster R, 1996, MOL CELL BIOL, V16, P2689; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gardiol D, 2006, INT J CANCER, V119, P1285, DOI 10.1002/ijc.21982; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hooper S, 2010, BRIT J CANCER, V102, P392, DOI 10.1038/sj.bjc.6605469; Huang Y, 2009, J CELL SCI, V122, P1637, DOI 10.1242/jcs.046219; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; JOHNSON JD, 1993, P NATL ACAD SCI USA, V90, P5677, DOI 10.1073/pnas.90.12.5677; Kuphal S, 2006, ONCOGENE, V25, P103, DOI 10.1038/sj.onc.1209008; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; Nakayama M, 2008, DEV CELL, V14, P205, DOI 10.1016/j.devcel.2007.11.021; Osmani N, 2006, CURR BIOL, V16, P2395, DOI 10.1016/j.cub.2006.10.026; Peacock JG, 2007, MOL BIOL CELL, V18, P3860, DOI 10.1091/mbc.E07-01-0075; Pinheiro EM, 2004, DEVELOPMENT, V131, P5243, DOI 10.1242/dev.01412; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Riento K, 2005, BIOCHEM SOC T, V33, P649, DOI 10.1042/BST0330649; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Schimanski CC, 2005, ONCOGENE, V24, P3100, DOI 10.1038/sj.onc.1208520; Schmoranzer J, 2009, CURR BIOL, V19, P1065, DOI 10.1016/j.cub.2009.05.065; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shimada K, 2008, CANCER SCI, V99, P39, DOI 10.1111/j.1349-7006.2007.00655.x; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Simoes SD, 2010, DEV CELL, V19, P377, DOI 10.1016/j.devcel.2010.08.011; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Vogel W, 2000, J BIOL CHEM, V275, P5779, DOI 10.1074/jbc.275.8.5779; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wang CZ, 2009, AM J PHYSIOL-CELL PH, V297, pC419, DOI 10.1152/ajpcell.00101.2009; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wood W, 2002, NAT CELL BIOL, V4, P907, DOI 10.1038/ncb875; YAMAMOTO E, 1983, CANCER, V51, P2175, DOI 10.1002/1097-0142(19830615)51:12<2175::AID-CNCR2820511205>3.0.CO;2-M; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020; Zhang JK, 2005, J CELL SCI, V118, P5549, DOI 10.1242/jcs.02639	53	249	255	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2011	13	1					49	U123		10.1038/ncb2133	http://dx.doi.org/10.1038/ncb2133			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697GV	21170030	Green Accepted			2022-12-25	WOS:000285502200010
J	Li, PH; Ponnala, L; Gandotra, N; Wang, L; Si, YQ; Tausta, SL; Kebrom, TH; Provart, N; Patel, R; Myers, CR; Reidel, EJ; Turgeon, R; Liu, P; Sun, Q; Nelson, T; Brutnell, TP				Li, Pinghua; Ponnala, Lalit; Gandotra, Neeru; Wang, Lin; Si, Yaqing; Tausta, S. Lori; Kebrom, Tesfamichael H.; Provart, Nicholas; Patel, Rohan; Myers, Christopher R.; Reidel, Edwin J.; Turgeon, Robert; Liu, Peng; Sun, Qi; Nelson, Timothy; Brutnell, Thomas P.			The developmental dynamics of the maize leaf transcriptome	NATURE GENETICS			English	Article							BUNDLE-SHEATH; GENE-EXPRESSION; METABOLIC PATHWAYS; DIFFERENTIATION; MESOPHYLL; PHOTOSYNTHESIS; INTEGRATION; PLASTIDS; SHOOT; TOOL	We have analyzed the maize leaf transcriptome using illumina sequencing. We mapped more than 120 million reads to define gene structure and alternative splicing events and to quantify transcript abundance along a leaf developmental gradient and in mature bundle sheath and mesophyll cells. We detected differential mRNA processing events for most maize genes. We found that 64% and 21% of genes were differentially expressed along the developmental gradient and between bundle sheath and mesophyll cells, respectively. We implemented Gbrowse, an electronic fluorescent pictograph browser, and created a two-cell biochemical pathway viewer to visualize datasets. Cluster analysis of the data revealed a dynamic transcriptome, with transcripts for primary cell wall and basic cellular metabolism at the leaf base transitioning to transcripts for secondary cell wall biosynthesis and C-4 photosynthetic development toward the tip. This dataset will serve as the foundation for a systems biology approach to the understanding of photosynthetic development.	[Li, Pinghua; Wang, Lin; Kebrom, Tesfamichael H.; Brutnell, Thomas P.] Cornell Univ, Boyce Thompson Inst, Ithaca, NY 14850 USA; [Ponnala, Lalit; Myers, Christopher R.; Sun, Qi] Cornell Univ, Computat Biol Serv Unit, Ithaca, NY USA; [Gandotra, Neeru; Tausta, S. Lori; Nelson, Timothy] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Si, Yaqing; Liu, Peng] Iowa State Univ, Dept Stat, Ames, IA USA; [Si, Yaqing; Liu, Peng] Iowa State Univ, Stat Lab, Ames, IA USA; [Provart, Nicholas; Patel, Rohan] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Provart, Nicholas; Patel, Rohan] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada; [Reidel, Edwin J.; Turgeon, Robert; Brutnell, Thomas P.] Cornell Univ, Dept Plant Biol, Ithaca, NY USA	Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; Yale University; Iowa State University; Iowa State University; University of Toronto; University of Toronto; Cornell University	Brutnell, TP (corresponding author), Cornell Univ, Boyce Thompson Inst, Ithaca, NY 14850 USA.	tpb8@cornell.edu	Ding, Cheng-Qiang/B-6287-2011; Myers, Christopher R/I-8516-2017; Li, Ping/GYV-4914-2022; Brutnell, Thomas/M-2840-2013; Tausta, Lori/GXH-7773-2022	Brutnell, Thomas/0000-0002-3581-8211; 	National Science Foundation [IOS-0701736]; Bill and Melinda Gates Foundation; iPlant Collaborative for development of the eFP browser	National Science Foundation(National Science Foundation (NSF)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); iPlant Collaborative for development of the eFP browser(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by grants from the National Science Foundation (IOS-0701736 to R.T., P.L., Q.S., T.N. and T.P.B.). C.R.M. acknowledges support from a grant to the International Rice Research Institute from the Bill and Melinda Gates Foundation and T.P.B. acknowledges support from the iPlant Collaborative for development of the eFP browser.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barbazuk WB, 2008, GENOME RES, V18, P1381, DOI 10.1101/gr.053678.106; Bayer EM, 2009, GENE DEV, V23, P373, DOI 10.1101/gad.497009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Esau Katherine, 1943, HILGARDIA, V15, P327; Evert RF, 1996, INT J PLANT SCI, V157, P247, DOI 10.1086/297344; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Friso G, 2010, PLANT PHYSIOL, V152, P1219, DOI 10.1104/pp.109.152694; Gou JY, 2009, P NATL ACAD SCI USA, V106, P18855, DOI 10.1073/pnas.0905555106; Hall LN, 1998, PLANT CELL, V10, P925, DOI 10.1105/tpc.10.6.925; Hannemann J, 2009, PLANT CELL ENVIRON, V32, P1185, DOI 10.1111/j.1365-3040.2009.01964.x; HATCH MD, 1966, BIOCHEM J, V101, P103, DOI 10.1042/bj1010103; Hay A, 2009, CURR OPIN PLANT BIOL, V12, P593, DOI 10.1016/j.pbi.2009.06.006; Husbands AY, 2009, GENE DEV, V23, P1986, DOI 10.1101/gad.1819909; Juarez MT, 2004, DEVELOPMENT, V131, P4533, DOI 10.1242/dev.01328; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; KIRCHANSKI SJ, 1975, AM J BOT, V62, P695, DOI 10.2307/2442058; Lee WY, 2009, PLANT J, V58, P511, DOI 10.1111/j.1365-313X.2009.03795.x; LEECH RM, 1973, PLANT PHYSIOL, V52, P240, DOI 10.1104/pp.52.3.240; Li PH, 2008, PLANT CELL ENVIRON, V31, P1673, DOI 10.1111/j.1365-3040.2008.01874.x; Liu T, 2009, DEVELOPMENT, V136, P2265, DOI 10.1242/dev.032938; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; Lycett G, 2008, J EXP BOT, V59, P4061, DOI 10.1093/jxb/ern255; Majeran W, 2005, PLANT CELL, V17, P3111, DOI 10.1105/tpc.105.035519; Majeran W, 2008, MOL CELL PROTEOMICS, V7, P1609, DOI 10.1074/mcp.M800016-MCP200; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Molina I, 2009, PLANT PHYSIOL, V151, P1317, DOI 10.1104/pp.109.144907; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ohtsu K, 2007, PLANT J, V52, P391, DOI 10.1111/j.1365-313X.2007.03244.x; POETHIG RS, 1995, MAYDICA, V40, P67; Reidel EJ, 2009, PLANT PHYSIOL, V149, P1601, DOI 10.1104/pp.108.134791; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Sawers RJH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-12; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Severing EI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-154; Sharman BC, 1942, ANN BOT-LONDON, V6, P245, DOI 10.1093/oxfordjournals.aob.a088407; Sheen J, 1999, ANNU REV PLANT PHYS, V50, P187, DOI 10.1146/annurev.arplant.50.1.187; Snyder M, 2009, FEBS LETT, V583, P3895, DOI 10.1016/j.febslet.2009.11.011; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; SYLVESTER AW, 1990, DEVELOPMENT, V110, P985; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wang BB, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-17; Wingler A, 1999, PLANT PHYSIOL, V120, P539, DOI 10.1104/pp.120.2.539; Winnall WR, 2009, INT J ANDROL, V32, P542, DOI 10.1111/j.1365-2605.2008.00895.x; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348; Xu T, 2001, P NATL ACAD SCI USA, V98, P2295, DOI 10.1073/pnas.041610098; Yanagisawa S, 1998, PLANT CELL, V10, P75, DOI 10.1105/tpc.10.1.75; Zhu XG, 2008, CURR OPIN BIOTECH, V19, P153, DOI 10.1016/j.copbio.2008.02.004	52	543	577	5	272	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2010	42	12					1060	U51		10.1038/ng.703	http://dx.doi.org/10.1038/ng.703			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684UZ	21037569				2022-12-25	WOS:000284578800008
J	Farrar, JT				Farrar, John T.			Advances in clinical research methodology for pain clinical trials	NATURE MEDICINE			English	Review							NEUROPATHIC PAIN; OUTCOME MEASURES; PLACEBO-RESPONSE; RATING-SCALES; RELIEF SCALE; INTENSITY; VALIDATION; MECHANISMS; NUMBER; PREVALENCE	Pain is a ubiquitous phenomenon, but the experience of pain varies considerably from person to person. Advances in understanding of the growing number of pathophysiologic mechanisms that underlie the generation of pain and the influence of the brain on the experience of pain led to the investigation of numerous compounds for treating pain. Improved knowledge of the subjective nature of pain, the variations in the measurement of pain, the mind-body placebo effect and the impact of differences in the conduct of a clinical trial on the outcome have changed approaches to design and implement studies. Careful consideration of how these concepts affect the choice of study population, the randomization and blinding process, the measurement and collection of data, and the analysis and interpretation of results should improve the quality of clinical trials for potential pain therapies.	Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Farrar, JT (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	jfarrar@upenn.edu	Farrar, John T/AAP-4788-2021; Farrar, John/A-1037-2007	Farrar, John T/0000-0001-8656-5157; Farrar, John/0000-0001-8656-5157				Angst MS, 1999, ANESTHESIOLOGY, V91, P34, DOI 10.1097/00000542-199907000-00009; Baker R, 1998, INT J QUAL HEALTH C, V10, P207, DOI 10.1093/intqhc/10.3.207; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Beecher H. K., 1959, MEASUREMENT SUBJECTI; Bellamy N, 1997, J RHEUMATOL, V24, P799; Bennett M, 2001, PAIN, V92, P147, DOI 10.1016/S0304-3959(00)00482-6; Bergh I, 2000, AGING CLIN EXP RES, V12, P380, DOI 10.1007/BF03339864; Bingel U, 2008, PHYSIOLOGY, V23, P371, DOI 10.1152/physiol.00024.2008; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Bouhassira D, 2008, PAIN, V136, P380, DOI 10.1016/j.pain.2007.08.013; Boutron I, 2007, PLOS MED, V4, P370, DOI 10.1371/journal.pmed.0040061; Boutron I, 2006, PLOS MED, V3, P1931, DOI 10.1371/journal.pmed.0030425; Breivik EK, 2000, CLIN J PAIN, V16, P22, DOI 10.1097/00002508-200003000-00005; Cepeda MS, 2003, PAIN, V106, P439, DOI 10.1016/j.pain.2003.09.006; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; *COMM NAT STAT, 2010, CLIN TRIALS PANEL HA, pCH2; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; de Tovar C, 2010, PAIN RES MANAG, V15, P163, DOI 10.1155/2010/475907; Decruynaere C, 2009, EUR J PAIN, V13, P641, DOI 10.1016/j.ejpain.2008.07.004; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dworkin RH, 2005, NEUROLOGY, V65, pS7, DOI 10.1212/WNL.65.12_suppl_4.S7; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Dworkin RH, 2010, PAIN, V150, P12, DOI 10.1016/j.pain.2010.02.002; Edelsberg J, 2009, EUR J PAIN, V13, P11, DOI 10.1016/j.ejpain.2008.03.012; Farrar JT, 2010, ANESTHESIOLOGY, V112, P1464, DOI 10.1097/ALN.0b013e3181de0e6d; Farrar JT, 2010, J PAIN, V11, P109, DOI 10.1016/j.jpain.2009.06.007; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Farrar JT, 2000, PAIN, V88, P287, DOI 10.1016/S0304-3959(00)00339-0; FISHMAN B, 1987, PAIN, V30, pS415; FITZPATRICK R, 1993, BRIT J RHEUMATOL, V32, P807; Flaherty S A, 1996, AANA J, V64, P133; Galer BS, 1997, NEUROLOGY, V48, P332, DOI 10.1212/WNL.48.2.332; GRACELY RH, 1978, INT DENT J, V28, P52; Guy W, 1976, ECDEU ASSESSMENT MAN, P217; Guyatt GH, 2002, MAYO CLIN PROC, V77, P371, DOI 10.4065/77.4.371; HEFT MW, 1980, PAIN, V9, P363, DOI 10.1016/0304-3959(80)90050-0; HILL AB, 1952, NEW ENGL J MED, V247, P113, DOI 10.1056/NEJM195207242470401; Horny C, 1996, MED CARE, V34, P234; Houde R.W., 1956, FED PROC, V15, P440; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; Irizarry MC, 2009, CLIN J PAIN, V25, P469, DOI 10.1097/AJP.0b013e31819ddded; Jamison RN, 2002, PAIN, V99, P341, DOI 10.1016/S0304-3959(02)00178-1; Jenkinson C, 1999, INDIVIDUAL QUALITY L, P75; JENSEN MP, 1993, PAIN, V55, P195, DOI 10.1016/0304-3959(93)90148-I; JENSEN MP, 1994, PAIN, V58, P387, DOI 10.1016/0304-3959(94)90133-3; Katz N, 2005, NEUROLOGY, V65, pS32, DOI 10.1212/WNL.65.12_suppl_4.S32; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; KERNS RD, 1985, PAIN, V23, P345, DOI 10.1016/0304-3959(85)90004-1; Krause SJ, 2003, CLIN J PAIN, V19, P306, DOI 10.1097/00002508-200309000-00004; Kundt G, 2009, METHOD INFORM MED, V48, P129, DOI 10.3414/ME0538; LASAGNA L, 1954, J PHARMACOL EXP THER, V112, P356; Lee S, 2004, DEPRESS ANXIETY, V19, P10, DOI 10.1002/da.10134; Marceau LD, 2007, PAIN MED, V8, pS101, DOI 10.1111/j.1526-4637.2007.00374.x; MCDOWELL I, 1996, MEASURING HLTH GUIDE, pCH8; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Merskey H, 1994, CLASSIFICATION CHRON, DOI DOI 10.1016/0304-3959(86)90113-2; Moiniche S, 2002, ANESTHESIOLOGY, V96, P725, DOI 10.1097/00000542-200203000-00032; Moore A, 1996, PAIN, V66, P229, DOI 10.1016/0304-3959(96)03032-1; PORTENOY RK, 1994, EUR J CANCER, V30A, P1326, DOI 10.1016/0959-8049(94)90182-1; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; SERLIN RC, 1995, PAIN, V61, P277, DOI 10.1016/0304-3959(94)00178-H; Shavit Y, 2006, J NEUROIMMUNE PHARM, V1, P443, DOI 10.1007/s11481-006-9043-1; Sloan JA, 2002, MAYO CLIN PROC, V77, P479, DOI 10.4065/77.5.479; Temple RJ, 2003, ARCH INTERN MED, V163, P371, DOI 10.1001/archinte.163.3.371-b; TESLER MD, 1991, RES NURS HEALTH, V14, P361, DOI 10.1002/nur.4770140507; Torrance N, 2006, J PAIN, V7, P281, DOI 10.1016/j.jpain.2005.11.008; Tracey I, 2008, BRIT J ANAESTH, V101, P32, DOI 10.1093/bja/aen102; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Turk DC, 2003, PAIN, V106, P337, DOI 10.1016/j.pain.2003.08.001; Turner JA, 2002, PAIN, V99, P91, DOI 10.1016/S0304-3959(02)00060-X; Woolf CJ, 2004, ANN INTERN MED, V140, P441, DOI 10.7326/0003-4819-140-8-200404200-00010; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0	73	52	56	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1284	1293		10.1038/nm.2249	http://dx.doi.org/10.1038/nm.2249			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	20948532				2022-12-25	WOS:000283860100040
J	Jucker, M				Jucker, Mathias			The benefits and limitations of animal models for translational research in neurodegenerative diseases	NATURE MEDICINE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; AMYLOID-BETA-PEPTIDE; FRONTOTEMPORAL LOBAR DEGENERATION; POSITRON-EMISSION-TOMOGRAPHY; MULTIPLE SYSTEM ATROPHY; TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; TAU-PATHOLOGY	Age-related neurodegenerative diseases are largely limited to humans and rarely occur spontaneously in animals. Genetically engineered mouse models recapitulate aspects of the corresponding human diseases and are instrumental in studying disease mechanisms and testing therapeutic strategies. If considered within the range of their validity, mouse models have been predictive of clinical outcome. Translational failure is less the result of the incomplete nature of the models than of inadequate preclinical studies and misinterpretation of the models. This commentary summarizes current models and highlights key questions we should be asking about animal models, as well as questions that cannot be answered with the current models.	[Jucker, Mathias] Univ Tubingen, Dept Cellular Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany; [Jucker, Mathias] DZNE German Ctr Neurodegenerat Dis, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Jucker, M (corresponding author), Univ Tubingen, Dept Cellular Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany.	mathias.jucker@uni-tuebingen.de			German National Genome Network (NGFNPlus)	German National Genome Network (NGFNPlus)	I would like to thank L. Walker and M. Staufenbiel for various discussions and help with this manuscript. The systematic review of the literature by R. Radde is greatly acknowledged. I also thank M. Neumann, V. Lee, J. McLaurin, D. Schenk, D. Thal, J. Gotz, D. DiMonte, M. Goedert, T. Gasser and P. Kahle for comments on various parts of this commentary and the attendees of the Herrenhausen Symposium on Neurodegeneration for the inspiring discussions from which this commentary has emerged. The work was supported by the German National Genome Network (NGFNPlus).	Abbott A, 2010, NATURE, V465, P410, DOI 10.1038/465410a; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Beckers J, 2009, NAT REV GENET, V10, P371, DOI 10.1038/nrg2578; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Bento-Abreu A, 2010, EUR J NEUROSCI, V31, P2247, DOI 10.1111/j.1460-9568.2010.07260.x; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Blennow K, 2010, NAT MED, V16, P1218, DOI 10.1038/nm.2221; Boche D, 2008, BRAIN, V131, P3299, DOI 10.1093/brain/awn261; Bolmont T, 2007, AM J PATHOL, V171, P2012, DOI 10.2353/ajpath.2007.070403; Brody DL, 2008, ANNU REV NEUROSCI, V31, P175, DOI 10.1146/annurev.neuro.31.060407.125529; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Chesselet MF, 2008, EXP NEUROL, V209, P22, DOI 10.1016/j.expneurol.2007.08.006; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; Coomaraswamy J, 2010, P NATL ACAD SCI USA, V107, P7969, DOI 10.1073/pnas.1001056107; CORK LC, 1988, J NEUROPATH EXP NEUR, V47, P629, DOI 10.1097/00005072-198811000-00006; CUMMINGS BJ, 1993, NEUROBIOL AGING, V14, P547, DOI 10.1016/0197-4580(93)90038-D; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Denk F, 2009, NEUROBIOL AGING, V30, P1, DOI 10.1016/j.neurobiolaging.2007.05.010; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Duyckaerts C, 2008, ACTA NEUROPATHOL, V115, P5, DOI 10.1007/s00401-007-0312-8; Forman MS, 2005, J NEUROSCI, V25, P3539, DOI 10.1523/JNEUROSCI.0081-05.2005; Fuchs H, 2009, CURR PHARM BIOTECHNO, V10, P236, DOI 10.2174/138920109787315051; Fukuhara R, 2002, GENE, V296, P99, DOI 10.1016/S0378-1119(02)00837-5; Furlan R, 2003, BRAIN, V126, P285, DOI 10.1093/brain/awg031; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gasser T, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001148; Gerlach M, 1996, J NEURAL TRANSM, V103, P987, DOI 10.1007/BF01291788; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Hamilton BA, 2004, GENOMICS, V83, P739, DOI 10.1016/j.ygeno.2003.09.016; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Herzig MC, 2006, BRAIN PATHOL, V16, P40, DOI 10.1111/j.1750-3639.2006.tb00560.x; Heutink P, 2000, HUM MOL GENET, V9, P979, DOI 10.1093/hmg/9.6.979; Higuchi M, 2005, J NEUROSCI, V25, P9434, DOI 10.1523/JNEUROSCI.2691-05.2005; Hock BJ, 2001, TRENDS GENET, V17, P7, DOI DOI 10.1016/S0168-9525(01)02449-0; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Holzer M, 2004, GENE, V341, P313, DOI 10.1016/j.gene.2004.07.013; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Ishihara T, 2001, AM J PATHOL, V158, P555, DOI 10.1016/S0002-9440(10)63997-1; Kahle PJ, 2008, ACTA NEUROPATHOL, V115, P87, DOI 10.1007/s00401-007-0302-x; Klunk WE, 2005, J NEUROSCI, V25, P10598, DOI 10.1523/JNEUROSCI.2990-05.2005; Kuo YM, 2001, J BIOL CHEM, V276, P12991, DOI 10.1074/jbc.M007859200; Lee EB, 2005, FEBS LETT, V579, P2564, DOI 10.1016/j.febslet.2005.03.070; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LeVine H, 2010, NEUROBIOL AGING, V31, P542, DOI 10.1016/j.neurobiolaging.2008.05.026; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; MACKENZIE IRA, LANCET NEUR IN PRESS; Maeda J, 2007, J NEUROSCI, V27, P10957, DOI 10.1523/JNEUROSCI.0673-07.2007; Martin B, 2010, P NATL ACAD SCI USA, V107, P6127, DOI 10.1073/pnas.0912955107; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morris JC, 2009, ARCH NEUROL-CHICAGO, V66, P1469, DOI 10.1001/archneurol.2009.269; NELSON PT, 1994, NEUROSCI LETT, V170, P187, DOI 10.1016/0304-3940(94)90270-4; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; PODLISNY MB, 1991, AM J PATHOL, V138, P1423; Price DL, 1991, BRAIN PATHOL, V1, P287, DOI 10.1111/j.1750-3639.1991.tb00672.x; Racke MM, 2005, J NEUROSCI, V25, P629, DOI 10.1523/JNEUROSCI.4337-04.2005; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rosen RF, 2008, J COMP NEUROL, V509, P259, DOI 10.1002/cne.21744; Rosen RF, 2010, ACTA NEUROPATHOL, V119, P221, DOI 10.1007/s00401-009-0583-3; Rosen RF, 2011, NEUROBIOL AGING, V32, P223, DOI 10.1016/j.neurobiolaging.2009.02.011; RUPP NJ, NEUROBIOL A IN PRESS; Ryan NS, 2010, BIOMARK MED, V4, P99, DOI 10.2217/BMM.09.92; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schultz C, 2001, ADV EXP MED BIOL, V487, P59; Serrano-Pozo A, 2010, BRAIN, V133, P1312, DOI 10.1093/brain/awq056; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shults CW, 2005, J NEUROSCI, V25, P10689, DOI 10.1523/JNEUROSCI.3527-05.2005; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Sleegers K, 2010, ANNU REV NEUROSCI, V33, P71, DOI 10.1146/annurev-neuro-060909-153144; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Teschendorf D, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-38; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Walker LC, 1997, BRAIN RES REV, V25, P70, DOI 10.1016/S0165-0173(97)00017-9; Walker LC, 1999, ALZHEIMER DIS, P233; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Yazawa I, 2005, NEURON, V45, P847, DOI 10.1016/j.neuron.2005.01.032; Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471; Zahs KR, 2010, TRENDS NEUROSCI, V33, P381, DOI 10.1016/j.tins.2010.05.004; Zilka N, 2009, ACTA NEUROPATHOL, V118, P71, DOI 10.1007/s00401-009-0499-y	106	225	227	0	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2010	16	11					1210	1214		10.1038/nm.2224	http://dx.doi.org/10.1038/nm.2224			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	21052075				2022-12-25	WOS:000283860100027
J	Woolf, CJ				Woolf, Clifford J.			Overcoming obstacles to developing new analgesics	NATURE MEDICINE			English	Review							TRIALS IMMPACT RECOMMENDATIONS; OF-FUNCTION MUTATIONS; CHRONIC PAIN; NEUROPATHIC PAIN; CENTRAL SENSITIZATION; GTP CYCLOHYDROLASE; PLACEBO ANALGESIA; SODIUM-CHANNEL; IN-VIVO; PREGABALIN	Despite substantial investment by the pharmaceutical industry over several decades, there has been little progress in developing new, efficacious and safe analgesics. As a result, many large pharmaceutical companies are leaving the area of pain medication. Nevertheless, the chances of success could increase if analgesic drug development strategy changed. To achieve such a paradigm shift we must understand why development of drugs for pain relief is so challenging.	[Woolf, Clifford J.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Woolf, Clifford J.] Childrens Hosp, Program Neurobiol, Dept Neurol, Boston, MA 02115 USA; [Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Woolf, CJ (corresponding author), Childrens Hosp, FM Kirby Neurobiol Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	clifford.woolf@childrens.harvard.edu	Woolf, Clifford/A-9784-2010		US National Institutes of Health	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	I thank E. Forster, P. Vallance, S. Tate, R. Mannion, B. Wainger and J. Sprague for useful and constructive criticism and comments. This work was supported by the US National Institutes of Health.	Aquina CT, 2009, POSTGRAD MED, V121, P163, DOI 10.3810/pgm.2009.03.1988; Attal N, 2010, EUR J NEUROL, V17, P1113, DOI 10.1111/j.1468-1331.2010.02999.x; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bauer CS, 2010, BIOCHEM SOC T, V38, P525, DOI 10.1042/BST0380525; Becerra L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008016; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Bradley Laurence A, 2009, Am J Med, V122, pS22, DOI 10.1016/j.amjmed.2009.09.008; Campbell CM, 2009, PAIN, V141, P114, DOI 10.1016/j.pain.2008.10.023; Chen Y, 2009, CURR PAIN HEADACHE R, V13, P484, DOI 10.1007/s11916-009-0078-x; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; DIDHAJJ SD, 2010, ANNU REV NEUROSCI, V33, P325; Dworkin RH, 2010, PAIN, V149, P177, DOI 10.1016/j.pain.2010.02.018; Dworkin RH, 2010, MAYO CLIN PROC, V85, pS3, DOI 10.4065/mcp.2009.0649; Dworkin RH, 2009, PAIN, V146, P238, DOI 10.1016/j.pain.2009.08.019; Eippert F, 2009, SCIENCE, V326, P404, DOI 10.1126/science.1180142; Estacion M, 2008, J NEUROSCI, V28, P11079, DOI 10.1523/JNEUROSCI.3443-08.2008; Finnerup Nanna B, 2007, MedGenMed, V9, P36; Fischer TZ, 2010, ANN NY ACAD SCI, V1184, P196, DOI 10.1111/j.1749-6632.2009.05110.x; Garami A, 2010, J NEUROSCI, V30, P1435, DOI 10.1523/JNEUROSCI.5150-09.2010; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Grosser T, 2010, ANNU REV MED, V61, P17, DOI 10.1146/annurev-med-011209-153129; Hauser W, 2010, J PAIN, V11, P505, DOI 10.1016/j.jpain.2010.01.002; Helfand M, 2009, PAIN MED, V10, P1183, DOI 10.1111/j.1526-4637.2009.00718.x; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jensen TS, 2009, CURR OPIN NEUROL, V22, P467, DOI 10.1097/WCO.0b013e3283311e13; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kissin I, 2010, ANESTH ANALG, V110, P780, DOI 10.1213/ANE.0b013e3181cde882; LaCroix-Fralish ML, 2009, ANNU REV PHARMACOL, V49, P97, DOI 10.1146/annurev-pharmtox-061008-103222; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lotsch J, 2010, PAIN, V148, P103, DOI 10.1016/j.pain.2009.10.021; Marchand Fabien, 2009, Handb Exp Pharmacol, P589, DOI 10.1007/978-3-540-79090-7_17; McCormick CG, 2009, DRUG ALCOHOL DEPEN, V105, pS42, DOI 10.1016/j.drugalcdep.2009.08.003; McMahon SB, 2009, NEURON, V64, P46, DOI 10.1016/j.neuron.2009.09.033; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Moore RA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007076.pub2; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; Petrovic P, 2010, PAIN, V150, P59, DOI 10.1016/j.pain.2010.03.011; Pollo A, 2009, PROG BRAIN RES, V175, P283, DOI 10.1016/S0079-6123(09)17520-9; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Rappaport BA, 2010, ANESTHESIOLOGY, V112, P509, DOI 10.1097/ALN.0b013e3181cf4279; Reimann F, 2010, P NATL ACAD SCI USA, V107, P5148, DOI 10.1073/pnas.0913181107; Saito YA, 2010, GASTROENTEROLOGY, V138, P1276, DOI 10.1053/j.gastro.2010.02.037; Schneider MF, 2009, PHARMACOEPIDEM DR S, V18, P778, DOI 10.1002/pds.1780; Scholz J, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000047; Sharma U, 2010, AM J THER, V17, P577, DOI 10.1097/MJT.0b013e3181d5e4f3; Straube S, 2010, RHEUMATOLOGY, V49, P706, DOI 10.1093/rheumatology/kep432; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; Tegeder I, 2009, J CELL MOL MED, V13, P1605, DOI 10.1111/j.1582-4934.2009.00703.x; Tracey I, 2009, J PAIN, V10, P1113, DOI 10.1016/j.jpain.2009.09.001; Watson A, 2009, PAIN, V145, P24, DOI 10.1016/j.pain.2009.04.003; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2451, DOI 10.1001/jama.296.20.2451; Whiteside GT, 2008, NEUROPHARMACOLOGY, V54, P767, DOI 10.1016/j.neuropharm.2008.01.001; Williams DA, 2009, J PAIN, V10, P777, DOI 10.1016/j.jpain.2009.06.001; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; WOOLF CJ, 1994, NEUROSCIENCE, V62, P327, DOI 10.1016/0306-4522(94)90366-2; Zee AV, 2009, AM J PUBLIC HEALTH, V99, P221, DOI 10.2105/AJPH.2007.131714	58	161	163	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2010	16	11					1241	1247		10.1038/nm.2230	http://dx.doi.org/10.1038/nm.2230			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	675TV	20948534				2022-12-25	WOS:000283860100035
J	Zhang, EE; Liu, Y; Dentin, R; Pongsawakul, PY; Liu, AC; Hirota, T; Nusinow, DA; Sun, XJ; Landais, S; Kodama, Y; Brenner, DA; Montminy, M; Kay, SA				Zhang, Eric E.; Liu, Yi; Dentin, Renaud; Pongsawakul, Pagkapol Y.; Liu, Andrew C.; Hirota, Tsuyoshi; Nusinow, Dmitri A.; Sun, Xiujie; Landais, Severine; Kodama, Yuzo; Brenner, David A.; Montminy, Marc; Kay, Steve A.			Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis	NATURE MEDICINE			English	Article							RESPONSE ELEMENT; GLUCOSE; PHOSPHORYLATION; TRANSCRIPTION	During fasting, mammals maintain normal glucose homeostasis by stimulating hepatic gluconeogenesis1. Elevations in circulating glucagon and epinephrine, two hormones that activate hepatic gluconeogenesis, trigger the cAMP-mediated phosphorylation of cAMP response element-binding protein (Creb) and dephosphorylation of the Creb-regulated transcription coactivator-2 (Crtc2)-two key transcriptional regulators of this process(2). Although the underlying mechanism is unclear, hepatic gluconeogenesis is also regulated by the circadian clock, which coordinates glucose metabolism with changes in the external environment(3-6). Circadian control of gene expression is achieved by two transcriptional activators, Clock and Bmal1, which stimulate cryptochrome (Cry1 and Cry2) and Period (Per1, Per2 and Per3) repressors that feed back on Clock-Bmal1 activity. Here we show that Creb activity during fasting is modulated by Cry1 and Cry2, which are rhythmically expressed in the liver. Cry1 expression was elevated during the night-day transition, when it reduced fasting gluconeogenic gene expression by blocking glucagon-mediated increases in intracellular cAMP concentrations and in the protein kinase A-mediated phosphorylation of Creb. In biochemical reconstitution studies, we found that Cry1 inhibited accumulation of cAMP in response to G protein-coupled receptor (GPCR) activation but not to forskolin, a direct activator of adenyl cyclase. Cry proteins seemed to modulate GPCR activity directly through interaction with G(s)alpha. As hepatic overexpression of Cry1 lowered blood glucose concentrations and improved insulin sensitivity in insulin-resistant db/db mice, our results suggest that compounds that enhance cryptochrome activity may provide therapeutic benefit to individuals with type 2 diabetes.	[Liu, Yi; Dentin, Renaud; Landais, Severine; Montminy, Marc] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Zhang, Eric E.; Pongsawakul, Pagkapol Y.; Liu, Andrew C.; Hirota, Tsuyoshi; Nusinow, Dmitri A.; Kay, Steve A.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Zhang, Eric E.; Liu, Andrew C.; Hirota, Tsuyoshi] Novartis Res Fdn, Gen Inst, San Diego, CA USA; [Liu, Yi; Sun, Xiujie] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutrit Sci, Key Lab Nutrit & Metab, Shanghai, Peoples R China; [Liu, Andrew C.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Kodama, Yuzo; Brenner, David A.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; Novartis; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Memphis; University of California System; University of California San Diego	Montminy, M (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu; skay@ucsd.edu	Hirota, Tsuyoshi/D-8158-2015; Pongsawakul, Pagkapol Y./GSD-2959-2022; Liu, Andrew C/B-3548-2009; Nusinow, Dmitri A/K-9129-2013; dentin, Renaud/P-4939-2017; Sun, Xiujie/L-1244-2017; Kay, Steve A/F-6025-2011; Dentin, Renaud/AAV-5818-2020	Hirota, Tsuyoshi/0000-0003-4876-3608; Liu, Andrew C/0000-0003-1927-0900; Nusinow, Dmitri A/0000-0002-0497-1723; dentin, Renaud/0000-0003-0988-4458; Sun, Xiujie/0000-0003-3814-7406; Kay, Steve A/0000-0002-0402-2878; Dentin, Renaud/0000-0003-0988-4458; Brenner, David/0000-0003-2573-525X; Zhang, Eric/0000-0002-4472-7493	US National Institutes of Health [R01 GM074868, R01 MH051573, R01 DK083834, R01 DK049777, GM083585]; Chinese Academy of Sciences [2010OHTP08]; Shanghai Pujiang Program in China [10PJ1411200]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK083834, R01DK049777, R01DK083834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041804, R01GM074868, F32GM083585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051573] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Pujiang Program in China(Shanghai Pujiang Program); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank L. Vera, A. Luzader, E. Rodrigo and X. Li for adenoviral injections, J. Altarejos and M. Lindstrom for mouse blood collection and glucose measurement and N. Goebel for preparing primary hepatocytes. We also thank M. Yamout and P. E. Wright for stimulating discussions and N. Gekakis, D. Welsh and S. Wang for reading the manuscript. This is manuscript 080809 of Genomics Institute of the Novartis Research Foundation, and the research was supported in part by grants from the US National Institutes of Health (R01 GM074868 and R01 MH051573 to S. A. K; R01 DK083834 and R01 DK049777 to M. M.). Y.L. is supported by the "One Hundred Talents" Program of the Chinese Academy of Sciences (No. 2010OHTP08) and Shanghai Pujiang Program (10PJ1411200) in China, and D.A.N. is supported by a fellowship (GM083585) from the US National Institutes of Health.	Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; KIDA K, 1980, J BIOCHEM-TOKYO, V88, P1009, DOI 10.1093/oxfordjournals.jbchem.a133051; Li C, 2007, P NATL ACAD SCI USA, V104, P4206, DOI 10.1073/pnas.0611641104; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pulivarthy SR, 2007, P NATL ACAD SCI USA, V104, P20356, DOI 10.1073/pnas.0708877104; Ramsey KM, 2007, ANNU REV NUTR, V27, P219, DOI 10.1146/annurev.nutr.27.061406.093546; Sanada K, 2004, GENES CELLS, V9, P697, DOI 10.1111/j.1356-9597.2004.00758.x; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	19	351	382	2	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2010	16	10					1152	U133		10.1038/nm.2214	http://dx.doi.org/10.1038/nm.2214			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	660LR	20852621	Green Accepted			2022-12-25	WOS:000282644800047
J	Niemeyer, CM; Kang, MW; Shin, DH; Furlan, I; Erlacher, M; Bunin, NJ; Bunda, S; Finklestein, JZ; Sakamoto, KM; Gorr, TA; Mehta, P; Schmid, I; Kropshofer, G; Corbacioglu, S; Lang, PJ; Klein, C; Schlegel, PG; Heinzmann, A; Schneider, M; Stary, J; van den Heuvel-Eibrink, MM; Hasle, H; Locatelli, F; Sakai, D; Archambeault, S; Chen, L; Russell, RC; Sybingco, SS; Ohh, M; Braun, BS; Flotho, C; Loh, ML				Niemeyer, Charlotte M.; Kang, Michelle W.; Shin, Danielle H.; Furlan, Ingrid; Erlacher, Miriam; Bunin, Nancy J.; Bunda, Severa; Finklestein, Jerry Z.; Sakamoto, Kathleen M.; Gorr, Thomas A.; Mehta, Parinda; Schmid, Irene; Kropshofer, Gabriele; Corbacioglu, Selim; Lang, Peter J.; Klein, Christoph; Schlegel, Paul-Gerhard; Heinzmann, Andrea; Schneider, Michaela; Stary, Jan; van den Heuvel-Eibrink, Marry M.; Hasle, Henrik; Locatelli, Franco; Sakai, Debbie; Archambeault, Sophie; Chen, Leslie; Russell, Ryan C.; Sybingco, Stephanie S.; Ohh, Michael; Braun, Benjamin S.; Flotho, Christian; Loh, Mignon L.			Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia	NATURE GENETICS			English	Article							GENOTYPE-PHENOTYPE CORRELATION; COLONY-STIMULATING FACTOR; GAIN-OF-FUNCTION; C-CBL; MYELODYSPLASTIC SYNDROMES; RETROSPECTIVE ANALYSIS; MYELOID-LEUKEMIA; TUMOR-SUPPRESSOR; PTPN11 MUTATIONS; NOONAN-SYNDROME	CBL encodes a member of the Cbl family of proteins, which functions as an E3 ubiquitin ligase. We describe a dominant developmental disorder resulting from germline missense CBL mutations, which is characterized by impaired growth, developmental delay, cryptorchidism and a predisposition to juvenile myelomonocytic leukemia (JMML). Some individuals experienced spontaneous regression of their JMML but developed vasculitis later in life. Importantly, JMML specimens from affected children show loss of the normal CBL allele through acquired isodisomy. Consistent with these genetic data, the common p.371Y>H altered Cbl protein induces cytokine-independent growth and constitutive phosphorylation of ERK, AKT and S6 only in hematopoietic cells in which normal Cbl expression is reduced by RNA interference. We conclude that germline CBL mutations have developmental, tumorigenic and functional consequences that resemble disorders that are caused by hyperactive Ras/Raf/MEK/ERK signaling and include neurofibromatosis type 1, Noonan syndrome, Costello syndrome, cardiofaciocutaneous syndrome and Legius syndrome.	[Kang, Michelle W.; Shin, Danielle H.; Sakai, Debbie; Archambeault, Sophie; Chen, Leslie; Braun, Benjamin S.; Loh, Mignon L.] Univ Calif San Francisco, Dept Pediat, Ctr Comprehens Canc, San Francisco, CA 94143 USA; [Niemeyer, Charlotte M.; Furlan, Ingrid; Erlacher, Miriam; Gorr, Thomas A.; Heinzmann, Andrea; Schneider, Michaela; Flotho, Christian] Univ Freiburg, Dept Pediat & Adolescent Med, Freiburg, Germany; [Bunin, Nancy J.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Bunda, Severa; Russell, Ryan C.; Sybingco, Stephanie S.; Ohh, Michael] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Finklestein, Jerry Z.] Miller Childrens Hosp Harbor UCLA, Jonathan Jaques Canc Ctr, Long Beach, CA USA; [Sakamoto, Kathleen M.] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Dept Pediat, Los Angeles, CA 90095 USA; [Mehta, Parinda] Cincinnati Childrens Hosp Med Ctr, Div Hematol Oncol, Cincinnati, OH USA; [Schmid, Irene] LMU Munich Univ, von Hauner Childrens Hosp, Munich, Germany; [Kropshofer, Gabriele] Med Univ, Dept Pediat & Adolescent Med, Innsbruck, Austria; [Corbacioglu, Selim] Univ Ulm, Dept Pediat, D-7900 Ulm, Germany; [Lang, Peter J.] Univ Tubingen, Dept Pediat, Tubingen, Germany; [Klein, Christoph] Hannover Med Sch, Dept Pediat, D-3000 Hannover, Germany; [Schlegel, Paul-Gerhard] Univ Wurzburg, Dept Pediat, Wurzburg, Germany; [Stary, Jan] Charles Univ Prague, Dept Pediat Hematol & Oncol, Prague, Czech Republic; [van den Heuvel-Eibrink, Marry M.] Erasmus MC, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; [Hasle, Henrik] Aarhus Univ, Hosp Skejby, Dept Pediat, Aarhus, Denmark; [Locatelli, Franco] Univ Pavia, Dept Pediat Hematol & Oncol, IRCCS Osped Bambino Gesu, Rome, Italy	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Freiburg; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Toronto; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cincinnati Children's Hospital Medical Center; University of Munich; Medical University of Innsbruck; Ulm University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Hannover Medical School; University of Wurzburg; Charles University Prague; Erasmus University Rotterdam; Erasmus MC; Aarhus University; IRCCS Bambino Gesu; University of Pavia	Loh, ML (corresponding author), Univ Calif San Francisco, Dept Pediat, Ctr Comprehens Canc, San Francisco, CA 94143 USA.	charlotte.niemeyer@uniklinik-freiburg.de; lohm@peds.ucsf.edu	Corbacioglu, Selim/N-6152-2019; Erlacher, Miriam/GRR-7418-2022; Lang, Peter/P-1983-2019; Stary, Jan/AAB-9635-2020	Erlacher, Miriam/0000-0002-7261-1447; Loh, Mignon/0000-0003-4099-4700; Gorr, Thomas/0000-0002-6023-4234; Russell, Ryan/0000-0003-3364-8869; Sakamoto, Kathleen/0000-0003-0494-8838; Hasle, Henrik/0000-0003-3976-9231; Archambeault, Sophie/0000-0001-9409-7541	US National Institutes of Health [CA113557]; V Foundation for Cancer Research; NIH/NCI [K08 CA103868, R01 CA104282]; Leukemia Lymphoma Society [6059-09, 2157-08]; Frank A. Campini Foundation; Concern Foundation; Deutsche Forschungsgemeinschaft [KR3473/1-1]; Deutsche Krebshilfe [108220]; Deutsche Jose Carreras Leukamie-Stiftung [R08/19]; Canadian Cancer Society [16056]; National Institute of General Medical Sciences [T32GM007618]; NATIONAL CANCER INSTITUTE [T32CA128583, K08CA103868, K22CA113557, R01CA104282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation for Cancer Research; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia Lymphoma Society(Leukemia and Lymphoma Society); Frank A. Campini Foundation; Concern Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Jose Carreras Leukamie-Stiftung; Canadian Cancer Society(Canadian Cancer Society (CCS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge the generous participation of the families included in this report. Supported in part by the US National Institutes of Health (CA113557 to M. L. L.); the V Foundation for Cancer Research (M. L. L. and B. S. B.); NIH/NCI (K08 CA103868 to B. S. B., R01 CA104282 to M. L. L. and B. S. B.); The Leukemia Lymphoma Society (6059-09, 2157-08 to M. L. L.); the Frank A. Campini Foundation (M. L. L. and B. S. B.); The Concern Foundation (B. S. B.); Deutsche Forschungsgemeinschaft (KR3473/1-1 to C. F.); Deutsche Krebshilfe (108220 to C.M.N. and C. F.); Deutsche Jose Carreras Leukamie-Stiftung (R08/19 to C. F.); the Canadian Cancer Society (16056 to M.O.); and the National Institute of General Medical Sciences (T32GM007618 to D. H. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.	ANDONIOU CE, 1994, EMBO J, V13, P4515, DOI 10.1002/j.1460-2075.1994.tb06773.x; BaderMeunier B, 1997, J PEDIATR-US, V130, P885, DOI 10.1016/S0022-3476(97)70273-7; BLAKE TJ, 1991, ONCOGENE, V6, P653; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Chan RJ, 2008, LEUKEMIA RES, V33, P355; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; EMANUEL PD, 1991, BLOOD, V77, P925; Flotho C, 2008, BLOOD, V111, P966, DOI 10.1182/blood-2007-09-111831; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Hashimoto S, 2002, MECH DEVELOP, V119, pS303, DOI 10.1016/S0925-4773(03)00132-1; Hasle H, 2003, LEUKEMIA, V17, P277, DOI 10.1038/sj.leu.2402765; KALRA R, 1994, BLOOD, V84, P3435; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; Kitaura Y, 2007, IMMUNITY, V26, P567, DOI 10.1016/j.immuni.2007.03.015; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; LANGDON WY, 1989, J VIROL, V63, P5420, DOI 10.1128/JVI.63.12.5420-5424.1989; Le DT, 2004, BLOOD, V103, P4243, DOI 10.1182/blood-2003-08-2650; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Locatelli F, 2005, BLOOD, V105, P410, DOI 10.1182/blood-2004-05-1944; Loh ML, 2009, BLOOD, V114, P1859, DOI 10.1182/blood-2009-01-198416; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Makishima H, 2009, J CLIN ONCOL, V27, P6109, DOI 10.1200/JCO.2009.23.7503; Matsuda K, 2007, BLOOD, V109, P5477, DOI 10.1182/blood-2006-09-046649; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Niemeyer CM, 2008, BRIT J HAEMATOL, V140, P610, DOI 10.1111/j.1365-2141.2007.06958.x; Niemeyer CM, 1997, BLOOD, V89, P3534; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Oishi K, 2006, HUM MOL GENET, V15, P543, DOI 10.1093/hmg/ddi471; Onida F, 2002, BLOOD, V99, P840, DOI 10.1182/blood.V99.3.840; Pai LM, 2000, CELL, V103, P51, DOI 10.1016/S0092-8674(00)00104-5; Ramshaw HS, 2002, EXP HEMATOL, V30, P1124, DOI 10.1016/S0301-472X(02)00903-7; RAUEN KA, 2009, AM J MED GEN A, V152, P4; Robertson H, 2000, ONCOGENE, V19, P3299, DOI 10.1038/sj.onc.1203624; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Schubbert S, 2005, BLOOD, V106, P311, DOI 10.1182/blood-2004-11-4207; Schubbert S, 2007, MOL CELL BIOL, V27, P7765, DOI 10.1128/MCB.00965-07; SHANNON KM, 1994, NEW ENGL J MED, V330, P597, DOI 10.1056/NEJM199403033300903; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236	49	231	238	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2010	42	9					794	U93		10.1038/ng.641	http://dx.doi.org/10.1038/ng.641			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	644OM	20694012	Green Accepted, Green Submitted			2022-12-25	WOS:000281388400018
J	Li, AQ; Saito, M; Chuang, JZ; Tseng, YY; Dedesma, C; Tomizawa, K; Kaitsuka, T; Sung, CH				Li, Aiqun; Saito, Masaki; Chuang, Jen-Zen; Tseng, Yun-Yu; Dedesma, Carlos; Tomizawa, Kazuhito; Kaitsuka, Taku; Sung, Ching-Hwa			Ciliary transition zone activation of phosphorylated Tctex-1 controls ciliary resorption, S-phase entry and fate of neural progenitors	NATURE CELL BIOLOGY			English	Article							DYNEIN LIGHT-CHAIN; CELL-CYCLE CONTROL; CYTOPLASMIC DYNEIN; PRIMARY CILIUM; STEM-CELLS; MAMMALIAN NEUROGENESIS; NEURONAL MIGRATION; PLANAR DIVISIONS; PROTEIN; BRAIN	Primary cilia are displayed during the G(0)/G(1) phase of many cell types. Cilia are resorbed as cells prepare to re-enter the cell cycle, but the causal and molecular link between these two cellular events remains unclear. We show that Tctex-1 phosphorylated at Thr 94 is recruited to ciliary transition zones before S-phase entry and has a pivotal role in both ciliary disassembly and cell cycle progression. However, the role of Tctex-1 in S-phase entry is dispensable in non-ciliated cells. Exogenously adding a phosphomimic Tctex-1(T94E) mutant accelerates cilium disassembly and S-phase entry. These results support a model in which the cilia act as a brake to prevent cell cycle progression. Mechanistic studies show the involvement of actin dynamics in Tctex-1-regulated cilium resorption. Tctex-1 phosphorylated at Thr 94 is also selectively enriched at the ciliary transition zones of cortical neural progenitors, and has a key role in controlling G(1) length, cell cycle entry and fate determination of these cells during corticogenesis.	[Li, Aiqun; Saito, Masaki; Chuang, Jen-Zen; Tseng, Yun-Yu; Dedesma, Carlos; Sung, Ching-Hwa] Cornell Univ, Weill Med Coll, Dept Ophthalmol, Margaret M Dyson Vis Res Inst, New York, NY 10065 USA; [Saito, Masaki] Tohoku Univ, Inst Int Adv Interdisciplinary Res, Int Adv Res & Educ Org, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Saito, Masaki] Tohoku Univ, Dept Cellular Signalling, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Tomizawa, Kazuhito; Kaitsuka, Taku] Kumamoto Univ, Fac Life Sci, Dept Mol Physiol, Kumamoto 8608556, Japan; [Sung, Ching-Hwa] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA	Cornell University; Tohoku University; Tohoku University; Kumamoto University; Cornell University	Sung, CH (corresponding author), Cornell Univ, Weill Med Coll, Dept Ophthalmol, Margaret M Dyson Vis Res Inst, 1300 York Ave, New York, NY 10065 USA.	chsung@mail.med.cornell.edu	Tomizawa, Kazuhito/F-2405-2015; Saito, Masaki/P-8792-2019	Tomizawa, Kazuhito/0000-0002-5663-2627; Saito, Masaki/0000-0001-7259-4248	Tri-Institutional Starr Foundation; NYSTEM; NIH [EY11307, EY016805]; RPB; Tohoku University; New Energy and Industrial Technology Development Organization; Ministry of Education, Science, Sports, and Culture of Japan; NATIONAL EYE INSTITUTE [R01EY016805, R01EY011307] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23770136] Funding Source: KAKEN	Tri-Institutional Starr Foundation; NYSTEM; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RPB(Research to Prevent Blindness (RPB)); Tohoku University; New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are indebted to the following grant support: Tri-Institutional Starr Foundation, NYSTEM, NIH (EY11307, EY016805), RPB (to C-H.S.), Tohoku University (to M. S.), New Energy and Industrial Technology Development Organization, and Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan (to K.T.). We thank G. Pazour, K. Anderson, R. Hevner, Y. Shi, N. Heintz, C. Cepko, A. Liu and S. Doxsey for reagents, and S. Anderson, M. E. Ross, D. Cobrinik and B. Tsou for discussion.	Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004; Calegari F, 2003, J CELL SCI, V116, P4947, DOI 10.1242/jcs.00825; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; Chuang JZ, 2005, DEV CELL, V9, P75, DOI 10.1016/j.devcel.2005.04.003; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; Dedesma C, 2006, J COMP NEUROL, V496, P773, DOI 10.1002/cne.20958; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Gauthier-Fisher A, 2009, NAT NEUROSCI, V12, P735, DOI 10.1038/nn.2339; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Jia JP, 2009, DEV BIOL, V330, P452, DOI 10.1016/j.ydbio.2009.04.009; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; King SM, 1996, J BIOL CHEM, V271, P32281, DOI 10.1074/jbc.271.50.32281; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lange C, 2009, CELL STEM CELL, V5, P320, DOI 10.1016/j.stem.2009.05.026; Mahjoub MR, 2004, MOL BIOL CELL, V15, P5172, DOI 10.1091/mbc.E04-07-0571; Matsushita M, 2001, J NEUROSCI, V21, P6000, DOI 10.1523/JNEUROSCI.21-16-06000.2001; Mittnacht S, 1998, CURR OPIN GENET DEV, V8, P21, DOI 10.1016/S0959-437X(98)80057-9; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Pan JM, 2007, CELL, V129, P1255, DOI 10.1016/j.cell.2007.06.018; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Pilaz LJ, 2009, P NATL ACAD SCI USA, V106, P21924, DOI 10.1073/pnas.0909894106; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Qin HM, 2007, CURR BIOL, V17, P193, DOI 10.1016/j.cub.2006.12.040; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Seeley ES, 2009, CANCER RES, V69, P422, DOI 10.1158/0008-5472.CAN-08-1290; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tai AW, 1998, J BIOL CHEM, V273, P19639, DOI 10.1074/jbc.273.31.19639; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Takeuchi A, 2006, J NEUROSCI, V26, P4460, DOI 10.1523/JNEUROSCI.4935-05.2006; Thomas M, 2005, P NATL ACAD SCI USA, V102, P5679, DOI 10.1073/pnas.0502067102; TUCKER RW, 1979, CELL, V17, P527, DOI 10.1016/0092-8674(79)90261-7; Xia XG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng098; Zhong XY, 2006, CELL CYCLE, V5, P457, DOI 10.4161/cc.5.4.2481	50	157	161	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2011	13	4					402	U142		10.1038/ncb2218	http://dx.doi.org/10.1038/ncb2218			18	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	744CK	21394082	Green Accepted			2022-12-25	WOS:000289070900012
J	Shimono, K; Tung, WE; Macolino, C; Chi, AHT; Didizian, JH; Mundy, C; Chandraratna, RA; Mishina, Y; Enomoto-Iwamoto, M; Pacifici, M; Iwamoto, M				Shimono, Kengo; Tung, Wei-en; Macolino, Christine; Chi, Amber Hsu-Tsai; Didizian, Johanna H.; Mundy, Christina; Chandraratna, Roshantha A.; Mishina, Yuji; Enomoto-Iwamoto, Motomi; Pacifici, Maurizio; Iwamoto, Masahiro			Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-gamma agonists	NATURE MEDICINE			English	Article							ENDOCHONDRAL BONE-FORMATION; I RECEPTOR; MORPHOGENETIC PROTEIN; VITAMIN-A; SKELETOGENESIS; IDENTIFICATION; GROWTH; DIFFERENTIATION; PROGRESSIVA; ANTAGONISTS	Heterotopic ossification consists of ectopic bone formation within soft tissues after surgery or trauma. It can have debilitating consequences, but there is no definitive cure. Here we show that heterotopic ossification was essentially prevented in mice receiving a nuclear retinoic acid receptor-gamma (RAR-gamma) agonist. Side effects were minimal, and there was no significant rebound effect. To uncover the mechanisms of these responses, we treated mouse mesenchymal stem cells with an RAR-gamma agonist and transplanted them into nude mice. Whereas control cells formed ectopic bone masses, cells that had been pretreated with the RAR-gamma agonist did not, suggesting that they had lost their skeletogenic potential. The cells became unresponsive to rBMP-2 treatment in vitro and showed decreases in phosphorylation of Smad1, Smad5 and Smad8 and in overall levels of Smad proteins. In addition, an RAR-gamma agonist blocked heterotopic ossification in transgenic mice expressing activin receptor-like kinase-2 (ALK2) Q207D, a constitutively active form of the receptor that is related to ALK2 R206H found in individuals with fibrodysplasia ossificans progressiva. The data indicate that RAR-gamma agonists are potent inhibitors of heterotopic ossification in mouse models and, thus, may also be effective against injury-induced and congenital heterotopic ossification in humans.	[Chandraratna, Roshantha A.] Io Therapeut, Irvine, CA USA; [Mishina, Yuji] Univ Michigan, Sch Dent, Ann Arbor, MI 48109 USA; [Shimono, Kengo; Tung, Wei-en; Macolino, Christine; Chi, Amber Hsu-Tsai; Didizian, Johanna H.; Mundy, Christina; Enomoto-Iwamoto, Motomi; Pacifici, Maurizio; Iwamoto, Masahiro] Thomas Jefferson Univ, Coll Med, Dept Orthopaed Surg, Philadelphia, PA 19107 USA	University of Michigan System; University of Michigan; Jefferson University	Iwamoto, M (corresponding author), Childrens Hosp Philadelphia, Div Orthopaed Surg, Philadelphia, PA 19104 USA.	pacificim@email.chop.edu; iwamotom@email.chop.edu			Department of the Army [W81XWH-07-1-0212]; United States Army Medical Research Acquisition Activity; US National Institutes of Health [AR056837]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056837] Funding Source: NIH RePORTER	Department of the Army; United States Army Medical Research Acquisition Activity; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank T. Katagiri (Saitama) for the Id1-luc reporter plasmid; S. Otsuru and E. Horwitz (Children's Hospital of Philadelphia) for the GFP-expressing MSCs and culture methods; and N. Ghyselinck and P. Chambon (Institut National de la Sante et de la Recherche Medicale, Illkirch Cedex) for the RAR floxed and null mouse lines. This work was supported by contract no. W81XWH-07-1-0212 from the Department of the Army, United States Army Medical Research Acquisition Activity (M. P.) and US National Institutes of Health RO1 grant AR056837 (M. I. and M. P.).	Benglis D, 2008, NEUROSURGERY, V62, P423, DOI 10.1227/01.neu.0000326030.24220.d8; BERNARD BA, 1992, BIOCHEM BIOPH RES CO, V186, P977, DOI 10.1016/0006-291X(92)90842-9; Blaner William S., 1994, P229; BONE LB, 1989, J BONE JOINT SURG AM, V71A, P336, DOI 10.2106/00004623-198971030-00004; CHALMERS J, 1975, J BONE JOINT SURG BR, VB 57, P36, DOI 10.1302/0301-620X.57B1.36; Chao ST, 2007, ORTHOPEDICS, V30, P457, DOI 10.3928/01477447-20070601-18; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DESIMONE DP, 1983, CALCIFIED TISSUE INT, V35, P732, DOI 10.1007/BF02405115; Forsberg JA, 2009, J BONE JOINT SURG AM, V91A, P1084, DOI 10.2106/JBJS.H.00792; Fukuda T, 2006, GENESIS, V44, P159, DOI 10.1002/dvg.20201; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Gehin M, 1999, CHEM BIOL, V6, P519, DOI 10.1016/S1074-5521(99)80084-2; Hind M, 2009, CURR OPIN INVEST DR, V10, P1243; Hoffman LM, 2006, J CELL BIOL, V174, P101, DOI 10.1083/jcb.200604150; Kakudo N, 2006, LIFE SCI, V79, P1847, DOI 10.1016/j.lfs.2006.06.033; KAPLAN FS, 2008, CLIN P INT CLIN CONS, V3, P1082; KEIDEL S, 1994, MOL CELL BIOL, V14, P287, DOI 10.1128/MCB.14.1.287; Klein ES, 1996, J BIOL CHEM, V271, P22692, DOI 10.1074/jbc.271.37.22692; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Koyama E, 1999, DEV BIOL, V208, P375, DOI 10.1006/dbio.1999.9207; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McCarthy EF, 2005, SKELETAL RADIOL, V34, P609, DOI 10.1007/s00256-005-0958-z; Nilsson Olle S., 1999, Current Opinion in Rheumatology, V11, P127, DOI 10.1097/00002281-199903000-00008; Nozaki Y, 2006, CLIN IMMUNOL, V119, P272, DOI 10.1016/j.clim.2005.11.012; O'Connor JP, 1998, CLIN ORTHOP RELAT R, P71; Otsuru S, 2010, EXP HEMATOL, V38, P836, DOI 10.1016/j.exphem.2010.04.015; PACIFICI M, 1980, EXP CELL RES, V129, P469, DOI 10.1016/0014-4827(80)90517-0; Pendaries V, 2003, ONCOGENE, V22, P8212, DOI 10.1038/sj.onc.1206913; Pignolo RJ, 2005, CLIN REV BONE MINER, V3, P195, DOI 10.1385/BMM:3:3-4:195; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Shao JS, 2006, ARTERIOSCL THROM VAS, V26, P1423, DOI 10.1161/01.ATV.0000220441.42041.20; Shen Q, 2009, J CLIN INVEST, V119, P3462, DOI 10.1172/JCI37412; Shimono K, 2010, J ORTHOP RES, V28, P271, DOI 10.1002/jor.20985; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; Thacher SM, 2000, CURR PHARM DESIGN, V6, P25, DOI 10.2174/1381612003401415; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Weston AD, 2002, J CELL BIOL, V158, P39, DOI 10.1083/jcb.200112029; Weston Andrea D., 2003, Birth Defects Research, V69, P156, DOI 10.1002/bdrc.10010; Williams JA, 2009, DEV BIOL, V328, P315, DOI 10.1016/j.ydbio.2009.01.031; Yasuhara R, 2010, J BIOL CHEM, V285, P317, DOI 10.1074/jbc.M109.053926; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Zasloff MA, 1998, CLIN ORTHOP RELAT R, P121; Zhang DH, 2003, J BONE MINER RES, V18, P1593, DOI 10.1359/jbmr.2003.18.9.1593	45	234	253	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2011	17	4					454	U91		10.1038/nm.2334	http://dx.doi.org/10.1038/nm.2334			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	746KI	21460849	Green Accepted, Green Submitted			2022-12-25	WOS:000289245100036
J	Yan, XJ; Xu, J; Gu, ZH; Pan, CM; Lu, G; Shen, Y; Shi, JY; Zhu, YM; Tang, L; Zhang, XW; Liang, WX; Mi, JQ; Song, HD; Li, KQ; Chen, Z; Chen, SJ				Yan, Xiao-Jing; Xu, Jie; Gu, Zhao-Hui; Pan, Chun-Ming; Lu, Gang; Shen, Yang; Shi, Jing-Yi; Zhu, Yong-Mei; Tang, Lin; Zhang, Xiao-Wei; Liang, Wen-Xue; Mi, Jian-Qing; Song, Huai-Dong; Li, Ke-Qin; Chen, Zhu; Chen, Sai-Juan			Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; DE-NOVO METHYLATION; HOX GENES; CLASSIFICATION; PROGNOSIS; EXPRESSION; REVEALS; GENOME; NSD1; EZH2	Abnormal epigenetic regulation has been implicated in oncogenesis. We report here the identification of somatic mutations by exome sequencing in acute monocytic leukemia, the M5 subtype of acute myeloid leukemia (AML-M5). We discovered mutations in DNMT3A (encoding DNA methyltransferase 3A) in 23 of 112 (20.5%) cases. The DNMT3A mutants showed reduced enzymatic activity or aberrant affinity to histone H3 in vitro. Notably, there were alterations of DNA methylation patterns and/or gene expression profiles (such as HOXB genes) in samples with DNMT3A mutations as compared with those without such changes. Leukemias with DNMT3A mutations constituted a group of poor prognosis with elderly disease onset and of promonocytic as well as monocytic predominance among AML-M5 individuals. Screening other leukemia subtypes showed Arg882 alterations in 13.6% of acute myelomonocytic leukemia (AML-M4) cases. Our work suggests a contribution of aberrant DNA methyltransferase activity to the pathogenesis of acute monocytic leukemia and provides a useful new biomarker for relevant cases.	[Yan, Xiao-Jing; Xu, Jie; Pan, Chun-Ming; Lu, Gang; Shen, Yang; Shi, Jing-Yi; Zhu, Yong-Mei; Tang, Lin; Zhang, Xiao-Wei; Liang, Wen-Xue; Mi, Jian-Qing; Song, Huai-Dong; Li, Ke-Qin; Chen, Zhu; Chen, Sai-Juan] Shanghai Jiao Tong Univ, State Key Lab Med Gen, Shanghai Inst Hematol, Rui Jin Hosp,Sch Med, Shanghai 200030, Peoples R China; [Yan, Xiao-Jing] China Med Univ, Dept Hematol, Hosp 1, Shenyang, Peoples R China; [Gu, Zhao-Hui; Chen, Zhu; Chen, Sai-Juan] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; China Medical University; Shanghai Jiao Tong University	Chen, Z (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Med Gen, Shanghai Inst Hematol, Rui Jin Hosp,Sch Med, Shanghai 200030, Peoples R China.	zchen@stn.sh.cn; sjchen@stn.sh.cn	Zhang, Xiaowei/B-5126-2013; Gu, Zhaohui/L-8586-2015; Song, Huai-Dong/G-8961-2011	Song, Huai-Dong/0000-0002-9609-5803	China National High Tech Program for Biotechnology (863) [2006AA02A405]; Chinese National Key Basic Research Project (973) [2010CB529203]; National Natural Science Foundation of China [30772744, 30821063, 81000213]; Shanghai Municipal Commission for Science and Technology [07DZ05908, 08DZ2200100]	China National High Tech Program for Biotechnology (863)(National High Technology Research and Development Program of China); Chinese National Key Basic Research Project (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission for Science and Technology	This work was supported in part by the China National High Tech Program for Biotechnology (863:2006AA02A405), Chinese National Key Basic Research Project (973:2010CB529203), the National Natural Science Foundation of China (30772744, 30821063, 81000213) and the Shanghai Municipal Commission for Science and Technology (07DZ05908,08DZ2200100). We thank Jiangsu Institute of Hematology of the First Affiliated Hospital of Soochow University, Department of Hematology of the First Affiliated Hospital of Zhejiang University, Department of Hematology of the Tongji Hospital of Tongji University and Department of Hematology of Luwan division of Ruijin Hospital for providing AML-M5 samples. We are grateful to W.-L. Zhao, F. Yang, Y.-Y. Wang and X. Fan for assistance in clinical analysis of the AML-M5 samples, and to B. Chen and S.-M. Xiong for carrying out the hematological morphological analysis.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bennett JM, 1997, CANCER, V80, P2205; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Boissel N, 2005, BLOOD, V106, P3618, DOI 10.1182/blood-2005-05-2174; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Eklund EA, 2007, CURR OPIN HEMATOL, V14, P85, DOI 10.1097/MOH.0b013e32801684b6; El-Maarri O, 2009, HUM MOL GENET, V18, P1755, DOI 10.1093/hmg/ddp088; FENAUX P, 1990, BRIT J HAEMATOL, V75, P41, DOI 10.1111/j.1365-2141.1990.tb02614.x; Gilliland DG, 2002, CANCER CELL, V1, P417, DOI 10.1016/S1535-6108(02)00081-8; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jones PA, 2002, ONCOGENE, V21, P5358, DOI 10.1038/sj.onc.1205597; Koh Y, 2009, ANN HEMATOL, V88, P1089, DOI 10.1007/s00277-009-0733-7; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lucio-Eterovic AK, 2010, P NATL ACAD SCI USA, V107, P16952, DOI 10.1073/pnas.1002653107; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; OGara M, 1996, J MOL BIOL, V261, P634, DOI 10.1006/jmbi.1996.0489; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Panarello C, 2002, GENE CHROMOSOME CANC, V35, P277, DOI 10.1002/gcc.10119; PETERSON L, 1981, AM J CLIN PATHOL, V75, P140; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Porcu P, 2000, LEUKEMIA LYMPHOMA, V39, P1, DOI 10.3109/10428190009053534; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schoch C, 2003, BLOOD, V102, P2395, DOI 10.1182/blood-2003-02-0434; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tallman MS, 2004, J CLIN ONCOL, V22, P1276, DOI 10.1200/JCO.2004.08.060; Weng AP, 2003, CANCER CELL, V4, P417, DOI 10.1016/S1535-6108(03)00305-2; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xie SP, 1999, GENE, V236, P87, DOI 10.1016/S0378-1119(99)00252-8; Xie ZH, 2006, HUM MOL GENET, V15, P1375, DOI 10.1093/hmg/ddl059; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yamashita Y, 2010, ONCOGENE, V29, P3723, DOI 10.1038/onc.2010.117; Zhang SJ, 2008, P NATL ACAD SCI USA, V105, P2076, DOI 10.1073/pnas.0711824105	45	585	622	3	119	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2011	43	4					309	U51		10.1038/ng.788	http://dx.doi.org/10.1038/ng.788			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	741YL	21399634				2022-12-25	WOS:000288903700009
J	Boulting, GL; Kiskinis, E; Croft, GF; Amoroso, MW; Oakley, DH; Wainger, BJ; Williams, DJ; Kahler, DJ; Yamaki, M; Davidow, L; Rodolfa, CT; Dimos, JT; Mikkilineni, S; MacDermott, AB; Woolf, CJ; Henderson, CE; Wichterle, H; Eggan, K				Boulting, Gabriella L.; Kiskinis, Evangelos; Croft, Gist F.; Amoroso, Mackenzie W.; Oakley, Derek H.; Wainger, Brian J.; Williams, Damian J.; Kahler, David J.; Yamaki, Mariko; Davidow, Lance; Rodolfa, Christopher T.; Dimos, John T.; Mikkilineni, Shravani; MacDermott, Amy B.; Woolf, Clifford J.; Henderson, Christopher E.; Wichterle, Hynek; Eggan, Kevin			A functionally characterized test set of human induced pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							DIRECTED DIFFERENTIATION; NEURAL CONVERSION; HUMAN ES; TISSUE; LINES; ALS	Human induced pluripotent stem cells (iPSCs) present exciting opportunities for studying development and for in vitro disease modeling. However, reported variability in the behavior of iPSCs has called their utility into question. We established a test set of 16 iPSC lines from seven individuals of varying age, sex and health status, and extensively characterized the lines with respect to pluripotency and the ability to terminally differentiate. Under standardized procedures in two independent laboratories, 13 of the iPSC lines gave rise to functional motor neurons with a range of efficiencies similar to that of human embryonic stem cells (ESCs). Although three iPSC lines were resistant to neural differentiation, early neuralization rescued their performance. Therefore, all 16 iPSC lines passed a stringent test of differentiation capacity despite variations in karyotype and in the expression of early pluripotency markers and transgenes. This iPSC and ESC test set is a robust resource for those interested in the basic biology of stem cells and their applications.	[Boulting, Gabriella L.; Kiskinis, Evangelos; Yamaki, Mariko; Eggan, Kevin] Howard Hughes Med Inst, Cambridge, MA USA; [Boulting, Gabriella L.; Kiskinis, Evangelos; Yamaki, Mariko; Davidow, Lance; Mikkilineni, Shravani; Eggan, Kevin] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Boulting, Gabriella L.; Rodolfa, Christopher T.; Dimos, John T.; Mikkilineni, Shravani; Eggan, Kevin] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Oakley, Derek H.; Henderson, Christopher E.; Wichterle, Hynek] Columbia Univ, Jenifer Estess Lab Stem Cell Res, Project ALS, New York, NY USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Oakley, Derek H.; Henderson, Christopher E.; Wichterle, Hynek] Columbia Univ, Ctr Motor Neuron Biol & Dis MNC, Dept Pathol, New York, NY USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Oakley, Derek H.; Henderson, Christopher E.; Wichterle, Hynek] Columbia Univ, Ctr Motor Neuron Biol & Dis MNC, Dept Neurol & Neurosci, New York, NY USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Oakley, Derek H.; Henderson, Christopher E.; Wichterle, Hynek] Columbia Stem Cell Initiat CSCI, New York, NY USA; [Wainger, Brian J.; Woolf, Clifford J.] Childrens Hosp, Program Neurobiol, Boston, MA 02115 USA; [Wainger, Brian J.; Woolf, Clifford J.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Wainger, Brian J.; Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Wainger, Brian J.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Williams, Damian J.; MacDermott, Amy B.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA; [Williams, Damian J.; MacDermott, Amy B.] Columbia Univ, Dept Neurosci, New York, NY USA; [Kahler, David J.] New York Stem Cell Fdn Inc, New York, NY USA	Howard Hughes Medical Institute; Harvard University; Harvard University; Columbia University; Columbia University; Columbia University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Columbia University; Columbia University; The New York Stem Cell Foundation	Eggan, K (corresponding author), Howard Hughes Med Inst, Cambridge, MA USA.	hw350@columbia.edu; keggan@scrb.harvard.edu	Eggan, Kevin/P-7119-2018; Williams, Damian/K-4023-2014; Kahler, David J/I-9275-2019; Oakley, Derek/ABA-4689-2020; Woolf, Clifford/A-9784-2010; Wainger, Brian/L-7553-2017	Kahler, David J/0000-0002-7144-2215; Oakley, Derek/0000-0002-6998-9510; Wichterle, Hynek/0000-0002-7817-0080; Henderson, Christopher/0000-0002-9936-3279; Croft, Gist/0000-0002-9721-0148; Williams, Damian/0000-0001-5891-6300; Mathis, Mackenzie/0000-0001-7368-4456; Boulting, Gabriella/0000-0003-2012-1259	A.L.S.; P2ALS; NYSTEM; National Institutes of Health (NIH) [1RC2 NS069395-01, 5T32GM007592]; National Institute of Neurological Disorders and Stroke; National Institute of Child Health and Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038253] Funding Source: NIH RePORTER	A.L.S.; P2ALS; NYSTEM; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Mitsumoto, J. Montes, P. Kaufmann and J. Andrews for collecting skin biopsies; K. Koszka, A. Sproul, A. Hon and A. Garcia-Diaz for technical assistance; M. Park, A. Meissner and C. Bock for manuscript assistance, as well as S. Brenner-Morton and T. Jessell for providing Islet antibodies. This work was funded by Project A.L.S., P<SUP>2</SUP>ALS, NYSTEM and the National Institutes of Health (NIH) GO grant 1RC2 NS069395-01. G. L. B. is a Harvard Stem Cell Institute/NIH Trainee. E. K. is an EMBO Postdoctoral Fellow. B.J.W. is supported by NIH Training Grant 5T32GM007592. C.J.W. is supported by grants from the National Institute of Neurological Disorders and Stroke and the National Institute of Child Health and Development. K. E. is a Howard Hughes Medical Institute early career scientist.	Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Grigoriadis AE, 2010, BLOOD, V115, P2769, DOI 10.1182/blood-2009-07-234690; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; James D, 2006, DEV BIOL, V295, P90, DOI 10.1016/j.ydbio.2006.03.026; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Taura D, 2009, FEBS LETT, V583, P1029, DOI 10.1016/j.febslet.2009.02.031; Tokumoto Y, 2010, J BIOSCI BIOENG, V109, P622, DOI 10.1016/j.jbiosc.2009.11.013; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Xi JY, 2010, FASEB J, V24, P2739, DOI 10.1096/fj.09-145177; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504	24	349	371	0	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2011	29	3					279	U147		10.1038/nbt.1783	http://dx.doi.org/10.1038/nbt.1783			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	732RL	21293464	Green Accepted			2022-12-25	WOS:000288206700024
J	John, S; Sabo, PJ; Thurman, RE; Sung, MH; Biddie, SC; Johnson, TA; Hager, GL; Stamatoyannopoulos, JA				John, Sam; Sabo, Peter J.; Thurman, Robert E.; Sung, Myong-Hee; Biddie, Simon C.; Johnson, Thomas A.; Hager, Gordon L.; Stamatoyannopoulos, John A.			Chromatin accessibility pre-determines glucocorticoid receptor binding patterns	NATURE GENETICS			English	Article							IN-VIVO; HYPERSENSITIVE SITES; DNA; GENE; INTERPLAY; CELLS	Development, differentiation and response to environmental stimuli are characterized by sequential changes in cellular state initiated by the de novo binding of regulated transcriptional factors to their cognate genomic sites(1-3). The mechanism whereby a given regulatory factor selects a limited number of in vivo targets from a myriad of potential genomic binding sites is undetermined. Here we show that up to 95% of de novo genomic binding by the glucocorticoid receptor(4), a paradigmatic ligand-activated transcription factor, is targeted to preexisting foci of accessible chromatin. Factor binding invariably potentiates chromatin accessibility. Cell-selective glucocorticoid receptor occupancy patterns appear to be comprehensively predetermined by cell-specific differences in baseline chromatin accessibility patterns, with secondary contributions from local sequence features. The results define a framework for understanding regulatory factor-genome interactions and provide a molecular basis for the tissue selectivity of steroid pharmaceuticals and other agents that intersect the living genome.	[Sabo, Peter J.; Thurman, Robert E.; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [John, Sam; Sung, Myong-Hee; Biddie, Simon C.; Johnson, Thomas A.; Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle	Stamatoyannopoulos, JA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	hagerg@exchange.nih.gov; jstam@uw.edu		Mott, Richard/0000-0002-1022-9330; Biddie, Simon/0000-0002-8253-0253; Sung, Myong-Hee/0000-0002-9739-8558	US NIH, National Cancer Institute, Center for Cancer Research; US NIH [1RC2HG005654]; NATIONAL CANCER INSTITUTE [ZIABC005450] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005654] Funding Source: NIH RePORTER	US NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We would like to thank T. Miranda, S. Morris, K. Nalley and L. Grontved for critical reading of the manuscript. We also thank M. Weaver, K. Lee, F. Neri, D. Bates and M. Diegel for technical assistance with the DNase I library preparation and sequencing. This research was supported in part by the Intramural Research Program of the US NIH, National Cancer Institute, Center for Cancer Research and funding from US NIH grant 1RC2HG005654 to J.A.S.	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2000, BIOINFORMATICS, V16, P488, DOI 10.1093/bioinformatics/16.5.488; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; BECKER P, 1984, EMBO J, V3, P2015, DOI 10.1002/j.1460-2075.1984.tb02084.x; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; CORDINGLEY MG, 1988, NUCLEIC ACIDS RES, V16, P609, DOI 10.1093/nar/16.2.609; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; HAGER GL, 1993, COLD SPRING HARB SYM, V58, P63, DOI 10.1101/SQB.1993.058.01.010; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; RIGAUD G, 1991, CELL, V67, P977, DOI 10.1016/0092-8674(91)90370-E; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; Sekimata M, 2009, IMMUNITY, V31, P551, DOI 10.1016/j.immuni.2009.08.021; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; STALDER J, 1980, CELL, V20, P451, DOI 10.1016/0092-8674(80)90631-5; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; VONDERAHE D, 1985, NATURE, V313, P706, DOI 10.1038/313706a0; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0	30	661	677	2	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2011	43	3					264	U116		10.1038/ng.759	http://dx.doi.org/10.1038/ng.759			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	726BR	21258342	Green Accepted			2022-12-25	WOS:000287693800019
J	Crossan, GP; van der Weyden, L; Rosado, IV; Langevin, F; Gaillard, PHL; McIntyre, RE; Project, SMG; Gallagher, F; Kettunen, MI; Lewis, DY; Brindle, K; Arends, MJ; Adams, DJ; Patel, KJ				Crossan, Gerry P.; van der Weyden, Louise; Rosado, Ivan V.; Langevin, Frederic; Gaillard, Pierre-Henri L.; McIntyre, Rebecca E.; Project, Sanger Mouse Genetics; Gallagher, Ferdia; Kettunen, Mikko I.; Lewis, David Y.; Brindle, Kevin; Arends, Mark J.; Adams, David J.; Patel, Ketan J.			Disruption of mouse Slx4, a regulator of structure-specific nucleases, phenocopies Fanconi anemia	NATURE GENETICS			English	Article							STRUCTURE-SPECIFIC ENDONUCLEASE; HOLLIDAY JUNCTION RESOLVASE; REPAIR GENE ERCC1; DNA-REPAIR; DEFICIENT MICE; SPERMATOGENESIS; PROLIFERATION; ABNORMALITIES; SLX1-SLX4; PROTEIN	The evolutionarily conserved SLX4 protein, a key regulator of nucleases, is critical for DNA damage response. SLX4 nuclease complexes mediate repair during replication and can also resolve Holliday junctions formed during homologous recombination. Here we describe the phenotype of the Btbd12 knockout mouse, the mouse ortholog of SLX4, which recapitulates many key features of the human genetic illness Fanconi anemia. Btbd12-deficient animals are born at sub-Mendelian ratios, have greatly reduced fertility, are developmentally compromised and are prone to blood cytopenias. Btbd12(-/-) cells prematurely senesce, spontaneously accumulate damaged chromosomes and are particularly sensitive to DNA crosslinking agents. Genetic complementation reveals a crucial requirement for Btbd12 (also known as Slx4) to interact with the structure-specific endonuclease Xpf-Ercc1 to promote crosslink repair. The Btbd12 knockout mouse therefore establishes a disease model for Fanconi anemia and genetically links a regulator of nuclease incision complexes to the Fanconi anemia DNA crosslink repair pathway.	[Crossan, Gerry P.; Rosado, Ivan V.; Langevin, Frederic; Patel, Ketan J.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [van der Weyden, Louise; McIntyre, Rebecca E.; Project, Sanger Mouse Genetics; Adams, David J.] Wellcome Trust Sanger Inst, Cambridge, England; [Gaillard, Pierre-Henri L.] Convent Univ Aix Marseille 2, CNRS, Genome Instabil & Carcinogenesis UPR3081, Marseille, France; [Gallagher, Ferdia; Kettunen, Mikko I.; Lewis, David Y.; Brindle, Kevin] Li Ka Shing Ctr, Cambridge Res Inst, Canc Res UK, Cambridge, England; [Arends, Mark J.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England; [Patel, Ketan J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England	MRC Laboratory Molecular Biology; Wellcome Trust Sanger Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Patel, KJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	kjp@mrc-lmb.cam.ac.uk	Ismail, Ozama/AFQ-9517-2022; van der Weyden, Louise/AAV-5711-2021; gaillard, pierre-henri/AAC-6004-2020; Kettunen, Mikko I/K-2299-2012; Rosado, Ivan/AAZ-9068-2020; Lewis, David/AAN-9235-2021	van der Weyden, Louise/0000-0002-0645-1879; gaillard, pierre-henri/0000-0003-0781-0826; Kettunen, Mikko I/0000-0002-2004-660X; Rosado, Ivan/0000-0001-7409-7341; Crossan, Gerry/0000-0002-7974-009X; Adams, David/0000-0001-9490-0306; Lewis, David/0000-0001-9329-1326; Ismail, Ozama/0000-0002-0871-3924; Gallagher, Ferdia Aidan/0000-0003-4784-5230	Cancer Research-UK; Wellcome Trust; ATIP-Centre National de la Recherche Scientifique; Association pour la Recherche sur le Cancer; Fondation pour la Recherche Medicale; MRC [MC_U105178811] Funding Source: UKRI; Cancer Research UK [12401] Funding Source: researchfish; Medical Research Council [MC_U105178811] Funding Source: researchfish	Cancer Research-UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); ATIP-Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We wish to thank L. Neidernhofer for the kind gift of Ercc1-deficient and wild-type congenic MEFs. Fanca- and Fancc-deficient MEFs were obtained from the Fanconi Anaemia Research Fund Cell Repository, Eugene, Oregon, USA. We thank A. Shortland for substantial contributions in the planning of animal experiments. The authors would like to thank M. Taylor for cloning of the mouse Slx4 cDNA. We would also like to thank T. Langford, J. Cruickshank, A. Mead, M. Brown, J. Wiles, K. Robinson, C. Shepherd, M. Reed, V. Smith and R. Berks for assistance in animal husbandry and handling. We would also like to thank G. Nemeth (Mediso Ltd.) for assistance with the computed tomography methodology. D. J. A. was supported by Cancer Research-UK and the Wellcome Trust. P. H. L. G. is supported by ATIP-Centre National de la Recherche Scientifique, Association pour la Recherche sur le Cancer and Fondation pour la Recherche Medicale grants.	Adams DJ, 2005, MOL CELL BIOL, V25, P779, DOI 10.1128/MCB.25.2.779-788.2005; Agoulnik AI, 2002, HUM MOL GENET, V11, P3047, DOI 10.1093/hmg/11.24.3047; Cheng NC, 2000, HUM MOL GENET, V9, P1805, DOI 10.1093/hmg/9.12.1805; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Coulon S, 2004, MOL BIOL CELL, V15, P71, DOI 10.1091/mbc.E03-08-0586; de Waard MC, 2010, ACTA NEUROPATHOL, V120, P461, DOI 10.1007/s00401-010-0715-9; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Flott S, 2007, MOL CELL BIOL, V27, P6433, DOI 10.1128/MCB.00135-07; Fricke WM, 2003, GENE DEV, V17, P1768, DOI 10.1101/gad.1105203; Gillio AP, 1997, BLOOD, V90, P105; Hancock JM, 2007, MAMM GENOME, V18, P157, DOI 10.1007/s00335-007-9004-x; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Hsia KT, 2003, DEVELOPMENT, V130, P369, DOI 10.1242/dev.00221; Lawrence NJ, 2008, DNA REPAIR, V7, P281, DOI 10.1016/j.dnarep.2007.10.005; Lu B, 2003, BIOL REPROD, V69, P161, DOI 10.1095/biolreprod.102.014654; Masuya H, 2005, MAMM GENOME, V16, P829, DOI 10.1007/s00335-005-2430-8; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Pace P, 2002, EMBO J, V21, P3414, DOI 10.1093/emboj/cdf355; Patel KJ, 2007, DNA REPAIR, V6, P885, DOI 10.1016/j.dnarep.2007.02.002; Selfridge J, 2001, NUCLEIC ACIDS RES, V29, P4541, DOI 10.1093/nar/29.22.4541; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Svendsen JM, 2010, GENE DEV, V24, P521, DOI 10.1101/gad.1903510; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; Zhang XY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000645	28	157	160	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2011	43	2					147	U99		10.1038/ng.752	http://dx.doi.org/10.1038/ng.752			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	711XD	21240276	Green Accepted			2022-12-25	WOS:000286623800014
J	Ponomarev, ED; Veremeyko, T; Barteneva, N; Krichevsky, AM; Weiner, HL				Ponomarev, Eugene D.; Veremeyko, Tatyana; Barteneva, Natasha; Krichevsky, Anna M.; Weiner, Howard L.			MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway	NATURE MEDICINE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MONOCYTE LINEAGE COMMITMENT; NECROSIS-FACTOR RECEPTOR; C/EBP-ALPHA; NEURONAL DIFFERENTIATION; CELLS; PU.1; CNS; PROLIFERATION; EXPRESSION	MicroRNAs are a family of regulatory molecules involved in many physiological processes, including differentiation and activation of cells of the immune system. We found that brain-specific miR-124 is expressed in microglia but not in peripheral monocytes or macrophages. When overexpressed in macrophages, miR-124 directly inhibited the transcription factor CCAAT/enhancer-binding protein-alpha (C/EBP-alpha) and its downstream target PU.1, resulting in transformation of these cells from an activated phenotype into a quiescent CD45(low), major histocompatibility complex (MHC) class IIlow phenotype resembling resting microglia. During experimental autoimmune encephalomyelitis (EAE), miR-124 was downregulated in activated microglia. Peripheral administration of miR-124 in EAE caused systemic deactivation of macrophages, reduced activation of myelin-specific T cells and marked suppression of disease. Conversely, knockdown of miR-124 in microglia and macrophages resulted in activation of these cells in vitro and in vivo. These findings identify miR-124 both as a key regulator of microglia quiescence in the central nervous system and as a previously unknown modulator of monocyte and macrophage activation.	[Ponomarev, Eugene D.; Veremeyko, Tatyana; Krichevsky, Anna M.; Weiner, Howard L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Barteneva, Natasha] Harvard Univ, Immune Dis Inst, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Krichevsky, AM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	akrichevsky@rics.bwh.harvard.edu; hweiner@rics.bwh.harvard.edu	Barteneva, Natasha/B-9094-2017; Barteneva, Natalie/V-3826-2019; Ponomarev, Eugene D./K-1546-2013	Barteneva, Natalie/0000-0002-8109-1754; Ponomarev, Eugene D./0000-0002-0871-8522; Krichevsky, Anna/0000-0002-5080-5507	US National Institutes of Health [R01 NS071039-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071039] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank V. Kuchroo and F.J. Quintana for critical discussion of the results and I. Sotnikov for technical assistance with immunohistochemistry. 2D2 mice were kindly provided by V. Kuchroo (Brigham and Women's Hospital, Harvard Medical School). This work was supported in part by US National Institutes of Health grant R01 NS071039-01A1.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anderson KL, 2001, J BIOL CHEM, V276, P7637, DOI 10.1074/jbc.M009133200; Basson M, 2007, NAT MED, V13, P541, DOI 10.1038/nm0507-541; Bi YJ, 2009, J CELL PHYSIOL, V218, P467, DOI 10.1002/jcp.21639; Bristol JA, 2009, MOL IMMUNOL, V46, P2706, DOI 10.1016/j.molimm.2009.05.024; Cai DH, 2008, ONCOGENE, V27, P2772, DOI 10.1038/sj.onc.1210940; Cardinaux JR, 2000, GLIA, V29, P91, DOI 10.1002/(SICI)1098-1136(20000101)29:1<91::AID-GLIA9>3.0.CO;2-I; Celada A, 1996, J EXP MED, V184, P61, DOI 10.1084/jem.184.1.61; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; GORDON EJ, 1995, J NEUROIMMUNOL, V62, P153, DOI 10.1016/0165-5728(95)00120-2; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mishima T, 2007, BRAIN RES, V1131, P37, DOI 10.1016/j.brainres.2006.11.035; Nakamachi Y, 2009, ARTHRITIS RHEUM-US, V60, P1294, DOI 10.1002/art.24475; Nishiyama C, 2004, FEBS LETT, V561, P63, DOI 10.1016/S0014-5793(04)00116-4; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Soulet D, 2008, CURR OPIN PHARMACOL, V8, P508, DOI 10.1016/j.coph.2008.04.002; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tran EH, 1998, J IMMUNOL, V161, P3767; TREFZER U, 1993, J CLIN INVEST, V92, P462, DOI 10.1172/JCI116589; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Walton M, 1998, MOL BRAIN RES, V61, P11, DOI 10.1016/S0169-328X(98)00169-7; Weiner HL, 2008, J NEUROL, V255, P3, DOI 10.1007/s00415-008-1002-8; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Yeamans C, 2007, BLOOD, V110, P3136, DOI 10.1182/blood-2007-03-080291; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	45	587	615	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2011	17	1					64	U234		10.1038/nm.2266	http://dx.doi.org/10.1038/nm.2266			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	703QH	21131957	Green Accepted			2022-12-25	WOS:000285994000037
J	Morelli, G; Song, YJ; Mazzoni, CJ; Eppinger, M; Roumagnac, P; Wagner, DM; Feldkamp, M; Kusecek, B; Vogler, AJ; Li, YJ; Cui, YJ; Thomson, NR; Jombart, T; Leblois, R; Lichtner, P; Rahalison, L; Petersen, JM; Balloux, F; Keim, P; Wirth, T; Ravel, J; Yang, RF; Carniel, E; Achtman, M				Morelli, Giovanna; Song, Yajun; Mazzoni, Camila J.; Eppinger, Mark; Roumagnac, Philippe; Wagner, David M.; Feldkamp, Mirjam; Kusecek, Barica; Vogler, Amy J.; Li, Yanjun; Cui, Yujun; Thomson, Nicholas R.; Jombart, Thibaut; Leblois, Raphael; Lichtner, Peter; Rahalison, Lila; Petersen, Jeannine M.; Balloux, Francois; Keim, Paul; Wirth, Thierry; Ravel, Jacques; Yang, Ruifu; Carniel, Elisabeth; Achtman, Mark			Yersinia pestis genome sequencing identifies patterns of global phylogenetic diversity	NATURE GENETICS			English	Article							EVOLUTION; INSIGHTS; STRAIN; PHYLOGEOGRAPHY; DYNAMICS; SPREAD; PLAGUE	Plague is a pandemic human invasive disease caused by the bacterial agent Yersinia pestis. We here report a comparison of 17 whole genomes of Y. pestis isolates from global sources. We also screened a global collection of 286 Y. pestis isolates for 933 SNPs using Sequenom MassArray SNP typing. We conducted phylogenetic analyses on this sequence variation dataset, assigned isolates to populations based on maximum parsimony and, from these results, made inferences regarding historical transmission routes. Our phylogenetic analysis suggests that Y. pestis evolved in or near China and spread through multiple radiations to Europe, South America, Africa and Southeast Asia, leading to country- specific lineages that can be traced by lineage-specific SNPs. All 626 current isolates from the United States reflect one radiation, and 82 isolates from Madagascar represent a second radiation. Subsequent local microevolution of Y. pestis is marked by sequential, geographically specific SNPs.	[Song, Yajun; Li, Yanjun; Cui, Yujun; Yang, Ruifu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Morelli, Giovanna; Mazzoni, Camila J.; Roumagnac, Philippe; Feldkamp, Mirjam; Kusecek, Barica; Achtman, Mark] Max Planck Inst Infekt Biol, Dept Mol Biol, Berlin, Germany; [Song, Yajun; Mazzoni, Camila J.; Achtman, Mark] Univ Coll Cork, Environm Res Inst, Cork, Ireland; [Eppinger, Mark; Ravel, Jacques] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Roumagnac, Philippe] Ctr Cooprat Int Rech Agron Dev, Mixte Res Unit Biol & Genet Plant Pathogen Intera, Montpellier, France; [Wagner, David M.; Vogler, Amy J.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Thomson, Nicholas R.] Wellcome Trust Sanger Inst, Cambridge, England; [Jombart, Thibaut; Balloux, Francois] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC, Ctr Outbreak Anal & Modeling, London, England; [Leblois, Raphael; Wirth, Thierry] Museum Natl Hist Nat, CNRS, Ecole Prat Hautes Etud, Dept Systemat & Evolut,UMR 7205, Paris, France; [Lichtner, Peter] German Res Ctr Environm Hlth, Inst Human Genet, Neuherberg, Germany; [Rahalison, Lila] Inst Pasteur Madagascar, Unite Peste, Antananarivo, Madagascar; [Petersen, Jeannine M.] Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO USA; [Keim, Paul] Translat Genom Res Inst, Pathogen Genom Div, Phoenix, AZ USA; [Carniel, Elisabeth] Inst Pasteur, Yersinia Res Unit, Paris, France; [Achtman, Mark] Univ Coll Cork, Dept Microbiol, Cork, Ireland	Beijing Institute of Microbiology & Epidemiology; Max Planck Society; University College Cork; University System of Maryland; University of Maryland Baltimore; CIRAD; Northern Arizona University; Wellcome Trust Sanger Institute; Imperial College London; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Centers for Disease Control & Prevention - USA; Translational Genomics Research Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University College Cork	Yang, RF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	ruifuyang@gmail.com; elisabeth.carniel@pasteur.fr; m.achtman@ucc.ie	Song, Yajun/GQQ-0476-2022; Balloux, Francois/D-4783-2009; Leblois, Raphael/A-8815-2008; Mazzoni, Camila J/L-3441-2014; Ravel, Jacques/D-2530-2009; Mazzoni, Camila/AAJ-9702-2020; Wagner, David M/A-5125-2010; Keim, Paul S/A-2269-2010; Yang, Ruifu/A-2273-2011; Wirth, Thierry/B-4915-2008; Cui, Yujun/E-7015-2012; Pacific-Southwest, RCE/B-6155-2009; Balloux, Francois/X-7856-2019; Song, Yajun/F-3714-2011; Thomson, Nicholas/P-5988-2014	Song, Yajun/0000-0002-6628-2747; Balloux, Francois/0000-0003-1978-7715; Leblois, Raphael/0000-0002-3051-4497; Mazzoni, Camila/0000-0001-6758-5427; Yang, Ruifu/0000-0003-3219-7269; Wirth, Thierry/0000-0002-7371-0172; Balloux, Francois/0000-0003-1978-7715; Song, Yajun/0000-0002-6628-2747; Roumagnac, Philippe/0000-0001-5002-6039; Ravel, Jacques/0000-0002-0851-2233; Wagner, David/0000-0003-2684-6007; Thomson, Nicholas/0000-0002-4432-8505; Achtman, Mark/0000-0001-6815-0070	NIAID NIH HHS [N01 AI030071, U54 AI065359, AI065359] Funding Source: Medline; Science Foundation Ireland [05/FE1/B882] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Medical Research Council [G0600719B] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Adjemian JZ, 2007, AM J TROP MED HYG, V76, P365, DOI 10.4269/ajtmh.2007.76.365; Anisimov AP, 2004, CLIN MICROBIOL REV, V17, P434, DOI 10.1128/CMR.17.2.434-464.2004; Auerbach RK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000770; Brygoo ER, 1966, ARCH I PASTEUR MADAG, V35, P7; Chain PSG, 2006, J BACTERIOL, V188, P4453, DOI 10.1128/JB.00124-06; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; DELRIO A, 1904, CHILENA HIJIENE, V9, P1; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; DEVIGNAT R, 1951, Bull World Health Organ, V4, P247; DIAMOND J, 1997, GUNS GERMS STEEL FAT, P1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eppinger M, 2007, PLOS GENET, V3, P1508, DOI 10.1371/journal.pgen.0030142; Eppinger M, 2010, J BACTERIOL, V192, P1685, DOI 10.1128/JB.01518-09; Eppinger M, 2009, J BACTERIOL, V191, P7628, DOI 10.1128/JB.01227-09; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; Garcia E, 2007, ADV EXP MED BIOL, V603, P17; GIRARD G., 1963, BIOL MED [PARIS], V52, P631; Guiyoule A, 1997, J CLIN MICROBIOL, V35, P2826, DOI 10.1128/JCM.35.11.2826-2833.1997; Haensch S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001134; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Huson D H, 2001, Bioinformatics, V17 Suppl 1, pS132; Keeling MJ, 2000, NATURE, V407, P903, DOI 10.1038/35038073; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LAUZERAL P., 1932, Bulletin de la Societe de Pathologie Exotique, V25, P935; Levathes L., 1996, CHINA RULED SEAS TRE, P1; Li YQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006701; LINK V B, 1955, Public Health Monogr, V26, P1; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; NOCHT B, 1903, ARBEITEN KAISERLICHE, V20, P6; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Pearson T, 2009, INFECT GENET EVOL, V9, P1010, DOI 10.1016/j.meegid.2009.05.014; POLLITZER R, 1951, Bull World Health Organ, V4, P475; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; *SILKR FDN, 2009, BRIDG E W CULT; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Touchman JW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000220; Vogler AJ, 2008, BIOTECHNIQUES, V44, P201, DOI 10.2144/000112815; Vogler AJ, 2009, J BACTERIOL, V191, P2474, DOI 10.1128/JB.01786-08; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Wu L, 1936, PLAGUE MANUAL MED PU, P1; Yu Hwa-Lung, 2006, Int J Health Geogr, V5, P12, DOI 10.1186/1476-072X-5-12; Zhou DS, 2004, J BACTERIOL, V186, P5138, DOI [10.1128/JB.186.15.5138-5146.2004, 10.1128/jb.186.15.5138-5146.2004]	47	370	409	4	120	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2010	42	12					1140	+		10.1038/ng.705	http://dx.doi.org/10.1038/ng.705			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	684UZ	21037571	Green Accepted, Green Submitted, Bronze			2022-12-25	WOS:000284578800020
J	Choi, HMT; Chang, JY; Trinh, LA; Padilla, JE; Fraser, SE; Pierce, NA				Choi, Harry M. T.; Chang, Joann Y.; Trinh, Le A.; Padilla, Jennifer E.; Fraser, Scott E.; Pierce, Niles A.			Programmable in situ amplification for multiplexed imaging of mRNA expression	NATURE BIOTECHNOLOGY			English	Article							WHOLE-MOUNT; INSITU HYBRIDIZATION; DROSOPHILA EMBRYOS; GENE-EXPRESSION; DNA; MOLECULES; TRANSCRIPTS; DESIGN; PROBES	In situ hybridization methods enable the mapping of mRNA expression within intact biological samples(1,2). With current approaches, it is challenging to simultaneously map multiple target mRNAs within whole-mount vertebrate embryos(3-6), representing a significant limitation in attempting to study interacting regulatory elements in systems most relevant to human development and disease. Here, we report a multiplexed fluorescent in situ hybridization method based on orthogonal amplification with hybridization chain reactions (HCR)(7). With this approach, RNA probes complementary to mRNA targets trigger chain reactions in which fluorophore-labeled RNA hairpins self-assemble into tethered fluorescent amplification polymers. The programmability and sequence specificity of these amplification cascades enable multiple HCR amplifiers to operate orthogonally at the same time in the same sample. Robust performance is achieved when imaging five target mRNAs simultaneously in fixed whole-mount and sectioned zebrafish embryos. HCR amplifiers exhibit deep sample penetration, high signal-to-background ratios and sharp signal localization.	[Choi, Harry M. T.; Chang, Joann Y.; Padilla, Jennifer E.; Fraser, Scott E.; Pierce, Niles A.] CALTECH, Dept Bioengn, Pasadena, CA USA; [Trinh, Le A.; Fraser, Scott E.] CALTECH, Dept Biol, Pasadena, CA USA; [Pierce, Niles A.] CALTECH, Dept Appl & Computat Math, Pasadena, CA USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Pierce, NA (corresponding author), CALTECH, Dept Bioengn, Pasadena, CA USA.	niles@caltech.edu	Pierce, Niles A/F-6535-2010; Fraser, Scott/Y-3406-2019	Fraser, Scott/0000-0002-5377-0223; Choi, Harry/0000-0002-1530-0773	US National Institutes of Health [R01 EB006192, P50 HG004071]; National Science Foundation [CCF-0448835, CCF-0832824]; Beckman Institute at Caltech; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006192] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Beckman Institute at Caltech; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank V. A. Beck, J.S. Bois, S. Venkataraman, J.R. Vieregg and P. Yin for discussions. We thank C. Johnson and A.J. Ewald for performing preliminary studies. We thank J.N. Zadeh for the use of unpublished software. We thank the Caltech Biological Imaging Center and A. Collazo of the House Ear Institute for the use of multispectral confocal microscopes. This work was funded by the US National Institutes of Health (R01 EB006192 and P50 HG004071), the National Science Foundation (CCF-0448835 and CCF-0832824) and the Beckman Institute at Caltech.	Acloque H, 2008, METHOD CELL BIOL, V87, P169, DOI 10.1016/S0091-679X(08)00209-4; Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; Barroso-Chinea P, 2007, J NEUROSCI METH, V162, P119, DOI 10.1016/j.jneumeth.2006.12.017; Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104; CHOI HMT, 2009, THESIS CALIFORNIA I; Denkers N, 2004, DEV DYNAM, V229, P651, DOI 10.1002/dvdy.20005; Dirks RM, 2004, P NATL ACAD SCI USA, V101, P15275, DOI 10.1073/pnas.0407024101; Dirks RM, 2004, NUCLEIC ACIDS RES, V32, P1392, DOI 10.1093/nar/gkh291; Dirks RM, 2007, SIAM REV, V49, P65, DOI 10.1137/060651100; Feldkamp U, 2006, ANGEW CHEM INT EDIT, V45, P1856, DOI 10.1002/anie.200502358; Feldkamp U, 2008, ANGEW CHEM INT EDIT, V47, P3871, DOI 10.1002/anie.200800675; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; GALL JG, 1969, P NATL ACAD SCI USA, V63, P378, DOI 10.1073/pnas.63.2.378; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; KISLAUSKIS EH, 1993, J CELL BIOL, V123, P165, DOI 10.1083/jcb.123.1.165; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Lambros MBK, 2007, HUM PATHOL, V38, P1105, DOI 10.1016/j.humpath.2007.04.011; Larsson C, 2010, NAT METHODS, V7, P395, DOI [10.1038/NMETH.1448, 10.1038/nmeth.1448]; LAWRENCE JB, 1989, CELL, V57, P493, DOI 10.1016/0092-8674(89)90924-0; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; ONEILL JW, 1994, BIOTECHNIQUES, V17, P870; Player AN, 2001, J HISTOCHEM CYTOCHEM, V49, P603, DOI 10.1177/002215540104900507; Qian X, 2004, J HISTOTECHNOL, V27, P53, DOI 10.1179/his.2004.27.1.53; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Silverman AP, 2007, ADV CLIN CHEM, V43, P79, DOI 10.1016/S0065-2423(06)43003-1; Simmel FC, 2005, SMALL, V1, P284, DOI 10.1002/smll.200400111; Speel EJM, 1999, J HISTOCHEM CYTOCHEM, V47, P281, DOI 10.1177/002215549904700302; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Venkataraman S, 2007, NAT NANOTECHNOL, V2, P490, DOI 10.1038/nnano.2007.225; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; ZADEH JN, 2010, J COMPU CHEM, DOI DOI 10.1002/JCC.2163; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zaidi AU, 2000, J HISTOCHEM CYTOCHEM, V48, P1369, DOI 10.1177/002215540004801007	34	424	469	9	332	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2010	28	11					1208	U103		10.1038/nbt.1692	http://dx.doi.org/10.1038/nbt.1692			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	676PI	21037591	Green Accepted			2022-12-25	WOS:000283924100024
J	DePianto, D; Kerns, ML; Dlugosz, AA; Coulombe, PA				DePianto, Daryle; Kerns, Michelle L.; Dlugosz, Andrzej A.; Coulombe, Pierre A.			Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin	NATURE GENETICS			English	Article							BASAL-CELL CARCINOMAS; CUTANEOUS INFLAMMATION; GENE-EXPRESSION; HAIR FOLLICLE; CARCINOGENESIS; HEDGEHOG; TRANSCRIPTION; PROTEINS; DISTINCT; BARRIER	Basaloid skin tumors, including basal cell carcinoma (BCC) and basaloid follicular hamartoma, are associated with aberrant Hedgehog (Hh) signaling(1) and, in the case of BCC, an expanding set of genetic variants including keratin 5 (encoded by KRT5)(2), an intermediate filament-forming protein. We here show that genetic ablation of keratin 17 (Krt17) protein, which is induced in basaloid skin tumors(3,4) and co-polymerizes with Krt5 in vivo(5), delays basaloid follicular hamartoma tumor initiation and growth in mice with constitutive Hh signaling in epidermis(6,7). This delay is preceded by a reduced inflammation and a polarization of inflammatory cytokines from a Th1-and Th17-dominated profile to a Th2-dominated profile. Absence of Krt17 also attenuates hyperplasia and inflammation in models of acute dermatitis. Re-expression of Krt17 in Gli2(tg); Krt17(-/-) keratinocytes induces select Th1 chemokines that have established roles in BCC. Our findings establish an immunomodulatory	[DePianto, Daryle; Kerns, Michelle L.; Coulombe, Pierre A.] Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Dlugosz, Andrzej A.] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI USA; [Dlugosz, Andrzej A.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA; [Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins University	Coulombe, PA (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	coulombe@jhsph.edu			US National Institutes of Health [CA123530, AR44232, F32 CA110618, CA087837]; NATIONAL CANCER INSTITUTE [R01CA087837, F32CA110618, P30CA046592, R01CA160255, R21CA123530, T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045973, R01AR044232] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank M. Han for technical support and J. Seykora for expertise. These studies were supported in part by grants CA123530 and AR44232 to P. A. C., fellowship grant F32 CA110618 to D. D. and grant CA087837 to A. A. D., all from the US National Institutes of Health.	Berger A, 2000, BRIT MED J, V321, P424, DOI 10.1136/bmj.321.7258.424; Bernot KM, 2004, METHOD CELL BIOL, V78, P453; Bernot KM, 2002, J INVEST DERMATOL, V119, P1137, DOI 10.1046/j.1523-1747.2002.19518.x; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Braff MH, 2005, J INVEST DERMATOL, V125, P9, DOI 10.1111/j.0022-202X.2004.23587.x; Bunting K, 2007, J IMMUNOL, V178, P7097, DOI 10.4049/jimmunol.178.11.7097; Callahan CA, 2004, GENE DEV, V18, P2724, DOI 10.1101/gad.1221804; Cataisson C, 2009, CANCER RES, V69, P319, DOI 10.1158/0008-5472.CAN-08-2490; Demehri S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000067; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Elias PM, 2009, CURR OPIN ALLERGY CL, V9, P437, DOI 10.1097/ACI.0b013e32832e7d36; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Grachtchouk V, 2003, EMBO J, V22, P2741, DOI 10.1093/emboj/cdg271; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Hattori Y, 2003, EXP MOL PATHOL, V74, P230, DOI 10.1016/S0014-4800(03)00014-5; Jee SH, 2004, J INVEST DERMATOL, V123, P1169, DOI 10.1111/j.0022-202X.2004.23497.x; Jih DM, 2003, AM J DERMATOPATH, V25, P130, DOI 10.1097/00000372-200304000-00006; Kerns ML, 2007, P NATL ACAD SCI USA, V104, P14460, DOI 10.1073/pnas.0706486104; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Larouche D, 2008, FASEB J, V22, P1404, DOI 10.1096/fj.07-8109com; Lo BKK, 2010, AM J PATHOL, V176, P2435, DOI 10.2353/ajpath.2010.081059; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; MARKEY AC, 1992, BRIT J DERMATOL, V126, P154, DOI 10.1111/j.1365-2133.1992.tb07813.x; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; McGowan KM, 2002, GENE DEV, V16, P1412, DOI 10.1101/gad.979502; Miyazaki H, 2006, CANCER RES, V66, P4279, DOI 10.1158/0008-5472.CAN-05-4398; Nickoloff BJ, 2007, NAT MED, V13, P242, DOI 10.1038/nm0307-242; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Paus R, 2003, J INVEST DERM SYMP P, V8, P188, DOI 10.1046/j.1087-0024.2003.00807.x; PHILLIPS WG, 1995, CLIN EXP IMMUNOL, V101, P177; Sarbia M, 2007, AM J CLIN PATHOL, V128, P255, DOI 10.1309/EEML5CH79PWD0R2D; Smith JB, 2002, IMMUNOGENETICS, V54, P599, DOI 10.1007/s00251-002-0501-5; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Tensen CP, 1999, BBA-GENE STRUCT EXPR, V1446, P167, DOI 10.1016/S0167-4781(99)00084-6; Tong XM, 2006, GENE DEV, V20, P1353, DOI 10.1101/gad.1387406; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; Ying S, 1999, J IMMUNOL, V163, P3976; Yu M, 2008, J INVEST DERMATOL, V128, P1797, DOI 10.1038/sj.jid.5701243; YUSPA SH, 1994, CANCER RES, V54, P1178	41	160	164	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2010	42	10					910	+		10.1038/ng.665	http://dx.doi.org/10.1038/ng.665			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	655UO	20871598	Green Accepted			2022-12-25	WOS:000282276600025
